PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Joshi, A; Garg, H; Ablan, SD; Freed, EO				Joshi, Anjali; Garg, Himanshu; Ablan, Sherimay D.; Freed, Eric O.			Evidence of a Role for Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE) Machinery in HIV-1 Assembly and Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIOUS-ANEMIA VIRUS; GAG-MEMBRANE-BINDING; PLASMA-MEMBRANE; INTRACELLULAR TRAFFICKING; CELL-SURFACE; PARTICLE-PRODUCTION; PRIMARY MACROPHAGES; FUSION PROTEIN; MATRIX DOMAIN	Retrovirus assembly is a complex process that requires the orchestrated participation of viral components and host-cell factors. The concerted movement of different viral proteins to specific sites in the plasma membrane allows for virus particle assembly and ultimately budding and maturation of infectious virions. The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins constitute the minimal machinery that catalyzes the fusion of intracellular vesicles with the plasma membrane, thus regulating protein trafficking. Using siRNA and dominant negative approaches we demonstrate here that generalized disruption of the host SNARE machinery results in a significant reduction in human immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus particle production. Further analysis of the mechanism involved revealed a defect at the level of HIV-1 Gag localization to the plasma membrane. Our findings demonstrate for the first time a role of SNARE proteins in HIV-1 assembly and release, likely by affecting cellular trafficking pathways required for Gag transport and association with the plasma membrane.	[Joshi, Anjali; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis, El Paso, TX 79905 USA; [Joshi, Anjali; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Pediat, El Paso, TX 79905 USA; [Ablan, Sherimay D.; Freed, Eric O.] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Joshi, A (corresponding author), 5001 El Paso Dr,MSB-1, El Paso, TX 79905 USA.	anjali.joshi@ttuhsc.edu			Center for Cancer Research, NCI, National Institutes of Health; Intramural AIDS Targeted Antiviral Program; NATIONAL CANCER INSTITUTE [ZIABC010775] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health. This work was also supported by the Intramural AIDS Targeted Antiviral Program.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chang YF, 2007, J MOL BIOL, V370, P585, DOI 10.1016/j.jmb.2007.05.020; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Dubinsky WP, 1999, P NATL ACAD SCI USA, V96, P9421, DOI 10.1073/pnas.96.16.9421; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; Ehrlich LS, 2010, J VIROL, V84, P6438, DOI 10.1128/JVI.01588-09; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GELDERBLOM HR, 1991, AIDS, V5, P617, DOI 10.1097/00002030-199106000-00001; GOFF SP, 2001, RETROVIRUSES THEIR R; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Harrist AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005020; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; JOSHI A, 2007, FUTURE HIV THER, V1, P427; Joshi A, 2008, MOL CELL, V30, P227, DOI 10.1016/j.molcel.2008.03.015; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Joshi A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-72; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martin-Serrano J, 2003, J VIROL, V77, P12373, DOI 10.1128/JVI.77.22.12373-12377.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Mcnew JA, 2008, CHEM REV, V108, P1669, DOI 10.1021/cr0782325; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Molle D, 2009, J BIOL CHEM, V284, P19727, DOI 10.1074/jbc.M109.019844; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Okayama M, 2007, FEBS LETT, V581, P4583, DOI 10.1016/j.febslet.2007.08.046; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Ono A, 2007, VIROLOGY, V360, P27, DOI 10.1016/j.virol.2006.10.011; Patnaik A, 2002, J VIROL, V76, P2641, DOI 10.1128/JVI.76.6.2641-2647.2002; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Ryzhova EV, 2006, J VIROL, V80, P2694, DOI 10.1128/JVI.80.6.2694-2704.2006; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Shehu-Xhilaga M, 2004, J VIROL, V78, P724, DOI 10.1128/JVI.78.2.724-732.2004; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; SUMIDA M, 1994, J BIOL CHEM, V269, P20636; Swanstrom R., 1997, P263; Tang Y, 1999, J VIROL, V73, P10508, DOI 10.1128/JVI.73.12.10508-10513.1999; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vogt V. M., 1997, P27; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032; Zimmerman C, 2002, NATURE, V415, P88, DOI 10.1038/415088a	86	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29861	29871		10.1074/jbc.M111.241521	http://dx.doi.org/10.1074/jbc.M111.241521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21680744	Green Published, hybrid			2022-12-27	WOS:000294046600045
J	Childers, BM; Cao, XH; Weber, GG; Demeler, B; Hart, PJ; Klose, KE				Childers, Brandon M.; Cao, Xiaohang; Weber, Gregor G.; Demeler, Borries; Hart, P. John; Klose, Karl E.			N-terminal Residues of the Vibrio cholerae Virulence Regulatory Protein ToxT Involved in Dimerization and Modulation by Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; MOLECULAR-WEIGHT; IDENTIFICATION; COLONIZATION; MECHANISMS; INHIBITOR; MOTILITY; VECTORS; CASCADE	The regulatory protein ToxT is an AraC family protein that is responsible for activating transcription of the genes encoding cholera toxin and toxin coregulated pilus, which are required for virulence by the human pathogen Vibrio cholerae. The N terminus of ToxT contains dimerization and regulatory elements, whereas the C terminus contains the DNA binding domain. Bile and long chain fatty acids negatively regulate ToxT activity. Utilizing a comprehensive alanine substitution mutant library of ToxT, 19 N-terminal residues were found to be critical for dimerization and transcriptional activation. One of these mutant proteins (F151A) was confirmed to be monomeric via centrifugation and exhibited a weakened ability to bind to the tcpA promoter in a gel mobility shift assay. Moreover, a V. cholerae toxTF151A mutant failed to colonize the infant mouse intestine, emphasizing the importance of ToxT N-terminal dimerization to cholera pathogenesis. Six N-terminal alanine substitutions allowed ToxT transcriptional activity in the presence of inhibitory concentrations of bile, palmitoleic acid, and the small molecule inhibitor virstatin. Two of these mutations (N106A and L114A) enhance N-terminal dimerization in a bacterial two-hybrid system reconstituted in V. cholerae, which is otherwise disrupted by bile, palmitoleic acid, and virstatin. We demonstrate that V. cholerae toxTN106A and toxTL114A strains colonize the infant mouse intestine at significantly higher levels than the wild type strain. Our results demonstrate that ToxT N-terminal dimerization is required for transcriptional activation and cholera pathogenesis and that fatty acids modulate ToxT activity via modulation of dimerization.	[Childers, Brandon M.; Weber, Gregor G.; Klose, Karl E.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Childers, Brandon M.; Weber, Gregor G.; Klose, Karl E.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Cao, Xiaohang; Demeler, Borries; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio	Klose, KE (corresponding author), Univ Texas San Antonio, Dept Biol, 1 UTSA Circle, San Antonio, TX 78249 USA.	Karl.Klose@utsa.edu		Demeler, Borries/0000-0002-2414-9518	National Institutes of Health [AI51333, RR-022200, P30 CA054174]; Robert Welch Foundation [AQ-1399]; National Science Foundation [TG-MCB070039]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051333, R56AI051333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI51333 (to K.E.K.). This work was also supported by Robert Welch Foundation Grant AQ-1399 (to P.J.H.).; We thank John Mekalanos for the V. cholerae transposon library and Haruo Watanabe for the toxT::Cm V. cholerae strain SY1002. Supercomputer analysis was performed on Lonestar at the Texas Advanced Computing Center using National Science Foundation Allocation Grant TG-MCB070039 (to B. D.). The Ultra-Scan development was supported by National Institutes of Health Grant RR-022200 (to B. D.). Analytical ultracentrifugation experiments were performed by Virgil Schirf at the Center for Analytical Ultracentrifugation of Macromolecular Assemblies, supported by National Institutes of Health Grant P30 CA054174 to Cancer Therapy and Research Center in San Antonio.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Brookes E, 2006, PROG COLL POL SCI S, V131, P33, DOI 10.1007/2882_004; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Brookes EH, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P361; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Champion GA, 1997, MOL MICROBIOL, V23, P323, DOI 10.1046/j.1365-2958.1997.2191585.x; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; Chatterjee S, 2010, FEMS MICROBIOL LETT, V306, P54, DOI 10.1111/j.1574-6968.2010.01931.x; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Childers BM, 2007, J MOL BIOL, V367, P1413, DOI 10.1016/j.jmb.2007.01.061; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B., 2011, COMPREHENSIVE DATA A; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; DiRita VJ, 1996, P NATL ACAD SCI USA, V93, P7991, DOI 10.1073/pnas.93.15.7991; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hava DL, 2001, J MICROBIOL METH, V46, P217, DOI 10.1016/S0167-7012(01)00276-7; HOLMGREN J, 1977, J INFECT DIS, V136, pS105, DOI 10.1093/infdis/136.Supplement.S105; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hsiao A, 2009, INFECT IMMUN, V77, P1383, DOI 10.1128/IAI.01156-08; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu JR, 2007, BIOTECHNIQUES, V43, P487, DOI 10.2144/000112574; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; MILLER JH, 1992, SHORT COURSE BACTERI, P71; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Prouty MG, 2005, MOL MICROBIOL, V58, P1143, DOI 10.1111/j.1365-2958.2005.04897.x; Schuhmacher DA, 1999, J BACTERIOL, V181, P1508, DOI 10.1128/JB.181.5.1508-1514.1999; Shakhnovich EA, 2007, MOL MICROBIOL, V66, P1331, DOI 10.1111/j.1365-2958.2007.05984.x; Shakhnovich EA, 2007, P NATL ACAD SCI USA, V104, P2372, DOI 10.1073/pnas.0611643104; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; SVENNERHOLM AM, 1978, CURR MICROBIOL, V1, P19, DOI 10.1007/BF02601701; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; Withey JH, 2006, MOL MICROBIOL, V59, P1779, DOI 10.1111/j.1365-2958.2006.05053.x; Withey JH, 2005, J BACTERIOL, V187, P7890, DOI 10.1128/JB.187.23.7890-7900.2005; Yamamoto S, 2009, GENE, V438, P57, DOI 10.1016/j.gene.2009.02.015; Yu RR, 2002, MOL MICROBIOL, V43, P119, DOI 10.1046/j.1365-2958.2002.02721.x	44	40	43	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28644	28655		10.1074/jbc.M111.258780	http://dx.doi.org/10.1074/jbc.M111.258780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673111	Green Published, hybrid			2022-12-27	WOS:000293557800078
J	Picciocchi, A; Debeurme, F; Beaumel, S; Dagher, MC; Grunwald, D; Jesaitis, AJ; Stasia, MJ				Picciocchi, Antoine; Debeurme, Franck; Beaumel, Sylvain; Dagher, Marie-Claire; Grunwald, Didier; Jesaitis, Algirdas J.; Stasia, Marie-Jose			Role of Putative Second Transmembrane Region of Nox2 Protein in the Structural Stability and Electron Transfer of the Phagocytic NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SITE-DIRECTED MUTAGENESIS; FLAVOCYTOCHROME B(558); DIAPHORASE ACTIVITY; GP91(PHOX) SUBUNIT; BINDING-SITE; CYTOCHROME-B; FAMILY; ACTIVATION; DOMAINS	Flavocytochrome b(558) (cytb) of phagocytes is a heterodimeric integral membrane protein composed of two subunits, p22(phox) and gp91(phox). The latter subunit, also known as Nox2, has a cytosolic C-terminal "dehydrogenase domain" containing FAD/NADPH-binding sites. The N-terminal half of Nox2 contains six predicted transmembrane alpha-helices coordinating two hemes. We studied the role of the second transmembrane alpha-helix, which contains a "hot spot" for mutations found in rare X+ and X- chronic granulomatous disease. By site-directed mutagenesis and transfection in X-CGD PLB-985 cells, we examined the functional and structural impact of seven missense mutations affecting five residues. P56L and C59F mutations drastically influence the level of Nox2 expression indicating that these residues are important for the structural stability of Nox2. A53D, R54G, R54M, and R54S mutations do not affect spectral properties of oxidized/reduced cytb, oxidase complex assembly, FAD binding, nor iodonitrotetrazolium (INT) reductase (diaphorase) activity but inhibit superoxide production. This suggests that Ala-53 and Arg-54 are essential in control of electron transfer from FAD. Surprisingly, the A57E mutation partially inhibits FAD binding, diaphorase activity, and oxidase assembly and affects the affinity of immunopurified A57E cytochrome b(558) for p67(phox). By competition experiments, we demonstrated that the second transmembrane helix impacts on the function of the first intracytosolic B-loop in the control of diaphorase activity of Nox2. Finally, by comparing INT reductase activity of immunopurified mutated and wild type cytb under aerobiosis versus anaerobiosis, we showed that INT reduction reflects the electron transfer from NADPH to FAD only in the absence of superoxide production.	[Stasia, Marie-Jose] CHU Grenoble, Chron Granulomatous Dis Diag & Res Ctr, F-38043 Grenoble 9, France; [Picciocchi, Antoine; Debeurme, Franck; Beaumel, Sylvain; Dagher, Marie-Claire; Stasia, Marie-Jose] Univ Grenoble 1, CNRS, Chron Granulomatous Dis Diag & Res Ctr, UMR 5525,Therex TIMC Imag, F-38041 Grenoble, France; [Jesaitis, Algirdas J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Grunwald, Didier] CEA, Inst Rech Sci & Technol Vivant, F-38054 Grenoble 9, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Montana State University System; Montana State University Bozeman; CEA	Stasia, MJ (corresponding author), CHU Grenoble, Chron Granulomatous Dis Diag & Res Ctr, BP 217, F-38043 Grenoble 9, France.	mjstasia@chu-grenoble.fr	STASIA, Marie José/M-7165-2014; beaumel, sylvain/M-7397-2014; DAGHER, Marie-Claire/M-6145-2014	DAGHER, Marie-Claire/0000-0001-6878-3169; Jesaitis, Algirdas/0000-0001-9001-5617; STASIA, Marie jose/0000-0003-4466-4880	National Institutes of Health from the Immunodeficiency Network [N01-AI-30070]; Primary Immunodeficiency Disease Consortium; CGD Research Trust, UK [J4G/09/09]; Joseph Fourier University Medical School; Delegation for Clinical Research and Innovations, Grenoble, France; National Institutes of Health from USPHS [3R01AI026711-21S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026711, N01AI030070] Funding Source: NIH RePORTER	National Institutes of Health from the Immunodeficiency Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Primary Immunodeficiency Disease Consortium; CGD Research Trust, UK; Joseph Fourier University Medical School; Delegation for Clinical Research and Innovations, Grenoble, France; National Institutes of Health from USPHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant N01-AI-30070 from the Immunodeficiency Network and the Primary Immunodeficiency Disease Consortium and by CGD Research Trust Grant Award reference J4G/09/09, UK. This work was also supported by grants from Joseph Fourier University Medical School and the Delegation for Clinical Research and Innovations, Grenoble, France.; Supported by National Institutes of Health Grant 3R01AI026711-21S1 from USPHS.	ALIVERTI A, 1993, BIOCHEMISTRY-US, V32, P6374, DOI 10.1021/bi00076a010; Baniulis D, 2005, BBA-PROTEINS PROTEOM, V1752, P186, DOI 10.1016/j.bbapap.2005.07.018; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 1999, J BIOL CHEM, V274, P10451, DOI 10.1074/jbc.274.15.10451; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CALCATERRA NB, 1995, BIOCHEMISTRY-US, V34, P12842, DOI 10.1021/bi00039a045; COHENTANUGI L, 1991, EUR J BIOCHEM, V202, P649, DOI 10.1111/j.1432-1033.1991.tb16419.x; CROSS AR, 1994, J BIOL CHEM, V269, P21448; CROSS AR, 1995, J BIOL CHEM, V270, P8194, DOI 10.1074/jbc.270.14.8194; CSANYI G, 2011, FREE RADIC IN PRESS; Dang PMC, 1999, BIOCHEMISTRY-US, V38, P5746, DOI 10.1021/bi982750f; Debeurme F, 2010, J BIOL CHEM, V285, P33197, DOI 10.1074/jbc.M110.151555; Henderson LM, 1998, J BIOL CHEM, V273, P33216, DOI 10.1074/jbc.273.50.33216; Jackson HM, 2010, J BIOL CHEM, V285, P10281, DOI 10.1074/jbc.M109.084939; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Li XJ, 2005, J BIOL CHEM, V280, P14962, DOI 10.1074/jbc.M500226200; Lord CI, 2008, J IMMUNOL METHODS, V329, P201, DOI 10.1016/j.jim.2007.10.008; Paclet MH, 2004, BIOCHEM J, V382, P981, DOI 10.1042/BJ20040954; Poinas A, 2002, EUR J BIOCHEM, V269, P1243, DOI 10.1046/j.1432-1033.2002.02764.x; Roos D, 2010, BLOOD CELL MOL DIS, V45, P246, DOI 10.1016/j.bcmd.2010.07.012; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; Stasia MJ, 2002, BBA-MOL BASIS DIS, V1586, P316, DOI 10.1016/S0925-4439(01)00110-7; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; Yoshida LS, 1998, J BIOL CHEM, V273, P27879, DOI 10.1074/jbc.273.43.27879; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	38	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28357	28369		10.1074/jbc.M111.220418	http://dx.doi.org/10.1074/jbc.M111.220418			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659519	hybrid, Green Published			2022-12-27	WOS:000293557800052
J	Gianni, S; Haq, SR; Montemiglio, LC; Jurgens, MC; Engstrom, A; Chi, CN; Brunori, M; Jemth, P				Gianni, Stefano; Haq, S. Raza; Montemiglio, Linda C.; Jurgens, Maike C.; Engstrom, Ake; Chi, Celestine N.; Brunori, Maurizio; Jemth, Per			Sequence-specific Long Range Networks in PSD-95/Discs Large/ZO-1 (PDZ) Domains Tune Their Binding Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND INTERACTIONS; TRANSITION-STATES; PROTEIN FAMILIES; PLAUSIBLE MODEL; MECHANISM; DYNAMICS; ALLOSTERY; PATHWAYS; MUTATIONS; CATALYSIS	Protein-protein interactions mediated by modular protein domains are critical for cell scaffolding, differentiation, signaling, and ultimately, evolution. Given the vast number of ligands competing for binding to a limited number of domain families, it is often puzzling how specificity can be achieved. Selectivity may be modulated by intradomain allostery, whereby a remote residue is energetically connected to the functional binding site via side chain or backbone interactions. Whereas several energetic pathways, which could mediate intradomain allostery, have been predicted in modular protein domains, there is a paucity of experimental data to validate their existence and roles. Here, we have identified such functional energetic networks in one of the most common protein-protein interaction modules, the PDZ domain. We used double mutant cycles involving site-directed mutagenesis of both the PDZ domain and the peptide ligand, in conjunction with kinetics to capture the fine energetic details of the networks involved in peptide recognition. We performed the analysis on two homologous PDZ-ligand complexes and found that the energetically coupled residues differ for these two complexes. This result demonstrates that amino acid sequence rather than topology dictates the allosteric pathways. Furthermore, our data support a mechanism whereby the whole domain and not only the binding pocket is optimized for a specific ligand. Such cross-talk between binding sites and remote residues may be used to fine tune target selectivity.	[Haq, S. Raza; Jurgens, Maike C.; Engstrom, Ake; Chi, Celestine N.; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Gianni, Stefano; Montemiglio, Linda C.; Brunori, Maurizio] Sapienza Univ Roma, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Gianni, Stefano; Montemiglio, Linda C.; Brunori, Maurizio] Sapienza Univ Roma, Ist Biol & Patol Mol, Consiglio Nazl Ric, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy	Uppsala University; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Chi, CN (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr Box 582, SE-75123 Uppsala, Sweden.	Celestine.Chi@imbim.uu.se; Per.Jemth@imbim.uu.se	gianni, stefano/C-8536-2009	Gianni, Stefano/0000-0003-1653-1925; Brunori, Maurizio/0000-0002-7795-1635	Swedish Research Council [2009-5659]; Human Frontiers Science Program; Italian Ministero dell'Istruzione dell'Universita e della Ricerca [FIRB RBRN07BMCT_007]; Higher Education Commission of Pakistan	Swedish Research Council(Swedish Research CouncilEuropean Commission); Human Frontiers Science Program(Human Frontier Science Program); Italian Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by the Swedish Research Council Grant 2009-5659 (to P. J.), the Human Frontiers Science Program (to P. J.), and the Italian Ministero dell'Istruzione dell'Universita e della Ricerca FIRB RBRN07BMCT_007 (to M. B.).; Supported in part by a fellowship from the Higher Education Commission of Pakistan.	AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; DeLano W.L, PYMOL MOL GRAPHICS S; Dhulesia A, 2008, J AM CHEM SOC, V130, P8931, DOI 10.1021/ja0752080; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Fuentes EJ, 2006, J MOL BIOL, V364, P337, DOI 10.1016/j.jmb.2006.08.076; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2005, PROTEIN ENG DES SEL, V18, P389, DOI 10.1093/protein/gzi047; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Gianni S, 2006, STRUCTURE, V14, P1801, DOI 10.1016/j.str.2006.10.010; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; GREEN SM, 1993, BIOCHEMISTRY-US, V32, P10131, DOI 10.1021/bi00089a032; Harris BZ, 2001, J CELL SCI, V114, P3219; Ho BK, 2010, PROTEIN SCI, V19, P398, DOI 10.1002/pro.318; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Kaneko T, 2011, TRENDS BIOCHEM SCI, V36, P183, DOI 10.1016/j.tibs.2010.12.001; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; Kozlov G, 2002, J MOL BIOL, V320, P813, DOI 10.1016/S0022-2836(02)00544-2; Liu ZX, 2009, PROTEINS, V77, P823, DOI 10.1002/prot.22498; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Velthuis AJWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016047	44	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27167	27175		10.1074/jbc.M111.239541	http://dx.doi.org/10.1074/jbc.M111.239541			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21653701	Green Published, hybrid			2022-12-27	WOS:000293268700012
J	Chung, YSA; Kocks, C				Chung, Yoon-Suk Alexander; Kocks, Christine			Recognition of Pathogenic Microbes by the Drosophila Phagocytic Pattern Recognition Receptor Eater	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; MACROPHAGE SCAVENGER RECEPTORS; INNATE IMMUNE-SYSTEM; PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; TEICHOIC-ACIDS; PEPTIDOGLYCAN; PROTEIN; RESISTANCE; BACTERIA	Non-opsonic phagocytosis is a primordial form of pathogen recognition that is mediated by the direct interaction of phagocytic receptors with microbial surfaces. In the fruit fly Drosophila melanogaster, the EGF-like repeat containing scavenger receptor Eater is expressed by phagocytes and is required to survive infections with Gram-positive and Gram-negative bacteria. However, the mechanisms by which this receptor recognizes different types of bacteria are poorly understood. To address this problem, we generated a soluble, Fc-tagged receptor variant of Eater comprising the N-terminal 199 amino acids including four EGF-like repeats. We first established that Eater-Fc displayed specific binding to broad yet distinct classes of heat- or ethanol-inactivated microbes and behaved similarly to the membrane-bound, full-length Eater receptor. We then used Eater-Fc as a tool to probe Eater binding to the surface of live bacteria. Eater-Fc bound equally well to naive or inactivated Staphylococcus aureus or Enterococcus faecalis, suggesting that in vivo, Eater directly targets live Gram-positive bacteria, enabling their phagocytic clearance and destruction. By contrast, Eater-Fc was unable to interact with live, naive Gram-negative bacteria (Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa). For these bacteria, Eater-Fc binding required membrane-disrupting treatments. Furthermore, we found that cecropin A, a cationic, membrane-disrupting antimicrobial peptide, could promote Eater-Fc binding to live E. coli, even at sublethal concentrations. These results suggest a previously unrecognized mechanism by which antimicrobial peptides cooperate with phagocytic receptors to extend the range of microbes that can be targeted by a single, germline-encoded receptor.	[Kocks, Christine] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kocks, C (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, 185 Cambridge St,CPZN 7-250, Boston, MA 02114 USA.	kocks@molbio.mgh.harvard.edu			National Institutes of Health [P01 AI44220]; National Institutes of Health Center for the Study of Inflammatory Bowel Disease [DK43351]; Boston Area Diabetes and Endocrinology Research Center [DK57521]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center for the Study of Inflammatory Bowel Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes and Endocrinology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AI44220.; We thank Bol-Luel Lee for the gift of a baculovirus expression plasmid, Janice Lee for synthesizing dsRNAs, Joseph Garlick, Ji-Joon Song, and Robert E. Kingston for help with baculovirus expression, Dominique Ferrandon, Frederick M. Ausubel, and Iain Fraser for microbial strains, David McLaughlin, Lizabeth A. Perkins, and the members of the Ausubel laboratory for support, advice, suggestions, or comments on the manuscript, in particular Brent Cezairliyan, Mark Rosenzweig, and Fred Ausubel. EM was performed by Mary McKee in the Microscopy Core of the Center for Systems Biology/Program in Membrane Biology, which is partially supported by a National Institutes of Health Center for the Study of Inflammatory Bowel Disease Grant DK43351 and a Boston Area Diabetes and Endocrinology Research Center Award DK57521.	Andre G, 2008, J BACTERIOL, V190, P7079, DOI 10.1128/JB.00519-08; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Avet-Rochex A, 2007, GENES CELLS, V12, P1193, DOI 10.1111/j.1365-2443.2007.01121.x; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Beutler B, 2003, IMMUNITY, V19, P155, DOI 10.1016/S1074-7613(03)00212-7; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; Dupres V, 2010, TRENDS MICROBIOL, V18, P397, DOI 10.1016/j.tim.2010.06.004; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Ganz T, 2004, J LEUKOCYTE BIOL, V75, P34, DOI 10.1189/jlb.0403150; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Ju JS, 2006, J IMMUNOL, V177, P1838, DOI 10.4049/jimmunol.177.3.1838; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Mengin-Lecreulx D, 2005, J ENDOTOXIN RES, V11, P105, DOI 10.1179/096805105X35233; Metchnikoff I. I., 1908, ILYA MECHNIKOV NOBEL; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nehme NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014743; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Peiser L, 2006, INFECT IMMUN, V74, P5191, DOI 10.1128/IAI.00124-06; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Pluddemann A, 2009, J INNATE IMMUN, V1, P153, DOI 10.1159/000155227; POWELL DA, 1975, BIOCHEM J, V151, P387, DOI 10.1042/bj1510387; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rizki T.M., 1984, P579; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Roux S, 2008, J PEPT SCI, V14, P354, DOI 10.1002/psc.951; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; SAWYER JG, 1988, INFECT IMMUN, V56, P693, DOI 10.1128/IAI.56.3.693-698.1988; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; Speert D P, 1993, Trends Microbiol, V1, P217, DOI 10.1016/0966-842X(93)90135-E; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; van Oss CJ, 1984, MOL IMMUNOL, P91; Weber JR, 2003, IMMUNITY, V19, P269, DOI 10.1016/S1074-7613(03)00205-X; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; WRIGHT AE, 1989, REV INFECT DIS, V11, P827	67	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26524	26532		10.1074/jbc.M110.214007	http://dx.doi.org/10.1074/jbc.M110.214007			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21613218	Green Published, hybrid			2022-12-27	WOS:000293078200031
J	Skau, CT; Courson, DS; Bestul, AJ; Winkelman, JD; Rock, RS; Sirotkin, V; Kovar, DR				Skau, Colleen T.; Courson, David S.; Bestul, Andrew J.; Winkelman, Jonathan D.; Rock, Ronald S.; Sirotkin, Vladimir; Kovar, David R.			Actin Filament Bundling by Fimbrin Is Important for Endocytosis, Cytokinesis, and Polarization in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARP2/3 COMPLEX; F-ACTIN; CAPPING PROTEIN; CONTRACTILE RING; CROSS-LINKING; SCHIZOSACCHAROMYCES-POMBE; ALPHA-ACTININ; IN-VIVO; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS	Through the coordinated action of diverse actin-binding proteins, cells simultaneously assemble actin filaments with distinct architectures and dynamics to drive different processes. Actin filament cross-linking proteins organize filaments into higher order networks, although the requirement of cross-linking activity in cells has largely been assumed rather than directly tested. Fission yeast Schizosaccharomyces pombe assembles actin into three discrete structures: endocytic actin patches, polarizing actin cables, and the cytokinetic contractile ring. The fission yeast filament cross-linker fimbrin Fim1 primarily localizes to Arp2/3 complex-nucleated branched filaments of the actin patch and by a lesser amount to bundles of linear antiparallel filaments in the contractile ring. It is unclear whether Fim1 associates with bundles of parallel filaments in actin cables. We previously discovered that a principal role of Fim1 is to control localization of tropomyosin Cdc8, thereby facilitating cofilin-mediated filament turnover. Therefore, we hypothesized that the bundling ability of Fim1 is dispensable for actin patches but is important for the contractile ring and possibly actin cables. By directly visualizing actin filament assembly using total internal reflection fluorescence microscopy, we determined that Fim1 bundles filaments in both parallel and antiparallel orientations and efficiently bundles Arp2/3 complex-branched filaments in the absence but not the presence of actin capping protein. Examination of cells exclusively expressing a truncated version of Fim1 that can bind but not bundle actin filaments revealed that bundling activity of Fim1 is in fact important for all three actin structures. Therefore, fimbrin Fim1 has diverse roles as both a filament "gatekeeper" and as a filament cross-linker.	[Skau, Colleen T.; Bestul, Andrew J.; Winkelman, Jonathan D.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Courson, David S.; Rock, Ronald S.; Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Sirotkin, Vladimir] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	University of Chicago; University of Chicago; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kovar, DR (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St,Suite 915E, Chicago, IL 60637 USA.	drkovar@uchicago.edu			National Institutes of Health [RO1GM079265, RO1GM078450, T32 GM007183]; William Rainey Harper Fellowship; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, R01GM079265, R01GM078450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Rainey Harper Fellowship; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM079265 (to D. R. K.) and RO1GM078450 (to R. S. R.) and Molecular and Cellular Biology Training Grant T32 GM007183 (to C. T. S.). This work was also supported by a William Rainey Harper Fellowship (to C. T. S.) and an American Heart Association Predoctoral Fellowship (to D. S. C.).	ADAMS AEM, 1989, SCIENCE, V243, P231, DOI 10.1126/science.2643162; ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Bathe M, 2010, TRENDS MICROBIOL, V18, P38, DOI 10.1016/j.tim.2009.10.002; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BRETSCHER A, 1980, J CELL BIOL, V86, P335, DOI 10.1083/jcb.86.1.335; BRETSCHER A, 1981, P NATL ACAD SCI-BIOL, V78, P6849, DOI 10.1073/pnas.78.11.6849; BROWER SM, 1995, GENETICS, V140, P91; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Carlsson AE, 2004, BIOPHYS J, V86, P1074, DOI 10.1016/S0006-3495(04)74182-X; Carlsson AE, 2002, BIOPHYS J, V82, P2333, DOI 10.1016/S0006-3495(02)75579-3; Carnahan RH, 2003, J CELL BIOL, V162, P851, DOI 10.1083/jcb.200305012; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; GLENNEY JR, 1981, J BIOL CHEM, V256, P9283; Goldsmith SC, 1997, NAT STRUCT BIOL, V4, P708, DOI 10.1038/nsb0997-708; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goodman A, 2003, MOL BIOL CELL, V14, P2617, DOI 10.1091/mbc.E03-01-0028; Grallert A, 2007, J CELL SCI, V120, P4093, DOI 10.1242/jcs.012468; Hanein D, 1998, NAT STRUCT BIOL, V5, P787, DOI 10.1038/1828; Hanein D, 1997, J CELL BIOL, V139, P387, DOI 10.1083/jcb.139.2.387; Higaki T, 2010, PLANT J, V61, P156, DOI 10.1111/j.1365-313X.2009.04032.x; HONTS JE, 1994, J CELL BIOL, V126, P413, DOI 10.1083/jcb.126.2.413; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kamasaki T, 2005, NAT CELL BIOL, V7, P916, DOI 10.1038/ncb1295; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Klein MG, 2004, STRUCTURE, V12, P999, DOI 10.1016/j.str.2004.04.010; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2001, PLANTA, V213, P390, DOI 10.1007/s004250000494; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lebart MC, 2004, BIOCHEMISTRY-US, V43, P2428, DOI 10.1021/bi030151p; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; MAEKAWA S, 1982, J BIOCHEM-TOKYO, V92, P1959, DOI 10.1093/oxfordjournals.jbchem.a134127; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; MATSUDAIRA P, 1983, NATURE, V301, P209, DOI 10.1038/301209a0; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Nakano K, 2006, MOL BIOL CELL, V17, P1933, DOI 10.1091/mbc.E05-09-0900; Nakano K, 2005, FEBS LETT, V579, P6311, DOI 10.1016/j.febslet.2005.10.011; Nakano K, 2001, MOL BIOL CELL, V12, P3515, DOI 10.1091/mbc.12.11.3515; Nakano K, 2006, GENES CELLS, V11, P893, DOI 10.1111/j.1365-2443.2006.00987.x; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; OTTO JJ, 1980, CELL MOTIL CYTOSKEL, V1, P31, DOI 10.1002/cm.970010104; Park SJ, 2007, GENES CELLS, V12, P611, DOI 10.1111/j.1365-2443.2007.01081.x; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Roberts-Galbraith RH, 2010, MOL CELL, V39, P86, DOI 10.1016/j.molcel.2010.06.012; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Skau CT, 2010, CURR BIOL, V20, P1415, DOI 10.1016/j.cub.2010.06.020; Skau CT, 2009, MOL BIOL CELL, V20, P2160, DOI 10.1091/mbc.E08-12-1201; Skoumpla K, 2007, J CELL SCI, V120, P1635, DOI 10.1242/jcs.001115; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Takaine M, 2009, EMBO J, V28, P3117, DOI 10.1038/emboj.2009.252; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Win TZ, 2001, J CELL SCI, V114, P69; Wu JQ, 2001, MOL BIOL CELL, V12, P1061, DOI 10.1091/mbc.12.4.1061; Young ME, 2004, J CELL BIOL, V166, P629, DOI 10.1083/jcb.200404159	92	80	82	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26964	26977		10.1074/jbc.M111.239004	http://dx.doi.org/10.1074/jbc.M111.239004			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642440	Green Published, hybrid			2022-12-27	WOS:000293078200070
J	Torres, AM; Dnyanmote, AV; Bush, KT; Wu, W; Nigam, SK				Torres, Adriana M.; Dnyanmote, Ankur V.; Bush, Kevin T.; Wu, Wei; Nigam, Sanjay K.			Deletion of Multispecific Organic Anion Transporter Oat1/Slc22a6 Protects against Mercury-induced Kidney Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC MERCURY; PROXIMAL TUBULE; RENAL-FAILURE; OAT1; TOXICITY; METHYLMERCURY; CELLS; RAT; NEPHROTOXICITY; ELIMINATION	The primary site of mercury-induced injury is the kidney due to uptake of the reactive Hg2+-conjugated organic anions in the proximal tubule. Here, we investigated the in vivo role of Oat1 (organic anion transporter 1; originally NKT (Lopez-Nieto, C. E., You, G., Bush, K. T., Barros, E. J., Beier, D. R., and Nigam, S. K. (1997) J. Biol. Chem. 272, 6471-6478)) in handling of known nephrotoxic doses of HgCl2. Oat1 (Slc22a6) is a multispecific organic anion drug transporter that is expressed on the basolateral aspects of renal proximal tubule cells and that mediates the initial steps of elimination of a broad range of endogenous metabolites and commonly prescribed pharmaceuticals. Mercury-induced nephrotoxicity was observed in a wild-type model. We then used the Oat1 knock-out to determine in vivo whether the renal injury effects of mercury are mediated by Oat1. Most of the renal injury (both histologically and biochemically as measured by blood urea nitrogen and creatinine) was abolished following HgCl2 treatment of Oat1 knock-outs. Thus, acute kidney injury by HgCl2 was found to be mediated mainly by Oat1. Our findings raise the possibility that pharmacological modulation of the expression and/or function of Oat1 might be an effective therapeutic strategy for reducing renal injury by mercury. This is one of the most striking phenotypes so far identified in the Oat1 knock-out. (Eraly, S. A., Vallon, V., Vaughn, D. A., Gangoiti, J. A., Richter, K., Nagle, M., Monte, J. C., Rieg, T., Truong, D. M., Long, J. M., Barshop, B. A., Kaler, G., and Nigam, S. K. (2006) J. Biol. Chem. 281, 5072-5083).	[Dnyanmote, Ankur V.; Wu, Wei; Nigam, Sanjay K.] Univ Calif San Diego, Div Nephrol & Hypertens, Dept Med, La Jolla, CA 92093 USA; [Torres, Adriana M.] Univ Nacl Rosario, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, Div Nephrol & Hypertens, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@ucsd.edu		Torres, Adriana/0000-0002-8133-0137	National Institutes of Health [DK079784, GM88824]; Fund for Scientific and Technological Research (FONCYT) [PICT 00966]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 01665]; Society of Toxicology and Colgate-Palmolive; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Scientific and Technological Research (FONCYT)(FONCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Society of Toxicology and Colgate-Palmolive; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079784 and GM88824 (to S. K. N.). This work was also supported by Fund for Scientific and Technological Research (FONCYT) Grant PICT 00966 and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant PIP 01665 (to A. M. T.) and the Society of Toxicology and Colgate-Palmolive (to A. V. D.).	Aslamkhan AG, 2003, MOL PHARMACOL, V63, P590, DOI 10.1124/mol.63.3.590; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Brady WJ, 2004, EMERG MED CLIN N AM, V22, P865, DOI 10.1016/j.emc.2004.05.010; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; Bridges CC, 2010, J TOXICOL ENV HEAL B, V13, P385, DOI 10.1080/10937401003673750; Burckhardt BC, 2003, REV PHYSIOL BIOCH P, V146, P95, DOI 10.1007/s10254-002-0003-8; CLARKSON TW, 1993, ENVIRON HEALTH PERSP, V100, P31, DOI 10.2307/3431518; Di Giusto G, 2008, PHARMACOLOGY, V81, P127, DOI 10.1159/000110555; Giusto G, 2010, ARCH TOXICOL, V84, P741, DOI 10.1007/s00204-010-0541-9; Di Giusto G, 2009, ARCH TOXICOL, V83, P887, DOI 10.1007/s00204-009-0445-8; Drasch G, 2001, SCI TOTAL ENVIRON, V267, P151, DOI 10.1016/S0048-9697(00)00806-8; Endou H, 1998, TOXICOL LETT, V103, P29, DOI 10.1016/S0378-4274(98)00275-6; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Green BT, 2000, SOUTHERN MED J, V93, P721; Koh AS, 2002, MOL PHARMACOL, V62, P921, DOI 10.1124/mol.62.4.921; Lee R, 2009, ENVIRON HEALTH PERSP, V117, P871, DOI 10.1289/ehp.0800337; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lungkaphin A, 2004, AM J PHYSIOL-RENAL, V286, pF68, DOI 10.1152/ajprenal.00075.2003; Magos L, 2006, ANN CLIN BIOCHEM, V43, P257, DOI 10.1258/000456306777695654; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nava M, 2000, AM J PHYSIOL-RENAL, V279, pF910, DOI 10.1152/ajprenal.2000.279.5.F910; Nigam SK, 2007, NAT CLIN PRACT NEPHR, V3, P443, DOI 10.1038/ncpneph0558; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Stacchiotti A, 2006, TOXICOL LETT, V166, P168, DOI 10.1016/j.toxlet.2006.06.644; Steckling N, 2011, SCI TOTAL ENVIRON, V409, P994, DOI 10.1016/j.scitotenv.2010.11.029; Tanaka-Kagawa T, 1998, J PHARMACOL EXP THER, V285, P335; Torres AM, 2005, BBA-MOL BASIS DIS, V1740, P29, DOI 10.1016/j.bbadis.205.03.002; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Villar SR, 2005, KIDNEY INT, V68, P2704, DOI 10.1111/j.1523-1755.2005.00741.x; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Wu W, 2009, PHYSIOL GENOMICS, V38, P116, DOI 10.1152/physiolgenomics.90309.2008; Zalups RK, 2005, KIDNEY INT, V68, P1684, DOI 10.1111/j.1523-1755.2005.00585.x; Zalups RK, 2004, J AM SOC NEPHROL, V15, P2023, DOI 10.1097/01.ASN.0000135115.63412.A9; Zalups RK, 2002, TOXICOL APPL PHARM, V182, P234, DOI 10.1006/taap.2002.9448; Zalups RK, 2000, PHARMACOL REV, V52, P113; Zalups RK, 1998, J TOXICOL ENV HEAL A, V53, P615, DOI 10.1080/009841098159079	40	61	65	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26391	26395		10.1074/jbc.M111.249292	http://dx.doi.org/10.1074/jbc.M111.249292			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652719	hybrid, Green Published			2022-12-27	WOS:000293078200016
J	Murphy, RC; Gaskell, SJ				Murphy, Robert C.; Gaskell, Simon J.			New Applications of Mass Spectrometry in Lipid Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FAST ATOM BOMBARDMENT; ELECTROSPRAY-IONIZATION; BIOLOGICAL SAMPLES; FATTY-ACIDS; PHOSPHOLIPIDS; CHROMATOGRAPHY; DERIVATIVES; SECTIONS; DOLICHOL; REVEALS	Mass spectrometry has emerged as a powerful tool for the analysis of all lipids. Lipidomic analysis of biological systems using various approaches is now possible with a quantitative measurement of hundreds of lipid molecular species. Although availability of reference and internal standards lags behind the field, approaches using stable isotope-labeled derivative tagging permit precise determination of specific phospholipids in an experimental series. The use of reactivity of ozone has enabled assessment of double bond positions in fatty acyl groups even when species remain in complex lipid mixtures. Rapid scanning tandem mass spectrometers are capable of quantitative analysis of hundreds of targeted lipids at high sensitivity in a single on-line chromatographic separation. Imaging mass spectrometry of lipids in tissues has opened new insights into the distribution of lipid molecular species with promising application to study pathophysiological events and diseases.	[Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Gaskell, Simon J.] Queen Mary Univ London, London E1 4NS, England	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of London; Queen Mary University London	Murphy, RC (corresponding author), Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA.	robert.murphy@ucdenver.edu	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [HL25785]; LIPID MAPS Consortium [GM06338]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025785, R37HL025785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LIPID MAPS Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL25785 and LIPID MAPS Consortium Grant GM06338. This is the second article in the Thematic Minireview Series on Biological Applications of Mass Spectrometry. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	BARBER M, 1981, NATURE, V293, P270, DOI 10.1038/293270a0; Berry KAZ, 2009, ANAL CHEM, V81, P6633, DOI 10.1021/ac900583a; Berry KAZ, 2006, ANAL BIOCHEM, V349, P118, DOI 10.1016/j.ab.2005.11.020; BLAIR IA, 1990, METHOD ENZYMOL, V187, P13; Burnum KE, 2009, J LIPID RES, V50, P2290, DOI 10.1194/jlr.M900100-JLR200; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Cheng CF, 2000, MASS SPECTROM REV, V19, P398; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Esch SW, 2007, J LIPID RES, V48, P235, DOI 10.1194/jlr.D600034-JLR200; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Fletcher JS, 2011, MASS SPECTROM REV, V30, P142, DOI 10.1002/mas.20275; Garrett TA, 2007, METHOD ENZYMOL, V432, P117, DOI 10.1016/S0076-6879(07)32005-3; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Girod M, 2010, J AM SOC MASS SPECTR, V21, P1177, DOI 10.1016/j.jasms.2010.03.028; GRANSTROM E, 1969, J AM CHEM SOC, V91, P3398, DOI 10.1021/ja01040a067; Griffiths WJ, 2003, MASS SPECTROM REV, V22, P81, DOI 10.1002/mas.10046; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Hankin JA, 2010, ANAL CHEM, V82, P8476, DOI 10.1021/ac101079v; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P680, DOI 10.1016/S1044-0305(02)00362-8; Hutchins PM, 2008, J LIPID RES, V49, P804, DOI 10.1194/jlr.M700521-JLR200; Jackson SN, 2008, J AM SOC MASS SPECTR, V19, P1655, DOI 10.1016/j.jasms.2008.07.005; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kliman M, 2010, MOL BIOSYST, V6, P958, DOI 10.1039/b927494d; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Kurczy ME, 2010, J AM SOC MASS SPECTR, V21, P833, DOI 10.1016/j.jasms.2010.01.014; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Manicke NE, 2009, ANAL CHEM, V81, P8702, DOI 10.1021/ac901739s; Masoodi M, 2010, ANAL CHEM, V82, P8176, DOI 10.1021/ac1015563; MURPHY RC, 1982, PROSTAGLANDINS, V23, P201, DOI 10.1016/0090-6980(82)90046-6; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Murphy RC, 2011, MASS SPECTROM REV, V30, P579, DOI 10.1002/mas.20284; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Nakanishi H, 2009, METHODS MOL BIOL, V579, P287, DOI 10.1007/978-1-60761-322-0_15; Perry RH, 2008, MASS SPECTROM REV, V27, P661, DOI 10.1002/mas.20186; Poad BLJ, 2010, J AM SOC MASS SPECTR, V21, P1989, DOI 10.1016/j.jasms.2010.08.011; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Reyzer ML, 2010, METHODS MOL BIOL, V656, P285, DOI 10.1007/978-1-60761-746-4_17; RYHAGE RAGNAR, 1960, JOUR LIPID RES, V1, P361; Schwudke D, 2007, ANAL CHEM, V79, P4083, DOI 10.1021/ac062455y; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Steinhauer J, 2009, MOL BIOL CELL, V20, P5224, DOI 10.1091/mbc.E09-05-0382; Thomas MC, 2007, ANAL CHEM, V79, P5013, DOI 10.1021/ac0702185; Trimpin S, 2009, INT J MASS SPECTROM, V287, P58, DOI 10.1016/j.ijms.2008.12.020; VANLEAR GE, 1969, ANNU REV BIOCHEM, V38, P289, DOI 10.1146/annurev.bi.38.070169.001445; Vestal ML, 2005, METHOD ENZYMOL, V402, P79, DOI 10.1016/S0076-6879(05)02003-3; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033	51	46	47	4	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25427	25433		10.1074/jbc.R111.233478	http://dx.doi.org/10.1074/jbc.R111.233478			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632539	Green Published, hybrid			2022-12-27	WOS:000293073000004
J	Yoshiyama-Yanagawa, T; Enya, S; Shimada-Niwa, Y; Yaguchi, S; Haramoto, Y; Matsuya, T; Shiomi, K; Sasakura, Y; Takahashi, S; Asashima, M; Kataoka, H; Niwa, R				Yoshiyama-Yanagawa, Takuji; Enya, Sora; Shimada-Niwa, Yuko; Yaguchi, Shunsuke; Haramoto, Yoshikazu; Matsuya, Takeshi; Shiomi, Kensuke; Sasakura, Yasunori; Takahashi, Shuji; Asashima, Makoto; Kataoka, Hiroshi; Niwa, Ryusuke			The Conserved Rieske Oxygenase DAF-36/Neverland Is a Novel Cholesterol-metabolizing Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; ELEGANS DAUER FORMATION; LEMLI-OPITZ-SYNDROME; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; 7-DEHYDROCHOLESTEROL REDUCTASE; ECDYSTEROIDOGENIC PATHWAY; DROSOPHILA-MELANOGASTER; BIOSYNTHESIS; GENOME; HORMONE	Steroid hormones play essential roles in a wide variety of biological processes in multicellular organisms. The principal steroid hormones in nematodes and arthropods are dafachronic acids and ecdysteroids, respectively, both of which are synthesized from cholesterol as an indispensable precursor. The first critical catalytic step in the biosynthesis of these ecdysozoan steroids is the conversion of cholesterol to 7-dehydrocholesterol. However, the enzymes responsible for cholesterol 7,8-dehydrogenation remain unclear at the molecular level. Here we report that the Rieske oxygenase DAF-36/Neverland (Nvd) is a cholesterol 7,8-dehydrogenase. The daf-36/nvd genes are evolutionarily conserved, not only in nematodes and insects but also in deuterostome species that do not produce dafachronic acids or ecdysteroids, including the sea urchin Hemicentrotus pulcherrimus, the sea squirt Ciona intestinalis, the fish Danio rerio, and the frog Xenopus laevis. An in vitro enzymatic assay system reveals that all DAF-36/Nvd proteins cloned so far have the ability to convert cholesterol to 7-dehydrocholesterol. Moreover, the lethality of loss of nvd function in the fruit fly Drosophila melanogaster is rescued by the expression of daf-36/nvd genes from the nematode Caenorhabditis elegans, the insect Bombyx mori, or the vertebrates D. rerio and X. laevis. These data suggest that daf-36/nvd genes are functionally orthologous across the bilaterian phylogeny. We propose that the daf-36/nvd family of proteins is a novel conserved player in cholesterol metabolism across the animal phyla.	[Yoshiyama-Yanagawa, Takuji; Matsuya, Takeshi; Kataoka, Hiroshi] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Chiba 2778562, Japan; [Yoshiyama-Yanagawa, Takuji; Enya, Sora; Shimada-Niwa, Yuko; Yaguchi, Shunsuke; Sasakura, Yasunori; Niwa, Ryusuke] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Yaguchi, Shunsuke; Niwa, Ryusuke] Univ Tsukuba, Initiat Promot Young Scientists Independent Res, Tsukuba, Ibaraki 3058577, Japan; [Yaguchi, Shunsuke; Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; [Haramoto, Yoshikazu; Takahashi, Shuji] Univ Tokyo, Komaba Org Educ Excellence, Div Life Sci, Coll Arts & Sci,Meguro Ku, Tokyo 1538902, Japan; [Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Shiomi, Kensuke] Univ Tsukuba, Dept Mol Neurobiol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Haramoto, Yoshikazu; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan	University of Tokyo; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tokyo; University of Tokyo; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Kataoka, H (corresponding author), Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwanoha 5-1-5, Chiba 2778562, Japan.	kataoka@k.u-tokyo.ac.jp; ryusuke-niwa@umin.ac.jp	Asashima, Makoto/O-8389-2018; Yaguchi, Shunsuke/H-7270-2019; Haramoto, Yoshikazu/M-1081-2018	Asashima, Makoto/0000-0002-0012-026X; Yaguchi, Shunsuke/0000-0002-8326-5762; Haramoto, Yoshikazu/0000-0002-9460-0837	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government; Agricultural Chemical Research Foundation; Japan Association for Marine Biology; Japan Society for the Promotion of Science (JSPS) [19380034]; Program for Promotion of Basic Research Activities for Innovative Biosciences	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Agricultural Chemical Research Foundation(Agricultural Chemical Research Foundation, Japan); Japan Association for Marine Biology; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government; by grants from the Agricultural Chemical Research Foundation and the Japan Association for Marine Biology (to R. N.); and by Grant-in-Aid for Scientific Research 19380034 from the Japan Society for the Promotion of Science (JSPS) and a grant from the Program for Promotion of Basic Research Activities for Innovative Biosciences (to H. K.).	BRAND AH, 1993, DEVELOPMENT, V118, P401; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Correa-Cerro LS, 2005, MOL GENET METAB, V84, P112, DOI 10.1016/j.ymgme.2004.09.017; DECAPRIO J, 1992, J LIPID RES, V33, P441; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Glossmann HH, 2010, J INVEST DERMATOL, V130, P2139, DOI 10.1038/jid.2010.118; GRIENEISEN ML, 1993, INSECT BIOCHEM MOLEC, V23, P13, DOI 10.1016/0965-1748(93)90077-6; Griffiths WJ, 2008, CLIN CHEM, V54, P1317, DOI 10.1373/clinchem.2007.100644; Griffiths WJ, 2006, J AM SOC MASS SPECTR, V17, P341, DOI 10.1016/j.jasms.2005.10.012; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Hsu HJ, 2006, MOL CELL ENDOCRINOL, V248, P160, DOI 10.1016/j.mce.2005.10.011; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Jiang HY, 1996, J BACTERIOL, V178, P3133, DOI 10.1128/jb.178.11.3133-3139.1996; Koide T, 2006, DEVELOPMENT, V133, P2395, DOI 10.1242/dev.02393; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Lee EY, 2005, BIOCHEM BIOPH RES CO, V328, P929, DOI 10.1016/j.bbrc.2005.01.050; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2011, CHOLESTEROL, DOI 10.1155/2011/176802; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Schmidt CL, 2001, J BIOENERG BIOMEMBR, V33, P9, DOI 10.1023/A:1005616505962; Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5; Tadjuidje E, 2006, DEV DYNAM, V235, P2095, DOI 10.1002/dvdy.20860; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	33	112	123	7	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25756	25762		10.1074/jbc.M111.244384	http://dx.doi.org/10.1074/jbc.M111.244384			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632547	Green Published, hybrid			2022-12-27	WOS:000293073000037
J	Guan, WX; Huang, QF; Cheng, F; Qiu, JM				Guan, Wuxiang; Huang, Qinfeng; Cheng, Fang; Qiu, Jianming			Internal Polyadenylation of the Parvovirus B19 Precursor mRNA Is Regulated by Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROID PROGENITOR CELLS; HUMAN-BONE MARROW; VIRUS TYPE-5 RNA; TRANSCRIPTION PROFILE; POLY(A) SITE; INFECTIOUS CLONE; UNIQUE FEATURES; REPLICATION; PROTEIN; PROMOTER	Alternative processing of parvovirus B19 (B19V) pre-mRNA is critical to generating appropriate levels of B19V mRNA transcripts encoding capsid proteins and small nonstructural proteins. Polyadenylation of the B19V pre-mRNA at the proximal polyadenylation site ((pA)p), which prevents generation of full-length capsid proteins encoding mRNA transcripts, has been suggested as a step that blocks B19V permissiveness. We report here that efficient splicing of the B19V pre-mRNA within the first intron (upstream of the (pA) p site) stimulated the polyadenylation; in contrast, splicing of the B19V pre-mRNA within the second intron (in which the (pA) p site resides) interfered with the polyadenylation, leading to the generation of a sufficient number of B19V mRNA transcripts polyadenylated at the distal polyadenylation site ((pA)d). We also found that splicing within the second intron and polyadenylation at the (pA) p site compete during processing of the B19V pre-mRNA. Furthermore, we discovered that the U1 RNA that binds to the 5' splice donor site of the second intron is fully responsible for inhibiting polyadenylation at the (pA) p site, whereas actual splicing, and perhaps assembly of the functional spliceosome, is not required. Finally, we demonstrated that inhibition of B19V pre-mRNA splicing within the second intron by targeting an intronic splicing enhancer using a Morpholino antisense oligonucleotide prevented B19V mRNA transcripts polyadenylated at the (pA) d site during B19V infection of human erythroid progenitors. Thus, our study reveals the mechanism by which alternative splicing coordinates alternative polyadenylation to generate full-length B19V mRNA transcripts at levels sufficient to support productive B19V infection.	[Guan, Wuxiang; Huang, Qinfeng; Cheng, Fang; Qiu, Jianming] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Qiu, JM (corresponding author), Mail Stop 3029,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jqiu@kumc.edu	Huang, Qinfeng/AAJ-7454-2021		National Institutes of Health USPHS from NIAID [R01 AI070723]; National Center for Research Resources Centers of Biomedical Research [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070723] Funding Source: NIH RePORTER	National Institutes of Health USPHS from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources Centers of Biomedical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health USPHS Grant R01 AI070723 from NIAID and Grant P20 RR016443 from the National Center for Research Resources Centers of Biomedical Research Excellence Program.	ASHE MP, 1995, GENE DEV, V9, P3008, DOI 10.1101/gad.9.23.3008; BARKSDALE SK, 1995, J VIROL, V69, P6553, DOI 10.1128/JVI.69.10.6553-6556.1995; Chen AY, 2010, J VIROL, V84, P12385, DOI 10.1128/JVI.01229-10; Chen AY, 2010, BLOOD, V115, P1070, DOI 10.1182/blood-2009-04-215756; Cotmore SF, 2005, PARVOVIRUSES, P73; deJong L, 1996, CRIT REV EUKAR GENE, V6, P215, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.60; Fauquet C. M., 2004, VIRUS TAXONOMY, P277; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Gilmartin GM, 1996, J VIROL, V70, P1775, DOI 10.1128/JVI.70.3.1775-1783.1996; Guan WX, 2008, J VIROL, V82, P9951, DOI 10.1128/JVI.01162-08; Guan WX, 2011, J VIROL, V85, P2463, DOI 10.1128/JVI.01708-10; Guan WX, 2009, J VIROL, V83, P9541, DOI 10.1128/JVI.00702-09; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; LIU JM, 1992, J VIROL, V66, P4686, DOI 10.1128/JVI.66.8.4686-4692.1992; Liu ZW, 2004, J VIROL, V78, P12929, DOI 10.1128/JVI.78.23.12929-12939.2004; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Morita E, 2001, J VIROL, V75, P7555, DOI 10.1128/JVI.75.16.7555-7563.2001; NAEGER LK, 1992, GENE DEV, V6, P1107, DOI 10.1101/gad.6.6.1107; OZAWA K, 1986, SCIENCE, V233, P883, DOI 10.1126/science.3738514; OZAWA K, 1987, J VIROL, V61, P2395, DOI 10.1128/JVI.61.8.2395-2406.1987; Qiu J, 2007, J VIROL, V81, P12080, DOI 10.1128/JVI.00815-07; Qiu JM, 2006, J VIROL, V80, P654, DOI 10.1128/JVI.80.2.654-662.2006; Qiu JM, 2004, J BIOL CHEM, V279, P14889, DOI 10.1074/jbc.M312734200; Qiu JM, 2004, J VIROL, V78, P83, DOI 10.1128/JVI.78.1.83-93.2004; SCHOBORG RV, 1991, VIROLOGY, V181, P22, DOI 10.1016/0042-6822(91)90466-O; Sol N, 1999, J VIROL, V73, P8762, DOI 10.1128/JVI.73.10.8762-8770.1999; SRIVASTAVA A, 1988, J VIROL, V62, P3059, DOI 10.1128/JVI.62.8.3059-3063.1988; STAMAND J, 1991, VIROLOGY, V183, P133, DOI 10.1016/0042-6822(91)90126-V; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; Vagner S, 2000, GENE DEV, V14, P403; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Wong S, 2008, J VIROL, V82, P2470, DOI 10.1128/JVI.02247-07; Wong S, 2006, J CLIN VIROL, V35, P407, DOI 10.1016/j.jcv.2005.12.008; Yoto Y, 2006, J VIROL, V80, P1604, DOI 10.1128/JVI.80.3.1604-1609.2006; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zhi N, 2004, VIROLOGY, V318, P142, DOI 10.1016/j.virol.2003.09.011; Zhi N, 2006, J VIROL, V80, P5941, DOI 10.1128/JVI.02430-05; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	39	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24793	24805		10.1074/jbc.M111.227439	http://dx.doi.org/10.1074/jbc.M111.227439			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622561	Green Published, hybrid			2022-12-27	WOS:000292547900030
J	Brown, HC; Gangadharan, B; Doering, CB				Brown, Harrison C.; Gangadharan, Bagirath; Doering, Christopher B.			Enhanced Biosynthesis of Coagulation Factor VIII through Diminished Engagement of the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; HIGH-LEVEL EXPRESSION; PORCINE FACTOR-VIII; GLUCOSE-REGULATED PROTEINS; HEMATOPOIETIC STEM-CELLS; HEMOPHILIA-A; GENE-THERAPY; SECRETION; TRANSGENE; IMMUNITY	Human and porcine coagulation factor VIII (fVIII) display a biosynthetic efficiency differential that is being exploited for the development of new protein and gene transfer-based therapies for hemophilia A. The cellular and/or molecular mechanism(s) responsible for this phenomenon have yet to be uncovered, although it has been temporally localized to post-translational biosynthetic steps. The unfolded protein response (UPR) is a cellular adaptation to structurally distinct (e.g. misfolded) or excess protein in the endoplasmic reticulum and is known to be induced by heterologous expression of recombinant human fVIII. Therefore, it is plausible that the biosynthetic differential between human and porcine fVIII results from differential UPR activation. In the current study, UPR induction was examined in the context of ongoing fVIII expression. UPR activation was greater during human fVIII expression when compared with porcine fVIII expression as determined by ER response element (ERSE)-luciferase reporter activity, X-box-binding protein 1 (XBP1) splicing, and immunoglobulin-binding protein (BiP) up-regulation. Immunofluorescence microscopy of fVIII expressing cells revealed that human fVIII was notably absent in the Golgi apparatus, confirming that endoplasmic reticulum to Golgi transport is rate-limiting. In contrast, a significant proportion of porcine fVIII was localized to the Golgi indicating efficient transit through the secretory pathway. Overexpression of BiP, an integral UPR protein, reduced the secretion of human fVIII by 50%, but had no effect on porcine fVIII biosynthesis. In contrast, expression of BiP shRNA increased human fVIII expression levels. The current data support the model of differential engagement of UPR by human and porcine fVIII as a non-traditional mechanism for regulation of gene product biosynthesis.	[Doering, Christopher B.] Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Blood Disorders Serv, Atlanta, GA 30322 USA; Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; Emory University; Children's Healthcare of Atlanta (CHOA)	Doering, CB (corresponding author), Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, 2015 Uppergate Dr,Room 418, Atlanta, GA 30322 USA.	cdoerin@emory.edu	Doering, Christopher/W-2064-2019		National Institutes of Health from the NHLBI [HL 092179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092179] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 092179 from the NHLBI (to C. B. D.).	Bohn RL, 1998, THROMB HAEMOSTASIS, V79, P932; Doering CB, 2004, J BIOL CHEM, V279, P6546, DOI 10.1074/jbc.M312451200; Doering CB, 2002, J BIOL CHEM, V277, P38345, DOI 10.1074/jbc.M206959200; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; Doering CB, 2007, MOL THER, V15, P1093, DOI 10.1038/sj.mt.6300146; Doering CB, 2009, EXPERT REV HEMATOL, V2, P673, DOI 10.1586/EHM.09.63; Doering CB, 2009, MOL THER, V17, P1145, DOI 10.1038/mt.2009.35; Dooriss KL, 2009, HUM GENE THER, V20, P465, DOI 10.1089/hum.2008.150; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; DORNER AJ, 1989, J BIOL CHEM, V264, P20602; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gangadharan B, 2006, BLOOD, V107, P3859, DOI 10.1182/blood-2005-12-4961; Goodeve AC, 2010, HAEMOPHILIA, V16, P79, DOI 10.1111/j.1365-2516.2010.02303.x; Ide LM, 2007, BLOOD, V110, P2855, DOI 10.1182/blood-2007-04-082602; Ide LM, 2010, J GENE MED, V12, P333, DOI 10.1002/jgm.1442; Kaufman RJ, 1997, BLOOD COAGUL FIBRIN, V8, pS3; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Spencer HT, 2011, MOL THER, V19, P302, DOI 10.1038/mt.2010.239; Spreafico M, 2009, SEMIN THROMB HEMOST, V35, P390, DOI 10.1055/s-0029-1225761; Swaroop M, 1997, J BIOL CHEM, V272, P24121, DOI 10.1074/jbc.272.39.24121; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Yoshida H, 2007, ANTIOXID REDOX SIGN, V9, P2323, DOI 10.1089/ars.2007.1800	27	34	34	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24451	24457		10.1074/jbc.M111.238758	http://dx.doi.org/10.1074/jbc.M111.238758			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606503	hybrid, Green Published			2022-12-27	WOS:000292294900085
J	Kunchithapautham, K; Rohrer, B				Kunchithapautham, Kannan; Rohrer, Baerbel			Sublytic Membrane-Attack-Complex (MAC) Activation Alters Regulated Rather than Constitutive Vascular Endothelial Growth Factor (VEGF) Secretion in Retinal Pigment Epithelium Monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; AU-RICH ELEMENTS; MACULAR DEGENERATION; OXIDATIVE-STRESS; PROTEIN-KINASE; CELL-LINE; INDUCED EXPRESSION; SERPING1 GENE; PATHWAY; RAS	Uncontrolled activation of the alternative complement pathway and secretion of vascular endothelial growth factor (VEGF) are thought to be associated with age-related macular degeneration (AMD). Previously, we have shown that in RPE monolayers, oxidative-stress reduced complement inhibition on the cell surface. The resulting increased level of sublytic complement activation resulted in VEGF release, which disrupted the barrier facility of these cells as determined by transepithelial resistance (TER) measurements. Induced rather than basal VEGF release in RPE is thought to be controlled by different mechanisms, including voltage-dependent calcium channel (VDCC) activation and mitogen-activated protein kinases. Here we examined the potential intracellular links between sublytic complement activation and VEGF release in RPE cells challenged with H2O2 and complement-sufficient normal human serum (NHS). Disruption of barrier function by H2O2 + NHS rapidly increased Ras expression and Erk and Src phosphorylation, but had no effect on P38 phosphorylation. Either treatment alone had little effect. TER reduction could be attenuated by inhibiting Ras, Erk and Src activation, or blocking VDCC or VEGF-R2 activation, but not by inhibiting P38. Combinatorial analysis of inhibitor effects demonstrated that sublytic complement activation triggers VEGF secretion via two pathways, Src and Ras-Erk, with the latter being amplified by VEGF-R2 activation, but has no effect on constitutive VEGF secretion mediated via P38. Finally, effects on TER were directly correlated with release of VEGF; and sublytic MAC activation decreased levels of zfp36, a negative modulator of VEGF transcription, resulting in increased VEGF expression. Taken together, identifying how sublytic MAC induces VEGF expression and secretion might offer opportunities to selectively inhibit pathological VEGF release only.	[Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Neurosci, Div Res, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Rohrer, B (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave,SEI 511, Charleston, SC 29425 USA.	rohrer@musc.edu			National Institutes of Health [R01 EY019320, C06 RR015455]; Dept. of Veterans Affairs, Foundation Fighting Blindness [I01 RX000444]; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs, Foundation Fighting Blindness(US Department of Veterans Affairs); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by Grant R01 EY019320 from the National Institutes of Health, Grant I01 RX000444 from the Dept. of Veterans Affairs, Foundation Fighting Blindness, and an unrestricted grant to Medical University of South Carolina from Research to Prevent Blindness, Inc.; We thank Joshua Thurman (University of Colorado Denver School of Medicine, Denver, CO) for helpful discussions and Luanna Bartholomew for critical review (Medical University of South Carolina, Charleston, SC). Animal studies were conducted in a facility constructed with support from the National Institutes of Health (C06 RR015455).	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Augustin AJ, 2009, CLIN OPHTHALMOL, V3, P175; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Bohana-Kashtan O, 2004, MOL IMMUNOL, V41, P583, DOI 10.1016/j.molimm.2004.04.007; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen YW, 2007, EUR J IMMUNOL, V37, P167, DOI 10.1002/eji.200636285; CHOI NH, 1990, INT IMMUNOL, V2, P413, DOI 10.1093/intimm/2.5.413; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Choudhary S, 2005, TOXICOL APPL PHARM, V204, P122, DOI 10.1016/j.taap.2004.08.023; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002; Ennis S, 2008, LANCET, V372, P1828, DOI 10.1016/S0140-6736(08)61348-3; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Fearon DT, 1998, SEMIN IMMUNOL, V10, P355, DOI 10.1006/smim.1998.0137; Fehrenbach H, 1999, ANAT REC, V254, P61; Finnegan S, 2010, EUR J NEUROSCI, V32, P322, DOI 10.1111/j.1460-9568.2010.07301.x; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Holers VM, 2003, CLIN IMMUNOL, V107, P140, DOI 10.1016/S1521-6616(03)00034-2; Holers VM, 2000, IMMUNOPHARMACOLOGY, V49, P125, DOI 10.1016/S0162-3109(00)80298-2; Ito S, 2006, ONCOGENE, V25, P2420, DOI 10.1038/sj.onc.1209263; JACKSON MB, 1981, P NATL ACAD SCI-BIOL, V78, P6421, DOI 10.1073/pnas.78.10.6421; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kannan R, 2006, MOL VIS, V12, P1649; Kijlstra A, 2005, OCUL IMMUNOL INFLAMM, V13, P3, DOI 10.1080/09273940590909185; Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5; Klettner A, 2009, GRAEF ARCH CLIN EXP, V247, P1487, DOI 10.1007/s00417-009-1139-x; Lai WS, 1998, J BIOL CHEM, V273, P506, DOI 10.1074/jbc.273.1.506; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Lommatzsch A, 2008, GRAEF ARCH CLIN EXP, V246, P803, DOI 10.1007/s00417-007-0749-4; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; NICHOLSONWELLER A, 1993, IMMUNOL RES, V12, P244, DOI 10.1007/BF02918256; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Park KH, 2009, MOL VIS, V15, P200; Peng HW, 2002, J IMMUNOL, V169, P2594, DOI 10.4049/jimmunol.169.5.2594; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; PODACK ER, 1984, MOL IMMUNOL, V21, P589, DOI 10.1016/0161-5890(84)90044-0; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rosenthal R, 2007, MOL VIS, V13, P443; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sala-Newby GB, 1998, IMMUNOLOGY, V93, P601; Samuel W, 2008, J NEUROCHEM, V106, P591, DOI 10.1111/j.1471-4159.2008.05409.x; SARMA JV, 2010, CELL TISSUE RES; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schneider-Merck T, 2009, EUR J CANCER, V45, P2050, DOI 10.1016/j.ejca.2009.04.014; SCOLDING NJ, 1989, NATURE, V339, P620, DOI 10.1038/339620a0; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; STEPHENS CL, 1979, J IMMUNOL, V122, P455; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Wijngaarden P, 2008, CLIN EXP OPTOM, V91, P427, DOI 10.1111/j.1444-0938.2008.00305.x; WOOD A, 1993, J NEUROSCI, V13, P3319; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Yun HY, 1999, DIABETES RES CLIN PR, V45, P113, DOI 10.1016/S0168-8227(99)00039-X; Zerbib J, 2010, MOL VIS, V16, P1324	73	56	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23717	23724		10.1074/jbc.M110.214593	http://dx.doi.org/10.1074/jbc.M110.214593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566137	Green Published, hybrid			2022-12-27	WOS:000292294900013
J	Glebov, K; Schutze, S; Walter, J				Glebov, Konstantin; Schuetze, Sebastian; Walter, Jochen			Functional Relevance of a Novel SlyX Motif in Non-conventional Secretion of Insulin-degrading Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL PROTEIN SECRETION; AMYLOID BETA-PROTEIN; SUBSTRATE RECOGNITION; LOCALIZATION; BRAIN; DEGRADATION; REMOVES; PATHWAY; DISEASE; DOMAIN	Insulin-degrading enzyme (IDE) is a Zn2+ metalloprotease with a characteristic inverted catalytic motif. IDE is ubiquitously expressed and degrades peptide substrates including insulin, endorphin, and the amyloid-beta peptide. Although IDE is mainly expressed in the cytosol, it can also be found on the cell surface and in secreted form in extracellular fluids. As IDE lacks a characteristic signal sequence that targets the protein to the classical secretory pathway, release of the enzyme involves non-conventional mechanisms. However, functional domains of IDE involved in its secretion remain elusive. By bioinformatical, biochemical, and cell biological methods, we identified a novel amino acid motif ((EKPPHY858)-E-853) close to the C terminus of IDE and characterized its function in the non-conventional secretion of the protein. Because of its close homology to an amino acid sequence found in bacterial proteins belonging to the SlyX family, we propose to call it the SlyX motif. Mutagenesis revealed that deletion of this motif strongly decreased the release of IDE, whereas deletion of a potential microbody-targeting signal at the extreme C terminus had little effect on secretion. The combined data indicate that the non-conventional secretion of IDE is regulated by the newly identified SlyX motif.	[Glebov, Konstantin; Schuetze, Sebastian; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany	University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	Jochen.Walter@ukb.uni-bonn.de	Walter, Jochen/B-3677-2014; Wang, Caihong/T-5837-2019	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912	Deutsche Forschungsgemeinschaft [SFB645, KFO177]; Federal Ministry for Education and Research (BMBF) [01GI0708]; BONFOR Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BONFOR Program	This work was supported in part by the Deutsche Forschungsgemeinschaft (Grants SFB645 and KFO177), the Federal Ministry for Education and Research (BMBF) (Grant 01GI0708), and the BONFOR Program.	AKIYAMA H, 1988, BIOCHEM BIOPH RES CO, V155, P914, DOI 10.1016/S0006-291X(88)80583-7; Behl Mamta, 2009, Cerebrospinal Fluid Res, V6, P11, DOI 10.1186/1743-8454-6-11; Bernstein HG, 1999, NEUROSCI LETT, V263, P161, DOI 10.1016/S0304-3940(99)00135-4; Bothmann H, 2000, J BIOL CHEM, V275, P17100, DOI 10.1074/jbc.M910233199; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Chesneau V, 1997, ENDOCRINOLOGY, V138, P3444, DOI 10.1210/en.138.8.3444; Crossgrove JS, 2005, EXP BIOL MED, V230, P771, DOI 10.1177/153537020523001011; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leal MC, 2006, J NEUROPATH EXP NEUR, V65, P976, DOI 10.1097/01.jnen.0000235853.70092.ba; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Merregaert J, 2010, J BIOL CHEM, V285, P37823, DOI 10.1074/jbc.M110.136408; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	24	21	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22711	22715		10.1074/jbc.C110.217893	http://dx.doi.org/10.1074/jbc.C110.217893			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21576244	Green Published, hybrid			2022-12-27	WOS:000292025000005
J	Ujvari, A; Pal, M; Luse, DS				Ujvari, Andrea; Pal, Mahadeb; Luse, Donal S.			The Functions of TFIIF during Initiation and Transcript Elongation Are Differentially Affected by Phosphorylation by Casein Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TERMINAL DOMAIN PHOSPHATASE; START SITE UTILIZATION; SACCHAROMYCES-CEREVISIAE; RAP74 SUBUNIT; PREINITIATION COMPLEX; HUMAN-CELLS; CK2; BINDING; TRANSITION	The RNA polymerase II (pol II) initiation and elongation factor elongation factor TFIIF can be extensively phosphorylated in vivo, although the significance of this modification has not been clear. We now show that phosphorylation of recombinant TFIIF by casein kinase 2 (CK2) reduces or eliminates some of the functions of TFIIF while paradoxically leaving others intact. Phospho-IIF is fully functional in binding to free pol II and is able to support the initiation of transcription. However, the phosphorylated factor does not bind to stalled elongation complexes as measured in a gel mobility shift assay. Significantly, phosphorylation strongly reduces (or for some truncated versions of RAP74, eliminates) stimulation of transcript elongation by TFIIF. Thus, although TFIIF must participate at the initiation of transcription, its ability to continue its association with pol II and stimulate transcript elongation can be specifically regulated by CK2. This is particularly interesting because CK2 is required for initiation at a subset of pol II promoters. Modulation of TFIIF function could be important in controlling promoter-proximal pausing by pol II during the early stage of transcript elongation.	[Ujvari, Andrea; Pal, Mahadeb; Luse, Donal S.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Luse, DS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Genet, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.	lused@ccf.org			National Institute of General Medical Sciences [GM 29487]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029487] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grant GM 29487 from the National Institute of General Medical Sciences (to D. S. L.).	Bierhoff H, 2008, MOL CELL BIOL, V28, P4988, DOI 10.1128/MCB.00492-08; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Cheng B, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn630; Cojocaru M, 2008, BIOCHEM J, V409, P139, DOI 10.1042/BJ20070751; CONAWAY JW, 1990, SCIENCE, V248, P1550, DOI 10.1126/science.2193400; Egyhazi E, 1999, MOL CELL BIOCHEM, V191, P149; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; FLORES O, 1989, J BIOL CHEM, V264, P8913; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Friedl EM, 2003, P NATL ACAD SCI USA, V100, P2328, DOI 10.1073/pnas.2628049100; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hu P, 2003, MOL CELL, V12, P699, DOI 10.1016/j.molcel.2003.08.011; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Johnston IM, 2002, MOL CELL BIOL, V22, P3757, DOI 10.1128/MCB.22.11.3757-3768.2002; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kamada K, 2001, P NATL ACAD SCI USA, V98, P3115, DOI 10.1073/pnas.051631098; KEPHART DD, 1994, J BIOL CHEM, V269, P13536; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lei L, 1999, MOL CELL BIOL, V19, P8372; Lei L, 1998, MOL CELL BIOL, V18, P2130, DOI 10.1128/MCB.18.4.2130; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Luse DS, 2011, J BIOL CHEM, V286, P6040, DOI 10.1074/jbc.M110.174722; Majovski RC, 2005, J BIOL CHEM, V280, P34917, DOI 10.1074/jbc.M502932200; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Palancade B, 2002, J BIOL CHEM, V277, P36061, DOI 10.1074/jbc.M205192200; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Rossignol M, 1999, J BIOL CHEM, V274, P22387, DOI 10.1074/jbc.274.32.22387; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SOPTA M, 1985, J BIOL CHEM, V260, P353; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; WANG BQ, 1995, J BIOL CHEM, V270, P27035, DOI 10.1074/jbc.270.45.27035; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; YONAHA M, 1993, NUCLEIC ACIDS RES, V21, P273, DOI 10.1093/nar/21.2.273; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005	52	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23160	23167		10.1074/jbc.M110.205658	http://dx.doi.org/10.1074/jbc.M110.205658			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566144	Green Published, hybrid			2022-12-27	WOS:000292025000050
J	Sawa, J; Malet, H; Krojer, T; Canellas, F; Ehrmann, M; Clausen, T				Sawa, Justyna; Malet, Helene; Krojer, Tobias; Canellas, Flavia; Ehrmann, Michael; Clausen, Tim			Molecular Adaptation of the DegQ Protease to Exert Protein Quality Control in the Bacterial Cell Envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTRA FAMILY; PDZ DOMAIN; REGULATED PROTEOLYSIS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; SERINE PROTEASES; STRESS-RESPONSE; IN-VIVO; CHAPERONE; VIRULENCE	To react to distinct stress situations and to prevent the accumulation of misfolded proteins, all cells employ a number of proteases and chaperones, which together set up an efficient protein quality control system. The functionality of proteins in the cell envelope of Escherichia coli is monitored by the HtrA proteases DegS, DegP, and DegQ. In contrast with DegP and DegS, the structure and function of DegQ has not been addressed in detail. Here, we show that substrate binding triggers the conversion of the resting DegQ hexamer into catalytically active 12- and 24-mers. Interestingly, substrate-induced oligomer reassembly and protease activation depends on the first PDZ domain but not on the second. Therefore, the regulatory mechanism originally identified in DegP should be a common feature of HtrA proteases, most of which encompass only a single PDZ domain. Using a DegQ mutant lacking the second PDZ domain, we determined the high resolution crystal structure of a dodecameric HtrA complex. The nearly identical domain orientation of protease and PDZ domains within 12and 24-meric HtrA complexes reveals a conserved PDZ1 -> L3 -> LD/L1/L2 signaling cascade, in which loop L3 senses the repositioned PDZ1 domain of higher order, substrate-engaged particles and activates protease function. Furthermore, our in vitro and in vivo data imply a pH-related function of DegQ in the bacterial cell envelope.	[Sawa, Justyna; Krojer, Tobias; Canellas, Flavia; Clausen, Tim] Inst Mol Pathol, A-1030 Vienna, Austria; [Malet, Helene] Univ London Birkbeck Coll, Inst Struct Mol Biol, Dept Biol Sci, London WC1E 7HX, England; [Ehrmann, Michael] Univ Duisburg Essen, Fac Biol & Geog, Ctr Med Biotechnol, D-45117 Essen, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of London; Birkbeck University London; University of Duisburg Essen	Clausen, T (corresponding author), Inst Mol Pathol, A-1030 Vienna, Austria.	clausen@imp.univie.ac.at	Ehrmann, Michael/A-7307-2012; Krojer, Tobias/ABE-3829-2021	Ehrmann, Michael/0000-0002-1927-260X; MALET, Helene/0000-0002-2834-7386; Krojer, Tobias/0000-0003-0661-0814; Clausen, Tim/0000-0003-1582-6924	ERA-Net (NEURON) [FWF I 235-B09]; Boehringer Ingelheim; Austrian Science Fund (FWF) [I 235] Funding Source: researchfish	ERA-Net (NEURON); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by an ERA-Net (NEURON, FWF I 235-B09) studentship (to F. C.). The Institute of Molecular Pathology is funded by Boehringer Ingelheim.	Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; Baldi A, 2008, PHARMACOGENOMICS, V9, P1069, DOI 10.2217/14622416.9.8.1069; Bhuiyan MS, 2009, CURR DRUG TARGETS, V10, P372, DOI 10.2174/138945009787846399; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campioni M, 2010, MOL CANCER RES, V8, P1248, DOI 10.1158/1541-7786.MCR-09-0473; Chassin Y, 2002, PLANT PHYSIOL, V130, P857, DOI 10.1104/pp.007922; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Cortes G, 2002, INFECT IMMUN, V70, P4772, DOI 10.1128/IAI.70.9.4772-4776.2002; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; DeLano W.L, PYMOL MOL GRAPHICS S; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Hasenbein S, 2007, GENE DEV, V21, P6, DOI 10.1101/gad.1507807; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; HAUSER M, 1995, PLANT PHYSIOL, V108, P1059, DOI 10.1104/pp.108.3.1059; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Ibrahim YM, 2004, INFECT IMMUN, V72, P3584, DOI 10.1128/IAI.72.6.3584-3591.2004; Itzhaki H, 1998, J BIOL CHEM, V273, P7094, DOI 10.1074/jbc.273.12.7094; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jones CH, 2001, INFECT IMMUN, V69, P5538, DOI 10.1128/IAI.69.9.5538-5545.2001; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Kirk R., 2010, SENSORY MECH BACTERI; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis C, 2009, MICROBIOL-SGM, V155, P873, DOI 10.1099/mic.0.023754-0; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meltzer M, 2009, RES MICROBIOL, V160, P660, DOI 10.1016/j.resmic.2009.07.012; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Mo E, 2006, MICROB PATHOGENESIS, V41, P174, DOI 10.1016/j.micpath.2006.07.004; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x; PFUNDEL EE, 1994, PLANT PHYSIOL, V106, P1647, DOI 10.1104/pp.106.4.1647; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Shridhar V, 2002, CANCER RES, V62, P262; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Waller PRH, 1996, J BACTERIOL, V178, P1146, DOI 10.1128/jb.178.4.1146-1153.1996; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wilson RL, 2006, INFECT IMMUN, V74, P765, DOI 10.1128/IAI.74.1.765-768.2006; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	60	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30680	30690		10.1074/jbc.M111.243832	http://dx.doi.org/10.1074/jbc.M111.243832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21685389	Green Published, hybrid			2022-12-27	WOS:000294283600048
J	Peltier, J; Courtin, P; El Meouche, I; Lemee, L; Chapot-Chartier, MP; Pons, JL				Peltier, Johann; Courtin, Pascal; El Meouche, Imane; Lemee, Ludovic; Chapot-Chartier, Marie-Pierre; Pons, Jean-Louis			Clostridium difficile Has an Original Peptidoglycan Structure with a High Level of N-Acetylglucosamine Deacetylation and Mainly 3-3 Cross-links	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM RESISTANCE; PENICILLIN-BINDING PROTEINS; BACILLUS-SUBTILIS 168; ESCHERICHIA-COLI; ENTEROCOCCUS-FAECIUM; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL-PEPTIDOGLYCAN; GENUS CLOSTRIDIUM; TRANSPEPTIDATION; L,D-TRANSPEPTIDATION	The structure of the vegetative cell wall peptidoglycan of Clostridium difficile was determined by analysis of its constituent muropeptides with a combination of reverse-phase high pressure liquid chromatography separation of muropeptides, amino acid analysis, mass spectrometry and tandem mass spectrometry. The structures assigned to 36 muropeptides evidenced several original features in C. difficile vegetative cell peptidoglycan. First, it is characterized by a strikingly high level of N-acetylglucosamine deacetylation. In addition, the majority of dimers (around 75%) contains A(2)pm(3) -> A(2)pm(3) (A(2)pm, 2,6-diaminopimelic acid) cross-links and only a minority of the more classical Ala(4) -> A(2)pm(3) cross-links. Moreover, a significant amount of muropeptides contains a modified tetrapeptide stem ending in Gly instead of D-Ala(4). Two L,D-transpeptidases homologues encoding genes present in the genome of C. difficile 630 and named ldt(cd1) and ldt(cd2), were inactivated. The inactivation of either ldt(cd1) or ldt(cd2) significantly decreased the abundance of 3-3 cross-links, leading to a marked decrease of peptidoglycan reticulation and demonstrating that both ldt(cd1)-and ldt(cd2)-encoded proteins have a redundant L, D-transpeptidase activity. The contribution of 3-3 cross-links to peptidoglycan synthesis increased in the presence of ampicillin, indicating that this drug does not inhibit the L,D-transpeptidation pathway in C. difficile.	[Peltier, Johann; El Meouche, Imane; Lemee, Ludovic; Pons, Jean-Louis] Rouen Univ Hosp, Lab GRAM, IFR 23, EA 2656, F-76183 Rouen, France; [Courtin, Pascal; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Courtin, Pascal; Pons, Jean-Louis] AgroParisTech, UMR Michalis, F-78350 Jouy En Josas, France	CHU de Rouen; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Pons, JL (corresponding author), Univ Rouen, Grp Rech Antimicrobiens & Microorganismes, UPRES EA2656, IFR23, 22 Blvd Gambetta, F-76183 Rouen, France.	jean-louis.pons@univ-rouen.fr	Peltier, Johann/Q-2001-2017	Peltier, Johann/0000-0003-3207-9465; El Meouche, Imane/0000-0002-0886-6752; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	University of Rouen; Rouen University Hospital	University of Rouen; Rouen University Hospital	This work was supported by the University of Rouen and Rouen University Hospital.	Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Citron DM, 2003, ANTIMICROB AGENTS CH, V47, P2334, DOI 10.1128/AAC.47.7.2334-2338.2003; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Depardieu F, 2003, MOL MICROBIOL, V50, P931, DOI 10.1046/j.1365-2958.2003.03737.x; Dhalluin A, 2005, MICROBIOL-SGM, V151, P2343, DOI 10.1099/mic.0.27878-0; FINEGOLD SM, 1986, SCAND J INFECT DIS, P160; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Kelly CP, 1998, ANNU REV MED, V49, P375; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Lavollay M, 2011, J BACTERIOL, V193, P778, DOI 10.1128/JB.00606-10; Lavollay M, 2009, MOL MICROBIOL, V74, P650, DOI 10.1111/j.1365-2958.2009.06887.x; Magnet S, 2008, J BACTERIOL, V190, P4782, DOI 10.1128/JB.00025-08; Magnet S, 2007, J BACTERIOL, V189, P3927, DOI 10.1128/JB.00084-07; Mainard JL, 2002, J BIOL CHEM, V277, P35801, DOI 10.1074/jbc.M204319200; Mainardi JL, 2008, FEMS MICROBIOL REV, V32, P386, DOI 10.1111/j.1574-6976.2007.00097.x; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; PISABARRO AG, 1985, J BACTERIOL, V161, P238, DOI 10.1128/JB.161.1.238-242.1985; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Sacco E, 2010, MOL MICROBIOL, V75, P874, DOI 10.1111/j.1365-2958.2009.07014.x; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Viswanathan VK, 2010, GUT MICROBES, V1, P234, DOI 10.4161/gmic.1.4.12706; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; WARTH AD, 1972, BIOCHEMISTRY-US, V11, P1389, DOI 10.1021/bi00758a010; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	42	84	85	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29053	29062		10.1074/jbc.M111.259150	http://dx.doi.org/10.1074/jbc.M111.259150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21685382	hybrid, Green Published			2022-12-27	WOS:000293837000042
J	Chen, IH; Hu, JH; Jow, GM; Chuang, CC; Lee, TT; Liu, DC; Jeng, CJ				Chen, I-Hsiu; Hu, Jui-Hsiang; Jow, Guey-Mei; Chuang, Chao-Chin; Lee, Ting-Ting; Liu, Dai-Chi; Jeng, Chung-Jiuan			Distal End of Carboxyl Terminus Is Not Essential for the Assembly of Rat Eag1 Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CLOSED STATE; SUBUNIT; DOMAIN; ETHER; EXPRESSION; DROSOPHILA; HERG	The assembly of four pore-forming alpha-subunits into tetramers is a prerequisite for the formation of functional K+ channels. A short carboxyl assembly domain (CAD) in the distal end of the cytoplasmic carboxyl terminus has been implicated in the assembly of Eag alpha-subunits, a subfamily of the ether-a-go-go K+ channel family. The precise role of CAD in the formation of Eag tetrameric channels, however, remains unclear. Moreover, it has not been determined whether other protein regions also contribute to the assembly of Eag subunits. We addressed these questions by studying the biophysical properties of a series of different rat Eag1 (rEag1) truncation mutants. Two truncation mutants without CAD (K848X and W823X) yielded functional phenotypes similar to those for wild-type (WT) rEag1 channels. Furthermore, nonfunctional rEag1 truncation mutants lacking the distal region of the carboxyl terminus displayed substantial dominant-negative effects on the functional expression of WT as well as K848X and W823X channels. Our co-immunoprecipitation studies further revealed that truncation mutants containing no CAD indeed displayed significant association with rEag1-WT subunits. Finally, surface biotinylation and protein glycosylation analyses demonstrated that progressive truncations of the carboxyl terminus resulted in aggravating disruptions of membrane trafficking and glycosylation of rEag1 proteins. Overall, our data suggest that the distal carboxyl terminus, including CAD, is dispensable for the assembly of rEag1 K+ channels but may instead be essential for ensuring proper protein biosynthesis. We propose that the S6 segment and the proximal carboxyl terminus may constitute the principal subunit recognition site for the assembly of rEag1 channels.	[Chen, I-Hsiu; Hu, Jui-Hsiang; Chuang, Chao-Chin; Lee, Ting-Ting; Liu, Dai-Chi; Jeng, Chung-Jiuan] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 12212, Taiwan; [Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, Hsinchuang 24205, Taipei County, Taiwan	National Yang Ming Chiao Tung University; Fu Jen Catholic University	Jeng, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 12212, Taiwan.	cjjeng@ym.edu.tw			National Science Council, Taiwan [NSC97-2320-B-010-020-MY3]; Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by National Science Council, Taiwan, Research Grant NSC97-2320-B-010-020-MY3 and by Aim for the Top University Plan, Ministry of Education, Taiwan (to C. J. J.).	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Brelidze TI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012523; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dreyer I, 2004, BIOPHYS J, V87, P858, DOI 10.1529/biophysj.103.037671; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Flagg TP, 1999, J GEN PHYSIOL, V114, P685, DOI 10.1085/jgp.114.5.685; Hille B., 2001, ION CHANNELS EXCITAB, P131; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Koster JC, 1998, BIOPHYS J, V74, P1821, DOI 10.1016/S0006-3495(98)77892-0; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Ribera AB, 1996, J NEUROSCI, V16, P1123; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Tang CY, 2000, J GEN PHYSIOL, V115, P319, DOI 10.1085/jgp.115.3.319; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; TU LW, 1995, BIOPHYS J, V68, P147, DOI 10.1016/S0006-3495(95)80169-4; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	42	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27183	27196		10.1074/jbc.M111.233825	http://dx.doi.org/10.1074/jbc.M111.233825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646358	Green Published, hybrid			2022-12-27	WOS:000293268700014
J	Croasdale, R; Ivins, FJ; Muskett, F; Daviter, T; Scott, DJ; Hardy, T; Smerdon, SJ; Fry, AM; Pfuhl, M				Croasdale, Rebecca; Ivins, Frank J.; Muskett, Fred; Daviter, Tina; Scott, David J.; Hardy, Tara; Smerdon, Steven J.; Fry, Andrew M.; Pfuhl, Mark			An Undecided Coiled Coil THE LEUCINE ZIPPER OF Nek2 KINASE EXHIBITS ATYPICAL CONFORMATIONAL EXCHANGE DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-ZIPPER DOMAIN; PROTEIN-KINASE; DIPOLAR COUPLINGS; FUNCTIONAL-ROLE; BINDING DOMAIN; NMR; ALPHA; NEK2; STABILITY; PACKING	Leucine zippers are oligomerization domains used in a wide range of proteins. Their structure is based on a highly conserved heptad repeat sequence in which two key positions are occupied by leucines. The leucine zipper of the cell cycle-regulated Nek2 kinase is important for its dimerization and activation. However, the sequence of this leucine zipper is most unusual in that leucines occupy only one of the two hydrophobic positions. The other position, depending on the register of the heptad repeat, is occupied by either acidic or basic residues. Using NMR spectroscopy, we show that this leucine zipper exists in two conformations of almost equal population that exchange with a rate of 17 s(-1). We propose that the two conformations correspond to the two possible registers of the heptad repeat. This hypothesis is supported by a cysteine mutant that locks the protein in one of the two conformations. NMR spectra of this mutant showed the predicted 2-fold reduction of peaks in the N-15 HSQC spectrum and the complete removal of cross peaks in exchange spectra. It is possible that interconversion of these two conformations may be triggered by external signals in a manner similar to that proposed recently for the microtubule binding domain of dynein and the HAMP domain. As a result, the leucine zipper of Nek2 kinase is the first example where the frameshift of coiled-coil heptad repeats has been directly observed experimentally.	[Croasdale, Rebecca; Muskett, Fred; Hardy, Tara; Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Ivins, Frank J.; Smerdon, Steven J.] Natl Inst Med Res, Div Mol Struct, MRC, London NW7 1AA, England; [Daviter, Tina] Univ London, ISMB Biophys Ctr, London WC1E 7HX, England; [Scott, David J.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England	University of Leicester; MRC National Institute for Medical Research; University of London; University of Nottingham	Fry, AM (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	amf5@le.ac.uk; Pfuhl@kcl.ac.uk		Pfuhl, Mark/0000-0001-9592-6639; Scott, David/0000-0002-6726-2078; Smerdon, Stephen/0000-0001-5688-8465	Hope Foundation for Cancer Research; Cancer Research UK; Association for International Cancer Research; Wellcome Trust; Medical Research Council [MC_U117584228] Funding Source: researchfish; MRC [MC_U117584228] Funding Source: UKRI	Hope Foundation for Cancer Research; Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants (to A. M. F.) from the Hope Foundation for Cancer Research, Cancer Research UK, the Association for International Cancer Research, and The Wellcome Trust.	Adamson J. Gordon, 1993, Current Opinion in Biotechnology, V4, P428, DOI 10.1016/0958-1669(93)90008-K; Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Junius FK, 1996, J BIOL CHEM, V271, P13663, DOI 10.1074/jbc.271.23.13663; JUNIUS FK, 1995, BIOCHEMISTRY-US, V34, P6164, DOI 10.1021/bi00018a020; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V199, P897, DOI 10.1006/bbrc.1994.1313; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Nooren IMA, 1999, NAT STRUCT BIOL, V6, P755; OAS TG, 1990, BIOCHEMISTRY-US, V29, P2891, DOI 10.1021/bi00464a001; OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SAUDEK V, 1991, PROTEIN ENG, V4, P519, DOI 10.1093/protein/4.5.519; SAUDEK V, 1990, PROTEIN ENG, V4, P3, DOI 10.1093/protein/4.1.3; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; ZHOU NE, 1993, BIOCHEMISTRY-US, V32, P3178, DOI 10.1021/bi00063a033; Zweckstetter M, 2005, J AM CHEM SOC, V127, P11918, DOI 10.1021/ja0534654; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	39	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27537	27547		10.1074/jbc.M110.196972	http://dx.doi.org/10.1074/jbc.M110.196972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669869	hybrid, Green Published			2022-12-27	WOS:000293268700048
J	Nayak, B; Kondeti, VK; Xie, P; Lin, S; Viswakarma, N; Raparia, K; Kanwar, YS				Nayak, Baibaswata; Kondeti, Vinay K.; Xie, Ping; Lin, Sun; Viswakarma, Navin; Raparia, Kirtee; Kanwar, Yashpal S.			Transcriptional and Post-translational Modulation of myo-Inositol Oxygenase by High Glucose and Related Pathobiological Stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UP-REGULATION; DIABETIC-NEPHROPATHY; ALDOSE REDUCTASE; RESPONSE ELEMENT; MESANGIAL CELLS; INOSITOL; GENE; ACTIVATION; EXPRESSION; ENZYME	Renal-specific oxidoreductase/myo-inositol oxygenase (RSOR/MIOX) catabolizes myo-inositol and is implicated in the pathogenesis of diabetic nephropathy. How high glucose (HG) ambience up-regulates its expression and enzyme activity was investigated. MIOX up-regulation was associated with an increase in enzyme activity, which was reduced to basal levels with phosphatase treatment. Using phosphothreonine, protein kinase A (PKA), and PKC substrate antibodies, analyses of kidney lysates of diabetic animals and LLC-PK1/HK-2 cells subjected to HG ambience indicated MIOX to be a phosphoprotein. Kinase phosphorylated recombinant RSOR/MIOX proteins had increased activity confined to exons 2-5. Mutants with substituted phosphorylation sites had a minimal increase in activity. Treatment of cells with PKC, PKA, and PDK1 kinase activators increased activity, whereas inhibitors reduced it. Inhibitors also reduced the phosphorylation and activity of MIOX induced by HG. Besides HG, exposure of cells to oxidants H2O2 and methylglyoxal up-regulated MIOX expression and its phosphorylation and activity, whereas antioxidants N-acetylcysteine, beta-naphthoflavone, and tertiary butyl hydroquinone reduced MIOX expression. Treatment with HG or oxidants or overexpression of MIOX induced nuclear translocation of redox-sensitive transcription factor Nrf2, which binds to antioxidant response elements of various promoters. Promoter analyses revealed an increase in luciferase activity with HG and oxidants. Analyses of antioxidant response elements and carbohydrate response elements revealed an accentuation of DNA-protein interactions with oxidants and under HG ambience. ChIP-PCR and immunofluorescence studies revealed nuclear translocation of carbohydrate response element-binding protein. These findings suggest that phosphorylation of RSOR/MIOX enhances its activity, which is augmented by HGvia transcriptional/translational events that are also modulated by diabetes-related pathobiological stresses.	[Nayak, Baibaswata; Kondeti, Vinay K.; Xie, Ping; Viswakarma, Navin; Raparia, Kirtee; Kanwar, Yashpal S.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Nayak, Baibaswata; Kondeti, Vinay K.; Xie, Ping; Viswakarma, Navin; Raparia, Kirtee; Kanwar, Yashpal S.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Lin, Sun] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China; [Lin, Sun] Cent S Univ, Xiangya Hosp 2, Renal Inst, Changsha 410011, Hunan, Peoples R China	Northwestern University; Northwestern University; Central South University; Central South University	Kanwar, YS (corresponding author), Northwestern Univ, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	y-kanwar@northwestern.edu	Nayak, Baibaswata/L-6156-2016; kondeti, vinay kumar/C-3171-2012		National Institutes of Health [DK60635]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK60635.	Alam J, 2000, J BIOL CHEM, V275, P27694; ANSARI NH, 1993, BIOCHEM MOL BIOL INT, V30, P37; Arner RJ, 2001, BIOCHEM J, V360, P313, DOI 10.1042/bj3600313; Barski OA, 2005, AM J PHYSIOL-RENAL, V289, pF200, DOI 10.1152/ajprenal.00411.2004; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Brownt PM, 2006, P NATL ACAD SCI USA, V103, P15032, DOI 10.1073/pnas.0605143103; CHARALAMPOUS FC, 1957, J BIOL CHEM, V228, P1; Colodny L, 1998, Altern Med Rev, V3, P432; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; GABBAY KH, 1975, ANNU REV MED, V26, P521, DOI 10.1146/annurev.me.26.020175.002513; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; HANKES LV, 1969, ANN NY ACAD SCI, V165, P564; HOLUB BJ, 1986, ANNU REV NUTR, V6, P563, DOI 10.1146/annurev.nu.06.070186.003023; Hu E, 2000, AM J PHYSIOL-RENAL, V279, pF426, DOI 10.1152/ajprenal.2000.279.3.F426; Huang JS, 2007, AM J PHYSIOL-RENAL, V293, pF1072, DOI 10.1152/ajprenal.00020.2007; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jiang ZQ, 2003, LIFE SCI, V72, P2243, DOI 10.1016/S0024-3205(03)00101-2; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kaspar JW, 2010, J BIOL CHEM, V285, P21349, DOI 10.1074/jbc.M110.121863; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kawa JM, 2003, EXP BIOL MED, V228, P907, DOI 10.1177/153537020322800806; Lauer ME, 2007, J BIOL CHEM, V282, P843, DOI 10.1074/jbc.M608823200; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Nakamura N, 2000, FREE RADICAL BIO MED, V29, P17, DOI 10.1016/S0891-5849(00)00286-0; Narayanan A, 2009, CURR OPIN STRUC BIOL, V19, P156, DOI 10.1016/j.sbi.2009.02.007; Nayak B, 2005, P NATL ACAD SCI USA, V102, P17952, DOI 10.1073/pnas.0509089102; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nishinaka T, 2001, FREE RADICAL BIO MED, V31, P205, DOI 10.1016/S0891-5849(01)00571-8; OLGEMOLLER B, 1993, DIABETES, V42, P1119, DOI 10.2337/diabetes.42.8.1119; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; PALMANO KP, 1977, BIOCHEM J, V167, P229, DOI 10.1042/bj1670229; Pendaries C, 2003, FEBS LETT, V546, P25, DOI 10.1016/S0014-5793(03)00437-X; Phillips Aled O, 2003, Curr Diab Rep, V3, P491, DOI 10.1007/s11892-003-0013-1; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247, DOI 10.14670/HH-17.247; Prabhu KS, 2005, J BIOL CHEM, V280, P19895, DOI 10.1074/jbc.M502621200; PRICE RG, 1987, RENAL BASEMENT MEMBR, P237; REDDY AS, 2004, DIABETIC NEPHROPATHY; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Reusch JEB, 2003, J CLIN INVEST, V112, P986, DOI 10.1172/JCI200319902; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; STEVENS MJ, 1993, DIABETOLOGIA, V36, P608, DOI 10.1007/BF00404069; Susztak K, 2006, J AM SOC NEPHROL, V17, P361, DOI 10.1681/ASN.2005101109; Ton ALY, 2007, SEMIN NEPHROL, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006; Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WHITING PH, 1979, BIOCHEM J, V179, P549, DOI 10.1042/bj1790549; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Xie P, 2009, J AM SOC NEPHROL, V20, P807, DOI 10.1681/ASN.2008091007; Xing G, 2006, BIOCHEMISTRY-US, V45, P5402, DOI 10.1021/bi0526276; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yang BM, 2010, J DIABETES COMPLICAT, V24, P404, DOI 10.1016/j.jdiacomp.2009.09.005; Yang QW, 2000, P NATL ACAD SCI USA, V97, P9896, DOI 10.1073/pnas.160266197; Zhang YL, 2006, J AM SOC NEPHROL, V17, P1090, DOI 10.1681/ASN.2005111148	58	31	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27594	27611		10.1074/jbc.M110.217141	http://dx.doi.org/10.1074/jbc.M110.217141			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652700	hybrid, Green Published			2022-12-27	WOS:000293268700053
J	Kroken, AR; Karalewitz, APA; Fu, ZJ; Kim, JJP; Barbieri, JT				Kroken, Abby R.; Karalewitz, Andrew P. -A.; Fu, Zhuji; Kim, Jung-Ja P.; Barbieri, Joseph T.			Novel Ganglioside-mediated Entry of Botulinum Neurotoxin Serotype D into Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE; CLOSTRIDIAL-NEUROTOXINS; COMPLEX GANGLIOSIDES; STRUCTURAL-ANALYSIS; BINDING SITES; HEAVY-CHAIN; RECEPTOR; TOXIN; IDENTIFICATION; MEMBRANE	Botulinum Neurotoxins (BoNTs) are organized into seven serotypes, A-G. Although several BoNT serotypes enter neurons through synaptic vesicle cycling utilizing dual receptors (a ganglioside and a synaptic vesicle-associated protein), the entry pathway of BoNT/D is less well understood. Although BoNT/D entry is ganglioside-dependent, alignment and structural studies show that BoNT/D lacks key residues within a conserved ganglioside binding pocket that are present in BoNT serotypes A, B, E, F, and G, which indicate that BoNT/D-ganglioside interactions may be unique. In this study BoNT/D is shown to have a unique association with ganglioside relative to the other BoNT serotypes, utilizing a ganglioside binding loop (GBL, residues Tyr-1235-Ala-1245) within the receptor binding domain of BoNT/D (HCR/D) via b-series gangliosides, including GT1b, GD1b, and GD2. HCR/D bound gangliosides and entered neurons dependent upon the aromatic ring of Phe-1240 within the GBL. This is the first BoNT-ganglioside interaction that is mediated by a phenylalanine. In contrast, Trp-1238, located near the N terminus of the ganglioside binding loop, was mostly solvent-inaccessible and appeared to contribute to maintaining the loop structure. BoNT/D entry and intoxication were enhanced by membrane depolarization via synaptic vesicle cycling, where HCR/D colocalized with synaptophysin, a synaptic vesicle marker, but immunoprecipitation experiments did not detect direct association with synaptic vesicle protein 2. Thus, BoNT/D utilizes unique associations with gangliosides and synaptic vesicles to enter neurons, which may facilitate new neurotoxin therapies.	[Kroken, Abby R.; Karalewitz, Andrew P. -A.; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Fu, Zhuji; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Barbieri, JT (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jtb01@mcw.edu		Kroken, Abby/0000-0003-1807-1125	National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases; NIAID; National Institutes of Health [GM62116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program and the NIAID (to J. T. B. and J. J. K.).; We acknowledge the assistance of Amanda Przedpelski for HCR production. Glycan microarray data were obtained through the Protein-Glycan Interaction Core (Core H) of the Consortium for Functional Glycomics supported by National Institutes of Health Grant GM62116.	Ando S, 1998, ANN NY ACAD SCI, V845, P232, DOI 10.1111/j.1749-6632.1998.tb09676.x; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2008, INFECT IMMUN, V76, P1314, DOI 10.1128/IAI.01025-07; Baldwin MR, 2007, BIOCHEMISTRY-US, V46, P3200, DOI 10.1021/bi602396x; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; Bonanomi D, 2006, PROG NEUROBIOL, V80, P177, DOI 10.1016/j.pneurobio.2006.09.002; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Coffield JA, 1997, J PHARMACOL EXP THER, V280, P1489; Cole AA, 2010, BIOCHEM J, V427, P535, DOI 10.1042/BJ20091344; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Eleopra R, 1997, NEUROSCI LETT, V224, P91, DOI 10.1016/S0304-3940(97)13448-6; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Karalewitz APA, 2010, BIOCHEMISTRY-US, V49, P8117, DOI 10.1021/bi100865f; KELLER JE, 2004, NAT STRUCT BIOL, V7, P693; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MCPHERSON A, 1999, CRYSTALLIZATION BIOL, P188; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; OCHANDA JO, 1986, J BIOCHEM-TOKYO, V100, P27, DOI 10.1093/oxfordjournals.jbchem.a121702; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; ROUSSEL A, 1999, TURBO FRODO VERSION; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Strotmeier J, 2010, BIOCHEM J, V431, P207, DOI 10.1042/BJ20101042; Sugiura Y, 2005, NEUROSCIENCE, V135, P1167, DOI 10.1016/j.neuroscience.2005.07.035; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Tsukamoto K, 2008, MICROB PATHOGENESIS, V44, P484, DOI 10.1016/j.micpath.2007.12.003; Woodward LA, 2003, INFECT IMMUN, V71, P2941, DOI 10.1128/IAI.71.5.2941-2944.2003; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207; Yoshinaka K, 2004, NEUROSCI LETT, V363, P168, DOI 10.1016/j.neulet.2004.04.002; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang YF, 2010, BIOCHEM BIOPH RES CO, V401, P498, DOI 10.1016/j.bbrc.2010.09.063	55	30	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26828	26837		10.1074/jbc.M111.254086	http://dx.doi.org/10.1074/jbc.M111.254086			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632541	Green Published, hybrid			2022-12-27	WOS:000293078200058
J	Reilly, MC; Aoki, K; Wang, ZA; Skowyra, ML; Williams, M; Tiemeyer, M; Doering, TL				Reilly, Morgann C.; Aoki, Kazuhiro; Wang, Zhuo A.; Skowyra, Michael L.; Williams, Matthew; Tiemeyer, Michael; Doering, Tamara L.			A Xylosylphosphotransferase of Cryptococcus neoformans Acts in Protein O-Glycan Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; MUTANT STRAINS; YEAST; FAMILY; GENE; BETA-1,2-XYLOSYLTRANSFERASE; GALACTOXYLOMANNAN; GLYCOSYLATION; BIOSYNTHESIS; DIVERSITY	Cryptococcal meningoencephalitis is an AIDS-defining illness caused by the opportunistic pathogen Cryptococcus neoformans. This organism possesses an elaborate polysaccharide capsule that is unique among pathogenic fungi, and the glycobiology of C. neoformans has been a focus of research in the field. The capsule and other cellular glycans and glycoconjugates have been described, but the machinery responsible for their synthesis remains largely unexplored. We recently discovered Xpt1p, an enzyme with the unexpected activity of generating a xylose-phosphate-mannose linkage. We now demonstrate that this novel activity is conserved throughout the C. neoformans species complex, localized to the Golgi apparatus, and functions in the O-glycosylation of proteins. We also present the first survey of O-glycans from C. neoformans.	[Reilly, Morgann C.; Wang, Zhuo A.; Skowyra, Michael L.; Williams, Matthew; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Washington University (WUSTL); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Doering, TL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	doering@wustl.edu	Skowyra, Michal Leszek/AAS-4850-2020; Wang, Zhuo/L-6912-2019; Aoki, Kazuhiro/H-8283-2014	Skowyra, Michal Leszek/0000-0002-1365-034X; Wang, Zhuo/0000-0002-4707-036X; Reilly, Morgann/0000-0002-5526-8245; Aoki, Kazuhiro/0000-0003-0029-4291	National Institutes of Health [R01 GM071007, R21 AI076737]; National Institutes of Health (National Center for Research Resources) [P01 GM085354, P41 RR018502]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354, R01GM071007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM071007 and R21 AI076737 (to T. L. D.) and P01 GM085354 and P41 RR018502 (National Center for Research Resources) (to M. T.).	ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Castle SA, 2008, EUKARYOT CELL, V7, P1611, DOI 10.1128/EC.00458-07; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Cottrell TR, 2007, EUKARYOT CELL, V6, P776, DOI 10.1128/EC.00015-07; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Djordjevic JT, 2005, BIOCHEM J, V389, P803, DOI 10.1042/BJ20050063; ECKERT TF, 1987, INFECT IMMUN, V55, P1895, DOI 10.1128/IAI.55.8.1895-1899.1987; Eigenheer RA, 2007, FEMS YEAST RES, V7, P499, DOI 10.1111/j.1567-1364.2006.00198.x; Franzot SP, 1999, BIOCHEM J, V340, P25, DOI 10.1042/0264-6021:3400025; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Gallagher Sean R, 2006, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1002as75; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Heise N, 2002, GLYCOBIOLOGY, V12, P409, DOI 10.1093/glycob/cwf053; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; JARS MU, 1995, J BIOL CHEM, V270, P24810, DOI 10.1074/jbc.270.42.24810; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; Klutts JS, 2007, J BIOL CHEM, V282, P17890, DOI 10.1074/jbc.M701941200; Kozel TR, 2003, INFECT IMMUN, V71, P2868, DOI 10.1128/IAI.71.5.2868-2875.2003; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P1869, DOI 10.1128/IAI.60.5.1869-1874.1992; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; McQuiston T, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P373; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; Netski D, 2002, INFECT IMMUN, V70, P2812, DOI 10.1128/IAI.70.6.2812-2819.2002; NISHIKAWA S, 1994, MOL BIOL CELL, V5, P1129, DOI 10.1091/mbc.5.10.1129; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Reilly MC, 2009, J BIOL CHEM, V284, P36118, DOI 10.1074/jbc.M109.056226; Rhome R, 2007, EUKARYOT CELL, V6, P1715, DOI 10.1128/EC.00208-07; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schutzbach J, 2007, CARBOHYD RES, V342, P881, DOI 10.1016/j.carres.2007.01.002; SPIROPULU C, 1989, INFECT IMMUN, V57, P3240, DOI 10.1128/IAI.57.10.3240-3242.1989; Trimble RB, 2004, GLYCOBIOLOGY, V14, P265, DOI 10.1093/glycob/cwh036; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; Warren RL, 2005, BIOTECHNIQUES, V38, P715, DOI 10.2144/05385ST01; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; WICKES BL, 1994, MICROBIOL-SGM, V140, P543, DOI 10.1099/00221287-140-3-543; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	44	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26888	26899		10.1074/jbc.M111.262162	http://dx.doi.org/10.1074/jbc.M111.262162			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21606487	Green Published, hybrid			2022-12-27	WOS:000293078200063
J	Sekiya, A; Okano-Kosugi, H; Yamazaki, CM; Koide, T				Sekiya, Atsushi; Okano-Kosugi, Hitomi; Yamazaki, Chisato M.; Koide, Takaki			Pigment Epithelium-derived Factor (PEDF) Shares Binding Sites in Collagen with Heparin/Heparan Sulfate Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-ANGIOGENIC ACTIVITY; AMINO-ACID-SEQUENCE; CRYSTAL-STRUCTURE; HEPARIN-BINDING; I COLLAGEN; CROSS-LINKING; TUMOR-GROWTH; CELLS; RECEPTOR; STABILITY	Pigment epithelium-derived factor (PEDF) is a collagen-binding protein that is abundantly distributed in various tissues, including the eye. It exhibits various biological functions, such as anti-angiogenic, neurotrophic, and neuroprotective activities. PEDF also interacts with extracellular matrix components such as collagen, heparan sulfate proteoglycans (HSPGs), and hyaluronan. The collagen-binding property has been elucidated to be important for the anti-angiogenic activity in vivo (Hosomichi, J., Yasui, N., Koide, T., Soma, K., and Morita, I. (2005) Biochem. Biophys. Res. Commun. 335, 756-761). Here, we investigated the collagen recognition mechanism by PEDF. We first narrowed down candidate PEDF-binding sequences by taking advantage of previously reported structural requirements in collagen. Subsequent searches for PEDF-binding sequences employing synthetic collagen-like peptides resulted in the identification of one of the critical binding sites for PEDF, human alpha 1(I)(929-938) (IKGHRGFSGL). Further analysis revealed that the collagen recognition by PEDF is sequence-and conformation-specific, and the high affinity binding motif is KGXRG-FXGL in the triple helix. The PEDF-binding motif significantly overlapped with the heparin/HSPG-binding motif, KGHRG(F/Y). The interaction of PEDF with collagen I was specifically competed with by heparin but not by chondroitin sulfate-C or hyaluronan. The binding sequences for PEDF and heparin/HSPG also overlapped with the covalent cross-linking sites between collagen molecules. These findings imply a functional relationship between PEDF and HSPGs during angiogenesis, and the interaction of these molecules is regulated by collagen modifications.	[Sekiya, Atsushi; Yamazaki, Chisato M.; Koide, Takaki] Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Tokyo 1698555, Japan; [Okano-Kosugi, Hitomi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Niigata 9568603, Japan	Waseda University; Niigata University	Koide, T (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Tokyo 1698555, Japan.	koi@waseda.jp			Japan Society for the Promotion of Science [19390032]; Waseda University [2008B-098]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Waseda University	This work was supported by a Grant-in-aid for Scientific Research (B) 19390032 from the Japan Society for the Promotion of Science and Waseda University Grant for Special Research Projects 2008B-098.	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Alberdi Elena M, 2003, BMC Biochem, V4, P1, DOI 10.1186/1471-2091-4-1; Baba H, 2005, ARTERIOSCL THROM VAS, V25, P1938, DOI 10.1161/01.ATV.0000175759.78338.1e; Becerra SP, 2008, J BIOL CHEM, V283, P33310, DOI 10.1074/jbc.M801287200; Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DOGGETT DL, 1992, MECH AGEING DEV, V65, P239, DOI 10.1016/0047-6374(92)90039-G; Fietzek P P, 1976, Int Rev Connect Tissue Res, V7, P1; FIETZEK PP, 1977, P NATL ACAD SCI USA, V74, P84, DOI 10.1073/pnas.74.1.84; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Garcia M, 2004, CANCER RES, V64, P5632, DOI 10.1158/0008-5472.CAN-04-0230; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Hosomichi J, 2005, BIOCHEM BIOPH RES CO, V335, P756, DOI 10.1016/j.bbrc.2005.07.140; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Ishikawa T, 2010, EXP CELL RES, V316, P951, DOI 10.1016/j.yexcr.2009.12.013; Jairajpuri MA, 2003, J BIOL CHEM, V278, P15941, DOI 10.1074/jbc.M212319200; Kivirikko K I, 1979, Int Rev Connect Tissue Res, V8, P23; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; KODA JE, 1985, J BIOL CHEM, V260, P8157; Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005; Konson A, 2011, J BIOL CHEM, V286, P3540, DOI 10.1074/jbc.M110.151548; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Notari L, 2010, FEBS J, V277, P2192, DOI 10.1111/j.1742-4658.2010.07641.x; Oh JH, 2010, INT J GYNECOL CANCER, V20, P751, DOI 10.1111/IGC.0b013e3181e02faa; Okano-Kosugi H, 2009, ANAL BIOCHEM, V394, P125, DOI 10.1016/j.ab.2009.07.017; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; Robins SP, 2007, BIOCHEM SOC T, V35, P849, DOI 10.1042/BST0350849; SANANTONIO JD, 1994, GLYCOBIOLOGY, V4, P327; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275; TANIWAKI T, 1995, J NEUROCHEM, V64, P2509; Valnickova Z, 2007, J BIOL CHEM, V282, P6661, DOI 10.1074/jbc.M610471200; Wang L, 2003, MOL THER, V8, P72, DOI 10.1016/S1525-0016(03)00128-X; WU JJ, 1984, BIOCHEMISTRY-US, V23, P1850, DOI 10.1021/bi00303a041; Wu YQ, 1996, INVEST OPHTH VIS SCI, V37, P1984; Yang WD, 2005, TISSUE ENG, V11, P76, DOI 10.1089/ten.2005.11.76; Yasui N, 2003, J AM CHEM SOC, V125, P15728, DOI 10.1021/ja038148g; Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558	52	46	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26364	26374		10.1074/jbc.M111.252684	http://dx.doi.org/10.1074/jbc.M111.252684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652703	Green Published, hybrid			2022-12-27	WOS:000293078200013
J	Hennessy, EJ; Sheedy, FJ; Santamaria, D; Barbacid, M; O'Neill, LAJ				Hennessy, Elizabeth J.; Sheedy, Frederick J.; Santamaria, David; Barbacid, Mariano; O'Neill, Luke A. J.			Toll-like Receptor-4 (TLR4) Down-regulates MicroRNA-107, Increasing Macrophage Adhesion via Cyclin-dependent Kinase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; NUCLEAR HORMONE-RECEPTORS; BREAST-CANCER CELLS; NF-KAPPA-B; IMMUNE-RESPONSES; GENE-EXPRESSION; HUMAN MONOCYTES; IN-VIVO; ACTIVATION; ENDOTOXIN	Toll-like receptors (TLRs) modulate the expression of multiple microRNAs (miRNAs). Here, we report the down-regulation of miR-107 by TLR4 in multiple cell types. The miR-107 sequence occurs in an intron within the sequence encoding the gene for pantothenate kinase 1 alpha (PanK1 alpha), which is regulated by the transcription factor peroxisome proliferator-activating receptor alpha (PPAR-alpha). PanK1 alpha is also decreased in response to lipopolysaccharide (LPS). The effect on both miR-107 and PanK1 alpha is consistent with a decrease in PPAR-alpha expression. We have found that the putative miR-107 target cyclin-dependent kinase 6 (CDK6) expression is increased by TLR4 as a result of the decrease in miR-107. This effect is required for increased adhesion of macrophages in response to LPS, and CDK6-deficient mice are resistant to the lethal effect of LPS. We have therefore identified a mechanism for LPS signaling which involves a decrease in miR-107 leading to an increase in CDK6.	[Hennessy, Elizabeth J.; Sheedy, Frederick J.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Santamaria, David; Barbacid, Mariano] Ctr Nacl Invest Oncol, Mol Oncol Programme, E-28029 Madrid, Spain	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie	Santamaria, David/D-3930-2011; Hennessy, Elizabeth/AAJ-4800-2021	Santamaria, David/0000-0002-4711-3569; Hennessy, Elizabeth/0000-0002-1231-5777; Sheedy, Frederick/0000-0002-4722-3135; Sheedy, Frederick/0000-0003-2645-8493; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; Health Research Board Ireland [PhD/20007/9]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board Ireland	This work was supported by Science Foundation Ireland and the Health Research Board Ireland Grant PhD/20007/9.	Becker J, 2008, PULM PHARMACOL THER, V21, P324, DOI 10.1016/j.pupt.2007.08.001; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bradfield PF, 2008, INT IMMUNOL, V20, P247, DOI 10.1093/intimm/dxm136; Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gantier MP, 2007, IMMUNOL CELL BIOL, V85, P458, DOI 10.1038/sj.icb.7100091; GOTO M, 1994, METABOLISM, V43, P1248, DOI 10.1016/0026-0495(94)90218-6; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; LANG CH, 1993, METABOLISM, V42, P1351, DOI 10.1016/0026-0495(93)90137-D; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Marx N, 2001, CIRCULATION, V103, P213; Mccoy CE, 2008, J BIOL CHEM, V283, P14277, DOI 10.1074/jbc.M709731200; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Memon RA, 1999, BBA-MOL CELL BIOL L, V1440, P118, DOI 10.1016/S1388-1981(99)00120-1; Memon RA, 1998, AM J PHYSIOL-ENDOC M, V275, pE64, DOI 10.1152/ajpendo.1998.275.1.E64; Murakami K, 2007, EUR J PHARMACOL, V561, P206, DOI 10.1016/j.ejphar.2006.12.037; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Pauley KM, 2008, ANN NY ACAD SCI, V1143, P226, DOI 10.1196/annals.1443.009; Ramaswamy G, 2004, J LIPID RES, V45, P17, DOI 10.1194/jlr.M300279-JLR200; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Slomiany P, 2006, J CELL BIOCHEM, V99, P635, DOI 10.1002/jcb.20966; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108	42	50	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25531	25539		10.1074/jbc.M111.256206	http://dx.doi.org/10.1074/jbc.M111.256206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628465	Green Published, hybrid			2022-12-27	WOS:000293073000015
J	Shirakawa, J; Amo, K; Ohminami, H; Orime, K; Togashi, Y; Ito, Y; Tajima, K; Koganei, M; Sasaki, H; Takeda, E; Terauchi, Y				Shirakawa, Jun; Amo, Kikuko; Ohminami, Hirokazu; Orime, Kazuki; Togashi, Yu; Ito, Yuzuru; Tajima, Kazuki; Koganei, Megumi; Sasaki, Hajime; Takeda, Eiji; Terauchi, Yasuo			Protective Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor against Increased beta Cell Apoptosis Induced by Dietary Sucrose and Linoleic Acid in Mice with Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PLASMA-INSULIN CONCENTRATION; OIL-ENRICHED DIET; GLUCOSE-TOLERANCE; E-CADHERIN; ER STRESS; INTESTINAL CONTENT; KEY ROLE; ACTIVATION; MASS	Chronic exposure to high glucose and fatty acid levels caused by dietary sugar and fat intake induces beta cell apoptosis, leading to the exacerbation of type 2 diabetes. Oleic acid and linoleic acid are two major dietary fatty acids, but their effects in diabetes are unclear. We challenged beta cell-specific glucokinase haploinsufficient (Gck(+/-)) mice with a diet containing sucrose and oleic acid (SO) or sucrose and linoleic acid (SL) and analyzed beta cell apoptosis. In Gck(+/-) but not wild-type mice, SL significantly decreased the beta cell mass and beta cell proportion in islet cells arising from increased apoptosis to a greater degree than did SO. The mRNA expression of SREBP-1c was significantly higher, and that of E-cadherin was significantly lower in the islets of Gck(+/-) mice fed SL compared with mice fed SO. We next evaluated monotherapy with desfluorositagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, in these mouse groups. DPP-4 inhibitor protected against beta cell apoptosis, restored the beta cell mass, and normalized islet morphology in Gck(+/-) mice fed SL. DPP-4 inhibition normalized the changes in the islet expression of SREBP-1c and E-cadherin mRNA induced by the SL diet. Furthermore, linoleic acid induced beta cell apoptosis to a greater degree in the presence of high glucose levels than in the presence of low glucose levels in vitro in islets and MIN6 cells, whereas a GLP-1 receptor agonist prevented apoptosis. In conclusion, SL exacerbated beta cell apoptosis in diabetic Gck(+/-) mice but not in euglycemic wild-type mice, and DPP-4 inhibition protected against these effects.	[Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Amo, Kikuko; Ohminami, Hirokazu; Takeda, Eiji] Univ Tokushima, Inst Hlth Biosci, Dept Clin Nutr, Tokushima 7708503, Japan; [Koganei, Megumi; Sasaki, Hajime] Meiji Dairies Corp, Div Res & Dev, Inst Food Sci, Odawara, Kanagawa 2500862, Japan	Yokohama City University; Tokushima University; Meiji Holdings Co., Ltd.	Terauchi, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	terauchi-tky@umin.ac.jp	Terauchi, Yasuo/AAO-4347-2020	Shirakawa, Jun/0000-0002-0822-8750	Ministry of Education, Culture, Sports, Science and Technology of Japan [19390251, 21390282]; Japan Medical Association; Japan Diabetes Foundation; Suzuken Memorial Foundation; Naito Foundation; Uehara Memorial Foundation; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Medical Association; Japan Diabetes Foundation; Suzuken Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research (B) 19390251 and (B) 21390282 from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a medical award from the Japan Medical Association, a grant-in-aid from the Japan Diabetes Foundation, a grant-in-aid from the Suzuken Memorial Foundation, a grant-in-aid from the Naito Foundation, a grant-in-aid from the Uehara Memorial Foundation (to Y. T.), and a grant-in-aid for Japan Society for the Promotion of Science fellows (to J. S.).	Ahren B, 2004, HORM METAB RES, V36, P842, DOI 10.1055/s-2004-826173; Andrikopoulos S, 2000, DIABETES, V49, P2056, DOI 10.2337/diabetes.49.12.2056; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosco D, 2007, J ENDOCRINOL, V194, P21, DOI 10.1677/JOE-06-0169; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cancelas J, 2006, HORM METAB RES, V38, P98, DOI 10.1055/s-2006-925126; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Grundy SM, 2002, AM J MED, V113, P25, DOI 10.1016/S0002-9343(01)00988-3; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jain R, 2009, DIABETES OBES METAB, V11, P159, DOI 10.1111/j.1463-1326.2009.01102.x; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kato T, 2008, DIABETES, V57, P2382, DOI 10.2337/db06-1806; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Natalicchio A, 2010, ENDOCRINOLOGY, V151, P2019, DOI 10.1210/en.2009-1166; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x; Prieto PG, 2005, ENDOCRINE, V26, P107, DOI 10.1385/ENDO:26:2:107; Ritzel RA, 2006, DIABETES CARE, V29, P717, DOI 10.2337/diacare.29.03.06.dc05-1538; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; Sato K, 2007, J NUTR, V137, P1908, DOI 10.1093/jn/137.8.1908; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Terauchi Y, 1995, J BIOL CHEM, V270, P30253, DOI 10.1074/jbc.270.51.30253; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Tsunekawa S, 2007, J ENDOCRINOL, V193, P65, DOI 10.1677/JOE-06-0148; Villareal DT, 2010, DIABETES, V59, P479, DOI 10.2337/db09-1169; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	44	44	47	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25467	25476		10.1074/jbc.M110.217216	http://dx.doi.org/10.1074/jbc.M110.217216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613229	Green Published, hybrid			2022-12-27	WOS:000293073000009
J	Tian, RQ; Wang, XH; Hou, J; Jia, WH; Yang, Q; Li, YX; Liu, M; Li, X; Tang, H				Tian, Rui-Qing; Wang, Xing-Hua; Hou, Juan; Jia, Wei-Hua; Yang, Qian; Li, Yi-Xuan; Liu, Min; Li, Xin; Tang, Hua			MicroRNA-372 Is Down-regulated and Targets Cyclin-dependent Kinase 2 (CDK2) and Cyclin A1 in Human Cervical Cancer, Which May Contribute to Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; BREAST-CANCER; SMALL RNAS; EXPRESSION; PROLIFERATION; P27(KIP1); ONCOGENES; GENOMICS; HOMOLOG; MIR-222	MicroRNAs are a class of noncoding RNAs that are similar to 22 nucleotides in length. MicroRNAs have been shown to play important roles in cell differentiation and in cancer. Recently, studies have shown that miR-372 is tumorigenic in human reproductive system cancers. However, we provide evidence that miR-372 acts as a tumor suppressor gene in cervical carcinoma. miR-372 was found down-regulated in cervical carcinoma tissues as compared with adjacent normal cervical tissues. Growth curve and FACS assays indicated that ectopic expression of miR-372 suppressed cell growth and induced arrest in the S/G(2) phases of cell cycle in HeLa cells. We used bioinformatic predictions to determine that CDK2 and cyclin A1 were possible targets of miR-372 and confirmed this prediction using a fluorescent reporter assay. Taken together, these findings indicate that an anti-oncogenic role of miR-372 may be through control of cell growth and cell cycle progression by down-regulating the cell cycle genes CDK2 and cyclin A1.	[Tian, Rui-Qing; Wang, Xing-Hua; Hou, Juan; Yang, Qian; Li, Yi-Xuan; Liu, Min; Li, Xin; Tang, Hua] Tianjin Med Univ, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China; [Tian, Rui-Qing; Wang, Xing-Hua; Hou, Juan; Yang, Qian; Li, Yi-Xuan; Liu, Min; Li, Xin; Tang, Hua] Tianjin Med Univ, Basic Med Sch, Tianjin 300070, Peoples R China; [Jia, Wei-Hua] Sun Sat Sen Univ Med Sci, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Tianjin Medical University; Tianjin Medical University	Tang, H (corresponding author), 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	htang2002@yahoo.com	li, yixuan/P-5376-2016; wang, xinghua/AAE-4659-2022		National Natural Science Foundation of China [30873017, 30900736, 31071191]; Natural Science Foundation of Tianjin [08JCZDJC23300, 09JCZDJC17500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (Grants 30873017, 30900736, and 31071191) and the Natural Science Foundation of Tianjin (Grants 08JCZDJC23300 and 09JCZDJC17500).	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Arellano M, 1997, INT J BIOCHEM CELL B, V29, P559, DOI 10.1016/S1357-2725(96)00178-1; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Cho WJ, 2009, MOL CELLS, V28, P521, DOI 10.1007/s10059-009-0158-0; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu B, 2001, MOL CELL BIOL, V21, P2755, DOI 10.1128/MCB.21.8.2755-2766.2001; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li A, 2001, NAT CELL BIOL, V3, pE182, DOI 10.1038/35087119; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; ROSENTHAL ET, 1980, CELL, V20, P487, DOI 10.1016/0092-8674(80)90635-2; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Yang R, 1999, MOL CELL BIOL, V19, P2400; Yang R, 1997, CANCER RES, V57, P913; Yang R, 1999, BLOOD, V93, P2067; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	44	85	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25556	25563		10.1074/jbc.M111.221564	http://dx.doi.org/10.1074/jbc.M111.221564			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21646351	hybrid, Green Published			2022-12-27	WOS:000293073000018
J	Tipton, JD; Tran, JC; Catherman, AD; Ahlf, DR; Durbin, KR; Kelleher, NL				Tipton, Jeremiah D.; Tran, John C.; Catherman, Adam D.; Ahlf, Dorothy R.; Durbin, Kenneth R.; Kelleher, Neil L.			Analysis of Intact Protein Isoforms by Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ION-CYCLOTRON RESONANCE; TOP-DOWN PROTEOMICS; ELECTRON-CAPTURE DISSOCIATION; INTEGRAL MEMBRANE-PROTEINS; COLLISIONALLY ACTIVATED DISSOCIATION; INFRARED MULTIPHOTON DISSOCIATION; MULTIPLY-CHARGED IONS; EMBRYONIC STEM-CELLS; STRUCTURAL-CHARACTERIZATION; COMBINATORIAL MODIFICATION	The diverse proteome of an organism arises from such events as single nucleotide substitutions at the DNA level, different RNA processing, and dynamic enzymatic post-translational modifications. This minireview focuses on the measurement of intact proteins to describe the diversity found in proteomes. The field of biological mass spectrometry has steadily advanced, enabling improvements in the characterization of single proteins to proteins derived from cells or tissues. In this minireview, we discuss the basic technology for "top-down" intact protein analysis. Furthermore, examples of studies involved with the qualitative and quantitative analysis of full-length polypeptides are provided.	[Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Kelleher, NL (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	n-kelleher@northwestern.edu	Tran, John/AAI-2593-2020; Tran, John/E-7195-2014	Tran, John/0000-0003-1697-9404; Tran, John/0000-0003-1697-9404; Tipton, Jeremiah/0000-0002-3671-8239	National Institutes of Health from NIGMS [R01 GM067193]; National Institute on Drug Abuse [P30 DA018310]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM067193 from NIGMS and National Institute on Drug Abuse Grant P30 DA018310. This is the fifth article in the Thematic Minireview Series on Biological Applications of Mass Spectrometry. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Bondarenko PV, 2009, J AM SOC MASS SPECTR, V20, P1415, DOI 10.1016/j.jasms.2009.03.020; Boyne MT, 2006, J PROTEOME RES, V5, P248, DOI 10.1021/pr050269n; Breuker K, 2008, J AM SOC MASS SPECTR, V19, P1045, DOI 10.1016/j.jasms.2008.05.013; Carroll J, 2007, P NATL ACAD SCI USA, V104, P14330, DOI 10.1073/pnas.0706817104; Carroll J, 2006, P NATL ACAD SCI USA, V103, P16170, DOI 10.1073/pnas.0607719103; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Chait BT, 2006, SCIENCE, V314, P65, DOI 10.1126/science.1133987; Chanthamontri C, 2009, INT J MASS SPECTROM, V283, P9, DOI 10.1016/j.ijms.2008.12.007; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Cilia M, 2011, J VIROL, V85, P2148, DOI 10.1128/JVI.01504-10; Cobb JS, 2010, J AM SOC MASS SPECTR, V21, P949, DOI 10.1016/j.jasms.2010.02.009; Collier TS, 2010, J AM SOC MASS SPECTR, V21, P879, DOI 10.1016/j.jasms.2010.01.031; Demirev PA, 2008, J MASS SPECTROM, V43, P1441, DOI 10.1002/jms.1474; Du Y, 2006, ANAL CHEM, V78, P686, DOI 10.1021/ac050993p; Fagerquist CK, 2009, APPL ENVIRON MICROB, V75, P4341, DOI 10.1128/AEM.00079-09; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Ferguson JT, 2009, J AM SOC MASS SPECTR, V20, P1743, DOI 10.1016/j.jasms.2009.05.014; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Ge Y, 2009, P NATL ACAD SCI USA, V106, P12658, DOI 10.1073/pnas.0813369106; Grey AC, 2009, J PROTEOME RES, V8, P3278, DOI 10.1021/pr800956y; Johnson JR, 2002, ELECTROPHORESIS, V23, P3217, DOI 10.1002/1522-2683(200209)23:18<3217::AID-ELPS3217>3.0.CO;2-K; Jungblut PR, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-16; Kaletas BK, 2009, PROTEOMICS, V9, P2622, DOI 10.1002/pmic.200800364; Karabacak NM, 2009, MOL CELL PROTEOMICS, V8, P846, DOI 10.1074/mcp.M800099-MCP200; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Kelleher NL, 1999, J AM CHEM SOC, V121, P806, DOI 10.1021/ja973655h; Kellie JF, 2010, MOL BIOSYST, V6, P1532, DOI 10.1039/c000896f; Kurien BT, 2006, METHODS, V38, P283, DOI 10.1016/j.ymeth.2005.11.007; Lee JE, 2009, J AM SOC MASS SPECTR, V20, P2183, DOI 10.1016/j.jasms.2009.08.001; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Li WQ, 1999, ANAL CHEM, V71, P4397, DOI 10.1021/ac990011e; Lin M, 2003, RAPID COMMUN MASS SP, V17, P1809, DOI 10.1002/rcm.1102; LITTLE DP, 1994, ANAL CHEM, V66, P2809, DOI 10.1021/ac00090a004; Liu J, 2009, ANAL CHEM, V81, P1433, DOI 10.1021/ac802204j; Liu ZL, 2008, J AM SOC MASS SPECTR, V19, P231, DOI 10.1016/j.jasms.2007.06.006; LOO JA, 1990, SCIENCE, V248, P201, DOI 10.1126/science.2326633; Lourette N, 2010, J AM SOC MASS SPECTR, V21, P930, DOI 10.1016/j.jasms.2010.02.027; Macek B, 2006, MOL CELL PROTEOMICS, V5, P949, DOI 10.1074/mcp.T500042-MCP200; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; McLafferty FW, 2007, FEBS J, V274, P6256, DOI 10.1111/j.1742-4658.2007.06147.x; MCLAFFERTY FW, 1994, ACCOUNTS CHEM RES, V27, P379, DOI 10.1021/ar00047a009; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; Misek DE, 2005, PROTEOMICS, V5, P3343, DOI 10.1002/pmic.200500103; Mohr J, 2010, PROTEOMICS, V10, P3598, DOI 10.1002/pmic.201000341; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Parks BA, 2007, ANAL CHEM, V79, P7984, DOI 10.1021/ac070553t; Patrie SM, 2006, MOL CELL PROTEOMICS, V5, P14, DOI 10.1074/mcp.M500219-MCP200; Patton WF, 2002, J CHROMATOGR B, V771, P3, DOI 10.1016/S1570-0232(02)00043-0; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Ren D, 2009, ANAL BIOCHEM, V384, P42, DOI 10.1016/j.ab.2008.09.026; Resemann A, 2010, ANAL CHEM, V82, P3283, DOI 10.1021/ac1000515; Roth MJ, 2008, ANAL CHEM, V80, P2857, DOI 10.1021/ac800141g; Ryan CM, 2010, MOL CELL PROTEOMICS, V9, P791, DOI 10.1074/mcp.M900516-MCP200; Ryan CM, 2010, J AM SOC MASS SPECTR, V21, P908, DOI 10.1016/j.jasms.2010.01.025; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Schluter H, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-11; Schwartz JC, 2002, J AM SOC MASS SPECTR, V13, P659, DOI 10.1016/S1044-0305(02)00384-7; Seeley EH, 2011, TRENDS BIOTECHNOL, V29, P136, DOI 10.1016/j.tibtech.2010.12.002; SENKO MW, 1994, ANAL CHEM, V66, P2801, DOI 10.1021/ac00090a003; Siuti N, 2006, J PROTEOME RES, V5, P233, DOI 10.1021/pr050268v; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; Barnes CAS, 2007, MASS SPECTROM REV, V26, P370, DOI 10.1002/mas.20129; Stephenson JL, 1996, J AM CHEM SOC, V118, P7390, DOI 10.1021/ja9611755; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/RCM.1290020802, DOI 10.1002/RCM.1290020802, 10.1002/rcm.1290020802]; Tannu NS, 2006, NAT PROTOC, V1, P1732, DOI 10.1038/nprot.2006.256; Thangaraj B, 2010, PROTEOMICS, V10, P3644, DOI 10.1002/pmic.201000190; Tipton JD, 2009, ANAL CHEM, V81, P7611, DOI 10.1021/ac9009935; Tran JC, 2008, J PROTEOME RES, V7, P1761, DOI 10.1021/pr700677u; Tran JC, 2008, ANAL CHEM, V80, P1568, DOI 10.1021/ac702197w; Tsai YS, 2009, J AM SOC MASS SPECTR, V20, P2154, DOI 10.1016/j.jasms.2009.07.024; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Wall DB, 2000, ANAL CHEM, V72, P1099, DOI 10.1021/ac991332t; Wang H, 2005, MASS SPECTROM REV, V24, P413, DOI 10.1002/mas.20018; Wenger CD, 2008, ANAL CHEM, V80, P8055, DOI 10.1021/ac8010704; Whitelegge JP, 2006, J EXP BOT, V57, P1515, DOI 10.1093/jxb/erj163; Whitelegge J, 2006, EXPERT REV PROTEOMIC, V3, P585, DOI 10.1586/14789450.3.6.585; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wu S, 2009, ANAL CHEM, V81, P4210, DOI 10.1021/ac802487q; Wynne C, 2010, PROTEOMICS, V10, P3631, DOI 10.1002/pmic.201000172; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Young NL, 2010, J AM SOC MASS SPECTR, V21, P960, DOI 10.1016/j.jasms.2010.01.020; Zabrouskov V, 2006, BIOCHEMISTRY-US, V45, P987, DOI 10.1021/bi0517584; Zabrouskov V, 2005, J AM SOC MASS SPECTR, V16, P2027, DOI 10.1016/j.jasms.2005.08.004; Zamdborg L, 2007, NUCLEIC ACIDS RES, V35, pW701, DOI 10.1093/nar/gkm371; Zhang J, 2010, J MASS SPECTROM, V45, P112, DOI 10.1002/jms.1700; Zhang JA, 2010, J AM SOC MASS SPECTR, V21, P940, DOI 10.1016/j.jasms.2010.02.005; Zhang ZQ, 2009, MASS SPECTROM REV, V28, P147, DOI 10.1002/mas.20190; Zubarev RA, 1998, J AM CHEM SOC, V120, P3265, DOI 10.1021/ja973478k	100	79	80	1	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25451	25458		10.1074/jbc.R111.239442	http://dx.doi.org/10.1074/jbc.R111.239442			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632550	hybrid, Green Published			2022-12-27	WOS:000293073000007
J	Vetting, MW; Hegde, SS; Wang, MH; Jacoby, GA; Hooper, DC; Blanchard, JS				Vetting, Matthew W.; Hegde, Subray S.; Wang, Minghua; Jacoby, George A.; Hooper, David C.; Blanchard, John S.			Structure of QnrB1, a Plasmid-mediated Fluoroquinolone Resistance Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTAPEPTIDE REPEAT PROTEINS; QUINOLONE-RESISTANCE; CRYSTAL-STRUCTURE; INTRINSIC RESISTANCE; MICROCIN B17; DNA CLEAVAGE; GENE; GYRASE; CRYSTALLIZATION; RECOGNITION	QnrB1 is a plasmid-encoded pentapeptide repeat protein (PRP) that confers a moderate degree of resistance to fluoroquinolones. Its gene was cloned into an expression vector with an N-terminal polyhistidine tag, and the protein was purified by nickel affinity chromatography. The structure of QnrB1 was determined by a combination of trypsinolysis, surface mutagenesis, and single anomalous dispersion phasing. QnrB1 folds as a right-handed quadrilateral beta-helix with a highly asymmetric dimeric structure typical of PRP-topoisomerase poison resistance factors. The threading of pentapeptides into the beta-helical fold is interrupted by two noncanonical PRP sequences that produce outward projecting loops that interrupt the regularity of the PRP surface. Deletion of the larger upper loop eliminated the protective effect of QnrB1 on DNA gyrase toward inhibition by quinolones, whereas deletion of the smaller lower loop drastically reduced the protective effect. These loops are conserved among all plasmid-based Qnr variants (QnrA, QnrC, QnrD, and QnrS) and some chromosomally encoded Qnr varieties. A mechanism in which PRP-topoisomerase poison resistance factors bind to and disrupt the quinolone-DNA-gyrase interaction is proposed.	[Vetting, Matthew W.; Hegde, Subray S.; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Wang, Minghua; Hooper, David C.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Jacoby, George A.] Lahey Clin Fdn, Burlington, MA 01805 USA	Yeshiva University; Albert Einstein College of Medicine; Harvard University; Massachusetts General Hospital; Lahey Hospital & Medical Center	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	blanchar@aecom.yu.edu	Jacoby, George A/G-2604-2011		National Institutes of Health [R01AI033696, R01AI057576]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033696, R01AI057576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI033696 (to J. S. B.) and R01AI057576 (to D. C. H. and G. A. J.).	Arsene S, 2007, ANTIMICROB AGENTS CH, V51, P3254, DOI 10.1128/AAC.00274-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLACK K, 1995, J BACTERIOL, V177, P6440, DOI 10.1128/jb.177.22.6440-6448.1995; Buchko GW, 2008, J STRUCT BIOL, V162, P184, DOI 10.1016/j.jsb.2007.11.008; Buchko GW, 2006, PROTEIN SCI, V15, P2579, DOI 10.1110/ps.062407506; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chandler LE, 2003, BIOCHEMISTRY-US, V42, P5508, DOI 10.1021/bi027113a; Da Re S, 2009, EMBO REP, V10, P929, DOI 10.1038/embor.2009.99; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; GARRIDO MD, 1988, EMBO J, V7, P1853, DOI 10.1002/j.1460-2075.1988.tb03018.x; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Hashimi SM, 2007, ANTIMICROB AGENTS CH, V51, P181, DOI 10.1128/AAC.00918-06; Hata M, 2005, ANTIMICROB AGENTS CH, V49, P801, DOI 10.1128/AAC.49.2.801-803.2005; Heddle JG, 2001, J MOL BIOL, V307, P1223, DOI 10.1006/jmbi.2001.4562; Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699; Hegde SS, 2011, ANTIMICROB AGENTS CH, V55, P110, DOI 10.1128/AAC.01158-10; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; Jacoby G, 2008, ANTIMICROB AGENTS CH, V52, P2297, DOI 10.1128/AAC.00147-08; Jacoby GA, 2009, ANTIMICROB AGENTS CH, V53, P1665, DOI 10.1128/AAC.01447-08; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P639, DOI 10.1128/AAC.01051-08; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Merens A, 2009, J BACTERIOL, V191, P1587, DOI 10.1128/JB.01205-08; Montero C, 2001, ANTIMICROB AGENTS CH, V45, P3387, DOI 10.1128/AAC.45.12.3387-3392.2001; Ni SS, 2009, J STRUCT BIOL, V165, P47, DOI 10.1016/j.jsb.2008.09.010; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Poirel L, 2005, J ANTIMICROB CHEMOTH, V56, P1118, DOI 10.1093/jac/dki371; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Robicsek A, 2005, ANTIMICROB AGENTS CH, V49, P3001, DOI 10.1128/AAC.49.7.3001-3003.2005; Rodriguez-Martinez JM, 2007, ANTIMICROB AGENTS CH, V51, P2236, DOI 10.1128/AAC.01444-06; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P118, DOI 10.1128/AAC.49.1.118-125.2005; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P3050, DOI 10.1128/AAC.49.7.3050-3052.2005; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Vetting MW, 2007, PROTEIN SCI, V16, P755, DOI 10.1110/ps.062637707; Vetting MW, 2011, ACTA CRYSTALLOGR F, V67, P296, DOI 10.1107/S1744309110053315; Vetting MW, 2006, BIOCHEMISTRY-US, V45, P1, DOI 10.1021/bi052130w; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P821, DOI 10.1128/AAC.00132-08; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; Xiong XL, 2011, NUCLEIC ACIDS RES, V39, P3917, DOI 10.1093/nar/gkq1296	55	56	59	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25265	25273		10.1074/jbc.M111.226936	http://dx.doi.org/10.1074/jbc.M111.226936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21597116	Green Published, hybrid			2022-12-27	WOS:000292547900072
J	Ohnishi, A; Hull, JJ; Kaji, M; Hashimoto, K; Lee, JM; Tsuneizumi, K; Suzuki, T; Dohmae, N; Matsumoto, S				Ohnishi, Atsushi; Hull, J. Joe; Kaji, Misato; Hashimoto, Kana; Lee, Jae Min; Tsuneizumi, Kazuhide; Suzuki, Takehiro; Dohmae, Naoshi; Matsumoto, Shogo			Hormone Signaling Linked to Silkmoth Sex Pheromone Biosynthesis Involves Ca2+/Calmodulin-dependent Protein Kinase II-mediated Phosphorylation of the Insect PAT Family Protein Bombyx mori Lipid Storage Droplet Protein-1 (BmLsd1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING NEUROPEPTIDE PBAN; TRANSDUCTION CASCADE; MANDUCA-SEXTA; FAT-BODY; SILKWORM; IDENTIFICATION; INVOLVEMENT; EXPRESSION; LIPOLYSIS; RECEPTOR	Species-specific sex pheromones released by female moths to attract conspecific male moths are synthesized de novo in the pheromone gland (PG) via the fatty acid biosynthetic pathway. This pathway is regulated by a neurohormone termed pheromone biosynthesis activating neuropeptide (PBAN), a 33-amino acid peptide that originates in the subesophageal ganglion. In the silkmoth, Bombyx mori, cytoplasmic lipid droplets, which store the sex pheromone (bombykol) precursor fatty acid, accumulate in PG cells. PBAN stimulates lipolysis of the stored lipid droplet triacylglycerols (TAGs) and releases the precursor for final modification. PBAN exerts its physiological function via the PG cell-surface PBAN receptor, a G protein-coupled receptor that belongs to the neuromedin U receptor family. The PBAN receptor-mediated signal is transmitted via a canonical store-operated channel activation pathway utilizing Gq-mediated phospholipase C activation (Hull, J. J., Kajigaya, R., Imai, K., and Matsumoto, S. (2007) Biosci. Biotechnol. Biochem. 71, 1993-2001; Hull, J. J., Lee, J. M., Kajigaya, R., and Matsumoto, S. (2009) J. Biol. Chem. 284, 31200-31213; Hull, J. J., Lee, J. M., and Matsumoto, S. (2010) Insect Mol. Biol. 19, 553-566). Little, however, is known about the molecular components regulating TAG lipolysis in PG cells. In the current study we found that PBAN signaling involves phosphorylation of an insect PAT family protein named B. mori lipid storage droplet protein-1 (BmLsd1) and that BmLsd1 plays an essential role in the TAG lipolysis associated with bombykol production. Unlike mammalian PAT family perilipins, however, BmLsd1 activation is dependent on phosphorylation by B. mori Ca2+/calmodulin-dependent protein kinase II rather than protein kinase A.	[Ohnishi, Atsushi; Hull, J. Joe; Kaji, Misato; Hashimoto, Kana; Lee, Jae Min; Tsuneizumi, Kazuhide; Suzuki, Takehiro; Dohmae, Naoshi; Matsumoto, Shogo] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan	RIKEN	Ohnishi, A (corresponding author), RIKEN, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	aohnishi@riken.jp; smatsu@riken.jp	Dohmae, Naoshi/C-2040-2011; Suzuki, Takehiro/B-3210-2013	Dohmae, Naoshi/0000-0002-5242-9410; Ohnishi, Atsushi/0000-0003-1213-4439	RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20380040]	RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Lipid Dynamics Research Program from RIKEN and the Targeted Proteins Research Program and Grants-in-aid for Scientific Research (B) 20380040 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Arrese EL, 2008, INSECT BIOCHEM MOLEC, V38, P993, DOI 10.1016/j.ibmb.2008.08.004; Bjostad L.B., 1987, P77; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fonagy A, 2005, ANN NY ACAD SCI, V1040, P310, DOI 10.1196/annals.1327.049; FONAGY A, 1992, J PESTIC SCI, V17, P47; Fonagy A, 2000, J INSECT PHYSIOL, V46, P735, DOI 10.1016/S0022-1910(99)00162-6; Fonagy A, 2001, ARTHROPOD STRUCT DEV, V30, P113, DOI 10.1016/S1467-8039(01)00027-5; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Gade G, 2003, GEN COMP ENDOCR, V132, P10, DOI 10.1016/S0016-6480(03)00159-X; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hull JJ, 2010, INSECT MOL BIOL, V19, P553, DOI 10.1111/j.1365-2583.2010.01013.x; Hull JJ, 2007, BIOSCI BIOTECH BIOCH, V71, P1993, DOI 10.1271/bbb.70175; Hull JJ, 2007, J INSECT PHYSIOL, V53, P782, DOI 10.1016/j.jinsphys.2007.02.013; Hull JJ, 2009, J BIOL CHEM, V284, P31200, DOI 10.1074/jbc.M109.044198; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; Jurenka R.A., 2003, P53, DOI 10.1016/B978-012107151-6/50005-0; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; KITAMURA A, 1989, BIOCHEM BIOPH RES CO, V163, P520, DOI 10.1016/0006-291X(89)92168-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; LAW JH, 1989, J BIOL CHEM, V264, P16335; MATSUMOTO S, 1995, BIOSCI BIOTECH BIOCH, V59, P560, DOI 10.1271/bbb.59.560; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; Matsumoto S, 2002, INSECT BIOCHEM MOLEC, V32, P1447, DOI 10.1016/S0965-1748(02)00065-6; Matsumoto S, 2001, INSECT BIOCHEM MOLEC, V31, P603, DOI 10.1016/S0965-1748(00)00165-X; Matsumoto S, 2007, J INSECT PHYSIOL, V53, P752, DOI 10.1016/j.jinsphys.2007.02.014; Matsumoto S, 2010, VITAM HORM, V83, P425, DOI 10.1016/S0083-6729(10)83018-3; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Ohnishi A, 2009, J BIOL CHEM, V284, P5128, DOI 10.1074/jbc.M806072200; Ozawa R, 1996, INSECT BIOCHEM MOLEC, V26, P259, DOI 10.1016/0965-1748(95)00088-7; Patel RT, 2006, ARCH INSECT BIOCHEM, V63, P73, DOI 10.1002/arch.20143; Patel RT, 2005, J BIOL CHEM, V280, P22624, DOI 10.1074/jbc.M413128200; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Percy JE, 1974, PHEROMONES, P11; Rafaeli A, 2002, INT REV CYTOL, V213, P49; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; Uno T, 2006, ARCH INSECT BIOCHEM, V61, P65, DOI 10.1002/arch.20098; Van der Horst DJ, 2001, INT REV CYTOL, V211, P179, DOI 10.1016/S0074-7696(01)11019-3; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726	47	29	31	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24101	24112		10.1074/jbc.M111.250555	http://dx.doi.org/10.1074/jbc.M111.250555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572162	Green Published, hybrid			2022-12-27	WOS:000292294900052
J	Stephens, AS; Stephens, SR; Hobbs, C; Hutmacher, DW; Bacic-Welsh, D; Woodruff, MA; Morrison, NA				Stephens, Alexandre S.; Stephens, Sebastien R.; Hobbs, Carl; Hutmacher, Deitmar W.; Bacic-Welsh, Desa; Woodruff, Maria Ann; Morrison, Nigel A.			Myocyte Enhancer Factor 2C, an Osteoblast Transcription Factor Identified by Dimethyl Sulfoxide (DMSO)-enhanced Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; MC3T3-E1 CELLS; DIFFERENTIATION; EXPRESSION; MEF2C; GENE	Rapid mineralization of cultured osteoblasts could be a useful characteristic in stem cell-mediated therapies for fracture and other orthopedic problems. Dimethyl sulfoxide (DMSO) is a small amphipathic solvent molecule capable of stimulating cell differentiation. We report that, in primary human osteoblasts, DMSO dose-dependently enhanced the expression of osteoblast differentiation markers alkaline phosphatase activity and extracellular matrix mineralization. Furthermore, similar DMSO-mediated mineralization enhancement was observed in primary osteoblast-like cells differentiated from mouse mesenchymal cells derived from fat, a promising source of starter cells for cell-based therapy. Using a convenient mouse pre-osteoblast model cell line MC3T3-E1, we further investigated this phenomenon showing that numerous osteoblast-expressed genes were elevated in response to DMSO treatment and correlated with enhanced mineralization. Myocyte enhancer factor 2c (Mef2c) was identified as the transcription factor most induced by DMSO, among the numerous DMSO-induced genes, suggesting a role for Mef2c in osteoblast gene regulation. Immunohistochemistry confirmed expression of Mef2c in osteoblast-like cells in mouse mandible, cortical, and trabecular bone. shRNAi-mediated Mef2c gene silencing resulted in defective osteoblast differentiation, decreased alkaline phosphatase activity, and matrix mineralization and knockdown of osteoblast specific gene expression, including osteocalcin and bone sialoprotein. A flow on knockdown of bone-specific transcription factors, Runx2 and osterix by shRNAi knockdown of Mef2c, suggests that Mef2c lies upstream of these two important factors in the cascade of gene expression in osteoblasts.	[Stephens, Alexandre S.; Stephens, Sebastien R.; Bacic-Welsh, Desa; Morrison, Nigel A.] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia; [Hobbs, Carl] Kings Coll London, London WC2R 2LS, England; [Hutmacher, Deitmar W.; Woodruff, Maria Ann] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Griffith University; University of London; King's College London; Queensland University of Technology (QUT)	Morrison, NA (corresponding author), Griffith Univ, Sch Med Sci, Gold Coast Campus, Southport, Qld 4215, Australia.	n.morrison@griffith.edu.au	Morrison, Nigel A/F-4082-2012; Woodruff, Maria/J-1247-2012; Stephens, Alexandre S/P-1396-2016	Morrison, Nigel A/0000-0003-4774-3808; Stephens, Alexandre S/0000-0003-2465-8117; Woodruff, Maria/0000-0002-4909-5288; Hutmacher, Dietmar Werner/0000-0001-5678-2134	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia (to N. A. M.) and the Australian Research Council (to D. W. H.).	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; AUBIN JE, 1995, BONE, V17, P77; Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Cheung WMW, 2006, FEBS LETT, V580, P121, DOI 10.1016/j.febslet.2005.11.062; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; KARSENTY G, 2003, ANN NY ACAD SCI, V423, P385; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lassaux A, 2005, J VIROL, V79, P6560, DOI 10.1128/JVI.79.10.6560-6564.2005; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Sakai K, 2001, MATRIX BIOL, V19, P761, DOI 10.1016/S0945-053X(00)00122-0; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Schuler A, 2008, BLOOD, V111, P4532, DOI 10.1182/blood-2007-10-116343; Woods EJ, 2009, CRYOBIOLOGY, V59, P150, DOI 10.1016/j.cryobiol.2009.06.005; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zyuz'kov GN, 2007, B EXP BIOL MED+, V143, P535, DOI 10.1007/s10517-007-0173-0	25	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30071	30086		10.1074/jbc.M111.253518	http://dx.doi.org/10.1074/jbc.M111.253518			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21652706	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000294046600065
J	Debelyy, MO; Platta, HW; Saffian, D; Hensel, A; Thoms, S; Meyer, HE; Warscheid, B; Girzalsky, W; Erdmann, R				Debelyy, Mykhaylo O.; Platta, Harald W.; Saffian, Delia; Hensel, Astrid; Thoms, Sven; Meyer, Helmut E.; Warscheid, Bettina; Girzalsky, Wolfgang; Erdmann, Ralf			Ubp15p, a Ubiquitin Hydrolase Associated with the Peroxisomal Export Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TYPE-1 RECEPTOR; SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; DEUBIQUITINATING ENZYME; AAA-PEROXINS; ENDOPLASMIC-RETICULUM; CONSERVED CYSTEINE; PTS1 RECEPTOR; YEAST; PEX5P	Peroxisomal matrix protein import is facilitated by cycling receptors shuttling between the cytosol and the peroxisomal membrane. One crucial step in this cycle is the ATP-dependent release of the receptors from the peroxisomal membrane. This step is facilitated by the peroxisomal AAA (ATPases associated with various cellular activities) proteins Pex1p and Pex6p with ubiquitination of the receptor being the main signal for its export. Here we report that the AAA complex contains dislocase as well as deubiquitinating activity. Ubp15p, a ubiquitin hydrolase, was identified as a novel constituent of the complex. Ubp15p partially localizes to peroxisomes and is capable of cleaving off ubiquitin moieties from the type I peroxisomal targeting sequence (PTS1) receptor Pex5p. Furthermore, Ubp15p-deficient cells are characterized by a stress-related PTS1 import defect. The results merge into a picture in which removal of ubiquitin from the PTS1 receptor Pex5p is a specific event and might represent a vital step in receptor recycling.	[Erdmann, Ralf] Ruhr Univ Bochum, Inst Physiol Chem, Fak Med, Abt Syst Biochem, D-44780 Bochum, Germany; [Thoms, Sven; Meyer, Helmut E.; Warscheid, Bettina] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Fak Med, Abt Syst Biochem, Univ Str 150, D-44780 Bochum, Germany.	Ralf.Erdmann@rub.de	Thoms, Sven/B-5763-2013; Platta, Harald Wolfgang/G-7423-2014; Thoms, Sven/K-4530-2019	Platta, Harald Wolfgang/0000-0001-8968-7280; Thoms, Sven/0000-0003-3018-6363; Debelyy, Mykhaylo/0000-0001-9746-5055; Astrid, Hensel/0000-0002-0793-0249; Warscheid, Bettina/0000-0001-5096-1975	Deutsche Forschungsgemeinschaft [SFB642]; European Molecular Biology Organization	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB642.; Supported by a European Molecular Biology Organization long term fellowship. Present address: Dept. of Biochemistry, Inst. for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 1997, EMBO J, V16, P4826; Birschmann I, 2005, FEBS J, V272, P47, DOI 10.1111/j.1432-1033.2004.04393.x; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; ENTIAN KD, 1988, FEBS LETT, V236, P195, DOI 10.1016/0014-5793(88)80313-2; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Grunau S, 2011, BIOCHEM J, V434, P161, DOI 10.1042/BJ20101115; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; IZAWA S, 1995, FEBS LETT, V368, P73, DOI 10.1016/0014-5793(95)00603-7; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam SK, 2010, P NATL ACAD SCI USA, V107, P21523, DOI 10.1073/pnas.1013397107; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; Terlecky SR, 2006, BBA-MOL CELL RES, V1763, P1749, DOI 10.1016/j.bbamcr.2006.08.017; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Vornlocher HP, 1999, J BIOL CHEM, V274, P16802, DOI 10.1074/jbc.274.24.16802; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; ZHANG JW, 1993, J CELL BIOL, V123, P1133, DOI 10.1083/jcb.123.5.1133; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308	79	74	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28223	28234		10.1074/jbc.M111.238600	http://dx.doi.org/10.1074/jbc.M111.238600			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21665945	Green Published, hybrid			2022-12-27	WOS:000293557800040
J	Tarsio, M; Zheng, HM; Smardon, AM; Martinez-Munoz, GA; Kane, PM				Tarsio, Maureen; Zheng, Huimei; Smardon, Anne M.; Martinez-Munoz, Gloria A.; Kane, Patricia M.			Consequences of Loss of Vph1 Protein-containing Vacuolar ATPases (V-ATPases) for Overall Cellular pH Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; CYTOSOLIC PH; PROTON PUMPS; GENE ENCODES; YEAST; ACIDIFICATION; MUTANTS; GLUCOSE; LOCALIZATION; DISSOCIATION	In yeast cells, subunit a of the vacuolar proton pump (V-ATPase) is encoded by two organelle-specific isoforms, VPH1 and STV1. V-ATPases containing Vph1 and Stv1 localize predominantly to the vacuole and the Golgi apparatus/endosomes, respectively. Ratiometric measurements of vacuolar pH confirm that loss of STV1 has little effect on vacuolar pH. Loss of VPH1 results in vacuolar alkalinization that is even more rapid and pronounced than in vma mutants, which lack all V-ATPase activity. Cytosolic pH responses to glucose addition in the vph1 Delta mutant are similar to those in vma mutants. The extended cytosolic acidification in these mutants arises from reduced activity of the plasma membrane proton pump, Pma1p. Pma1p is mislocalized in vma mutants but remains at the plasma membrane in both vph1 Delta and stv1 Delta mutants, suggesting multiple mechanisms for limiting Pma1 activity when organelle acidification is compromised. pH measurements in early pre-vacuolar compartments via a pHluorin fusion to the Golgi protein Gef1 demonstrate that pH responses of these compartments parallel cytosolic pH changes. Surprisingly, these compartments remain acidic even in the absence of V-ATPase function, possibly as a result of cytosolic acidification. These results emphasize that loss of a single subunit isoform may have effects far beyond the organelle where it resides.	[Tarsio, Maureen; Zheng, Huimei; Smardon, Anne M.; Martinez-Munoz, Gloria A.; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	kanepm@upstate.edu		Zheng, Janet/0000-0001-8838-1263	National Institutes of Health [R01 GM50322]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM50322 (to P. M. K.).	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Amberg DC., 2005, METHODS YEAST GENETI; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Hirata R., 2001, RIKEN REV, V41, P90; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lopez R, 1999, YEAST, V15, P553, DOI 10.1002/(SICI)1097-0061(199905)15:7<553::AID-YEA397>3.0.CO;2-V; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Miranda KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009531; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Perzov N, 2002, J EXP BIOL, V205, P1209; Perzov N, 2000, J BIOL CHEM, V275, P40088, DOI 10.1074/jbc.M007011200; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Qi J, 2007, J BIOL CHEM, V282, P24743, DOI 10.1074/jbc.M700663200; RAMOS S, 1989, J GEN MICROBIOL, V135, P2413; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005	37	48	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28089	28096		10.1074/jbc.M111.251363	http://dx.doi.org/10.1074/jbc.M111.251363			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669878	Green Published, hybrid			2022-12-27	WOS:000293557800027
J	Dutta, A; Zheng, ST; Jain, D; Cameron, CE; Reese, JC				Dutta, Arnob; Zheng, Suting; Jain, Deepti; Cameron, Craig E.; Reese, Joseph C.			Intermolecular Interactions within the Abundant DEAD-box Protein Dhh1 Regulate Its Activity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; CYTOPLASMIC PROCESSING BODIES; NONSENSE-MEDIATED DECAY; SACCHAROMYCES-CEREVISIAE; CCR4-NOT COMPLEX; HELICASE ACTIVITY; DECAPPING ENZYME; TRANSLATION INITIATION; CRYSTAL-STRUCTURE; P-BODIES	Dhh1 is a highly conserved DEAD-box protein that has been implicated in many processes involved in mRNA regulation. At least some functions of Dhh1 may be carried out in cytoplasmic foci called processing bodies (P-bodies). Dhh1 was identified initially as a putative RNA helicase based solely on the presence of conserved helicase motifs found in the superfamily 2 (Sf2) of DEXD/H-box proteins. Although initial mutagenesis studies revealed that the signature DEAD-box motif is required for Dhh1 function in vivo, enzymatic (ATPase or helicase) or ATP binding activities of Dhh1 or those of any its many higher eukaryotic orthologues have not been described. Here we provide the first characterization of the biochemical activities of Dhh1. Dhh1 has weaker RNA-dependent ATPase activity than other well characterized DEAD-box helicases. We provide evidence that intermolecular interactions between the N- and C-terminal RecA-like helicase domains restrict its ATPase activity; mutation of residues mediating these interactions enhanced ATP hydrolysis. Interestingly, the interdomain interaction mutant displayed enhanced mRNA turnover, RNA binding, and recruitment into cytoplasmic foci in vivo compared with wild type Dhh1. Also, we demonstrate that the ATPase activity of Dhh1 is not required for it to be recruited into cytoplasmic foci, but it regulates its association with RNA in vivo. We hypothesize that the activity of Dhh1 is restricted by interdomain interactions, which can be regulated by cellular factors to impart stringent control over this very abundant RNA helicase.	[Dutta, Arnob; Zheng, Suting; Jain, Deepti; Reese, Joseph C.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Reese, JC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, 463A N Frear, University Pk, PA 16802 USA.	Jcr8@psu.edu	Zheng, Suting/B-7382-2013	Dutta, Arnob/0000-0003-0061-8428	National Institutes of Health [GM58672]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58672 ( to J. C. R.).	Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bergkessel M, 2004, GENETICS, V167, P21, DOI 10.1534/genetics.167.1.21; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Brachmann CB, 1998, YEAST, V14, P115; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brown CE, 1996, MOL CELL BIOL, V16, P5744; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Del Campo M, 2009, ACTA CRYSTALLOGR F, V65, P832, DOI 10.1107/S1744309109027225; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Dunckley T, 2001, GENETICS, V157, P27; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hata H, 1998, GENETICS, V148, P571; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kikuma T, 2004, J BIOL CHEM, V279, P20692, DOI 10.1074/jbc.M400231200; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Long RM, 2003, MOL CELL, V11, P1126, DOI 10.1016/S1097-2765(03)00198-9; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Muhlrad D, 2005, EMBO J, V24, P1033, DOI 10.1038/sj.emboj.7600560; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Park YU, 2006, EUKARYOT CELL, V5, P2120, DOI 10.1128/EC.00121-06; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Psathas JN, 2009, MOL CELL BIOL, V29, P6413, DOI 10.1128/MCB.00876-09; Reese JC, 2003, METHOD ENZYMOL, V370, P415; Reese JC, 2001, YEAST, V18, P1197, DOI 10.1002/yea.761; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; SCHMID SR, 1991, MOL CELL BIOL, V11, P3463, DOI 10.1128/MCB.11.7.3463; Selth LA, 2009, COLD SPRING HARB PRO, V2009; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; STRAHLBOLSINGER S, 1993, YEAST, V9, P429, DOI 10.1002/yea.320090414; Svitkin YV, 2001, RNA, V7, P1743; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Westmoreland TJ, 2003, J SURG RES, V113, P62, DOI 10.1016/S0022-4804(03)00155-0; Weston A, 2006, NUCLEIC ACIDS RES, V34, P3082, DOI 10.1093/nar/gkl409; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006; Zheng ST, 2010, MOL CELL BIOL, V30, P3635, DOI 10.1128/MCB.00324-10	77	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27454	27470		10.1074/jbc.M111.220251	http://dx.doi.org/10.1074/jbc.M111.220251			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21642421	Green Published, hybrid			2022-12-27	WOS:000293268700041
J	Klier, M; Schuler, C; Halestrap, AP; Sly, WS; Deitmer, JW; Becker, HM				Klier, Michael; Schueler, Christina; Halestrap, Andrew P.; Sly, William S.; Deitmer, Joachim W.; Becker, Holger M.			Transport Activity of the High-affinity Monocarboxylate Transporter MCT2 Is Enhanced by Extracellular Carbonic Anhydrase IV but Not by Intracellular Carbonic Anhydrase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; CENTRAL-NERVOUS-SYSTEM; LACTATE TRANSPORT; ANCILLARY PROTEIN; SKELETAL-MUSCLE; O-18 EXCHANGE; PH REGULATION; BINDING-SITE; GLIAL-CELLS; BICARBONATE	The ubiquitous enzyme carbonic anhydrase isoform II (CAII) has been shown to enhance transport activity of the proton-coupled monocarboxylate transporters MCT1 and MCT4 in a non-catalytic manner. In this study, we investigated the role of cytosolic CAII and of the extracellular, membrane-bound CA isoform IV (CAIV) on the lactate transport activity of the high-affinity monocarboxylate transporter MCT2, heterologously expressed in Xenopus oocytes. In contrast to MCT1 and MCT4, transport activity of MCT2 was not altered by CAII. However, coexpression of CAIV with MCT2 resulted in a significant increase in MCT2 transport activity when the transporter was coexpressed with its associated ancillary protein GP70 (embigin). The CAIV-mediated augmentation of MCT2 activity was independent of the catalytic activity of the enzyme, as application of the CA-inhibitor ethoxyzolamide or coexpressing the catalytically inactive mutant CAIV-V165Y did not suppress CAIV-mediated augmentation of MCT2 transport activity. Furthermore, exchange of His-88, mediating an intramolecular H+ -shuttle in CAIV, to alanine resulted only in a slight decrease in CAIV-mediated augmentation of MCT2 activity. The data suggest that extracellular membrane-bound CAIV, but not cytosolic CAII, augments transport activity of MCT2 in a non-catalytic manner, possibly by facilitating a proton pathway other than His-88.	[Klier, Michael; Becker, Holger M.] TU Kaiserslautern, FB Biol, Arbeitsgrp Zool Membrantransport, D-67653 Kaiserslautern, Germany; [Klier, Michael; Schueler, Christina; Deitmer, Joachim W.] TU Kaiserslautern, FB Biol, Abt Allgemeine Zool, D-67653 Kaiserslautern, Germany; [Halestrap, Andrew P.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; [Sly, William S.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Kaiserslautern; University of Kaiserslautern; University of Bristol; Saint Louis University	Becker, HM (corresponding author), TU Kaiserslautern, FB Biol, Arbeitsgrp Zool Membrantransport, POB 3049, D-67653 Kaiserslautern, Germany.	h.becker@biologie.uni-kl.de	Halestrap, Andrew P/G-7275-2011; Becker, Holger/AAB-4322-2020	Halestrap, Andrew/0000-0001-5374-2778	Deutsche Forschungsgemeinschaft [DE 231/24-1]; Landesschwerpunkt Membrantransport	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesschwerpunkt Membrantransport	The work was funded by the Deutsche Forschungsgemeinschaft Grant DE 231/24-1 (to J. W. D.) and by the Landesschwerpunkt Membrantransport (to H. B. and J. W. D.).	Almquist J, 2010, J COMPUT SCI SYST BI, V3, P107, DOI DOI 10.4172/JCSB.1000066; Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; BADGER MR, 1989, PLANT PHYSIOL, V89, P51, DOI 10.1104/pp.89.1.51; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Bolanos Juan P, 2010, Front Neuroenergetics, V2, P1, DOI 10.3389/neuro.14.001.2010; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; CAMMER W, 1979, J NEUROCHEM, V32, P651, DOI 10.1111/j.1471-4159.1979.tb00401.x; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Di Fiore A, 2008, BIOORG MED CHEM LETT, V18, P2669, DOI 10.1016/j.bmcl.2008.03.023; FOSSUM S, 1991, EUR J IMMUNOL, V21, P671, DOI 10.1002/eji.1830210320; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hallerdei J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015137; Hurt JD, 1997, J BIOL CHEM, V272, P13512, DOI 10.1074/jbc.272.21.13512; Jackson VN, 1997, BIOCHEM J, V324, P447, DOI 10.1042/bj3240447; Juel C, 2003, J PHYSIOL-LONDON, V548, P639, DOI 10.1113/jphysiol.2002.035899; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Messonnier L, 2007, J APPL PHYSIOL, V102, P1936, DOI 10.1152/japplphysiol.00691.2006; Ovens MJ, 2010, BIOCHEM J, V431, P217, DOI 10.1042/BJ20100890; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pushkin A, 2004, J PHYSIOL-LONDON, V559, P55, DOI 10.1113/jphysiol.2004.065110; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; SULTEMEYER DF, 1990, PLANT PHYSIOL, V94, P1250, DOI 10.1104/pp.94.3.1250; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Supuran CT, 2009, DRUG DESIGN ZINC ENZ, P15; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; Svichar N, 2003, GLIA, V41, P415, DOI 10.1002/glia.10187; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Vaughan-Jones RD, 2002, BIOCHEM CELL BIOL, V80, P579, DOI 10.1139/O02-157; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Voipio J, 1997, J PHYSIOL-LONDON, V499, P527, DOI 10.1113/jphysiol.1997.sp021946; Wetzel P, 2001, J PHYSIOL-LONDON, V531, P743, DOI 10.1111/j.1469-7793.2001.0743h.x; Wilson MC, 2009, J BIOL CHEM, V284, P20011, DOI 10.1074/jbc.M109.014217; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200	49	45	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27781	27791		10.1074/jbc.M111.255331	http://dx.doi.org/10.1074/jbc.M111.255331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21680735	Green Published, hybrid			2022-12-27	WOS:000293268700070
J	Cartier, J; Berthelet, J; Marivin, A; Gemble, S; Edmond, V; Plenchette, S; Lagrange, B; Hammann, A; Dupoux, A; Delva, L; Eymin, B; Solary, E; Dubrez, L				Cartier, Jessy; Berthelet, Jean; Marivin, Arthur; Gemble, Simon; Edmond, Valerie; Plenchette, Stephanie; Lagrange, Brice; Hammann, Arlette; Dupoux, Alban; Delva, Laurent; Eymin, Beatrice; Solary, Eric; Dubrez, Laurence			Cellular Inhibitor of Apoptosis Protein-1 (cIAP1) Can Regulate E2F1 Transcription Factor-mediated Control of Cyclin Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; FAMILY-MEMBERS; S-PHASE; C-IAPS; EXPRESSION; CANCER; C-IAP1	The inhibitor of apoptosis protein cIAP1 (cellular inhibitor of apoptosis protein-1) is a potent regulator of the tumor necrosis factor (TNF) receptor family and NF-kappa B signaling pathways in the cytoplasm. However, in some primary cells and tumor cell lines, cIAP1 is expressed in the nucleus, and its nuclear function remains poorly understood. Here, we show that the N-terminal part of cIAP1 directly interacts with the DNA binding domain of the E2F1 transcription factor. cIAP1 dramatically increases the transcriptional activity of E2F1 on synthetic and CCNE promoters. This function is not conserved for cIAP2 and XIAP, which are cytoplasmic proteins. Chromatin immunoprecipitation experiments demonstrate that cIAP1 is recruited on E2F binding sites of the CCNE and CCNA promoters in a cell cycle-and differentiation-dependent manner. cIAP1 silencing inhibits E2F1 DNA binding and E2F1-mediated transcriptional activation of the CCNE gene. In cells that express a nuclear cIAP1 such as HeLa, THP1 cells and primary human mammary epithelial cells, down-regulation of cIAP1 inhibits cyclin E and A expression and cell proliferation. We conclude that one of the functions of cIAP1 when localized in the nucleus is to regulate E2F1 transcriptional activity.	[Cartier, Jessy; Berthelet, Jean; Marivin, Arthur; Gemble, Simon; Plenchette, Stephanie; Lagrange, Brice; Hammann, Arlette; Dupoux, Alban; Delva, Laurent; Solary, Eric; Dubrez, Laurence] Fac Med, INSERM, UMR866, F-21079 Dijon, France; [Cartier, Jessy; Berthelet, Jean; Marivin, Arthur; Edmond, Valerie; Plenchette, Stephanie; Lagrange, Brice; Hammann, Arlette; Dupoux, Alban; Delva, Laurent; Solary, Eric; Dubrez, Laurence] Univ Burgundy, Fac Med, Inst Federatif Rech IFR 100, F-21079 Dijon, France; [Edmond, Valerie; Eymin, Beatrice] Inst Albert Bonniot, INSERM, Equipe Bases Mol Progress Canc Poumon, U823, F-38042 Grenoble, France; [Edmond, Valerie; Eymin, Beatrice] Univ Grenoble 1, F-38041 Grenoble, France; [Solary, Eric] Inst Gustave Roussy, INSERM, UMR1009, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Dubrez, L (corresponding author), Fac Med, INSERM, UMR866, 7 Blvd Jeanne dArc, F-21079 Dijon, France.	ldubrez@u-bourgogne.fr	Eymin, Beatrice/M-1962-2013; Plenchette, Stéphanie/AAA-5155-2021; Laurence, Dubrez/P-9472-2019; Dubrez, Laurence/I-4971-2016; eymin, beatrice/U-4670-2019	Eymin, Beatrice/0000-0002-7311-3810; Plenchette, Stéphanie/0000-0003-4483-9206; Laurence, Dubrez/0000-0002-7030-2181; Dubrez, Laurence/0000-0002-7030-2181; eymin, beatrice/0000-0002-7311-3810; Lagrange, Brice/0000-0002-4131-5995; DUPOUX, Alban/0000-0003-3112-2927; Berthelet, Jean/0000-0003-2562-0575; Solary, Eric/0000-0002-8629-1341; DELVA, Laurent/0000-0002-1086-3964; CARTIER, Jessy/0000-0002-0366-8546	Ligue Nationale Contre le Cancer; Comite de Cote d'Or, Nievre, Saone et Loire and Yonne of the Ligue contre le Cancer; Association pour la Recherche sur le Cancer (ARC); association "Cent pour Sang la Vie"; Association Nationale de la Recherche; National Institute of Cancer; "Ministere de l'Enseignement Superieur et de la Recherche" of France	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Comite de Cote d'Or, Nievre, Saone et Loire and Yonne of the Ligue contre le Cancer; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); association "Cent pour Sang la Vie"; Association Nationale de la Recherche; National Institute of Cancer; "Ministere de l'Enseignement Superieur et de la Recherche" of France	This work was supported by grants from the Ligue Nationale Contre le Cancer (equipe labellisee, ES) and the Comite de Cote d'Or, Nievre, Saone et Loire and Yonne of the Ligue contre le Cancer (to L. D.), the Association pour la Recherche sur le Cancer (ARC, to L. D.), the association "Cent pour Sang la Vie", the Association Nationale de la Recherche and the National Institute of Cancer, and fellowships from the "Ministere de l'Enseignement Superieur et de la Recherche" of France (to J. C., A. D., J. B., A. M., B. L. and S. P.) and ARC (to J. C.).	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Cheng L., 2010, ONCOGENE, V38, P62; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; DeGregori J, 2006, CURR MOL MED, V6, P739; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Dupoux A, 2009, BLOOD, V113, P175, DOI 10.1182/blood-2008-02-137919; Geng Y, 1996, ONCOGENE, V12, P1173; Gibbs J, 2008, ONCOGENE, V27, P98, DOI 10.1038/sj.onc.1210627; Gordon GJ, 2007, J PATHOL, V211, P439, DOI 10.1002/path.2120; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Imoto I, 2002, CANCER RES, V62, P4860; Imoto I, 2001, CANCER RES, V61, P6629; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Ivanova IA, 2009, ONCOGENE, V28, P52, DOI 10.1038/onc.2008.354; Kempkensteffen C, 2007, INT J CANCER, V120, P1081, DOI 10.1002/ijc.22416; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Ma O, 2009, CANCER RES, V69, P2559, DOI 10.1158/0008-5472.CAN-08-2929; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Paggetti J, 2010, ONCOGENE, V29, P5019, DOI 10.1038/onc.2010.254; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Plenchette S, 2004, BLOOD, V104, P2035, DOI 10.1182/blood-2004-01-0065; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Ponnelle T, 2003, PATHOL RES PRACT, V199, P723, DOI 10.1078/0344-0338-00488; Sahin F, 2010, INT J BIOL SCI, V6, P116; Samuel T, 2005, CANCER RES, V65, P210; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tanimoto T, 2005, CANCER LETT, V224, P141, DOI 10.1016/j.canlet.2004.11.049; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vischioni B, 2006, HUM PATHOL, V37, P78, DOI 10.1016/j.humpath.2005.09.022; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Xu L, 2007, MOL CELL, V28, P914, DOI 10.1016/j.molcel.2007.10.027; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao YG, 2007, J BIOL CHEM, V282, P7777, DOI 10.1074/jbc.M609146200	52	33	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26406	26417		10.1074/jbc.M110.191239	http://dx.doi.org/10.1074/jbc.M110.191239			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653699	hybrid, Green Published			2022-12-27	WOS:000293078200018
J	Chen, JC; Chuang, JG; Su, YY; Chiang, BL; Lin, YS; Chow, LP				Chen, Jui-Chieh; Chuang, Jiing-Guang; Su, Yu-Yi; Chiang, Bor-Luen; Lin, You-Shuei; Chow, Lu-Ping			The Protease Allergen Pen c 13 Induces Allergic Airway Inflammation and Changes in Epithelial Barrier Integrity and Function in a Murine Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITE ALLERGEN; SERINE-PROTEASE; BRONCHIAL HYPERRESPONSIVENESS; PROTEOLYTIC ACTIVITY; ASTHMA INSIGHTS; MOLECULAR-BASIS; TIGHT JUNCTION; ALPHA-CATENIN; LUNG INJURY; EXPRESSION	Fungal allergens are associated with the development of asthma, and some have been characterized as proteases. Here, we established an animal model of allergic airway inflammation in response to continuous exposure to proteolytically active Pen c 13, a major allergen secreted by Penicillium citrinum. In functional analyses, Pen c 13 exposure led to increased airway hyperresponsiveness, significant inflammatory cell infiltration, mucus overproduction, and collagen deposition in the lung, dramatically elevated serum levels of total IgE and Pen c 13-specific IgE and IgG1, and increased production of the Th2 cytokines IL-4, IL-5, and IL-13 by splenocytes stimulated in vitro with Pen c 13. To examine the mechanisms involved in the regulation of allergenicity by Pen c 13, we performed two-dimensional fluorescence difference gel electrophoresis analysis combined with nano-LC-MS/MS, followed by bioinformatics analysis to identify potential targets that associated with allergic inflammation, which suggested that galectin-3 and laminin might be involved in novel pathogenic mechanisms. Finally, we focused on junctional proteins between cells, because, in addition to opening of the epithelial barrier by environmental proteases possibly being the initial step in the development of asthma, these proteins are also associated with actin rearrangement. Taken together, our findings indicate that Pen c 13 exposure causes junctional structure alterations and actin cytoskeletal rearrangements, resulting in increased permeability and airway structural changes. These effects probably change the lung microenvironment and foster the development of allergic sensitization.	[Chen, Jui-Chieh; Chuang, Jiing-Guang; Su, Yu-Yi; Chow, Lu-Ping] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei 100, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 100, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan; [Lin, You-Shuei] Taipei Med Univ, Dept Physiol, Taipei 110, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Chow, LP (corresponding author), 1,Sec 1,Jen Ai Rd, Taipei 100, Taiwan.	chowip@ntu.edu.tw	é, çå/HCH-5712-2022	CHIANG, BOR-LUEN/0000-0002-6705-0286; Lin, You Shuei/0000-0003-1364-0245; Chen, Jui-Chieh/0000-0002-8854-9801; CHOW, LU-PING/0000-0002-4420-211X	Ministry of Education; Republic of China National Science Council [99-2320-B-002-012]	Ministry of Education; Republic of China National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by the Program for Excellence Research Teams from the Ministry of Education and Republic of China National Science Council Grant NSC 99-2320-B-002-012.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Altraja A, 1996, AM J RESP CELL MOL, V15, P482, DOI 10.1165/ajrcmb.15.4.8879182; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Bisht V, 2004, FEMS IMMUNOL MED MIC, V42, P205, DOI 10.1016/j.femsim.2004.05.003; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Chen CL, 2003, J IMMUNOL, V170, P528, DOI 10.4049/jimmunol.170.1.528; Chen HY, 2006, J IMMUNOL, V177, P4991, DOI 10.4049/jimmunol.177.8.4991; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Chiu LL, 2007, J IMMUNOL, V178, P5237, DOI 10.4049/jimmunol.178.8.5237; Comhair SAA, 2005, AM J RESP CRIT CARE, V172, P306, DOI 10.1164/rccm.200502-180OC; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Fan WH, 2002, J BIOL CHEM, V277, P9800, DOI 10.1074/jbc.M111213200; Fattouh R, 2005, AM J RESP CRIT CARE, V172, P314, DOI 10.1164/rccm.200502-198OC; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Folli C, 2008, CURR OPIN ALLERGY CL, V8, P367, DOI 10.1097/ACI.0b013e32830a7086; Furmonaviciene R, 2005, BIOINFORMATICS, V21, P4201, DOI 10.1093/bioinformatics/bti700; Furmonaviciene R, 2001, J CLIN PATHOL-MOL PA, V54, P155, DOI 10.1136/mp.54.3.155; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P728, DOI 10.1046/j.1365-2222.2002.01374.x; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hashimoto S, 2008, AM J PHYSIOL-LUNG C, V295, pL566, DOI 10.1152/ajplung.90250.2008; Inoue K, 2009, INT IMMUNOPHARMACOL, V9, P1281, DOI 10.1016/j.intimp.2009.07.010; Jensen LB, 2008, J IMMUNOL METHODS, V335, P116, DOI 10.1016/j.jim.2008.02.012; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Kurup VP, 2002, INT ARCH ALLERGY IMM, V129, P129, DOI 10.1159/000065882; Lai CH, 2005, BRAIN RES REV, V50, P7, DOI 10.1016/j.brainresrev.2005.03.007; Lai CKW, 2003, J ALLERGY CLIN IMMUN, V111, P263, DOI 10.1067/mai.2003.30; Lopez E, 2006, J IMMUNOL, V176, P1943, DOI 10.4049/jimmunol.176.3.1943; Matsuwaki Y, 2009, J IMMUNOL, V183, P6708, DOI 10.4049/jimmunol.0901220; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Rudiger M, 1998, BIOESSAYS, V20, P733; Ryan TP, 1997, FREE RADICAL BIO MED, V22, P901, DOI 10.1016/S0891-5849(96)00483-2; Saegusa J, 2009, AM J PATHOL, V174, P922, DOI 10.2353/ajpath.2009.080500; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; Shen HD, 2007, CURR ALLERGY ASTHM R, V7, P351, DOI 10.1007/s11882-007-0053-8; Shpacovitch V, 2007, TRENDS IMMUNOL, V28, P541, DOI 10.1016/j.it.2007.09.001; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Smith PK, 2006, ALLERGY, V61, P1441, DOI 10.1111/j.1398-9995.2006.01233.x; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Su NY, 1999, EUR J BIOCHEM, V261, P115, DOI 10.1046/j.1432-1327.1999.00242.x; Sudha VT, 2008, ALLERGY, V63, P768, DOI 10.1111/j.1398-9995.2007.01602.x; Sudha VT, 2009, EUR J CLIN INVEST, V39, P507, DOI 10.1111/j.1365-2362.2009.02112.x; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Tai HY, 2006, ALLERGY, V61, P382, DOI 10.1111/j.1398-9995.2005.00958.x; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Tripathi P, 2009, J CLIN IMMUNOL, V29, P292, DOI 10.1007/s10875-008-9261-9; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wan H, 2000, CLIN EXP ALLERGY, V30, P685, DOI 10.1046/j.1365-2222.2000.00820.x; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; WYNN TA, 1995, NATURE, V376, P594, DOI 10.1038/376594a0; YOUNG CL, 1994, J BIOL CHEM, V269, P13997; Yu CC, 2009, J IMMUNOL, V182, P7916, DOI 10.4049/jimmunol.0801582; Yu CK, 1999, J ALLERGY CLIN IMMUN, V104, P228, DOI 10.1016/S0091-6749(99)70140-5; Zuberi RI, 2004, AM J PATHOL, V165, P2045, DOI 10.1016/S0002-9440(10)63255-5	75	34	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26667	26679		10.1074/jbc.M110.193987	http://dx.doi.org/10.1074/jbc.M110.193987			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21613216	Green Published, hybrid			2022-12-27	WOS:000293078200044
J	Fu, R; Gupta, R; Geng, JF; Dornevil, K; Wang, SM; Zhang, Y; Hendrich, MP; Liu, AM				Fu, Rong; Gupta, Rupal; Geng, Jiafeng; Dornevil, Kednerlin; Wang, Siming; Zhang, Yong; Hendrich, Michael P.; Liu, Aimin			Enzyme Reactivation by Hydrogen Peroxide in Heme-based Tryptophan Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; HUMAN INDOLEAMINE 2,3-DIOXYGENASE; ELECTRON-PARAMAGNETIC-RESONANCE; CHLOROPEROXIDASE COMPOUND-II; DENSITY-FUNCTIONAL THEORY; CATALASE-PEROXIDASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; SPECTROSCOPIC PROPERTIES; MOSSBAUER-SPECTROSCOPY	An intriguing mystery about tryptophan 2,3-dioxygenase is its hydrogen peroxide-triggered enzyme reactivation from the resting ferric oxidation state to the catalytically active ferrous form. In this study, we found that such an odd Fe(III) reduction by an oxidant depends on the presence of L-Trp, which ultimately serves as the reductant for the enzyme. In the peroxide reaction with tryptophan 2,3-dioxygenase, a previously unknown catalase-like activity was detected. A ferryl species (delta = 0.055 mm/s and Delta E-Q = 1.755 mm/s) and a protein-based free radical (g = 2.0028 and 1.72 millitesla linewidth) were characterized by Mossbauer and EPR spectroscopy, respectively. This is the first compound ES-type of ferryl intermediate from a heme-based dioxygenase characterized by EPR and Mossbauer spectroscopy. Density functional theory calculations revealed the contribution of secondary ligand sphere to the spectroscopic properties of the ferryl species. In the presence of L-Trp, the reactivation was demonstrated by enzyme assays and by various spectroscopic techniques. ATrp-Trp dimer and a monooxygenated L-Trp were both observed as the enzyme reactivation by-products by mass spectrometry. Together, these results lead to the unraveling of an over 60-year old mystery of peroxide reactivation mechanism. These results may shed light on how a metalloenzyme maintains its catalytic activity in an oxidizing environment.	[Fu, Rong; Geng, Jiafeng; Dornevil, Kednerlin; Wang, Siming; Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Gupta, Rupal; Hendrich, Michael P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Zhang, Yong] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA	University System of Georgia; Georgia State University; Carnegie Mellon University; Stevens Institute of Technology	Liu, AM (corresponding author), Georgia State Univ, Dept Chem, POB 4098, Atlanta, GA 30303 USA.	Feradical@gsu.edu	Liu, Aimin/C-1572-2017; Geng, Jiafeng/G-4948-2015; Zhang, Yong/K-2395-2014	Liu, Aimin/0000-0002-4182-8176; Geng, Jiafeng/0000-0001-9488-0974; Zhang, Yong/0000-0001-7207-6416	National Science Foundation [MCB0843537]; National Institutes of Health [GM077387, GM085774]; Georgia Cancer Coalition Distinguished Scholar Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077387, R15GM085774] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0843537] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition Distinguished Scholar Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB0843537 (to A. L.) and Georgia Cancer Coalition Distinguished Scholar Program (to A. L.). This work was also supported in part by National Institutes of Health Grants GM077387 (to M. P. H.) and GM085774 (to Y. Z.).	Basran J, 2008, BIOCHEMISTRY-US, V47, P4752, DOI 10.1021/bi702393b; Batabyal D, 2009, J AM CHEM SOC, V131, P3260, DOI 10.1021/ja807969a; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p; BENDER ML, 1957, J AM CHEM SOC, V79, P116, DOI 10.1021/ja01558a030; BRADY FO, 1971, J BIOL CHEM, V246, P7119; BYRN M, 1966, J AM CHEM SOC, V88, P1916, DOI 10.1021/ja00961a013; Byrn M., 1965, UCRL16571 LAWR BERK, P1; Chung LW, 2010, J AM CHEM SOC, V132, P11993, DOI 10.1021/ja103530v; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; Dalosto SD, 2004, J PHYS CHEM B, V108, P6450, DOI 10.1021/jp0310697; De Laurentis W, 2007, BIOCHEMISTRY-US, V46, P12393, DOI 10.1021/bi7012189; de Montellano P. R. O., 1995, CYTCOCHROME P450 STR, P245; Debrunner P. G., 1989, IRON PORPHYRINS, V3, P137; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; FEIGELSON P, 1961, BIOCHIM BIOPHYS ACTA, V50, P200, DOI 10.1016/0006-3002(61)91088-5; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Fukumura E, 2009, J BIOCHEM, V145, P505, DOI 10.1093/jb/mvp002; Garcia-Serres R, 2007, J AM CHEM SOC, V129, P1402, DOI 10.1021/ja067209i; Gerdemann C, 2001, BBA-PROTEIN STRUCT M, V1548, P94, DOI 10.1016/S0167-4838(01)00219-9; Gouet P, 1996, NAT STRUCT BIOL, V3, P951, DOI 10.1038/nsb1196-951; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Guillemin GJ, 2005, NEURODEGENER DIS, V2, P166, DOI 10.1159/000089622; Guillemin GJ, 2002, REDOX REP, V7, P199, DOI 10.1179/135100002125000550; Gupta R, 2010, J AM CHEM SOC, V132, P1098, DOI 10.1021/ja908851e; HARAMI T, 1977, J CHEM PHYS, V67, P1164, DOI 10.1063/1.434969; HAYAISHI O, 1957, J BIOL CHEM, V229, P889; HAYAISHI O, 1993, PROTEIN SCI, V2, P472; HOFFMAN BM, 1981, J BIOL CHEM, V256, P6556; Horner O, 2007, J BIOL INORG CHEM, V12, P509, DOI 10.1007/s00775-006-0203-9; ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593; Jeng WY, 2004, J PEPT RES, V64, P104, DOI 10.1111/j.1399-3011.2004.00174.x; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; KNOX WE, 1950, J BIOL CHEM, V187, P419; KOPPENOL WH, 1987, BIOELECTROCH BIOENER, V18, P3, DOI 10.1016/0302-4598(87)85002-X; Kotake Y, 1936, H-S Z PHYSIOL CHEM, V243, P237, DOI 10.1515/bchm2.1936.243.6.237; KUHN H, 1981, EUR J BIOCHEM, V120, P161, DOI 10.1111/j.1432-1033.1981.tb05684.x; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; LANG G, 1976, BIOCHIM BIOPHYS ACTA, V451, P250, DOI 10.1016/0304-4165(76)90275-0; Laveille Paco, 2009, Biotechnology Journal, V4, P1460, DOI 10.1002/biot.200900100; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Li JS, 2007, ARCH INSECT BIOCHEM, V64, P74, DOI 10.1002/arch.20159; Li XH, 2008, P NATL ACAD SCI USA, V105, P8597, DOI 10.1073/pnas.0801643105; Ling Y, 2010, J PHYS CHEM LETT, V1, P2936, DOI 10.1021/jz101159x; Liu A., 2009, WILEY ENCY CHEM BIOL, V1, P591; MAEDA Y, 1967, BIOCHEM BIOPH RES CO, V29, P362, DOI 10.1016/0006-291X(67)90463-9; MEHLER AH, 1950, J BIOL CHEM, V187, P431; Mi, 1970, METHOD ENZYMOL, V17, P434, DOI 10.1016/0076-6879(71)17223-0; Munck E., 2000, PHYS METHODS BIOINOR, P287; Nagy JM, 1997, J BIOL CHEM, V272, P31265, DOI 10.1074/jbc.272.50.31265; Paglino A, 2008, INSECT BIOCHEM MOLEC, V38, P871, DOI 10.1016/j.ibmb.2008.05.011; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; Pfister TD, 2005, J BIOL CHEM, V280, P12858, DOI 10.1074/jbc.M410853200; Poljak A, 2006, ARCH BIOCHEM BIOPHYS, V450, P9, DOI 10.1016/j.abb.2006.03.003; PORTER TD, 1991, J BIOL CHEM, V266, P13469; Rana S.V.S., 1997, LIVER ENV XENOBIOTIC, P114; RAO SI, 1994, J BIOL CHEM, V269, P7210; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Robotka H, 2008, FUTUR NEUROL, V3, P169, DOI 10.2217/14796708.3.2.169; Ronsein GE, 2008, CHEM RES TOXICOL, V21, P1271, DOI 10.1021/tx800026g; RUTTER R, 1984, BIOCHEMISTRY-US, V23, P6809, DOI 10.1021/bi00321a082; Schulz C., 1979, Journal de Physique Colloque, V40, pC2/534, DOI 10.1051/jphyscol:19792185; SCHULZ CE, 1984, BIOCHEMISTRY-US, V23, P4743, DOI 10.1021/bi00315a033; Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Stone KL, 2006, J AM CHEM SOC, V128, P6147, DOI 10.1021/ja057876w; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; TANAKA T, 1959, J BIOL CHEM, V234, P1162; Thackray SJ, 2008, BIOCHEMISTRY-US, V47, P10677, DOI 10.1021/bi801202a; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Varnado CL, 2004, ARCH BIOCHEM BIOPHYS, V421, P166, DOI 10.1016/j.abb.2003.10.020; WACHTERS AJ, 1970, J CHEM PHYS, V52, P1033, DOI 10.1063/1.1673095; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; YONETANI T, 1965, J BIOL CHEM, V240, P4509; Zhang Y, 2004, J AM CHEM SOC, V126, P4470, DOI 10.1021/ja030664j; Zhang Y, 2007, BIOCHEMISTRY-US, V46, P145, DOI 10.1021/bi0620095	87	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26541	26554		10.1074/jbc.M111.253237	http://dx.doi.org/10.1074/jbc.M111.253237			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632548	Green Published, hybrid			2022-12-27	WOS:000293078200033
J	Iyengar, S; Farnham, PJ				Iyengar, Sushma; Farnham, Peggy J.			KAP1 Protein: An Enigmatic Master Regulator of the Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ZINC-FINGER PROTEINS; NUCLEAR COREPRESSOR KAP1; KRAB REPRESSION DOMAIN; EMBRYONIC STEM-CELLS; DOUBLE-STRAND BREAKS; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; MDM2 INTERACTION; TIF1 FAMILY; PHD DOMAIN	In mammalian cells, multiple cellular processes, including gene silencing, cell growth and differentiation, pluripotency, neoplastic transformation, apoptosis, DNA repair, and maintenance of genomic integrity, converge on the evolutionarily conserved protein KAP1, which is thought to regulate the dynamic organization of chromatin structure via its ability to influence epigenetic patterns and chromatin compaction. In this minireview, we discuss how KAP1 might execute such pleiotropic effects, focusing on genomic targeting mechanisms, protein-protein interactions, specific post-translational modifications of both KAP1 and associated histones, and transcriptome analyses of cells deficient in KAP1.	[Iyengar, Sushma; Farnham, Peggy J.] Univ So Calif, Dept Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Iyengar, Sushma] Univ Calif Davis, Genet Grad Grp, Davis, CA 95616 USA	University of Southern California; University of California System; University of California Davis	Farnham, PJ (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA.	pfarnham@usc.edu		Farnham, Peggy/0000-0003-4469-7914	United States Public Health Service [CA45240, HG004558]; NATIONAL CANCER INSTITUTE [R29CA045240, R01CA045240] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by United States Public Health Service Grants CA45240 and HG004558. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Barde I, 2009, J VIROL, V83, P5574, DOI 10.1128/JVI.00001-09; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Blahnik KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017121; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cammas F, 2002, J CELL SCI, V115, P3439; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Chang CJ, 1998, MOL CELL BIOL, V18, P5880, DOI 10.1128/MCB.18.10.5880; Chang PC, 2009, CANCER RES, V69, P5681, DOI 10.1158/0008-5472.CAN-08-4570; Doisne JM, 2009, J EXP MED, V206, P1365, DOI 10.1084/jem.20090127; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fertey J, 2011, J VIROL, V85, P2918, DOI 10.1128/JVI.01647-10; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gilchrist DA, 2009, METHODS, V48, P398, DOI 10.1016/j.ymeth.2009.02.024; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2009, BIOCHEM SOC T, V37, P569, DOI 10.1042/BST0370569; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Itokawa Y, 2009, BIOCHEM BIOPH RES CO, V388, P689, DOI 10.1016/j.bbrc.2009.08.065; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Jin VX, 2007, GENOME RES, V17, P807, DOI 10.1101/gr.6006107; Kamitani S, 2008, BIOCHEM BIOPH RES CO, V370, P366, DOI 10.1016/j.bbrc.2008.03.104; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Li X, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000781; Li ZB, 2003, EMBO J, V22, P1857, DOI 10.1093/emboj/cdg173; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Lorenz P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-206; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Mark C, 2001, DNA CELL BIOL, V20, P275, DOI 10.1089/104454901750232472; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Nakamura Y, 2006, INT J HEMATOL, V84, P377, DOI 10.1532/IJH97.06151; Niederreither K, 1999, MECH DEVELOP, V88, P111, DOI 10.1016/S0925-4773(99)00175-6; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nowick K, 2010, MOL BIOL EVOL, V27, P2606, DOI 10.1093/molbev/msq157; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Peng HZ, 2007, J MOL BIOL, V370, P269, DOI 10.1016/j.jmb.2007.03.047; Peng HZ, 2009, J BIOL CHEM, V284, P35670, DOI 10.1074/jbc.M109.032086; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Rambaud J, 2009, J BIOL CHEM, V284, P14147, DOI 10.1074/jbc.M809023200; Rooney JW, 2001, GENE DEV, V15, P3023, DOI 10.1101/gad.937201; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Silva FP, 2006, ONCOGENE, V25, P5063, DOI 10.1038/sj.onc.1209517; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yokoe T, 2010, ANN SURG ONCOL, V17, P821, DOI 10.1245/s10434-009-0795-8; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zeng L, 2008, NAT STRUCT MOL BIOL, V15, P626, DOI 10.1038/nsmb.1416; Zhao Xing-Hui, 2003, Sheng Wu Gong Cheng Xue Bao, V19, P608; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	82	230	233	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26267	26276		10.1074/jbc.R111.252569	http://dx.doi.org/10.1074/jbc.R111.252569			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652716	hybrid, Green Published			2022-12-27	WOS:000293078200003
J	Zhang, YL; Xiao, MF; Horiyama, T; Zhang, YF; Li, XC; Nishino, K; Yan, AX				Zhang, Yiliang; Xiao, Minfeng; Horiyama, Tsukasa; Zhang, Yinfeng; Li, Xuechen; Nishino, Kunihiko; Yan, Aixin			The Multidrug Efflux Pump MdtEF Protects against Nitrosative Damage during the Anaerobic Respiration in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANCE; NITRIC-OXIDE; TRANSCRIPTIONAL REGULATION; ACID RESISTANCE; EXPORTER GENES; BACTERIA; EXPRESSION; REGULATOR; INDOLE; SIGNAL	Drug efflux represents an important protection mechanism in bacteria to withstand antibiotics and environmental toxic substances. Efflux genes constitute 6-18% of all transporters in bacterial genomes, yet the expression and functions of only a handful of them have been studied. Among the 20 efflux genes encoded in the Escherichia coli K-12 genome, only the AcrAB-TolC system is constitutively expressed. The expression, activities, and physiological functions of the remaining efflux genes are poorly understood. In this study we identified a dramatic up-regulation of an additional efflux pump, MdtEF, under the anaerobic growth condition of E. coli, which is independent of antibiotic exposure. We found that expression of MdtEF is up-regulated more than 20-fold under anaerobic conditions by the global transcription factor ArcA, resulting in increased efflux activity and enhanced drug tolerance in anaerobically grown E. coli. Cells lacking mdtEF display a significantly decreased survival rate under the condition of anaerobic respiration of nitrate. Deletion of the genes responsible for the biosynthesis of indole, tnaAB, or replacing nitrate with fumarate as the terminal electron acceptor during the anaerobic respiration restores the decreased survival of Delta mdtEF cells. Moreover, Delta mdtEF cells are susceptible to indole nitrosative derivatives, a class of toxic byproducts formed and accumulated within E. coli when the bacterium respires nitrate under anaerobic conditions. Taken together, we conclude that the multidrug efflux pump MdtEF is up-regulated during the anaerobic physiology of E. coli to protect the bacterium from nitrosative damage through expelling the nitrosyl indole derivatives out of the cells.	[Zhang, Yiliang; Xiao, Minfeng; Yan, Aixin] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yinfeng; Li, Xuechen] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Horiyama, Tsukasa; Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	University of Hong Kong; University of Hong Kong; Osaka University	Yan, AX (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	ayan8@hku.hk		Xiao, Minfeng/0000-0002-0507-7352; Zhang, Yinfeng/0000-0002-4408-0175	Hong Kong General Research Fund [HKU 781509M]; Network Joint Research Center for Materials and Devices; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Hong Kong General Research Fund; Network Joint Research Center for Materials and Devices; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Hong Kong General Research Fund (HKU 781509M; to A. Y.) and by the Cooperative Research Program of "Network Joint Research Center for Materials and Devices" (to A. Y. and K. N.) as well as grants from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. N.).	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Astolfi P, 2006, ORG BIOMOL CHEM, V4, P3282, DOI 10.1039/b607680g; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ELLEDGE SJ, 1989, GENE DEV, V3, P185, DOI 10.1101/gad.3.2.185; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Helling RB, 2002, J BACTERIOL, V184, P3699, DOI 10.1128/JB.184.13.3699-3703.2002; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Hirakawa H, 2006, J BACTERIOL, V188, P5851, DOI 10.1128/JB.00301-06; Kawamura-Sato K, 1999, FEMS MICROBIOL LETT, V179, P345, DOI 10.1016/S0378-1097(99)00433-4; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Kwon YM, 2009, J BACTERIOL, V191, P5369, DOI 10.1128/JB.00586-09; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Mettert EL, 2007, J BACTERIOL, V189, P3036, DOI 10.1128/JB.00052-07; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2008, IUBMB LIFE, V60, P569, DOI 10.1002/iub.90; Nishino K, 2008, J ANTIBIOT, V61, P120, DOI 10.1038/ja.2008.120; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K., 2008, MICROBE, V3, P179, DOI DOI 10.1128/MICR0BE.3.179.1; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Rankin LD, 2008, J BACTERIOL, V190, P6170, DOI 10.1128/JB.00508-08; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x; SPIRO S, 1994, ANTON LEEUW INT J G, V66, P23, DOI 10.1007/BF00871630; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Vanaja SK, 2009, J BACTERIOL, V191, P1868, DOI 10.1128/JB.01481-08; Weiss B, 2006, J BACTERIOL, V188, P829, DOI 10.1128/JB.188.3.829-833.2006; Weiss B, 2001, MUTAT RES-DNA REPAIR, V461, P301, DOI 10.1016/S0921-8777(00)00062-8; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	41	51	51	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26576	26584		10.1074/jbc.M111.243261	http://dx.doi.org/10.1074/jbc.M111.243261			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642439	hybrid, Green Published			2022-12-27	WOS:000293078200036
J	Doherty, JT; Lenhart, KC; Cameron, MV; Mack, CP; Conlon, FL; Taylor, JM				Doherty, Jason T.; Lenhart, Kaitlin C.; Cameron, Morgan V.; Mack, Christopher P.; Conlon, Frank L.; Taylor, Joan M.			Skeletal Muscle Differentiation and Fusion Are Regulated by the BAR-containing Rho-GTPase-activating Protein (Rho-GAP), GRAF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MYOBLAST FUSION; GENE-EXPRESSION; TRANSCRIPTION FACTOR; MUSCULAR-DYSTROPHY; ACTIN CYTOSKELETON; DNA-BINDING; XENOPUS; CELLS; DOMAIN	Although RhoA activity is necessary for promoting myogenic mesenchymal stem cell fates, recent studies in cultured cells suggest that down-regulation of RhoA activity in specified myoblasts is required for subsequent differentiation and myotube formation. However, whether this phenomenon occurs in vivo and which Rho modifiers control these later events remain unclear. We found that expression of the Rho-GTPase-activating protein, GRAF1, was transiently up-regulated during myogenesis, and studies in C2C12 cells revealed that GRAF1 is necessary and sufficient for mediating RhoA down-regulation and inducing muscle differentiation. Moreover, forced expression of GRAF1 in pre-differentiated myoblasts drives robust muscle fusion by a process that requires GTPase-activating protein-dependent actin remodeling and BAR-dependent membrane binding or sculpting. Moreover, morpholino-based knockdown studies in Xenopus laevis determined that GRAF1 expression is critical for muscle development. GRAF1-depleted embryos exhibited elevated RhoA activity and defective myofibrillogenesis that resulted in progressive muscle degeneration, defective motility, and embryonic lethality. Our results are the first to identify a GTPase-activating protein that regulates muscle maturation and to highlight the functional importance of BAR domains in myotube formation.	[Taylor, Joan M.] Univ N Carolina, CB7525, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Conlon, Frank L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Conlon, Frank L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Mack, Christopher P.; Conlon, Frank L.; Taylor, Joan M.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Taylor, JM (corresponding author), Univ N Carolina, CB7525, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	jmt3x@med.unc.edu		Taylor, Joan/0000-0002-8794-5167	National Institutes of Health from NHLBI [HL-081844, HL-071054, HL-070953, HL-089641]; NIDCR [DE-018825]; American Heart Association [0355776U, 0555476U]; National Institutes of Health [T32HL69768, T32 HD046369-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070953, R01HL081844, R01HL071054, R01HL089641, R01HL102446, T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018825] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-081844 and HL-071054 (to J. M. T.), HL-070953 (to C. P. M.), and HL-089641 (to F. L. C.) from NHLBI and by Grant DE-018825 (to F. L. C.) from NIDCR. This work was also supported by American Heart Association Grants 0355776U (to J. M. T.) and 0555476U (to C. P. M.).; Trainee in the Integrative Vascular Biology Program supported by National Institutes of Health Grant T32HL69768.; Trainee in the Developmental Biology Program supported by National Institutes of Health Grant T32 HD046369-05.	Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLAU HM, 1985, ADV EXP MED BIOL, V182, P231; Bryan BA, 2005, MOL CELL BIOL, V25, P11089, DOI 10.1128/MCB.25.24.11089-11101.2005; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Chanturiya A, 2002, BIOPHYS J, V82, P3072, DOI 10.1016/S0006-3495(02)75648-8; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chong SW, 2005, TRENDS CELL BIOL, V15, P453, DOI 10.1016/j.tcb.2005.07.008; DiMichele LA, 2009, CIRC RES, V104, P1201, DOI 10.1161/CIRCRESAHA.109.195941; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Duan R, 2009, DEV BIOL, V325, P374, DOI 10.1016/j.ydbio.2008.10.035; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Goetz SC, 2006, DEVELOPMENT, V133, P2575, DOI 10.1242/dev.02420; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Henry CA, 2001, DEV BIOL, V240, P474, DOI 10.1006/dbio.2001.0467; Hidalgo M, 2009, DEV DYNAM, V238, P1332, DOI 10.1002/dvdy.21814; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Jacoby AS, 2009, DEVELOPMENT, V136, P3367, DOI 10.1242/dev.034561; Jansen Katie M., 2008, V475, P115, DOI 10.1007/978-1-59745-250-2_7; KALDERON N, 1979, J CELL BIOL, V81, P411, DOI 10.1083/jcb.81.2.411; Keller R, 2000, CURR TOP DEV BIOL, V47, P183; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Kragtorp KA, 2007, DEV DYNAM, V236, P2713, DOI 10.1002/dvdy.21280; Liu KJ, 2003, DEV BIOL, V264, P339, DOI 10.1016/j.ydbio.2003.08.017; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; Marrink SJ, 2003, J AM CHEM SOC, V125, P11144, DOI 10.1021/ja036138+; Meadows SM, 2008, P NATL ACAD SCI USA, V105, P1545, DOI 10.1073/pnas.0703918105; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Peckham M, 2008, J MICROSC-OXFORD, V231, P486, DOI 10.1111/j.1365-2818.2008.02061.x; Posey AD, 2011, J BIOL CHEM, V286, P7379, DOI 10.1074/jbc.M110.157222; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Schafer G, 2007, DEV BIOL, V304, P664, DOI 10.1016/j.ydbio.2007.01.015; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Suetsugu S, 2010, J BIOCHEM, V148, P1, DOI 10.1093/jb/mvq049; Swailes NT, 2004, J ANAT, V205, P381, DOI 10.1111/j.0021-8782.2004.00341.x; Taylor JM, 1999, J CELL SCI, V112, P231; Taylor JM, 1998, J BIOL CHEM, V273, P8063, DOI 10.1074/jbc.273.14.8063; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; WILSON L, 1995, J CELL SCI, V108, P2381; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06	55	50	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25903	25921		10.1074/jbc.M111.243030	http://dx.doi.org/10.1074/jbc.M111.243030			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622574	Green Published, hybrid			2022-12-27	WOS:000293073000051
J	Guillon-Munos, A; Oikonomopoulou, K; Michel, N; Smith, CR; Petit-Courty, AS; Canepa, S; Reverdiau, P; Heuze-Vourc'h, N; Diamandis, EP; Courty, Y				Guillon-Munos, Audrey; Oikonomopoulou, Katerina; Michel, Noemie; Smith, Chistopher R.; Petit-Courty, Agne S.; Canepa, Sylvie; Reverdiau, Pascale; Heuze-Vourc'h, Nathalie; Diamandis, Eleftherios P.; Courty, Yves			Kallikrein-related Peptidase 12 Hydrolyzes Matricellular Proteins of the CCN Family and Modifies Interactions of CCN1 and CCN5 with Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE KALLIKREINS; VEIN ENDOTHELIAL-CELLS; BREAST-CANCER CELLS; BIOLOGICAL-FLUIDS; LUNG-CANCER; TGF-BETA; SERINE PROTEASES; TERMINAL DOMAIN; FACTOR CTGF; EXPRESSION	Kallikrein-related peptidases (KLKs) are an emerging group of secreted serine proteases involved in several physiological and pathological processes. We used a degradomic approach to identify potential substrates of KLK12. MDA-MB-231cells were treated either with KLK12 or vehicle control, and the proteome of the overlying medium was analyzed by mass spectrometry. CCN1 (cyr61, ctgf, nov) was among the proteins released by the KLK12-treated cells, suggesting that KLK12 might be responsible for the shedding of this protein from the cell surface. Fragmentation of CCN1 by KLK12 was further confirmed in vitro, and the main cleavage site was localized in the hinge region between the first and second half of the recombinant protein. KLK12 can target all six members of the CCN family at different proteolytic sites. Limited proteolysis of CCNs (cyr61, ctgf, nov) was also observed in the presence of other members of the KLK family, such as KLK1, KLK5, and KLK14, whereas KLK6, KLK11, and KLK13 were unable to fragment CCNs. Because KLK12 seems to have a role in angiogenesis, we investigated the relations between KLK12, CCNs, and several factors known to be involved in angiogenesis. Solid phase binding assays showed that fragmentation of CCN1 or CCN5 by KLK12 prevents VEGF(165) binding, whereas it also triggers the release of intact VEGF and BMP2 from the CCN complexes. The KLK12-mediated release of TGF-beta 1 and FGF-2, either as intact or truncated forms, was found to be concentration-dependent. These findings suggest that KLK12 may indirectly regulate the bioavailability and activity of several growth factors through processing of their CCN binding partners.	[Guillon-Munos, Audrey; Michel, Noemie; Petit-Courty, Agne S.; Reverdiau, Pascale; Heuze-Vourc'h, Nathalie; Courty, Yves] Univ Tours, INSERM, U618, Fac Med, F-37032 Tours 1, France; [Oikonomopoulou, Katerina] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Smith, Chistopher R.; Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Canepa, Sylvie] Univ Tours, CNRS, UMR INRA, Biacore Lab, F-37380 Nouzilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours	Courty, Y (corresponding author), Univ Tours, INSERM, U618, Fac Med, 10 Blvd Tonnelle, F-37032 Tours 1, France.	courty@univ-tours.fr	HEUZE-VOURC'H, Nathalie/P-8081-2016	Diamandis, Eleftherios/0000-0002-1589-820X; Heuze-Vourc'h, Nathalie/0000-0003-4929-5068; PETIT, AGNES/0000-0003-3214-807X; REVERDIAU, Pascale/0000-0002-7530-6237; Courty, Yves/0000-0003-3694-8517	INCa; Region Centre; Association pour la Recherche sur le Cancer [7935]	INCa(Institut National du Cancer (INCA) France); Region Centre(Region Centre-Val de Loire); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by INCa Grant MATRIGO, Region Centre Grant KalliCap, and Association pour la Recherche sur le Cancer Grant 7935.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Ball DK, 1998, BIOL REPROD, V59, P828, DOI 10.1095/biolreprod59.4.828; Ball DK, 2003, REPRODUCTION, V125, P271, DOI 10.1530/rep.0.1250271; Bleau AM, 2007, J CELL BIOCHEM, V101, P1475, DOI 10.1002/jcb.21262; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2007, BIOL CHEM, V388, P1215, DOI 10.1515/BC.2007.124; Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096; Canalis E, 2007, ANN NY ACAD SCI, V1116, P50, DOI 10.1196/annals.1402.055; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; COLTRINI D, 1993, EUR J BIOCHEM, V214, P51, DOI 10.1111/j.1432-1033.1993.tb17895.x; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; Dziadzio M, 2005, QJM-INT J MED, V98, P485, DOI 10.1093/qjmed/hci078; Eissa A, 2008, BIOL CHEM, V389, P669, DOI 10.1515/BC.2008.079; Emami N, 2008, CLIN CHEM, V54, P1600, DOI 10.1373/clinchem.2008.105189; Emami N, 2007, MOL ONCOL, V1, P269, DOI 10.1016/j.molonc.2007.09.003; Francischetti IMB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009356; Giusti B, 2005, ARTHRITIS RHEUM-US, V52, P3618, DOI 10.1002/art.21383; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Holbourn KP, 2009, J CELL COMMUN SIGNAL, V3, P25, DOI 10.1007/s12079-009-0048-4; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Johnson SK, 2007, CANCER, V109, P1811, DOI 10.1002/cncr.22606; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; KILLIAN CS, 1993, BIOCHEM BIOPH RES CO, V192, P940, DOI 10.1006/bbrc.1993.1506; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kolesnikova TV, 1998, ONCOGENE, V16, P747, DOI 10.1038/sj.onc.1201572; Komatsu N, 2007, CLIN CHIM ACTA, V377, P228, DOI 10.1016/j.cca.2006.10.009; Kurlender L, 2005, BBA-REV CANCER, V1755, P1, DOI 10.1016/j.bbcan.2005.02.001; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Memari N, 2007, BIOL CHEM, V388, P427, DOI 10.1515/BC.2007.049; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Munemasa S, 2007, BRIT J HAEMATOL, V139, P41, DOI 10.1111/j.1365-2141.2007.06721.x; Nakamura Y, 2009, J CELL COMMUN SIGNAL, V3, P105, DOI 10.1007/s12079-009-0040-z; Oikonomopoulou K, 2008, BIOL CHEM, V389, P747, DOI 10.1515/BC.2008.086; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Oikonomopoulou K, 2010, BIOL CHEM, V391, P299, DOI 10.1515/BC.2010.038; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Perbal B, 1999, P NATL ACAD SCI USA, V96, P869, DOI 10.1073/pnas.96.3.869; Perbal B, 2009, J CELL COMMUN SIGNAL, V3, P153, DOI 10.1007/s12079-009-0051-9; Planque C, 2005, BIOCHEM BIOPH RES CO, V329, P1260, DOI 10.1016/j.bbrc.2005.02.100; Roestenberg P, 2004, DIABETES CARE, V27, P1164, DOI 10.2337/diacare.27.5.1164; Sano A, 2007, INT J ONCOL, V30, P1493; Scarisbrick IA, 2008, BIOL CHEM, V389, P739, DOI 10.1515/BC.2008.085; Shaw JLV, 2008, BIOL CHEM, V389, P681, DOI 10.1515/BC.2008.069; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shi Y, 2006, TRANSPL P, V38, P2187, DOI 10.1016/j.transproceed.2006.06.093; Singh P, 2007, CANCER LETT, V252, P19, DOI 10.1016/j.canlet.2006.11.012; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Tong XJ, 2001, J BIOL CHEM, V276, P47709, DOI 10.1074/jbc.M107878200; Tong ZY, 2006, J ENDOCRINOL, V188, pR1, DOI 10.1677/joe.1.06719; Veveris-Lowe TL, 2007, SEMIN THROMB HEMOST, V33, P87, DOI 10.1055/s-2006-958467; Yang DH, 1998, J CLIN ENDOCR METAB, V83, P2593, DOI 10.1210/jc.83.7.2593; Yoshida K, 2007, BBA-GEN SUBJECTS, V1770, P672, DOI 10.1016/j.bbagen.2006.11.010; Yousef GM, 2000, GENOMICS, V69, P331, DOI 10.1006/geno.2000.6346	64	51	55	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25505	25518		10.1074/jbc.M110.213231	http://dx.doi.org/10.1074/jbc.M110.213231			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628462	Green Published, hybrid			2022-12-27	WOS:000293073000013
J	Tokhtaeva, E; Sachs, G; Souda, P; Bassilian, S; Whitelegge, JP; Shoshani, L; Vagin, O				Tokhtaeva, Elmira; Sachs, George; Souda, Puneet; Bassilian, Sara; Whitelegge, Julian P.; Shoshani, Liora; Vagin, Olga			Epithelial Junctions Depend on Intercellular Trans-interactions between the Na,K-ATPase beta(1) Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; E-CADHERIN; TIGHT JUNCTIONS; ADHESION; GLYCOSYLATION; ANKYRIN; ATPASE; IDENTIFICATION; NA+,K+-ATPASE; ORGANIZATION	N-Glycans of the Na,K-ATPase beta(1) subunit are important for intercellular adhesion in epithelia, suggesting that epithelial junctions depend on N-glycan-mediated interactions between the beta(1) subunits of neighboring cells. The level of co-immunoprecipitation of the endogenous beta(1) subunit with various YFP-linked beta(1) subunits expressed in Madin-Darby canine kidney cells was used to assess beta(1)-beta(1) interactions. The amount of co-precipitated endogenous dog beta(1) was greater with dog YFP-beta(1) than with rat YFP-beta(1), showing that amino acid-mediated interactions are important for beta(1)-beta(1) binding. Co-precipitation of beta(1) was also less with the unglycosylated YFP-beta(1) than with glycosylated YFP-beta(1), indicating a role for N-glycans. Mixing cells expressing dog YFP-beta(1) with non-transfected cells increased the amount of co-precipitated beta(1), confirming the presence of intercellular (YFP-beta(1))-beta(1) complexes. Accordingly, disruption of intercellular junctions decreased the amount of co-precipitated beta(1) subunits. The decrease in beta(1) co-precipitation both with rat YFP-beta(1) and unglycosylated YFP-beta(1) was associated with decreased detergent stability of junctional proteins and increased paracellular permeability. Reducing N-glycan branching by specific inhibitors increased (YFP-beta(1))-beta(1) co-precipitation and strengthened intercellular junctions. Therefore, interactions between the beta(1) subunits of neighboring cells maintain integrity of intercellular junctions, and alterations in the beta(1) subunit N-glycan structure can regulate stability and tightness of intercellular junctions.	[Tokhtaeva, Elmira; Sachs, George; Bassilian, Sara; Vagin, Olga] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; [Tokhtaeva, Elmira; Sachs, George; Bassilian, Sara; Vagin, Olga] Vet Adm Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; [Souda, Puneet; Whitelegge, Julian P.] Univ Calif Los Angeles, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA; [Shoshani, Liora] IPN, CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City 07360, DF, Mexico	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Vagin, O (corresponding author), VAGLAHS W Los Angeles, 11301 Wilshire Blvd,Bldg 113,Rm 324, Los Angeles, CA 90073 USA.	olgav@ucla.edu			National Institutes of Health [DK077149, DK058333]; National Institutes of Health-NCRR [S10 RR023045]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK058333, R01DK077149, R01DK058333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077149 and DK058333.; We thank Dr. Glenn Nagami (UCLA) and Dr. Ralf Jacob (Marburg University) for careful reading of the manuscript and helpful suggestions. The LTQ-FT was purchased with National Institutes of Health-NCRR support from Grant S10 RR023045.	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Contreras RG, 2006, CELL MOL BIOL, V52, P31, DOI 10.1170/T758; Contreras RG, 2004, J MEMBRANE BIOL, V198, P147, DOI 10.1007/s00232-004-0670-2; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Doolittle MH, 2009, J LIPID RES, V50, P1173, DOI 10.1194/jlr.M800603-JLR200; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Laughery M, 2004, J BIOL CHEM, V279, P36339, DOI 10.1074/jbc.M402778200; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; NELSON WJ, 1991, SOC GEN PHY, V46, P77; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Padilla-Benavides T, 2010, MOL BIOL CELL, V21, P2217, DOI 10.1091/mbc.E10-01-0081; Piepenhagen PA, 1998, MOL BIOL CELL, V9, P3161, DOI 10.1091/mbc.9.11.3161; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 2009, FRONT BIOSCI-LANDMRK, V14, P2130, DOI 10.2741/3367; ROSENBERG I, 1991, J BIOL CHEM, V266, P18731; Shin JM, 2005, BIOCHEMISTRY-US, V44, P16321, DOI 10.1021/bi051342q; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; SUN Y, 1994, BBA-PROTEIN STRUCT M, V1207, P236, DOI 10.1016/0167-4838(94)00074-3; Taniguchi K, 2001, J BIOCHEM, V129, P335, DOI 10.1093/oxfordjournals.jbchem.a002862; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; TREUHEIT MJ, 1993, J BIOL CHEM, V268, P13914; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200	31	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25801	25812		10.1074/jbc.M111.252247	http://dx.doi.org/10.1074/jbc.M111.252247			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642423	Green Published, hybrid			2022-12-27	WOS:000293073000042
J	Albaugh, BN; Arnold, KM; Lee, S; Denu, JM				Albaugh, Brittany N.; Arnold, Kevin M.; Lee, Susan; Denu, John M.			Autoacetylation of the Histone Acetyltransferase Rtt109	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; COVALENT MODIFICATIONS; H3K56 ACETYLATION; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; LYSINE-56 ACETYLATION; CHAPERONE COMPLEX; GENOME INTEGRITY; H3	Rtt109 is a yeast histone acetyltransferase (HAT) that associates with histone chaperones Asf1 and Vps75 to acetylate H3K56, H3K9, and H3K27 and is important in DNA replication and maintaining genomic integrity. Recently, mass spectrometry and structural studies of Rtt109 have shown that active site residue Lys-290 is acetylated. However, the functional role of this modification and how the acetyl group is added to Lys-290 was unclear. Here, we examined the mechanism of Lys-290 acetylation and found that Rtt109 catalyzes intramolecular autoacetylation of Lys-290 similar to 200-times slower than H3 acetylation. Deacetylated Rtt109 was prepared by reacting with a sirtuin protein deacetylase, producing an enzyme with negligible HAT activity. Autoacetylation of Rtt109 restored full HAT activity, indicating that autoacetylation is necessary for HAT activity and is a fully reversible process. To dissect the mechanism of activation, biochemical, and kinetic analyses were performed with Lys-290 variants of the Rtt109-Vps75 complex. We found that autoacetylation of Lys-290 increases the binding affinity for acetyl-CoA and enhances the rate of acetyl-transfer onto histone substrates. This study represents the first detailed investigation of a HAT enzyme regulated by single-site intramolecular autoacetylation.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA; [Albaugh, Brittany N.; Arnold, Kevin M.; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Inst Discovery, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), 2140 Wisconsin Inst Discovery, 330 N Orchard St, Madison, WI 53715 USA.	jmdenu@wisc.edu			National Institutes of Health [GM059785]; Wisconsin Partnership Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, R01GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Partnership Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM059785 (to J. M. D.).; We thank all members in the research group of Dr. John Denu for helpful discussions, especially Dr. Erin Kolonko. We also thank Dr. Julie Mitchell (University of Wisconsin-Madison) for performing molecular simulations with the available Rtt109 structures, which has been useful in thinking about this study. We also appreciate the generosity of Dr. Deane Mosher (University of Wisconsin-Madison), who allowed us to use the Flouromax-3 instrument. We would also like to thank Dr. Paul Kaufman and Jessica Lopes da Rosa (University of Massachusetts Medical School). We acknowledge the University of Wisconsin-Madison Human Proteomics Program, funded by the Wisconsin Partnership Fund.	Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Agez M, 2007, STRUCTURE, V15, P191, DOI 10.1016/j.str.2007.01.002; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Antczak AJ, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-26; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Davie JR, 1998, CURR OPIN GENET DEV, V8, P173, DOI 10.1016/S0959-437X(98)80138-X; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Huang R, 2010, J AM CHEM SOC, V132, P9986, DOI 10.1021/ja103954u; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Scholes DT, 2001, GENETICS, V159, P1449; Smith CM, 2005, METHODS, V36, P395, DOI 10.1016/j.ymeth.2005.03.007; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Stavropoulos P, 2008, P NATL ACAD SCI USA, V105, P12236, DOI 10.1073/pnas.0805813105; Sundin BA, 2004, YEAST, V21, P793, DOI 10.1002/yea.1133; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tang Y, 2011, STRUCTURE, V19, P221, DOI 10.1016/j.str.2010.12.012; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Varv S, 2010, MOL CELL BIOL, V30, P1467, DOI 10.1128/MCB.01151-09; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Yu W, 2009, J BIOL CHEM, V284, P13669, DOI 10.1074/jbc.M901921200	58	51	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24694	24701		10.1074/jbc.M111.251579	http://dx.doi.org/10.1074/jbc.M111.251579			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606491	hybrid, Green Published			2022-12-27	WOS:000292547900020
J	Jiang, YJ; Che, MX; Yuan, JQ; Xie, YY; Yan, XZ; Hu, HY				Jiang, Ya-Jun; Che, Mei-Xia; Yuan, Jin-Qiao; Xie, Yuan-Yuan; Yan, Xian-Zhong; Hu, Hong-Yu			Interaction with Polyglutamine-expanded Huntingtin Alters Cellular Distribution and RNA Processing of Huntingtin Yeast Two-hybrid Protein A (HYPA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM WW DOMAINS; PROLINE-RICH REGION; LIGAND RECOGNITION; GROUP-II/III; IN-VIVO; DISEASE; AGGREGATION; BINDING; PATHOGENESIS; SPECIFICITY	Huntington disease (HD) is an autosomal inherited disorder that causes the deterioration of brain cells. The polyglutamine (polyQ) expansion of huntingtin (Htt) is implicated in the pathogenesis of HD via interaction with an RNA splicing factor, Htt yeast two-hybrid protein A/forming-binding protein 11 (HYPA/FBP11). Besides the pathogenic polyQ expansion, Htt also contains a proline-rich region (PRR) located exactly in the C terminus to the polyQ tract. However, how the polyQ expansion influences the PRR-mediated protein interaction and how this abnormal interaction leads to the biological consequence remain elusive. Our NMR structural analysis indicates that the PRR motif of Htt cooperatively interacts with the tandem WW domains of HYPA through domain chaperoning effect of WW1 on WW2. The polyQ-expanded Htt sequesters HYPA to the cytosolic location and then significantly reduces the efficiency of pre-mRNA splicing. We propose that the toxic gain-of-function of the polyQ-expanded Htt that causes dysfunction of cellular RNA processing contributes to the pathogenesis of HD.	[Jiang, Ya-Jun; Che, Mei-Xia; Xie, Yuan-Yuan; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Yuan, Jin-Qiao; Yan, Xian-Zhong] Natl Ctr Biomed Anal, NMR Lab, Beijing 100850, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	hyhu@sibs.ac.cn	Hu, Hong-Yu/AAQ-2633-2020; Xie, Yuanyuan/F-1974-2017; Che, Meixia/Q-2119-2019; Jiang, Yajun/AAE-7853-2020	Che, Meixia/0000-0002-4515-1414; Jiang, Yajun/0000-0002-0886-292X	National Basic Research Program of China [2006CB910305, 2006CB806508]; National Natural Science Foundation of China [30670431, 10979070]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2006CB910305 and 2006CB806508 and National Natural Science Foundation of China Grants 30670431 and 10979070.	Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Che M. X., 2011, FASEB J IN PRESS; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fedoroff OY, 2004, J BIOL CHEM, V279, P34991, DOI 10.1074/jbc.M404987200; Gao YG, 2006, STRUCTURE, V14, P1755, DOI 10.1016/j.str.2006.09.014; Goddard D., 2008, SPARKY 3; Huang XJ, 2009, J BIOL CHEM, V284, P25375, DOI 10.1074/jbc.M109.024828; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kato Y, 2006, PROTEINS, V63, P227, DOI 10.1002/prot.20880; Kato Y, 2004, J BIOL CHEM, V279, P31833, DOI 10.1074/jbc.M404719200; Kato Y, 2006, J BIOL CHEM, V281, P40321, DOI 10.1074/jbc.M609321200; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li XJ, 2007, TRENDS GENET, V23, P531, DOI 10.1016/j.tig.2007.07.007; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mizutani K, 2004, BIOCHEM BIOPH RES CO, V313, P468, DOI 10.1016/j.bbrc.2003.11.139; Nasim MT, 2006, NAT PROTOC, V1, P1022, DOI 10.1038/nprot.2006.148; Neduva V., 2007, SCI STKE, V2007, ppe1; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Passani LA, 2000, HUM MOL GENET, V9, P2175, DOI 10.1093/hmg/9.14.2175; Pires JR, 2005, J MOL BIOL, V348, P399, DOI 10.1016/j.jmb.2005.02.056; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wiesner S, 2002, J MOL BIOL, V324, P807, DOI 10.1016/S0022-2836(02)01145-2; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	52	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25236	25245		10.1074/jbc.M110.216333	http://dx.doi.org/10.1074/jbc.M110.216333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21566141	Green Published, hybrid			2022-12-27	WOS:000292547900069
J	Joe, Y; Kim, HJ; Kim, S; Chung, J; Ko, MS; Lee, WH; Chang, KC; Park, JW; Chung, HT				Joe, Yeonsoo; Kim, Hyo Jeong; Kim, Sena; Chung, Jiwha; Ko, Myoung Seok; Lee, Won Hyeok; Chang, Ki Churl; Park, Jeong Woo; Chung, Hun Taeg			Tristetraprolin Mediates Anti-inflammatory Effects of Nicotine in Lipopolysaccharide-stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; ACETYLCHOLINE-RECEPTOR ALPHA-7; MESSENGER-RNA DECAY; PROTEIN-KINASE P38; HYPER-IGE SYNDROME; GENE-EXPRESSION; VAGUS NERVE; POSTTRANSCRIPTIONAL REGULATION; INFLAMMATORY RESPONSE	Nicotine inhibits the release of TNF-alpha from macrophage through activation of STAT3. Tristetraprolin (TTP) is known to destabilize pro-inflammatory transcripts containing AU-rich elements (ARE) in 3'-untranslated region (3'-UTR). Here we show that in LPS-stimulated human macrophages the anti-inflammatory action of nicotine is mediated by TTP. Nicotine induced activation of STAT3 enhanced STAT3 binding to the TTP promoter, increased TTP promoter activity, and increased TTP expression resulting in the suppression of LPS-stimulated TNF-alpha production. Overexpression of a dominant negative mutant of STAT3 (R382W) or down-regulation of STAT3 by siRNA abolished nicotine-induced TTP expression and suppression of LPS-stimulated TNF-alpha production. Nicotine enhanced the decay of TNF-alpha mRNA and decreased luciferase expression of a TNF-alpha 3'-UTR reporter plasmid in U937 cells. However, siRNA to TTP abrogated these effects of nicotine. In this experiment, we are reporting for the first time the involvement of TTP in the cholinergic anti-inflammatory cascade consisting of nicotine-STAT3-TTP-dampening inflammation.	[Joe, Yeonsoo; Kim, Hyo Jeong; Kim, Sena; Chung, Jiwha; Ko, Myoung Seok; Lee, Won Hyeok; Park, Jeong Woo; Chung, Hun Taeg] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Chang, Ki Churl] Gyeongsang Natl Univ, Sch Med, Dept Pharmacol, Jinju 660751, South Korea; [Chang, Ki Churl] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju 660751, South Korea	University of Ulsan; Gyeongsang National University; Gyeongsang National University	Park, JW (corresponding author), Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea.	jwpark@ulsan.ac.kr; chung@ulsan.ac.kr		Kim, Sena/0000-0002-6930-2416	Korean government (MOEHRD) [BRL-2009-0087350]	Korean government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by grants from the Korea Research Foundation funded by the Korean government (MOEHRD) (BRL-2009-0087350).	Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Boutaud O, 2003, ADV EXP MED BIOL, V525, P157; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; HARANAKA K, 1986, P NATL ACAD SCI USA, V83, P3949, DOI 10.1073/pnas.83.11.3949; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sugano N, 1998, BIOCHEM BIOPH RES CO, V252, P25, DOI 10.1006/bbrc.1998.9599; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; WINGFIELD P, 1987, FEBS LETT, V211, P179, DOI 10.1016/0014-5793(87)81432-1; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588	41	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24735	24742		10.1074/jbc.M110.204859	http://dx.doi.org/10.1074/jbc.M110.204859			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606497	hybrid, Green Published			2022-12-27	WOS:000292547900024
J	Wang, CJ; Wang, C; Hoch, EG; Pitt, GS				Wang, Chaojian; Wang, Chuan; Hoch, Ethan G.; Pitt, Geoffrey S.			Identification of Novel Interaction Sites that Determine Specificity between Fibroblast Growth Factor Homologous Factors and Voltage-gated Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-HAND DOMAIN; C-TERMINUS; FACTOR 1B; INACTIVATION; CALMODULIN; MODULATION; FIBROBLAST-GROWTH-FACTOR-14; EXCITABILITY; NA(V)1.5; MUTATION	Fibroblast growth factor homologous factors (FHFs, FGF11-14) bind to the C termini (CTs) of specific voltage-gated sodium channels (VGSC) and thereby regulate their function. The effect of an individual FHF on a specific VGSC varies greatly depending upon the individual FHF isoform. How individual FHFs impart distinctive effects on specific VGSCs is not known and the specificity of these pairwise interactions is not understood. Using several biochemical approaches combined with functional analysis, we mapped the interaction site for FGF12B on the Na(V)1.5 C terminus and discovered previously unknown determinants necessary for FGF12 interaction. Also, we demonstrated that FGF12B binds to some, but not all Na(V)1 CTs, suggesting specificity of interaction. Exploiting a human single nucleotide polymorphism in the core domain of FGF12 (P149Q), we identified a surface proline that contributes a part of this pairwise specificity. This proline is conserved among all FHFs, and mutation of the homologous residue in FGF13 also leads to loss of interaction with a specific VGSCCT(Na(V)1.1) and loss of modulation of the resultant Na+ channel function. We hypothesized that some of the specificity mediated by this proline may result from differences in the affinity of the binding partners. Consistent with this hypothesis, surface plasmon resonance data showed that the P149Q mutation decreased the binding affinity between FHFs and VGSC CTs. Moreover, immunocytochemistry revealed that the mutation prevented proper subcellular targeting of FGF12 to the axon initial segment in neurons. Together, these results give new insights into details of the interactions between FHFs and Na(V)1.x CTs, and the consequent regulation of Na+ channels.	[Wang, Chaojian; Wang, Chuan; Hoch, Ethan G.; Pitt, Geoffrey S.] Duke Univ, Med Ctr, Dept Med, Ion Channel Res Unit, Durham, NC 27710 USA	Duke University	Pitt, GS (corresponding author), Duke Univ, Med Ctr, Dept Med, Ion Channel Res Unit, Box 103030 Med Ctr, Durham, NC 27710 USA.	geoffrey.pitt@duke.edu	Pitt, Geoffrey/L-4927-2019	Pitt, Geoffrey/0000-0003-2246-0289	National Institutes of Health [HL71165, HL088089]; Duke University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088089, R01HL071165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grants HL71165 and HL088089 from the National Institutes of Health and a Duke University SOM SR Voucher Program Award.	Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; Miloushev VZ, 2009, J BIOL CHEM, V284, P6446, DOI 10.1074/jbc.M807401200; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Wang C, 2008, J NEUROSCI, V28, P1865, DOI 10.1523/JNEUROSCI.5417-07.2008; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004	21	58	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24253	24263		10.1074/jbc.M111.245803	http://dx.doi.org/10.1074/jbc.M111.245803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566136	hybrid, Green Published			2022-12-27	WOS:000292294900067
J	Depil, K; Beyl, S; Stary-Weinzinger, A; Hohaus, A; Timin, E; Hering, S				Depil, Katrin; Beyl, Stanislav; Stary-Weinzinger, Anna; Hohaus, Annette; Timin, Eugen; Hering, Steffen			Timothy Mutation Disrupts the Link between Activation and Inactivation in Ca(V)1.2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNEL; STRUCTURAL DETERMINANTS; MOLECULAR DETERMINANTS; GATING MECHANISMS; BETA-SUBUNIT; PORE DOMAIN; IIS6; EXPRESSION; ALIGNMENT; SEQUENCE	The Timothy syndrome mutations G402S and G406R abolish inactivation of Ca(V)1.2 and cause multiorgan dysfunction and lethal arrhythmias. To gain insights into the consequences of the G402S mutation on structure and function of the channel, we systematically mutated the corresponding Gly-432 of the rabbit channel and applied homology modeling. All mutations of Gly-432 (G432A/M/N/V/W) diminished channel inactivation. Homology modeling revealed that Gly-432 forms part of a highly conserved structure motif (G/A/G/A) of small residues in homologous positions of all four domains (Gly-432 (IS6), Ala-780 (IIS6), Gly-1193 (IIIS6), Ala-1503 (IVS6)). Corresponding mutations in domains II, III, and IV induced, in contrast, parallel shifts of activation and inactivation curves indicating a preserved coupling between both processes. Disruption between coupling of activation and inactivation was specific for mutations of Gly-432 in domain I. Mutations of Gly-432 removed inactivation irrespective of the changes in activation. In all four domains residues G/A/G/A are in close contact with larger bulky amino acids from neighboring S6 helices. These interactions apparently provide adhesion points, thereby tightly sealing the activation gate of Ca(V)1.2 in the closed state. Such a structural hypothesis is supported by changes in activation gating induced by mutations of the G/A/G/A residues. The structural implications for Ca(V)1.2 activation and inactivation gating are discussed.	[Depil, Katrin; Beyl, Stanislav; Stary-Weinzinger, Anna; Hohaus, Annette; Timin, Eugen; Hering, Steffen] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria	University of Vienna	Hering, S (corresponding author), Univ Vienna, Dept Pharmacol & Toxicol, Althanstr 14, A-1090 Vienna, Austria.	steffen.hering@univie.ac.at	Stary-Weinzinger, Anna/A-3629-2014	Stary-Weinzinger, Anna/0000-0002-9202-0484	Fonds zur Forderung der Wissenschaftlichen Forschung (Austrian Science Fund) [P22600, W1232, P19614]; Austrian Science Fund (FWF) [P 22600, P 19614] Funding Source: researchfish	Fonds zur Forderung der Wissenschaftlichen Forschung (Austrian Science Fund)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work was supported by Fonds zur Forderung der Wissenschaftlichen Forschung (Austrian Science Fund) Grants P22600 (to S. B.), W1232 (to S. H.), and P19614 (to S. H.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Beyl S, 2011, PFLUG ARCH EUR J PHY, V461, P53, DOI 10.1007/s00424-010-0885-2; Bruhova I, 2010, J GEN PHYSIOL, V135, P261, DOI 10.1085/jgp.200910288; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Hohaus A, 2005, J BIOL CHEM, V280, P38471, DOI 10.1074/jbc.M507013200; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Irizarry SN, 2002, BIOCHEMISTRY-US, V41, P13653, DOI 10.1021/bi026393r; Kudrnac M, 2009, J BIOL CHEM, V284, P12276, DOI 10.1074/jbc.M808402200; Lipkind GM, 2001, BIOCHEMISTRY-US, V40, P6786, DOI 10.1021/bi010269a; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Paynter JJ, 2008, CHANNELS, V2, P413, DOI 10.4161/chan.2.6.6874; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Shafrir Y, 2008, BIOPHYS J, V95, P3650, DOI 10.1529/biophysj.108.135327; Shi CZ, 2002, J BIOL CHEM, V277, P6813, DOI 10.1074/jbc.M110524200; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Stary A, 2008, CHANNELS, V2, P216, DOI 10.4161/chan.2.3.6160; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Stotz SC, 2001, TRENDS NEUROSCI, V24, P176, DOI 10.1016/S0166-2236(00)01738-0; Tikhonov DB, 2011, J BIOL CHEM, V286, P2998, DOI 10.1074/jbc.M110.175406; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vitko I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003560; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yarotskyy V, 2009, J PHYSIOL-LONDON, V587, P551, DOI 10.1113/jphysiol.2008.161737	36	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31557	31564		10.1074/jbc.M111.255273	http://dx.doi.org/10.1074/jbc.M111.255273			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21685391	Green Published, hybrid			2022-12-27	WOS:000294487500050
J	Ranganathan, S; Cao, CZ; Catania, J; Migliorini, M; Zhang, L; Strickland, DK				Ranganathan, Sripriya; Cao, Chunzhang; Catania, Jason; Migliorini, Molly; Zhang, Li; Strickland, Dudley K.			Molecular Basis for the Interaction of Low Density Lipoprotein Receptor-related Protein 1 (LRP1) with Integrin alpha(M)beta(2) IDENTIFICATION OF BINDING SITES WITHIN alpha(M)beta(2) FOR LRP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL INHIBITORY FACTOR; LIGAND-BINDING; ALPHA-2-MACROGLOBULIN RECEPTOR; TYROSINE PHOSPHORYLATION; CORECEPTOR FUNCTION; CYTOPLASMIC DOMAIN; CR3 CD11B/CD18; I-DOMAIN; MAC-1; RECOGNITION	The LDL receptor-related protein 1 (LRP1) is a large endocytic receptor that controls macrophage migration in part by interacting with beta(2) integrin receptors. However, the molecular mechanism underlying LRP1 integrin recognition is poorly understood. Here, we report that LRP1 specifically recognizes alpha(M)beta(2) but not its homologous receptor alpha(L)beta(2). The interaction between these two cellular receptors in macrophages is significantly enhanced upon alpha(M)beta(2) activation by LPS and is mediated by multiple regions in both LRP1 and alpha(M)beta(2). Specifically, we find that both the heavy and light chains of LRP1 are involved in alpha(M)beta(2) binding. Within the heavy chain, the binding is mediated primarily via the second and fourth ligand binding repeats. For alpha(M)beta(2), we find that the alpha(M)-I domain represents a major LRP1 recognition site. Indeed, substitution of the I domain of the alpha(L)beta(2) receptor with that of alpha(M) confers the alpha(L)beta(2) receptor with the ability to interact with LRP1. Furthermore, we show that residues (160)EQLKKSKTL(170) within the alpha(M)-I domain represent a major LRP1 recognition site. Given that perturbation of this specific sequence leads to altered adhesive activity of alpha(M)beta(2), our finding suggests that binding of LRP1 to alpha(M)beta(2) could alter integrin function. Indeed, we further demonstrate that the soluble form of LRP1 (sLRP1) inhibits alpha(M)beta(2)-mediated adhesion of cells to fibrinogen. These studies suggest that sLRP1 may attenuate inflammation by modulating integrin function.	[Ranganathan, Sripriya; Cao, Chunzhang; Catania, Jason; Migliorini, Molly; Zhang, Li; Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Cao, Chunzhang; Zhang, Li; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ranganathan, Sripriya; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhang, L (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St,R216, Baltimore, MD 21201 USA.	LiZhang@som.umaryland.edu; dstrickland@som.umaryland.edu			National Institutes of Health [P01 HL054710, HL050784, HL072929]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072929, R01HL050784, P01HL054710, R01HL061589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL054710 (to D. K. S. and L. Z.) and HL050784 and HL072929 (to D. K. S.).	ANDERSON DC, 1986, J IMMUNOL, V137, P15; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu L, 2006, ARTERIOSCL THROM VAS, V26, P2710, DOI 10.1161/01.ATV.0000249641.96896.e6; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lillis AP, 2008, J IMMUNOL, V181, P364, DOI 10.4049/jimmunol.181.1.364; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MUCHOWSKI PJ, 1994, J BIOL CHEM, V269, P26419; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Spijkers PPEM, 2005, BLOOD, V105, P170, DOI 10.1182/blood-2004-02-0498; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680; VANSTRIJP JAG, 1993, J IMMUNOL, V151, P3324; Vetvicka V, 1996, J CLIN INVEST, V98, P50, DOI 10.1172/JCI118777; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; WITTHAUT R, 1994, J LEUKOCYTE BIOL, V55, P105, DOI 10.1002/jlb.55.1.105; Zhang L, 1999, BIOCHEMISTRY-US, V38, P8064, DOI 10.1021/bi990141h; Zhang L, 1996, J BIOL CHEM, V271, P29953, DOI 10.1074/jbc.271.47.29953; Zhang L, 1997, J BIOL CHEM, V272, P17558, DOI 10.1074/jbc.272.28.17558; Zhang L, 1996, J BIOL CHEM, V271, P18211, DOI 10.1074/jbc.271.30.18211; ZHOU LB, 1994, J BIOL CHEM, V269, P17075	44	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30535	30541		10.1074/jbc.M111.265413	http://dx.doi.org/10.1074/jbc.M111.265413			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21676865	hybrid, Green Published			2022-12-27	WOS:000294283600032
J	Hong, JA; Carroll, KS				Hong, Jiyoung A.; Carroll, Kate S.			Deciphering the Role of Histidine 252 in Mycobacterial Adenosine 5 '-Phosphosulfate (APS) Reductase Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; PSEUDOMONAS-AERUGINOSA; SULFATE REDUCTASE; 3'-PHOSPHOADENOSINE-5'-PHOSPHOSULFATE REDUCTASE; ADENOSINE-5'-PHOSPHOSULFATE REDUCTASE; 5-ADENYLYLSULFATE REDUCTASE; CRYSTAL-STRUCTURE; HIGHER-PLANTS; TUBERCULOSIS; BINDING	Mycobacterium tuberculosis adenosine 5'-phosphosulfate reductase (APR) catalyzes the first committed step in sulfate reduction for the biosynthesis of cysteine and is essential for survival in the latent phase of tuberculosis infection. The reaction catalyzed by APR involves the nucleophilic attack by conserved Cys-249 on adenosine 5'-phosphosulfate, resulting in a covalent S-sulfocysteine intermediate that is reduced in subsequent steps by thioredoxin to yield the sulfite product. Cys-249 resides on a mobile active site lid at the C terminus, within a K(R/T)ECG(L/I)H motif. Owing to its strict conservation among sulfonucleotide reductases and its proximity to the active site cysteine, it has been suggested that His-252 plays a key role in APR catalysis, specifically as a general base to deprotonate Cys-249. Using site-directed mutagenesis, we have changed His-252 to an alanine residue and analyzed the effect of this mutation on the kinetic parameters, pH rate profile, and ionization of Cys-249 of APR. Interestingly, our data demonstrate that His-252 does not perturb the pK(a) of Cys-249 or play a direct role in rate-limiting chemical steps of the reaction. Rather, we show that His-252 enhances substrate affinity via interaction with the alpha-phosphate and the endocyclic ribose oxygen. These findings were further supported by isothermal titration calorimetry to provide a thermodynamic profile of ligand-protein interactions. From an applied standpoint, our study suggests that small-molecules targeting residues in the dynamic C-terminal segment, particularly His-252, may lead to inhibitors with improved binding affinity.	[Carroll, Kate S.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Hong, Jiyoung A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Scripps Research Institute; University of Michigan System; University of Michigan	Carroll, KS (corresponding author), Scripps Res Inst, Dept Chem, 130 Scripps Way 2B2, Jupiter, FL 33458 USA.	kcarroll@scripps.edu		Hong, Jiyoung/0000-0002-0430-3290; Carroll, Kate/0000-0002-7624-9617	National Institutes of Health [GM087638]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087638 (to K. S. C.).	Berndt C, 2004, J BIOL CHEM, V279, P7850, DOI 10.1074/jbc.M309332200; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Bhave DP, 2011, J BIOL CHEM, V286, P1216, DOI 10.1074/jbc.M110.193722; Carroll KS, 2005, PLOS BIOL, V3, P1418, DOI 10.1371/journal.pbio.0030250; Carroll KS, 2005, BIOCHEMISTRY-US, V44, P14647, DOI 10.1021/bi051344a; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Cosconati S, 2008, J MED CHEM, V51, P6627, DOI 10.1021/jm800571m; Dawson RMC., 1989, DATA BIOCH RES; Gao H, 2007, J AM SOC MASS SPECTR, V18, P167, DOI 10.1016/j.jasms.2006.08.010; Hernick M, 2006, BIOCHEMISTRY-US, V45, P15240, DOI 10.1021/bi061405k; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Hirase Kangetsu, 2003, Weed Biology and Management, V3, P147, DOI 10.1046/j.1445-6664.2003.00098.x; Hong JA, 2009, J MED CHEM, V52, P5485, DOI 10.1021/jm900728u; HUTCHISON A, 1989, J HETEROCYCLIC CHEM, V26, P451, DOI 10.1002/jhet.5570260235; Kim SK, 2005, BBA-BIOENERGETICS, V1710, P103, DOI 10.1016/j.bbabio.2005.09.004; Kim SK, 2004, BIOCHEMISTRY-US, V43, P13478, DOI 10.1021/bi048811t; Kopriva S, 2002, J BIOL CHEM, V277, P21786, DOI 10.1074/jbc.M202152200; Kopriva S, 2001, J BIOL CHEM, V276, P42881, DOI 10.1074/jbc.M107424200; Kopriva S, 2007, J BIOL CHEM, V282, P22930, DOI 10.1074/jbc.M702522200; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Mdluli K, 2006, CURR OPIN PHARMACOL, V6, P459, DOI 10.1016/j.coph.2006.06.004; NODA LH, 1953, J AM CHEM SOC, V75, P913, DOI 10.1021/ja01100a041; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; SAWAI H, 1985, CHEM PHARM BULL, V33, P432; Schnell R, 2010, BIOCHEM BIOPH RES CO, V396, P33, DOI 10.1016/j.bbrc.2010.02.118; Senaratne RH, 2006, MOL MICROBIOL, V59, P1744, DOI 10.1111/j.1365-2958.2006.05075.x; Setya A, 1996, P NATL ACAD SCI USA, V93, P13383, DOI 10.1073/pnas.93.23.13383; Weber M, 2000, EUR J BIOCHEM, V267, P3647, DOI 10.1046/j.1432-1327.2000.01394.x; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Yu ZH, 2008, BIOCHEMISTRY-US, V47, P12777, DOI 10.1021/bi801118f	31	3	4	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28567	28573		10.1074/jbc.M111.238998	http://dx.doi.org/10.1074/jbc.M111.238998			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673113	hybrid, Green Published			2022-12-27	WOS:000293557800071
J	Chen, JX; Myerburg, MM; Passero, CJ; Winarski, KL; Sheng, SH				Chen, Jingxin; Myerburg, Mike M.; Passero, Christopher J.; Winarski, Katie L.; Sheng, Shaohu			External Cu2+ Inhibits Human Epithelial Na+ Channels by Binding at a Subunit Interface of Extracellular Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-INHIBITION; SODIUM-CHANNEL; ALPHA-SUBUNIT; GAMMA-SUBUNIT; ION CHANNELS; HISTIDINE-RESIDUES; PULMONARY TOXICITY; HEAVY-METALS; ENAC; EXPRESSION	Epithelial Na+ channels (ENaCs) play an essential role in the regulation of body fluid homeostasis. Certain transition metals activate or inhibit the activity of ENaCs. In this study, we examined the effect of extracellular Cu2+ on human ENaC expressed in Xenopus oocytes and investigated the structural basis for its effects. External Cu2+ inhibited human alpha beta gamma ENaC with an estimated IC50 of 0.3 mu M. The slow time course and a lack of change in the current-voltage relationship were consistent with an allosteric (non pore-plugging) inhibition of human ENaC by Cu2+. Experiments with mixed human and mouse ENaC subunits suggested that both the alpha and beta subunits were primarily responsible for the inhibitory effect of Cu2+ on human ENaC. Lowering bath solution pH diminished the inhibition by Cu2+. Mutations of two alpha, two beta, and two gamma His residues within extracellular domains significantly reduced the inhibition of human ENaC by Cu2+. We identified a pair of residues as potential Cu2+-binding sites at the subunit interface between thumb subdomain of alpha hENaC and palm subdomain of beta hENaC, suggesting a counterclockwise arrangement of alpha, beta, and gamma ENaC subunits in a trimeric channel complex when viewed from above. We conclude that extracellular Cu2+ is a potent inhibitor of human ENaC and binds to multiple sites within the extracellular domains including a subunit interface.	[Sheng, Shaohu] Univ Pittsburgh, Renal Electrolyte Div, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sheng, SH (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Sch Med, Dept Med, S929 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	shaohu@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 ES014701, K08 HL087932, P30 DK072506, P30 DK079307]; Dialysis Clinic, Inc.; Cystic Fibrosis Foundation RDP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087932, R01HL112863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, P30DK072506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dialysis Clinic, Inc.; Cystic Fibrosis Foundation RDP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES014701, K08 HL087932, P30 DK072506, and P30 DK079307. This work was also supported by a research grant from Dialysis Clinic, Inc. and the Cystic Fibrosis Foundation RDP to the University of Pittsburgh.	Adamson IYR, 1999, TOXICOL APPL PHARM, V157, P43, DOI 10.1006/taap.1999.8658; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chalfant ML, 1999, AM J PHYSIOL-CELL PH, V276, pC477, DOI 10.1152/ajpcell.1999.276.2.C477; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Davis IC, 2007, ADV EXP MED BIOL, V618, P127; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Ellingsen DG, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P529, DOI 10.1016/B978-012369413-3/50081-1; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HEGETSCHWEILER K, 1986, INORG CHEM, V25, P107, DOI 10.1021/ic00221a028; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; KISS T, 1994, PHARMACOL REV, V46, P245; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nevin ST, 2003, J BIOL CHEM, V278, P28985, DOI 10.1074/jbc.M300097200; Nie HG, 2010, AM J PHYSIOL-RENAL, V298, pF323, DOI 10.1152/ajprenal.00307.2009; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; Prieditis H, 2002, EXP LUNG RES, V28, P563, DOI 10.1080/01902140290096782; Restrepo-Angulo I, 2010, J APPL TOXICOL, V30, P497, DOI 10.1002/jat.1556; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2007, SELDIN GIEBISCHS KID, P743; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Tisato F, 2010, MED RES REV, V30, P708, DOI 10.1002/med.20174; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF236, DOI 10.1152/ajprenal.00002.2007	47	19	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27436	27446		10.1074/jbc.M111.232058	http://dx.doi.org/10.1074/jbc.M111.232058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659509	Green Published, hybrid			2022-12-27	WOS:000293268700039
J	Kosaka-Suzuki, N; Suzuki, T; Pugacheva, EM; Vostrov, AA; Morse, HC; Loukinov, D; Lobanenkov, V				Kosaka-Suzuki, Natsuki; Suzuki, Teruhiko; Pugacheva, Elena M.; Vostrov, Alexander A.; Morse, Herbert C., III; Loukinov, Dmitri; Lobanenkov, Victor			Transcription Factor BORIS (Brother of the Regulator of Imprinted Sites) Directly Induces Expression of a Cancer-Testis Antigen, TSP50, through Regulated Binding of BORIS to the Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC GENE; CTCF-BINDING; EPIGENETIC REGULATION; ENHANCER-BLOCKING; CONTROL REGION; BREAST-CANCER; LUNG-CANCER; PROTEIN; CHROMATIN; INSULATOR	Cancer-testis antigens (CTAs) are normally expressed in testis but are aberrantly expressed in a variety of cancers with varying frequency. More than 100 proteins have been identified as CTA including testes-specific protease 50 (TSP50) and the testis-specific paralogue of CCCTC-binding factor, BORIS (brother of the regulator of imprinted sites). Because many CTAs are considered as excellent targets for tumor immunotherapy, understanding the regulatory mechanisms governing their expression is important. In this study we demonstrate that BORIS is directly responsible for the transcriptional activation of TSP50. We found two BORIS binding sites in the TSP50 promoter that are highly conserved between mouse and human. Mutations of the binding sites resulted in loss of BORIS binding and the ability of BORIS to activate the promoter. However, although expression of BORIS was essential, it was not sufficient for high expression of TSP50 in cancer cells. Further studies showed that binding of BORIS to the target sites was methylation-independent but was diminished by nucleosomal occupancy consistent with the findings that high expression of TSP50 was associated with increased DNase I sensitivity and high BORIS occupancy of the promoter. These findings indicate that BORIS-induced expression of TSP50 is governed by accessibility and binding of BORIS to the promoter. To our knowledge this is the first report of regulated expression of one CTA by another to be validated in a physiological context.	[Lobanenkov, Victor] NIAID, Mol Pathol Sect, Immunopathol Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lobanenkov, V (corresponding author), NIAID, Mol Pathol Sect, Immunopathol Lab, NIH, Twinbrook 1,Rm 1417,MSC-8152,5640 Fishers Lane, Rockville, MD 20852 USA.	vlobanenkov@niaid.nih.gov	Lobanenkov, Victor/ABD-5710-2021; Pugacheva, Elena M/GNH-1756-2022; Lobanenkov, Victor V./AGQ-8903-2022	Pugacheva, Elena M/0000-0001-9693-9853; Lobanenkov, Victor/0000-0001-6665-3635; Morse, Herbert/0000-0002-9331-3705	National Institutes of Health of the NIAID; Japan Society for the Promotion of Science Research at the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001021, ZIAAI000860, ZIAAI000858, ZIAAI001024] Funding Source: NIH RePORTER	National Institutes of Health of the NIAID; Japan Society for the Promotion of Science Research at the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIAID. This work was also supported by the Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the National Institutes of Health (to T. S.).	Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Amelio AL, 2006, J VIROL, V80, P2358, DOI 10.1128/JVI.80.5.2358-2368.2006; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chau CM, 2006, J VIROL, V80, P5723, DOI 10.1128/JVI.00025-06; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Han L, 2008, MOL CELL BIOL, V28, P1124, DOI 10.1128/MCB.01361-07; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Huang Y, 2008, BIOCHEM BIOPH RES CO, V374, P658, DOI 10.1016/j.bbrc.2008.07.087; Jager E, 2006, P NATL ACAD SCI USA, V103, P14453, DOI 10.1073/pnas.0606512103; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kirkin AF, 2002, CANCER INVEST, V20, P222, DOI 10.1081/CNV-120001150; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Loukinov D, 2006, J CELL BIOCHEM, V98, P1037, DOI 10.1002/jcb.20953; Lu Qianjin, 2004, Methods Mol Biol, V287, P77; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Mkrtichyan M, 2008, GENE THER, V15, P61, DOI 10.1038/sj.gt.3303044; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Nativio R, 2011, HUM MOL GENET, V20, P1363, DOI 10.1093/hmg/ddr018; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wang M, 2008, DNA CELL BIOL, V27, P307, DOI 10.1089/dna.2007.0692; Woloszynska-Read A, 2011, CLIN CANCER RES, V17, P2170, DOI 10.1158/1078-0432.CCR-10-2315; Xu HP, 2007, CANCER RES, V67, P1239, DOI 10.1158/0008-5472.CAN-06-3688; Yang YX, 1999, J NEUROCHEM, V73, P2286, DOI 10.1046/j.1471-4159.1999.0732286.x; Yuan LM, 1999, CANCER RES, V59, P3215; Zhou LA, 2010, IUBMB LIFE, V62, P825, DOI 10.1002/iub.390	50	27	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27378	27388		10.1074/jbc.M111.243576	http://dx.doi.org/10.1074/jbc.M111.243576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659515	Green Published, hybrid			2022-12-27	WOS:000293268700033
J	Pentikainen, U; Jiang, PJ; Takala, H; Ruskamo, S; Campbell, ID; Ylanne, J				Pentikainen, Ulla; Jiang, Pengju; Takala, Heikki; Ruskamo, Salla; Campbell, Iain D.; Ylanne, Jari			Assembly of a Filamin Four-domain Fragment and the Influence of Splicing Variant-1 on the Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; BINDING PROTEIN HOMOLOG; X-RAY-SCATTERING; INTEGRIN BINDING; AUTO-INHIBITION; PHOSPHORYLATION; COMPETITION; DOMAINS; SYSTEM	Filamins are scaffold proteins that bind to various proteins, including the actin cytoskeleton, integrin adhesion receptors, and adaptor proteins such as migfilin. Alternative splicing of filamin, largely constructed from 24 Ig-like domains, is thought to have a role in regulating its interactions with other proteins. The filamin A splice variant-1 (FLNa var-1) lacks 41 amino acids, including the last beta-strand of domain 19, FLNa(19), and the first beta-strand of FLNa(20) that was previously shown to mask a key binding site on FLNa(21). Here, we present a structural characterization of domains 18-21, FLNa(18-21), in the FLNa var-1 as well as its nonspliced counterpart. A model of nonspliced FLNa(18-21), obtained from small angle x-ray scattering data, shows that these four domains form an L-shaped structure, with one arm composed of a pair of domains. NMR spectroscopy reveals that in the splice variant, FLNa(19) is unstructured whereas the other domains retain the same fold as in their canonical counterparts. The maximum dimensions predicted by small angle x-ray scattering data are increased upon migfilin binding in the FLNa(18-21) but not in the splice variant, suggesting that migfilin binding is able to displace the masking beta-strand and cause a rearrangement of the structure. Possible function roles for the spliced variants are discussed.	[Pentikainen, Ulla; Takala, Heikki; Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Pentikainen, Ulla; Takala, Heikki; Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Jiang, Pengju; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Jiang, Pengju] Changzhou Sci & Technol Bur, Changzhou 213022, Peoples R China	University of Jyvaskyla; University of Jyvaskyla; University of Oxford	Pentikainen, U (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35, FI-40014 Jyvaskyla, Finland.	ulla.m.pentikainen@jyu.fi	Takala, Heikki/GVT-1834-2022; Takala, Heikki/ABC-9139-2020	Takala, Heikki/0000-0003-2518-8583; Takala, Heikki/0000-0003-2518-8583; Pentikainen, Ulla/0000-0001-6547-1282; Ruskamo, Salla/0000-0002-9740-9077; Ylanne, Jari/0000-0003-4627-021X	Academy of Finland [121393, 114713]; National Doctoral Programme in Informational and Structural Biology; Biotechnology and Biological Sciences Research Council; Medical Research Council [G0900052] Funding Source: researchfish; MRC [G0900052] Funding Source: UKRI	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Academy of Finland Grants 121393 (to U. P.) and 114713 (to J. Y.) and by the National Doctoral Programme in Informational and Structural Biology (to S. R.).; Supported by the Biotechnology and Biological Sciences Research Council.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chen HS, 2009, BIOPHYS J, V97, P3095, DOI 10.1016/j.bpj.2009.08.059; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demchenko AP, 2001, J MOL RECOGNIT, V14, P42, DOI 10.1002/1099-1352(200101/02)14:1<42::AID-JMR518>3.0.CO;2-8; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jiang PJ, 2008, BIOCHEMISTRY-US, V47, P11055, DOI 10.1021/bi8011466; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xie ZW, 1998, BIOCHEM BIOPH RES CO, V251, P914, DOI 10.1006/bbrc.1998.9506; Xu WF, 1998, BLOOD, V92, P1268, DOI 10.1182/blood.V92.4.1268.416k12_1268_1276; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	40	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26921	26930		10.1074/jbc.M110.195958	http://dx.doi.org/10.1074/jbc.M110.195958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636571	Green Published, hybrid			2022-12-27	WOS:000293078200066
J	Zhu, W; Liang, G; Huang, ZP; Doty, SB; Boskey, AL				Zhu, Wei; Liang, Gang; Huang, Zhiping; Doty, Stephen B.; Boskey, Adele L.			Conditional Inactivation of the CXCR4 Receptor in Osteoprecursors Reduces Postnatal Bone Formation Due to Impaired Osteoblast Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; FACTOR-I; CHEMOKINE SDF-1; GROWTH-PLATE; OSTEOGENIC DIFFERENTIATION; MARROW; MIGRATION; EXPRESSION; MICE; PROGENITORS	Cysteine (C)-X-C motif chemokine receptor 4 (CXCR4), the primary receptor for stromal cell-derived factor-1 (SDF-1), is involved in bone morphogenic protein 2 (BMP2)-induced osteogenic differentiation of mesenchymal progenitors. To target the in vivo function of CXCR4 in bone and explore the underlying mechanisms, we conditionally inactivated CXCR4 in osteoprecursors by crossing osterix (Osx)-Cre mice with floxed CXCR4 (CXCR4(fl/fl)) mice to generate knock-outs with CXCR4 deletion driven by the Osx promoter (Osx::CXCR4(fl/fl)). The Cre-mediated excision of CXCR4 occurred exclusively in bone of Osx::CXCR4(fl/fl) mice. When compared with littermate controls, Osx::CXCR4(fl/fl) mice developed smaller osteopenic skeletons as evidenced by reduced trabecular and cortical bone mass, lower bone mineral density, and a slower mineral apposition rate. In addition, Osx::CXCR4(fl/fl) mice displayed chondrocyte disorganization in the epiphyseal growth plate associated with decreased proliferation and collagen matrix syntheses. Moreover, mature osteoblast-related expression of type I collagen alpha 1 and osteocalcin was reduced in bone of Osx::CXCR4(fl/fl) mice versus controls, suggesting that CXCR4 deficiency results in arrested osteoblast progression. Primary cultures for osteoblastic cells derived from Osx::CXCR4(fl/fl) mice also showed decreased proliferation and impaired osteoblast differentiation in response to BMP2 or BMP6 stimulation, and suppressed activation of intracellular BMP receptor-regulated Smads (R-Smads) and Erk1/2 was identified in CXCR4-deficient cells and bone tissues. These findings provide the first in vivo evidence that CXCR4 functions in postnatal bone development by regulating osteoblast development in cooperation with BMP signaling. Thus, CXCR4 acts as an endogenous signaling component necessary for bone formation.	[Zhu, Wei; Liang, Gang; Huang, Zhiping; Doty, Stephen B.; Boskey, Adele L.] Hosp Special Surg, Musculoskeletal Integr Program, New York, NY 10021 USA; [Zhu, Wei; Liang, Gang; Huang, Zhiping; Doty, Stephen B.; Boskey, Adele L.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; [Boskey, Adele L.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University; Cornell University	Zhu, W (corresponding author), Hosp Special Surg, Musculoskeletal Integr Program, Caspary Res Bldg,Rm 624,535 E 70th St, New York, NY 10021 USA.	zhuw@hss.edu		Boskey, Adele/0000-0002-6181-2219	National Institutes of Health, NIAMS [AR046121]; Arthritis Foundation; Beatrice and Samuel A. Seaver Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; Beatrice and Samuel A. Seaver Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR046121 from the NIAMS-funded Musculoskeletal Repair and Regeneration Core Centers. This work was also supported by grants from the Arthritis Foundation and Beatrice and Samuel A. Seaver Foundation.	Agarwal U, 2010, CIRC RES, V107, P667, DOI 10.1161/CIRCRESAHA.110.223289; Aiuti A, 1999, EUR J IMMUNOL, V29, P1823, DOI 10.1002/(SICI)1521-4141(199906)29:06<1823::AID-IMMU1823>3.0.CO;2-B; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Diaz GA, 2005, IMMUNOL REV, V203, P235, DOI 10.1111/j.0105-2896.2005.00226.x; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Majka M, 2000, STEM CELLS, V18, P128, DOI 10.1634/stemcells.18-2-128; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Wang Y, 2007, CELLS TISSUES ORGANS, V186, P192, DOI 10.1159/000105673; Wei L, 2010, DEV BIOL, V341, P236, DOI 10.1016/j.ydbio.2010.02.033; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	47	67	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26794	26805		10.1074/jbc.M111.250985	http://dx.doi.org/10.1074/jbc.M111.250985			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636574	Green Published, hybrid			2022-12-27	WOS:000293078200055
J	Goyal, A; Pal, N; Concannon, M; Paul, M; Doran, M; Poluzzi, C; Sekiguchi, K; Whitelock, JM; Neill, T; Iozzo, RV				Goyal, Atul; Pal, Nutan; Concannon, Matthew; Paul, Matthew; Doran, Mike; Poluzzi, Chiara; Sekiguchi, Kiyotoshi; Whitelock, John M.; Neill, Thomas; Iozzo, Renato V.			Endorepellin, the Angiostatic Module of Perlecan, Interacts with Both the alpha 2 beta 1 Integrin and Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) A DUAL RECEPTOR ANTAGONISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; PROTEIN-TYROSINE-PHOSPHATASE; MUSCLE-CELL PROLIFERATION; BASEMENT-MEMBRANE PROTEOGLYCANS; COLON-CARCINOMA-CELLS; TUMOR-GROWTH; IN-VIVO; ALPHA(2)BETA(1) INTEGRINS; EXTRACELLULAR MATRICES; INTIMAL HYPERPLASIA	Endorepellin, the C-terminal module of perlecan, negatively regulates angiogenesis counter to its proangiogenic parental molecule. Endorepellin (the C-terminal domain V of perlecan) binds the alpha 2 beta 1 integrin on endothelial cells and triggers a signaling cascade that leads to disruption of the actin cytoskeleton. Here, we show that both perlecan and endorepellin bind directly and with high affinity to both VEGF receptors 1 and 2, in a region that differs from VEGFA-binding site. In both human and porcine endothelial cells, this interaction evokes a physical down-regulation of both the alpha 2 beta 1 integrin and VEGFR2, with concurrent activation of the tyrosine phosphatase SHP-1 and downstream attenuation of VEGFA transcription. We demonstrate that endorepellin requires both the alpha 2 beta 1 integrin and VEGFR2 for its angiostatic activity. Endothelial cells that express alpha 2 beta 1 integrin but lack VEGFR2, do not respond to endorepellin treatment. Thus, we provide a new paradigm for the activity of an antiangiogenic protein and mechanistically explain the specificity of endorepellin for endothelial cells, the only cells that simultaneously express both receptors. We hypothesize that a mechanism such as dual receptor antagonism could operate for other angiostatic fragments.	[Goyal, Atul; Pal, Nutan; Concannon, Matthew; Paul, Matthew; Doran, Mike; Poluzzi, Chiara; Neill, Thomas; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Goyal, Atul; Pal, Nutan; Concannon, Matthew; Paul, Matthew; Doran, Mike; Poluzzi, Chiara; Neill, Thomas; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Sekiguchi, Kiyotoshi] Osaka Univ, Lab Extracellular Matrix Biochem, Inst Prot Res, Suita, Osaka 5650871, Japan; [Whitelock, John M.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia	Jefferson University; Jefferson University; Osaka University; University of New South Wales Sydney	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Kimmel Canc Ctr, 1020 Locust St,Ste 336,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	iozzo@KimmelCancerCenter.org	Concannon, Matthew/ABG-5026-2021; Iozzo, Renato/AAS-1980-2020; Poluzzi, Chiara/T-3376-2019	Concannon, Matthew/0000-0001-8777-4786; Pal, Nutan/0000-0002-5948-3508; Paul, Matthew/0000-0002-3020-7729; Whitelock, John/0000-0003-1835-802X; Iozzo, Renato/0000-0002-5908-5112; Doran, Michael/0000-0001-5876-4757	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA120975]; Mizutani Foundation for Glycoscience; National Research Service [T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA039481, R01CA120975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation for Glycoscience; National Research Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA120975. This work was also supported by a grant from the Mizutani Foundation for Glycoscience (to R. V. I.).; Supported by National Research Service Award Training Grant T32 AA07463.	Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Bhattacharya Resham, 2008, J Mol Signal, V3, P8, DOI 10.1186/1750-2187-3-8; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Borza CM, 2010, J BIOL CHEM, V285, P40114, DOI 10.1074/jbc.M110.156729; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; Chang JW, 2008, PROTEOM CLIN APPL, V2, P23, DOI 10.1002/prca.200780049; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; CHIANG MK, 1995, GROWTH FACTORS, V12, P1, DOI 10.3109/08977199509003208; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Chuang CY, 2010, BIOCHEMISTRY-US, V49, P5524, DOI 10.1021/bi1005199; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COHEN IR, 1994, CANCER RES, V54, P5771; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Davis GE, 2008, CURR OPIN HEMATOL, V15, P197, DOI 10.1097/MOH.0b013e3282fcc321; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; DODGE GR, 1990, J BIOL CHEM, V265, P18023; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fong TAT, 1999, CANCER RES, V59, P99; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gluzman-Poltorak Z, 2001, J BIOL CHEM, V276, P18688, DOI 10.1074/jbc.M006909200; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Grenache DG, 2007, J INVEST DERMATOL, V127, P455, DOI 10.1038/sj.jid.5700611; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; IOZZO RV, 1994, MATRIX BIOL, V14, P203, DOI 10.1016/0945-053X(94)90183-X; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; IOZZO RV, 1984, J CELL BIOL, V99, P403, DOI 10.1083/jcb.99.2.403; Ito N, 1999, Angiogenesis, V3, P159, DOI 10.1023/A:1009008926710; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kadenhe-Chiweshe A, 2008, MOL CANCER RES, V6, P1, DOI 10.1158/1541-7786.MCR-07-0101; Kaji T, 2006, BBA-GEN SUBJECTS, V1760, P1465, DOI 10.1016/j.bbagen.2006.06.010; Kendrew J, 2011, MOL CANCER THER, V10, P770, DOI 10.1158/1535-7163.MCT-10-0876; Kinsella MG, 2003, ARTERIOSCL THROM VAS, V23, P608, DOI 10.1161/01.ATV.0000063109.94810.EE; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lee SJ, 2010, LAB INVEST, V90, P374, DOI 10.1038/labinvest.2009.136; Li SL, 2010, J BIOL CHEM, V285, P36645, DOI 10.1074/jbc.M110.177865; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Mathiak M, 1997, CANCER RES, V57, P2130; Mattila E, 2008, J CELL SCI, V121, P3570, DOI 10.1242/jcs.031898; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; Muthusamy A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-43; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074/jbc.273.47.31273; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; PARK JE, 1994, J BIOL CHEM, V269, P25646; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; San Antonio JD, 2009, AM J PATHOL, V175, P1338, DOI 10.2353/ajpath.2009.090234; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Senger DR, 2010, MOL BIOL CELL, V21, P377, DOI 10.1091/mbc.E09-07-0591; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sharma B, 1998, J BIOL CHEM, V273, P4642, DOI 10.1074/jbc.273.8.4642; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1987, J BIOL CHEM, V262, P17668; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649; Zhang ZH, 2008, BLOOD, V111, P1980, DOI 10.1182/blood-2007-06-094680; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	111	86	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25947	25962		10.1074/jbc.M111.243626	http://dx.doi.org/10.1074/jbc.M111.243626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596751	hybrid, Green Published			2022-12-27	WOS:000293073000054
J	Lee, K; Kerner, J; Hoppel, CL				Lee, Kwangwon; Kerner, Janos; Hoppel, Charles L.			Mitochondrial Carnitine Palmitoyltransferase 1a (CPT1a) Is Part of an Outer Membrane Fatty Acid Transfer Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; RAT-LIVER MITOCHONDRIA; MALONYL-COA BINDING; CONTACT SITES; OXIDATIVE-PHOSPHORYLATION; PROTEIN COMPLEXES; STRIATED-MUSCLES; TRANSLOCASE; POLYANION; PURIFICATION	CPT1a (carnitine palmitoyltransferase 1a) in the liver mitochondrial outer membrane (MOM) catalyzes the primary regulated step in overall mitochondrial fatty acid oxidation. It has been suggested that the fundamental unit of CPT1a exists as a trimer, which, under native conditions, could form a dimer of the trimers, creating a hexamer channel for acylcarnitine translocation. To examine the state of CPT1a in the MOM, we employed a combined approach of sizing by mass and isolation using an immunological method. Blue native electrophoresis followed by detection with immunoblotting and mass spectrometry identified large molecular mass complexes that contained not only CPT1a but also long chain acyl-CoA synthetase (ACSL) and the voltage-dependent anion channel (VDAC). Immunoprecipitation with antisera against the proteins revealed a strong interaction between the three proteins. Immobilized CPT1a-specific antibodies immunocaptured not only CPT1a but also ACSL and VDAC, further strengthening findings with blue native electrophoresis and immunoprecipitation. This study shows strong protein-protein interaction between CPT1a, ACSL, and VDAC. We propose that this complex transfers activated fatty acids through the MOM.	[Lee, Kwangwon; Kerner, Janos; Hoppel, Charles L.] Case Western Reserve Univ, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Lee, Kwangwon; Kerner, Janos; Hoppel, Charles L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Hoppel, CL (corresponding author), Case Western Reserve Univ, Ctr Mitochondrial Dis, 10900 Euclid Ave, Cleveland, OH 44106 USA.	charles.hoppel@case.edu			National Institutes of Health [DK-066107]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-066107.	Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Anflous-Pharayra K, 2011, BBA-BIOENERGETICS, V1807, P150, DOI 10.1016/j.bbabio.2010.09.007; BARTANA J, 1973, BIOCHEM J, V135, P411, DOI 10.1042/bj1350411; BHUIYAN J, 1995, METABOLISM, V44, P1185, DOI 10.1016/0026-0495(95)90013-6; Brdiczka DG, 2006, BBA-MOL BASIS DIS, V1762, P148, DOI 10.1016/j.bbadis.2005.09.007; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Cesar MD, 2004, ARCH BIOCHEM BIOPHYS, V422, P191, DOI 10.1016/j.abb.2003.12.030; COLOMBINI M, 1987, BIOCHIM BIOPHYS ACTA, V905, P279, DOI 10.1016/0005-2736(87)90456-1; Craigen WJ, 2008, J BIOENERG BIOMEMBR, V40, P207, DOI 10.1007/s10863-008-9146-x; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Distler AM, 2007, BBA-PROTEINS PROTEOM, V1774, P628, DOI 10.1016/j.bbapap.2007.03.012; Distler AM, 2006, ANAL BIOCHEM, V356, P18, DOI 10.1016/j.ab.2006.03.053; Faye A, 2007, J BIOL CHEM, V282, P26908, DOI 10.1074/jbc.M705418200; FELGNER PL, 1979, J BIOL CHEM, V254, P4946; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Gavish M, 1999, PHARMACOL REV, V51, P629; Hoppel C, 2002, ANAL BIOCHEM, V302, P60, DOI 10.1006/abio.2001.5531; Hoppel C, 2001, ARCH BIOCHEM BIOPHYS, V392, P321, DOI 10.1006/abbi.2001.2463; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; Jenei ZA, 2009, J BIOL CHEM, V284, P6988, DOI 10.1074/jbc.M808487200; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; King KL, 2007, ARCH BIOCHEM BIOPHYS, V467, P234, DOI 10.1016/j.abb.2007.08.020; KONIG T, 1982, J BIOENERG BIOMEMBR, V14, P297, DOI 10.1007/BF00743059; Li H, 2007, BBA-MOL CELL BIOL L, V1771, P1246, DOI 10.1016/j.bbalip.2007.05.009; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; Nakamura Y, 2004, J BIOL CHEM, V279, P21223, DOI 10.1074/jbc.M314156200; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schenk S, 2006, AM J PHYSIOL-ENDOC M, V291, pE254, DOI 10.1152/ajpendo.00051.2006; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Turkaly P, 1999, FEBS LETT, V460, P241, DOI 10.1016/S0014-5793(99)01354-X; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; Werhahn W, 2001, PLANT PHYSIOL, V125, P943, DOI 10.1104/pp.125.2.943; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; ZAMMIT VA, 1989, BIOCHEM J, V263, P89, DOI 10.1042/bj2630089; Zammit VA, 1997, ADV ENZYME REGUL, V37, P295, DOI 10.1016/S0065-2571(96)00015-5	44	153	156	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25655	25662		10.1074/jbc.M111.228692	http://dx.doi.org/10.1074/jbc.M111.228692			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622568	Green Published, hybrid			2022-12-27	WOS:000293073000027
J	Maier, H; Meixner, M; Hartmann, D; Sandhoff, R; Wang-Eckhardt, L; Zoller, I; Gieselmann, V; Eckhardt, M				Maier, Helena; Meixner, Marion; Hartmann, Dieter; Sandhoff, Roger; Wang-Eckhardt, Lihua; Zoeller, Inge; Gieselmann, Volkmar; Eckhardt, Matthias			Normal Fur Development and Sebum Production Depends on Fatty Acid 2-Hydroxylase Expression in Sebaceous Glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; GRAM-POSITIVE BACTERIA; CATHEPSIN-L; HUMAN SKIN; BARRIER FUNCTION; ALPHA-OXIDATION; FAMILY-MEMBERS; PIG EPIDERMIS; PHYTANIC ACID; GROWTH CYCLE	2-Hydroxylated fatty acid (HFA)-containing sphingolipids are abundant in mammalian skin and are believed to play a role in the formation of the epidermal barrier. Fatty acid 2-hydroxylase (FA2H), required for the synthesis of 2-hydroxylated sphingolipids in various organs, is highly expressed in skin, and previous in vitro studies demonstrated its role in the synthesis of HFA sphingolipids in human keratinocytes. Unexpectedly, however, mice deficient in FA2H did not show significant changes in their epidermal HFA sphingolipids. Expression of FA2H in murine skin was restricted to the sebaceous glands, where it was required for synthesis of 2-hydroxylated glucosylceramide and a fraction of type II wax diesters. Absence of FA2H resulted in hyperproliferation of sebocytes and enlarged sebaceous glands during hair follicle morphogenesis and anagen (active growth phase) in adult mice. This was accompanied by a significant up-regulation of the epidermal growth factor receptor ligand epigen in sebocytes. Loss of FA2H significantly altered the composition and physicochemical properties of sebum, which often blocked the hair canal, apparently causing a delay in the hair fiber exit. Furthermore, mice lacking FA2H displayed a cycling alopecia with hair loss in telogen. These results underline the importance of the sebaceous glands and suggest a role of specific sebaceous gland or sebum lipids, synthesized by FA2H, in the hair follicle homeostasis.	[Maier, Helena; Meixner, Marion; Wang-Eckhardt, Lihua; Zoeller, Inge; Gieselmann, Volkmar; Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Hartmann, Dieter] Univ Bonn, Inst Anat, D-53115 Bonn, Germany; [Sandhoff, Roger] German Canc Res Ctr, D-69120 Heidelberg, Germany	University of Bonn; University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ)	Eckhardt, M (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	eckhardt@uni-bonn.de			Deutsche Forschungsgemeinschaft from the University of Bonn [SFB645]	Deutsche Forschungsgemeinschaft from the University of Bonn(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB645 from the University of Bonn.	Alderson NL, 2009, J LIPID RES, V50, P1203, DOI 10.1194/jlr.M800666-JLR200; Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Baron JM, 2008, CURR MED CHEM, V15, P2258, DOI 10.2174/092986708785747535; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Dahlhoff M, 2010, J INVEST DERMATOL, V130, P623, DOI 10.1038/jid.2009.251; Dick KJ, 2010, HUM MUTAT, V31, pE1251, DOI 10.1002/humu.21205; Doering T, 2002, J LIPID RES, V43, P1727, DOI 10.1194/jlr.M200208-JLR200; Eckhardt M, 2005, BIOCHEM J, V388, P245, DOI 10.1042/BJ20041451; Edvardson S, 2008, AM J HUM GENET, V83, P643, DOI 10.1016/j.ajhg.2008.10.010; Fewou SN, 2005, J NEUROCHEM, V94, P469, DOI 10.1111/j.1471-4159.2005.03221.x; Foulon V, 2003, J LIPID RES, V44, P2349, DOI 10.1194/jlr.M300230-JLR200; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; GATES AH, 1965, SCIENCE, V148, P1471, DOI 10.1126/science.148.3676.1471; Georgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005; Gu LH, 2008, AM J PATHOL, V173, P752, DOI 10.2353/ajpath.2008.071089; Guo L, 2010, J BIOL CHEM, V285, P25438, DOI 10.1074/jbc.M110.119933; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Higgins CA, 2009, J INVEST DERMATOL, V129, P2100, DOI 10.1038/jid.2009.66; Holleran WM, 2006, FEBS LETT, V580, P5456, DOI 10.1016/j.febslet.2006.08.039; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Mak KKL, 2003, J BIOL CHEM, V278, P26120, DOI 10.1074/jbc.M212082200; Marques M, 2002, J INVEST DERMATOL, V119, P913, DOI 10.1046/j.1523-1747.2002.01859.x; Milner Y, 2002, J INVEST DERMATOL, V119, P639, DOI 10.1046/j.1523-1747.2002.01842.x; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Mukherji M, 2002, CHEM BIOL, V9, P597, DOI 10.1016/S1074-5521(02)00139-4; NIKKARI T, 1974, J INVEST DERMATOL, V62, P257, DOI 10.1111/1523-1747.ep12676800; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; PENNYCUIK PR, 1986, GENET RES, V48, P179, DOI 10.1017/S0016672300024988; Ponec M, 2003, J INVEST DERMATOL, V120, P581, DOI 10.1046/j.1523-1747.2003.12103.x; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Schneider MR, 2010, INT J BIOCHEM CELL B, V42, P181, DOI 10.1016/j.biocel.2009.11.017; Selleri S, 2006, J INVEST DERMATOL, V126, P711, DOI 10.1038/sj.jid.5700175; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Stenn KS, 2008, J INVEST DERMATOL, V128, P1576, DOI 10.1038/sj.jid.5701200; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Thiele JJ, 1999, J INVEST DERMATOL, V113, P1006, DOI 10.1046/j.1523-1747.1999.00794.x; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Uchida Y, 2007, J BIOL CHEM, V282, P13211, DOI 10.1074/jbc.M611562200; WATKINS PA, 1994, BBA-LIPID LIPID MET, V1214, P288, DOI 10.1016/0005-2760(94)90075-2; WERTZ PW, 1983, J LIPID RES, V24, P753; WERTZ PW, 1983, J LIPID RES, V24, P759; Wille JJ, 2003, SKIN PHARMACOL APPL, V16, P176, DOI 10.1159/000069757; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhang L, 2006, PEPTIDES, V27, P413, DOI 10.1016/j.peptides.2005.05.030; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008	55	32	32	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25922	25934		10.1074/jbc.M111.231977	http://dx.doi.org/10.1074/jbc.M111.231977			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628453	hybrid, Green Published			2022-12-27	WOS:000293073000052
J	Mateos, L; Ismail, MAM; Gil-Bea, FJ; Schule, R; Schols, L; Heverin, M; Folkesson, R; Bjorkhem, I; Cedazo-Minguez, A				Mateos, Laura; Ismail, Muhammad-Al-Mustafa; Gil-Bea, Francisco-Javier; Schuele, Rebecca; Schoels, Ludger; Heverin, Maura; Folkesson, Ronnie; Bjorkhem, Ingemar; Cedazo-Minguez, Angel			Side Chain-oxidized Oxysterols Regulate the Brain Renin-Angiotensin System through a Liver X Receptor-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COGNITIVE FUNCTION; APOLIPOPROTEIN-E; GENE-EXPRESSION; LXR-ALPHA; IN-VIVO; CHOLESTEROL; 27-HYDROXYCHOLESTEROL; PROTEIN; LIGAND; MICE	Disturbances in cholesterol metabolism have been associated with hypertension and neurodegenerative disorders. Because cholesterol metabolism in the brain is efficiently separated from plasma cholesterol by the blood-brain barrier (BBB), it is an unsolved paradox how high blood cholesterol can cause an effect in the brain. Here, we discuss the possibility that cholesterol metabolites permeable to the BBB might account for these effects. We show that 27-hydroxycholesterol (27-OH) and 24S-hydroxycholesterol (24S-OH) up-regulate the renin-angiotensin system (RAS) in the brain. Brains of mice on a cholesterol-enriched diet showed up-regulated angiotensin converting enzyme (ACE), angiotensinogen (AGT), and increased JAK/STAT activity. These effects were confirmed in in vitro studies with primary neurons and astrocytes exposed to 27-OH or 24S-OH, and were partially mediated by liver X receptors. In contrast, brain RAS activity was decreased in Cyp27a1-deficient mice, a model exhibiting reduced 27-OH production from cholesterol. Moreover, in humans, normocholesterolemic patients with elevated 27-OH levels, due to a CYP7B1 mutation, had markers of activated RAS in their cerebrospinal fluid. Our results demonstrate that side chain-oxidized oxysterols are modulators of brain RAS. Considering that levels of cholesterol and 27-OH correlate in the circulation and 27-OH can pass the BBB into the brain, we suggest that this cholesterol metabolite could be a link between high plasma cholesterol levels, hypertension, and neurodegeneration.	[Mateos, Laura; Ismail, Muhammad-Al-Mustafa; Gil-Bea, Francisco-Javier; Folkesson, Ronnie; Cedazo-Minguez, Angel] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimers Dis Res Ctr, Novum, SE-14186 Stockholm, Sweden; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Ctr Neurol, D-72076 Tubingen, Germany; [Heverin, Maura; Bjorkhem, Ingemar] Karolinska Univ Hosp, Div Clin Chem, Dept Lab Med, S-14186 Huddinge, Sweden	Karolinska Institutet; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Karolinska Institutet; Karolinska University Hospital	Mateos, L (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimers Dis Res Ctr, Novum, 5th Floor, S-14186 Stockholm, Sweden.	Laura.Mateos-Montejo@ki.se; Angel.Cedazo-Minguez@ki.se	Ismail, Muhammad Al Mustafa/AAD-8555-2020; Cedazo-Minguez, Angel/C-6707-2012; Gil-Bea, Francisco J/L-5799-2014; Gil-Bea, Francisco Javier/GQY-6096-2022; Gil-Bea, Francisco J/T-8090-2017; Schöls, Ludger/ABB-2482-2021; Schüle, Rebecca/B-5763-2019; Heverin, Maura B/J-4101-2012	Cedazo-Minguez, Angel/0000-0003-4626-4864; Gil-Bea, Francisco J/0000-0002-8985-3792; Schöls, Ludger/0000-0001-7774-5025; Schüle, Rebecca/0000-0002-7781-2766; Bjorkhem, Ingemar/0000-0001-6087-9190; gil-bea, francico/0000-0002-1449-6233; Bjorkhem, Ingemar/0000-0002-0575-9425	Swedish Brain Power, Alice and Knut Wallenberg Foundation; Brain Foundation; Soderberg Foundation; Gun och Bertil Stohnes Stiftelse; Karolinska Institutet fund for Geriatric Research; Stiftelsen Gamla Tjanarinnor; Swedish Research Council; Alzheimerfonden; Stockholm County Council; Karolinska Institutet	Swedish Brain Power, Alice and Knut Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Brain Foundation; Soderberg Foundation; Gun och Bertil Stohnes Stiftelse; Karolinska Institutet fund for Geriatric Research; Stiftelsen Gamla Tjanarinnor; Swedish Research Council(Swedish Research CouncilEuropean Commission); Alzheimerfonden; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Swedish Brain Power, Alice and Knut Wallenberg Foundation, Brain Foundation, Soderberg Foundation, Gun och Bertil Stohnes Stiftelse, Karolinska Institutet fund for Geriatric Research, Stiftelsen Gamla Tjanarinnor, Swedish Research Council, Alzheimerfonden, and the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet.	Bavner A, 2010, J LIPID RES, V51, P2722, DOI 10.1194/jlr.M008326; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Bjorkhem I, 2010, J LIPID RES, V51, P2489, DOI 10.1194/jlr.R006338; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Cedazo-Minguez A, 2001, NEUROSCIENCE, V105, P651, DOI 10.1016/S0306-4522(01)00224-X; Dekroon RM, 2001, GLIA, V33, P298, DOI 10.1002/1098-1136(20010315)33:4<298::AID-GLIA1028>3.0.CO;2-N; Doulton TWR, 2009, J RENIN-ANGIO-ALDO S, V10, P185, DOI 10.1177/1470320309342733; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Ghribi O, 2008, J ALZHEIMERS DIS, V15, P673; Goldstein FC, 2008, ALZ DIS ASSOC DIS, V22, P336, DOI 10.1097/WAD.0b013e318188e80d; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Grobe JL, 2008, PHYSIOLOGY, V23, P187, DOI 10.1152/physiol.00002.2008; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Inaba S, 2009, STROKE, V40, P597, DOI 10.1161/STROKEAHA.108.519801; Inaba S, 2009, HYPERTENSION, V53, P356, DOI 10.1161/HYPERTENSIONAHA.108.123612; Iwai M, 2009, HYPERTENS RES, V32, P533, DOI 10.1038/hr.2009.74; Jansen PJ, 2009, J ALZHEIMERS DIS, V18, P319, DOI 10.3233/JAD-2009-1150; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kainu T, 1996, J MOL NEUROSCI, V7, P29, DOI 10.1007/BF02736846; KUMAR A, 1988, J NEUROSCI RES, V19, P287, DOI 10.1002/jnr.490190302; Leik CE, 2007, BRIT J PHARMACOL, V151, P450, DOI 10.1038/sj.bjp.0707241; Leoni V, 2004, CLIN CHEM LAB MED, V42, P186, DOI 10.1515/CCLM.2004.034; Ligthart SA, 2010, VASC HEALTH RISK MAN, V6, P775, DOI 10.2147/VHRM.S7343; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684; Mateos L., 2011, J ALZHEIMERS DIS; Mateos L, 2009, BRAIN PATHOL, V19, P69, DOI 10.1111/j.1750-3639.2008.00174.x; McKinley MJ, 2003, INT J BIOCHEM CELL B, V35, P901, DOI 10.1016/S1357-2725(02)00306-0; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Nikolova J G, 2000, Folia Med (Plovdiv), V42, P47; Nishimura Masuhiro, 2004, Drug Metab Pharmacokinet, V19, P135, DOI 10.2133/dmpk.19.135; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; PHILLIPS MI, 1987, ANNU REV PHYSIOL, V49, P413, DOI 10.1146/annurev.physiol.49.1.413; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Raghavendra V, 2001, NEUROPEPTIDES, V35, P65, DOI 10.1054/npep.2000.0845; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Schule R, 2009, NEUROGENETICS, V10, P97, DOI 10.1007/s10048-008-0158-9; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x; Ulven SM, 2004, J LIPID RES, V45, P2052, DOI 10.1194/jlr.M400119-JLR200; von Bohlen und Halbach O, 2006, CELL TISSUE RES, V326, P599, DOI 10.1007/s00441-006-0190-8; Wang YJ, 2010, BBA-MOL CELL BIOL L, V1801, P917, DOI 10.1016/j.bbalip.2010.02.012; Wei SG, 2009, AM J PHYSIOL-HEART C, V296, pH1425, DOI 10.1152/ajpheart.00942.2008; Wright JW, 2004, PROG NEUROBIOL, V72, P263, DOI 10.1016/j.pneurobio.2004.03.003; Yang GY, 1999, BRAIN RES, V817, P123, DOI 10.1016/S0006-8993(98)01236-0; Yehuda S, 2005, NUTR NEUROSCI, V8, P309, DOI 10.1080/00268970500509972	51	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25574	25585		10.1074/jbc.M111.236877	http://dx.doi.org/10.1074/jbc.M111.236877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628469	Green Published, hybrid			2022-12-27	WOS:000293073000020
J	Spivey, VL; Molle, V; Whalan, RH; Rodgers, A; Leiba, J; Stach, L; Walker, KB; Smerdon, SJ; Buxton, RS				Spivey, Vicky L.; Molle, Virginie; Whalan, Rachael H.; Rodgers, Angela; Leiba, Jade; Stach, Lasse; Walker, K. Barry; Smerdon, Stephen J.; Buxton, Roger S.			Forkhead-associated (FHA) Domain Containing ABC Transporter Rv1747 Is Positively Regulated by Ser/Thr Phosphorylation in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PROTEIN-KINASES; MYCOLIC ACID BIOSYNTHESIS; CELL-DIVISION; DNA-DAMAGE; PKNB; SPECIFICITY; SUBSTRATE; TRANSCRIPTION; MECHANISMS; VIRULENCE	One major signaling method employed by Mycobacterium tuberculosis, the causative agent of tuberculosis, is through reversible phosphorylation of proteins mediated by protein kinases and phosphatases. This study concerns one of these enzymes, the serine/threonine protein kinase PknF, that is encoded in an operon with Rv1747, an ABC transporter that is necessary for growth of M. tuberculosis in vivo and contains two forkhead-associated (FHA) domains. FHA domains are phosphopeptide recognition motifs that specifically recognize phosphothreonine-containing epitopes. Experiments to determine how PknF regulates the function of Rv1747 demonstrated that phosphorylation occurs on two specific threonine residues, Thr150 and Thr-208. To determine the in vivo consequences of phosphorylation, infection experiments were performed in bone marrow-derived macrophages and in mice using threonine-to-alanine mutants of Rv1747 that prevent specific phosphorylation and revealed that phosphorylation positively modulates Rv1747 function in vivo. The role of the FHA domains in this regulation was further demonstrated by isothermal titration calorimetry, using peptides containing both phosphothreonine residues. FHA-1 domain mutation resulted in attenuation in macrophages highlighting the critical role of this domain in Rv1747 function. A mutant deleted for pknF did not, however, have a growth phenotype in an infection, suggesting that other kinases can fulfill its role when it is absent. This study provides the first information on the molecular mechanism(s) regulating Rv1747 through PknF-dependent phosphorylation but also indicates that phosphorylation activates Rv1747, which may have important consequences in regulating growth of M. tuberculosis.	[Molle, Virginie; Leiba, Jade] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Molle, Virginie; Leiba, Jade] Univ Montpellier I, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Spivey, Vicky L.; Whalan, Rachael H.; Buxton, Roger S.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England; [Rodgers, Angela; Walker, K. Barry] Natl Inst Biol Stand & Controls, Immunol & Cellular Immun Sect, Bacteriol Div, Potters Bar EN6 3QG, Herts, England; [Stach, Lasse; Smerdon, Stephen J.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; MRC National Institute for Medical Research; National Institute for Biological Standards & Control; MRC National Institute for Medical Research	Molle, V (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Case 107,Pl Eugene Bataillon, F-34095 Montpellier 05, France.	virginie.molle@univ-montp2.fr; rbuxton@nimr.mrc.ac.uk	MOLLE, Virginie/D-4050-2019	MOLLE, Virginie/0000-0002-6573-3411; Rowlands, Vicky/0000-0002-1352-938X; Smerdon, Stephen/0000-0001-5688-8465; Leiba, Jade/0000-0003-0584-9524	Medical Research Council [U117585867, U117584228]; National Research Agency [ANR-06-MIME-027-01, ANR-09-MIEN-004]; Health Protection Agency; MRC [MC_U117585867, MC_U117584228] Funding Source: UKRI; Medical Research Council [MC_U117584228, MC_U117585867] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Agency(French National Research Agency (ANR)); Health Protection Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council studentships (to V. L. S. and L. S.), Medical Research Council Grants U117585867 and U117584228, National Research Agency Grants ANR-06-MIME-027-01 and ANR-09-MIEN-004, and by the Health Protection Agency.	AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Cohen-Gonsaud M, 2009, J BIOL CHEM, V284, P19290, DOI 10.1074/jbc.M109.019653; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P198, DOI 10.1159/000089648; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gopalaswamy R, 2008, FEMS MICROBIOL LETT, V278, P121, DOI 10.1111/j.1574-6968.2007.00989.x; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; Hegymegi-Barakonyi B, 2008, CURR MED CHEM, V15, P2760, DOI 10.2174/092986708786242886; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; KONG DQ, 1995, INFECT IMMUN, V63, P799, DOI 10.1128/IAI.63.3.799-803.1995; Li J, 2008, J BIOL CHEM, V283, P36019, DOI 10.1074/jbc.M804075200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lougheed K. E., 2011, TUBERCULOSIS; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Oatway WH, 1936, J INFECT DIS, V59, P306, DOI 10.1093/infdis/59.3.306; Papavinasasundaram KG, 2001, MICROBIOL-SGM, V147, P3271, DOI 10.1099/00221287-147-12-3271; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Springer B, 2001, INT J MED MICROBIOL, V290, P669; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Umeyama T, 2002, APPL MICROBIOL BIOT, V59, P419, DOI 10.1007/s00253-002-1045-1; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006	46	28	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26198	26209		10.1074/jbc.M111.246132	http://dx.doi.org/10.1074/jbc.M111.246132			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622570	hybrid, Green Published			2022-12-27	WOS:000293073000077
J	Ye, HH; Zhao, T; Tan, YLJ; Liu, JH; Pallen, CJ; Xiao, ZC				Ye, Haihong; Zhao, Tian; Tan, Yen Ling Jessie; Liu, Jianghong; Pallen, Catherine J.; Xiao, Zhi-Cheng			Receptor-like Protein-tyrosine Phosphatase alpha Enhances Cell Surface Expression of Neural Adhesion Molecule NB-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTP-ALPHA; RPTP-ALPHA; FUNCTIONAL INTERACTIONS; CONTACTIN/F3 SUBGROUP; DENDRITE ORIENTATION; NEURONAL MIGRATION; DOWN-REGULATION; CANCER CELLS; SRC; DIFFERENTIATION	Neural adhesion molecule NB-3 plays an important role in the apical dendrite development of layer V pyramidal neurons in the visual cortex, and receptor-like protein-tyrosine phosphatase alpha (PTP alpha) mediates NB-3 signaling in this process. Here we investigated the role of PTP alpha in regulating cell surface expression of NB-3. We found that cortical neurons from PTP alpha knock-out mice exhibited a lower level of NB-3 at the cell surface. When expressed in COS1 cells, NB-3 was enriched in the Golgi apparatus with a low level of cell surface expression. However, co-expression of PTP alpha increased the cell surface distribution of NB-3. Further analysis showed that PTP alpha facilitated Golgi exit of NB-3 and stabilized NB-3 protein at the cell surface by preventing its release from the plasma membrane. The extracellular region of PTP alpha but not its catalytic activity is necessary for its effect on NB-3 expression. Thus, the PTP alpha-mediated increase of NB-3 level at the cell surface represents a novel function of PTP alpha in NB-3 signaling in neural development.	[Ye, Haihong; Zhao, Tian; Liu, Jianghong] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Tan, Yen Ling Jessie; Xiao, Zhi-Cheng] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Pallen, Catherine J.] Univ British Columbia, Dept Paediat, Vancouver, BC V5Z 4H4, Canada; [Pallen, Catherine J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Xiao, Zhi-Cheng] Kunming Med Coll, Inst Mol & Clin Med, Kunming 650031, Peoples R China; [Xiao, Zhi-Cheng] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia	Chinese Academy of Sciences; Institute of Biophysics, CAS; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; Kunming Medical University; Monash University	Ye, HH (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Room 8821,15 Datun Rd, Beijing 100101, Peoples R China.	yehaihong@gmail.com		Ye, Haihong/0000-0001-7282-6280; xiao, zhicheng/0000-0001-5172-762X; Pallen, Catherine/0000-0002-3576-5295	Ministry of Science and Technology [2009CB825402, 2010CB529603]; National Science Foundation in China [30900845]; Canadian Institutes of Health Research [MOP-62759]; Child & Family Research Institute; Talent Program of Yunnan Province, China; Monash University, Australia	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation in China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute; Talent Program of Yunnan Province, China; Monash University, Australia(Monash University)	This work was supported in part by Ministry of Science and Technology Grants 2009CB825402 and 2010CB529603 and National Science Foundation Grant 30900845 in China (to H. Y.) and by Canadian Institutes of Health Research Grant MOP-62759 (to C. J. P.).; Recipient of an Investigator Award from the Child & Family Research Institute.; Recipient of financial support from both Talent Program of Yunnan Province, China, and Monash Professorial Fellowships Program, Monash University, Australia.	Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Cuoco C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-12; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Drumheller T, 1996, J MED GENET, V33, P842, DOI 10.1136/jmg.33.10.842; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Krndija D, 2010, ONCOGENE, V29, P2724, DOI 10.1038/onc.2010.25; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Ogawa J, 1996, NEUROSCI LETT, V218, P173, DOI 10.1016/S0304-3940(96)13156-6; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Pohjola P, 2010, AM J MED GENET A, V152A, P441, DOI 10.1002/ajmg.a.33215; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Sakurai K, 2009, DEV NEUROBIOL, V69, P811, DOI 10.1002/dneu.20742; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Skelton MR, 2003, BRAIN RES, V984, P1, DOI 10.1016/S0006-8993(03)02839-7; Stetak A, 2001, BIOCHEM BIOPH RES CO, V288, P564, DOI 10.1006/bbrc.2001.5811; Takeda Y, 2003, J NEUROBIOL, V56, P252, DOI 10.1002/neu.10222; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Vacaru AM, 2010, MOL CELL BIOL, V30, P2850, DOI 10.1128/MCB.01202-09; VERJAAL M, 1978, AM J DIS CHILD, V132, P43, DOI 10.1001/archpedi.1978.02120260045012; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Yang LT, 2002, J BIOL CHEM, V277, P17406, DOI 10.1074/jbc.M111902200; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zhang XQ, 2003, ONCOGENE, V22, P6704, DOI 10.1038/sj.onc.1206764; Zheng XM, 2002, J BIOL CHEM, V277, P21922, DOI 10.1074/jbc.M201394200; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	41	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26071	26080		10.1074/jbc.M110.214080	http://dx.doi.org/10.1074/jbc.M110.214080			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622556	Green Published, hybrid			2022-12-27	WOS:000293073000065
J	Durand, E; Alphonse, S; Brochier-Armanet, C; Ball, G; Douzi, B; Filloux, A; Bernard, C; Voulhoux, R				Durand, Eric; Alphonse, Sebastien; Brochier-Armanet, Celine; Ball, Genevieve; Douzi, Badreddine; Filloux, Alain; Bernard, Cedric; Voulhoux, Rome			The Assembly Mode of the Pseudopilus A HALLMARK TO DISTINGUISH A NOVEL SECRETION SYSTEM SUBTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II PROTEIN SECRETION; PSEUDOMONAS-AERUGINOSA; XCP GENES; PILUS; LOCALIZATION; SPECIFICITY; APPARATUS; COMPLEX	In Gram-negative bacteria, type II secretion systems assemble a piston-like structure, called pseudopilus, which expels exoproteins out of the cell. The pseudopilus is constituted by a major pseudopilin that when overproduced multimerizes into a long cell surface structure named hyper-pseudopilus. Pseudomonas aeruginosa possesses two type II secretion systems, Xcp and Hxc. Although major pseudopilins are exchangeable among type II secretion systems, we show that XcpT and HxcT are not. We demonstrate that HxcT does not form a hyper-pseudopilus and is different in amino acid sequence and multimerization properties. Using structure-based mutagenesis, we observe that five mutations are sufficient to revert HxcT into a functional XcpT-like protein, which also becomes capable of forming a hyper-pseudopilus. Phylogenetic and experimental analysis showed that the whole Hxc system was acquired by P. aeruginosa PAO1 and other Pseudomonas species through horizontal gene transfer. We thus identified a new type II secretion subfamily, of which the P. aeruginosa Hxc system is the archetype. This finding demonstrates how similar bacterial machineries evolve toward distinct mechanisms that may contribute specific functions.	[Durand, Eric; Ball, Genevieve; Douzi, Badreddine; Voulhoux, Rome] Univ Mediterranee, CNRS, Lab Ingn Syst Macromol LISM UPR9027, Inst Microbiol Mediterranee, F-13402 Marseille 20, France; [Alphonse, Sebastien; Douzi, Badreddine; Bernard, Cedric] Univ Aix Marseille 1, CNRS, Architecture & Fonct Macromol Biol AFMB UMR6098, F-13288 Marseille 9, France; [Alphonse, Sebastien; Douzi, Badreddine; Bernard, Cedric] Univ Mediterranee, F-13288 Marseille 9, France; [Brochier-Armanet, Celine] Univ Aix Marseille 1, CNRS, Lab Chim Bacterienne LCB UPR9043, Inst Microbiol Mediterranee, F-13402 Marseille 20, France; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, CMMI, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London	Voulhoux, R (corresponding author), Univ Mediterranee, CNRS, Lab Ingn Syst Macromol LISM UPR9027, Inst Microbiol Mediterranee, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	voulhoux@ifr88.cnrs-mrs.fr	Voulhoux, Rome/AAT-5333-2021; Durand, Eric/E-6739-2017; Brochier-Armanet, Celine/B-7898-2011; Douzi, Badreddine/ABA-4540-2021; douzi, Badreddine/Z-5707-2019	Durand, Eric/0000-0002-0577-8220; Douzi, Badreddine/0000-0003-3140-4713; Alphonse, Sebastien/0000-0002-2054-2005; Brochier-Armanet, Celine/0000-0003-4669-3589	Royal Society; 3D-Pilus Young Researcher Grant [ANR-JC 07-183230]	Royal Society(Royal Society of London); 3D-Pilus Young Researcher Grant	This work was supported by 3D-Pilus Young Researcher Grant ANR-JC 07-183230 (to E. D.).; Supported by the Royal Society.	Alphonse S, 2010, J STRUCT BIOL, V169, P75, DOI 10.1016/j.jsb.2009.09.003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; BALLY M, 1992, MOL MICROBIOL, V6, P1121, DOI 10.1111/j.1365-2958.1992.tb01550.x; Bleves S, 1998, MOL MICROBIOL, V27, P31, DOI 10.1046/j.1365-2958.1998.00653.x; Campos M, 2010, P NATL ACAD SCI USA, V107, P13081, DOI 10.1073/pnas.1001703107; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; De Groot A, 2001, J BACTERIOL, V183, P959, DOI 10.1128/JB.183.3.959-967.2001; deGroot A, 1996, MOL GEN GENET, V250, P491, DOI 10.1007/s004380050102; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Durand E, 2005, J BIOL CHEM, V280, P31378, DOI 10.1074/jbc.M505812200; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Hu NT, 2002, BIOCHEM J, V365, P205, DOI 10.1042/BJ20020194; Kagami Y, 1998, MOL MICROBIOL, V27, P221, DOI 10.1046/j.1365-2958.1998.00679.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2009, J BIOL CHEM, V284, P25466, DOI 10.1074/jbc.C109.037655; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; Michel Gerard P. F., 2009, P67; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Ruer S, 2008, EMBO J, V27, P2669, DOI 10.1038/emboj.2008.197; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Viarre V, 2009, J BIOL CHEM, V284, P33815, DOI 10.1074/jbc.M109.065938; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Yanez ME, 2008, J MOL BIOL, V377, P91, DOI 10.1016/j.jmb.2007.08.041; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035	30	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24407	24416		10.1074/jbc.M111.234278	http://dx.doi.org/10.1074/jbc.M111.234278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586577	hybrid, Green Published			2022-12-27	WOS:000292294900080
J	Liu, ZM; Blattner, SM; Tu, YZ; Tisherman, R; Wang, JH; Rastaldi, MP; Kretzler, M; Wu, CY				Liu, Zhongmin; Blattner, Simone Monika; Tu, Yizeng; Tisherman, Robert; Wang, James H.; Rastaldi, Maria Pia; Kretzler, Matthias; Wu, Chuanyue			alpha-Actinin-4 and CLP36 Protein Deficiencies Contribute to Podocyte Defects in Multiple Human Glomerulopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ACTIN CYTOSKELETON; MUTANT ALPHA-ACTININ-4; GLOMERULAR-DISEASES; STRESS FIBERS; SMOOTH-MUSCLE; CELL BIOLOGY; ADHESION; EXPRESSION; DYNAMICS	Genetic alterations of alpha-actinin-4 can cause podocyte injury through multiple mechanisms. Although a mechanism involving gain-of-alpha-actinin-4 function was well described and is responsible for a dominantly inherited form of human focal segmental glomerulosclerosis (FSGS), evidence supporting mechanisms involving loss-of-alpha-actinin-4 function in human glomerular diseases remains elusive. Here we show that alpha-actinin-4 deficiency occurs in multiple human primary glomerulopathies including sporadic FSGS, minimal change disease, and IgA nephropathy. Furthermore, we identify a close correlation between the levels of alpha-actinin-4 and CLP36, which form a complex in normal podocytes, in human glomerular diseases. siRNA-mediated depletion of alpha-actinin-4 in human podocytes resulted in a marked reduction of the CLP36 level. Additionally, two FSGS-associated alpha-actinin-4 mutations (R310Q and Q348R) inhibited the complex formation between alpha-actinin-4 and CLP36. Inhibition of the alpha-actinin-4-CLP36 complex, like loss of alpha-actinin-4, markedly reduced the level of CLP36 in podocytes. Finally, reduction of the CLP36 level or disruption of the alpha-actinin-4-CLP36 complex significantly inhibited RhoA activity and generation of traction force in podocytes. Our studies reveal a critical role of the alpha-actinin-4-CLP36 complex in podocytes and provide an explanation as to how alpha-actinin-4 deficiency or mutations found in human patients could contribute to podocyte defects and glomerular failure through a loss-of-function mechanism.	[Liu, Zhongmin; Tu, Yizeng; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Blattner, Simone Monika; Kretzler, Matthias] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Tisherman, Robert; Wang, James H.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Rastaldi, Maria Pia] Fdn DAmico Ric Malattie Renali, I-20122 Milan, Italy; [Rastaldi, Maria Pia] Fdn IRCCS Osped Maggiore Policlin, Renal Res Lab, I-20122 Milan, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; IRCCS Ca Granda Ospedale Maggiore Policlinico	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu		Tisherman, Robert/0000-0002-9710-808X	National Institutes of Health [DK54639, DK079912]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639, R01DK079912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54639 (to C.W.) and DK079912 (to M.K.).	Bauer K, 2000, BLOOD, V96, P4236; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Cheng HF, 2010, INT J BIOCHEM CELL B, V42, P1380, DOI 10.1016/j.biocel.2010.05.014; Chiang CK, 2010, NAT REV NEPHROL, V6, P539, DOI 10.1038/nrneph.2010.103; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Cybulsky AV, 2009, AM J PHYSIOL-RENAL, V297, pF987, DOI 10.1152/ajprenal.00055.2009; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Endlich N, 2006, EUR J CELL BIOL, V85, P229, DOI 10.1016/j.ejcb.2005.09.006; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Henderson JM, 2009, J AM SOC NEPHROL, V20, P961, DOI 10.1681/ASN.2008060613; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Jalanko H, 2001, ANN MED, V33, P526, DOI 10.3109/07853890108995962; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Lowik MM, 2009, EUR J PEDIATR, V168, P1291, DOI 10.1007/s00431-009-1017-x; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Mathieson PW, 2010, NEPHROL DIAL TRANSPL, V25, P1772, DOI 10.1093/ndt/gfq121; McCarthy HJ, 2011, NEPHRON EXP NEPHROL, V118, pE1, DOI 10.1159/000320878; Michaud JLR, 2006, KIDNEY INT, V70, P1054, DOI 10.1038/sj.ki.5001665; Michaud JLR, 2007, CLIN SCI, V112, P325, DOI 10.1042/CS20060143; Michaud JLR, 2009, CELL MOTIL CYTOSKEL, V66, P166, DOI 10.1002/cm.20339; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Moller CC, 2006, ADV CHRONIC KIDNEY D, V13, P166, DOI 10.1053/j.ackd.2006.01.009; Padiyar A, 2005, CURR MOL MED, V5, P497, DOI 10.2174/1566524054553487; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pollak MR, 2008, CURR OPIN NEPHROL HY, V17, P138, DOI 10.1097/MNH.0b013e3282f5dbe4; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Rastaldi MP, 1996, J AM SOC NEPHROL, V7, P2419; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Shiu YT, 2004, BIOPHYS J, V86, P2558, DOI 10.1016/S0006-3495(04)74311-8; Tamura N, 2007, BIOCHEM BIOPH RES CO, V364, P589, DOI 10.1016/j.bbrc.2007.10.064; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; Wang JHC, 2009, METHODS MOL BIOL, V586, P301, DOI 10.1007/978-1-60761-376-3_17; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yang YQ, 2005, J AM SOC NEPHROL, V16, P1966, DOI 10.1681/ASN.2004121112; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200	46	14	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30795	30805		10.1074/jbc.M111.255984	http://dx.doi.org/10.1074/jbc.M111.255984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21680739	Green Published, hybrid			2022-12-27	WOS:000294283600059
J	Shchedrina, VA; Kabil, H; Vorbruggen, G; Lee, BC; Turanov, AA; Hirosawa-Takamori, M; Kim, HY; Harshman, LG; Hatfield, DL; Gladyshev, VN				Shchedrina, Valentina A.; Kabil, Hadise; Vorbruggen, Gerd; Lee, Byung Cheon; Turanov, Anton A.; Hirosawa-Takamori, Mitsuko; Kim, Hwa-Young; Harshman, Lawrence G.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Analyses of Fruit Flies That Do Not Express Selenoproteins or Express the Mouse Selenoprotein, Methionine Sulfoxide Reductase B1, Reveal a Role of Selenoproteins in Stress Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; DROSOPHILA-MELANOGASTER; OXIDATIVE DAMAGE; SELENOPHOSPHATE SYNTHETASE; SELENOCYSTEINE INCORPORATION; ANTIOXIDANT DEFENSE; BINDING-PROTEIN; GENE; LONGEVITY; OVEREXPRESSION	Selenoproteins are essential in vertebrates because of their crucial role in cellular redox homeostasis, but some invertebrates that lack selenoproteins have recently been identified. Genetic disruption of selenoprotein biosynthesis had no effect on lifespan and oxidative stress resistance of Drosophila melanogaster. In the current study, fruit flies with knock-out of the selenocysteine-specific elongation factor were metabolically labeled with Se-75; they did not incorporate selenium into proteins and had the same lifespan on a chemically defined diet with or without selenium supplementation. These flies were, however, more susceptible to starvation than controls, and this effect could be ascribed to the function of selenoprotein K. We further expressed mouse methionine sulfoxide reductase B1 (MsrB1), a selenoenzyme that catalyzes the reduction of oxidized methionine residues and has protein repair function, in the whole body or the nervous system of fruit flies. This exogenous selenoprotein could only be expressed when the Drosophila selenocysteine insertion sequence element was used, whereas the corresponding mouse element did not support selenoprotein synthesis. Ectopic expression of MsrB1 in the nervous system led to an increase in the resistance against oxidative stress and starvation, but did not affect lifespan and reproduction, whereas ubiquitous MsrB1 expression had no effect. Dietary selenium did not influence lifespan of MsrB1-expressing flies. Thus, in contrast to vertebrates, fruit flies preserve only three selenoproteins, which are not essential and play a role only under certain stress conditions, thereby limiting the use of the micronutrient selenium by these organisms.	[Shchedrina, Valentina A.; Lee, Byung Cheon; Turanov, Anton A.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Shchedrina, Valentina A.; Lee, Byung Cheon; Turanov, Anton A.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kabil, Hadise; Harshman, Lawrence G.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Vorbruggen, Gerd; Hirosawa-Takamori, Mitsuko] Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, D-37077 Gottingen, Germany; [Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; Max Planck Society; Yeungnam University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), New Res Bldg,77 Ave Louis Pasteur,Rm 435, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013; shchedrina, valentina a/B-8398-2015	shchedrina, valentina a/0000-0003-1627-982X; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940	National Institutes of Health [AG021518, GM061603, DK074136]; Center for Cancer Research, NCI; National Research Foundation of Korea [2010-0001240]; NATIONAL CANCER INSTITUTE [ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021518, GM061603 (to V. N. G.), and DK074136 (to L. G. H.), the Intramural Research Program at the Center for Cancer Research, NCI (to D. L. H.), and National Research Foundation of Korea Grant 2010-0001240 (to H. Y. K.).	Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Alsina B, 1998, MOL GEN GENET, V257, P113, DOI 10.1007/s004380050630; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; BRAND AH, 1993, DEVELOPMENT, V118, P401; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; Chapple CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002968; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; Chung H, 2010, FEBS LETT, V584, P3609, DOI 10.1016/j.febslet.2010.07.033; Conrad M, 2006, SELENIUM ITS MOL BIO, P195; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Grundner-Culemann E, 1999, RNA, V5, P625, DOI 10.1017/S1355838299981542; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hirosawa-Takamori M, 2000, EMBO REP, V1, P441, DOI 10.1093/embo-reports/kvd087; Hirosawa-Takamori M, 2004, EMBO REP, V5, P317, DOI 10.1038/sj.embor.7400097; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kwon SY, 2003, MOL CELL BIOL, V23, P8495, DOI 10.1128/MCB.23.23.8495-8504.2003; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lin MJ, 2005, J BIOL CHEM, V280, P861, DOI 10.1074/jbc.C400477200; Lobanov AV, 2008, PROTEIN SCI, V17, P176, DOI 10.1110/ps.073261508; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Martin-Romero FJ, 2001, J BIOL CHEM, V276, P29798, DOI 10.1074/jbc.M100422200; Minniti AN, 2009, AGING CELL, V8, P690, DOI 10.1111/j.1474-9726.2009.00521.x; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Mockett RJ, 2010, FREE RADICAL BIO MED, V49, P2028, DOI 10.1016/j.freeradbiomed.2010.09.029; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; Oien D, 2007, AMINO ACIDS, V32, P603, DOI 10.1007/s00726-006-0448-1; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; PALLARES C, 2006, SELENIUM ITS MOL BIO, P343; Panee J, 2007, J BIOL CHEM, V282, P23759, DOI 10.1074/jbc.M702267200; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Persson BC, 1997, J MOL BIOL, V274, P174, DOI 10.1006/jmbi.1997.1371; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Shchedrina VA, 2009, MECH AGEING DEV, V130, P429, DOI 10.1016/j.mad.2009.04.003; Squires JE, 2008, IUBMB LIFE, V60, P232, DOI 10.1002/iub.38; Takeuchi A, 2009, NUCLEIC ACIDS RES, V37, P2126, DOI 10.1093/nar/gkp078; Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	59	21	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29449	29461		10.1074/jbc.M111.257600	http://dx.doi.org/10.1074/jbc.M111.257600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21622567	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000294046600002
J	Ge, Q; Nakagawa, T; Wynn, RM; Chook, YM; Miller, BC; Uyeda, K				Ge, Qiang; Nakagawa, Tsutomu; Wynn, R. Max; Chook, Yuh Min; Miller, Bonnie C.; Uyeda, Kosaku			Importin-alpha Protein Binding to a Nuclear Localization Signal of Carbohydrate Response Element-Binding Protein (ChREBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILLIAMS-BEUREN-SYNDROME; TRANSCRIPTION FACTOR; SUBCELLULAR-LOCALIZATION; STRUCTURAL BASIS; GLUCOSE; RECOGNITION; REGION; GENE; PHOSPHORYLATION; LIPOGENESIS	Carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that plays a critical role in the glucose-mediated induction of genes involved in hepatic glycolysis and lipogenesis. Circulating blood glucose levels affect ChREBP activity in hepatocytes largely by post-translational mechanisms that include phosphorylation-dependent subcellular localization. Previously, we showed that ChREBP is retained in the cytosol by phosphorylation-dependent binding to 14-3-3 protein dimers and identified the alpha 2 helix (residues 125-135) phospho-Ser(140) domain as the primary 14-3-3 binding site (Sakiyama, H., Wynn, R. M., Lee, W. R., Fukasawa, M., Mizuguchi, H., Gardner, K. H., Repa, J. J., and Uyeda, K. (2008) J. Biol. Chem. 283, 24899-24908). To enter the nucleus in response to high glucose, ChREBP must bind importin-alpha; this heterodimer then forms a complex with importin-beta to interact with the nuclear pore complex. In this work, we recharacterized the importin-alpha binding nuclear localization signal (NLS) of rat ChREBP, identifying it as an extended classical bipartite NLS encompassing minimally residues 158-190. Replacing Lys(159)/Lys(190) residues of ChREBP with alanine resulted in loss of importin-alpha binding, glucose-stimulated transcriptional activity and nuclear localization. Asecondary 14-3-3 protein binding site also was identified, the alpha 3 helix (residues 170-190) phospho-Ser(196) domain. Importin-alpha and 14-3-3 were found to bind competitively to this secondary site. These results suggest an important mechanism by which importin-alpha and 14-3-3 control movement of ChREBP in and out of the nucleus in response to changes in glucose levels in liver and thus further suggest that the extended NLS of ChREBP is a critical glucose-sensing, glucose-responsive site.	[Ge, Qiang; Nakagawa, Tsutomu; Wynn, R. Max; Uyeda, Kosaku] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chook, Yuh Min] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Miller, Bonnie C.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Uyeda, K (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kosaku.uyeda@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019	Wynn, Richard/0000-0002-1879-2136	National Institutes of Health, NIDDK [R01 DK063948]; Department of Veterans Affairs; Welch Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063948] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs(US Department of Veterans Affairs); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK Grant R01 DK063948 and the Department of Veterans Affairs. This work was also supported by the Welch Foundation.	Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cairo S, 2001, HUM MOL GENET, V10, P617, DOI 10.1093/hmg/10.6.617; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Davies MN, 2010, AM J PHYSIOL-ENDOC M, V299, pE665, DOI 10.1152/ajpendo.00349.2010; de Luis O, 2000, EUR J HUM GENET, V8, P215, DOI 10.1038/sj.ejhg.5200435; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; McLane LM, 2009, IUBMB LIFE, V61, P697, DOI 10.1002/iub.194; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	24	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28119	28127		10.1074/jbc.M111.237016	http://dx.doi.org/10.1074/jbc.M111.237016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21665952	Green Published, hybrid			2022-12-27	WOS:000293557800030
J	Anderson, DG; Mariappan, SVS; Buettner, GR; Doorn, JA				Anderson, David G.; Mariappan, S. V. Santhana; Buettner, Garry R.; Doorn, Jonathan A.			Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; PARKINSONS-DISEASE; SUPEROXIDE-DISMUTASE; NEURODEGENERATIVE DISEASES; REACTIVE INTERMEDIATE; SUBSTANTIA NIGRA; SPIN-RESONANCE; ACTIVE-SITE; PC12 CELLS; IN-VITRO	The oxidation and toxicity of dopamine is believed to contribute to the selective neurodegeneration associated with Parkinson disease. The formation of reactive radicals and quinones greatly contributes to dopaminergic toxicity through a variety of mechanisms. The physiological metabolism of dopamine to 3,4-dihydroxyphenylacetaldehyde (DOPAL) via monoamine oxidase significantly increases its toxicity. To more adequately explain this enhanced toxicity, we hypothesized that DOPAL is capable of forming radical and quinone species upon oxidation. Here, two unique oxidation products of DOPAL are identified. Several different oxidation methods gave rise to a transient DOPAL semiquinone radical, which was characterized by electron paramagnetic resonance spectroscopy. NMR identified the second oxidation product of DOPAL as the ortho-quinone. Also, carbonyl hydration of DOPAL in aqueous media was evident via NMR. Interestingly, the DOPAL quinone exists exclusively in the hydrated form. Furthermore, the enzymatic and chemical oxidation of DOPAL greatly enhance protein cross-linking, whereas auto-oxidation results in the production of superoxide. Also, DOPAL was shown to be susceptible to oxidation by cyclooxygenase-2 (COX-2). The involvement of this physiologically relevant enzyme in both oxidative stress and Parkinson disease underscores the potential importance of DOPAL in the pathogenesis of this condition.	[Anderson, David G.; Doorn, Jonathan A.] Univ Iowa, Div Med & Nat Prod Chem, Coll Pharm, Iowa City, IA 52242 USA; [Mariappan, S. V. Santhana] Univ Iowa, Cent High Field NMR Res Facil, Dept Chem, Iowa City, IA 52242 USA; [Buettner, Garry R.] Univ Iowa, Free Rad & Radiat Biol Program, ESR Facil, Dept Radiat Oncol,Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Doorn, JA (corresponding author), Univ Iowa, Div Med & Nat Prod Chem, Coll Pharm, 115 So Grand Ave, Iowa City, IA 52242 USA.	jonathan-doorn@uiowa.edu		Buettner, Garry/0000-0002-5594-1903	National Institutes of Health [R01ES15507, R01GM073929, P42ES013661]; NIGMS [T32GM 008365]; University of Iowa College of Pharmacy; American Foundation for Pharmaceutical Education; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013661, R01ES015507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008365, R01GM073929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Iowa College of Pharmacy; American Foundation for Pharmaceutical Education; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01ES15507 (to J. A. D.), R01GM073929 and P42ES013661 (to G. R. B.), and T32GM 008365 from NIGMS (to D. G. A.). This work was also supported by the University of Iowa College of Pharmacy and a fellowship through the American Foundation for Pharmaceutical Education (to D. G. A.).	ADAMS M, 1958, J CHEM PHYS, V28, P774, DOI 10.1063/1.1744269; Akagawa M, 2006, BIOCHEMISTRY-US, V45, P15120, DOI 10.1021/bi0614434; Asanuma M, 2004, CURR PHARM DESIGN, V10, P695, DOI 10.2174/1381612043453072; Baillet A, 2010, NEUROCHEM RES, V35, P1530, DOI 10.1007/s11064-010-0212-5; Bartels AL, 2010, CURR NEUROPHARMACOL, V8, P62, DOI 10.2174/157015910790909485; Buettner G R, 1986, Free Radic Res Commun, V1, P349, DOI 10.3109/10715768609051638; Burke WJ, 2003, CNS NEUROL DISORD-DR, V2, P143, DOI 10.2174/1568007033482913; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Carey F. A., 2000, ADV ORG CHEM, P449; Chae SW, 2008, NEUROSCI LETT, V436, P205, DOI 10.1016/j.neulet.2008.03.031; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Chinta SJ, 2008, BBA-GEN SUBJECTS, V1780, P1362, DOI 10.1016/j.bbagen.2008.02.005; Collins MA, 2002, NEUROTOXICOL TERATOL, V24, P571, DOI 10.1016/S0892-0362(02)00210-6; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; EYER P, 1991, CHEM-BIOL INTERACT, V80, P159, DOI 10.1016/0009-2797(91)90022-Y; FELLMAN JH, 1958, NATURE, V182, P311, DOI 10.1038/182311a0; Feng ZH, 2003, NEUROREPORT, V14, P1927, DOI 10.1097/00001756-200310270-00009; FORNSTEDT B, 1989, J NEURAL TRANSM-PARK, V1, P279, DOI 10.1007/BF02263482; Goncalves LL, 2009, CHEM RES TOXICOL, V22, P842, DOI 10.1021/tx800423s; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; GRAHAM DG, 1978, MOL PHARMACOL, V14, P644; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hashimoto T, 2002, BRAIN RES, V931, P96, DOI 10.1016/S0006-8993(02)02233-3; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; Jinsmaa Y, 2009, CHEM RES TOXICOL, V22, P835, DOI 10.1021/tx800405v; KALYANARAMAN B, 1985, ENVIRON HEALTH PERSP, V64, P185, DOI 10.2307/3430009; KALYANARAMAN B, 1982, BIOCHEM BIOPH RES CO, V106, P1119, DOI 10.1016/0006-291X(82)91228-1; Kirima K, 2001, CHEM PHARM BULL, V49, P576, DOI 10.1248/cpb.49.576; Kristal BS, 2001, FREE RADICAL BIO MED, V30, P924, DOI 10.1016/S0891-5849(01)00484-1; Lamensdorf I, 2000, EUR J PHARMACOL, V388, P147, DOI 10.1016/S0014-2999(99)00839-0; LAND EJ, 1971, BIOCHIM BIOPHYS ACTA, V226, P239, DOI 10.1016/0005-2728(71)90091-0; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Li SW, 2001, MOL BRAIN RES, V93, P1, DOI 10.1016/S0169-328X(01)00120-6; Li SW, 1998, BIOORG CHEM, V26, P45, DOI 10.1006/bioo.1998.1087; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; MATTAMMAL MB, 1995, J NEUROCHEM, V64, P1645; MATTAMMAL MB, 1995, NEURODEGENERATION, V4, P271, DOI 10.1016/1055-8330(95)90016-0; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P1066, DOI 10.1016/j.bbrc.2009.10.118; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Rees JN, 2007, CHEM RES TOXICOL, V20, P1536, DOI 10.1021/tx700248y; Rees JN, 2009, CHEM RES TOXICOL, V22, P1256, DOI 10.1021/tx9000557; SAGGU H, 1989, J NEUROCHEM, V53, P692, DOI 10.1111/j.1471-4159.1989.tb11759.x; Song Y, 2008, CHEM RES TOXICOL, V21, P1359, DOI 10.1021/tx8000175; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C; Teismann P, 2003, ANN NY ACAD SCI, V991, P272; Terland O, 2006, FREE RADICAL BIO MED, V41, P1266, DOI 10.1016/j.freeradbiomed.2006.07.009; TSUKAMOTO S, 1994, TETRAHEDRON, V50, P13583, DOI 10.1016/S0040-4020(01)85673-8; Vijitruth R, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-6; Wangpradit O, 2010, CHEMOSPHERE, V81, P1501, DOI 10.1016/j.chemosphere.2010.08.041; Wangpradit O, 2009, CHEM RES TOXICOL, V22, P64, DOI 10.1021/tx800300t	57	72	73	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26978	26986		10.1074/jbc.M111.249532	http://dx.doi.org/10.1074/jbc.M111.249532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642436	hybrid, Green Published			2022-12-27	WOS:000293078200071
J	Ortiz-Meoz, RF; Green, R				Ortiz-Meoz, Rodrigo F.; Green, Rachel			Helix 69 Is Key for Uniformity during Substrate Selection on the Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; TRANSLATION TERMINATION; CRYSTAL-STRUCTURE; 70S RIBOSOME; DECODING CENTER; ACTIVE-ROLE; STOP CODON; CRYO-EM; RECOGNITION; ANTICODON	Structural studies of ribosome complexes with bound tRNAs and release factors show considerable contacts between these factors and helix 69 (H69) of 23 S rRNA. Although biochemical and genetic studies have provided some general insights into the role of H69 in tRNA and RF selection, a detailed understanding of these contributions remains elusive. Here, we present a pre-steady-state kinetic analysis establishing that two distinct regions of H69 make critical contributions to substrate selection. The loop of H69 (A1913) forms contacts necessary for the efficient accommodation of a subset of natural tRNA species, whereas the base of the stem (G1922) is specifically critical for UGA codon recognition by the class 1 release factor RF2. These data define a broad and critical role for this centrally located intersubunit helix (H69) in accurate and efficient substrate recognition by the ribosome.	[Ortiz-Meoz, Rodrigo F.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, 702 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	ragreen@jhmi.edu		Ortiz-Meoz, Rodrigo/0000-0003-2134-8762	National Institutes of Health [GM059425]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059425, R01GM059425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM059425 and the Howard Hughes Medical Institute (to R. G.).	Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Cochella L, 2007, NAT STRUCT MOL BIOL, V14, P30, DOI 10.1038/nsmb1183; CURRAN JF, 1995, NUCLEIC ACIDS RES, V23, P683, DOI 10.1093/nar/23.4.683; Ejby M, 2007, P NATL ACAD SCI USA, V104, P19410, DOI 10.1073/pnas.0706558104; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; He SL, 2010, NAT STRUCT MOL BIOL, V17, P465, DOI 10.1038/nsmb.1766; Hirabayashi N, 2006, J BIOL CHEM, V281, P17203, DOI 10.1074/jbc.M511728200; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Kipper K, 2011, BIOCHIMIE, V93, P834, DOI 10.1016/j.biochi.2010.12.018; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Li W, 2008, EMBO J, V27, P3322, DOI 10.1038/emboj.2008.243; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P11251, DOI 10.1038/nsmb866; O'Connor M, 2009, MOL GENET GENOMICS, V282, P371, DOI 10.1007/s00438-009-0470-6; OCONNOR M, 1995, J MOL BIOL, V254, P838, DOI 10.1006/jmbi.1995.0659; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Ortiz-Meoz RF, 2010, RNA, V16, P2002, DOI 10.1261/rna.2232710; Pai RD, 2008, J MOL BIOL, V376, P1334, DOI 10.1016/j.jmb.2007.12.048; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2005, METHODS, V36, P305, DOI 10.1016/j.ymeth.2005.04.007	34	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25604	25610		10.1074/jbc.M111.256255	http://dx.doi.org/10.1074/jbc.M111.256255			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622559	Green Published, hybrid			2022-12-27	WOS:000293073000022
J	Yuan, KY; Jing, G; Chen, JF; Liu, H; Zhang, K; Li, YB; Wu, H; McDonald, JM; Chen, YB				Yuan, Kaiyu; Jing, Gu; Chen, Jianfeng; Liu, Hui; Zhang, Kui; Li, Yuebin; Wu, Hui; McDonald, Jay M.; Chen, Yabing			Calmodulin Mediates Fas-induced FADD-independent Survival Signaling in Pancreatic Cancer Cells via Activation of Src-Extracellular Signal-regulated Kinase (ERK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GASTROINTESTINAL TUMOR-CELLS; DEATH DOMAIN PROTEIN; INDUCED APOPTOSIS; CHOLANGIOCARCINOMA CELLS; INHIBITORY PROTEIN; GROWTH-FACTORS; IMMUNE-SYSTEM; CD95 LIGAND; PROLIFERATION	Pancreatic cancer remains a devastating malignancy with a poor prognosis and is largely resistant to current therapies. To understand the resistance of pancreatic tumors to Fas death receptor-induced apoptosis, we investigated the molecular mechanisms of Fas-activated survival signaling in pancreatic cancer cells. We found that knockdown of the Fas-associated protein with death domain (FADD), the adaptor that mediates downstream signaling upon Fas activation, rendered Fas-sensitive MiaPaCa-2 and BxPC-3 pancreatic cells resistant to Fas-induced apoptosis. By contrast, Fas activation promoted the survival of the FADD knockdown MiaPaCa-2 and BxPC-3 cells in a concentration-dependent manner. The pharmacological inhibitor of ERK, PD98059, abrogated Fas-promoted cell survival in FADD knockdown MiaPaCa-2 and BxPC-3 cells. Furthermore, increased phosphorylation of Src was demonstrated to mediate Fas-induced ERK activation and cell survival. Immunoprecipitation of Fas in the FADD knockdown cells identified the presence of increased calmodulin, Src, and phosphorylated Src in the Fas-associated protein complex upon Fas activation. Trifluoperazine, a calmodulin antagonist, inhibited Fas-induced recruitment of calmodulin, Src, and phosphorylated Src. Consistently, trifluoperazine blocked Fas-promoted cell survival. A direct interaction of calmodulin and Src and their binding site were identified with recombinant proteins. These results support an essential role of calmodulin in mediating Fas-induced FADD-independent activation of Src-ERK signaling pathways, which promote survival signaling in pancreatic cancer cells. Understanding the molecular mechanisms responsible for the resistance of pancreatic cells to apoptosis induced by Fas-death receptor signaling may provide molecular insights into designing novel therapies to treat pancreatic tumors.	[Yuan, Kaiyu; Jing, Gu; Chen, Jianfeng; McDonald, Jay M.; Chen, Yabing] Univ Alabama, Sch Dent, Dept Pathol, Birmingham, AL 35294 USA; [Liu, Hui] Univ Alabama, Sch Dent, Dept Physiol, Birmingham, AL 35294 USA; [Zhang, Kui] Univ Alabama, Sch Dent, Dept Biostat, Birmingham, AL 35294 USA; [Li, Yuebin; Wu, Hui] Univ Alabama, Sch Dent, Dept Pediat Dent, Birmingham, AL 35294 USA; [Li, Yuebin; Wu, Hui] Univ Alabama, Sch Med, Dept Pediat Dent, Birmingham, AL 35294 USA; [Yuan, Kaiyu; Jing, Gu; Chen, Jianfeng; McDonald, Jay M.; Chen, Yabing] Univ Alabama, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; [Liu, Hui] Univ Alabama, Sch Med, Dept Physiol, Birmingham, AL 35294 USA; [Zhang, Kui] Univ Alabama, Sch Med, Dept Biostat, Birmingham, AL 35294 USA; [McDonald, Jay M.; Chen, Yabing] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Chen, YB (corresponding author), Univ Alabama, Sch Dent, Dept Pathol, 710 Shelby Res Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA.	ybchen@uab.edu			Department of Pathology, University of Alabama at Birmingham; Veterans Affairs merit review award	Department of Pathology, University of Alabama at Birmingham; Veterans Affairs merit review award(US Department of Veterans Affairs)	This work was supported in part by start-up funds from the Department of Pathology, University of Alabama at Birmingham (to Y. C.), and a Veterans Affairs merit review award (to J. M. M.).	Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Ametller E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-161; BAHLER M, 1994, J CELL BIOL, V126, P375, DOI 10.1083/jcb.126.2.375; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chen KC, 2010, J CELL PHYSIOL, V222, P625, DOI 10.1002/jcp.21979; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chen YB, 2008, J CELL BIOCHEM, V103, P788, DOI 10.1002/jcb.21447; Chen YB, 2006, AM J PATHOL, V169, P1833, DOI 10.2353/ajpath.2006.060234; Christgen M, 2005, CANCER LETT, V227, P193, DOI 10.1016/j.canlet.2005.01.016; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; Griffiths GJ, 2004, J BIOL CHEM, V279, P46113, DOI 10.1074/jbc.M408550200; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; KAHAN C, 1992, J BIOL CHEM, V267, P13369; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Kornmann M, 2000, PANCREAS, V20, P123, DOI 10.1097/00006676-200003000-00003; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; MELOCHE S, 1995, J CELL PHYSIOL, V163, P577, DOI 10.1002/jcp.1041630319; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; Nabissi M, 2010, CARCINOGENESIS, V31, P794, DOI 10.1093/carcin/bgq019; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Park MA, 2008, MOL CANCER THER, V7, P2633, DOI 10.1158/1535-7163.MCT-08-0400; Park MA, 2010, CANCER RES, V70, P6313, DOI 10.1158/0008-5472.CAN-10-0999; Pawar P, 2009, CLIN CANCER RES, V15, P1288, DOI 10.1158/1078-0432.CCR-08-1150; Pawar PS, 2008, BIOCHEM J, V412, P459, DOI 10.1042/BJ20071507; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Reinehr R, 2008, GASTROENTEROLOGY, V134, P1494, DOI 10.1053/j.gastro.2008.02.021; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Salas V, 2005, PROTEIN EXPRES PURIF, V41, P384, DOI 10.1016/j.pep.2005.01.004; Schlottmann KE, 1996, J LEUKOCYTE BIOL, V60, P546, DOI 10.1002/jlb.60.4.546; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Suzuki I, 2000, J IMMUNOL, V165, P5537, DOI 10.4049/jimmunol.165.10.5537; Ungefroren H, 1998, CANCER RES, V58, P1741; Walker T, 2009, MOL PHARMACOL, V76, P342, DOI 10.1124/mol.109.056523; Wallach D, 1998, CURR OPIN IMMUNOL, V10, P279, DOI 10.1016/S0952-7915(98)80166-0; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033	59	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24776	24784		10.1074/jbc.M110.202804	http://dx.doi.org/10.1074/jbc.M110.202804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613217	Green Published, hybrid			2022-12-27	WOS:000292547900028
J	Celigoy, J; Ramirez, B; Tao, L; Rong, LJ; Yan, LY; Feng, YR; Quinnan, GV; Broder, CC; Caffrey, M				Celigoy, Jessica; Ramirez, Benjamin; Tao, Lin; Rong, Lijun; Yan, Lianying; Feng, Yan-Ru; Quinnan, Gerald V.; Broder, Christopher C.; Caffrey, Michael			Probing the HIV gp120 Envelope Glycoprotein Conformation by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL MEMBRANE-FUSION; 44 KDA ECTODOMAIN; DUAL ANTAGONIST; GP41; SPECTROSCOPY; RECEPTOR; ENTRY; TRIMERS; LIGANDS	The HIV envelope glycoprotein gp120 plays a critical role in virus entry, and thus, its structure is of extreme interest for the development of novel therapeutics and vaccines. To date, high resolution structural information about gp120 in complex with gp41 has proven intractable. In this study, we characterize the structural properties of gp120 in the presence and absence of gp41 domains by NMR. Using the peptide probe 12p1 (sequence, RINNIPWSEAMM), which was identified previously as an entry inhibitor that binds to gp120, we identify atoms of 12p1 in close contact with gp120 in the monomeric and trimeric states. Interestingly, the binding mode of 12p1 with gp120 is similar for clades B and C. In addition, we show a subtle difference in the binding mode of 12p1 in the presence of gp41 domains, i.e. the trimeric state, which we interpret as small differences in the gp120 structure in the presence of gp41.	[Celigoy, Jessica; Ramirez, Benjamin; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Tao, Lin] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Rong, Lijun] Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; [Yan, Lianying; Feng, Yan-Ru; Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Quinnan, Gerald V.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Caffrey, M (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland, Chicago, IL 60607 USA.	caffrey@uic.edu	Feng, YanRu/AAA-2183-2020; Broder, Christopher/E-1169-2013		National Institutes of Health [AI066709, AI077767]; Chicago Developmental Center for AIDS Research [AI082151]; University of Illinois at Chicago Center for Structural Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI082151, U01AI066709, U01AI077767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Developmental Center for AIDS Research; University of Illinois at Chicago Center for Structural Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI066709 and AI077767. This work was also supported by Chicago Developmental Center for AIDS Research Grant AI082151.; We acknowledge support of the University of Illinois at Chicago Center for Structural Biology.	Archary D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-92; Assadi-Porter FM, 2008, J AM CHEM SOC, V130, P7212, DOI 10.1021/ja8016939; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Biorn AC, 2004, BIOCHEMISTRY-US, V43, P1928, DOI 10.1021/bi035088i; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Caffrey M, 1997, J MOL BIOL, V271, P819, DOI 10.1006/jmbi.1997.1217; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Douglas NW, 1997, J MOL BIOL, V273, P122, DOI 10.1006/jmbi.1997.1277; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ferrer M, 1999, J VIROL, V73, P5795, DOI 10.1128/JVI.73.7.5795-5802.1999; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gopi H, 2008, J MED CHEM, V51, P2638, DOI 10.1021/jm070814r; Gopi HN, 2006, CHEMMEDCHEM, V1, P54, DOI 10.1002/cmdc.200500037; Guilhaudis L, 2002, EUR J BIOCHEM, V269, P4860, DOI 10.1046/j.1432-1033.2002.03187.x; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Haselhorst T, 2008, ANGEW CHEM INT EDIT, V47, P1910, DOI 10.1002/anie.200704872; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104	32	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23975	23981		10.1074/jbc.M111.251025	http://dx.doi.org/10.1074/jbc.M111.251025			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21592971	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000292294900040
J	Machtens, JP; Kovermann, P; Fahlke, C				Machtens, Jan-Philipp; Kovermann, Peter; Fahlke, Christoph			Substrate-dependent Gating of Anion Channels Associated with Excitatory Amino Acid Transporter 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUTAMATE TRANSPORTER; CHLORIDE CHANNEL; ION; EAAC1; SODIUM; FLUXES; GLT-1; TRANSLOCATION; DETERMINES; MECHANISM	EAAT glutamate transporters do not only function as secondary-active glutamate transporters but also as anion channels. EAAT anion channel activity depends on transport substrates. For most isoforms, it is negligible without external Na+ and increased by external glutamate. We here investigated gating of EAAT4 anion channels with various cations and amino acid substrates using patch clamp experiments on a mammalian cell line. We demonstrate that Li+ can substitute for Na+ in supporting substrate-activated anion currents, albeit with changed voltage dependence. Anion currents were recorded in glutamate, aspartate, and cysteine, and distinct time and voltage dependences were observed. For each substrate, gating was different in external Na+ or Li+. All features of voltage-dependent and substrate-specific anion channel gating can be described by a simplified nine-state model of the transport cycle in which only amino acid substrate-bound states assume high anion channel open probabilities. The kinetic scheme suggests that the substrate dependence of channel gating is exclusively caused by differences in substrate association and translocation. Moreover, the voltage dependence of anion channel gating arises predominantly from electrogenic cation binding and membrane translocation of the transporter. We conclude that all voltage-and substrate-dependent conformational changes of the EAAT4 anion channel are linked to transitions within the transport cycle.	[Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; Zentrum Syst Neurowissensch Hannover ZSN, D-30559 Hannover, Germany	Hannover Medical School	Fahlke, C (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	fahlke.christoph@mh-hannover.de	Machtens, Jan-Philipp/M-8659-2013; Fahlke, Christoph/G-3635-2013; Kovermann, Peter/AAF-4411-2020	Machtens, Jan-Philipp/0000-0003-1673-8571; Fahlke, Christoph/0000-0001-8602-9952; Kovermann, Peter/0000-0001-5296-4918	Deutsche Forschungsgemeinschaft [FA301/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FA301/9 to Ch. F.).	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bergles DE, 2002, J NEUROSCI, V22, P10153; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fairman WA, 1999, AM J PHYSIOL-RENAL, V277, pF481, DOI 10.1152/ajprenal.1999.277.4.F481; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Huang SW, 2007, BIOCHEMISTRY-US, V46, P9685, DOI 10.1021/bi700647f; Huang S, 2009, J BIOL CHEM, V284, P4510, DOI 10.1074/jbc.M808495200; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Otis TS, 2000, J NEUROSCI, V20, P2749; PARSEGIAN A, 1969, NATURE, V221, P844, DOI 10.1038/221844a0; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	32	20	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23780	23788		10.1074/jbc.M110.207514	http://dx.doi.org/10.1074/jbc.M110.207514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572047	hybrid, Green Published			2022-12-27	WOS:000292294900020
J	Rather, LJ; Weinert, T; Demmer, U; Bill, E; Ismail, W; Fuchs, G; Ermler, U				Rather, Liv J.; Weinert, Tobias; Demmer, Ulrike; Bill, Eckhard; Ismail, Wael; Fuchs, Georg; Ermler, Ulrich			Structure and Mechanism of the Diiron Benzoyl-Coenzyme A Epoxidase BoxB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL MULTICOMPONENT MONOOXYGENASES; AZOARCUS-EVANSII; METHANE MONOOXYGENASE; DIOXYGEN ACTIVATION; CRYSTAL-STRUCTURE; C-H; MOLECULAR-GRAPHICS; CATABOLIC PATHWAY; PROTEIN-STRUCTURE; DIAMOND CORE	The coenzyme A (CoA)-dependent aerobic benzoate metabolic pathway uses an unprecedented chemical strategy to overcome the high aromatic resonance energy by forming the nonaromatic 2,3-epoxybenzoyl-CoA. The crucial dearomatizing reaction is catalyzed by three enzymes, BoxABC, where BoxA is an NADPH-dependent reductase, BoxB is a benzoyl-CoA 2,3-epoxidase, and BoxC is an epoxide ring hydrolase. We characterized the key enzyme BoxB from Azoarcus evansii by structural and Mossbauer spectroscopic methods as a new member of class I diiron enzymes. Several family members were structurally studied with respect to the diiron center architecture, but no structure of an intact diiron enzyme with its natural substrate has been reported. X-ray structures between 1.9 and 2.5 angstrom resolution were determined for BoxB in the diferric state and with bound substrate benzoyl-CoA in the reduced state. The substrate-bound reduced state is distinguished from the diferric state by increased iron-ligand distances and the absence of directly bridging groups between them. The position of benzoyl-CoA inside a 20 angstrom long channel and the position of the phenyl ring relative to the diiron center are accurately defined. The C2 and C3 atoms of the phenyl ring are closer to one of the irons. Therefore, one oxygen of activated O-2 must be ligated predominantly to this proximate iron to be in a geometrically suitable position to attack the phenyl ring. Consistent with the observed iron/phenyl geometry, BoxB stereoselectively should form the 2S,3R-epoxide. We postulate a reaction cycle that allows a charge delocalization because of the phenyl ring and the electron-withdrawing CoA thioester.	[Weinert, Tobias; Demmer, Ulrike; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Rather, Liv J.; Ismail, Wael; Fuchs, Georg] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Bill, Eckhard] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany	Max Planck Society; University of Freiburg; Max Planck Society	Ermler, U (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	ulrich.ermler@biophys.mpg.de	Weinert, Tobias/I-4813-2013; Weinert, Tobias/J-6353-2017; Ismail, Wael/X-5336-2019	Weinert, Tobias/0000-0002-0339-3722; Weinert, Tobias/0000-0002-0339-3722; Ahmed Ismail El Moslimany, Wael/0000-0002-3027-928X	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft [FU 118/16-3, ER 222/5-1]; Graduiertenkolleg Biochemie der Enzyme	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg Biochemie der Enzyme	This work was supported by the Max-Planck-Gesellschaft, the Deutsche Forschungsgemeinschaft (FU 118/16-3; ER 222/5-1), and the Graduiertenkolleg Biochemie der Enzyme.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Bains J, 2009, J BIOL CHEM, V284, P16377, DOI 10.1074/jbc.M900226200; Boll M, 2000, J BIOL CHEM, V275, P31857, DOI 10.1074/jbc.M001508200; Choi YS, 2008, P NATL ACAD SCI USA, V105, P6858, DOI 10.1073/pnas.0712073105; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gescher J, 2005, MOL MICROBIOL, V56, P1586, DOI 10.1111/j.1365-2958.2005.04637.x; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Grishin AM, 2011, J BIOL CHEM, V286, P10735, DOI 10.1074/jbc.M110.194423; Han WG, 2008, INORG CHEM, V47, P2975, DOI 10.1021/ic701194b; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOTZELMANN R, 1992, J AM CHEM SOC, V114, P9470, DOI 10.1021/ja00050a028; Johansson AJ, 2009, DALTON T, P6741, DOI 10.1039/b907263b; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kung JW, 2009, P NATL ACAD SCI USA, V106, P17687, DOI 10.1073/pnas.0905073106; KURTZ DM, 1990, CHEM REV, V90, P585, DOI 10.1021/cr00102a002; Lippard SJ, 2005, PHILOS T ROY SOC A, V363, P861, DOI 10.1098/rsta.2004.1532; LIPPARD SJ, 2005, PHILOS T A, V363, P1035; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Moche M, 2003, J BIOL CHEM, V278, P25072, DOI 10.1074/jbc.M301662200; Mohamed ME, 2001, J BACTERIOL, V183, P1899, DOI 10.1128/JB.183.6.1899-1908.2001; MURRAY KS, 1974, COORDIN CHEM REV, V12, P1, DOI 10.1016/S0010-8545(00)80384-7; Murray LJ, 2007, J AM CHEM SOC, V129, P14500, DOI 10.1021/ja076121h; Murray LJ, 2007, ACCOUNTS CHEM RES, V40, P466, DOI 10.1021/ar600040e; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund P, 1995, CURR OPIN STRUC BIOL, V5, P758, DOI 10.1016/0959-440X(95)80008-5; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Rinaldo D, 2007, J AM CHEM SOC, V129, P3135, DOI 10.1021/ja0654074; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Tinberg CE, 2009, BIOCHEMISTRY-US, V48, P12145, DOI 10.1021/bi901672n; Wang D, 2009, NAT CHEM, V1, P145, DOI [10.1038/nchem.162, 10.1038/NCHEM.162]; Xue GQ, 2010, NAT CHEM, V2, P400, DOI [10.1038/NCHEM.586, 10.1038/nchem.586]; Zaar A, 2004, MOL MICROBIOL, V54, P223, DOI 10.1111/j.1365-2958.2004.04263.x; Zaar A, 2001, J BIOL CHEM, V276, P24997, DOI 10.1074/jbc.M100291200	48	22	23	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29241	29248		10.1074/jbc.M111.236893	http://dx.doi.org/10.1074/jbc.M111.236893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21632537	Green Published, hybrid			2022-12-27	WOS:000293837000059
J	Garcia-Marcos, M; Kietrsunthorn, PS; Wang, HH; Ghosh, P; Farquhar, MG				Garcia-Marcos, Mikel; Kietrsunthorn, Patrick S.; Wang, Honghui; Ghosh, Pradipta; Farquhar, Marilyn G.			G Protein Binding Sites on Calnuc (Nucleobindin 1) and NUCB2 (Nucleobindin 2) Define a New Class of G alpha(i)-regulatory Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE DISSOCIATION INHIBITOR; HETEROTRIMERIC G-PROTEINS; G-ALPHA-I; GOLOCO-MOTIF; HIGH-THROUGHPUT; DOMAIN; RGS; ACTIVATION; IDENTIFICATION; STABILIZATION	Heterotrimeric G proteins are molecular switches modulated by families of structurally and functionally related regulators. GIV (G alpha-interacting vesicle-associated protein) is the first nonreceptor guanine nucleotide exchange factor (GEF) that activates G alpha(i) subunits via a defined, evolutionarily conserved motif. Here we found that Calnuc and NUCB2, two highly homologous calcium-binding proteins, share a common motif with GIV for G alpha(i) binding and activation. Bioinformatics searches and structural analysis revealed that Calnuc and NUCB2 possess an evolutionarily conserved motif with sequence and structural similarity to the GEF sequence of GIV. Using in vitro pulldown and competition assays, we demonstrate that this motif binds preferentially to the inactive conformation of G alpha(i1) and G alpha(i3) over other G alpha subunits and, like GIV, docks onto the alpha 3/switch II cleft. Calnuc binding was impaired when Lys-248 in the alpha 3 helix of G alpha(i3) was replaced with M, the corresponding residue in G alpha(o), which does not bind to Calnuc. Moreover, mutation of hydrophobic residues in the conserved motif predicted to dock on the alpha 3/switch II cleft of G alpha(i3) impaired the ability of Calnuc and NUCB2 to bind and activate G alpha(i3) in vitro. We also provide evidence that calcium binding to Calnuc and NUCB2 abolishes their interaction with G alpha(i3) in vitro and in cells, probably by inducing a conformational change that renders the G alpha(i)-binding residues inaccessible. Taken together, our results identify a new type of G alpha(i)-regulatory motif named the GBA motif (for G alpha-binding and -activating motif), which is conserved across different proteins throughout evolution. These findings provide the structural basis for the properties of Calnuc and NUCB2 binding to G alpha subunits and its regulation by calcium ions.	[Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Ghosh, Pradipta] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Farquhar, MG (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mfarquhar@ucsd.edu	Wang, Hong-Hui/P-9466-2016	Wang, Hong-Hui/0000-0002-4420-9733; Garcia-Marcos, Mikel/0000-0001-9513-4826	National Institutes of Health [DKI7780, CA100768]; Susan G. Komen Foundation [KG080079]; American Gastroenterology Association; NATIONAL CANCER INSTITUTE [R01CA100768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); American Gastroenterology Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DKI7780 and CA100768 (to M. G. F.).; Supported by Postdoctoral Fellowship KG080079 from the Susan G. Komen Foundation.; Supported by a Career Award for Medical Scientists (CAMS) from the Burroughs Wellcome Fund and a Research Scholar Award from the American Gastroenterology Association.	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Austin RJ, 2008, J MOL BIOL, V377, P1406, DOI 10.1016/j.jmb.2008.01.032; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cuppen E, 2003, COMP FUNCT GENOM, V4, P479, DOI 10.1002/cfg.318; de Alba E, 2004, BIOCHEMISTRY-US, V43, P10039, DOI 10.1021/bi049310a; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 1998, MOL BIOL CELL, V9, P1123, DOI 10.1091/mbc.9.5.1123; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DENKER BM, 1992, J BIOL CHEM, V267, P9998; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kapoor N, 2010, J BIOL CHEM, V285, P31647, DOI 10.1074/jbc.M110.148429; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Lin P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-15; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; MIURA K, 1994, BIOCHEM BIOPH RES CO, V199, P1388, DOI 10.1006/bbrc.1994.1384; Morel-Huaux VM, 2002, EUR J CELL BIOL, V81, P87, DOI 10.1078/0171-9335-00224; Mukhopadhyay S, 2002, METHOD ENZYMOL, V344, P350; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Willard FS, 2006, BIOCHEM BIOPH RES CO, V339, P1107, DOI 10.1016/j.bbrc.2005.11.132; Woulfe DS, 1999, J BIOL CHEM, V274, P17718, DOI 10.1074/jbc.274.25.17718	48	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28138	28149		10.1074/jbc.M110.204099	http://dx.doi.org/10.1074/jbc.M110.204099			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21653697	Green Published, hybrid			2022-12-27	WOS:000293557800032
J	Harvey, H; Kus, JV; Tessier, L; Kelly, J; Burrows, LL				Harvey, Hanjeong; Kus, Julianne V.; Tessier, Luc; Kelly, John; Burrows, Lori L.			Pseudomonas aeruginosa D-Arabinofuranose Biosynthetic Pathway and Its Role in Type IV Pilus Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-RIBOSE 2'-EPIMERASE; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA-1244 PILIN; ESCHERICHIA-COLI; D-ARABINOSE; D-ARAF; GLYCOSYLATION; EXPRESSION; SEQUENCE; MUTANTS	Pseudomonas aeruginosa strains PA7 and Pa5196 glycosylate their type IVa pilins with alpha 1,5-linked D-arabinofuranose (D-Araf), a rare sugar configuration identical to that found in cell wall polymers of the Corynebacterineae. Despite this chemical identity, the pathway for biosynthesis of alpha 1,5-D-Araf in Gram-negative bacteria is unknown. Bioinformatics analyses pointed to a cluster of seven P. aeruginosa genes, including homologues of the Mycobacterium tuberculosis genes Rv3806c, Rv3790, and Rv3791, required for synthesis of a polyprenyl-linked D-ribose precursor and its epimerization to D-Araf. Pa5196 mutants lacking the orthologues of those genes had non-arabinosylated pilins, poor twitching motility, and significantly fewer surface pili than the wild type even in a retraction-deficient (pilT) background. The Pa5196 pilus system assembled heterologous nonglycosylated pilins efficiently, demonstrating that it does not require post-translationally modified subunits. Together the data suggest that pilins of group IV strains need to be glycosylated for productive subunit-subunit interactions. A recombinant P. aeruginosa PAO1 strain co-expressing the genes for D-Araf biosynthesis, the pilin modification enzyme TfpW, and the acceptor PilA(IV) produced arabinosylated pili, confirming that the Pa5196 genes identified are both necessary and sufficient. A P. aeruginosa epimerase knock-out could be complemented with the corresponding Mycobacterium smegmatis gene, demonstrating conservation between the systems of the Corynebacterineae and Pseudomonas. This work describes a novel Gram-negative pathway for biosynthesis of D-Araf, a key therapeutic target in Corynebacterineae.	[Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hlth Sci Ctr 4H18, Hamilton, ON L8N 3Z5, Canada; [Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hlth Sci Ctr 4H18, Hamilton, ON L8N 3Z5, Canada; [Kus, Julianne V.] Univ Toronto, Fac Dent, Toronto, ON M5G 1G5, Canada; [Tessier, Luc; Kelly, John] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	McMaster University; McMaster University; University of Toronto; National Research Council Canada	Burrows, LL (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hlth Sci Ctr 4H18, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	burrowl@mcmaster.ca			Canadian Institutes of Health [Grant MOP-86639]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-86639 (to L. L. B.).	Asikyan ML, 2008, J BACTERIOL, V190, P7022, DOI 10.1128/JB.00938-08; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Gallant CV, 2005, MOL MICROBIOL, V58, P1012, DOI 10.1111/j.1365-2958.2005.04892.x; Giltner CL, 2011, ENVIRON MICROBIOL, V13, P250, DOI 10.1111/j.1462-2920.2010.02327.x; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Huang HR, 2005, J BIOL CHEM, V280, P24539, DOI 10.1074/jbc.M504068200; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Keenleyside WJ, 1996, J BIOL CHEM, V271, P28581, DOI 10.1074/jbc.271.45.28581; King JD, 2009, FEBS J, V276, P2686, DOI 10.1111/j.1742-4658.2009.06993.x; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, CURR MED CHEM, V17, P3099, DOI 10.2174/092986710791959693; Mergaert P, 1997, MOL PLANT MICROBE IN, V10, P683, DOI 10.1094/MPMI.1997.10.5.683; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Smedley JG, 2005, INFECT IMMUN, V73, P7922, DOI 10.1128/IAI.73.12.7922-7931.2005; Trefzer C, 2010, J AM CHEM SOC, V132, P13663, DOI 10.1021/ja106357w; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x	35	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28128	28137		10.1074/jbc.M111.255794	http://dx.doi.org/10.1074/jbc.M111.255794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676874	Green Published, hybrid			2022-12-27	WOS:000293557800031
J	McMillin, SM; Heusel, M; Liu, T; Costanzi, S; Wess, J				McMillin, Sara M.; Heusel, Moritz; Liu, Tong; Costanzi, Stefano; Wess, Juergen			Structural Basis of M-3 Muscarinic Receptor Dimer/Oligomer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RESONANCE ENERGY-TRANSFER; ACETYLCHOLINE-RECEPTORS; QUANTITATIVE-ANALYSIS; INTERNATIONAL UNION; SECRETIN RECEPTOR; REVEALS OLIGOMERS; HORMONE RECEPTOR; MOLECULAR-BASIS; DRUG DISCOVERY	Class A G protein-coupled receptors (GPCRs) are known to form dimers and/or oligomeric arrays in vitro and in vivo. These complexes are thought to play important roles in modulating class A GPCR function. Many studies suggest that residues located on the "outer" (lipid-facing) surface of the transmembrane (TM) receptor core are critically involved in the formation of class A receptor dimers (oligomers). However, no clear consensus has emerged regarding the identity of the TM helices or TM subsegments involved in this process. To shed light on this issue, we have used the M-3 muscarinic acetylcholine receptor (M3R), a prototypic class A GPCR, as a model system. Using a comprehensive and unbiased approach, we subjected all outward-facing residues (70 amino acids total) of the TM helical bundle (TM1-7) of the M3R to systematic alanine substitution mutagenesis. We then characterized the resulting mutant receptors in radioligand binding and functional studies and determined their ability to form dimers (oligomers) in bioluminescence resonance energy transfer saturation assays. We found that M3R/M3R interactions are not dependent on the presence of one specific structural motif but involve the outer surfaces of multiple TM subsegments (TM1-5 and -7) located within the central and endofacial portions of the TM receptor core. Moreover, we demonstrated that the outward-facing surfaces of most TM helices play critical roles in proper receptor folding and/or function. Guided by the bioluminescence resonance energy transfer data, molecular modeling studies suggested the existence of multiple dimeric/oligomeric M3R arrangements, which may exist in a dynamic equilibrium. Given the high structural homology found among all class A GPCRs, our results should be of considerable general relevance.	[Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Costanzi, Stefano] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wess, J (corresponding author), NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bldg 8A,Rm B1A-05,8 Ctr Dr,MSC 0810, Bethesda, MD 20892 USA.	jwess@helix.nih.gov	Costanzi, Stefano/G-8990-2013	Costanzi, Stefano/0000-0003-3183-7332	National Institutes of Health, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013025, ZIADK031129] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NIDDK.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; [Anonymous], 2010, PRIM VERS 2 2; [Anonymous], 2010, MAESTR VERS 9 1; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BLUML K, 1994, J BIOL CHEM, V269, P402; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Breit A, 2004, J BIOL CHEM, V279, P28756, DOI 10.1074/jbc.M313310200; Carrillo JJ, 2004, MOL PHARMACOL, V66, P1123, DOI 10.1124/mol.104.001586; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Ciruela F, 2010, TRENDS BIOTECHNOL, V28, P407, DOI 10.1016/j.tibtech.2010.05.002; Davies A, 2001, J MOL BIOL, V314, P455, DOI 10.1006/jmbi.2001.5167; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Filizola M, 2005, FEBS J, V272, P2926, DOI 10.1111/j.1742-4658.2005.04730.x; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gautam D, 2009, P NATL ACAD SCI USA, V106, P6398, DOI 10.1073/pnas.0900977106; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Klco JM, 2009, FEBS J, V276, P2786, DOI 10.1111/j.1742-4658.2009.07002.x; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Kota P, 2006, P NATL ACAD SCI USA, V103, P3054, DOI 10.1073/pnas.0510982103; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Li B, 2005, J BIOL CHEM, V280, P5664, DOI 10.1074/jbc.M411623200; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lodowski DT, 2007, J STRUCT BIOL, V158, P455, DOI 10.1016/j.jsb.2007.01.017; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Oki T, 2005, MOL BRAIN RES, V133, P6, DOI 10.1016/j.molbrainres.2004.09.012; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Pioszak AA, 2010, J BIOL CHEM, V285, P12435, DOI 10.1074/jbc.M109.093138; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Raufman JP, 2008, CANCER RES, V68, P3573, DOI 10.1158/0008-5472.CAN-07-6810; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Shi Y, 2010, CELL METAB, V11, P231, DOI 10.1016/j.cmet.2010.01.005; Song GJ, 2007, P NATL ACAD SCI USA, V104, P18303, DOI 10.1073/pnas.0702857104; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487	71	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28584	28598		10.1074/jbc.M111.259788	http://dx.doi.org/10.1074/jbc.M111.259788			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685385	Green Published, hybrid			2022-12-27	WOS:000293557800073
J	Fagan, RP; Fairweather, NF				Fagan, Robert P.; Fairweather, Neil F.			Clostridium difficile Has Two Parallel and Essential Sec Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-LAYER PROTEINS; CELL-SURFACE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; ATP-BINDING; S-LAYER; TOXIN-B; BACTERIAL; GENES; WALL	Protein translocation across the cytoplasmic membrane is an essential process in all bacteria. The Sec system, comprising at its core an ATPase, SecA, and a membrane channel, SecYEG, is responsible for the majority of this protein transport. Recently, a second parallel Sec system has been described in a number of Gram-positive species. This accessory Sec system is characterized by the presence of a second copy of the energizing ATPase, SecA2; where it has been studied, SecA2 is responsible for the translocation of a subset of Sec substrates. In common with many pathogenic Gram-positive species, Clostridium difficile possesses two copies of SecA. Here, we describe the first characterization of the C. difficile accessory Sec system and the identification of its major substrates. Using inducible antisense RNA expression and dominant-negative alleles of secA1 and secA2, we demonstrate that export of the S-layer proteins (SLPs) and an additional cell wall protein (CwpV) is dependent on SecA2. Accumulation of the cytoplasmic precursor of the SLPs SlpA and other cell wall proteins was observed in cells expressing dominant-negative secA1 or secA2 alleles, concomitant with a decrease in the levels of mature SLPs in the cell wall. Furthermore, expression of either dominant-negative allele or antisense RNA knockdown of SecA1 or SecA2 dramatically impaired growth, indicating that both Sec systems are essential in C. difficile.	[Fagan, Robert P.; Fairweather, Neil F.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Fagan, RP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, S Kensington Campus, London SW7 2AZ, England.	r.fagan@imperial.ac.uk	Fagan, Robert/H-9925-2013	Fagan, Robert/0000-0002-8704-4828	Medical Research Council [G0800170]; MRC [G0800170] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0800170.	Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Caspers M, 2008, ARCH MICROBIOL, V189, P605, DOI 10.1007/s00203-008-0351-0; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Coulthurst SJ, 2008, MOL MICROBIOL, V69, P1331, DOI 10.1111/j.1365-2958.2008.06367.x; Dang THT, 2010, ACS CHEM BIOL, V5, P279, DOI 10.1021/cb9002859; de la Riva L, 2011, J BACTERIOL, V193, P3276, DOI 10.1128/JB.00248-11; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Economou A, 2001, Expert Opin Ther Targets, V5, P141, DOI 10.1517/14728222.5.2.141; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fagan R, 2010, METHODS MOL BIOL, V646, P117, DOI 10.1007/978-1-60327-365-7_8; Fagan RP, 2011, J MED MICROBIOL, V60, P1225, DOI 10.1099/jmm.0.028472-0; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; GEISSENDORFER M, 1990, APPL MICROBIOL BIOT, V33, P657, DOI 10.1007/BF00604933; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Janoir C, 2007, J BACTERIOL, V189, P7174, DOI 10.1128/JB.00578-07; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; KAWATA T, 1984, FEMS MICROBIOL LETT, V24, P323, DOI 10.1016/0378-1097(84)90273-8; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuipers EJ, 2008, LANCET, V371, P1486, DOI 10.1016/S0140-6736(08)60635-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Pechine S, 2005, J MED MICROBIOL, V54, P193, DOI 10.1099/jmm.0.45800-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Rigel NW, 2009, J BIOL CHEM, V284, P9927, DOI 10.1074/jbc.M900325200; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sheridan PP, 2003, GEOMICROBIOL J, V20, P1, DOI 10.1080/01490450303891; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Wright A, 2008, J MED MICROBIOL, V57, P750, DOI 10.1099/jmm.0.47532-0	48	154	155	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27483	27493		10.1074/jbc.M111.263889	http://dx.doi.org/10.1074/jbc.M111.263889			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659510	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000293268700043
J	Gong, R; Wang, YP; Feng, Y; Zhao, Q; Dimitrov, DS				Gong, Rui; Wang, Yanping; Feng, Yang; Zhao, Qi; Dimitrov, Dimiter S.			Shortened Engineered Human Antibody CH2 Domains INCREASED STABILITY AND BINDING TO THE HUMAN NEONATAL Fc RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-G; PROTEINS; REGION; SCAFFOLDS; LYSOZYME; AFFINITY	The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH2 domains are promising scaffolds for construction of libraries containing diverse binders that could also confer some effector functions. We have shown previously that an isolated human CH2 domain is relatively unstable to thermally induced unfolding, but its stability can be improved by engineering an additional disulfide bond (Gong, R., Vu, B. K., Feng, Y., Prieto, D. A., Dyba, M. A., Walsh, J. D., Prabakaran, P., Veenstra, T. D., Tarasov, S. G., Ishima, R., and Dimitrov, D. S. (2009) J. Biol. Chem. 284, 14203-14210). We have hypothesized that the stability of this engineered antibody domain could be further increased by removing unstructured residues. To test our hypothesis, we removed the seven N-terminal residues that are in a random coil as suggested by our analysis of the isolated CH2 crystal structure and NMR data. The resulting shortened engineered CH2 (m01s) was highly soluble, monomeric, and remarkably stable, with a melting temperature (T-m) of 82.6 degrees C, which is about 10 and 30 degrees C higher than those of the original stabilized CH2 (m01) and CH2, respectively. m01s and m01 were more resistant to protease digestion than CH2. A newly identified anti-CH2 antibody that recognizes a conformational epitope bound to m01s significantly better (> 10-fold higher affinity) than to CH2 and slightly better than to m01. m01s bound to a recombinant soluble human neonatal Fc receptor at pH 6.0 more strongly than CH2. These data suggest that shortening the m01 N terminus significantly increases stability without disrupting its conformation and that our approach for increasing stability and decreasing size by removing unstructured regions may also apply to other proteins.	[Gong, Rui; Wang, Yanping; Feng, Yang; Zhao, Qi; Dimitrov, Dimiter S.] NCI, Prot Interact Grp, CCRNP, CCR,NIH, Frederick, MD 21702 USA; [Wang, Yanping] NCI, SAIC Frederick Inc, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Dimitrov, DS (corresponding author), NCI, Prot Interact Grp, CCRNP, CCR,NIH, Bldg 469,Rm 150B, Frederick, MD 21702 USA.	dimiter.dimitrov@nih.gov		Zhao, Qi/0000-0002-5969-6407	National Institutes of Health; National Institutes of Health NIAID; National Institutes of Health NCI Center for Cancer Research; National Institutes of Health NCI [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC011155, ZIABC010701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP), the National Institutes of Health NIAID Intramural Biodefense Program, and the National Institutes of Health NCI Center for Cancer Research Intramural Research Program. This work was supported, in whole or in part, by federal funds from National Institutes of Health NCI Contract N01-CO-12400.	Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; De Sancho D, 2009, J AM CHEM SOC, V131, P2074, DOI 10.1021/ja808843h; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; ELLERSON JR, 1972, FEBS LETT, V24, P318, DOI 10.1016/0014-5793(72)80381-8; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; FENG Y, 2011, PROTEIN EXP IN PRESS; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Kolmar H, 2008, FEBS J, V275, P2667, DOI 10.1111/j.1742-4658.2008.06437.x; Nygren PA, 2004, J IMMUNOL METHODS, V290, P3, DOI 10.1016/j.jim.2004.04.006; Prabakaran P, 2008, ACTA CRYSTALLOGR D, V64, P1062, DOI 10.1107/S0907444908025274; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; YASMEEN D, 1976, J IMMUNOL, V116, P518; Zhu Zhongyu, 2009, V525, P129, DOI 10.1007/978-1-59745-554-1_6	20	44	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27288	27293		10.1074/jbc.M111.254219	http://dx.doi.org/10.1074/jbc.M111.254219			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669873	Green Published, hybrid			2022-12-27	WOS:000293268700024
J	Mohammadi, M; Viger, JF; Kumar, P; Barriault, D; Bolin, JT; Sylvestre, M				Mohammadi, Mahmood; Viger, Jean-Francois; Kumar, Pravindra; Barriault, Diane; Bolin, Jeffrey T.; Sylvestre, Michel			Retuning Rieske-type Oxygenases to Expand Substrate Range	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKHOLDERIA-XENOVORANS LB400; COMAMONAS-TESTOSTERONI B-356; RING-HYDROXYLATING DIOXYGENASE; BIPHENYL DIOXYGENASE; NAPHTHALENE DIOXYGENASE; DIRECTED EVOLUTION; ACTIVE-SITE; POLYCHLORINATED-BIPHENYLS; RANDOM MUTAGENESIS; CRYSTAL-STRUCTURE	Rieske-type oxygenases are promising biocatalysts for the destruction of persistent pollutants or for the synthesis of fine chemicals. In this work, we explored pathways through which Rieske-type oxygenases evolve to expand their substrate range. BphAE(p4), a variant biphenyl dioxygenase generated from Burkholderia xenovorans LB400 BphAE(LB400) by the double substitution T335A/F336M, and BphAE(RR41), obtained by changing Asn(338), Ile(341), and Leu(409) of BphAEp(4) to Gln(338), Val(341), and Phe(409), metabolize dibenzofuran two and three times faster than BphAE(LB400), respectively. Steady-state kinetic measurements of single-and multiple-substitution mutants of BphAE(LB400) showed that the single T335A and the double N338Q/L409F substitutions contribute significantly to enhanced catalytic activity toward dibenzofuran. Analysis of crystal structures showed that the T335A substitution relieves constraints on a segment lining the catalytic cavity, allowing a significant displacement in response to dibenzofuran binding. The combined N338Q/L409F substitutions alter substrate-induced conformational changes of protein groups involved in subunit assembly and in the chemical steps of the reaction. This suggests a responsive induced fit mechanism that retunes the alignment of protein atoms involved in the chemical steps of the reaction. These enzymes can thus expand their substrate range through mutations that alter the constraints or plasticity of the catalytic cavity to accommodate new substrates or that alter the induced fit mechanism required to achieve proper alignment of reaction-critical atoms or groups.	[Mohammadi, Mahmood; Viger, Jean-Francois; Barriault, Diane; Sylvestre, Michel] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada; [Kumar, Pravindra; Bolin, Jeffrey T.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kumar, Pravindra; Bolin, Jeffrey T.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Kumar, Pravindra] Indian Inst Technol, Dept Biotechnol, Roorkee 247667, Uttar Pradesh, India	University of Quebec; Institut national de la recherche scientifique (INRS); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Sylvestre, M (corresponding author), Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada.	Michel.Sylvestre@iaf.inrs.ca	KUMAR, PRAVINDRA/AAF-2859-2020	KUMAR, PRAVINDRA/0000-0003-2128-7736; Sylvestre, Michel/0000-0002-6942-3373	Natural Sciences and Engineering Research Council of Canada [RGPIN/39579-2007]; Indian Department of Science and Technology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Indian Department of Science and Technology(Department of Science & Technology (India))	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN/39579-2007 and an Indian Department of Science and Technology young scientist grant	Bak-Jensen KS, 2004, J BIOL CHEM, V279, P10093, DOI 10.1074/jbc.M312825200; Barriault D, 2004, J BIOL CHEM, V279, P47480, DOI 10.1074/jbc.M406805200; Barriault D, 2002, J BACTERIOL, V184, P3794, DOI 10.1128/JB.184.14.3794-3800.2002; Chang YS, 2008, J MOL MICROB BIOTECH, V15, P152, DOI 10.1159/000121327; Chun HK, 2003, J MOL CATAL B-ENZYM, V21, P113, DOI 10.1016/S1381-1177(02)00085-1; Dietrich M, 2009, J BIOTECHNOL, V139, P115, DOI 10.1016/j.jbiotec.2008.10.002; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; ERICKSON BD, 1992, J BACTERIOL, V174, P2903, DOI 10.1128/JB.174.9.2903-2912.1992; Ferraro DJ, 2006, J BACTERIOL, V188, P6986, DOI 10.1128/JB.00707-06; Furukawa K, 2004, J BACTERIOL, V186, P5189, DOI 10.1128/JB.186.16.5189-5196.2004; Furusawa Y, 2004, J MOL BIOL, V342, P1041, DOI 10.1016/j.jmb.2004.07.062; HADDOCK JD, 1995, J BACTERIOL, V177, P5834, DOI 10.1128/jb.177.20.5834-5839.1995; HADDOCK JD, 1995, J BACTERIOL, V177, P20, DOI 10.1128/jb.177.1.20-26.1995; Huang WC, 2007, J MOL BIOL, V373, P633, DOI 10.1016/j.jmb.2007.08.015; Hurtubise Y, 1996, J BIOL CHEM, V271, P8152, DOI 10.1074/jbc.271.14.8152; HURTUBISE Y, 1995, J BACTERIOL, V177, P6610, DOI 10.1128/jb.177.22.6610-6618.1995; Imbeault NYR, 2000, J BIOL CHEM, V275, P12430, DOI 10.1074/jbc.275.17.12430; Inoue K, 2009, J MOL BIOL, V392, P436, DOI 10.1016/j.jmb.2009.07.029; Jakoncic J, 2007, BIOCHEM BIOPH RES CO, V352, P861, DOI 10.1016/j.bbrc.2006.11.117; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kumar P, 2011, ACTA CRYSTALLOGR F, V67, P59, DOI 10.1107/S1744309110043393; Kumar P, 2011, J MOL BIOL, V405, P531, DOI 10.1016/j.jmb.2010.11.009; L'Abbee JB, 2005, APPL MICROBIOL BIOT, V67, P506, DOI 10.1007/s00253-004-1791-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN JJ, 1992, BIOTECHNIQUES, V12, P718; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mohammadi M, 2005, CHEM BIOL, V12, P835, DOI 10.1016/j.chembiol.2005.05.017; Mondello FJ, 1997, APPL ENVIRON MICROB, V63, P3096, DOI 10.1128/AEM.63.8.3096-3103.1997; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; Parales RE, 2000, J BACTERIOL, V182, P1641, DOI 10.1128/JB.182.6.1641-1649.2000; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; Sambrook J., 2002, MOL CLONING LAB MANU; Seeger M, 2001, J BACTERIOL, V183, P3548, DOI 10.1128/JB.183.12.3548-3555.2001; Seeger M, 2003, APPL ENVIRON MICROB, V69, P5045, DOI 10.1128/AEM.69.9.5045-5050.2003; Seo J, 2011, APPL MICROBIOL BIOT, V89, P1773, DOI 10.1007/s00253-010-2989-1; Suenaga H, 2001, J BACTERIOL, V183, P5441, DOI 10.1128/JB.183.18.5441-5444.2001; Suenaga H, 2001, J BIOL CHEM, V276, P22500, DOI 10.1074/jbc.M101323200; Suenaga H, 1999, J BIOSCI BIOENG, V87, P430, DOI 10.1016/S1389-1723(99)80090-5; Suenaga H, 2006, APPL MICROBIOL BIOT, V71, P168, DOI 10.1007/s00253-005-0135-2; Sylvestre M, 2004, INT BIODETER BIODEGR, V54, P153, DOI 10.1016/j.ibiod.2004.03.011; Vezina J, 2007, J BACTERIOL, V189, P779, DOI 10.1128/JB.01267-06; Xu D, 2002, BIOCHEMISTRY-US, V41, P13627, DOI 10.1021/bi020446n; Zielinski M, 2006, APPL ENVIRON MICROB, V72, P2191, DOI 10.1128/AEM.72.3.2191-2199.2006; Zielinski M, 2003, J BACTERIOL, V185, P6976, DOI 10.1128/JB.185.23.6976-6980.2003	45	29	32	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27612	27621		10.1074/jbc.M111.255174	http://dx.doi.org/10.1074/jbc.M111.255174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21653696	Green Published, hybrid			2022-12-27	WOS:000293268700054
J	Xiao, YC; Jackson, JO; Liang, SP; Cummins, TR				Xiao, Yucheng; Jackson, James O., II; Liang, Songping; Cummins, Theodore R.			Common Molecular Determinants of Tarantula Huwentoxin-IV Inhibition of Na+ Channel Voltage Sensors in Domains II and IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SCORPION TOXIN; GATED SODIUM-CHANNELS; GATING MODIFIER; PAIN DISORDERS; ALPHA-SUBUNIT; K+ CHANNEL; PROTX-II; INACTIVATION; ACTIVATION; PHARMACOLOGY	The voltage sensors of domains II and IV of sodium channels are important determinants of activation and inactivation, respectively. Animal toxins that alter electrophysiological excitability of muscles and neurons often modify sodium channel activation by selectively interacting with domain II and inactivation by selectively interacting with domain IV. This suggests that there may be substantial differences between the toxin-binding sites in these two important domains. Here we explore the ability of the tarantula huwentoxin-IV (HWTX-IV) to inhibit the activity of the domain II and IV voltage sensors. HWTX-IV is specific for domain II, and we identify five residues in the S1-S2 (Glu-753) and S3-S4 (Glu-811, Leu-814, Asp-816, and Glu-818) regions of domain II that are crucial for inhibition of activation by HWTX-IV. These data indicate that a single residue in the S3-S4 linker (Glu-818 in hNav1.7) is crucial for allowing HWTX-IV to interact with the other key residues and trap the voltage sensor in the closed configuration. Mutagenesis analysis indicates that the five corresponding residues in domain IV are all critical for endowing HWTX-IV with the ability to inhibit fast inactivation. Our data suggest that the toxin-binding motif in domain II is conserved in domain IV. Increasing our understanding of the molecular determinants of toxin interactions with voltage-gated sodium channels may permit development of enhanced isoform-specific voltage-gating modifiers.	[Xiao, Yucheng; Jackson, James O., II; Liang, Songping] Hunan Normal Univ, Life Sci Coll, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Hunan, Peoples R China; [Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Hunan Normal University; Indiana University System; Indiana University Bloomington	Liang, SP (corresponding author), Hunan Normal Univ, Life Sci Coll, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; trcummin@iupui.edu	Xiao, Yucheng/H-3600-2012		National Institutes of Health [NS054642, NS053422]; 973 Research Program of China [2010CB529800]; Hunan Provincial Education Department [07A035]; Program for New Century Excellent Talents in University [NCET-07-0279]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS053422, R21NS054642, R01NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Research Program of China(National Basic Research Program of China); Hunan Provincial Education Department(Hunan Provincial Education Department); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054642 and NS053422 (to T. R. C.). This work was also supported by the 973 Research Program of China under Contract 2010CB529800 (to S. L.); the Scientific Research Fund of Hunan Provincial Education Department (07A035) and the Program for New Century Excellent Talents in University under Contract NCET-07-0279 (to Y. X.).	Bechtold DA, 2005, J NEUROL SCI, V233, P27, DOI 10.1016/j.jns.2005.03.003; Blumenthal KM, 2003, CELL BIOCHEM BIOPHYS, V38, P215, DOI 10.1385/CBB:38:2:215; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; Karbat I, 2004, FASEB J, V18, P683, DOI 10.1096/fj.03-0733com; Kontis KJ, 1997, J GEN PHYSIOL, V110, P391, DOI 10.1085/jgp.110.4.391; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Liao Z, 2006, BIOCHEMISTRY-US, V45, P15591, DOI 10.1021/bi061457+; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mantegazza M, 2005, J PHYSIOL-LONDON, V568, P13, DOI 10.1113/jphysiol.2005.093484; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Sheets MF, 2007, J PHYSIOL-LONDON, V582, P317, DOI 10.1113/jphysiol.2007.134262; Struyk AF, 2000, J NEUROSCI, V20, P8610; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; Zuo XP, 2006, FEBS LETT, V580, P4508, DOI 10.1016/j.febslet.2006.07.024	35	50	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27301	27310		10.1074/jbc.M111.246876	http://dx.doi.org/10.1074/jbc.M111.246876			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659528	hybrid, Green Published			2022-12-27	WOS:000293268700026
J	Deleersnijder, A; Van Rompuy, AS; Desender, L; Pottel, H; Buee, L; Debyser, Z; Baekelandt, V; Gerard, M				Deleersnijder, Angelique; Van Rompuy, Anne-Sophie; Desender, Linda; Pottel, Hans; Buee, Luc; Debyser, Zeger; Baekelandt, Veerle; Gerard, Melanie			Comparative Analysis of Different Peptidyl-Prolyl Isomerases Reveals FK506-binding Protein 12 as the Most Potent Enhancer of alpha-Synuclein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; AMYLOID PRECURSOR PROTEIN; FK506 BINDING-PROTEINS; CIS-TRANS ISOMERASES; CYCLOSPORINE-A; NEURODEGENERATIVE DISEASE; IMMUNOPHILIN LIGANDS; RELEASE CHANNEL; BRAIN ISCHEMIA; CYCLOPHILIN-A	FK506-binding proteins (FKBPs) are members of the immunophilins, enzymes that assist protein folding with their peptidyl-prolyl isomerase (PPIase) activity. Some non-immunosuppressive inhibitors of these enzymes have neuroregenerative and neuroprotective properties with an unknown mechanism of action. We have previously shown that FKBPs accelerate the aggregation of alpha-synuclein (alpha-SYN) in vitro and in a neuronal cell culture model for synucleinopathy. In this study we investigated whether acceleration of alpha-SYN aggregation is specific for the FKBP or even the PPIase family. Therefore, we studied the effect of several physiologically relevant PPIases, namely FKBP12, FKBP38, FKBP52, FKBP65, Pin1, and cyclophilin A, on alpha-SYN aggregation in vitro and in neuronal cell culture. Among all PPIases tested in vitro, FKBP12 accelerated alpha-SYN aggregation the most. Furthermore, only FKBP12 accelerated alpha-SYN fibril formation at subnanomolar concentrations, pointing toward an enzymatic effect. Although stable overexpression of various FKBPs enhanced the aggregation of alpha-SYN and cell death in cell culture, they were less potent than FKBP12. When FKBP38, FKBP52, and FKBP65 were overexpressed in a stable FKBP12 knockdown cell line, they could not fully restore the number of alpha-SYN inclusion-positive cells. Both in vitro and cell culture data provide strong evidence that FKBP12 is the most important PPIase modulating alpha-SYN aggregation and validate the protein as an interesting drug target for Parkinson disease.	[Deleersnijder, Angelique; Desender, Linda; Debyser, Zeger; Gerard, Melanie] KU Leuven Kortrijk, Biochem Lab, B-8500 Kortrijk, Flanders, Belgium; [Pottel, Hans] KU Leuven Kortrijk, Biophys Lab, B-8500 Kortrijk, Flanders, Belgium; [Debyser, Zeger] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Flanders, Belgium; [Deleersnijder, Angelique; Van Rompuy, Anne-Sophie; Baekelandt, Veerle; Gerard, Melanie] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, B-3000 Louvain, Flanders, Belgium; [Buee, Luc] INSERM, U837, F-59000 Lille, France; [Buee, Luc] Univ Lille 2, Inst Med Predict & Rech Therapeut, Fac Med, UDSL,Univ Lille Nord France, F-59045 Lille, France; [Buee, Luc] CHRU, F-59037 Lille, France	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Baekelandt, V (corresponding author), KU Leuven Kortrijk, Biochem Lab, Etienne Sabbelaan 53, B-8500 Kortrijk, Flanders, Belgium.	veerle.baekelandt@med.kuleuven.be	Baekelandt, Veerle/ABB-9736-2020; Pottel, Hans/AAD-9444-2019; Gerard, Melanie/B-6898-2019; BUEE, Luc/B-3126-2010	Baekelandt, Veerle/0000-0001-8966-2921; Pottel, Hans/0000-0003-0074-8919; Gerard, Melanie/0000-0003-0585-6978; BUEE, Luc/0000-0002-6261-4230; Van Rompuy, Anne-Sophie/0000-0002-0138-4486	Science and Technology in Flanders [80020]; Flemish Research Foundation [G.0768.10]; Michael J. Fox Foundation; European FP7 RTD project MEFOPA [HEALTH2009-241791];  [OT/08/052A];  [IOF-KP/07/001]	Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Flemish Research Foundation(FWO); Michael J. Fox Foundation; European FP7 RTD project MEFOPA; ; 	This work was supported by the Institute for the Promotion of Innovation by Science and Technology in Flanders (Project IWT/SBO 80020; a doctoral fellowship (to A. D.) and a postdoctoral fellowship (to M. G.)), the Flemish Research Foundation FWO-Vlaanderen (project G.0768.10, a doctoral fellowship (to A.-S. V. R.), the Michael J. Fox Foundation (target validation 2010), European FP7 RTD project MEFOPA (Grant Agreement HEALTH2009-241791), and the K. U. Leuven (OT/08/052A and IOF-KP/07/001).	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Avramut M, 2002, PHYSIOL BEHAV, V77, P463, DOI 10.1016/S0031-9384(02)00934-4; Avramut M, 2001, DEV BRAIN RES, V132, P151, DOI 10.1016/S0165-3806(01)00307-8; BERGSMA DJ, 1991, J BIOL CHEM, V266, P23204; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Chambraud B, 2010, P NATL ACAD SCI USA, V107, P2658, DOI 10.1073/pnas.0914957107; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; COSS MC, 1995, J BIOL CHEM, V270, P29336, DOI 10.1074/jbc.270.49.29336; Coss MC, 1998, CELL GROWTH DIFFER, V9, P41; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2006, J BIOL CHEM, V281, P14961, DOI 10.1074/jbc.M600452200; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gerard M, 2006, FASEB J, V20, P524, DOI 10.1096/fj.05-5126fje; Gerard M., 2011, MOL NEUROBI IN PRESS; Gerard M, 2008, J NEUROCHEM, V106, P121, DOI 10.1111/j.1471-4159.2008.05342.x; Gerard M, 2010, J NEUROSCI, V30, P2454, DOI 10.1523/JNEUROSCI.5983-09.2010; Gold BG, 1999, J PHARMACOL EXP THER, V289, P1202; Gold BG, 2004, NEUROL RES, V26, P371, DOI 10.1179/016164104225013734; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Guo X, 2001, EUR J NEUROSCI, V13, P1683, DOI 10.1046/j.0953-816x.2001.01542.x; Hamdane M, 2002, J MOL NEUROSCI, V19, P275, DOI 10.1385/JMN:19:3:275; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Joseph James D, 2003, Prog Cell Cycle Res, V5, P477; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kullertz G, 1998, CLIN CHEM, V44, P502; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Lauwers E, 2003, BRAIN PATHOL, V13, P364; Lee D, 2002, J NEUROCHEM, V82, P1007, DOI 10.1046/j.1471-4159.2002.01024.x; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Liu D, 2007, J NEUROSCI METH, V163, P310, DOI 10.1016/j.jneumeth.2007.03.018; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu PJ, 1999, NATURE, V399, P784; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nielsen MS, 2001, J BIOL CHEM, V276, P22680, DOI 10.1074/jbc.M101181200; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Patterson CE, 2000, MOL BIOL CELL, V11, P3925, DOI 10.1091/mbc.11.11.3925; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pong K, 2003, CNS NEUROL DISORD-DR, V2, P349, DOI 10.2174/1568007033482652; Poulter MO, 2004, NEUROSCIENCE, V128, P1, DOI 10.1016/j.neuroscience.2004.06.016; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Redell JB, 2007, J NEUROSCI RES, V85, P1980, DOI 10.1002/jnr.21324; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Sheehan Jason, 2006, Neurosurg Focus, V20, pE9; Shim S, 2009, NEURON, V64, P471, DOI 10.1016/j.neuron.2009.09.025; Shin DW, 2002, BIOPHYS J, V83, P2539, DOI 10.1016/S0006-3495(02)75265-X; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sinigaglia-Coimbra R, 2002, J NEUROL SCI, V203, P273, DOI 10.1016/S0022-510X(02)00304-0; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steiner JP, 1997, P NATL ACAD SCI USA, V94, P2019, DOI 10.1073/pnas.94.5.2019; Wang XDJ, 2006, BIOPOLYMERS, V84, P125, DOI 10.1002/bip.20240; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	77	27	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26687	26701		10.1074/jbc.M110.182303	http://dx.doi.org/10.1074/jbc.M110.182303			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652707	hybrid, Green Published			2022-12-27	WOS:000293078200046
J	Lemmon, CA; Ohashi, T; Erickson, HP				Lemmon, Christopher A.; Ohashi, Tomoo; Erickson, Harold P.			Probing the Folded State of Fibronectin Type III Domains in Stretched Fibrils by Measuring Buried Cysteine Accessibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; CELL-ADHESION; MATRIX; PROTEIN; ELASTICITY; MOLECULE; CONFORMATION; EXTENSION	Fibronectin (FN) is an extracellular matrix protein that is assembled into fibrils by cells during tissue morphogenesis and wound healing. FN matrix fibrils are highly elastic, but the mechanism of elasticity has been debated: it may be achieved by mechanical unfolding of FN-III domains or by a conformational change of the molecule without domain unfolding. Here, we investigate the folded state of FN-III domains in FN fibrils by measuring the accessibility of buried cysteines. Four of the 15 FN-III domains (III-2, -3, -9, and -11) appear to unfold in both stretched fibrils and in solution, suggesting that these domains spontaneously open and close even in the absence of tension. Two FN-III domains (III-6 and -12) appear to unfold only in fibrils and not in solution. These results suggest that domain unfolding can at best contribute partially to the 4-fold extensibility of fibronectin fibrils.	[Lemmon, Christopher A.; Ohashi, Tomoo; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Lemmon, CA (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, 412 Nanaline Duke Bldg,Box 3709, Durham, NC 27710 USA.	christopher.lemmon@duke.edu	Lemmon, Christopher/GPP-1470-2022	Lemmon, Christopher/0000-0002-9049-6366	National Institutes of Health [CA47056, GM089331]; NATIONAL CANCER INSTITUTE [R01CA047056, R37CA047056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA47056 (to H. P. E.) and GM089331 (to C. A. L.).	Abu-Lail NI, 2006, MATRIX BIOL, V25, P175, DOI 10.1016/j.matbio.2005.10.007; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CHERNOUSOV MA, 1987, FEBS LETT, V217, P124, DOI 10.1016/0014-5793(87)81255-3; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; Erickson HP, 2002, J MUSCLE RES CELL M, V23, P575, DOI 10.1023/A:1023427026818; Fisher TE, 1999, TRENDS BIOCHEM SCI, V24, P379, DOI 10.1016/S0968-0004(99)01453-X; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NAGAI T, 1991, J CELL BIOL, V114, P1295, DOI 10.1083/jcb.114.6.1295; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; Ohashi T, 2002, J CELL SCI, V115, P1221; Ohashi T, 2009, BIOCHEMISTRY-US, V48, P4189, DOI 10.1021/bi900001g; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Sivakumar P, 2006, J CELL SCI, V119, P1350, DOI 10.1242/jcs.02830; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	36	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26375	26382		10.1074/jbc.M111.240028	http://dx.doi.org/10.1074/jbc.M111.240028			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652701	Green Published, hybrid			2022-12-27	WOS:000293078200014
J	Bellomo, EA; Meur, G; Rutter, GA				Bellomo, Elisa A.; Meur, Gargi; Rutter, Guy A.			Glucose Regulates Free Cytosolic Zn2+ Concentration, Slc39 (ZiP), and Metallothionein Gene Expression in Primary Pancreatic Islet beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; ZINC TRANSPORTER ZNT8; INSULIN-SECRETION; INTRACELLULAR ZINC; BUFFERING CAPACITY; ENDOCRINE PANCREAS; DIABETIC-RATS; CELLULAR ZINC; ALPHA-CELLS; RISK LOCI	Zn2+ is an important cofactor for insulin biosynthesis and storage in pancreatic beta-cells. Correspondingly, polymorphisms in the SLC30A8 gene, encoding the secretory granule Zn2+ transporter ZnT8, are associated with type 2 diabetes risk. Using a genetically engineered (FRET)-based sensor (eCALWY-4), we show here that elevated glucose time-dependently increases free cytosolic Zn2+ ([Zn2+](cyt)) in mouse pancreatic beta-cells. These changes become highly significant (853 +/- 96 pM versus 452 +/- 42 pM, p < 0.001) after 24 h and are associated with increased expression of the Zn2+ importer family members Slc39a6, Slc39a7, and Slc39a8, and decreased expression of metallothionein 1 and 2. Arguing that altered expression of the above genes is not due to altered [Zn2+] cyt, elevation of extracellular (and intracellular) [Zn2+] failed to mimic the effects of high glucose. By contrast, increases in intracellular cAMP prompted by 3-isobutyl-1-methylxanthine and forskolin partially mimicked the effects of glucose on metallothionein, although not ZiP, gene expression. Modulation of intracellular Ca2+ and insulin secretion with pharmacological agents (tolbutamide and diazoxide) suggested a possible role for changes in these parameters in the regulation of Slc39a6 and Slc39a7 but not Slc39a8, nor metallothionein expression. In summary, 1) glucose induces increases in [Zn2+] cyt, which are then likely to facilitate the processing and/or the storage of insulin and its cocrystallization with Zn2+, and 2) these increases are associated with elevated expression of zinc importers. Conversely, a chronic increase in [Zn2+] cyt following sustained hyperglycemia may contribute to beta-cell dysfunction and death in some forms of diabetes.	[Bellomo, Elisa A.; Meur, Gargi; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sect Cell Biol, Div Diabet Endocrinol & Metab,Dept Med, London SW7 2AZ, England	Imperial College London	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Sect Cell Biol, Div Diabet Endocrinol & Metab,Dept Med, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	g.rutter@imperial.ac.uk		Rutter, Guy/0000-0001-6360-0343; Bellomo, Elisa/0000-0003-4823-2209; Meur, Gargi/0000-0002-8466-2997	Wellcome Trust [081958/Z/07/Z]; Servier IdS; Royal Society; Medical Research Council [G0401641] Funding Source: researchfish; MRC [G0401641] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Servier IdS; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Programme Grant 081958/Z/07/Z and Servier IdS. This work was also supported by a Royal Society Wolfson Research merit award (to G. A. R.).	ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; Bryan J, 1997, CURR OPIN CELL BIOL, V9, P553, DOI 10.1016/S0955-0674(97)80033-6; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Chen HN, 2001, DIABETES, V50, P2040, DOI 10.2337/diabetes.50.9.2040; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chowanadisai W, 2008, BRAIN RES, V1199, P10, DOI 10.1016/j.brainres.2008.01.015; CORDOVA A, 1994, BIOL TRACE ELEM RES, V42, P209, DOI 10.1007/BF02911518; CROUCH RK, 1984, EXP MOL PATHOL, V41, P377, DOI 10.1016/0014-4800(84)90026-1; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; el-Yazigi A, 1993, Diabetes Res, V22, P67; ELAYAT AA, 1995, J ANAT, V186, P629; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; GHAFGHAZI T, 1981, DIABETES, V30, P341, DOI 10.2337/diabetes.30.4.341; GRILL V, 1973, FEBS LETT, V33, P311, DOI 10.1016/0014-5793(73)80218-2; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; HILL CP, 1991, BIOCHEMISTRY-US, V30, P917, DOI 10.1021/bi00218a006; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; HUTTON JC, 1990, BIOCHEM SOC T, V18, P122, DOI 10.1042/bst0180122; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Kahn SE, 2001, INT J CLIN PRACT, P13; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; KENNEDY ML, 1987, J NUTR, V117, P886, DOI 10.1093/jn/117.5.886; Kim BJ, 2000, DIABETES, V49, P367, DOI 10.2337/diabetes.49.3.367; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Leibiger B, 1998, P NATL ACAD SCI USA, V95, P9307, DOI 10.1073/pnas.95.16.9307; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Ma ZH, 2007, DIABETES, V56, P1095, DOI 10.2337/db06-0322; Maret W, 2007, MOL MED, V13, P371, DOI 10.2119/2007-00036.Maret; Meur G, 2011, J BIOL CHEM, V286, P13647, DOI 10.1074/jbc.M110.204248; Michael DJ, 2006, DIABETES, V55, P600, DOI 10.2337/diabetes.55.03.06.db05-1054; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Ohly P, 2000, DIABETOLOGIA, V43, P1020, DOI 10.1007/s001250050009; ORCI L, 1975, J CLIN INVEST, V56, P1066, DOI 10.1172/JCI108154; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; RAZ I, 1988, DIABETOLOGIA, V31, P329; Sanchez-Alvarez R, 2006, GLIA, V54, P125, DOI 10.1002/glia.20363; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott DA, 1938, J CLIN INVEST, V17, P725, DOI 10.1172/JCI101000; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sensi SL, 2003, CELL CALCIUM, V34, P281, DOI 10.1016/S0143-4160(03)00122-2; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Simon SF, 2001, EXP BIOL MED, V226, P43, DOI 10.1177/153537020122600107; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smidt K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005684; Sondergaard LG, 2003, APMIS, V111, P1147, DOI 10.1111/j.1600-0463.2003.apm1111211.x; SOUTHON S, 1988, BRIT J NUTR, V60, P499, DOI 10.1079/BJN19880122; Szollosi A, 2010, BRIT J PHARMACOL, V159, P669, DOI 10.1111/j.1476-5381.2009.00588.x; Taki M, 2004, J AM CHEM SOC, V126, P712, DOI 10.1021/ja039073j; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Trayhurn P, 2000, HORM METAB RES, V32, P542, DOI 10.1055/s-2007-978683; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wijesekara N, 2009, DIABETES OBES METAB, V11, P202, DOI 10.1111/j.1463-1326.2009.01110.x; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	77	89	92	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25778	25789		10.1074/jbc.M111.246082	http://dx.doi.org/10.1074/jbc.M111.246082			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613223	Green Published, hybrid			2022-12-27	WOS:000293073000040
J	Chavadi, SS; Edupuganti, UR; Vergnolle, O; Fatima, I; Singh, SM; Soll, CE; Quadri, LEN				Chavadi, Sivagami Sundaram; Edupuganti, Uthamaphani R.; Vergnolle, Olivia; Fatima, Itrat; Singh, Shaneen M.; Soll, Clifford E.; Quadri, Luis E. N.			Inactivation of tesA Reduces Cell Wall Lipid Production and Increases Drug Susceptibility in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHTHIOCEROL DIMYCOCEROSATE LOCUS; SIGNATURE-TAGGED MUTAGENESIS; SMALL-MOLECULE INHIBITION; STRUCTURAL BASIS; TUBERCULOSIS; VIRULENCE; THIOESTERASE; BIOSYNTHESIS; GENE; IDENTIFICATION	Phthiocerol dimycocerosates (PDIMs) and phenolic glycolipids (PGLs) are structurally related lipids noncovalently bound to the outer cell wall layer of Mycobacterium tuberculosis, Mycobacterium leprae, and several opportunistic mycobacterial human pathogens. PDIMs and PGLs are important effectors of virulence. Elucidation of the biosynthesis of these complex lipids will not only expand our understanding of mycobacterial cell wall biosynthesis, but it may also illuminate potential routes to novel therapeutics against mycobacterial infections. We report the construction of an in-frame deletion mutant of tesA (encoding a type II thioesterase) in the opportunistic human pathogen Mycobacterium marinum and the characterization of this mutant and its corresponding complemented strain control in terms of PDIM and PGL production. The growth and antibiotic susceptibility of these strains were also probed and compared with the parental wild-type strain. We show that deletion of tesA leads to a mutant that produces only traces of PDIMs and PGLs, has a slight growth yield increase and displays a substantial hypersusceptibility to several antibiotics. We also provide a robust model for the three-dimensional structure of M. marinum TesA (TesAmm) and demonstrate that a Ser-to-Ala substitution in the predicted catalytic Ser of TesAmm renders a mutant that recapitulates the phenotype of the tesA deletion mutant. Overall, our studies demonstrate a critical role for tesA in mycobacterial biology, advance our understanding of the biosynthesis of an important group of polyketide synthase-derived mycobacterial lipids, and suggest that drugs aimed at blocking PDIM and/or PGL production might synergize with antibiotic therapy in the control of mycobacterial infections.	[Chavadi, Sivagami Sundaram; Edupuganti, Uthamaphani R.; Vergnolle, Olivia; Fatima, Itrat; Singh, Shaneen M.; Quadri, Luis E. N.] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Soll, Clifford E.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY)	Quadri, LEN (corresponding author), CUNY Brooklyn Coll, Dept Biol, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	LQuadri@brooklyn.cuny.edu			National Institutes of Health [R01AI069209, 1S10RR022649-01]; CUNY Instrumentation Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CUNY Instrumentation Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI069209 (to L. E. N. Q.).; We acknowledge funding for the LC-MS system provided by NIH Shared Instrumentation Grant 1S10RR022649-01 and the CUNY Instrumentation Fund. We are grateful to Richard Moy (Quadri laboratory) for assistance in mutant construction.	Andreu N, 2008, TUBERCULOSIS, V88, P553, DOI 10.1016/j.tube.2008.03.005; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Collins DM, 2005, INFECT IMMUN, V73, P2379, DOI 10.1128/IAI.73.4.2379-2386.2005; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Crick D. C., 2008, HDB TUBERCULOSIS MOL, P1; DeLano W.L, PYMOL MOL GRAPHICS S; Dhungel S, 2008, Nepal Med Coll J, V10, P1; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; He WG, 2009, J AM CHEM SOC, V131, P16744, DOI 10.1021/ja904792q; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Murry JP, 2009, J INFECT DIS, V200, P774, DOI 10.1086/605128; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Onwueme KC, 2005, J BACTERIOL, V187, P4760, DOI 10.1128/JB.187.14.4760-4766.2005; Onwueme KC, 2004, P NATL ACAD SCI USA, V101, P4608, DOI 10.1073/pnas.0306928101; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1998, METH MOL B, V101, P1, DOI 10.1385/0-89603-471-2:1; Quadri LEN, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P341; Quadri Luis E. N., 2007, Infectious Disorders - Drug Targets, V7, P230, DOI 10.2174/187152607782110040; Rallis E, 2007, EXPERT OPIN PHARMACO, V8, P2965, DOI 10.1517/14656566.8.17.2965; Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631; Rao A, 2004, MOL GENET GENOMICS, V272, P571, DOI 10.1007/s00438-004-1088-3; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Robinson N, 2008, TRAFFIC, V9, P1936, DOI 10.1111/j.1600-0854.2008.00804.x; Ruley KM, 2004, FEMS MICROBIOL LETT, V232, P75, DOI 10.1016/S0378-1097(04)00017-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 2001, MOL CLONING LAB MANU; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Stirrett KL, 2008, BIOORG MED CHEM LETT, V18, P2662, DOI 10.1016/j.bmcl.2008.03.025; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Waddell SJ, 2005, LETT APPL MICROBIOL, V40, P201, DOI 10.1111/j.1472-765X.2005.01659.x	55	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24616	24625		10.1074/jbc.M111.247601	http://dx.doi.org/10.1074/jbc.M111.247601			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592957	Green Published, hybrid			2022-12-27	WOS:000292547900012
J	Kocher, O; Birrane, G; Yesilaltay, A; Shechter, S; Pal, R; Daniels, K; Krieger, M				Kocher, Olivier; Birrane, Gabriel; Yesilaltay, Ayce; Shechter, Sharon; Pal, Rinku; Daniels, Kathleen; Krieger, Monty			Identification of the PDZ3 Domain of the Adaptor Protein PDZK1 as a Second, Physiologically Functional Binding Site for the C Terminus of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; SR-BI; APOLIPOPROTEIN-E; HOMOLOGOUS RECOMBINATION; SURFACE LOCALIZATION; TARGETED DISRUPTION; METABOLISM; EXPRESSION; GENE; HYPERCHOLESTEROLEMIA	The normal expression, cell surface localization, and function of the murine high density lipoprotein receptor scavenger receptor class B type I (SR-BI) in hepatocytes in vivo, and thus normal lipoprotein metabolism, depend on its four PDZ domain (PDZ1-PDZ4) containing cytoplasmic adaptor protein PDZK1. Previous studies showed that the C terminus of SR-BI ("target peptide") binds directly to PDZ1 and influences hepatic SR-BI protein expression. Unexpectedly an inactivating mutation in PDZ1 (Tyr(20) -> Ala) only partially, rather than completely, suppresses the ability of PDZK1 to control hepatic SR-BI. We used isothermal titration calorimetry to show that PDZ3, but not PDZ2 or PDZ4, can also bind the target peptide (K-d = 37.0 mu M), albeit with similar to 10-fold lower affinity than PDZ1. This binding is abrogated by a Tyr(253) -> Ala substitution. Comparison of the 1.5-angstrom resolution crystal structure of PDZ3 with its bound target peptide ((505)QEAKL(509)) to that of peptide-bound PDZ1 indicated fewer target peptide stabilizing atomic interactions (hydrogen bonds and hydrophobic interactions) in PDZ3. A double (Tyr(20) -> Ala (PDZ1) + Tyr(253) -> Ala (PDZ3)) substitution abrogated all target peptide binding to PDZK1. In vivo hepatic expression of a singly substituted (Tyr(253) -> Ala (PDZ3)) PDZK1 transgene (Tg) was able to correct all of the SR-BI-related defects in PDZK1 knock-out mice, whereas the doubly substituted [Tyr(20) -> Ala (PDZ1) + Tyr(253) -> Ala (PDZ3)] Tg was unable to correct these defects. Thus, we conclude that PDZK1-mediated control of hepatic SR-BI requires direct binding of the SR-BIC terminus to either the PDZ1 or PDZ3 domains, and that binding to both domains simultaneously is not required for PDZK1 control of hepatic SR-BI.	[Kocher, Olivier; Shechter, Sharon; Pal, Rinku; Daniels, Kathleen] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Kocher, Olivier; Shechter, Sharon; Pal, Rinku; Daniels, Kathleen] Harvard Univ, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Birrane, Gabriel] Harvard Univ, Sch Med, Div Expt Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Yesilaltay, Ayce; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Kocher, O (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	okocher@bidmc.harvard.edu		Birrane, Gabriel/0000-0002-1759-5499	National Institutes of Health [HL077780, HL52212, HL66105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077780, P01HL066105, R01HL052212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077780 (to O. K.), HL52212 and HL66105 (to M. K.).	Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; DeLano W, 2002, PYMOL 0 99; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2010, J BIOL CHEM, V285, P34999, DOI 10.1074/jbc.M110.164418; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Yesilaltay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008103; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	36	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25171	25186		10.1074/jbc.M111.242362	http://dx.doi.org/10.1074/jbc.M111.242362			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602281	Green Published, hybrid			2022-12-27	WOS:000292547900064
J	Verma, R; Malik, C; Azmi, S; Srivastava, S; Ghosh, S; Ghosh, JK				Verma, Richa; Malik, Chetan; Azmi, Sarfuddin; Srivastava, Saurabh; Ghosh, Subhendu; Ghosh, Jimut Kanti			A Synthetic S6 Segment Derived from KvAP Channel Self-assembles, Permeabilizes Lipid Vesicles, and Exhibits Ion Channel Activity in Bilayer Lipid Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER POTASSIUM CHANNELS; DEPENDENT K+ CHANNEL; ZIPPER-LIKE MOTIF; FORMING PEPTIDE ALAMETHICIN; 4-HELIX BUNDLE PROTEINS; PORE-LINING STRUCTURE; SENDAI-VIRUS FUSION; TOXIN HEMOLYSIN-E; TRANSMEMBRANE SEGMENT; FUNCTIONAL-CHARACTERIZATION	KvAP is a voltage-gated tetrameric K+ channel with six transmembrane (S1-S6) segments in each monomer from the archaeon Aeropyrum pernix. The objective of the present investigation was to understand the plausible role of the S6 segment, which has been proposed to form the inner lining of the pore, in the membrane assembly and functional properties of KvAP channel. For this purpose, a 22-residue peptide, corresponding to the S6 transmembrane segment of KvAP (amino acids 218-239), and a scrambled peptide (S6-SCR) with rearrangement of only hydrophobic amino acids but without changing its composition were synthesized and characterized structurally and functionally. Although both peptides bound to the negatively charged phosphatidylcholine/phosphatidylglycerol model membrane with comparable affinity, significant differences were observed between these peptides in their localization, self-assembly, and aggregation properties onto this membrane. S6-SCR also exhibited reduced helical structures in SDS micelles and phosphatidylcholine/phosphatidylglycerol lipid vesicles as compared with the S6 peptide. Furthermore, the S6 peptide showed significant membrane-permeabilizing capability as evidenced by the release of calcein from the calcein-entrapped lipid vesicles, whereas S6-SCR showed much weaker efficacy. Interestingly, although the S6 peptide showed ion channel activity in the bilayer lipid membrane, despite having the same amino acid composition, S6-SCR was significantly inactive. The results demonstrated sequence-specific structural and functional properties of the S6 wild type peptide. The selected S6 segment is probably an important structural element that could play an important role in the membrane interaction, membrane assembly, and functional property of the KvAP channel.	[Verma, Richa; Azmi, Sarfuddin; Srivastava, Saurabh; Ghosh, Jimut Kanti] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226001, Uttar Pradesh, India; [Malik, Chetan; Ghosh, Subhendu] Univ Delhi S Campus, Dept Biophys, New Delhi 110021, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); University of Delhi	Ghosh, JK (corresponding author), CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Chattar Manzil Palace, Lucknow 226001, Uttar Pradesh, India.	jighosh@yahoo.com	Ghosh, Subhendu/GSN-2467-2022; Srivastava, Saurabh/L-1188-2017; Azmi, Sarfuddin/AAE-7602-2022	Srivastava, Saurabh/0000-0003-3159-7826; Azmi, Sarfuddin/0000-0002-1868-3458; Malik, Dr. Chetan/0000-0003-3428-7567	Central Drug Research Institute (CDRI) [MLP0007M]; Council for Scientific and Industrial Research India	Central Drug Research Institute (CDRI); Council for Scientific and Industrial Research India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Central Drug Research Institute (CDRI) In-house Project MLP0007M. The CDRI communication number of this manuscript is 8068.; Received fellowships from the Council for Scientific and Industrial Research India.	Ahmad A, 2009, BIOCHEMISTRY-US, V48, P10905, DOI 10.1021/bi9009874; ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; BAILIN G, 1990, FEBS LETT, V259, P254, DOI 10.1016/0014-5793(90)80021-A; Banerjee J, 2006, J NEUROCHEM, V98, P670, DOI 10.1111/j.1471-4159.2006.03853.x; BANUELOS S, 1995, J BIOL CHEM, V270, P29910, DOI 10.1074/jbc.270.50.29910; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BENEFRAIM I, 1993, BIOCHEMISTRY-US, V32, P2371, DOI 10.1021/bi00060a031; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P10995, DOI 10.1021/bi00501a018; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Biggin PC, 2000, CURR OPIN STRUC BIOL, V10, P456, DOI 10.1016/S0959-440X(00)00114-7; Bouchayer E, 2001, J PEPT RES, V57, P39, DOI 10.1034/j.1399-3011.2001.00792.x; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Choe S, 2002, NAT REV NEUROSCI, V3, P115, DOI 10.1038/nrn727; Clarke D, 2006, J BIOL CHEM, V281, P37057, DOI 10.1074/jbc.M602434200; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Ding SH, 2003, BIOPHYS J, V84, P295, DOI 10.1016/S0006-3495(03)74850-4; Ding SH, 2002, J GEN PHYSIOL, V120, P87, DOI 10.1085/jgp.20028611; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Finol-Urdaneta RK, 2010, BIOPHYS J, V98, P762, DOI 10.1016/j.bpj.2009.10.053; FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P12363, DOI 10.1021/bi00097a013; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P3429, DOI 10.1021/bi00064a029; Gerber D, 2000, J BIOL CHEM, V275, P23602, DOI 10.1074/jbc.M002596200; Ghosh JK, 1998, J BIOL CHEM, V273, P27182, DOI 10.1074/jbc.273.42.27182; Ghosh JK, 1997, BIOCHEMISTRY-US, V36, P15451, DOI 10.1021/bi971152i; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GROVE A, 1992, METHOD ENZYMOL, V207, P510; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HARIS PI, 1994, PROTEIN ENG, V7, P255, DOI 10.1093/protein/7.2.255; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; IWAMOTO T, 1994, INT J PEPT PROT RES, V43, P597, DOI 10.1111/j.1399-3011.1994.tb00562.x; JAN LY, 1994, NATURE, V371, P119, DOI 10.1038/371119a0; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; Jenkinson DH, 2006, BRIT J PHARMACOL, V147, pS63, DOI 10.1038/sj.bjp.0706447; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Katsu T, 2007, ANAL SCI, V23, P517, DOI 10.2116/analsci.23.517; KENNEDY SJ, 1977, SCIENCE, V196, P1341, DOI 10.1126/science.867034; KENNEDY SJ, 1978, J MEMBRANE BIOL, V42, P265, DOI 10.1007/BF01870362; KENNER RA, 1971, BIOCHEMISTRY-US, V10, P4433, DOI 10.1021/bi00800a013; Kovacs F, 1999, P NATL ACAD SCI USA, V96, P7910, DOI 10.1073/pnas.96.14.7910; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000315; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Lee J, 2009, J PEPT SCI, V15, P601, DOI 10.1002/psc.1157; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; Marti T, 1998, J BIOL CHEM, V273, P9312, DOI 10.1074/jbc.273.15.9312; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Melnyk RA, 2002, J MOL BIOL, V315, P63, DOI 10.1006/jmbi.2001.5214; OBLATTMONTAL M, 1993, J BIOL CHEM, V268, P14601; OBLATTMONTAL M, 1995, PROTEIN SCI, V4, P1490, DOI 10.1002/pro.5560040806; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Ogielska EM, 1998, J GEN PHYSIOL, V112, P243, DOI 10.1085/jgp.112.2.243; OIKI S, 1988, P NATL ACAD SCI USA, V85, P2393, DOI 10.1073/pnas.85.7.2393; Pandey BK, 2011, BIOCHEM J, V436, P609, DOI 10.1042/BJ20110056; PAWLAK M, 1994, BIOCHEMISTRY-US, V33, P283, DOI 10.1021/bi00167a037; PeledZehavi H, 1996, BIOCHEMISTRY-US, V35, P6828, DOI 10.1021/bi952988t; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PONGS O, 1992, TRENDS PHARMACOL SCI, V13, P359, DOI 10.1016/0165-6147(92)90109-J; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; RAJARATHNAM K, 1989, BIOCHEMISTRY-US, V28, P3168, DOI 10.1021/bi00434a009; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; Rapaport D, 1996, BIOPHYS J, V70, P2502, DOI 10.1016/S0006-3495(96)79822-3; REDDY GL, 1993, J BIOL CHEM, V268, P14608; Rich TC, 2002, AM J PHYSIOL-CELL PH, V282, pC161, DOI 10.1152/ajpcell.00232.2001; Riquelme G, 2004, J BIOL CHEM, V279, P50601, DOI 10.1074/jbc.M407859200; RIZZO V, 1987, BIOCHEMISTRY-US, V26, P2751, DOI 10.1021/bi00384a015; ROOS N, 1982, BIOCHIM BIOPHYS ACTA, V686, P204, DOI 10.1016/0005-2736(82)90114-6; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; SCHWARZ G, 1989, BIOCHIM BIOPHYS ACTA, V979, P82, DOI 10.1016/0005-2736(89)90526-9; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; SCHWARZ G, 1987, BIOPHYS J, V52, P685, DOI 10.1016/S0006-3495(87)83263-0; SHAI Y, 1991, J BIOL CHEM, V266, P22346; SHINOZAKI K, 1994, BIOCHEM BIOPH RES CO, V198, P445, DOI 10.1006/bbrc.1994.1065; SPUHLER P, 1994, J BIOL CHEM, V269, P23904; Swartz KJ, 2005, J GEN PHYSIOL, V126, P413, DOI 10.1085/jgp.200509430; TAGLIALATELA M, 1994, J BIOL CHEM, V269, P13867; Thundimadathil J, 2005, BIOCHEM BIOPH RES CO, V330, P585, DOI 10.1016/j.bbrc.2005.02.184; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; TOSTESON MT, 1989, P NATL ACAD SCI USA, V86, P707, DOI 10.1073/pnas.86.2.707; Trauner D, 2003, ANGEW CHEM INT EDIT, V42, P5671, DOI 10.1002/anie.200301724; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Verma R, 2010, BBA-BIOMEMBRANES, V1798, P461, DOI 10.1016/j.bbamem.2009.12.014; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Yadav SP, 2007, BBA-BIOMEMBRANES, V1768, P1574, DOI 10.1016/j.bbamem.2007.03.019; Yadav SP, 2009, BBA-BIOMEMBRANES, V1788, P538, DOI 10.1016/j.bbamem.2008.11.013; Yadav SP, 2003, J BIOL CHEM, V278, P51023, DOI 10.1074/jbc.M310052200; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	106	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24828	24841		10.1074/jbc.M110.209676	http://dx.doi.org/10.1074/jbc.M110.209676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592970	Green Published, hybrid			2022-12-27	WOS:000292547900033
J	Zahn, KE; Tchesnokov, EP; Gotte, M; Doublie, S				Zahn, Karl E.; Tchesnokov, Egor P.; Goette, Matthias; Doublie, Sylvie			Phosphonoformic Acid Inhibits Viral Replication by Trapping the Closed Form of the DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; HUMAN CYTOMEGALOVIRUS RESISTANCE; ANTIVIRAL DRUGS; CRYSTAL-STRUCTURE; PHOSPHONOACETIC-ACID; FOSCARNET RESISTANCE; MULTIDRUG-RESISTANCE; BACTERIOPHAGE RB69; MUTATIONS; ALIGNMENT	Phosphonoformic acid (PFA, foscarnet) belongs to a class of antiviral drugs that inhibit the human cytomegalovirus DNA polymerase (UL54) by mimicking the pyrophosphate leaving group of the nucleotide transfer reaction. Difficulties expressing UL54 have hampered investigation of the precise structural requirements rendering inhibition by this drug. However, a previously engineered chimeric DNA polymerase, constructed by mutating the homologous polymerase from bacteriophage RB69 (gp43) to express several variable elements from UL54, can bypass this obstacle because of its favorable expression and acquired sensitivity to PFA (Tchesnokov, E. P., Obikhod, A., Schinazi, R. F., and Gotte, M. (2008) J. Biol. Chem. 283, 34218-34228). Here, we compare two crystal structures that depict the chimeric DNA polymerase with and without PFA bound. PFA is visualized for the first time in the active site of a DNA polymerase, where interactions are resolved between the PPi mimic and two basic residues absolutely conserved in the fingers domain of family B polymerases. PFA also chelates metal ion B, the cation that contacts the triphosphate tail of the incoming nucleotide. These DNA complexes utilize a primer-template pair enzymatically chain-terminated by incorporation of acyclo-GMP, the phosphorylated form of the anti-herpes drug acyclovir. We postulate that the V478W mutation present in the chimera is critical in that it pushes the fingers domain to more readily adopt the closed conformation whether or not the drug is bound. The closed state of the fingers domain traps the variant polymerase in the untranslocated state and increases affinity for PFA. This finding provides a model for the mechanism of UL54 stalling by PFA.	[Tchesnokov, Egor P.; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Zahn, Karl E.; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	McGill University; University of Vermont	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca; sdoublie@uvm.edu		Zahn, Karl/0000-0002-4865-2708; Doublie, Sylvie/0000-0002-6294-5304	National Institutes of Health [CA52040]; Canadian Institutes of Health Research; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Dept. of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA052040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Dept. of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA52040 (to S. D.). This work was also supported by a grant from the Canadian Institutes of Health Research (to M. G.). The beamline 23ID-B and the Advanced Photon Source were supported by National Cancer Institute Grant Y1-CO-1020, National Institute of General Medical Sciences Grant Y1-GM-1104, and U.S. Dept. of Energy, Basic Energy Sciences, Office of Science Contract DE-AC02-06CH11357.	Abou-Zeid KA, 2007, J FOOD PROTECT, V70, P2620, DOI 10.4315/0362-028X-70.11.2620; Baldanti F, 1996, J VIROL, V70, P1390, DOI 10.1128/JVI.70.3.1390-1395.1996; Baldanti F, 2003, J ANTIMICROB CHEMOTH, V52, P324, DOI 10.1093/jac/dkg354; Baldanti F, 2004, HUM IMMUNOL, V65, P403, DOI 10.1016/j.humimm.2004.02.007; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chou SW, 1998, J INFECT DIS, V178, P526, DOI 10.1086/515648; Chou SW, 1997, J INFECT DIS, V176, P786, DOI 10.1086/517302; Cihlar T, 1998, J VIROL, V72, P5927, DOI 10.1128/JVI.72.7.5927-5936.1998; De Clercq E, 2005, NAT REV DRUG DISCOV, V4, P928, DOI 10.1038/nrd1877; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garcia-Diaz M, 2007, DNA REPAIR, V6, P1333, DOI 10.1016/j.dnarep.2007.03.005; Gilbert C, 2002, DRUG RESIST UPDATE, V5, P88, DOI 10.1016/S1368-7646(02)00021-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Hogg M, 2010, BIOCHEMISTRY-US, V49, P2317, DOI 10.1021/bi901488d; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LERNER CW, 1984, MEDICINE, V63, P155, DOI 10.1097/00005792-198405000-00002; Li L, 2005, GENETICS, V170, P569, DOI 10.1534/genetics.104.040295; Liu SP, 2006, J BIOL CHEM, V281, P18193, DOI 10.1074/jbc.M602414200; Magee WC, 2008, ANTIMICROB AGENTS CH, V52, P586, DOI 10.1128/AAC.01172-07; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Mercorelli B, 2008, REV MED VIROL, V18, P177, DOI 10.1002/rmv.558; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REARDON JE, 1989, J BIOL CHEM, V264, P19039; REHAKRANTZ LJ, 1993, J VIROL, V67, P60, DOI 10.1128/JVI.67.1.60-66.1993; REHAKRANTZ LJ, 1994, J BIOL CHEM, V269, P5635; Rould MA, 1997, METHOD ENZYMOL, V276, P461, DOI 10.1016/S0076-6879(97)76072-5; Scott GM, 2007, ANTIMICROB AGENTS CH, V51, P89, DOI 10.1128/AAC.00633-06; Shi R, 2006, PROTEINS, V64, P301, DOI 10.1002/prot.21005; Smith IL, 1997, J INFECT DIS, V176, P69, DOI 10.1086/514041; SPECTOR SA, 1985, ANTIMICROB AGENTS CH, V27, P600, DOI 10.1128/AAC.27.4.600; STEIN M, 1994, TUMORI, V80, P216, DOI 10.1177/030089169408000310; Tchesnokov EP, 2009, J BIOL CHEM, V284, P26439, DOI 10.1074/jbc.M109.012500; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; Tchesnokov EP, 2006, J VIROL, V80, P1440, DOI 10.1128/JVI.80.3.1440-1450.2006; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x; Xu CL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000225; Zahn KE, 2007, BIOCHEMISTRY-US, V46, P10551, DOI 10.1021/bi7008807; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p	50	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25246	25255		10.1074/jbc.M111.248864	http://dx.doi.org/10.1074/jbc.M111.248864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21566148	hybrid, Green Published			2022-12-27	WOS:000292547900070
J	Peil, K; Varv, S; Looke, M; Kristjuhan, K; Kristjuhan, A				Peil, Kadri; Vaerv, Signe; Loeoke, Marko; Kristjuhan, Kersti; Kristjuhan, Arnold			Uniform Distribution of Elongating RNA Polymerase II Complexes in Transcribed Gene Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOMAL BARRIER; GENOME-WIDE; YEAST; INITIATION; REGION	The intensity of gene transcription is generally reflected by the level of RNA polymerase II (RNAPII) recruitment to the gene. However, genome-wide studies of polymerase occupancy indicate that RNAPII distribution varies among genes. In some loci more polymerases are found in the 5' region, whereas in other loci, in the 3' region of the gene. We studied the distribution of elongating RNAPII complexes at highly transcribed GAL-VPS13 locus in Saccharomyces cerevisiae and found that in the cell population the amount of polymerases gradually decreased toward the 3' end of the gene. However, the conventional chromatin immunoprecipitation assay averages the signal from the cell population, and no data on single cell level can be gathered. To study the spacing of elongating polymerases on single chromosomes, we used a sequential chromatin immunoprecipitation assay for the detection of multiple RNAPII complexes on the same DNA fragment. Our results demonstrate uniform distribution of elongating polymerases throughout all regions of the GAL-VPS13 gene.	[Peil, Kadri; Vaerv, Signe; Loeoke, Marko; Kristjuhan, Kersti; Kristjuhan, Arnold] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia	University of Tartu	Kristjuhan, A (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	arnoldk@ut.ee		Kristjuhan, Arnold/0000-0002-5842-4952	Wellcome Trust [081756]; European Molecular Biology Organization [1454]	Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by Wellcome Trust International Senior Research Fellowship Grant 081756 and European Molecular Biology Organization Installation Grant 1454.	Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Kim TS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r75; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Pelechano V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015442; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Varv S, 2007, BIOCHEM BIOPH RES CO, V358, P666, DOI 10.1016/j.bbrc.2007.05.003; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	28	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23817	23822		10.1074/jbc.M111.230805	http://dx.doi.org/10.1074/jbc.M111.230805			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606489	hybrid, Green Published			2022-12-27	WOS:000292294900024
J	Roy, S; Sun, Y; Pearlman, E				Roy, Sanhita; Sun, Yan; Pearlman, Eric			Interferon-gamma-induced MD-2 Protein Expression and Lipopolysaccharide (LPS) Responsiveness in Corneal Epithelial Cells Is Mediated by Janus Tyrosine Kinase-2 Activation and Direct Binding of STAT1 Protein to the MD-2 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; TLR4; ENDOTOXIN; COMPLEX; INFLAMMATION; RECOGNITION; INHIBITION; RESPONSES; SIGNALS	The inability of epithelial cells from the cornea and other tissues to respond to LPS is reportedly due to low expression of the TLR4 co-receptor MD-2. We generated MD-2(-/-) bone marrow chimeras, and showed that MD-2 expression on non-myeloid cells was sufficient to mediate LPS-induced corneal inflammation. As IFN-gamma is produced during Pseudomonas aeruginosa corneal infection, we examined the role of this cytokine on MD-2 expression by primary human corneal epithelial (HCE) cells and HCE cell lines. Exogenous IFN-gamma was found to induce MD-2 mRNA, MD-2 cell surface expression, and LPS responsiveness as determined by p65 translocation to the nucleus and production of IL-6, CXCL1, and CXCL8/IL-8. Incubation with either the AG490 JAK2 inhibitor or with STAT1 siRNA blocked STAT1 phosphorylation and MD-2 transcription. Furthermore, EMSA analysis demonstrated that STAT1 binds to the MD-2 promoter, indicating that STAT1 is an MD-2 transcription factor. Together, these findings demonstrate that IFN-gamma induces MD-2 expression and LPS responsiveness in HCE cells by JAK-2-dependent STAT1 activation and direct binding to the MD-2 promoter. Furthermore, given our findings on LPS-induced corneal inflammation, it is likely that IFN-gamma-induced MD-2 expression by corneal epithelial cells contributes to the host response in vivo, determining the extent of tissue damage and bacterial clearance.	[Roy, Sanhita; Sun, Yan; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44095 USA	Case Western Reserve University	Pearlman, E (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44095 USA.	Eric.Pearlman@case.edu		ROY, SANHITA/0000-0002-0407-8177	National Institutes of Health [RO1EY14362, P30EY11373]; The Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; Alcon Research Institute; NATIONAL EYE INSTITUTE [P30EY011373, R01EY014362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; Alcon Research Institute(Novartis); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1EY14362 and P30EY11373 (both to E. P.). Additional support was provided by The Research to Prevent Blindness Foundation and the Ohio Lions Eye Research Foundation.; Recipient of an Alcon Research Institute award. To whom correspondence should be addressed: Dept. of Ophthalmology and Visual Sciences, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44095. E-mail: Eric.Pearlman@case.edu.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Adhikary G, 2008, J LEUKOCYTE BIOL, V83, P991, DOI 10.1189/jlb.1107783; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Chinnery HR, 2007, INVEST OPHTH VIS SCI, V48, P1568, DOI 10.1167/iovs.06-0746; Chinnery HR, 2009, J IMMUNOL, V182, P2738, DOI 10.4049/jimmunol.0803505; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hazlett LD, 2007, J IMMUNOL, V179, P1138, DOI 10.4049/jimmunol.179.2.1138; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Knickelbein JE, 2009, OPHTHALMOL EYE DIS, V1, P45; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Malemud CJ, 2009, CURR SIGNAL TRANSD T, V4, P201, DOI 10.2174/157436209789057467; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rossignol DP, 2002, J ENDOTOXIN RES, V8, P483, DOI 10.1179/096805102125001127; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Sun Y, 2009, INVEST OPHTH VIS SCI, V50, P1247, DOI 10.1167/iovs.08-2628; Talreja J, 2005, INFLAMMATION, V29, P170, DOI 10.1007/s10753-006-9014-y; Uehara A, 2002, J MED MICROBIOL, V51, P626, DOI 10.1099/0022-1317-51-8-626; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; Ueta M, 2004, J IMMUNOL, V173, P3337, DOI 10.4049/jimmunol.173.5.3337; Vamadevan AS, 2010, INNATE IMMUN-LONDON, V16, P93, DOI 10.1177/1753425909339231; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219; Zhang J, 2009, IMMUNOL CELL BIOL, V87, P141, DOI 10.1038/icb.2008.75	41	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23753	23762		10.1074/jbc.M111.219345	http://dx.doi.org/10.1074/jbc.M111.219345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572044	Green Published, hybrid			2022-12-27	WOS:000292294900017
J	Springauf, A; Bresenitz, P; Grunder, S				Springauf, Andreas; Bresenitz, Pia; Gruender, Stefan			The Interaction between Two Extracellular Linker Regions Controls Sustained Opening of Acid-sensing Ion Channel 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL-NEURONS; ACTIVATED CURRENTS; SENSORY NEURONS; DESENSITIZATION; PH; ION-CHANNEL-1; ASIC1; PAIN; CONTRIBUTES	Activation of acid-sensing ion channels (ASICs) contributes to neuronal death during stroke, to axonal degeneration during neuroinflammation, and to pain during inflammation. Although understanding ASIC gating may help to modulate ASIC activity during these pathologic situations, at present it is poorly understood. The ligand, H+, probably binds to several sites, among them amino acids within the large extracellular domain. The extracellular domain is linked to the two transmembrane domains by the wrist region that is connected to two anti-parallel beta-strands, beta 1 and beta 12. Thus, the wrist region together with those beta-strands may have a crucial role in transmitting ligand binding to pore opening and closing. Here we show that amino acids in the beta 1-beta 2 linker determine constitutive opening of ASIC1b from shark. The most crucial residue within the beta 1-beta 2 linker (Asp(110)), when mutated from aspartate to cysteine, can be altered by cysteine-modifying reagents much more readily when channels are closed than when they are desensitized. Finally, engineering of a cysteine at position 110 and at an adjacent position in the beta 11-beta 12 linker leads to spontaneous formation of a disulfide bond that traps the channel in the desensitized conformation. Collectively, our results suggest that the beta 1-beta 2 and beta 11-beta 12 linkers are dynamic during gating and tightly appose to each other during desensitization gating. Hindrance of this tight apposition leads to reopening of the channel. It follows that the beta 1-beta 2 and beta 11-beta 12 linkers modulate gating movements of ASIC1 and may thus be drug targets to modulate ASIC activity.	[Springauf, Andreas; Bresenitz, Pia; Gruender, Stefan] Rhein Westfal TH Aachen, Dept Physiol, D-52074 Aachen, Germany	RWTH Aachen University	Grunder, S (corresponding author), Rhein Westfal TH Aachen, Dept Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	sgruender@ukaachen.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883	Deutsche Forschungsgemeinschaft [GR1771/3-5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GR1771/3-5 (to S. G.).	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 1999, CIRC RES, V84, P921; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Madeja M, 1995, J NEUROSCI METH, V63, P211, DOI 10.1016/0165-0270(95)00094-1; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sluka KA, 2009, CURR OPIN DRUG DISC, V12, P693; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Vukicevic M, 2004, AM J PHYSIOL-CELL PH, V287, pC682, DOI 10.1152/ajpcell.00127.2004; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	34	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24374	24384		10.1074/jbc.M111.230797	http://dx.doi.org/10.1074/jbc.M111.230797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576243	Green Published, hybrid			2022-12-27	WOS:000292294900077
J	Mizutani, A; Koinuma, D; Tsutsumi, S; Kamimura, N; Morikawa, M; Suzuki, HI; Imamura, T; Miyazono, K; Aburatani, H				Mizutani, Anna; Koinuma, Daizo; Tsutsumi, Shuichi; Kamimura, Naoko; Morikawa, Masato; Suzuki, Hiroshi I.; Imamura, Takeshi; Miyazono, Kohei; Aburatani, Hiroyuki			Cell Type-specific Target Selection by Combinatorial Binding of Smad2/3 Proteins and Hepatocyte Nuclear Factor 4 alpha in HepG2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-BINDING; TGF-BETA; GENE-EXPRESSION; CHIP-CHIP; MESODERM INDUCERS; EPITHELIAL-CELLS; ORPHAN RECEPTOR; DOWN-REGULATION; TILING-ARRAYS; HOMEOBOX GENE	Specific regulation of target genes by transforming growth factor-beta (TGF-beta) in a given cellular context is determined in part by transcription factors and cofactors that interact with the Smad complex. In this study, we determined Smad2 and Smad3 (Smad2/3) binding regions in the promoters of known genes in HepG2 hepatoblastoma cells, and we compared them with those in HaCaT epidermal keratinocytes to elucidate the mechanisms of cell type- and context-dependent regulation of transcription induced by TGF-beta. Our results show that 81% of the Smad2/3 binding regions in HepG2 cells were not shared with those found in HaCaT cells. Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is expressed in HepG2 cells but not in HaCaT cells, and the HNF4 alpha-binding motif was identified as an enriched motif in the HepG2-specific Smad2/3 binding regions. Chromatin immunoprecipitation sequencing analysis of HNF4 alpha binding regions under TGF-beta stimulation revealed that 32.5% of the Smad2/3 binding regions overlapped HNF4 alpha bindings. MIXL1 was identified as a new combinatorial target of HNF4 alpha and Smad2/3, and both the HNF4 alpha protein and its binding motif were required for the induction of MIXL1 by TGF-beta in HepG2 cells. These findings generalize the importance of binding of HNF4 alpha on Smad2/3 binding genomic regions for HepG2-specific regulation of transcription by TGF-beta and suggest that certain transcription factors expressed in a cell type-specific manner play important roles in the transcription regulated by the TGF-beta-Smad signaling pathway.	[Mizutani, Anna; Koinuma, Daizo; Morikawa, Masato; Suzuki, Hiroshi I.; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Tsutsumi, Shuichi; Kamimura, Naoko; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, Tokyo 1358550, Japan	University of Tokyo; University of Tokyo; Japanese Foundation for Cancer Research	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	Morikawa, Masato/D-1932-2011; Koinuma, Daizo/Y-8716-2018	Morikawa, Masato/0000-0002-6191-7176; Koinuma, Daizo/0000-0001-5611-2122; Suzuki, Hiroshi/0000-0003-4682-5086	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20221009, 22112002]; Japan Society for the Promotion of Science; Ishidsu Shun Memorial Scholarship	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ishidsu Shun Memorial Scholarship	This work was supported by KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas, Integrative Research on Cancer Microenvironment Network, 22112002 (to K. M.) Grants-in-Aid for Scientific Research (S) 20221009 (to H. A.) and for Young Scientists (B) 10014456 (to D. K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Genome Network Project from Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. A.), and the Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Japan Society for the Promotion of Science.; Supported by an Ishidsu Shun Memorial Scholarship.	Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chou WC, 2003, MOL BIOL CELL, V14, P1279, DOI 10.1091/mbc.E02-07-0375; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; de Boussac H, 2010, J BIOL CHEM, V285, P22798, DOI 10.1074/jbc.M110.105593; Ecochard V, 1998, DEVELOPMENT, V125, P2577; Eeckhoute J, 2009, METHODS MOL BIOL, V556, P155, DOI 10.1007/978-1-60327-192-9_11; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ganjam GK, 2009, J BIOL CHEM, V284, P30783, DOI 10.1074/jbc.M109.045260; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hart AH, 2005, BIOCHEM BIOPH RES CO, V333, P1361, DOI 10.1016/j.bbrc.2005.06.044; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ho JWK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-134; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Ishikawa F, 2008, EXP CELL RES, V314, P2131, DOI 10.1016/j.yexcr.2008.03.013; Izzi L, 2007, EMBO J, V26, P3132, DOI 10.1038/sj.emboj.7601753; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; JIANG GQ, 1995, MOL CELL BIOL, V15, P5131; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kaneshiro K, 2007, GENOMICS, V89, P178, DOI 10.1016/j.ygeno.2006.09.001; Kardassis D, 2000, J BIOL CHEM, V275, P41405, DOI 10.1074/jbc.M007896200; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Koinuma D, 2009, CANCER SCI, V100, P2133, DOI 10.1111/j.1349-7006.2009.01299.x; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; LUCAS SS, 2004, BIOCHEM BIOPH RES CO, V321, P688, DOI DOI 10.1016/J.BBRC.2004.07.025]; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mizutani A, 2010, J BIOCHEM, V148, P733, DOI 10.1093/jb/mvq127; Mosialou I, 2010, J BIOL CHEM, V285, P30719, DOI 10.1074/jbc.M110.131771; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; ROSA FM, 1989, CELL, V57, P965, DOI 10.1016/0092-8674(89)90335-8; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Taylor DG, 1996, NUCLEIC ACIDS RES, V24, P2930, DOI 10.1093/nar/24.15.2930; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Vize PD, 1996, DEV BIOL, V177, P226, DOI 10.1006/dbio.1996.0158; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	60	37	39	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29848	29860		10.1074/jbc.M110.217745	http://dx.doi.org/10.1074/jbc.M110.217745			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21646355	hybrid, Green Published			2022-12-27	WOS:000294046600044
J	Deisenroth, C; Itahana, Y; Tollini, L; Jin, AW; Zhang, YP				Deisenroth, Chad; Itahana, Yoko; Tollini, Laura; Jin, Aiwen; Zhang, Yanping			p53-inducible DHRS3 Is an Endoplasmic Reticulum Protein Associated with Lipid Droplet Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; STELLATE CELLS; P53; ADIPOGENESIS; EXPRESSION; RETINOL; ENZYMES; DIFFERENTIATION; GENE	The transcription factor p53 plays a critical role in maintaining homeostasis as it relates to cellular growth, proliferation, and metabolism. In an effort to identify novel p53 target genes, a microarray approach was utilized to identify DHRS3 (also known as retSDR1) as a robust candidate gene. DHRS3 is a highly conserved member of the short chain alcohol dehydrogenase/reductase superfamily with a reported role in lipid and retinoid metabolism. Here, we demonstrate that DHRS3 is an endoplasmic reticulum (ER) protein that is shuttled to the ER via an N-terminal endoplasmic reticulum targeting signal. One important function of the ER is synthesis of neutral lipids that are packaged into lipid droplets whose biogenesis occurs from ER-derived membranes. DHRS3 is enriched at focal points of lipid droplet budding where it also localizes to the phospholipid monolayer of ER-derived lipid droplets. p53 promotes lipid droplet accumulation in a manner consistent with DHRS3 enrichment in the ER. As a p53 target gene, the observations of Dhrs3 location and potential function provide novel insight into an unexpected role for p53 in lipid droplet dynamics with implications in cancer cell metabolism and obesity.	[Deisenroth, Chad; Itahana, Yoko; Tollini, Laura; Jin, Aiwen; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Deisenroth, Chad; Itahana, Yoko; Tollini, Laura; Jin, Aiwen; Zhang, Yanping] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tollini, Laura] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhang, YP (corresponding author), Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA.	ypzhang@med.unc.edu			National Institutes of Health; American Cancer Society [2R01-CA100302, 1R01-CA127770, 1RC2CA148487-01]; NATIONAL CANCER INSTITUTE [R01CA127770, RC2CA148487, R01CA100302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the National Institutes of Health and the American Cancer Society (2R01-CA100302, 1R01-CA127770, and 1RC2CA148487-01, to Y.Z.).	Barba I, 1999, CANCER RES, V59, P1861; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Cerignoli F, 2002, CANCER RES, V62, P1196; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2006, J GASTROEN HEPATOL, V21, pS79, DOI 10.1111/j.1440-1746.2006.04585.x; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kam RKT, 2010, INT J DEV BIOL, V54, P1355, DOI 10.1387/ijdb.092984rk; Kamei N, 2009, PEDIATR SURG INT, V25, P931, DOI 10.1007/s00383-009-2448-1; Kirschner RD, 2010, CELL CYCLE, V9, P2177, DOI 10.4161/cc.9.11.11844; Kondoh H, 2005, CANCER RES, V65, P177; Korotchkina LG, 2009, CELL CYCLE, V8, P3777, DOI 10.4161/cc.8.22.10121; Lefebvre P, 2005, VITAM HORM, V70, P199, DOI 10.1016/S0083-6729(05)70007-8; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Moise AR, 2004, J BIOL CHEM, V279, P50230, DOI 10.1074/jbc.M409130200; MORIWAKI H, 1988, J LIPID RES, V29, P1523; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Okuno M, 2002, FRONT BIOSCI-LANDMRK, V7, pD204, DOI 10.2741/okuno; Oler G, 2008, CLIN CANCER RES, V14, P4735, DOI 10.1158/1078-0432.CCR-07-4372; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Ramsby ML, 1999, METH MOL B, V112, P53; Schupp M, 2009, P NATL ACAD SCI USA, V106, P1105, DOI 10.1073/pnas.0812065106; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Staab CA, 2008, CELL MOL LIFE SCI, V65, P3653, DOI 10.1007/s00018-008-8554-8; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	42	43	44	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28343	28356		10.1074/jbc.M111.254227	http://dx.doi.org/10.1074/jbc.M111.254227			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659514	Green Published, hybrid			2022-12-27	WOS:000293557800051
J	Liu, ZT; Lin, XW; Cai, ZP; Zhang, ZQ; Han, CS; Jia, SJ; Meng, AM; Wang, Q				Liu, Zhaoting; Lin, Xiwen; Cai, Zhaoping; Zhang, Zhuqiang; Han, Chunsheng; Jia, Shunji; Meng, Anming; Wang, Qiang			Global Identification of SMAD2 Target Genes Reveals a Role for Multiple Co-regulatory Factors in Zebrafish Early Gastrulas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-EYED-PINHEAD; TGF-BETA; MESODERM INDUCTION; SIGNALS; CATENIN; EMBRYOS; DORSAL; DROSOPHILA; DIFFERENTIATION; NORMALIZATION	Nodal and Smad2/3 signals play pivotal roles in mesendoderm induction and axis determination during late blastulation and early gastrulation in vertebrate embryos. However, Smad2/3 direct target genes during those critical developmental stages have not been systematically identified. Here, through ChIP-chip assay, we show that the promoter/enhancer regions of 679 genes are bound by Smad2 in the zebrafish early gastrulas. Expression analyses confirm that a significant proportion of Smad2 targets are indeed subjected to Nodal/Smad2 regulation at the onset of gastrulation. The co-existence of DNA-binding sites of other transcription factors in the Smad2-bound regions allows the identification of well known Smad2-binding partners, such as FoxH1 and Lef1/beta-catenin, as well as many previously unknown Smad2 partners, including Oct1 and Gata6, during embryogenesis. We demonstrate that Oct1 physically associates with and enhances the transcription and mesendodermal induction activity of Smad2, whereas Gata6 exerts an inhibitory role in Smad2 signaling and mesendodermal induction. Thus, our study systemically uncovers a large number of Smad2 targets in early gastrulas and suggests cooperative roles of Smad2 and other transcription factors in controlling target gene transcription, which will be valuable for studying regulatory cascades during germ layer formation and patterning of vertebrate embryos.	[Liu, Zhaoting; Cai, Zhaoping; Meng, Anming; Wang, Qiang] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Lin, Xiwen; Zhang, Zhuqiang; Han, Chunsheng] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Jia, Shunji; Meng, Anming] Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 10084, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Tsinghua University	Meng, AM (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China.	mengam@mail.tsinghua.edu.cn; qiangwang@ioz.ac.cn	Meng, Anming/A-4785-2012; Zhang, Zhuqiang/P-7329-2019	Zhang, Zhuqiang/0000-0001-6513-2854; Meng, Anming/0000-0001-7228-3431; Wang, Qiang/0000-0002-8735-8771	National Basic Research Program of China [2011CB943904, 2011CB943800]; Chinese Academy of Sciences [XDA01010104]; National Natural Science Foundation of China [90919058, 30830068, 30921004/C061003]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2011CB943904 and 2011CB943800, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010104, and the National Natural Science Foundation of China Grants 90919058, 30830068, and 30921004/C061003.	Agius E, 2000, DEVELOPMENT, V127, P1173; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bennett JT, 2007, DEV BIOL, V304, P525, DOI 10.1016/j.ydbio.2007.01.012; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; CONLON FL, 1994, DEVELOPMENT, V120, P1919; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Dick A, 2000, GENE, V246, P69, DOI 10.1016/S0378-1119(00)00056-1; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Fan X, 2007, DEV BIOL, V310, P363, DOI 10.1016/j.ydbio.2007.08.008; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; IANNACCONE PM, 1992, DEV DYNAM, V194, P198, DOI 10.1002/aja.1001940305; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Jia SJ, 2009, DEV BIOL, V333, P273, DOI 10.1016/j.ydbio.2009.06.037; KANE DA, 1993, DEVELOPMENT, V119, P447; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Li M, 2001, CHINESE SCI BULL, V46, P1523, DOI 10.1007/BF02900572; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Marstrand TT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001623; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Seiliez I, 2006, DEV BIOL, V290, P152, DOI 10.1016/j.ydbio.2005.11.021; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Sun ZH, 2007, PROG BIOCHEM BIOPHYS, V34, P595; Sun ZH, 2006, BIOCHEM BIOPH RES CO, V345, P694, DOI 10.1016/j.bbrc.2006.04.148; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Watanabe M, 2002, DEV DYNAM, V225, P448, DOI 10.1002/dvdy.10176; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	70	43	46	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28520	28532		10.1074/jbc.M111.236307	http://dx.doi.org/10.1074/jbc.M111.236307			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669877	hybrid, Green Published			2022-12-27	WOS:000293557800067
J	da Silva, TC; Hussainzada, N; Khantwal, CM; Polli, JE; Swaan, PW				da Silva, Tatiana Claro; Hussainzada, Naissan; Khantwal, Chandra M.; Polli, James E.; Swaan, Peter W.			Transmembrane Helix 1 Contributes to Substrate Translocation and Protein Stability of Bile Acid Transporter SLC10A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAINS; FAMILY SLC10; RESIDUES; NA+; COTRANSPORTER; CHOLESTEROL; MUTAGENESIS; TRAFFICKING; CHAPERONES; INHIBITOR	The human apical sodium-dependent bile acid transporter (hASBT, SLC10A2) plays a critical role in the enterohepatic circulation of bile acids, as well as in cholesterol homeostasis. ASBT reclaims bile acids from the distal ileum via active sodium co-transport, in a multistep process, orchestrated by key residues in exofacial loop regions, as well as in membrane-spanning helices. Here, we unravel the functional contribution of highly conserved transmembrane helix 1 (TM1) on the hASBT transport cycle. Consecutive cysteine substitution of individual residues along the TM1 helix (Ile(29)-Gly(50)), as well as exofacial Asn(27) and Asn(28), resulted in functional impairment of similar to 70% of mutants, despite appreciable cell surface expression for all but G50C. Cell surface expression of G50C and G50A was rescued upon MG132 treatment as well as cyclosporine A, but not by FK506 or bile acids, suggesting that Gly(50) is involved in hASBT folding. TM1 accessibility to membrane-impermeant MTSET remains confined to the exofacial half of the helix along a single, discrete face. Substrate protection from MTSET labeling was temperature-dependent for L34C, T36C, and L38C, consistent with conformational changes playing a role in solvent accessibility for these mutants. Residue Leu(30) was shown to be critical for both bile acid and sodium affinity, while Asn(27), Leu(38), Thr(39), and Met(46) participate in sodium co-transport. Combined, our data demonstrate that TM1 plays a pivotal role in ASBT function and stability, thereby providing further insight in its dynamic transport mechanism.	[da Silva, Tatiana Claro; Hussainzada, Naissan; Khantwal, Chandra M.; Polli, James E.; Swaan, Peter W.] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Swaan, PW (corresponding author), 20 Penn St, Baltimore, MD 21201 USA.	pswaan@rx.umaryland.edu		Swaan, Peter/0000-0003-1767-1487	National Institutes of Health [NIDDK DK061425, DK067530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067530, R01DK061425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants NIDDK DK061425 (to P. W. S.) and DK067530 (to J. E. P.) from the National Institutes of Health.	Absalom NL, 2009, NEUROCHEM RES, V34, P1805, DOI 10.1007/s11064-009-9971-2; Balakrishnan A, 2006, MOL PHARMACEUT, V3, P223, DOI 10.1021/mp060022d; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P943, DOI 10.1021/bi052202j; Banerjee A, 2005, BIOCHEMISTRY-US, V44, P8908, DOI 10.1021/bi050553s; Banerjee A, 2008, BIOCHEM J, V410, P391, DOI 10.1042/BJ20071300; Bergheim I, 2006, J LIPID RES, V47, P42, DOI 10.1194/jlr.M500215-JLR200; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Huff MW, 2002, ARTERIOSCL THROM VAS, V22, P1884, DOI 10.1161/01.ATV.0000035390.87288.26; Hussainzada N, 2008, J BIOL CHEM, V283, P20653, DOI 10.1074/jbc.M802885200; Hussainzada N, 2008, MOL PHARMACOL, V73, P305, DOI 10.1124/mol.107.041640; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; Hussainzada N, 2009, BIOCHEMISTRY-US, V48, P8528, DOI 10.1021/bi900616w; Ivery MTG, 2000, MED RES REV, V20, P452, DOI 10.1002/1098-1128(200011)20:6<452::AID-MED2>3.0.CO;2-6; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Kagedahl M, 1997, PHARM RES-DORDR, V14, P176, DOI 10.1023/A:1012044526054; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Khantwal CM, 2008, BIOCHEMISTRY-US, V47, P3606, DOI 10.1021/bi702498w; Kitayama K, 2006, EUR J PHARMACOL, V539, P89, DOI 10.1016/j.ejphar.2006.04.005; Kosters A, 2008, XENOBIOTICA, V38, P1043, DOI [10.1080/00498250802040584, 10.1080/00498250802040584 ]; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Ray A, 2006, BIOORG MED CHEM LETT, V16, P1473, DOI 10.1016/j.bmcl.2005.12.050; Saeki T, 2009, BIOSCI BIOTECH BIOCH, V73, P1535, DOI 10.1271/bbb.90023; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Sun AQ, 2006, J BIOL CHEM, V281, P16410, DOI 10.1074/jbc.M600034200; Tolle-Sander S, 2004, MOL PHARMACEUT, V1, P40, DOI 10.1021/mp034010t; TUCHSEN E, 1987, BIOCHEMISTRY-US, V26, P1918, DOI 10.1021/bi00381a020; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200; Zhang EY, 2004, BIOCHEMISTRY-US, V43, P11380, DOI 10.1021/bi049270a; Zhang Qiang, 2011, Int J Biochem Mol Biol, V2, P31	35	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27322	27332		10.1074/jbc.M110.217802	http://dx.doi.org/10.1074/jbc.M110.217802			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646357	hybrid, Green Published			2022-12-27	WOS:000293268700028
J	Minano-Molina, AJ; Espana, J; Martin, E; Barneda-Zahonero, B; Fado, R; Sole, M; Trullas, R; Saura, CA; Rodriguez-Alvarez, J				Minano-Molina, Alfredo J.; Espana, Judit; Martin, Elsa; Barneda-Zahonero, Bruna; Fado, Rut; Sole, Montse; Trullas, Ramon; Saura, Carlos A.; Rodriguez-Alvarez, Jose			Soluble Oligomers of Amyloid-beta Peptide Disrupt Membrane Trafficking of alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Contributing to Early Synapse Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; AMPA-RECEPTORS; ALZHEIMERS-DISEASE; PKA PHOSPHORYLATION; PERISYNAPTIC SITES; SECRETED OLIGOMERS; MOLECULAR-BASIS; PROTEIN-KINASE; IN-VIVO; PLASTICITY	beta-Amyloid (A beta), a peptide generated from the amyloid precursor protein, is widely believed to underlie the pathophysiology of Alzheimer disease (AD). Emerging evidences suggest that soluble A beta oligomers adversely affect synaptic function, leading to cognitive failure associated with AD. The A beta-induced synaptic dysfunction has been attributed to the synaptic removal of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors (AMPARs). However, the molecular mechanisms underlying the loss of AMPAR induced by A beta at synapses are largely unknown. In this study we have examined the effect of A beta oligomers on phosphorylated GluA1 at serine 845, a residue that plays an essential role in the trafficking of AMPARs toward extrasynaptic sites and the subsequent delivery to synapses during synaptic plasticity events. We found that A beta oligomers reduce basal levels of Ser-845 phosphorylation and surface expression of AMPARs affecting AMPAR subunit composition. A beta-induced GluA1 dephosphorylation and reduced receptor surface levels are mediated by an increase in calcium influx into neurons through ionotropic glutamate receptors and activation of the calcium-dependent phosphatase calcineurin. Moreover, A beta oligomers block the extrasynaptic delivery of AMPARs induced by chemical synaptic potentiation. In addition, reduced levels of total and phosphorylated GluA1 are associated with initial spatial memory deficits in a transgenic mouse model of AD. These findings indicate that A beta oligomers could act as a synaptic depressor affecting the mechanisms involved in the targeting of AMPARs to the synapses during early stages of the disease.	[Minano-Molina, Alfredo J.; Espana, Judit; Martin, Elsa; Barneda-Zahonero, Bruna; Fado, Rut; Sole, Montse; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Minano-Molina, Alfredo J.; Espana, Judit; Martin, Elsa; Barneda-Zahonero, Bruna; Fado, Rut; Sole, Montse; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Minano-Molina, Alfredo J.; Espana, Judit; Martin, Elsa; Fado, Rut; Trullas, Ramon; Saura, Carlos A.; Rodriguez-Alvarez, Jose] CSIC, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08036, Spain; [Trullas, Ramon] CSIC, Inst Invest Biomed Barcelona, Barcelona 08036, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona	Rodriguez-Alvarez, J (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M,Campus Bellaterra, E-08193 Barcelona, Spain.	jose.rodriguez@uab.es	Piñol, Montse Solé/D-1133-2011; Andrés, Fadó Fadó/L-8585-2014; Rodriguez-Alvarez, Jose/F-8403-2011; Saura, Carlos A/D-2727-2011; Miñano-Molina, Alfredo J/C-9863-2011; Saura, Carlos A/AFM-9239-2022; Trullas, Ramon/D-2197-2016	Piñol, Montse Solé/0000-0003-4240-6562; Andrés, Fadó Fadó/0000-0002-3293-2342; Rodriguez-Alvarez, Jose/0000-0001-8582-8082; Saura, Carlos A/0000-0003-3692-5657; Miñano-Molina, Alfredo J/0000-0002-7761-5682; Trullas, Ramon/0000-0001-7951-9881; Barneda Zahonero, Bruna/0000-0002-6557-5222	Ministerio de Ciencia e Innovacion [SAF2008-01904, SAF2010-20925]; RENEVAS [RD06/0026/1009]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas [CB06/05/0042]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); RENEVAS(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas	This work was supported by the Ministerio de Ciencia e Innovacion (Grants SAF2008-01904 to J. R. A. and SAF2010-20925 to C. A. S.), by RENEVAS (Grant RD06/0026/1009 to J. R. A.), and by the Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (Grant CB06/05/0042 to J. R. A.).	Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cullen WK, 1996, NEUROREPORT, V8, P87, DOI 10.1097/00001756-199612200-00018; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Espana J, 2010, J NEUROSCI, V30, P9402, DOI 10.1523/JNEUROSCI.2154-10.2010; Espana J, 2010, BIOL PSYCHIAT, V67, P513, DOI 10.1016/j.biopsych.2009.06.015; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Estus S, 1997, J NEUROSCI, V17, P7736; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Liu SJ, 2010, J ALZHEIMERS DIS, V21, P655, DOI 10.3233/JAD-2010-091654; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Szegedi V, 2005, BRAIN RES, V1062, P120, DOI 10.1016/j.brainres.2005.09.014; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	57	78	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27311	27321		10.1074/jbc.M111.227504	http://dx.doi.org/10.1074/jbc.M111.227504			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21665950	Green Published, hybrid			2022-12-27	WOS:000293268700027
J	Saunders, EC; Ng, WW; Chambers, JM; Ng, M; Naderer, T; Kromer, JO; Likic, VA; McConville, MJ				Saunders, Eleanor C.; Ng, William W.; Chambers, Jennifer M.; Ng, Milica; Naderer, Thomas; Kroemer, Jens O.; Likic, Vladimir A.; McConville, Malcolm J.			Isotopomer Profiling of Leishmania mexicana Promastigotes Reveals Important Roles for Succinate Fermentation and Aspartate Uptake in Tricarboxylic Acid Cycle (TCA) Anaplerosis, Glutamate Synthesis, and Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCYCLIC TRYPANOSOMA-BRUCEI; PHOSPHOGLYCERATE KINASE GENES; CARBON METABOLISM; ENERGY-METABOLISM; CARBOHYDRATE-METABOLISM; GLUCOSE-METABOLISM; KREBS CYCLE; VIRULENCE; AMASTIGOTES; PARASITES	Leishmania parasites proliferate within nutritionally complex niches in their sandfly vector and mammalian hosts. However, the extent to which these parasites utilize different carbon sources remains poorly defined. In this study, we have followed the incorporation of various C-13-labeled carbon sources into the intracellular and secreted metabolites of Leishmania mexicana promastigotes using gas chromatography-mass spectrometry and C-13 NMR. [U-C-13] Glucose was rapidly incorporated into intermediates in glycolysis, the pentose phosphate pathway, and the cytoplasmic carbohydrate reserve material, mannogen. Enzymes involved in the upper glycolytic pathway are sequestered within glycosomes, and the ATP and NAD(+) consumed by these reactions were primarily regenerated by the fermentation of phosphoenolpyruvate to succinate( glycosomal succinate fermentation). The initiating enzyme in this pathway, phosphoenolpyruvate carboxykinase, was exclusively localized to the glycosome. Although some of the glycosomal succinate was secreted, most of the C4 dicarboxylic acids generated during succinate fermentation were further catabolized in the TCA cycle. A high rate of TCA cycle anaplerosis was further suggested by measurement of [U-C-13] aspartate and [U-C-13] alanine uptake and catabolism. TCA cycle anaplerosis is apparently needed to sustain glutamate production under standard culture conditions. Specifically, inhibition of mitochondrial aconitase with sodium fluoroacetate resulted in the rapid depletion of intracellular glutamate pools and growth arrest. Addition of high concentrations of exogenous glutamate alleviated this growth arrest. These findings suggest that glycosomal and mitochondrial metabolism in Leishmania promastigotes is tightly coupled and that, in contrast to the situation in some other trypanosomatid parasites, the TCA cycle has crucial anabolic functions.	[Saunders, Eleanor C.; Ng, William W.; Chambers, Jennifer M.; Ng, Milica; Naderer, Thomas; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Saunders, Eleanor C.; Ng, William W.; Chambers, Jennifer M.; Ng, Milica; Naderer, Thomas; Likic, Vladimir A.; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Parkville, Vic 3010, Australia; [Kroemer, Jens O.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia	University of Melbourne; University of Melbourne; University of Queensland	McConville, MJ (corresponding author), 30 Flemington Rd, Parkville, Vic 3010, Australia.	malcolmm@unimelb.edu.au	Krömer, Jens O./C-5958-2009	Krömer, Jens O./0000-0001-5006-0819; Saunders, Eleanor/0000-0002-3247-8522; Naderer, Thomas/0000-0003-2691-0283	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council.	Adje CA, 1997, MOL BIOCHEM PARASIT, V90, P155, DOI 10.1016/S0166-6851(97)00152-7; BALOGUN RA, 1974, COMP BIOCHEM PHYSIOL, V49, P215, DOI 10.1016/0300-9629(74)90110-8; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Chavali AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.15; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Coustou V, 2006, J BIOL CHEM, V281, P26832, DOI 10.1074/jbc.M601377200; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; De Souza DP, 2006, BIOINFORMATICS, V22, P1391, DOI 10.1093/bioinformatics/btl085; Dey R, 2010, MOL MICROBIOL, V77, P399, DOI 10.1111/j.1365-2958.2010.07214.x; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; Doyle MA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-57; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Guerra DG, 2006, MOL BIOCHEM PARASIT, V149, P155, DOI 10.1016/j.molbiopara.2006.05.006; HANNAERT V, 1992, MOL BIOCHEM PARASIT, V55, P115, DOI 10.1016/0166-6851(92)90132-4; HART DT, 1982, EXP PARASITOL, V54, P397, DOI 10.1016/0014-4894(82)90049-2; Leroux AE, 2011, MOL BIOCHEM PARASIT, V177, P61, DOI 10.1016/j.molbiopara.2011.01.010; Lutz NW, 1996, MAGNET RESON MED, V36, P788, DOI 10.1002/mrm.1910360519; Marciano D, 2009, MOL BIOCHEM PARASIT, V166, P172, DOI 10.1016/j.molbiopara.2009.04.001; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Mazareb S, 1999, EXP PARASITOL, V91, P341, DOI 10.1006/expr.1998.4391; McKoy G, 1997, MOL BIOCHEM PARASIT, V90, P169, DOI 10.1016/S0166-6851(97)00172-2; Merlen T, 1999, AM J TROP MED HYG, V60, P41, DOI 10.4269/ajtmh.1999.60.41; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; MOTTRAM JC, 1985, EXP PARASITOL, V59, P265, DOI 10.1016/0014-4894(85)90081-5; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Naderer T, 2008, MOL MICROBIOL, V69, P858, DOI 10.1111/j.1365-2958.2008.06314.x; Naderer T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001245; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Paes LS, 2008, J EUKARYOT MICROBIOL, V55, P382, DOI 10.1111/j.1550-7408.2008.00346.x; RAINEY PM, 1991, MOL BIOCHEM PARASIT, V45, P307, DOI 10.1016/0166-6851(91)90099-R; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Saunders EC, 2010, PARASITOLOGY, V137, P1303, DOI 10.1017/S0031182010000077; SCHLEIN Y, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.1.TM0500010020; Sernee MF, 2006, P NATL ACAD SCI USA, V103, P9458, DOI 10.1073/pnas.0603539103; terKuile BH, 1997, J BACTERIOL, V179, P4699, DOI 10.1128/jb.179.15.4699-4705.1997; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Uboldi AD, 2006, INT J PARASITOL, V36, P1499, DOI 10.1016/j.ijpara.2006.08.006; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; VanHellemond JJ, 1997, MOL BIOCHEM PARASIT, V85, P135, DOI 10.1016/S0166-6851(97)02828-4; Vernal J, 1998, MOL BIOCHEM PARASIT, V96, P83, DOI 10.1016/S0166-6851(98)00117-0; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	56	64	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27706	27717		10.1074/jbc.M110.213553	http://dx.doi.org/10.1074/jbc.M110.213553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21636575	Green Published, hybrid			2022-12-27	WOS:000293268700063
J	Blank, M; Kiger, L; Thielebein, A; Gerlach, F; Hankeln, T; Marden, MC; Burmester, T				Blank, Miriam; Kiger, Laurent; Thielebein, Anke; Gerlach, Frank; Hankeln, Thomas; Marden, Michael C.; Burmester, Thorsten			Oxygen Supply from the Bird's Eye Perspective GLOBIN E IS A RESPIRATORY PROTEIN IN THE CHICKEN RETINA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROGLOBIN; CYTOGLOBIN; MYOGLOBIN; EVOLUTION; GENOME; GENE; HEMOGLOBINS; MECHANISMS; SEQUENCE; SEARCH	The visual process in the vertebrate eye requires high amounts of metabolic energy and thus oxygen. Oxygen supply of the avian retina is a challenging task because birds have large eyes, thick retinae, and high metabolic rates but neither deep retinal nor superficial capillaries. Respiratory proteins such as myoglobin may enhance oxygen supply to certain tissues, and thus the mammalian retina harbors high amounts of neuroglobin. Globin E (GbE) was recently identified as an eye-specific globin of chicken (Gallus gallus). Orthologous GbE genes were found in zebra finch and turkey genomes but appear to be absent in non-avian vertebrate classes. Analyses of globin phylogeny and gene synteny showed an ancient origin of GbE but did not help to assign it to any specific globin type. We show that the photoreceptor cells of the chicken retina have a high level ofGbE protein, which accumulates to similar to 10 mu M in the total eye. Quantitative real-time RT-PCR revealed an similar to 50,000-fold higher level of GbE mRNA in the eye than in the brain. Spectroscopic analysis and ligand binding kinetics of recombinant chicken GbE reveal a penta-coordinated globin with an oxygen affinity of P-50 = 5.8 torrs at 25 degrees C and 15 torrs at 41 degrees C. Together these data suggest that GbE helps to sustain oxygen supply to the avian retina.	[Blank, Miriam; Thielebein, Anke; Gerlach, Frank; Burmester, Thorsten] Univ Hamburg, Inst Zool, D-20146 Hamburg, Germany; [Burmester, Thorsten] Univ Hamburg, Zool Museum, Bioctr Grindel, D-20146 Hamburg, Germany; [Kiger, Laurent; Marden, Michael C.] Univ Paris 11, INSERM U779, F-94275 Le Kremlin Bicetre, France; [Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55099 Mainz, Germany	University of Hamburg; University of Hamburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Johannes Gutenberg University of Mainz	Burmester, T (corresponding author), Univ Hamburg, Inst Zool, Martin Luther King Pl 3, D-20146 Hamburg, Germany.	thorsten.burmester@uni-hamburg.de	Marden, Michael/AAA-5923-2020; Kiger, Laurent/Q-1686-2018; Marden, Michael C/G-3139-2012; Burmester, Thorsten/I-7225-2013; Götting, Miriam/I-8222-2014	Marden, Michael C/0000-0002-5254-6385; Burmester, Thorsten/0000-0002-5772-7863; Götting, Miriam/0000-0001-5336-1422	Deutsche Forschungsgemeinschaft [Bu956/11, Ha2103/3]; INSERM	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (Grants Bu956/11 and Ha2103/3) and INSERM.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bentmann A, 2005, J BIOL CHEM, V280, P20660, DOI 10.1074/jbc.M501338200; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, IUBMB LIFE, V56, P703, DOI 10.1080/15216540500037257; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Burr AHJ, 2000, J BIOL CHEM, V275, P4810, DOI 10.1074/jbc.275.7.4810; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dickerson AE, 1983, HEMOGLOBIN STRUCTURE; ENOKI Y, 1984, BIOCHIM BIOPHYS ACTA, V789, P334, DOI 10.1016/0167-4838(84)90189-4; Fuchs C, 2006, CYTOGENET GENOME RES, V112, P296, DOI 10.1159/000089884; Gillemans N, 2003, BLOOD, V101, P2842, DOI 10.1182/blood-2002-09-2850; Griffin DK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-168; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoffmann FG, 2010, P NATL ACAD SCI USA, V107, P14274, DOI 10.1073/pnas.1006756107; Kugelstadt D, 2004, BIOCHEM BIOPH RES CO, V325, P719, DOI 10.1016/j.bbrc.2004.10.080; Mitz SA, 2009, NEUROSCIENCE, V163, P552, DOI 10.1016/j.neuroscience.2009.06.058; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Nicholas K. B., 1997, EMBNET NEWS, V4, P14; Organisciak D T, 1989, Prog Clin Biol Res, V314, P493; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Patel VS, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-34; PENN JS, 1987, EXP EYE RES, V44, P779, DOI 10.1016/S0014-4835(87)80041-6; PETTIGREW JD, 1990, NATURE, V343, P362, DOI 10.1038/343362a0; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; SONO M, 1976, J BIOL CHEM, V251, P1418; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; Wystub S, 2004, CYTOGENET GENOME RES, V105, P65, DOI 10.1159/000078011; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; [No title captured]	45	34	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26507	26515		10.1074/jbc.M111.224634	http://dx.doi.org/10.1074/jbc.M111.224634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21622558	Green Published, hybrid			2022-12-27	WOS:000293078200029
J	Shin, SY; Kim, CG; Lim, Y; Lee, YH				Shin, Soon Young; Kim, Chang Gun; Lim, Yoongho; Lee, Young Han			The ETS Family Transcription Factor ELK-1 Regulates Induction of the Cell Cycle-regulatory Gene p21(Waf1)Cip1 and the BAX Gene in Sodium Arsenite-exposed Human Keratinocyte HaCaT Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAPK SIGNALING PATHWAYS; BRCA1 SPLICE VARIANTS; SERUM RESPONSE FACTOR; CARCINOMA A431 CELLS; MOLECULAR-MECHANISMS; DNA-DAMAGE; P21(WAF1/CIP1) EXPRESSION; P21 WAF1/CIP1; INHIBITOR P21	Cyclin-dependent kinase inhibitor (CDKN1A), often referred to as p21(Waf1/Cip1) (p21), is induced by a variety of environmental stresses. Transcription factor ELK-1 is a member of the ETS oncogene superfamily. Here, we show that ELK-1 directly trans-activates the p21 gene, independently of p53 and EGR-1, in sodium arsenite (NaASO(2))-exposed HaCaT cells. Promoter deletion analysis and site-directed mutagenesis identified the presence of an ELK-1-binding core motif between -190 and -170 bp of the p21 promoter that confers inducibility by NaASO(2). Chromatin immunoprecipitation and electrophoretic mobility shift analyses confirmed the specific binding of ELK-1 to its putative binding sequence within the p21 promoter. In addition, NaASO(2)-induced p21 promoter activity was enhanced by exogenous expression of ELK-1 and reduced by expression of siRNA targeted to ELK-1 mRNA. The importance of ELK-1 in response to NaASO(2) was further confirmed by the observation that stable expression of ELK-1 siRNA in HaCaT cells resulted in the attenuation of NaASO(2)-induced p21 expression. Although ELK-1 was activated by ERK, JNK, and p38 MAPK in response toNaASO(2), ELK-1-mediated activation of the p21 promoter was largely dependent on ERK. In addition, EGR-1 induced by ELK-1 seemed to be involved in NaASO2-induced expression of BAX. This supports the view that the ERK/ELK-1 cascade is involved in p53-independent induction of p21 and BAX gene expression.	[Shin, Soon Young] Konkuk Univ, SMART Inst Adv Biomed Sci, Dept Biomed Sci & Technol, Res Ctr Transcript Control, Seoul 143701, South Korea; [Lim, Yoongho] Konkuk Univ, Div Biosci & Biotechnol, BMIC, Seoul 143701, South Korea	Konkuk University; Konkuk University	Shin, SY (corresponding author), Konkuk Univ, SMART Inst Adv Biomed Sci, Dept Biomed Sci & Technol, Res Ctr Transcript Control, 1 Hwayang Dong, Seoul 143701, South Korea.	shinsy@konkuk.ac.kr; yhlee58@konkuk.ac.kr			Ministry of Education, Science and Technology, Republic of Korea [20090084181, KRF-2008-314-C00290, NRF-2010-0014208]; Konkuk University	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Konkuk University	This work was supported by Disease Network Research Program Grant 20090084181 and Basic Research Promotion Fund Grants KRF-2008-314-C00290 and NRF-2010-0014208 from the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology, Republic of Korea. This work was also supported by the SMART Research Professor Program of Konkuk University.	Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Al-Sarraj A, 2004, J MOL MED, V82, P530, DOI 10.1007/s00109-004-0545-0; Aono J, 2003, BIOCHEM BIOPH RES CO, V305, P271, DOI 10.1016/S0006-291X(03)00728-9; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; BETTLEY FR, 1975, BRIT J DERMATOL, V92, P563; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; Boros J, 2009, NUCLEIC ACIDS RES, V37, P7368, DOI 10.1093/nar/gkp804; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chai YL, 2001, ONCOGENE, V20, P1357, DOI 10.1038/sj.onc.1204256; Chan TA, 2000, GENE DEV, V14, P1584; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; Chou RH, 2002, BIOCHEM BIOPH RES CO, V293, P298, DOI 10.1016/S0006-291X(02)00212-7; Ciccarelli C, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-41; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; De Siervi A, 2004, CANCER RES, V64, P743, DOI 10.1158/0008-5472.CAN-03-2505; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; Dong ZG, 2002, ENVIRON HEALTH PERSP, V110, P757, DOI 10.1289/ehp.02110s5757; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Facchinetti MM, 2004, CANCER RES, V64, P3629, DOI 10.1158/0008-5472.CAN-03-3741; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gillis LD, 2009, CELL CYCLE, V8, P253, DOI 10.4161/cc.8.2.7550; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; HARPER JW, 1993, CELL, V75, P805; Huang CS, 2004, MOL CELL BIOCHEM, V255, P57, DOI 10.1023/B:MCBI.0000007261.04684.78; Huang CS, 1999, J BIOL CHEM, V274, P14595, DOI 10.1074/jbc.274.21.14595; Huang HS, 2002, FREE RADICAL BIO MED, V33, P864, DOI 10.1016/S0891-5849(02)00983-8; Kim CG, 2007, CELL SIGNAL, V19, P1290, DOI 10.1016/j.cellsig.2007.01.008; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim JY, 2002, J CELL PHYSIOL, V190, P29, DOI 10.1002/jcp.10049; Kivinen L, 1999, ONCOGENE, V18, P6252, DOI 10.1038/sj.onc.1203000; Kweon MH, 2007, ONCOGENE, V26, P3559, DOI 10.1038/sj.onc.1210135; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Liebmann C, 2001, CELL SIGNAL, V13, P777, DOI 10.1016/S0898-6568(01)00192-9; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Lincet H, 2000, CANCER LETT, V161, P17, DOI 10.1016/S0304-3835(00)00586-3; Liu ZM, 2006, CELL SIGNAL, V18, P244, DOI 10.1016/j.cellsig.2005.04.006; Lu ML, 2000, ONCOGENE, V19, P6351, DOI 10.1038/sj.onc.1204025; Nuntharatanapong N, 2005, AM J PHYSIOL-HEART C, V289, pH99, DOI 10.1152/ajpheart.00901.2004; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Qian Y, 2003, J INORG BIOCHEM, V96, P271, DOI 10.1016/S0162-0134(03)00235-6; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Sidhu JS, 2006, TOXICOL SCI, V89, P475, DOI 10.1093/toxsci/kfj032; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Tchounwou PB, 2003, CELL MOL BIOL, V49, P1071; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Yamazaki Y, 2003, J BIOL CHEM, V278, P30642, DOI 10.1074/jbc.M212242200; Yan GZ, 1997, J NEUROSCI, V17, P6122; Yang SH, 2006, BIOCHEM SOC SYMP, V73, P121, DOI 10.1042/bss0730121; Yang SH, 2005, EMBO J, V24, P2161, DOI 10.1038/sj.emboj.7600690; Zagurovskaya M, 2009, ONCOGENE, V28, P1121, DOI 10.1038/onc.2008.461; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhang CL, 2003, J BIOL CHEM, V278, P27903, DOI 10.1074/jbc.M304328200	73	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26860	26872		10.1074/jbc.M110.216721	http://dx.doi.org/10.1074/jbc.M110.216721			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642427	Green Published, hybrid			2022-12-27	WOS:000293078200061
J	Tian, Q; Li, T; Hou, WH; Zheng, JY; Schrum, LW; Bonkovsky, HL				Tian, Qing; Li, Ting; Hou, Weihong; Zheng, Jianyu; Schrum, Laura W.; Bonkovsky, Herbert L.			Lon Peptidase 1 (LONP1)-dependent Breakdown of Mitochondrial 5-Aminolevulinic Acid Synthase Protein by Heme in Human Liver Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; MESSENGER-RNA; DEGRADATION; TRANSCRIPTION; EXPRESSION; REPRESSION; PORPHYRIA; GENE	5-Aminolevulinic acid synthase (ALAS-1) is the first rate controlling enzyme that controls cellular heme biosynthesis. Negative feedback regulation of ALAS-1 by the end product heme is well documented and provides the foundation for heme treatment of acute porphyrias, a group of diseases caused by genetic defects in the heme biosynthesis pathway and exacerbated by controlled up-regulation of ALAS-1. Heme is known to affect ALAS-1 activity by repressing gene transcription, accelerating mRNA degradation, and impeding pre-ALAS-1 mitochondrial translocation. In the current study, we examined the effect of heme on the rate of mature ALAS-1 protein turnover in human cells and tissues and explored the mediator involved in this new regulatory mechanism. We found that heme and other metalloporphyrins such as CoPP and CrPP decreased mitochondrial ALAS-1 protein through proteolysis. This degradative effect cannot be emulated by iron or free protoporphyrin, two major chemical components of the heme ring, and is independent of oxidative stress. Down-regulating the activity of mitochondrial LONP1, an ATP-dependent protease that controls the selective turnover of mitochondrial matrix proteins, with potent inhibitors and specific siRNA diminished the negative effect of heme on mitochondrial ALAS-1. Therefore, our data support the existence of a conserved heme feedback regulatory mechanism that functions on the mature form of ALAS-1 protein through the activity of a mitochondrial proteolytic system.	[Bonkovsky, Herbert L.] Carolinas Med Ctr, Cannon Res Ctr, Liver Digest & Metab Disorders Lab, Charlotte, NC 28203 USA; [Tian, Qing; Li, Ting; Hou, Weihong; Zheng, Jianyu; Schrum, Laura W.; Bonkovsky, Herbert L.] Carolinas Med Ctr, Liver Biliary Pancreat Ctr, Charlotte, NC 28203 USA; [Schrum, Laura W.; Bonkovsky, Herbert L.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Bonkovsky, Herbert L.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA; [Bonkovsky, Herbert L.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	Carolinas Medical Center; Carolinas Medical Center; University of North Carolina; University of North Carolina Charlotte; University of Connecticut; University of North Carolina; University of North Carolina Chapel Hill	Bonkovsky, HL (corresponding author), Carolinas Med Ctr, Cannon Res Ctr, Liver Digest & Metab Disorders Lab, Ste 201,1000 Blythe Blvd, Charlotte, NC 28203 USA.	herbert.bonkovsky@carolinashealthcare.org	hou, wei/GWM-4800-2022; Bonkovsky, Herbert L./AAH-1892-2021	Bonkovsky, Herbert L./0000-0001-7387-3230	National Institutes of Health [5R01DK38825]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038825, U54DK083909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01DK38825 (to H. B. L.).	Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; Bayot A, 2008, BIOCHIMIE, V90, P260, DOI 10.1016/j.biochi.2007.10.010; Bonkovsky H.L., 1990, HEPATOLOGY TXB LIVER, V2nd ed., P378; BONKOWSKY HL, 1971, P NATL ACAD SCI USA, V68, P2725, DOI 10.1073/pnas.68.11.2725; Cable EE, 2000, ARCH BIOCHEM BIOPHYS, V384, P280, DOI 10.1006/abbi.2000.2117; Correia MA, 2011, DRUG METAB REV, V43, P1, DOI 10.3109/03602532.2010.515222; DREW PD, 1989, BIOCHEM BIOPH RES CO, V162, P102, DOI 10.1016/0006-291X(89)91968-2; Elder G H, 1982, Semin Liver Dis, V2, P87, DOI 10.1055/s-2008-1040699; Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200; GRANICK S, 1975, J BIOL CHEM, V250, P9215; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; HAMILTON JW, 1991, ARCH BIOCHEM BIOPHYS, V289, P387, DOI 10.1016/0003-9861(91)90428-L; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; HAYASHI N, 1983, BIOCHEM BIOPH RES CO, V115, P700, DOI 10.1016/S0006-291X(83)80201-0; Hou WH, 2009, WORLD J GASTROENTERO, V15, P4499, DOI 10.3748/wjg.15.4499; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kolluri S, 2005, BIOCHEM J, V392, P173, DOI 10.1042/BJ20050354; Langer T, 1996, EXPERIENTIA, V52, P1069, DOI 10.1007/BF01952104; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Meyer UA, 2007, DRUG METAB REV, V39, P639, DOI 10.1080/03602530701498737; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; Podvinec M, 2004, P NATL ACAD SCI USA, V101, P9127, DOI 10.1073/pnas.0401845101; SRIVASTAVA G, 1988, J BIOL CHEM, V263, P5202; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yoshino K, 2007, J BIOCHEM, V142, P453, DOI 10.1093/jb/mvm159; Zheng JY, 2008, MOL CELL BIOCHEM, V319, P153, DOI 10.1007/s11010-008-9888-0	27	90	95	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26424	26430		10.1074/jbc.M110.215772	http://dx.doi.org/10.1074/jbc.M110.215772			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659532	hybrid, Green Published			2022-12-27	WOS:000293078200020
J	Meyer, EH; Solheim, C; Tanz, SK; Bonnard, G; Millar, AH				Meyer, Etienne H.; Solheim, Cory; Tanz, Sandra K.; Bonnard, Geraldine; Millar, A. Harvey			Insights into the Composition and Assembly of the Membrane Arm of Plant Complex I through Analysis of Subcomplexes in Arabidopsis Mutant Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CARBONIC-ANHYDRASE SUBUNITS; MITOCHONDRIAL-COMPLEX; NUCLEAR GENE; OXIDATIVE-PHOSPHORYLATION; ESCHERICHIA-COLI; THALIANA; IDENTIFICATION; DEHYDROGENASE; DEFICIENCY	NADH-ubiquinone oxidoreductase (Complex I, EC 1.6.5.3) is the largest complex of the mitochondrial respiratory chain. In eukaryotes, it is composed of more than 40 subunits that are encoded by both the nuclear and mitochondrial genomes. Plant Complex I differs from the enzyme described in other eukaryotes, most notably due to the large number of plant-specific subunits in the membrane arm of the complex. The elucidation of the assembly pathway of Complex I has been a long-standing research aim in cellular biochemistry. We report the study of Arabidopsis mutants in Complex I subunits using a combination of Blue-Native PAGE and immunodetection to identify stable subcomplexes containing Complex I components, along with mass spectrometry analysis of Complex I components in membrane fractions and two-dimensional diagonal Tricine SDS-PAGE to study the composition of the largest subcomplex. Four subcomplexes of the membrane arm of Complex I with apparent molecular masses of 200, 400, 450, and 650 kDa were observed. We propose a working model for the assembly of the membrane arm of Complex I in plants and assign putative roles during the assembly process for two of the subunits studied.	[Meyer, Etienne H.; Bonnard, Geraldine] Univ Strasbourg, Inst Biol Mol Plantes, CNRS UPR2357, F-67084 Strasbourg, France; [Meyer, Etienne H.; Solheim, Cory; Tanz, Sandra K.; Millar, A. Harvey] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Crawley, WA 6009, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Western Australia	Meyer, EH (corresponding author), Univ Strasbourg, Inst Biol Mol Plantes, CNRS UPR2357, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	etienne.meyer@ibmp-cnrs.unistra.fr	Millar, A. Harvey/A-5452-2008; Meyer, Etienne H/C-1952-2008; Tanz, Sandra K/C-2686-2011	Millar, A. Harvey/0000-0001-9679-1473; Meyer, Etienne H/0000-0003-4712-9824; Tanz, Sandra/0000-0002-0632-4095	Centre National pour le Recherche Scientifique; Australian Research Council (ARC) Centre of Excellence; University of Western Australia; ARC	Centre National pour le Recherche Scientifique; Australian Research Council (ARC) Centre of Excellence(Australian Research Council); University of Western Australia; ARC(Australian Research Council)	This work was supported by the Centre National pour le Recherche Scientifique, an Australian Research Council (ARC) Centre of Excellence Grant, a grant from the University of Western Australia Research Grants Scheme (to E. H. M.), and an ARC Australian Professorial Fellowship (to A. H. M.).	Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Barbieri MR, 2011, GENETICS, V188, P349, DOI 10.1534/genetics.111.128827; Braun HP, 2007, PHYSIOL PLANTARUM, V129, P114, DOI 10.1111/j.1399-3054.2006.00773.x; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Heazlewood JL, 2003, BBA-BIOENERGETICS, V1604, P159, DOI 10.1016/S0005-2728(03)00045-8; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Karpova OV, 1999, PLANT J, V17, P511, DOI 10.1046/j.1365-313X.1999.00401.x; Keren I, 2009, RNA, V15, P2299, DOI 10.1261/rna.1776409; Klodmann J, 2011, PHYTOCHEMISTRY, V72, P1071, DOI 10.1016/j.phytochem.2010.11.012; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Koprivova A, 2010, J BIOL CHEM, V285, P32192, DOI 10.1074/jbc.M110.147603; Kuhn K, 2009, PLANT CELL, V21, P2762, DOI 10.1105/tpc.109.068536; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; Meyer EH, 2008, J PROTEOME RES, V7, P786, DOI 10.1021/pr700595p; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Nakagawa N, 2006, PLANT CELL PHYSIOL, V47, P772, DOI 10.1093/pcp/pcj051; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Sung TY, 2010, PLANT J, V63, P499, DOI 10.1111/j.1365-313X.2010.04258.x; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	49	75	77	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26081	26092		10.1074/jbc.M110.209601	http://dx.doi.org/10.1074/jbc.M110.209601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21606486	hybrid, Green Published			2022-12-27	WOS:000293073000066
J	Zhu, MS; Zhang, HY; Humphreys, WG				Zhu, Mingshe; Zhang, Haiying; Humphreys, W. Griffith			Drug Metabolite Profiling and Identification by High-resolution Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							THOROUGH BACKGROUND SUBTRACTION; LC/MS DATA APPLICATION; ELECTRON-CAPTURE DISSOCIATION; TRAPPED REACTIVE METABOLITES; IN-VITRO; HIGH-THROUGHPUT; TOP-DOWN; STRUCTURAL-CHARACTERIZATION; ANALYTICAL STRATEGIES; BIOLOGICAL MATRICES	Mass spectrometry plays a key role in drug metabolite identification, an integral part of drug discovery and development. The development of high-resolution (HR) MS instrumentation with improved accuracy and stability, along with new data processing techniques, has improved the quality and productivity of metabolite identification processes. In this minireview, HR-MS-based targeted and non-targeted acquisition methods and data mining techniques (e. g. mass defect, product ion, and isotope pattern filters and background subtraction) that facilitate metabolite identification are examined. Methods are presented that enable multiple metabolite identification tasks with a single LC/HR-MS platform and/or analysis. Also, application of HR-MS-based strategies to key metabolite identification activities and future developments in the field are discussed.	[Zhu, Mingshe; Zhang, Haiying; Humphreys, W. Griffith] Bristol Myers Squibb Pharmaceut Co, Princeton, NJ 08543 USA	Bristol-Myers Squibb	Humphreys, WG (corresponding author), Bristol Myers Squibb Pharmaceut Co, Princeton, NJ 08543 USA.	william.humphreys@bms.com		Zhang, Haiying/0000-0001-9592-8669				Anari MR, 2004, ANAL CHEM, V76, P823, DOI 10.1021/ac034980s; BAILLIE TA, 1993, BIOL MASS SPECTROM, V22, P319, DOI 10.1002/bms.1200220602; Baillie TA, 2008, CHEM RES TOXICOL, V21, P129, DOI 10.1021/tx7002273; Bajrami B, 2009, J AM SOC MASS SPECTR, V20, P2124, DOI 10.1016/j.jasms.2009.07.005; Bateman KP, 2007, RAPID COMMUN MASS SP, V21, P1485, DOI 10.1002/rcm.2996; Bateman KP, 2009, J AM SOC MASS SPECTR, V20, P1441, DOI 10.1016/j.jasms.2009.03.002; BLAIR IA, 1993, CHEM RES TOXICOL, V6, P741, DOI 10.1021/tx00036a001; Bloomfield N., 2009, U.S. Patent, Patent No. [7,589,318, 7589318]; Bristow AWT, 2006, MASS SPECTROM REV, V25, P99, DOI 10.1002/mas.20058; Bristow T, 2008, RAPID COMMUN MASS SP, V22, P1213, DOI 10.1002/rcm.3499; Castro-Perez J, 2005, RAPID COMMUN MASS SP, V19, P843, DOI 10.1002/rcm.1859; Castro-Perez J, 2005, RAPID COMMUN MASS SP, V19, P798, DOI 10.1002/rcm.1855; Chen GD, 2009, J MASS SPECTROM, V44, P203, DOI 10.1002/jms.1498; Clarke N, 2001, ANAL CHEM, V73, p430A, DOI 10.1021/ac012480y; Cuyckens F, 2008, ANAL BIOANAL CHEM, V390, P1717, DOI 10.1007/s00216-007-1761-6; Cuyckens F, 2009, RAPID COMMUN MASS SP, V23, P327, DOI 10.1002/rcm.3881; Erve JCL, 2009, RAPID COMMUN MASS SP, V23, P4003, DOI 10.1002/rcm.4341; Hill AW, 2005, RAPID COMMUN MASS SP, V19, P3111, DOI 10.1002/rcm.2177; Humphreys WG, 2006, CHEM RES TOXICOL, V19, P1564, DOI 10.1021/tx6002547; Jiwan JLH, 2011, CLIN BIOCHEM, V44, P136, DOI 10.1016/j.clinbiochem.2010.08.018; Krivos KL, 2010, J AM SOC MASS SPECTR, V21, P1387, DOI 10.1016/j.jasms.2010.03.043; Leclercq L, 2009, RAPID COMMUN MASS SP, V23, P39, DOI 10.1002/rcm.3854; Li AC, 2009, RAPID COMMUN MASS SP, V23, P3003, DOI 10.1002/rcm.4207; Lim HK, 2008, RAPID COMMUN MASS SP, V22, P1295, DOI 10.1002/rcm.3504; Lim HK, 2007, RAPID COMMUN MASS SP, V21, P1821, DOI 10.1002/rcm.3024; Lourette N, 2010, J AM SOC MASS SPECTR, V21, P930, DOI 10.1016/j.jasms.2010.02.027; Ma L, 2008, CHEM RES TOXICOL, V21, P1477, DOI 10.1021/tx8001115; Ma SG, 2008, DRUG METABOLISM IN DRUG DESIGN AND DEVELOPMENT: BASIC CONCEPTS AND PRACTICE, P319; Ma SG, 2006, CURR DRUG METAB, V7, P503, DOI 10.2174/138920006777697891; Ma SG, 2009, CHEM-BIOL INTERACT, V179, P25, DOI 10.1016/j.cbi.2008.09.014; Maurer HH, 2010, THER DRUG MONIT, V32, P324, DOI 10.1097/FTD.0b013e3181dca295; Mortishire-Smith RJ, 2005, RAPID COMMUN MASS SP, V19, P2659, DOI 10.1002/rcm.2111; Mortishire-Smith RJ, 2009, RAPID COMMUN MASS SP, V23, P939, DOI 10.1002/rcm.3951; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Papasotiriou DG, 2010, J PROTEOME RES, V9, P2619, DOI 10.1021/pr100055z; Perry RH, 2008, MASS SPECTROM REV, V27, P661, DOI 10.1002/mas.20186; Peterman SM, 2006, J AM SOC MASS SPECTR, V17, P363, DOI 10.1016/j.jasms.2005.11.014; Prakash C, 2007, MASS SPECTROM REV, V26, P340, DOI 10.1002/mas.20128; Ramanathan R, 2010, BIOANALYSIS, V2, P1291, DOI 10.4155/BIO.10.83; Rousu T, 2009, RAPID COMMUN MASS SP, V23, P843, DOI 10.1002/rcm.3953; Ruan Q, 2008, J MASS SPECTROM, V43, P251, DOI 10.1002/jms.1311; Ruan Q, 2010, CHEM RES TOXICOL, V23, P909, DOI 10.1021/tx1000046; Sanders M, 2006, CURR DRUG METAB, V7, P547, DOI 10.2174/138920006777697972; Shi Y, 2009, ANAL CHEM, V81, P6438, DOI 10.1021/ac9008034; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Stagliano MC, 2010, RAPID COMMUN MASS SP, V24, P3578, DOI 10.1002/rcm.4796; Thevis M, 2010, EUR J MASS SPECTROM, V16, P301, DOI 10.1255/ejms.1047; Tiller PR, 2008, RAPID COMMUN MASS SP, V22, P1053, DOI 10.1002/rcm.3472; Tiller PR, 2008, RAPID COMMUN MASS SP, V22, P3510, DOI 10.1002/rcm.3758; Tiller PR, 2002, RAPID COMMUN MASS SP, V16, P1225, DOI 10.1002/rcm.708; Tipton JD, 2009, ANAL CHEM, V81, P7611, DOI 10.1021/ac9009935; van der Merwe DE, 2007, ADV CANCER RES, V96, P23, DOI 10.1016/S0065-230X(06)96002-3; Wen B, 2009, EXPERT OPIN DRUG MET, V5, P39, DOI [10.1517/17425250802665706, 10.1517/17425250802665706 ]; Wrona M, 2005, RAPID COMMUN MASS SP, V19, P2597, DOI 10.1002/rcm.2101; Wu S, 2011, METHODS MOL BIOL, V694, P291, DOI 10.1007/978-1-60761-977-2_18; Yao M, 2009, RAPID COMMUN MASS SP, V23, P1683, DOI 10.1002/rcm.4045; Zhang DL, 2006, DRUG METAB DISPOS, V34, P267, DOI 10.1124/dmd.105.007153; Zhang HY, 2008, J MASS SPECTROM, V43, P1191, DOI 10.1002/jms.1432; Zhang HY, 2008, J MASS SPECTROM, V43, P1181, DOI 10.1002/jms.1390; Zhang HY, 2008, RAPID COMMUN MASS SP, V22, P2082, DOI 10.1002/rcm.3585; Zhang HY, 2010, ANAL CHEM, V82, P3834, DOI 10.1021/ac100287a; Zhang HY, 2009, ANAL CHEM, V81, P2695, DOI 10.1021/ac8027189; Zhang HY, 2009, J MASS SPECTROM, V44, P999, DOI 10.1002/jms.1610; Zhang H, 2010, J AM SOC MASS SPECTR, V21, P1966, DOI 10.1016/j.jasms.2010.08.006; Zhang HY, 2003, J MASS SPECTROM, V38, P1110, DOI 10.1002/jms.521; Zhang NR, 2009, RAPID COMMUN MASS SP, V23, P1085, DOI 10.1002/rcm.3975; Zhang NY, 2000, ANAL CHEM, V72, P800, DOI 10.1021/ac9911701; Zhang ZP, 2009, CURR PHARM DESIGN, V15, P2220, DOI 10.2174/138161209788682460; Zhu MS, 2007, ANAL CHEM, V79, P8333, DOI 10.1021/ac071119u; Zhu MS, 2006, DRUG METAB DISPOS, V34, P1722, DOI 10.1124/dmd.106.009241; Zhu MS, 2009, BIOPHARM DRUG DISPOS, V30, P163, DOI 10.1002/bdd.659; Zhu PJ, 2009, ANAL CHEM, V81, P5910, DOI 10.1021/ac900626d; Zhu PJ, 2009, RAPID COMMUN MASS SP, V23, P1563, DOI 10.1002/rcm.4041	73	153	155	2	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25419	25425		10.1074/jbc.R110.200055	http://dx.doi.org/10.1074/jbc.R110.200055			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632546	hybrid, Green Published			2022-12-27	WOS:000293073000003
J	Kinney, SM; Chin, HG; Vaisvila, R; Bitinaite, J; Zheng, Y; Esteve, PO; Feng, SH; Stroud, H; Jacobsen, SE; Pradhan, S				Kinney, Shannon Morey; Chin, Hang Gyeong; Vaisvila, Romualdas; Bitinaite, Jurate; Zheng, Yu; Esteve, Pierre-Olivier; Feng, Suhua; Stroud, Hume; Jacobsen, Steven E.; Pradhan, Sriharsa			Tissue-specific Distribution and Dynamic Changes of 5-Hydroxymethylcytosine in Mammalian Genomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; BINDING; 5-METHYLCYTOSINE; CPG; TRANSCRIPTION; CONVERSION; REVEALS; PROTEIN; DOMAIN	Cytosine residues in the vertebrate genome are enzymatically modified to 5-methylcytosine, which participates in transcriptional repression of genes during development and disease progression. 5-Methylcytosine can be further enzymatically modified to 5-hydroxymethylcytosine by the TET family of methylcytosine dioxygenases. Analysis of 5-methylcytosine and 5-hydroxymethylcytosine is confounded, as these modifications are indistinguishable by traditional sequencing methods even when supplemented by bisulfite conversion. Here we demonstrate a simple enzymatic approach that involves cloning, identification, and quantification of 5-hydroxymethylcytosine in various CCGG loci within murine and human genomes. 5-Hydroxymethylcytosine was prevalent in human and murine brain and heart genomic DNAs at several regions. The cultured cell lines NIH3T3 and HeLa both displayed very low or undetectable amounts of 5-hydroxymethylcytosine at the examined loci. Interestingly, 5-hydroxymethylcytosine levels in mouse embryonic stem cell DNA first increased then slowly decreased upon differentiation to embryoid bodies, whereas 5-methylcytosine levels increased gradually over time. Finally, using a quantitative PCR approach, we established that a portion of VANGL1 and EGFR gene body methylation in human tissue DNA samples is indeed hydroxymethylation.	[Kinney, Shannon Morey; Chin, Hang Gyeong; Vaisvila, Romualdas; Bitinaite, Jurate; Zheng, Yu; Esteve, Pierre-Olivier; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA; [Feng, Suhua; Stroud, Hume; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	New England Biolabs; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Pradhan, S (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	pradhan@neb.com	Stroud, Hume/ABF-1325-2021; Kinney, Shannon/AAW-5301-2021	Bitinaite, Jurate/0000-0002-9190-6355	Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; New England Biolabs, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398] Funding Source: NIH RePORTER	Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; New England Biolabs, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an innovation award from the Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA (to S. E. J.).; We thank Jack Benner for nucleotide analysis of the genomic DNA and Thomas C. Evans and William Jack for reading the manuscript. We thank Drs. Donald G. Comb, Richard J. Roberts, James V. Ellard, and New England Biolabs, Inc. for supporting the basic research.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dahlmann HA, 2009, BIOCHEMISTRY-US, V48, P9347, DOI 10.1021/bi901059k; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Goosen N, 2010, DNA REPAIR, V9, P593, DOI 10.1016/j.dnarep.2010.02.015; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; WAALWIJK C, 1978, NUCLEIC ACIDS RES, V5, P3231, DOI 10.1093/nar/5.9.3231; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	34	129	141	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24685	24693		10.1074/jbc.M110.217083	http://dx.doi.org/10.1074/jbc.M110.217083			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610077	Green Published, hybrid			2022-12-27	WOS:000292547900019
J	Yamanaka, Y; Karuppaiah, K; Abu-Amer, Y				Yamanaka, Yasuhiro; Karuppaiah, Kannan; Abu-Amer, Yousef			Polyubiquitination Events Mediate Polymethylmethacrylate (PMMA) Particle Activation of NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; KINASE COMPLEX; INDUCED OSTEOCLASTOGENESIS; INFLAMMATORY OSTEOLYSIS; IKK ACTIVATION; PERIPROSTHETIC OSTEOLYSIS; NEMO; TAK1; GAMMA; ALPHA	The pathologic response to implant wear-debris constitutes a major component of inflammatory osteolysis and remains under intense investigation. Polymethylmethacrylate (PMMA) particles, which are released during implant wear and loosening, constitute a major culprit by virtue of inducing inflammatory and osteolytic responses by macrophages and osteoclasts, respectively. Recent work by several groups has identified important cellular entities and secreted factors that contribute to inflammatory osteolysis. In previous work, we have shown that PMMA particles contribute to inflammatory osteolysis through stimulation of major pathways in monocytes/macrophages, primarily NF-kappa B and MAP kinases. The former pathway requires assembly of large IKK complex encompassing IKK1, IKK2, and IKK gamma/NEMO. We have shown recently that interfering with the NF-gamma B and MAPK activation pathways, through introduction of inhibitors and decoy molecules, impedes PMMA-induced inflammation and osteolysis in mouse models of experimental calvarial osteolysis and inflammatory arthritis. In this study, we report that PMMA particles activate the upstream transforming growth factor beta-activated kinase-1 (TAK1), which is a key regulator of signal transduction cascades leading to activation of NF-kappa B and AP-1 factors. More importantly, we found that PMMA particles induce TAK1 binding to NEMO and UBC13. In addition, we show that PMMA particles induce TRAF6 and UBC13 binding to NEMO and that lack of TRAF6 significantly attenuates NEMO ubiquitination. Altogether, these observations suggest that PMMA particles induce ubiquitination of NEMO, an event likely mediated by TRAF6, TAK1, and UBC13. Our findings provide important information for better understanding of the mechanisms underlying PMMA particle-induced inflammatory responses.	[Yamanaka, Yasuhiro] Asahikawa Med Coll, Dept Orthoped Surg, Asahikawa, Hokkaido 0788510, Japan; [Karuppaiah, Kannan; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA; [Karuppaiah, Kannan; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Asahikawa Medical College; Washington University (WUSTL); Washington University (WUSTL)	Abu-Amer, Y (corresponding author), 660 S Euclid Ave,Campus Box 8233, St Louis, MO 63110 USA.	abuamery@wustl.edu			National Institutes of Health [AR049192, AR054326]; Shriners Hospital for Children [8570, 8510]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049192, R01AR054326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR049192, and AR054326 and the Shriners Hospital for Children Grants 8570 and 8510.	Abbas S, 2003, J ORTHOPAED RES, V21, P1041, DOI 10.1016/S0736-0266(03)00081-0; Abu-Amer Y., 2006, FUTURE MED, V1, P133, DOI DOI 10.2217/17460816.1.1.133; Abu-Amer Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2170; ABUAMER Y, 2003, MOL BIOL ORTHOPEDICS, P229; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Archibeck M J, 2001, Instr Course Lect, V50, P185; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Burns KA, 2004, CURR BIOL, V14, pR1040, DOI 10.1016/j.cub.2004.11.040; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; CLOHISY DR, 1989, J BIOL CHEM, V264, P5370; Clohisy JC, 2004, J ORTHOPAED RES, V22, P13, DOI 10.1016/S0736-0266(03)00156-6; Clohisy JC, 2003, J ORTHOPAED RES, V21, P202, DOI 10.1016/S0736-0266(02)00133-X; Clohisy JC, 2002, J ORTHOPAED RES, V20, P174, DOI 10.1016/S0736-0266(01)00088-2; Clohisy JC, 2006, J ORTHOP RES, V24, P1358, DOI 10.1002/jor.20184; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Hay RT, 2004, NAT CELL BIOL, V6, P89, DOI 10.1038/ncb0204-89; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Kawadler H, 2006, CANCER BIOL THER, V5, P1273, DOI 10.4161/cbt.5.10.3289; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Minematsu H, 2007, ANN NY ACAD SCI, V1117, P143, DOI 10.1196/annals.1402.026; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schwarz EM, 2000, J ORTHOPAED RES, V18, P472, DOI 10.1002/jor.1100180321; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shifera AS, 2008, MOL CELL BIOCHEM, V310, P181, DOI 10.1007/s11010-007-9679-z; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wei S, 2008, PATHOL RES PRACT, V204, P695, DOI 10.1016/j.prp.2008.07.002; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yamanaka Y, 2006, J ORTHOP RES, V24, P1349, DOI 10.1002/jor.20199; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	51	19	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23735	23741		10.1074/jbc.M111.223669	http://dx.doi.org/10.1074/jbc.M111.223669			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566132	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000292294900015
J	Jansen, S; Collins, A; Yang, CS; Rebowski, G; Svitkina, T; Dominguez, R				Jansen, Silvia; Collins, Agnieszka; Yang, Changsong; Rebowski, Grzegorz; Svitkina, Tatyana; Dominguez, Roberto			Mechanism of Actin Filament Bundling by Fascin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; EVOLUTIONARY CONSERVATION; PROTEIN; EXPRESSION	Fascin is the main actin filament bundling protein in filopodia. Because of the important role filopodia play in cell migration, fascin is emerging as a major target for cancer drug discovery. However, an understanding of the mechanism of bundle formation by fascin is critically lacking. Fascin consists of four beta-trefoil domains. Here, we show that fascin contains two major actin-binding sites, coinciding with regions of high sequence conservation in beta-trefoil domains 1 and 3. The site in beta-trefoil-1 is located near the binding site of the fascin inhibitor macro-ketone and comprises residue Ser-39, whose phosphorylation by protein kinase C down-regulates actin bundling and formation of filopodia. The site in beta-trefoil-3 is related by pseudo-2-fold symmetry to that in beta-trefoil-1. The two sites are similar to 5 nm apart, resulting in a distance between actin filaments in the bundle of similar to 8.1 nm. Residue mutations in both sites disrupt bundle formation in vitro as assessed by co-sedimentation with actin and electron microscopy and severely impair formation of filopodia in cells as determined by rescue experiments in fascin-depleted cells. Mutations of other areas of the fascin surface also affect actin bundling and formation of filopodia albeit to a lesser extent, suggesting that, in addition to the two major actin-binding sites, fascin makes secondary contacts with other filaments in the bundle. In a high resolution crystal structure of fascin, molecules of glycerol and polyethylene glycol are bound in pockets located within the two major actin-binding sites. These molecules could guide the rational design of new anticancer fascin inhibitors.	[Svitkina, Tatyana] Univ Penn, Dept Biol, Leidy Labs 221, Philadelphia, PA 19104 USA; [Dominguez, Roberto] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Svitkina, T (corresponding author), Univ Penn, Dept Biol, Leidy Labs 221, 3740 Hamilton Walk, Philadelphia, PA 19104 USA.	svitkina@sas.upenn.edu; droberto@mail.med.upenn.edu			National Institutes of Health [MH087950, HL086655, GM070898, S10 RR-224820898]; Research Foundation of Flanders; United States Department of Energy [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022482] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Foundation of Flanders(FWO); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH087950 and HL086655 (to R. D.) and GM070898 (to T. S.). This work was also supported by a fellowship from the Research Foundation of Flanders (to S. J.).; We thank Farida Korobova for help with the expression of fascin mutants in cells. Use of the Industrial Macromolecular Crystallography Association Collaborative Access Team beamline 17-ID was supported by the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. The Advanced Photon Source was supported by United States Department of Energy Contract W-31-109-Eng-38. The transmission electron microscope was supported by National Institutes of Health Shared Instrumentation Grant S10 RR-22482 (to T. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Cant K, 1996, GENETICS, V143, P249; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; EDWARDS RA, 1995, J BIOL CHEM, V270, P10764, DOI 10.1074/jbc.270.18.10764; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Holmes KC, 2009, NATURE, V457, P389, DOI 10.1038/457389a; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; MOSIALOS G, 1994, J VIROL, V68, P7320, DOI 10.1128/JVI.68.11.7320-7328.1994; Ono S, 1997, J BIOL CHEM, V272, P2527; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; Sukow C, 1998, J MOL BIOL, V284, P1039, DOI 10.1006/jmbi.1998.2211; Tao YS, 1996, J CELL BIOL, V134, P1271, DOI 10.1083/jcb.134.5.1271; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; YAMASHIROMATSUMURA S, 1985, J BIOL CHEM, V260, P5087; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	26	120	120	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30087	30096		10.1074/jbc.M111.251439	http://dx.doi.org/10.1074/jbc.M111.251439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21685497	hybrid, Green Published			2022-12-27	WOS:000294046600066
J	Cisse, M; Duplan, E; Guillot-Sestier, MV; Rumigny, J; Bauer, C; Pages, G; Orzechowski, HD; Slack, BE; Checler, F; Vincent, B				Cisse, Moustapha; Duplan, Eric; Guillot-Sestier, Marie-Victoire; Rumigny, Joaquim; Bauer, Charlotte; Pages, Gilles; Orzechowski, Hans-Dieter; Slack, Barbara E.; Checler, Frederic; Vincent, Bruno			The Extracellular Regulated Kinase-1 (ERK1) Controls Regulated alpha-Secretase-mediated Processing, Promoter Transactivation, and mRNA Levels of the Cellular Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCIBLE PROTEIN-1; NECROSIS-FACTOR-ALPHA; CASPASE-3 ACTIVATION; FUNCTIONAL-CHARACTERIZATION; MUSCARINIC RECEPTORS; SIGNAL-TRANSDUCTION; CONVERTING ENZYME; TRUNCATED PRION; ISCHEMIC-INJURY; NEURONAL CELLS	The alpha-secretases A disintegrin and metalloprotease 10 (ADAM10) and ADAM17 trigger constitutive and regulated processing of the cellular prion protein (PrPc) yielding N1 fragment. The latter depends on protein kinase C (PKC)-coupled M1/M3 muscarinic receptor activation and subsequent phosphorylation of ADAM17 on its intracytoplasmic threonine 735. Here we show that regulated PrPc processing and ADAM17 phosphorylation and activation are controlled by the extracellular-regulated kinase-1/MAP-ERK kinase (ERK1/MEK) cascade. Thus, reductions of ERK1 or MEK activities by dominant-negative analogs, pharmacological inhibition, or genetic ablation all impair N1 secretion, whereas constitutively active proteins increase N1 recovery in the conditioned medium. Interestingly, we also observed an ERK1-mediated enhanced expression of PrPc. We demonstrate that the ERK1-associated increase in PrPc promoter transactivation and mRNA levels involve transcription factor AP-1 as a downstream effector. Altogether, our data identify ERK1 as an important regulator of PrPc cellular homeostasis and indicate that this kinase exerts a dual control of PrPc levels through transcriptional and post-transcriptional mechanisms.	[Cisse, Moustapha; Duplan, Eric; Guillot-Sestier, Marie-Victoire; Rumigny, Joaquim; Bauer, Charlotte; Checler, Frederic; Vincent, Bruno] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Unite Mixte Rech 6097, Equipe Labellisee,Fdn Rech Med,CNRS, F-06560 Valbonne, France; [Cisse, Moustapha; Duplan, Eric; Guillot-Sestier, Marie-Victoire; Rumigny, Joaquim; Bauer, Charlotte; Checler, Frederic; Vincent, Bruno] Univ Nice Sophia Antipolis, Inst Neuromed Mol, Unite Mixte Rech 6097, Equipe Labellisee,Fdn Rech Med,CNRS, F-06560 Valbonne, France; [Pages, Gilles] Univ Nice Sophia Antipolis, Inst Dev Biol & Canc, Unite Mixte Rech 6543, Ctr Antoine Lacassagne,CNRS, F-06189 Nice, France; [Orzechowski, Hans-Dieter] Charite, Inst Clin Pharmacol & Toxicol, D-10117 Berlin, Germany; [Slack, Barbara E.] Boston Univ, Sch Med, Boston, MA 02118 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Boston University	Checler, F (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Unite Mixte Rech 6097, Equipe Labellisee,Fdn Rech Med,CNRS, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr; mbbvc@mahidol.ac.th	Duplan, Eric/AAK-8224-2020; CISSE, Moustapha/AAM-1022-2021; Pages, Gilles/N-7135-2017; Slack, Barbara/AAU-9917-2021; Checler, Frederic/C-1241-2009	Duplan, Eric/0000-0002-1348-1507; Checler, Frederic/0000-0003-2098-1750; Slack, Barbara/0000-0002-7619-410X; Guillot-Sestier, Marie-Victoire/0000-0001-9674-7114; Vincent, Bruno/0000-0003-3876-2118; CISSE, Moustapha/0000-0003-3890-9183	Fondation pour la Recherche Medicale; Conseil General des Alpes-Maritimes	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes-Maritimes(Region Provence-Alpes-Cote d'Azur)	This work was supported by the Fondation pour la Recherche Medicale and the Conseil General des Alpes-Maritimes.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Arantes C, 2009, GLIA, V57, P1439, DOI 10.1002/glia.20861; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BRUNET A, 1994, ONCOGENE, V9, P3379; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burgess STG, 2009, J BIOL CHEM, V284, P6716, DOI 10.1074/jbc.M807065200; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Cisse M, 2011, MOL CELL NEUROSCI, V47, P223, DOI 10.1016/j.mcn.2011.04.008; Cisse MA, 2008, MOL CELL NEUROSCI, V39, P400, DOI 10.1016/j.mcn.2008.07.013; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Cisse MA, 2006, BIOCHEM BIOPH RES CO, V347, P254, DOI 10.1016/j.bbrc.2006.06.065; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Endres K, 2009, NEUROBIOL DIS, V36, P233, DOI 10.1016/j.nbd.2009.07.015; Ettaiche M, 2000, J BIOL CHEM, V275, P36487, DOI 10.1074/jbc.C000579200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Funke-Kaiser H, 2001, J MOL MED-JMM, V79, P529, DOI 10.1007/s001090100270; Gavin R, 2005, FEBS LETT, V579, P4099, DOI 10.1016/j.febslet.2005.06.037; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Mahal SP, 2001, GENE, V268, P105, DOI 10.1016/S0378-1119(01)00424-3; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Nicolas O, 2007, FASEB J, V21, P3107, DOI 10.1096/fj.06-7827com; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Paitel E, 2003, J BIOL CHEM, V278, P10061, DOI 10.1074/jbc.M211580200; Paitel E, 2002, J NEUROCHEM, V83, P1208, DOI 10.1046/j.1471-4159.2002.01234.x; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Vincent B, 1996, J NEUROSCI, V16, P5049; Vincent B, 2009, J NEUROSCI, V29, P6752, DOI 10.1523/JNEUROSCI.0789-09.2009; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	63	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29192	29206		10.1074/jbc.M110.208249	http://dx.doi.org/10.1074/jbc.M110.208249			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21586567	hybrid, Green Published			2022-12-27	WOS:000293837000055
J	Green, MF; Scott, JW; Steel, R; Oakhill, JS; Kemp, BE; Means, AR				Green, Michelle F.; Scott, John W.; Steel, Rohan; Oakhill, Jonathan S.; Kemp, Bruce E.; Means, Anthony R.			Ca2+/Calmodulin-dependent Protein Kinase Kinase beta Is Regulated by Multisite Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; MOLECULAR-CLONING; CALMODULIN; CASCADE; ALPHA; BDNF; ACTIVATION; EXPRESSION; MECHANISM; CALCIUM	Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKK beta) is a serine/threonine-directed kinase that is activated following increases in intracellular Ca2+. CaMKK beta activates Ca2+/calmodulin-dependent protein kinase I, Ca2+/calmodulin-dependent protein kinase IV, and the AMP-dependent protein kinase in a number of physiological pathways, including learning and memory formation, neuronal differentiation, and regulation of energy balance. Here, we report the novel regulation of CaMKK beta activity by multisite phosphorylation. We identify three phosphorylation sites in the N terminus of CaMKK beta, which regulate its Ca2+/calmodulin-independent autonomous activity. We then identify the kinases responsible for these phosphorylations as cyclin-dependent kinase 5 (CDK5) and glycogen synthase kinase 3 (GSK3). In addition to regulation of autonomous activity, we find that phosphorylation of CaMKK beta regulates its half-life. We find that cellular levels of CaMKK beta correlate with CDK5 activity and are regulated developmentally in neurons. Finally, we demonstrate that appropriate phosphorylation of CaMKK beta is critical for its role in neurite development. These results reveal a novel regulatory mechanism for CaMKK beta-dependent signaling cascades.	[Green, Michelle F.; Means, Anthony R.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Scott, John W.; Steel, Rohan; Oakhill, Jonathan S.; Kemp, Bruce E.] Univ Melbourne, Prot Chem & Metab Unit, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia	Duke University; St. Vincent's Institute of Medical Research; University of Melbourne	Means, AR (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	means001@mc.duke.edu	Scott, John W/AAA-2676-2021; Kemp, Bruce E/L-2633-2014; Scott, John W/P-1170-2018; Kemp, Bruce/G-9602-2019; Oakhill, Jonathan S/F-5724-2011	Scott, John W/0000-0002-1896-9798; Kemp, Bruce E/0000-0001-6735-5082; Scott, John W/0000-0002-1896-9798; Kemp, Bruce/0000-0001-6735-5082; Oakhill, Jonathan S/0000-0002-9475-1440; Green, Michelle/0000-0002-6055-4342; /0000-0002-0423-6120	National Institutes of Health [DK074701, GM033976]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK074701 and GM033976.	Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Atilla-Gokcumen GE, 2006, CHEMBIOCHEM, V7, P1443, DOI 10.1002/cbic.200600117; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; Davare MA, 2009, J NEUROSCI, V29, P9794, DOI 10.1523/JNEUROSCI.1544-09.2009; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ichimura T, 2008, FEBS LETT, V582, P661, DOI 10.1016/j.febslet.2008.01.037; Jin X, 2003, J NEUROSCI, V23, P5662; Kitani T, 2001, J BIOCHEM, V130, P515, DOI 10.1093/oxfordjournals.jbchem.a003014; Ko J, 2001, J NEUROSCI, V21, P6758; Kokubo M, 2009, J NEUROSCI, V29, P8901, DOI 10.1523/JNEUROSCI.0040-09.2009; LEE JSC, 1994, J BIOL CHEM, V269, P2158; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Mizuno K, 2007, NEUROSCIENCE, V145, P393, DOI 10.1016/j.neuroscience.2006.11.056; Mizuno K, 2006, MOL CELL BIOL, V26, P9094, DOI 10.1128/MCB.01221-06; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 2000, METHOD ENZYMOL, V325, P200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohshima T, 1999, J NEUROSCI, V19, P6017, DOI 10.1523/JNEUROSCI.19-14-06017.1999; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Okuno S, 2001, J BIOCHEM, V130, P503, DOI 10.1093/oxfordjournals.jbchem.a003013; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; SEGAL RA, 1995, J NEUROSCI, V15, P4970; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vinet J, 2003, MOL BRAIN RES, V111, P216, DOI 10.1016/S0169-328X(02)00698-8; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	53	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28066	28079		10.1074/jbc.M111.251504	http://dx.doi.org/10.1074/jbc.M111.251504			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669867	Green Published, hybrid			2022-12-27	WOS:000293557800025
J	Salin-Cantegrel, A; Riviere, JB; Shekarabi, M; Rasheed, S; DaCal, S; Laganiere, J; Gaudet, R; Rochefort, D; Lesca, G; Gaspar, C; Dion, PA; Lapointe, JY; Rouleau, GA				Salin-Cantegrel, Adele; Riviere, Jean-Baptiste; Shekarabi, Masoud; Rasheed, Sarah; DaCal, Sandra; Laganiere, Janet; Gaudet, Rebecca; Rochefort, Daniel; Lesca, Gaetan; Gaspar, Claudia; Dion, Patrick A.; Lapointe, Jean-Yves; Rouleau, Guy A.			Transit Defect of Potassium-Chloride Co-transporter 3 Is a Major Pathogenic Mechanism in Hereditary Motor and Sensory Neuropathy with Agenesis of the Corpus Callosum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CHANNEL ACTIVITY; CURCUMIN; KCC3; CL; EXPRESSION; TRUNCATION; MUTATIONS; CFTR	Missense and protein-truncating mutations of the human potassium-chloride co-transporter 3 gene (KCC3) cause hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC), which is a severe neurodegenerative disease characterized by axonal dysfunction and neurodevelopmental defects. We previously reported that KCC3-truncating mutations disrupt brain-type creatine kinase-dependent activation of the co-transporter through the loss of its last 140 amino acids. Here, we report a novel and more distal HMSN/ACC-truncating mutation (3402C -> T; R1134X) that eliminates only the last 17 residues of the protein. This small truncation disrupts the interaction with brain-type creatine kinase in mammalian cells but also affects plasma membrane localization of the mutant transporter. Although it is not truncated, the previously reported HMSN/ACC-causing 619C -> T (R207C) missense mutation also leads to KCC3 loss of function in Xenopus oocyte flux assay. Immunodetection in Xenopus oocytes and in mammalian cultured cells revealed a decreased amount of R207C at the plasma membrane, with significant retention of the mutant proteins in the endoplasmic reticulum. In mammalian cells, curcumin partially corrected these mutant protein mislocalizations, with more protein reaching the plasma membrane. These findings suggest that mis-trafficking of mutant protein is an important pathophysiological feature of HMSN/ACC causative KCC3 mutations.	[Salin-Cantegrel, Adele; Riviere, Jean-Baptiste; Shekarabi, Masoud; Rasheed, Sarah; Laganiere, Janet; Gaudet, Rebecca; Rochefort, Daniel; Gaspar, Claudia; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, CHUM, Res Ctr, Ctr Excellence Neur, Montreal, PQ H2L 4M1, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [DaCal, Sandra; Lapointe, Jean-Yves] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Lesca, Gaetan] Hop Edouard Herriot, Serv Genet Mol & Clin, F-69003 Lyon, France	Universite de Montreal; Universite de Montreal; Universite de Montreal; CHU Lyon	Rouleau, GA (corresponding author), 2099 Rue Alexandre de Seve,Off Y-3633, Montreal, PQ H2L 2W5, Canada.	guy.rouleau@umontreal.ca	Lesca, Gaetan/C-6111-2019	Lesca, Gaetan/0000-0001-7691-9492	Canadian Institutes of Health Research; Fondation des Jumelles Coude	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation des Jumelles Coude	This work was supported by a grant from the Canadian Institutes of Health Research and a grant by the Fondation des Jumelles Coude.	Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; Dupre N, 2003, ANN NEUROL, V54, P9, DOI 10.1002/ana.77777; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Harada K, 2007, BIOCHEM BIOPH RES CO, V353, P351, DOI 10.1016/j.bbrc.2006.12.036; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Leduc-Nadeau A, 2007, AM J PHYSIOL-CELL PH, V292, pC1132, DOI 10.1152/ajpcell.00136.2006; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; Lu M, 2006, J CLIN INVEST, V116, P797, DOI 10.1172/JCI26961; Nezu A, 2009, J BIOL CHEM, V284, P6869, DOI 10.1074/jbc.M804302200; Salin-Cantegrel A, 2007, NEUROLOGY, V69, P1350, DOI 10.1212/01.wnl.0000291779.35643.15; Salin-Cantegrel A, 2008, HUM MOL GENET, V17, P2703, DOI 10.1093/hmg/ddn172; Shen MR, 2003, J BIOL CHEM, V278, P39941, DOI 10.1074/jbc.M308232200; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; SMIT LS, 1995, HUM MOL GENET, V4, P269, DOI 10.1093/hmg/4.2.269; Uyanik G, 2006, NEUROLOGY, V66, P1044, DOI 10.1212/01.wnl.0000204181.31175.8b; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443	17	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28456	28465		10.1074/jbc.M111.226894	http://dx.doi.org/10.1074/jbc.M111.226894			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21628467	Green Published, hybrid			2022-12-27	WOS:000293557800061
J	Tremblay, R; Lemay, JF; Blouin, S; Mulhbacher, J; Bonneau, E; Legault, P; Dupont, P; Penedo, JC; Lafontaine, DA				Tremblay, Renaud; Lemay, Jean-Francois; Blouin, Simon; Mulhbacher, Jerome; Bonneau, Eric; Legault, Pascale; Dupont, Paul; Penedo, J. Carlos; Lafontaine, Daniel A.			Constitutive Regulatory Activity of an Evolutionarily Excluded Riboswitch Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; 4-WAY DNA JUNCTION; SAM-I RIBOSWITCH; APTAMER DOMAIN; PURINE RIBOSWITCH; BACILLUS-SUBTILIS; RNA STRUCTURE; ADENINE RIBOSWITCH; STRUCTURAL BASIS; GENE-EXPRESSION	The exquisite specificity of the adenine-responsive riboswitch toward its cognate metabolite has been shown to arise from the formation of a Watson-Crick interaction between the adenine ligand and residue U65. A recent crystal structure of a U65C adenine aptamer variant has provided a rationale for the phylogenetic conservation observed at position 39 for purine aptamers. The G39-C65 variant adopts a compact ligand-free structure in which G39 is accommodated by the ligand binding site and is base-paired to the cytosine at position 65. Here, we demonstrate using a combination of biochemical and biophysical techniques that the G39-C65 base pair not only severely impairs ligand binding but also disrupts the functioning of the riboswitch in vivo by constitutively activating gene expression. Folding studies using single-molecule FRET revealed that the G39-C65 variant displays a low level of dynamic heterogeneity, a feature reminiscent of ligand-bound wild-type complexes. A restricted conformational freedom together with an ability to significantly fold in monovalent ions are exclusive to the G39-C65 variant. This work provides a mechanistic framework to rationalize the evolutionary exclusion of certain nucleotide combinations in favor of sequences that preserve ligand binding and gene regulation functionalities.	[Dupont, Paul; Penedo, J. Carlos] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Tremblay, Renaud; Lemay, Jean-Francois; Blouin, Simon; Mulhbacher, Jerome; Lafontaine, Daniel A.] Univ Sherbrooke, Fac Sci, Dept Biol, Grp ARN,RNA Grp, Sherbrooke, PQ J1K 2R1, Canada; [Bonneau, Eric; Legault, Pascale] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	University of St Andrews; University of Sherbrooke; Universite de Montreal	Penedo, JC (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.	jcp10@st-andrews.ac.uk; Daniel.Lafontaine@USherbrooke.ca	Penedo, Carlos/B-5568-2009	Penedo, Carlos/0000-0002-5807-5385; Legault, Pascale/0000-0003-1782-5204; Blouin, Simon/0000-0001-8433-4654	National Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes for Health Research (CIHR) [MOP-86502, MOP-166290]; University of St. Andrews; Scottish Universities Physics Alliance (SUPA); Universite de Montreal	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of St. Andrews; Scottish Universities Physics Alliance (SUPA); Universite de Montreal	This work was supported by a grant from the National Sciences and Engineering Research Council of Canada (NSERC) (to E. B.), and by Canadian Institutes for Health Research (CIHR) Grants MOP-86502 (to P. L.), and MOP-166290 (to D. A. L.).; Supported by the University of St. Andrews and the Scottish Universities Physics Alliance (SUPA).; Supported by the graduate scholarship from the Universite de Montreal.	Bassi GS, 1997, EMBO J, V16, P7481, DOI 10.1093/emboj/16.24.7481; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blouin S, 2011, NUCLEIC ACIDS RES, V39, P3373, DOI 10.1093/nar/gkq1247; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Christiansen LC, 1997, J BACTERIOL, V179, P2540, DOI 10.1128/jb.179.8.2540-2550.1997; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Edwards AL, 2009, J MOL BIOL, V385, P938, DOI 10.1016/j.jmb.2008.10.074; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Gilbert SD, 2006, CHEM BIOL, V13, P805, DOI 10.1016/j.chembiol.2006.08.002; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Heppell B, 2011, NAT CHEM BIOL, V7, P384, DOI [10.1038/NCHEMBIO.563, 10.1038/nchembio.563]; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim JN, 2009, ACS CHEM BIOL, V4, P915, DOI 10.1021/cb900146k; Lafontaine DA, 2002, EMBO J, V21, P2461, DOI 10.1093/emboj/21.10.2461; Lafontaine DA, 2002, J MOL BIOL, V323, P23, DOI 10.1016/S0022-2836(02)00910-5; Lafontaine DA, 2001, EMBO J, V20, P1415, DOI 10.1093/emboj/20.6.1415; Lemay JF, 2007, RNA, V13, P339, DOI 10.1261/rna.142007; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Mulhbacher J, 2007, NUCLEIC ACIDS RES, V35, P5568, DOI 10.1093/nar/gkm572; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P5262, DOI 10.1093/nar/gkm565; Nudler E, 2006, CELL, V126, P19, DOI 10.1016/j.cell.2006.06.024; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pleiss JA, 1998, RNA, V4, P1313, DOI 10.1017/S135583829800106X; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2009, CURR OPIN STRUC BIOL, V19, P251, DOI 10.1016/j.sbi.2009.02.002; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; WARD DC, 1969, J BIOL CHEM, V244, P1228; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	49	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27406	27415		10.1074/jbc.M111.229047	http://dx.doi.org/10.1074/jbc.M111.229047			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676871	hybrid, Green Published			2022-12-27	WOS:000293268700036
J	Lombardi, ML; Jaalouk, DE; Shanahan, CM; Burke, B; Roux, KJ; Lammerding, J				Lombardi, Maria L.; Jaalouk, Diana E.; Shanahan, Catherine M.; Burke, Brian; Roux, Kyle J.; Lammerding, Jan			The Interaction between Nesprins and Sun Proteins at the Nuclear Envelope Is Critical for Force Transmission between the Nucleus and Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; MECHANICAL STIFFNESS; ACTIN CYTOSKELETON; MEMBRANE PROTEIN; LAMIN; STRAIN; CONNECTIONS; MECHANOTRANSDUCTION; LAMINOPATHIES; INTEGRITY	Maintaining physical connections between the nucleus and the cytoskeleton is important for many cellular processes that require coordinated movement and positioning of the nucleus. Nucleo-cytoskeletal coupling is also necessary to transmit extra-cellular mechanical stimuli across the cytoskeleton to the nucleus, where they may initiate mechanotransduction events. The LINC (Linker of Nucleoskeleton and Cytoskeleton) complex, formed by the interaction of nesprins and SUN proteins at the nuclear envelope, can bind to nuclear and cytoskeletal elements; however, its functional importance in transmitting intracellular forces has never been directly tested. This question is particularly relevant since recent findings have linked nesprin mutations to muscular dystrophy and dilated cardiomyopathy. Using biophysical assays to assess intracellular force transmission and associated cellular functions, we identified the LINC complex as a critical component for nucleo-cytoskeletal force transmission. Disruption of the LINC complex caused impaired propagation of intracellular forces and disturbed organization of the perinuclear actin and intermediate filament networks. Although mechanically induced activation of mechanosensitive genes was normal (suggesting that nuclear deformation is not required for mechanotransduction signaling) cells exhibited other severe functional defects after LINC complex disruption; nuclear positioning and cell polarization were impaired in migrating cells and in cells plated on micropatterned substrates, and cell migration speed and persistence time were significantly reduced. Taken together, our findings suggest that the LINC complex is critical for nucleo-cytoskeletal force transmission and that LINC complex disruption can result in defects in cellular structure and function that may contribute to the development of muscular dystrophies and cardiomyopathies.	[Lombardi, Maria L.; Jaalouk, Diana E.; Lammerding, Jan] Harvard Univ, Dept Med, Brigham & Womens Hosp, Sch Med, Cambridge, MA 02139 USA; [Shanahan, Catherine M.] Kings Coll London, Div Cardiovasc, London SE5 9NU, England; [Burke, Brian] Inst Med Biol, Singapore 138648, Singapore; [Roux, Kyle J.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	Harvard University; Brigham & Women's Hospital; University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); State University System of Florida; University of Florida	Lammerding, J (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Biomed Engn, 235 Weill Hall, Ithaca, NY 14853 USA.	jan.lammerding@cornell.edu	Roux, Kyle/AAH-2019-2021; Lammerding, Jan/A-9498-2016	Roux, Kyle/0000-0001-7530-5528; Lammerding, Jan/0000-0003-4335-8611; Shanahan, Catherine/0000-0002-8352-8171	National Institutes of Health [R01 NS059348, R01 HL082792]; Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER; British Heart Foundation [RG/09/008/27923] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); British Heart Foundation(British Heart Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS059348 and R01 HL082792 (to J.L.). and the Brigham and Women's Hospital Cardiovascular Leadership Group Award.	Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Brosig M, 2010, INT J BIOCHEM CELL B, V42, P1717, DOI 10.1016/j.biocel.2010.07.001; Caille N, 1998, ANN BIOMED ENG, V26, P409, DOI 10.1114/1.132; Chancellor TJ, 2010, BIOPHYS J, V99, P115, DOI 10.1016/j.bpj.2010.04.011; Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28; Coffinier C, 2010, J BIOL CHEM, V285, P20818, DOI 10.1074/jbc.M110.128835; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; De Keulenaer GW, 2002, CIRC RES, V90, P690, DOI 10.1161/01.RES.0000012922.40318.05; Folker ES, 2011, P NATL ACAD SCI USA, V108, P131, DOI 10.1073/pnas.1000824108; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Heydemann A, 2007, TRENDS CARDIOVAS MED, V17, P55, DOI 10.1016/j.tcm.2006.12.002; Lammerding J, 2003, IEEE ENG MED BIOL, V22, P124, DOI 10.1109/MEMB.2003.1256282; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Morawietz H, 1999, CIRC RES, V84, P678, DOI 10.1161/01.RES.84.6.678; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Puckelwartz MJ, 2010, J MOL CELL CARDIOL, V48, P600, DOI 10.1016/j.yjmcc.2009.11.006; Schneider M, 2011, CELL MOL LIFE SCI, V68, P1593, DOI 10.1007/s00018-010-0535-z; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; Verstraeten VLRM, 2008, AGING CELL, V7, P383, DOI 10.1111/j.1474-9726.2008.00382.x; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhen YY, 2002, J CELL SCI, V115, P3207	33	329	335	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26743	26753		10.1074/jbc.M111.233700	http://dx.doi.org/10.1074/jbc.M111.233700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652697	hybrid, Green Published			2022-12-27	WOS:000293078200051
J	Seminario-Vidal, L; Okada, SF; Sesma, JI; Kreda, SM; van Heusden, CA; Zhu, YX; Jones, LC; O'Neal, WK; Penuela, S; Laird, DW; Boucher, RC; Lazarowski, ER				Seminario-Vidal, Lucia; Okada, Seiko F.; Sesma, Juliana I.; Kreda, Silvia M.; van Heusden, Catharina A.; Zhu, Yunxiang; Jones, Lisa C.; O'Neal, Wanda K.; Penuela, Silvia; Laird, Dale W.; Boucher, Richard C.; Lazarowski, Eduardo R.			Rho Signaling Regulates Pannexin 1-mediated ATP Release from Airway Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SURFACE LIQUID VOLUME; FIND-ME SIGNAL; CILIARY ACTIVITY; MUCIN SECRETION; TRPV4 CHANNEL; SHEAR-STRESS; ACTIVATION; CELLS; MEMBRANE	ATP released from airway epithelial cells promotes purinergic receptor-regulated mucociliary clearance activities necessary for innate lung defense. Cell swelling-induced membrane stretch/strain is a common stimulus that promotes airway epithelial ATP release, but the mechanisms transducing cell swelling into ATP release are incompletely understood. Using knockdown and knockout approaches, we tested the hypothesis that pannexin 1 mediates ATP release from hypotonically swollen airway epithelia and investigated mechanisms regulating this activity. Well differentiated primary cultures of human bronchial epithelial cells subjected to hypotonic challenge exhibited enhanced ATP release, which was paralleled by the uptake of the pannexin probe propidium iodide. Both responses were reduced by pannexin 1 inhibitors and by knocking down pannexin 1. Importantly, hypotonicity-evoked ATP release from freshly excised tracheas and dye uptake in primary tracheal epithelial cells were impaired in pannexin 1 knockout mice. Hypotonicity-promoted ATP release and dye uptake in primary well differentiated human bronchial epithelial cells was accompanied by RhoA activation and myosin light chain phosphorylation and was reduced by the RhoA dominant negative mutant RhoA(T19N) and Rho and myosin light chain kinase inhibitors. ATP release and Rho activation were reduced by highly selective inhibitors of transient receptor potential vanilloid 4 (TRPV4). Lastly, knocking down TRPV4 impaired hypotonicity-evoked airway epithelial ATP release. Our data suggest that TRPV4 and Rho transduce cell membrane stretch/strain into pannexin 1-mediated ATP release in airway epithelia.	[Seminario-Vidal, Lucia; Okada, Seiko F.; Sesma, Juliana I.; Kreda, Silvia M.; van Heusden, Catharina A.; Zhu, Yunxiang; Jones, Lisa C.; O'Neal, Wanda K.; Boucher, Richard C.; Lazarowski, Eduardo R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Seminario-Vidal, Lucia] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario)	Lazarowski, ER (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 7017 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	eduardo_lazarowski@med.unc.edu	Laird, Dale W/AAL-2407-2020; Penuela, Silvia/A-6961-2010; Seminario-Vidal, Lucia/AAR-3314-2020; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; Penuela, Silvia/0000-0003-4829-5517; Seminario-Vidal, Lucia/0000-0002-6004-2451	National Institutes of Health [P01-HL034322]; Cystic Fibrosis Foundation [CFF-SEMINA08FO]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL034322. This work was also supported by Cystic Fibrosis Foundation Grant CFF-SEMINA08FO.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Blum AE, 2008, AM J PHYSIOL-CELL PH, V295, pC231, DOI 10.1152/ajpcell.00175.2008; Blum AE, 2010, AM J PHYSIOL-CELL PH, V298, pC386, DOI 10.1152/ajpcell.00430.2009; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cressman VL, 1999, J BIOL CHEM, V274, P26461, DOI 10.1074/jbc.274.37.26461; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; Davis CW, 2008, RESP PHYSIOL NEUROBI, V163, P208, DOI 10.1016/j.resp.2008.05.015; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Devor DC, 1999, AM J PHYSIOL-CELL PH, V276, pC827, DOI 10.1152/ajpcell.1999.276.4.C827; Donaldson SH, 2000, MOL MED, V6, P969, DOI 10.1007/BF03401831; Ehre C, 2007, AM J PHYSIOL-CELL PH, V293, pC1445, DOI 10.1152/ajpcell.00051.2007; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Grygorczyk R, 1996, J MEMBRANE BIOL, V151, P139, DOI 10.1007/s002329900065; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Harron SA, 2009, CAN J PHYSIOL PHARM, V87, P337, DOI [10.1139/Y09-009, 10.1139/y09-009]; Hirakawa M, 2004, J PHYSIOL-LONDON, V558, P479, DOI 10.1113/jphysiol.2004.065334; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Koyama T, 2001, J PHYSIOL-LONDON, V532, P759, DOI 10.1111/j.1469-7793.2001.0759e.x; Kreda SM, 2008, BRIT J PHARMACOL, V153, P1528, DOI 10.1038/sj.bjp.0707692; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Kreda SM, 2010, J PHYSIOL-LONDON, V588, P2255, DOI 10.1113/jphysiol.2009.186643; Krepinsky JC, 2003, J AM SOC NEPHROL, V14, P2790, DOI 10.1097/01.ASN.0000094085.04161.A7; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Sesma JI, 2009, J BIOL CHEM, V284, P12572, DOI 10.1074/jbc.M806759200; Sidhaye VK, 2008, P NATL ACAD SCI USA, V105, P3345, DOI 10.1073/pnas.0712287105; Silva GB, 2008, AM J PHYSIOL-RENAL, V295, pF1090, DOI 10.1152/ajprenal.90365.2008; Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tatur S, 2007, J PHYSIOL-LONDON, V584, P419, DOI 10.1113/jphysiol.2007.133314; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Watt WC, 1998, J BIOL CHEM, V273, P14053, DOI 10.1074/jbc.273.22.14053; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310; Zsembery A, 2004, J BIOL CHEM, V279, P10720, DOI 10.1074/jbc.M313391200	75	166	170	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26277	26286		10.1074/jbc.M111.260562	http://dx.doi.org/10.1074/jbc.M111.260562			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21606493	Green Published, hybrid			2022-12-27	WOS:000293078200004
J	Dasgupta, S; Cushman, I; Kpetemey, M; Casey, PJ; Vishwanatha, JK				Dasgupta, Subhamoy; Cushman, Ian; Kpetemey, Marilyne; Casey, Patrick J.; Vishwanatha, Jamboor K.			Prenylated C17orf37 Induces Filopodia Formation to Promote Cell Migration and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; GERANYLGERANYLTRANSFERASE-I; 17Q12 AMPLICON; LIPID RAFTS; MICE; RAS; FARNESYLTRANSFERASE; PROTEINS; GENE; MICRODOMAINS	Post-translational modification by covalent attachment of isoprenoid lipids (prenylation) regulates the functions and biological activities of several proteins implicated in the oncogenic transformation and metastatic progression of cancer. The largest group of prenylated proteins contains a CAAX motif at the C-terminal that serves as a substrate for a series of post-translational modifications that convert these otherwise hydrophilic proteins to lipidated proteins, thus facilitating membrane association. C17orf37 (chromosome 17 open reading frame 37), also known as C35/Rdx12/MGC14832, located in the 17q12 amplicon, is overexpressed in human cancer, and its expression correlates with the migratory and invasive phenotype of cancer cells. Here we show that C17orf37 contains a functional CAAX motif and is post-translationally modified by protein geranylgeranyltransferase-I (GGTase-I). Geranylgeranylation of C17orf37 at the CAAX motif facilitates association of the protein to the inner leaflet of plasma membrane, enhances migratory phenotype of cells by inducing increased filopodia formation, and potentiates directional migration. A prenylation-deficient mutant of C17orf37 is functionally inactive and fails to trigger dissemination of tail vein-injected cells in a mouse model of metastasis. These findings demonstrate that prenylation is required for the function of the C17orf37 protein in cancer cells and imply that the post-translational modification may functionally regulate metastatic progression of disease.	[Dasgupta, Subhamoy; Kpetemey, Marilyne; Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Dept Biomed Sci, Ft Worth, TX 76107 USA; [Dasgupta, Subhamoy; Kpetemey, Marilyne; Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX 76107 USA; [Cushman, Ian; Casey, Patrick J.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Cushman, Ian; Casey, Patrick J.] Duke Natl Univ Singapore Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; Duke University	Vishwanatha, JK (corresponding author), 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	jamboor.vishwanatha@unthsc.edu	Dasgupta, Subhamoy/I-6022-2015	Dasgupta, Subhamoy/0000-0001-7167-908X; Casey, Patrick/0000-0002-7366-9309; Vishwanatha, Jamboor/0000-0002-0266-6020	National Institutes of Health [MD 001633]; Department of Defense [PC081282]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001633] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant MD 001633 (to J. K. V.). This work was also supported by Department of Defense Grant PC081282 (to S. D.).	Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Axelrod D, 2001, J BIOMED OPT, V6, P6, DOI 10.1117/1.1335689; Bergo MO, 2004, J BIOL CHEM, V279, P4729, DOI 10.1074/jbc.M310081200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; BRADLEY MO, 1986, P NATL ACAD SCI USA, V83, P5277, DOI 10.1073/pnas.83.14.5277; Carrico D, 2004, BIOORGAN MED CHEM, V12, P6517, DOI 10.1016/j.bmc.2004.09.020; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; DER CJ, 1991, CANCER CELL-MON REV, V3, P331; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Kauraniemi P, 2003, AM J PATHOL, V163, P1979, DOI 10.1016/S0002-9440(10)63556-0; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Lin X, 2002, GASTROENTEROLOGY, V123, P345, DOI 10.1053/gast.2002.34279; Magdalena J, 2003, MOL BIOL CELL, V14, P670, DOI 10.1091/mbc.e02-06-0345; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Magee Anthony I, 2003, Biochem J, V376, pe3, DOI 10.1042/BJ20031531; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Maqani N, 2006, MOL CANCER RES, V4, P449, DOI 10.1158/1541-7786.MCR-06-0058; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Ostrom Rennolds S., 2007, V400, P459; Pei ZT, 2003, J BIOL CHEM, V278, P47070, DOI 10.1074/jbc.M310075200; Peterson YK, 2006, J BIOL CHEM, V281, P12445, DOI 10.1074/jbc.M600168200; Prior IA, 2001, J CELL SCI, V114, P1603; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rothermund Christy A, 2005, BMC Urol, V5, P5, DOI 10.1186/1471-2490-5-5; Shaikh SR, 2006, CHEM PHYS LIPIDS, V144, P1, DOI 10.1016/j.chemphyslip.2006.06.017; Sun JZ, 1999, CANCER RES, V59, P4919; Thissen JA, 1996, ANAL BIOCHEM, V243, P80, DOI 10.1006/abio.1996.0484; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van Meer G, 2002, SCIENCE, V296, P855, DOI 10.1126/science.1071491; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Woo JT, 2005, BIOCHEM PHARMACOL, V69, P87, DOI 10.1016/j.bcp.2004.08.036; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; ZHANG FL, 1994, J BIOL CHEM, V269, P23465; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	42	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25935	25946		10.1074/jbc.M111.254599	http://dx.doi.org/10.1074/jbc.M111.254599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628459	Green Published, hybrid			2022-12-27	WOS:000293073000053
J	Leung, GP; Lee, L; Schmidt, TI; Shirahige, K; Kobor, MS				Leung, Grace P.; Lee, Linda; Schmidt, Thorsten I.; Shirahige, Katsuhiko; Kobor, Michael S.			Rtt107 Is Required for Recruitment of the SMC5/6 Complex to DNA Double Strand Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE RESPONSE; REPAIR; GENES; YEAST; RECOMBINATION; CHECKPOINT; REVEALS; MODULES	Genome integrity is maintained by a network of DNA damage response pathways, including checkpoints and DNA repair processes. In Saccharomyces cerevisiae, the BRCT domain-containing protein Rtt107/Esc4 is required for the restart of DNA replication after successful repair of DNA damage and for cellular resistance to DNA-damaging agents. In addition to its well characterized interaction with the endonuclease Slx4, Rtt107 interacts with a number of other DNA repair and recombination proteins. These include the evolutionarily conserved SMC5/6 complex, which is involved in numerous chromosome maintenance activities, such as DNA repair, chromosome segregation, and telomere function. The interaction between Rtt107 and the SMC5/6 complex was mediated through the N-terminal BRCT domains of Rtt107 and the Nse6 subunit of SMC5/6 and was independent of methyl methane sulfonate-induced damage and Slx4. Supporting a shared function in the DNA damage response, Rtt107 was required for recruitment of SMC5/6 to DNA double strand breaks. However, this functional relationship did not extend to other types of DNA lesions such as protein-bound nicks. Interestingly, Rtt107 was phosphorylated when SMC5/6 function was compromised in the absence of DNA-damaging agents, indicating a connection beyond the DNA damage response. Genetic analyses revealed that, although a subset of Rtt107 and SMC5/6 functions was shared, these proteins also contributed independently to maintenance of genome integrity.	[Leung, Grace P.; Lee, Linda; Schmidt, Thorsten I.; Kobor, Michael S.] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; [Shirahige, Katsuhiko] Univ Tokyo, Lab Genome Struct & Funct, Ctr Epigenet Dis, Inst Mol & Cellular Biosci,Bunkyo Ku, Tokyo 1130032, Japan	Child & Family Research Institute; University of British Columbia; University of Tokyo	Kobor, MS (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	msk@cmmt.ubc.ca		Shirahige, Katsuhiko/0000-0002-7862-1144; Kobor, Michael/0000-0003-4140-1743	Canadian Institutes of Health Research [MOP-79442]; Natural Sciences and Engineering Research Council of Canada; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Child and Family Research Institute	This work was supported in part by Canadian Institutes of Health Research Grant MOP-79442 (to M. S. K.).; Supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada.; Supported by a fellowship from the Child and Family Research Institute.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; AMBERG DC, 2005, METHODS YEAST GENETI, P155; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Flott S, 2005, BIOCHEM J, V391, P325, DOI 10.1042/BJ20050768; Fujioka Y, 2002, J BIOL CHEM, V277, P21585, DOI 10.1074/jbc.M201523200; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Haber JE, 2002, METHOD ENZYMOL, V350, P141, DOI 10.1016/S0076-6879(02)50961-7; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; James P, 1996, GENETICS, V144, P1425; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Levesque N, 2010, J BIOL CHEM, V285, P35113, DOI 10.1074/jbc.M110.116855; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Nielsen I, 2009, NAT METHODS, V6, P753, DOI [10.1038/NMETH.1372, 10.1038/nmeth.1372]; OGAWA H, 1995, ADV BIOPHYS, V31, P67, DOI 10.1016/0065-227X(95)99383-Z; Ohouo PY, 2010, MOL CELL, V39, P300, DOI 10.1016/j.molcel.2010.06.019; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Rouse J, 2004, EMBO J, V23, P1188, DOI 10.1038/sj.emboj.7600129; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	35	32	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26250	26257		10.1074/jbc.M111.235200	http://dx.doi.org/10.1074/jbc.M111.235200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642432	Green Published, hybrid			2022-12-27	WOS:000293073000082
J	Zhang, NY; Jacobson, AD; MacFadden, A; Liu, CW				Zhang, Nan-Yan; Jacobson, Andrew D.; MacFadden, Andrea; Liu, Chang-Wei			Ubiquitin Chain Trimming Recycles the Substrate Binding Sites of the 26 S Proteasome and Promotes Degradation of Lysine 48-linked Polyubiquitin Conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYME; PROTEIN; SUBUNIT; RPN13; UCH37; RECOGNITION; ACTIVATION; RECEPTOR; REVEALS; ANALOGS	The 26 S proteasome possesses two distinct deubiquitinating activities. The ubiquitin (Ub) chain amputation activity removes the entire polyUb chain from the substrates. The Ub chain trimming activity progressively cleaves a polyUb chain from the distal end. The Ub chain amputation activity mediates degradation-coupled deubiquitination. The Ub chain trimming activity can play a supportive or an inhibitory role in degradation, likely depending on features of the substrates. How Ub chain trimming assists degradation is not clear. We find that inhibition of the chain trimming activity of the 26 S proteasome with Ub aldehyde significantly inhibits degradation of Ub(4) (Lys-48)-UbcH10 and causes accumulation of free Ub(4) (generated from chain amputation) that can be retained on the proteasome. Also, a non-trimmable Lys-48-mimic Ub(4) efficiently targets UbcH10 to the 26 S proteasome, but it cannot support efficient degradation of UbcH10 compared with regular Lys-48 Ub(4). These results indicate that polyUb chain trimming promotes proteasomal degradation of Lys-48-linked substrates. Mechanistically, we propose that Ub chain trimming cleaves the proteasome-bound Lys-48-linked polyUb chains, which vacates the Ub binding sites of the 26 S proteasome, thus allowing continuous substrate loading.	[Zhang, Nan-Yan; Jacobson, Andrew D.; MacFadden, Andrea; Liu, Chang-Wei] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Liu, CW (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	changwei.liu@ucdenver.edu			American Heart Association; American Cancer Society	American Heart Association(American Heart Association); American Cancer Society(American Cancer Society)	This work was supported in part by grants from the American Heart Association and the American Cancer Society (to C. W. L.).	Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; MA CP, 1994, J BIOL CHEM, V269, P3539; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; Park KC, 1997, ARCH BIOCHEM BIOPHYS, V347, P78, DOI 10.1006/abbi.1997.0311; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Raasi Shahri, 2005, V301, P47; Russell NS, 2004, BIOCHEMISTRY-US, V43, P4844, DOI 10.1021/bi035626r; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zhao ML, 2010, J BIOL CHEM, V285, P4771, DOI 10.1074/jbc.M109.060095	38	11	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25540	25546		10.1074/jbc.M111.260505	http://dx.doi.org/10.1074/jbc.M111.260505			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632534	hybrid, Green Published			2022-12-27	WOS:000293073000016
J	Boyle, KA; Stanitsa, ES; Greseth, MD; Lindgren, JK; Traktman, P				Boyle, Kathleen A.; Stanitsa, Eleni S.; Greseth, Matthew D.; Lindgren, Jill K.; Traktman, Paula			Evaluation of the Role of the Vaccinia Virus Uracil DNA Glycosylase and A20 Proteins as Intrinsic Components of the DNA Polymerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; TEMPERATURE-SENSITIVE MUTANTS; VIRAL-DNA; PROCESSIVITY FACTOR; GENETIC-CHARACTERIZATION; CRYSTAL-STRUCTURE; CATALYTIC-SITE; D5 PROTEIN; IN-VITRO; REPLICATION	The vaccinia virus DNA polymerase is inherently distributive but acquires processivity by associating with a heterodimeric processivity factor comprised of the viral A20 and D4 proteins. D4 is also an enzymatically active uracil DNA glycosylase (UDG). The presence of an active repair protein as an essential component of the polymerase holoenzyme is a unique feature of the replication machinery. We have shown previously that the A20-UDG complex has a stoichiometry of similar to 1:1, and our data suggest that A20 serves as a bridge between polymerase and UDG. Here we show that conserved hydrophobic residues in the N' terminus of A20 are important for its binding to UDG. Our data argue against the assembly of D4 into higher order multimers, suggesting that the processivity factor does not form a toroidal ring around the DNA. Instead, we hypothesize that the intrinsic, processive DNA scanning activity of UDG tethers the holoenzyme to the DNA template. The inclusion of UDG as an essential holoenzyme component suggests that replication and base excision repair may be coupled. Here we show that the DNA polymerase can utilize dUTP as a substrate in vitro. Moreover, uracil moieties incorporated into the nascent strand during holoenzyme-mediated DNA synthesis can be excised by the viral UDG present within this holoenzyme, leaving abasic sites. Finally, we show that the polymerase stalls upon encountering an abasic site in the template strand, indicating that, like many replicative polymerases, the poxviral holoenzyme cannot perform translesion synthesis across an abasic site.	[Boyle, Kathleen A.; Stanitsa, Eleni S.; Greseth, Matthew D.; Lindgren, Jill K.; Traktman, Paula] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Traktman, P (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd,BSB 273, Milwaukee, WI 53226 USA.	ptrakt@mcw.edu		Traktman, Paula/0000-0002-6517-0225	National Institutes of Health [2 R01 AI21758]; Great Lakes Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research [1-U54-AI057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI021758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Great Lakes Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 AI21758. This work was also supported by developmental grants from the Great Lakes Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (1-U54-AI057153; to P. T.).	Andrei G, 2006, J VIROL, V80, P9391, DOI 10.1128/JVI.00605-06; Beaud G, 1995, BIOCHIMIE, V77, P774, DOI 10.1016/0300-9084(96)88195-8; Bogani F, 2008, P NATL ACAD SCI USA, V105, P11709, DOI 10.1073/pnas.0806375105; Bogani F, 2010, J BIOL CHEM, V285, P27664, DOI 10.1074/jbc.M110.131235; Bogani F, 2009, J BIOL CHEM, V284, P16784, DOI 10.1074/jbc.M109.010413; Boyle K, 2009, VIRAL GENOME REPLICATION, P225, DOI 10.1007/b135974_12; Boyle KA, 2007, J VIROL, V81, P844, DOI 10.1128/JVI.02217-06; BROYLES SS, 1993, VIROLOGY, V195, P863, DOI 10.1006/viro.1993.1446; Bruck I, 2001, GENOME BIOL, V2; CHALLBERG MD, 1979, J BIOL CHEM, V254, P7820; CHALLBERG MD, 1979, J BIOL CHEM, V254, P7812; D'Costa SM, 2010, VIROLOGY, V401, P49, DOI 10.1016/j.virol.2010.01.020; DALES S, 1978, VIROLOGY, V84, P403, DOI 10.1016/0042-6822(78)90258-1; De Silva FS, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-23; De Silva FS, 2007, P NATL ACAD SCI USA, V104, P18724, DOI 10.1073/pnas.0709276104; De Silva FS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-145; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; DEFILIPPES FM, 1984, J VIROL, V52, P474, DOI 10.1128/JVI.52.2.474-482.1984; DEFILIPPES FM, 1989, J VIROL, V63, P4060, DOI 10.1128/JVI.63.9.4060-4063.1989; Ellison KS, 1996, J VIROL, V70, P7965, DOI 10.1128/JVI.70.11.7965-7973.1996; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; EVANS E, 1995, J VIROL, V69, P5353, DOI 10.1128/JVI.69.9.5353-5361.1995; EVANS E, 1992, CHROMOSOMA, V102, pS72, DOI 10.1007/BF02451789; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; FOCHER F, 1990, MUTAT RES, V237, P65, DOI 10.1016/0921-8734(90)90012-G; FOCHER F, 1992, CHROMOSOMA, V102, pS67, DOI 10.1007/BF02451788; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gammon DB, 2009, J VIROL, V83, P4236, DOI 10.1128/JVI.02255-08; Garcia AD, 2001, J VIROL, V75, P6460, DOI 10.1128/JVI.75.14.6460-6471.2001; Holzer GW, 1997, J VIROL, V71, P4997, DOI 10.1128/JVI.71.7.4997-5002.1997; Hwang YT, 1997, J VIROL, V71, P7791, DOI 10.1128/JVI.71.10.7791-7798.1997; Ishii K, 2002, VIROLOGY, V303, P232, DOI 10.1006/viro.2002.1721; Ishii K, 2001, J VIROL, V75, P1656, DOI 10.1128/JVI.75.4.1656-1663.2001; Kato SEM, 2008, VIROLOGY, V375, P213, DOI 10.1016/j.virol.2008.01.027; Klemperer N, 2001, J VIROL, V75, P12298, DOI 10.1128/JVI.75.24.12298-12307.2001; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lackner CA, 2003, VIROLOGY, V305, P240, DOI 10.1006/viro.2002.1745; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; McConnell M, 1996, BIOCHEMISTRY-US, V35, P8268, DOI 10.1021/bi9530649; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McDonald WF, 1997, VIROLOGY, V234, P168, DOI 10.1006/viro.1997.8639; MCDONALD WF, 1994, PROTEIN EXPRES PURIF, V5, P409, DOI 10.1006/prep.1994.1059; MCDONALD WF, 1994, J BIOL CHEM, V269, P31190; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; Moss Bernard, 2006, V47, P707; MULLANEY J, 1989, J GEN VIROL, V70, P449, DOI 10.1099/0022-1317-70-2-449; NEUMULLER M, 1990, BIOTECHNOL APPL BIOC, V12, P34; Paran N, 2009, CELL HOST MICROBE, V6, P563, DOI 10.1016/j.chom.2009.11.005; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Prichard MN, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-55; Punjabi A, 2001, J VIROL, V75, P12308, DOI 10.1128/JVI.75.24.12308-12318.2001; Randell JCW, 2004, J MOL BIOL, V335, P409, DOI 10.1016/j.jmb.2003.10.064; Ranneberg-Nilsen T, 2008, J MOL BIOL, V381, P276, DOI 10.1016/j.jmb.2008.05.028; Reddy SM, 1998, VIROLOGY, V251, P393, DOI 10.1006/viro.1998.9428; Reineks EZ, 2003, J MOL BIOL, V328, P1027, DOI 10.1016/S0022-2836(03)00370-X; REMPEL RE, 1990, J VIROL, V64, P574, DOI 10.1128/JVI.64.2.574-583.1990; REMPEL RE, 1992, J VIROL, V66, P4413, DOI 10.1128/JVI.66.7.4413-4426.1992; Rochester SC, 1998, J VIROL, V72, P2917, DOI 10.1128/JVI.72.4.2917-2926.1998; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Schormann N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-45; Senkevich TG, 2009, P NATL ACAD SCI USA, V106, P17921, DOI 10.1073/pnas.0909529106; Shudofsky AMD, 2010, J VIROL, V84, P12325, DOI 10.1128/JVI.01435-10; SRIDHAR P, 1983, VIROLOGY, V128, P444, DOI 10.1016/0042-6822(83)90269-6; Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200; Strang BL, 2010, J GEN VIROL, V91, P2029, DOI 10.1099/vir.0.022160-0; STUART DT, 1993, J VIROL, V67, P2503, DOI 10.1128/JVI.67.5.2503-2512.1993; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TADDIE JA, 1991, J VIROL, V65, P869, DOI 10.1128/JVI.65.2.869-879.1991; TADDIE JA, 1993, J VIROL, V67, P4323, DOI 10.1128/JVI.67.7.4323-4336.1993; Tanguy Le Gac Nicolas, 2004, J Mol Biol, V336, P1023; TRAKTMAN P, 1989, J BIOL CHEM, V264, P21458; TRAKTMAN P, 1989, J VIROL, V63, P841, DOI 10.1128/JVI.63.2.841-846.1989; TRAKTMAN P, 1996, DNA REPLICATION EUKA, P775; Traktman Paula, 2004, Methods Mol Biol, V269, P169; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017; Zhu Y, 2008, DNA REPAIR, V7, P95, DOI 10.1016/j.dnarep.2007.08.001; Zhu YL, 2003, J VIROL, V77, P10147, DOI 10.1128/JVI.77.18.10147-10153.2003	86	34	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24702	24713		10.1074/jbc.M111.222216	http://dx.doi.org/10.1074/jbc.M111.222216			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21572084	Green Published, hybrid			2022-12-27	WOS:000292547900021
J	Xu, T; Wang, XH; Zhong, B; Nurieva, RI; Ding, S; Dong, C				Xu, Tao; Wang, Xiaohu; Zhong, Bo; Nurieva, Roza I.; Ding, Sheng; Dong, Chen			Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of ROR lambda t Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; GAMMA-T; TH17 CELLS; DIFFERENTIATION; LINEAGE; ALPHA; EXPRESSION; DISTINCT	Th17 cells have recently emerged as a major player in inflammatory and autoimmune diseases via the production of pro-inflammatory cytokines IL-17, IL-17F, and IL-22. The differentiation of Th17 cells and the associated cytokine production is directly controlled by ROR gamma t. Here we show that ursolic acid (UA), a small molecule present in herbal medicine, selectively and effectively inhibits the function of ROR gamma t, resulting in greatly decreased IL-17 expression in both developing and differentiated Th17 cells. In addition, treatment with UA ameliorated experimental autoimmune encephalomyelitis. The results thus suggest UA as a valuable drug candidate or leading compound for developing treatments of Th17-mediated inflammatory diseases and cancer.	[Xu, Tao; Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wang, Xiaohu; Zhong, Bo; Nurieva, Roza I.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Wang, Xiaohu; Zhong, Bo; Nurieva, Roza I.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77030 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ding, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	sheng.ding@gladstone.ucsf.edu; CDong@mdanderson.org	dong, chen/B-3181-2009; Xu, Tao/I-1561-2014	dong, chen/0000-0002-0084-9130; Xu, Tao/0000-0002-3436-3024; Xu, Tao/0000-0002-4085-6191	National Multiple Sclerosis Society (NMSS); NIH through NIAID; National Institutes of Health through NICHD; NHLBI; National Institute of Mental Health; California Institute for Regenerative Medicine; Prostate Cancer Foundation; Fate Therapeutics; Esther B. O'Keeffe Foundation; Scripps Research Institute; National Institutes of Health through NIAMS; Leukemia and Lymphoma, Society; M.D. Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083761] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); NIH through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health through NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Prostate Cancer Foundation; Fate Therapeutics; Esther B. O'Keeffe Foundation; Scripps Research Institute; National Institutes of Health through NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Leukemia and Lymphoma, Society(Leukemia and Lymphoma Society); M.D. Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Recipient of a National Multiple Sclerosis Society (NMSS) postdoctoral fellowship.; Supported by NIH through NIAID.; Supported by funding from the National Institutes of Health through NICHD, NHLBI, and the National Institute of Mental Health, the California Institute for Regenerative Medicine, the Prostate Cancer Foundation, Fate Therapeutics, the Esther B. O'Keeffe Foundation, and the Scripps Research Institute. To whom correspondence may be addressed. E-mail: sheng.ding@gladstone.ucsf.edu.; Supported by grants from the National Institutes of Health through NIAMS, the Leukemia and Lymphoma, Society, and the M.D. Anderson Cancer Center. To whom correspondence may be addressed. E-mail: CDong@mdanderson.org.	Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huang HC, 2009, MOL CARCINOGEN, V48, P517, DOI 10.1002/mc.20490; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lauthier F, 2000, ANTI-CANCER DRUG, V11, P737; Lee AW, 2010, J AGR FOOD CHEM, V58, P12941, DOI 10.1021/jf103265x; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Shishodia S, 2003, CANCER RES, V63, P4375; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Xie HM, 2005, J IMMUNOL, V175, P3800, DOI 10.4049/jimmunol.175.6.3800; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	23	162	175	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22707	22710		10.1074/jbc.C111.250407	http://dx.doi.org/10.1074/jbc.C111.250407			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566134	hybrid, Green Published			2022-12-27	WOS:000292025000004
J	Zhou, HH; Zha, Z; Liu, Y; Zhang, HT; Zhu, JJ; Hu, SY; Shen, GD; Cheng, LS; Niu, LW; Greene, MI; Teng, MK; Liu, J				Zhou, Huihao; Zha, Zhao; Liu, Yang; Zhang, Hongtao; Zhu, Juanjuan; Hu, Siyi; Shen, Guodong; Cheng, Liansheng; Niu, Liwen; Greene, Mark I.; Teng, Maikun; Liu, Jing			Structural Insights into the Down-regulation of Overexpressed p185(her2/neu) Protein of Transformed Cells by the Antibody chA21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; METASTATIC BREAST-CANCER; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; ERBB RECEPTORS; EXTRACELLULAR REGION; TYROSINE KINASES; PHASE-II; HER2; TRASTUZUMAB	p185(her2/neu) belongs to the ErbB receptor tyrosine kinase family, which has been associated with human breast, ovarian, and lung cancers. Targeted therapies employing ectodomain-specific p185(her2/neu) monoclonal antibodies (mAbs) have demonstrated clinical efficacy for breast cancer. Our previous studies have shown that p185(her2/neu) mAbs are able to disable the kinase activity of homomeric and heteromeric kinase complexes and induce the conversion of the malignant to normal phenotype. We previously developed a chimeric antibody chA21 that specifically inhibits the growth of p185(her2/neu)-overexpressing cancer cells in vitro and in vivo. Herein, we report the crystal structure of the single-chain Fv of chA21 in complex with an N-terminal fragment of p185(her2/neu), which reveals that chA21 binds a region opposite to the dimerization interface, indicating that chA21 does not directly disrupt the dimerization. In contrast, the bivalent chA21 leads to internalization and down-regulation of p185(her2/neu). We propose a structure-based model in which chA21 cross-links two p185(her2/neu) molecules on separate homo- or heterodimers to form a large oligomer in the cell membrane. This model reveals a mechanism for mAbs to drive the receptors into the internalization/degradation path from the inactive hypophosphorylated tetramers formed dynamically by active dimers during a "physiologic process."	[Zhou, Huihao; Zha, Zhao; Liu, Yang; Zhu, Juanjuan; Hu, Siyi; Shen, Guodong; Cheng, Liansheng; Niu, Liwen; Teng, Maikun; Liu, Jing] Univ Sci & Technol China, Chinese Acad Sci, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Zhou, Huihao; Niu, Liwen; Teng, Maikun] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China; [Zhang, Hongtao; Greene, Mark I.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Pennsylvania	Teng, MK (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, 96 Jinzhai Rd, Hefei 230027, Anhui, Peoples R China.	mkteng@ustc.edu.cn; jliu@ustc.edu.cn	沈, 国栋/ABA-5925-2021; ZHOU, HUIHAO/L-6133-2016	沈, 国栋/0000-0003-2521-8738; ZHOU, HUIHAO/0000-0002-9675-5007; Zhang, Hongtao/0000-0001-9173-0049	National Natural Science Foundation of China [30570362, 30121001, 30025012, 30571066]; Hi-Tech Research and Development Program ("863" Program) of China [2006AA02A245]; Ministry of Science and Technology of China [2006CB806500, 2006CB910200, 2006AA02A318]; Chinese Academy of Sciences [KSCX2-YW-R-60]; National Major Special Science and Technology Project of China [2009ZX09102-223]; NATIONAL CANCER INSTITUTE [R01CA089481, R01CA149425] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Major Special Science and Technology Project of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants from the National Natural Science Foundation of China (Grants 30570362, 30121001, 30025012, and 30571066), Hi-Tech Research and Development Program ("863" Program) of China (Grant 2006AA02A245), Ministry of Science and Technology of China (Grants 2006CB806500, 2006CB910200, and 2006AA02A318), Chinese Academy of Sciences (Grant KSCX2-YW-R-60), and National Major Special Science and Technology Project of China (Grant 2009ZX09102-223).	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Baulida J, 1997, EXP CELL RES, V232, P167, DOI 10.1006/excr.1997.3515; Baulida J, 1996, J BIOL CHEM, V271, P5251; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Cai Z, 2008, ONCOGENE, V27, P3870, DOI 10.1038/onc.2008.13; Chandarlapaty S, 2010, ONCOGENE, V29, P325, DOI 10.1038/onc.2009.337; Cheng LS, 2003, CELL RES, V13, P35, DOI 10.1038/sj.cr.7290149; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Furuuchi K, 2007, J IMMUNOL, V178, P1021, DOI 10.4049/jimmunol.178.2.1021; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Hu SY, 2008, PROTEINS, V70, P938, DOI 10.1002/prot.21551; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Klapper LN, 1997, ONCOGENE, V14, P2099, DOI 10.1038/sj.onc.1201029; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; LESCAR J, 1995, J BIOL CHEM, V270, P18067, DOI 10.1074/jbc.270.30.18067; Li X, 2007, CANCER RES, V67, P8716, DOI 10.1158/0008-5472.CAN-06-3731; Liu Y, 2009, ACTA CRYSTALLOGR F, V65, P692, DOI 10.1107/S1744309109020107; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Molina MA, 2001, CANCER RES, V61, P4744; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Rourke DM, 1998, P NATL ACAD SCI USA, V95, P10842, DOI 10.1073/pnas.95.18.10842; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; QIAN XL, 1995, ONCOGENE, V10, P211; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Shen GD, 2011, CANCER IMMUNOL IMMUN, V60, P339, DOI 10.1007/s00262-010-0937-7; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; WADA T, 1990, ONCOGENE, V5, P489; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; WILSON IA, 1991, CIBA F SYMP, V159, P13; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; XU FG, 1993, INT J CANCER, V53, P401, DOI 10.1002/ijc.2910530310; Yip YL, 2003, INT J CANCER, V104, P303, DOI 10.1002/ijc.10951; Zhang AL, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-20	48	24	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31676	31683		10.1074/jbc.M111.235184	http://dx.doi.org/10.1074/jbc.M111.235184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21680730	Green Published, hybrid			2022-12-27	WOS:000294487500060
J	Wu, H; Teng, PN; Jayaraman, T; Onishi, S; Li, JH; Bannon, L; Huang, HZ; Close, J; Sfeir, C				Wu, Hong; Teng, Pang-Ning; Jayaraman, Thottala; Onishi, Shinsuke; Li, Jinhua; Bannon, Leslie; Huang, Hongzhang; Close, John; Sfeir, Charles			Dentin Matrix Protein 1 (DMP1) Signals via Cell Surface Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; GENE-TRANSCRIPTION; MESENCHYMAL CELLS; STEM-CELLS; KINASE; DIFFERENTIATION; BIOMINERALIZATION; ACTIVATION; PATHWAY; ROLES	Dentin matrix phosphoprotein 1 (DMP1) is a non-collagenous, acidic extracellular matrix protein expressed chiefly in bone and dentin. We examined the DMP1 ability to engage cell-surface receptors and subsequently activate intracellular signaling pathways. Our data indeed show that the presence of extracellular DMP1 triggers focal adhesion point formation in human mesenchymal stem cells and osteoblast-like cells. We determine that DMP1 acts via interaction with alpha v beta 3 integrin and stimulates phosphorylation of focal adhesion kinase. Further biochemical characterization confirms the activation of downstream effectors of the MAPK pathways, namely ERK and JNK, after DMP1 treatment. This activation is specifically inhibitable and can also be blocked by the addition of anti-alpha v beta 3 integrin antibody. Furthermore, we show that extracellular treatment with DMP1 stimulates the translocation of phosphorylated JNK to the nucleus and a concomitant up-regulation of transcriptional activation by phosphorylated c-Jun. The evidence presented here indicates that DMP1 is specifically involved in signaling via extracellular matrix-cell surface interaction. Combined with the published DMP1-null data (Feng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S. I., Zhang, S., Rios, H., Drezner, M. K., Quarles, L. D., Bonewald, L. F., and White, K. E. (2006) Nat. Genet. 38, 1310-1315) it can be hypothesized that DMP1 could be a key effector of ECM-osteocyte signaling.	[Wu, Hong; Huang, Hongzhang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Stomotol, Guangzhou 51025, Guangdong, Peoples R China; [Wu, Hong; Teng, Pang-Ning; Jayaraman, Thottala; Onishi, Shinsuke; Li, Jinhua; Bannon, Leslie; Close, John; Sfeir, Charles] Univ Pittsburgh, Dept Oral Biol, Ctr Craniofacial Regenerat, Pittsburgh, PA 15261 USA; [Teng, Pang-Ning; Sfeir, Charles] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA	Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sfeir, C (corresponding author), 552 Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.	csfeir@pitt.edu			National Tissue Engineering Center [DAMD17-02-1-0717]; Center for Craniofacial Regeneration at the University of Pittsburgh	National Tissue Engineering Center; Center for Craniofacial Regeneration at the University of Pittsburgh	This work was supported by National Tissue Engineering Center Grant DAMD17-02-1-0717 and the Center for Craniofacial Regeneration at the University of Pittsburgh for supporting this research.	Almushayt A, 2006, GENE THER, V13, P611, DOI 10.1038/sj.gt.3302687; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Caverzasio J, 2007, ENDOCRINOLOGY, V148, P5323, DOI 10.1210/en.2007-0520; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Karadag A, 2005, CANCER RES, V65, P11545, DOI 10.1158/0008-5472.CAN-05-2861; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kulkarni GV, 2000, ARCH ORAL BIOL, V45, P475, DOI 10.1016/S0003-9969(00)00010-8; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Nemoto S, 1998, MOL CELL BIOL, V18, P3518, DOI 10.1128/MCB.18.6.3518; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin CL, 2006, J BIOL CHEM, V281, P8034, DOI 10.1074/jbc.M512964200; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Robinson CJM, 2001, CELL SIGNAL, V13, P29, DOI 10.1016/S0898-6568(00)00121-2; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; von Marschall Z, 2008, J BIOL CHEM, V283, P32730, DOI 10.1074/jbc.M804283200; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Wang JX, 2006, CALCIFIED TISSUE INT, V79, P179, DOI 10.1007/s00223-006-0018-2; Zhao M, 2002, J BONE MINER RES, V17, P1441, DOI 10.1359/jbmr.2002.17.8.1441	38	41	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29462	29469		10.1074/jbc.M110.194746	http://dx.doi.org/10.1074/jbc.M110.194746			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21642437	Green Published, hybrid			2022-12-27	WOS:000294046600003
J	Marrs, WR; Horne, EA; Ortega-Gutierrez, S; Cisneros, JA; Xu, C; Lin, YH; Muccioli, GG; Lopez-Rodriguez, ML; Stella, N				Marrs, William R.; Horne, Eric A.; Ortega-Gutierrez, Silvia; Antonio Cisneros, Jose; Xu, Cong; Lin, Yi Hsing; Muccioli, Giulio G.; Lopez-Rodriguez, Maria L.; Stella, Nephi			Dual Inhibition of alpha/beta-Hydrolase Domain 6 and Fatty Acid Amide Hydrolase Increases Endocannabinoid Levels in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOACYLGLYCEROL LIPASE; ANANDAMIDE HYDROLYSIS; CANNABINOID RECEPTORS; CORTICAL-NEURONS; BRAIN; BLOCKADE; MODULATION; 2-ARACHIDONOYLGLYCEROL; IDENTIFICATION; EFFICACY	Agonists at cannabinoid receptors, such as the phytocannabinoid Delta(9)-tetrahydrocannabinol, exert a remarkable array of therapeutic effects but are also associated with undesirable psychoactive side effects. Conversely, targeting enzymes that hydrolyze endocannabinoids (eCBs) allows for more precise fine-tuning of cannabinoid receptor signaling, thus providing therapeutic relief with reduced side effects. Here, we report the development and characterization of an inhibitor of eCB hydrolysis, UCM710, which augments both N-arachidonoylethanolamine and 2-arachidonoylglycerol levels in neurons. This compound displays a unique pharmacological profile in that it inhibits fatty acid amide hydrolase and alpha/beta-hydrolase domain 6 but not monoacylglycerol lipase. Thus, UCM710 represents a novel tool to delineate the therapeutic potential of compounds that manipulate a subset of enzymes that control eCB signaling.	[Horne, Eric A.; Xu, Cong; Lin, Yi Hsing; Stella, Nephi] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Marrs, William R.] Univ Washington, Neurobiol & Behav Grad Program, Seattle, WA 98195 USA; [Ortega-Gutierrez, Silvia; Antonio Cisneros, Jose; Lopez-Rodriguez, Maria L.] Univ Complutense, Fac Ciencias Quim, Dept Quim Organ 1, E-28040 Madrid, Spain; [Muccioli, Giulio G.] Catholic Univ Louvain, Bioanal & Pharmacol Bioact Lipids Lab, CHAM7230, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Stella, Nephi] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Complutense University of Madrid; Universite Catholique Louvain; University of Washington; University of Washington Seattle	Stella, N (corresponding author), Univ Washington, Dept Pharmacol, 1959 Pacific Ave N, Seattle, WA 98195 USA.	nstella@uw.edu	Lopez-Rodriguez, Maria L/S-6342-2016; Ortega-Gutierrez, Silvia/I-1935-2017; Ortega-Gutierrez, Silvia/ABC-7653-2021; Cisneros Trigo, Jose Antonio/B-1050-2018	Lopez-Rodriguez, Maria L/0000-0001-8607-1085; Ortega-Gutierrez, Silvia/0000-0002-0257-6754; Cisneros Trigo, Jose Antonio/0000-0003-3679-7878; Muccioli, Giulio/0000-0002-1600-9259	National Institute on Drug Abuse [DA026430]; National Institutes of Health United States Public Health Service from NIGMS [2T32 GM007270]; Spanish Ministerio de Ciencia e Innovacion (MICINN); European Social Fund [SAF2010-22198-C02-01]; Ramon y Cajal Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026430] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health United States Public Health Service from NIGMS; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Social Fund(European Social Fund (ESF)); Ramon y Cajal Program(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute on Drug Abuse Grant DA026430 (to N. S.) and National Institutes of Health United States Public Health Service National Research Service Award 2T32 GM007270 from NIGMS (to W. R. M.). This work was also supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN), European Social Fund Grant SAF2010-22198-C02-01 (to M. L. L.-R.), and the Ramon y Cajal Program (to S. O.-G.).	Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Cisneros JA, 2007, J MED CHEM, V50, P5012, DOI 10.1021/jm070642y; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Horne EA, 2008, FUTURE LIPIDOL, V3, P435, DOI 10.2217/17460875.3.4.435; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; King AR, 2009, BRIT J PHARMACOL, V157, P974, DOI 10.1111/j.1476-5381.2009.00276.x; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Lichtman AH, 2005, HANDB EXP PHARMACOL, V168, P691; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marrs W, 2007, CHEM BIOL, V14, P1309, DOI 10.1016/j.chembiol.2007.12.004; Marrs W, 2009, AAPS J, V11, P307, DOI 10.1208/s12248-009-9109-0; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STELLA N, 1995, J NEUROSCI, V15, P3307; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437	26	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28723	28728		10.1074/jbc.M110.202853	http://dx.doi.org/10.1074/jbc.M110.202853			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21665953	hybrid, Green Published			2022-12-27	WOS:000293837000010
J	Crottes, D; Martial, S; Rapetti-Mauss, R; Pisani, DF; Loriol, C; Pellissier, B; Martin, P; Chevet, E; Borgese, F; Soriani, O				Crottes, David; Martial, Sonia; Rapetti-Mauss, Raphael; Pisani, Didier F.; Loriol, Celine; Pellissier, Bernard; Martin, Patrick; Chevet, Eric; Borgese, Franck; Soriani, Olivier			Sig1R Protein Regulates hERG Channel Expression through a Post-translational Mechanism in Leukemic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PITUITARY MELANOTROPE CELLS; SIGMA-1 RECEPTOR; POTASSIUM CHANNEL; I-KR; K+ CHANNEL; ION CHANNELS; LIPID RAFTS; SURFACE; CANCER; SITES	Sig1R (Sigma-1receptor) is a 25-kDa protein structurally unrelated to other mammalian proteins. Sig1R is present in brain, liver, and heart and is overexpressed in cancer cells. Studies using exogenous sigma ligands have shown that Sig1R interacts with a variety of ion channels, but its intrinsic function and mechanism of action remain unclear. The human ether-a-gogo related gene (hERG) encodes a cardiac channel that is also abnormally expressed in many primary human cancers, potentiating tumor progression through the modulation of extracellular matrix adhesive interactions. We show herein that sigma ligands inhibit hERG current density and cell adhesion to fibronectin in K562 myeloid leukemia cells. Heterologous expression in Xenopus oocytes demonstrates that Sig1R potentiates hERG current by stimulating channel subunit biosynthesis. Silencing Sig1R in leukemic K562 cells depresses hERG current density and cell adhesion to fibronectin by reducing hERG membrane expression. In K562 cells, Sig1R silencing does not modify hERG mRNA contents but reduces hERG mature form densities. In HEK cells expressing hERG and Sig1R, both proteins co-immunoprecipitate, demonstrating a physical association. Finally, Sig1R expression enhances both channel protein maturation and stability. Altogether, these results demonstrate for the first time that Sig1R controls ion channel expression through the regulation of subunit trafficking activity.	[Crottes, David; Martial, Sonia; Rapetti-Mauss, Raphael; Pisani, Didier F.; Pellissier, Bernard; Martin, Patrick; Borgese, Franck; Soriani, Olivier] CNRS, UMR 6543, F-06108 Nice 2, France; [Crottes, David; Martial, Sonia; Rapetti-Mauss, Raphael; Pisani, Didier F.; Pellissier, Bernard; Martin, Patrick; Borgese, Franck; Soriani, Olivier] Univ Nice, UMR 6543, F-06108 Nice 2, France; [Loriol, Celine] CNRS, Inst Pharmacol Mol & Cellulaire, Inst Neuromed Mol, F-06560 Valbonne, France; [Chevet, Eric] Univ Bordeaux 2, INSERM, U1053, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Soriani, O (corresponding author), CNRS, UMR 6543, F-06108 Nice 2, France.	soriani@unice.fr	RAPETTI-MAUSS, Raphael/A-6486-2010; Pisani, Didier/AAC-2997-2019; Rapetti-Mauss, Raphael/P-3437-2016; chevet, eric/E-4992-2016; Martial, Sonia/L-8270-2019	Pisani, Didier/0000-0001-5879-8527; chevet, eric/0000-0001-5855-4522; Martial, Sonia/0000-0002-6732-0936; soriani, olivier/0000-0001-9485-3992; BORGESE, Franck/0000-0001-7718-2111; RAPETTI-MAUSS, Raphael/0000-0002-3518-4845	University of Nice-Sophia Antipolis; CNRS; Association Ti'Toine Normandie; Region PACA; Vaincre la Mucoviscidose	University of Nice-Sophia Antipolis; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association Ti'Toine Normandie; Region PACA(Region Provence-Alpes-Cote d'Azur); Vaincre la Mucoviscidose	This work was supported by the University of Nice-Sophia Antipolis, the CNRS and the Association Ti'Toine Normandie.; Recipient of a fellowship from Region PACA and CNRS.; Recipient of a fellowship from Vaincre la Mucoviscidose.	Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Cavarra MS, 2007, J MEMBRANE BIOL, V219, P49, DOI 10.1007/s00232-007-9060-x; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Fraser SP, 2008, EMBO REP, V9, P512, DOI 10.1038/embor.2008.75; Ganapathi SB, 2010, AM J PHYSIOL-CELL PH, V299, pC74, DOI 10.1152/ajpcell.00462.2009; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Herrera Y, 2008, J PHARMACOL EXP THER, V327, P491, DOI 10.1124/jpet.108.143974; Hofmann G, 2001, J BIOL CHEM, V276, P4923, DOI 10.1074/jbc.M005682200; Jean-Yves L, 2007, RECENT PAT ANTI-CANC, V2, P189, DOI 10.2174/157489207782497244; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Mavlyutov Timur A, 2007, J Mol Signal, V2, P8, DOI 10.1186/1750-2187-2-8; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Meng XB, 2005, J CELL SCI, V118, P4009, DOI 10.1242/jcs.02520; Monnet FP, 2006, J PHARMACOL SCI, V100, P93, DOI 10.1254/jphs.CR0050032; Morin-Surun MP, 1999, P NATL ACAD SCI USA, V96, P8196, DOI 10.1073/pnas.96.14.8196; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Pillozzi S, 2011, BLOOD, V117, P902, DOI 10.1182/blood-2010-01-262691; Pillozzi S, 2010, ADV EXP MED BIOL, V674, P55; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Renaudo A, 2004, J PHARMACOL EXP THER, V311, P1105, DOI 10.1124/jpet.104.072413; Renaudo A, 2007, J BIOL CHEM, V282, P2259, DOI 10.1074/jbc.M607915200; ROMAN FJ, 1990, J PHARM PHARMACOL, V42, P439, DOI 10.1111/j.2042-7158.1990.tb06588.x; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Soriani O, 1998, J PHARMACOL EXP THER, V286, P163; Soriani O, 1999, J PHARMACOL EXP THER, V289, P321; Soriani O, 1999, AM J PHYSIOL-ENDOC M, V277, pE73, DOI 10.1152/ajpendo.1999.277.1.E73; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tsai Shang-Yi, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P184; Vernon-Wilson EF, 2007, J LEUKOCYTE BIOL, V82, P1278, DOI 10.1189/jlb.0507283	48	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27947	27958		10.1074/jbc.M111.226738	http://dx.doi.org/10.1074/jbc.M111.226738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680736	Green Published, hybrid			2022-12-27	WOS:000293557800013
J	Guo, AJY; Choi, RCY; Cheung, AWH; Chen, VP; Xu, SL; Dong, TTX; Chen, JJ; Tsim, KWK				Guo, Ava J. Y.; Choi, Roy C. Y.; Cheung, Anna W. H.; Chen, Vicky P.; Xu, Sherry L.; Dong, Tina T. X.; Chen, Ji J.; Tsim, Karl W. K.			Baicalin, a Flavone, Induces the Differentiation of Cultured Osteoblasts AN ACTION VIA THE Wnt/beta-CATENIN SIGNALING PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-REPLACEMENT THERAPY; BONE LOSS; POSTMENOPAUSAL OSTEOPOROSIS; SCUTELLARIA-BAICALENSIS; HEME OXYGENASE-1; GENE-EXPRESSION; PROTEIN; OSTEOPROTEGERIN; GENISTEIN; CELLS	Flavonoids, a group of natural compounds found in a variety of vegetables and herbal medicines, have been intensively reported on regarding their estrogen-like activities and particularly their ability to affect bone metabolism. Here, different subclasses of flavonoids were screened for their osteogenic properties by measuring alkaline phosphatase activity in cultured rat osteoblasts. The flavone baicalin derived mainly from the roots of Scutellaria baicalensis showed the strongest induction of alkaline phosphatase activity. In cultured osteoblasts, application of baicalin increased significantly the osteoblastic mineralization and the levels of mRNAs encoding the bone differentiation markers, including osteonectin, osteocalcin, and collagen type 1 alpha 1. Interestingly, the osteogenic effect of baicalin was not mediated by its estrogenic activity. In contrast, baicalin promoted osteoblastic differentiation via the activation of the Wnt/beta-catenin signaling pathway; the activation resulted in the phosphorylation of glycogen synthase kinase 3 beta and, subsequently, induced the nuclear accumulation of the beta-catenin, leading to the transcription activation of Wnt-targeted genes for osteogenesis. The baicalin-induced osteogenic effects were fully abolished by DKK-1, a blocker of Wnt/beta-catenin receptor. Moreover, baicalin also enhanced the mRNA expression of osteoprotegerin, which could regulate indirectly the activation of osteoclasts. Taken together, our results suggested that baicalin could act via Wnt/beta-catenin signaling to promote osteoblastic differentiation. The osteogenic flavonoids could be very useful in finding potential drugs, or food supplements, for treating post-menopausal osteoporosis.	[Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Ji J.] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources W China, Kunming Inst Bot, Kunming 650204, Yunnan, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.	BOTSIM@UST.HK	CHEN, VICKY/C-9223-2016; chen, JJ/HGB-6029-2022	CHEN, VICKY/0000-0003-3753-7170; 	Research Grants Council of Hong Kong HKUST [6419/06M, 662608, N-HKUST629/07]; Croucher Foundation [CAS-CF07/08.SC03]	Research Grants Council of Hong Kong HKUST(Hong Kong Research Grants Council); Croucher Foundation	This work was supported by Research Grants Council of Hong Kong HKUST 6419/06M, 662608, and N-HKUST629/07 and The Croucher Foundation Grant CAS-CF07/08.SC03 (to K. W. K. T.).	Akao T, 2000, J PHARM PHARMACOL, V52, P1563, DOI 10.1211/0022357001777621; Arjmandi BH, 1998, AM J CLIN NUTR, V68, p1358S, DOI 10.1093/ajcn/68.6.1358S; Arjmandi BH, 1996, J NUTR, V126, P161, DOI 10.1093/jn/126.1.161; Berg AO, 2003, AM J NURS, V103, P83; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi RCY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen085; Choi RCY, 2010, J ALZHEIMERS DIS, V19, P795, DOI 10.3233/JAD-2010-1293; Chow JM, 2005, BIOCHEM PHARMACOL, V69, P1839, DOI 10.1016/j.bcp.2005.03.017; DIDDLE AW, 1984, SOUTH MED J, V77, P868, DOI 10.1097/00007611-198407000-00020; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Gao YH, 1999, BIOCHEM PHARMACOL, V58, P767, DOI 10.1016/S0006-2952(99)00162-8; Glazier MG, 2001, ARCH INTERN MED, V161, P1161, DOI 10.1001/archinte.161.9.1161; Heino TJ, 2008, J ENDOCRINOL, V197, pR1, DOI 10.1677/JOE-07-0629; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382; Horcajada-Molteni MN, 2000, J BONE MINER RES, V15, P2251, DOI 10.1359/jbmr.2000.15.11.2251; Kim HM, 1999, TOXICOLOGY, V135, P109, DOI 10.1016/S0300-483X(99)00047-5; Lin HY, 2005, J CELL PHYSIOL, V202, P579, DOI 10.1002/jcp.20160; Morabito N, 2002, J BONE MINER RES, V17, P1904, DOI 10.1359/jbmr.2002.17.10.1904; MOSCARINI M, 1994, GYNECOL ENDOCRINOL, V8, P203, DOI 10.3109/09513599409072456; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; RIZZOLI R, 1997, LANCET S1, V49, pS20; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; SEEMAN E, 1992, J BONE MINER RES, V7, P1467; Shang YZ, 2006, BIOL PHARM BULL, V29, P805, DOI 10.1248/bpb.29.805; Shen YC, 2003, EUR J PHARMACOL, V465, P171, DOI 10.1016/S0014-2999(03)01378-5; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Song Yuan-zong, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P339; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Walle T, 2005, J NUTR, V135, P48, DOI 10.1093/jn/135.1.48; Windahl SH, 2002, TRENDS ENDOCRIN MET, V13, P195, DOI 10.1016/S1043-2760(02)00594-5; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu JB, 2008, EUR J PHARMACOL, V588, P333, DOI 10.1016/j.ejphar.2008.04.030; Yamaguchi M, 1998, BIOCHEM PHARMACOL, V55, P71, DOI 10.1016/S0006-2952(97)00402-4; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zheng YZ, 2010, PLANTA MED, V76, P439, DOI 10.1055/s-0029-1186222; Zhu JTT, 2007, J AGR FOOD CHEM, V55, P2438, DOI 10.1021/jf063299z	40	95	99	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27882	27893		10.1074/jbc.M111.236281	http://dx.doi.org/10.1074/jbc.M111.236281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21652696	hybrid, Green Published			2022-12-27	WOS:000293557800007
J	Mandic, SA; Skelin, M; Johansson, JU; Rupnik, MS; Berggren, PO; Bark, C				Mandic, Slavena A.; Skelin, Masa; Johansson, Jenny U.; Rupnik, Marjan S.; Berggren, Per-Olof; Bark, Christina			Munc18-1 and Munc18-2 Proteins Modulate beta-Cell Ca2+ Sensitivity and Kinetics of Insulin Exocytosis Differently	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETION; SYNTAXIN; SNARE; INTERACTS; MUNC-18; ROLES; IDENTIFICATION; ISOFORM; RELEASE; GLUCOSE	Fast neurotransmission and slower hormone release share the same core fusion machinery consisting of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins. In evoked neurotransmission, interactions between SNAREs and the Munc18-1 protein, a member of the Sec1/Munc18 (SM) protein family, are essential for exocytosis, whereas other SM proteins are dispensable. To address if the exclusivity of Munc18-1 demonstrated in neuroexocytosis also applied to fast insulin secretion, we characterized the presence and function of Munc18-1 and its closest homologue Munc18-2 in beta-cell stimulus-secretion coupling. We show that pancreatic beta-cells express both Munc18-1 and Munc18-2. The two Munc18 homologues exhibit different subcellular localization, and only Munc18-1 redistributes in response to glucose stimulation. However, both Munc18-1 and Munc18-2 augment glucose-stimulated hormone release. Ramp-like photorelease of caged Ca2+ and high resolution whole-cell patch clamp recordings show that Munc18-1 and Munc18-2 overexpression shift the Ca2+ sensitivity of the fastest phase of insulin exocytosis differently. In addition, we reveal that Ca2+ sensitivity of exocytosis in beta-cells depends on the phosphorylation status of the Munc18 proteins. Even though Munc18-1 emerges as the key SM-protein determining the Ca2+ threshold for triggering secretory activity in a stimulated beta-cell, Munc18-2 has the ability to increase Ca2+ sensitivity and thus mediates the release of fusion-competent granules requiring a lower cytoplasmic-free Ca2+ concentration, [Ca2+](i). Hence, Munc18-1 and Munc18-2 display distinct subcellular compartmentalization and can coordinate the insulin exocytotic process differently as a consequence of the actual [Ca2+](i).	[Mandic, Slavena A.; Berggren, Per-Olof; Bark, Christina] Karolinska Inst, Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; [Skelin, Masa; Rupnik, Marjan S.] Univ Maribor, Inst Physiol, Fac Med, SLO-2000 Maribor, Slovenia; [Johansson, Jenny U.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Karolinska Institutet; Karolinska University Hospital; University of Maribor; Stanford University	Berggren, PO (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, L1-03, SE-17176 Stockholm, Sweden.	Per-Olof.Berggren@ki.se	Rupnik, Marjan Slak/R-4738-2019; Slak Rupnik, Marjan/E-6246-2015	Rupnik, Marjan Slak/0000-0002-3744-4882; Slak Rupnik, Marjan/0000-0002-3744-4882; Bark, Christina/0000-0002-0724-6017; Berggren, Per-Olof/0000-0001-8991-413X	Swedish Research Council; Novo Nordisk Foundation; Swedish Council for Working Life and Social Research; Stockholm County Council; Karolinska Institutet; Anders Otto Swards/Ulrika Eklunds Foundations; Family Erling-Persson Foundation; Swedish Diabetes Association; Berth von Kantzows Foundation; Euro-Dia; Family Knut and Alice Wallenberg Foundation; VIBRANT [FP7-228933-2]; Skandia Insurance Company Ltd.; Slovenian Research Agency [J3-7618-2334]; Max-Planck International Partner Group; Novo Nordisk Fonden [NNF11OC1014706] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Anders Otto Swards/Ulrika Eklunds Foundations; Family Erling-Persson Foundation; Swedish Diabetes Association; Berth von Kantzows Foundation; Euro-Dia; Family Knut and Alice Wallenberg Foundation; VIBRANT; Skandia Insurance Company Ltd.; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Max-Planck International Partner Group; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by The Swedish Research Council, The Novo Nordisk Foundation, The Swedish Council for Working Life and Social Research, The Stockholm County Council, Funds from Karolinska Institutet, Anders Otto Swards/Ulrika Eklunds Foundations, the Family Erling-Persson Foundation, The Swedish Diabetes Association, The Berth von Kantzows Foundation, Euro-Dia, The Family Knut and Alice Wallenberg Foundation, VIBRANT (FP7-228933-2), Skandia Insurance Company Ltd., Strategic Research Program in Diabetes at Karolinska Institutet, Slovenian Research Agency Grant J3-7618-2334, and Max-Planck International Partner Group scheme.	Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dong YM, 2007, BIOCHEM BIOPH RES CO, V360, P609, DOI 10.1016/j.bbrc.2007.06.107; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Fukuda M, 2005, J BIOL CHEM, V280, P39175, DOI 10.1074/jbc.M505759200; Gauthier BR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1279, DOI 10.1152/ajpendo.90568.2008; Halachmi N, 1996, J NEUROCHEM, V66, P889; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; HELLMAN B, 1965, ANN NY ACAD SCI, V131, P541, DOI 10.1111/j.1749-6632.1965.tb34819.x; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Imai A, 2004, ARCH BIOCHEM BIOPHYS, V422, P175, DOI 10.1016/j.abb.2003.12.021; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kang Y, 2002, DIABETOLOGIA, V45, P231, DOI 10.1007/s00125-001-0718-0; KATAGIRI H, 1995, J BIOL CHEM, V270, P4963, DOI 10.1074/jbc.270.10.4963; Ko J, 2001, J NEUROSCI, V21, P6758; Kortevveg N, 2005, BIOL CELL, V97, P445, DOI 10.1042/BC20040101; Korteweg N, 2004, EUR J NEUROSCI, V19, P2944, DOI 10.1111/j.0953-816X.2004.03383.x; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Lam PPL, 2007, MOL BIOL CELL, V18, P2473, DOI 10.1091/mbc.E06-10-0950; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Nigam R, 2005, BBA-GENE STRUCT EXPR, V1728, P77, DOI 10.1016/j.bbaexp.2005.01.018; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Peng RW, 2010, METAB ENG, V12, P18, DOI 10.1016/j.ymben.2009.08.007; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Riento K, 1996, EUR J BIOCHEM, V239, P638, DOI 10.1111/j.1432-1033.1996.0638u.x; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Rose T, 2007, J GEN PHYSIOL, V129, P493, DOI 10.1085/jgp.200609604; Schutz D, 2005, EUR J NEUROSCI, V21, P2419, DOI 10.1111/j.1460-9568.2005.04095.x; Sedej S, 2004, J PHYSIOL-LONDON, V555, P769, DOI 10.1113/jphysiol.2003.058271; Skelin M, 2011, CELL CALCIUM, V49, P89, DOI 10.1016/j.ceca.2010.12.005; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tang D, 1996, Prog Cell Cycle Res, V2, P205; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Tomas A, 2008, TRAFFIC, V9, P813, DOI 10.1111/j.1600-0854.2008.00709.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wan QF, 2004, J GEN PHYSIOL, V124, P653, DOI 10.1085/jgp.200409082; Yang Y, 2004, J GEN PHYSIOL, V124, P641, DOI 10.1085/jgp.200409081; Zhang W, 2000, J BIOL CHEM, V275, P41521, DOI 10.1074/jbc.M005479200; Zhang Y, 2009, J BIOL CHEM, V284, P20840, DOI 10.1074/jbc.M109.017467	54	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28026	28040		10.1074/jbc.M111.235366	http://dx.doi.org/10.1074/jbc.M111.235366			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21690086	Green Published, hybrid			2022-12-27	WOS:000293557800021
J	Pan, MR; Peng, G; Hung, WC; Lin, SY				Pan, Mei-Ren; Peng, Guang; Hung, Wen-Chun; Lin, Shiaw-Yih			Monoubiquitination of H2AX Protein Regulates DNA Damage Response Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; GENOMIC INSTABILITY; UBIQUITIN; REPAIR; MDC1; BMI1; UBIQUITYLATION; RECRUITMENT; GAMMA-H2AX	Double strand breaks (DSBs) are the most deleterious of the DNA lesions that initiate genomic instability and promote tumorigenesis. Cells have evolved a complex protein network to detect, signal, and repair DSBs. In mammalian cells, a key component in this network is H2AX, which becomes rapidly phosphorylated at Ser(139) (gamma-H2AX) at DSBs. Here we show that monoubiquitination of H2AX mediated by the RNF2-BMI1 complex is critical for the efficient formation of gamma-H2AX and functions as a proximal regulator in DDR (DNA damage response). RNF2-BMI1 interacts with H2AX in a DNA damage-dependent manner and is required for monoubiquitination of H2AX at Lys(119)/Lys(120). As a functional consequence, we show that the H2AX K120R mutant abolishes H2AX monoubiquitination, impairs the recruitment of p-ATM (Ser(1981)) to DSBs, and thereby reduces the formation of gamma-H2AX and the recruitment of MDC1 to DNA damage sites. These data suggest that monoubiquitination of H2AX plays a critical role in initiating DNA damage signaling. Consistent with these observations, impairment of RNF2-BMI1 function by siRNA knockdown or overexpression of the ligase-dead RNF2 mutant all leads to significant defects both in accumulation of gamma-H2AX, p-ATM, and MDC1 at DSBs and in activation of NBS1 and CHK2. Additionally, the regulatory effect of RNF2-BMI1 on gamma-H2AX formation is dependent on ATM. Lacking their ability to properly activate the DNA damage signaling pathway, RNF2-BMI1 complex-depleted cells exhibit impaired DNA repair and increased sensitivity to ionizing radiation. Together, our findings demonstrate a distinct monoubiquitination-dependent mechanism that is required for H2AX phosphorylation and the initiation of DDR.	[Pan, Mei-Ren; Peng, Guang; Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA; [Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 70456, Taiwan	University of Texas System; UTMD Anderson Cancer Center; National Health Research Institutes - Taiwan	Lin, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, 7435 Fannin St, Houston, TX 77054 USA.	sylin@mdanderson.org	Hung, Wen-Chun/F-4846-2011; Pan, Mei-Ren/I-2021-2013					Alajez NM, 2009, CELL DEATH DIFFER, V16, P1469, DOI 10.1038/cdd.2009.85; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lukas J, 2009, NATURE, V458, P581, DOI 10.1038/458581a; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005	35	112	117	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28599	28607		10.1074/jbc.M111.256297	http://dx.doi.org/10.1074/jbc.M111.256297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676867	Green Published, hybrid			2022-12-27	WOS:000293557800074
J	Albrecht, R; Zeth, K				Albrecht, Reinhard; Zeth, Kornelius			Structural Basis of Outer Membrane Protein Biogenesis in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; YAET COMPLEX; BAM COMPLEX; DOMAIN; SECRETION; INSIGHTS; CONSERVATION; ARCHITECTURE; FLEXIBILITY; RECOGNITION	In Escherichia coli, a multicomponent BAM (beta-barrel assembly machinery) complex is responsible for recognition and assembly of outer membrane beta-barrel proteins. The functionality of BAM in protein biogenesis is mainly orchestrated through the presence of two essential components, BamA and BamD. Here, we present crystal structures of four lipoproteins (BamBE). Monomeric BamB and BamD proteins display scaffold architectures typically implied in transient protein interactions. BamB is a beta-propeller protein comprising eight WD40 repeats. BamD shows an elongated fold on the basis of five tetratricopeptide repeats, three of which form the scaffold for protein recognition. The rod-shaped BamC protein has evolved through the gene duplication of two conserved domains known to mediate protein interactions in structurally related complexes. By contrast, the dimeric BamE is formed through a domain swap and indicates fold similarity to the beta-lactamase inhibitor protein family, possibly integrating cell wall stability in BAM function. Structural and biochemical data show evidence for the specific recognition of amphipathic sequences through the tetratricopeptide repeat architecture of BamD. Collectively, our data advance the understanding of the BAM complex and highlight the functional importance of BamD in amphipathic outer membrane beta-barrel protein motif recognition and protein delivery.	[Albrecht, Reinhard; Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society	Zeth, K (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	Kornelius.Zeth@tuebingen.mpg.de						Albrecht R, 2010, ACTA CRYSTALLOGR F, V66, P1586, DOI 10.1107/S1744309110034160; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Barta ML, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-21; Behrens-Kneip S, 2010, INT J MED MICROBIOL, V300, P421, DOI 10.1016/j.ijmm.2010.04.012; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; deCock H, 1997, J MOL BIOL, V269, P473, DOI 10.1006/jmbi.1997.1069; DORAN JL, 1990, J BACTERIOL, V172, P4909, DOI 10.1128/jb.172.9.4909-4918.1990; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FRASCH CE, 1978, J BACTERIOL, V136, P1127, DOI 10.1128/JB.136.3.1127-1134.1978; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Glover WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007316; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Gretes M, 2009, J MOL BIOL, V389, P289, DOI 10.1016/j.jmb.2009.03.058; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; HAGAN CL, 2010, ANN REV BIOCH; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; HEUCK A, 2011, J MOL BIOL; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Lehr U, 2010, MOL MICROBIOL, V78, P932, DOI 10.1111/j.1365-2958.2010.07377.x; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; POOLMAN JT, 1980, INFECT IMMUN, V30, P642; Reynolds KA, 2006, J BIOL CHEM, V281, P26745, DOI 10.1074/jbc.M603878200; Ryan KR, 2010, MICROBIOL-SGM, V156, P742, DOI 10.1099/mic.0.035055-0; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Soo PC, 2005, INFECT IMMUN, V73, P6075, DOI 10.1128/IAI.73.9.6075-6084.2005; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 1997, PROTEINS, V27, P110; Vanini MMT, 2008, PROTEINS, V71, P2051, DOI 10.1002/prot.21886; Tokuda H, 2004, BIOCHIM BIOPHYS ACTA, V1694, pIN1; Tokuda H, 2009, BIOSCI BIOTECH BIOCH, V73, P465, DOI 10.1271/bbb.80778; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xu CX, 2006, PROTEOMICS, V6, P462, DOI 10.1002/pmic.200500219	62	68	74	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27792	27803		10.1074/jbc.M111.238931	http://dx.doi.org/10.1074/jbc.M111.238931			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21586578	Green Published, hybrid			2022-12-27	WOS:000293268700071
J	Jefferson, T; Causevic, M; Keller, UAD; Schilling, O; Isbert, S; Geyer, R; Maier, W; Tschickardt, S; Jumpertz, T; Weggen, S; Bond, JS; Overall, CM; Pietrzik, CU; Becker-Pauly, C				Jefferson, Tamara; Causevic, Mirsada; Keller, Ulrich Auf Dem; Schilling, Oliver; Isbert, Simone; Geyer, Rebecca; Maier, Wladislaw; Tschickardt, Sabrina; Jumpertz, Thorsten; Weggen, Sascha; Bond, Judith S.; Overall, Christopher M.; Pietrzik, Claus U.; Becker-Pauly, Christoph			Metalloprotease Meprin beta Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; ALPHA-SUBUNIT; CLEAVAGE; BINDING; HIPPOCAMPAL; ACTIVATION; EXPRESSION; SECRETASE; DOMAIN; SITE	Identification of physiologically relevant substrates is still the most challenging part in protease research for understanding the biological activity of these enzymes. The zinc-dependent metalloprotease meprin beta is known to be expressed in many tissues with functions in health and disease. Here, we demonstrate unique interactions between meprin beta and the amyloid precursor protein (APP). Although APP is intensively studied as a ubiquitously expressed cell surface protein, which is involved in Alzheimer disease, its precise physiological role and relevance remain elusive. Based on a novel proteomics technique termed terminal amine isotopic labeling of substrates (TAILS), APP was identified as a substrate for meprin beta. Processing of APP by meprin beta was subsequently validated using in vitro and in vivo approaches. N-terminal APP fragments of about 11 and 20 kDa were found in human and mouse brain lysates but not in meprin beta(-/-)mouse brain lysates. Although these APP fragments were in the range of those responsible for caspase-induced neurodegeneration, we did not detect cytotoxicity to primary neurons treated by these fragments. Our data demonstrate that meprin beta is a physiologically relevant enzyme in APP processing.	[Causevic, Mirsada; Isbert, Simone; Maier, Wladislaw; Tschickardt, Sabrina; Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55128 Mainz, Germany; [Keller, Ulrich Auf Dem] ETH Honggerberg, Swiss Fed Inst Technol Zurich, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Schilling, Oliver] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Jumpertz, Thorsten; Weggen, Sascha] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Bond, Judith S.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	Johannes Gutenberg University of Mainz; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; Heinrich Heine University Dusseldorf; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of British Columbia	Pietrzik, CU (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55128 Mainz, Germany.	pietrzik@uni-mainz.de; beckerpa@uni-mainz.de	Keller, Ulrich auf dem/G-6004-2012; Keller, Ulrich auf dem/X-2710-2019; Causevic, Mirsada/AAM-7423-2020; Schilling, O/AAC-8302-2019; Becker-Pauly, Christoph/B-7569-2011	Keller, Ulrich auf dem/0000-0002-3431-7415; Keller, Ulrich auf dem/0000-0002-3431-7415; Causevic, Mirsada/0000-0002-6099-6415; Schilling, Oliver/0000-0001-7678-7653	Deutsche Forschungsgemeinschaft [DFG BE 4086/1-2, DFG PI 379/5-1, SCHI871/2-1]; Competence Network Degenerative Dementias of the German Federal Ministry of Education [01GI1004D, 01GI1004B]; Johannes Gutenberg-University Mainz, Germany; National Institutes of Health, NIDDK [DK 54625, DK 19691]; European Community [200931]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019691, R56DK019691, R01DK054625, R37DK019691] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Competence Network Degenerative Dementias of the German Federal Ministry of Education; Johannes Gutenberg-University Mainz, Germany; National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Community(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Deutsche Forschungsgemeinschaft Grants DFG BE 4086/1-2 (to C. B.-P.), DFG PI 379/5-1 (to C. U. P.), and SCHI871/2-1 (to O.S.), by the Competence Network Degenerative Dementias of the German Federal Ministry of Education Grants 01GI1004D (to C. U. P.) and 01GI1004B (to S. W.), and a start-up grant of the Johannes Gutenberg-University Mainz, Germany (to C. B.-P.). The meprin beta<SUP>-/-</SUP> mice were generated with support from National Institutes of Health Grants DK 54625 and DK 19691 from NIDDK (to J. S. B.). The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7) under Grant 200931 (Project IBDase).	Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Bondarava M, 2009, PFLUG ARCH EUR J PHY, V458, P675, DOI 10.1007/s00424-009-0649-z; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; De Strooper B, 2000, J CELL SCI, V113, P1857; DELVAUX A, 1992, FEBS LETT, V297, P124, DOI 10.1016/0014-5793(92)80341-D; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoareau C, 2008, NEUROBIOL AGING, V29, P542, DOI 10.1016/j.neurobiolaging.2006.11.012; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Keller UAD, 2010, BIOCHIMIE, V92, P1705, DOI 10.1016/j.biochi.2010.04.027; Keller UAD, 2010, MOL CELL PROTEOMICS, V9, P912, DOI 10.1074/mcp.M000032-MCP201; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kusumoto M, 1996, J NEUROCHEM, V67, P1613; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; Multhaup G, 1998, BIOCHEMISTRY-US, V37, P7224, DOI 10.1021/bi980022m; Nday CM, 2010, BRAIN RES, V1352, P265, DOI 10.1016/j.brainres.2010.07.008; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x; Oneda B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002278; PETERSEN LC, 1993, EUR J BIOCHEM, V214, P271, DOI 10.1111/j.1432-1033.1993.tb17921.x; PORTELIUS E, 1996, NEUROBIOL AGING, V67, P1613; Portelius E, 2009, NEURODEGENER DIS, V6, P87, DOI 10.1159/000203774; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; SAMBROOK J, 1989, NATURE, V342, P224, DOI 10.1038/342224a0; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schutte A, 2007, BIOL CHEM, V388, P523, DOI 10.1515/BC.2007.060; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Sinha S, 2002, MED CLIN N AM, V86, P629, DOI 10.1016/S0025-7125(02)00022-6; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SMALL DH, 1994, J NEUROSCI, V14, P2117; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; White AR, 1999, J NEUROSCI, V19, P9170; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Yura RE, 2009, AM J PHYSIOL-RENAL, V296, pF135, DOI 10.1152/ajprenal.90524.2008; Zhang HD, 2009, NEUROBIOL AGING, V30, P1245, DOI 10.1016/j.neurobiolaging.2007.11.013	61	76	79	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27741	27750		10.1074/jbc.M111.252718	http://dx.doi.org/10.1074/jbc.M111.252718			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646356	hybrid, Green Published			2022-12-27	WOS:000293268700066
J	Takematsu, H; Yamamoto, H; Naito-Matsui, Y; Fujinawa, R; Tanaka, K; Okuno, Y; Tanaka, Y; Kyogashima, M; Kannagi, R; Kozutsumi, Y				Takematsu, Hiromu; Yamamoto, Harumi; Naito-Matsui, Yuko; Fujinawa, Reiko; Tanaka, Kouji; Okuno, Yasushi; Tanaka, Yoshimasa; Kyogashima, Mamoru; Kannagi, Reiji; Kozutsumi, Yasunori			Quantitative Transcriptomic Profiling of Branching in a Glycosphingolipid Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI-APPARATUS; GLYCOLIPID SYNTHESIS; MOLECULAR-CLONING; CYTOPLASMIC TAIL; UDP-GLCNAC; RAT-BRAIN; SYNTHASE; CELLS; LACTOSYLCERAMIDE; EXPRESSION	Cellular biosynthesis of macromolecules often involves highly branched enzyme pathways, thus cellular regulation of such pathways could be rather difficult. To understand the regulatory mechanism, a systematic approach could be useful. We genetically analyzed a branched biosynthetic pathway for glycosphingolipid (GSL) GM1 using correlation index-based responsible enzyme gene screening (CIRES), a novel quantitative phenotype-genotype correlation analysis. CIRES utilizes transcriptomic profiles obtained from multiple cells. Among a panel of B cell lines, expression of GM1 was negatively correlated with and suppressed by gene expression of CD77 synthase (CD77Syn), whereas no significant positive correlation was found for enzymes actually biosynthesizing GM1. Unexpectedly, a GM1-suppressive phenotype was also observed in the expression of catalytically inactive CD77Syn, ruling out catalytic consumption of lactosylceramide (LacCer) as the main cause for such negative regulation. Rather, CD77Syn seemed to limit other branching reaction(s) by targeting LacCer synthase (LacCer-Syn), a proximal enzyme in the pathway, because they were closely localized in the Golgi apparatus and formed a complex. Moreover, turnover of LacCerSyn was accelerated upon CD77Syn expression to globally change the GSL species expressed. Collectively, these data suggest that transcriptomic assessment of macromolecule biosynthetic pathways can disclose a global regulatory mechanism(s) even when unexpected.	[Takematsu, Hiromu; Yamamoto, Harumi; Naito-Matsui, Yuko; Kozutsumi, Yasunori] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto 6068501, Japan; [Okuno, Yasushi] Kyoto Univ, Dept Syst Biosci Drug Discovery, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Tanaka, Yoshimasa] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Yamamoto, Harumi; Fujinawa, Reiko; Kozutsumi, Yasunori] RIKEN, RIKEN Frontier Res Syst, Supra Macromol Syst Res Grp, Wako, Saitama 3510198, Japan; [Tanaka, Kouji; Kyogashima, Mamoru; Kannagi, Reiji] Aichi Canc Ctr, Div Mol Pathol, Aichi 4648681, Japan; [Tanaka, Kouji; Kyogashima, Mamoru] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Oncol, Aichi 4648681, Japan	Kyoto University; Kyoto University; Kyoto University; RIKEN; Aichi Cancer Center; Nagoya City University	Takematsu, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto 6068501, Japan.	htakema@pharm.kyoto-u.ac.jp	Kannagi, Reiji/Q-6459-2018	Kannagi, Reiji/0000-0003-4202-2921; Tanaka, Yoshimasa/0000-0002-5024-0614	Takeda Science Foundation; Mizutani Foundation of Glycoscience; Ministry of Science and Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research [21590063] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Mizutani Foundation of Glycoscience; Ministry of Science and Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Takeda Science Foundation, Mizutani Foundation of Glycoscience, and a Grant-in-aid for Scientific Research from the Ministry of Science and Culture, Sports and Technology of Japan.	Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Allende ML, 2000, GLYCOBIOLOGY, V10, P1025, DOI 10.1093/glycob/10.10.1025; Anastasia L, 2008, BBA-GEN SUBJECTS, V1780, P504, DOI 10.1016/j.bbagen.2007.11.011; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Breton C, 1998, J BIOCHEM, V123, P1000; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; CONNELL TD, 1995, MOL MICROBIOL, V16, P21, DOI 10.1111/j.1365-2958.1995.tb02388.x; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; FISHMAN PH, 1978, BIOCHEMISTRY-US, V17, P711, DOI 10.1021/bi00597a024; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; Ishii A, 1998, J BIOL CHEM, V273, P31652, DOI 10.1074/jbc.273.48.31652; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; KANNAGI R, 1983, P NATL ACAD SCI-BIOL, V80, P2844, DOI 10.1073/pnas.80.10.2844; Keusch JJ, 2000, J BIOL CHEM, V275, P25315, DOI 10.1074/jbc.M002630200; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kumagai T, 2010, GLYCOCONJUGATE J, V27, P685, DOI 10.1007/s10719-010-9313-2; Kumagai T, 2009, BIOCHEM BIOPH RES CO, V379, P456, DOI 10.1016/j.bbrc.2008.12.078; Kyogashima M, 2006, GLYCOBIOLOGY, V16, P719, DOI 10.1093/glycob/cwj122; Lala P, 2000, J BIOL CHEM, V275, P6246, DOI 10.1074/jbc.275.9.6246; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; Levine TP, 2007, J CELL BIOL, V179, P11, DOI 10.1083/jcb.200709055; Li JG, 2001, GLYCOBIOLOGY, V11, P217, DOI 10.1093/glycob/11.3.217; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; NAKAMURA M, 1992, J BIOL CHEM, V267, P23507; Nomura T, 1998, J BIOL CHEM, V273, P13570, DOI 10.1074/jbc.273.22.13570; PREUSS U, 1993, J BIOL CHEM, V268, P26273; Quintero CA, 2008, BIOCHEM J, V412, P19, DOI 10.1042/BJ20071725; ROSEMAN S, 1970, CHEM PHYS LIPIDS, V5, P270, DOI 10.1016/0009-3084(70)90024-1; Roseman S, 2001, J BIOL CHEM, V276, P41527, DOI 10.1074/jbc.R100053200; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHWARTZALBIEZ R, 1990, INT IMMUNOL, V2, P929, DOI 10.1093/intimm/2.10.929; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; Togayachi A, 2001, J BIOL CHEM, V276, P22032, DOI 10.1074/jbc.M011369200; Uemura S, 2009, MOL BIOL CELL, V20, P3088, DOI 10.1091/mbc.E08-12-1219; Uliana AS, 2006, J BIOL CHEM, V281, P32852, DOI 10.1074/jbc.M605805200; VANECHTEN G, 1993, J BIOL CHEM, V268, P5341; VARKI A, 2009, ESSENTIALS GLYCOBIOL, pCH3; Weiss M, 2000, FEBS LETT, V486, P2, DOI 10.1016/S0014-5793(00)02155-4; Weiss M, 2003, TRAFFIC, V4, P65, DOI 10.1034/j.1600-0854.2003.40202.x; Wendland B, 1998, CURR OPIN CELL BIOL, V10, P513, DOI 10.1016/S0955-0674(98)80067-7; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Yamamoto H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001232; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5	54	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27214	27224		10.1074/jbc.M111.234526	http://dx.doi.org/10.1074/jbc.M111.234526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21665948	hybrid, Green Published			2022-12-27	WOS:000293268700017
J	Brewer, PD; Romenskaia, I; Kanow, MA; Mastick, CC				Brewer, Paul Duffield; Romenskaia, Irina; Kanow, Mark A.; Mastick, Cynthia Corley			Loss of AS160 Akt Substrate Causes Glut4 Protein to Accumulate in Compartments That Are Primed for Fusion in Basal Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; RAT ADIPOSE-CELLS; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; GLUCOSE-TRANSPORTER; SUBCELLULAR TRAFFICKING; INTRACELLULAR RETENTION; STORAGE-VESICLES; INSULIN ACTION; MUSCLE-CELLS	The Akt substrate AS160 (TCB1D4) regulates Glut4 exocytosis; shRNA knockdown of AS160 increases surface Glut4 in basal adipocytes. AS160 knockdown is only partially insulin-mimetic; insulin further stimulates Glut4 translocation in these cells. Insulin regulates translocation as follows: 1) by releasing Glut4 from retention in a slowly cycling/noncycling storage pool, increasing the actively cycling Glut4 pool, and 2) by increasing the intrinsic rate constant for exocytosis of the actively cycling pool (k(ex)). Kinetic studies were performed in 3T3-L1 adipocytes to measure the effects of AS160 knockdown on the rate constants of exocytosis (k(ex)), endocytosis (k(en)), and release from retention into the cycling pool. AS160 knockdown released Glut4 into the actively cycling pool without affecting k(ex) or k(en). Insulin increased k(ex) in the knockdown cells, further increasing cell surface Glut4. Inhibition of phosphatidylinositol 3-kinase or Akt affected both k(ex) and release from retention in control cells but only k(ex) in AS160 knockdown cells. Glut4 vesicles accumulate in a primed pre-fusion pool in basal AS160 knockdown cells. Akt regulates the rate of exocytosis of the primed vesicles through an AS160-independent mechanism. Therefore, there is an additional Akt substrate that regulates the fusion of Glut4 vesicles that remain to be identified. Mathematical modeling was used to test the hypothesis that this substrate regulates vesicle priming (release from retention), whereas AS160 regulates the reverse step by stimulating GTP turnover of a Rab protein required for vesicle tethering/docking/fusion. Our analysis indicates that fusion of the primed vesicles with the plasma membrane is an additional non-Akt-dependent insulin-regulated step.	[Brewer, Paul Duffield; Romenskaia, Irina; Kanow, Mark A.; Mastick, Cynthia Corley] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Mastick, CC (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	National Institutes of Health [DK56197]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK56197. This work was also supported by grants from the American Diabetes Association.	Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Habtemichael EN, 2011, J BIOL CHEM, V286, P10115, DOI 10.1074/jbc.M111.217935; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Muretta JM, 2007, J CELL SCI, V120, P1168, DOI 10.1242/jcs.03413; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Ramm G, 2000, MOL BIOL CELL, V11, P4079, DOI 10.1091/mbc.11.12.4079; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; YANG J, 1993, J BIOL CHEM, V268, P4600; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333; Zhou LX, 1999, MOL ENDOCRINOL, V13, P505, DOI 10.1210/me.13.3.505	43	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26287	26297		10.1074/jbc.M111.253880	http://dx.doi.org/10.1074/jbc.M111.253880			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21613213	hybrid, Green Published			2022-12-27	WOS:000293078200005
J	Jiang, Y; Miao, ZH; Xu, L; Yu, B; Gong, JX; Tong, LJ; Chen, Y; Zhou, ZL; Liu, HC; Wang, Y; Guo, YW; Ding, J				Jiang, Yi; Miao, Ze-Hong; Xu, Lei; Yu, Bing; Gong, Jing-Xu; Tong, Lin-Jiang; Chen, Yi; Zhou, Zhao-Li; Liu, Hong-Chun; Wang, Yi; Guo, Yue-Wei; Ding, Jian			Drug Transporter-independent Liver Cancer Cell Killing by a Marine Steroid Methyl Spongoate via Apoptosis Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; TOPOISOMERASE-II; DOWN-REGULATION; MULTIDRUG-RESISTANCE; MEDIATED APOPTOSIS; PROSTATE-CANCER; BREAST-CANCER; TUMOR-CELLS; SALVICINE; STAT3	Hepatocellular carcinoma (HCC) is inherently resistant to the majority of clinical anticancer drugs. To obtain drugs that can circumvent or evade such inherent drug resistance of HCC, we investigated the effect of the marinely derived steroid methyl spongoate (MESP) on HCC cells. MESP displayed potent cell killing against a panel of six HCC cell lines, independent of their expression of drug transporters. MESP did not change the function of the drug transporters, and its cell killing was not impaired in multidrug-resistant cancer cells overexpressing the transporters. The cell killing of MESP was irrelevant to estrogen or androgen signaling and was not associated with cell cycle progression, inhibition of microtubules, and topoisomerases. In contrast, MESP potently induced apoptosis via activation of a proapoptotic caspase cascade and relief of the suppression of antiapoptotic signal transducers and activators of transcription 3 (STAT3) signaling. MESP inhibited the phosphorylation of STAT3, a critical survival signaling factor that reduced the expression of the antiapoptotic protein x-linked inhibitor of apoptosis protein but enhanced the expression of the proapoptotic protein Bax, thus promoting caspase-dependent apoptosis. These data reveal that MESP may well serve as an important candidate drug lead for HCC therapy.	[Jiang, Yi; Miao, Ze-Hong; Xu, Lei; Yu, Bing; Gong, Jing-Xu; Tong, Lin-Jiang; Chen, Yi; Zhou, Zhao-Li; Liu, Hong-Chun; Wang, Yi; Guo, Yue-Wei; Ding, Jian] Chinese Acad Sci, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Miao, ZH (corresponding author), Chinese Acad Sci, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	zhmiao@mail.shcnc.ac.cn; jding@mail.shcnc.ac.cn			National Natural Science Foundation of China [81025020, 81021062, 21072204, 30730108]; National Basic Research Program of China [2010CB934000]; Chinese Academy of Sciences [KSCX1-YW-22, SIMM0907KF-09]; Science and Technology Commission of Shanghai Municipality [09540704100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by National Natural Science Foundation of China Grants 81025020, 81021062, 21072204 and 30730108); National Basic Research Program of China Grant 2010CB934000; Major Program of Knowledge Innovation of the Chinese Academy of Sciences Grant KSCX1-YW-22; Science and Technology Commission of Shanghai Municipality Grant 09540704100; and Chinese Academy of Sciences, Key Project Grant SIMM0907KF-09.	Abraham I, 2010, BIOCHEM PHARMACOL, V80, P1497, DOI 10.1016/j.bcp.2010.08.001; Barthomeuf C, 2008, ANTI-CANCER AGENT ME, V8, P886, DOI 10.2174/187152008786847729; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cai Y, 2007, CANCER BIOL THER, V6, P1794, DOI 10.4161/cbt.6.11.4860; Fletcher S, 2009, BIOCHEM CELL BIOL, V87, P825, DOI [10.1139/O09-044, 10.1139/o09-044]; Gimenez-Bonafe P, 2009, CURR CANCER DRUG TAR, V9, P320, DOI 10.2174/156800909788166600; Gong JX, 2010, SYNLETT, P480, DOI 10.1055/s-0029-1218567; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; He X, 2008, CANCER RES, V68, P8678, DOI 10.1158/0008-5472.CAN-08-0294; Isaacs JT, 2010, EXPERT OPIN INV DRUG, V19, P1235, DOI 10.1517/13543784.2010.514262; Jiang CS, 2010, STEROIDS, V75, P1153, DOI 10.1016/j.steroids.2010.08.002; Kanzaki A, 2002, MOL CANCER THER, V1, P1327; Kusaba M, 2007, J HEPATOL, V47, P546, DOI 10.1016/j.jhep.2007.04.017; LaPensee EW, 2010, ENDOCR-RELAT CANCER, V17, pR91, DOI 10.1677/ERC-09-0253; Lee TKW, 2009, LIVER INT, V29, P955, DOI 10.1111/j.1478-3231.2009.02040.x; Liu Y, 2011, APOPTOSIS, V16, P502, DOI 10.1007/s10495-011-0578-0; Masuda M, 2010, CURR CANCER DRUG TAR, V10, P117, DOI 10.2174/156800910790980197; Meng LH, 2001, BIOCHEM PHARMACOL, V62, P733, DOI 10.1016/S0006-2952(01)00732-8; Miao ZH, 2004, INT J CANCER, V110, P627, DOI 10.1002/ijc.20026; Miao ZH, 2003, CANCER RES, V63, P4527; Miao ZH, 2003, INT J CANCER, V106, P108, DOI 10.1002/ijc.11174; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Msaouel P, 2007, EXPERT OPIN EMERG DR, V12, P285, DOI 10.1517/14728214.12.2.285; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; Peng J, 2009, ANTI-CANCER AGENT ME, V9, P481, DOI 10.2174/187152009788451833; Rajendran P, 2011, CLIN CANCER RES, V17, P1425, DOI 10.1158/1078-0432.CCR-10-1123; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; TANABE K, 1991, CANCER RES, V51, P4903; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Thomas M, 2009, J GASTROENTEROL, V44, P136, DOI 10.1007/s00535-008-2252-z; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Yan XH, 2007, BIOORG MED CHEM LETT, V17, P2661, DOI 10.1016/j.bmcl.2007.01.095; Yin J, 2011, ACTA PHARMACOL SIN, V32, P99, DOI 10.1038/aps.2010.185	39	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26461	26469		10.1074/jbc.M111.232728	http://dx.doi.org/10.1074/jbc.M111.232728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659517	hybrid, Green Published			2022-12-27	WOS:000293078200024
J	Rojas, DA; Moreira-Ramos, S; Zock-Emmenthal, S; Urbina, F; Contreras-Levicoy, J; Kaufer, NF; Maldonado, E				Rojas, Diego A.; Moreira-Ramos, Sandra; Zock-Emmenthal, Susanne; Urbina, Fabiola; Contreras-Levicoy, Juan; Kaeufer, Norbert F.; Maldonado, Edio			Rrn7 Protein, an RNA Polymerase I Transcription Factor, Is Required for RNA Polymerase II-dependent Transcription Directed by Core Promoters with a HomolD Box Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; BASAL TRANSCRIPTION; INITIATION-FACTOR; DNA-BINDING; FACTOR SL1; MEDIATOR; ELEMENTS; RECRUITMENT; TBP	The region in promoters that specifies the transcription machinery is called the core promoter, displaying core promoter elements (CPE) necessary for establishment of a preinitiation complex and the initiation of transcription. A classical CPE is the TATA box. In fission yeast, Schizosaccharomyces pombe, a new CPE, called HomolD box, was discovered. Collectively, 141 ribosomal protein genes encoding the full set of 79 different ribosomal proteins and more than 60 other housekeeping genes display a HomolD box in the core promoter. Here, we show that transcription directed by the HomolD box requires the RNA polymerase II machinery, including the general transcription factors. Most intriguingly, however, we identify, by DNA affinity purification, Rrn7 as the protein binding to the HomolD box. Rrn7 is an evolutionary conserved member of the RNA polymerase I machinery involved in transcription initiation of core ribosomal DNA promoters. ChIP shows that Rrn7 cross-links to a ribosomal protein gene promoter containing the HomolD box but not to a promoter containing a TATA box. Taken together, our results suggest that Rrn7 is an excellent candidate to be involved in the coordination of ribosomal DNA and ribosomal gene transcription during ribosome synthesis and, therefore, offer a new perspective to study conservation and evolvability of regulatory networks in eukaryotes.	[Rojas, Diego A.; Moreira-Ramos, Sandra; Urbina, Fabiola; Contreras-Levicoy, Juan; Maldonado, Edio] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Biol Celular & Mol, Santiago 7, Chile; [Zock-Emmenthal, Susanne; Kaeufer, Norbert F.] Univ Braunschweig Tech Univ, Inst Genet, D-38106 Braunschweig, Germany	Universidad de Chile	Maldonado, E (corresponding author), Independencia 1027, Santiago 7, Chile.	emaldona@med.uchile.cl	Rojas, Diego/E-4369-2014; Rojas, Diego A./AAT-4173-2021	Rojas, Diego A./0000-0002-5388-1070				Boukhgalter B, 2002, GENE, V291, P187, DOI 10.1016/S0378-1119(02)00597-8; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; Contreras-Levicoy J, 2008, FEBS J, V275, P2873, DOI 10.1111/j.1742-4658.2008.06429.x; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; FLORES O, 1989, J BIOL CHEM, V264, P8913; Gross T, 1998, NUCLEIC ACIDS RES, V26, P3319, DOI 10.1093/nar/26.14.3319; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hamada M, 2001, MOL CELL BIOL, V21, P6870, DOI 10.1128/MCB.21.20.6870-6881.2001; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; Nabavi S, 2008, CURR GENET, V54, P175, DOI 10.1007/s00294-008-0210-1; Newo ANS, 2007, NUCLEIC ACIDS RES, V35, P1391, DOI 10.1093/nar/gkl1144; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; Siddiqi I, 2001, MOL CELL BIOL, V21, P2292, DOI 10.1128/MCB.21.7.2292-2297.2001; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Tamayo E, 2004, EUR J BIOCHEM, V271, P2561, DOI 10.1111/j.1432-1033.2004.04187.x; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; Witt I, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P343; WITT I, 1993, EMBO J, V12, P1201, DOI 10.1002/j.1460-2075.1993.tb05761.x; WITT I, 1995, NUCLEIC ACIDS RES, V23, P4296, DOI 10.1093/nar/23.21.4296; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	34	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26480	26486		10.1074/jbc.M111.224337	http://dx.doi.org/10.1074/jbc.M111.224337			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21673110	hybrid, Green Published			2022-12-27	WOS:000293078200026
J	Wang, YH; Wang, YC; Xu, Y; Tong, WY; Pan, TT; Li, JH; Sun, SH; Shao, JJ; Ding, HP; Toyoda, T; Yuan, ZH				Wang, Yaohui; Wang, Yuchan; Xu, Yan; Tong, Wenyan; Pan, TingTing; Li, Jianhua; Sun, Shuhui; Shao, Junjie; Ding, Huanping; Toyoda, Tetsuya; Yuan, Zhenghong			Hepatitis C Virus NS5B Protein Delays S Phase Progression in Human Hepatocyte-derived Cells by Relocalizing Cyclin-dependent Kinase 2-interacting Protein (CINP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; DNA-DAMAGE RESPONSE; RNA-POLYMERASE; HEPATOCELLULAR-CARCINOMA; GENOMIC INSTABILITY; CDC25 PHOSPHATASES; REACTIVE OXYGEN; INTERFERON-BETA; DOWN-REGULATION; BINDING MOTIF	Cell cycle dysregulation is a critical event in virus infection-associated tumorigenesis. Previous studies have suggested that hepatitis C virus NS5B modulates cell cycle progression in addition to participating in RNA synthesis as an RNA-dependent RNA polymerase. However, the molecular mechanisms have thus far remained unclear. In this study, a HepG2 Tet-On NS5B stable cell line was generated to confirm the effect of NS5B on the cell cycle. To better understand the role of NS5B in cell cycle regulation, yeast two-hybrid assays were performed using a human liver cDNA library. The cyclin-dependent kinase 2-interacting protein (CINP) was identified. The interaction between NS5B and CINP was further demonstrated by in vivo and in vitro assays, and their association was found to be indispensable for S phase delay and cell proliferation suppression. Further experiments indicated that NS5B relocalized CINP from the nucleus to the cytoplasm. Directly knocking down CINP by specific siRNA resulted in a significant alteration in the DNA damage response and expression of cell cycle checkpoint proteins, including an increase in p21 and a decrease in phosphorylated Retinoblastoma and Chk1. Similar results were observed in cells expressing NS5B, and the effects were partially reversed upon ectopic overexpression of CINP. These studies suggest that the DNA damage response might be exploited by NS5B to hinder cell cycle progression. Taken together, our data demonstrate that NS5B delays cells in S phase through interaction with CINP and relocalization of the protein from the nucleus to the cytoplasm. Such effects might contribute to hepatitis C virus persistence and pathogenesis.	[Wang, Yaohui; Wang, Yuchan; Xu, Yan; Tong, Wenyan; Pan, TingTing; Li, Jianhua; Sun, Shuhui; Yuan, Zhenghong] Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China; [Ding, Huanping; Yuan, Zhenghong] Fudan Univ, Inst Med Microbiol, Shanghai 200032, Peoples R China; [Ding, Huanping; Yuan, Zhenghong] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Yuan, Zhenghong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Res Unit, Shanghai 201508, Peoples R China; [Shao, Junjie] Shanghai Ctr Dis Prevent & Control, Shanghai 200332, Peoples R China; [Toyoda, Tetsuya] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Unit Viral Genome Regulat, Shanghai 200025, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Yuan, ZH (corresponding author), Shanghai Med Coll, Key Lab Med Mol Virol, POB 228,138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	zhyuan@shmu.edu.cn	Wang, Yaohui/ABD-4904-2021	Wang, Yaohui/0000-0003-0165-6573	National Megaprojects [2008ZX10203]; Program for Outstanding Medical Academic Leader of Shanghai	National Megaprojects; Program for Outstanding Medical Academic Leader of Shanghai	This work was supported in part by National Megaprojects for Infectious Diseases Grant 2008ZX10203 and the Program for Outstanding Medical Academic Leader of Shanghai.	Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Ariumi Y, 2008, J VIROL, V82, P9639, DOI 10.1128/JVI.00351-08; Baek KH, 2006, J MOL BIOL, V359, P22, DOI 10.1016/j.jmb.2006.03.020; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Bowen DG, 2005, J HEPATOL, V42, P408, DOI 10.1016/j.jhep.2004.12.013; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Choi BH, 2001, DNA CELL BIOL, V20, P75, DOI 10.1089/104454901750070274; Deore RR, 2010, CURR MED CHEM, V17, P3806; Einav S, 2008, HEPATOLOGY, V47, P827, DOI 10.1002/hep.22108; Gimenez-Barcons M, 2005, J INTERF CYTOK RES, V25, P152, DOI 10.1089/jir.2005.25.152; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Grishina I, 2005, CELL CYCLE, V4, P1120; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hirano M, 2003, J BIOL CHEM, V278, P5109, DOI 10.1074/jbc.M207629200; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hu BC, 2001, J BIOL CHEM, V276, P17693, DOI 10.1074/jbc.M009340200; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jakobs A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm617; Jirmanova L, 2005, CELL CYCLE, V4, P1428, DOI 10.4161/cc.4.10.2055; Kerkvliet J, 2011, J VIROL, V85, P621, DOI 10.1128/JVI.01626-10; Kitay-Cohen Y, 2000, BLOOD, V96, P2910; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Machida K, 2004, J VIROL, V78, P8835, DOI 10.1128/JVI.78.16.8835-8843.2004; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06; Machida K, 2010, J IMMUNOL, V185, P6985, DOI 10.4049/jimmunol.1000618; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; McGivern DR, 2009, J VIROL, V83, P7422, DOI 10.1128/JVI.00262-09; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Miller LD, 2001, MOL CELL BIOL, V21, P6626, DOI 10.1128/MCB.21.19.6626-6639.2001; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Naka K, 2006, VIROLOGY, V346, P348, DOI 10.1016/j.virol.2005.10.023; Naruyama H, 2008, BIOCHEM BIOPH RES CO, V374, P79, DOI 10.1016/j.bbrc.2008.06.112; Ohkawa K, 2004, J BIOL CHEM, V279, P11719, DOI 10.1074/jbc.M308560200; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; SAKAMURO D, 1995, J VIROL, V69, P3893, DOI 10.1128/JVI.69.6.3893-3896.1995; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Shimakami T, 2006, J VIROL, V80, P3332, DOI 10.1128/JVI.80.7.3332-3340.2006; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Siavoshian S, 2004, ARCH VIROL, V149, P323, DOI 10.1007/s00705-003-0205-7; Srinivasan SV, 2007, J BIOL CHEM, V282, P23867, DOI 10.1074/jbc.M700542200; van Harn T, 2010, GENE DEV, V24, P1377, DOI 10.1101/gad.580710; Vannucchi S, 2000, ONCOGENE, V19, P5041, DOI 10.1038/sj.onc.1203883; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; von dem Bussche A, 2010, J HEPATOL, V53, P797, DOI 10.1016/j.jhep.2010.05.022; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Weng LY, 2009, ARCH VIROL, V154, P765, DOI 10.1007/s00705-009-0366-0; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhu YH, 2004, MOL CELL BIOL, V24, P6268, DOI 10.1128/MCB.24.14.6268-6277.2004; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	74	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26603	26615		10.1074/jbc.M111.225672	http://dx.doi.org/10.1074/jbc.M111.225672			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21628470	Green Published, hybrid			2022-12-27	WOS:000293078200039
J	Geetha, N; Mihaly, J; Stockenhuber, A; Blasi, F; Uhrin, P; Binder, BR; Freissmuth, M; Breuss, JM				Geetha, Nishamol; Mihaly, Judit; Stockenhuber, Alexander; Blasi, Francesco; Uhrin, Pavel; Binder, Bernd R.; Freissmuth, Michael; Breuss, Johannes M.			RETRACTED: Signal Integration and Coincidence Detection in the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) Cascade CONCOMITANT ACTIVATION OF RECEPTOR TYROSINE KINASES AND OF LRP-1 LEADS TO SUSTAINED ERK PHOSPHORYLATION VIA DOWN-REGULATION OF DUAL SPECIFICITY PHOSPHATASES (DUSP1 AND -6) (Retracted article. See vol. 294, pg. 13201, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							RECEPTOR-RELATED PROTEIN-1; PLASMINOGEN-ACTIVATOR; CELLS; PHOSPHATASES; SPECIFICITY; CANCER; MEK; PATHWAYS; DYNAMICS; CLEAVAGE	Diverse stimuli can feed into the MAPK/ERK cascade; this includes receptor tyrosine kinases, G protein-coupled receptors, integrins, and scavenger receptors (LDL receptor-related protein (LRP)). Here, we investigated the consequence of concomitant occupancy of the receptor tyrosine kinases (by EGF, basic FGF, VEGF, etc.) and of LRP family members (by LDL or lactoferrin). The simultaneous stimulation of a receptor tyrosine kinase by its cognate ligand and of LRP-1 (by lactoferrin or LDL) resulted in sustained activation of ERK, which was redirected to the cytoplasm. Accordingly, elevated levels of active cytosolic ERK were translated into accelerated adhesion to vitronectin. The sustained ERK response was seen in several cell types, but it was absent in cells deficient in LRP-1 (but not in cells lacking the LDL receptor). This response was also contingent on the presence of urokinase (uPA) and its receptor (uPAR), because it was absent in uPA(-/-) and uPAR(-/-) fibroblasts. Combined stimulation of the EGF receptor and of LRP-1 delayed nuclear accumulation of phosphorylated ERK. This shift in favor of cytosolic accumulation of phospho-ERK was accounted for by enhanced proteasomal degradation of dual specificity phosphatases DUSP1 and DUSP6, which precluded dephosphorylation of cytosolic ERK. These observations demonstrate that the ERK cascade can act as a coincidence detector to decode the simultaneous engagement of a receptor tyrosine kinase and of LRP-1 and as a signal integrator that encodes this information in a spatially and temporally distinct biological signal. In addition, the findings provide an explanation of why chronic elevation of LRP-1 ligands (e. g. PAI-1) can predispose to cancer.	[Freissmuth, Michael] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Geetha, Nishamol; Mihaly, Judit; Stockenhuber, Alexander; Uhrin, Pavel; Binder, Bernd R.; Breuss, Johannes M.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; [Blasi, Francesco] San Raffale Sci Res Inst, Dept Mol Biol & Funct Genom, Dipartimento Biotechnol DiBiT, I-20132 Milan, Italy	Medical University of Vienna; Medical University of Vienna	Freissmuth, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Wahringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at		breuss, johannes/0000-0003-1312-3387; Stockenhuber, Alexander/0000-0002-5523-6673; Freissmuth, Michael/0000-0001-9398-1765; Uhrin, Pavel/0000-0002-9792-3420	Fonds zur Forderung der Wissenschaftlichen Forschung (Austrian Science Fund); Medical University of Vienna	Fonds zur Forderung der Wissenschaftlichen Forschung (Austrian Science Fund)(Austrian Science Fund (FWF)); Medical University of Vienna	This work was supported by the Cell Communication in Health and disease (CCHD) doctoral program, which is funded by the Fonds zur Forderung der Wissenschaftlichen Forschung (Austrian Science Fund) and the Medical University of Vienna.	Barry OP, 2001, J BIOL CHEM, V276, P15537, DOI 10.1074/jbc.M010847200; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; HERZ J, 1994, ANN NY ACAD SCI, V737, P14, DOI 10.1111/j.1749-6632.1994.tb44298.x; Hursting SD, 2010, J CLIN ONCOL, V28, P4058, DOI 10.1200/JCO.2010.27.9935; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kholodenko BN, 2009, WIRES SYST BIOL MED, V1, P28, DOI 10.1002/wsbm.16; Kim SC, 1999, BLOOD, V93, P3893, DOI 10.1182/blood.V93.11.3893.407k14_3893_3899; Klinger M, 2002, J BIOL CHEM, V277, P32490, DOI 10.1074/jbc.M200556200; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Lin YW, 2003, J BIOL CHEM, V278, P21534, DOI 10.1074/jbc.M301854200; Look MP, 2002, JNCI-J NATL CANCER I, V94, P116, DOI 10.1093/jnci/94.2.116; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; Prager GW, 2004, BLOOD, V103, P955, DOI 10.1182/blood-2003-07-2214; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sidenius N, 2000, FEBS LETT, V475, P52, DOI 10.1016/S0014-5793(00)01624-0; Slack JK, 1999, J BIOL CHEM, V274, P27177, DOI 10.1074/jbc.274.38.27177; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; WATERS SB, 1995, J BIOL CHEM, V270, P20883, DOI 10.1074/jbc.270.36.20883; Yang XL, 2008, CAN MED ASSOC J, V179, P427, DOI 10.1503/cmaj.071474; Yip-Schneider MT, 2001, BIOCHEM BIOPH RES CO, V280, P992, DOI 10.1006/bbrc.2001.4243	39	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25663	25674		10.1074/jbc.M111.221903	http://dx.doi.org/10.1074/jbc.M111.221903			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21610072	hybrid, Green Published			2022-12-27	WOS:000293073000028
J	Haldar, S; Bevers, LE; Tosha, T; Theil, EC				Haldar, Suranjana; Bevers, Loes E.; Tosha, Takehiko; Theil, Elizabeth C.			Moving Iron through Ferritin Protein Nanocages Depends on Residues throughout Each Four alpha-Helix Bundle Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-CHAIN FERRITIN; CORE FORMATION; HYDROGEN-PEROXIDE; FERROXIDASE REACTION; ANGSTROM RESOLUTION; DNA-BINDING; MINERALIZATION; SITE; INTERMEDIATE; MECHANISM	Eukaryotic Hferritins move iron through protein cages to form biologically required, iron mineral concentrates. The biominerals are synthesized during protein-based Fe2+/O-2 oxidoreduction and formation of [Fe3+O](n) multimers within the protein cage, en route to the cavity, at sites distributed over similar to 50 angstrom. Recent NMR and Co2+-protein x-ray diffraction (XRD) studies identified the entire iron path andnewmetal-protein interactions: (i) lines of metal ions in 8 Fe2+ ion entry channels with three-way metal distribution points at channel exits and (ii) interior Fe3+O nucleation channels. To obtain functional information on the newly identified metal-protein interactions, weanalyzed effects of amino acid substitution on formation of the earliest catalytic intermediate (diferric peroxo-A(650 nm)) and on mineral growth (Fe3+O-A(350) (nm)), in A26S, V42G, D127A, E130A, and T149C. The results show that all of the residues influenced catalysis significantly (p < 0.01), with effects on four functions: (i) Fe2+ access/selectivity to the active sites (Glu(130)), (ii) distribution of Fe2+ to each of the three active sites near each ion channel (Asp(127)), (iii) product (diferric oxo) release into the Fe3+O nucleation channels (Ala(26)), and (iv) [Fe3+O](n) transit through subunits (Val(42), Thr(149)). Synthesis of ferritin biominerals depends on residues along the entire length of H subunits from Fe2+ substrate entry at 3-fold cage axes at one subunit end through active sites and nucleation channels, at the other subunit end, inside the cage at 4-fold cage axes. Ferritin subunit-subunit geometry contributes to mineral order and explains the physiological impact of ferritin H and L subunits.	[Haldar, Suranjana; Bevers, Loes E.; Tosha, Takehiko; Theil, Elizabeth C.] CHORI, Oakland, CA 94609 USA; [Theil, Elizabeth C.] Univ Calif Berkeley, Dept Nutr Sci & Mol Toxicol, Berkeley, CA 94720 USA	Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Theil, EC (corresponding author), CHORI, 5700 Martin Luther King, Oakland, CA 94609 USA.	etheil@CHORI.org	Tosha, Takehiko/AAR-2404-2020	Tosha, Takehiko/0000-0002-8971-0759	National Institutes of Health [DK-20251]; Netherlands Organization for Scientific Research; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020251, R37DK020251, R56DK020251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-20251 (to L. E. B., S. H., T. T., and E. C. T.). This work was also supported by grants from The Netherlands Organization for Scientific Research (to L. E. B.) and the Japan Society for the Promotion of Science (to T. T.).	BAUMINGER ER, 1993, BIOCHEM J, V296, P709, DOI 10.1042/bj2960709; Bou-Abdallah F, 2004, BIOCHEMISTRY-US, V43, P4332, DOI 10.1021/bi0498813; Bou-Abdallah F, 2002, BIOCHEM J, V364, P57, DOI 10.1042/bj3640057; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chiancone E, 2010, FRONT BIOSCI, V15, P122, DOI 10.2741/3610; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Fetter J, 1997, J BIOL INORG CHEM, V2, P652, DOI 10.1007/s007750050180; Gallois B, 1997, J BIOL INORG CHEM, V2, P360, DOI 10.1007/s007750050143; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Jameson GNL, 2002, BIOCHEMISTRY-US, V41, P13435, DOI 10.1021/bi026478s; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; LEVI S, 1988, J BIOL CHEM, V263, P18086; Li CR, 2009, J BIOL CHEM, V284, P16743, DOI 10.1074/jbc.M109.011528; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; MERTZ JR, 1983, J BIOL CHEM, V258, P1719; Moenne-Loccoz P, 1999, BIOCHEMISTRY-US, V38, P5290, DOI 10.1021/bi990095l; Pereira AS, 1998, BIOCHEMISTRY-US, V37, P9871, DOI 10.1021/bi980847w; ROHRER JS, 1987, J BIOL CHEM, V262, P13385; ROHRER JS, 1989, INORG CHEM, V28, P3393, DOI 10.1021/ic00316a031; Schwartz JK, 2008, J AM CHEM SOC, V130, P9441, DOI 10.1021/ja801251q; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; STPIERRE TG, 1991, BIOL MET, V4, P162, DOI 10.1007/BF01141308; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Theil EC, 2011, CURR OPIN CHEM BIOL, V15, P304, DOI 10.1016/j.cbpa.2011.01.004; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Tosha T, 2008, P NATL ACAD SCI USA, V105, P18182, DOI 10.1073/pnas.0805083105; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v	44	45	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25620	25627		10.1074/jbc.M110.205278	http://dx.doi.org/10.1074/jbc.M110.205278			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21592958	hybrid, Green Published			2022-12-27	WOS:000293073000024
J	Matsushita, H; Endo, S; Kobayashi, E; Sakamoto, Y; Kobayashi, K; Kitaguchi, K; Kuroki, K; Soderhall, A; Maenaka, K; Nakamura, A; Strittmatter, SM; Takai, T				Matsushita, Haruka; Endo, Shota; Kobayashi, Eiji; Sakamoto, Yuzuru; Kobayashi, Keisuke; Kitaguchi, Kohji; Kuroki, Kimiko; Soderhall, Arvid; Maenaka, Katsumi; Nakamura, Akira; Strittmatter, Stephen M.; Takai, Toshiyuki			Differential but Competitive Binding of Nogo Protein and Class I Major Histocompatibility Complex (MHCI) to the PIR-B Ectodomain Provides an Inhibition of Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; MYELIN-ASSOCIATED GLYCOPROTEIN; OCULAR-DOMINANCE PLASTICITY; NEURITE OUTGROWTH; AXONAL REGENERATION; MICE; RECOGNITION; SHP-1; IDENTIFICATION; ASSOCIATION	Binding of class I MHC molecules (MHCI) to an inhibitory receptor, PIR-B, expressed on B cells and myeloid cells provides constitutive cellular inhibition, thus ensuring peripheral tolerance. Recent unexpected findings pointed to a novel inhibitory role of PIR-B in neuritere generation through binding to three axonal outgrowth inhibitors of myelin, including Nogo. Thus, it becomes interesting to determine whether the actions of the inhibitory myelin proteins and MHCI could coexist independently or be mutually exclusive as to the PIR-B-mediated immune and neural cell inhibition. Here, we present data supporting the competition of Nogo-and MHCI-mediated inhibition where they coexist. Kinetic analyses of Nogo and MHCI binding to the whole or a part of the recombinant PIR-B ectodomain revealed that PIR-B binds with higher affinity to Nogo than MHCI and that the MHCI binding only occurred with the N-terminal domains of PIR-B, whereas Nogo binding occurred with either the N- or C-terminal ectodomains. Importantly, kinetic tests indicated that the binding to PIR-B of Nogo and MHCI was competitive. Both endogenous and exogenous Nogo intensified the PIR-B-mediated suppression of interleukin-6 release from lipopolysaccharide-stimulated wildtype, but not PIR-B-deficient, cultured mast cells, indicating that PIR-B mediates Nogo-induced inhibition. Thus, we propose a novel mechanism by which PIR-B-mediated regulation is achieved differentially but competitively via MHCI and Nogo in cells of the immune system.	[Matsushita, Haruka; Endo, Shota; Kobayashi, Eiji; Sakamoto, Yuzuru; Kobayashi, Keisuke; Kitaguchi, Kohji; Nakamura, Akira; Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Sakamoto, Yuzuru] Tohoku Inst Technol, Ctr Gen Educ, Div Human Sci, Sendai, Miyagi 9828577, Japan; [Kuroki, Kimiko; Maenaka, Katsumi] Kyushu Univ, Div Struct Biol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Soderhall, Arvid] Sidec Technol AB, SE-16440 Stockholm, Sweden; [Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06536 USA	Tohoku University; Tohoku Institute Technology; Kyushu University; Yale University	Takai, T (corresponding author), Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	tostakai@idac.tohoku.ac.jp	Kuroki, Kimiko/F-6906-2012; Sakamoto, Yuzuru/L-7690-2019; Strittmatter, Stephen/F-5739-2011	Sakamoto, Yuzuru/0000-0002-4863-3179; Strittmatter, Stephen/0000-0001-8188-3092; Kobayashi, Eiji/0000-0002-7303-2797	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; 21st Century Center of Excellence (COE); Grants-in-Aid for Scientific Research [22659057, 22121007] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042304, R37NS033020] Funding Source: NIH RePORTER	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency, a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the 21st Century Center of Excellence (COE) Program "Center for Innovative Therapeutic Development Towards the Conquest of Signal Transduction Diseases" and Global COE Program "Innovative Therapeutic Development Towards the Conquest of Signal Transduction Diseases with Network Medicine".	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Allen RL, 2001, J IMMUNOL, V167, P5543, DOI 10.4049/jimmunol.167.10.5543; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Endo S, 2008, P NATL ACAD SCI USA, V105, P14515, DOI 10.1073/pnas.0804571105; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Kanehira M, 2006, J BIOCHEM, V140, P211, DOI 10.1093/jb/mvj140; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Taylor LS, 1999, BLOOD, V94, P1790, DOI 10.1182/blood.V94.5.1790.417k16_1790_1796; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867	34	32	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25739	25747		10.1074/jbc.M110.157859	http://dx.doi.org/10.1074/jbc.M110.157859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636572	Green Published, hybrid			2022-12-27	WOS:000293073000035
J	Ishijima, N; Suzuki, M; Ashida, H; Ichikawa, Y; Kanegae, Y; Saito, I; Boren, T; Haas, R; Sasakawa, C; Mimuro, H				Ishijima, Nozomi; Suzuki, Masato; Ashida, Hiroshi; Ichikawa, Yusuke; Kanegae, Yumi; Saito, Izumu; Boren, Thomas; Haas, Rainer; Sasakawa, Chihiro; Mimuro, Hitomi			BabA-mediated Adherence Is a Potentiator of the Helicobacter pylori Type IV Secretion System Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-BINDING ADHESIN; OUTER-MEMBRANE PROTEINS; CAG PATHOGENICITY ISLAND; GASTRIC EPITHELIAL-CELLS; BLOOD-GROUP ANTIGENS; MONGOLIAN GERBILS; INTESTINAL METAPLASIA; INFECTION; EXPRESSION; STOMACH	Chronic infection of Helicobacter pylori in the stomach mucosa with translocation of the bacterial cytotoxin-associated gene A (CagA) effector protein via the cag-Type IV secretion system (TFSS) into host epithelial cells are major risk factors for gastritis, gastric ulcers, and cancer. The blood group antigen-binding adhesin BabA mediates the adherence of H. pylori to ABO/Lewis b (Le(b)) blood group antigens in the gastric pit region of the human stomach mucosa. Here, we show both in vitro and in vivo that BabA-mediated binding of H. pylori to Le(b) on the epithelial surface augments TFSS-dependent H. pylori pathogenicity by triggering the production of proinflammatory cytokines and precancer-related factors. We successfully generated Le(b)-positive cell lineages by transfecting Le(b)-negative cells with several glycosyltransferase genes. Using these established cell lines, we found increased mRNA levels of proinflammatory cytokines (CCL5 and IL-8) as well as precancer-related factors (CDX2 and MUC2) after the infection of Le(b)-positive cells with WTH. pylori but not with babA or TFSS deletion mutants. This increased mRNA expression was abrogated when Le(b)-negative cells were infected with WT H. pylori. Thus, H. pylori can exploit BabA-Le(b) binding to trigger TFSS-dependent host cell signaling to induce the transcription of genes that enhance inflammation, development of intestinal metaplasia, and associated precancerous transformations.	[Ishijima, Nozomi; Suzuki, Masato; Ashida, Hiroshi; Ichikawa, Yusuke; Sasakawa, Chihiro; Mimuro, Hitomi] Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Sasakawa, Chihiro] Univ Tokyo, Dept Infect Dis Control, Int Res Ctr Infect Dis, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Kanegae, Yumi; Saito, Izumu] Univ Tokyo, Minato Ku, Mol Genet Lab, Inst Med Sci, Tokyo 1088639, Japan; [Boren, Thomas] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Haas, Rainer] Univ Munich, Dept Bakteriol, Max von Pettenkofer Inst Hyg & Med Mikrobiol, D-80336 Munich, Germany	University of Tokyo; University of Tokyo; University of Tokyo; Umea University; University of Munich	Mimuro, H (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	mim@ims.u-tokyo.ac.jp	Suzuki, Masato/B-7568-2013	Suzuki, Masato/0000-0001-8975-2193; Ashida, Hiroshi/0000-0003-1408-6864	Founding Research Centers for Emerging and Reemerging Infectious Diseases; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Naito Foundation;  [23390102];  [20229006];  [23659220];  [18073003];  [23790472]	Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); ; ; ; ; 	This work was supported by Grant-in-aid for Scientific Research (B) 23390102 (to H. M.), (S) 20229006 (to C. S.), Grant-in-aid for Challenging Exploratory Research 23659220 (to H. M.), Grant-in-aid for Scientific Research on Priority Areas 18073003 (to C. S.), Grant-in-aid for Young Scientists (B) 23790472 (to H. A.), and the Contract Research Fund for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (to C. S.), from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. This work was also supported in part by grants from the Naito Foundation (to H. M.).	Alm RA, 2000, INFECT IMMUN, V68, P4155, DOI 10.1128/IAI.68.7.4155-4168.2000; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Bai YQ, 2002, CANCER LETT, V176, P47, DOI 10.1016/S0304-3835(01)00753-4; BAKER BW, 1992, NUCLEIC ACIDS RES, V20, P5234, DOI 10.1093/nar/20.19.5234; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; CRABTREE JE, 1993, SCAND J IMMUNOL, V37, P65, DOI 10.1111/j.1365-3083.1993.tb01666.x; de Jonge R, 2004, J MED MICROBIOL, V53, P375, DOI 10.1099/jmm.0.45551-0; Dossumbekova A, 2006, J INFECT DIS, V194, P1346, DOI 10.1086/508426; FALK PG, 1995, P NATL ACAD SCI USA, V92, P1515, DOI 10.1073/pnas.92.5.1515; Fujimoto S, 2007, CLIN GASTROENTEROL H, V5, P49, DOI 10.1016/j.cgh.2006.09.015; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Guruge JL, 1998, P NATL ACAD SCI USA, V95, P3925, DOI 10.1073/pnas.95.7.3925; HESSEY SJ, 1990, GUT, V31, P134, DOI 10.1136/gut.31.2.134; Hirayama F, 1996, J GASTROENTEROL, V31, P755, DOI 10.1007/BF02347631; Holgersson J, 2006, GLYCOBIOLOGY, V16, P584, DOI 10.1093/glycob/cwj090; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Isomoto H, 2000, AM J GASTROENTEROL, V95, P2768, DOI 10.1016/S0002-9270(00)01096-0; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Kikuchi T, 2000, J PATHOL, V192, P243, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH688>3.0.CO;2-D; Kodama K, 2002, HELICOBACTER, V7, P9, DOI 10.1046/j.1523-5378.2002.00050.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lofling J, 2008, GLYCOBIOLOGY, V18, P494, DOI 10.1093/glycob/cwn030; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mimuro H, 2008, BIOESSAYS, V30, P515, DOI 10.1002/bies.20768; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nagai S, 2007, P NATL ACAD SCI USA, V104, P8971, DOI 10.1073/pnas.0609014104; Odenbreit S, 2002, INT J MED MICROBIOL, V292, P257, DOI 10.1078/1438-4221-00205; Ohno T, 2011, J INFECT DIS, V203, P726, DOI 10.1093/infdis/jiq090; Osawa H, 2001, DIGEST DIS SCI, V46, P69, DOI 10.1023/A:1005657708342; Peck B, 1999, NUCLEIC ACIDS RES, V27, P3325, DOI 10.1093/nar/27.16.3325; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pride DT, 2001, INFECT IMMUN, V69, P1160, DOI 10.1128/IAI.69.2.1160-1171.2001; Rad R, 2002, J IMMUNOL, V168, P3033, DOI 10.4049/jimmunol.168.6.3033; Shimoyama T, 1998, J CLIN PATHOL, V51, P765, DOI 10.1136/jcp.51.10.765; Snider JL, 2008, J BIOL CHEM, V283, P13952, DOI 10.1074/jbc.M800289200; Sugiyama A, 1998, CANCER RES, V58, P2067; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Yamamoto H, 2003, BIOCHEM BIOPH RES CO, V300, P813, DOI 10.1016/S0006-291X(02)02935-2; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Yamaoka Y, 2008, WORLD J GASTROENTERO, V14, P4265, DOI 10.3748/wjg.14.4265; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141	52	120	123	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25256	25264		10.1074/jbc.M111.233601	http://dx.doi.org/10.1074/jbc.M111.233601			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596743	hybrid, Green Published			2022-12-27	WOS:000292547900071
J	Jasion, VS; Polanco, JA; Meharenna, YT; Li, HY; Poulos, TL				Jasion, Victoria S.; Polanco, Julio A.; Meharenna, Yergalem T.; Li, Huiying; Poulos, Thomas L.			Crystal Structure of Leishmania major Peroxidase and Characterization of the Compound I Tryptophan Radical	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; QUANTITATIVE EPR SPECTROMETRY; ENGINEERED CATION SITE; ASCORBATE-PEROXIDASE; SPINACH-CHLOROPLASTS; SUBSTRATE-BINDING; PRIMARY STANDARD; ACTIVE-SITE; WILD-TYPE; ENZYME	The parasitic protozoa Leishmania major produces a peroxidase (L. major peroxidase; LmP) that exhibits activities characteristic of both yeast cytochrome c peroxidase (CCP) and plant cytosolic ascorbate peroxidase (APX). One common feature is a key Trp residue, Trp(208) in LmP and Trp(191) in CCP, that is situated adjacent to the proximal His heme ligand in CCP, APX, and LmP. In CCP, Trp(191) forms a stable cationic radical after reaction with H2O2 to form Compound I; in APX, the radical is located on the porphyrin ring. In order to clarify the role of Trp(208) in LmP and to further probe peroxidase structure-function relationships, we have determined the crystal structure of LmP and have studied the role of Trp(208) using electron paramagnetic resonance spectroscopy (EPR), mutagenesis, and enzyme kinetics. Both CCP and LmP have an extended section of beta structure near Trp(191) and Trp(208), respectively, which is absent in APX. This region provides stability to the Trp(191) radical in CCP. EPR of LmP Compound I exhibits an intense and stable signal similar to CCP Compound I. In the LmP W208F mutant, this signal disappears, indicating that Trp(208) forms a stable cationic radical. In LmP conversion of the Cys(197) to Thr significantly weakens the Compound I EPR signal and dramatically lowers enzyme activity. These results further support the view that modulation of the local electrostatic environment controls the stability of the Trp radical in peroxidases. Our results also suggest that the biological role of LmP is to function as a cytochrome c peroxidase.	[Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	poulos@uci.edu			National Institutes of Health [GM42614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42614.	Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Barrows TP, 2004, BIOCHEMISTRY-US, V43, P8826, DOI 10.1021/bi049531g; Barrows TP, 2005, BIOCHEMISTRY-US, V44, P14062, DOI 10.1021/bi0507128; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bonagura CA, 1996, BIOCHEMISTRY-US, V35, P6107, DOI 10.1021/bi960122x; Bonagura CA, 1999, BIOCHEMISTRY-US, V38, P5538, DOI 10.1021/bi982996k; BUETTNER GR, 1988, J BIOCHEM BIOPH METH, V16, P27, DOI 10.1016/0165-022X(88)90100-5; Bursey EH, 2000, BIOCHEMISTRY-US, V39, P7374, DOI 10.1021/bi000446s; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; Dunford H. B., 2010, PEROXIDASES CATALASE; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISHEL LA, 1991, BIOCHEMISTRY-US, V30, P1986, DOI 10.1021/bi00221a036; FITZGERALD MM, 1994, BIOCHEMISTRY-US, V33, P3807, DOI 10.1021/bi00179a004; Fowler RM, 1935, J RES NAT BUR STAND, V15, P493, DOI 10.6028/jres.015.032; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; HOUSEMAN ALP, 1993, BIOCHEMISTRY-US, V32, P4430, DOI 10.1021/bi00067a036; Jensen GM, 1998, J PHYS CHEM B, V102, P8221, DOI 10.1021/jp9811326; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; MARGOLIASH E, 1952, NATURE, V170, P1014, DOI 10.1038/1701014a0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meharenna YT, 2008, BIOCHEMISTRY-US, V47, P10324, DOI 10.1021/bi8007565; MILLER MA, 1994, P NATL ACAD SCI USA, V91, P11118, DOI 10.1073/pnas.91.23.11118; Murphy EJ, 2008, BIOCHEMISTRY-US, V47, P13933, DOI 10.1021/bi801480r; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musah RA, 1997, BIOCHEMISTRY-US, V36, P11665, DOI 10.1021/bi9708038; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NAKANO Y, 1987, PLANT CELL PHYSIOL, V28, P131; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Yadav RK, 2008, BBA-PROTEINS PROTEOM, V1784, P863, DOI 10.1016/j.bbapap.2008.02.006; Yadav RK, 2010, ARCH BIOCHEM BIOPHYS, V495, P129, DOI 10.1016/j.abb.2010.01.002; YONETANI T, 1965, J BIOL CHEM, V240, P4509; YONETANI T, 1965, J BIOL CHEM, V240, P4503; YONETANI T, 1970, ADV ENZYMOL REL S BI, V33, P309; YORDANOV ND, 1994, APPL MAGN RESON, V6, P341, DOI 10.1007/BF03162498; Yordanov ND, 1996, APPL MAGN RESON, V10, P339, DOI 10.1007/BF03163117	42	29	29	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24608	24615		10.1074/jbc.M111.230524	http://dx.doi.org/10.1074/jbc.M111.230524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21566139	Green Published, hybrid			2022-12-27	WOS:000292547900011
J	Montero, JC; Rodriguez-Barrueco, R; Pandiella, A				Carlos Montero, Juan; Rodriguez-Barrueco, Ruth; Pandiella, Atanasio			Transautocrine Signaling by Membrane Neuregulins Requires Cell Surface Targeting, Which Is Controlled by Multiple Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; BREAST-CANCER; CYTOPLASMIC TAIL; ANCHORING DOMAIN; HEREGULIN; ERBB2; RECEPTORS; CLEAVAGE; LIGAND; ALPHA	The neuregulins (NRGs) play important roles in animal development and homeostasis, and their deregulation has been linked to diseases such as cancer and schizophrenia. The NRGs belong to the epidermal growth factor (EGF) family of transmembrane growth factors. Although NRGs may be synthesized as transmembrane proteins (the pro-NRGs), some of them lack an N-terminal signal sequence, raising the question of how these pro-NRGs are directed to the plasma membrane. Here we have explored the domains of pro-NRGs that are required for their membrane anchoring, cell surface exposure, and biological activity. We show that an internal hydrophobic region acts as a membrane-anchoring domain, but other regions of pro-NRG are required for proper sorting to the plasma membrane. Using mutants that are located in different subcellular compartments, we show that only plasma membrane-exposed pro-NRG is biologically active. At this location, the pro-NRGs may act as transautocrine molecules (i.e. as membrane factors able to activate receptors present in cells that are in physical contact with the pro-NRG-producing cells (in trans) or capable of activating receptors present in the pro-NRG-producing cells (in cis)).	[Carlos Montero, Juan; Rodriguez-Barrueco, Ruth; Pandiella, Atanasio] Univ Salamanca, Consejo Super Invest Cient, Inst Biol Mol & Celular Canc, Ctr Invest Canc, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Pandiella, A (corresponding author), Univ Salamanca, Consejo Super Invest Cient, Inst Biol Mol & Celular Canc, Ctr Invest Canc, Campus Miguel de Unamuno, Salamanca 37007, Spain.	atanasio@usal.es	Rodriguez-Barrueco, Ruth/F-6810-2010; Montero, Juan Carlos/AAO-1780-2020; Pandiella, Atanasio/O-5180-2014	Rodriguez-Barrueco, Ruth/0000-0003-4925-8865; Montero, Juan Carlos/0000-0003-4773-053X; Pandiella, Atanasio/0000-0002-4704-8971	Ministry of Science and Technology of Spain [BMC2003-01192, BFU2006-01813/BMC, BFU2009-07728/BMC]; European Community; Fundacion Ramon Areces; Scientific Foundation of the Spanish Association for Cancer Research; Instituto de Salud Carlos III [RD06/0020/0041]; Spanish Ministry of Education	Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); Fundacion Ramon Areces; Scientific Foundation of the Spanish Association for Cancer Research; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Education(Spanish Government)	This work was supported in part by Ministry of Science and Technology of Spain Grants BMC2003-01192, BFU2006-01813/BMC, and BFU2009-07728/BMC. Our Cancer Research Institute receives support from the European Community through the regional development funding program (FEDER/ERDF) and the Fundacion Ramon Areces.; Supported by the Scientific Foundation of the Spanish Association for Cancer Research.; Supported by the Cancer Center Network Program from the Instituto de Salud Carlos III (RD06/0020/0041).; Recipient of a fellowship from the Spanish Ministry of Education.	Aguilar Z, 2001, J BIOL CHEM, V276, P44099, DOI 10.1074/jbc.M103442200; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Atlas E, 2003, MOL CANCER RES, V1, P165; Borges J, 2007, CELL SIGNAL, V19, P1473, DOI 10.1016/j.cellsig.2007.01.023; BOSENBERG MW, 1992, CELL, V71, P1157, DOI 10.1016/S0092-8674(05)80064-9; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; BURGESS TL, 1995, J BIOL CHEM, V270, P19188, DOI 10.1074/jbc.270.32.19188; Cabrera N, 1996, J CELL BIOL, V132, P427, DOI 10.1083/jcb.132.3.427; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; de Alava E, 2007, J CLIN ONCOL, V25, P2656, DOI 10.1200/JCO.2006.08.6850; Dong JY, 2005, MOL BIOL CELL, V16, P2984, DOI 10.1091/mbc.E04-11-0994; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; Hayes NVL, 2008, ONCOGENE, V27, P715, DOI 10.1038/sj.onc.1210689; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krane IM, 1996, ONCOGENE, V12, P1781; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; MASSAGUE J, 1983, J BIOL CHEM, V258, P3614; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Montero JC, 2007, MOL BIOL CELL, V18, P380, DOI 10.1091/mbc.E06-06-0511; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; THORNE BA, 1994, MOL CELL BIOL, V14, P1635, DOI 10.1128/MCB.14.3.1635; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; Wiley HS, 1998, J CELL BIOL, V143, P1317, DOI 10.1083/jcb.143.5.1317; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yuste L, 2005, CANCER RES, V65, P6801, DOI 10.1158/0008-5472.CAN-04-4023; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562	40	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24350	24363		10.1074/jbc.M110.190835	http://dx.doi.org/10.1074/jbc.M110.190835			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572038	hybrid, Green Published			2022-12-27	WOS:000292294900075
J	Raab, M; Smith, X; Matthess, Y; Strebhardt, K; Rudd, CE				Raab, Monika; Smith, Xin; Matthess, Yves; Strebhardt, Klaus; Rudd, Christopher E.			SKAP1 Protein PH Domain Determines RapL Membrane Localization and Rap1 Protein Complex Formation for T Cell Receptor (TCR) Activation of LFA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTING ADAPTER PROTEIN; TYROSINE KINASE; INTEGRIN ACTIVATION; INTERLEUKIN-2 PRODUCTION; MOLECULAR-CLONING; UP-REGULATION; ADHESION; BINDING; FYN; CD4	Although essential for T cell function, the identity of the T cell receptor (TCR) "inside-out" pathway for the activation of lymphocyte function-associated antigen 1 (LFA-1) is unclear. SKAP1 (SKAP-55) is the upstream regulator needed for TCR-induced RapL-Rap1 complex formation and LFA-1 activation. In this paper, we show that SKAP1 is needed for RapL binding to membranes in a manner dependent on the PHdomain of SKAP1 and the PI3K pathway. ASKAP1 PH domain-inactivating mutation (i.e. R131M) markedly impaired RapL translocation to membranes for Rap1 and LFA-1 binding and the up-regulation of LFA-1-intercellular adhesion molecule 1 (ICAM-1) binding. Further, N-terminal myr-tagged SKAP1 for membrane binding facilitated constitutive RapL membrane and Rap1 binding and effectively substituted for PI3K and TCR ligation in the activation of LFA-1 in T cells.	[Raab, Monika; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Cell Signaling Sect, Cambridge CB2 1QP, England; [Smith, Xin; Rudd, Christopher E.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Matthess, Yves; Strebhardt, Klaus] Goethe Univ Frankfurt, Sch Med, Dept Obstet & Gynaecol, D-60590 Frankfurt, Germany	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Goethe University Frankfurt	Raab, M (corresponding author), Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	moniraab@yahoo.com	Strebhardt, Klaus/E-8765-2011; Rudd, Christopher E/GOH-2021-2022; Rudd, Christopher E/ABF-7259-2021	Rudd, Christopher E/0000-0001-5295-9019; Strebhardt, Klaus/0000-0003-2173-9763				BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Collins TL, 1997, IMMUNOL TODAY, V18, P221; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Duke-Cohan JS, 2006, J BIOL CHEM, V281, P13743, DOI 10.1074/jbc.M508774200; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Geng LP, 1999, J IMMUNOL, V163, P5753; Geng LP, 2001, P NATL ACAD SCI USA, V98, P11527, DOI 10.1073/pnas.191378198; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Huang YP, 2005, J BIOL CHEM, V280, P23576, DOI 10.1074/jbc.M413201200; Jo EK, 2005, J EXP MED, V201, P1733, DOI 10.1084/jem.20042577; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; Kupfer A, 2006, IMMUNITY, V25, P11, DOI 10.1016/j.immuni.2006.07.005; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee JY, 2007, SCIENCE, V317, P206, DOI 10.1126/science.1146073; Liu J, 1998, P NATL ACAD SCI USA, V95, P8779, DOI 10.1073/pnas.95.15.8779; Marie-Cardine A, 1998, J BIOL CHEM, V273, P25789, DOI 10.1074/jbc.273.40.25789; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; MAZEROLLES F, 1991, EUR J IMMUNOL, V21, P887, DOI 10.1002/eji.1830210405; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; RUDD CE, 1990, IMMUNOL TODAY, V11, P400, DOI 10.1016/0167-5699(90)90159-7; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Shimizu Y, 1995, J CELL BIOL, V131, P1867, DOI 10.1083/jcb.131.6.1867; Swanson KD, 2008, MOL CELL, V32, P564, DOI 10.1016/j.molcel.2008.09.022; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Veale M, 1999, J BIOL CHEM, V274, P28427, DOI 10.1074/jbc.274.40.28427; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wang H, 2007, MOL CELL BIOL, V27, P6863, DOI 10.1128/MCB.00556-07; Wang HY, 2010, IMMUNOL LETT, V128, P148, DOI 10.1016/j.imlet.2009.10.010; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wu JN, 2006, J IMMUNOL, V176, P6681, DOI 10.4049/jimmunol.176.11.6681	47	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29663	29670		10.1074/jbc.M111.222661	http://dx.doi.org/10.1074/jbc.M111.222661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21669874	hybrid, Green Published			2022-12-27	WOS:000294046600025
J	Bas, T; Gao, GY; Lvov, A; Chandrasekhar, KD; Gilmore, R; Kobertz, WR				Bas, Tuba; Gao, Grace Y.; Lvov, Anatoli; Chandrasekhar, Kshama D.; Gilmore, Reid; Kobertz, William R.			Post-translational N-Glycosylation of Type I Transmembrane KCNE1 Peptides IMPLICATIONS FOR MEMBRANE PROTEIN BIOGENESIS AND DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; AMINO-ACID; INTEGRATION; OLIGOSACCHARYLTRANSFERASE; MUTAGENESIS; K(V)LQT1; DISTANCE; SEQUONS; KCNQ1; SITE	N-Glycosylation of membrane proteins is critical for their proper folding, co-assembly and subsequent matriculation through the secretory pathway. Here, we examine the kinetics of N-glycan addition to type I transmembrane KCNE1 K+ channel beta-subunits, where point mutations that prevent N-glycosylation at one consensus site give rise to disorders of the cardiac rhythm and congenital deafness. We show that KCNE1 has two distinct N-glycosylation sites: a typical co-translational site and a consensus site similar to 20 residues away that unexpectedly acquires N-glycans after protein synthesis (post-translational). Mutations that ablate the co-translational site concomitantly reduce glycosylation at the post-translational site, resulting in unglycosylated KCNE1 subunits that cannot reach the cell surface with their cognate K+ channel. This long range inhibition is highly specific for post-translational N-glycosylation because mutagenic conversion of the KCNE1 post-translational site into a co-translational site restored both monoglycosylation and anterograde trafficking. These results directly explain how a single point mutation can prevent N-glycan attachment at multiple sites, providing a new biogenic mechanism for human disease.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Chem Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kobertz, WR (corresponding author), 364 Plantat St, Worcester, MA 01605 USA.	william.kobertz@umassmed.edu			National Institutes of Health [DC-007669]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043768, R01GM070650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by Grant DC-007669 from the National Institutes of Health.	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Ben-Dor S, 2004, GLYCOBIOLOGY, V14, P95, DOI 10.1093/glycob/cwh004; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Breuer W, 2001, FEBS LETT, V501, P106, DOI 10.1016/S0014-5793(01)02641-2; CHANDRASEKHAR KD, 2011, J PHYSL IN PRESS; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Duvet S, 2002, GLYCOBIOLOGY, V12, P95, DOI 10.1093/glycob/12.2.95; Finley MR, 2002, AM J PHYSIOL-HEART C, V283, pH126, DOI 10.1152/ajpheart.00622.2001; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; Kolhekar AS, 1998, J BIOL CHEM, V273, P23012, DOI 10.1074/jbc.273.36.23012; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Park KH, 2003, FASEB J, V17, DOI 10.1096/fj.03-0577fje; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Teixeira M, 2006, J BIOL CHEM, V281, P10496, DOI 10.1074/jbc.M512254200; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wu DM, 2006, HEART RHYTHM, V3, P1469, DOI 10.1016/j.hrthm.2006.08.019	32	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28150	28159		10.1074/jbc.M111.235168	http://dx.doi.org/10.1074/jbc.M111.235168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676880	Green Published, hybrid			2022-12-27	WOS:000293557800033
J	Song, WH; Dyer, E; Stuckey, DJ; Copeland, O; Leung, MC; Bayliss, C; Messer, A; Wilkinson, R; Tremoleda, JL; Schneider, MD; Harding, SE; Redwood, CS; Clarke, K; Nowak, K; Monserrat, L; Wells, D; Marston, SB				Song, Weihua; Dyer, Emma; Stuckey, Daniel J.; Copeland, O'Neal; Leung, Man-Ching; Bayliss, Christopher; Messer, Andrew; Wilkinson, Ross; Tremoleda, Jordi Lopez; Schneider, Michael D.; Harding, Sian E.; Redwood, Charles S.; Clarke, Kieran; Nowak, Kristen; Monserrat, Lorenzo; Wells, Dominic; Marston, Steven B.			Molecular Mechanism of the E99K Mutation in Cardiac Actin (ACTC Gene) That Causes Apical Hypertrophy in Man and Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITRO MOTILITY ANALYSIS; TROPONIN-T MUTATIONS; THIN FILAMENT; DILATED CARDIOMYOPATHY; HUMAN HEART; REGULATORY PROPERTIES; FUNCTIONAL CONSEQUENCES; CONTRACTILE PROTEINS; MUSCLE CONTRACTION; ALTERED REGULATION	We generated a transgenic mouse model expressing the apical hypertrophic cardiomyopathy-causing mutation ACTC E99K at 50% of total heart actin and compared it with actin from patients carrying the same mutation. The actin mutation caused a higher Ca2+ sensitivity in reconstituted thin filaments measured by in vitro motility assay (2.3-fold for mice and 1.3-fold for humans) and in skinned papillary muscle. The mutation also abolished the change in Ca2+ sensitivity normally linked to troponin I phosphorylation. MyBP-C and troponin I phosphorylation levels were the same as controls in transgenic mice and human carrier heart samples. ACTC E99K mice exhibited a high death rate between 28 and 45 days (48% females and 22% males). At 21 weeks, the hearts of the male survivors had enlarged atria, increased interstitial fibrosis, and sarcomere disarray. MRI showed hypertrophy, predominantly at the apex of the heart. End-diastolic volume and end-diastolic pressure were increased, and relaxation rates were reduced compared with non-transgenic littermates. End-systolic pressures and volumes were unaltered. ECG abnormalities were present, and the contractile response to beta-adrenergic stimulation was much reduced. Older mice (29-week-old females and 38-week-old males) developed dilated cardiomyopathy with increased end-systolic volume and continuing increased end-diastolic pressure and slower contraction and relaxation rates. ECG showed atrial flutter and frequent atrial ectopic beats at rest in some ACTC E99K mice. We propose that the ACTC E99K mutation causes higher myofibrillar Ca2+ sensitivity that is responsible for the sudden cardiac death, apical hypertrophy, and subsequent development of heart failure in humans and mice.	[Song, Weihua; Dyer, Emma; Stuckey, Daniel J.; Copeland, O'Neal; Leung, Man-Ching; Bayliss, Christopher; Messer, Andrew; Wilkinson, Ross; Schneider, Michael D.; Harding, Sian E.; Marston, Steven B.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW32 6LY, England; [Redwood, Charles S.] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Nowak, Kristen] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Monserrat, Lorenzo] Complejo Hos Univ Juan Canalejo, Dept Cardiol, La Coruna 15006, Spain; [Tremoleda, Jordi Lopez] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, London W12 0NN, England; [Wells, Dominic] Univ London Imperial Coll Sci Technol & Med, Ctr Neurosci, London W12 0NN, England; [Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	Imperial College London; University of Oxford; University of Western Australia; Complejo Hospitalario Universitario A Coruna; Imperial College London; Imperial College London; University of Oxford	Marston, SB (corresponding author), Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	s.marston@imperial.ac.uk		Schneider, Michael/0000-0001-9645-1938; stuckey, daniel/0000-0001-8888-627X; Wells, Dominic/0000-0002-1425-6344; Monserrat, Lorenzo/0000-0001-5776-0623; Harding, Sian/0000-0002-3651-6354	British Heart Foundation; British Heart Foundation Centre of Research Excellence; European Union [241577]; British Heart Foundation [RG/07/004/22659, PG/08/077/25587, PS/02/002/14893] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation Centre of Research Excellence(British Heart Foundation); European Union(European Commission); British Heart Foundation(British Heart Foundation)	This work was funded by grants from the British Heart Foundation, a generous donation from The Dr. E. G. J. Olsen Charitable Fund, the British Heart Foundation Centre of Research Excellence, and the 7th Framework Program of the European Union Grant 241577 ("BIG-HEART").	Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Bing W, 1997, BIOCHEM J, V327, P335, DOI 10.1042/bj3270335; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Bottinelli R, 1998, CIRC RES, V82, P106; Copeland O, 2010, J MUSCLE RES CELL M, V31, P207, DOI 10.1007/s10974-010-9224-7; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; Debold EP, 2010, J MOL CELL CARDIOL, V48, P286, DOI 10.1016/j.yjmcc.2009.09.014; Deng Y, 2001, BIOCHEMISTRY-US, V40, P14593, DOI 10.1021/bi0115232; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Force T, 2010, CIRCULATION, V122, P1130, DOI 10.1161/CIRCULATIONAHA.110.950089; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Hoskins AC, 2010, J MOL CELL CARDIOL, V49, P737, DOI 10.1016/j.yjmcc.2010.06.006; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Huke S, 2010, J MOL CELL CARDIOL, V48, P824, DOI 10.1016/j.yjmcc.2010.01.011; Jacoby C, 2006, BASIC RES CARDIOL, V101, P87, DOI 10.1007/s00395-005-0542-7; Jacques A, 2008, J MUSCLE RES CELL M, V29, P239, DOI 10.1007/s10974-009-9174-0; James AF, 2007, PROG BIOPHYS MOL BIO, V94, P265, DOI 10.1016/j.pbiomolbio.2005.05.010; Jweied E, 2007, J MOL CELL CARDIOL, V42, P722, DOI 10.1016/j.yjmcc.2007.02.002; Kaski JP, 2009, CIRC-CARDIOVASC GENE, V2, P436, DOI 10.1161/CIRCGENETICS.108.821314; Knollmann BC, 2001, TRENDS CARDIOVAS MED, V11, P206, DOI 10.1016/S1050-1738(01)00115-3; Knott A, 2002, J MOL CELL CARDIOL, V34, P469, DOI 10.1006/jmcc.2002.1528; Kumar A, 2004, TRANSGENIC RES, V13, P531, DOI 10.1007/s11248-004-2823-6; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Marston S, 2003, J MUSCLE RES CELL M, V24, P149, DOI 10.1023/A:1026097313020; Marston SB, 1996, J MUSCLE RES CELL M, V17, P497, DOI 10.1007/BF00123365; Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2; Mason SA, 2009, BIOCHEM BIOPH RES CO, V388, P565, DOI 10.1016/j.bbrc.2009.08.050; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; Mogensen J, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010447; Monserrat L, 2007, EUR HEART J, V28, P1953, DOI 10.1093/eurheartj/ehm239; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Nier V, 1999, FEBS LETT, V461, P246, DOI 10.1016/S0014-5793(99)01433-7; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Olson TM, 2000, J MOL CELL CARDIOL, V32, P1687, DOI 10.1006/jmcc.2000.1204; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Redwood C, 2000, CIRC RES, V86, P1146; Redwood CS, 1999, CARDIOVASC RES, V44, P20, DOI 10.1016/S0008-6363(99)00213-8; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; RUBENSTEIN PA, 1983, J BIOL CHEM, V258, P1354; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891	60	44	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27582	27593		10.1074/jbc.M111.252320	http://dx.doi.org/10.1074/jbc.M111.252320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21622575	hybrid, Green Published			2022-12-27	WOS:000293268700052
J	Imashimizu, M; Bernat, G; Sunamura, EI; Broekmans, M; Konno, H; Isato, K; Rogner, M; Hisabori, T				Imashimizu, Mari; Bernat, Gabor; Sunamura, Ei-Ichiro; Broekmans, Martin; Konno, Hiroki; Isato, Kota; Roegner, Matthias; Hisabori, Toru			Regulation of F0F1-ATPase from Synechocystis sp PCC 6803 by gamma and epsilon Subunits Is Significant for Light/Dark Adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST ATP SYNTHASE; C-TERMINAL DOMAIN; COUPLING FACTOR-I; GREEN-ALGA; ACTIVATION; F-1-ATPASE; BINDING; MUTAGENESIS; INHIBITION; EVOLUTION	The gamma and epsilon subunits of F0F1-ATP synthase from photosynthetic organisms display unique properties not found in other organisms. Although the gamma subunit of both chloroplast and cyanobacterial F0F1 contains an extra amino acid segment whose deletion results in a high ATP hydrolysis activity (Sunamura, E., Konno, H., Imashimizu-Kobayashi, M., Sugano, Y., and Hisabori, T. (2010) Plant Cell Physiol. 51, 855-865), its epsilon subunit strongly inhibits ATP hydrolysis activity. To understand the physiological significance of these phenomena, we studied mutant strains with (i) a C-terminally truncated epsilon (epsilon(Delta C)), (ii) gamma lacking the inserted sequence (gamma(Delta 198-222)), and (iii) a double mutation of (i) and (ii) in Synechocystis sp. PCC 6803. Although thylakoid membranes from the epsilon(Delta C) strain showed higher ATP hydrolysis and lower ATP synthesis activities than those of the wild type, no significant difference was observed in growth rate and in intracellular ATP level both under light conditions and during light-dark cycles. However, both the epsilon(Delta C) and gamma(Delta 198-222) and the double mutant strains showed a lower intracellular ATP level and lower cell viability under prolonged dark incubation compared with the wild type. These data suggest that internal inhibition of ATP hydrolysis activity is very important for cyanobacteria that are exposed to prolonged dark adaptation and, in general, for the survival of photosynthetic organisms in an ever-changing environment.	[Imashimizu, Mari; Sunamura, Ei-Ichiro; Konno, Hiroki; Isato, Kota; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Bernat, Gabor; Broekmans, Martin; Roegner, Matthias] Ruhr Univ Bochum, Dept Plant Biochem, D-44780 Bochum, Germany	Tokyo Institute of Technology; Ruhr University Bochum	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Bernat, Gabor/J-6333-2017; Hisabori, Toru/E-5205-2014	Bernat, Gabor/0000-0001-6147-9391; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18074002]; German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB 480, C1]; German Federal Ministry of Education and Research (BMBF); European Union [Solar-H2]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grants-in-aid for Scientific Research on Priority Areas 18074002; to T. H.), the German Research Foundation (Deutsche Forschungsgemeinschaft, SFB 480, project C1 (to M. R.)), the German Federal Ministry of Education and Research (BMBF, project Bio-H<INF>2</INF> (to G. B. and M. R.)), and the European Union project Solar-H<INF>2</INF> (to M. B. and M. R.)	ARANA JL, 1982, J BIOL CHEM, V257, P1125; Bernat G, 2009, PHOTOSYNTH RES, V99, P205, DOI 10.1007/s11120-008-9398-7; BOTTOMLEY PJ, 1976, ARCH MICROBIOL, V108, P249, DOI 10.1007/BF00454849; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; DANN MS, 1992, PLANT PHYSIOL, V99, P153, DOI 10.1104/pp.99.1.153; Das A, 2003, J BACTERIOL, V185, P5527, DOI 10.1128/JB.185.18.5527-5535.2003; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fiske CH, 1925, J BIOL CHEM, V66, P375; Frasch WD, 1994, MOL BIOL CYANOBACTER, P361; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GRIMME LH, 1972, BIOCHEM BIOPH RES CO, V49, P1617, DOI 10.1016/0006-291X(72)90527-X; Hisabori T, 2003, FEBS LETT, V545, P71, DOI 10.1016/S0014-5793(03)00395-8; Hishiya S, 2008, PLANT CELL PHYSIOL, V49, P11, DOI 10.1093/pcp/pcm158; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Johnson EA, 2008, PHOTOSYNTH RES, V96, P153, DOI 10.1007/s11120-008-9296-z; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kim Y, 2011, J BIOL CHEM, V286, P9071, DOI 10.1074/jbc.M110.200584; KLIONSKY DJ, 1985, J BIOL CHEM, V260, P1200; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; KUKI M, 1988, J BIOL CHEM, V263, P17437; LABARRE J, 1989, J BACTERIOL, V171, P3449, DOI 10.1128/jb.171.6.3449-3457.1989; MAMEDOV MD, 1991, FEBS LETT, V294, P271, DOI 10.1016/0014-5793(91)81446-F; NALIN CM, 1984, J BIOL CHEM, V259, P7275; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Nowak KF, 2004, BIOCHEMISTRY-US, V43, P3273, DOI 10.1021/bi035820d; Nowak KF, 2002, BIOCHEMISTRY-US, V41, P15130, DOI 10.1021/bi026594v; OHTA Y, 1993, PLANT CELL PHYSIOL, V34, P523; PATRIE WJ, 1984, J BIOL CHEM, V259, P1121; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; ROBERTSON D, 1990, MOL GEN GENET, V221, P155, DOI 10.1007/BF00261715; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; STERNWEIS PC, 1978, J BIOL CHEM, V253, P3123; Sunamura EI, 2010, PLANT CELL PHYSIOL, V51, P855, DOI 10.1093/pcp/pcq061; Teuber M, 2001, BBA-BIOENERGETICS, V1506, P31, DOI 10.1016/S0005-2728(01)00178-5; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Waschewski N., 2010, BIOMASS BIOFUELS, P388; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WERNER S, 1990, FEBS LETT, V261, P204, DOI 10.1016/0014-5793(90)80671-5; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i; Xu M, 2008, PLANT CELL PHYSIOL, V49, P1672, DOI 10.1093/pcp/pcn139; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yagi H, 2010, BIOCHEM J, V425, P85, DOI 10.1042/BJ20091247; YOSHIDA M, 1977, P NATL ACAD SCI USA, V74, P936, DOI 10.1073/pnas.74.3.936; YOSHIDA M, 1979, J BIOL CHEM, V254, P9525; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	49	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26595	26602		10.1074/jbc.M111.234138	http://dx.doi.org/10.1074/jbc.M111.234138			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21610078	hybrid, Green Published			2022-12-27	WOS:000293078200038
J	Madsen, DH; Ingvarsen, S; Jurgensen, HJ; Melander, MC; Kjoller, L; Moyer, A; Honore, C; Madsen, CA; Garred, P; Burgdorf, S; Bugge, TH; Behrendt, N; Engelholm, LH				Madsen, Daniel H.; Ingvarsen, Signe; Jurgensen, Henrik J.; Melander, Maria C.; Kjoller, Lars; Moyer, Amanda; Honore, Christian; Madsen, Charlotte A.; Garred, Peter; Burgdorf, Sven; Bugge, Thomas H.; Behrendt, Niels; Engelholm, Lars H.			The Non-phagocytic Route of Collagen Uptake A DISTINCT DEGRADATION PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; MACROPHAGE MANNOSE RECEPTOR; TUMOR-CELL LINES; UROKINASE RECEPTOR; HUMAN-FIBROBLASTS; MONOCLONAL-ANTIBODIES; ENDOTHELIAL-CELLS; TRANSMEMBRANE GLYCOPROTEIN; BINDING-PROPERTIES; LECTIN RECEPTOR	The degradation of collagens, the most abundant proteins of the extracellular matrix, is involved in numerous physiological and pathological conditions including cancer invasion. An important turnover pathway involves cellular internalization and degradation of large, soluble collagen fragments, generated by initial cleavage of the insoluble collagen fibers. We have previously observed that in primary mouse fibroblasts, this endocytosis of collagen fragments is dependent on the receptor urokinase plasminogen activator receptor-associated protein (uPARAP)/Endo180. Others have identified additional mechanisms of collagen uptake, with different associated receptors, in other cell types. These receptors include beta 1-integrins, being responsible for collagen phagocytosis, and the mannose receptor. We have now utilized a newly developed monoclonal antibody against uPARAP/Endo180, which down-regulates the receptor protein level on treated cells, to examine the role of uPARAP/Endo180 as a mediator of collagen internalization by a wide range of cultured cell types. With the exception of macrophages, all cells that proved capable of efficient collagen internalization were of mesenchymal origin and all of these utilized uPARAP/Endo180 for their collagen uptake process. Macrophages internalized collagen in a process mediated by the mannose receptor, a protein belonging to the same protein family as uPARAP/Endo180. beta 1-Integrins were found not to be involved in the endocytosis of soluble collagen, irrespectively of whether this was mediated by uPARAP/Endo180 or the mannose receptor. This further distinguishes these pathways from the phagocytic uptake of particulate collagen.	[Madsen, Daniel H.; Ingvarsen, Signe; Jurgensen, Henrik J.; Melander, Maria C.; Kjoller, Lars; Madsen, Charlotte A.; Behrendt, Niels; Engelholm, Lars H.] Rigshosp, Finsen Lab BRIC, DK-2200 Copenhagen, Denmark; [Honore, Christian; Garred, Peter] Rigshosp, Dept Clin Immunol, Mol Med Lab, DK-2200 Copenhagen, Denmark; [Ingvarsen, Signe] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Moyer, Amanda; Bugge, Thomas H.] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Burgdorf, Sven] Univ Bonn, Life & Med Sci LIMES Inst, D-53115 Bonn, Germany	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Bonn	Engelholm, LH (corresponding author), Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	lhe@finsenlab.dk	Ingvarsen, Signe Ziir/AAT-3296-2020	Ingvarsen, Signe Ziir/0000-0001-7800-6443; Honore, Christian/0000-0003-4846-1319; Garred, Peter/0000-0002-2876-8586; Engelholm, Lars/0000-0002-6616-1232; Behrendt, Niels/0000-0003-1833-3922; Madsen, Daniel Hargboel/0000-0002-3183-6201	National Institutes of Health NIDCR; Danish Cancer Society; Danish Medical Research Council; Danish Cancer Research Foundation; Lundbeck Foundation; Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer); European Community [201279]; "Grosserer Alfred Nielsen og Hustrus" foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; Lundbeck Foundation [R67-2010-6200] Funding Source: researchfish	National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer)(Danmarks Grundforskningsfond); European Community(European Commission); "Grosserer Alfred Nielsen og Hustrus" foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lundbeck Foundation(Lundbeckfonden)	This work was supported, in whole or in part, by the National Institutes of Health NIDCR Intramural Research Program (to A. M. and T. H. B.), the Danish Cancer Society, the Danish Medical Research Council, the Danish Cancer Research Foundation, the Lundbeck Foundation, the Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer), European Community's Seventh Framework Programme FP7/2007-2011 Grant 201279 (to N. B.), grants from the Lundbeck Foundation and the "Grosserer Alfred Nielsen og Hustrus" foundation (to L. H. E.), the Copenhagen University Hospital (to D. H. M. and H. J. J.), and the University of Copenhagen, Faculty of Science (to S. I.).	ANCIAN P, 1995, BIOCHEMISTRY-US, V34, P13146, DOI 10.1021/bi00040a028; Arora PD, 2008, AM J PHYSIOL-CELL PH, V295, pC130, DOI 10.1152/ajpcell.00168.2008; Arora PD, 2003, EXP CELL RES, V286, P366, DOI 10.1016/S0014-4827(03)00096-X; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Behrendt N, 2000, J BIOL CHEM, V275, P1993, DOI 10.1074/jbc.275.3.1993; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Blair HC, 2002, BIOCHEM J, V364, P329, DOI 10.1042/BJ20020165; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; CLAESSON MH, 1994, SCAND J IMMUNOL, V40, P257, DOI 10.1111/j.1365-3083.1994.tb03459.x; DECLERCK PJ, 1995, J BIOL CHEM, V270, P8397, DOI 10.1074/jbc.270.15.8397; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Engelholm LH, 2001, LAB INVEST, V81, P1403, DOI 10.1038/labinvest.3780354; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Fasquelle C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000666; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; GRAHAM FL, 1974, COLD SPRING HARB SYM, V39, P637, DOI 10.1101/SQB.1974.039.01.077; Hansen LV, 2004, BIOCHEM J, V380, P845, DOI 10.1042/BJ20031478; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hillig T, 2008, J BIOL CHEM, V283, P15217, DOI 10.1074/jbc.C700214200; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck Kenn, 2006, Birth Defects Research, V78, P11, DOI 10.1002/bdrc.20064; Honardoust HA, 2006, HISTOPATHOLOGY, V49, P634, DOI 10.1111/j.1365-2559.2006.02559.x; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Howard MJ, 2002, J BIOL CHEM, V277, P32320, DOI 10.1074/jbc.M203631200; Howard MJ, 2004, OSTEOARTHR CARTILAGE, V12, P74, DOI 10.1016/j.joca.2003.07.001; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Ingvarsen S, 2008, BIOL CHEM, V389, P943, DOI 10.1515/BC.2008.097; ISACKE CM, 1990, MOL CELL BIOL, V10, P2606, DOI 10.1128/MCB.10.6.2606; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jogi A, 2007, J THROMB HAEMOST, V5, P1936, DOI 10.1111/j.1538-7836.2007.02653.x; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Kogianni G, 2009, EUR J CANCER, V45, P685, DOI 10.1016/j.ejca.2008.11.023; Lee JW, 2002, J ORTHOP RES, V20, P66, DOI 10.1016/S0736-0266(01)00073-0; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; LUND LR, 1992, FEBS LETT, V298, P177, DOI 10.1016/0014-5793(92)80050-Q; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Martinez-Pomares L, 2001, IMMUNOBIOLOGY, V204, P527, DOI 10.1078/0171-2985-00089; MCALLISTER BS, 1993, ARCH BIOCHEM BIOPHYS, V304, P294, DOI 10.1006/abbi.1993.1352; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1; Pataridis S, 2008, J SEP SCI, V31, P3483, DOI 10.1002/jssc.200800351; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; ROMER J, 1994, INT J CANCER, V57, P553, DOI 10.1002/ijc.2910570419; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; SANFORD KK, 1959, J NATL CANCER I, V23, P1035; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schnack N. B., 2002, INT J CANCER, V98, P656; SCHWARTZ AL, 1986, J BIOL CHEM, V261, P5225; Segal G, 2001, J CELL SCI, V114, P119; Sheikh H, 2000, J CELL SCI, V113, P1021; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; SMEDSROD B, 1990, BIOCHEM J, V271, P345, DOI 10.1042/bj2710345; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Szekanecz Z, 2007, CURR OPIN RHEUMATOL, V19, P289, DOI 10.1097/BOR.0b013e32805e87ae; VONFIGURA K, 1984, EMBO J, V3, P1281, DOI 10.1002/j.1460-2075.1984.tb01963.x; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; WATTS C, 1992, J CELL SCI, V103, P1; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Wu K, 1996, J BIOL CHEM, V271, P21323, DOI 10.1074/jbc.271.35.21323; Ye QS, 2010, EUR CELLS MATER, V20, P197	81	88	88	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26996	27010		10.1074/jbc.M110.208033	http://dx.doi.org/10.1074/jbc.M110.208033			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652704	Green Published, hybrid			2022-12-27	WOS:000293078200073
J	Tavares, AFN; Teixeira, M; Romao, CC; Seixas, JD; Nobre, LS; Saraiva, LM				Tavares, Ana Filipa N.; Teixeira, Miguel; Romao, Carlos C.; Seixas, Joao D.; Nobre, Ligia S.; Saraiva, Ligia M.			Reactive Oxygen Species Mediate Bactericidal Killing Elicited by Carbon Monoxide-releasing Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; ANTIMICROBIAL ACTION; DNA-DAMAGE; SUPEROXIDE; RESPIRATION; ACONITASE; PATHWAYS; TARGET	CO-releasing molecules (CO-RMs) were previously shown by us to be more potent bactericides than CO gas. This suggests a mechanism of action for CO-RM, which either potentiates the activity of CO or uses another CO-RM-specific effect. We have also reported that CORM-2 induces the expression of genes related to oxidative stress. In the present study we intend to establish whether the generation of reactive oxygen species by CO-RMs may indeed result in the inhibition of bacterial cellular function. We now report that two CO-RMs (CORM-2 and ALF062) stimulate the production of ROS in Escherichia coli, an effect that is abolished by addition of antioxidants. Furthermore, deletion of genes encoding E. coli systems involved in reactive oxygen species scavenging, namely catalases and superoxide dismutases, potentiates the lethality of CORM-2 due to an increase of intracellular ROS content. CORM-2 also induces the expression of the E. coli DNA repair/SOS system recA, and its inactivation enhances toxicity of CORM-2. Moreover, fluorescence microscopy images reveal that CORM-2 causes DNA lesions to bacterial cells. We also demonstrate that cells treated with CORM-2 contain higher levels of free iron arising from destruction of iron-sulfur proteins. Importantly, we show that CO-RMs generate hydroxyl radicals in a cell-free solution, a process that is abolished by scavenging CO. Altogether, we provide a novel insight into the molecular basis of CO-RMs action by showing that their bactericidal properties are linked to cell damage inflicted by the oxidative stress that they are able to generate.	[Saraiva, Ligia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Estacao Agron Nacl, P-2780157 Oeiras, Portugal; [Romao, Carlos C.; Seixas, Joao D.] Alfama Lda, P-2740122 Porto Salvo, Portugal	National Institute for Agricultural Research Portugal; Universidade Nova de Lisboa	Saraiva, LM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Estacao Agron Nacl, Ave Republ, P-2780157 Oeiras, Portugal.	lst@itqb.unl.pt	Saraiva, Ligia M/H-8537-2012; Teixeira, Miguel/A-9098-2011; Teixeira, Miguel/M-1509-2019; Romão, Carlos C/D-1162-2010	Saraiva, Ligia M/0000-0002-0675-129X; Teixeira, Miguel/0000-0003-4124-6237; Teixeira, Miguel/0000-0003-4124-6237; Romão, Carlos C/0000-0001-5061-3743; Nobre, Ligia/0000-0002-3060-2593	Fundacao para a Ciencia e Tecnologia [PTDC/BIA-PRO/098224/2008]; Fundacao para a Ciencia e Tecnologia Studentships [SFRH/BD/38457/2007];  [SFRH/BPD/69325/2010]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia Studentships; 	This work was supported by Fundacao para a Ciencia e Tecnologia project Grant PTDC/BIA-PRO/098224/2008 and Fundacao para a Ciencia e Tecnologia Studentships SFRH/BD/38457/2007 (to A. F. N. T.) and SFRH/BPD/69325/2010 (to L. S. N.).	Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becerra MC, 2002, BIOCHEM BIOPH RES CO, V297, P1003, DOI 10.1016/S0006-291X(02)02331-8; Brzoska K, 2006, ACTA BIOCHIM POL, V53, P685; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Desmard M, 2009, FASEB J, V23, P1023, DOI 10.1096/fj.08-122804; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Haldane JBS, 1927, BIOCHEM J, V21, P1068, DOI 10.1042/bj0211068; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson TR, 2007, DALTON T, P1500, DOI 10.1039/b613629j; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; MEISTER A, 1985, METHOD ENZYMOL, V113, P327; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Nobre LS, 2009, MICROBIOL-SGM, V155, P813, DOI 10.1099/mic.0.023911-0; Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924; Santos-Silva T, 2011, J AM CHEM SOC, V133, P1192, DOI 10.1021/ja108820s; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Seixas JD, 2010, THESIS U NOVA LISBOA; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yonezawa Y, 1999, J TOXICOL ENV HEAL A, V57, P237, DOI 10.1080/009841099157683; ZHANG J, 1992, J CLIN INVEST, V90, P1193, DOI 10.1172/JCI115980; Zhao HT, 2001, FREE RADICAL BIO MED, V31, P599, DOI 10.1016/S0891-5849(01)00619-0	39	95	97	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26708	26717		10.1074/jbc.M111.255752	http://dx.doi.org/10.1074/jbc.M111.255752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646348	Green Published, hybrid			2022-12-27	WOS:000293078200048
J	Zhou, H; Zhang, Y; Fu, Y; Chan, LR; Lee, AS				Zhou, Hui; Zhang, Yi; Fu, Yong; Chan, Lauren; Lee, Amy S.			Novel Mechanism of Anti-apoptotic Function of 78-kDa Glucose-regulated Protein (GRP78) ENDOCRINE RESISTANCE FACTOR IN BREAST CANCER, THROUGH RELEASE OF B-CELL LYMPHOMA 2 (BCL-2) FROM BCL-2-INTERACTING KILLER (BIK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; CYTOCHROME-C RELEASE; CELL-DEATH; BH3-ONLY PROTEINS; AROMATASE INHIBITORS; FAMILY PROTEINS; X-L; INDUCTION; STRESS; BAX	Activation of the intrinsic apoptotic pathway represents a major mechanism for breast cancer regression resulting from anti-estrogen therapy. The BH3-only protein BIK is inducible by estrogen-starvation and anti-estrogen treatment and plays an important role in anti-estrogen induced apoptosis of breast cancer cells. BIK is predominantly localized to the endoplasmic reticulum where it regulates BAX/BAK-dependent release of Ca2+ from the endoplasmic reticulum stores and cooperates with other BH3-only proteins such as NOXA to cause rapid release of cytochrome c from mitochondria and activate apoptosis. BIK is also known to inactivate BCL-2 through complex formation. Previously, we demonstrated that apoptosis triggered by BIK in estrogen-starved human breast cancer cells is suppressed by GRP78, a major endoplasmic reticulum chaperone. Here we described the isolation of a novel clonal human breast cancer cell line (MCF-7/BUS-10) resistant to long-term estrogen deprivation. These cells exhibit elevated level of GRP78, which protects them from estrogen starvation-induced apoptosis. Our studies revealed that overexpression of GRP78 suppresses apoptosis induced by BIK and NOXA, either alone or in combination. Surprisingly, the interaction of GRP78 with BIK does not require its BH3 domain, which has been implicated in all previous BIK protein interactions. We further showed GRP78 and BCL-2 form independent complex with BIK and that increased expression of GRP78 decreases BIK binding to BCL-2. Our findings provide the first evidence that GRP78 can decrease BCL-2 sequestration by BIK at the endoplasmic reticulum, thus uncovering a potential new mechanism whereby GRP78 confers endocrine resistance in breast cancer.	[Zhou, Hui; Zhang, Yi; Fu, Yong; Chan, Lauren; Lee, Amy S.] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California	Lee, AS (corresponding author), Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, 1441 Eastlake Ave, Los Angeles, CA 90089 USA.	amylee@ccnt.usc.edu	Fu, Yong/A-4247-2012	Fu, Yong/0000-0002-8423-8803; Lee, Amy/0000-0002-0378-5443	National Institutes of Health [CA027607, CA111700]; Department of Defense [W81XWH-07-1-0480]; National Cancer Institute [P30CA014089]; NATIONAL CANCER INSTITUTE [R01CA111700, R37CA027607, P30CA014089, R01CA027607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA027607 and CA111700 and Department of Defense Grant W81XWH-07-1-0480.; We thank Drs. Gordon Shore for the gift of BIK expression plasmids, John Nicholas for BIM expression plasmid, Jianze Li for the NOXA expression plasmid, Parkash Gill for purified GRP78 protein, Cheng Ji for the antibody against BIM, and Ana Soto for MCF-7/BUS cell line. We thank Brenda Lee and Minal Patel for technical assistance. The FACS analysis was performed in the USC Norris Cancer Center Flow Cytometry Core Facility supported in part by Grant P30CA014089 from the National Cancer Institute.	BOYD JM, 1995, ONCOGENE, V11, P1921; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cameron DA, 2000, EUR J CANCER, V36, P845, DOI 10.1016/S0959-8049(00)00013-7; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Choi YB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001031; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; Daidone MG, 2000, BRIT J CANCER, V82, P270; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hur J, 2006, CANCER RES, V66, P10153, DOI 10.1158/0008-5472.CAN-05-3696; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Mathai JP, 2002, ONCOGENE, V21, P2534, DOI 10.1038/sj.onc.1205340; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nikrad M, 2005, MOL CANCER THER, V4, P443; Oppermann M, 2005, ONCOGENE, V24, P7369, DOI 10.1038/sj.onc.1208890; Penas C., 2011, CELL DEATH IN PRESS; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Teles AVF, 2008, NEUROSCI LETT, V442, P96, DOI 10.1016/j.neulet.2008.06.073; Thiantanawat A, 2003, CANCER RES, V63, P8037; Tripathy D, 2009, J CLIN ONCOL, V27, P2580, DOI 10.1200/JCO.2008.21.2142; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wu F, 1998, NUCLEIC ACIDS RES, V26, P4837, DOI 10.1093/nar/26.21.4837; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	43	97	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25687	25696		10.1074/jbc.M110.212944	http://dx.doi.org/10.1074/jbc.M110.212944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622563	Green Published, hybrid			2022-12-27	WOS:000293073000030
J	Witney, TH; Kettunen, MI; Brindle, KM				Witney, Timothy H.; Kettunen, Mikko I.; Brindle, Kevin M.			Kinetic Modeling of Hyperpolarized C-13 Label Exchange between Pyruvate and Lactate in Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE ISOZYMES; INHIBITION; METABOLISM; TRANSPORT; SPECTROSCOPY; SUBSTRATE; H-1-NMR	Measurements of the kinetics of hyperpolarized C-13 label exchange between [1-C-13] pyruvate and lactate in suspensions of intact and lysed murine lymphoma cells, and in cells in which lactate dehydrogenase expression had been modulated by inhibition of the PI3K pathway, were used to determine quantitatively the role of enzyme activity and membrane transport in controlling isotope flux. Both steps were shown to share in the control of isotope flux in these cells. The kinetics of label exchange were well described by a kinetic model that employed rate constants for the lactate dehydrogenase reaction that had been determined previously from steady state kinetic studies. The enzyme showed pyruvate inhibition in steady state kinetic measurements, which the kinetic model predicted should also be observed in the isotope exchange measurements. However, no such pyruvate inhibition was observed in either intact cells or cell lysates and this could be explained by the much higher enzyme concentrations present in the isotope exchange experiments. The kinetic analysis presented here shows how lactate dehydrogenase activity can be determined from the isotope exchange measurements. The kinetic model should be useful for modeling the exchange reaction in vivo, particularly as this technique progresses to the clinic.	[Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Brindle, KM (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	kmb1001@cam.ac.uk	Kettunen, Mikko I/K-2299-2012; Witney, Timothy/R-9440-2017	Kettunen, Mikko I/0000-0002-2004-660X; Witney, Timothy/0000-0002-9475-2873	Cancer Research UK [C197/A3514]; Leukemia and Lymphoma Society; GE Healthcare-Biotechnology and Biosciences Research Council	Cancer Research UK(Cancer Research UK); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); GE Healthcare-Biotechnology and Biosciences Research Council	*The work was supported in part by Cancer Research UK Programme Grant C197/A3514 (to K. M. B.) and by a Translational Research Program Award from The Leukemia and Lymphoma Society. This research was conducted under a research agreement with GE Healthcare, who provided the polarizer and related materials. K. M. B. holds two patents with GE Healthcare.; <SUP>1</SUP>Supported by a GE Healthcare-Biotechnology and Biosciences Research Council CASE studentship.	ARAGON JJ, 1980, P NATL ACAD SCI-BIOL, V77, P6324, DOI 10.1073/pnas.77.11.6324; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Bohndiek SE, 2010, EXPERT REV MOL DIAGN, V10, P417, DOI [10.1586/erm.10.20, 10.1586/ERM.10.20]; BORGMANN U, 1974, BIOCHEMISTRY-US, V13, P5152, DOI 10.1021/bi00722a016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINDLE KM, 1986, EUR J BIOCHEM, V158, P299, DOI 10.1111/j.1432-1033.1986.tb09751.x; BRINDLE KM, 1982, BIOCHEM J, V208, P583, DOI 10.1042/bj2080583; BURGNER JW, 1978, BIOCHEMISTRY-US, V17, P1646, DOI 10.1021/bi00602a011; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Gallagher FA, 2009, PROG NUCL MAG RES SP, V55, P285, DOI 10.1016/j.pnmrs.2009.06.001; Gillies RJ, 2005, ANNU REV BIOMED ENG, V7, P287, DOI 10.1146/annurev.bioeng.7.060804.100411; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Kettunen MI, 2010, MAGN RESON MED, V63, P872, DOI 10.1002/mrm.22276; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Merritt ME, 2008, MAGN RESON MED, V60, P1029, DOI 10.1002/mrm.21760; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Roden M, 1999, ANNU REV MED, V50, P277, DOI 10.1146/annurev.med.50.1.277; Schmitz JE, 2005, MAGN RESON MED, V54, P43, DOI 10.1002/mrm.20529; Schroeder MA, 2008, P NATL ACAD SCI USA, V105, P12051, DOI 10.1073/pnas.0805953105; Simaga S, 2008, INT J GYNECOL CANCER, V18, P1272, DOI 10.1111/j.1525-1438.2008.01196.x; STINSON RA, 1973, BIOCHEM J, V131, P719, DOI 10.1042/bj1310719; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Witney TH, 2010, BRIT J CANCER, V103, P1400, DOI 10.1038/sj.bjc.6605945; Witney TH, 2009, NEOPLASIA, V11, P574, DOI 10.1593/neo.09254; WUNTCH T, 1970, SCIENCE, V169, P480, DOI 10.1126/science.169.3944.480; WUNTCH T, 1970, SCIENCE, V167, P63, DOI 10.1126/science.167.3914.63; YAGIL G, 1969, BIOCHEMISTRY-US, V8, P352, DOI 10.1021/bi00829a049; ZEWE V, 1962, J BIOL CHEM, V237, P1668; Zierhut ML, 2010, J MAGN RESON, V202, P85, DOI 10.1016/j.jmr.2009.10.003	34	116	117	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24572	24580		10.1074/jbc.M111.237727	http://dx.doi.org/10.1074/jbc.M111.237727			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596745	hybrid, Green Published			2022-12-27	WOS:000292547900007
J	Huang, L; Mollet, S; Souquere, S; Le Roy, F; Ernoult-Lange, M; Pierron, G; Dautry, F; Weil, D				Huang, Lue; Mollet, Stephanie; Souquere, Sylvie; Le Roy, Florence; Ernoult-Lange, Michele; Pierron, Gerard; Dautry, Francois; Weil, Dominique			Mitochondria Associate with P-bodies and Modulate MicroRNA-mediated RNA Interference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS GRANULES; HUMAN-CELLS; PROCESSING BODIES; TRANSLATIONAL REPRESSION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; BINDING PROTEIN; BODY FORMATION; IN-VIVO; DECAY	P-bodies are cytoplasmic granules that are linked to mRNA decay, mRNA storage, and RNA interference (RNAi). They are known to interact with stress granules in stressed cells, and with late endosomes. Here, we report that P-bodies also interact with mitochondria, as previously described for P-body-related granules in germ cells. The interaction is dynamic, as a large majority of P-bodies contacts mitochondria at least once within a 3-min interval, and for about 18 s. This association requires an intact microtubule network. The depletion of P-bodies does not seem to affect mitochondria, nor the mitochondrial activity to be required for their contacts with P-bodies. However, inactivation of mitochondria leads to a strong decrease of miRNA-mediated RNAi efficiency, and to a lesser extent of siRNA-mediated RNAi. The defect occurs during the assembly of active RISC and is associated with a specific delocalization of endogeneous Ago2 from P-bodies. Our study reveals the possible involvement of RNAi defect in pathologies involving mitochondrial deficiencies.	[Mollet, Stephanie; Le Roy, Florence; Ernoult-Lange, Michele; Weil, Dominique] Univ Paris 06, CNRS FRE 3402, F-75005 Paris, France; [Huang, Lue; Dautry, Francois] Ecole Normale Super, LBPA, CNRS, F-94230 Cachan, France; [Souquere, Sylvie; Pierron, Gerard] Inst Gustave Roussy, CNRS UMR 8122, F-94800 Villejuif, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Weil, D (corresponding author), Univ Paris 06, CNRS FRE 3402, 9 Quai St Bernard, F-75005 Paris, France.	dominique.weil@upmc.fr	Le Roy, florence/J-7455-2013; WEIL, Dominique/AAE-4214-2020	WEIL, Dominique/0000-0001-7630-1772; HUANG, LUE/0000-0001-8450-8781	Centre National de la Recherche Scientifique; Association pour la Recherche contre le Cancer; Agence Nationale pour la Recherche; Ligue Nationale contre le Cancer; Ministere de l'Enseignement Superieur; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Enseignement Superieur; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique, the Association pour la Recherche contre le Cancer, the Agence Nationale pour la Recherche, and the Ligue Nationale contre le Cancer.; Supported by the Ministere de l'Enseignement Superieur.; Supported by the Ministere de l'Enseignement Superieur.; Supported by the Fondation pour la Recherche Medicale.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Serman A, 2007, NUCLEIC ACIDS RES, V35, P4715, DOI 10.1093/nar/gkm491; Souquere S, 2009, J CELL SCI, V122, P3619, DOI 10.1242/jcs.054437; Stalder L, 2009, RNA, V15, P1265, DOI 10.1261/rna.1672509; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Thomson T, 2008, MECH DEVELOP, V125, P865, DOI 10.1016/j.mod.2008.06.005; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zhang DH, 2006, J LEUKOCYTE BIOL, V80, P309, DOI 10.1189/jlb.1005611	47	75	77	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24219	24230		10.1074/jbc.M111.240259	http://dx.doi.org/10.1074/jbc.M111.240259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576251	Green Published, hybrid			2022-12-27	WOS:000292294900064
J	Kajiho, H; Sakurai, K; Minoda, T; Yoshikawa, M; Nakagawa, S; Fukushima, S; Kontani, K; Katada, T				Kajiho, Hiroaki; Sakurai, Kyoko; Minoda, Tomohiro; Yoshikawa, Manabu; Nakagawa, Satoshi; Fukushima, Shinichi; Kontani, Kenji; Katada, Toshiaki			Characterization of RIN3 as a Guanine Nucleotide Exchange Factor for the Rab5 Subfamily GTPase Rab31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY ENDOCYTIC PATHWAY; GROWTH-FACTOR RECEPTOR; TRANS-GOLGI NETWORK; ENDOSOME DYNAMICS; MOLECULAR-CLONING; STRUCTURAL BASIS; BINDING-PROTEIN; MEMBRANE-FUSION; DOMAIN; TRAFFICKING	The small GTPase Rab5, which cycles between GDP-bound inactive and GTP-bound active forms, plays essential roles in membrane budding and trafficking in the early endocytic pathway. Rab5 is activated by various vacuolar protein sorting 9 (VPS9) domain-containing guanine nucleotide exchange factors. Rab21, Rab22, and Rab31 (members of the Rab5 subfamily) are also involved in the trafficking of early endosomes. Mechanisms controlling the activation Rab5 subfamily members remain unclear. RIN (Ras and Rab interactor) represents a family of multifunctional proteins that have a VPS9 domain in addition to Src homology 2 (SH2) and Ras association domains. We investigated whether RIN family members act as guanine nucleotide exchange factors (GEFs) for the Rab5 subfamily on biochemical and cell morphological levels. RIN3 stimulated the formation of GTP-bound Rab31 in cell-free and in cell GEF activity assays. RIN3 also formed enlarged vesicles and tubular structures, where it colocalized with Rab31 in HeLa cells. In contrast, RIN3 did not exhibit any apparent effects on Rab21. We also found that serine to alanine substitutions in the sequences between SH2 and RIN family homology domain of RIN3 specifically abolished its GEF action on Rab31 but not Rab5. We examined whether RIN3 affects localization of the cation-dependent mannose 6-phosphate receptor (CD-MPR), which is transported between trans-Golgi network and endocytic compartments. We found that RIN3 partially translocates CD-MPR from the trans-Golgi network to peripheral vesicles and that this is dependent on its Rab31-GEF activity. These results indicate that RIN3 specifically acts as a GEF for Rab31.	[Katada, Toshiaki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Katada, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	katada@mol.f.u-tokyo.ac.jp		Kajiho, Hiroaki/0000-0001-6376-7629	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants (to H. K., K. K., and T. K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Japan Society for the Promotion of Science.	Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Deininger K, 2008, P NATL ACAD SCI USA, V105, P12539, DOI 10.1073/pnas.0801174105; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Hadano S, 2004, FEBS LETT, V575, P64, DOI 10.1016/j.febslet.2004.07.092; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hunker CM, 2006, EXP CELL RES, V312, P1106, DOI 10.1016/j.yexcr.2005.12.021; Hunker CM, 2006, BIOCHEM BIOPH RES CO, V340, P967, DOI 10.1016/j.bbrc.2005.12.099; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Kong C, 2007, J BIOL CHEM, V282, P15294, DOI 10.1074/jbc.M611538200; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Mesa R, 2001, J CELL SCI, V114, P4041; Ng EL, 2007, BIOCHEM BIOPH RES CO, V361, P751, DOI 10.1016/j.bbrc.2007.07.076; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; Opdam FJM, 2000, EUR J CELL BIOL, V79, P308, DOI 10.1078/S0171-9335(04)70034-5; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Rodriguez-Gabin AG, 2009, EXP CELL RES, V315, P2215, DOI 10.1016/j.yexcr.2009.03.020; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Saito K, 2005, METHOD ENZYMOL, V403, P276, DOI 10.1016/S0076-6879(05)03023-5; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Simpson JC, 2005, BIOCHEM SOC SYMP, V72, P99, DOI 10.1042/bss0720099; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stenmark H, 2001, GENOME BIOL, V2; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Suzuki-Utsunomiya K, 2007, BIOCHEM BIOPH RES CO, V354, P491, DOI 10.1016/j.bbrc.2006.12.229; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Yoshikawa M, 2008, BIOCHEM BIOPH RES CO, V372, P168, DOI 10.1016/j.bbrc.2008.05.027; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	49	37	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24364	24373		10.1074/jbc.M110.172445	http://dx.doi.org/10.1074/jbc.M110.172445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586568	hybrid, Green Published			2022-12-27	WOS:000292294900076
J	Kriebel, M; Metzger, J; Trinks, S; Chugh, D; Harvey, RJ; Harvey, K; Volkmer, H				Kriebel, Martin; Metzger, Jennifer; Trinks, Sabine; Chugh, Deepti; Harvey, Robert J.; Harvey, Kirsten; Volkmer, Hansjuergen			The Cell Adhesion Molecule Neurofascin Stabilizes Axo-axonic GABAergic Terminals at the Axon Initial Segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL BETA-1; INHIBITORY SYNAPSES; HETEROPHILIC INTERACTIONS; PYRAMIDAL NEURONS; GEPHYRIN; SUBUNITS; RANVIER; COLLYBISTIN; HIPPOCAMPUS; CHANDELIER	Cell adhesion molecules regulate synapse formation and maintenance via transsynaptic contact stabilization involving both extracellular interactions and intracellular postsynaptic scaffold assembly. The cell adhesion molecule neurofascin is localized at the axon initial segment of granular cells in rat dentate gyrus, which is mainly targeted by chandelier cells. Lentiviral shRNA-mediated knockdown of neurofascin in adult rat brain indicates that neurofascin regulates the number and size of postsynaptic gephyrin scaffolds, the number of GABA(A) receptor clusters as well as presynaptic glutamate decarboxylase-positive terminals at the axon initial segment. By contrast, overexpression of neurofascin in hippocampal neurons increases gephyrin cluster size presumably via stimulation of fibroblast growth factor receptor 1 signaling pathways.	[Kriebel, Martin; Metzger, Jennifer; Trinks, Sabine; Chugh, Deepti; Volkmer, Hansjuergen] Univ Tubingen, NMI, D-72770 Reutlingen, Germany; [Harvey, Robert J.; Harvey, Kirsten] Univ London, Dept Pharmacol, Sch Pharm, London WC1N 1AX, England; [Chugh, Deepti] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; University of London; University College London; University of London School of Pharmacy; Eberhard Karls University of Tubingen	Volkmer, H (corresponding author), Univ Tubingen, NMI, Markwiesenstr 55, D-72770 Reutlingen, Germany.	volkmer@nmi.de	Harvey, Robert/D-3994-2016; Volkmer, Hansjuergen/AAU-9641-2021	Harvey, Robert/0000-0001-5956-6664; Volkmer, Hansjuergen/0000-0002-3867-0603	European Union [LSHM-CT-2005-512012]; Bundesministerium fur Bildung und Forschung [0315512]; Medical Research Council [G0501258, G0800498]; Hertie-Institute for Clinical Brain Research; MRC [G0800498, G0501258] Funding Source: UKRI	European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hertie-Institute for Clinical Brain Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by European Union Grant LSHM-CT-2005-512012 and Bundesministerium fur Bildung und Forschung Grant 0315512 (to H. V.) and Medical Research Council Grants G0501258 and G0800498 (to K. H. and R. J. H.).; Supported by a scholarship from the Hertie-Institute for Clinical Brain Research.	Basak S, 2007, DEV BIOL, V311, P408, DOI 10.1016/j.ydbio.2007.08.045; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Burkarth N, 2007, MOL CELL NEUROSCI, V36, P59, DOI 10.1016/j.mcn.2007.06.001; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hardwick C, 2005, BRAIN RES, V1031, P238, DOI 10.1016/j.brainres.2004.10.047; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hassel B, 1997, J BIOL CHEM, V272, P28742, DOI 10.1074/jbc.272.45.28742; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kirschbaum K, 2009, J BIOL CHEM, V284, P28533, DOI 10.1074/jbc.M109.004440; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Koticha D, 2005, MOL CELL NEUROSCI, V30, P137, DOI 10.1016/j.mcn.2005.06.007; Lewis DA, 2011, DEV NEUROBIOL, V71, P118, DOI 10.1002/dneu.20825; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Pruss T, 2006, MOL CELL NEUROSCI, V31, P354, DOI 10.1016/j.mcn.2005.10.009; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Schultz C, 2006, MOL CELL NEUROSCI, V33, P68, DOI 10.1016/j.mcn.2006.06.008; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; SOMOGYI P, 1983, J NEUROSCI, V3, P1450; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Woodruff AR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00201; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	45	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24385	24393		10.1074/jbc.M110.212191	http://dx.doi.org/10.1074/jbc.M110.212191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576239	Green Published, hybrid			2022-12-27	WOS:000292294900078
J	Luo, XY; Prior, M; He, WX; Hu, XY; Tang, XY; Shen, WZ; Yadav, S; Kiryu-Seo, S; Miller, R; Trapp, BD; Yan, RQ				Luo, Xiaoyang; Prior, Marguerite; He, Wanxia; Hu, Xiangyou; Tang, Xiaoying; Shen, Weizhen; Yadav, Satya; Kiryu-Seo, Sumiko; Miller, Robert; Trapp, Bruce D.; Yan, Riqiang			Cleavage of Neuregulin-1 by BACE1 or ADAM10 Protein Produces Differential Effects on Myelination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE BACE1; ALPHA-SECRETASE; NEURAL DEVELOPMENT; PERIPHERAL-NERVE; APP; INHIBITORS; DOMAIN; SCHIZOPHRENIA; REMYELINATION	Neuregulin-1 (Nrg1) is encoded by a single gene and exists in naturally secreted and transmembrane isoforms. Nrg1 exerts its signaling activity through interaction with its cognate ErbB receptors. Multiple membrane-anchored Nrg1 isoforms, present in six different membrane topologies, must be processed by a protease to initiate a signaling cascade. Here, we demonstrate that BACE1 and ADAM10 can process type I and III Nrg1 at two adjacent sites. Our cleavage site mapping experiments showed that the BACE1 cleavage site is located eight amino acids downstream of the ADAM10 cleavage site, and this order of cleavage is the opposite of amyloid precursor protein cleavage by these two enzymes. Cleavages were further confirmed via optimized electrophoresis. Cleavage of type I or III Nrg1 by ADAM10 and BACE1 released a signaling-capable N-terminal fragment (ntf), either Nrg1-ntf alpha or Nrg1-ntf beta, which could similarly activate an ErbB receptor as evidenced by increased phosphorylation of Akt and ERK, two downstream signaling molecules. Although both Nrg1-ntf alpha and Nrg1-ntf beta could initiate a common signaling cascade, inhibition or down-regulation of ADAM10 alone in a co-culture system did not affect normal myelination, whereas specific inhibition of BACE1 impaired normal myelination. Thus, processing of Nrg1 by BACE1 appears to be more critical for regulating myelination. Our results imply that a significant inhibition of BACE1 could potentially impair Nrg1 signaling activity in vivo.	[Luo, Xiaoyang; Prior, Marguerite; He, Wanxia; Hu, Xiangyou; Tang, Xiaoying; Trapp, Bruce D.; Yan, Riqiang] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Kiryu-Seo, Sumiko] Osaka City Univ, Grad Sch Med, Dept Anat & Neurobiol, Osaka 5458585, Japan; [Miller, Robert] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Osaka Metropolitan University; Case Western Reserve University	Yan, RQ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	yanr@ccf.org	Kiryu-Seo, Sumiko/M-8865-2014	Kiryu-Seo, Sumiko/0000-0001-6213-1258; Yan, Riqiang/0000-0001-7195-7617	National Multiple Sclerosis Society [RG4012]; American Health Assistance Foundation; National Institutes of Health [AG025493]; NATIONAL INSTITUTE ON AGING [R01AG025493] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Multiple Sclerosis Society Grant RG4012 and by an American Health Assistance Foundation Research Fellowship (to M. P.).; Supported by National Institutes of Health Grant AG025493. To whom correspondence should be addressed: Dept. of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-2690; Fax: 216-444-7927; E-mail: yanr@ccf.org.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Brady SF, 2004, BIOORG MED CHEM LETT, V14, P601, DOI 10.1016/j.bmcl.2003.11.061; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; BURGESS TL, 1995, J BIOL CHEM, V270, P19188, DOI 10.1074/jbc.270.32.19188; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Freese C, 2009, FEBS J, V276, P1568, DOI 10.1111/j.1742-4658.2009.06889.x; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; Gersbacher MT, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-61; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Jangouk P, 2009, GLIA, V57, P1765, DOI 10.1002/glia.20889; Kiryu-Seo S, 2010, J NEUROSCI, V30, P6658, DOI 10.1523/JNEUROSCI.5265-09.2010; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Neve RL, 2003, TRENDS NEUROSCI, V26, P461, DOI 10.1016/S0166-2236(03)00231-5; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Pietrak BL, 2005, ANAL BIOCHEM, V342, P144, DOI 10.1016/j.ab.2005.04.019; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200	36	89	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23967	23974		10.1074/jbc.M111.251538	http://dx.doi.org/10.1074/jbc.M111.251538			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576249	hybrid, Green Published			2022-12-27	WOS:000292294900039
J	Zhao, RB; Shin, DS; Diop-Bove, N; Ovits, CG; Goldman, ID				Zhao, Rongbao; Shin, Daniel Sanghoon; Diop-Bove, Ndeye; Ovits, Channa Gila; Goldman, I. David			Random Mutagenesis of the Proton-coupled Folate Transporter (SLC46A1), Clustering of Mutations, and the Bases for Associated Losses of Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELA-CELL LINE; AMINO-ACID; MALABSORPTION; PCFT-SLC46A1; RESIDUES; GENE; TRANSLATION; INITIATION; REVEALS; CARRIER	Loss-of-function mutations in the proton-coupled folate transporter (PCFT, SLC46A1) result in the autosomal recessive disorder, hereditary folate malabsorption (HFM). Identification and characterization of HFM mutations provide a wealth of information on the structure-function relationship of this transporter. In the current study, PCR-based random mutagenesis was employed to generate unbiased loss-of-function mutations of PCFT, simulating the spectrum of alterations that might occur in the human disorder. A total of 26 mutations were generated and 4 were identical to HFM mutations. Eleven were base deletion or insertion mutations that led to a frameshift and, along with similar HFM mutations, are predominantly localized to two narrow regions of the pcft gene at the 5'-end. Base substitution mutations identified in the current study and HFM patients were largely distributed across the pcft gene. Elimination of the ATG initiation codon by a one-base substitution (G > A) did not result in a complete lack of translation at the same codon consistent with rare non-ATG translation initiation. Among six missense mutants evaluated, three mutant PCFTs were not detected at the plasma membrane, one mutation resulted in decreased binding to folate substrate, and one had a reduced rate of conformational change associated with substrate translocation. The remaining PCFT mutant had defects in both processes. These results broaden understanding of the regions of the pcft gene prone to base insertion and deletion and inform further approaches to the analysis of the structure-function of PCFT.	[Zhao, Rongbao] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zhao, RB (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.	rzhao@aecom.yu.edu		Shin, Daniel/0000-0002-3784-5336	National Institutes of Health [CA-82621]; NATIONAL CANCER INSTITUTE [R01CA082621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-82621.	Atabay B, 2010, PEDIATR HEMAT ONCOL, V27, P614, DOI 10.3109/08880018.2010.481705; Borzutzky A, 2009, CLIN IMMUNOL, V133, P287, DOI 10.1016/j.clim.2009.08.006; Diop-Bove NK, 2009, MOL CANCER THER, V8, P2424, DOI 10.1158/1535-7163.MCT-08-0938; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; MAHADEO K, 2011, J PEDIAT IN PRESS; MAHADEO KM, 2010, GENEREVIEWS; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Penado KMY, 1998, J BIOL CHEM, V273, P28098, DOI 10.1074/jbc.273.43.28098; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Shibagaki N, 2006, J BIOL CHEM, V281, P22964, DOI 10.1074/jbc.M603462200; Shin DS, 2011, MOL GENET METAB, V103, P33, DOI 10.1016/j.ymgme.2011.01.008; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V294, pC233, DOI 10.1152/ajpcell.00468.2007; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Unal ES, 2009, AM J PHYSIOL-CELL PH, V297, pC66, DOI 10.1152/ajpcell.00096.2009; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2011, BBA-BIOMEMBRANES, V1808, P1140, DOI 10.1016/j.bbamem.2011.01.008; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439	28	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24150	24158		10.1074/jbc.M111.236539	http://dx.doi.org/10.1074/jbc.M111.236539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21602279	Green Published, hybrid			2022-12-27	WOS:000292294900057
J	Boyman, L; Hagen, BM; Giladi, M; Hiller, R; Lederer, WJ; Khananshvili, D				Boyman, Liron; Hagen, Brian M.; Giladi, Moshe; Hiller, Reuben; Lederer, W. Jonathan; Khananshvili, Daniel			Proton-sensing Ca2+ Binding Domains Regulate the Cardiac Na+/Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; RAT VENTRICULAR MYOCYTES; NA+-CA2+ EXCHANGER; GUINEA-PIG; INTRACELLULAR PH; CA2+-BINDING DOMAIN; CYTOPLASMIC PROTONS; HEART-FAILURE; NCX1 PROTEIN; CYTOSOLIC CA	The cardiac Na+/Ca2(+) exchanger (NCX) regulates cellular [Ca2+](i) and plays a central role in health and disease, but its molecular regulation is poorly understood. Here we report on how protons affect this electrogenic transporter by modulating two critically important NCX C-2 regulatory domains, Ca2+ binding domain-1 (CBD1) and CBD2. The NCX transport rate in intact cardiac ventricular myocytes was measured as a membrane current, I-NCX, whereas [H+](i) was varied using an ammonium chloride "rebound" method at constant extracellular pH 7.4. At pH(i) = 7.2 and [Ca2(+)](i) < 120 nM, I-NCX was less than 4% that of its maximally Ca2+-activated value. I-NCX increases steeply at [Ca2+](i) between 130-150 nM with a Hill coefficient (n(H)) of 8.0 +/- 0.7 and K-0.5 = 310 +/- 5 nM. At pH(i) = 6.87, the threshold of Ca2+-dependent activation of I-NCX was shifted to much higher [Ca2+](i) (600-700 nM), and the relationship was similarly steep (n(H) = 8.0 +/- 0.8) with K-0.5 = 1042 +/- 15 nM. The V-max of Ca2+-dependent activation of I-NCX was not significantly altered by low pHi. The Ca2+ affinities for CBD1 (0.39 +/- 0.06 mu M) and CBD2 (K-d = 18.4 +/- 6 mu M) were exquisitely sensitive to [H+], decreasing 1.3-2.3-fold as pH(i) decreased from 7.2 to 6.9. This work reveals for the first time that NCX can be switched off by physiologically relevant intracellular acidification and that this depends on the competitive binding of protons to its C-2 regulatory domains CBD1 and CBD2.	[Boyman, Liron; Giladi, Moshe; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, IL-69978 Ramat Aviv, Israel; [Boyman, Liron; Hagen, Brian M.; Lederer, W. Jonathan] Univ Maryland, Mol Cardiol Lab, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	Tel Aviv University; Sackler Faculty of Medicine; University System of Maryland; University of Maryland Baltimore	Khananshvili, D (corresponding author), Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, IL-69978 Ramat Aviv, Israel.	dhanan@post.tau.ac.il		Khananshvili, Daniel/0000-0002-4202-9966; Giladi, Moshe/0000-0002-8589-6920	National Institutes of Health (NHLBI) [P01 HL67849, R01-HL36974]; Israeli Ministry of Health [2010-3-6266]; USA-Israeli Binational Research Grant [2009-334]; Israel Science Foundation [23/10]; Shteicher Foundation; Leducq North American-European Atrial Fibrillation Research Alliance; European Union; Dr. Miriam and Sheldon G. Edelson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067849, R01HL036974] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Israeli Ministry of Health; USA-Israeli Binational Research Grant; Israel Science Foundation(Israel Science Foundation); Shteicher Foundation; Leducq North American-European Atrial Fibrillation Research Alliance; European Union(European Commission); Dr. Miriam and Sheldon G. Edelson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL67849 and R01-HL36974 (NHLBI). This work was also supported by Israeli Ministry of Health Grant 2010-3-6266, USA-Israeli Binational Research Grant 2009-334, Israel Science Foundation Grant 23/10, the Shteicher Foundation, the Leducq North American-European Atrial Fibrillation Research Alliance, and the European Union Seventh Framework Program (FP7) "Identification and Therapeutic Targeting of Common Arrhythmia Trigger Mechanisms."; Supported by the Dr. Miriam and Sheldon G. Edelson Foundation.	Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bers DM, 2007, ANN NY ACAD SCI, V1099, P326, DOI 10.1196/annals.1387.060; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; BLANK PS, 1992, AM J PHYSIOL, V263, pH276, DOI 10.1152/ajpheart.1992.263.1.H276; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2008, BIOCHEMISTRY-US, V47, P6602, DOI 10.1021/bi8004279; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chaptal Vincent, 2007, Channels (Austin), V1, P397; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Choi HS, 2000, J PHYSIOL-LONDON, V529, P661, DOI 10.1111/j.1469-7793.2000.00661.x; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; DIPOLO R, 1982, BIOCHIM BIOPHYS ACTA, V688, P237, DOI 10.1016/0005-2736(82)90599-5; DOERING AE, 1993, J PHYSIOL-LONDON, V466, P481; DOERING AE, 1994, J PHYSIOL-LONDON, V480, P9, DOI 10.1113/jphysiol.1994.sp020336; Doering AE, 1996, ANN NY ACAD SCI, V779, P182, DOI 10.1111/j.1749-6632.1996.tb44786.x; GARLICK PB, 1979, BIOCHEM J, V184, P547, DOI 10.1042/bj1840547; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; HARRISON SM, 1992, AM J PHYSIOL, V262, pC348; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; KHANANSHVILI D, 1994, BIOCHEMISTRY-US, V33, P312, DOI 10.1021/bi00167a041; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; Leem CH, 1998, J PHYSIOL-LONDON, V509, P471, DOI 10.1111/j.1469-7793.1998.471bn.x; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Malmberg NJ, 2004, BIOCHEMISTRY-US, V43, P16320, DOI 10.1021/bi0482405; MIURA Y, 1989, J GEN PHYSIOL, V93, P1129, DOI 10.1085/jgp.93.6.1129; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; PHILIPSON KD, 1982, CIRC RES, V50, P287, DOI 10.1161/01.RES.50.2.287; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; REEVES JP, 1984, J BIOL CHEM, V259, P7733; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Sobie EA, 2002, BIOPHYS J, V83, P59, DOI 10.1016/S0006-3495(02)75149-7; Soeller C, 1997, BIOPHYS J, V73, P97, DOI 10.1016/S0006-3495(97)78051-2; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Trafford AW, 1999, PFLUG ARCH EUR J PHY, V437, P501, DOI 10.1007/s004240050808; Weber CR, 2003, CIRCULATION, V108, P2224, DOI 10.1161/01.CIR.0000095274.72486.94; Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119; Yamamoto T, 2005, J PHYSIOL-LONDON, V562, P455, DOI 10.1113/jphysiol.2004.071068	47	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28811	28820		10.1074/jbc.M110.214106	http://dx.doi.org/10.1074/jbc.M110.214106			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21680748	Green Published, hybrid			2022-12-27	WOS:000293837000019
J	Davis-Dusenbery, BN; Chan, MC; Reno, KE; Weisman, AS; Layne, MD; Lagna, G; Hata, A				Davis-Dusenbery, Brandi N.; Chan, Mun Chun; Reno, Kelsey E.; Weisman, Alexandra S.; Layne, Matthew D.; Lagna, Giorgio; Hata, Akiko			Down-regulation of Kruppel-like Factor-4 (KLF4) by MicroRNA-143/145 Is Critical for Modulation of Vascular Smooth Muscle Cell Phenotype by Transforming Growth Factor-beta and Bone Morphogenetic Protein 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; EMBRYONIC STEM-CELLS; ZINC-FINGER PROTEIN; GENE-EXPRESSION; TRANSCRIPTION FACTORS; CARDIAC-HYPERTROPHY; SIGNALING PATHWAYS; MYOCARDIN; DIFFERENTIATION; SMAD	In the postnatal vasculature, fully differentiated and quiescent vascular smooth muscle cells (VSMCs) in a "contractile" phenotype are required for the normal regulation of vascular tone. The transforming growth factor-beta (TGF-beta) superfamily of growth factors (TGF-beta s and bone morphogenetic proteins (BMPs)) are potent inducers of contractile phenotype and mediate (i) induction of contractile genes, and (ii) inhibition of VSMC growth and migration. Transcription of contractile genes is positively regulated by a regulatory DNA element called a CArG box. The CArG box is activated by the binding of serum response factor and its coactivators, myocardin (Myocd) or Myocd-related transcription factors (MRTFs). Kruppel-like factor-4 (KLF4) is known to inhibit activation of the CArG box. However, the potential role of KLF4 in the contractile activities of TGF-beta or BMP has not been explored. Here, we demonstrate that TGF-beta and BMP4 rapidly down-regulate KLF4 through induction of microRNA-143 (miR-143) and miR-145, which leads to a reduction of KLF4 transcripts and decreased KLF4 protein expression. Inhibition of miR-145 prevents down-regulation of KLF4 and activation of contractile genes by TGF-beta or BMP4, suggesting that modulation of KLF4 is a prerequisite for induction of contractile genes by TGF-beta and BMP4. Interestingly, both TGF-beta and BMP4 activate transcription of the miR-143/145 gene cluster through the CArG box, however, TGF-beta mediates this effect through induction of Myocd expression, whereas BMP4 utilizes nuclear translocation of MRTF-A. Thus, this study sheds light on both the similarities and the differences of TGF-beta and BMP4 signaling in the regulation of KLF4 and contractile genes.	[Davis-Dusenbery, Brandi N.; Chan, Mun Chun; Weisman, Alexandra S.; Lagna, Giorgio; Hata, Akiko] Tufts Univ, Sch Med, Mol Cardiol Res Inst, Tufts Med Ctr, Boston, MA 02111 USA; [Reno, Kelsey E.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Tufts Medical Center; Tufts University; Tufts University; Boston University	Hata, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, MC 3118,555 Mission Bay Blvd S,Rm 252T, San Francisco, CA 94158 USA.	akiko.hata@ucsf.edu	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613; Layne, Matthew/0000-0003-0007-4870	National Institutes of Health [HD042149, HL082854, HL078869, HL086572, T32 HL069770]; American Heart Association [0940095N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grants HD042149 and HL082854 (to A. H.), HL078869 (to M. D. L.), HL086572 (to G. L.), Training Grant T32 HL069770 (to B. N. D.-D.), and American Heart Association Grant 0940095N (to A. H.).	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Barst RJ, 2005, J CLIN INVEST, V115, P2691, DOI 10.1172/JCI26593; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chen CH, 2010, ARTERIOSCL THROM VAS, V30, P835, DOI 10.1161/ATVBAHA.109.197251; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Chivukula RR, 2009, CELL, V137, P606, DOI 10.1016/j.cell.2009.04.059; Choi BJ, 2006, PATHOL RES PRACT, V202, P585, DOI 10.1016/j.prp.2006.05.001; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Han Z, 2004, P NATL ACAD SCI USA, V101, P12567, DOI 10.1073/pnas.0405085101; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu D, 2011, J BIOL CHEM, V286, P6890, DOI 10.1074/jbc.M110.179952; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Jeon ES, 2008, CIRC RES, V103, P635, DOI 10.1161/CIRCRESAHA.108.180885; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Kuhn AR, 2010, AM J RESP CELL MOL, V42, P506, DOI 10.1165/rcmb.2009-0123OC; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; LAIHO M, 1987, J BIOL CHEM, V262, P17467; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miano JM, 2004, CIRC RES, V95, P340, DOI 10.1161/01.RES.0000140893.16465.2d; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Shats I, 2007, CELL CYCLE, V6, P1141, DOI 10.4161/cc.6.10.4251; Tai SK, 2011, CANCER SCI, V102, P895, DOI 10.1111/j.1349-7006.2011.01859.x; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yet SF, 1998, J BIOL CHEM, V273, P1026, DOI 10.1074/jbc.273.2.1026; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; YU F, 2011, ONCOGENE	61	198	211	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28097	28110		10.1074/jbc.M111.236950	http://dx.doi.org/10.1074/jbc.M111.236950			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673106	hybrid, Green Published			2022-12-27	WOS:000293557800028
J	Kautzmann, MAI; Kim, DS; Felder-Schmittbuhl, MP; Swaroop, A				Kautzmann, Marie-Audrey I.; Kim, Douglas S.; Felder-Schmittbuhl, Marie-Paule; Swaroop, Anand			Combinatorial Regulation of Photoreceptor Differentiation Factor, Neural Retina Leucine Zipper Gene Nrl, Revealed by in Vivo Promoter Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NR2E3; TRANSCRIPTION FACTOR NRL; CELL-FATE; PINEAL-GLAND; ROR-BETA; EXPRESSION; DEGENERATION; HOMEODOMAIN; MUTATIONS; COMPLEX	Development and homeostasis require stringent spatiotemporal control of gene expression patterns that are established, to a large extent, by combinatorial action of transcription regulatory proteins. The bZIP transcription factor NRL (neural retina leucine zipper) is critical for rod versus cone photoreceptor cell fate choice during retinal development and acts as a molecular switch to produce rods from postmitotic precursors. Loss of Nrl in mouse leads to a cone-only retina, whereas ectopic expression of Nrl in photoreceptor precursors generates rods. To decipher the transcriptional regulatory mechanisms upstream of Nrl, we identified putative cis-control elements in the Nrl promoter/enhancer region by examining cross-species sequence conservation. Using in vivo transfection of promoter-reporter constructs into the mouse retina, we show that a 0.9-kb sequence upstream of the Nrl transcription initiation site is sufficient to drive reporter gene expression in photoreceptors. We further define a 0.3-kb sequence including a proximal promoter (cluster A1) and an enhancer (cluster B) that can direct rod-specific expression in vivo. Electrophoretic mobility shift assays using mouse retinal nuclear extracts, in combination with specific antibodies, demonstrate the binding of retinoid-related orphan nuclear receptor beta (ROR beta), cone rod homeobox, orthodenticle homolog 2, and cyclic AMP response element-binding protein to predicted consensus elements within clusters A and B. Our studies demonstrate Nrl as a direct transcriptional target of ROR beta and suggest that combinatorial action of multiple regulatory factors modulates the expression of Nrl in developing and mature retina.	[Kautzmann, Marie-Audrey I.; Kim, Douglas S.; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Felder-Schmittbuhl, Marie-Paule] CNRS, UPR 3212, Inst Neurosci Cellulaires & Integrat, Dept Neurobiol Rythmes, F-67084 Strasbourg, France	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Swaroop, A (corresponding author), NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bldg 6-338,6 Ctr Dr,MSC0610, Bethesda, MD 20892 USA.	swaroopa@nei.nih.gov		Swaroop, Anand/0000-0002-1975-1141; Kim, Douglas/0000-0001-9029-314X	NEI, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000450] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the intramural program of NEI, National Institutes of Health.	Akagi T, 2004, J BIOL CHEM, V279, P28492, DOI 10.1074/jbc.M400871200; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Andre E, 1998, GENE, V216, P277, DOI 10.1016/S0378-1119(98)00348-5; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Brzezinski JA, 2010, DEVELOPMENT, V137, P619, DOI 10.1242/dev.043968; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; DeAngelis MM, 2002, ARCH OPHTHALMOL-CHIC, V120, P369; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Trujillo MJ, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<80::AID-HUMU27>3.0.CO;2-G; KAROLCHIK D, 2009, CURR PROTOC BIOINFOR, V28; Katoh K, 2010, J NEUROSCI, V30, P6515, DOI 10.1523/JNEUROSCI.0771-10.2010; Khanna H, 2006, J BIOL CHEM, V281, P27327, DOI 10.1074/jbc.M605500200; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lu AL, 2009, ENDOCRINOLOGY, V150, P1536, DOI 10.1210/en.2008-1092; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marquardt T, 2003, PROG RETIN EYE RES, V22, P567, DOI 10.1016/S1350-9462(03)00036-3; Matsuda Takahiko, 2008, V423, P259, DOI 10.1007/978-1-59745-194-9_19; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Mitton KP, 2003, HUM MOL GENET, V12, P365, DOI 10.1093/hmg/ddg035; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nir I, 2001, EXP EYE RES, V73, P265, DOI 10.1006/exer.2001.1037; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Nishiguchi KM, 2004, P NATL ACAD SCI USA, V101, P17819, DOI 10.1073/pnas.0408183101; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Parapuram SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013885; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Roger JE, 2010, J BIOL CHEM, V285, P25637, DOI 10.1074/jbc.M110.142810; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Siffroi-Fernandez S, 2008, INVEST OPHTH VIS SCI, V49, P1696, DOI 10.1167/iovs.07-1272; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Tjian R, 1996, PHILOS T R SOC B, V351, P491, DOI 10.1098/rstb.1996.0047; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WEISS ER, 1995, BIOCHEM BIOPH RES CO, V216, P755, DOI 10.1006/bbrc.1995.2686; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717	66	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28247	28255		10.1074/jbc.M111.257246	http://dx.doi.org/10.1074/jbc.M111.257246			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673114	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000293557800042
J	Evron, T; Philipp, M; Lu, JY; Meloni, AR; Burkhalter, M; Chen, W; Caron, MG				Evron, Tama; Philipp, Melanie; Lu, Jiuyi; Meloni, Alison R.; Burkhalter, Martin; Chen, Wei; Caron, Marc G.			Growth Arrest Specific 8 (Gas8) and G Protein-coupled Receptor Kinase 2 (GRK2) Cooperate in the Control of Smoothened Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN REGULATORY COMPLEX; PRIMARY CILIUM; GENE-PRODUCT; ZEBRAFISH; LOCALIZATION; TRANSDUCTION; PATHWAY; BETA-ARRESTIN-2; VERTEBRATES; EXPRESSION	The G protein-coupled receptor (GPCR)-like molecule Smoothened (Smo) undergoes dynamic intracellular trafficking modulated by the microtubule associated kinase GRK2 and recruitment of beta-arrestin. Of this trafficking, especially the translocation of Smo into primary cilia and back to the cytoplasm is essential for the activation of Hedgehog (Hh) signaling in vertebrates. The complete mechanism of this bidirectional transport, however, is not completely understood. Here we demonstrate that Growth Arrest Specific 8 (Gas8), a microtubule associated subunit of the Dynein Regulatory Complex (DRC), interacts with Smo to modulate this process. Gas8 knockdown in ciliated cells reduces Smo signaling activity and ciliary localization whereas overexpression stimulates Smo activity in a GRK2-dependent manner. The C terminus of Gas8 is important for both Gas8 interaction with Smo and facilitating Smo signaling. In zebrafish, knocking down Gas8 results in attenuated Hh transcriptional responses and impaired early muscle development. These effects can be reversed by the co-injection of Gas8 mRNA or by constitutive activation of the downstream Gli transcription factors. Furthermore, Gas8 and GRK2 display a synergistic effect on zebrafish early muscle development and some effects of GRK2 knockdown can be rescued by Gas8 mRNA. Interestingly, Gas8 does not interfere with cilia assembly, as the primary cilia architecture is unchanged upon Gas8 knock down or heterologous expression. This is in contrast to cells stably expressing both GRK2 and Smo, in which cilia are significantly elongated. These results identify Gas8 as a positive regulator of Hh signaling that cooperates with GRK2 to control Smo signaling.	[Evron, Tama; Philipp, Melanie; Meloni, Alison R.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lu, Jiuyi; Chen, Wei] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Burkhalter, Martin] Univ Ulm, Dept Mol Med, D-89081 Ulm, Germany; [Burkhalter, Martin] Univ Ulm, Max Planck Res Grp Stem Cell Aging, D-89081 Ulm, Germany	Duke University; Duke University; Ulm University; Max Planck Society; Ulm University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287,RM 487,Carl Bldg, Durham, NC 27710 USA.	caron002@mc.duke.edu	Philipp, Melanie/B-5198-2016	Philipp, Melanie/0000-0003-2714-965X; Chen, Wei/0000-0002-9934-4000; Burkhalter, Martin/0000-0002-8646-3131	National Institutes of Health [NS19576, MH073853]; Machiah Foundation; Jewish Community Federation of San Francisco; Peninsula County; Marin County; Sonoma County; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853, R01MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Machiah Foundation; Jewish Community Federation of San Francisco; Peninsula County; Marin County; Sonoma County; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS19576 and MH073853.; Recipient of a postdoctoral fellowship from The Machiah Foundation, a supporting foundation of the Jewish Community Federation of San Francisco, the Peninsula, Marin, & Sonoma Counties.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Bekker JM, 2007, CELL MOTIL CYTOSKEL, V64, P461, DOI 10.1002/cm.20196; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Colantonio JR, 2006, TRAFFIC, V7, P538, DOI 10.1111/j.1600-0854.2006.00411.x; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hammond KL, 2010, DEVELOPMENT, V137, P1361, DOI 10.1242/dev.045666; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Kalderon D, 2005, CURR BIOL, V15, pR175, DOI 10.1016/j.cub.2005.02.046; Kim HR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-65; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Lunt SC, 2009, DEV DYNAM, V238, P1744, DOI 10.1002/dvdy.21999; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Penela P, 2010, P NATL ACAD SCI USA, V107, P1118, DOI 10.1073/pnas.0905778107; Philipp M, 2008, MOL BIOL CELL, V19, P5478, DOI 10.1091/mbc.E08-05-0448; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wilson CW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-102	41	25	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27676	27686		10.1074/jbc.M111.234666	http://dx.doi.org/10.1074/jbc.M111.234666			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659505	hybrid, Green Published			2022-12-27	WOS:000293268700060
J	Zhu, M; Torres, MP; Kelley, JB; Dohlman, HG; Wang, YQ				Zhu, Ming; Torres, Matthew P.; Kelley, Joshua B.; Dohlman, Henrik G.; Wang, Yuqi			Pheromone- and RSP5-dependent Ubiquitination of the G Protein beta Subunit Ste4 in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; RGS PROTEINS; MECHANISMS; INSIGHTS; PHOSPHORYLATION; UBIQUITYLATION; SPECIFICITY; ACTIVATION; TRANSIENT; PATHWAYS	Ste4 is the beta subunit of a heterotrimeric G protein that mediates mating responses in Saccharomyces cerevisiae. Here we show that Ste4 undergoes ubiquitination in response to pheromone stimulation. Ubiquitination of Ste4 is dependent on the E3 ligase Rsp5. Disrupting the activity of Rsp5 abolishes ubiquitination of Ste4 in vivo, and recombinant Rsp5 is capable of ubiquitinating Ste4 in vitro. We find also that Lys-340 is a major ubiquitination site on Ste4, as pheromone-induced ubiquitination of the protein is prevented when this residue is mutated to an arginine. Functionally, ubiquitination does not appear to regulate the stability of Ste4, as blocking ubiquitination has no apparent effect on either the abundance or the half-life of the protein. However, when presented with a concentration gradient of pheromone, Ste4(K340R) mutant cells polarize significantly faster than wild-type cells, indicating that ubiquitination limits pheromone-directed polarized growth. Together, these findings reveal a novel stimulus-dependent posttranslational modification of a G beta subunit, establish Ste4 as a new substrate of the E3 ligase Rsp5, and demonstrate a role for G protein ubiquitination in cell polarization.	[Zhu, Ming; Wang, Yuqi] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Torres, Matthew P.; Kelley, Joshua B.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Saint Louis University; University of North Carolina; University of North Carolina Chapel Hill	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA.	ywang8@slu.edu	Kelley, Joshua Brian/S-1031-2019	Kelley, Joshua Brian/0000-0002-5700-1173; Torres, Matthew/0000-0001-7296-4536; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [R15GM093313-01, K99 GM094533-01, R01 GM073180]; American Heart Association [0635271N]; Sigma Xi; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073180, R01GM080739, R01GM059167, K99GM094533, R15GM093313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Sigma Xi; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R15GM093313-01 (to Y. W.), K99 GM094533-01 (to M. T.), and R01 GM073180 (to H. G. D.). This work was also supported by American Heart Association Scientist Development Grant 0635271N (to Y. W.) and a research grant from Sigma Xi (to M. Z.).	Bar EE, 2003, J BIOL CHEM, V278, P21798, DOI 10.1074/jbc.M212636200; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; CIECHANOVER A, 1984, J CELL BIOCHEM, V24, P27, DOI 10.1002/jcb.240240104; COLE GM, 1991, CELL, V64, P703, DOI 10.1016/0092-8674(91)90500-X; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Esch RK, 2006, EUKARYOT CELL, V5, P2147, DOI 10.1128/EC.00270-06; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hamilton MH, 2003, P NATL ACAD SCI USA, V100, P5081, DOI 10.1073/pnas.0831228100; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Li E, 1998, MOL GEN GENET, V258, P608, DOI 10.1007/s004380050774; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Naviglio S, 2004, CELL SIGNAL, V16, P1229, DOI 10.1016/j.cellsig.2004.03.012; Obin M, 2002, J BIOL CHEM, V277, P44566, DOI 10.1074/jbc.M205308200; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Shcherbik N, 2004, J BIOL CHEM, V279, P53892, DOI 10.1074/jbc.M410325200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Suchkov DV, 2010, MOL BIOL CELL, V21, P1737, DOI 10.1091/mbc.E09-08-0706; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wang YQ, 2006, CIRC RES, V99, P1305, DOI 10.1161/01.RES.0000251641.57410.81; Wang YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007456; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217	53	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27147	27155		10.1074/jbc.M111.254193	http://dx.doi.org/10.1074/jbc.M111.254193			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21685393	Green Published, hybrid			2022-12-27	WOS:000293268700010
J	Hargrove, TY; Wawrzak, Z; Liu, JL; Nes, WD; Waterman, MR; Lepesheva, GI				Hargrove, Tatiana Y.; Wawrzak, Zdzislaw; Liu, Jialin; Nes, W. David; Waterman, Michael R.; Lepesheva, Galina I.			Substrate Preferences and Catalytic Parameters Determined by Structural Characteristics of Sterol 14 alpha-Demethylase (CYP51) from Leishmania infantum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							14 ALPHA-DEMETHYLASE; OBTUSIFOLIOL 14-ALPHA-DEMETHYLASE; CHOLESTEROL-BIOSYNTHESIS; CYTOCHROME-P450 3A4; C-32 DEMETHYLATION; TRYPANOSOMA-BRUCEI; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; EXPRESSION; LANOSTEROL	Leishmaniasis is a major health problem that affects populations of similar to 90 countries worldwide, with no vaccine and only a few moderately effective drugs. Here we report the structure/function characterization of sterol 14 alpha-demethylase (CYP51) from Leishmania infantum. The enzyme catalyzes removal of the 14 alpha-methyl group from sterol precursors. The reaction is essential for membrane biogenesis and therefore has great potential to become a target for antileishmanial chemotherapy. Although L. infantum CYP51 prefers C4-monomethylated sterol substrates such as C4-norlanosterol and obtusifoliol (V-max of similar to 10 and 8min(-1), respectively), it is also found to 14 alpha-demethylate C4-dimethylated lanosterol (V-max = 0.9 min(-1)) and C4-desmethylated 14 alpha-methylzymosterol (V-max = 1.9 min(-1)). Binding parameters with six sterols were tested, with K-d values ranging from 0.25 to 1.4 mu M. Thus, L. infantum CYP51 is the first example of a plant-like sterol 14 alpha-demethylase, where requirements toward the composition of the C4 atom substituents are not strict, indicative of possible branching in the postsqualene portion of sterol biosynthesis in the parasite. Comparative analysis of three CYP51 substrate binding cavities (Trypanosoma brucei, Trypanosoma cruzi, and L. infantum) suggests that substrate preferences of plant- and fungal-like protozoan CYP51s largely depend on the differences in the enzyme active site topology. These minor structural differences are also likely to underlie CYP51 catalytic rates and drug susceptibility and can be used to design potent and specific inhibitors.	[Hargrove, Tatiana Y.; Waterman, Michael R.; Lepesheva, Galina I.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Life Sci Collaborat Access Team, Ctr Synchrotron Res, Argonne, IL 60439 USA; [Liu, Jialin; Nes, W. David] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA	Vanderbilt University; Northwestern University; Texas Tech University System; Texas Tech University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 622 RRB,23rd Pierce, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu			National Institutes of Health [GM 067871]; Vanderbilt Institute of Chemical Biology; National Science Foundation [MCB-0929212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Institute of Chemical Biology; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 067871 (to M. R. W. and G. I. L.). This work was also supported by Vanderbilt Institute of Chemical Biology Pilot Project Grant 2011 (to G. I. L.) and National Science Foundation Grant MCB-0929212 (to W. D. N.).	Alrajhi AA, 2002, NEW ENGL J MED, V346, P891, DOI 10.1056/NEJMoa011882; Bak S, 1997, PLANT J, V11, P191, DOI 10.1046/j.1365-313X.1997.11020191.x; Balana-Fouce R, 1998, GEN PHARMACOL-VASC S, V30, P435, DOI 10.1016/S0306-3623(97)00268-1; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; BEACH DH, 1988, MOL BIOCHEM PARASIT, V31, P149, DOI 10.1016/0166-6851(88)90166-1; Cabello-Hurtado F, 1999, EUR J BIOCHEM, V262, P435, DOI 10.1046/j.1432-1327.1999.00376.x; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOTOH O, 1992, J BIOL CHEM, V267, P83; Haughan P.A., 1991, P312; Jackson CJ, 2002, J BIOL CHEM, V277, P46959, DOI 10.1074/jbc.M203523200; Kahn RA, 1996, J BIOL CHEM, V271, P32944, DOI 10.1074/jbc.271.51.32944; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Lepesheva GI, 2006, BIOCHEM SOC T, V34, P1161, DOI 10.1042/BST0341161; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 2001, J BIOL CHEM, V276, P28413, DOI 10.1074/jbc.M102767200; Lepesheva GI, 1999, BBA-PROTEIN STRUCT M, V1434, P31, DOI 10.1016/S0167-4838(99)00156-9; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama K, 2001, J BIOL CHEM, V276, P31459, DOI 10.1074/jbc.M103943200; Nes W. R., 1977, BIOCH STEROIDS OTHER; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; OMURA T, 1964, J BIOL CHEM, V239, P2370; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Petrikkos G, 2007, INT J ANTIMICROB AG, V30, P108, DOI 10.1016/j.ijantimicag.2007.03.009; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Rodrigues JCF, 2002, ANTIMICROB AGENTS CH, V46, P487, DOI 10.1128/AAC.46.2.487-499.2002; Rodriguez NE, 2006, CELL MICROBIOL, V8, P1106, DOI 10.1111/j.1462-5822.2006.00695.x; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Singh Sarman, 2004, Journal of Infection and Chemotherapy, V10, P307, DOI 10.1007/s10156-004-0348-9; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; TABACIK C, 1981, BIOCHEM BIOPH RES CO, V101, P1087, DOI 10.1016/0006-291X(81)91559-X; TATON M, 1991, BIOCHEM J, V277, P483, DOI 10.1042/bj2770483; TRZASKOS JM, 1986, J BIOL CHEM, V261, P6937; TRZASKOS JM, 1984, J BIOL CHEM, V259, P3402; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4235, DOI 10.1128/AAC.00587-10; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4225, DOI 10.1128/AAC.00316-10; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; YOSHIDA Y, 1984, J BIOL CHEM, V259, P1655; Yoshida Y, 2000, BIOCHEM BIOPH RES CO, V273, P799, DOI 10.1006/bbrc.2000.3030; Zonios DI, 2008, SEMIN RESP CRIT CARE, V29, P198, DOI 10.1055/s-2008-1063858	51	78	82	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26838	26848		10.1074/jbc.M111.237099	http://dx.doi.org/10.1074/jbc.M111.237099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632531	Green Published, hybrid			2022-12-27	WOS:000293078200059
J	Seeley, EH; Schwamborn, K; Caprioli, RM				Seeley, Erin H.; Schwamborn, Kristina; Caprioli, Richard M.			Imaging of Intact Tissue Sections: Moving beyond the Microscope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ASSISTED-LASER-DESORPTION/IONIZATION; PARAFFIN-EMBEDDED TISSUE; MALDI MASS-SPECTROMETRY; PROTEIN EXPRESSION; BREAST-CANCER; ANTIGEN RETRIEVAL; CARCINOMA; HISTOLOGY; LOCALIZATION; SENSITIVITY	MALDI-imaging MS is a new molecular imaging technology for direct in situ analysis of thin tissue sections. Multiple analytes can be monitored simultaneously without prior knowledge of their identities and without the need for target-specific reagents such as antibodies. Imaging MS provides important insights into biological processes because the native distributions of molecules are minimally disturbed, and histological features remain intact throughout the analysis. A wide variety of molecules can be imaged, including proteins, peptides, lipids, drugs, and metabolites. Several specific examples are presented to highlight the utility of the technology.	[Caprioli, Richard M.] Vanderbilt Univ, Mass Spectrometry Res Ctr, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Caprioli, RM (corresponding author), Vanderbilt Univ, Mass Spectrometry Res Ctr, Sch Med, 221 Kirkland Hall, Nashville, TN 37232 USA.	r.caprioli@vanderbilt.edu		Seeley, Erin/0000-0002-8000-5754	National Institutes of Health from NIGMS [5R01 GM58008]; United States Department of Defense [W81XWH-05-1-0179]; Vanderbilt Ingram Cancer Center [P30 CA68485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Defense(United States Department of Defense); Vanderbilt Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01 GM58008 from NIGMS. This work was also supported by United States Department of Defense Grant W81XWH-05-1-0179 and Vanderbilt Ingram Cancer Center Core Support Grant P30 CA68485. This is the sixth article in the Thematic Minireview Series on Biological Applications of Mass Spectrometry. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Aerni HR, 2006, ANAL CHEM, V78, P827, DOI 10.1021/ac051534r; Andersson M, 2008, NAT METHODS, V5, P101, DOI [10.1038/nmeth1145, 10.1038/NMETH1145]; Bauer JA, 2010, CLIN CANCER RES, V16, P681, DOI 10.1158/1078-0432.CCR-09-1091; Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bouslimani A, 2010, RAPID COMMUN MASS SP, V24, P415, DOI 10.1002/rcm.4408; Burnum KE, 2008, ENDOCRINOLOGY, V149, P3274, DOI 10.1210/en.2008-0309; Burnum KE, 2009, J LIPID RES, V50, P2290, DOI 10.1194/jlr.M900100-JLR200; Caldwell Robert L., 2005, Cancer Genomics & Proteomics, V2, P333; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; Cornett DS, 2006, MOL CELL PROTEOMICS, V5, P1975, DOI 10.1074/mcp.M600119-MCP200; Crecelius AC, 2005, J AM SOC MASS SPECTR, V16, P1093, DOI 10.1016/j.jasms.2005.02.026; Djidja MC, 2010, ANAL BIOANAL CHEM, V397, P587, DOI 10.1007/s00216-010-3554-6; Djidja MC, 2009, J PROTEOME RES, V8, P4876, DOI 10.1021/pr900522m; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; Groseclose MR, 2008, PROTEOMICS, V8, P3715, DOI 10.1002/pmic.200800495; Gustafsson JOR, 2010, J PROTEOME RES, V9, P4315, DOI 10.1021/pr9011766; Han EC, 2011, CLIN CHIM ACTA, V412, P230, DOI 10.1016/j.cca.2010.09.021; Han XL, 2003, J BIOL CHEM, V278, P8043, DOI 10.1074/jbc.M212340200; Hankin JA, 2007, J AM SOC MASS SPECTR, V18, P1646, DOI 10.1016/j.jasms.2007.06.010; Jackson SN, 2005, J AM SOC MASS SPECTR, V16, P2052, DOI 10.1016/j.jasms.2005.08.014; Katz-Brull R, 2002, CANCER RES, V62, P1966; KHAN WA, 1995, CELL SIGNAL, V7, P171, DOI 10.1016/0898-6568(94)00089-T; Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Kim HK, 2010, J PROTEOME RES, V9, P4123, DOI 10.1021/pr100302b; Kitteringham NR, 2009, J CHROMATOGR B, V877, P1229, DOI 10.1016/j.jchromb.2008.11.013; Krutchinsky AN, 2002, J AM SOC MASS SPECTR, V13, P129, DOI 10.1016/S1044-0305(01)00336-1; Lemaire R, 2007, J PROTEOME RES, V6, P1295, DOI 10.1021/pr060549i; Liu Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-186; M'Koma AE, 2011, INFLAMM BOWEL DIS, V17, P875, DOI 10.1002/ibd.21442; Marshall P, 2010, ANAL CHEM, V82, P7787, DOI 10.1021/ac1017524; Meriaux C, 2010, J PROTEOMICS, V73, P1204, DOI 10.1016/j.jprot.2010.02.010; Morita Y, 2010, CANCER SCI, V101, P267, DOI 10.1111/j.1349-7006.2009.01384.x; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Oppenheimer SR, 2010, J PROTEOME RES, V9, P2182, DOI 10.1021/pr900936z; Prideaux B, 2010, METHODS MOL BIOL, V656, P405, DOI 10.1007/978-1-60761-746-4_23; Puolitaival SM, 2008, J AM SOC MASS SPECTR, V19, P882, DOI 10.1016/j.jasms.2008.02.013; Rahman SMJ, 2005, AM J RESP CRIT CARE, V172, P1556, DOI 10.1164/rccm.200502-274OC; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Reyzer ML, 2004, CANCER RES, V64, P9093, DOI 10.1158/0008-5472.CAN-04-2231; Reyzer ML, 2003, J MASS SPECTROM, V38, P1081, DOI 10.1002/jms.525; Rompp A, 2010, ANGEW CHEM INT EDIT, V49, P3834, DOI 10.1002/anie.200905559; Ronci M, 2008, PROTEOMICS, V8, P3702, DOI 10.1002/pmic.200701143; Schwamborn K, 2007, INT J MOL MED, V20, P155; Schwartz SA, 2004, CLIN CANCER RES, V10, P981, DOI 10.1158/1078-0432.CCR-0927-3; Schwartz SA, 2005, CANCER RES, V65, P7674, DOI 10.1158/0008-5472.CAN-04-3016; Seeley EH, 2008, J AM SOC MASS SPECTR, V19, P1069, DOI 10.1016/j.jasms.2008.03.016; Signor L, 2007, J MASS SPECTROM, V42, P900, DOI 10.1002/jms.1225; Sinha TK, 2008, NAT METHODS, V5, P57, DOI 10.1038/NMETH1147; Spraggins JM, 2011, J AM SOC MASS SPECTR, V22, P1022, DOI 10.1007/s13361-011-0121-0; Stoeckli M, 2007, INT J MASS SPECTROM, V260, P195, DOI 10.1016/j.ijms.2006.10.007; Stoeckli M, 2006, METHOD ENZYMOL, V412, P94, DOI 10.1016/S0076-6879(06)12007-8; Su SP, 2010, EXP EYE RES, V91, P97, DOI 10.1016/j.exer.2010.04.010; Wagner M, 2008, J CHROMATOGR B, V872, P68, DOI 10.1016/j.jchromb.2008.07.009; Walch A, 2008, HISTOCHEM CELL BIOL, V130, P421, DOI 10.1007/s00418-008-0469-9; Wang HYJ, 2005, ANAL CHEM, V77, P6682, DOI 10.1021/ac050868d; Willems SM, 2010, J PATHOL, V222, P400, DOI 10.1002/path.2771; Wisztorski M, 2010, METHODS MOL BIOL, V656, P303, DOI 10.1007/978-1-60761-746-4_18; Woods AS, 2006, AAPS J, V8, pE391, DOI 10.1007/BF02854910; Xu H, 2008, J PROTEOME RES, V7, P1098, DOI 10.1021/pr7006768	60	90	90	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25459	25466		10.1074/jbc.R111.225854	http://dx.doi.org/10.1074/jbc.R111.225854			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632549	hybrid, Green Published			2022-12-27	WOS:000293073000008
J	Soesanto, Y; Luo, B; Parker, G; Jones, D; Cooksey, RC; McClain, DA				Soesanto, Yudi; Luo, Bai; Parker, Glendon; Jones, Deborah; Cooksey, Robert C.; McClain, Donald A.			Pleiotropic and Age-dependent Effects of Decreased Protein Modification by O-Linked N-Acetylglucosamine on Pancreatic beta-Cell Function and Vascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; STIMULATED INSULIN-SECRETION; TRANSGENIC MICE; GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; CYTOSOLIC PROTEINS; GLYCOGEN-SYNTHASE; VEGF-A; GLUCOSE; GLCNAC; EXPRESSION	The hexosamine biosynthesis pathway (HBP) regulates the post-translational modification of nuclear and cytoplasmic protein by O-linked N-acetylglucosamine (O-GlcNAc). Numerous studies have demonstrated increased flux through this pathway contributes to the development of beta-cell dysfunction. The effect of decreased O-GlcNAc on the maintenance of normal beta-cell function, however, is not well understood. We studied transgenic mice that over express beta-N-acetylglucosaminidase (O-GlcNAcase), an enzyme that catalyzes the removal of O-GlcNAc from proteins, in the pancreatic beta-cell under control of the rat insulin promoter. 3-4-Month-old O-GlcNAcase transgenic mice have higher glucose excursions with a concomitant decrease in circulating insulin levels, insulin mRNA levels, and total islet insulin content. In older (8-9-month-old) O-GlcNAcase transgenic mice glucose tolerance is no longer impaired. This is associated with increased serum insulin, islet insulin content, and insulin mRNA in the O-GlcNAcase transgenic mice. These improvements in beta-cell function with aging are associated with increased angiogenesis and increased VEGF expression, with parallel increases in activation of Akt and expression of PGC1 alpha. The biphasic effects as a function of age are consistent with published observations of mice with increased O-GlcNAc in islets and demonstrate that O-GlcNAc signaling exerts multiple effects on both insulin secretion and islet survival.	[McClain, Donald A.] Univ Utah, Div Endocrinol, Dept Biochem, Sch Med, Salt Lake City, UT 84132 USA; [Soesanto, Yudi; Luo, Bai; Parker, Glendon; Jones, Deborah; Cooksey, Robert C.; McClain, Donald A.] Univ Utah, Dept Internal Med, Sch Med, Salt Lake City, UT 84132 USA; [McClain, Donald A.] Vet Adm Med Ctr, Res Serv, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	McClain, DA (corresponding author), Univ Utah, Div Endocrinol, Dept Biochem, Sch Med, 30 N 2030 E, Salt Lake City, UT 84132 USA.	donald.mcclain@hsc.utah.edu		McClain, Don/0000-0002-3310-2359	National Institutes of Health [DK-43526, UL1-RR025764, C06-RR11234]; Research Service of the Veterans Administration; Robinson Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR011234, UL1RR025764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081842, R29DK043526, R01DK043526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Veterans Administration; Robinson Family Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-43526, UL1-RR025764, and C06-RR11234 and the Research Service of the Veterans Administration. This work was also supported by the Robinson Family Foundation.	Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; AUGUSTINVOSS HG, 1993, J CELL PHYSIOL, V157, P279, DOI 10.1002/jcp.1041570210; Chatham JC, 2010, BBA-GEN SUBJECTS, V1800, P57, DOI 10.1016/j.bbagen.2009.07.004; Cooksey RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE334, DOI 10.1152/ajpendo.00265.2005; Cooksey RC, 1999, ENDOCRINOLOGY, V140, P1151, DOI 10.1210/en.140.3.1151; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Hanover JA, 2010, CHEM BIOL, V17, P1272, DOI 10.1016/j.chembiol.2010.12.001; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kaneto H, 2001, J BIOL CHEM, V276, P31099, DOI 10.1074/jbc.M104115200; Kidszun A, 2006, CELL TRANSPLANT, V15, P489, DOI 10.3727/000000006783981774; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KURODA M, 1995, J CLIN ENDOCR METAB, V80, P3196, DOI 10.1210/jc.80.11.3196; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Parker G, 2004, J BIOL CHEM, V279, P20636, DOI 10.1074/jbc.M312139200; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Tang JP, 2000, DIABETES, V49, P1492, DOI 10.2337/diabetes.49.9.1492; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Veerababu G, 2000, DIABETES, V49, P2070, DOI 10.2337/diabetes.49.12.2070; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Vosseller K, 2010, AGING-US, V2, P749, DOI 10.18632/aging.100225; Watada H, 2010, ENDOCR J, V57, P185, DOI 10.1507/endocrj.K09E-035	43	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26118	26126		10.1074/jbc.M111.249508	http://dx.doi.org/10.1074/jbc.M111.249508			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622566	Green Published, hybrid			2022-12-27	WOS:000293073000069
J	Gregor, CR; Cerasoli, E; Schouten, J; Ravi, J; Slootstra, J; Horgan, A; Martyna, GJ; Ryadnov, MG; Davis, P; Crain, J				Gregor, Craig R.; Cerasoli, Eleonora; Schouten, James; Ravi, Jascindra; Slootstra, Jerry; Horgan, Adrian; Martyna, Glenn J.; Ryadnov, Maxim G.; Davis, Paul; Crain, Jason			Antibody Recognition of a Human Chorionic Gonadotropin Epitope (hCG beta(66-80)) Depends on Local Structure Retained in the Free Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN HORMONES; SECONDARY STRUCTURE; HCG; PROTEINS; STANDARDIZATION; IMMUNOASSAYS; ASSIGNMENT; PREGNANCY; SUBUNITS; DYNAMICS	Human chorionic gonadotropin (hCG) is an important biomarker in pregnancy and oncology, where it is routinely detected and quantified by specific immunoassays. Intelligent epitope selection is essential to achieving the required assay performance. We present binding affinity measurements demonstrating that a typical beta 3-loop-specific monoclonal antibody (8G5) is highly selective in competitive immunoassays and distinguishes between hCG beta(66-80) and the closely related luteinizing hormone (LH) fragment LH beta(86-100), which differ only by a single amino acid residue. A combination of optical spectroscopic measurements and atomistic computer simulations on these free peptides reveals differences in turn type stabilized by specific hydrogen bonding motifs. We propose that these structural differences are the basis for the observed selectivity in the full protein.	[Gregor, Craig R.; Ryadnov, Maxim G.; Crain, Jason] Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland; [Cerasoli, Eleonora; Ravi, Jascindra; Horgan, Adrian; Ryadnov, Maxim G.; Crain, Jason] Natl Phys Lab, Teddington TW11 0WL, Middx, England; [Schouten, James; Davis, Paul] Mologic Ltd, Sharnbrook MK44 1LQ, Beds, England; [Slootstra, Jerry] Pepscan Presto BV, NL-8243 RC Lelystad, Netherlands; [Martyna, Glenn J.] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	University of Edinburgh; National Physical Laboratory - UK; Pepscan Therapeutics B.V.; International Business Machines (IBM)	Crain, J (corresponding author), Univ Edinburgh, Sch Phys, Mayfield Rd, Edinburgh EH9 3JZ, Midlothian, Scotland.	jason.crain@npl.co.uk			National Physical Laboratory; Engineering and Physical Sciences Research Council	National Physical Laboratory; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Strategic Research Programme of the National Physical Laboratory and the Engineering and Physical Sciences Research Council.	BANDEKAR J, 1979, P NATL ACAD SCI USA, V76, P774, DOI 10.1073/pnas.76.2.774; Berger P, 2002, TUMOR BIOL, V23, P1, DOI 10.1159/000048686; BIRKEN S, 1988, ENDOCRINOLOGY, V123, P572, DOI 10.1210/endo-123-1-572; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cole LA, 2007, PLACENTA, V28, P977, DOI 10.1016/j.placenta.2007.01.011; Elliott MM, 1997, ENDOCRINE, V7, P15, DOI 10.1007/BF02778058; Gronowski AM, 2009, CLIN CHEM, V55, P1447, DOI 10.1373/clinchem.2009.129205; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Lund T, 1998, REV REPROD, V3, P71, DOI 10.1530/ror.0.0030071; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meloen R. H., 1997, IMMUNOLOGY METHODS M, P982; Mitchell H, 2007, MOL CELL ENDOCRINOL, V260, P310, DOI 10.1016/j.mce.2006.09.003; OCONNOR JF, 1994, ENDOCR REV, V15, P650, DOI 10.1210/er.15.5.650; OZTURK M, 1987, ENDOCRINOLOGY, V120, P549, DOI 10.1210/endo-120-2-549; OZTURK M, 1988, AM J OBSTET GYNECOL, V158, P193, DOI 10.1016/0002-9378(88)90809-5; PERCZEL A, 1992, PROTEIN SCI, V1, P378; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; PIERCE JG, 1971, ENDOCRINOLOGY, V89, P1331, DOI 10.1210/endo-89-6-1331; Samuelson S, 1997, J PHYS CHEM B, V101, P7592, DOI 10.1021/jp9704269; Slootstra JW, 1996, MOL DIVERS, V1, P87, DOI 10.1007/BF01721323; Stenman UH, 2001, CLIN CHEM, V47, P815; Sturgeon CM, 2009, CLIN CHEM, V55, P1484, DOI 10.1373/clinchem.2009.124578; Sturgeon CM, 1998, ANN CLIN BIOCHEM, V35, P460, DOI 10.1177/000456329803500402; Tuckerman ME, 2000, COMPUT PHYS COMMUN, V128, P333, DOI 10.1016/S0010-4655(00)00077-1; Valenti LE, 2011, ANAL BIOCHEM, V410, P118, DOI 10.1016/j.ab.2010.11.006; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X	28	4	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25016	25026		10.1074/jbc.M111.246637	http://dx.doi.org/10.1074/jbc.M111.246637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592960	Green Published, hybrid			2022-12-27	WOS:000292547900050
J	Kilmartin, JR; Maher, MJ; Krusong, K; Noble, CJ; Hanson, GR; Bernhardt, PV; Riley, MJ; Kappler, U				Kilmartin, James R.; Maher, Megan J.; Krusong, Kuakarun; Noble, Christopher J.; Hanson, Graeme R.; Bernhardt, Paul V.; Riley, Mark J.; Kappler, Ulrike			Insights into Structure and Function of the Active Site of SoxAX Cytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTROPIC SULFUR-OXIDATION; MAGNETIC CIRCULAR-DICHROISM; CHARGE-TRANSFER TRANSITIONS; PARACOCCUS-PANTOTROPHUS; THIOSULFATE OXIDATION; PROTEIN; MODEL; IDENTIFICATION; HEMOPROTEINS; REFINEMENT	SoxAX cytochromes catalyze the formation of heterodisulfide bonds between inorganic sulfur compounds and a carrier protein, SoxYZ. They contain unusual His/Cys-ligated heme groups with complex spectroscopic signatures. The heme-ligating cysteine has been implicated in SoxAX catalysis, but neither the SoxAX spectroscopic properties nor its catalysis are fully understood at present. We have solved the first crystal structure for a group 2 SoxAX protein (SnSoxAX), where an N-terminal extension of SoxX forms a novel structure that supports dimer formation. Crystal structures of SoxAX with a heme ligand substitution (C236M) uncovered an inherent flexibility of this SoxA heme site, with both bonding distances and relative ligand orientation differing between asymmetric units and the new residue, Met(236), representing an unusual rotamer of methionine. The flexibility of the SnSoxAX(C236M) SoxA heme environment is probably the cause of the four distinct, new EPR signals, including a high spin ferric heme form, that were observed for the enzyme. Despite the removal of the catalytically active cysteine heme ligand and drastic changes in the redox potential of the SoxA heme (WT, -479 mV; C236M, +85 mV), the substituted enzyme was catalytically active in glutathione-based assays although with reduced turnover numbers (WT, 3.7 s(-1); C236M, 2.0 s(-1)). SnSoxAX(C236M) was also active in assays using SoxYZ and thiosulfate as the sulfur substrate, suggesting that Cys(236) aids catalysis but is not crucial for it. The SoxYZ-based SoxAX assay is the first assay for an isolated component of the Sox multienzyme system.	[Kilmartin, James R.; Bernhardt, Paul V.; Riley, Mark J.; Kappler, Ulrike] Univ Queensland, Sch Chem & Mol Biosci, Ctr Met Biol, St Lucia, Qld 4072, Australia; [Noble, Christopher J.; Hanson, Graeme R.] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld 4072, Australia; [Maher, Megan J.] Centenary Inst, Struct Biol Program, Sydney, NSW 2042, Australia; [Maher, Megan J.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Krusong, Kuakarun] Chulalongkorn Univ, Dept Biochem, Bangkok 10330, Thailand	University of Queensland; University of Queensland; University of Sydney; Centenary Institute; University of Sydney; Chulalongkorn University	Kappler, U (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Ctr Met Biol, St Lucia, Qld 4072, Australia.	u.kappler@uq.edu.au	Maher, Megan/B-2239-2012; Riley, Mark/E-1251-2011; Kappler, Ulrike/A-9483-2013; Bernhardt, Paul V/J-8008-2013; /C-3940-2008	Kappler, Ulrike/0000-0002-2642-1319; Bernhardt, Paul V/0000-0001-6839-1763; /0000-0003-0306-4360; Maher, Megan/0000-0003-0848-9640	Australian Research Council [DP0878525]; Society of Biological Inorganic Chemistry; Biotechnology and Biological Sciences Research Council [BB/C51725]; European Membrane Protein Consortium [LSHG-CT-2004-504601]; Cancer Institute of New South Wales	Australian Research Council(Australian Research Council); Society of Biological Inorganic Chemistry(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Membrane Protein Consortium; Cancer Institute of New South Wales	This work was supported by Australian Research Council Grant and Fellowship DP0878525 (to U. K.).; Recipient of a Society of Biological Inorganic Chemistry travel award.; Supported by Biotechnology and Biological Sciences Research Council Grant BB/C51725, European Membrane Protein Consortium Grant LSHG-CT-2004-504601, and a Cancer Institute of New South Wales Career Development Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bernhardt PV, 2006, J BIOL INORG CHEM, V11, P930, DOI 10.1007/s00775-006-0148-z; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; CHEESMAN MR, 1991, ADV INORG CHEM, V36, P201, DOI 10.1016/S0898-8838(08)60040-9; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frausto da Silva J. J. R., 2001, BIOL CHEM ELEMENTS I, P370; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; GADSBY PMA, 1990, J AM CHEM SOC, V112, P5003, DOI 10.1021/ja00169a002; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kappler U, 2005, FEBS LETT, V579, P2491, DOI 10.1016/j.febslet.2005.03.060; Kappler U, 2004, J BIOL CHEM, V279, P6252, DOI 10.1074/jbc.M310644200; Kappler U, 2001, FEMS MICROBIOL LETT, V203, P1, DOI 10.1016/S0378-1097(01)00304-4; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; Kappler U, 2008, MICROBIAL SULFUR METABOLISM, P151, DOI 10.1007/978-3-540-72682-1_13; Kappler U, 2006, BIOCHEMISTRY-US, V45, P9696, DOI 10.1021/bi060058b; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKNIGHT J, 1993, EUR J BIOCHEM, V213, P683, DOI 10.1111/j.1432-1033.1993.tb17808.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogawa T, 2008, J BACTERIOL, V190, P6097, DOI 10.1128/JB.00634-08; Omura T, 2005, BIOCHEM BIOPH RES CO, V338, P404, DOI 10.1016/j.bbrc.2005.08.267; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Quentmeier A, 2008, FEBS LETT, V582, P3701, DOI 10.1016/j.febslet.2008.09.043; Quentmeier A, 2007, BIOCHEMISTRY-US, V46, P10990, DOI 10.1021/bi700378k; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Spilotros A, 2010, BIOPHYS CHEM, V147, P8, DOI 10.1016/j.bpc.2009.12.001; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; THOMSON AJ, 1990, J CHEM SOC DALTON, P1921, DOI 10.1039/dt9900001921; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; Wilson JJ, 2009, BBA-BIOENERGETICS, V1787, P1516, DOI 10.1016/j.bbabio.2009.07.005	48	17	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24872	24881		10.1074/jbc.M110.212183	http://dx.doi.org/10.1074/jbc.M110.212183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592966	Green Published, hybrid			2022-12-27	WOS:000292547900037
J	Park, E; Iaccarino, C; Lee, J; Kwon, I; Baik, SM; Kim, M; Seong, JY; Son, GH; Borrelli, E; Kim, K				Park, Eonyoung; Iaccarino, Ciro; Lee, Jiwon; Kwon, Ilmin; Baik, Sun Mi; Kim, Myungjin; Seong, Jae Young; Son, Gi Hoon; Borrelli, Emiliana; Kim, Kyungjin			Regulatory Roles of Heterogeneous Nuclear Ribonucleoprotein M and Nova-1 Protein in Alternative Splicing of Dopamine D2 Receptor Pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; RIBONUCLEIC-ACID; D-2; DROSOPHILA; ENHANCER; BRAIN; MICE; SPECIFICITY; INCLUSION; ISOFORMS	The dopamine D2 receptor (D2R) plays a crucial role in the regulation of diverse key physiological functions, including motor control, reward, learning, and memory. This receptor is present in vivo in two isoforms, D2L and D2S, generated from the same gene by alternative pre-mRNA splicing. Each isoform has a specific role in vivo, underlining the importance of a strict control of its synthesis, yet the molecular mechanism modulating alternative D2R pre-mRNA splicing has not been completely elucidated. Here, we identify heterogeneous nuclear ribonucleoprotein M(hnRNP M) as a key molecule controlling D2R splicing. We show that binding of hnRNP M to exon 6 inhibited the inclusion of this exon in the mRNA. Importantly, the splicing factor Nova-1 counteracted hnRNP M effects on D2R pre-mRNA splicing. Indeed, mutations of the putative Nova-1-binding site on exon 6 disrupted Nova-1 RNA assembly and diminished the inhibitory effect of Nova-1 on hnRNP M-dependent exon 6 exclusion. These results identify Nova-1 and hnRNP M as D2R pre-mRNA-binding proteins and show their antagonistic role in the alternative splicing of D2R pre-mRNA.	[Iaccarino, Ciro; Borrelli, Emiliana] Univ Calif Irvine, Dept Microbiol & Mol Genet, INSERM, U904, Irvine, CA 92697 USA; [Park, Eonyoung; Lee, Jiwon; Kwon, Ilmin; Baik, Sun Mi; Kim, Myungjin; Son, Gi Hoon; Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Seong, Jae Young] Korea Univ, Grad Sch Med, Seoul 136705, South Korea	Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Irvine; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Borrelli, E (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, INSERM, U904, 3113 Gillespie, Irvine, CA 92697 USA.	borrelli@uci.edu; kyungjin@snu.ac.kr	Seong, Jae Young/A-5794-2012; Borrelli, Emiliana/M-8994-2018	Seong, Jae Young/0000-0002-3312-6924; 	National Institute on Drug Abuse [DA 024689-02]; Ministry of Science and Technology, Republic of Korea; INSERM; Korea Ministry of Education and Human Resources; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024689] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Korea Ministry of Education and Human Resources(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA 024689-02 from the National Institute on Drug Abuse (to E.B.). This work was also supported by a grant from the Brain Research Center of the 21st Century Frontier Research Program in Neuroscience funded by the Ministry of Science and Technology, Republic of Korea (to K.K.), INSERM (to E.B.), and Brain Korea 21 research fellowships from the Korea Ministry of Education and Human Resources (to E.P., J.L., I.K., S.M.B., and G.H.S.).	BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bertolino A, 2009, J NEUROSCI, V29, P1224, DOI 10.1523/JNEUROSCI.4858-08.2009; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; DATAR KV, 1993, NUCLEIC ACIDS RES, V21, P439, DOI 10.1093/nar/21.3.439; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; GUIRAMAND J, 1995, J BIOL CHEM, V270, P7354, DOI 10.1074/jbc.270.13.7354; Guivarc'H D, 1998, ENDOCRINOLOGY, V139, P4213, DOI 10.1210/en.139.10.4213; Hase ME, 2006, J BIOL CHEM, V281, P39135, DOI 10.1074/jbc.M604235200; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Iaccarino C, 2002, P NATL ACAD SCI USA, V99, P14530, DOI 10.1073/pnas.222319599; Jain RA, 2008, DEVELOPMENT, V135, P973, DOI 10.1242/dev.015438; Kiesler E, 2005, J CELL BIOL, V168, P1013, DOI 10.1083/jcb.200407173; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; Lleres D, 2010, EMBO REP, V11, P445, DOI 10.1038/embor.2010.64; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Racca C, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.005.2010; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Sasabe T, 2011, J NEUROCHEM, V116, P76, DOI 10.1111/j.1471-4159.2010.07086.x; Seong JY, 2002, MOL ENDOCRINOL, V16, P2426, DOI 10.1210/me.2001-0297; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Tirotta E, 2010, RECEPT SER, P303, DOI 10.1007/978-1-60327-333-6_12; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Welter M, 2007, P NATL ACAD SCI USA, V104, P6840, DOI 10.1073/pnas.0610790104; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577	37	24	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25301	25308		10.1074/jbc.M110.206540	http://dx.doi.org/10.1074/jbc.M110.206540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622564	hybrid, Green Published			2022-12-27	WOS:000292547900076
J	Allahverdiyeva, Y; Ermakova, M; Eisenhut, M; Zhang, PP; Richaud, P; Hagemann, M; Cournac, L; Aro, EM				Allahverdiyeva, Yagut; Ermakova, Maria; Eisenhut, Marion; Zhang, Pengpeng; Richaud, Pierre; Hagemann, Martin; Cournac, Laurent; Aro, Eva-Mari			Interplay between Flavodiiron Proteins and Photorespiration in Synechocystis sp. PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO2 CONCENTRATING MECHANISMS; PHOTOSYNTHETIC ORGANISMS; OXYGEN; PHOTOPROTECTION; CHLAMYDOMONAS; CYANOBACTERIA; CHLOROPLASTS; RESPIRATION; COMPONENTS; REDUCTION	Flavodiiron (Flv) proteins are involved in detoxification of O-2 and NO in anaerobic bacteria and archaea. Cyanobacterial Flv proteins, on the contrary, function in oxygenic environment and possess an extra NAD(P) H: flavin oxidoreductase module. Synechocystis sp. PCC 6803 has four genes (sll1521, sll0219, sll0550, and sll0217) encoding Flv proteins (Flv1, Flv2, Flv3, and Flv4). Previous in vitro studies with recombinant Flv3 protein from Synechocystis provided evidence that it functions as a NAD(P) H: oxygen oxidoreductase, and subsequent in vivo studies with Synechocystis confirmed the role of Flv1 and Flv3 proteins in the Mehler reaction (photoreduction of O-2 to H2O). Interestingly, homologous proteins to Flv1 and Flv3 can be found also in green algae, mosses, and Selaginella. Here, we addressed the function of Flv1 and Flv3 in Synechocystis using the Delta flv1, Delta flv3, and Delta flv1/Delta flv3 mutants and applying inorganic carbon (C-i)-deprivation conditions. We propose that only the Flv1/Flv3 heterodimer form is functional in the Mehler reaction in vivo. O-18(2) labeling was used to discriminate between O-2 evolution in photosynthetic water splitting and O-2 consumption. In wild type, similar to 20% of electrons originated from water was targeted to O-2 under air level CO2 conditions but increased up to 60% in severe limitation of C-i. Gas exchange experiments with Delta flv1, Delta flv3, and Delta flv1/Delta flv3 mutants demonstrated that a considerable amount of electrons in these mutants is directed to photorespiration under C-i deprivation. This assumption is in line with increased transcript abundance of photorespiratory genes and accumulation of photorespiratory intermediates in the WT and to a higher extent in mutant cells under C-i deprivation.	[Allahverdiyeva, Yagut; Ermakova, Maria; Eisenhut, Marion; Zhang, Pengpeng; Aro, Eva-Mari] Univ Turku, Dept Biochem & Food Chem, Plant Mol Biol Lab, FI-20014 Turku, Finland; [Richaud, Pierre; Cournac, Laurent] CEN Cadarache, CEA, Inst Biol Environm & Biotechnol, Direct Sci Vivant,Lab Bioenerget & Biotechnol Bac, F-13108 St Paul Les Durance, France; [Richaud, Pierre; Cournac, Laurent] CNRS, UMR Biol Vegetale & Microbiol Environm, F-13108 St Paul Les Durance, France; [Richaud, Pierre; Cournac, Laurent] Aix Marseille Univ, F-13108 St Paul Les Durance, France; [Hagemann, Martin] Univ Rostock, Inst Biowissensch, D-18059 Rostock, Germany	University of Turku; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Rostock	Aro, EM (corresponding author), Univ Turku, Dept Biochem & Food Chem, Plant Mol Biol Lab, FI-20014 Turku, Finland.	evaaro@utu.fi	Cournac, Laurent/G-2564-2010; Allahverdiyeva, Yagut/I-5652-2013; Aro, Eva-Mari/Q-8664-2017	Allahverdiyeva, Yagut/0000-0002-9262-1757; Aro, Eva-Mari/0000-0002-2922-1435; Cournac, Laurent/0000-0003-0371-938X; Ermakova, Maria/0000-0001-8466-4186	Academy of Finland Center of Excellence [118637]; European Union [212508]; CNRS/Japan Science and Technology Agency; Nordic Energy Research Program; European Union; Region Provence Alpes Cote d'Azur; French Ministry of Research; Commissariat a l'Energie Atomique	Academy of Finland Center of Excellence(Academy of Finland); European Union(European Commission); CNRS/Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Centre National de la Recherche Scientifique (CNRS)); Nordic Energy Research Program; European Union(European Commission); Region Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by Academy of Finland Center of Excellence Project 118637, the European Union Project Solar-H2 (FP7 Contract 212508), CNRS/Japan Science and Technology Agency (Program "Structure and Function of Biomolecules: Response Mechanism to Environments"), and the Nordic Energy Research Program (Project Nordic BioH<INF>2</INF>). This work was also supported by the HelioBiotec platform (funded by the European Union (European Regional Development Fund)), the Region Provence Alpes Cote d'Azur, the French Ministry of Research, and the Commissariat a l'Energie Atomique.	Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; ARTUS NN, 1986, CRIT REV PLANT SCI, V4, P121, DOI 10.1080/07352688609382221; ASADA K, 1974, J BIOL CHEM, V249, P2175; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bader MR, 2000, PHILOS T R SOC B, V355, P1433, DOI 10.1098/rstb.2000.0704; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; BATTCHIKOVA N, 2010, BIOCH BIOPH IN PRESS; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; COLMAN B, 1989, AQUAT BOT, V34, P211, DOI 10.1016/0304-3770(89)90057-0; Di Matteo A, 2008, J BIOL CHEM, V283, P4061, DOI 10.1074/jbc.M705605200; DIMON B, 1988, METHOD ENZYMOL, V167, P686; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Hackenberg C, 2009, PLANTA, V230, P625, DOI 10.1007/s00425-009-0972-9; Hagemann M, 2005, PLANT BIOLOGY, V7, P15, DOI 10.1055/s-2004-830445; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; MILLER AG, 1989, PLANT PHYSIOL, V91, P1044, DOI 10.1104/pp.91.3.1044; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; OSMOND CB, 1981, BIOCHIM BIOPHYS ACTA, V639, P77, DOI 10.1016/0304-4173(81)90006-9; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Talling J.F., 1985, INORGANIC CARBON UPT, P403; Tikkanen M, 2011, TRENDS PLANT SCI, V16, P126, DOI 10.1016/j.tplants.2010.11.006; Vicente JB, 2002, BIOCHEM BIOPH RES CO, V294, P82, DOI 10.1016/S0006-291X(02)00434-5; Vicente JB, 2008, METHOD ENZYMOL, V437, P21, DOI 10.1016/S0076-6879(07)37002-X; Vicente JB, 2009, ARCH BIOCHEM BIOPHYS, V488, P9, DOI 10.1016/j.abb.2009.06.011; WILDNER GF, 1976, BIOCHEM BIOPH RES CO, V69, P268, DOI 10.1016/S0006-291X(76)80302-6; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331	35	91	94	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24007	24014		10.1074/jbc.M111.223289	http://dx.doi.org/10.1074/jbc.M111.223289			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21602273	Green Published, hybrid			2022-12-27	WOS:000292294900043
J	Severe, N; Miraoui, H; Marie, PJ				Severe, Nicolas; Miraoui, Hichem; Marie, Pierre J.			The Casitas B Lineage Lymphoma (Cbl) Mutant G306E Enhances Osteogenic Differentiation in Human Mesenchymal Stromal Cells in Part by Decreased Cbl-mediated Platelet-derived Growth Factor Receptor alpha and Fibroblast Growth Factor Receptor 2 Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; STEM-CELLS; C-CBL; OSTEOBLAST DIFFERENTIATION; LIGASE CBL; IN-VITRO; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; DOWN-REGULATION	Human bone marrow-derived mesenchymal stromal cells (hMSCs) have the capacity to differentiate into several cell types including osteoblasts and are therefore an important cell source for bone tissue regeneration. A crucial issue is to identify mechanisms that trigger hMSC osteoblast differentiation to promote osteogenic potential. Casitas B lineage lymphoma (Cbl) is an E3 ubiquitin ligase that ubiquitinates and targets several molecules for degradation. We hypothesized that attenuation of Cbl-mediated degradation of receptor tyrosine kinases (RTKs) may promote osteogenic differentiation in hMSCs. We show here that specific inhibition of Cbl interaction with RTKs using a Cbl mutant (G306E) promotes expression of osteoblast markers (Runx2, alkaline phosphatase, type 1 collagen, osteocalcin) and increases osteogenic differentiation in clonal bone marrow-derived hMSCs and primary hMSCs. Analysis of molecular mechanisms revealed that the Cbl mutant increased PDGF receptor alpha and FGF receptor 2 but not EGF receptor expression in hMSCs, resulting in increased ERK1/2 and PI3K signaling. Pharmacological inhibition of FGFR or PDGFR abrogated in vitro osteogenesis induced by the Cbl mutant. The data reveal that specific inhibition of Cbl interaction with RTKs promotes the osteogenic differentiation program in hMSCs in part by decreased Cbl-mediated PDGFR alpha and FGFR2 ubiquitination, providing a novel mechanistic approach targeting Cbl to promote the osteogenic capacity of hMSCs.	[Severe, Nicolas; Miraoui, Hichem; Marie, Pierre J.] Hop Lariboisiere, INSERM, U606, Lab Osteoblast Biol & Pathol, F-75475 Paris 10, France; [Severe, Nicolas; Miraoui, Hichem; Marie, Pierre J.] Univ Paris Diderot, UMR606, F-75475 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, U606, Lab Osteoblast Biol & Pathol, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr			Institut National de la Sante et de la Recherche Medicale; Ministere de la Recherche (Paris, France)	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de la Recherche (Paris, France)(Ministry of Research, France)	This work was supported in part by Institut National de la Sante et de la Recherche Medicale.; Recipients of a Ph.D. award from the Ministere de la Recherche (Paris, France).	Ahdjoudj S, 2001, J CELL BIOCHEM, V81, P23, DOI 10.1002/1097-4644(20010401)81:1<23::AID-JCB1021>3.0.CO;2-H; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Carcamo-Orive I, 2010, J BONE MINER RES, V25, P2115, DOI 10.1002/jbmr.120; Charbord P, 2011, STEM CELL REV REP, V7, P32, DOI 10.1007/s12015-010-9125-6; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Dardalhon V, 2001, GENE THER, V8, P190, DOI 10.1038/sj.gt.3301378; Dufour C, 2008, BONE, V42, P1032, DOI 10.1016/j.bone.2008.02.009; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fromigue O, 2001, J BONE MINER RES, V16, P1600, DOI 10.1359/jbmr.2001.16.9.1600; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Giuliani N, 2007, BLOOD, V110, P334, DOI 10.1182/blood-2006-11-059188; Gronthos S, 2007, STEM CELLS DEV, V16, P953, DOI 10.1089/scd.2007.0069; Gruber R, 2004, PLATELETS, V15, P29, DOI 10.1080/09537100310001643999; Guenou H, 2006, AM J PATHOL, V169, P1303, DOI 10.2353/ajpath.2006.060102; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; Kassem M, 2004, CLONING STEM CELLS, V6, P369, DOI 10.1089/clo.2004.6.369; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; LANGDON WY, 1990, CURR TOP MICROBIOL, V166, P159; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Miraoui H, 2010, HUM MOL GENET, V19, P1678, DOI 10.1093/hmg/ddq045; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Mitlak BH, 1996, J BONE MINER RES, V11, P238; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Moenning A, 2009, MOL CELL BIOL, V29, P881, DOI 10.1128/MCB.00885-08; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Orosco A, 2007, CANCER RES, V67, P3708, DOI 10.1158/0008-5472.CAN-06-4164; Oyajobi BO, 1999, J BONE MINER RES, V14, P351, DOI 10.1359/jbmr.1999.14.3.351; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Rahimi N, 2009, BIOCHEM SOC T, V37, P1189, DOI 10.1042/BST0371189; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; SANJAY A, 2001, SCI STKE, pPE40; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Smit GDV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000217; Suzue N, 2006, J BONE MINER RES, V21, P722, DOI 10.1359/JBMR.060207; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Ueno H, 1997, J BIOL CHEM, V272, P8739, DOI 10.1074/jbc.272.13.8739; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493	61	24	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24443	24450		10.1074/jbc.M110.197525	http://dx.doi.org/10.1074/jbc.M110.197525			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596750	Green Published, hybrid			2022-12-27	WOS:000292294900084
J	Tsui, S; Fernando, R; Chen, BL; Smith, TJ				Tsui, Shanli; Fernando, Roshini; Chen, Beiling; Smith, Terry J.			Divergent Sp1 Protein Levels May Underlie Differential Expression of UDP-Glucose Dehydrogenase by Fibroblasts ROLE IN SUSCEPTIBILITY TO ORBITAL GRAVES DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; THYROID-ASSOCIATED OPHTHALMOPATHY; MAMMALIAN HYALURONAN SYNTHASES; HUMAN-SKIN FIBROBLASTS; BREAST-CANCER CELLS; MOLECULAR-CLONING; BOVINE LIVER; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; RECEPTOR-ALPHA	UDP-glucose dehydrogenase (UGDH) catalyzes the formation of UDP-glucuronate. Glucuronate represents an integral component of the glycosaminoglycan, hyaluronan, which accumulates in orbital Graves disease. Here we report that orbital fibroblasts express higher levels of UGDH than do those from skin. This is a consequence of greater UGDH gene promoter activity and more abundant steady-state UGDH mRNA. Six Sp1 sites located in the proximal 550 bp of the UGDH gene promoter appear to determine basal promoter activity, as does a previously unrecognized 49-bp sequence spanning -1436 nucleotides (nt) and -1388 nt that negatively affects activity. Nuclear Sp1 protein is more abundant in orbital fibroblasts, and its binding to specific sites on DNA is greater than that in dermal fibroblasts. Mutating each of these Sp1 sites in a UGDH gene promoter fragment, extending from -1387 to +71 nt and fused to a luciferase reporter, results in divergent activities when transfected in orbital and dermal fibroblasts. Reducing Sp1 attenuated UGDH gene promoter activity, lowered steady-state UGDH mRNA levels, and reduced UGDH enzyme activity. Targeting Sp1 and UGDH with specific siRNAs also lowered hyaluronan synthase-1 (HAS-1) and HAS-2 levels and reduced hyaluronan accumulation in orbital fibroblasts. These findings suggest that orbital fibroblasts express high levels of UGDH in an anatomic-specific manner, apparently the result of greater constitutive Sp1. These high UGDH levels may underlie susceptibility of the orbit to localized overproduction of hyaluronan in Graves disease.	[Smith, Terry J.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; [Smith, Terry J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48105 USA; Harbor UCLA Med Ctr, Dept Med, Div Mol Med, Torrance, CA 90502 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Smith, TJ (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Kellogg Eye Ctr, 1000 Wall St, Ann Arbor, MI 48105 USA.	terrysmi@med.umich.edu	Smith, Terry/ABG-1360-2020	Smith, Terry/0000-0002-6279-9685	National Institutes of Health [EY008976, EY011708, DK063121]; Research to Prevent Blindness Award; Bell Charitable Trust; NATIONAL EYE INSTITUTE [R01EY011708, R01EY008976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Award(Research to Prevent Blindness (RPB)); Bell Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008976, EY011708, and DK063121. This work was also supported by a Research to Prevent Blindness Award and by the Bell Charitable Trust.	Bontemps Y, 2000, BIOCHEM BIOPH RES CO, V275, P981, DOI 10.1006/bbrc.2000.3389; Bontemps Y, 2003, J BIOL CHEM, V278, P21566, DOI 10.1074/jbc.M209366200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Busch-Nentwich E, 2004, DEVELOPMENT, V131, P943, DOI 10.1242/dev.00961; Cao HJ, 1998, J BIOL CHEM, V273, P29615, DOI 10.1074/jbc.273.45.29615; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELUCA G, 1981, BASIC APPL HISTOCHEM, V25, P67; DREYER C, 1978, NUCLEIC ACIDS RES, V5, P3325, DOI 10.1093/nar/5.9.3325; FRANZEN JS, 1980, BIOCHEMISTRY-US, V19, P6080, DOI 10.1021/bi00567a021; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; GRUBB MF, 1993, BIOCHEM MOL BIOL INT, V30, P819; Guo NX, 2010, J BIOL CHEM, V285, P15794, DOI 10.1074/jbc.M109.074534; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HEMPEL J, 1994, PROTEIN SCI, V3, P1074, DOI 10.1002/pro.5560030710; HUFNAGEL TJ, 1984, OPHTHALMOLOGY, V91, P1411; Huh JW, 2004, J BIOL CHEM, V279, P37491, DOI 10.1074/jbc.M404234200; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; JAENICKE R, 1986, BIOCHEMISTRY-US, V25, P7283, DOI 10.1021/bi00371a006; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Kaback LA, 1999, J CLIN ENDOCR METAB, V84, P4079, DOI 10.1210/jc.84.11.4079; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kazim M, 2002, ARCH OPHTHALMOL-CHIC, V120, P380; KORNFELD R, 1980, BIOCH GLYCOPROTEINS, P38; KRISHNAN V, 1994, J BIOL CHEM, V269, P15912; Lapointe J, 1999, ENDOCRINOLOGY, V140, P4486, DOI 10.1210/en.140.10.4486; Lind T, 1999, GLYCOBIOLOGY, V9, P595, DOI 10.1093/glycob/9.6.595; Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191; Marcu O, 1999, CYTOGENET CELL GENET, V86, P244, DOI 10.1159/000015350; Martin B, 1999, NUCLEIC ACIDS RES, V27, P3402, DOI 10.1093/nar/27.17.3402; Mijakovic I, 2004, J MOL MICROB BIOTECH, V8, P19, DOI 10.1159/000082077; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; Peng Hwei-Ling, 1998, Proceedings of the National Science Council Republic of China Part B Life Sciences, V22, P166; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; RIZZOTTI M, 1986, BASIC APPL HISTOCHEM, V30, P85; Schultz JR, 2005, J BIOL CHEM, V280, P347, DOI 10.1074/jbc.M407879200; Smith H S, 1991, Basic Life Sci, V57, P329; Smith TJ, 2005, CLIN EXP IMMUNOL, V141, P388, DOI 10.1111/j.1365-2249.2005.02824.x; SMITH TJ, 1989, ENDOCR REV, V10, P366, DOI 10.1210/edrv-10-3-366; SMITH TJ, 1995, AM J PHYSIOL-CELL PH, V268, pC382, DOI 10.1152/ajpcell.1995.268.2.C382; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; SMITH TJ, 1987, J CLIN INVEST, V79, P1493, DOI 10.1172/JCI112979; SMITH TJ, 1995, J CLIN ENDOCR METAB, V80, P2620, DOI 10.1210/jc.80.9.2620; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Spicer AP, 1997, GENOMICS, V41, P493, DOI 10.1006/geno.1997.4696; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; STROMINGER JL, 1957, J BIOL CHEM, V224, P79; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; TOMIDA M, 1974, BIOCHIM BIOPHYS ACTA, V338, P352, DOI 10.1016/0304-4165(74)90295-5; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; TURLEY EA, 1992, CANCER METAST REV, V11, P21, DOI 10.1007/BF00047600; Vatsyayan J, 2005, J BIOCHEM MOL TOXIC, V19, P279, DOI 10.1002/jbt.20099; Vatsyayan J, 2005, J BIOCHEM, V137, P703, DOI 10.1093/jb/mvi082; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wegrowski Y, 1998, BIOCHEM BIOPH RES CO, V250, P206, DOI 10.1006/bbrc.1998.9262; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Yeo TK, 1996, AM J PATHOL, V148, P1733; ZALITIS J, 1968, BIOCHEM BIOPH RES CO, V31, P693, DOI 10.1016/0006-291X(68)90617-7; Zhang JH, 2003, J BIOL CHEM, V278, P29192, DOI 10.1074/jbc.M213043200; Zhang L, 2009, J BIOL CHEM, V284, P26447, DOI 10.1074/jbc.M109.003616	69	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24487	24499		10.1074/jbc.M111.241166	http://dx.doi.org/10.1074/jbc.M111.241166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576248	hybrid, Green Published			2022-12-27	WOS:000292294900089
J	Zhang, GF; Sadhukhan, S; Tochtrop, GP; Brunengraber, H				Zhang, Guo-Fang; Sadhukhan, Sushabhan; Tochtrop, Gregory P.; Brunengraber, Henri			Metabolomics, Pathway Regulation, and Pathway Discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MASS ISOTOPOMER ANALYSIS; CITRIC-ACID CYCLE; LIVER GLUCONEOGENESIS; NMR; AMINOOXYACETATE; KIDNEY; METABONOMICS; METABOLISM; STANDARDS; TOXICITY	Metabolomics is a data-based research strategy, the aims of which are to identify biomarker pictures of metabolic systems and metabolic perturbations and to formulate hypotheses to be tested. It involves the assay by mass spectrometry or NMR of many metabolites present in the biological system investigated. In this minireview, we outline studies in which metabolomics led to useful biomarkers of metabolic processes. We also illustrate how the discovery potential of metabolomics is enhanced by associating it with stable isotopic techniques.	[Zhang, Guo-Fang; Brunengraber, Henri] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Sadhukhan, Sushabhan; Tochtrop, Gregory P.] Case Western Reserve Univ, Sch Med, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA.	hxb8@case.edu	Sadhukhan, Sushabhan/AAS-7136-2020	Sadhukhan, Sushabhan/0000-0002-3302-5875	National Institutes of Health [R33DK070291, R01ES013925]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Roadmap Grant R33DK070291 and Grant R01ES013925. This is the second article in the Thematic Minireview Series on Computational Systems Biology. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Boren J, 2003, J BIOL CHEM, V278, P28395, DOI 10.1074/jbc.M302932200; Castle AL, 2006, BRIEF BIOINFORM, V7, P159, DOI 10.1093/bib/bbl008; Chen C, 2008, J BIOL CHEM, V283, P4543, DOI 10.1074/jbc.M706299200; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Fiehn O, 2006, OMICS, V10, P158, DOI 10.1089/omi.2006.10.158; Gavaghan CL, 2000, FEBS LETT, V484, P169, DOI 10.1016/S0014-5793(00)02147-5; Griffin JL, 2000, COMP BIOCHEM PHYS B, V127, P357, DOI 10.1016/S0305-0491(00)00276-5; Griffin JL, 2008, PHYSIOL GENOMICS, V34, P1, DOI 10.1152/physiolgenomics.00009.2008; Hiller K, 2010, ANAL CHEM, V82, P6621, DOI 10.1021/ac1011574; JOMAINBAUM M, 1976, J BIOL CHEM, V251, P37; Kasumov T, 2007, ARCH BIOCHEM BIOPHYS, V463, P110, DOI 10.1016/j.abb.2007.02.022; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kind T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005440; Kose F, 2001, BIOINFORMATICS, V17, P1198, DOI 10.1093/bioinformatics/17.12.1198; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; LONGSHAW ID, 1972, EUR J BIOCHEM, V25, P366, DOI 10.1111/j.1432-1033.1972.tb01705.x; Nicholls AW, 2001, CHEM RES TOXICOL, V14, P975, DOI 10.1021/tx000231j; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Robertson D G, 2001, Cardiovasc Toxicol, V1, P7, DOI 10.1385/CT:1:1:07; Robertson DG, 2000, TOXICOL SCI, V57, P326, DOI 10.1093/toxsci/57.2.326; ROGNSTAD R, 1974, ARCH BIOCHEM BIOPHYS, V161, P638, DOI 10.1016/0003-9861(74)90348-8; Sadhukhan S, 2010, J AM CHEM SOC, V132, P6309, DOI 10.1021/ja100399m; Sansone SA, 2007, NAT BIOTECHNOL, V25, P844, DOI 10.1038/nbt0807-846b; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665	33	49	53	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23631	23635		10.1074/jbc.R110.171405	http://dx.doi.org/10.1074/jbc.R110.171405			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566142	Green Published, hybrid			2022-12-27	WOS:000292294900003
J	Zhang, P; Liu, JZ; Xu, QA; Harber, G; Feng, X; Michalek, SM; Katz, J				Zhang, Ping; Liu, Jianzhong; Xu, Qingan; Harber, Gregory; Feng, Xu; Michalek, Suzanne M.; Katz, Jenny			TLR2-dependent Modulation of Osteoclastogenesis by Porphyromonas gingivalis through Differential Induction of NFATc1 and NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; PERIODONTAL-DISEASE; BONE LOSS; CYTOKINE PRODUCTION; SIGNALING PATHWAY; LIPOPOLYSACCHARIDE; EXPRESSION; RANKL; OSTEOIMMUNOLOGY; INHIBITION	Osteolytic diseases, including rheumatoid arthritis, osteomyelitis, and periodontitis, are usually associated with bacterial infections. However, the precise mechanisms by which bacteria induce bone loss still remain unclear. Evidence exists that Toll-like receptor (TLR) signaling regulates both inflammation and bone metabolism and that the receptor activator of NF-kappa B ligand (RANKL) and its receptor RANK are the key regulators for bone remodeling and for the activation of osteoclasts. Here, we investigate the direct effects of the periodontal pathogen Porphyromonas gingivalis on osteoclast differentiation and show that P. gingivalis differentially modulates RANKL-induced osteoclast formation contingent on the state of differentiation of osteoclast precursors. In addition, although an optimal induction of cytokines by P. gingivalis is dependent on TLR2 and TLR4, as well as myeloid differentiation factor 88 and Toll/IL-1R domain-containing adaptor-inducing IFN-beta, P. gingivalis utilizes TLR2/ myeloid differentiation factor 88 in modulating osteoclast differentiation. P. gingivalis modulates RANKL-induced osteoclast formation by differential induction of NFATc1 and c-Fos. More importantly, RANKL-mediated lineage commitment also has an impact on P. gingivalis-induced cytokine production. RANKL inhibits P. gingivalis-induced cytokine production by down-regulation of TLR/NF-kappa B and up-regulation of NFATc1. Our findings reveal novel aspects of the interactions between TLR and RANK signaling and provide a new model for understanding the mechanism underlying the pathogenesis of bacteria-mediated bone loss.	[Zhang, Ping; Katz, Jenny] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Xu, Qingan] Wuhan Univ, Key Lab Oral Biomed Engn, Sch Stomatol, Minist Educ, Wuhan 430079, Hubei, Peoples R China; [Xu, Qingan] Wuhan Univ, Key Lab Oral Biomed Engn, Hosp Stomatol, Minist Educ, Wuhan 430079, Hubei, Peoples R China	University of Alabama System; University of Alabama Birmingham; Wuhan University; Wuhan University	Zhang, P (corresponding author), 845 19th St S,BBRB 258-5, Birmingham, AL 35294 USA.	pingz@uab.edu; meow@uab.edu		Zhang, Ping/0000-0002-4585-9893	University of Alabama at Birmingham Center for Metabolic Bone Disease through National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30 AR0406031]; UAB School of Dentistry; National Institute of Dental and Craniofacial Research [DE14215]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014215, R56DE014215] Funding Source: NIH RePORTER	University of Alabama at Birmingham Center for Metabolic Bone Disease through National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UAB School of Dentistry; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a pilot project award from the University of Alabama at Birmingham Center for Metabolic Bone Disease (to P. Z.) through Grant P30 AR0406031 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (to Dr. Jay M. McDonald), by a faculty development award from the UAB School of Dentistry (to P. Z.), and by Grant DE14215 from the National Institute of Dental and Craniofacial Research (to J. K.).	Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Bobetsis YA, 2006, J AM DENT ASSOC, V137, p7S, DOI 10.14219/jada.archive.2006.0403; Bochniak Mariusz, 2004, Przegl Lek, V61, P518; Boggess KA, 2006, AM J OBSTET GYNECOL, V194, P1316, DOI 10.1016/j.ajog.2005.11.059; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; David JP, 2007, ADV IMMUNOL, V95, P149, DOI 10.1016/S0065-2776(07)95005-1; de Lumley M, 2004, J MOL BIOL, V339, P1059, DOI 10.1016/j.jmb.2004.03.083; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Grossi S G, 2001, Ann Periodontol, V6, P138, DOI 10.1902/annals.2001.6.1.138; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Gyurko R, 2005, BONE, V36, P472, DOI 10.1016/j.bone.2004.12.002; Hiramine H, 2003, FEMS MICROBIOL LETT, V229, P49, DOI 10.1016/S0378-1097(03)00788-2; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; HOLT S C, 1991, Critical Reviews in Oral Biology and Medicine, V2, P177; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Jiang YL, 2002, INFECT IMMUN, V70, P3143, DOI 10.1128/IAI.70.6.3143-3148.2002; Kadono H, 1999, INFECT IMMUN, V67, P2841, DOI 10.1128/IAI.67.6.2841-2846.1999; Kaneko H, 2007, PROSTAG LEUKOTR ESS, V77, P181, DOI 10.1016/j.plefa.2007.09.002; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kubota T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2298; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lessem Jan, 2005, J Int Acad Periodontol, V7, P49; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Michalek SM, 2002, IMMUNOL RES, V26, P223, DOI 10.1385/IR:26:1-3:223; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oliver RC, 1998, J PERIODONTOL, V69, P269, DOI 10.1902/jop.1998.69.2.269; Paquette David W, 2004, Compend Contin Educ Dent, V25, P681; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Rho J, 2004, MOL CELLS, V17, P1; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Seinost G, 2005, AM HEART J, V149, P1050, DOI 10.1016/j.ahj.2004.09.059; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Suda K, 2004, J IMMUNOL, V172, P2504, DOI 10.4049/jimmunol.172.4.2504; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Teng YTA, 2006, J DENT RES, V85, P198, DOI 10.1177/154405910608500301; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Yoshimura A, 2002, INFECT IMMUN, V70, P218, DOI 10.1128/IAI.70.1.218-225.2002; Zhang P, 2005, INFECT IMMUN, V73, P3990, DOI 10.1128/IAI.73.7.3990-3998.2005; Zhang P, 2009, MOL IMMUNOL, V46, P677, DOI 10.1016/j.molimm.2008.08.281; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	66	74	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24159	24169		10.1074/jbc.M110.198085	http://dx.doi.org/10.1074/jbc.M110.198085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566133	Green Published, hybrid			2022-12-27	WOS:000292294900058
J	Xia, S; Sha, HB; Yang, L; Ji, YW; Ostrand-Rosenberg, S; Qi, L				Xia, Sheng; Sha, Haibo; Yang, Liu; Ji, Yewei; Ostrand-Rosenberg, Suzanne; Qi, Ling			Gr-1(+) CD11b(+) Myeloid-derived Suppressor Cells Suppress Inflammation and Promote Insulin Sensitivity in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; ADIPOSE-TISSUE; PPAR-GAMMA; ALTERNATIVE ACTIVATION; TUMOR-GROWTH; MACROPHAGES; RESISTANCE; MONOCYTES; MECHANISM; CANCER	Activation of immune cells, including macrophages and CD8(+) T cells, contributes significantly to the advancement of obesity and its associated medical complications, such as atherosclerosis, insulin resistance, and type 2 diabetes. However, how the activation of these immune cells is regulated in vivo remains largely unexplored. Here we show that a group of immature myeloid cells with cell surface markers of Gr-1(+) CD11b(+) are highly enriched in peripheral tissues (i.e. liver and adipose tissues) during obesity. Down-regulation of these cells in obese animals significantly increases inflammation and impairs insulin sensitivity and glucose tolerance, whereas elevation of these cells via adoptive transfer has the opposite effects. Mechanistically, we show that under obese conditions, the Gr-1(+) cells suppress proliferation and induce apoptosis of CD8(+) T cells and are capable of skewing differentiation of macrophages into insulin-sensitizing, alternatively activated M2 macrophages. Taken together, our study demonstrates that immature myeloid cells provide a checks-and-balances platform to counter proinflammatory immune cells in the liver and adipose tissue during obesity to prevent overt immune responses.	[Xia, Sheng; Sha, Haibo; Ji, Yewei; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Yang, Liu; Qi, Ling] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Xia, Sheng] Jiangsu Univ, Dept Immunol, Sch Med, Zhenjiang 212013, Jiangsu, Peoples R China; [Ostrand-Rosenberg, Suzanne] Univ Maryland, Dept Biol Sci, Baltimore, MD 21201 USA	Cornell University; Cornell University; Jiangsu University; University System of Maryland; University of Maryland Baltimore	Xia, S (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	sx43@cornell.edu; lq35@cornell.edu	Ji, Yewei/F-5040-2014	Ji, Yewei/0000-0002-4249-6812; Qi, Ling/0000-0001-8229-0184	National Institutes of Health [RO1DK082582]; Cornell Center for Vertebrate Genomics Scholarship; Rosalinde and Arthur Foundation; American Diabetes Association [7-08-JF47]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Center for Vertebrate Genomics Scholarship; Rosalinde and Arthur Foundation; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK082582 (to L. Q.). This work was also supported by the Cornell Center for Vertebrate Genomics Scholarship (to H. S.), the 2008 Rosalinde and Arthur Foundation/AFAR New Investigator Award (to L. Q.), the American Diabetes Association Junior Faculty Award (to L. Q.), and the American Diabetes Association Grant 7-08-JF47 (to L. Q.).	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; BRUMMER E, 1984, J LEUKOCYTE BIOL, V36, P505, DOI 10.1002/jlb.36.4.505; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nausch N, 2008, BLOOD, V112, P4080, DOI 10.1182/blood-2008-03-143776; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; PAK AS, 1995, CLIN CANCER RES, V1, P95; Puri V, 2007, J LIPID RES, V48, P465, DOI 10.1194/jlr.D600033-JLR200; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Saio M, 2001, J IMMUNOL, V167, P5583, DOI 10.4049/jimmunol.167.10.5583; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Terabe M, 2003, J EXP MED, V198, P1741, DOI 10.1084/jem.20022227; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; YOUNG MRI, 1992, CANCER RES, V52, P6335; Young MRI, 1999, CLIN EXP METASTAS, V17, P881, DOI 10.1023/A:1006708607666	44	115	120	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23591	23599		10.1074/jbc.M111.237123	http://dx.doi.org/10.1074/jbc.M111.237123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21592961	Green Published, hybrid			2022-12-27	WOS:000292025000089
J	Flowers, S; Beck, GR; Moran, E				Flowers, Stephen; Beck, George R., Jr.; Moran, Elizabeth			Tissue-specific Gene Targeting by the Multiprotein Mammalian DREAM Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G(2)/M GENES; B-MYB; DIFFERENTIATION; TRANSCRIPTION; PRB; PROTEIN; EXPRESSION; DISTINCT; MECHANISMS; GROWTH	The mammalian DP, RB-like, E2F, and MuvB-like proteins (DREAM) complex, whose key components include p130 and E2F4, plays a fundamental role in repression of cell cycle-specific genes during growth arrest. Mammalian DREAM is well conserved with Drosophila and Caenorhabditis elegans complexes that repress pivotal developmental genes, but the mammalian complex has been thought to exist only in quiescent cells and not to be linked with development. However, new findings here identify tissue-specific promoters repressed by DREAM in proliferating precursors, revealing a new connection between control of growth arrest and terminal differentiation. Mechanistically, tissue-specific promoter occupation by DREAM is dependent on the integrity of a repressor form of the SWI/SNF chromatin-remodeling complex.	[Flowers, Stephen; Moran, Elizabeth] Univ Med & Dent New Jersey, NJMS UH Canc Ctr, Dept Orthopaed, Newark, NJ 07103 USA; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Emory University	Moran, E (corresponding author), Univ Med & Dent New Jersey, NJMS UH Canc Ctr, Dept Orthopaed, 205 S Orange Ave, Newark, NJ 07103 USA.	moranel@umdnj.edu	Beck, George/AAO-2117-2020		National Institutes of Health under the United States Public Health Service [GM073257, T32-CA134268]; NATIONAL CANCER INSTITUTE [T32CA134268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073257] Funding Source: NIH RePORTER	National Institutes of Health under the United States Public Health Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM073257 (to E. M.) and T32-CA134268 (to S. F.) under the United States Public Health Service.	Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; DeCaprio JA, 2009, VIROLOGY, V384, P274, DOI 10.1016/j.virol.2008.12.010; DeGregori J, 2006, CURR MOL MED, V6, P739; Flowers S, 2010, CANCER RES, V70, P8282, DOI 10.1158/0008-5472.CAN-10-2205; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lee H, 2010, MOL CELL BIOL, V30, P2563, DOI 10.1128/MCB.01075-09; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Luan Y, 2007, J BIOL CHEM, V282, P16860, DOI 10.1074/jbc.M610943200; Miller ES, 2010, CELL CYCLE, V9, P2620, DOI 10.4161/cc.9.13.12108; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Rizzolio F, 2010, J CELL BIOCHEM, V109, P839, DOI 10.1002/jcb.22448; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; TERAO M, 1990, BIOCHEM J, V268, P641, DOI 10.1042/bj2680641; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469	29	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27867	27871		10.1074/jbc.C111.255091	http://dx.doi.org/10.1074/jbc.C111.255091			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685383	Green Published, hybrid			2022-12-27	WOS:000293557800004
J	Kalchishkova, N; Furst, CM; Heinegard, D; Blom, AM				Kalchishkova, Nikolina; Furst, Camilla Melin; Heinegard, Dick; Blom, Anna M.			NC4 Domain of Cartilage-specific Collagen IX Inhibits Complement Directly Due to Attenuation of Membrane Attack Formation and Indirectly through Binding and Enhancing Activity of Complement Inhibitors C4B-binding Protein and Factor H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; EXTRACELLULAR-MATRIX; RHEUMATOID-ARTHRITIS; ALPHA-CHAIN; STRUCTURAL REQUIREMENTS; MASS-SPECTROMETRY; COFACTOR FUNCTION; 9TH COMPONENT; C1Q; DEFICIENCY	Collagen IX containing the N-terminal noncollagenous domain 4 (NC4) is unique to cartilage and a member of the family of fibril-associated collagens with both collagenous and noncollagenous domains. Collagen IX is located at the surface of fibrils formed by collagen II and a minor proportion of collagen XI, playing roles in tissue stability and integrity. The NC4 domain projects out from the fibril surface and provides sites for interaction with other matrix components such as cartilage oligomeric matrix protein, matrilins, fibromodulin, and osteoadherin. Fragmentation of collagen IX and loss of the NC4 domain are early events in cartilage degradation in joint diseases that precedes major damage of collagen II fibrils. Our results demonstrate that NC4 can function as a novel inhibitor of the complement system able to bind C4, C3, and C9 and to directly inhibit C9 polymerization and assembly of the lytic membrane attack complex. NC4 also binds the complement inhibitors C4b-binding protein and factor H and enhances their cofactor activity in degradation of activated complement components C4b and C3b. NC4 interactions with fibromodulin and osteoadherin inhibited binding to C1q and complement activation by these proteins. Taken together, our results suggest that collagen IX and its interactions with matrix components are important parts of a machinery that protects the cartilage from complement activation and chronic inflammation seen in diseases like rheumatoid arthritis.	[Blom, Anna M.] Lund Univ, Dept Lab Med, Wallenberg Lab, Sect Med Prot Chem, S-20502 Malmo, Sweden; [Heinegard, Dick] Lund Univ, Dept Clin Sci, Rheumatol Sect, S-22184 Lund, Sweden	Lund University; Lund University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, Wallenberg Lab, Sect Med Prot Chem, Floor 4, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Melin Furst, Camilla/0000-0001-5487-4270	NIAMS; Swedish Research Council [K2009-68X-14928-06-3, K2011-52X-05668-32-3]; Swedish Foundation for Strategic Research; Greta and Johan Kock, Foundation of Osterlund; Inga-Britt, Foundation of Osterlund; Arne Lundberg, Foundation of Osterlund; King Gustav Vth's 80th Anniversary, Foundation of Osterlund; Knut and Alice Wallenberg Foundation; University Hospital in Malmo/Lund; Anna-Greta Crafoord Foundation	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Greta and Johan Kock, Foundation of Osterlund; Inga-Britt, Foundation of Osterlund; Arne Lundberg, Foundation of Osterlund; King Gustav Vth's 80th Anniversary, Foundation of Osterlund; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); University Hospital in Malmo/Lund; Anna-Greta Crafoord Foundation	This work was supported, in whole or in part, by a National Institutes of Health grant from NIAMS. This work was also supported by Swedish Research Council Grants K2009-68X-14928-06-3 and K2011-52X-05668-32-3, Swedish Foundation for Strategic Research, Foundations of Osterlund, Greta and Johan Kock, Inga-Britt, and Arne Lundberg, King Gustav Vth's 80th Anniversary, Knut and Alice Wallenberg Foundation, and grants from the University Hospital in Malmo/Lund. Conflict of interest: Dr. Heinegard owns stock in AnaMar Medical and has filed a patent application concerning type IX collagen as marker of joint destruction.; Recipient of a postdoctoral stipend from the Anna-Greta Crafoord Foundation.	ANDERSSON M, 1991, EUR J CLIN PHARMACOL, V40, P261, DOI 10.1007/BF00315206; BIESECKER G, 1980, J IMMUNOL, V124, P1291; Blom AM, 2003, J BIOL CHEM, V278, P43437, DOI 10.1074/jbc.M306620200; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Carlsen S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1989; Crnkic M, 2003, ARTHRITIS RES THER, V5, pR181, DOI 10.1186/ar760; DAHLBACK B, 1983, BIOCHEM J, V209, P837, DOI 10.1042/bj2090837; Danfelter M, 2007, J BIOL CHEM, V282, P36933, DOI 10.1074/jbc.M702491200; DE FRUTOS PG, 1995, J BIOL CHEM, V270, P26950, DOI 10.1074/jbc.270.45.26950; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Groeneveld TWL, 2005, J IMMUNOL, V175, P4715, DOI 10.4049/jimmunol.175.7.4715; Happonen KE, 2010, ARTHRITIS RHEUM-US, V62, P3574, DOI 10.1002/art.27720; Happonen KE, 2009, J IMMUNOL, V182, P1518, DOI 10.4049/jimmunol.182.3.1518; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; Kask L, 2002, BIOCHEMISTRY-US, V41, P9349, DOI 10.1021/bi025980+; Kojima T, 2001, ARTHRITIS RHEUM, V44, P120, DOI 10.1002/1529-0131(200101)44:1<120::AID-ANR16>3.0.CO;2-X; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Pflieger D, 2010, MOL CELL PROTEOMICS, V9, P593, DOI 10.1074/mcp.M900350-MCP200; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; PODACK ER, 1982, J BIOL CHEM, V257, P5204; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; VANDERREST M, 1985, J BIOL CHEM, V260, P220; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; WOTTON S F, 1991, Biochemical Society Transactions, V19, p375S; Wotton SF, 1999, RHEUMATOLOGY, V38, P338, DOI 10.1093/rheumatology/38.4.338; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	43	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27915	27926		10.1074/jbc.M111.242834	http://dx.doi.org/10.1074/jbc.M111.242834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659506	Green Published, hybrid			2022-12-27	WOS:000293557800010
J	Sadeqzadeh, E; de Bock, CE; Zhang, XD; Shipman, KL; Scott, NM; Song, CJ; Yeadon, T; Oliveira, CS; Jin, BQ; Hersey, P; Boyd, AW; Burns, GF; Thorne, RF				Sadeqzadeh, Elham; de Bock, Charles E.; Zhang, Xu Dong; Shipman, Kristy L.; Scott, Naomi M.; Song, Chaojun; Yeadon, Trina; Oliveira, Camila S.; Jin, Boquan; Hersey, Peter; Boyd, Andrew W.; Burns, Gordon F.; Thorne, Rick F.			Dual Processing of FAT1 Cadherin Protein by Human Melanoma Cells Generates Distinct Protein Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; ADHESION MOLECULE; PROTOCADHERIN FAT1; SIGNALING PATHWAY; ACTIN DYNAMICS; EXPRESSION; DROSOPHILA; HOMOLOG; CLONING; CD36	The giant cadherin FAT1 is one of four vertebrate orthologues of the Drosophila tumor suppressor fat. It engages in several functions, including cell polarity and migration, and in Hippo signaling during development. Homozygous deletions in oral cancer suggest that FAT1 may play a tumor suppressor role, although overexpression of FAT1 has been reported in some other cancers. Here we show using Northern blotting that human melanoma cell lines variably but universally express FAT1 and less commonly FAT2, FAT3, and FAT4. Both normal melanocytes and keratinocytes also express comparable FAT1 mRNA relative to melanoma cells. Analysis of the protein processing of FAT1 in keratinocytes revealed that, like Drosophila FAT, human FAT1 is cleaved into a non-covalent heterodimer before achieving cell surface expression. The use of inhibitors also established that such cleavage requires the proprotein convertase furin. However, in melanoma cells, the non-cleaved proform of FAT1 is also expressed at the cell surface together with the furin-cleaved heterodimer. Moreover, furin-independent processing generates a potentially functional proteolytic product in melanoma cells, a persistent 65-kDa membrane-bound cytoplasmic fragment no longer in association with the extracellular fragment. In vitro localization studies of FAT1 showed that melanoma cells display high levels of cytosolic FAT1 protein, whereas keratinocytes, despite comparable FAT1 expression levels, exhibited mainly cell-cell junctional staining. Such differences in protein distribution appear to reconcile with the different protein products generated by dual FAT1 processing. We suggest that the uncleaved FAT1 could promote altered signaling, and the novel products of alternate processing provide a dominant negative function in melanoma.	[de Bock, Charles E.; Yeadon, Trina; Boyd, Andrew W.] Queensland Inst Med Res, Leukaemia Fdn, Queensland Res Unit, Brisbane, Qld 4006, Australia; [Zhang, Xu Dong; Hersey, Peter] Calvary Mater Newcastle Hosp, Immunol & Oncol Unit, Waratah, NSW 2298, Australia; [Song, Chaojun; Jin, Boquan] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Shaanxi Prov, Peoples R China; [Sadeqzadeh, Elham; de Bock, Charles E.; Shipman, Kristy L.; Scott, Naomi M.; Oliveira, Camila S.; Burns, Gordon F.; Thorne, Rick F.] Univ Newcastle, Canc Res Unit, Sch Pharm & Biomed Sci, Callaghan, NSW 2308, Australia	QIMR Berghofer Medical Research Institute; Calvary Mater Newcastle Hospital; Air Force Military Medical University; University of Newcastle	Thorne, RF (corresponding author), Canc Inst New S Wales, Westmead, NSW, Australia.	Rick.Thorne@newcastle.edu.au	Scott, Naomi/R-9951-2017; de Bock, Charles/H-7699-2019; Zhang, xiaoyu/GXA-3206-2022; zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022	de Bock, Charles/0000-0001-5182-8535; Thorne, Rick/0000-0001-7882-7081; Zhang, Xu Dong/0000-0001-9457-8003	National Health and Medical Research Council of Australia; Hunter Medical Research Institute; Cancer Institute New South Wales	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; Cancer Institute New South Wales	This work was supported in part by grants from the National Health and Medical Research Council of Australia and the Hunter Medical Research Institute (to R. F. T., X. D. Z., P. H., A. W. B., and G. F. B.).; Recipient of a career development fellowship from the Cancer Institute New South Wales.; Recipient of a career development fellowship from the Cancer Institute New South Wales. To whom correspondence should be addressed. Tel.: 61-2-49217860; Fax: 61-2-49216903; E- mail: Rick.Thorne@newcastle.edu.au.	Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Braun GS, 2007, J BIOL CHEM, V282, P22823, DOI 10.1074/jbc.M701758200; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; Cox B, 2000, DEV DYNAM, V217, P233, DOI 10.1002/(SICI)1097-0177(200003)217:3<233::AID-DVDY1>3.0.CO;2-O; de Bock CE, 2005, FEBS J, V272, P3572, DOI 10.1111/j.1742-4658.2005.04778.x; Down M, 2005, GENE EXPR PATTERNS, V5, P483, DOI 10.1016/j.modgep.2004.12.005; DUNNE J, 1995, GENOMICS, V30, P207, DOI 10.1006/geno.1995.9884; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Feng YQ, 2009, P NATL ACAD SCI USA, V106, P11989, DOI 10.1073/pnas.0811540106; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Hou R, 2009, J BIOL CHEM, V284, P6955, DOI 10.1074/jbc.M809333200; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Kwaepila N, 2006, PATHOLOGY, V38, P125, DOI 10.1080/00313020600559975; Liu L, 1997, CELL SIGNAL, V9, P299, DOI 10.1016/S0898-6568(97)89891-9; Magg T, 2005, EXP CELL RES, V307, P100, DOI 10.1016/j.yexcr.2005.03.006; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Ponassi M, 1999, MECH DEVELOP, V80, P207, DOI 10.1016/S0925-4773(98)00217-2; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Settakorn J, 2005, J CLIN PATHOL, V58, P1249, DOI 10.1136/jcp.2005.026575; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Sopko R, 2009, CURR BIOL, V19, P1112, DOI 10.1016/j.cub.2009.05.049; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Thorne RF, 1997, BIOCHEM BIOPH RES CO, V240, P812, DOI 10.1006/bbrc.1997.7755; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Thorne RF, 2006, DNA CELL BIOL, V25, P302, DOI 10.1089/dna.2006.25.302; Thorne RF, 2010, BBA-MOL CELL RES, V1803, P1298, DOI 10.1016/j.bbamcr.2010.07.002; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665	34	44	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28181	28191		10.1074/jbc.M111.234419	http://dx.doi.org/10.1074/jbc.M111.234419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680732	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000293557800036
J	Ceccarelli, V; Racanicchi, S; Martelli, MP; Nocentini, G; Fettucciari, K; Riccardi, C; Marconi, P; Di Nardo, P; Grignani, F; Binaglia, L; Vecchini, A				Ceccarelli, Veronica; Racanicchi, Serena; Martelli, Maria Paola; Nocentini, Giuseppe; Fettucciari, Katia; Riccardi, Carlo; Marconi, Pierfrancesco; Di Nardo, Paolo; Grignani, Francesco; Binaglia, Luciano; Vecchini, Alba			Eicosapentaenoic Acid Demethylates a Single CpG That Mediates Expression of Tumor Suppressor CCAAT/Enhancer-binding Protein delta in U937 Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; STIMULATING FACTOR-RECEPTOR; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER CELLS; C-JUN; C/EBP-DELTA; GENE-EXPRESSION; MACROPHAGE DIFFERENTIATION; TRANSCRIPTION FACTORS; MYELOID DEVELOPMENT	Polyunsaturated fatty acids (PUFAs) inhibit proliferation and induce differentiation in leukemia cells. To investigate the molecular mechanisms whereby fatty acids affect these processes, U937 leukemia cells were conditioned with stearic, oleic, linolenic, alpha-linolenic, arachidonic, eicosapentaenoic, and docosahexaenoic acids. PUFAs affected proliferation; eicosapentaenoic acid (EPA) was the most potent on cell cycle progression. EPA enhanced the expression of the myeloid lineage-specific transcription factors CCAAT/enhancer-binding proteins (C/EBP beta and C/EBP delta), PU.1, and c-Jun, resulting in increased expression of the monocyte lineage-specific target gene, the macrophage colony-stimulating factor receptor. Indeed, it is known that PU.1 and C/EBPs interact with their consensus sequences on a small DNA fragment of macrophage colony-stimulating factor receptor promoter, which is a determinant for expression. We demonstrated that C/EBP beta and C/EBP delta bind the same response element as a heterodimer. We focused on the enhanced expression of C/EBP delta, which has been reported to be a tumor suppressor gene silenced by promoter hypermethylation in U937 cells. After U937 conditioning with EPA and bisulfite sequencing of the -370/-20 CpG island on the C/EBP delta promoter region, we found a site-specific CpG demethylation that was a determinant for the binding activity of Sp1, an essential factor for C/EBP delta gene basal expression. Our results provide evidence for a new role of PUFAs in the regulation of gene expression. Moreover, we demonstrated for the first time that re-expression of the tumor suppressor C/EBP delta is controlled by the methylation state of a site-specific CpG dinucleotide.	[Ceccarelli, Veronica; Binaglia, Luciano; Vecchini, Alba] Univ Perugia, Dept Expt Med & Biochem Sci, I-06126 Perugia, Italy; [Racanicchi, Serena; Martelli, Maria Paola; Nocentini, Giuseppe; Fettucciari, Katia; Riccardi, Carlo; Marconi, Pierfrancesco; Grignani, Francesco] Univ Perugia, Dept Clin & Expt Med, I-06126 Perugia, Italy; [Di Nardo, Paolo] Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy	University of Perugia; University of Perugia; University of Rome Tor Vergata	Vecchini, A (corresponding author), Univ Perugia, Fac Med, Biochem Sect, Dept Expt Med & Biochem Sci, Via Giochetto 3, I-06122 Perugia, Italy.	vecchini@unipg.it	Fettucciari, Katia/K-7661-2015; Martelli, Maria Paola/ABH-3300-2021; Riccardi, Carlo/N-4610-2014; FETTUCCIARI, Katia/N-8664-2019; Nocentini, Giuseppe/GZB-0146-2022; Nocentini, Giuseppe/B-9412-2013; Grignani, Francesco/AAC-2565-2022; Martelli, Maria Paola/I-5618-2012	Fettucciari, Katia/0000-0001-8074-8243; Martelli, Maria Paola/0000-0001-9139-1729; Riccardi, Carlo/0000-0001-9257-3997; FETTUCCIARI, Katia/0000-0001-8074-8243; Nocentini, Giuseppe/0000-0002-5209-0488; DI NARDO, PAOLO/0000-0003-4460-9494; Ceccarelli, Veronica/0000-0003-0424-6940; Vecchini, Alba/0000-0003-1253-7625; Marconi, Pierfrancesco/0000-0002-4213-3413	Ministero delle Politiche Agricole, Alimentari e Forestali; Associazione Italiana per la Ricerca sul Cancro	Ministero delle Politiche Agricole, Alimentari e Forestali; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The work was supported by grants from the Ministero delle Politiche Agricole, Alimentari e Forestali (to L. B.) and Associazione Italiana per la Ricerca sul Cancro (to F. G.).	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Anderson BM, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-33; Arapshian A, 2000, ONCOGENE, V19, P4066, DOI 10.1038/sj.onc.1203734; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; BECK SA, 1991, CANCER RES, V51, P6089; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Boultwood J, 2007, BRIT J HAEMATOL, V138, P3, DOI 10.1111/j.1365-2141.2007.06604.x; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Calviello G, 1998, INT J CANCER, V75, P699, DOI 10.1002/(SICI)1097-0215(19980302)75:5&lt;699::AID-IJC7&gt;3.0.CO;2-U; Chim CS, 2002, HEMATOL ONCOL, V20, P167, DOI 10.1002/hon.694; Dai ZY, 2004, ONCOGENE, V23, P3521, DOI 10.1038/sj.onc.1207441; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Evans LM, 2009, NUTR CANCER, V61, P746, DOI 10.1080/01635580902825597; Finstad HS, 1998, LEUKEMIA, V12, P921, DOI 10.1038/sj.leu.2401030; FINSTAD HS, 1994, BLOOD, V84, P3799, DOI 10.1182/blood.V84.11.3799.bloodjournal84113799; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; GABOR H, 1986, J NATL CANCER I, V76, P1223; GAYNOR R, 1991, BLOOD, V77, P2618; Gerashchenko BI, 2004, CYTOM PART A, V61A, P134, DOI 10.1002/cyto.a.20065; Gery S, 2005, ONCOGENE, V24, P1589, DOI 10.1038/sj.onc.1208393; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; GUFFY MM, 1984, CANCER RES, V44, P1863; Hamm CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008340; Harris WS, 2009, J NUTR, V139, p804S, DOI 10.3945/jn.108.101329; Hass R, 1997, LEUKEMIA RES, V21, P589, DOI 10.1016/S0145-2126(97)00010-6; Hawcroft G, 2010, NEOPLASIA, V12, P618, DOI 10.1593/neo.10388; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Hutt JA, 2000, J BIOL CHEM, V275, P29123, DOI 10.1074/jbc.M004476200; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Jung KC, 2006, LEUKEMIA, V20, P122, DOI 10.1038/sj.leu.2404022; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Li AC, 1998, J BIOL CHEM, V273, P5389, DOI 10.1074/jbc.273.9.5389; LI JM, 1994, CELL GROWTH DIFFER, V5, P743; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; REDDY MA, 1994, J EXP MED, V180, P2309, DOI 10.1084/jem.180.6.2309; REICH R, 1989, BIOCHEM BIOPH RES CO, V160, P559, DOI 10.1016/0006-291X(89)92469-8; ROBERTS WM, 1992, BLOOD, V79, P586; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Sivko GS, 2004, J CELL BIOCHEM, V93, P844, DOI 10.1002/jcb.20224; Spencer L, 2009, EUR J CANCER, V45, P2077, DOI 10.1016/j.ejca.2009.04.026; SZABO E, 1994, CELL GROWTH DIFFER, V5, P439; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Vecchini A, 2005, BBA-MOL CELL BIOL L, V1737, P138, DOI 10.1016/j.bbalip.2005.10.008; Vecchini A, 2004, J LIPID RES, V45, P308, DOI 10.1194/jlr.M300396-JLR200; Vegesna VA, 2002, LEUKEMIA RES, V26, P451, DOI 10.1016/S0145-2126(01)00150-3; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Wendel M, 2009, ANTI-CANCER AGENT ME, V9, P457, DOI 10.2174/1871520610909040457; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	66	60	60	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27092	27102		10.1074/jbc.M111.253609	http://dx.doi.org/10.1074/jbc.M111.253609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659508	Green Published, hybrid			2022-12-27	WOS:000293268700004
J	Haynes, KA; Silver, PA				Haynes, Karmella A.; Silver, Pamela A.			Synthetic Reversal of Epigenetic Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3; CELL FATE; GENE-EXPRESSION; AXIAL SKELETON; POLYCOMB; CHROMATIN; CANCER; OVEREXPRESSION; ACTIVATION; SENESCENCE	Controlling cell fate-determining gene expression is key to stem cell differentiation, tissue regeneration, and cancer therapy. To date, custom-built transcription factors recognize the information encoded in specific DNA sequences. Chromatin proteins undergo covalent modifications and form complexes that encode a second layer of information that determines proximal gene activity. Here, we employ a novel gene-targeting approach that exploits a specific chromatin modification to reactivate silenced loci in human cells. We used the human Polycomb chromatin protein and homologues from other species to construct modular synthetic transcription factors, called Pc-TFs, that recognize the repressive trimethyl-histone H3 lysine 27 (H3K27me3) signal and switch silenced genes to an active state. Pc-TF expression in U2OS osteosarcoma cells leads to increased transcription of the senescence locus CDKN2A (p16) and other loci in a chromodomain- and activation module-dependent manner, a switch to a senescence phenotype, and reduced cell proliferation. These results indicate that silenced developmental regulators can be reactivated by a synthetic transcription factor that interacts with chromatin rather than DNA, resulting in an altered cell state. As such, our work extends the flexibility of transcription factor engineering and is the first example of chromatin-mediated synthetic transcription factor targeting.	[Haynes, Karmella A.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Silver, Pamela A.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Silver, PA (corresponding author), 200 Longwood Ave WAB 536, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu		Haynes, Karmella/0000-0002-5975-577X	National Institutes of Health [GM057476, GM36373, 1F32GM087860]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036373, R37GM036373, F32GM087860, R01GM057476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM057476 and GM36373 (to P. A. S.) and 1F32GM087860 (to K. A. H.).	Akasaka T, 1996, DEVELOPMENT, V122, P1513; ALKEMA MJ, 1995, NATURE, V374, P724, DOI 10.1038/374724a0; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gravina GL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-305; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Haynes KA, 2009, J CELL BIOL, V187, P589, DOI 10.1083/jcb.200908138; Kawamura A, 2002, BIOCHEM BIOPH RES CO, V294, P456, DOI 10.1016/S0006-291X(02)00497-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Noppe G, 2009, CYTOM PART A, V75A, P910, DOI 10.1002/cyto.a.20796; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020	29	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27176	27182		10.1074/jbc.C111.229567	http://dx.doi.org/10.1074/jbc.C111.229567			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669865	Green Published, hybrid			2022-12-27	WOS:000293268700013
J	Treberg, JR; Quinlan, CL; Brand, MD				Treberg, Jason R.; Quinlan, Casey L.; Brand, Martin D.			Evidence for Two Sites of Superoxide Production by Mitochondrial NADH-Ubiquinone Oxidoreductase (Complex I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES GENERATION; ELECTRON-TRANSPORT CHAIN; RAT-HEART MITOCHONDRIA; NAD(P)H REDOX STATE; MECHANISM; INHIBITION; MEMBRANE; TOPOLOGY	Complex I (NADH-ubiquinone oxidoreductase) can form superoxide during forward electron flow (NADH-oxidizing) or, at sufficiently high protonmotive force, during reverse electron transport from the ubiquinone (Q) pool (NAD(+)-reducing). We designed an assay system to allow titration of the redox state of the superoxide-generating site during reverse electron transport in rat skeletal muscle mitochondria: a protonmotive force generated by ATP hydrolysis, succinate: malonate to alter electron supply and modulate the redox state of the Q pool, and inhibition of complex III to prevent QH(2) oxidation via the Q cycle. Stepwise oxidation of the QH(2)/Q pool by increasing malonate concentration slowed the rates of both reverse electron transport and rotenone-sensitive superoxide production by complex I. However, the superoxide production rate was not uniquely related to the resultant potential of the NADH/NAD(+) redox couple. Thus, there is a superoxide producer during reverse electron transport at complex I that responds to Q pool redox state and is not in equilibrium with the NAD reduction state. In contrast, superoxide production during forward electron transport in the presence of rotenone was uniquely related to NAD redox state. These results support a two-site model of complex I superoxide production; one site in equilibrium with the NAD pool, presumably the flavin of the FMN moiety (site I-F) and the other dependent not only on NAD redox state, but also on protonmotive force and the reduction state of the Q pool, presumably a semiquinone in the Q-binding site (site I-Q).	[Treberg, Jason R.; Quinlan, Casey L.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Treberg, JR (corresponding author), Univ Manitoba, Biol Sci Bldg, Winnipeg, MB R3T 2N2, Canada.	jtreberg@mun.ca	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Treberg, Jason/0000-0001-5112-7325; Quinlan, Casey/0000-0002-7808-8271	National Institutes of Health [P01 AG025901, PL1 AG032118, R01 AG033542]; Ellison Medical Foundation [AG-SS-2288-09]; NATIONAL INSTITUTE ON AGING [P01AG025901, R01AG033542, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG025901, PL1 AG032118, and R01 AG033542. This work was also supported by Ellison Medical Foundation Grant AG-SS-2288-09.	Ambrus A, 2009, J NEUROCHEM, V109, P222, DOI 10.1111/j.1471-4159.2009.05942.x; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; BROWN GC, 1988, BIOCHEM J, V252, P473, DOI 10.1042/bj2520473; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; Fato R, 2009, BBA-BIOENERGETICS, V1787, P384, DOI 10.1016/j.bbabio.2008.11.003; Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KRISHNAMOORTHY G, 1988, J BIOL CHEM, V263, P17566; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Quinlan C.L., 2011, HDB BIOL AGING, V7th, P47; RAMSAY RR, 1992, BIOCHEM BIOPH RES CO, V189, P47, DOI 10.1016/0006-291X(92)91523-S; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Treberg JR, 2011, J BIOL CHEM, V286, P17579, DOI 10.1074/jbc.M111.227751; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; URBAN PF, 1969, EUR J BIOCHEM, V9, P519, DOI 10.1111/j.1432-1033.1969.tb00640.x; Vinogradov AD, 2005, BIOCHEMISTRY-MOSCOW+, V70, P120, DOI 10.1007/s10541-005-0090-7	32	152	154	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27103	27110		10.1074/jbc.M111.252502	http://dx.doi.org/10.1074/jbc.M111.252502			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659507	Green Published, hybrid			2022-12-27	WOS:000293268700005
J	Zhang, Y; Matkovich, SJ; Duan, XJ; Diwan, A; Kang, MY; Dorn, GW				Zhang, Yan; Matkovich, Scot J.; Duan, Xiujun; Diwan, Abhinav; Kang, Min-Young; Dorn, Gerald W., II			Receptor-independent Protein Kinase C alpha (PKC alpha) Signaling by Calpain-generated Free Catalytic Domains Induces HDAC5 Nuclear Export and Regulates Cardiac Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HEART-FAILURE; GENE-EXPRESSION; HISTONE DEACETYLASE-5; HYPERTROPHY; CONTRACTILITY; INHIBITORS; GROWTH; PHOSPHORYLATION; ACTIVATION	Receptor-mediated activation of protein kinase (PK) C is a central pathway regulating cell growth, homeostasis, and programmed death. Recently, we showed that calpain-mediated proteolytic processing of PKC alpha in ischemic myocardium activates PKC signaling in a receptor-independent manner by releasing a persistent and constitutively active free catalytic fragment, PKC alpha-CT. This unregulated kinase provokes cardiomyopathy, but the mechanisms remain unclear. Here, we demonstrate that PKC alpha-CT is a potent regulator of pathological cardiac gene expression. PKC alpha-CT constitutively localizes to nuclei and directly promotes nucleo-cytoplasmic shuttling of HDAC5, inducing expression of apoptosis and other deleterious genes. Whereas PKD activation is required for HDAC5 nuclear export induced by unprocessed PKCs activated by phorbol ester, PKC alpha-CT directly drives HDAC cytosolic relocalization. Activation of MEF2-dependent inflammatory pathway genes by PKC alpha-CT can induce a cell-autonomous transcriptional response that mimics, but anticipates, actual inflammation. Because calpain-mediated processing of PKC isoforms occurs in many tissues wherein calcium is increased by stress or injury, our observation that the catalytically active product of this interaction is a constitutively active transcriptional regulator has broad ramifications for understanding and preventing the pathological transcriptional stress response.	[Zhang, Yan; Matkovich, Scot J.; Duan, Xiujun; Diwan, Abhinav; Kang, Min-Young; Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogen, Dept Med, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Dorn, GW (corresponding author), Washington Univ, Ctr Pharmacogen, Dept Med, Sch Med, 660 S Euclid Ave,Campus Box 8220, St Louis, MO 63110 USA.	gdorn@dom.wustl.edu	Matkovich, Scot J/AFP-0908-2022; Matkovich, Scot J/B-9077-2009	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857	National Institutes of Health [R01 HL080008, R01 HL059888]; National Center for Research Resources [UL1 RR024992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059888, R01HL080008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL080008 and R01 HL059888 and by UL1 RR024992 from the National Center for Research Resources (to G. W. D. II).	Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Bright R, 2005, STROKE, V36, P2781, DOI 10.1161/01.STR.0000189996.71237.f7; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; Clerk A, 1999, AM J CARDIOL, V83, p64H; DAVIS PD, 1992, J MED CHEM, V35, P994, DOI 10.1021/jm00084a004; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Galvez AS, 2006, J BIOL CHEM, V281, P1442, DOI 10.1074/jbc.M509056200; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17; Hambleton M, 2007, AM J PHYSIOL-HEART C, V293, pH3768, DOI 10.1152/ajpheart.00486.2007; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; JAMES G, 1992, J CELL BIOL, V116, P863, DOI 10.1083/jcb.116.4.863; Kang MY, 2010, CIRC RES, V107, P903, DOI 10.1161/CIRCRESAHA.110.220772; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Liu QH, 2009, CIRC RES, V105, P194, DOI 10.1161/CIRCRESAHA.109.195313; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mann D L, 2001, Heart Fail Rev, V6, P71, DOI 10.1023/A:1011449708842; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mochly-Rosen D, 2000, CIRC RES, V86, P1173; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Olson Eric N, 2006, Novartis Found Symp, V274, P3; Putt ME, 2009, CIRC-CARDIOVASC GENE, V2, P212, DOI 10.1161/CIRCGENETICS.108.816686; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; SIMPSON PC, 1991, MOL CELL BIOCHEM, V104, P35; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775	46	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26943	26951		10.1074/jbc.M111.234757	http://dx.doi.org/10.1074/jbc.M111.234757			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642422	Green Published, hybrid			2022-12-27	WOS:000293078200068
J	Debnath, S; Chatterjee, S; Arif, M; Kundu, TK; Roy, S				Debnath, Subrata; Chatterjee, Snehajyoti; Arif, Mohammed; Kundu, Tapas K.; Roy, Siddhartha			Peptide-Protein Interactions Suggest That Acetylation of Lysines 381 and 382 of p53 Is Important for Positive Coactivator 4-p53 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; PC4; COMPLEX; GENE; DNA; PHOSPHORYLATION; TRANSACTIVATION; MDM2; DEGRADATION; PROMOTES	The human transcriptional positive coactivator 4 (PC4) activates several p53-dependent genes. It has been demonstrated that this is a consequence of direct interaction with p53. Previously, we have concluded that PC4 interacts mainly with the C-terminal negative regulatory domain of p53 through its DNA binding C-terminal half. NMR chemical shift perturbation studies with peptide fragments indicated that amino acids 380-386 of p53 are crucial for interaction with PC4. This was verified by fluorescence anisotropy and sedimentation velocity studies. A peptide consisting of p53-(380-386) sequence, when attached to a cell penetration tag and nuclear localization signal, localizes to the nucleus and inhibits luciferase gene expression from a transfected plasmid carrying a Luc gene under a p53-dependent promoter. Acetylation of lysine 382/381 enhanced the binding of this peptide to PC4 by about an order of magnitude. NMR and mutagenesis studies indicated that serine 73 of PC4 is an important residue for recognition of p53. Intermolecular nuclear Overhauser effect placed aspartate 76 in the vicinity of lysine 381, indicating that the region around residues 73-76 of PC4 is important for p53 recognition. We conclude that the 380-386 region of p53 interacts with the region around residues 73-76 of PC4, and acetylation of lysine 382/381 of p53 may play an important role in modulating p53-PC4 interaction and as a consequence PC4 mediated activation of p53 target genes.	[Chatterjee, Snehajyoti; Arif, Mohammed; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Debnath, Subrata; Roy, Siddhartha] Council Sci & Ind Res India, Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata 700032, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in; sidroykolkata@gmail.com	Debnath, Subrata/X-8773-2019; Chatterjee, Snehajyoti/AAV-3919-2021; Chatterjee, Snehajyoti/D-1609-2011	Chatterjee, Snehajyoti/0000-0002-4873-9416; MOHAMMED, ARIF/0000-0003-1300-5081; Kundu, Tapas/0000-0001-7790-214X	Council of Scientific and Industrial Research (India); Department of Science and Technology (Government of India)	Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (Government of India)(Department of Science & Technology (India))	Recipient of a Council of Scientific and Industrial Research (India) and Department of Science and Technology (Government of India) J. C. Bose Fellowship. To whom correspondence may be addressed. E-mail: sidroykolkata@gmail.com.	Arrowsmith CH, 1999, CELL DEATH DIFFER, V6, P1169, DOI 10.1038/sj.cdd.4400619; Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Batta K, 2009, J MOL BIOL, V385, P788, DOI 10.1016/j.jmb.2008.11.008; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; FESIK SW, 1988, BIOCHEMISTRY-US, V27, P8297, DOI 10.1021/bi00422a001; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Jonker HRA, 2006, FEBS J, V273, P1430, DOI 10.1111/j.1742-4658.2006.05165.x; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; Kishore AH, 2007, BIOCHEM J, V406, P437, DOI 10.1042/BJ20070390; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar BRP, 2001, J BIOL CHEM, V276, P16804, DOI 10.1074/jbc.M100934200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Polley S, 2008, J MOL BIOL, V376, P8, DOI 10.1016/j.jmb.2007.11.082; Rajagopalan S, 2009, J BIOL CHEM, V284, P21728, DOI 10.1074/jbc.M109.006429; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Werten S, 2006, NAT STRUCT MOL BIOL, V13, P181, DOI 10.1038/nsmb1044	27	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25076	25087		10.1074/jbc.M110.205328	http://dx.doi.org/10.1074/jbc.M110.205328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21586571	hybrid, Green Published			2022-12-27	WOS:000292547900056
J	Khan, S; Rodriguez, E; Patel, R; Gor, J; Mulloy, B; Perkins, SJ				Khan, Sanaullah; Rodriguez, Elizabeth; Patel, Rima; Gor, Jayesh; Mulloy, Barbara; Perkins, Stephen J.			The Solution Structure of Heparan Sulfate Differs from That of Heparin IMPLICATIONS FOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; NEUTRON-SCATTERING; SEDIMENTATION-VELOCITY; SOLUTION CONFORMATION; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; PROTEOGLYCANS; DOMAINS; BINDING; GROWTH	The highly sulfated polysaccharides heparin and heparan sulfate (HS) play key roles in the regulation of physiological and pathophysiological processes. Despite its importance, no molecular structures of free HS have been reported up to now. By combining analytical ultracentrifugation, small angle x-ray scattering, and constrained scattering modeling recently used for heparin, we have analyzed the solution structures for eight purified HS fragments degree of polymerization 6-18 (dp6-dp18) and dp24, corresponding to the predominantly unsulfated GlcA-GlcNAc domains of heparan sulfate. Unlike heparin, the sedimentation coefficient s(20,w) of HS dp6-dp24 showed a small rotor speed dependence, where similar s(20,w) values of 0.82-1.26 S (absorbance optics) and 1.05-1.34 S (interference optics) were determined. The corresponding x-ray scattering measurements of HS dp6-dp24 gave radius of gyration (R-G) values from 1.03 to 2.82 nm, cross-sectional radius of gyration (R-XS) values from 0.31 to 0.65 nm, and maximum lengths (L) from 3.0 to 10.0 nm. These data showed that HS has a longer and more bent structure than heparin. Constrained scattering modeling starting from 5000-8000 conformationally randomized HS structures gave best fit dp6-dp16 molecular structures that were longer and more bent than their equivalents in heparin. No fits were obtained for HS dp18 or dp24, indicating their higher flexibility. We conclude that HS displays an extended bent conformation that is significantly distinct from that for heparin. The difference is attributed to the different predominant monosaccharide sequence and reduced sulfation of HS, indicating that HS may interact differently with proteins compared with heparin.	[Khan, Sanaullah; Rodriguez, Elizabeth; Patel, Rima; Gor, Jayesh; Perkins, Stephen J.] UCL, Div Biosci, Dept Struct & Mol Biol, London WC1E 6BT, England; [Mulloy, Barbara] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England	University of London; University College London; National Institute for Biological Standards & Control	Perkins, SJ (corresponding author), UCL, Div Biosci, Dept Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@medsch.ucl.ac.uk	KHAN, SANAULLAH/A-8386-2015	KHAN, SANAULLAH/0000-0003-2480-6239	Higher Education Commission of Pakistan; Biotechnology and Biological Sciences Research Council; Henry Smith Charity; Fight for Sight Charity; BBSRC [BB/E013104/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Henry Smith Charity; Fight for Sight Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Higher Education Commission of Pakistan, the Biotechnology and Biological Sciences Research Council, the Henry Smith Charity, and the Mercer Fund of the Fight for Sight Charity.	Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CASU B, 1983, ARZNEIMITTELFORSCH, V33-1, P135; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Conrad H. E., 1998, HEPARIN BINDING PROT; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Dam J, 2004, METHOD ENZYMOL, V384, P185; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; FUJIWARA S, 1984, EUR J BIOCHEM, V143, P145, DOI 10.1111/j.1432-1033.1984.tb08353.x; Furtado PB, 2008, J MOL BIOL, V375, P102, DOI 10.1016/j.jmb.2007.09.085; GALLAGHER JT, 1992, ADV EXP MED BIOL, V313, P49; Gilbert HE, 2006, J MOL BIOL, V362, P1132, DOI 10.1016/j.jmb.2006.08.012; Glatter O., 1982, SMALL ANGLE XRAY SCA; Hricovini M, 1997, CARBOHYD RES, V300, P69, DOI 10.1016/S0008-6215(97)00036-0; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DL, 1989, HEPARIN CHEM BIOL PR; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Lyon M, 1998, MATRIX BIOL, V17, P485, DOI 10.1016/S0945-053X(98)90096-8; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Mobli M, 2008, GLYCOCONJUGATE J, V25, P401, DOI 10.1007/s10719-007-9081-9; MULLOY B, 1994, CARBOHYD RES, V255, P1, DOI 10.1016/S0008-6215(00)90968-6; Mulloy B, 1997, THROMB HAEMOSTASIS, V77, P668; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Perkins SJ, 1998, INT J BIOL MACROMOL, V22, P1, DOI 10.1016/S0141-8130(97)00088-3; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; Powell AK, 2010, NAT PROTOC, V5, P821, DOI 10.1038/nprot.2010.17; RICE KG, 1985, ANAL BIOCHEM, V150, P325, DOI 10.1016/0003-2697(85)90518-4; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Sasisekharan R, 1997, Angiogenesis, V1, P45, DOI 10.1023/A:1018318914258; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shaya D, 2010, J BIOL CHEM, V285, P20051, DOI 10.1074/jbc.M110.101071; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; Stringer SE, 2002, BLOOD, V100, P1543, DOI 10.1182/blood.V100.5.1543.h81702001543_1543_1550; Vives RR, 2001, BIOCHEM J, V354, P141, DOI 10.1042/0264-6021:3540141	53	19	19	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24842	24854		10.1074/jbc.M111.226027	http://dx.doi.org/10.1074/jbc.M111.226027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21576246	Green Published, hybrid			2022-12-27	WOS:000292547900034
J	Liu, HJ; Roose, JL; Cameron, JC; Pakrasi, HB				Liu, Haijun; Roose, Johnna L.; Cameron, Jeffrey C.; Pakrasi, Himadri B.			A Genetically Tagged Psb27 Protein Allows Purification of Two Consecutive Photosystem II (PSII) Assembly Intermediates in Synechocystis 6803, a Cyanobacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE CLUSTER; THERMOSYNECHOCOCCUS-VULCANUS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; D1 PROTEIN; RESOLUTION; COMPLEXES; POLYPEPTIDE; BIOGENESIS; BINDING	Photosystem II (PSII) is a large membrane bound molecular machine that catalyzes light-driven oxygen evolution from water. PSII constantly undergoes assembly and disassembly because of the unavoidable damage that results from its normal photochemistry. Thus, under physiological conditions, in addition to the active PSII complexes, there are always PSII subpopulations incompetent of oxygen evolution, but are in the process of undergoing elaborate biogenesis and repair. These transient complexes are difficult to characterize because of their low abundance, structural heterogeneity, and thermodynamic instability. In this study, we show that a genetically tagged Psb27 protein allows for the biochemical purification of two monomeric PSII assembly intermediates, one with an unprocessed form of D1 (His27 Delta ctpAPSII) and a second one with a mature form of D1 (His27PSII). Both forms were capable of light-induced charge separation, but unable to photooxidize water, largely because of the absence of a functional tetramanganese cluster. Unexpectedly, there was a significant amount of the extrinsic lumenal PsbO protein in the His27PSII, but not in the His27 Delta ctpAPSII complex. In contrast, two other lumenal proteins, PsbU and PsbV, were absent in both of these PSII intermediate complexes. Additionally, the only cytoplasmic extrinsic protein, Psb28 was detected in His27PSII complex. Based on these data, we have presented a refined model of PSII biogenesis, illustrating an important role of Psb27 as a gate-keeper during the complex assembly process of the oxygen-evolving centers in PSII.	[Liu, Haijun; Roose, Johnna L.; Cameron, Jeffrey C.; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	Pakrasi@wustl.edu		Liu, Haijun/0000-0003-0537-0302	National Science Foundation [NSF-MCB0745611]; Direct For Biological Sciences [0745611] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant NSF-MCB0745611 (to H. B. P.).	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Becker K, 2011, J PHOTOCH PHOTOBIO B, V104, P204, DOI 10.1016/j.jphotobiol.2011.02.005; Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; BRICKER TM, 1987, ARCH BIOCHEM BIOPHYS, V256, P295, DOI 10.1016/0003-9861(87)90449-8; BRICKER TM, 1990, PHOTOSYNTH RES, V24, P1, DOI 10.1007/BF00032639; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; CHENIAE GM, 1971, BIOCHIM BIOPHYS ACTA, V253, P167, DOI 10.1016/0005-2728(71)90242-8; Chu HA, 2004, BIOCHEMISTRY-US, V43, P3152, DOI 10.1021/bi035915f; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; Fagerlund RD, 2011, J PHOTOCH PHOTOBIO B, V104, P191, DOI 10.1016/j.jphotobiol.2011.01.022; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frasch WD, 2001, PHOTOSYNTH RES, V70, P245, DOI 10.1023/A:1014773304784; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hwang HJ, 2008, BIOCHEMISTRY-US, V47, P9747, DOI 10.1021/bi800568p; Ikeuchi M, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL III, P297; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, PLANT CELL PHYSIOL, V43, P1366, DOI 10.1093/pcp/pcf168; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kashino Y, 2001, ELECTROPHORESIS, V22, P1004, DOI 10.1002/1522-2683()22:6<1004::AID-ELPS1004>3.0.CO;2-Y; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; METZ JG, 1986, FEBS LETT, V205, P269, DOI 10.1016/0014-5793(86)80911-5; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P942, DOI 10.1021/bi00118a041; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nowaczyk MM, 2010, EUR J CELL BIOL, V89, P974, DOI 10.1016/j.ejcb.2010.08.008; ODOM WR, 1992, BIOCHEMISTRY-US, V31, P5616, DOI 10.1021/bi00139a027; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Sakurai I, 2007, PLANT PHYSIOL, V145, P1361, DOI 10.1104/pp.107.106781; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; SEIBERT M, 1989, BIOCHIM BIOPHYS ACTA, V974, P185, DOI 10.1016/S0005-2728(89)80371-8; Shagger H., 1991, ANAL BIOCHEM, V199, P223; Stull JA, 2010, J AM CHEM SOC, V132, P446, DOI 10.1021/ja908688t; Wei LL, 2010, J BIOL CHEM, V285, P21391, DOI 10.1074/jbc.M110.105064; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	42	42	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24865	24871		10.1074/jbc.M111.246231	http://dx.doi.org/10.1074/jbc.M111.246231			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592967	hybrid, Green Published			2022-12-27	WOS:000292547900036
J	Moore, SF; Hunter, RW; Hers, I				Moore, Samantha F.; Hunter, Roger W.; Hers, Ingeborg			mTORC2 Protein-mediated Protein Kinase B (Akt) Serine 473 Phosphorylation Is Not Required for Akt1 Activity in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; SUBSTRATE-SPECIFICITY; RAPAMYCIN MTOR; ACTIVATION; INSULIN; RICTOR; MICE; INHIBITOR; PATHWAY; AGGREGATION	Protein kinase B (PKB, Akt) is a Ser/Thr kinase involved in the regulation of cell survival, proliferation, and metabolism and is activated by dual phosphorylation on Thr(308) in the activation loop and Ser(473) in the hydrophobic motif. It plays a contributory role to platelet function, although little is known about its regulation. In this study, we investigated the role of the mammalian target of rapamycin complex (mTORC)-2 in Akt regulation using the recently identified small molecule ATP competitive mTOR inhibitors PP242 and Torin1. Both PP242 and Torin1 blocked thrombin and insulin-like growth factor 1-mediated Akt Ser(473) phosphorylation with an IC50 between 1 and 5 nM, whereas the mTORC1 inhibitor rapamycin had no effect. Interestingly, PP242 and Torin1 had no effect on Akt Thr(308) phosphorylation, Akt1 activity, and phosphorylation of the Akt substrate glycogen synthase kinase 3 beta, indicating that Ser(473) phosphorylation is not necessary for Thr(308) phosphorylation and maximal Akt1 activity. In contrast, Akt2 activity was significantly reduced, concurrent with inhibition of PRAS40 phosphorylation, in the presence of PP242 and Torin1. Other signaling pathways, including phospholipase C/PKC and the MAPK pathway, were unaffected by PP242 and Torin1. Together, these results demonstrate that mTORC2 is the kinase that phosphorylates Akt Ser(473) in human platelets but that this phosphorylation is dispensable for Thr(308) phosphorylation and Akt1 activity.	[Moore, Samantha F.; Hunter, Roger W.; Hers, Ingeborg] Univ Bristol, Sch Med Sci, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol	Hers, I (corresponding author), Univ Bristol, Sch Med Sci, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England.	i.hers@bris.ac.uk	Hers, Ingeborg/ABG-3357-2020	Hers, Ingeborg/0000-0002-6467-5715; Moore, Samantha/0000-0003-0944-7055	British Heart Foundation [PG/08/113/25515, FS/05/047/18875, PG/08/056/25325]; British Heart Foundation [PG/10/100/28658] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants PG/08/113/25515, FS/05/047/18875, and PG/08/056/25325 (to I. H.).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Campus F, 2005, J BIOL CHEM, V280, P24386, DOI 10.1074/jbc.M501174200; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gresele P, 2008, TRENDS PHARMACOL SCI, V29, P352, DOI 10.1016/j.tips.2008.05.002; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hayashi H, 2009, THROMB HAEMOSTASIS, V102, P327, DOI 10.1160/TH08-12-0781; Hers I, 2005, BIOCHEM J, V388, P713, DOI 10.1042/BJ20041531; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hunter RW, 2008, J THROMB HAEMOST, V6, P1923, DOI 10.1111/j.1538-7836.2008.03140.x; Hunter RW, 2009, J THROMB HAEMOST, V7, P2123, DOI 10.1111/j.1538-7836.2009.03637.x; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; O'Brien KA, 2010, CIRCULATION, V122; Pasquet JM, 2000, BLOOD, V95, P3429, DOI 10.1182/blood.V95.11.3429.011k22_3429_3434; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	44	73	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24553	24560		10.1074/jbc.M110.202341	http://dx.doi.org/10.1074/jbc.M110.202341			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592956	Green Published, hybrid			2022-12-27	WOS:000292547900005
J	Yamanaka, K; Saito, Y; Yamamori, T; Urano, Y; Noguchi, N				Yamanaka, Kazunori; Saito, Yoshiro; Yamamori, Tohru; Urano, Yasuomi; Noguchi, Noriko			24(S)-Hydroxycholesterol Induces Neuronal Cell Death through Necroptosis, a Form of Programmed Necrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; ADAPTIVE RESPONSE; UP-REGULATION; HYDROGEN-PEROXIDE; BRAIN CHOLESTEROL; OXIDATIVE STRESS; APOPTOSIS; GLUTATHIONE; PATHWAY; 24S-HYDROXYCHOLESTEROL	24(S)-Hydroxycholesterol (24S-OHC) produced by cholesterol 24-hydroxylase expressed mainly in neurons plays an important physiological role in the brain. Conversely, it has been reported that 24S-OHC possesses potent cytotoxicity. The molecular mechanisms of 24S-OHC-induced cell death have not yet been fully elucidated. In this study, using human neuroblastoma SH-SY5Y cells and primary cortical neuronal cells derived from rat embryo, we characterized the form of cell death induced by 24S-OHC. SH-SY5Y cells treated with 24S-OHC exhibited neither fragmentation of the nucleus nor caspase activation, which are the typical characteristics of apoptosis. 24S-OHC-treated cells showed necrosis-like morphological changes but did not induce ATP depletion, one of the features of necrosis. When cells were treated with necrostatin-1, an inhibitor of receptor-interacting serine/threonine kinase 1 (RIPK1) required for necroptosis, 24S-OHC-induced cell death was significantly suppressed. The knockdown of RIPK1 by transfection of small interfering RNA of RIPK1 effectively attenuated 24S-OHC-induced cell death. It was found that neither SH-SY5Y cells nor primary cortical neuronal cells expressed caspase-8, which was regulated for RIPK1-dependent apoptosis. Collectively, these results suggest that 24S-OHC induces neuronal cell death by necroptosis, a form of programmed necrosis.	[Yamanaka, Kazunori; Saito, Yoshiro; Yamamori, Tohru; Urano, Yasuomi; Noguchi, Noriko] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 6100394, Japan; [Yamamori, Tohru] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Radiat Biol Lab, Sapporo, Hokkaido 0600818, Japan	Doshisha University; Hokkaido University	Saito, Y (corresponding author), Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 6100394, Japan.	ysaito@mail.doshisha.ac.jp; nnoguchi@mail.doshisha.ac.jp	Saito, Yoshiro/H-4597-2019; Yamamori, Tohru/A-7285-2012	Saito, Yoshiro/0000-0002-0559-5889; Urano, Yasuomi/0000-0002-4901-1937	Ministry of Education, Culture, Sports, Science, and Technology; Cosmetology Research Foundation; Science and Engineering Research Institute; Japan Society for the Promotion of Science [21800075]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cosmetology Research Foundation; Science and Engineering Research Institute; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Academic Frontier Research Project on "New Frontier of Biomedical Engineering Research" from the Ministry of Education, Culture, Sports, Science, and Technology (to N. N.), by the Cosmetology Research Foundation (to Y. S.), by a research grant from the Science and Engineering Research Institute (to Y. S.), and by Grant-in-aid for Research Activity Start-Up 21800075 (to Y. U.) from the Japan Society for the Promotion of Science.	Bao LP, 2006, J BIOL CHEM, V281, P33635, DOI 10.1074/jbc.M606339200; Berthier A, 2004, CELL DEATH DIFFER, V11, P897, DOI 10.1038/sj.cdd.4401434; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Bjorkhem I, 2007, LIPIDS, V42, P5, DOI 10.1007/s11745-006-1003-2; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Chen TY, 2009, FREE RADICAL BIO MED, V46, P643, DOI 10.1016/j.freeradbiomed.2008.11.022; Chen ZH, 2006, J BIOL CHEM, V281, P14440, DOI 10.1074/jbc.M600260200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Kolsch H, 1999, BRAIN RES, V818, P171, DOI 10.1016/S0006-8993(98)01274-8; Kolsch H, 2002, MOL PSYCHIATR, V7, P899, DOI 10.1038/sj.mp.4001109; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lutjohann D, 2000, J LIPID RES, V41, P195; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; Ogawa Y, 2008, FREE RADICAL RES, V42, P674, DOI 10.1080/10715760802277396; Panza F, 2007, J AM GERIATR SOC, V55, P133, DOI 10.1111/j.1532-5415.2006.01003.x; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Royer MC, 2009, J BIOL CHEM, V284, P15826, DOI 10.1074/jbc.M808641200; Saito Y, 2007, FEBS LETT, V581, P4349, DOI 10.1016/j.febslet.2007.08.010; Saito Y, 2007, J NEUROCHEM, V102, P1625, DOI 10.1111/j.1471-4159.2007.04701.x; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; Shafaati M, 2007, NEUROSCI LETT, V425, P78, DOI 10.1016/j.neulet.2007.08.014; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Torocsik D, 2009, MOL ASPECTS MED, V30, P134, DOI 10.1016/j.mam.2009.02.002; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vejux A, 2009, J NUTR BIOCHEM, V20, P45, DOI 10.1016/j.jnutbio.2007.12.001; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	42	92	94	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24666	24673		10.1074/jbc.M111.236273	http://dx.doi.org/10.1074/jbc.M111.236273			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613228	hybrid, Green Published			2022-12-27	WOS:000292547900017
J	Chatterjee, S; Ju, ZL; Hassan, R; Volpi, SA; Emelyanov, AV; Birshtein, BK				Chatterjee, Sanjukta; Ju, Zhongliang; Hassan, Rabih; Volpi, Sabrina A.; Emelyanov, Alexander V.; Birshtein, Barbara K.			Dynamic Changes in Binding of Immunoglobulin Heavy Chain 3 ' Regulatory Region to Protein Factors during Class Switching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-INDUCED DEAMINASE; NF-KAPPA-B; IGH LOCUS; CHROMATIN ARCHITECTURE; INTRONIC ENHANCER; GENE-EXPRESSION; HS4 ENHANCER; CTCF SITES; IN-VIVO; RECOMBINATION	The 3' regulatory region (3' RR) of the Igh locus works at long distances on variable region (V-H) and switch region (I) region promoters to initiate germ line (non-coding) transcription (GT) and promote class switch recombination (CSR). The 3' RR contains multiple elements, including enhancers (hs3a, hs1.2, hs3b, and hs4) and a proposed insulator region containing CTCF (CCCTC-binding factor) binding sites, i.e. hs5/6/7 and the downstream region ("38"). Notably, deletion of each individual enhancer (hs3a-hs4) has no significant phenotypic consequence, suggesting that the 3' RR has considerable structural flexibility in its function. To better understand how the 3' RR functions, we identified transcription factor binding sites and used chromatin immunoprecipitation (ChIP) assays to monitor their occupancy in splenic B cells that initiate GT and undergo CSR (LPS +/- IL4), are deficient inGTand CSR (p50(-/-)), or do not undergo CSR despite efficient GT (anti-IgM + IL4). Like 3' RR enhancers, hs5-7 and the 38 region were observed to contain multiple Pax5 binding sites (in addition to multiple CTCF sites). We found that the Pax5 binding profile to the 3' RR dynamically changed during CSR independent of the specific isotype to which switching was induced, and binding focused on hs1.2, hs4, and hs7. CTCF-associated and CTCF-independent cohesin interactions were also identified. Our observations are consistent with a scaffold model in which a platform of active protein complexes capable of facilitating GT and CSR can be formed by varying constellations of 3' RR elements.	[Chatterjee, Sanjukta; Ju, Zhongliang; Hassan, Rabih; Volpi, Sabrina A.; Emelyanov, Alexander V.; Birshtein, Barbara K.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Birshtein, BK (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	barbara.birshtein@einstein.yu.edu			National Institutes of Health [AI13509]; Albert Einstein Cancer Center [P30 CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013509, R37AI013509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI13509. This work was also supported by Albert Einstein Cancer Center Grant P30 CA13330.	Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; Bebin AG, 2010, J IMMUNOL, V184, P3710, DOI 10.4049/jimmunol.0901978; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Cogne M, 2004, MOL BIOL B CELLS, P289; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dunnick WA, 2005, J EXP MED, V201, P1459, DOI 10.1084/jem.20041988; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Helternes-Harris LM, 2008, MOL IMMUNOL, V45, P1799, DOI 10.1016/j.molimm.2007.09.020; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Jabara HH, 2008, J ALLERGY CLIN IMMUN, V121, P191, DOI 10.1016/j.jaci.2007.08.008; Ju ZL, 2007, J BIOL CHEM, V282, P35169, DOI 10.1074/jbc.M705719200; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Lieberson R, 1995, EMBO J, V14, P6229, DOI 10.1002/j.1460-2075.1995.tb00313.x; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Max E E., 2003, FUNDAMENTAL IMMUNOLO, P107; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Michaelson JS, 1996, J IMMUNOL, V156, P2828; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Sepulveda MA, 2004, J IMMUNOL, V172, P1054, DOI 10.4049/jimmunol.172.2.1054; Singh M, 1996, P NATL ACAD SCI USA, V93, P4392, DOI 10.1073/pnas.93.9.4392; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; Snapper CM, 1996, J IMMUNOL, V156, P183; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stevens S, 2000, J IMMUNOL, V164, P5306, DOI 10.4049/jimmunol.164.10.5306; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Vincent-Fabert C, 2009, J IMMUNOL, V182, P6926, DOI 10.4049/jimmunol.0900214; Wang LL, 2006, EUR J IMMUNOL, V36, P3315, DOI 10.1002/eji.200636294; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zhang BY, 2007, J IMMUNOL, V178, P6297, DOI 10.4049/jimmunol.178.10.6297	50	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29303	29312		10.1074/jbc.M111.243543	http://dx.doi.org/10.1074/jbc.M111.243543			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21685395	Green Published, hybrid			2022-12-27	WOS:000293837000065
J	Singh, SK; Baumgart, S; Singh, G; Konig, AO; Reutlinger, K; Hofbauer, LC; Barth, P; Gress, TM; Lomberk, G; Urrutia, R; Fernandez-Zapico, ME; Ellenrieder, V				Singh, Shiv K.; Baumgart, Sandra; Singh, Garima; Koenig, Alexander O.; Reutlinger, Kristina; Hofbauer, Lorenz C.; Barth, Peter; Gress, Thomas M.; Lomberk, Gwen; Urrutia, Raul; Fernandez-Zapico, Martin E.; Ellenrieder, Volker			Disruption of a Nuclear NFATc2 Protein Stabilization Loop Confers Breast and Pancreatic Cancer Growth Suppression by Zoledronic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; C-MYC; SIGNALING PATHWAY; CARCINOMA CELLS; TUMOR-GROWTH; SURVIVAL; BISPHOSPHONATES; INHIBITION; APOPTOSIS; INVASION	The aminobisphosphonate zoledronic acid has elicited significant attention due to its remarkable anti-tumoral activity, although its detailed mechanism of action remains unclear. Here, we demonstrate the existence of a nuclear GSK-3 beta-NFATc2 stabilization pathway that promotes breast and pancreatic cancer growth in vitro and in vivo and serves as a bona fide target of zoledronic acid. Specifically, the serine/threonine kinase GSK-3 beta stabilizes nuclear NFATc2 through phosphorylation of the serine-rich SP2 domain, thus protecting the transcription factor from E3-ubiquitin ligase HDM2-mediated proteolysis. Zoledronic acid disrupts this NFATc2 stabilization pathway through two mechanisms, namely GSK-3 beta inhibition and induction of HDM2 activity. Upon nuclear accumulation, HDM2 targets unphosphorylated NFATc2 for ubiquitination at acceptor lysine residues Lys-684/Lys-897 and hence labels the factor for subsequent proteasomal degradation. Conversely, mutagenesis-induced constitutive serine phosphorylation (Ser-215, Ser-219, and Ser-223) of the SP2 domain prevents NFATc2 from HDM2-mediated ubiquitination and degradation and consequently rescues cancer cells from growth suppression by zoledronic acid. In conclusion, this study demonstrates a critical role of the GSK-3 beta-HDM2 signaling loop in the regulation of NFATc2 protein stability and growth promotion and suggests that double targeting of this pathway is responsible, at least to a significant part, for the potent and reliable anti-tumoral effects of zoledronic acid.	[Singh, Shiv K.; Baumgart, Sandra; Singh, Garima; Koenig, Alexander O.; Reutlinger, Kristina; Gress, Thomas M.; Ellenrieder, Volker] Univ Marburg, Signaling & Transcript Lab, Dept Gastroenterol, D-35043 Marburg, Germany; [Hofbauer, Lorenz C.] Tech Univ Dresden, Div Endocrinol Diabet & Bone Dis, Dept Med 3, D-01307 Dresden, Germany; [Barth, Peter] Univ Marburg, Dept Pathol, D-35043 Marburg, Germany; [Lomberk, Gwen; Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Dept Biochem, Rochester, MN 55905 USA; [Lomberk, Gwen; Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Dept Mol Biol, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55904 USA	Philipps University Marburg; Technische Universitat Dresden; Philipps University Marburg; Mayo Clinic; Mayo Clinic; Mayo Clinic	Ellenrieder, V (corresponding author), Univ Marburg, Signaling & Transcript Lab, Dept Gastroenterol, D-35043 Marburg, Germany.	ellenrie@med.uni-marburg.de	Hofbauer, Lorenz C/G-2490-2010; Lomberk, Gwen/AAL-8490-2020	Hofbauer, Lorenz C/0000-0002-8691-8423; Lomberk, Gwen/0000-0001-5463-789X; Singh, Shiv K./0000-0002-5725-4058; Gress, Thomas/0000-0002-9333-5461	Deutsche Forschungsgemeinschaft [KFO210, SFB-TR17]; LOEWE-Schwerpunkt "Tumor and Inflammation"; German Cancer Research Foundation [70-3022-El I]; Novartis Foundation; Wilhelm Sander Foundation; National Institutes of Health [DK 52913]; Mayo Clinic [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [NIDDK P30 DK084567]; NATIONAL CANCER INSTITUTE [P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052913, P30DK084567, R01DK052913] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE-Schwerpunkt "Tumor and Inflammation"; German Cancer Research Foundation; Novartis Foundation(Novartis); Wilhelm Sander Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was generously supported by the Deutsche Forschungsgemeinschaft (Grant KFO210, SFB-TR17) (to V. E.), the LOEWE-Schwerpunkt "Tumor and Inflammation" (to V. E.) and the Max-Eder program of the German Cancer Research Foundation (Grant 70-3022-El I) (to V. E.), the Novartis Foundation (to V. E. and L. C. H.), the Wilhelm Sander Foundation (to L. C. H.), National Institutes of Health Grant DK 52913 (to R. U.), Mayo Clinic Pancreatic SPORE Grant P50 CA102701 (to M. E. F. Z.), and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant NIDDK P30 DK084567 (to M. E. F. Z.).	Bertoldo F, 2009, NAT REV CLIN ONCOL, V6, P191, DOI 10.1038/nrclinonc.2009.24; Bilezikian JP, 2009, AM J MED, V122, P14, DOI 10.1016/j.amjmed.2008.12.003; Boissier S, 2000, CANCER RES, V60, P2949; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Chuah C, 2005, LEUKEMIA, V19, P1896, DOI 10.1038/sj.leu.2403949; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Li YY, 2008, LUNG CANCER, V59, P180, DOI 10.1016/j.lungcan.2007.08.026; Lyseng-Williamson KA, 2008, DRUGS, V68, P2661, DOI 10.2165/0003495-200868180-00010; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Ottewell PD, 2010, INT J CANCER, V126, P522, DOI 10.1002/ijc.24756; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Peng HJ, 2007, CANCER RES, V67, P9346, DOI 10.1158/0008-5472.CAN-06-4508; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Szuhai K, 2009, CLIN CANCER RES, V15, P2259, DOI 10.1158/1078-0432.CCR-08-2184; Tanvetyanon T, 2006, ANN ONCOL, V17, P897, DOI 10.1093/annonc/mdj105; Tassone P, 2003, BRIT J CANCER, V88, P1971, DOI 10.1038/sj.bjc.6600986; Tenta R, 2008, HORM METAB RES, V40, P737, DOI 10.1055/s-2008-1078753; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Winter MC, 2009, CURR OPIN ONCOL, V21, P499, DOI 10.1097/CCO.0b013e328331c794; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yoeli-Lerner M, 2009, MOL CANCER RES, V7, P425, DOI 10.1158/1541-7786.MCR-08-0342	36	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28761	28771		10.1074/jbc.M110.197533	http://dx.doi.org/10.1074/jbc.M110.197533			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21628454	hybrid, Green Published			2022-12-27	WOS:000293837000014
J	Bonnefond, A; Lomberk, G; Buttar, N; Busiah, K; Vaillant, E; Lobbens, S; Yengo, L; Dechaume, A; Mignot, B; Simon, A; Scharfmann, R; Neve, B; Tanyolac, S; Hodoglugil, U; Pattou, F; Cave, H; Iovanna, J; Stein, R; Polak, M; Vaxillaire, M; Froguel, P; Urrutia, R				Bonnefond, Amelie; Lomberk, Gwen; Buttar, Navtej; Busiah, Kanetee; Vaillant, Emmanuel; Lobbens, Stephane; Yengo, Loic; Dechaume, Aurelie; Mignot, Brigitte; Simon, Albane; Scharfmann, Raphael; Neve, Bernadette; Tanyolac, Sinan; Hodoglugil, Ugur; Pattou, Francois; Cave, Helene; Iovanna, Juan; Stein, Roland; Polak, Michel; Vaxillaire, Martine; Froguel, Philippe; Urrutia, Raul			Disruption of a Novel Kruppel-like Transcription Factor p300-regulated Pathway for Insulin Biosynthesis Revealed by Studies of the c.-331 INS Mutation Found in Neonatal Diabetes Mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR KLF11; GENE; GLUCOSE; EXPRESSION; FINGER; P300; PURIFICATION; SUBFAMILY; VARIANTS; FAMILY	Kruppel-like transcription factors (KLFs) have elicited significant attention because of their regulation of essential biochemical pathways and, more recently, because of their fundamental role in the mechanisms of human diseases. Neonatal diabetes mellitus is a monogenic disorder with primary alterations in insulin secretion. We here describe a key biochemical mechanism that underlies neonatal diabetes mellitus insulin biosynthesis impairment, namely a homozygous mutation within the insulin gene (INS) promoter, c.-331C>G, which affects a novel KLF-binding site. The combination of careful expression profiling, electromobility shift assays, reporter experiments, and chromatin immunoprecipitation demonstrates that, among 16 different KLF proteins tested, KLF11 is the most reliable activator of this site. Congruently, the c.-331C>G INS mutation fails to bind KLF11, thus inhibiting activation by this transcription factor. Klf11(-/-) mice recapitulate the disruption in insulin production and blood levels observed in patients. Thus, these data demonstrate an important role for KLF11 in the regulation of INS transcription via the novel c.-331 KLF site. Lastly, our screening data raised the possibility that other members of the KLF family may also regulate this promoter under distinct, yet unidentified, cellular contexts. Collectively, this study underscores a key role for KLF proteins in biochemical mechanisms of human diseases, in particular, early infancy onset diabetes mellitus.	[Polak, Michel] Univ Paris 05, Hop Necker Enfants Malad, AP HP,INSERM,U845, Dept Pediat Endocrinol,Serv Endocrinol Pediat, F-75015 Paris, France; [Bonnefond, Amelie; Vaillant, Emmanuel; Lobbens, Stephane; Yengo, Loic; Dechaume, Aurelie; Neve, Bernadette; Vaxillaire, Martine; Froguel, Philippe] Lille Nord France Univ, Lille Pasteur Inst, CNRS, UMR 8199, F-59800 Lille, France; [Lomberk, Gwen; Buttar, Navtej; Urrutia, Raul] Mayo Clin, Gastroenterol Res Unit, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Mignot, Brigitte] Ctr Hosp Univ CHU St Jacques, Dept Pediat Endocrinol, F-25030 Besancon, France; [Tanyolac, Sinan] Univ Calif San Francisco, Mt Zion Med Ctr, Dept Med, San Francisco, CA 94115 USA; [Tanyolac, Sinan] Univ Calif San Francisco, Mt Zion Med Ctr, Ctr Diabet, San Francisco, CA 94115 USA; [Hodoglugil, Ugur] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Pattou, Francois] Univ Lille Nord France, Univ Hosp Lille, INSERM, U859, F-75019 Paris, France; [Cave, Helene] Hop Robert Debre, AP HP, Dept Genet, F-75019 Paris, France; [Iovanna, Juan] INSERM, U624, F-13288 Marseille, France; [Stein, Roland] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London W12 0NN, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Mayo Clinic; Universite de Franche-Comte; CHU Besancon; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; The J David Gladstone Institutes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Vanderbilt University; Imperial College London	Polak, M (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, AP HP,INSERM,U845, Dept Pediat Endocrinol,Serv Endocrinol Pediat, F-75015 Paris, France.	michel.polak@nck.aphp.fr; p.froguel@imperial.ac.uk; urrutia.raul@mayo.edu	Neve, Bernadette/J-6008-2014; Lomberk, Gwen/AAL-8490-2020; Tanyolac, Sinan/AAP-5966-2021; Pattou, Francois/O-6151-2017; Iovanna, Juan/M-9805-2017; FROGUEL, Philippe/O-6799-2017; Kanetee, BUSIAH/AAP-8292-2020; Bonnefond, Amélie/O-2784-2017; Yengo, Loic/D-2692-2017; scharfmann, raphael/L-3296-2017	Neve, Bernadette/0000-0003-1516-1379; Lomberk, Gwen/0000-0001-5463-789X; Tanyolac, Sinan/0000-0003-4238-5132; Pattou, Francois/0000-0001-8388-3766; Iovanna, Juan/0000-0003-1822-2237; FROGUEL, Philippe/0000-0003-2972-0784; Kanetee, BUSIAH/0000-0002-1059-0791; Bonnefond, Amélie/0000-0001-9976-3005; Yengo, Loic/0000-0002-4272-9305; Scharfmann, Raphael/0000-0001-7619-337X; Cave, Helene/0000-0003-2840-1511	National Institutes of Health [DK52913, DK050203]; Agence Nationale de la Recherche-Maladies Rares (ANR-MRAR) [ANR-07-MRAR-000]; Transnational European Research Grant on Rare Diseases [ERANET-09-RARE-005]; European Union of the European Community [LSHM-CT-2006-518153]; Conseil Regional du Nord Pas de Calais (France); Centre National de la Recherche Scientifique; Societe Francaise de Pediatrie, Convention Industrielle de Formation par la Recherche; HRA Pharma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, R01DK050203, R56DK050203, R56DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche-Maladies Rares (ANR-MRAR)(French National Research Agency (ANR)); Transnational European Research Grant on Rare Diseases; European Union of the European Community; Conseil Regional du Nord Pas de Calais (France)(Region Hauts-de-FranceRegion Ile-de-France); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Societe Francaise de Pediatrie, Convention Industrielle de Formation par la Recherche; HRA Pharma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52913 (to R. U.) and DK050203 (to R. S.). This work was also supported by Agence Nationale de la Recherche-Maladies Rares (ANR-MRAR) Research Program Grant ANR-07-MRAR-000 (to M. P.), Transnational European Research Grant on Rare Diseases ERANET-09-RARE-005 (to M. V. and M. P.), and European Union Integrated Project EuroDia LSHM-CT-2006-518153 in Framework Programme 6 of the European Community (to P. F.).; Supported by a research fellowship from the Conseil Regional du Nord Pas de Calais (France) and the Centre National de la Recherche Scientifique.; Supported by Societe Francaise de Pediatrie, Convention Industrielle de Formation par la Recherche and HRA Pharma.	Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Alevizos I, 2007, CELL CYCLE, V6, P1631, DOI 10.4161/cc.6.13.4380; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; Bieker JJ, 2010, NAT GENET, V42, P733, DOI 10.1038/ng0910-733; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Bureau C, 2009, CURR GENOMICS, V10, P353, DOI 10.2174/138920209788921010; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Fernandez-Zapico ME, 2011, BIOCHEM J, V435, P529, DOI 10.1042/BJ20100773; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Greeley SAW, 2010, TRENDS ENDOCRIN MET, V21, P464, DOI 10.1016/j.tem.2010.03.004; Gutierrez-Aguilar R, 2008, J CLIN ENDOCR METAB, V93, P3128, DOI 10.1210/jc.2007-2504; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Kanazawa A, 2005, DIABETOLOGIA, V48, P1315, DOI 10.1007/s00125-005-1797-0; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Ling ZD, 2006, DIABETES, V55, P78, DOI 10.2337/diabetes.55.01.06.db05-0820; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Nagai R, 2009, BIOLOGY OF KRUPPEL-LIKE FACTORS, P3, DOI 10.1007/978-4-431-87775-2_1; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Polak M, 2008, DIABETES, V57, P1115, DOI 10.2337/db07-1358; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Qiu Y, 1998, MOL CELL BIOL, V18, P2957, DOI 10.1128/MCB.18.5.2957; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Song CZ, 2005, BLOOD CELL MOL DIS, V34, P53, DOI 10.1016/j.bcmd.2004.08.027; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Vaxillaire Martine, 2009, Pediatr Endocrinol Rev, V6, P405; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; WHELAN J, 1989, MOL CELL BIOL, V9, P3253, DOI 10.1128/MCB.9.8.3253; Yamamoto K, 2010, BIOCHEM BIOPH RES CO, V400, P175, DOI 10.1016/j.bbrc.2010.08.039	45	59	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28414	28424		10.1074/jbc.M110.215822	http://dx.doi.org/10.1074/jbc.M110.215822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21592955	Green Published, hybrid			2022-12-27	WOS:000293557800057
J	Gerdts, J; Sasaki, Y; Vohra, B; Marasa, J; Milbrandt, J				Gerdts, Josiah; Sasaki, Yo; Vohra, Bhupinder; Marasa, Jayne; Milbrandt, Jeffrey			Image-based Screening Identifies Novel Roles for I kappa B Kinase and Glycogen Synthase Kinase 3 in Axonal Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; WALLERIAN DEGENERATION; METAMORPHOSIS; KINASE-3-BETA; DEGRADATION; MECHANISMS; WITHDRAWAL; NEURONS; PATHWAY; CELLS	Axon degeneration is an active, evolutionarily conserved self-destruction program by which compromised axons fragment in response to varied insults. Unlike programmed cell death, axon degeneration is poorly understood. We have combined robotic liquid handling with automated microscopy and image analysis to create a robust screening platform to measure axon degeneration in mammalian primary neuronal cultures. Using this assay, we performed an unbiased screen of 480 bioactive compounds, identifying 11 that reproducibly delay fragmentation of severed axons in vitro, including two inhibitors of glycogen synthase kinase 3 and two inhibitors of I kappa B kinase. Knockdown of each of these targets by shRNA lentivirus also delays axon degeneration in vitro, further supporting their role in the axon degeneration program.	[Gerdts, Josiah; Sasaki, Yo; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, Mol Imaging Ctr,Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Marasa, Jayne] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Vohra, Bhupinder] Univ Cent Arkansas, Dept Biol, Conway, AR 72034 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Central Arkansas	Milbrandt, J (corresponding author), 660 S Euclid Ave,Campus Box 8232, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu			National Institutes of Health [AG13730, NS065053, NS070053, P50 CA91842]; NIH Neuroscience Blueprint Center [P30 NS057105]; HOPE Center for Neurological Disorders; Craig H. Neilsen Foundation [124030]; National Institutes of Health NCI Cancer Center [P30 CA091842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070053, R01NS065053, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Neuroscience Blueprint Center; HOPE Center for Neurological Disorders; Craig H. Neilsen Foundation; National Institutes of Health NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG13730 (to J. Milbrandt) and NS065053 and NS070053 (to J. Milbrandt and A. DiAntonio), NIH Neuroscience Blueprint Center Core Grant P30 NS057105 to Washington University, the HOPE Center for Neurological Disorders, and Craig H. Neilsen Foundation Grant 124030 (to J. Milbrandt).; We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, MO, for the use of the High-Throughput Screening Core. The Siteman Cancer Center is supported in part by National Institutes of Health NCI Cancer Center Support Grant P30 CA091842. The Screening Core is supported by NIH Grant P50 CA91842 and an Anheuser-Busch/Emerson challenge gift. We also thank Aaron DiAntonio and Martha Bhattacharya for help with manuscript preparation, Scott Wildman for help with compound library selection, and S. Joshua Swamidass for help with the development of methods.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Eom TY, 2007, J BIOL CHEM, V282, P22856, DOI 10.1074/jbc.M702973200; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Hetman M, 2000, J NEUROSCI, V20, P2567; Ikegami K, 2004, BRAIN RES, V1030, P81, DOI 10.1016/j.brainres.2004.09.050; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mok SA, 2009, CELL RES, V19, P546, DOI 10.1038/cr.2009.11; Moss BL, 2008, J BIOL CHEM, V283, P8687, DOI 10.1074/jbc.M706831200; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Rumpf S, 2011, DEVELOPMENT, V138, P1153, DOI 10.1242/dev.062703; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sun SC, 1996, MOL CELL BIOL, V16, P1058; Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	25	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28011	28018		10.1074/jbc.M111.250472	http://dx.doi.org/10.1074/jbc.M111.250472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685387	Green Published, hybrid			2022-12-27	WOS:000293557800019
J	Zhao, B; Mankowski, MK; Snyder, BA; Ptak, RG; LiWang, PJ				Zhao, Bo; Mankowski, Marie K.; Snyder, Beth A.; Ptak, Roger G.; LiWang, Patricia J.			Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FUSION-INHIBITOR; HTLV-III; MONONUCLEAR PHAGOCYTES; VIRAL ENVELOPE; PSC-RANTES; T-CELLS; TYPE-1; INFECTION; GP41	Blocking HIV-1 cell entry has long been a major goal of anti-HIV drug development. Here, we report a successful design of two highly potent chimeric HIV entry inhibitors composed of one CCR5-targeting RANTES (regulated on activation normal T cell expressed and secreted) variant (5P12-RANTES or 5P14-RANTES (Gaertner, H., Cerini, F., Escola, J. M., Kuenzi, G., Melotti, A., Offord, R., Rossitto-Borlat, I., Nedellec, R., Salkowitz, J., Gorochov, G., Mosier, D., and Hartley, O. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 17706-17711)) linked to a gp41 fusion inhibitor, C37. Chimeric inhibitors 5P12-linker-C37 and 5P14-linker-C37 showed extremely high antiviral potency in single cycle and replication-competent viral assays against R5-tropic viruses, with IC50 values as low as 0.004 nM. This inhibition was somewhat strain-dependent and was up to 100-fold better than the RANTES variant alone or in combination with unlinked C37. The chimeric inhibitors also fully retained the antiviral activity of C37 against X4-tropic viruses, and this inhibition can be further enhanced significantly if the target cell co-expresses CCR5 receptor. On human peripheral blood mononuclear cells, the inhibitors showed very strong inhibition against R5-tropic Ba-L strain and X4-tropic IIIB strain, with IC50 values as low as 0.015 and 0.44 nM, which are 45- and 16-fold better than the parent inhibitors, respectively. A clear delivery mechanism requiring a covalent linkage between the two segments of the chimera was observed and characterized. Furthermore, the two chimeric inhibitors are fully recombinant and are easily produced at low cost. These attributes make them excellent candidates for anti-HIV microbicides. The results of this study also suggest a potent approach for optimizing existing HIV entry inhibitors or designing new inhibitors.	[LiWang, Patricia J.] Univ Calif, Merced, CA 95343 USA; [Zhao, Bo] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Mankowski, Marie K.; Snyder, Beth A.; Ptak, Roger G.] So Res Inst, Dept Infect Dis Res, Frederick, MD 21701 USA	University of California System; University of California Merced; Texas A&M University System; Texas A&M University College Station	LiWang, PJ (corresponding author), Univ Calif, 5200 N Lake Rd, Merced, CA 95343 USA.	pliwang@ucmerced.edu	Zhao, Bo/GVT-7665-2022	Zhao, Bo/0000-0002-2163-6484	National Institutes of Health [AI079777]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI079777.	Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Champagne K, 2009, J BIOL CHEM, V284, P3619, DOI 10.1074/jbc.M809269200; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; ChengMayer C, 1997, J VIROL, V71, P1657, DOI 10.1128/JVI.71.2.1657-1661.1997; CIMINALE V, 1990, AIDS RES HUM RETROV, V6, P1281, DOI 10.1089/aid.1990.6.1281; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GENDELMAN HE, 1992, J IMMUNOL, V148, P422; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; Hartley O, 2005, CURR PROTEIN PEPT SC, V6, P207, DOI 10.2174/1389203054065400; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Heredia A, 2007, AIDS, V21, P1317, DOI 10.1097/QAD.0b013e32815278ea; Ji CH, 2009, J BIOL CHEM, V284, P5175, DOI 10.1074/jbc.M808745200; Kagiampakis I, 2011, ANTIMICROB AGENTS CH, V55, P264, DOI 10.1128/AAC.00376-10; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Kawamura T, 2004, J VIROL, V78, P7602, DOI 10.1128/JVI.78.14.7602-7609.2004; Kopetzki E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-56; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Pace P, 2008, CURR OPIN DRUG DISC, V11, P471; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; POPOVIC M, 1984, LANCET, V2, P1472; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Poveda E, 2005, AIDS REV, V7, P139; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Root MJ, 2004, CURR PHARM DESIGN, V10, P1805, DOI 10.2174/1381612043384448; Stamatatos L, 2000, AIDS RES HUM RETROV, V16, P981, DOI 10.1089/08892220050058407; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Stoddart CA, 2008, J BIOL CHEM, V283, P34045, DOI 10.1074/jbc.M805536200; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wang HGH, 2004, CURR PHARM DESIGN, V10, P1785, DOI 10.2174/1381612043384565; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WESTERVELT P, 1991, P NATL ACAD SCI USA, V88, P3097, DOI 10.1073/pnas.88.8.3097; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777	62	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28370	28381		10.1074/jbc.M111.234799	http://dx.doi.org/10.1074/jbc.M111.234799			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659523	hybrid, Green Published			2022-12-27	WOS:000293557800053
J	Chatterjee, TK; Idelman, G; Blanco, V; Blomkalns, AL; Piegore, MG; Weintraub, DS; Kumar, S; Rajsheker, S; Manka, D; Rudich, SM; Tang, YL; Hui, DY; Bassel-Duby, R; Olson, EN; Lingrel, JB; Ho, SM; Weintraub, NL				Chatterjee, Tapan K.; Idelman, Gila; Blanco, Victor; Blomkalns, Andra L.; Piegore, Mark G., Jr.; Weintraub, Daniel S.; Kumar, Santosh; Rajsheker, Srinivas; Manka, David; Rudich, Steven M.; Tang, Yaoliang; Hui, David Y.; Bassel-Duby, Rhonda; Olson, Eric N.; Lingrel, Jerry B.; Ho, Shuk-Mei; Weintraub, Neal L.			Histone Deacetylase 9 Is a Negative Regulator of Adipogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE CELL SIZE; GENE-EXPRESSION; ADIPOCYTE SIZE; VALPROIC ACID; MUSCLE DIFFERENTIATION; INSULIN-RESISTANCE; STEM-CELLS; OBESITY; TISSUE; BINDING	Differentiation of preadipocytes into mature adipocytes capable of efficiently storing lipids is an important regulatory mechanism in obesity. Here, we examined the involvement of histone deacetylases (HDACs) and histone acetyltransferases (HATs) in the regulation of adipogenesis. We find that among the various members of the HDAC and HAT families, only HDAC9 exhibited dramatic down-regulation preceding adipogenic differentiation. Preadipocytes from HDAC9 gene knock-out mice exhibited accelerated adipogenic differentiation, whereas HDAC9 overexpression in 3T3-L1 preadipocytes suppressed adipogenic differentiation, demonstrating its direct role as a negative regulator of adipogenesis. HDAC9 expression was higher in visceral as compared with subcutaneous preadipocytes, negatively correlating with their potential to undergo adipogenic differentiation in vitro. HDAC9 localized in the nucleus, and its negative regulation of adipogenesis segregates with the N-terminal nuclear targeting domain, whereas the C-terminal deacetylase domain is dispensable for this function. HDAC9 co-precipitates with USF1 and is recruited with USF1 at the E-box region of the C/EBP alpha gene promoter in preadipocytes. Upon induction of adipogenic differentiation, HDAC9 is down-regulated, leading to its dissociation from the USF1 complex, whereas p300HATis up-regulated to allow its association with USF1 and accumulation at the E-box site of the C/EBP alpha promoter in differentiated adipocytes. This reciprocal regulation of HDAC9 and p300HAT in the USF1 complex is associated with increased C/EBP alpha expression, a master regulator of adipogenic differentiation. These findings provide new insights into mechanisms of adipogenic differentiation and document a critical regulatory role for HDAC9 in adipogenic differentiation through a deacetylase-independent mechanism.	[Chatterjee, Tapan K.; Idelman, Gila; Piegore, Mark G., Jr.; Weintraub, Daniel S.; Kumar, Santosh; Rajsheker, Srinivas; Manka, David; Tang, Yaoliang; Weintraub, Neal L.] Univ Cincinnati, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA; [Blanco, Victor; Blomkalns, Andra L.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; [Rudich, Steven M.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Ho, Shuk-Mei] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Lingrel, Jerry B.] Univ Cincinnati, Dept Mol Genet Biochem & Mol Biol, Cincinnati, OH 45267 USA; [Hui, David Y.] Univ Cincinnati, Metab Dis Inst, Dept Pathol, Cincinnati, OH 45215 USA; [Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Ho, Shuk-Mei] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Chatterjee, TK (corresponding author), Univ Cincinnati, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA.	tapan.chatterjee@uc.edu		Weintraub, Neal/0000-0002-5138-3705; Tang, Yaoliang/0000-0002-8372-1545	National Institutes of Health [HL076684, HL62984, ES019480]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076684, P01HL062984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL076684, HL62984 (to N. L. W.), and ES019480 (to S. H.)	BROOK CGD, 1973, ARCH DIS CHILD, V48, P301, DOI 10.1136/adc.48.4.301; Brown R, 2008, NEUROENDOCRINOLOGY, V88, P25, DOI 10.1159/000113927; Catalioto RM, 2009, EXP CELL RES, V315, P3267, DOI 10.1016/j.yexcr.2009.09.012; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Crepaldi L, 2009, EPIGENETICS-US, V4, P23, DOI 10.4161/epi.4.1.7604; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haumaitre C, 2009, CELL CYCLE, V8, P536, DOI 10.4161/cc.8.4.7610; HIRSCH J, 1970, FED PROC, V29, P1516; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JW, 2007, BIOCHEM BIOPH RES CO, V354, P517, DOI 10.1016/j.bbrc.2007.01.008; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lagace DC, 2004, J BIOL CHEM, V279, P18851, DOI 10.1074/jbc.M312795200; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Martin M, 2009, INT J DEV BIOL, V53, P291, DOI 10.1387/ijdb.082698mm; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Monteiro R, 2006, OBES SURG, V16, P804, DOI 10.1381/096089206777346600; Muralidhar SA, 2011, J BIOL CHEM, V286, P2343, DOI 10.1074/jbc.M110.115725; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Qiao LP, 2006, ENDOCRINOLOGY, V147, P865, DOI 10.1210/en.2005-1030; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Ross AS, 2008, BIOCHEM BIOPH RES CO, V366, P927, DOI 10.1016/j.bbrc.2007.12.060; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Smih F, 2002, DIABETES, V51, P293, DOI 10.2337/diabetes.51.2.293; Smith U, 2010, BBA-MOL CELL BIOL L, V1801, P377, DOI 10.1016/j.bbalip.2009.11.006; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Vincent A, 2009, DIFFERENTIATION, V78, P99, DOI 10.1016/j.diff.2009.07.002; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Wu SL, 2010, HUM MOL GENET, V19, P597, DOI 10.1093/hmg/ddp526; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200	49	101	107	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27836	27847		10.1074/jbc.M111.262964	http://dx.doi.org/10.1074/jbc.M111.262964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21680747	Green Published, hybrid			2022-12-27	WOS:000293268700075
J	Dixon, AS; Pendley, SS; Bruno, BJ; Woessner, DW; Shimpi, AA; Cheatham, TE; Lim, CS				Dixon, Andrew S.; Pendley, Scott S.; Bruno, Benjamin J.; Woessner, David W.; Shimpi, Adrian A.; Cheatham, Thomas E., III; Lim, Carol S.			Disruption of Bcr-Abl Coiled Coil Oligomerization by Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITORS; FREE-ENERGY CALCULATIONS; GCN4 LEUCINE-ZIPPER; CYTOCHEMICAL METHODS; MOLECULAR-MECHANICS; SECONDARY STRUCTURE; PROTEIN SWITCH; SALT BRIDGES; HIV-1 ENTRY	Oligomerization is an important regulatory mechanism for many proteins, including oncoproteins and other pathogenic proteins. The oncoprotein Bcr-Abl relies on oligomerization via its coiled coil domain for its kinase activity, suggesting that a designed coiled coil domain with enhanced binding to Bcr-Abl and reduced self-oligomerization would be therapeutically useful. Key mutations in the coiled coil domain of Bcr-Abl were identified that reduce homo-oligomerization through intermolecular charge-charge repulsion yet increase interaction with the Bcr-Abl coiled coil through additional salt bridges, resulting in an enhanced ability to disrupt the oligomeric state of Bcr-Abl. The mutations were modeled computationally to optimize the design. Assays performed in vitro confirmed the validity and functionality of the optimal mutations, which were found to exhibit reduced homo-oligomerization and increased binding to the Bcr-Abl coiled coil domain. Introduction of the mutant coiled coil into K562 cells resulted in decreased phosphorylation of Bcr-Abl, reduced cell proliferation, and increased caspase-3/7 activity and DNA segmentation. Importantly, the mutant coiled coil domain was more efficacious than the wild type in all experiments performed. The improved inhibition of Bcr-Abl through oligomeric disruption resulting from this modified coiled coil domain represents a viable alternative to small molecule inhibitors for therapeutic intervention.	[Cheatham, Thomas E., III; Lim, Carol S.] Univ Utah, Coll Pharm, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84108 USA; [Woessner, David W.] Univ Utah, Coll Pharm, Dept Pharmacol & Toxicol, Salt Lake City, UT 84108 USA; [Cheatham, Thomas E., III] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84108 USA; [Shimpi, Adrian A.] Juan Diego Catholic High Sch, Draper, UT 84020 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lim, CS (corresponding author), Univ Utah, Coll Pharm, Dept Pharmaceut & Pharmaceut Chem, 421 Wakara Way,Rm 318, Salt Lake City, UT 84108 USA.	tec3@utah.edu; carol.lim@pharm.utah.edu			National Institutes of Health [CA129528, GM079383]; American Foundation for Pharmaceutical Education; University of Utah; ALSAM Foundation; National Science Foundation [TG-MCA01S027]; NCI Cancer Center, Huntsman Cancer Institute [P30 CA042014]; NATIONAL CANCER INSTITUTE [R01CA129528, P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Pharmaceutical Education; University of Utah; ALSAM Foundation; National Science Foundation(National Science Foundation (NSF)); NCI Cancer Center, Huntsman Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129528 (to C. S. L.) and GM079383 (to T. E. C.). This work was also supported by an American Foundation for Pharmaceutical Education predoctoral fellowship (to A. S. D), Graduate Research Fellowship, University of Utah (to A. S. D.) the ALSAM Foundation (to A. A. S), and National Science Foundation Grant TG-MCA01S027 (to T. E. C.; for computer time).; We acknowledge the use of the DNA/Peptide Core (NCI Cancer Center Support Grant P30 CA042014, Huntsman Cancer Institute) and computer time from the Center for High Performance Computing at the University of Utah. We thank Dr. Debbie Eckert for technical assistance in protein purification and Jonathan Constance, Rian Davis, Mohanad Mossalam, Matthew Weinstock, and Dr. Michael Kay for scientific discussions.	Arlinghaus RB, 2002, ONCOGENE, V21, P8560, DOI 10.1038/sj.onc.1206083; Barrett KL, 2001, J HISTOCHEM CYTOCHEM, V49, P821, DOI 10.1177/002215540104900703; Beissert T, 2003, BLOOD, V102, P2985, DOI 10.1182/blood-2003-03-0811; Beissert T, 2008, INT J CANCER, V122, P2744, DOI 10.1002/ijc.23467; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Case DA, 2006, AMBER; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dixon AS, 2010, BIOTECHNIQUES, V49, P519, DOI 10.2144/000113452; Dixon AS, 2009, J CONTROL RELEASE, V140, P245, DOI 10.1016/j.jconrel.2009.06.026; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo XYD, 1998, ONCOGENE, V17, P825, DOI 10.1038/sj.onc.1201999; Gurnon DG, 2003, J AM CHEM SOC, V125, P7518, DOI 10.1021/ja0357590; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; HODGES RS, 1981, J BIOL CHEM, V256, P1214; Huang SF, 2009, PROTEIN EXPRES PURIF, V64, P167, DOI 10.1016/j.pep.2008.10.023; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Jamieson Catriona H, 2008, Hematology Am Soc Hematol Educ Program, P436, DOI 10.1182/asheducation-2008.1.436; Janssen JJWM, 2009, CURR STEM CELL RES T, V4, P224, DOI 10.2174/157488809789057428; Jelesarov I, 1996, J MOL BIOL, V263, P344, DOI 10.1006/jmbi.1996.0579; Kakar M, 2007, PHARM RES-DORDR, V24, P2146, DOI 10.1007/s11095-007-9333-1; Kakar M, 2007, J CONTROL RELEASE, V120, P220, DOI 10.1016/j.jconrel.2007.04.017; Kammerer RA, 2001, J BIOL CHEM, V276, P13685, DOI 10.1074/jbc.M010492200; Kantarjian HM, 2010, CANCER-AM CANCER SOC, V116, P1419, DOI 10.1002/cncr.24928; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; Martin MG, 2009, LEUKEMIA LYMPHOMA, V50, P14, DOI 10.1080/10428190802517765; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Meli M, 2009, METHODS MOL BIOL, V570, P77, DOI 10.1007/978-1-60327-394-7_4; Mian AA, 2009, LEUKEMIA, V23, P2242, DOI 10.1038/leu.2009.194; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Ryan SJ, 2007, J AM CHEM SOC, V129, P10255, DOI 10.1021/ja073717w; Santos FPS, 2009, LEUKEMIA LYMPHOMA, V50, P16, DOI 10.3109/10428190903383427; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Steinbrecher T, 2010, CURR MED CHEM, V17, P767, DOI 10.2174/092986710790514453; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Taylor CM, 2005, BIOCHEMISTRY-US, V44, P16246, DOI 10.1021/bi051493t; Willingham MC, 1999, J HISTOCHEM CYTOCHEM, V47, P1101, DOI 10.1177/002215549904700901; Yan Z, 2006, J STRUCT BIOL, V155, P162, DOI 10.1016/j.jsb.2006.03.024; Zhang XW, 2001, MOL CELL BIOL, V21, P840, DOI 10.1128/MCB.21.3.840-853.2001; Zhao X, 2002, NAT STRUCT BIOL, V9, P117; Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507	55	24	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27751	27760		10.1074/jbc.M111.264903	http://dx.doi.org/10.1074/jbc.M111.264903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659527	Green Published, hybrid			2022-12-27	WOS:000293268700067
J	Eliades, A; Papadantonakis, N; Bhupatiraju, A; Burridge, KA; Johnston-Cox, HA; Migliaccio, AR; Crispino, JD; Lucero, HA; Trackman, PC; Ravid, K				Eliades, Alexia; Papadantonakis, Nikolaos; Bhupatiraju, Ajoy; Burridge, Kelley A.; Johnston-Cox, Hillary A.; Migliaccio, Anna Rita; Crispino, John D.; Lucero, Hector A.; Trackman, Philip C.; Ravid, Katya			Control of Megakaryocyte Expansion and Bone Marrow Fibrosis by Lysyl Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ENDOMITOTIC CELL-CYCLE; MATRIX-FORMING ENZYME; EX-VIVO EXPANSION; GROWTH-FACTOR; PLATELET PRODUCTION; OSTEOBLASTIC CELLS; BREAST-CANCER; CORD BLOOD; IN-VIVO	Lysyl oxidase (LOX), a matrix cross-linking protein, is known to be selectively expressed and to enhance a fibrotic phenotype. A recent study of ours showed that LOX oxidizes the PDGF receptor-beta (PDGFR-beta), leading to amplified downstream signaling. Here, we examined the expression and functions of LOX in megakaryocytes (MKs), the platelet precursors. Cells committed to the MK lineage undergo mitotic proliferation to yield diploid cells, followed by endomitosis and acquisition of polyploidy. Intriguingly, LOX expression is detected in diploid-tetraploid MKs, but scarce in polyploid MKs. PDGFR-BB is an inducer of mitotic proliferation in MKs. LOX inhibition with beta-aminopropionitrile reduces PDGFR-BB binding to cells and downstream signaling, as well as its proliferative effect on the MK lineage. Inhibition of LOX activity has no influence on MK polyploidy. We next rationalized that, in a system with an abundance of low ploidy MKs, LOX could be highly expressed and with functional significance. Thus, we resorted to GATA-1(low) mice, where there is an increase in low ploidy MKs, augmented levels of PDGF-BB, and an extensive matrix of fibers. MKs from these mice display high expression of LOX, compared with control mice. Importantly, treatment of GATA-1(low) mice with beta-aminopropionitrile significantly improves the bone marrow fibrotic phenotype, and MK number in the spleen. Thus, our in vitro and in vivo data support a novel role for LOX in regulating MK expansion by PDGF-BB and suggest LOX as a new potential therapeutic target for myelofibrosis.	[Eliades, Alexia; Papadantonakis, Nikolaos] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Johnston-Cox, Hillary A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Eliades, Alexia; Papadantonakis, Nikolaos; Bhupatiraju, Ajoy; Burridge, Kelley A.; Johnston-Cox, Hillary A.; Lucero, Hector A.; Ravid, Katya] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Eliades, Alexia; Papadantonakis, Nikolaos; Bhupatiraju, Ajoy; Burridge, Kelley A.; Johnston-Cox, Hillary A.] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Boston, MA 02118 USA; [Trackman, Philip C.] Boston Univ, Sch Med, Div Oral Biol, Boston, MA 02118 USA; [Migliaccio, Anna Rita] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Crispino, John D.] Northwestern Univ, Div Hematol & Oncol, Chicago, IL 60611 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Icahn School of Medicine at Mount Sinai; Northwestern University	Ravid, K (corresponding author), Boston Univ, Sch Med, Cardiovasc Inst, W-601,700 Albany St, Boston, MA 02118 USA.	kravid@bu.edu	Trackman, Philip C/AAX-9280-2021; Migliaccio, Anna Rita/GWZ-9323-2022; cheng, yong/I-4270-2012	Trackman, Philip C/0000-0001-5064-614X; Crispino, John/0000-0002-8182-8306; Eliades, Alexia/0000-0001-8459-7163; FRANCO MIGLIACCIO, ANNA RITA/0000-0003-1800-271X; Ravid, Katya/0000-0002-9918-3024	National Institutes of Health NHLBI [HL80442]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Grant HL80442 (to K. R.).	Arnold JT, 1997, BLOOD, V89, P823, DOI 10.1182/blood.V89.3.823; Atsawasuwan P, 2005, BIOCHEM BIOPH RES CO, V327, P1042, DOI 10.1016/j.bbrc.2004.12.119; Balduini CL, 2002, HAEMATOLOGICA, V87, P860; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; BRIDDELL RA, 1990, BLOOD, V76, P516; BURSTEIN SA, 1992, J CELL PHYSIOL, V153, P305, DOI 10.1002/jcp.1041530210; Centurione L, 2004, BLOOD, V104, P3573, DOI 10.1182/blood-2004-01-0193; Chui CMY, 2003, CYTOKINE, V21, P51, DOI 10.1016/S1043-4666(02)00499-4; Debret R, 2010, J INVEST DERMATOL, V130, P2594, DOI 10.1038/jid.2010.186; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Eliades A, 2010, J BIOL CHEM, V285, P18909, DOI 10.1074/jbc.M110.102145; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; FORNIERI C, 1987, J CELL BIOL, V105, P1463, DOI 10.1083/jcb.105.3.1463; Gilad GM, 2005, NEUROSCI LETT, V376, P210, DOI 10.1016/j.neulet.2004.11.054; Gilad GM, 2001, NEUROSCI LETT, V310, P45, DOI 10.1016/S0304-3940(01)02089-4; Guo Y, 2007, AM J PHYSIOL-CELL PH, V292, pC2095, DOI 10.1152/ajpcell.00613.2006; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231; Hong HH, 1999, LAB INVEST, V79, P1655; ISHIBASHI T, 1989, BLOOD, V74, P1241; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; KOIKE K, 1990, BLOOD, V75, P2286; Lee JE, 2006, J BIOL CHEM, V281, P37282, DOI 10.1074/jbc.M600977200; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Mazharian A, 2009, EXP HEMATOL, V37, P1238, DOI 10.1016/j.exphem.2009.07.006; McCrann DJ, 2009, BLOOD, V114, P1243, DOI 10.1182/blood-2008-12-195883; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Muntean AG, 2007, BLOOD, V109, P5199, DOI 10.1182/blood-2006-11-059378; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; Nguyen HG, 2005, BLOOD, V106, P1559, DOI 10.1182/blood-2005-02-0638; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Papadantonakis N, 2008, CELL CYCLE, V7, P2352, DOI 10.4161/cc.6325; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Su RJ, 2005, STEM CELLS DEV, V14, P223, DOI 10.1089/scd.2005.14.223; Su RJ, 2001, BONE MARROW TRANSPL, V27, P1075, DOI 10.1038/sj.bmt.1703042; TANG SS, 1983, J BIOL CHEM, V258, P4331; TANG SS, 1989, CONNECT TISSUE RES, V19, P93, DOI 10.3109/03008208909016817; Thompson A, 1996, J BIOL CHEM, V271, P22976, DOI 10.1074/jbc.271.38.22976; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Ulich TR, 1996, BLOOD, V87, P5006, DOI 10.1182/blood.V87.12.5006.bloodjournal87125006; Vannucchi AM, 2002, BLOOD, V100, P1123, DOI 10.1182/blood-2002-06-1913; Vannucchi AM, 2005, BLOOD, V105, P3493, DOI 10.1182/blood-2004-04-1320; Vyas P, 1999, BLOOD, V93, P2867; Williams JL, 1998, BLOOD, V91, P4118, DOI 10.1182/blood.V91.11.4118.411k01_4118_4126; Wu Y, 2007, BLOOD, V110, P851, DOI 10.1182/blood-2006-05-022087; YANG M, 1995, BRIT J HAEMATOL, V91, P285, DOI 10.1111/j.1365-2141.1995.tb05291.x; Ye JY, 2010, HAEMATOL-HEMATOL J, V95, P1745, DOI 10.3324/haematol.2009.020958; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zimmet JM, 1997, MOL CELL BIOL, V17, P7248, DOI 10.1128/MCB.17.12.7248	57	66	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27630	27638		10.1074/jbc.M111.243113	http://dx.doi.org/10.1074/jbc.M111.243113			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21665949	Green Published, hybrid			2022-12-27	WOS:000293268700056
J	Hashimoto, T; Adams, KW; Fan, ZY; McLean, PJ; Hyman, BT				Hashimoto, Tadafumi; Adams, Kenneth W.; Fan, Zhanyun; McLean, Pamela J.; Hyman, Bradley T.			Characterization of Oligomer Formation of Amyloid-beta Peptide Using a Split-luciferase Complementation Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALZHEIMERS-DISEASE; IN-VIVO; PROTOFIBRIL FORMATION; SYNAPTIC PLASTICITY; SECRETED OLIGOMERS; PROTEIN OLIGOMERS; SENILE PLAQUES; A-BETA-40; MEMORY	Amyloid-beta peptide (A beta) is the amyloid component of senile plaques in Alzheimer disease (AD) brains. Recently a soluble oliomeric form of A beta in A beta precursor protein transgenic mouse brains and AD brains was identified as a potential causative molecule for memory impairment, suggesting that soluble A beta oligomers cause neurodegeneration in AD. Further characterization of this species has been hampered, however, because the concentrations are quite small and it is difficult to monitor A beta oligomers specifically. Here we developed a novel method for monitoring A beta oligomers using a split-luciferase complementation assay. In this assay, the Nand C-terminal fragments of Gaussia luciferase (Gluc) are fused separately to A beta. We found that conditioned media from both N- and C-terminal fragments of Gluc-tagged A beta 1-42 doubly transfected HEK293 cells showed strong luminescence. We used gel filtration analyses to analyze the size of oligomers formed by the luciferase complementation assay, and found that it matched closely with oligomers formed by endogenous A beta in Tg2576 neurons. Large oligomers (24-36-mers), 8-mers, trimers, and dimers predominate. In both systems, A beta formed oligomers intracellularly, which then appear to be secreted as oligomers. We then evaluated several factors that might impact oligomer formation. The level of oligomerization of A beta 1-40 was similar to that of A beta 1-42. Homodimers formed more readily than heterodimers. The level of oligomerization of murine A beta 1-42 was similar to that of human A beta 1-42. As expected, the familial AD-linked Arctic mutation (E22G) significantly enhanced oligomer formation. These data suggest that Gluc-tagged A beta enables the analysis of A beta oligomers.	[Hashimoto, Tadafumi; Adams, Kenneth W.; Fan, Zhanyun; McLean, Pamela J.; Hyman, Bradley T.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Alzheimer Dis Res Unit, Bldg 114,16th St, Charlestown, MA 02129 USA.	bhyman@partners.org	Hashimoto, Tadafumi/A-7723-2013	Hashimoto, Tadafumi/0000-0001-5442-4800; McLean, Pamela/0000-0003-4870-5715	National Institutes of Health [AG12406]; JSPS; Ellison Medical Foundation/AFAR [2009A059868]; NATIONAL INSTITUTE ON AGING [R37AG012406, R01AG012406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ellison Medical Foundation/AFAR(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG12406 (to B. T. H.), the JSPS Postdoctoral Fellow for Research Abroad (to T. H.), and the Ellison Medical Foundation/AFAR 2009A059868 (to T. H.).	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Murray MM, 2009, J AM CHEM SOC, V131, P6316, DOI 10.1021/ja8092604; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200	38	47	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27081	27091		10.1074/jbc.M111.257378	http://dx.doi.org/10.1074/jbc.M111.257378			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652708	Green Published, hybrid			2022-12-27	WOS:000293268700003
J	Tanaka, H; Senda, M; Venugopalan, N; Yamamoto, A; Senda, T; Ishida, T; Horiike, K				Tanaka, Hiroyuki; Senda, Miki; Venugopalan, Nagarajan; Yamamoto, Atsushi; Senda, Toshiya; Ishida, Tetsuo; Horiike, Kihachiro			Crystal Structure of a Zinc-dependent D-Serine Dehydratase from Chicken Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID OXIDASE; ALANINE RACEMASE; D-ASPARTATE; REACTION SPECIFICITY; THREONINE ALDOLASE; DIFFRACTION DATA; ENZYME; BRAIN; IDENTIFICATION; MECHANISM	D-Serine is a physiological co-agonist of the N-methyl-D-aspartate receptor. It regulates excitatory neurotransmission, which is important for higher brain functions in vertebrates. In mammalian brains, D-amino acid oxidase degrades D-serine. However, we have found recently that in chicken brains the oxidase is not expressed and instead a D-serine dehydratase degrades D-serine. The primary structure of the enzyme shows significant similarities to those of metal-activated D-threonine aldolases, which are fold-type III pyridoxal 5'-phosphate (PLP)-dependent enzymes, suggesting that it is a novel class of D-serine dehydratase. In the present study, we characterized the chicken enzyme biochemically and also by x-ray crystallography. The enzyme activity on D-serine decreased 20-fold by EDTA treatment and recovered nearly completely by the addition of Zn2+. None of the reaction products that would be expected from side reactions of the PLP-D-serine Schiff base were detected during the >6000 catalytic cycles of dehydration, indicating high reaction specificity. We have determined the first crystal structure of the D-serine dehydratase at 1.9 angstrom resolution. In the active site pocket, a zinc ion that coordinates His(347) and Cys(349) is located near the PLP-Lys(45) Schiff base. A theoretical model of the enzyme-D-serine complex suggested that the hydroxyl group of D-serine directly coordinates the zinc ion, and that the epsilon-NH2 group of Lys(45) is a short distance from the substrate C alpha atom. The alpha-proton abstraction from D-serine by Lys(45) and the elimination of the hydroxyl group seem to occur with the assistance of the zinc ion, resulting in the strict reaction specificity.	[Senda, Toshiya] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Tanaka, Hiroyuki; Yamamoto, Atsushi; Ishida, Tetsuo; Horiike, Kihachiro] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Shiga 5202192, Japan; [Senda, Miki] Japan Biol Informat Consortium, JBIC Res Inst, Struct Guided Drug Dev Project, Koto Ku, Tokyo 1350064, Japan; [Venugopalan, Nagarajan] NCI, Collaborat Access Team, Biosci Div, Argonne Natl Lab, Argonne, IL 60439 USA; [Venugopalan, Nagarajan] Natl Inst Gen Med Sci, Argonne, IL 60439 USA	National Institute of Advanced Industrial Science & Technology (AIST); Shiga University of Medical Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS)	Senda, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan.	toshiya-senda@aist.go.jp; teishida@belle.shiga-med.ac.jp		Senda, Toshiya/0000-0002-5153-928X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; New Energy and Industrial Technology Development Organization of Japan; Shiga University of Medical Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Shiga University of Medical Science(Shiga University of Medical Science)	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by the New Energy and Industrial Technology Development Organization of Japan; and by a grant-in-aid (Heisei era 22) from the Shiga University of Medical Science.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Counago RM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-53; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEDERIUK CS, 1983, J BIOL CHEM, V258, P5379; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Goto M, 2009, J BIOL CHEM, V284, P25944, DOI 10.1074/jbc.M109.010470; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; Ikushiro H, 2008, J BIOL CHEM, V283, P7542, DOI 10.1074/jbc.M706874200; Ito T, 2008, BIOCHEM J, V409, P399, DOI 10.1042/BJ20070642; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Liu JQ, 1998, J BIOL CHEM, V273, P16678, DOI 10.1074/jbc.273.27.16678; MARCEAU M, 1988, J BIOL CHEM, V263, P16926; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGATA Y, 1994, BRAIN RES, V634, P291, DOI 10.1016/0006-8993(94)91932-1; Oliet SHR, 2009, NEUROSCIENCE, V158, P275, DOI 10.1016/j.neuroscience.2008.01.071; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paiardini A, 2003, BBA-PROTEINS PROTEOM, V1647, P214, DOI 10.1016/S1570-9639(03)00050-5; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pollegioni L, 2010, CELL MOL LIFE SCI, V67, P2387, DOI 10.1007/s00018-010-0307-9; Schell MJ, 2004, PHILOS T R SOC B, V359, P943, DOI 10.1098/rstb.2003.1399; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P3557, DOI 10.1021/bi00583a019; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Senda M, 2011, ACTA CRYSTALLOGR F, V67, P147, DOI 10.1107/S1744309110048438; Stevens RC, 2001, SCIENCE, V294, P89, DOI 10.1126/science.1066011; Tanaka H, 2008, J BIOCHEM, V143, P49, DOI 10.1093/jb/mvm203; Tanaka H, 2007, ANAL BIOCHEM, V362, P83, DOI 10.1016/j.ab.2006.12.025; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99; Watanabe A, 2002, J BIOL CHEM, V277, P19166, DOI 10.1074/jbc.M201615200; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p	42	19	21	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27548	27558		10.1074/jbc.M110.201160	http://dx.doi.org/10.1074/jbc.M110.201160			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676877	Green Published, hybrid			2022-12-27	WOS:000293268700049
J	Yao, Q; Li, H; Liu, BQ; Huang, XY; Guo, L				Yao, Qi; Li, Hui; Liu, Bing-Qian; Huang, Xin-Yun; Guo, Lin			SUMOylation-regulated Protein Phosphorylation, Evidence from Quantitative Phosphoproteomics Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE 1B; SUMO; IDENTIFICATION; SITES	Protein modification is critical for the regulation of protein functions. Cross-talks among different types of protein modifications should yield concerted and coordinated regulatory networks for physiological functions. Here we have employed system-wide and quantitative phosphoproteomics analyses to reveal a global cross-talk for SUMOylation-modulated phosphorylation. Furthermore, as specific examples, we have shown that the alpha subunit of casein kinase II is SUMOylated and that this affects the phosphorylation of its substrates. SUMO-regulated phosphorylation is involved in cell cycle control. Our data demonstrate an interplay between protein SUMOylation and phosphorylation and imply a regulatory role for this SUMOylation-modulated phosphorylation.	[Yao, Qi; Li, Hui; Liu, Bing-Qian; Guo, Lin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Guo, Lin] Wuhan Univ, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China; [Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA	Wuhan University; Wuhan University; Cornell University	Guo, L (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	guol@whu.edu.cn			National Basic Research Program of China [2007CB914200]; National Science Foundation of China [31028015, 30921001]; PCSIRT [IRT0745]; 111 Project of China [B06018]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by National Basic Research Program of China Grant 2007CB914200, National Science Foundation of China Grants 31028015 and 30921001, PCSIRT Grant IRT0745, and 111 Project of China Grant B06018.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Luo PJ, 2010, J CHROMATOGR B, V878, P207, DOI 10.1016/j.jchromb.2009.10.002; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013	26	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27342	27349		10.1074/jbc.M111.220848	http://dx.doi.org/10.1074/jbc.M111.220848			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21685386	hybrid, Green Published			2022-12-27	WOS:000293268700030
J	Chattopadhyay, R; de la Vega, P; Paik, SH; Murata, Y; Ferguson, EW; Richie, TL; Ooi, GT				Chattopadhyay, Rana; de la Vega, Patricia; Paik, Sun H.; Murata, Yoko; Ferguson, Earl W.; Richie, Thomas L.; Ooi, Guck T.			Early Transcriptional Responses of HepG2-A16 Liver Cells to Infection by Plasmodium falciparum Sporozoites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; GLYPICAN-3 EXPRESSION; GENE-EXPRESSION; MALARIA; STAGE; PARASITES; INHIBITION; PROTECTION; INVOLVEMENT; RECOGNITION	Invasion of hepatocytes by Plasmodium sporozoites deposited by Anopheles mosquitoes, and their subsequent transformation into infective merozoites is an obligatory step in the initiation of malaria. Interactions between the sporozoites and hepatocytes lead to a distinct, complex and coordinated cellular and systemic host response. Little is known about host liver cell response to sporozoite invasion, or whether it is primarily adaptive for the parasite, for the host, or for both. Our present study used gene expression profiling of human HepG2-A16 liver cells infected with Plasmodium falciparum sporozoites to understand the host early cellular events and factors influencing parasite infectivity and sporozoite development. Our results show that as early as 30 min following wild-type, non-irradiated sporozoite exposure, the expressions of at least 742 genes was selectively altered. These genes regulate diverse biological functions, such as immune processes, cell adhesion and communications, metabolism pathways, cell cycle regulation, and signal transduction. These functions reflect cellular events consistent with initial host cell defense responses, as well as alterations in host cells to sustain sporozoites growth and survival. Irradiated sporozoites gave very similar gene expression pattern changes, but direct comparative analysis between liver gene expression profiles caused by irradiated and non-irradiated sporozoites identified 29 genes, including glypican-3, that were specifically up-regulated only in irradiated sporozoites. Elucidating the role of this subset of genes may help identify the molecular basis for the irradiated sporozoites inability to develop intrahepatically, and their usefulness as an immunogen for developing protective immunity against pre-erythrocytic stage malaria.	[Chattopadhyay, Rana; de la Vega, Patricia; Richie, Thomas L.] US Mil Malaria Vaccine Program, Malaria Program, Silver Spring, MD 20910 USA; [de la Vega, Patricia] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Richie, Thomas L.] USN, Med Res Ctr, Silver Spring, MD 20910 USA; [Paik, Sun H.; Murata, Yoko; Ferguson, Earl W.; Ooi, Guck T.] Sun BioMed Technol Inc, Ridgecrest, CA 93555 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Navy	Chattopadhyay, R (corresponding author), US FDA, Div Vaccines & Related Prod Applicat, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA.	rana.chattopadhyay@fda.hhs.gov; guckooi@sunbmt.com		Richie, Thomas/0000-0002-2946-5456	Department of Defense [W81XWH-05-C-0030]; CRADA [LP-CRADA-NMRC-05-2107, 6000.RAD1.F.A0309]	Department of Defense(United States Department of Defense); CRADA	This work was supported by Department of Defense Small Business Innovative Research Grant W81XWH-05-C-0030 (to S. H. P., Y. M., E. W. F., and G. T. O.) and the work between Sun BioMedical Technologies and the Malaria Program, Naval Medical Research Center was conducted through a CRADA collaboration Grant LP-CRADA-NMRC-05-2107 and was supported by Grant 6000.RAD1.F.A0309 (to R. C., P. V., and T. L. R.).	Abdul-Al HM, 2008, HUM PATHOL, V39, P209, DOI 10.1016/j.humpath.2007.06.004; Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; BECKETT GJ, 1993, ADV CLIN CHEM, V30, P281, DOI 10.1016/S0065-2423(08)60198-5; BECKETT GJ, 1985, CLIN CHIM ACTA, V146, P11, DOI 10.1016/0009-8981(85)90119-6; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Beutler B, 2001, BIOCHEM SOC T, V29, P853, DOI 10.1042/0300-5127:0290853; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Carrolo M, 2003, NAT MED, V9, P1363, DOI 10.1038/nm947; Carvalho RS, 2009, EUR J PHARMACOL, V616, P265, DOI 10.1016/j.ejphar.2009.05.030; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; De-Oliveira ACAX, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-81; Ejigiri I, 2009, CURR OPIN MICROBIOL, V12, P401, DOI 10.1016/j.mib.2009.06.006; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; Hippo Y, 2004, CANCER RES, V64, P2418, DOI 10.1158/0008-5472.CAN-03-2191; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOLLINGDALE MR, 1984, J IMMUNOL, V132, P909; HOLLINGDALE MR, 1985, AM J TROP MED HYG, V34, P216, DOI 10.4269/ajtmh.1985.34.216; Hsu HC, 1997, CANCER RES, V57, P5179; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kalmbach Y, 2010, J INFECT DIS, V202, P313, DOI 10.1086/653586; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Karnasuta C, 1995, AM J TROP MED HYG, V53, P607, DOI 10.4269/ajtmh.1995.53.607; Krucken J, 2005, INFECT IMMUN, V73, P436, DOI 10.1128/IAI.73.1.436-443.2005; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Liu BW, 2009, AM J PATHOL, V175, P717, DOI 10.2353/ajpath.2009.081129; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; Moreira CK, 2004, INT J PARASITOL, V34, P1431, DOI 10.1016/j.ijpara.2004.10.007; MOSER G, 1978, J PROTOZOOL, V25, P119, DOI 10.1111/j.1550-7408.1978.tb03881.x; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; Nakatsura T, 2003, BIOCHEM BIOPH RES CO, V306, P16, DOI 10.1016/S0006-291X(03)00908-2; Ouwe-Missi-Oukem-Boyer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016034; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Rasmussen SB, 2009, APMIS, V117, P323, DOI 10.1111/j.1600-0463.2009.02456.x; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; Rathore D, 2003, J BIOL CHEM, V278, P40905, DOI 10.1074/jbc.M306250200; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Renia Laurent, 2002, Methods Mol Med, V72, P507, DOI 10.1385/1-59259-271-6:507; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sacci John B Jr, 2002, Methods Mol Med, V72, P517, DOI 10.1385/1-59259-271-6:517; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; SIGLER CI, 1984, AM J TROP MED HYG, V33, P544, DOI 10.4269/ajtmh.1984.33.544; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Simon R, 2007, CANCER INFORM, V3, P11; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; SMITH JE, 1984, LANCET, V2, P757; Sohail M, 2007, CLIN BIOCHEM, V40, P377, DOI 10.1016/j.clinbiochem.2007.01.005; Takai H, 2009, CANCER BIOL THER, V8, P2329, DOI 10.4161/cbt.8.24.9985; Takai H, 2009, LIVER INT, V29, P1056, DOI 10.1111/j.1478-3231.2008.01968.x; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Torgler R, 2008, J IMMUNOL, V180, P3990, DOI 10.4049/jimmunol.180.6.3990; Wang QA, 2004, MOL BIOCHEM PARASIT, V137, P161, DOI 10.1016/j.molbiopara.2004.06.001; Wang XY, 2006, HUM PATHOL, V37, P1435, DOI 10.1016/j.humpath.2006.05.016; Westenberger SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000653; Williams CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010267; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	64	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26396	26405		10.1074/jbc.M111.240879	http://dx.doi.org/10.1074/jbc.M111.240879			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652718	Green Published, hybrid			2022-12-27	WOS:000293078200017
J	Ding, L; Ma, WS; Littmann, T; Camp, R; Shen, JZ				Ding, Ling; Ma, Wanshu; Littmann, Timothy; Camp, Riley; Shen, Jianzhong			The P2Y(2) Nucleotide Receptor Mediates Tissue Factor Expression in Human Coronary Artery Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; FACTOR PATHWAY INHIBITOR; GROWTH-FACTOR RECEPTOR; FOCAL TYROSINE KINASE; UP-REGULATION; PROTEIN-KINASE; MESSENGER-RNA; P2 RECEPTORS; TNF-ALPHA	The discovery of the role of P2Y(12) receptor in platelet aggregation leads to a new anti-thrombotic drug Plavix; however, little is known about non-platelet P2Y receptors in thrombosis. This study tested the hypothesis that endothelial P2Y receptor(s) mediates up-regulation of tissue factor (TF), the initiator of coagulation cascade. Stimulation of human coronary artery endothelial cells (HCAEC) by UTP/ATP increased the mRNA level of TF but not of its counterpart-tissue factor pathway inhibitor, which was accompanied by up-regulation of TF protein and cell surface activity. RT-PCR revealed a selective expression of P2Y(2) and P2Y(11) receptors in HCAEC. Consistent with this, TF up-regulation was inhibited by suramin or by siRNA silencing of P2Y(2) receptor, but not by NF-157, a P2Y(11)-selective antagonist, suggesting a role for the P2Y(2) receptor. In addition, P2Y(2) receptor activated ERK1/2, JNK, and p38 MAPK pathways without affecting the positive NF-kappa B and negative AKT regulatory pathways of TF expression. Furthermore, TF up-regulation was abolished or partially suppressed by inhibition of p38 or JNK but not ERK1/2. Interestingly, blockade of the PLC/Ca2+ pathway did not affect P2Y(2) receptor activation of p38, JNK, and TF induction. However, blockade of Src kinase reduced phosphorylation of p38 but not JNK, eliminating TF induction. In contrast, inhibition of Rho kinase reduced phosphorylation of JNK but not p38, decreasing TF expression. These findings demonstrate that P2Y(2) receptor mediates TF expression in HCAEC through new mechanisms involving Src/p38 and Rho/JNK pathways, possibly contributing to a prothrombotic status after vascular injury.	[Ding, Ling; Ma, Wanshu; Littmann, Timothy; Camp, Riley; Shen, Jianzhong] Auburn Univ, Harrison Sch Pharm, Dept Pharmacal Sci, Div Pharmacol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Shen, JZ (corresponding author), Auburn Univ, Sch Pharm, Dept Pharmacal Sci, Div Pharmacol, 4306G Walker Bldg, Auburn, AL 36849 USA.	jzs0019@auburn.edu	Ma, Wanshu/J-2447-2019; Ma, Wanshu/A-5233-2018; Shen, Jianzhong/AAH-8184-2019	Ma, Wanshu/0000-0001-7462-2759; 	Auburn University	Auburn University	This work was supported by the New Faculty Startup Fund from Auburn University (to J.S.).	AMERI A, 1992, BLOOD, V79, P3219; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BAJAJ MS, 1990, P NATL ACAD SCI USA, V87, P8869, DOI 10.1073/pnas.87.22.8869; BIERHAUS A, 1995, J BIOL CHEM, V270, P26419, DOI 10.1074/jbc.270.44.26419; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Breitenstein A, 2010, CIRC J, V74, P3, DOI 10.1253/circj.CJ-09-0818; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; BURNSTOCK G, 1986, CIRC RES, V58, P319, DOI 10.1161/01.RES.58.3.319; Camera M, 1999, ARTERIOSCL THROM VAS, V19, P531, DOI 10.1161/01.ATV.19.3.531; CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Fang QH, 2006, AM J RESP CELL MOL, V35, P714, DOI 10.1165/rcmb.2005-0026OC; Gachet C, 2005, SEMIN THROMB HEMOST, V31, P162, DOI 10.1055/s-2005-869521; Hou MY, 2000, ARTERIOSCL THROM VAS, V20, P2064, DOI 10.1161/01.ATV.20.9.2064; Kawano H, 2001, BLOOD, V97, P1697, DOI 10.1182/blood.V97.6.1697; Kishi Y, 2003, J HYPERTENS, V21, P1347, DOI 10.1097/00004872-200307000-00024; Koshiba M, 1997, P NATL ACAD SCI USA, V94, P831, DOI 10.1073/pnas.94.3.831; Kunapuli SP, 2003, CURR OPIN PHARMACOL, V3, P175, DOI 10.1016/S1471-4892(03)00007-9; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Mandal SK, 2006, BLOOD, V107, P4746, DOI 10.1182/blood-2005-11-4674; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Moons AHM, 2002, CARDIOVASC RES, V53, P313, DOI 10.1016/S0008-6363(01)00452-7; Napoleone E, 1997, BLOOD, V89, P541, DOI 10.1182/blood.V89.2.541; OLSSON RA, 1990, PHYSIOL REV, V70, P761, DOI 10.1152/physrev.1990.70.3.761; PARRY GCN, 1995, ARTERIOSCL THROM VAS, V15, P612, DOI 10.1161/01.ATV.15.5.612; PEARSON JD, 1979, NATURE, V281, P384, DOI 10.1038/281384a0; SCARPATI EM, 1989, J BIOL CHEM, V264, P20705; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Seye CI, 2002, CIRCULATION, V106, P2720, DOI 10.1161/01.CIR.0000038111.00518.35; Seye CI, 1997, ARTERIOSCL THROM VAS, V17, P3602, DOI 10.1161/01.ATV.17.12.3602; Shen JZ, 2005, CIRC RES, V96, P982, DOI 10.1161/01.RES.0000165800.81876.52; Shen JZ, 2004, MOL PHARMACOL, V66, P1265, DOI 10.1124/mol.104.002642; Shimokawa T, 2000, THROMB RES, V100, P211, DOI 10.1016/S0049-3848(00)00332-7; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Soltoff SP, 1998, J BIOL CHEM, V273, P23110, DOI 10.1074/jbc.273.36.23110; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Steffel J, 2005, CIRCULATION, V111, P1685, DOI 10.1161/01.CIR.0000160358.63804.C9; Steffel J, 2005, CIRCULATION, V112, P341, DOI 10.1161/CIRCULATIONAHA.105.553735; Viswambharan H, 2004, CIRC RES, V94, P918, DOI 10.1161/01.RES.0000124302.20396.B7; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839	45	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27027	27038		10.1074/jbc.M111.235176	http://dx.doi.org/10.1074/jbc.M111.235176			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652710	Green Published, hybrid			2022-12-27	WOS:000293078200076
J	Kim, YC; DeMartino, GN				Kim, Young-Chan; DeMartino, George N.			C Termini of Proteasomal ATPases Play Nonequivalent Roles in Cellular Assembly of Mammalian 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PARTICLE; 20S PROTEASOME; SUBSTRATE ENTRY; CORE PARTICLE; AAA SUBUNITS; COMPLEX; DEGRADATION; PA700; ACTIVATION; PATHWAY	The 26 S proteasome comprises two multisubunit subcomplexes as follows: 20 S proteasome and PA700/19 S regulatory particle. The cellular mechanisms by which these subcomplexes assemble into 26 S proteasome and the molecular determinants that govern the assembly process are poorly defined. Here, we demonstrate the nonequivalent roles of the C termini of six AAA subunits (Rpt1-Rpt6) of PA700 in 26 S proteasome assembly in mammalian cells. The C-terminal HbYX motif (where Hb is a hydrophobic residue, Y is tyrosine, and X is any amino acid) of each of two subunits, Rpt3 and Rpt5, but not that of a third subunit Rpt2, was essential for assembly of 26 S proteasome. The C termini of none of the three non-HbYX motif Rpt subunits were essential for cellular 26 S proteasome assembly, although deletion of the last three residues of Rpt6 destabilized the 20 S-PA700 interaction. Rpt subunits defective for assembly into 26 S proteasome due to C-terminal truncations were incorporated into intact PA700. Moreover, intact PA700 accumulated as an isolated subcomplex when cellular 20 S proteasome content was reduced by RNAi. These results indicate that 20 S proteasome is not an obligatory template for assembly of PA700. Collectively, these results identify specific structural elements of two Rpt subunits required for 26 S proteasome assembly, demonstrate that PA700 can be assembled independently of the 20 S proteasome, and suggest that intact PA700 is a direct intermediate in the cellular pathway of 26 S proteasome assembly.	[Kim, Young-Chan; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu			National Institutes of Health [R01 DK46181]; Welch Foundation [I-500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK46181. This work was also supported by Welch Foundation Grant I-500 (to G. N. D.).	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster F, 2009, BIOCHEM BIOPH RES CO, V388, P228, DOI 10.1016/j.bbrc.2009.07.145; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; MA CP, 1994, J BIOL CHEM, V269, P3539; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Park S, 2010, BIOCHEM SOC T, V38, P6, DOI 10.1042/BST0380006; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Tanaka K., 2009, CELL, V137, P914; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382	54	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26652	26666		10.1074/jbc.M111.246793	http://dx.doi.org/10.1074/jbc.M111.246793			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21628461	Green Published, hybrid			2022-12-27	WOS:000293078200043
J	Korytowski, W; Basova, LV; Pilat, A; Kernstock, RM; Girotti, AW				Korytowski, Witold; Basova, Liana V.; Pilat, Anna; Kernstock, Robert M.; Girotti, Albert W.			Permeabilization of the Mitochondrial Outer Membrane by Bax/Truncated Bid (tBid) Proteins as Sensitized by Cardiolipin Hydroperoxide Translocation MECHANISTIC IMPLICATIONS FOR THE INTRINSIC PATHWAY OF OXIDATIVE APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; 5-AMINOLEVULINATE-TREATED TUMOR-CELLS; CATHODE ELECTROCHEMICAL DETECTION; LIPID-PEROXIDATION; INTERMEMBRANE TRANSFER; MEDIATED APOPTOSIS; YEAST MITOCHONDRIA; BCL-2 FAMILY; CONTACT SITE	Cytochrome c (cyt c) release upon oxidation of cardiolipin (CL) in the mitochondrial inner membrane (IM) under oxidative stress occurs early in the intrinsic apoptotic pathway. We postulated that CL oxidation mobilizes not only cyt c but also CL itself in the form of hydroperoxide (CLOOH) species. Relatively hydrophilic CLOOHs could assist in apoptotic signaling by translocating to the outer membrane (OM), thus promoting recruitment of the pro-apoptotic proteins truncated Bid (tBid) and Bax for generation of cyt c-traversable pores. Initial testing of these possibilities showed that CLOOH-containing liposomes were permeabilized more readily by tBid plus Ca2+ than CL-containing counterparts. Moreover, CLOOH translocated more rapidly from IM-mimetic to OM-mimetic liposomes than CL and permitted more extensive OM permeabilization. We found that tBid bound more avidly to CLOOH-containing membranes than to CL counterparts, and binding increased with increasing CLOOH content. Permeabilization of CLOOH-containing liposomes in the presence of tBid could be triggered by monomeric Bax, consistent with tBid/Bax cooperation in pore formation. Using CL-null mitochondria from a yeast mutant, we found that tBid binding and cyt c release were dramatically enhanced by transfer acquisition of CLOOH. Additionally, we observed a pre-apoptotic IM-to-OM transfer of oxidized CL in cardiomyocytes treated with the Complex III blocker, antimycin A. These findings provide new mechanistic insights into the role of CL oxidation in the intrinsic pathway of oxidative apoptosis.	[Korytowski, Witold; Basova, Liana V.; Pilat, Anna; Kernstock, Robert M.; Girotti, Albert W.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Korytowski, Witold] Jagiellonian Univ, Inst Mol Biol, PL-30387 Krakow, Poland	Medical College of Wisconsin; Jagiellonian University	Girotti, AW (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	agirotti@mcw.edu	Girotti, Albert/AAF-6910-2020		National Institutes of Health [HL85677, CA72630 (USPHS)]; Polish Ministry of Science [3P05A-5523]; NATIONAL CANCER INSTITUTE [R01CA072630] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science(Ministry of Science and Higher Education, Poland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL85677 and CA72630 (USPHS). This work was also supported by Polish Ministry of Science Grant 3P05A-5523.	Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Cristea IM, 2004, CHEM PHYS LIPIDS, V129, P133, DOI 10.1016/j.chemphyslip.2004.02.002; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; Epand RF, 2007, BIOPHYS J, V92, P126, DOI 10.1529/biophysj.106.092353; Epand RF, 2003, BIOCHEMISTRY-US, V42, P14576, DOI 10.1021/bi035348w; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Esposti MD, 2002, CELL DEATH DIFFER, V9, P234, DOI 10.1038/sj.cdd.4400997; Fernandez MG, 2002, CELL GROWTH DIFFER, V13, P449; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Girotti AW, 2008, FREE RADICAL BIO MED, V44, P956, DOI 10.1016/j.freeradbiomed.2007.12.004; Girotti AW, 2000, METHOD ENZYMOL, V319, P85; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009342; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; ITOH YH, 1986, ANAL BIOCHEM, V154, P200, DOI 10.1016/0003-2697(86)90515-4; Iverson SL, 2004, J BIOL CHEM, V279, P1100, DOI 10.1074/jbc.M305020200; Jiang YJ, 2004, J LIPID RES, V45, P244, DOI 10.1194/jlr.M300314-JLR200; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2; Korytowski W, 1999, METHOD ENZYMOL, V300, P23; Korytowski W, 2005, ANAL BIOCHEM, V343, P136, DOI 10.1016/j.ab.2005.04.005; Kriska T, 2005, ARCH BIOCHEM BIOPHYS, V433, P435, DOI 10.1016/j.abb.2004.09.025; Kriska T, 2002, FREE RADICAL BIO MED, V33, P1389, DOI 10.1016/S0891-5849(02)01078-X; Kriska T, 2004, ANAL BIOCHEM, V327, P97, DOI 10.1016/j.ab.2003.12.021; Kriska T, 2006, J BIOL CHEM, V281, P23643, DOI 10.1074/jbc.M600744200; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lesnefsky EJ, 2000, ANAL BIOCHEM, V285, P246, DOI 10.1006/abio.2000.4783; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Liu JH, 2008, BIOCHEMISTRY-US, V47, P4518, DOI 10.1021/bi701962c; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; Mari M, 2008, GASTROENTEROLOGY, V134, P1507, DOI 10.1053/j.gastro.2008.01.073; McIntyre JA, 2003, PROG LIPID RES, V42, P176, DOI 10.1016/S0163-7827(02)00048-6; Montessuit S, 1999, PROTEIN EXPRES PURIF, V15, P202, DOI 10.1006/prep.1998.1010; Morin C, 2003, BIOCHEM BIOPH RES CO, V307, P477, DOI 10.1016/S0006-291X(03)01203-8; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Petrosillo G, 2001, FEBS LETT, V509, P435, DOI 10.1016/S0014-5793(01)03206-9; Polcic P, 2005, CELL DEATH DIFFER, V12, P310, DOI 10.1038/sj.cdd.4401566; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; RYTOMAA M, 1992, J BIOL CHEM, V267, P22243; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; SPECK SH, 1983, FEBS LETT, V164, P379, DOI 10.1016/0014-5793(83)80321-4; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Terrones O, 2008, J BIOL CHEM, V283, P7790, DOI 10.1074/jbc.M708814200; Thomson M, 2003, BIOESSAYS, V25, P252, DOI 10.1002/bies.10243; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; VANKUIJK FJGM, 1987, TRENDS BIOCHEM SCI, V12, P31, DOI 10.1016/0968-0004(87)90014-4; VIK SB, 1981, P NATL ACAD SCI-BIOL, V78, P1456, DOI 10.1073/pnas.78.3.1456; Vila A, 2004, BIOCHEMISTRY-US, V43, P12592, DOI 10.1021/bi0491200; Vila A, 2001, BIOCHEMISTRY-US, V40, P14715, DOI 10.1021/bi011408r; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	71	72	78	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26334	26343		10.1074/jbc.M110.188516	http://dx.doi.org/10.1074/jbc.M110.188516			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642428	Green Published, hybrid			2022-12-27	WOS:000293078200010
J	Lin, YC; Chen, CC; Cheng, CJ; Yang, RB				Lin, Yuh-Charn; Chen, Chun-Chuan; Cheng, Chien-Jui; Yang, Ruey-Bing			Domain and Functional Analysis of a Novel Breast Tumor Suppressor Protein, SCUBE2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; E-CADHERIN; CANCER; GENE; EXPRESSION; GROWTH; ADHESION; ZEBRAFISH; BINDING; IDENTIFICATION	Signal peptide CUB (complement proteins C1r/C1s, Uegf, and Bmp 1)-EGF domain-containing protein 2 (SCUBE2) is a secreted, membrane-associated multidomain protein composed of five recognizable motifs: an NH2-terminal signal peptide sequence, nine copies of epidermal growth factor (EGF)like repeats, a spacer region, three cysteine-rich repeats, and one CUB domain at the COOH terminus. Our previous clinical study showed that SCUBE2 may act as a novel breast tumor suppressor gene and serve as a useful prognostic marker. However, the specific domain responsible for its tumor suppressor activity and the precise mechanisms of its anti-tumor effect remain unknown. Using a combination of biochemical, molecular, and cell biology techniques, we further dissected the molecular functions and signal pathways mediated by the NH2-terminal EGF-like repeats or COOH-terminal CUB domain of SCUBE2. Independent overexpression of the NH2-terminal EGF-like repeats or COOH-terminal CUB domain resulted in suppression of MCF-7 breast cancer cell proliferation and reduced MCF-7 xenograft tumor growth in nude mice. Molecular and biochemical analyses revealed that the COOH-terminal CUB domain could directly bind to and antagonize bone morphogenetic protein activity in an autocrine manner, whereas the NH2-terminal EGF-like repeats could mediate cell-cell homophilic adhesions in a calcium-dependent fashion, interact with E-cadherin (a master tumor suppressor), and decrease the beta-catenin signaling pathway. Together, our data-demonstrate that SCUBE2 has growth inhibitory effects through a coordinated regulation of two distinct mechanisms: antagonizing bone morphogenetic protein and suppressing the beta-catenin pathway in breast cancer cells.	[Cheng, Chien-Jui] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei 110, Taiwan; [Cheng, Chien-Jui] Taipei Med Univ Hosp, Dept Pathol, Taipei 110, Taiwan; [Lin, Yuh-Charn] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Lin, Yuh-Charn; Chen, Chun-Chuan; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Yang, Ruey-Bing] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Defense Medical Center; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Cheng, CJ (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei 110, Taiwan.	cjcheng@tmu.edu.tw; rbyang@ibms.sinica.edu.tw	Lin, Yuh-Charn/P-2520-2018; Yang, Ruey-Bing/O-1494-2018	Yang, Ruey-Bing/0000-0003-3017-3714; Lin, Yuh-Charn/0000-0002-8501-4596	Taiwan National Science Council [NSC 97-2320-B-038-019-MY3, NSC 99-2311-B-001-022-MY3]; Academia Sinica [AS-97-FP-L16]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Taiwan National Science Council Grants NSC 97-2320-B-038-019-MY3 (to C. J. C.) and NSC 99-2311-B-001-022-MY3 (to R. B. Y.) and Academia Sinica Grant AS-97-FP-L16 (to R. B. Y.).	Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Clement JH, 2005, INT J ONCOL, V27, P401; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grimmond S, 2001, MECH DEVELOP, V102, P209, DOI 10.1016/S0925-4773(00)00586-4; Hajra KM, 2002, CANCER RES, V62, P1613; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hollway GE, 2006, DEV BIOL, V294, P104, DOI 10.1016/j.ydbio.2006.02.032; Ishii J, 2002, J BIOL CHEM, V277, P39696, DOI 10.1074/jbc.M206140200; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Pouliot F, 2003, CANCER RES, V63, P277; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Tsai MT, 2009, BIOCHEM J, V422, P119, DOI 10.1042/BJ20090341; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200	36	41	44	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27039	27047		10.1074/jbc.M111.244418	http://dx.doi.org/10.1074/jbc.M111.244418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652720	Green Published, hybrid			2022-12-27	WOS:000293078200077
J	Anju, V; Kapros, T; Waterborg, JH				Anju, Verma; Kapros, Tamas; Waterborg, Jakob H.			Identification of a Replication-independent Replacement Histone H3 in the Basidiomycete Ustilago maydis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-56 ACETYLATION; VARIANTS; GENE; CHAPERONE; CHROMATIN; TURNOVER; DYNAMICS; SEQUENCE; ANIMALS; PROTEIN	Ustilago maydis is a haploid basidiomycete with single genes for two distinct histone H3 variants. The solitary U1 gene codes for H3.1, predicted to be a replication-independent replacement histone. The U2 gene is paired with histone H4 and produces a putative replication-coupled H3.2 variant. These predictions were evaluated experimentally. U2 was confirmed to be highly expressed in the S phase and had reduced expression in hydroxyurea, and H3.2 protein was not incorporated into transcribed chromatin of stationary phase cells. Constitutive expression of U1 during growth produced similar to 25% of H3 as H3.1 protein, more highly acetylated than H3.2. The level of H3.1 increased when cell proliferation slowed, a hallmark of replacement histones. Half of new H3.1 incorporated into highly acetylated chromatin was lost with a half-life of 2.5 h, the fastest rate of replacement H3 turnover reported to date. This response reflects the characteristic incorporation of replacement H3 into transcribed chromatin, subject to continued nucleosome displacement and a loss of H3 as in animals and plants. Although the two H3 variants are functionally distinct, neither appears to be essential for vegetative growth. KO gene disruption transformants of the U1 and U2 loci produced viable cell lines. The structural and functional similarities of the Ustilago replication-coupled and replication-independent H3 variants with those in animals, in plants, and in ciliates are remarkable because these distinct histone H3 pairs of variants arose independently in each of these clades and in basidiomycetes.	[Anju, Verma; Kapros, Tamas; Waterborg, Jakob H.] UMKC, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Waterborg, JH (corresponding author), UMKC, Sch Biol Sci, Div Cell Biol & Biophys, 414 BSB,5007 Rockhill Rd, Kansas City, MO 64110 USA.	WaterborgJ@umkc.edu	Waterborg, Jakob H./J-5479-2013	Waterborg, Jakob H./0000-0002-2881-4634	Missouri Life Sciences Research Board [13254]	Missouri Life Sciences Research Board	This work was supported by Missouri Life Sciences Research Board Award 13254 (to J. H. W.).	Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Agez M, 2007, STRUCTURE, V15, P191, DOI 10.1016/j.str.2007.01.002; Aslam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010851; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Flor-Parra I, 2006, PLANT CELL, V18, P2369, DOI 10.1105/tpc.106.042754; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Garcia-Muse T, 2003, EUKARYOT CELL, V2, P494, DOI 10.1128/EC.2.3.494-500.2003; Holloman WK, 2008, FUNGAL GENET BIOL, V45, pS31, DOI 10.1016/j.fgb.2008.04.006; Holloman WK, 2007, TRENDS MICROBIOL, V15, P525, DOI 10.1016/j.tim.2007.10.007; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; KAPROS T, 1995, PLANT MOL BIOL, V28, P901, DOI 10.1007/BF00042074; Kojic M, 2008, MOL MICROBIOL, V67, P1156, DOI 10.1111/j.1365-2958.2008.06116.x; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Minard LV, 2011, J BIOL CHEM, V286, P7082, DOI 10.1074/jbc.M110.193813; RIDSDALE JA, 1987, NUCLEIC ACIDS RES, V15, P1081, DOI 10.1093/nar/15.3.1081; RIDSDALE JA, 1988, NUCLEIC ACIDS RES, V16, P5915, DOI 10.1093/nar/16.13.5915; RUIZHERRERA J, 1995, MICROBIOL-UK, V141, P695, DOI 10.1099/13500872-141-3-695; Scherer M, 2006, PLANT CELL, V18, P2388, DOI 10.1105/tpc.106.043521; Steinberg G, 2008, TRENDS CELL BIOL, V18, P61, DOI 10.1016/j.tcb.2007.11.008; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Takayama Y, 2007, NUCLEIC ACIDS RES, V35, P3223, DOI 10.1093/nar/gkm213; Tang Y, 2011, STRUCTURE, V19, P221, DOI 10.1016/j.str.2010.12.012; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P180, DOI 10.1093/nar/22.2.180; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; URBAN MK, 1983, DEV BIOL, V95, P421, DOI 10.1016/0012-1606(83)90043-X; Waterborg J. H., 2002, PROTEIN PROTOCOLS HD, P113; WATERBORG JH, 1991, PLANT PHYSIOL, V96, P453, DOI 10.1104/pp.96.2.453; WATERBORG JH, 1992, PLANT MOL BIOL, V18, P181, DOI 10.1007/BF00034947; WATERBORG JH, 1990, ELECTROPHORESIS, V11, P638, DOI 10.1002/elps.1150110811; WATERBORG JH, 1993, J BIOL CHEM, V268, P4912; Waterborg JH, 1998, J BIOL CHEM, V273, P27602, DOI 10.1074/jbc.273.42.27602; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P279, DOI 10.1139/O02-021; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; WATERBORG JH, 1990, J BIOL CHEM, V265, P17157; WATERBORG JH, 1995, PLANT PHYSIOL, V109, P393, DOI 10.1104/pp.109.2.393; Waterborg JH, 1996, J MOL EVOL, V43, P194, DOI 10.1007/BF02338827; WATERBORG JH, 2002, PROTEIN PROTOCOLS HD, P103; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0; Zweidler A., 1980, DEV BIOCHEM, V15, P47	46	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25790	25800		10.1074/jbc.M111.254383	http://dx.doi.org/10.1074/jbc.M111.254383			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21646347	Green Published, hybrid			2022-12-27	WOS:000293073000041
J	Aramini, JM; Ma, LC; Zhou, LG; Schauder, CM; Hamilton, K; Amer, BR; Mack, TR; Lee, HW; Ciccosanti, CT; Zhao, L; Xiao, R; Krug, RM; Montelione, GT				Aramini, James M.; Ma, Li-Chung; Zhou, Ligang; Schauder, Curtis M.; Hamilton, Keith; Amer, Brendan R.; Mack, Timothy R.; Lee, Hsiau-Wei; Ciccosanti, Colleen T.; Zhao, Li; Xiao, Rong; Krug, Robert M.; Montelione, Gaetano T.			Dimer Interface of the Effector Domain of Non-structural Protein 1 from Influenza A Virus AN INTERFACE WITH MULTIPLE FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERONUCLEAR NMR-SPECTROSCOPY; TORSION ANGLE DYNAMICS; DOUBLE-STRANDED-RNA; PRE-MESSENGER-RNAS; X-RAY-STRUCTURE; NS1 PROTEIN; BACKBONE DYNAMICS; BINDING-SITE; RESONANCE ASSIGNMENTS; ESCHERICHIA-COLI	Non-structural protein 1 from influenza A virus, NS1A, is a key multifunctional virulence factor composed of two domains: an N-terminal double-stranded RNA (dsRNA)-binding domain and a C-terminal effector domain (ED). Isolated RNA-binding and effector domains of NS1A both exist as homodimers in solution. Despite recent crystal structures of isolated ED and full-length NS1A proteins from different influenza virus strains, controversy remains over the actual biologically relevant ED dimer interface. Here, we report the biophysical properties of the NS1A ED from H3N2 influenza A/Udorn/307/1972 (Ud) virus in solution. Several lines of evidence, including N-15 NMR relaxation, NMR chemical shift perturbations, static light scattering, and analytical sedimentation equilibrium, demonstrate that Ud NS1A ED forms a relatively weak dimer in solution (K-d = 90 +/- 2 mu M), featuring a symmetric helix-helix dimer interface. Mutations within and near this interface completely abolish dimerization, whereas mutations consistent with other proposed ED dimer interfaces have no effect on dimer formation. In addition, the critical Trp-187 residue in this interface serves as a sensitive NMR spectroscopic marker for the concentration-dependent dimerization of NS1A ED in solution. Finally, dynamic light scattering and gel shift binding experiments demonstrate that the ED interface plays a role in both the oligomerization and the dsRNA binding properties of the full-length NS1A protein. In particular, mutation of the critical tryptophan in the ED interface substantially reduces the propensity of full-length NS1A from different strains to oligomerize and results in a reduction in dsRNA binding affinity for full-length NS1A.	[Mack, Timothy R.; Ciccosanti, Colleen T.; Zhao, Li; Xiao, Rong; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, NE Struct Genom Consortium, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Zhou, Ligang; Krug, Robert M.] Univ Texas Austin, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Lee, Hsiau-Wei] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Montelione, Gaetano T.] Univ Med & Dent New Jersey, Dept Biochem, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; University of Texas System; University of Texas Austin; University System of Georgia; University of Georgia; Rutgers State University New Brunswick; Rutgers State University Medical Center	Montelione, GT (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, NE Struct Genom Consortium, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	jma@cabm.rutgers.edu; guy@cabm.rutgers.edu	LEE, HSIAU-WEI/A-1415-2012; Zhou, Ligang/I-9516-2012	Zhou, Ligang/0000-0002-1297-0288; Lee, Hsiau-Wei/0000-0002-6060-6341; Amer, Brendan/0000-0001-6564-3347; Montelione, Gaetano/0000-0002-9440-3059	National Institutes of Health through the NIGMS Protein Structure Initiative [U54-GM094597]; National Institutes of Health [U01 AI074497, R01 AI11772]; National Institutes of Health through Protein Structure Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074497, R01AI011772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS Protein Structure Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54-GM094597 through the NIGMS Protein Structure Initiative (to G. T. M.) and National Institutes of Health Grants U01 AI074497 (to G. T. M. and R. M. K.) and R01 AI11772 (to R. M. K.).; We thank Paolo Rossi, Christopher Barbieri, Arthur Clark, Brian Radvansky, Alexander Lemak, and Rongjin Guan for valuable scientific discussions. Yeast SUMO protease was kindly provided by Prof. Steven Brill. Structures were determined through the Northeast Structural Genomics Consortium (NESG), which is supported by the National Institutes of Health through the PSI-Biology program of the Protein Structure Initiative.	Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Basu D, 2009, J VIROL, V83, P1881, DOI 10.1128/JVI.01805-08; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FUSHMAN D, 1994, J BIOMOL NMR, V4, P61, DOI 10.1007/BF00178336; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Goddard T. D., 2006, SPARKY 3; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Jansson M, 1996, J BIOMOL NMR, V7, P131; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kerry PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017946; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Krug RM, 2009, TRENDS PHARMACOL SCI, V30, P269, DOI 10.1016/j.tips.2009.03.002; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Moseley HNB, 2001, METHOD ENZYMOL, V339, P91, DOI 10.1016/S0076-6879(01)39311-4; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; PELTON JG, 1993, PROTEIN SCI, V2, P543; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Xia SL, 2010, ARCH BIOCHEM BIOPHYS, V494, P198, DOI 10.1016/j.abb.2009.12.008; Xia SL, 2009, ACTA CRYSTALLOGR D, V65, P11, DOI 10.1107/S0907444908032186; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	59	50	50	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26050	26060		10.1074/jbc.M111.248765	http://dx.doi.org/10.1074/jbc.M111.248765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622573	Green Published, hybrid			2022-12-27	WOS:000293073000063
J	Bonner, C; Farrelly, AM; Concannon, CG; Dussmann, H; Baquie, M; Virard, I; Wobser, H; Kogel, D; Wollheim, CB; Rupnik, M; Byrne, MM; Konig, HG; Prehn, JHM				Bonner, Caroline; Farrelly, Angela M.; Concannon, Caoimhin G.; Dussmann, Heiko; Baquie, Mathurin; Virard, Isabelle; Wobser, Hella; Koegel, Donat; Wollheim, Claes B.; Rupnik, Marjan; Byrne, Maria M.; Koenig, Hans-Georg; Prehn, Jochen H. M.			Bone Morphogenetic Protein 3 Controls Insulin Gene Expression and Is Down-regulated in INS-1 Cells Inducibly Expressing a Hepatocyte Nuclear Factor 1A-Maturity-onset Diabetes of the Young Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE SUPPRESSION; PANCREAS DEVELOPMENT; SIGNAL-TRANSDUCTION; ENDOCRINE PANCREAS; BETA-CELLS; SECRETION; GLUCOSE; TRANSCRIPTION; DYSFUNCTION; APOPTOSIS	Inactivating mutations in the transcription factor hepatocyte nuclear factor (HNF) 1A cause HNF1A-maturity-onset diabetes of the young (HNF1A-MODY), the most common monogenic form of diabetes. To examine HNF1A-MODY-induced defects in gene expression, we performed a microarray analysis of the transcriptome of rat INS-1 cells inducibly expressing the common hot spot HNF1A frameshift mutation, Pro291fsinsC-HNF1A. Real-time quantitative PCR (qPCR), Western blotting, immunohistochemistry, reporter assays, and chromatin immunoprecipitation (ChIP) were used to validate alterations in gene expression and to explore biological activities of target genes. Twenty-four hours after induction of the mutant HNF1A protein, we identified a prominent down-regulation of the bone morphogenetic protein 3 gene (Bmp-3) mRNA expression. Reporter assays, qPCR, and Western blot analysis validated these results. In contrast, inducible expression of wild-type HNF1A led to a time-dependent increase in Bmp-3 mRNA and protein levels. Moreover, reduced protein levels of BMP-3 and insulin were detected in islets of transgenic HNF1A-MODY mice. Interestingly, treatment of naive INS-1 cells or murine organotypic islet cultures with recombinant human BMP-3 potently increased their insulin levels and restored the decrease in SMAD2 phosphorylation and insulin gene expression induced by the HNF1A frameshift mutation. Our study suggests a critical link between HNF1A-MODY-induced alterations in Bmp-3 expression and insulin gene levels in INS-1 cells and indicates that the reduced expression of growth factors involved in tissue differentiation may play an important role in the pathophysiology of HNF1A-MODY.	[Bonner, Caroline; Farrelly, Angela M.; Concannon, Caoimhin G.; Dussmann, Heiko; Virard, Isabelle; Wobser, Hella; Koenig, Hans-Georg; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Farrelly, Angela M.; Byrne, Maria M.] Mater Misericordiae Univ Hosp, Dublin 7, Ireland; [Baquie, Mathurin; Wollheim, Claes B.] Univ Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva 1211, Switzerland; [Koegel, Donat] Goethe Univ Hosp, Ctr Neurol & Neurosurg, D-60590 Frankfurt, Germany; [Rupnik, Marjan] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia	Royal College of Surgeons - Ireland; Mater Misericordiae University Hospital; University College Dublin; University of Geneva; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Maribor	Prehn, JHM (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, 123 St Stephens Green, Dublin 2, Ireland.	prehn@rcsi.ie	Concannon, Caoimhin/B-2075-2010; Rupnik, Marjan Slak/R-4738-2019; Slak Rupnik, Marjan/E-6246-2015; Byrne, Maria/A-8310-2017; Pattou, Francois/O-6151-2017; Prehn, Jochen HM/A-3928-2010; Bonner, Caroline/A-9819-2015; Farrelly, Angela/E-8010-2017	Rupnik, Marjan Slak/0000-0002-3744-4882; Slak Rupnik, Marjan/0000-0002-3744-4882; Byrne, Maria/0000-0002-9394-8698; Pattou, Francois/0000-0001-8388-3766; Prehn, Jochen HM/0000-0003-3479-7794; Bonner, Caroline/0000-0002-4430-8280; Virard, Isabelle/0000-0002-3980-0078; Dussmann, Heiko/0000-0002-3582-8057; Kogel, Donat/0000-0003-1209-0210; Farrelly, Angela/0000-0002-1242-5693	Health Research Board [RP/2008/14, RP/2004/220, RP/2007/316]; Science Foundation Ireland [08/IN1/1949]	Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Health Research Board Grant RP/2008/14 and Science Foundation Ireland Grant 08/IN1/1949 (to J. H. M. P.) and Health Research Board Grants RP/2004/220 and RP/2007/316 (to M. M. B.).	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bahamonde ME, 2001, J BONE JOINT SURG AM, V83A, pS56; Ball EMA, 2001, DEV BIOL, V238, P1, DOI 10.1006/dbio.2001.0399; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bonner C, 2010, DIABETES, V59, P2799, DOI 10.2337/db09-1478; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Byrne MM, 1996, DIABETES, V45, P1503, DOI 10.2337/diabetes.45.11.1503; FAJANS SS, 1990, DIABETES CARE, V13, P49, DOI 10.2337/diacare.13.1.49; Farrelly AM, 2009, DIABETOLOGIA, V52, P136, DOI 10.1007/s00125-008-1168-8; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frayling TM, 2001, DIABETES, V50, pS94, DOI 10.2337/diabetes.50.2007.S94; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Hagenfeldt-Johansson KA, 2001, ENDOCRINOLOGY, V142, P5311, DOI 10.1210/en.142.12.5311; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Jiang FX, 2002, J CELL SCI, V115, P753; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kuang CZ, 2006, P NATL ACAD SCI USA, V103, P1858, DOI 10.1073/pnas.0508977103; Lehto M, 1997, J CLIN INVEST, V99, P582, DOI 10.1172/JCI119199; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MIQUEROL L, 1994, J BIOL CHEM, V269, P8944; Rane SG, 2006, CYTOKINE GROWTH F R, V17, P107, DOI 10.1016/j.cytogfr.2005.09.003; Rozen S, 2000, Methods Mol Biol, V132, P365; SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109; SANVITO F, 1994, DEVELOPMENT, V120, P3451; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Wang HY, 2002, J BIOL CHEM, V277, P17564, DOI 10.1074/jbc.M111037200; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wobser H, 2006, DIABETOLOGIA, V49, P519, DOI 10.1007/s00125-005-0119-x; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamaoka T, 1998, J CLIN INVEST, V102, P294, DOI 10.1172/JCI2769	41	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25719	25728		10.1074/jbc.M110.215525	http://dx.doi.org/10.1074/jbc.M110.215525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628466	Green Published, hybrid			2022-12-27	WOS:000293073000033
J	Lei, ZT; Huhman, DV; Sumner, LW				Lei, Zhentian; Huhman, David V.; Sumner, Lloyd W.			Mass Spectrometry Strategies in Metabolomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							2-DIMENSIONAL GAS-CHROMATOGRAPHY; STIMULATED INSULIN-SECRETION; TRUNCATULA CELL-CULTURES; LIQUID-CHROMATOGRAPHY; ELECTROSPRAY-IONIZATION; MEDICAGO-TRUNCATULA; SHOTGUN LIPIDOMICS; GC-MS/MS; SAMPLE PREPARATION; HUMAN PLASMA	MS has evolved as a critical component in metabolomics, which seeks to answer biological questions through large-scale qualitative and quantitative analyses of the metabolome. MS-based metabolomics techniques offer an excellent combination of sensitivity and selectivity, and they have become an indispensable platform in biology and metabolomics. In this minireview, various MS technologies used in metabolomics are briefly discussed, and future needs are suggested.	[Lei, Zhentian; Huhman, David V.; Sumner, Lloyd W.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA	Noble Research Institute	Sumner, LW (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, POB 2180, Ardmore, OK 73402 USA.	lwsumner@noble.org	Sumner, Lloyd W/A-3270-2013	Sumner, Lloyd W/0000-0002-4086-663X; Huhman, David/0000-0002-3148-7400	Oklahoma Center for the Advancement of Science and Technology [PSB10-027]; National Science Foundation [MCB 1024976, MCB 0520140]; LECO Corp.; Agilent Technologies; Samuel Roberts Noble Foundation	Oklahoma Center for the Advancement of Science and Technology; National Science Foundation(National Science Foundation (NSF)); LECO Corp.; Agilent Technologies; Samuel Roberts Noble Foundation	This work was supported by Oklahoma Center for the Advancement of Science and Technology Grant PSB10-027, National Science Foundation Grants MCB 1024976 and MCB 0520140, the LECO Corp., and Agilent Technologies. Financial personnel support was provided by the Samuel Roberts Noble Foundation. This is the third article in the Thematic Minireview Series on Biological Applications of Mass Spectrometry. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Adahchour M, 2005, J CHROMATOGR A, V1067, P245, DOI 10.1016/j.chroma.2004.09.094; Allegrand J, 2010, RAPID COMMUN MASS SP, V24, P3602, DOI 10.1002/rcm.4805; Allwood JW, 2009, METABOLOMICS, V5, P479, DOI 10.1007/s11306-009-0169-z; Aturki Z, 2004, J AGR FOOD CHEM, V52, P5303, DOI 10.1021/jf0400967; Aturki Z, 2010, ELECTROPHORESIS, V31, P1256, DOI 10.1002/elps.200900629; Babushok VI, 2007, J CHROMATOGR A, V1157, P414, DOI 10.1016/j.chroma.2007.05.044; Bedair M, 2008, TRAC-TREND ANAL CHEM, V27, P238, DOI 10.1016/j.trac.2008.01.006; Begley P, 2009, ANAL CHEM, V81, P7038, DOI 10.1021/ac9011599; Bleeker PM, 2009, PLANT PHYSIOL, V151, P925, DOI 10.1104/pp.109.142661; Broeckling CD, 2005, J EXP BOT, V56, P323, DOI 10.1093/jxb/eri058; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Cai F, 2010, J CHROMATOGR B, V878, P1845, DOI 10.1016/j.jchromb.2010.05.024; Castrillo JI, 2003, PHYTOCHEMISTRY, V62, P929, DOI 10.1016/S0031-9422(02)00713-6; Chen HW, 2006, CHEM COMMUN, P2042, DOI 10.1039/b602614a; Chiwocha SDS, 2003, PLANT J, V35, P405, DOI 10.1046/j.1365-313X.2003.01800.x; Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j; Cooks RG, 2006, SCIENCE, V311, P1566, DOI 10.1126/science.1119426; Cubbon S, 2007, ANAL CHEM, V79, P8911, DOI 10.1021/ac071008v; Dugo P, 2006, J CHROMATOGR A, V1112, P269, DOI 10.1016/j.chroma.2005.10.070; Dugo P, 2009, J SEP SCI, V32, P973, DOI 10.1002/jssc.200800696; Ebert B, 2010, J EXP BOT, V61, P1321, DOI 10.1093/jxb/erq002; Edison SE, 2011, RAPID COMMUN MASS SP, V25, P127, DOI 10.1002/rcm.4831; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Farag MA, 2008, PLANT PHYSIOL, V146, P387, DOI 10.1104/pp.107.108431; Farag MA, 2007, PHYTOCHEMISTRY, V68, P342, DOI 10.1016/j.phytochem.2006.10.023; Francois I, 2008, J CHROMATOGR A, V1178, P33, DOI 10.1016/j.chroma.2007.11.032; Fukushima A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-1; Giavalisco P, 2008, ANAL CHEM, V80, P9417, DOI 10.1021/ac8014627; Girod M, 2010, J AM SOC MASS SPECTR, V21, P1177, DOI 10.1016/j.jasms.2010.03.028; Gomez-Gonzalez S, 2010, J AGR FOOD CHEM, V58, P12292, DOI 10.1021/jf102350s; Gross RW, 2009, AM J PHYSIOL-ENDOC M, V297, pE297, DOI 10.1152/ajpendo.90970.2008; Guo K, 2007, ANAL CHEM, V79, P8631, DOI 10.1021/ac0704356; Hagan SO, 2007, ANAL CHEM, V79, P464, DOI 10.1021/ac061443+; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Hiller K, 2010, ANAL CHEM, V82, P6621, DOI 10.1021/ac1011574; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227; Hope JL, 2005, TALANTA, V65, P380, DOI 10.1016/j.talanta.2004.06.025; Huang XD, 2008, ANAL CHEM, V80, P107, DOI 10.1021/ac071263f; Hughey CA, 2002, ANAL CHEM, V74, P4145, DOI 10.1021/ac020146b; Huhman DV, 2005, J AGR FOOD CHEM, V53, P1914, DOI 10.1021/jf0482663; Huhman DV, 2002, PHYTOCHEMISTRY, V59, P347, DOI 10.1016/S0031-9422(01)00432-0; Kato M, 2009, J CHROMATOGR A, V1216, P8277, DOI 10.1016/j.chroma.2009.06.074; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Koek MM, 2010, ANAL CHEM, V82, P156, DOI 10.1021/ac9015787; Kusano M, 2007, J CHROMATOGR B, V855, P71, DOI 10.1016/j.jchromb.2007.05.002; Lane AL, 2009, P NATL ACAD SCI USA, V106, P7314, DOI 10.1073/pnas.0812020106; Law WS, 2010, ANALYST, V135, P773, DOI 10.1039/b924156f; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Ma CF, 2009, METABOLOMICS, V5, P497, DOI 10.1007/s11306-009-0170-6; Makarov A, 2000, ANAL CHEM, V72, P1156, DOI 10.1021/ac991131p; Martin DM, 2009, P NATL ACAD SCI USA, V106, P7245, DOI 10.1073/pnas.0901387106; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; Mattila Ismo, 2008, V456, P123, DOI 10.1007/978-1-59745-245-8_9; Mayer F, 2008, J AGR FOOD CHEM, V56, P3749, DOI 10.1021/jf0732915; Mesaros C, 2010, RAPID COMMUN MASS SP, V24, P3237, DOI 10.1002/rcm.4760; Mistrik R., 2004, U.S. Patent, Patent No. [10/967,018, 10967018]; Mondello L, 2008, ANAL CHEM, V80, P5418, DOI 10.1021/ac800484y; Mondello L, 2008, MASS SPECTROM REV, V27, P101, DOI 10.1002/mas.20158; Navare AT, 2010, ANAL BIOANAL CHEM, V398, P3005, DOI 10.1007/s00216-010-4269-4; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nordstrom A, 2008, ANAL CHEM, V80, P421, DOI 10.1021/ac701982e; Nordstrom A, 2006, ANAL CHEM, V78, P3289, DOI 10.1021/ac060245f; Pereira J, 2011, TALANTA, V83, P899, DOI 10.1016/j.talanta.2010.10.064; Bolanos PP, 2007, RAPID COMMUN MASS SP, V21, P2282, DOI 10.1002/rcm.3091; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Purcaro G, 2010, J SEP SCI, V33, P2334, DOI 10.1002/jssc.201000160; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Schad M, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-2; Skogerson K, 2010, J AGR FOOD CHEM, V58, P3600, DOI 10.1021/jf903705y; Spagou K, 2011, ANAL CHEM, V83, P382, DOI 10.1021/ac102523q; Stoll DR, 2008, ANAL CHEM, V80, P268, DOI 10.1021/ac701676b; Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2; Takats Z, 2005, J MASS SPECTROM, V40, P1261, DOI 10.1002/jms.922; Thomas A, 2010, J SEP SCI, V33, P873, DOI 10.1002/jssc.200900593; Tolonen A, 2004, RAPID COMMUN MASS SP, V18, P3113, DOI 10.1002/rcm.1736; Urakami K, 2010, BIOMED RES-TOKYO, V31, P161, DOI 10.2220/biomedres.31.161; Walorczyk S, 2008, RAPID COMMUN MASS SP, V22, P3791, DOI 10.1002/rcm.3800; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693; Wolf S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-148; Wong JW, 2010, J AGR FOOD CHEM, V58, P5868, DOI 10.1021/jf903854n; Wudy SA, 2002, STEROIDS, V67, P851, DOI 10.1016/S0039-128X(02)00052-1; Yang K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001368; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Zeng YC, 2008, BIOCHEM J, V410, P81, DOI 10.1042/BJ20070976; Zhao T, 2010, PHYTOCHEMISTRY, V71, P1332, DOI 10.1016/j.phytochem.2010.05.017; Zhou M, 2010, J AM SOC MASS SPECTR, V21, P68, DOI 10.1016/j.jasms.2009.09.004; Zhu LA, 2010, ANAL BIOANAL CHEM, V398, P405, DOI 10.1007/s00216-010-3945-8; Zoerner AA, 2009, J CHROMATOGR B, V877, P2909, DOI 10.1016/j.jchromb.2009.04.016	93	304	315	4	193	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25435	25442		10.1074/jbc.R111.238691	http://dx.doi.org/10.1074/jbc.R111.238691			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632543	Green Published, hybrid			2022-12-27	WOS:000293073000005
J	Duex, JE; Comeau, L; Sorkin, A; Purow, B; Kefas, B				Duex, Jason E.; Comeau, Laurey; Sorkin, Alexander; Purow, Benjamin; Kefas, Benjamin			Usp18 Regulates Epidermal Growth Factor (EGF) Receptor Expression and Cancer Cell Survival via MicroRNA-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-SPECIFIC PROTEASE; LUNG-CANCER; ISG15; APOPTOSIS; UBP43; BIOGENESIS; KINASE; GLIOMA; IDENTIFICATION; STIMULATION	Epidermal growth factor receptor (EGFR) is involved in development and progression of many human cancers. We have previously demonstrated that the ubiquitin-specific peptidase Usp18 (Ubp43) is a potent regulator of EGFR protein expression. Here we report that the 3'-untranslated region (3'-UTR) of the EGFR message modulates RNA translation following cell treatment with Usp18 siRNA, suggesting microRNA as a possible mediator. Given earlier evidence of EGFR regulation by the microRNA miR-7, we assessed whether miR-7 mediates Usp18 siRNA effects. We found that Usp18 depletion elevates miR-7 levels in several cancer cell lines because of a transcriptional activation and/or mRNA stabilization of miR-7 host genes and that miR-7 acts downstream of Usp18 to regulate EGFR mRNA translation via the 3'-UTR. Also, depletion of Usp18 led to a decrease in protein levels of other known oncogenic targets of miR-7, reduced cell proliferation and soft agar colony formation, and increased apoptosis. Notably, all of these phenotypes were reversed by a specific inhibitor of miR-7. Thus, our findings support a model in which Usp18 inhibition promotes upregulation of miR-7, which in turn inhibits EGFR expression and the tumorigenic activity of cancer cells.	[Duex, Jason E.; Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Purow, Benjamin; Kefas, Benjamin] Univ Virginia Hlth Syst, Dept Neurol, Div Neurooncol, Old Med Sch, Charlottesville, VA 22908 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia	Sorkin, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S368 Biomed Sci Tower S,3500 Terrace St, Pittsburgh, PA 15261 USA.	sorkin@pitt.edu; bwp5g@virginia.edu; bak4x@virginia.edu		Sorkin, Alexander/0000-0002-4446-1920	National Institutes of Health [R01 CA136803, R01 CA089151]; Howard Hughes Medical Institute;  [F32CA126344]; NATIONAL CANCER INSTITUTE [F32CA126344, R01CA136803, R01CA089151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA136803 (to B.P.) and a Howard Hughes Medical Institute Physician-Scientist Early Career Award (to B.P.), a F32CA126344 fellowship (to J.E.D.), and National Institutes of Health Grant R01 CA089151 (to A.S. and J.E.D.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bektas N, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2117; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Broniscer A, 2004, ONCOLOGIST, V9, P197, DOI 10.1634/theoncologist.9-2-197; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Duex JE, 2010, EXP CELL RES, V316, P2136, DOI 10.1016/j.yexcr.2010.04.017; Duex JE, 2009, MOL BIOL CELL, V20, P1833, DOI 10.1091/mbc.E08-08-0880; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Feng Q, 2008, MOL CANCER THER, V7, P3780, DOI 10.1158/1535-7163.MCT-08-0753; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kiessling A, 2009, ONCOGENE, V28, P2606, DOI 10.1038/onc.2009.115; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Lemmon M. A., J CELL, V141, P1117; Liu LQ, 1999, MOL CELL BIOL, V19, P3029; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Ritchie KJ, 2002, GENE DEV, V16, P2207, DOI 10.1101/gad.1010202; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; Shen L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-232; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Weiss GJ, 2008, ANN ONCOL, V19, P1053, DOI 10.1093/annonc/mdn006; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120	50	52	55	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25377	25386		10.1074/jbc.M111.222760	http://dx.doi.org/10.1074/jbc.M111.222760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592959	Green Published, hybrid			2022-12-27	WOS:000292547900083
J	Joshi, P; Stoddart, CA				Joshi, Pheroze; Stoddart, Cheryl A.			Impaired Infectivity of Ritonavir-resistant HIV Is Rescued by Heat Shock Protein 90AB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CAPSID PROTEIN; CYCLOPHILIN-A; GAG PROTEIN; MATURATION; HSP90; REPLICATION; INHIBITORS; GLYCOPROTEIN; MECHANISM	Certain ritonavir resistance mutations impair HIV infectivity through incomplete Gag processing by the mutant viral protease. Analysis of the mutant virus phenotype indicates that accumulation of capsid-spacer peptide 1 precursor protein in virus particles impairs HIV infectivity and that the protease mutant virus is arrested during the early postentry stage of HIV infection before proviral DNA synthesis. However, activation of the target cell can rescue this defect, implying that specific host factors expressed in activated cells can compensate for the defect in ritonavir-resistant HIV. This ability to rescue impaired HIV replication presented a unique opportunity to identify host factors involved in postentry HIV replication, and we designed a functional genetic screen so that expression of a given host factor extracted from activated T cells would lead directly to its discovery by rescuing mutant virus replication in nonactivated T cells. We identified the cellular heat shock protein 90 kDa alpha (cytosolic), class B member 1 (HSP90AB1) as a host factor that can rescue impaired replication of ritonavir-resistant HIV. Moreover, we show that pharmacologic inhibition of HSP90AB1 with 17-(allylamino)-17-demethoxygeldanamycin (tanespimycin) has potent in vitro anti-HIV activity and that ritonavir-resistant HIV is hypersensitive to the drug. These results suggest a possible role for HSP90AB1 in postentry HIV replication and may provide an attractive target for therapeutic intervention.	[Joshi, Pheroze; Stoddart, Cheryl A.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Stoddart, CA (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA.	cheryl.stoddart@ucsf.edu			National Institutes of Health, NIAID [N01-AI-70002]; California HIV/AIDS Research Program [ID09-SF-051]; University of California; San Francisco AIDS Research Institute; Harvey V. Berneking Living Trust	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California HIV/AIDS Research Program; University of California(University of California System); San Francisco AIDS Research Institute; Harvey V. Berneking Living Trust	This work was supported, in whole or in part, by a National Institutes of Health grant from NIAID under Contract N01-AI-70002. This work was also supported by California HIV/AIDS Research Program Grant ID09-SF-051 (to C. A. S.) and in part by the University of California, San Francisco AIDS Research Institute and the Harvey V. Berneking Living Trust.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Anderson Jeffrey, 2009, V189, P85; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Butan C, 2008, J MOL BIOL, V376, P1168, DOI 10.1016/j.jmb.2007.12.003; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chadli A, 2008, BIOCHEMISTRY-US, V47, P2850, DOI 10.1021/bi7023332; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Cornetta Kenneth, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.top29; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Rhee SY, 2007, PLOS COMPUT BIOL, V3, P836, DOI 10.1371/journal.pcbi.0030087; Sakalian M, 2006, J VIROL, V80, P5716, DOI 10.1128/JVI.02743-05; SALMON P, 2007, CURR PROTOC HUM GENE, pCH12, DOI DOI 10.1002/0471142905.HG0808S52; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; Stoddart CA, 2001, NAT MED, V7, P712, DOI 10.1038/89090; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001251; Vogt VM, 1996, CURR TOP MICROBIOL, V214, P95; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Vozzolo L, 2010, J BIOL CHEM, V285, P39314, DOI 10.1074/jbc.M110.155275; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Yin PD, 2006, CELL MOL LIFE SCI, V63, P1706, DOI 10.1007/s00018-006-6009-7; Yu Hong, 2008, V433, P1, DOI 10.1007/978-1-59745-237-3_1; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhou J, 2005, J BIOL CHEM, V280, P42149, DOI 10.1074/jbc.M508951200	47	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24581	24592		10.1074/jbc.M111.248021	http://dx.doi.org/10.1074/jbc.M111.248021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602280	hybrid, Green Published			2022-12-27	WOS:000292547900008
J	Li, YP; Zhang, CZ; Chen, XD; Yu, J; Wang, Y; Yang, Y; Du, MJ; Jin, HL; Ma, YJ; He, B; Cao, YJ				Li, Yapeng; Zhang, Cuizhu; Chen, Xiangdong; Yu, Jia; Wang, Yu; Yang, Yin; Du, Mingjuan; Jin, Huali; Ma, Yijie; He, Bin; Cao, Youjia			ICP34.5 Protein of Herpes Simplex Virus Facilitates the Initiation of Protein Translation by Bridging Eukaryotic Initiation Factor 2 alpha (eIF2 alpha) and Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; MOLECULAR-WEIGHT COMPLEX; GAMMA(1)34.5 PROTEIN; LIVING CELLS; DNA-DAMAGE; CARBOXYL-TERMINUS; GROWTH ARREST; ARGININE-RICH; ALPHA-SUBUNIT; KINASE	The ICP34.5 protein of herpes simplex virus type 1 is a neurovirulence factor that plays critical roles in viral replication and anti-host responses. One of its functions is to recruit protein phosphatase 1 (PP1) that leads to the dephosphorylation of the alpha subunit of translation initiation factor eIF2 (eIF2 alpha), which is inactivated by infection-induced phosphorylation. As PP1 is a protein phosphatase with a wide range of substrates, the question remains to be answered how ICP34.5 directs PP1 to specifically dephosphorylate eIF2 alpha. Here we report that ICP34.5 not only binds PP1 but also associates with eIF2 alpha by in vitro and in vivo assays. The binding site of eIF2 alpha is identified at amino acids 233-248 of ICP34.5, which falls in the highly homologous region with human gene growth arrest and DNA damage 34. The interaction between ICP34.5 and eIF2 alpha is independent of the phosphorylation status of eIF2 alpha at serine 51. Deletion mutation of this region results in the failure of dephosphorylation of eIF2 alpha by PP1 and, consequently, interrupts viral protein synthesis and replication. Our data illustrated that the binding between viral protein ICP34.5 and the host eIF2 alpha is crucial for the specific dephosphorylation of eIF2 alpha by PP1. We propose that herpes simplex virus protein ICP34.5 bridges PP1 and eIF2 alpha via their binding motifs and thereby facilitates the protein synthesis and viral replication.	[Li, Yapeng; Zhang, Cuizhu; Chen, Xiangdong; Yu, Jia; Wang, Yu; Yang, Yin; Du, Mingjuan; Cao, Youjia] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Jin, Huali; Ma, Yijie; He, Bin] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	Nankai University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cao, YJ (corresponding author), Mol Biol Inst Bldg,Rm 224,94 Weijin Rd, Tianjin 300071, Peoples R China.	caoyj@nankai.edu.cn	Jin, Huali/F-3650-2011		National Natural Science Foundation of China [30670080, 30870128]; Ministry of Science and Technology of China [2007CB914800, 2006DFB32420]; National Institute of Allergy and Infectious Diseases [AI092230]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092230] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grants 30670080 and 30870128 (to Y. C.), Ministry of Science and Technology of China Grants 2007CB914800 and 2006DFB32420, and National Institute of Allergy and Infectious Diseases Grant AI092230 (to B. H.).	Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Cheng GF, 2003, J VIROL, V77, P10154, DOI 10.1128/JVI.77.18.10154-10161.2003; Cheng GF, 2001, J VIROL, V75, P3666, DOI 10.1128/JVI.75.8.3666-3674.2001; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; CHOU J, 1994, P NATL ACAD SCI USA, V91, P5247, DOI 10.1073/pnas.91.12.5247; CHOU J, 1990, J VIROL, V64, P1014, DOI 10.1128/JVI.64.3.1014-1020.1990; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; GUNNERY S, 1990, P NATL ACAD SCI USA, V87, P8687, DOI 10.1073/pnas.87.22.8687; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1996, J VIROL, V70, P84, DOI 10.1128/JVI.70.1.84-90.1996; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Khoo D, 2002, J VIROL, V76, P11971, DOI 10.1128/JVI.76.23.11971-11981.2002; LORD KA, 1990, NUCLEIC ACIDS RES, V18, P2823, DOI 10.1093/nar/18.9.2823; Mao HW, 2002, J BIOL CHEM, V277, P11423, DOI 10.1074/jbc.M111553200; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Salvatore M, 2002, J VIROL, V76, P1206, DOI 10.1128/JVI.76.3.1206-1212.2002; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhang CZ, 2008, FEBS LETT, V582, P171, DOI 10.1016/j.febslet.2007.11.082	28	71	73	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24785	24792		10.1074/jbc.M111.232439	http://dx.doi.org/10.1074/jbc.M111.232439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622569	Green Published, hybrid			2022-12-27	WOS:000292547900029
J	Sathe, MN; Woo, K; Kresge, C; Bugde, A; Luby-Phelps, K; Lewis, MA; Feranchak, AP				Sathe, Meghana N.; Woo, Kangmee; Kresge, Charles; Bugde, Abhijit; Luby-Phelps, Kate; Lewis, Matthew A.; Feranchak, Andrew P.			Regulation of Purinergic Signaling in Biliary Epithelial Cells by Exocytosis of SLC17A9-dependent ATP-enriched Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ADENOSINE-TRIPHOSPHATE RELEASE; PROTEIN-KINASE-C; FUNCTIONAL-CHARACTERIZATION; EXTRACELLULAR NUCLEOTIDES; BICARBONATE SECRETION; VESICULAR EXOCYTOSIS; DEPENDENT REGULATION; VOLUME REGULATION; CHOLANGIOCYTES	ATP in bile is a potent secretogogue, stimulating biliary epithelial cell (BEC) secretion through binding apical purinergic receptors. In response to mechanosensitive stimuli, BECs release ATP into bile, although the cellular basis of ATP release is unknown. The aims of this study in human and mouse BECs were to determine whether ATP release occurs via exocytosis of ATP-enriched vesicles and to elucidate the potential role of the vesicular nucleotide transporter SLC17A9 in purinergic signaling. Dynamic, multiscale, live cell imaging (confocal and total internal reflection fluorescence microscopy and a luminescence detection system with a high sensitivity charge-coupled device camera) was utilized to detect vesicular ATP release from cell populations, single cells, and the submembrane space of a single cell. In response to increases in cell volume, BECs release ATP, which was dependent on intact microtubules and vesicular trafficking pathways. ATP release occurred as stochastic point source bursts of luminescence consistent with exocytic events. Parallel studies identified ATP-enriched vesicles ranging in size from 0.4 to 1 mu m that underwent fusion and release in response to increases in cell volume in a protein kinase C-dependent manner. Present in all models, SLC17A9 contributed to ATP vesicle formation and regulated ATP release. The findings are consistent with the existence of an SLC17A9-dependent ATP-enriched vesicular pool in biliary epithelium that undergoes regulated exocytosis to initiate purinergic signaling.	[Sathe, Meghana N.; Woo, Kangmee; Kresge, Charles; Feranchak, Andrew P.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Bugde, Abhijit; Luby-Phelps, Kate] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Lewis, Matthew A.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Feranchak, AP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	drew.feranchak@utsouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409	NIDDK [DK078587]; Cystic Fibrosis Foundation [FERANC08G0]; Children's Medical Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078587] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Children's Medical Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK078587 from the NIDDK (to A.P.F.). This work was also supported by Cystic Fibrosis Foundation Grant FERANC08G0 and the Children's Medical Center Foundation (to A.P.F.).	Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Bankston LA, 1996, J BIOL CHEM, V271, P17132, DOI 10.1074/jbc.271.29.17132; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Burnstock G, 2003, CURR TOP MEMBR, V54, P307, DOI 10.1016/S1063-5823(03)01010-X; BURNSTOCK G, 1970, BRIT J PHARMACOL, V40, P668, DOI 10.1111/j.1476-5381.1970.tb10646.x; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; COHN JA, 1993, GASTROENTEROLOGY, V105, P1857, DOI 10.1016/0016-5085(93)91085-V; Doctor RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1042, DOI 10.1152/ajpcell.00367.2001; Dutta AK, 2008, AM J PHYSIOL-GASTR L, V295, pG1004, DOI 10.1152/ajpgi.90382.2008; Dutta AK, 2011, J BIOL CHEM, V286, P766, DOI 10.1074/jbc.M110.164970; Dutta AK, 2009, AM J PHYSIOL-GASTR L, V297, pG1009, DOI 10.1152/ajpgi.00223.2009; Feranchak AP, 2007, GASTROENTEROLOGY, V133, P1726, DOI 10.1053/j.gastro.2007.09.050; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Feranchak AP, 1999, J BIOL CHEM, V274, P30979, DOI 10.1074/jbc.274.43.30979; Feranchak AP, 2000, J HEPATOL, V33, P174, DOI 10.1016/S0168-8278(00)80357-8; Feranchak AP, 2004, GASTROENTEROLOGY, V127, P903, DOI 10.1053/j.gastro.2004.06.047; Feranchak AP, 2002, SEMIN LIVER DIS, V22, P251, DOI 10.1055/s-2002-34503; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Gatof D, 2004, AM J PHYSIOL-GASTR L, V286, pG538, DOI 10.1152/ajpgi.00355.2003; Gigliozzi A, 2000, GASTROENTEROLOGY, V119, P1113, DOI 10.1053/gast.2000.18156; Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6; Gradilone SA, 2007, P NATL ACAD SCI USA, V104, P19138, DOI 10.1073/pnas.0705964104; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; IRVIN JL, 1954, J BIOL CHEM, V210, P45; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Maroto R, 2001, J BIOL CHEM, V276, P23867, DOI 10.1074/jbc.M101500200; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; Roman RM, 2001, J MEMBRANE BIOL, V183, P165, DOI 10.1007/s00232-001-0064-7; Roman RM, 1998, HEPATOLOGY, V28, P1073, DOI 10.1002/hep.510280423; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Spivey J. R., 1993, J CLIN INVEST, V92, P17; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Thevananther S, 2004, HEPATOLOGY, V39, P393, DOI 10.1002/hep.20075; Tokunaga A, 2010, J BIOL CHEM, V285, P17406, DOI 10.1074/jbc.M110.112417; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; Watt WC, 1998, J BIOL CHEM, V273, P14053, DOI 10.1074/jbc.273.22.14053; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Woo K, 2010, HEPATOLOGY, V52, P1819, DOI 10.1002/hep.23883; Yang W, 2001, ACTA PHYSIOL SCAND, V171, P413, DOI 10.1046/j.1365-201X.2001.00809.x; Yu J, 2009, AM J PHYSIOL-GASTR L, V296, pG563, DOI 10.1152/ajpgi.90502.2008; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhao YQ, 2007, J BIOL CHEM, V282, P1249, DOI 10.1074/jbc.M606998200	50	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25363	25376		10.1074/jbc.M111.232868	http://dx.doi.org/10.1074/jbc.M111.232868			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613220	Green Published, hybrid			2022-12-27	WOS:000292547900082
J	Moon, JS; Kim, HE; Koh, E; Park, SH; Jin, WJ; Park, BW; Park, SW; Kim, KS				Moon, Jong-Seok; Kim, Hee Eun; Koh, Eunjin; Park, Se Ho; Jin, Won-Ji; Park, Byeong-Woo; Park, Sahng Wook; Kim, Kyung-Sup			Kruppel-like Factor 4 (KLF4) Activates the Transcription of the Gene for the Platelet Isoform of Phosphofructokinase (PFKP) in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCITES TUMOR-CELLS; DNA-DAMAGE; EXPRESSION; OVEREXPRESSION; TRANSFORMATION; PROGRESSION; ONCOGENE; PROMOTER; CLONING; GROWTH	Kruppel-like factor 4 (KLF4) is a transcription factor that plays an important role in cell differentiation, proliferation, and survival, especially in the context of cancers. This study revealed that KLF4 activates glycolytic metabolism in breast cancer cells by up-regulating the platelet isoform of phosphofructokinase (PFKP). KLF4 activated the transcription of the PFKP gene by directly binding to the PFKP promoter. Whereas glucose uptake and lactate production were inhibited by the knockdown of KLF4, they were activated by the overexpression of KLF4. Unlike PFKP, the expressions of the other isoforms of phosphofructokinase and glycolytic genes were unaffected by KLF4. The human breast cancer tissues showed a close correlation between KLF4 and PFKP expression. This study also showed that PFKP plays a critical role in cell proliferation in breast cancer cells. In conclusion, it is suggested that KLF4 plays a role in maintenance of high glycolytic metabolism by transcriptional activation of the PFKP gene in breast cancer cells.	[Moon, Jong-Seok; Kim, Hee Eun; Koh, Eunjin; Jin, Won-Ji; Park, Sahng Wook; Kim, Kyung-Sup] Yonsei Univ, Ctr Chron Metab Dis Res, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol,Coll Med,Inst Genet Sci, Seoul 120752, South Korea; [Park, Se Ho; Park, Byeong-Woo] Yonsei Univ, Coll Med, Dept Surg, Brain Korea Project Med Sci 21, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, SW (corresponding author), Yonsei Univ, Ctr Chron Metab Dis Res, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol,Coll Med,Inst Genet Sci, 134 Shinchon Dong, Seoul 120752, South Korea.	swpark64@yuhs.ac; kyungsup59@yuhs.ac		Park, Seho/0000-0001-8089-2755; Koh, Eunjin/0000-0001-8967-6266; Park, Sahng Wook/0000-0002-9594-7074; Park, Byeong-Woo/0000-0003-1353-2607; Kim, Kyung-sup/0000-0001-8483-8537	Korea government (MEST) [2010-0028364]; Yonsei University College of Medicine [6-2009-0073]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Yonsei University College of Medicine(General Electric)	This work was supported by the National Research Foundation funded by the Korea government (MEST) (grant number 2010-0028364) and Yonsei University College of Medicine Faculty Research Grant 6-2009-0073 for 2009.	Atsumi T, 2002, CANCER RES, V62, P5881; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Medina RA, 2002, BIOL RES, V35, P9, DOI 10.4067/S0716-97602002000100004; Minchenko OH, 2005, BIOCHIMIE, V87, P1005, DOI 10.1016/j.biochi.2005.04.007; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sanchez-Martinez C, 2000, BIOCHEM BIOPH RES CO, V271, P635, DOI 10.1006/bbrc.2000.2681; SanchezMartinez C, 1997, FEBS LETT, V409, P86, DOI 10.1016/S0014-5793(97)00496-1; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VORA S, 1985, CANCER RES, V45, P2993; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; WEBER G, 1977, NEW ENGL J MED, V296, P541, DOI 10.1056/NEJM197703102961005; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wong CW, 2010, STEM CELLS, V28, P1510, DOI 10.1002/stem.477; Yoon HS, 2005, ONCOGENE, V24, P4017, DOI 10.1038/sj.onc.1208576; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yun M, 2009, J NUCL MED, V50, P1222, DOI 10.2967/jnumed.109.062703; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200	28	69	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23808	23816		10.1074/jbc.M111.236737	http://dx.doi.org/10.1074/jbc.M111.236737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586797	Green Published, hybrid			2022-12-27	WOS:000292294900023
J	Bryksa, BC; Bhaumik, P; Magracheva, E; De Moura, DC; Kurylowicz, M; Zdanov, A; Dutcher, JR; Wlodawer, A; Yada, RY				Bryksa, Brian C.; Bhaumik, Prasenjit; Magracheva, Eugenia; De Moura, Dref C.; Kurylowicz, Martin; Zdanov, Alexander; Dutcher, John R.; Wlodawer, Alexander; Yada, Rickey Y.			Structure and Mechanism of the Saposin-like Domain of a Plant Aspartic Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMAGGLUTININ FUSION PEPTIDE; INFLUENZA HEMAGGLUTININ; CRYSTAL-STRUCTURE; ANTIMICROBIAL ACTIVITY; SECONDARY-STRUCTURE; PROTEINASE; CELL; ENZYMES; VISUALIZATION; ACTIVATION	Many plant aspartic proteases contain an additional sequence of similar to 100 amino acids termed the plant-specific insert, which is involved in host defense and vacuolar targeting. Similar to all saposin-like proteins, the plant-specific insert functions via protein-membrane interactions; however, the structural basis for such interactions has not been studied, and the nature of plantspecific insert-mediated membrane disruption has not been characterized. In the present study, the crystal structure of the saposin-like domain of potato aspartic protease was resolved at a resolution of 1.9 angstrom, revealing an open V-shaped configuration similar to the open structure of human saposin C. Notably, vesicle disruption activity followed Michaelis-Menten-like kinetics, a finding not previously reported for saposin-like proteins including plant-specific inserts. Circular dichroism data suggested that secondary structure was pH-dependent in a fashion similar to influenza A hemagglutinin fusion peptide. Membrane effects characterized by atomic force microscopy and light scattering indicated bilayer solubilization as well as fusogenic activity. Taken together, the present study is the first report to elucidate the membrane interaction mechanism of plant saposin-like domains whereby pH-dependent membrane interactions resulted in bilayer fusogenic activity that probably arose from a viral type pH-dependent helix-kink-helix motif at the plant-specific insert N terminus.	[Bryksa, Brian C.; De Moura, Dref C.; Yada, Rickey Y.] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada; [Kurylowicz, Martin; Dutcher, John R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Bhaumik, Prasenjit; Zdanov, Alexander; Wlodawer, Alexander] NCI, Prot Struct Sect, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; [Magracheva, Eugenia] NCI, Basic Res Program, SAIC Frederick, NIH, Frederick, MD 21702 USA	University of Guelph; University of Guelph; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Yada, RY (corresponding author), Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada.	ryada@uoguelph.ca	Yada, Rickey Y/A-8289-2013; Bryksa, Brian/A-8281-2013	Bryksa, Brian/0000-0001-5626-8012; Yada, Rickey/0000-0002-8648-2156	National Institutes of Health, NCI; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NCI. This work was also supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, and the Center for Cancer Research.	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; Alattia JR, 2006, J MOL BIOL, V362, P943, DOI 10.1016/j.jmb.2006.08.009; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER D, 1994, STRUCTURE, V2, P907, DOI 10.1016/S0969-2126(94)00091-3; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bissonnette MLZ, 2009, J MOL BIOL, V386, P14, DOI 10.1016/j.jmb.2008.12.029; BLUNDELL TL, 1993, PROTEIN SCI, V2, P877, DOI 10.1002/pro.5560020602; Braun HP, 1999, PLANTA, V209, P267, DOI 10.1007/s004250050632; BRAUN HP, 1995, TRENDS BIOCHEM SCI, V20, P171, DOI 10.1016/S0968-0004(00)88999-9; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Bryksa BC, 2010, PROTEIN ENG DES SEL, V23, P711, DOI 10.1093/protein/gzq039; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Ciaffoni F, 2001, J BIOL CHEM, V276, P31583, DOI 10.1074/jbc.M102736200; Ciaffoni F, 2006, J LIPID RES, V47, P1045, DOI 10.1194/jlr.M500547-JLR200; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; DeLano W.L, PYMOL MOL GRAPHICS S; Egas C, 2000, J BIOL CHEM, V275, P38190, DOI 10.1074/jbc.M006093200; Egawa H, 1999, LANGMUIR, V15, P1660, DOI 10.1021/la980923w; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faro C, 1999, J BIOL CHEM, V274, P28724, DOI 10.1074/jbc.274.40.28724; Fiske CH, 1925, J BIOL CHEM, V66, P375; Frazao C, 1999, J BIOL CHEM, V274, P27694, DOI 10.1074/jbc.274.39.27694; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Glathe S, 1998, J BIOL CHEM, V273, P31230, DOI 10.1074/jbc.273.47.31230; Gordon LM, 2000, J PEPT RES, V55, P330, DOI 10.1034/j.1399-3011.2000.00693.x; Gray C, 1996, BIOPHYS J, V70, P2275, DOI 10.1016/S0006-3495(96)79793-X; Guevara MG, 2002, EUR J PLANT PATHOL, V108, P131, DOI 10.1023/A:1015049629736; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Huster D, 2000, BIOPHYS J, V78, P3011, DOI 10.1016/S0006-3495(00)76839-1; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kasson PM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000829; Kervinen J, 1999, EMBO J, V18, P3947, DOI 10.1093/emboj/18.14.3947; Kingsley DH, 1999, MOL BIOL CELL, V10, P4191, DOI 10.1091/mbc.10.12.4191; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lai AL, 2010, J BIOL CHEM, V285, P37467, DOI 10.1074/jbc.M110.153700; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAZAROWITZ SG, 1973, VIROLOGY, V56, P172, DOI 10.1016/0042-6822(73)90296-1; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Lukatsky DB, 2004, EUR PHYS J E, V14, P3, DOI 10.1140/epje/i2004-10005-5; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Markovic I, 1998, J CELL BIOL, V143, P1155, DOI 10.1083/jcb.143.5.1155; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; MATSUZAKI K, 1989, BIOCHIM BIOPHYS ACTA, V981, P130, DOI 10.1016/0005-2736(89)90090-4; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mazorra-Manzano MA, 2010, PHYTOCHEMISTRY, V71, P515, DOI 10.1016/j.phytochem.2009.12.005; Meyer V, 2008, APPL MICROBIOL BIOT, V78, P17, DOI 10.1007/s00253-007-1291-3; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Munoz FF, 2010, PEPTIDES, V31, P777, DOI 10.1016/j.peptides.2010.02.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mutlu A, 1999, PHYSIOL PLANTARUM, V105, P569, DOI 10.1034/j.1399-3054.1999.105324.x; Paumet F, 2005, J BIOL CHEM, V280, P21137, DOI 10.1074/jbc.M500841200; Paumet F, 2004, P NATL ACAD SCI USA, V101, P3376, DOI 10.1073/pnas.0400271101; Payie KG, 2000, BIOTECHNOL LETT, V22, P1515, DOI 10.1023/A:1005656208075; Payie KG, 2003, BIOCHEM J, V372, P671, DOI 10.1042/BJ20021126; Petrache HI, 1998, CHEM PHYS LIPIDS, V95, P83, DOI 10.1016/S0009-3084(98)00068-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Ramalho-Santos M, 1998, EUR J BIOCHEM, V255, P133, DOI 10.1046/j.1432-1327.1998.2550133.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Remmel N, 2007, FEBS J, V274, P3405, DOI 10.1111/j.1742-4658.2007.05873.x; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; RUNEBERGROOS P, 1991, EUR J BIOCHEM, V202, P1021, DOI 10.1111/j.1432-1033.1991.tb16465.x; Schaller A, 1996, PLANT MOL BIOL, V31, P1073, DOI 10.1007/BF00040725; SHAROM FJ, 1995, J BIOL CHEM, V270, P10334, DOI 10.1074/jbc.270.17.10334; Simoes I, 2004, EUR J BIOCHEM, V271, P2067, DOI 10.1111/j.1432-1033.2004.04136.x; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stiasny K, 2007, PLOS PATHOG, V3, P191, DOI 10.1371/journal.ppat.0030020; Tseng HK, 2011, EXPERT OPIN PHARMACO, V12, P241, DOI 10.1517/14656566.2010.517195; VACCARO AM, 1994, FEBS LETT, V349, P181, DOI 10.1016/0014-5793(94)00659-8; VACCARO AM, 1995, J BIOL CHEM, V270, P9953, DOI 10.1074/jbc.270.17.9953; Wang Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P43, DOI 10.1016/S0003-9861(03)00219-4; You HX, 2003, BIOPHYS J, V84, P2043, DOI 10.1016/S0006-3495(03)75012-7; Zhai YF, 2000, BBA-REV BIOMEMBRANES, V1469, P87, DOI 10.1016/S0304-4157(00)00003-4	85	35	39	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28265	28275		10.1074/jbc.M111.252619	http://dx.doi.org/10.1074/jbc.M111.252619			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676875	Green Published, hybrid			2022-12-27	WOS:000293557800044
J	Waldeck-Weiermair, M; Jean-Quartier, C; Rost, R; Khan, MJ; Vishnu, N; Bondarenko, AI; Imamura, H; Malli, R; Graier, WF				Waldeck-Weiermair, Markus; Jean-Quartier, Claire; Rost, Rene; Khan, Muhammad Jadoon; Vishnu, Neelanjan; Bondarenko, Alexander I.; Imamura, Hiromi; Malli, Roland; Graier, Wolfgang F.			Leucine Zipper EF Hand-containing Transmembrane Protein 1 (Letm1) and Uncoupling Proteins 2 and 3 (UCP2/3) Contribute to Two Distinct Mitochondrial Ca2+ Uptake Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL LINE; ENDOPLASMIC-RETICULUM; CALCIUM MICRODOMAINS; INTRACELLULAR CA2+; T-LYMPHOCYTES; CRAC CHANNELS; STIMULATION; ACTIVATION; INDICATORS; MEMBRANE	Cytosolic Ca2+ signals are transferred into mitochondria over a huge concentration range. In our recent work we described uncoupling proteins 2 and 3 (UCP2/3) to be fundamental for mitochondrial uptake of high Ca2+ domains in mitochondria-ER junctions. On the other hand, the leucine zipper EF hand-containing transmembrane protein 1 (Letm1) was identified as a mitochondrial Ca2+/H+ antiporter that achieved mitochondrial Ca2+ sequestration at small Ca2+ increases. Thus, the contributions of Letm1 and UCP2/3 to mitochondrial Ca2+ uptake were compared in endothelial cells. Knock-down of Letm1 did not affect the UCP2/3-dependent mitochondrial uptake of intracellularly released Ca2+ but strongly diminished the transfer of entering Ca2+ into mitochondria, subsequently, resulting in a reduction of store-operated Ca2+ entry (SOCE). Knock-down of Letm1 and UCP2/3 did neither impact on cellular ATP levels nor the membrane potential. The enhanced mitochondrial Ca2+ signals in cells overexpressing UCP2/3 rescued SOCE upon Letm1 knock-down. In digitonin-permeabilized cells, Letm1 exclusively contributed to mitochondrial Ca2+ uptake at low Ca2+ conditions. Neither the Letm1-nor the UCP2/3-dependent mitochondrial Ca2+ uptake was affected by a knock-down of mRNA levels of mitochondrial calcium uptake 1 (MICU1), a protein that triggers mitochondrial Ca2+ uptake in HeLa cells. Our data indicate that Letm1 and UCP2/3 independently contribute to two distinct, mitochondrial Ca2+ uptake pathways in intact endothelial cells.	[Waldeck-Weiermair, Markus; Jean-Quartier, Claire; Rost, Rene; Khan, Muhammad Jadoon; Vishnu, Neelanjan; Bondarenko, Alexander I.; Malli, Roland; Graier, Wolfgang F.] Med Univ Graz, Ctr Mol Med, Mol & Cellular Physiol Res Unit, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Imamura, Hiromi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci, Chiyoda Ku, Tokyo 1020075, Japan	Medical University of Graz; Japan Science & Technology Agency (JST)	Graier, WF (corresponding author), Med Univ Graz, Ctr Mol Med, Mol & Cellular Physiol Res Unit, Inst Mol Biol & Biochem, Harrachgasse 21-3, A-8010 Graz, Austria.	wolfgang.graier@medunigraz.at	Graier, Wolfgang F./B-7052-2008; Bondarenko, Alexander I/B-3080-2013; Imamura, Hiromi/AAD-5109-2019; Khan, Muhammad Jadoon/AAG-5484-2019; Waldeck-Weiermair, Markus/AAV-5193-2020	Graier, Wolfgang F./0000-0003-1871-3298; Imamura, Hiromi/0000-0002-1896-0443; Waldeck-Weiermair, Markus/0000-0002-5792-6766; Malli, Roland/0000-0001-6327-8729; Bondarenko, Oleksandr/0000-0003-2629-5962; Rost, Rene/0000-0002-5393-0370; Jean-Quartier, Claire/0000-0002-0840-2173; Vishnu, Neelanjan/0000-0001-6395-4686	Austrian Science Funds (FWF) [P20181-B05, P21857-B18, P22553-B18, W 1226-B18]; FWF at the Medical University of Graz; Austrian Science Fund (FWF) [P 21857, P 22553] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); FWF at the Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Funds (FWF, P20181-B05, P21857-B18, and P22553-B18). C. J.-Q. and N. V. are funded by the FWF (W 1226-B18, DKplus Metabolic and Cardiovascular Disease), and M. J. K. is funded by the FWF within the program Molecular Medicine at the Medical University of Graz.	Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; Bondarenko A, 2004, BRIT J PHARMACOL, V143, P9, DOI 10.1038/sj.bjp.0705866; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Bondarenko AI, 2011, PFLUG ARCH EUR J PHY, V461, P177, DOI 10.1007/s00424-010-0898-x; Collins S, 2010, NATURE, V467, P283, DOI 10.1038/467283a; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Frieden M, 2000, J PHYSIOL-LONDON, V524, P715, DOI 10.1111/j.1469-7793.2000.00715.x; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Frieden M, 2002, J PHYSIOL-LONDON, V540, P73, DOI 10.1113/jphysiol.2002.017053; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Graier WF, 1998, J PHYSIOL-LONDON, V506, P109, DOI 10.1111/j.1469-7793.1998.109bx.x; GRAIER WF, 1992, BIOCHEM BIOPH RES CO, V186, P1539, DOI 10.1016/S0006-291X(05)81582-7; Graier WF, 2008, CELL CALCIUM, V44, P36, DOI 10.1016/j.ceca.2008.01.001; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Koncz P, 2006, CELL CALCIUM, V40, P347, DOI 10.1016/j.ceca.2006.04.003; Malli R, 2005, J BIOL CHEM, V280, P12114, DOI 10.1074/jbc.M409353200; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Malli R, 2010, FEBS LETT, V584, P1942, DOI 10.1016/j.febslet.2010.01.010; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Parekh AB, 2003, NEWS PHYSIOL SCI, V18, P252, DOI 10.1152/nips.01458.2003; Parekh AB, 2008, CELL CALCIUM, V44, P6, DOI 10.1016/j.ceca.2007.12.006; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pitter JG, 2002, CELL CALCIUM, V31, P97, DOI 10.1054/ceca.2001.0264; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; Rizzuto R, 1999, CELL CALCIUM, V26, P193, DOI 10.1054/ceca.1999.0076; RIZZUTO R, 1994, METHOD CELL BIOL, V40, P339; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Spat A, 2009, ACTA PHYSIOL, V195, P139, DOI 10.1111/j.1748-1716.2008.01928.x; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; Trenker M, 2008, NAT CELL BIOL, V10, P1237, DOI 10.1038/ncb1108-1237; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2010, CELL CALCIUM, V48, P288, DOI 10.1016/j.ceca.2010.10.004; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004	53	76	77	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28444	28455		10.1074/jbc.M111.244517	http://dx.doi.org/10.1074/jbc.M111.244517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21613221	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000293557800060
J	Binder, M; Eberle, F; Seitz, S; Mucke, N; Huber, CM; Kiani, N; Kaderali, L; Lohmann, V; Dalpke, A; Bartenschlager, R				Binder, Marco; Eberle, Florian; Seitz, Stefan; Muecke, Norbert; Hueber, Christian M.; Kiani, Narsis; Kaderali, Lars; Lohmann, Volker; Dalpke, Alexander; Bartenschlager, Ralf			Molecular Mechanism of Signal Perception and Integration by the Innate Immune Sensor Retinoic Acid-inducible Gene-I (RIG-I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; DOUBLE-STRANDED-RNA; INTERFERON INDUCTION; 5'-TRIPHOSPHATE RNA; ADAPTER PROTEIN; RECOGNITION; MDA5; ACTIVATION; INFECTION; RESPONSES	RIG-I is a major innate immune sensor for viral infection, triggering an interferon (IFN)-mediated antiviral response upon cytosolic detection of viral RNA. Double-strandedness and 5'-terminal triphosphates were identified as motifs required to elicit optimal immunological signaling. However, very little is known about the response dynamics of the RIG-I pathway, which is crucial for the ability of the cell to react to diverse classes of viral RNA while maintaining self-tolerance. In the present study, we addressed the molecular mechanism of RIG-I signal detection and its translation into pathway activation. By employing highly quantitative methods, we could establish the length of the double-stranded RNA(dsRNA) to be the most critical determinant of response strength. Size exclusion chromatography and direct visualization in scanning force microscopy suggested that this was due to cooperative oligomerization of RIG-I along dsRNA. The initiation efficiency of this oligomerization process critically depended on the presence of high affinity motifs, like a 5'-triphosphate. It is noteworthy that for dsRNA longer than 200 bp, internal initiation could effectively compensate for a lack of terminal triphosphates. In summary, our data demonstrate a very flexible response behavior of the RIG-I pathway, in which sensing and integration of at least two distinct signals, initiation efficiency and double strand length, allow the host cell to mount an antiviral response that is tightly adjusted to the type of the detected signal, such as viral genomes, replication intermediates, or small by-products.	[Binder, Marco; Eberle, Florian; Seitz, Stefan; Hueber, Christian M.; Lohmann, Volker; Dalpke, Alexander; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Muecke, Norbert] German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany; [Kiani, Narsis; Kaderali, Lars] Heidelberg Univ, Viroquant Res Grp Modeling, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Binder, M (corresponding author), Heidelberg Univ, Dept Infect Dis, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.	marco_binder@med.uni-heidelberg.de	Binder, Marco/E-9717-2011; Lohmann, Volker/H-4211-2019; kiani, narsis/J-8545-2013; Kiani, Narsis/Y-1045-2019; Bartenschlager, Ralf/L-2582-2015	Binder, Marco/0000-0002-5805-6109; Lohmann, Volker/0000-0001-8719-7608; Kiani, Narsis/0000-0002-0949-046X; Mucke, Norbert/0000-0002-0683-4386; Kaderali, Lars/0000-0002-2359-2294; Bartenschlager, Ralf/0000-0001-5601-9307	Deutsche Forschungsgemeinschaft [FOR1202]; Bundesministerium fur Bildung und Forschung [01KI0786]; Medical Faculty of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Medical Faculty of Heidelberg	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR1202 "Mechanisms of Persistence of Hepatotropic Viruses" (to R. B. and V. L.) and Bundesministerium fur Bildung und Forschung Grant 01KI0786 (to R. B.).; Supported by the Postdoc Fellowship of the Medical Faculty of Heidelberg.	Barchet W, 2008, CURR OPIN IMMUNOL, V20, P389, DOI 10.1016/j.coi.2008.07.007; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2010, MOL THER, V18, P1254, DOI 10.1038/mt.2010.90; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	36	95	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27278	27287		10.1074/jbc.M111.256974	http://dx.doi.org/10.1074/jbc.M111.256974			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659521	Green Published, hybrid			2022-12-27	WOS:000293268700023
J	Cao, JY; Qiu, S; Zhang, J; Wang, JJ; Zhang, XM; Luo, JH				Cao, Jing-yuan; Qiu, Shuang; Zhang, Jie; Wang, Jie-jie; Zhang, Xiao-min; Luo, Jian-hong			Transmembrane Region of N-Methyl-D-aspartate Receptor (NMDAR) Subunit Is Required for Receptor Subunit Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM RETENTION; GLUTAMATE-RECEPTOR; LIGAND-BINDING; PHARMACOLOGICAL CHAPERONES; TERMINAL DOMAIN; ION CHANNELS; PROTEIN; KAINATE; SIGNAL; AMPA	N-Methyl-D-aspartate receptors (NMDARs), one of three main classes of ionotropic glutamate receptors, play major roles in synaptic plasticity, synaptogenesis, and excitotoxicity. Unlike non-NMDA receptors, NMDARs are thought to comprise obligatory heterotetrameric complexes mainly composed of GluN1 and GluN2 subunits. When expressed alone in heterogenous cells, such as HEK293 cells, most of the NMDAR subunits can neither leave the endoplasmic reticulum (ER) nor be expressed in the cell membrane because of the ER retention signals. Only when NMDARs are heteromerically assembled can the ER retention signals be masked and NMDARs be expressed in the surface membrane. However, the mechanisms underlying NMDAR assembly remain poorly understood. To identify regions in subunits that mediate this assembly, we made a series of truncated or chimeric cDNA constructs. Using FRET measurement in living cells combined with immunostaining and coimmunoprecipitation analysis, we examined the assembly-determining domains of NMDAR subunits. Our results indicate that the transmembrane region of subunits is necessary for the assembly of NMDAR subunits, both for the homodimer and the heteromer.	[Cao, Jing-yuan; Qiu, Shuang; Zhang, Jie; Wang, Jie-jie; Zhang, Xiao-min; Luo, Jian-hong] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol,Dept Neurobiol, Minist Hlth China,Key Lab Med Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Luo, JH (corresponding author), 388 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn	ZHANG, Jie/S-6936-2019; Luo, jian/HGE-7331-2022	ZHANG, Jie/0000-0002-5492-8088; Wang, Jiejie/0000-0001-7585-0585; Zhang, Xiaomin/0000-0002-1179-979X	National Basic Research Program of China [2010CB912002]; National Natural Science Foundation of China [30730038, 30800308]; Fundamental Research Funds for the Central Universities of China	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Program of China Grant 2010CB912002, National Natural Science Foundation of China Grants 30730038 and 30800308, and by the Fundamental Research Funds for the Central Universities of China.	Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Fleck MW, 2003, J NEUROSCI, V23, P1219; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gee VJ, 2007, BRIT J PHARMACOL, V152, P501, DOI 10.1038/sj.bjp.0707429; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200	38	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27698	27705		10.1074/jbc.M111.235333	http://dx.doi.org/10.1074/jbc.M111.235333			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659529	hybrid, Green Published			2022-12-27	WOS:000293268700062
J	Couturier, J; Stroher, E; Albetel, AN; Roret, T; Muthuramalingam, M; Tarrago, L; Seidel, T; Tsan, P; Jacquot, JP; Johnson, MK; Dietz, KJ; Didierjean, C; Rouhier, N				Couturier, Jeremy; Stroeher, Elke; Albetel, Angela-Nadia; Roret, Thomas; Muthuramalingam, Meenakumari; Tarrago, Lionel; Seidel, Thorsten; Tsan, Pascale; Jacquot, Jean-Pierre; Johnson, Michael K.; Dietz, Karl-Josef; Didierjean, Claude; Rouhier, Nicolas			Arabidopsis Chloroplastic Glutaredoxin C5 as a Model to Explore Molecular Determinants for Iron-Sulfur Cluster Binding into Glutaredoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI GLUTAREDOXIN; MIXED DISULFIDE; ACTIVE-SITE; MONOTHIOL GLUTAREDOXINS; NMR STRUCTURE; THIOREDOXIN; PROTEIN; GLUTATHIONE; EXPRESSION; GRX5	Unlike thioredoxins, glutaredoxins are involved in iron-sulfur cluster assembly and in reduction of specific disulfides (i.e. protein-glutathione adducts), and thus they are also important redox regulators of chloroplast metabolism. Using GFP fusion, AtGrxC5 isoform, present exclusively in Brassicaceae, was shown to be localized in chloroplasts. A comparison of the biochemical, structural, and spectroscopic properties of Arabidopsis GrxC5 (WCSYC active site) with poplar GrxS12 (WCSYS active site), a chloroplastic paralog, indicated that, contrary to the solely apomonomeric GrxS12 isoform, AtGrxC5 exists as two forms when expressed in Escherichia coli. The monomeric apoprotein possesses deglutathionylation activity mediating the recycling of plastidial methionine sulfoxide reductase B1 and peroxiredoxin IIE, whereas the dimeric holoprotein incorporates a [2Fe-2S] cluster. Site-directed mutagenesis experiments and resolution of the x-ray crystal structure of AtGrxC5 in its holoform revealed that, although not involved in its ligation, the presence of the second active site cysteine (Cys(32)) is required for cluster formation. In addition, thiol titrations, fluorescence measurements, and mass spectrometry analyses showed that, despite the presence of a dithiol active site, AtGrxC5 does not form any inter-or intramolecular disulfide bond and that its activity exclusively relies on a monothiol mechanism.	[Roret, Thomas; Tsan, Pascale; Didierjean, Claude] Nancy Univ, Univ Henri Poincare, Fac Sci & Technol, Equipe Biocristallog,CNRS,UMR 7036, F-54506 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Tarrago, Lionel; Jacquot, Jean-Pierre; Rouhier, Nicolas] Nancy Univ, Inst Federatif Rech Ecosyst Forestiers Agroressou, Inst Natl Rech Agron, UMR 1136, F-54506 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Stroeher, Elke; Muthuramalingam, Meenakumari; Seidel, Thorsten; Dietz, Karl-Josef] Univ Bielefeld, Fac Biol W5 134, D-33501 Bielefeld, Germany; [Albetel, Angela-Nadia; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Albetel, Angela-Nadia; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; INRAE; Universite de Lorraine; University of Bielefeld; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Didierjean, C (corresponding author), Nancy Univ, Univ Henri Poincare, Fac Sci & Technol, Equipe Biocristallog,CNRS,UMR 7036, BP 239, F-54506 Vandoeuvre Les Nancy, France.	Claude.Didierjean@crm2.uhp-nancy.fr; nrouhier@scbiol.uhp-nancy.fr	DIDIERJEAN, Claude/L-1493-2013; Couturier, Jérémy/AAF-6588-2020; Tarrago, Lionel/N-3534-2016; Tarrago, Lionel/CAH-1308-2022; Jacquot, Jean-Pierre/A-1571-2012; Dietz, Karl-Josef/B-6029-2009	DIDIERJEAN, Claude/0000-0002-3176-8974; Couturier, Jérémy/0000-0003-3127-2669; Tarrago, Lionel/0000-0001-7115-8137; Tarrago, Lionel/0000-0001-7115-8137; Jacquot, Jean-Pierre/0000-0003-4975-8587; Dietz, Karl-Josef/0000-0003-0311-2182; tsan, pascale/0000-0002-0218-0258; Rouhier, Nicolas/0000-0002-2036-7884	National Institutes of Health [GM62524]; Alexander von Humboldt Foundation; Agence Nationale de la Recherche [JC07_204825]; Deutsche Forschungsgemeinschaft [DI346-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062524, R37GM062524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Agence Nationale de la Recherche(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62524 (to M. K. J.). This work was also supported by the Alexander von Humboldt Foundation (to J. P. J.), Agence Nationale de la Recherche Grant JC07_204825 (to J. C. and N. R.), and Deutsche Forschungsgemeinschaft Grant DI346-14 (to K. J. D.).	Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Behm M, 2000, PLANT PHYSIOL BIOCH, V38, P363, DOI 10.1016/S0981-9428(00)00760-9; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Ceylan S, 2010, J BIOL CHEM, V285, P35224, DOI 10.1074/jbc.M110.165860; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng NH, 2006, J BIOL CHEM, V281, P26280, DOI 10.1074/jbc.M601354200; Couturier J, 2010, BIOCHEM BIOPH RES CO, V403, P435, DOI 10.1016/j.bbrc.2010.11.050; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gama F, 2008, PHYSIOL PLANTARUM, V133, P599, DOI 10.1111/j.1399-3054.2008.01097.x; Gao XH, 2010, FEBS LETT, V584, P2242, DOI 10.1016/j.febslet.2010.04.034; Greetham D, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-3; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Horling F, 2003, PLANT PHYSIOL, V131, P317, DOI 10.1104/pp.010017; Iwema T, 2009, BIOCHEMISTRY-US, V48, P6041, DOI 10.1021/bi900440m; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Molina-Navarro MM, 2006, FEBS LETT, V580, P2273, DOI 10.1016/j.febslet.2006.03.037; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIKKOLA M, 1991, J BIOL CHEM, V266, P16105; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Saaranen MJ, 2009, ANTIOXID REDOX SIGN, V11, P1819, DOI [10.1089/ars.2008.2387, 10.1089/ARS.2008.2387]; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Seidel T, 2005, FEBS LETT, V579, P4374, DOI 10.1016/j.febslet.2005.06.077; Stroher E, 2009, MOL PLANT, V2, P357, DOI 10.1093/mp/ssn084; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wormuth D, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-15; XIA TH, 1992, PROTEIN SCI, V1, P310; YANG YF, 1991, J BIOL CHEM, V266, P12759; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200	62	63	66	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27515	27527		10.1074/jbc.M111.228726	http://dx.doi.org/10.1074/jbc.M111.228726			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21632542	Green Published, hybrid			2022-12-27	WOS:000293268700046
J	Dong, SY; Wang, Y; Cassidy-Amstutz, C; Lu, G; Bigler, R; Jezyk, MR; Li, CH; Hall, TMT; Wang, ZF				Dong, Shuyun; Wang, Yang; Cassidy-Amstutz, Caleb; Lu, Gang; Bigler, Rebecca; Jezyk, Mark R.; Li, Chunhua; Hall, Traci M. Tanaka; Wang, Zefeng			Specific and Modular Binding Code for Cytosine Recognition in Pumilio/FBF (PUF) RNA-binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTERACTIONS; SYSTEM; SMART; VEGF	Pumilio/fem-3 mRNA-binding factor (PUF) proteins possess a recognition code for bases A, U, and G, allowing designed RNA sequence specificity of their modular Pumilio (PUM) repeats. However, recognition side chains in a PUM repeat for cytosine are unknown. Here we report identification of a cytosine-recognition code by screening random amino acid combinations at conserved RNA recognition positions using a yeast three-hybrid system. This C-recognition code is specific and modular as specificity can be transferred to different positions in the RNA recognition sequence. A crystal structure of a modified PUF domain reveals specific contacts between an arginine side chain and the cytosine base. We applied the C-recognition code to design PUF domains that recognize targets with multiple cytosines and to generate engineered splicing factors that modulate alternative splicing. Finally, we identified a divergent yeast PUF protein, Nop9p, that may recognize natural target RNAs with cytosine. This work deepens our understanding of natural PUF protein target recognition and expands the ability to engineer PUF domains to recognize any RNA sequence.	[Dong, Shuyun; Wang, Yang; Bigler, Rebecca; Wang, Zefeng] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Cassidy-Amstutz, Caleb; Lu, Gang; Jezyk, Mark R.; Hall, Traci M. Tanaka] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Cassidy-Amstutz, Caleb] N Carolina State Univ, Program Bioinformat, Raleigh, NC 27695 USA; [Li, Chunhua] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; North Carolina State University; Beijing University of Technology	Wang, ZF (corresponding author), Univ N Carolina, Dept Pharmacol, CB 7365, Chapel Hill, NC 27599 USA.	zefeng@med.unc.edu	Wang, Yang/A-1849-2010; Hall, Traci/F-5849-2019	Wang, Yang/0000-0001-9385-7393; Hall, Traci/0000-0001-6166-3009; Bigler, Rebecca/0000-0002-0075-6188; Wang, Zefeng/0000-0002-6605-3637; Dong, Shuyun/0000-0003-2988-6864	National Institute of Environmental Health Sciences; Beckman Foundation; Kimmel Sidney Scholar; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [R01CA158283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR061640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050165] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Beckman Foundation; Kimmel Sidney Scholar; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by a grant from the Intramural Research Program of the National Institute of Environmental Health Sciences (to T. M. T. H.) and by a grant from the Beckman Foundation and the Kimmel Sidney Scholar award (to Z.W.).; We thank Dr. Marvin Wickens (University of Wisconsin) for providing the plasmids and yeast strains for the Y3H assay. We thank Dr. Rajarshi Chudhury for suggestions and help in protein purification, Dr. Chen Qiu for help with RNA binding assays, and Dr. Lars Pedersen and the staff at the SER-CAT beamline for help with X-ray data collection. Data were collected at SER-CAT 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found on-line. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Chen GX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000026; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipovska A., 2011, NAT CHEM BIOL, DOI 10.1038; Fox JE, 2008, NAT PROTOC, V3, P637, DOI 10.1038/nprot.2008.33; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hook B, 2005, RNA, V11, P227, DOI 10.1261/rna.7202705; Koh YY, 2011, RNA, V17, P718, DOI 10.1261/rna.2540311; Koh YY, 2009, RNA, V15, P1090, DOI 10.1261/rna.1545309; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lu G, 2011, STRUCTURE, V19, P361, DOI 10.1016/j.str.2010.12.019; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Opperman L, 2005, NAT STRUCT MOL BIOL, V12, P945, DOI 10.1038/nsmb1010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Qiu Y, 2009, BIOCHEM SOC T, V37, P1207, DOI 10.1042/BST0371207; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schweers BA, 2002, GENETICS, V161, P1177; Stumpf CR, 2008, METHOD ENZYMOL, V449, P295, DOI 10.1016/S0076-6879(08)02414-2; Thomson E, 2007, RNA, V13, P2165, DOI 10.1261/rna.747607; Tilsner J, 2009, PLANT J, V57, P758, DOI 10.1111/j.1365-313X.2008.03720.x; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106	34	82	91	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26732	26742		10.1074/jbc.M111.244889	http://dx.doi.org/10.1074/jbc.M111.244889			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653694	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000293078200050
J	Jha, BK; Polyakova, I; Kessler, P; Dong, BH; Dickerman, B; Sen, GC; Silverman, RH				Jha, Babal Kant; Polyakova, Irina; Kessler, Patricia; Dong, Beihua; Dickerman, Benjamin; Sen, Ganes C.; Silverman, Robert H.			Inhibition of RNase L and RNA-dependent Protein Kinase (PKR) by Sunitinib Impairs Antiviral Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; 2-5A-DEPENDENT RNASE; 2',5'-OLIGOADENYLATE SYNTHETASE; INTERFERON ACTION; ACTIVATION; IRE1; CLEAVAGE; DOMAIN; 2-5A; OLIGOADENYLATES	RNase L and RNA-dependent protein kinase (PKR) are effectors of the interferon antiviral response that share homology in their pseudokinase and protein kinase domains, respectively. Sunitinib is an orally available, ATP-competitive inhibitor of VEGF andPDGFreceptors used clinically to suppress angiogenesis and tumor growth. Sunitinib also impacts IRE1, an endoplasmic reticulum protein involved in the unfolded protein response that is closely related to RNase L. Here, we report that sunitinib is a potent inhibitor of both RNase L and PKR with IC50 values of 1.4 and 0.3 mu M, respectively. In addition, flavonol activators of IRE1 inhibited RNase L. Sunitinib treatment of wild type (WT) mouse embryonic fibroblasts resulted in about a 12-fold increase in encephalomyocarditis virus titers. However, sunitinib had no effect on encephalomyocarditis virus growth in cells lacking both PKR and RNase L. Furthermore, oral delivery of sunitinib inWTmice resulted in 10-fold higher viral titers in heart tissues while suppressing by about 2-fold the IFN-beta levels. In contrast, sunitinib had no effect on viral titers in mice deficient in both RNase L and PKR. Also, sunitinib reduced mean survival times from 12 to 6 days in virus-infectedWTmice while having no effect on survival of mice lacking both RNase L and PKR. Results indicate that sunitinib treatments prevent antiviral innate immune responses mediated by RNase L and PKR.	[Jha, Babal Kant; Polyakova, Irina; Kessler, Patricia; Dong, Beihua; Silverman, Robert H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Dickerman, Benjamin; Sen, Ganes C.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Silverman, RH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.	silverr@ccf.org	jha, babal k/B-1803-2010	jha, babal k/0000-0002-7660-5255	National Institutes of Health, NCI [CA044059, CA062220]; NATIONAL CANCER INSTITUTE [R01CA044059, P01CA062220, R01CA068782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073303] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA044059 (to R. H. S.) and CA062220 (to G. S.) from NCI.	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; BAUMAL R, 1986, CANCER RES, V46, P3994; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Carroll SS, 1997, J BIOL CHEM, V272, P19193, DOI 10.1074/jbc.272.31.19193; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Dong BH, 1997, J BIOL CHEM, V272, P22236, DOI 10.1074/jbc.272.35.22236; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; DONG BH, 1994, J BIOL CHEM, V269, P14153; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; Luthra P, 2011, P NATL ACAD SCI USA, V108, P2118, DOI 10.1073/pnas.1012409108; Malathi K, 2004, CANCER RES, V64, P9144, DOI 10.1158/0008-5472.CAN-04-2226; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Malathi K, 2010, RNA, V16, P2108, DOI 10.1261/rna.2244210; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Molinaro RJ, 2006, NUCLEIC ACIDS RES, V34, P6684, DOI 10.1093/nar/gkl968; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Nakanishi M, 2005, PROTEINS, V60, P131, DOI 10.1002/prot.20474; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Silverman RH, 2000, METHOD ENZYMOL, V313, P522; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Tanaka N, 2004, EMBO J, V23, P3929, DOI 10.1038/sj.emboj.7600420; Thakur CS, 2007, P NATL ACAD SCI USA, V104, P9585, DOI 10.1073/pnas.0700590104; Thakur CS, 2005, METH MOLEC MED, V116, P103; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; WRESCHNER DH, 1982, EUR J BIOCHEM, V124, P261; WRESCHNER DH, 1981, NUCLEIC ACIDS RES, V9, P1571, DOI 10.1093/nar/9.7.1571; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	40	61	63	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26319	26326		10.1074/jbc.M111.253443	http://dx.doi.org/10.1074/jbc.M111.253443			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636578	Green Published, hybrid			2022-12-27	WOS:000293078200008
J	Lee, J; Arvan, P				Lee, Jaemin; Arvan, Peter			Repeat Motif-containing Regions within Thyroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINESTERASE-LIKE DOMAIN; CONGENITAL GOITER; THYROID PEROXIDASE; HORMONE FORMATION; PROTEIN; GENE; ACETYLCHOLINESTERASE; HYPOTHYROIDISM; MUTATIONS; SECRETION	Thyroglobulin (precursor for thyroid hormone synthesis) is a large secreted glycoprotein comprising contiguous region I (multiple type-1 repeating units engaging the first similar to 1,191 residues, followed by a similar to 245-residue hinge region), regions II-III (multiple type-2 and 3 repeating units, comprising similar to 720 residues), and the C-terminal cholinesterase-like (ChEL) domain (similar to 570 residues). A signal peptide attached to ChEL makes an independent secretory protein that binds to I-II-III, stabilizing it and rescuing the secretion of I-II-III that would otherwise be trapped in the endoplasmic reticulum (ER). In this study, we found that a signal peptide attached to regions II-III also makes for an efficient secretory protein that neither demonstrably interacts nor has its secretion enhanced by the presence of secretory ChEL. By contrast, region I, either with or without the hinge region, cannot be secreted on its own and remains in the ER where it is bound to ER chaperones BiP and GRP94. Whereas ChEL can rescue secretion of I-II-III, it can rescue I-II only very weakly, and region I not at all. Yet, ChEL begins to rescue region I in cells that also co-express secretory II-III. The data suggest that conformational maturation of region I is a limiting step in the thyroglobulin maturation process, and this step is facilitated by the presence of both regions II-III and ChEL. Mutations causing hypothyroidism might induce solely local/regional misfolding or may interfere more globally by impeding interactions between regions that are required for thyroglobulin secretion.	[Lee, Jaemin; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, 5560 MSRB2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umich.edu	Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141	National Institutes of Health [R01-DK40344]; University of Michigan Diabetes Research and Training Center [NIH5P60-DK20572, P30 CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Diabetes Research and Training Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK40344 (to P. A.). This work was also supported by University of Michigan Diabetes Research and Training Center Grant NIH5P60-DK20572 for the Molecular Biology and Sequencing Cores and University of Michigan Cancer Center Core Laboratories Grant P30 CA46592.	Aryan P, 2004, THYROID, P77; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Gutnisky VJ, 2004, J CLIN ENDOCR METAB, V89, P646, DOI 10.1210/jc.2003-030587; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; Hishinuma A, 1999, J CLIN ENDOCR METAB, V84, P1438, DOI 10.1210/jc.84.4.1438; Hishinuma A, 2006, J CLIN ENDOCR METAB, V91, P3100, DOI 10.1210/jc.2005-2702; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; Mihelic M, 2007, BIOL CHEM, V388, P1123, DOI 10.1515/BC.2007.155; MONACO F, 1981, COMP BIOCHEM PHYS B, V70, P341, DOI 10.1016/0305-0491(81)90054-7; MORI N, 1987, P NATL ACAD SCI USA, V84, P2813, DOI 10.1073/pnas.84.9.2813; Pardo V, 2009, J CLIN ENDOCR METAB, V94, P2938, DOI 10.1210/jc.2009-0150; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Peteiro-Gonzalez D, 2010, J CLIN ENDOCR METAB, V95, P3522, DOI 10.1210/jc.2009-2109; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SWILLENS S, 1986, BIOCHEM BIOPH RES CO, V137, P142, DOI 10.1016/0006-291X(86)91187-3; Targovnik HM, 2010, MOL CELL ENDOCRINOL, V322, P44, DOI 10.1016/j.mce.2010.01.009; TARGOVNIK HM, 1993, J CLIN ENDOCR METAB, V77, P210, DOI 10.1210/jc.77.1.210; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Turakulov Ia Kh, 1976, Biokhimiia, V41, P1004; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	28	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26327	26333		10.1074/jbc.M111.242099	http://dx.doi.org/10.1074/jbc.M111.242099			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636579	Green Published, hybrid			2022-12-27	WOS:000293078200009
J	Meruvu, S; Hugendubler, L; Mueller, E				Meruvu, Sunitha; Hugendubler, Lynne; Mueller, Elisabetta			Regulation of Adipocyte Differentiation by the Zinc Finger Protein ZNF638	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING NUCLEAR-PROTEIN; TRANSCRIPTIONAL CONTROL; DOMAIN; ZFP423; FAMILY; MOTIF	Zinc finger proteins constitute the largest family of transcription regulators in eukaryotes. These factors are involved in diverse processes in many tissues, including development and differentiation. We report here the characterization of the zinc finger protein ZNF638 as a novel regulator of adipogenesis. ZNF638 is induced early during adipocyte differentiation. Ectopic expression of ZNF638 increases adipogenesis in vitro, whereas its knockdown inhibits differentiation and decreases the expression of adipocyte-specific genes. ZNF638 physically interacts and transcriptionally cooperates with CCAAT/enhancer-binding protein (C/EBP) beta and C/EBP delta. This interaction leads to the expression of peroxisome proliferator-activated receptor gamma, which is the key regulator of adipocyte differentiation. In summary, ZNF638 is a novel and early regulator of adipogenesis that works as a transcription cofactor of C/EBPs.	[Meruvu, Sunitha; Hugendubler, Lynne; Mueller, Elisabetta] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Mueller, E (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bldg 10,Rm 8D12B,9000 Rockville Pike, Bethesda, MD 20892 USA.	elisabettam@niddk.nih.gov			National Institutes of Health NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056023, ZIADK075004] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole by the National Institutes of Health NIDDK Intramural Research Program.	Auboeuf D, 2005, MOL CELL BIOL, V25, P5307, DOI 10.1128/MCB.25.13.5307-5316.2005; Brey CW, 2009, INT J BIOL SCI, V5, P622; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Inagaki H, 1996, J BIOL CHEM, V271, P12525, DOI 10.1074/jbc.271.21.12525; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Matsushima Y, 1996, BIOCHEM BIOPH RES CO, V223, P427, DOI 10.1006/bbrc.1996.0910; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Ng EKO, 2002, J CELL BIOCHEM, V84, P556, DOI 10.1002/jcb.10041.abs; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05	14	49	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26516	26523		10.1074/jbc.M110.212506	http://dx.doi.org/10.1074/jbc.M110.212506			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21602272	Green Published, hybrid			2022-12-27	WOS:000293078200030
J	Katz, RA; Merkel, G; Andrake, MD; Roder, H; Skalka, AM				Katz, Richard A.; Merkel, George; Andrake, Mark D.; Roder, Heinrich; Skalka, Anna Marie			Retroviral Integrases Promote Fraying of Viral DNA Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA VIRUS INTEGRASE; HIV-1 INTEGRASE; MOLECULAR-MECHANISMS; CA DINUCLEOTIDE; RECOGNITION; SUBSTRATE; SITE; CONFORMATION; FLUORESCENCE; INHIBITION	In the initial step of integration, retroviral integrase (IN) introduces precise nicks in the degenerate, short inverted repeats at the ends of linear viral DNA. The scissile phosphodiester bond is located immediately 3' of a highly conserved CA/GT dinucleotide, usually 2 bp from the ends. These nicks create new recessed 3'-OH viral DNA ends that are required for joining to host cell DNA. Previous studies have indicated that unpairing, "fraying," of the viral DNA ends by IN contributes to end recognition or catalysis. Here, we report that end fraying can be detected independently of catalysis with both avian sarcoma virus (ASV) and human immunodeficiency virus type 1 (HIV-1) IN proteins by use of fluorescence resonance energy transfer (FRET). The results were indicative of an IN-induced intramolecular conformational change in the viral DNA ends (cis FRET). Fraying activity is tightly coupled to the DNA binding capabilities of these enzymes, as follows: an inhibitor effective against both IN proteins was shown to block ASV IN DNA binding and end fraying, with similar dose responses; ASV IN substitutions that reduced DNA binding also reduced end fraying activity; and HIV-1 IN DNA binding and end fraying were both undetectable in the absence of a metal cofactor. Consistent with our previous results, end fraying is sequence-independent, suggesting that the DNA terminus per se is a major structural determinant for recognition. We conclude that frayed ends represent a functional intermediate in which DNA termini can be sampled for suitability for endonucleolytic processing.	[Katz, Richard A.; Merkel, George; Andrake, Mark D.; Roder, Heinrich; Skalka, Anna Marie] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Skalka, AM (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	AM_Skalka@fccc.edu	Roder, Heinrich/B-3455-2009	Roder, Heinrich/0000-0003-1860-2491	National Institutes of Health [AI40385, CA71515, CA006927]; NATIONAL CANCER INSTITUTE [R01CA071515, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40385, CA71515, and CA006927.	Agapkina J, 2004, EUR J BIOCHEM, V271, P205, DOI 10.1046/j.1432-1033.2003.03921.x; Aiyar A, 1996, J VIROL, V70, P3571, DOI 10.1128/JVI.70.6.3571-3580.1996; Andrake Mark D, 2009, AIDS Res Ther, V6, P14, DOI 10.1186/1742-6405-6-14; AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; Iqbal A, 2008, BIOCHEMISTRY-US, V47, P7857, DOI 10.1021/bi800773f; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Katz RA, 2001, J BIOL CHEM, V276, P34213, DOI 10.1074/jbc.M104632200; Katzman M, 1999, ADV VIRUS RES, V52, P371, DOI 10.1016/S0065-3527(08)60307-3; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Lee I, 2003, NUCLEIC ACIDS RES, V31, P4531, DOI 10.1093/nar/gkg499; Lee I, 2003, J MOL BIOL, V330, P261, DOI 10.1016/S0022-2836(03)00574-6; Levitus M, 2011, Q REV BIOPHYS, V44, P123, DOI 10.1017/S0033583510000247; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Lubkowski J, 1998, P NATL ACAD SCI USA, V95, P4831, DOI 10.1073/pnas.95.9.4831; Merkel G, 2009, METHODS, V47, P243, DOI 10.1016/j.ymeth.2008.10.024; Montano SP, 2006, NUCLEIC ACIDS RES, V34, P5353, DOI 10.1093/nar/gkl693; Oh J, 2008, J VIROL, V82, P11480, DOI 10.1128/JVI.01353-08; Oh J, 2008, J VIROL, V82, P503, DOI 10.1128/JVI.01441-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramreddy T, 2007, J PHYS CHEM B, V111, P5757, DOI 10.1021/jp068818f; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; Skalka AM, 2005, CELL DEATH DIFFER, V12, P971, DOI 10.1038/sj.cdd.4401573; Spring BQ, 2007, J PHYS CHEM B, V111, P10040, DOI 10.1021/jp0725782; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; Vandegraaff Nick, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000257; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; Woehler A, 2010, BIOPHYS J, V99, P2344, DOI 10.1016/j.bpj.2010.07.053; Yi JZ, 1999, BIOCHEMISTRY-US, V38, P8458, DOI 10.1021/bi982870n	40	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25710	25718		10.1074/jbc.M111.229179	http://dx.doi.org/10.1074/jbc.M111.229179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622554	Green Published, hybrid			2022-12-27	WOS:000293073000032
J	Kolte, D; Osman, N; Yang, J; Shariat-Madar, Z				Kolte, Dhaval; Osman, Noah; Yang, Jia; Shariat-Madar, Zia			High Molecular Weight Kininogen Activates B-2 Receptor Signaling Pathway in Human Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; CYTOKERATIN 1; INTRACELLULAR CALCIUM; EXTRACELLULAR CALCIUM; ION CHANNELS; FACTOR-XII; IN-VIVO; BRADYKININ; IDENTIFICATION; PREKALLIKREIN	The nonenzymatic cofactor high molecular weight kininogen (HK) is a precursor of bradykinin (BK). The production of BK from HK by plasma kallikrein has been implicated in the pathogenesis of inflammation and vascular injury. However, the functional role of HK in the absence of prekallikrein (PK), the proenzyme of plasma kallikrein, on vascular endothelial cells is not fully defined. In addition, no clinical abnormality is seen in PK-deficient patients. Therefore, an investigation into the effect of HK, in the absence of PK, on human pulmonary artery endothelial cell (HPAEC) function was performed. HK caused a marked and dose-dependent increase in the intracellular calcium [Ca2+](i) level in HPAEC. Gd3+ and verapamil potentiated the HK-induced increase in [Ca2+](i). HK-induced Ca2+ increase stimulated endothelial nitric oxide (NO) and prostacyclin (PGI(2)) production. The inhibitors of B-2 receptor-dependent signaling pathway impaired HK-mediated signal transduction in HPAEC. HK had no effect on endothelial permeability at physiological concentration. This study demonstrated that HK regulates endothelial cell function. HK could play an important role in maintaining normal endothelial function and blood flow and serve as a cardioprotective peptide.	[Kolte, Dhaval; Yang, Jia; Shariat-Madar, Zia] Univ Mississippi, Dept Pharmacol, University, MS 38677 USA; [Shariat-Madar, Zia] Univ Mississippi, Pharmaceut Sci Res Inst, University, MS 38677 USA	University of Mississippi; University of Mississippi	Shariat-Madar, Z (corresponding author), Univ Mississippi, Dept Pharmacol, University, MS 38677 USA.	madar@olemiss.edu	Kolte, Dhaval/AAL-4032-2020; Kolte, Dhaval/G-9294-2015	Kolte, Dhaval/0000-0002-7107-3667	NCRR/National Institutes of Health [P20RR021929]; National Science Foundation [MRI 0619774]; American Heart Association [0330193N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021929] Funding Source: NIH RePORTER	NCRR/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by NCRR/National Institutes of Health Grant P20RR021929 (to Z. S.-M.), National Science Foundation Grant MRI 0619774, and American Heart Association Grant 0330193N.	ADAMS DJ, 1989, FASEB J, V3, P2389, DOI 10.1096/fasebj.3.12.2477294; Berkels, 1999, J Cardiovasc Pharmacol Ther, V4, P175, DOI 10.1177/107424849900400307; Berkels R, 2003, PHARMACOLOGY, V69, P171, DOI 10.1159/000073659; Bior AD, 2007, J THROMB HAEMOST, V5, P403, DOI 10.1111/j.1538-7836.2007.02352.x; Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234; Chajkowski SM, 2011, BIOCHEM BIOPH RES CO, V405, P338, DOI 10.1016/j.bbrc.2010.12.036; COLDENSTANFIELD M, 1987, CIRC RES, V61, P632, DOI 10.1161/01.RES.61.5.632; Colman RW, 1997, J CLIN INVEST, V100, P1481, DOI 10.1172/JCI119669; Dedio J, 1996, FEBS LETT, V399, P255, DOI 10.1016/S0014-5793(96)01339-7; DOLOR RJ, 1992, AM J PHYSIOL, V262, pC171, DOI 10.1152/ajpcell.1992.262.1.C171; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Fernando AN, 2005, AM J PHYSIOL-HEART C, V289, pH251, DOI 10.1152/ajpheart.00206.2004; Gryglewski RJ, 2002, PEDIATR PATHOL MOL M, V21, P279, DOI 10.1080/02770930290056514; HASAN AAK, 1994, J BIOL CHEM, V269, P31822; Hasan AAK, 1998, P NATL ACAD SCI USA, V95, P3615, DOI 10.1073/pnas.95.7.3615; Imamura T, 1996, LAB INVEST, V74, P861; Isordia-Salas I, 2005, ARCH MED RES, V36, P87, DOI 10.1016/j.arcmed.2005.02.001; Isordia-Salas I, 2002, INT IMMUNOPHARMACOL, V2, P1895, DOI 10.1016/S1567-5769(02)00183-2; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Joseph K, 1996, P NATL ACAD SCI USA, V93, P8552, DOI 10.1073/pnas.93.16.8552; Joseph K, 1999, CLIN IMMUNOL, V92, P246, DOI 10.1006/clim.1999.4753; Lombardi AM, 2003, THROMB HAEMOSTASIS, V90, P1040, DOI 10.1160/TH03-05-0275; Ma JX, 1996, EXP EYE RES, V63, P19, DOI 10.1006/exer.1996.0087; Mahdi F, 2004, J BIOL CHEM, V279, P16621, DOI 10.1074/jbc.M313850200; Mashiko H, 1999, IMMUNOPHARMACOLOGY, V45, P103, DOI 10.1016/S0162-3109(99)00061-2; McGinnis KM, 1998, J NEUROCHEM, V70, P139; MURPHY HS, 1994, AM J PHYSIOL, V267, pL145, DOI 10.1152/ajplung.1994.267.2.L145; Nakazawa Y, 2002, INT IMMUNOPHARMACOL, V2, P1875, DOI 10.1016/S1567-5769(02)00182-0; Ngo ML, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-3; Nilius B, 1997, J PHYSIOL-LONDON, V498, P381, DOI 10.1113/jphysiol.1997.sp021865; Nilius B, 1997, ANNU REV PHYSIOL, V59, P145, DOI 10.1146/annurev.physiol.59.1.145; OCONNOR ER, 1993, J NEUROSCI, V13, P2638, DOI 10.1523/JNEUROSCI.13-06-02638.1993; Oehmcke S, 2009, BLOOD, V114, P444, DOI 10.1182/blood-2008-10-182527; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; PATRASSI G M, 1982, Folia Haematologica (Leipzig), V109, P644; Perkins R, 2008, BIOCHEM BIOPH RES CO, V366, P938, DOI 10.1016/j.bbrc.2007.12.042; Pixley RA, 2011, THROMB HAEMOSTASIS, V105, P1053, DOI 10.1160/TH10-09-0591; POON MC, 1982, AM J HEMATOL, V12, P261, DOI 10.1002/ajh.2830120308; Sainz IM, 2005, ARTHRITIS RHEUM-US, V52, P2549, DOI 10.1002/art.21202; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; SAUVE R, 1990, J HYPERTENS, V8, pS193; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Shariat-Madar Z, 1999, TRENDS CARDIOVAS MED, V9, P238, DOI 10.1016/S1050-1738(00)00028-1; Shariat-Madar Z, 1999, J BIOL CHEM, V274, P7137, DOI 10.1074/jbc.274.11.7137; SMITH PL, 1980, J CLIN INVEST, V66, P1072, DOI 10.1172/JCI109936; Takano M, 1997, BBA-GENE STRUCT EXPR, V1352, P222, DOI 10.1016/S0167-4781(97)00018-3; UENO A, 1995, BRIT J PHARMACOL, V114, P1250, DOI 10.1111/j.1476-5381.1995.tb13340.x; White PJ, 1996, J EXP BOT, V47, P713, DOI 10.1093/jxb/47.5.713; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhao YQ, 2001, AM J PHYSIOL-HEART C, V280, pH1821, DOI 10.1152/ajpheart.2001.280.4.H1821	51	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24561	24571		10.1074/jbc.M110.211557	http://dx.doi.org/10.1074/jbc.M110.211557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21586566	Green Published, hybrid			2022-12-27	WOS:000292547900006
J	Singh, RP; Prasad, HK; Sinha, I; Agarwal, N; Natarajan, K				Singh, Rana Pratap; Prasad, Himanshu K.; Sinha, Ishani; Agarwal, Neha; Natarajan, Krishnamurthy			Cap2-HAP Complex Is a Critical Transcriptional Regulator That Has Dual but Contrasting Roles in Regulation of Iron Homeostasis in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT-BINDING FACTOR; YEAST SCHIZOSACCHAROMYCES-POMBE; FACTOR NF-Y; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; OXIDATIVE STRESS; FISSION YEAST; DNA-BINDING; MULTIDRUG-RESISTANCE; BIOLOGICAL NETWORKS	Iron homeostasis is highly regulated in organisms across evolutionary time scale as iron is essential for various cellular processes. In a computational screen, we identified the Yap/bZIP domain family in Candida clade genomes. Cap2/Hap43 is essential for C. albicans growth under iron-deprivation conditions and for virulence in mouse. Cap2 has an amino-terminal bipartite domain comprising a fungal-specific Hap4-like domain and a bZIP domain. Our mutational analyses showed that both the bZIP and Hap4-like domains perform critical and independent functions for growth under iron-deprivation conditions. Transcriptome analysis conducted under iron-deprivation conditions identified about 16% of the C. albicans ORFs that were differentially regulated in a Cap2-dependent manner. Microarray data also suggested that Cap2 is required to mobilize iron through multiple mechanisms; chiefly by activation of genes in three iron uptake pathways and repression of iron utilizing and iron storage genes. The expression of HAP2, HAP32, and HAP5, core components of the HAP regulatory complex was induced in a Cap2-dependent manner indicating a feed-forward loop. In a feed-back loop, Cap2 repressed the expression of Sfu1, a negative regulator of iron uptake genes. Cap2 was coimmunoprecipitated with Hap5 from cell extracts prepared from iron-deprivation conditions indicating an in vivo association. ChIP assays demonstrated Hap32-dependent recruitment of Hap5 to the promoters of FRP1 (Cap2-induced) and ACO1 (Cap2-repressed). Together our data indicates that the Cap2-HAP complex functions both as a positive and a negative regulator to maintain iron homeostasis in C. albicans.	[Singh, Rana Pratap; Prasad, Himanshu K.; Sinha, Ishani; Agarwal, Neha; Natarajan, Krishnamurthy] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Natarajan, K (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	nat0200@mail.jnu.ac.in		Singh, Rana Pratap/0000-0003-4261-7044	Department of Biotechnology, Ministry of Science and Technology, Government of India; Jawaharlal Nehru University; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Jawaharlal Nehru University; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a research grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India, and the UPOE and DST-PURSE grants from Jawaharlal Nehru University.; Supported by Junior and Senior Research Fellowships from Council of Scientific and Industrial Research, New Delhi.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alarco AM, 1997, J BIOL CHEM, V272, P19304, DOI 10.1074/jbc.272.31.19304; Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Baek YU, 2008, EUKARYOT CELL, V7, P1168, DOI 10.1128/EC.00108-08; BOWTELL D, 2003, DNA MICROARRAYS MOL; Brakhage AA, 1999, FUNGAL GENET BIOL, V27, P243, DOI 10.1006/fgbi.1999.1136; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Chao LY, 2008, BIOCHEMISTRY-US, V47, P7274, DOI 10.1021/bi800066s; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Corvey C, 2005, J BIOL CHEM, V280, P25323, DOI 10.1074/jbc.M503719200; De Freitas JM, 2000, J BIOL CHEM, V275, P11645, DOI 10.1074/jbc.275.16.11645; Fairhead C, 1996, YEAST, V12, P1439; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Heymann P, 2002, INFECT IMMUN, V70, P5246, DOI 10.1128/IAI.70.9.5246-5255.2002; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Hu CJ, 2002, J BIOL CHEM, V277, P30598, DOI 10.1074/jbc.M204545200; Johnson DC, 2005, EUKARYOT CELL, V4, P1662, DOI 10.1128/EC.4.10.1662-1676.2005; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Knight SAB, 2005, INFECT IMMUN, V73, P5482, DOI 10.1128/IAI.73.9.5482-5492.2005; Knight SAB, 2002, MICROBIOL-SGM, V148, P29, DOI 10.1099/00221287-148-1-29; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Kornitzer D, 2009, CURR OPIN MICROBIOL, V12, P377, DOI 10.1016/j.mib.2009.05.005; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Liang Y, 2010, MICROBIOL-SGM, V156, P2912, DOI 10.1099/mic.0.037978-0; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Marck C, 2006, NUCLEIC ACIDS RES, V34, P1816, DOI 10.1093/nar/gkl085; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Natarajan K., 2007, METHODS GEN MOL MICR, P978; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; PU WT, 1991, MOL CELL BIOL, V11, P4918, DOI 10.1128/MCB.11.10.4918; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Santos R, 2004, MOL MICROBIOL, V54, P507, DOI 10.1111/j.1365-2958.2004.04281.x; Santos R, 2003, MICROBIOL-SGM, V149, P579, DOI 10.1099/mic.0.26108-0; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; Sutak R, 2008, TRENDS MICROBIOL, V16, P261, DOI 10.1016/j.tim.2008.03.005; Sybirna K, 2005, CURR GENET, V47, P172, DOI 10.1007/s00294-004-0556-y; Sybirna K, 2010, YEAST, V27, P941, DOI 10.1002/yea.1802; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; Yang XS, 2001, YEAST, V18, P1217, DOI 10.1002/yea.770; Yatskou Mikalai, 2008, BMC Res Notes, V1, P80, DOI 10.1186/1756-0500-1-80; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256	82	68	933	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25154	25170		10.1074/jbc.M111.233569	http://dx.doi.org/10.1074/jbc.M111.233569			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592964	Green Published, hybrid			2022-12-27	WOS:000292547900063
J	Yu, W; Chiaw, PK; Bear, CE				Yu, Wilson; Chiaw, Patrick Kim; Bear, Christine E.			Probing Conformational Rescue Induced by a Chemical Corrector of F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG ABC TRANSPORTER; CYSTIC-FIBROSIS; DELTA-F508 MUTATION; PROCESSING MUTANTS; CHANNEL FUNCTION; TRAFFICKING; IDENTIFICATION; BINDING; MATURATION; STABILITY	Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that cause loss of function of the CFTR channel on the apical surface of epithelial cells. The major CF-causing mutation, F508del-CFTR, is misfolded, retained in the endoplasmic reticulum, and degraded. Small molecule corrector compounds have been identified using high throughput screens, which partially rescue the trafficking defect of F508del-CFTR, allowing a fraction of the mutant protein to escape endoplasmic reticulum retention and traffic to the plasma membrane, where it exhibits partial function as a cAMP-regulated chloride channel. A subset of such corrector compounds binds directly to the mutant protein, prompting the hypothesis that they rescue the biosynthetic defect by inducing improved protein conformation. We tested this hypothesis directly by evaluating the consequences of a corrector compound on the conformation of each nucleotide binding domain (NBD) in the context of the full-length mutant protein in limited proteolytic digest studies. Interestingly, we found that VRT-325 was capable of partially restoring compactness in NBD1. However, VRT-325 had no detectable effect on the conformation of the second half of the molecule. In comparison, ablation of the di-arginine sequence, (RXR555)-X-553 (F508del-KXK-CFTR), modified protease susceptibility of NBD1, NBD2, and the full-length protein. Singly, each intervention led to a partial correction of the processing defect. Together, these interventions restored processing of F508del-CFTR to near wild type. Importantly, however, a defect in NBD1 conformation persisted, as did a defect in channel activation after the combined interventions. Importantly, this defect in channel activation can be fully corrected by the addition of the potentiator, VX-770.	[Yu, Wilson; Chiaw, Patrick Kim; Bear, Christine E.] Hosp Sick Children, Programme Mol Struct & Funct, Res Inst, Toronto, ON M5G 1X8, Canada; [Chiaw, Patrick Kim; Bear, Christine E.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Chiaw, Patrick Kim; Bear, Christine E.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Yu, Wilson; Bear, Christine E.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Bear, CE (corresponding author), Hosp Sick Children, Programme Mol Struct & Funct, Res Inst, 555 Univ Ave,Rm 3203B, Toronto, ON M5G 1X8, Canada.	bear@sickkids.ca	yu, wilson/I-1292-2014; yu, wilson/AAC-8459-2021	yu, wilson/0000-0002-4030-1620; yu, wilson/0000-0002-7743-0872	Cystic Fibrosis Canada (CFC); Canadian Institutes of Health Research (CIHR); Cystic Fibrosis Foundation	Cystic Fibrosis Canada (CFC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	*This work was supported by operating grants from the Cystic Fibrosis Canada (CFC), the Canadian Institutes of Health Research (CIHR), and the Cystic Fibrosis Foundation (to C. E. B.).	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Chiaw PK, 2010, MOL PHARMACOL, V78, P411, DOI 10.1124/mol.110.065862; Chiaw PK, 2009, CHEM BIOL, V16, P520, DOI 10.1016/j.chembiol.2009.04.005; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; Cormet-Boyaka E, 2009, FASEB J, V23, P3743, DOI 10.1096/fj.08-127878; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Hwang TC, 1999, TRENDS PHARMACOL SCI, V20, P448, DOI 10.1016/S0165-6147(99)01386-3; Kartner N, 1998, METHOD ENZYMOL, V292, P629; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Sampson HM, 2011, CHEM BIOL, V18, P231, DOI 10.1016/j.chembiol.2010.11.016; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	46	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24714	24725		10.1074/jbc.M111.239699	http://dx.doi.org/10.1074/jbc.M111.239699			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602569	Green Published, hybrid			2022-12-27	WOS:000292547900022
J	Lu, JP; Wang, Y; Sliter, DA; Pearce, MMP; Wojcikiewicz, RJH				Lu, Justine P.; Wang, Yuan; Sliter, Danielle A.; Pearce, Margaret M. P.; Wojcikiewicz, Richard J. H.			RNF170 Protein, an Endoplasmic Reticulum Membrane Ubiquitin Ligase, Mediates Inositol 1,4,5-Trisphosphate Receptor Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; PATHWAY; COMPLEX; CELLS; ER	Inositol 1,4,5-trisphosphate (IP3) receptors are endoplasmic reticulum membrane calcium channels that, upon activation, are degraded via the ubiquitin-proteasome pathway. While searching for novel mediators of IP3 receptor processing, we discovered that RNF170, an uncharacterized RING domain-containing protein, associates rapidly with activated IP3 receptors. RNF170 is predicted to have three membrane-spanning helices, is localized to the ER membrane, and possesses ubiquitin ligase activity. Depletion of endogenous RNF170 by RNA interference inhibited stimulus-induced IP3 receptor ubiquitination, and degradation and overexpression of a catalytically inactive RNF170 mutant suppressed stimulus-induced IP3 receptor processing. A substantial proportion of RNF170 is constitutively associated with the erlin1/2 (SPFH1/2) complex, which has been shown previously to bind to IP3 receptors immediately after their activation. Depletion of RNF170 did not affect the binding of the erlin1/2 complex to stimulated IP3 receptors, whereas erlin1/2 complex depletion inhibited RNF170 binding. These results suggest a model in which the erlin1/2 complex recruits RNF170 to activated IP3 receptors where it mediates IP3 receptor ubiquitination. Thus, RNF170 plays an essential role in IP3 receptor processing via the ubiquitin-proteasome pathway.	[Lu, Justine P.; Wang, Yuan; Sliter, Danielle A.; Pearce, Margaret M. P.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Panning Pearce, Margaret/0000-0002-5846-9632	National Institutes of Health [DK049194]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049194, R01DK049194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK049194.	Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; BEZPROZVANNY I, 2011, NEUROCHEM R IN PRESS; Darom A, 2010, MOL BIOL CELL, V21, P1788, DOI 10.1091/mbc.E09-09-0774; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; KAHN MT, 2003, BIOCHEM J, V375, P603; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Maruyama Y, 2008, BIOCHEM BIOPH RES CO, V374, P737, DOI 10.1016/j.bbrc.2008.07.126; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Ogawa M, 2008, GENES CELLS, V13, P397, DOI 10.1111/j.1365-2443.2008.01169.x; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Peng Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-41; Sliter DA, 2011, J BIOL CHEM, V286, P1074, DOI 10.1074/jbc.M110.188383; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Valdmanis PN, 2011, BRAIN, V134, P602, DOI 10.1093/brain/awq329; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Y, 2009, BBA-MOL CELL RES, V1793, P1710, DOI 10.1016/j.bbamcr.2009.09.004; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhu CC, 2000, BIOCHEM J, V348, P551, DOI 10.1042/0264-6021:3480551	30	63	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24426	24433		10.1074/jbc.M111.251983	http://dx.doi.org/10.1074/jbc.M111.251983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21610068	Green Published, hybrid			2022-12-27	WOS:000292294900082
J	Benned-Jensen, T; Smethurst, C; Holst, PJ; Page, KR; Sauls, H; Sivertsen, B; Schwartz, TW; Blanchard, A; Jepras, R; Rosenkilde, MM				Benned-Jensen, Tau; Smethurst, Christopher; Holst, Peter J.; Page, Kevin R.; Sauls, Howard; Sivertsen, Bjorn; Schwartz, Thue W.; Blanchard, Andy; Jepras, Robert; Rosenkilde, Mette M.			Ligand Modulation of the Epstein-Barr Virus-induced Seven-transmembrane Receptor EBI2 IDENTIFICATION OF A POTENT AND EFFICACIOUS INVERSE AGONIST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CHEMOKINE; BINDING; HERPESVIRUS; ACTIVATION; EXPRESSION; BILF1; ANTAGONISTS; ONCOGENE; ENCODES	The Epstein-Barr virus-induced receptor 2 (EBI2) is a constitutively active seven-transmembrane receptor, which was recently shown to orchestrate the positioning of B cells in the follicle. To date, no ligands, endogenously or synthetic, have been identified that modulate EBI2 activity. Here we describe an inverse agonist, GSK682753A, which selectively inhibited the constitutive activity of EBI2 with high potency and efficacy. In cAMP-response element-binding protein-based reporter and guanosine 5'-3-O-(thio)-triphosphate (GTP gamma S) binding assays, the potency of this compound was 2.6-53.6 nM, and its inhibitory efficacy was 75%. In addition, we show that EBI2 constitutively activated extracellular signal-regulated kinase (ERK) in a pertussis toxin-insensitive manner. Intriguingly, GSK682753A inhibited ERK phosphorylation, GTP gamma S binding, and cAMP-response element-binding protein activation with similar potency. Overexpression of EBI2 profoundly potentiated antibody-stimulated ex vivo proliferation of murine B cells compared with WT cells, whereas this was equivalently reduced for EBI2-deficient B cells. Inhibition of EBI2 constitutive activity suppressed the proliferation in all cases. Importantly, the suppression was of much higher potency (32-fold) in WT or EBI2-overexpressing B cells compared with EBI2-deficient counterparts. Finally, we screened GSK682753A against an EBI2 mutant library to determine putative molecular binding determinants in EBI2. We identified Phe(111) at position III:08/3.32 as being crucial for GSK682753A inverse agonism because Ala substitution resulted in a > 500-fold decrease in IC50. In conclusion, we present the first ligand targeting EBI2. In turn, this molecule provides a useful tool for further characterization of EBI2 as well as serving as a potent lead compound.	[Schwartz, Thue W.; Rosenkilde, Mette M.] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Smethurst, Christopher; Page, Kevin R.; Blanchard, Andy; Jepras, Robert] GlaxoSmithKline, Stevenage SG1 2NY, Herts, England; [Holst, Peter J.] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen N, Denmark; [Sauls, Howard] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA	University of Copenhagen; GlaxoSmithKline; University of Copenhagen; GlaxoSmithKline	Rosenkilde, MM (corresponding author), Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth Sci, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	rosenkilde@sund.ku.dk		Holst, Peter Johannes/0000-0002-1279-304X; Sivertsen, Borge/0000-0003-4654-9296; Rosenkilde, Mette Marie/0000-0001-9600-3254; Schwartz, Thue W./0000-0002-0261-6904				Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Beisser PS, 2005, J VIROL, V79, P441, DOI 10.1128/JVI.79.1.441-449.2005; Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; BRITT WJ, 1996, FIELDS VIROLOGY, P771; Buck E, 2005, P NATL ACAD SCI USA, V102, P2719, DOI 10.1073/pnas.0500016102; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Craig FE, 2007, DIAGN MOL PATHOL, V16, P158, DOI 10.1097/PDM.0b013e31804f54a9; Cussac D, 2009, J PHARMACOL EXP THER, V331, P222, DOI 10.1124/jpet.109.156307; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Han SJ, 2005, J BIOL CHEM, V280, P34849, DOI 10.1074/jbc.M506711200; Holst PJ, 2001, J CLIN INVEST, V108, P1789, DOI 10.1172/JCI13622; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Jensen PC, 2009, METHOD ENZYMOL, V461, P171, DOI 10.1016/S0076-6879(09)05408-1; Joost P, 2002, GENOME BIOL, V3; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Kostenis E, 2002, J RECEPT SIGNAL TR R, V22, P267, DOI 10.1081/RRS-120014601; Lapinsh M, 2002, PROTEIN SCI, V11, P795, DOI 10.1110/ps.2500102; Lyngaa R, 2010, ONCOGENE, V29, P4388, DOI 10.1038/onc.2010.173; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; McCune DF, 2000, MOL PHARMACOL, V57, P659, DOI 10.1124/mol.57.4.659; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Paulsen SJ, 2005, J VIROL, V79, P536, DOI 10.1128/JVI.79.1.536-546.2005; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Rosenkilde MM, 2006, CURR DRUG TARGETS, V7, P103, DOI 10.2174/138945006775270259; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shin N, 2002, MOL PHARMACOL, V62, P38, DOI 10.1124/mol.62.1.38; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	46	33	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29292	29302		10.1074/jbc.M110.196345	http://dx.doi.org/10.1074/jbc.M110.196345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21673108	Green Published, hybrid			2022-12-27	WOS:000293837000064
J	Aggarwal, V; Kulothungan, SR; Balamurali, MM; Saranya, SR; Varadarajan, R; Ainavarapu, RK				Aggarwal, Vasudha; Kulothungan, S. Rajendra; Balamurali, M. M.; Saranya, S. R.; Varadarajan, Raghavan; Ainavarapu, Rama Koti			Ligand-modulated Parallel Mechanical Unfolding Pathways of Maltose-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; KINETIC PARTITIONING MECHANISM; SINGLE-MOLECULE; ESCHERICHIA-COLI; ACTIVE-TRANSPORT; DIHYDROFOLATE-REDUCTASE; DISULFIDE BONDS; STABILITY; CHEMOTAXIS; OLIGOSACCHARIDES	Protein folding and unfolding are complex phenomena, and it is accepted that multidomain proteins generally follow multiple pathways. Maltose-binding protein (MBP) is a large (a two-domain, 370-amino acid residue) bacterial periplasmic protein involved in maltose uptake. Despite the large size, it has been shown to exhibit an apparent two-state equilibrium unfolding in bulk experiments. Single-molecule studies can uncover rare events that are masked by averaging in bulk studies. Here, we use single-molecule force spectroscopy to study the mechanical unfolding pathways of MBP and its precursor protein (preMBP) in the presence and absence of ligands. Our results show that MBP exhibits kinetic partitioning on mechanical stretching and unfolds via two parallel pathways: one of them involves a mechanically stable intermediate (path I) whereas the other is devoid of it (path II). The apoMBP unfolds via path I in 62% of the mechanical unfolding events, and the remaining 38% follow path II. In the case of maltose-bound MBP, the protein unfolds via the intermediate in 79% of the cases, the remaining 21% via path II. Similarly, on binding to maltotriose, a ligand whose binding strength with the polyprotein is similar to that of maltose, the occurrence of the intermediate is comparable (82% via path I) with that of maltose. The precursor protein preMBP also shows a similar behavior upon mechanical unfolding. The percentages of molecules unfolding via path I are 53% in the apo form and 68% and 72% upon binding to maltose and maltotriose, respectively, for preMBP. These observations demonstrate that ligand binding can modulate the mechanical unfolding pathways of proteins by a kinetic partitioning mechanism. This could be a general mechanism in the unfolding of other large two-domain ligand-binding proteins of the bacterial periplasmic space.	[Aggarwal, Vasudha; Ainavarapu, Rama Koti] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Ainavarapu, Rama Koti] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Kulothungan, S. Rajendra; Balamurali, M. M.; Saranya, S. R.; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR); Indian Institute of Science (IISC) - Bangalore	Ainavarapu, RK (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India.	koti@tifr.res.in	MM, Balamurali/ABG-9767-2020; Ainavarapu, Sri Rama Koti/D-1231-2011; Aggarwal, Vasudha/C-3284-2018	Ainavarapu, Sri Rama Koti/0000-0002-1646-2731; Aggarwal, Vasudha/0000-0001-9856-1292; MM, Balamurali/0000-0001-7948-9950	Tata Institute of Fundamental Research	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	This work was supported by the Tata Institute of Fundamental Research (to S. R. K. A.).	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Ainavarapu SRK, 2008, J AM CHEM SOC, V130, P436, DOI 10.1021/ja077851s; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; Arad-Haase G, 2010, BIOPHYS J, V99, P238, DOI 10.1016/j.bpj.2010.04.004; BASSFORD PJ, 1990, J BIOENERG BIOMEMBR, V22, P401, DOI 10.1007/BF00763175; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; Bertz M, 2008, J MOL BIOL, V378, P447, DOI 10.1016/j.jmb.2008.02.025; Bertz M, 2009, J MOL BIOL, V393, P1097, DOI 10.1016/j.jmb.2009.08.066; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2006, ANGEW CHEM INT EDIT, V45, P642, DOI 10.1002/anie.200502623; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Duan XQ, 2001, J MOL BIOL, V306, P1115, DOI 10.1006/jmbi.2001.4456; Feller G, 1999, BIOCHEMISTRY-US, V38, P4613, DOI 10.1021/bi982650+; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Galera-Prat A, 2010, CURR OPIN STRUC BIOL, V20, P63, DOI 10.1016/j.sbi.2010.01.003; Ganesh C, 1997, BIOCHEMISTRY-US, V36, P5020, DOI 10.1021/bi961967b; Hann E, 2007, BIOPHYS J, V92, pL79, DOI 10.1529/biophysj.106.102475; Jones K, 2003, J AM CHEM SOC, V125, P9606, DOI 10.1021/ja0358807; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455; Krishnan B, 2009, J MOL BIOL, V385, P1243, DOI 10.1016/j.jmb.2008.10.094; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; SCHWARTZ M, 1976, EUR J BIOCHEM, V71, P167, DOI 10.1111/j.1432-1033.1976.tb11102.x; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Thirumalai D, 1997, THEOR CHEM ACC, V96, P14, DOI 10.1007/s002140050198; Thomson J, 1998, BIOPHYS CHEM, V70, P101, DOI 10.1016/S0301-4622(97)00113-0; Udgaonkar JB, 2008, ANNU REV BIOPHYS, V37, P489, DOI 10.1146/annurev.biophys.37.032807.125920; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wright CF, 2003, NAT STRUCT BIOL, V10, P658, DOI 10.1038/nsb947; Zaidi FN, 1997, NAT STRUCT BIOL, V4, P1016, DOI 10.1038/nsb1297-1016; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P2764, DOI 10.1073/pnas.0400091101	50	37	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28056	28065		10.1074/jbc.M111.249045	http://dx.doi.org/10.1074/jbc.M111.249045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659518	Green Published, hybrid			2022-12-27	WOS:000293557800024
J	Amemiya-Kudo, M; Oka, J; Takeuchi, Y; Okazaki, H; Yamamoto, T; Yahagi, N; Matsuzaka, K; Okazaki, S; Osuga, J; Yamada, N; Murase, T; Shimano, H				Amemiya-Kudo, Michiyo; Oka, Junko; Takeuchi, Yoshinori; Okazaki, Hiroaki; Yamamoto, Takashi; Yahagi, Naoya; Matsuzaka, Kaori; Okazaki, Sachiko; Osuga, Jun-ichi; Yamada, Nobuhiro; Murase, Toshio; Shimano, Hitoshi			Suppression of the Pancreatic Duodenal Homeodomain Transcription Factor-1 (Pdx-1) Promoter by Sterol Regulatory Element-binding Protein-1c (SREBP-1c)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-TRANSCRIPTION; NUCLEAR FACTOR 3-BETA; BETA-CELL DYSFUNCTION; TRANSGENIC MICE; DIABETES-MELLITUS; TARGET PROMOTERS; HOMEOBOX FACTOR; X-RECEPTOR; EXPRESSION; ACTIVATION	Overexpression of sterol regulatory element-binding protein-1c (SREBP-1c) in beta cells causes impaired insulin secretion and beta cell dysfunction associated with diminished pancreatic duodenal homeodomain transcription factor-1 (PDX-1) expression in vitro and in vivo. To identify the molecular mechanism responsible for this effect, the mouse Pdx-1 gene promoter (2.7 kb) was analyzed in beta cell and non-beta cell lines. Despite no apparent sterol regulatory element-binding protein-binding sites, the Pdx-1 promoter was suppressed by SREBP-1c in beta cells in a dose-dependent manner. PDX-1 activated its own promoter. The E-box (-104/-99 bp) in the proximal region, occupied by ubiquitously expressed upstream stimulatory factors (USFs), was crucial for the PDX-1-positive autoregulatory loop through direct PDX-1.USF binding. This positive feedback activation was a prerequisite for SREBP-1c suppression of the promoter in non-beta cells. SREBP-1c and PDX-1 directly interact through basic helix-loop-helix and homeobox domains, respectively. This robust SREBP-1c.PDX-1 complex interferes with PDX-1.USF formation and inhibits the recruitment of PDX-1 coactivators. SREBP-1c also inhibits PDX-1 binding to the previously described PDX-1-binding site (-2721/-2646 bp) in the distal enhancer region of the Pdx-1 promoter. Endogenous up-regulation of SREBP-1c in INS-1 cells through the activation of liver X receptor and retinoid X receptor by 9-cis-retinoic acid and 22-hydroxycholesterol inhibited PDX-1 mRNA and protein expression. Conversely, SREBP-1c RNAi restored Pdx-1 mRNA and protein levels. Through these multiple mechanisms, SREBP-1c, when induced in a lipotoxic state, repressed PDX-1 expression contributing to the inhibition of insulin expression and beta cell dysfunction.	[Amemiya-Kudo, Michiyo] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Minato Ku, Tokyo 1058470, Japan; [Takeuchi, Yoshinori; Yamamoto, Takashi; Yahagi, Naoya; Matsuzaka, Kaori; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Dept Internal Med Endocrinol & Metab, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Okazaki, Hiroaki; Okazaki, Sachiko; Osuga, Jun-ichi] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo 1138655, Japan	Toranomon Hospital; University of Tsukuba; University of Tokyo	Amemiya-Kudo, M (corresponding author), Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	michiyoame-tky@umin.ac.jp	Yahagi, Naoya/D-2360-2014; Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019	Yahagi, Naoya/0000-0002-1823-1865; Shimano, Hitoshi/0000-0002-5562-5572	Japan Foundation of Cardiovascular Research; Grants-in-Aid for Scientific Research [21591123] Funding Source: KAKEN	Japan Foundation of Cardiovascular Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Japan Foundation of Cardiovascular Research (to M.A.-K.).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Amemiya-Kudo M, 2005, J BIOL CHEM, V280, P34577, DOI 10.1074/jbc.M506718200; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Ben-Shushan E, 2001, J BIOL CHEM, V276, P17533, DOI 10.1074/jbc.M009088200; Bennett MK, 2004, J BIOL CHEM, V279, P37360, DOI 10.1074/jbc.M404693200; BrethertonWatt D, 1996, BIOCHEM J, V313, P495, DOI 10.1042/bj3130495; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carty MD, 1997, J BIOL CHEM, V272, P11986, DOI 10.1074/jbc.272.18.11986; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Ishikawa M, 2008, J LIPID RES, V49, P2524, DOI 10.1194/jlr.M800238-JLR200; Iwasaki Y, 2009, BIOCHEM BIOPH RES CO, V378, P545, DOI 10.1016/j.bbrc.2008.11.105; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Marshak S, 2000, MOL CELL BIOL, V20, P7583, DOI 10.1128/MCB.20.20.7583-7590.2000; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Najima Y, 2005, J BIOL CHEM, V280, P27523, DOI 10.1074/jbc.M414549200; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Peshavaria M, 1997, MOL CELL BIOL, V17, P3987, DOI 10.1128/MCB.17.7.3987; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Qian J, 1999, BIOCHEM J, V341, P315, DOI 10.1042/0264-6021:3410315; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Samaras SE, 2003, J BIOL CHEM, V278, P12263, DOI 10.1074/jbc.M210801200; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Sharma S, 1996, J BIOL CHEM, V271, P2294, DOI 10.1074/jbc.271.4.2294; Shimano H, 2007, DIABETES OBES METAB, V9, P133, DOI 10.1111/j.1463-1326.2007.00779.x; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 2007, J MOL MED, V85, P437, DOI 10.1007/s00109-007-0158-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Stanojevic V, 2004, ENDOCRINOLOGY, V145, P2918, DOI 10.1210/en.2003-1188; Stoffers DA, 1998, J CLIN INVEST, V102, P232, DOI 10.1172/JCI2242; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Takahashi A, 2005, DIABETES, V54, P492, DOI 10.2337/diabetes.54.2.492; Taniguchi H, 2003, GENE THER, V10, P15, DOI 10.1038/sj.gt.3301846; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang HY, 2003, J BIOL CHEM, V278, P16622, DOI 10.1074/jbc.M212488200; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	49	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27902	27914		10.1074/jbc.M110.186221	http://dx.doi.org/10.1074/jbc.M110.186221			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21652712	Green Published, hybrid			2022-12-27	WOS:000293557800009
J	Gandhi, UH; Kaushal, N; Ravindra, KC; Hegde, S; Nelson, SM; Narayan, V; Vunta, H; Paulson, RF; Prabhu, KS				Gandhi, Ujjawal H.; Kaushal, Naveen; Ravindra, Kodihalli C.; Hegde, Shailaja; Nelson, Shakira M.; Narayan, Vivek; Vunta, Hema; Paulson, Robert F.; Prabhu, K. Sandeep			Selenoprotein-dependent Up-regulation of Hematopoietic Prostaglandin D-2 Synthase in Macrophages Is Mediated through the Activation of Peroxisome Proliferator-activated Receptor (PPAR) gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; GLUTATHIONE-PEROXIDASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); SELENIUM DEFICIENCY; GENE-EXPRESSION; INFLAMMATION; CELLS; CYCLOOXYGENASE-2; MECHANISMS; PATHWAY	The plasticity of macrophages is evident from their dual role in inflammation and resolution of inflammation that are accompanied by changes in the transcriptome and metabolome. Along these lines, we have previously demonstrated that the micronutrient selenium increases macrophage production of arachidonic acid (AA)-derived anti-inflammatory 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) and decreases the proinflammatory PGE(2). Here, we hypothesized that selenium modulated the metabolism of AA by a differential regulation of various prostaglandin (PG) synthases favoring the production of PGD(2) metabolites, Delta(12)-PGJ(2) and 15d-PGJ(2). A dose-dependent increase in the expression of hematopoietic-PGD(2) synthase (H-PGDS) by selenium and a corresponding increase in Delta(12)-PGJ(2) and 15d-PGJ(2) in RAW264.7 macrophages and primary bone marrow-derived macrophages was observed. Studies with organic non-bioavailable forms of selenium and the genetic manipulation of cellular selenium incorporation machinery indicated that selenoproteins were necessary for H-PGDS expression and 15d-PGJ(2) production. Treatment of selenium-deficient macrophages with rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, up-regulated H-PGDS. Furthermore, electrophoretic mobility shift assays indicated the presence of an active peroxisome proliferator-activated receptor-response element in murine Hpgds promoter suggesting a positive feedback mechanism of H-PGDS expression. Alternatively, the expression of nuclear factor-kappa B-dependent thromboxane synthase and microsomal PGE(2) synthase was down-regulated by selenium. Using a Friend virus infection model of murine leukemia, the onset of leukemia was observed only in selenium-deficient and indomethacin-treated selenium-supplemented mice but not in the selenium-supplemented group or those treated with 15d-PGJ(2). These results suggest the importance of selenium in the shunting of AA metabolism toward the production of PGD(2) metabolites, which may have clinical implications.	[Kaushal, Naveen; Ravindra, Kodihalli C.; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Gandhi, Ujjawal H.] Penn State Univ, Ctr Mol Immunol & Infect Dis, Grad Program Mol Toxicol, University Pk, PA 16802 USA; [Hegde, Shailaja; Nelson, Shakira M.; Vunta, Hema] Penn State Univ, Ctr Mol Immunol & Infect Dis, Grad Program Pathobiol, University Pk, PA 16802 USA; [Narayan, Vivek] Penn State Univ, Ctr Mol Immunol & Infect Dis, Grad Program Immunol & Infect Dis, University Pk, PA 16802 USA; Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	ksprabhu@psu.edu		Narayan, Vivek/0000-0002-3232-7898; Kaushal, Naveen/0000-0001-9979-5664	National Institutes of Health [DK077152, AT004350]; American Institute for Cancer Research; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152, R01DK080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077152 and AT004350. This work was also supported by the American Institute for Cancer Research.	Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Brigelius-Flohe R, 2008, CHEM BIODIVERS, V5, P389, DOI 10.1002/cbdv.200890039; Cao YZ, 2000, FREE RADICAL BIO MED, V28, P381, DOI 10.1016/S0891-5849(99)00251-8; Catley MC, 2003, FEBS LETT, V547, P75, DOI 10.1016/S0014-5793(03)00672-0; Chen J, 2003, J NEUROCHEM, V86, P1, DOI 10.1046/j.1471-4159.2003.01854.x; Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Forceville X, 2001, THERAPIE, V56, P653; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Gartner R, 1999, MED KLIN, V94, P54; Gartner R, 2003, BIOFACTORS, V19, P165; Hashimoto K, 2005, J IMMUNOL, V174, P525, DOI 10.4049/jimmunol.174.1.525; Herlong JL, 2006, IMMUNOL LETT, V102, P121, DOI 10.1016/j.imlet.2005.10.004; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; Kim EH, 2006, BIOCHEM PHARMACOL, V72, P1516, DOI 10.1016/j.bcp.2006.07.030; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CR, 2003, ANTICANCER RES, V23, P2159; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; MADDIPATI KR, 1987, J BIOL CHEM, V262, P17398; Maxey KM, 2000, PROSTAG OTH LIPID M, V62, P15, DOI 10.1016/S0090-6980(00)00072-1; McKenzie RC, 1998, IMMUNOL TODAY, V19, P342, DOI 10.1016/S0167-5699(98)01294-8; Nakamura Y, 2002, J BIOL CHEM, V277, P2687, DOI 10.1074/jbc.M109641200; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Persons DA, 1999, NAT GENET, V23, P159, DOI 10.1038/13787; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Rouzer CA, 2006, BIOCHEMISTRY-US, V45, P14795, DOI 10.1021/bi061723j; Small-Howard AL, 2005, BIOCHEM SOC T, V33, P1493, DOI 10.1042/BST0331493; SMITH WL, 1983, J BIOL CHEM, V258, P5922; Stachowska E, 2009, J PHYSIOL PHARMACOL, V60, P77; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Subramanian A, 2008, J VIROL, V82, P382, DOI 10.1128/JVI.02487-06; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Yamaguchi S, 2010, J AM CHEM SOC, V132, P824, DOI 10.1021/ja908878n; Zamamiri-Davis F, 2002, FREE RADICAL BIO MED, V32, P890, DOI 10.1016/S0891-5849(02)00775-X	43	72	76	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27471	27482		10.1074/jbc.M111.260547	http://dx.doi.org/10.1074/jbc.M111.260547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669866	hybrid, Green Published			2022-12-27	WOS:000293268700042
J	Hedl, M; Abraham, C				Hedl, Matija; Abraham, Clara			Distinct Roles for Nod2 Protein and Autocrine Interleukin-1 beta in Muramyl Dipeptide-induced Mitogen-activated Protein Kinase Activation and Cytokine Secretion in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; TUMOR-NECROSIS-FACTOR; IL-1-BETA PRODUCTION; HUMAN MONOCYTES; TNF-ALPHA; LIPOPOLYSACCHARIDE; EXPRESSION; DISEASE; MICE; PEPTIDOGLYCAN	Elucidating factors regulating Crohn's disease-associated nucleotide-binding oligomerization domain 2 (Nod2) responses is critical to understanding the mechanisms of intestinal immune homeostasis. Stimulation of primary monocyte-derived macrophages by muramyl dipeptide (MDP), a component of bacterial peptidoglycan and specific Nod2 ligand, produces cytokines, including IL-1 beta. We found that IL-1 beta blockade profoundly inhibits MDP-induced cytokine production in human monocyte-derived macrophages, demonstrating a key role for IL-1 beta autocrine secretion in Nod2-mediated responses. Importantly, although MAPK activation has previously been attributed directly to Nod2 signaling, we determined that the IL-1 beta autocrine loop is responsible for the majority of MDP-induced MAPK activation. Because the critical effects of IL-1 beta autocrine secretion on MAPK activation are observed as early as 10 min after Nod2 stimulation, we hypothesized that secretion of IL-1 beta from preexisting intracellular pro-IL-1 beta stores is necessary for optimal MDP-mediated cytokine induction. Consistently, we detected IL-1 beta secretion within 10 min of MDP treatment. Moreover, caspase-1 inhibition significantly attenuates MDP-mediated early MAPK activation. Importantly, selective JNK/p38 activation is sufficient to rescue the decreased cytokine secretion during Nod2 stimulation in the absence of autocrine IL-1 beta. Finally, we found that the IL-1 beta autocrine loop significantly enhances responses by a broad range of pattern recognition receptors. Taken together, MDP stimulation activates Nod2 to process and release preexisting pro-IL-1 beta stores in a caspase-1-dependent fashion; this secreted IL-1 beta, in turn, contributes to the majority of MDP-initiated MAPK activation and leads to subsequent cytokine secretion. Our findings clarify mechanisms of IL-1 beta contributions to Nod2 responses and elucidate the dominant role of IL-1 beta in MDP-initiated MAPK and cytokine secretion.	[Abraham, Clara] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA	Yale University	Abraham, C (corresponding author), Yale Univ, Dept Internal Med, Sect Digest Dis, 333 Cedar St,LMP 1080, New Haven, CT 06520 USA.	clara.abraham@yale.edu			National Institutes of Health [R01DK077905, DK-P30-34989, U19-AI082713]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, R01DK077905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK077905, DK-P30-34989, and U19-AI082713 (to C. A.). This work was also supported by the Crohn's and Colitis Foundation of America (to C. A. and M. H.).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Carter JD, 2003, JCR-J CLIN RHEUMATOL, V9, P276, DOI 10.1097/01.RHU.0000081265.06408.e4; CASSATELLA MA, 1993, J EXP MED, V178, P2207, DOI 10.1084/jem.178.6.2207; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; DONNELLY RP, 1995, J IMMUNOL, V155, P1420; Ferwerda G, 2008, EUR J IMMUNOL, V38, P184, DOI 10.1002/eji.200737103; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gonzalez-Navajas JM, 2010, J EXP MED, V207, P2799, DOI 10.1084/jem.20101326; GRANOWITZ EV, 1992, BLOOD, V79, P2364; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hedl M, 2011, GASTROENTEROLOGY, V140, P231, DOI 10.1053/j.gastro.2010.09.009; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Pioli PA, 2006, J IMMUNOL, V176, P6647, DOI 10.4049/jimmunol.176.11.6647; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rosenzweig HL, 2008, J LEUKOCYTE BIOL, V84, P529, DOI 10.1189/jlb.0108015; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Shikama Y, 2011, INNATE IMMUN-LONDON, V17, P3, DOI 10.1177/1753425909347508; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; Vidal VF, 2001, EUR J IMMUNOL, V31, P1962, DOI 10.1002/1521-4141(200107)31:7<1962::AID-IMMU1962>3.0.CO;2-V; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200	43	51	55	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26440	26449		10.1074/jbc.M111.237495	http://dx.doi.org/10.1074/jbc.M111.237495			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659536	hybrid, Green Published			2022-12-27	WOS:000293078200022
J	Lau, ATY; Lee, SY; Xu, YM; Zheng, D; Cho, YY; Zhu, F; Kim, HG; Li, SQ; Zhang, ZG; Bode, AM; Dong, ZG				Lau, Andy T. Y.; Lee, Sung-Young; Xu, Yan-Ming; Zheng, Duo; Cho, Yong-Yeon; Zhu, Feng; Kim, Hong-Gyum; Li, Sheng-Qing; Zhang, Zhiguo; Bode, Ann M.; Dong, Zigang			Phosphorylation of Histone H2B Serine 32 Is Linked to Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN MODIFICATIONS; STERILE-20 KINASE; CANCER; H3; TRANSCRIPTION; APOPTOSIS; PROTEIN; REQUIREMENT; ACTIVATION; REGULATOR	Various types of post-translational modifications of the histone tails have been revealed, but a few modifications have been found within the histone core sequences. Histone core post-translational modifications have the potential to modulate nucleosome structure and DNA accessibility. Here, we studied the histone H2B core domain and found that phosphorylation of H2B serine 32 occurs in normal cycling and mitogen-stimulated cells. Notably, this phosphorylation is elevated in skin cancer cell lines and tissues compared with normal counterparts. The JB6 Cl41 mouse skin epidermal cell line is a well established model for tumor promoter-induced cell transformation and was used to study the function of H2B during EGF-induced carcinogenesis. Remarkably, cells overexpressing a nonphosphorylatable H2BS32A mutant exhibited suppressed growth and EGF-induced cell transformation, possibly because of decreased activation of activator protein-1, compared with control cells overexpressing wild type H2B. We identified ribosomal S6 kinase 2 (RSK2) as the kinase responsible for H2BS32 phosphorylation. Serum-starved JB6 cells contain very little endogenous H2BS32 phosphorylation, and EGF treatment induced this phosphorylation. The phosphorylation was attenuated in RSK2 knock-out MEFs and RSK2 knockdown JB6 cells. Taken together, our results demonstrate a novel role for H2B phosphorylation in cell transformation and show that H2BS32 phosphorylation is critical for controlling activator protein-1 activity, which is a major driver in cell transformation.	[Lau, Andy T. Y.; Lee, Sung-Young; Xu, Yan-Ming; Zheng, Duo; Cho, Yong-Yeon; Zhu, Feng; Kim, Hong-Gyum; Li, Sheng-Qing; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Zhang, Zhiguo] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	University of Minnesota System; Mayo Clinic	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	yongyeon@catholic.ac.kr; zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; ZHU, Feng/G-3567-2010; Lau, Andy Tao Yin/AAX-9980-2021; ZHU, Feng/C-1303-2010	Lau, Andy Tao Yin/0000-0002-7146-7789; Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA077646, R37CA081064, CA120388, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA077646, R37CA081064, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, R37CA081064, CA120388, and ES016548. This work was also supported by the Hormel Foundation.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; BODE AM, 2005, SCI STKE, pRE4; Bode AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259mr2; Bonisch C, 2008, EXPERT REV PROTEOMIC, V5, P105, DOI 10.1586/14789450.5.1.105; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Clark DE, 2005, CANCER RES, V65, P3108; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; Lee SY, 2010, J BIOL CHEM, V285, P29525, DOI 10.1074/jbc.M110.127233; Lenfant F, 1996, EMBO J, V15, P3974, DOI 10.1002/j.1460-2075.1996.tb00771.x; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001; MANDERS EMM, 1992, J CELL SCI, V103, P857; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sarma K, 2004, METHOD ENZYMOL, V376, P255; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306	30	26	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26628	26637		10.1074/jbc.M110.215590	http://dx.doi.org/10.1074/jbc.M110.215590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646345	Green Published, hybrid			2022-12-27	WOS:000293078200041
J	Theesfeld, CL; Pourmand, D; Davis, T; Garza, RM; Hampton, RY				Theesfeld, Chandra L.; Pourmand, Deeba; Davis, Talib; Garza, Renee M.; Hampton, Randolph Y.			The Sterol-sensing Domain (SSD) Directly Mediates Signal-regulated Endoplasmic Reticulum-associated Degradation (ERAD) of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Isozyme Hmg2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA REDUCTASE; MEMBRANE-PROTEIN; CHOLESTEROL HOMEOSTASIS; UBIQUITIN LIGASE; SCAP PROTEIN; YEAST; INSIG; REQUIRES; PATHWAY; BINDING	The sterol-sensing domain (SSD) is a conserved motif in membrane proteins responsible for sterol regulation. Mammalian proteins SREBP cleavage-activating protein (SCAP) and HMG-CoA reductase (HMGR) both possess SSDs required for feedback regulation of sterol-related genes and sterol synthetic rate. Although these two SSD proteins clearly sense sterols, the range of signals detected by this eukaryotic motif is not clear. The yeastHMG-CoAreductase isozyme Hmg2, like its mammalian counterpart, undergoes endoplasmic reticulum (ER)-associated degradation that is subject to feedback control by the sterol pathway. The primary degradation signal for yeast Hmg2 degradation is the 20-carbon isoprene geranylgeranyl pyrophosphate, rather than a sterol. Nevertheless, the Hmg2 protein possesses an SSD, leading us to test its role in feedback control of Hmg2 stability. We mutated highly conserved SSD residues of Hmg2 and evaluated regulated degradation. Our results indicated that the SSD was required for sterol pathway signals to stimulate Hmg2 ER-associated degradation and was employed for detection of both geranylgeranyl pyrophosphate and a secondary oxysterol signal. Our data further indicate that the SSD allows a signal-dependent structural change in Hmg2 that promotes entry into the ER degradation pathway. Thus, the eukaryotic SSD is capable of significant plasticity in signal recognition or response. We propose that the harnessing of cellular quality control pathways to bring about feedback regulation of normal proteins is a unifying theme for the action of all SSDs.	[Theesfeld, Chandra L.; Pourmand, Deeba; Davis, Talib; Garza, Renee M.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health [NRSA 5F32GM82195, 5R01DK051996]; National Institutes of Health through NIGMS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NRSA 5F32GM82195 (to C. L. T.) and 5R01DK051996 to R. Y. H.) through the NIGMS.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Cronin SR, 1999, METHOD ENZYMOL, V302, P58, DOI 10.1016/S0076-6879(99)02010-8; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Peng ZL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-420; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; SENGSTAG C, 1990, MOL CELL BIOL, V10, P672, DOI 10.1128/MCB.10.2.672; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	38	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26298	26307		10.1074/jbc.M111.244798	http://dx.doi.org/10.1074/jbc.M111.244798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21628456	Green Published, hybrid			2022-12-27	WOS:000293078200006
J	Guimaraes, BG; Barbosa, RL; Soprano, AS; Campos, BM; de Souza, TA; Tonoli, CCC; Leme, AFP; Murakami, MT; Benedetti, CE				Guimaraes, Beatriz G.; Barbosa, Rosicler L.; Soprano, Adriana S.; Campos, Bruna M.; de Souza, Tiago A.; Tonoli, Celisa C. C.; Leme, Adriana F. P.; Murakami, Mario T.; Benedetti, Celso E.			Plant Pathogenic Bacteria Utilize Biofilm Growth-associated Repressor (BigR), a Novel Winged-helix Redox Switch, to Control Hydrogen Sulfide Detoxification under Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; AGROBACTERIUM-TUMEFACIENS; XYLELLA-FASTIDIOSA; ESCHERICHIA-COLI; INTERNAL OXYGEN; ZINC SENSOR; PROTEIN; RHODANESE; OPERON; FAMILY	Winged-helix transcriptional factors play important roles in the control of gene expression in many organisms. In the plant pathogens Xylella fastidiosa and Agrobacterium tumefaciens, the winged-helix protein BigR, a member of the ArsR/SmtB family of metal sensors, regulates transcription of the bigR operon involved in bacterial biofilm growth. Previous studies showed that BigR represses transcription of its own operon through the occupation of the RNA polymerase-binding site; however, the signals that modulate its activity and the biological function of its operon are still poorly understood. Here we show that although BigR is a homodimer similar to metal sensors, it functions as a novel redox switch that derepresses transcription upon oxidation. Crystal structures of reduced and oxidized BigR reveal that formation of a disulfide bridge involving two critical cysteines induces conformational changes in the dimer that remarkably alter the topography of the winged-helix DNA-binding interface, precluding DNA binding. This structural mechanism of DNA association-dissociation is novel among winged-helix factors. Moreover, we demonstrate that the bigR operon is required for hydrogen sulfide detoxification through the action of a sulfur dioxygenase (Blh) and sulfite exporter. As hydrogen sulfide strongly inhibits cytochrome c oxidase, it must be eliminated to allow aerobic growth under low oxygen tension, an environmental condition found in bacterial bio-films, xylem vessels, and root tissues. Accordingly, we show that the bigR operon is critical to sustain bacterial growth under hypoxia. These results suggest that BigR integrates the transcriptional regulation of a sulfur oxidation pathway to an oxidative signal through a thiol-based redox switch.	[Guimaraes, Beatriz G.; Barbosa, Rosicler L.; Soprano, Adriana S.; Campos, Bruna M.; de Souza, Tiago A.; Tonoli, Celisa C. C.; Leme, Adriana F. P.; Murakami, Mario T.; Benedetti, Celso E.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil		Benedetti, CE (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, CP6192, Sao Paulo, Brazil.	celso.benedetti@lnbio.org.br	Murakami, Mario T/F-5640-2016; Leme, Adriana F Paes/C-9679-2012; Murakami, Mario T/C-2087-2012; Guimarães, Beatriz Gomes/Z-6242-2019; de Souza, Tiago Antonio/C-1039-2012; Guimarães, Beatriz G/D-3858-2014; Citros, Inct/I-2442-2013	Murakami, Mario T/0000-0002-0405-8010; Leme, Adriana F Paes/0000-0001-7959-147X; Guimarães, Beatriz Gomes/0000-0002-8546-2460; de Souza, Tiago Antonio/0000-0001-6283-4359; Benedetti, Celso/0000-0002-4602-0256; Santos Soprano, Adriana/0000-0001-7117-927X; Tonoli, Celisa/0000-0003-2580-5588	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Armstrong W, 2009, ANN BOT-LONDON, V103, P281, DOI 10.1093/aob/mcn177; Arunkumar AI, 2009, P NATL ACAD SCI USA, V106, P18177, DOI 10.1073/pnas.0905558106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barbosa RL, 2007, J BACTERIOL, V189, P6185, DOI 10.1128/JB.00331-07; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Bricogne G., 2009, BUSTER VERSION 2 9 1; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Campbell DR, 2007, J BIOL CHEM, V282, P32298, DOI 10.1074/jbc.M703451200; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Eicken C, 2003, J MOL BIOL, V333, P683, DOI 10.1016/j.jmb.2003.09.007; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eklund L, 2000, TREES-STRUCT FUNCT, V14, P177, DOI 10.1007/PL00009761; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERRIGE AG, 1992, RAPID COMMUN MASS SP, V6, P707, DOI 10.1002/rcm.1290061115; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gueune H, 2008, APPL ENVIRON MICROB, V74, P1954, DOI 10.1128/AEM.02294-07; Hanzelmann P, 2009, PROTEIN SCI, V18, P2480, DOI 10.1002/pro.260; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KANVINDE L, 1990, APPL ENVIRON MICROB, V56, P2087, DOI 10.1128/AEM.56.7.2087-2092.1990; Krishna SS, 2007, PROTEINS, V69, P415, DOI 10.1002/prot.21314; Lazaro Barbosa R, 2007, ACTA CRYSTALLOGR F, V63, P596, DOI 10.1107/S1744309107028722; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Leite B, 2002, BRAZ J MED BIOL RES, V35, P645, DOI 10.1590/S0100-879X2002000600003; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu T, 2008, BIOCHEMISTRY-US, V47, P10564, DOI 10.1021/bi801313y; Lloyd D, 2006, TRENDS MICROBIOL, V14, P456, DOI 10.1016/j.tim.2006.08.003; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Mandal S, 2007, MICROBIOL-SGM, V153, P80, DOI 10.1099/mic.0.29197-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pavlovkin J, 2002, J EXP BOT, V53, P1143, DOI 10.1093/jexbot/53.371.1143; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Spicer R, 2007, J EXP BOT, V58, P1313, DOI 10.1093/jxb/erl296; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; THOMSON CJ, 1991, PLANT PHYSIOL, V96, P1294, DOI 10.1104/pp.96.4.1294; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; van Dongen JT, 2003, PLANT PHYSIOL, V131, P1529, DOI 10.1104/pp.102.017202; Vonrhein C., 2006, MACROMOLECULAR CRYST, V2, P215; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; WELLS JM, 1987, INT J SYST BACTERIOL, V37, P136, DOI 10.1099/00207713-37-2-136; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wilson K, 2008, DIGEST DIS SCI, V53, P277, DOI 10.1007/s10620-007-9854-9	54	54	55	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26148	26157		10.1074/jbc.M111.234039	http://dx.doi.org/10.1074/jbc.M111.234039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632538	Green Published, hybrid			2022-12-27	WOS:000293073000072
J	Vetrivel, KS; Barman, A; Chen, Y; Nguyen, PD; Wagner, SL; Prabhakar, R; Thinakaran, G				Vetrivel, Kulandaivelu S.; Barman, Arghya; Chen, Ying; Nguyen, Phuong D.; Wagner, Steven L.; Prabhakar, Rajeev; Thinakaran, Gopal			Loss of Cleavage at beta '-Site Contributes to Apparent Increase in beta-Amyloid Peptide (A beta) Secretion by beta-Secretase (BACE1)-Glycosylphosphatidylinositol (GPI) Processing of Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; LIPID RAFTS; GAMMA-SECRETASE; CLEAVING ENZYME; BACE1; GOLGI; TRAFFICKING; METABOLISM; SUBSTRATE; COMPLEX	Several lines of evidence implicate lipid raft microdomains in Alzheimer disease-associated beta-amyloid peptide (A beta) production. Notably, targeting beta-secretase (beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)) exclusively to lipid rafts by the addition of a glycosylphosphatidylinositol (GPI) anchor to its ectodomain has been reported to elevate A beta secretion. Paradoxically, A beta secretion is not reduced by the expression of non-raft resident S-palmitoylation-deficient BACE1 (BACE1-4C/A (C474A/C478A/C482A/C485A)). We addressed this apparent discrepancy in raft microdomain-associated BACE1 processing of APP in this study. As previously reported, we found that expression of BACE1-GPI elevated A beta secretion as compared with wild-type BACE1 (WTBACE1) or BACE1-4C/A. However, this increase occurred without any difference in the levels of APP ectodomain released following BACE1 cleavage (soluble APP beta), arguing against an overall increase in BACE1 processing of APP per se. Further analysis revealed that WTBACE1 cleaves APP at beta- and beta'-sites, generating +1 and +11 beta-C-terminal fragments and secreting intact as well as N-terminally truncated A beta. In contrast, three different BACE1-GPI chimeras preferentially cleaved APP at the beta-site, mainly generating +1 beta-C-terminal fragment and secreting intact A beta. As a consequence, cells expressing BACE1-GPI secreted relatively higher levels of intact A beta without an increase in BACE1 processing of APP. Markedly reduced cleavage at beta'-site exhibited by BACE1-GPI was cell type-independent and insensitive to subcellular localization of APP or the pathogenic KM/NL mutant. We conclude that the apparent elevation in A beta secretion by BACE1-GPI is mainly attributed to preferential cleavage at the beta-site and failure to detect +11 A beta species secreted by cells expressing WTBACE1.	[Vetrivel, Kulandaivelu S.; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Vetrivel, Kulandaivelu S.; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Vetrivel, Kulandaivelu S.; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Barman, Arghya; Prabhakar, Rajeev] Univ Miami, Dept Chem, Coral Gables, FL 33146 USA; [Nguyen, Phuong D.; Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA	University of Chicago; University of Chicago; University of Chicago; University of Miami; University of California System; University of California San Diego	Thinakaran, G (corresponding author), Univ Chicago, Dept Neurobiol, Knapp R212,924 E 57th St, Chicago, IL 60637 USA.	gopal@uchicago.edu		Prabhakar, Rajeev/0000-0003-1137-1272	National Institutes of Health [AG021495, AG019070]; Alzheimer's Association; Department of Health of the Florida State Health Department [08KN-11]; NATIONAL INSTITUTE ON AGING [R01AG021495, R01AG019070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Department of Health of the Florida State Health Department; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021495 and AG019070 (to G. T.). This work was also supported by grants from the Alzheimer's Association (to G. T. and to K. S. V.) and Department of Health Grant 08KN-11 from the James and Esther King Biomedical Research Program of the Florida State Health Department (to R. P.).	Barman A, 2011, BIOCHEMISTRY-US, V50, P4337, DOI 10.1021/bi200081h; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Cheng HP, 2007, NAT CLIN PRACT NEURO, V3, P374, DOI 10.1038/ncpneuro0549; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Fujita M, 2010, FEBS LETT, V584, P1670, DOI 10.1016/j.febslet.2009.10.079; Gorfe AA, 2005, STRUCTURE, V13, P1487, DOI 10.1016/j.str.2005.06.015; Gouras GK, 1998, J NEUROCHEM, V71, P1920; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hong L, 2004, BIOCHEMISTRY-US, V43, P4689, DOI 10.1021/bi0498252; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Iwata H, 2001, J BIOL CHEM, V276, P21678, DOI 10.1074/jbc.M007989200; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Koo EH, 1996, J CELL SCI, V109, P991; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Onishi M, 1996, EXP HEMATOL, V24, P324; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Qahwash I, 2004, J BIOL CHEM, V279, P39010, DOI 10.1074/jbc.M407101200; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Steinhilb ML, 2002, J NEUROCHEM, V80, P1019, DOI 10.1046/j.0022-3042.2002.00764.x; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Xiong B, 2004, ACTA PHARMACOL SIN, V25, P705; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	46	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26166	26177		10.1074/jbc.M111.260471	http://dx.doi.org/10.1074/jbc.M111.260471			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642424	hybrid, Green Published			2022-12-27	WOS:000293073000074
J	von Roretz, C; Macri, AM; Gallouzi, IE				von Roretz, Christopher; Macri, Angelo M.; Gallouzi, Imed-Eddine			Transportin 2 Regulates Apoptosis through the RNA-binding Protein HuR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; MESSENGER-RNA; NUCLEAR IMPORT; HEAT-SHOCK; IN-VIVO; CLEAVAGE; INHIBITION; PATHWAYS; RELEASE; STRESS	In response to severe stress, apoptotic cell death is engaged. Apoptosis is a well orchestrated process that involves the activation and implication of many factors. In this study, we identified a role for the nuclear trafficking factor TRN2(transportin 2) in cell death. TRN2 is normally responsible for the nuclear import of the RNA-binding protein HuR. During apoptosis, however, HuR accumulates in the cytoplasm. This is due to the caspase-mediated cleavage of the cytoplasmic fraction of HuR. One of the cleavage fragments generated by this processing of HuR interacts with TRN2 and thus blocks the re-import of HuR into the nucleus. This concentrates HuR in the cytoplasm, advancing apoptosis. Therefore, increasing or decreasing the levels of TRN2 has an inverse consequential effect on cell death, demonstrating for the first time the role of a nucleocytoplasmic transport factor in apoptosis.	[Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Gallouzi, IE (corresponding author), McGill Univ, Dept Biochem, McIntyre Bldg,Rm 915,3655 Promenade Sir William O, Montreal, PQ H3G 1Y6, Canada.	imed.gallouzi@mcgill.ca			National Cancer Institute of Canada [016247]; Canadian Institutes of Health Research [MOP-89798]; Natural Sciences and Engineering Research Council of Canada; Tier 2 Canada Research Chair	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Tier 2 Canada Research Chair(Canada Research Chairs)	This work was supported in part by National Cancer Institute of Canada Operating Grant 016247 and Canadian Institutes of Health Research Operating Grant MOP-89798 (to I.-E. G.).; Recipient of a Natural Sciences and Engineering Research Council of Canada summer undergraduate student award.; Recipient of a Tier 2 Canada Research Chair.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Beauchamp P, 2010, CELL DEATH DIFFER, V17, P1588, DOI 10.1038/cdd.2010.34; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Di Marco S, 2001, NUCLEIC ACIDS RES, V29, P863, DOI 10.1093/nar/29.4.863; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Johnson CR, 2004, APOPTOSIS, V9, P423, DOI 10.1023/B:APPT.0000031457.90890.13; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Lian XJ, 2009, J BIOL CHEM, V284, P8868, DOI 10.1074/jbc.M806372200; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Pan W, 2009, J BIOL CHEM, V284, P6946, DOI 10.1074/jbc.M805801200; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; van der Giessen K, 2007, MOL BIOL CELL, V18, P2619, DOI 10.1091/mbc.E07-02-0167; von Roretz C, 2010, J BIOL CHEM, V285, P16806, DOI 10.1074/jbc.M109.087320	26	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25983	25991		10.1074/jbc.M110.216184	http://dx.doi.org/10.1074/jbc.M110.216184			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21646354	Green Published, hybrid			2022-12-27	WOS:000293073000057
J	Wu, SF; Morrison, A; Sun, HZ; De Luca, F				Wu, Shufang; Morrison, Allison; Sun, Hongzhi; De Luca, Francesco			Nuclear Factor-kappa B (NF-kappa B) p65 Interacts with Stat5b in Growth Plate Chondrocytes and Mediates the Effects of Growth Hormone on Chondrogenesis and on the Expression of Insulin-like Growth Factor-1 and Bone Morphogenetic Protein-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GH RECEPTOR; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCER; ACTIVATION; GENE; TRANSCRIPTION; INSENSITIVITY; MOUSE; CELLS; IDENTIFICATION	Growth hormone (GH) stimulates growth plate chondrogenesis and longitudinal bone growth with its stimulatory effects primarily mediated by insulin-like growth factor-1 (IGF-1) both systemically and locally in the growth plate. It has been shown that the transcription factor Stat5b mediates the GH promoting effect on IGF-1 expression and on chondrogenesis, yet it is not known whether other signaling molecules are activated by GH in growth plate chondrocytes. We have previously demonstrated that nuclear factor-kappa B p65 is a transcription factor expressed in growth plate chondrocytes where it facilitates chondrogenesis. We have also shown that fibroblasts isolated from a patient with growth failure and a heterozygous mutation of inhibitor-kappa B alpha (I kappa B; component of the nuclear factor-kappa B (NF-kappa B) signaling pathway) exhibit GH insensitivity. In this study, we cultured rat metatarsal bones in the presence of GH and/or pyrrolidine dithiocarbamate (PDTC), a known NF-kappa B inhibitor. The GH-mediated stimulation of metatarsal longitudinal growth and growth plate chondrogenesis was neutralized by PDTC. In cultured chondrocytes isolated from rat metatarsal growth plates, GH induced NF-kappa B-DNA binding and chondrocyte proliferation and differentiation and prevented chondrocyte apoptosis. The inhibition of NF-kappa B p65 expression and activity (by NF-kappa B p65 siRNA and PDTC, respectively) in chondrocytes reversed the GH-mediated effects on chondrocyte proliferation, differentiation, and apoptosis. Lastly, the inhibition of Stat5b expression in chondrocytes prevented the GH promoting effects on NF-kappa B-DNA binding, whereas the inhibition of NF-kappa B p65 expression or activity prevented the GH-dependent activation of IGF-1 and bone morphogenetic protein-2 expression.	[Wu, Shufang; Morrison, Allison; De Luca, Francesco] Drexel Univ, Sect Endocrinol & Diabet, St Christophers Hosp Children, Coll Med, Philadelphia, PA 19134 USA; [Wu, Shufang; Morrison, Allison; De Luca, Francesco] Drexel Univ, Coll Med, Dept Pediat, Philadelphia, PA 19134 USA; [Wu, Shufang; Sun, Hongzhi] Xi An Jiao Tong Univ, Sch Med, Xian 710061, Shannxi, Peoples R China	Drexel University; Drexel University; Xi'an Jiaotong University	De Luca, F (corresponding author), Drexel Univ, Sect Endocrinol & Diabet, St Christophers Hosp Children, Coll Med, 3601 A St, Philadelphia, PA 19134 USA.	francesco.deluca@drexelmed.edu			Novo Nordisk	Novo Nordisk(Novo Nordisk)	This work was supported by a grant from Novo Nordisk.	APTE SS, 1992, EUR J BIOCHEM, V206, P217, DOI 10.1111/j.1432-1033.1992.tb16919.x; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAGI C, 1989, CALCIFIED TISSUE INT, V45, P342, DOI 10.1007/BF02556004; BARNARD R, 1988, ENDOCRINOLOGY, V122, P2562, DOI 10.1210/endo-122-6-2562; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; CAMPBELL GS, 1995, J BIOL CHEM, V270, P3974, DOI 10.1074/jbc.270.8.3974; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Choi HK, 2000, GROWTH HORM IGF RES, V10, P1, DOI 10.1016/S1096-6374(00)80002-7; Costoya JA, 1999, ENDOCRINOLOGY, V140, P5937, DOI 10.1210/en.140.12.5937; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; FOSTER CM, 1988, BIOCHEMISTRY-US, V27, P326, DOI 10.1021/bi00401a049; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; ISAKSSON OGP, 1982, SCIENCE, V216, P1237, DOI 10.1126/science.7079756; ISAKSSON OGP, 1987, ENDOCR REV, V8, P426, DOI 10.1210/edrv-8-4-426; Jeay S, 2001, ENDOCRINOLOGY, V142, P147, DOI 10.1210/en.142.1.147; Jeay S, 2000, MOL ENDOCRINOL, V14, P650, DOI 10.1210/me.14.5.650; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285; Liang L, 2000, ENDOCRINOLOGY, V141, P3328, DOI 10.1210/en.141.9.3328; Liu ZH, 2002, ACTA PHARMACOL SIN, V23, P887; MOLLER C, 1992, J BIOL CHEM, V267, P23403; Mora AL, 2001, J IMMUNOL, V166, P2218, DOI 10.4049/jimmunol.166.4.2218; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; ROSENFELD RG, 1994, ENDOCR REV, V15, P369, DOI 10.1210/er.15.3.369; SCHEVEN BAA, 1991, ACTA ENDOCRINOL-COP, V124, P602, DOI 10.1530/acta.0.1240602; SILVA CM, 1993, ENDOCRINOLOGY, V133, P2307, DOI 10.1210/en.133.5.2307; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; WERTHER GA, 1993, ACTA PAEDIATR, V82, P50, DOI 10.1111/j.1651-2227.1993.tb12929.x; WINSTON LA, 1992, J BIOL CHEM, V267, P4747; Wit JM, 1996, PEDIATR RES, V39, P295, DOI 10.1203/00006450-199602000-00018; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Wu SF, 2010, J CLIN ENDOCR METAB, V95, P1220, DOI 10.1210/jc.2009-1662; Wu SF, 2008, J BIOL CHEM, V283, P34037, DOI 10.1074/jbc.M803754200; Yau TO, 2009, J PATHOL, V217, P353, DOI 10.1002/path.2451; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	43	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24726	24734		10.1074/jbc.M110.175364	http://dx.doi.org/10.1074/jbc.M110.175364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592969	Green Published, hybrid			2022-12-27	WOS:000292547900023
J	Yonesu, K; Kubota, K; Tamura, M; Inaba, S; Honda, T; Yahara, C; Watanabe, N; Matsuoka, T; Nara, F				Yonesu, Kiyoaki; Kubota, Kazuishi; Tamura, Masakazu; Inaba, Shin-ichi; Honda, Tomohiro; Yahara, Chizuko; Watanabe, Nobuaki; Matsuoka, Tatsuji; Nara, Futoshi			Purification and Identification of Activating Enzymes of CS-0777, a Selective Sphingosine 1-Phosphate Receptor 1 Modulator, in Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELAPSING MULTIPLE-SCLEROSIS; FRUCTOSAMINE 3-KINASE-RELATED PROTEIN; FUNCTIONAL-CHARACTERIZATION; IMMUNOSUPPRESSANT FTY720; IMMUNOMODULATOR FTY720; SUBSTRATE-SPECIFICITY; LYMPHOCYTE EGRESS; MOLECULAR-CLONING; ORAL FINGOLIMOD; KINASE TYPE-2	CS-0777 is a selective sphingosine 1-phosphate (S1P) receptor 1 modulator with potential benefits in the treatment of autoimmune diseases, including multiple sclerosis. CS-0777 is a prodrug that requires phosphorylation to an active S1P analog, similar to the first-in-class S1P receptor modulator FTY720 (fingolimod). We sought to identify the kinase(s) involved in phosphorylation of CS-0777, anticipating sphingosine kinase (SPHK) 1 or 2 as likely candidates. Unlike kinase activity for FTY720, which is found predominantly in platelets, CS-0777 kinase activity was found mainly in red blood cells (RBCs). N,N-Dimethylsphingosine, an inhibitor of SPHK1 and -2, did not inhibit CS-0777 kinase activity. We purified CS-0777 kinase activity from human RBCs by more than 10,000-fold using ammonium sulfate precipitation and successive chromatography steps, and we identified fructosamine 3-kinase (FN3K) and fructosamine 3-kinase-related protein (FN3K-RP) by mass spectrometry. Incubation of human RBC lysates with 1-deoxy-1-morpholinofructose, a competitive inhibitor of FN3K, inhibited similar to 10% of the kinase activity, suggesting FN3K-RP is the principal kinase responsible for activation of CS-0777 in blood. Lysates from HEK293 cells overexpressing FN3K or FN3K-RP resulted in phosphorylation of CS-0777 and structurally related molecules but showed little kinase activity for FTY720 and no kinase activity for sphingosine. Substrate preference was highly correlated among FN3K, FN3K-RP, and rat RBC lysates. FN3K and FN3K-RP are known to phosphorylate sugar moieties on glycosylated proteins, but this is the first report that these enzymes can phosphorylate hydrophobic xenobiotics. Identification of the kinases responsible for CS-0777 activation will permit a better understanding of the pharmacokinetics and pharmacodynamics of this promising new drug.	[Yonesu, Kiyoaki; Nara, Futoshi] Daiichi Sankyo Co Ltd, Cardiovasc Metab Res Labs, Tokyo 1348630, Japan; [Kubota, Kazuishi] Daiichi Sankyo Co Ltd, Translat Med & Clin Pharmacol Dept, Tokyo 1348630, Japan; [Tamura, Masakazu; Matsuoka, Tatsuji] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo 1348630, Japan; [Inaba, Shin-ichi; Honda, Tomohiro; Yahara, Chizuko; Watanabe, Nobuaki] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo 1348630, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Kubota, K (corresponding author), 1-16-13 Kitakasai,Edogawa Ku, Tokyo 1348630, Japan.	kubota.kazuishi.ht@daiichisankyo.co.jp; nara.futoshi.fm@daiichisankyo.co.jp		Matsuoka, Tatsuji/0000-0001-5982-4248				Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Anada Y, 2007, EUR J PHARMACOL, V568, P106, DOI 10.1016/j.ejphar.2007.04.053; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Bohler T, 2004, NEPHROL DIAL TRANSPL, V19, P702, DOI 10.1093/ndt/gfg599; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2001, TRANSPLANTATION, V72, P764, DOI 10.1097/00007890-200109150-00002; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Budde K, 2003, AM J TRANSPLANT, V3, P846, DOI 10.1034/j.1600-6143.2003.00130.x; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Collard F, 2004, BIOCHEM J, V382, P137, DOI 10.1042/BJ20040307; Collard FO, 2003, DIABETES, V52, P2888, DOI 10.2337/diabetes.52.12.2888; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Delpierre G, 2000, DIABETES, V49, P1627, DOI 10.2337/diabetes.49.10.1627; Delpierre G, 2000, BIOCHEM J, V352, P835, DOI 10.1042/0264-6021:3520835; Delplanque J, 2004, J BIOL CHEM, V279, P46606, DOI 10.1074/jbc.M407678200; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Fujita T, 1996, J MED CHEM, V39, P4451, DOI 10.1021/jm960391l; Galetta SL, 2005, CNS DRUGS, V19, P239, DOI 10.2165/00023210-200519030-00005; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Horga A, 2010, EXPERT OPIN PHARMACO, V11, P1183, DOI 10.1517/14656561003769866; Ishizuka T, 2010, J BIOL CHEM, V285, P11892, DOI 10.1074/jbc.M109.072629; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kovarik JM, 2009, J CLIN PHARMACOL, V49, P212, DOI 10.1177/0091270008329553; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Kubota K, 2003, PROTEOMICS, V3, P616, DOI 10.1002/pmic.200300410; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; Kubota K, 2009, NAT BIOTECHNOL, V27, P933, DOI 10.1038/nbt.1566; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Moberly J., 2011, J CLIN PHAR IN PRESS; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nava VE, 2000, FEBS LETT, V473, P81, DOI 10.1016/S0014-5793(00)01510-6; Nishi T, 2011, ACS MED CHEM LETT, V2, P368, DOI 10.1021/ml100301k; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Szwergold B, 2007, BIOCHEM BIOPH RES CO, V361, P870, DOI 10.1016/j.bbrc.2007.07.127; Szwergold BS, 2001, DIABETES, V50, P2139, DOI 10.2337/diabetes.50.9.2139; Van Schaftingen E., 2010, AMINO ACIDS IN PRESS; Van Schaftingen E, 2007, ADV ENZYME REGUL, V47, P261, DOI 10.1016/j.advenzreg.2006.12.002	51	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24765	24775		10.1074/jbc.M110.217299	http://dx.doi.org/10.1074/jbc.M110.217299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613209	hybrid, Green Published			2022-12-27	WOS:000292547900027
J	Dong, M; Lam, PCH; Pinon, DI; Hosohata, K; Orry, A; Sexton, PM; Abagyan, R; Miller, LJ				Dong, Maoqing; Lam, Polo C. -H.; Pinon, Delia I.; Hosohata, Keiko; Orry, Andrew; Sexton, Patrick M.; Abagyan, Ruben; Miller, Laurence J.			Molecular Basis of Secretin Docking to Its Intact Receptor Using Multiple Photolabile Probes Distributed throughout the Pharmacophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; VASOACTIVE-INTESTINAL-PEPTIDE; CORTICOTROPIN-RELEASING-FACTOR; AMINO-TERMINAL REGION; CRYSTAL-STRUCTURE; SPATIAL APPROXIMATION; PARATHYROID-HORMONE; EXTRACELLULAR DOMAIN; AGONIST-BINDING	The molecular basis of ligand binding and activation of family B G protein-coupled receptors is not yet clear due to the lack of insight into the structure of intact receptors. Although NMR and crystal structures of amino-terminal domains of several family members support consistency in general structural motifs that include a peptide-binding cleft, there are variations in the details of docking of the carboxyl terminus of peptide ligands within this cleft, and there is no information about siting of the amino terminus of these peptides. There are also no empirical data to orient the receptor amino terminus relative to the core helical bundle domain. Here, we prepared a series of five new probes, incorporating photolabile moieties into positions 2, 15, 20, 24, and 25 of full agonist secretin analogues. Each bound specifically to the receptor and covalently labeled single distinct receptor residues. Peptide mapping of labeled wild-type and mutant receptors identified that the position 15, 20, and 25 probes labeled residues within the distal amino terminus of the receptor, whereas the position 24 probe labeled the amino terminus adjacent to TM1. Of note, the position 2 probe labeled a residue within the first extracellular loop of the receptor, a region not previously labeled, providing an important new constraint for docking the amino-terminal region of secretin to its receptor core. These additional experimentally derived constraints help to refine our understanding of the structure of the secretin-intact receptor complex and provide new insights into understanding the molecular mechanism for activation of family B G protein-coupled receptors.	[Dong, Maoqing; Pinon, Delia I.; Hosohata, Keiko; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C. -H.; Orry, Andrew; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA	Mayo Clinic; Mayo Clinic Phoenix; Monash University; Monash University; University of California System; University of California San Diego	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473	National Institutes of Health [DK46577]; Australian Research Council [DP0985210]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577 (to L.J.M.). This work was also supported by Australian Research Council Grant DP0985210 (to P. M. S.).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2010, J BIOL CHEM, V285, P9919, DOI 10.1074/jbc.M109.089730; Dong MQ, 2000, J BIOL CHEM, V275, P26032, DOI 10.1074/jbc.M000612200; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; Dong MQ, 1999, J BIOL CHEM, V274, P19161, DOI 10.1074/jbc.274.27.19161; Dong MQ, 2002, MOL ENDOCRINOL, V16, P2490, DOI 10.1210/me.2002-0111; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; GARDNER JD, 1977, GASTROENTEROLOGY, V73, P52; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Greenberg Z, 2000, BIOCHEMISTRY-US, V39, P8142, DOI 10.1021/bi000195n; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar KG, 2007, J BIOL CHEM, V282, P32834, DOI 10.1074/jbc.M704563200; Harikumar KG, 2006, J BIOL CHEM, V281, P2543, DOI 10.1074/jbc.M509197200; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Igarashi H, 2002, J PHARMACOL EXP THER, V303, P445, DOI 10.1124/jpet.102.038075; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; KOFOD H, 1991, INT J PEPT PROT RES, V37, P185; Koth CM, 2010, BIOCHEMISTRY-US, V49, P1862, DOI 10.1021/bi901848m; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nicole P, 2000, J BIOL CHEM, V275, P24003, DOI 10.1074/jbc.M002325200; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Ulrich CD, 1998, GASTROENTEROLOGY, V114, P382, DOI 10.1016/S0016-5085(98)70491-3; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993	56	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23888	23899		10.1074/jbc.M111.245969	http://dx.doi.org/10.1074/jbc.M111.245969			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566140	Green Published, hybrid			2022-12-27	WOS:000292294900031
J	Ehlting, C; Ronkina, N; Bohmer, O; Albrecht, U; Bode, KA; Lang, KS; Kotlyarov, A; Radzioch, D; Gaestel, M; Haussinger, D; Bode, JG				Ehlting, Christian; Ronkina, Natalia; Boehmer, Oliver; Albrecht, Ute; Bode, Konrad A.; Lang, Karl S.; Kotlyarov, Alexey; Radzioch, Danuta; Gaestel, Matthias; Haeussinger, Dieter; Bode, Johannes G.			Distinct Functions of the Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinases MK2 and MK3 MK2 MEDIATES LIPOPOLYSACCHARIDE-INDUCED SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION 3 (STAT3) ACTIVATION BY PREVENTING NEGATIVE REGULATORY EFFECTS OF MK3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SOCS3 MESSENGER-RNA; GENE-EXPRESSION; TNF-ALPHA; CYTOKINE SIGNALING-3; HUMAN MACROPHAGES; CUTTING EDGE; BETA; IL-10	In LPS-treated macrophages, activation of STAT3 is considered to be crucial for terminating the production of inflammatory cytokines. By analyzing the role of MAPK-activated protein kinase (MK) 2 and MK3 for LPS-induced STAT3 activation in macrophages, the present study provides evidence that MK2 is crucial for STAT3 activation in response to LPS because it prevents MK3 from impeding IFN beta gene expression. Accordingly, LPS-induced IFN beta gene expression is down-regulated in MK2-deficient macrophages and can be reconstituted by additional ablation of the MK3 gene in MK2/3(-/-) macrophages. This is in contrast to LPS-induced IL-10 expression, which essentially requires the presence of MK2. Further analysis of downstream signaling events involved in the transcriptional regulation of IFN beta gene expression suggests that, in the absence of MK2, MK3 impairs interferon regulatory factor 3 protein expression and activation and inhibits nuclear translocation of p65. This inhibition of p65 nuclear translocation coincides with enhanced expression and delayed degradation of I kappa B alpha, whereas expression of I kappa B alpha mRNA and protein is impaired in the absence of MK2. The observation that siRNA directed against I kappa B alpha is able to reconstitute I kappa B alpha expression in MK2(-/-) macrophages suggests that enhanced expression and delayed degradation of I kappa B alpha and impaired NF kappa B-dependent I kappa B alpha expression are functionally linked. In summary, evidence is provided that MK2 regulates LPS-induced IFN beta expression and downstream STAT3 activation as it restrains MK3 from mediating negative regulatory effects on NF kappa B-and interferon regulatory factor 3-dependent LPS signaling.	[Ehlting, Christian; Boehmer, Oliver; Albrecht, Ute; Lang, Karl S.; Haeussinger, Dieter; Bode, Johannes G.] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Fac Med, D-40225 Dusseldorf, Germany; [Ronkina, Natalia; Kotlyarov, Alexey; Gaestel, Matthias] Hannover Med Sch, Dept Physiol Chem, D-30625 Hannover, Germany; [Bode, Konrad A.] Univ Heidelberg, Dept Infect Dis Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada	Heinrich Heine University Dusseldorf; Hannover Medical School; Ruprecht Karls University Heidelberg; McGill University	Bode, JG (corresponding author), Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Fac Med, Moorenstr 5, D-40225 Dusseldorf, Germany.	Johannes.Bode@med.uni-duesseldorf.de	Gaestel, Matthias/A-6560-2013; Lang, Karl S/R-2505-2016; Ehlting, Christian/AAI-3791-2020	Gaestel, Matthias/0000-0002-4944-4652; Ehlting, Christian/0000-0003-0103-1856; Lang, Karl/0000-0001-9783-7605; Radzioch, Danuta/0000-0002-1601-2757	Deutsche Forschungsgemeinschaft (Bonn), through Collaborative Research Centers [575, 542]; Deutsche Forschungsgemeinschaft;  [Ga 453/11]	Deutsche Forschungsgemeinschaft (Bonn), through Collaborative Research Centers(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by the Deutsche Forschungsgemeinschaft (Bonn), through Collaborative Research Centers 575 (to J.G.B. and D. H.), and 542 to J.B.) and through Project Ga 453/11 (to M. G.).; Supported by the Heisenberg Program of the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed: Dept. of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, Heinrich-Heine-University, Moorenstrasse 5, D-40225 Dusseldorf, Germany. Fax: 49-211-81-18752; E-mail: Johannes. Bode@med.uni-duesseldorf.de.	Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; Bode KA, 2009, J IMMUNOL, V182, P2176, DOI 10.4049/jimmunol.0802560; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kiu H, 2007, GROWTH FACTORS, V25, P319, DOI 10.1080/08977190701830151; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lang R, 2005, IMMUNOBIOLOGY, V210, P63, DOI 10.1016/j.imbio.2005.05.001; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PEPPEL K, 1991, J EXP MED, V173, P349, DOI 10.1084/jem.173.2.349; PEPPEL K, 1991, J BIOL CHEM, V266, P6663; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	37	60	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24113	24124		10.1074/jbc.M111.235275	http://dx.doi.org/10.1074/jbc.M111.235275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586572	Green Published, hybrid			2022-12-27	WOS:000292294900053
J	Muruganandan, S; Parlee, SD; Rourke, JL; Ernst, MC; Goralski, KB; Sinal, CJ				Muruganandan, Shanmugam; Parlee, Sebastian D.; Rourke, Jillian L.; Ernst, Matthew C.; Goralski, Kerry B.; Sinal, Christopher J.			Chemerin, a Novel Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; CCAAT/ENHANCER-BINDING PROTEINS; TYPE-2 DIABETES-MELLITUS; ADIPOCYTE DIFFERENTIATION; METABOLIC SYNDROME; ROSIGLITAZONE TREATMENT; SKELETAL-MUSCLE; REGULATES ADIPOGENESIS; INSULIN-RESISTANCE; C3H10T1/2 CELLS	Chemerin is an adipocyte-secreted protein that regulates adipogenesis and the metabolic function of mature adipocytes via activation of chemokine-like receptor 1 (CMKLR1). Herein we report the interaction of peroxisome proliferator-activated receptor gamma (PPAR gamma) and chemerin in the context of adipogenesis. Knockdown of chemerin or CMKLR1 expression or antibody neutralization of secreted chemerin protein arrested adipogenic clonal expansion of bone marrow mesenchymal stem cells (BMSCs) by inducing a loss of G(2)/M cyclins (cyclin A2/B2) but not the G(1)/S cyclin D2. Forced expression of PPAR gamma in BMSCs did not completely rescue this loss of clonal expansion and adipogenesis following chemerin or CMKLR1 knockdown. However, forced expression and/or activation of PPAR gamma in BMSCs as well as non-adipogenic cell types such as NIH-3T3 embryonic fibroblasts and MCA38 colon carcinoma cells significantly induced chemerin expression and secretion. Sequence analysis revealed a putative PPAR gamma response element (PPRE) sequence within the chemerin promoter. This PPRE was able to confer PPAR gamma responsiveness on a heterologous promoter, and mutation of this sequence abolished activation of the chemerin promoter by PPAR gamma. Chromatin immunoprecipitation confirmed the direct association of PPAR gamma with this PPRE. Treatment of mice with rosiglitazone elevated chemerin mRNA levels in adipose tissue and bone marrow coincident with an increase in circulating chemerin levels. Together, these findings support a fundamental role for chemerin/CMKLR1 signaling in clonal expansion during adipocyte differentiation as well as a role for PPAR gamma in regulating chemerin expression.	[Muruganandan, Shanmugam; Parlee, Sebastian D.; Rourke, Jillian L.; Ernst, Matthew C.; Goralski, Kerry B.; Sinal, Christopher J.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4R2, Canada; [Goralski, Kerry B.] Dalhousie Univ, Coll Pharm, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University	Sinal, CJ (corresponding author), Dalhousie Univ, Dept Pharmacol, 1459 Oxford St, Halifax, NS B3H 4R2, Canada.	csinal@dal.ca	Muruganandan, Shanmugam/H-5673-2019	Sinal, Christopher/0000-0001-8301-3349; Goralski, Kerry/0000-0003-0040-5879; Shanmugam, Muruganandan/0000-0001-9552-2175	Canadian Institutes of Health Research; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported in part by grants from the Canadian Institutes of Health Research and the Canadian Foundation for Innovation.	Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Bahia L, 2007, ATHEROSCLEROSIS, V195, P138, DOI 10.1016/j.atherosclerosis.2006.09.003; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Becker M, 2010, DIABETES, V59, P2898, DOI 10.2337/db10-0362; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Cho YC, 2004, J CELL BIOCHEM, V91, P336, DOI 10.1002/jcb.10743; DeVos P, 1996, J CLIN INVEST, V98, P1004, DOI 10.1172/JCI118860; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Fajas L, 2001, J MOL ENDOCRINOL, V27, P1, DOI 10.1677/jme.0.0270001; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Ghanim H, 2006, J CLIN ENDOCR METAB, V91, P3553, DOI 10.1210/jc.2005-2609; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Goralski KB, 2007, CAN J PHYSIOL PHARM, V85, P113, DOI 10.1139/Y06-092; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001; Haluzik Martin, 2005, Curr Opin Investig Drugs, V6, P988; Hishida T, 2008, BIOCHEM BIOPH RES CO, V370, P289, DOI 10.1016/j.bbrc.2008.03.091; Jefcoate Colin R., 2008, V456, P173, DOI 10.1007/978-1-59745-245-8_13; Kantartzis K, 2005, OBES RES, V13, P1683, DOI 10.1038/oby.2005.206; Kaul S, 2010, NAT REV CARDIOL, V7, P670, DOI 10.1038/nrcardio.2010.160; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Liu Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE657, DOI 10.1152/ajpendo.00186.2009; Long QQ, 2010, ENDOCRINOLOGY, V151, P3195, DOI 10.1210/en.2009-1501; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Miard S, 2005, INT J OBESITY, V29, pS10, DOI 10.1038/sj.ijo.0802906; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Mundle SD, 2003, FASEB J, V17, P569, DOI 10.1096/fj.02-0431rev; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Nishimura Satoshi, 2009, Discov Med, V8, P55; O'Rourke RW, 2009, SURGERY, V145, P255, DOI 10.1016/j.surg.2008.08.038; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Stejskal D, 2008, BIOMED PAP, V152, P217, DOI 10.5507/bp.2008.033; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tomaru T, 2009, J BIOL CHEM, V284, P6116, DOI 10.1074/jbc.M808407200; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Weigert J, 2010, CLIN ENDOCRINOL, V72, P342, DOI 10.1111/j.1365-2265.2009.03664.x; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zhu Hui-Li, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1050	61	97	106	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23982	23995		10.1074/jbc.M111.220491	http://dx.doi.org/10.1074/jbc.M111.220491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572083	Green Published, hybrid			2022-12-27	WOS:000292294900041
J	Ting, TC; Miyazaki-Anzai, S; Masuda, M; Levi, M; Demer, LL; Tintut, Y; Miyazaki, M				Ting, Tabitha C.; Miyazaki-Anzai, Shinobu; Masuda, Masashi; Levi, Moshe; Demer, Linda L.; Tintut, Yin; Miyazaki, Makoto			Increased Lipogenesis and Stearate Accelerate Vascular Calcification in Calcifying Vascular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESATURASE-1 DEFICIENCY PROTECTS; ENDOPLASMIC-RETICULUM STRESS; UNSATURATED FATTY-ACIDS; X-RECEPTOR; GENE-EXPRESSION; SIGNALING PATHWAYS; BETA-CELLS; BILE-ACIDS; LIVER; LXR	Vascular calcification is recognized as an independent predictor of cardiovascular mortality, particularly in subjects with chronic kidney disease. However, the pathways by which dysregulation of lipid and mineral metabolism simultaneously occur in this particular population remain unclear. We have shown that activation of the farnesoid X receptor (FXR) blocks mineralization of bovine calcifying vascular cells (CVCs) and in ApoE knock-out mice with 5/6 nephrectomy. In contrast to FXR, this study showed that liver X receptor (LXR) activation by LXR agonists and adenovirus-mediated LXR overexpression by VP16-LXR alpha and VP16-LXR beta accelerated mineralization of CVCs. Conversely, LXR inhibition by dominant negative (DN) forms of LXR alpha and LXR beta reduced calcium content in CVCs. The regulation of mineralization by FXR and LXR agonists was highly correlated with changes in lipid accumulation, fatty acid synthesis, and the expression of sterol regulatory element binding protein-1 (SREBP-1). The rate of lipogenesis in CVCs through the SREBP-1c dependent pathway was reduced by FXR activation, but increased by LXR activation. SREBP-1c overexpression augmented mineralization in CVCs, whereas SREBP-1c DN inhibited alkaline phosphatase activity and mineralization induced by LXR agonists. LXR and SREBP-1c activations increased, whereas FXR activation decreased, saturated and monounsaturated fatty acids derived from lipogenesis. In addition, we found that stearate markedly promoted mineralization of CVCs as compared with other fatty acids. Furthermore, inhibition of either acetyl-CoA carboxylase or acyl-CoA synthetase reduced mineralization of CVCs, whereas inhibition of stearoyl-CoA desaturase induced mineralization. Therefore, a stearate metabolite derived from lipogenesis might be a risk factor for the development of vascular calcification.	[Miyazaki, Makoto] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Ting, Tabitha C.; Miyazaki-Anzai, Shinobu; Masuda, Masashi; Levi, Moshe; Miyazaki, Makoto] Denver VA Med Ctr, Div Renal Dis & Hypertens, Dept Med, Aurora, CO 80045 USA; [Miyazaki, Makoto] Denver VA Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Aurora, CO 80045 USA; [Demer, Linda L.; Tintut, Yin] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of California System; University of California Los Angeles	Miyazaki, M (corresponding author), Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, 12700 E 19th Ave,C281, Aurora, CO 80045 USA.	Makoto.Miyazaki@ucdenver.edu	Demer, Linda L/I-5770-2013	Demer, Linda L/0000-0002-9618-6895; Ting, Tabitha/0000-0001-5206-9243; Masuda, Masashi/0000-0003-3762-2770; Levi, Moshe/0000-0002-6225-946X	National Institutes of Health [HL081202, DK081346]; American Heart Association [10BGIA458005]; Colorado Clinical Nutrition Research Unit (National Institutes of Health) [5P30DK048520]; UCHSC Diabetes and Endocrinology Research Center (National Institutes of Health) [P30DK57516]; NIGMS-IMSD [R25GM083333]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081202, R21HL109628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK076009, R01DK081346, P30DK048520, P30DK057516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Colorado Clinical Nutrition Research Unit (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCHSC Diabetes and Endocrinology Research Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS-IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081202 and DK081346, the American Heart Association Grant 10BGIA458005, as well as the Colorado Clinical Nutrition Research Unit (National Institutes of Health Grant 5P30DK048520), and the UCHSC Diabetes and Endocrinology Research Center (National Institutes of Health Grant P30DK57516). T. C. T. was supported by NIGMS-IMSD #R25GM083333.	Achenbach S, 2002, CIRCULATION, V106, P1077, DOI 10.1161/01.CIR.0000027567.49283.FF; Baigent C, 2010, AM HEART J, V160, P785, DOI 10.1016/j.ahj.2010.08.012; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hsu JJ, 2009, FEBS LETT, V583, P1344, DOI 10.1016/j.febslet.2009.03.039; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2003, CURR OPIN PHARMACOL, V3, P192, DOI 10.1016/S1471-4892(03)00009-2; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Matsuzaka T, 2002, J LIPID RES, V43, P911; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Miyazaki-Anzai S, 2010, CIRC RES, V106, P1807, DOI 10.1161/CIRCRESAHA.109.212969; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sampath H, 2005, LIPIDS, V40, P1187, DOI 10.1007/s11745-005-1484-z; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P9558, DOI 10.1073/pnas.95.16.9558; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Zhang YQ, 2008, FEBS LETT, V582, P10, DOI 10.1016/j.febslet.2007.11.015	48	34	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23938	23949		10.1074/jbc.M111.237065	http://dx.doi.org/10.1074/jbc.M111.237065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596756	Green Published, hybrid			2022-12-27	WOS:000292294900036
J	Wang, JW; Valentijn, KM; de Boer, HC; Dirven, RJ; van Zonneveld, AJ; Koster, AJ; Voorberg, J; Reitsma, PH; Eikenboom, J				Wang, Jiong-Wei; Valentijn, Karine M.; de Boer, Hetty C.; Dirven, Richard J.; van Zonneveld, Anton Jan; Koster, Abraham J.; Voorberg, Jan; Reitsma, Pieter H.; Eikenboom, Jeroen			Intracellular Storage and Regulated Secretion of Von Willebrand Factor in Quantitative Von Willebrand Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEIBEL-PALADE BODIES; MUTATED CYSTEINE RESIDUES; HUMAN ENDOTHELIAL-CELLS; FACTOR PROPEPTIDE; DEFECTIVE MULTIMERIZATION; D3 DOMAIN; MUTATIONS; PHENOTYPE; VWF; MCMDM-1VWD	Several missense mutations in the von Willebrand Factor (VWF) gene of von Willebrand disease (VWD) patients have been shown to cause impaired constitutive secretion and intracellular retention of VWF. However, the effects of those mutations on the intracellular storage in Weibel-Palade bodies (WPBs) of endothelial cells and regulated secretion of VWF remain unknown. We demonstrate, by expression of quantitative VWF mutants in HEK293 cells, that four missense mutations in the D3 and CK-domain of VWF diminished the storage in pseudo-WPBs, and led to retention of VWF within the endoplasmic reticulum (ER). Immunofluorescence and electron microscopy data showed that the pseudo-WPBs formed by missense mutant C1060Y are indistinguishable from those formed by normal VWF. C1149R, C2739Y, and C2754W formed relatively few pseudo-WPBs, which were often short and sometimes round rather than cigar-shaped. The regulated secretion of VWF was impaired slightly for C1060Y but severely for C1149R, C2739Y, and C2754W. Upon co-transfection with wild-type VWF, both intracellular storage and regulated secretion of all mutants were (partly) corrected. In conclusion, defects in the intracellular storage and regulated secretion of VWF following ER retention may be a common mechanism underlying VWD with a quantitative deficiency of VWF.	[Wang, Jiong-Wei; de Boer, Hetty C.; Dirven, Richard J.; van Zonneveld, Anton Jan; Reitsma, Pieter H.; Eikenboom, Jeroen] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, NL-2333 ZA Leiden, Netherlands; [Wang, Jiong-Wei; Dirven, Richard J.; Reitsma, Pieter H.; Eikenboom, Jeroen] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, NL-2333 ZA Leiden, Netherlands; [Valentijn, Karine M.; Koster, Abraham J.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 ZC Leiden, Netherlands; [de Boer, Hetty C.; van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, NL-2333 ZA Leiden, Netherlands; [Voorberg, Jan] Sanquin AMC Landsteiner Lab, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam	Eikenboom, J (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Thrombosis & Hemostasis, C2-R,POB 9600, NL-2300 RC Leiden, Netherlands.	h.c.j.eikenboom@LUMC.nl	Wang, Jiong-Wei/C-5346-2012; van Zonneveld, Anton Jan/D-8060-2018; Eikenboom, Jeroen/F-9156-2018; Wang, Jiong-Wei/AAW-9118-2021; Koster, Abraham/I-7665-2017	van Zonneveld, Anton Jan/0000-0002-1676-7738; Eikenboom, Jeroen/0000-0002-3268-5759; Wang, Jiong-Wei/0000-0001-7986-6082; Dirven, Richard/0000-0001-9626-9925; Voorberg, Jan/0000-0003-4585-2621; Koster, Abraham/0000-0003-1717-2549	China Scholarship Council [2007U21083]; Netherlands Organization for Scientific Research (NWO) [91209006]	China Scholarship Council(China Scholarship Council); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the China Scholarship Council (2007U21083) and in part, by a grant from the Netherlands Organization for Scientific Research (NWO), Grant No. 91209006.	Allen S, 2000, BLOOD, V96, P560; Allen S, 2000, BLOOD, V95, P2000, DOI 10.1182/blood.V95.6.2000; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Berriman JA, 2009, P NATL ACAD SCI USA, V106, P17407, DOI 10.1073/pnas.0902977106; Bodo I, 2001, BLOOD, V98, P2973, DOI 10.1182/blood.V98.10.2973; Casonato A, 2004, J LAB CLIN MED, V144, P254, DOI 10.1016/j.lab.2004.08.002; Casonato A, 2003, BLOOD, V101, P151, DOI 10.1182/blood-2002-04-1046; Casonato A, 2007, THROMB HAEMOSTASIS, V98, P1182, DOI 10.1160/TH07-05-0347; Castaman G, 2010, J THROMB HAEMOST, V8, P2011, DOI 10.1111/j.1538-7836.2010.03971.x; Cumming A, 2006, THROMB HAEMOSTASIS, V96, P630, DOI 10.1160/TH06-07-0383; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Eikenboom J, 2009, J THROMB HAEMOST, V7, P1304, DOI 10.1111/j.1538-7836.2009.03486.x; Eikenboom JCJ, 1996, BLOOD, V88, P2433, DOI 10.1182/blood.V88.7.2433.bloodjournal8872433; Eikenboom JCJ, 2001, BEST PRACT RES CL HA, V14, P365, DOI 10.1053/beha.2001.0139; EWENSTEIN BM, 1987, J CELL BIOL, V104, P1423, DOI 10.1083/jcb.104.5.1423; Federici AB, 2008, HAEMOPHILIA, V14, P5, DOI 10.1111/j.1365-2516.2007.01610.x; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Goodeve A, 2007, BLOOD, V109, P112, DOI 10.1182/blood-2006-05-020784; Hampshire DJ, 2010, HAEMATOL-HEMATOL J, V95, P2163, DOI 10.3324/haematol.2010.027177; Hommais A, 2006, J THROMB HAEMOST, V4, P148, DOI 10.1111/j.1538-7836.2005.01652.x; Hop C, 2000, ARTERIOSCL THROM VAS, V20, P1763, DOI 10.1161/01.ATV.20.7.1763; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; James PD, 2007, BLOOD, V109, P145, DOI 10.1182/blood-2006-05-021105; Lui-Roberts WWY, 2005, J CELL BIOL, V170, P627, DOI 10.1083/jcb.200503054; MAYADAS T, 1989, BLOOD, V73, P706; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Michaux G, 2003, BLOOD, V102, P2452, DOI 10.1182/blood-2003-02-0599; MOMMAAS AM, 1995, EUR J IMMUNOL, V25, P520, DOI 10.1002/eji.1830250232; Rosenberg JB, 2002, BLOOD, V100, P1699, DOI 10.1182/blood-2002-03-0789; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneppenheim R, 2001, BLOOD, V97, P2059, DOI 10.1182/blood.V97.7.2059; Schneppenheim R, 2010, BLOOD, V115, P4894, DOI 10.1182/blood-2009-07-226324; Schooten CJ, 2005, J THROMB HAEMOST, V3, P2228, DOI 10.1111/j.1538-7836.2005.01571.x; SPORN LA, 1987, BLOOD, V69, P1531; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Tjernberg P, 2006, BRIT J HAEMATOL, V133, P409, DOI 10.1111/j.1365-2141.2006.06055.x; Tjernberg P, 2004, J THROMB HAEMOST, V2, P257, DOI 10.1111/j.1538-7836.2003.00435.x; Tjernberg P, 2006, THROMB HAEMOSTASIS, V96, P717, DOI 10.1160/TH06-08-0460; Valentijn KM, 2008, J STRUCT BIOL, V161, P447, DOI 10.1016/j.jsb.2007.08.001; VERWEIJ CL, 1986, EMBO J, V5, P1839, DOI 10.1002/j.1460-2075.1986.tb04435.x; VOORBERG J, 1993, EMBO J, V12, P749, DOI 10.1002/j.1460-2075.1993.tb05709.x; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; Wang JW, 2010, HAMOSTASEOLOGIE, V30, P150, DOI 10.1055/s-0037-1619048; WIT TD, 2003, ARTERIOSCLER THROMB, V23, P755; Zenner HL, 2007, J CELL SCI, V120, P2117, DOI 10.1242/jcs.007781; ZHANG ZP, 1994, GENOMICS, V21, P188, DOI 10.1006/geno.1994.1241	48	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24180	24188		10.1074/jbc.M110.215194	http://dx.doi.org/10.1074/jbc.M110.215194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596755	hybrid, Green Published			2022-12-27	WOS:000292294900060
J	Wang, XJ; Wang, JR; Jiang, XJ				Wang, Xinjiang; Wang, Junru; Jiang, Xuejun			MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; DNA-DAMAGE; EMBRYONIC LETHALITY; DEGRADATION; ACTIVATION; PHOSPHORYLATION; DIMERIZATION; INHIBITION; EXPRESSION; E3	Genetic evidence has implicated both Mdm2 and MdmX as essential in negative regulation of p53. However, the exact role of MdmX in this Mdm2-dependent protein degradation is not well understood. Most, if not all, previous Mdm2 studies used GST-Mdm2 fusion proteins in the in vitro assays. Here, we show that the p53 polyubiquitination activity of GST-Mdm2 is conferred by the GST tag and non-GST-tagged Mdm2 only catalyzes monoubiquitination of p53 even at extremely high concentrations. We further demonstrate that MdmX is a potent activator of Mdm2, facilitating dose-dependent p53 polyubiquitination. This activation process requires the RING domains of both MdmX and Mdm2 proteins. The polyubiquitination activity of Mdm2/MdmX is Mdm2-dependent. Unlike Mdm2 or MdmX overexpression alone, co-overexpression of MdmX and Mdm2 consistently triggered p53 degradation in cells. Moreover, cellular polyubiquitination of p53 was only observable in the cytoplasm where both Mdm2 and MdmX are readily detectable. Importantly, RNAi knockdown of MdmX increased levels of endogenous p53 accompanied by reduced p53 polyubiquitination. In conclusion, our work has resolved a major confusion in the field derived from using GST-Mdm2 and demonstrated that MdmX is the cellular activator that converts Mdm2 from a monoubiquitination E3 ligase to a polyubiquitination E3 ligase toward p53. Together, our findings provide a biochemical basis for the requirement of both Mdm2 and MdmX in the dynamic regulation of p53 stability.	[Wang, Xinjiang] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Wang, Junru; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA	Roswell Park Cancer Institute; Memorial Sloan Kettering Cancer Center	Wang, XJ (corresponding author), Elm & Carlton St, Buffalo, NY 14263 USA.	xinjiang.wang@roswellpark.org; jiangx@mskcc.org			American Cancer Society; Geoffrey Beene Cancer Research Fund award; Roswell Park Cancer Institute; Elsa U. Pardee Foundation	American Cancer Society(American Cancer Society); Geoffrey Beene Cancer Research Fund award; Roswell Park Cancer Institute; Elsa U. Pardee Foundation	This work was supported by the American Cancer Society and a Geoffrey Beene Cancer Research Fund award (to X. J.) and by start-up funds from the Roswell Park Cancer Institute (to X. W.) and Elsa U. Pardee Foundation (to X. W.).	Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gilkes DM, 2008, MOL CELL BIOL, V28, P1999, DOI 10.1128/MCB.01633-07; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jackson MW, 1999, DNA CELL BIOL, V18, P693, DOI 10.1089/104454999314971; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ohtsubo C, 2009, CANCER SCI, V100, P1291, DOI 10.1111/j.1349-7006.2009.01180.x; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Xiong SB, 2007, CIRCULATION, V115, P2925, DOI 10.1161/CIRCULATIONAHA.107.689901; YAN H, 1995, ANAL BIOCHEM, V231, P455, DOI 10.1006/abio.1995.0080	47	78	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23725	23734		10.1074/jbc.M110.213868	http://dx.doi.org/10.1074/jbc.M110.213868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572037	hybrid, Green Published			2022-12-27	WOS:000292294900014
J	Zhang, Y; Gladyshev, VN				Zhang, Yan; Gladyshev, Vadim N.			Comparative Genomics of Trace Element Dependence in Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MICRONUTRIENT DEFICIENCIES; EVOLUTIONARY DYNAMICS; ZINC HOMEOSTASIS; COPPER PROTEINS; 3 DOMAINS; SELENOCYSTEINE; TYROSINASE; METAL; SELENIUM; BINDING	Biological trace elements are needed in small quantities but are used by all living organisms. A growing list of trace element-dependent proteins and trace element utilization pathways highlights the importance of these elements for life. In this mini-review, we focus on recent advances in comparative genomics of trace elements and explore the evolutionary dynamics of the dependence of user proteins on these elements. Many zinc protein families evolved representatives that lack this metal, whereas selenocysteine in proteins is dynamically exchanged with cysteine. Several other elements, such as molybdenum and nickel, have a limited number of user protein families, but they are strictly dependent on these metals. Comparative genomics of trace elements provides a foundation for investigating the fundamental properties, functions, and evolutionary dynamics of trace element dependence in biology.	[Zhang, Yan; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Div Genet, Boston, MA 02115 USA; [Zhang, Yan] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gladyshev, VN (corresponding author), Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Div Genet, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [GM061603, CA080946]; NATIONAL CANCER INSTITUTE [R01CA080946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061603 and CA080946 (to V. N. G.). This is the first article in the Thematic Minireview Series on Computational Systems Biology. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Ames BN, 2001, MUTAT RES-FUND MOL M, V475, P7, DOI 10.1016/S0027-5107(01)00070-7; Ames BN, 2006, P NATL ACAD SCI USA, V103, P17589, DOI 10.1073/pnas.0608757103; Andreini C, 2004, BIOINFORMATICS, V20, P1373, DOI 10.1093/bioinformatics/bth095; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2008, J PROTEOME RES, V7, P209, DOI 10.1021/pr070480u; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; ARCHIBALD F, 1983, FEMS MICROBIOL LETT, V19, P29, DOI 10.1111/j.1574-6968.1983.tb00504.x; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Baran EJ, 2004, MINI-REV MED CHEM, V4, P1, DOI 10.2174/1389557043487556; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Burmester T, 2002, J COMP PHYSIOL B, V172, P95, DOI 10.1007/s00360-001-0247-7; Castellano S, 2009, BBA-GEN SUBJECTS, V1790, P1463, DOI 10.1016/j.bbagen.2009.03.027; Castellano S, 2009, MOL BIOL EVOL, V26, P2031, DOI 10.1093/molbev/msp109; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; COHEN T, 1990, NUCLEIC ACIDS RES, V18, P2807, DOI 10.1093/nar/18.9.2807; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Degtyarenko K, 2000, BIOINFORMATICS, V16, P851, DOI 10.1093/bioinformatics/16.10.851; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Filipski Alan, 2005, P521, DOI 10.1016/B978-012301463-4/50011-5; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Frassinetti S, 2006, J ENVIRON PATHOL TOX, V25, P597, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i3.40; Furumura M, 1998, BIOCHEM BIOPH RES CO, V242, P579, DOI 10.1006/bbrc.1997.8007; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; GLADYSHEV VN, 2007, SELENIUM ITS MOL BIO, P83; Gregory T. Ryan, 2005, P585; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hardison RC, 2003, PLOS BIOL, V1, P156, DOI 10.1371/journal.pbio.0000058; Harris ED, 2000, ANNU REV NUTR, V20, P291, DOI 10.1146/annurev.nutr.20.1.291; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Jaenicke E, 2004, CHEMBIOCHEM, V5, P163, DOI 10.1002/cbic.200300714; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Keen CL, 2003, J NUTR, V133, p1597S, DOI 10.1093/jn/133.5.1597S; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Krautler B, 2005, BIOCHEM SOC T, V33, P806; Kryukov GV, 2004, EMBO REP, V5, P538, DOI 10.1038/sj.embor.7400126; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Ma JX, 1997, BIOCHEMISTRY-US, V36, P11298, DOI 10.1021/bi9709710; MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9; MAKAROVA KS, 2001, GENOME BIOL, V2, P9; Martins JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-23; Mendel RR, 2007, NAT PROD REP, V24, P963, DOI 10.1039/b703112m; Mertz W, 1998, BIOL TRACE ELEM RES, V66, P185, DOI 10.1007/BF02783137; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; Mulkidjanian AY, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-26; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Musser SM, 1998, J MOL EVOL, V46, P508, DOI 10.1007/PL00006332; Nakamura M, 2000, BIOCHEM J, V350, P537, DOI 10.1042/0264-6021:3500537; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; PRASAD AS, 1995, NUTRITION, V11, P93; Prentice AM, 2005, PUBLIC HEALTH NUTR, V8, P932, DOI 10.1079/PHN2005779; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Ridge PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001378; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Romero H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r66; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Salgueiro J, 1999, Acta Physiol Pharmacol Ther Latinoam, V49, P1; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Shi W, 2008, CELL MOL LIFE SCI, V65, P3040, DOI 10.1007/s00018-008-8189-9; Shi WX, 2005, STRUCTURE, V13, P1473, DOI 10.1016/j.str.2005.07.014; Solano F, 1996, BIOCHEM J, V313, P447, DOI 10.1042/bj3130447; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Sukdeo N, 2004, BIOCHEM J, V384, P111, DOI 10.1042/BJ20041006; SWINBURN BA, 1994, BAILLIERE CLIN ENDOC, V8, P527, DOI 10.1016/S0950-351X(05)80285-X; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Zhang Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r37; Zhang Y, 2005, BIOINFORMATICS, V21, P2580, DOI 10.1093/bioinformatics/bti400; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000095; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051; Zhang Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r94; Zhang Y, 2010, J BIOL CHEM, V285, P3393, DOI 10.1074/jbc.M109.071746; Zhang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-78; Zhang Y, 2009, CHEM REV, V109, P4828, DOI 10.1021/cr800557s	93	41	42	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23623	23629		10.1074/jbc.R110.172833	http://dx.doi.org/10.1074/jbc.R110.172833			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566146	Green Published, hybrid			2022-12-27	WOS:000292294900002
J	Marquer, C; Fruchart-Gaillard, C; Letellier, G; Marcon, E; Mourier, G; Zinn-Justin, S; Menez, A; Servent, D; Gilquin, B				Marquer, Catherine; Fruchart-Gaillard, Carole; Letellier, Guillaume; Marcon, Elodie; Mourier, Gilles; Zinn-Justin, Sophie; Menez, Andre; Servent, Denis; Gilquin, Bernard			Structural Model of Ligand-G Protein-coupled Receptor (GPCR) Complex Based on Experimental Double Mutant Cycle Data MT7 SNAKE TOXIN BOUND TO DIMERIC hM1 MUSCARINIC RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-1 MUSCARINIC RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; DATA-DRIVEN DOCKING; ACETYLCHOLINE-RECEPTORS; ALLOSTERIC LIGANDS; MOLECULAR-DYNAMICS; HIGH-AFFINITY; AMINO-ACIDS; MT7 TOXIN; BINDING	The snake toxin MT7 is a potent and specific allosteric modulator of the human M1 muscarinic receptor (hM1). We previously characterized by mutagenesis experiments the functional determinants of the MT7-hM1 receptor interaction (Fruchart-Gaillard, C., Mourier, G., Marquer, C., Stura, E., Birdsall, N. J., and Servent, D. (2008) Mol. Pharmacol. 74, 1554-1563) and more recently collected evidence indicating that MT7 may bind to a dimeric form of hM1 (Marquer, C., Fruchart-Gaillard, C., Mourier, G., Grandjean, O., Girard, E., le Maire, M., Brown, S., and Servent, D. (2010) Biol. Cell 102, 409-420). To structurally characterize the MT7-hM1 complex, we adopted a strategy combining double mutant cycle experiments and molecular modeling calculations. First, thirty-three ligand-receptor proximities were identified from the analysis of sixty-one double mutant binding affinities. Several toxin residues that are more than 25 angstrom apart still contact the same residues on the receptor. As a consequence, attempts to satisfy all the restraints by docking the toxin onto a single receptor failed. The toxin was then positioned onto two receptors during five independent flexible docking simulations. The different possible ligand and receptor extracellular loop conformations were described by performing simulations in explicit solvent. All the docking calculations converged to the same conformation of the MT7-hM1 dimer complex, satisfying the experimental restraints and in which (i) the toxin interacts with the extracellular side of the receptor, (ii) the tips of MT7 loops II and III contact one hM1 protomer, whereas the tip of loop I binds to the other protomer, and (iii) the hM1 dimeric interface involves the transmembrane helices TM6 and TM7. These results structurally support the high affinity and selectivity of the MT7-hM1 interaction and highlight the atypical mode of interaction of this allosteric ligand on its G protein-coupled receptor target.	[Marquer, Catherine; Fruchart-Gaillard, Carole; Marcon, Elodie; Mourier, Gilles; Servent, Denis] CEA, iBiTecS, SIMOPRO, Lab Toxinol Mol & Biotechnol, F-91191 Gif Sur Yvette, France; [Menez, Andre] Museum Natl Hist Nat, F-75005 Paris, France; [Letellier, Guillaume; Zinn-Justin, Sophie; Gilquin, Bernard] CEA, iBiTecS, SB2SM, Lab Biol Struct & Radiobiol,CNRS,URA 2096, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Museum National d'Histoire Naturelle (MNHN); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Servent, D (corresponding author), CEA, iBiTecS, SIMOPRO, Lab Toxinol Mol & Biotechnol, F-91191 Gif Sur Yvette, France.	denis.servent@cea.fr; bernard.gilquin@cea.fr	Fruchart Gaillard, Carole/GWV-2801-2022	Fruchart Gaillard, Carole/0000-0002-3149-4774; Servent, Denis/0000-0002-0774-1691				Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chung F, 2009, CHEM-EUR J, V15, P7109, DOI 10.1002/chem.200802451; Cohavi O, 2009, J MOL BIOL, V390, P503, DOI 10.1016/j.jmb.2009.05.029; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; DePristo MA, 2005, STRUCTURE, V13, P1311, DOI 10.1016/j.str.2005.06.008; Durrant JD, 2010, J MOL RECOGNIT, V23, P173, DOI 10.1002/jmr.989; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Fruchart-Gaillard C, 2006, MOL PHARMACOL, V69, P1641, DOI 10.1124/mol.105.020883; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Fruchart-Gaillard C, 2008, MOL PHARMACOL, V74, P1554, DOI 10.1124/mol.108.050773; Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x; Gilquin B, 2005, J BIOL CHEM, V280, P27093, DOI 10.1074/jbc.M413626200; Gilquin B, 2002, J BIOL CHEM, V277, P37406, DOI 10.1074/jbc.M206205200; Gilquin B, 2003, PROTEIN SCI, V12, P266, DOI 10.1110/ps.0227703; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; GUILBERT C, 1995, COMPUT PHYS COMMUN, V91, P263, DOI 10.1016/0010-4655(95)00052-H; Hansen JL, 2009, J BIOL CHEM, V284, P1831, DOI 10.1074/jbc.M804607200; Harel M, 2007, J MOL BIOL, V371, P180, DOI 10.1016/j.jmb.2007.05.032; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Ilien B, 2009, J BIOL CHEM, V284, P19533, DOI 10.1074/jbc.M109.017145; Imredy JP, 2000, J MOL BIOL, V296, P1283, DOI 10.1006/jmbi.2000.3522; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kukkonen A, 2004, J BIOL CHEM, V279, P50923, DOI 10.1074/jbc.M406424200; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Marquer C, 2010, BIOL CELL, V102, P409, DOI 10.1042/BC20090171; MAX SI, 1993, MOL PHARMACOL, V44, P1171; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Olianas MC, 2000, BRIT J PHARMACOL, V131, P447, DOI 10.1038/sj.bjp.0703606; Oliveira L, 2004, FEBS LETT, V564, P269, DOI 10.1016/S0014-5793(04)00320-5; Park PSH, 2003, BIOCHEMISTRY-US, V42, P12960, DOI 10.1021/bi034491m; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Roisman LC, 2001, P NATL ACAD SCI USA, V98, P13231, DOI 10.1073/pnas.221290398; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schulz MN, 2009, CURR OPIN PHARMACOL, V9, P615, DOI 10.1016/j.coph.2009.04.009; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Simpson LM, 2010, CURR OPIN PHARMACOL, V10, P30, DOI 10.1016/j.coph.2009.11.001; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Trankle C, 2005, MOL PHARMACOL, V68, P1597, DOI 10.1124/mol.105.017707; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Valant C, 2009, MOL INTERV, V9, P125, DOI 10.1124/mi.9.3.6; van Dijk ADJ, 2005, PROTEINS, V60, P232, DOI 10.1002/prot.20563; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; VANSCHAIK RC, 1993, J MOL BIOL, V234, P751, DOI 10.1006/jmbi.1993.1624; Vaughan CK, 1999, J MOL BIOL, V286, P1487, DOI 10.1006/jmbi.1998.2559; Venkatakrishnan AJ, 2010, BIOCHEM SOC T, V38, P879, DOI 10.1042/BST0380879; Verdier L, 2005, J BIOL CHEM, V280, P21246, DOI 10.1074/jbc.M502376200; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zvi A, 2000, EUR J BIOCHEM, V267, P767, DOI 10.1046/j.1432-1327.2000.01055.x	86	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31661	31675		10.1074/jbc.M111.261404	http://dx.doi.org/10.1074/jbc.M111.261404			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21685390	hybrid, Green Published			2022-12-27	WOS:000294487500059
J	Chew, YC; Adhikary, G; Wilson, GM; Reece, EA; Eckert, RL				Chew, Yap Ching; Adhikary, Gautam; Wilson, Gerald M.; Reece, E. Albert; Eckert, Richard L.			Protein Kinase C (PKC) delta Suppresses Keratinocyte Proliferation by Increasing p21(Cip1) Level by a KLF4 Transcription Factor-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INVOLUCRIN PROMOTER; HUMAN EPIDERMAL-KERATINOCYTES; KRUPPEL-LIKE FACTOR; SQUAMOUS-CELL CARCINOMA; CALCIUM-INDUCED DIFFERENTIATION; DISTAL REGULATORY REGION; GREEN TEA POLYPHENOL; GENE-EXPRESSION; TUMOR SUPPRESSION; TRANSGENIC MICE	PKC delta increases keratinocyte differentiation and suppresses keratinocyte proliferation and survival. However, the mechanism of proliferation suppression is not well understood. The present studies show that PKC delta overexpression increases p21(Cip1) mRNA and protein level and promoter activity and that treatment with dominant-negative PKC delta, PKC delta-siRNA, or rottlerin inhibits promoter activation. Analysis of the p21(Cip1) promoter upstream regulatory region reveals three DNA segments that mediate PKC delta-dependent promoter activation. The PKC delta response element most proximal to the transcription start site encodes six GC-rich DNA elements. Mutation of these sites results in a loss of PKC delta-dependent promoter activation. Gel mobility supershift and chromatin immunoprecipitation reveal that these DNA elements bind the Kruppel-like transcription factor KLF4. PKC delta increases KLF4 mRNA and protein level and KLF4 binding to the GC-rich elements in the p21(Cip1) proximal promoter. In addition, KLF4-siRNA inhibits PKC delta-dependent p21(Cip1) promoter activity. PKC delta increases KLF4 expression leading to enhanced KLF4 interaction with the GC-rich elements in the p21(Cip1) promoter to activate transcription.	[Chew, Yap Ching; Adhikary, Gautam; Wilson, Gerald M.; Reece, E. Albert; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Reece, E. Albert; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507; Chew, Yap Ching/0000-0002-1686-6541	National Institutes of Health [R01 AR046494]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR046494 (to R. L. E.).	Acs P, 2000, CARCINOGENESIS, V21, P887, DOI 10.1093/carcin/21.5.887; Adhikary G, 2004, INVEST OPHTH VIS SCI, V45, P1080, DOI 10.1167/iovs.03-1180; Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Agarwal C, 1999, J BIOL CHEM, V274, P6190, DOI 10.1074/jbc.274.10.6190; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Aziz MH, 2009, J INVEST DERMATOL, V129, P2011, DOI 10.1038/jid.2008.458; Balasubramanian S, 2004, J BIOL CHEM, V279, P24007, DOI 10.1074/jbc.M314331200; Balasubramanian S, 2002, J BIOL CHEM, V277, P1828, DOI 10.1074/jbc.M110376200; Balasubramanian S, 2007, J BIOL CHEM, V282, P6707, DOI 10.1074/jbc.M606003200; Balasubramanian S, 2006, J BIOL CHEM, V281, P36162, DOI 10.1074/jbc.M605368200; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bollag WB, 2004, DRUG NEWS PERSPECT, V17, P117, DOI 10.1358/dnp.2004.17.2.829045; Bollag WB, 2009, J INVEST DERMATOL, V129, P2330, DOI 10.1038/jid.2009.165; Cabodi S, 2000, MOL CELL, V6, P1121, DOI 10.1016/S1097-2765(00)00110-6; Cheng F, 2009, MOL BIOL CELL, V20, P319, DOI 10.1091/mbc.E08-07-0681; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; DLUGOSZ AA, 1994, J INVEST DERMATOL, V102, P409, DOI 10.1111/1523-1747.ep12372171; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Eckert RL, 2003, J INVEST DERMATOL, V120, P823, DOI 10.1046/j.1523-1747.2003.12120.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISHER GJ, 1993, J INVEST DERMATOL, V101, P553, DOI 10.1111/1523-1747.ep12365967; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; GHERZI R, 1992, BIOCHEM BIOPH RES CO, V184, P283, DOI 10.1016/0006-291X(92)91190-2; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Hara T, 2005, CANCER RES, V65, P7356, DOI 10.1158/0008-5472.CAN-04-4241; Hauser P, 2004, MOL CANCER RES, V2, P96; Hwang CY, 2009, MOL CELL BIOL, V29, P3379, DOI 10.1128/MCB.01758-08; Jansen AP, 2001, CANCER RES, V61, P808; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Jerome-Morais A, 2009, J INVEST DERMATOL, V129, P2365, DOI 10.1038/jid.2009.74; Jiang D, 2009, J CHROMATOGR A, V1216, P6881, DOI 10.1016/j.chroma.2009.08.044; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kamioka N, 2010, BIOCHEM BIOPH RES CO, V394, P106, DOI 10.1016/j.bbrc.2010.02.125; Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kraft CA, 2007, ARCH DERMATOL RES, V299, P71, DOI 10.1007/s00403-006-0727-4; LI WQ, 1995, J BIOL CHEM, V270, P8311, DOI 10.1074/jbc.270.14.8311; MATSUI MS, 1992, J INVEST DERMATOL, V99, P565, DOI 10.1111/1523-1747.ep12667411; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Okuyama R, 2004, J INVEST DERM SYMP P, V9, P248, DOI 10.1111/j.1087-0024.2004.09308.x; OSADA S, 1990, J BIOL CHEM, V265, P22434; Papp H, 2004, CELL MOL LIFE SCI, V61, P1095, DOI 10.1007/s00018-004-4014-2; Praskova M, 2002, EXP DERMATOL, V11, P344, DOI 10.1034/j.1600-0625.2002.110408.x; Reddig PJ, 1999, CANCER RES, V59, P5710; Riethoven JJM, 2010, METHODS MOL BIOL, V674, P33, DOI 10.1007/978-1-60761-854-6_3; Rorke EA, 2010, ONCOGENE, V29, P5873, DOI 10.1038/onc.2010.315; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shen S, 2001, DIABETES, V50, P255, DOI 10.2337/diabetes.50.2.255; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Szegedi A, 2009, EXP DERMATOL, V18, P122, DOI 10.1111/j.1600-0625.2008.00771.x; Verma AK, 2006, MOL CARCINOGEN, V45, P381, DOI 10.1002/mc.20230; Wheeler DL, 2005, PHOTOCHEM PHOTOBIOL, V81, P9, DOI 10.1562/2004-08-12-RA-271.1; Wheeler DL, 2002, ONCOGENE, V21, P3620, DOI 10.1038/sj.onc.1205451; Wong PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008369; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhu L, 2008, J INVEST DERMATOL, V128, P833, DOI 10.1038/sj.jid.5701103	83	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28772	28782		10.1074/jbc.M110.205245	http://dx.doi.org/10.1074/jbc.M110.205245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21652709	hybrid, Green Published			2022-12-27	WOS:000293837000015
J	Morosky, SA; Zhu, JZ; Mukherjee, A; Sarkar, SN; Coyne, CB				Morosky, Stefanie A.; Zhu, Jianzhong; Mukherjee, Amitava; Sarkar, Saumendra N.; Coyne, Carolyn B.			Retinoic Acid-induced Gene-I (RIG-I) Associates with Nucleotide-binding Oligomerization Domain-2 (NOD2) to Negatively Regulate Inflammatory Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; ANTIVIRAL INNATE IMMUNITY; CROHNS-DISEASE; ACTIN CYTOSKELETON; ADAPTER PROTEIN; ACTIVATION; SUSCEPTIBILITY; RECRUITMENT; INDUCTION	Cytoplasmic caspase recruiting domain (CARD)-containing molecules often function in the induction of potent antimicrobial responses in order to protect mammalian cells from invading pathogens. Retinoic acid-induced gene-I (RIG-I) and nucleotide binding oligomerization domain 2 (NOD2) serve as key factors in the detection of viral and bacterial pathogens, and in the subsequent initiation of innate immune signals to combat infection. RIG-I and NOD2 share striking similarities in their cellular localization, both localize to membrane ruffles in non-polarized epithelial cells and both exhibit a close association with the junctional complex of polarized epithelia. Here we show that RIG-I and NOD2 not only colocalize to cellular ruffles and cell-cell junctions, but that they also form a direct interaction that is mediated by the CARDs of RIG-I and multiple regions of NOD2. Moreover, we show that RIG-I negatively regulates ligand-induced nuclear factor-kappa B (NF-kappa B) signaling mediated by NOD2, and that NOD2 negatively regulates type I interferon induction by RIG-I. We also show that the three main Crohn disease-associated mutants of NOD2 (1007fs, R702W, G908R) form an interaction with RIG-I and negatively regulate its signaling to a greater extent than wild-type NOD2. Our results show that in addition to their role in innate immune recognition, RIG-I and NOD2 form a direct interaction at actin-enriched sites within cells and suggest that this interaction may impact RIG-I-and NOD2-dependent innate immune signaling.	[Morosky, Stefanie A.; Zhu, Jianzhong; Sarkar, Saumendra N.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Mukherjee, Amitava] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15219 USA; [Zhu, Jianzhong; Sarkar, Saumendra N.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Coyne, CB (corresponding author), 518 Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15219 USA.	coynec2@pitt.edu	Sarkar, Saumendra N/B-5038-2011; Mukherjee, Amitava/AAK-4002-2020	Sarkar, Saumendra N/0000-0002-2850-6121; Mukherjee, Amitava/0000-0001-5603-5147	National Institutes of Health [R01AI081759, U24AI082673]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI082673, R01AI081759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI081759 (to C. B. C.) and U24AI082673 (to S. N. S.).	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Begue B, 2006, J CELL PHYSIOL, V209, P241, DOI 10.1002/jcp.20739; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hampe J, 2002, P NATL ACAD SCI USA, V99, P321, DOI 10.1073/pnas.261567999; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hong GS, 2002, J BIOCHEM MOL BIOL, V35, P19; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhu JZ, 2010, J IMMUNOL, V184, P5768, DOI 10.4049/jimmunol.0903559	31	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28574	28583		10.1074/jbc.M111.227942	http://dx.doi.org/10.1074/jbc.M111.227942			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21690088	Green Published, hybrid			2022-12-27	WOS:000293557800072
J	Lu, RZ; Niesen, MJM; Hu, WD; Vaidehi, N; Shively, JE				Lu, Rongze; Niesen, Michiel J. M.; Hu, Weidong; Vaidehi, Nagarajan; Shively, John E.			Interaction of Actin with Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1) Receptor in Liposomes Is Ca2+- and Phospholipid-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTIONS; DYNAMICS SIMULATIONS; CYTOPLASMIC DOMAIN; CONSTANT-PRESSURE; MEMBRANE; DIMERIZATION; HYDRATION; RESIDUES; SYSTEMS; VIEW	The regulation of binding of G-actin to cytoplasmic domains of cell surface receptors is a common mechanism to control diverse biological processes. To model the regulation of G-actin binding to a cell surface receptor we used the cell-cell adhesion molecule carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1-S) in which G-actin binds to its short cytoplasmic domain (12 amino acids; Chen, C. J., Kirshner, J., Sherman, M. A., Hu, W., Nguyen, T., and Shively, J. E. (2007) J. Biol. Chem. 282, 5749-5760). A liposome model system demonstrates that G-actin binds to the cytosolic domain peptide of CEACAM1-S in the presence of negatively charged palmitoyloleoyl phosphatidylserine (POPS) liposomes and Ca2+. In contrast, no binding of G-actin was observed in palmitoyl-oleoyl phosphatidylcholine (POPC) liposomes or when a key residue in the peptide, Phe-454, is replaced with Ala. Molecular Dynamics simulations on CEACAM1-S in an asymmetric phospholipid bilayer show migration of Ca2+ ions to the lipid leaflet containing POPS and reveal two conformations for Phe-454 explaining the reversible availability of this residue for G-actin binding. NMR transverse relaxation optimized spectroscopic analysis of C-13-labeled Phe-454 CEACAM1-S peptide in liposomes plus actin further confirmed the existence of two peptide conformers and the Ca2+ dependence of actin binding. These findings explain how a receptor with a short cytoplasmic domain can recruit a cytosolic protein in a phospholipid and Ca2+-specific manner. In addition, this model system provides a powerful approach that can be applied to study other membrane protein interactions with their cytosolic targets.	[Niesen, Michiel J. M.; Hu, Weidong; Vaidehi, Nagarajan; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA; [Lu, Rongze] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, 1450 E Duarte Rd, Duarte, CA 91010 USA.	jshively@coh.org	Niesen, Michiel/AAF-6824-2020; Niesen, Michiel JM/L-8985-2013; Lu, Rongze/R-2149-2016		National Institutes of Health [CA 84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 84202.	Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bouchard M, 1998, BIOCHEMISTRY-US, V37, P3149, DOI 10.1021/bi971892r; Bouschet T, 2008, TRENDS PHARMACOL SCI, V29, P633, DOI 10.1016/j.tips.2008.09.002; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fallahi-Sichani M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006604; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Ida M, 2004, J BIOCHEM, V135, P583, DOI 10.1093/jb/mvh071; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Ko KS, 2001, J CELL SCI, V114, P1155; KUMPF RA, 1993, SCIENCE, V261, P1708, DOI 10.1126/science.8378771; Muenzner P, 2008, CELL MICROBIOL, V10, P1074, DOI 10.1111/j.1462-5822.2007.01106.x; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pervushin K, 1998, J AM CHEM SOC, V120, P6394, DOI 10.1021/ja980742g; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Thorp EB, 2004, J VIROL, V78, P2682, DOI 10.1128/JVI.78.6.2682-2692.2004; Tieleman DP, 1998, BIOCHEMISTRY-US, V37, P17554, DOI 10.1021/bi981802y; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t	38	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27528	27536		10.1074/jbc.M111.235762	http://dx.doi.org/10.1074/jbc.M111.235762			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669871	Green Published, hybrid			2022-12-27	WOS:000293268700047
J	Kato, H; Gruenwald, A; Suh, JH; Miner, JH; Barisoni-Thomas, L; Taketo, MM; Faul, C; Millar, SE; Holzman, LB; Susztak, K				Kato, Hideki; Gruenwald, Antje; Suh, Jung Hee; Miner, Jeffrey H.; Barisoni-Thomas, Laura; Taketo, Makoto M.; Faul, Christian; Millar, Sarah E.; Holzman, Lawrence B.; Susztak, Katalin			Wnt/beta-Catenin Pathway in Podocytes Integrates Cell Adhesion, Differentiation, and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; KIDNEY; BETA-1-INTEGRIN; ALPHA-ACTININ-4; NEPHROPATHY; PROTEINURIA; PROGRESSION; VARIANTS; DELETION; DISEASE	Diabetic kidney disease (DKD) is the single most common cause of albuminuria and end-stage kidney disease in the United States. We found increased expression of Wnt/beta-catenin (Ctnnb1) pathway transcripts and proteins in glomeruli and podocytes of patients and mouse models of DKD. Mice with podocyte-specific expression of stabilized Ctnnb1 exhibited basement membrane abnormalities, albuminuria, and increased susceptibility to glomerular injury. Mice with podocyte-specific deletion of Ctnnb1 or podocyte-specific expression of the canonical Wnt inhibitor Dickkopf-related protein 1 (Dkk1) also showed increased susceptibility to DKD. Podocytes with stabilized Ctnnb1 were less motile and less adhesive to different matrices. Deletion of Ctnnb1 in cultured podocytes increased the expression of podocyte differentiation markers and enhanced cell motility; however, these cells were more susceptible to apoptosis. These results indicate that Wnt/Ctnnb1 signaling in podocytes plays a critical role in integrating cell adhesion, motility, cell death, and differentiation. Balanced Ctnnb1 expression is critical for glomerular filtration barrier maintenance.	[Kato, Hideki; Gruenwald, Antje; Susztak, Katalin] Albert Einstein Coll Med, Div Nephrol, Dept Med, Bronx, NY 10461 USA; [Suh, Jung Hee; Miner, Jeffrey H.] Washington Univ Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; [Barisoni-Thomas, Laura] New York Univ Sch Med, Dept Pathol, New York, NY 10016 USA; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; [Faul, Christian] Univ Miami, Dept Med, Div Nephrol, Miller Sch Med, Coral Gables, FL 33136 USA; [Millar, Sarah E.] Univ Penn Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Holzman, Lawrence B.] Univ Penn Sch Med, Dept Med, Renal Elect & Hypertens Div, Philadelphia, PA 19104 USA; [Susztak, Katalin] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); New York University; Kyoto University; University of Miami; University of Pennsylvania; University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine	Susztak, K (corresponding author), Albert Einstein Coll Med, Div Nephrol, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	katalin.susztak@einstein.yu.edu	Susztak, Katalin/ABE-7474-2021	Susztak, Katalin/0000-0002-1005-3726; Holzman, Lawrence/0000-0002-8961-234X	National Institutes of Health [5R01DK076077-04, R01DK078314]; American Diabetes Association; NephCure Foundation; Uehara Memorial Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078314, R01DK076077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NephCure Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01DK076077-04 (to K. S.) and R01DK078314 (to J. H. M.). This work was also supported by the American Diabetes Association (to K. S.), the NephCure Foundation, and the Uehara Memorial Foundation (to H. K.).	Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Brault V, 2001, DEVELOPMENT, V128, P1253; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Cohen CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002937; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harvey SJ, 2008, CURR OPIN NEPHROL HY, V17, P393, DOI 10.1097/MNH.0b013e32830464de; Heikkila E, 2010, NEPHROL DIAL TRANSPL, V25, P2437, DOI 10.1093/ndt/gfq076; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kottgen A, 2008, J AM SOC NEPHROL, V19, P1989, DOI 10.1681/ASN.2007121291; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Lin CL, 2006, J AM SOC NEPHROL, V17, P2812, DOI 10.1681/ASN.2005121355; Lin CL, 2010, J AM SOC NEPHROL, V21, P124, DOI 10.1681/ASN.2008101059; Lorenzen J, 2008, J AM SOC NEPHROL, V19, P884, DOI 10.1681/ASN.2007040486; Ma H, 2010, J AM SOC NEPHROL, V21, P1145, DOI 10.1681/ASN.2009090991; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Sale MM, 2007, DIABETES, V56, P2638, DOI 10.2337/db07-0012; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Si H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004802; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Szabo C, 2006, DIABETES, V55, P3004, DOI 10.2337/db06-0147; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	42	151	157	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26003	26015		10.1074/jbc.M111.223164	http://dx.doi.org/10.1074/jbc.M111.223164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613219	Green Published, hybrid			2022-12-27	WOS:000293073000059
J	Barnes, J; Lim, JM; Godard, A; Blanchard, F; Wells, L; Steet, R				Barnes, Jarrod; Lim, Jae-Min; Godard, Anne; Blanchard, Frederic; Wells, Lance; Steet, Richard			Extensive Mannose Phosphorylation on Leukemia Inhibitory Factor (LIF) Controls Its Extracellular Levels by Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II RECEPTOR; PROTEIN RECOGNITION DETERMINANTS; LYSOSOMAL-ENZYME PHOSPHORYLATION; COLONY-STIMULATING FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; PROCATHEPSIN-D; SECRETORY GLYCOPROTEIN; 6-PHOSPHATE RECEPTORS; CATHEPSIN-D; DNASE I	In addition to soluble acid hydrolases, many nonlysosomal proteins have been shown to bear mannose 6-phosphate (Man-6-P) residues. Quantification of the extent of mannose phosphorylation and the relevance to physiological function, however, remain poorly defined. In this study, we investigated the mannose phosphorylation status of leukemia inhibitory factor (LIF), a previously identified high affinity ligand for the cation-independent mannose 6-phosphate receptor (CI-MPR), and we analyzed the effects of this modification on its secretion and uptake in cultured cells. When media from LIF-overexpressing cells were fractionated using a CI-MPR affinity column, 35-45% of the total LIF molecules were bound and specifically eluted with free Man-6-P thus confirming LIF as a bona fide Man-6-P-modified protein. Surprisingly, mass spectrometric analysis of LIF glycopeptides enriched on the CI-MPR column revealed that all six N-glycan sites could be Man-6-P-modified. The relative utilization of these sites, however, was not uniform. Analysis of glycan-deleted LIF mutants demonstrated that loss of glycans bearing the majority of Man-6-P residues leads to higher steady-state levels of secreted LIF. Using mouse embryonic stem cells, we showed that the mannose phosphorylation of LIF mediates its internalization thereby reducing extracellular levels and stimulating embryonic stem cell differentiation. Finally, immunofluorescence experiments indicate that LIF is targeted directly to lysosomes following its biosynthesis, providing another mechanism whereby mannose phosphorylation serves to control extracellular levels of LIF. Failure to modify LIF in the context of mucolipidosis II and its subsequent accumulation in the extracellular space may have important implications for disease pathogenesis.	[Barnes, Jarrod; Lim, Jae-Min; Wells, Lance; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Godard, Anne] Univ Nantes, INSERM, CRCNA, U892, F-44035 Nantes, France; [Blanchard, Frederic] Univ Nantes, INSERM, U957, F-44035 Nantes, France	University System of Georgia; University of Georgia; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Steet, R (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu	Barnes, Jarrod/V-6127-2019; Blanchard, Frederic/AAS-1930-2021; Blanchard, Frederic/K-8018-2015; Wells, Lance/H-3118-2013	Blanchard, Frederic/0000-0003-1055-2573; Blanchard, Frederic/0000-0003-1055-2573; Barnes, Jarrod/0000-0002-1027-6591; Wells, Lance/0000-0003-4956-5363	NIGMS [1R01GM086524-01]; NCRR [5P41RR018502]; Cousins Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086524] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cousins Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM086524-01 from NIGMS (to R. S.) and Grant 5P41RR018502 from NCRR (to L. W.).; Recipient of a graduate fellowship from the Cousins Foundation.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTMANN SW, 1992, ARCH BIOCHEM BIOPHYS, V293, P349, DOI 10.1016/0003-9861(92)90405-L; BARANSKI TJ, 1992, J BIOL CHEM, V267, P23342; Blanchard F, 1999, J BIOL CHEM, V274, P24685, DOI 10.1074/jbc.274.35.24685; Blanchard F, 1998, J BIOL CHEM, V273, P20886, DOI 10.1074/jbc.273.33.20886; CANTOR AB, 1992, J BIOL CHEM, V267, P23349; Cathey SS, 2010, J MED GENET, V47, P38, DOI 10.1136/jmg.2009.067736; Chavez CA, 2007, BIOCHEMISTRY-US, V46, P12604, DOI 10.1021/bi7011806; Cuozzo JW, 1998, J BIOL CHEM, V273, P21067, DOI 10.1074/jbc.273.33.21067; Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; ELIAS JA, 1994, AM J PHYSIOL, V266, pL426, DOI 10.1152/ajplung.1994.266.4.L426; FAUST PL, 1987, J CELL BIOL, V105, P1947, DOI 10.1083/jcb.105.5.1947; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; GODARD A, 1992, J BIOL CHEM, V267, P3214; Gonzalez-Perez Oscar, 2010, Current Immunology Reviews, V6, P167; Grimaud E, 2002, CYTOKINE, V20, P224, DOI 10.1006/cyto.2002.2002; Hering KW, 2005, J ORG CHEM, V70, P9892, DOI 10.1021/jo0516382; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Knight DA, 1999, AM J RESP CELL MOL, V20, P834, DOI 10.1165/ajrcmb.20.4.3429; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; LAZZARINO DA, 1989, J BIOL CHEM, V264, P5015; LEE SJ, 1988, J BIOL CHEM, V263, P3521; Lim JM, 2009, J PROTEOME RES, V8, P673, DOI 10.1021/pr800855f; LOTZ M, 1992, J CLIN INVEST, V90, P888, DOI 10.1172/JCI115964; Maruta S, 2009, CLIN EXP METASTAS, V26, P133, DOI 10.1007/s10585-008-9223-x; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Nishikawa A, 1999, J BIOL CHEM, V274, P19309, DOI 10.1074/jbc.274.27.19309; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; OKAMOTO M, 1991, ARCH BIOCHEM BIOPHYS, V286, P562, DOI 10.1016/0003-9861(91)90080-3; Olson LJ, 2010, P NATL ACAD SCI USA, V107, P12493, DOI 10.1073/pnas.1004232107; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; PURCHIO AF, 1988, J BIOL CHEM, V263, P14211; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; Richards CD, 2000, CYTOKINE, V12, P613, DOI 10.1006/cyto.1999.0635; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; Ruan M, 2010, ENDOCRINOLOGY, V151, P1713, DOI 10.1210/en.2009-0813; Shin JE, 2011, MOL CELLS, V31, P181, DOI 10.1007/s10059-011-0020-z; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Slaets H, 2010, TRENDS MOL MED, V16, P493, DOI 10.1016/j.molmed.2010.08.007; Sleat DE, 2008, J PROTEOME RES, V7, P3010, DOI 10.1021/pr800135v; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P1942, DOI 10.1074/mcp.M600030-MCP200; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; Steet R, 2006, MOL BIOL CELL, V17, P2312, DOI 10.1091/mbc.E05-08-0822; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; Upadhyay A, 2009, CYTOKINE, V46, P332, DOI 10.1016/j.cyto.2009.03.001; VILLIGER PM, 1993, J CLIN INVEST, V91, P1575, DOI 10.1172/JCI116363; Wang JM, 2003, J BIOL CHEM, V278, P31226, DOI 10.1074/jbc.M301820200; Warner JB, 2002, J BIOL CHEM, V277, P41897, DOI 10.1074/jbc.M203097200; Yang LJ, 2000, WOUND REPAIR REGEN, V8, P538, DOI 10.1046/j.1524-475x.2000.00538.x	61	17	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24855	24864		10.1074/jbc.M111.221432	http://dx.doi.org/10.1074/jbc.M111.221432			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613225	hybrid, Green Published			2022-12-27	WOS:000292547900035
J	Jenkins, JL; Krucinska, J; McCarty, RM; Bandarian, V; Wedekind, JE				Jenkins, Jermaine L.; Krucinska, Jolanta; McCarty, Reid M.; Bandarian, Vahe; Wedekind, Joseph E.			Comparison of a PreQ(1) Riboswitch Aptamer in Metabolite-bound and Free States with Implications for Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-GUANINE TRANSGLYCOSYLASE; STRUCTURAL BASIS; ESCHERICHIA-COLI; TPP RIBOSWITCH; MESSENGER-RNA; BINDING; SCATTERING; PROTEIN; BIOSYNTHESIS; NUCLEOSIDES	Riboswitches are RNA regulatory elements that govern gene expression by recognition of small molecule ligands via a high affinity aptamer domain. Molecular recognition can lead to active or attenuated gene expression states by controlling accessibility to mRNA signals necessary for transcription or translation. Key areas of inquiry focus on how an aptamer attains specificity for its effector, the extent to which the aptamer folds prior to encountering its ligand, and how ligand binding alters expression signal accessibility. Here we present crystal structures of the preQ(1) riboswitch from Thermoanaerobacter tengcongensis in the preQ(1)-bound and free states. Although the mode of preQ(1) recognition is similar to that observed for preQ(0), surface plasmon resonance revealed an apparent K-D of 2.1 +/- 0.3 nM for preQ(1) but a value of 35.1 +/- 6.1 nM for preQ(0). This difference can be accounted for by interactions between the preQ(1) methylamine and base G5 of the aptamer. To explore conformational states in the absence of metabolite, the free-state aptamer structure was determined. A14 from the ceiling of the ligand pocket shifts into the preQ(1)-binding site, resulting in "closed" access to the metabolite while simultaneously increasing exposure of the ribosome-binding site. Solution scattering data suggest that the free-state aptamer is compact, but the "closed" free-state crystal structure is inadequate to describe the solution scattering data. These observations are distinct from transcriptional preQ(1) riboswitches of the same class that exhibit strictly ligand-dependent folding. Implications for gene regulation are discussed.	[Jenkins, Jermaine L.; Krucinska, Jolanta; Wedekind, Joseph E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [McCarty, Reid M.; Bandarian, Vahe] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Rochester; University of Arizona	Wedekind, JE (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	joseph.wedekind@rochester.edu		Jenkins, Jermaine/0000-0003-2548-3275	National Institutes of Health [GM072623, GM063162, RR026501, RR027241]; National Science Foundation [DMR-0225180]; NCRR, National Institutes of Health [RR-01646SSRL]; Department of Energy; NIGMS, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027241, S10RR026501, P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072623, R01GM063162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072623 (to V. B.) and GM063162 and RR026501 (to J. E. W.).; We thank Nils Walter and Robert Batey for critical remarks on the manuscript. We thank Jason Salter and other members of the Wedekind laboratory for helpful discussions. We thank Clara L. Kielkopf for assistance with SPR, which was obtained through National Institutes of Health Grant RR027241 (to Clara L. Kielkopf). We thank Richard Gillilan and the staff of MacCHESS for assistance with SAXS and crystallography. We thank the staff of SSRL for help with remote data collection. MacCHESS is supported by National Science Foundation Award DMR-0225180 and NCRR, National Institutes of Health, Award RR-01646SSRL. SSRL is operated by Stanford on behalf of the United States Department of Energy. The SSRL Structural Molecular Biology Program is supported by the Department of Energy and by NCRR and NIGMS, National Institutes of Health.	Ali M, 2010, J MOL BIOL, V396, P153, DOI 10.1016/j.jmb.2009.11.030; Ando N, 2008, J APPL CRYSTALLOGR, V41, P167, DOI 10.1107/S0021889807056944; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baird NJ, 2010, RNA BIOL, V7, P328, DOI 10.4161/rna.7.3.11932; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; DAVOLL J, 1960, J CHEM SOC, P131, DOI 10.1039/jr9600000131; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano W.L, PYMOL MOL GRAPHICS S; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feigin L.A., 1987, STRUCTURE ANAL SMALL; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Forconi M, 2010, BIOCHEMISTRY-US, V49, P2753, DOI 10.1021/bi902200n; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Grosjean H, 2004, TRENDS BIOCHEM SCI, V29, P519, DOI 10.1016/j.tibs.2004.08.005; HOOPS GC, 1995, BIOCHEMISTRY-US, V34, P15381, DOI 10.1021/bi00046a047; HUANG BS, 1992, CANCER RES, V52, P4696; Huang LL, 2010, MOL CELL, V40, P774, DOI 10.1016/j.molcel.2010.11.026; Hurt JK, 2007, NUCLEIC ACIDS RES, V35, P4905, DOI 10.1093/nar/gkm473; Irnov AK, 2006, COLD SH Q B, V71, P239, DOI 10.1101/sqb.2006.71.021; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kang M, 2009, MOL CELL, V33, P784, DOI 10.1016/j.molcel.2009.02.019; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lang K, 2007, NUCLEIC ACIDS RES, V35, P5370, DOI 10.1093/nar/gkm580; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Lee ER, 2009, RNA BIOL, V6, P187, DOI 10.4161/rna.6.2.7727; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; Marks T, 1997, BIOCHEM BIOPH RES CO, V230, P233, DOI 10.1006/bbrc.1996.5768; McCarty RM, 2008, CHEM BIOL, V15, P790, DOI 10.1016/j.chembiol.2008.07.012; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Meyer MM, 2008, RNA, V14, P685, DOI 10.1261/rna.937308; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Quaranta D, 2007, J BACTERIOL, V189, P5361, DOI 10.1128/JB.00377-07; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rieder U, 2010, P NATL ACAD SCI USA, V107, P10804, DOI 10.1073/pnas.0914925107; Rieder U, 2009, CHEMBIOCHEM, V10, P1141, DOI 10.1002/cbic.200900155; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Rueda D, 2004, P NATL ACAD SCI USA, V101, P10066, DOI 10.1073/pnas.0403575101; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2010, RNA BIOL, V7, P98, DOI 10.4161/rna.7.1.10756; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Spitale RC, 2009, J BIOL CHEM, V284, P11012, DOI 10.1074/jbc.C900024200; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Wedekind JE, 2000, METHOD ENZYMOL, V317, P149; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645	66	80	91	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24626	24637		10.1074/jbc.M111.230375	http://dx.doi.org/10.1074/jbc.M111.230375			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592962	hybrid, Green Published			2022-12-27	WOS:000292547900013
J	Ramachandran, R; Mihara, K; Chung, H; Renaux, B; Lau, CS; Muruve, DA; DeFea, KA; Bouvier, M; Hollenberg, MD				Ramachandran, Rithwik; Mihara, Koichiro; Chung, Hyunjae; Renaux, Bernard; Lau, Chang S.; Muruve, Daniel A.; DeFea, Kathryn A.; Bouvier, Michel; Hollenberg, Morley D.			Neutrophil Elastase Acts as a Biased Agonist for Proteinase-activated Receptor-2 (PAR(2))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARRESTIN-DEPENDENT ENDOCYTOSIS; LUNG EPITHELIAL-CELLS; BETA-ARRESTINS; THROMBIN; EXPRESSION; DESENSITIZATION; PANCREATITIS; TRAFFICKING; RESPONSES; COLITIS	Human neutrophil proteinases (elastase, proteinase-3, and cathepsin-G) are released at sites of acute inflammation. We hypothesized that these inflammation-associated proteinases can affect cell signaling by targeting proteinase-activated receptor-2 (PAR(2)). The PAR family of G protein-coupled receptors is triggered by a unique mechanism involving the proteolytic unmasking of an N-terminal self-activating tethered ligand (TL). Proteinases can either activate PAR signaling by unmasking the TL sequence or disarm the receptor for subsequent enzyme activation by cleaving downstream from the TL sequence. We found that none of neutrophil elastase, cathepsin-G, and proteinase-3 can activate G(q)-coupled PAR(2) calcium signaling; but all of these proteinases can disarm PAR(2), releasing the N-terminal TL sequence, thereby preventing G(q)-coupled PAR(2) signaling by trypsin. Interestingly, elastase (but neither cathepsin-G nor proteinase-3) causes a TL-independent PAR(2)-mediated activation of MAPK that, unlike the canonical trypsin activation, does not involve either receptor internalization or recruitment of beta-arrestin. Cleavage of synthetic peptides derived from the extracellular N terminus of PAR(2), downstream of the TL sequence, demonstrated distinct proteolytic sites for all three neutrophil-derived enzymes. We conclude that in inflammation, neutrophil proteinases can modulate PAR(2) signaling by preventing/disarming the G(q)/calcium signal pathway and, via elastase, can selectively activate the p44/42MAPK pathway. Our data illustrate a new mode of PAR regulation that involves biased PAR(2) signaling by neutrophil elastase and a disarming/silencing effect of cathepsin-G and proteinase-3.	[Ramachandran, Rithwik; Mihara, Koichiro; Chung, Hyunjae; Renaux, Bernard; Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Ramachandran, Rithwik; Mihara, Koichiro; Chung, Hyunjae; Renaux, Bernard; Muruve, Daniel A.; Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 4N1, Canada; [Lau, Chang S.; DeFea, Kathryn A.] Univ Calif Riverside, Div Biomed Sci & Biochem & Mol Biol, Riverside, CA 92521 USA; [Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	University of Calgary; University of Calgary; University of California System; University of California Riverside; Universite de Montreal	Ramachandran, R (corresponding author), Univ Calgary, Fac Med, Dept Physiol & Pharmacol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	rramacha@ucalgary.ca	Bouvier, Michel/H-2758-2014; Ramachandran, Rithwik/N-7815-2015; Hollenberg, Morley/AFV-6966-2022	Bouvier, Michel/0000-0003-1128-0100; Ramachandran, Rithwik/0000-0001-9557-9905; 	Canadian Institutes of Health Research; National Institutes of Health [RO1GM066151]; CHO/FoMD University of Alberta; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066151] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHO/FoMD University of Alberta(University of Alberta); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Canadian Institutes of Health Research (to M. D. H. and M. B.). This work was also supported in part by National Institutes of Health Grant RO1GM066151 (to K. D.).; Supported by a CHO/FoMD University of Alberta Emerging Teams Grant graduate scholarship.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 2004, MOL PHARMACOL, V65, P149, DOI 10.1124/mol.65.1.149; Chin AC, 2008, J IMMUNOL, V181, P5702, DOI 10.4049/jimmunol.181.8.5702; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Goh FG, 2009, BRIT J PHARMACOL, V158, P1695, DOI 10.1111/j.1476-5381.2009.00415.x; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Kumar P, 2007, AM J PHYSIOL-CELL PH, V293, pC346, DOI 10.1152/ajpcell.00010.2007; Laukkarinen JM, 2008, J BIOL CHEM, V283, P20703, DOI 10.1074/jbc.M801779200; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Mccoy KL, 2010, MOL PHARMACOL, V77, P1005, DOI 10.1124/mol.109.062018; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Meyer-Hoffert U, 2009, FRONT BIOSCI-LANDMRK, V14, P3409, DOI 10.2741/3462; Motta JP, 2011, GASTROENTEROLOGY, V140, P1272, DOI 10.1053/j.gastro.2010.12.050; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2007, AM J PHYSIOL-LUNG C, V292, pL788, DOI 10.1152/ajplung.00226.2006; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Schuepbach RA, 2008, BLOOD, V111, P2667, DOI 10.1182/blood-2007-09-113076; Scott G, 2003, J INVEST DERMATOL, V121, P529, DOI 10.1046/j.1523-1747.2003.12427.x; Singh VP, 2007, GUT, V56, P958, DOI 10.1136/gut.2006.094268; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Suzuki T, 2005, AM J RESP CELL MOL, V33, P231, DOI 10.1165/rcmb.2005-0109OC; Suzuki T, 2009, AM J RESP CELL MOL, V41, P742, DOI 10.1165/rcmb.2008-0157OC; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Vergnolle N, 2005, GUT, V54, P867, DOI 10.1136/gut.2004.048876; Vesey DA, 2007, AM J PHYSIOL-RENAL, V293, pF1441, DOI 10.1152/ajprenal.00088.2007; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; White LR, 2007, AM J PHYSIOL-RENAL, V292, pF567, DOI 10.1152/ajprenal.00212.2006	43	120	124	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24638	24648		10.1074/jbc.M110.201988	http://dx.doi.org/10.1074/jbc.M110.201988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21576245	hybrid, Green Published			2022-12-27	WOS:000292547900014
J	Attia, RR; Sharma, P; Janssen, RC; Friedman, JE; Deng, X; Lee, JS; Elam, MB; Cook, GA; Park, EA				Attia, Ramy R.; Sharma, Pragya; Janssen, Rachel C.; Friedman, Jacob E.; Deng, Xiong; Lee, Jae Seung; Elam, Marshall B.; Cook, George A.; Park, Edwards A.			Regulation of Pyruvate Dehydrogenase Kinase 4 (PDK4) by CCAAT/Enhancer-binding Protein beta (C/EBP beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; THYROID-HORMONE; GENE-EXPRESSION; I-ALPHA; TRANSCRIPTIONAL REGULATION; RETINOIC ACID; FATTY-ACIDS; PROMOTER; LIVER	The conversion of pyruvate to acetyl-CoA in mitochondria is catalyzed by the pyruvate dehydrogenase complex (PDC). Activity of PDC is inhibited by phosphorylation via the pyruvate dehydrogenase kinases (PDKs). Here, we examined the regulation of Pdk4 gene expression by the CCAAT/enhancer-binding protein beta (C/EBP beta). C/EBP beta modulates the expression of multiple hepatic genes including those involved in metabolism, development, and inflammation. We found that C/EBP beta induced Pdk4 gene expression and decreased PDC activity. This transcriptional induction was mediated through two C/EBP beta binding sites in the Pdk4 promoter. C/EBP beta participates in the hormonal regulation of gluconeogenic genes. Previously, we reported that Pdk4 was induced by thyroid hormone (T-3). Therefore, we investigated the role of C/EBP beta in the T-3 regulation of Pdk4. T-3 increased C/EBP beta abundance in primary rat hepatocytes. Knockdown of C/EBP beta with siRNA diminished the T-3 induction of the Pdk4 and carnitine palmitoyltransferase (Cpt1a) genes. CPT1a is an initiating step in the mitochondrial oxidation of long chain fatty acids. Our results indicate that C/EBP beta stimulates Pdk4 expression and participates in the T-3 induction of the Cpt1a and Pdk4 genes.	[Attia, Ramy R.; Sharma, Pragya; Deng, Xiong; Lee, Jae Seung; Elam, Marshall B.; Cook, George A.; Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Coll Med, Memphis, TN 38163 USA; [Deng, Xiong; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38105 USA; [Janssen, Rachel C.; Friedman, Jacob E.] Univ Colorado, Dept Pediat Biochem & Mol Genet, Aurora, CO 80045 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Park, EA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Coll Med, 874 Union Ave, Memphis, TN 38163 USA.	epark@uthsc.edu			National Institutes of Health [NIH-DK0059368, NIH-DK059767, NIH-DK075504, T35DK007405]; American Heart Association [4590018]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075504, T35DK007405, R01DK059767, R01DK059368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH-DK0059368 (to E. A. P.), American Heart Association Grant 4590018 (to E. A. P.), NIH-DK059767 (to J. E. F.), and NIH-DK075504 (to M. B. E.).; Supported by a National Institutes of Health medical student training grant (T35DK007405).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carmona MC, 2002, J BIOL CHEM, V277, P21489, DOI 10.1074/jbc.M201710200; Connaughton S, 2010, MOL CELL ENDOCRINOL, V315, P159, DOI 10.1016/j.mce.2009.08.011; Croniger CM, 2001, J BIOL CHEM, V276, P629, DOI 10.1074/jbc.M007576200; De Leo V, 2009, J LIPID RES, V50, P256, DOI 10.1194/jlr.M800312-JLR200; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Ghosh AK, 2001, J BIOL CHEM, V276, P8507, DOI 10.1074/jbc.M008541200; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; HEIMBERG M, 1985, ENDOCR REV, V6, P590, DOI 10.1210/edrv-6-4-590; Holness MJ, 2003, BIOCHEM J, V369, P687, DOI 10.1042/BJ20021509; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; IYNEDJIAN PB, 1984, EUR J BIOCHEM, V145, P489, DOI 10.1111/j.1432-1033.1984.tb08583.x; Jackson-Hayes L, 2003, J BIOL CHEM, V278, P7964, DOI 10.1074/jbc.M211062200; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Krus U, 2010, BIOCHEM J, V429, P205, DOI 10.1042/BJ20100142; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MenendezHurtado A, 1997, BIOCHEM BIOPH RES CO, V234, P605, DOI 10.1006/bbrc.1997.6635; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V315, P199, DOI 10.1006/abbi.1994.1490; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; PARK EA, 1993, J BIOL CHEM, V268, P613; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Stenson BM, 2009, ENDOCRINOLOGY, V150, P4104, DOI 10.1210/en.2009-0676; Sugden MC, 2000, BIOCHEM J, V352, P731, DOI 10.1042/0264-6021:3520731; Sugden MC, 2000, J ENDOCRINOL, V167, P339, DOI 10.1677/joe.0.1670339; TAE HJ, 1994, J BIOL CHEM, V269, P10475; Teixido N, 2006, MOL ENDOCRINOL, V20, P389, DOI 10.1210/me.2005-0229; Wang H, 2008, MOL ENDOCRINOL, V22, P1596, DOI 10.1210/me.2007-0388; Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148; Yamada K, 1999, J BIOL CHEM, V274, P5880, DOI 10.1074/jbc.274.9.5880; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yin LY, 2005, MOL CELL ENDOCRINOL, V245, P43, DOI 10.1016/j.mce.2005.10.002; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	52	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23799	23807		10.1074/jbc.M111.246389	http://dx.doi.org/10.1074/jbc.M111.246389			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586575	Green Published, hybrid			2022-12-27	WOS:000292294900022
J	Peng, H; Wang, XS; Barnes, PF; Tang, H; Townsend, JC; Samten, B				Peng, Hui; Wang, Xisheng; Barnes, Peter F.; Tang, Hua; Townsend, James C.; Samten, Buka			The Mycobacterium tuberculosis Early Secreted Antigenic Target of 6 kDa Inhibits T Cell Interferon-gamma Production through the p38 Mitogen-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAT4 SERINE PHOSPHORYLATION; ANTHRAX LETHAL FACTOR; PORE-FORMING TOXINS; IFN-GAMMA; CALMETTE-GUERIN; BOVIS BCG; RECEPTOR; MACROPHAGES; IMMUNITY; ESAT-6	We reported previously that the early secreted antigenic target of 6 kDa (ESAT-6) from Mycobacterium tuberculosis directly inhibits human T cell IFN-gamma production and proliferation in response to stimulation with anti-CD3 and anti-CD28. To determine the mechanism of this effect, we treated T cells with kinase inhibitors before stimulation with ESAT-6. Only the p38 MAPK inhibitor, SB203580, abrogated ESAT-6-mediated inhibition of IFN-gamma production in a dose-dependent manner. SB203580 did not reverse ESAT-6-mediated inhibition of IL-17 and IL-10 production, suggesting a specific effect of SB203580 on IFN-gamma production. SB203580 did not act through inhibition of AKT (PKB) as an AKT inhibitor did not affect ESAT-6 inhibition of T cell IFN-gamma production and proliferation. ESAT-6 did not reduce IFN-gamma production by expanding FoxP3(+) T regulatory cells. Incubation of T cells with ESAT-6 induced phosphorylation and increased functional p38 MAPK activity, but not activation of ERK or JNK. Incubation of peripheral blood mononuclear cells with ESAT-6 induced activation of p38 MAPK, and inhibition of p38 MAPK with SB203580 reversed ESAT-6 inhibition of M. tuberculosis-stimulated IFN-gamma production by peripheral blood mononuclear cells from subjects with latent tuberculosis infection. Silencing of p38 alpha MAPK with siRNA rendered T cells resistant to ESAT-6 inhibition of IFN-gamma production. Taken together, our results demonstrate that ESAT-6 inhibits T cell IFN-gamma production in a p38 MAPK-dependent manner.	[Peng, Hui; Wang, Xisheng; Barnes, Peter F.; Townsend, James C.; Samten, Buka] Univ Texas Hlth Sci Ctr Tyler, CPIDC, Tyler, TX 75708 USA; [Peng, Hui; Wang, Xisheng; Barnes, Peter F.; Townsend, James C.; Samten, Buka] Univ Texas Hlth Sci Ctr Tyler, Dept Microbiol & Immunol, Tyler, TX 75708 USA; [Barnes, Peter F.] Univ Texas Hlth Sci Ctr Tyler, Dept Med, Tyler, TX 75708 USA; [Tang, Hua] Univ Texas Hlth Sci Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Samten, B (corresponding author), Univ Texas Hlth Sci Ctr Tyler, CPIDC, 11937 US Hwy 271, Tyler, TX 75708 USA.	buka.samten@uthct.edu	Samten, Buka/AAV-3140-2021; , Hui/AAT-5093-2020	, Hui/0000-0002-2646-129X	National Institutes of Health [AI082335, AI063514]; James Byers Cain Research Endowment; Center for Pulmonary and Infectious Disease Control; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082335, R01AI063514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Byers Cain Research Endowment; Center for Pulmonary and Infectious Disease Control; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI082335 (to B. S.) and AI063514 (to P. F. B. and B. S.) and by funds from the James Byers Cain Research Endowment and the Center for Pulmonary and Infectious Disease Control.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Adler HS, 2007, BLOOD, V109, P4351, DOI 10.1182/blood-2006-09-047563; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Aleman M, 2004, INFECT IMMUN, V72, P5150, DOI 10.1128/IAI.72.9.5150-5158.2004; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Ceponis PJM, 2005, CAN J GASTROENTEROL, V19, P415, DOI 10.1155/2005/731817; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Daley CL, 2010, AM J RESP CRIT CARE, V181, P550, DOI 10.1164/rccm.201001-0140UP; Dodeller F, 2005, EUR J IMMUNOL, V35, P3631, DOI 10.1002/eji.200535029; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Gagliardi MC, 2009, INFECT IMMUN, V77, P4947, DOI 10.1128/IAI.00607-09; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Huber S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003302; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Juffermans NP, 2000, J INFECT DIS, V182, P888, DOI 10.1086/315750; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; Kim JM, 2005, J IMMUNOL, V174, P1239, DOI 10.4049/jimmunol.174.3.1239; Kinhikar AG, 2010, MOL MICROBIOL, V75, P92, DOI 10.1111/j.1365-2958.2009.06959.x; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Li C, 2011, IMMUNOLOGY, V132, P104, DOI 10.1111/j.1365-2567.2010.03345.x; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Ohkusu-Tsukada K, 2010, EUR J IMMUNOL, V40, P1011, DOI 10.1002/eji.200939513; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Perskvist N, 2000, J IMMUNOL, V164, P959, DOI 10.4049/jimmunol.164.2.959; Porta H, 2011, PEPTIDES, V32, P601, DOI 10.1016/j.peptides.2010.06.012; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Samten B, 2005, J IMMUNOL, V174, P6357, DOI 10.4049/jimmunol.174.10.6357; Samten B, 2008, J LEUKOCYTE BIOL, V84, P115, DOI 10.1189/jlb.1207835; Singh G, 2005, IMMUNOL LETT, V98, P180, DOI 10.1016/j.imlet.2004.11.011; Sloan DD, 2007, J VIROL, V81, P12504, DOI 10.1128/JVI.01111-07; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stuart JK, 2010, INT IMMUNOPHARMACOL, V10, P1068, DOI 10.1016/j.intimp.2010.06.007; Veiopoulou C, 2004, NEUROIMMUNOMODULAT, V11, P199, DOI 10.1159/000078437; Verhagen CE, 2000, J EXP MED, V192, P517, DOI 10.1084/jem.192.4.517; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Wang XS, 2009, J IMMUNOL, V182, P3668, DOI 10.4049/jimmunol.0803579; Yang LF, 2010, BIOCHEM BIOPH RES CO, V400, P16, DOI 10.1016/j.bbrc.2010.07.126; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhang SM, 2000, J IMMUNOL, V165, P1374, DOI 10.4049/jimmunol.165.3.1374	59	31	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24508	24518		10.1074/jbc.M111.234062	http://dx.doi.org/10.1074/jbc.M111.234062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586573	hybrid, Green Published			2022-12-27	WOS:000292294900091
J	Chen, CA; Lin, CH; Druhan, LJ; Wang, TY; Chen, YR; Zweier, JL				Chen, Chun-An; Lin, Cho-Hao; Druhan, Lawrence J.; Wang, Tse-Yao; Chen, Yeong-Renn; Zweier, Jay L.			Superoxide Induces Endothelial Nitric-oxide Synthase Protein Thiyl Radical Formation, a Novel Mechanism Regulating eNOS Function and Coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-GLUTATHIONYLATION; REPERFUSION INJURY; ESCHERICHIA-COLI; NO SYNTHASE; ELECTRON-TRANSFER; OXIDATIVE STRESS; HEART-FAILURE; GENERATION; NITRATION; ENZYME	An increase in production of reactive oxygen species resulting in a decrease in nitric oxide bioavailability in the endothelium contributes to many cardiovascular diseases, and these reactive oxygen species can oxidize cellular macromolecules. Protein thiols are critical reducing equivalents that maintain cellular redox state and are primary targets for oxidative modification. We demonstrate endothelial NOS(eNOS) oxidant-induced protein thiyl radical formation from tetrahydrobiopterin-free enzyme or following exposure to exogenous superoxide using immunoblotting, immunostaining, and mass spectrometry. Spin trapping with 5,5-dimethyl-1-pyrroline N-oxide (DMPO) followed by immunoblotting using an anti-DMPO antibody demonstrated the formation of eNOS protein radicals, which were abolished by superoxide dismutase and L-NAME, indicating that protein radical formation was due to superoxide generation from the eNOS heme. With tetrahydrobiopterin-reconstituted eNOS, eNOS protein radical formation was completely inhibited. Using mass spectrometric and mutagenesis analysis, we identified Cys-908 as the residue involved in protein radical formation. Mutagenesis of this key cysteine to alanine abolished eNOS thiyl radical formation and uncoupled eNOS, leading to increased superoxide generation. Protein thiyl radical formation leads to oxidation or modification of cysteine with either disulfide bond formation or S-glutathionylation, which induces eNOS uncoupling. Furthermore, in endothelial cells treated with menadione to trigger cellular superoxide generation, eNOS protein radical formation, as visualized with confocal microscopy, was increased, and these results were confirmed by immunoprecipitation with anti-eNOS antibody, followed by immunoblotting with an anti-DMPO antibody. Thus, eNOS protein radical formation provides the basis for a mechanism of superoxide-directed regulation of eNOS, involving thiol oxidation, defining a unique pathway for the redox regulation of cardiovascular function.	[Zweier, Jay L.] Ohio State Univ, Davis Heart & Lung Res Inst, Coll Med, Columbus, OH 43210 USA; Ohio State Univ, Div Cardiovasc Med, Coll Med, Dept Internal Med, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Zweier, JL (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Coll Med, 473 W 12th Ave, Columbus, OH 43210 USA.	Jay.Zweier@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institutes of Health [HL63744, HL65608, HL38324, HL081734, HL83237, K99HL103846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237, R01HL038324, R29HL038324, K99HL103846, P01HL065608, R01HL081734, R01HL063744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63744, HL65608, and HL38324 (to J. L. Z.); HL081734 (to L. J. D.); HL83237 (to Y.-R.C.); and K99HL103846 (to C.-A. C.).	ABUSOUD HM, 1995, BIOCHEMISTRY-US, V34, P11167, DOI 10.1021/bi00035a023; ADACHI T, 2005, DRUG DISCOV TODAY, V2, P39; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; CHEN CA, 2009, CIRCULATION, V120, pS1070; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chen CA, 2008, CIRCULATION, V118, pS274; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Cuzzocrea S, 1998, BRIT J PHARMACOL, V123, P525, DOI 10.1038/sj.bjp.0701612; Druhan LJ, 2008, BIOCHEMISTRY-US, V47, P7256, DOI 10.1021/bi702377a; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Forstermann U, 2006, BIOL CHEM, V387, P1521, DOI 10.1515/BC.2006.190; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; GERBER NC, 1995, J BIOL CHEM, V270, P17791, DOI 10.1074/jbc.270.30.17791; GNANAIAH W, 1986, J BIOL CHEM, V261, P2649; Harbrecht BG, 1997, ANN SURG, V225, P76, DOI 10.1097/00000658-199701000-00009; HOFMANN H, 1995, BIOCHEMISTRY-US, V34, P13443, DOI 10.1021/bi00041a023; Hothersall JS, 1997, BIOCHEM J, V322, P477, DOI 10.1042/bj3220477; Huang AN, 2001, AM J PHYSIOL-CELL PH, V281, pC719, DOI 10.1152/ajpcell.2001.281.2.C719; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Parodi O, 2007, J CARDIOVASC MED, V8, P765, DOI 10.2459/JCM.0b013e32801194d4; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; POU S, 1992, J BIOL CHEM, V267, P24173; RodriguezCrespo I, 1996, ARCH BIOCHEM BIOPHYS, V336, P151, DOI 10.1006/abbi.1996.0543; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Tummala M, 2008, DNA CELL BIOL, V27, P25, DOI 10.1089/dna.2007.0655; Turko IV, 2002, PHARMACOL REV, V54, P619, DOI 10.1124/pr.54.4.619; Vanin AF, 2000, BBA-GEN SUBJECTS, V1474, P365, DOI 10.1016/S0304-4165(00)00033-7; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Xia Y, 2000, FREE RADICAL BIO MED, V29, P793, DOI 10.1016/S0891-5849(00)00427-5; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Zhang H, 2008, METHOD ENZYMOL, V440, P65, DOI 10.1016/S0076-6879(07)00804-X; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	54	53	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29098	29107		10.1074/jbc.M111.240127	http://dx.doi.org/10.1074/jbc.M111.240127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21666221	Green Published, hybrid			2022-12-27	WOS:000293837000046
J	Liu, JP; Zhang, JH; Gong, QG; Xiong, P; Huang, HD; Wu, B; Lu, GW; Wu, JH; Shi, YY				Liu, Jianping; Zhang, Jiahai; Gong, Qingguo; Xiong, Peng; Huang, Hongda; Wu, Bo; Lu, Guowei; Wu, Jihui; Shi, Yunyu			Solution Structure of Tandem SH2 Domains from Spt6 Protein and Their Binding to the Phosphorylated RNA Polymerase II C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR SPT6; SRC HOMOLOGY-2 DOMAIN; TRANSCRIPTION ELONGATION; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURES; NMR; SEQUENCE; SPECIFICITY; ROLES; IICTD	Spt6 is a highly conserved transcription elongation factor and histone chaperone. It binds directly to the RNA polymerase II C-terminal domain (RNAPII CTD) through its C-terminal region that recognizes RNAPII CTD phosphorylation. In this study, we determined the solution structure of the C-terminal region of Saccharomyces cerevisiae Spt6, and we discovered that Spt6 has two SH2 domains in tandem. Structural and phylogenetic analysis revealed that the second SH2 domain was evolutionarily distant from canonical SH2 domains and represented a novel SH2 subfamily with a novel binding site for phosphoserine. In addition, NMR chemical shift perturbation experiments demonstrated that the tandem SH2 domains recognized Tyr(1), Ser(2), Ser(5), and Ser(7) phosphorylation of RNAPII CTD with millimolar binding affinities. The structural basis for the binding of the tandem SH2 domains to different forms of phosphorylated RNAPII CTD and its physiological relevance are discussed. Our results also suggest that Spt6 may use the tandem SH2 domain module to sense the phosphorylation level of RNAPII CTD.	[Wu, Jihui; Shi, Yunyu] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Huang, Hongda/G-8962-2015; Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759; Wu, Bo/0000-0003-4556-0477	Chinese National Natural Science Foundation [30830031]; National Basic Research Program of China [2011CB966302, 2011CB911104]; Chinese National High Technology RD Program [2006AA02A315]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese National High Technology RD Program	This work is supported by grants from the Chinese National Natural Science Foundation (Grant 30830031), the National Basic Research Program of China (Grants 2011CB966302 and 2011CB911104), and the Chinese National High Technology R&D Program (Grant 2006AA02A315).	Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Baskaran R, 1997, J BIOL CHEM, V272, P18905, DOI 10.1074/jbc.272.30.18905; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Close D, 2011, J MOL BIOL, V408, P697, DOI 10.1016/j.jmb.2011.03.002; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; DUYSTER J, 1995, P NATL ACAD SCI USA, V92, P1555, DOI 10.1073/pnas.92.5.1555; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Endoh M, 2004, MOL CELL BIOL, V24, P3324, DOI 10.1128/MCB.24.8.3324-3336.2004; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gan WX, 2009, PROTEINS, V74, P996, DOI 10.1002/prot.22209; GODDARD TD, 2008, SPARKY 3 VERSION 3 1; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sun M, 2010, J BIOL CHEM, V285, P41597, DOI 10.1074/jbc.M110.144568; Svejstrup JQ, 2003, SCIENCE, V301, P1053, DOI 10.1126/science.1088901; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; WAKSMAN G, 1993, TEST, V72, P779; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08	47	26	26	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29218	29226		10.1074/jbc.M111.252130	http://dx.doi.org/10.1074/jbc.M111.252130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21676864	Green Published, hybrid			2022-12-27	WOS:000293837000057
J	Ranganathan, P; Vasquez-Del Carpio, R; Kaplan, FM; Wang, H; Gupta, A; VanWye, JD; Capobianco, AJ				Ranganathan, Prathibha; Vasquez-Del Carpio, Rodrigo; Kaplan, Fred M.; Wang, Hong; Gupta, Ashu; VanWye, Jeffrey D.; Capobianco, Anthony J.			Hierarchical Phosphorylation within the Ankyrin Repeat Domain Defines a Phosphoregulatory Loop That Regulates Notch Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SULFATE-POLYACRYLAMIDE-GEL; MAMMARY EPITHELIAL-CELLS; SPLIT COMPLEX GENES; NF-KAPPA-B; INTRACELLULAR DOMAIN; MAMMALIAN NOTCH; IN-VITRO; NEOPLASTIC TRANSFORMATION; NUCLEAR-LOCALIZATION	The Notch signal transduction pathway mediates important cellular functions through direct cell-to-cell contact. Deregulation of Notch activity can lead to an altered cell proliferation and has been linked to many human cancers. Casein kinase 2 (CK2), a ubiquitous kinase, regulates several cellular processes by phosphorylating proteins involved in signal transduction, gene expression, and protein synthesis. In this report we identify Notch(ICD) as a novel target of phosphorylation by CK2. Using mapping and mutational studies, we identified serine 1901, located in the ankyrin domain of Notch, as the target amino acid. Interestingly, phosphorylation of serine 1901 by CK2 appears to generate a second phosphorylation site at threonine 1898. Furthermore, threonine 1898 phosphorylation only occurs when Notch forms a complex with Mastermind and CSL. Phosphorylation of both threonine 1898 and serine 1901 resulted in decreased binding of the Notch-Mastermind-CSL ternary complex to DNA and consequently lower transcriptional activity. These data indicate that the phosphorylation of serine 1901 and threonine 1898 negatively regulates Notch function by dissociating the complex from DNA. This study identifies a new component involved in regulation of Notch(ICD) transcriptional activity, reinforcing the notion that a precise and tight regulation is required for this essential signaling pathway.	[Ranganathan, Prathibha; Vasquez-Del Carpio, Rodrigo; Kaplan, Fred M.; Wang, Hong; Gupta, Ashu; VanWye, Jeffrey D.; Capobianco, Anthony J.] Univ Miami, Mol Oncol Program, Div Surg Oncol,Miller Sch Med, Dewitt Daughtry Family Surg & Sylvester Comprehen, Miami, FL 33136 USA	University of Miami	Capobianco, AJ (corresponding author), 1600 NW 10th Ave,104, Miami, FL 33136 USA.	TCapobianco@med.miami.edu		Capobianco, Anthony/0000-0002-3706-6797	National Institutes of Health (NCI) [ROI CA 83736, 125044-04]; Samuel Waxman Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA083736] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Samuel Waxman Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants ROI CA 83736 and 125044-04 (NCI; to A. J. C.). This work was also supported by the Samuel Waxman Foundation for Cancer Research (to A. J. C.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 1997, J BIOL CHEM, V272, P11336; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; DeLano W.L, PYMOL MOL GRAPHICS S; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Fernandez-Martinez J, 2009, J CELL SCI, V122, P1574, DOI 10.1242/jcs.044354; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Foltz DR, 2001, BIOCHEM BIOPH RES CO, V286, P484, DOI 10.1006/bbrc.2001.5421; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; GALLAHAN D, 1987, J VIROL, V61, P218, DOI 10.1128/JVI.61.1.218-220.1987; Giusiano S, 2011, EUR J CANCER, V47, P792, DOI 10.1016/j.ejca.2010.11.028; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Hsieh JJD, 1997, J VIROL, V71, P1938, DOI 10.1128/JVI.71.3.1938-1945.1997; Ingles-Esteve J, 2001, J BIOL CHEM, V276, P44873, DOI 10.1074/jbc.M104703200; Ishitani T, 2010, NAT CELL BIOL, V12, P278, DOI 10.1038/ncb2028; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Jeffries S, 2000, MOL CELL BIOL, V20, P3928, DOI 10.1128/MCB.20.11.3928-3941.2000; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; LUO KX, 1991, METHOD ENZYMOL, V201, P149; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; ROBBINS J, 1992, J VIROL, V66, P2594, DOI 10.1128/JVI.66.4.2594-2599.1992; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Ronchini C, 2000, ONCOGENE, V19, P3914, DOI 10.1038/sj.onc.1203719; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; Soriano JV, 2000, INT J CANCER, V86, P652; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Vasquez-Del Carpio R, 2011, MOL CELL BIOL, V31, P1396, DOI 10.1128/MCB.00360-10; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	71	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28844	28857		10.1074/jbc.M111.243600	http://dx.doi.org/10.1074/jbc.M111.243600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21685388	Green Published, hybrid			2022-12-27	WOS:000293837000022
J	Sivan, G; Aviner, R; Elroy-Stein, O				Sivan, Gilad; Aviner, Ranen; Elroy-Stein, Orna			Mitotic Modulation of Translation Elongation Factor 1 Leads to Hindered tRNA Delivery to Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA DELTA; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; FACTOR EF-1-DELTA; CDC2 KINASE; PHOSPHORYLATION; COMPLEX; INITIATION; SUBUNIT; FACTOR-1-DELTA	Translation elongation in eukaryotes is mediated by the concerted actions of elongation factor 1A (eEF1A), which delivers aminoacylated tRNA to the ribosome; elongation factor 1B (eEF1B) complex, which catalyzes the exchange of GDP to GTP on eEF1A; and eEF2, which facilitates ribosomal translocation. Here we present evidence in support of a novel mode of translation regulation by hindered tRNA delivery during mitosis. A conserved consensus phosphorylation site for the mitotic cyclin-dependent kinase 1 on the catalytic delta subunit of eEF1B (termed eEF1D) is required for its posttranslational modification during mitosis, resulting in lower affinity to its substrate eEF1A. This modification is correlated with reduced availability of eEF1A.tRNA complexes, as well as reduced delivery of tRNA to and association of eEF1A with elongating ribosomes. This mode of regulation by hindered tRNA delivery, although first discovered in mitosis, may represent a more globally applicable mechanism employed under other physiological conditions that involve down-regulation of protein synthesis at the elongation level.	[Sivan, Gilad; Aviner, Ranen; Elroy-Stein, Orna] Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University	Elroy-Stein, O (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.	ornaes@tauex.tau.ac.il	Aviner, Ranen/AAE-6533-2019	Aviner, Ranen/0000-0002-2476-6487; Elroy-Stein, Orna/0000-0002-3716-1540	Israel Science Foundation [131/07]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 131/07.	Boulben S, 2003, CELL MOL LIFE SCI, V60, P2178, DOI 10.1007/s00018-003-3201-x; Brown T, 2004, CURR PROTOC MOL BIOL; Datta B, 1999, EXP CELL RES, V250, P223, DOI 10.1006/excr.1999.4508; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Gerlitz G, 2002, EUR J BIOCHEM, V269, P2810, DOI 10.1046/j.1432-1033.2002.02974.x; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; Guerrucci MA, 1999, GENE, V233, P83, DOI 10.1016/S0378-1119(99)00153-5; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; Jester BC, 2003, P NATL ACAD SCI USA, V100, P14351, DOI 10.1073/pnas.2036253100; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kim SB, 2007, CELL DEATH DIFFER, V14, P982, DOI 10.1038/sj.cdd.4402083; KINZY TG, 1995, GENETICS, V141, P481; Le Sourd F, 2006, FEBS LETT, V580, P2755, DOI 10.1016/j.febslet.2006.04.038; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; Marash L, 2008, MOL CELL, V30, P447, DOI 10.1016/j.molcel.2008.03.018; MARIN O, 1992, FEBS LETT, V301, P111, DOI 10.1016/0014-5793(92)80221-2; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; MINELLA O, 1994, CELL MOL BIOL, V40, P521; Minella O, 1996, EUR J BIOCHEM, V237, P685, DOI 10.1111/j.1432-1033.1996.0685p.x; Monnier A, 2001, ZYGOTE, V9, P229, DOI 10.1017/S0967199401001241; MULNERLORILLON O, 1992, EXP CELL RES, V202, P549, DOI 10.1016/0014-4827(92)90111-K; MULNERLORILLON O, 1994, J BIOL CHEM, V269, P20201; Nagano K, 2009, PROTEOMICS, V9, P2861, DOI 10.1002/pmic.200800667; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Ong LL, 2006, J BIOL CHEM, V281, P33621, DOI 10.1074/jbc.M607555200; Ong LL, 2003, J BIOL CHEM, V278, P32115, DOI 10.1074/jbc.M210917200; Pomerening JR, 2003, MOL GENET GENOMICS, V269, P776, DOI 10.1007/s00438-003-0888-1; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Sanders J, 1996, J CELL SCI, V109, P1113; SANG LJ, 2002, BIOCHEM BIOPH RES CO, V291, P158; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; Sheu GT, 1997, J BIOL CHEM, V272, P33290, DOI 10.1074/jbc.272.52.33290; Sivan G, 2008, CELL CYCLE, V7, P741, DOI 10.4161/cc.7.6.5596; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Xiao H, 1998, BIOCHEM BIOPH RES CO, V244, P384, DOI 10.1006/bbrc.1998.8274	40	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27927	27935		10.1074/jbc.M111.255810	http://dx.doi.org/10.1074/jbc.M111.255810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21665947	hybrid, Green Published			2022-12-27	WOS:000293557800011
J	Bellinzoni, M; Bastard, K; Perret, A; Zaparucha, A; Perchat, N; Vergne, C; Wagner, T; de Melo-Minardi, RC; Artiguenave, F; Cohen, GN; Weissenbach, J; Salanoubat, M; Alzari, PM				Bellinzoni, Marco; Bastard, Karine; Perret, Alain; Zaparucha, Anne; Perchat, Nadia; Vergne, Carine; Wagner, Tristan; de Melo-Minardi, Raquel C.; Artiguenave, Francois; Cohen, Georges N.; Weissenbach, Jean; Salanoubat, Marcel; Alzari, Pedro M.			3-Keto-5-aminohexanoate Cleavage Enzyme A COMMON FOLD FOR AN UNCOMMON CLAISEN-TYPE CONDENSATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAXIMUM-LIKELIHOOD; DEGRADATION; REFINEMENT; FAMILIES; GENOMICS; DOCKING; PATHWAY; GENES	The exponential increase in genome sequencing output has led to the accumulation of thousands of predicted genes lacking a proper functional annotation. Among this mass of hypothetical proteins, enzymes catalyzing new reactions or using novel ways to catalyze already known reactions might still wait to be identified. Here, we provide a structural and biochemical characterization of the 3-keto-5-aminohexanoate cleavage enzyme (Kce), an enzymatic activity long known as being involved in the anaerobic fermentation of lysine but whose catalytic mechanism has remained elusive so far. Although the enzyme shows the ubiquitous triose phosphate isomerase (TIM) barrel fold and a Zn2+ cation reminiscent of metal-dependent class II aldolases, our results based on a combination of x-ray snapshots and molecular modeling point to an unprecedented mechanism that proceeds through deprotonation of the 3-keto-5-aminohexanoate substrate, nucleophilic addition onto an incoming acetyl-CoA, intramolecular transfer of the CoA moiety, and final retro-Claisen reaction leading to acetoacetate and 3-aminobutyryl-CoA. This model also accounts for earlier observations showing the origin of carbon atoms in the products, as well as the absence of detection of any covalent acyl-enzyme intermediate. Kce is the first representative of a large family of prokaryotic hypothetical proteins, currently annotated as the "domain of unknown function" DUF849.	[Bellinzoni, Marco; Wagner, Tristan; Alzari, Pedro M.] Inst Pasteur, Unite Microbiol Struct, F-75724 Paris 15, France; [Bellinzoni, Marco; Wagner, Tristan; Alzari, Pedro M.] CNRS, URA2185, F-75724 Paris 15, France; [Bastard, Karine; Perret, Alain; Zaparucha, Anne; Perchat, Nadia; Vergne, Carine; de Melo-Minardi, Raquel C.; Artiguenave, Francois; Weissenbach, Jean; Salanoubat, Marcel] Inst Genom, CEA, Direct Sci Vivant, F-91057 Evry, France; [Bastard, Karine; Perret, Alain; Zaparucha, Anne; Perchat, Nadia; Vergne, Carine; de Melo-Minardi, Raquel C.; Artiguenave, Francois; Weissenbach, Jean; Salanoubat, Marcel] CNRS, UMR8030, F-91057 Evry, France; [Bastard, Karine; Perret, Alain; Zaparucha, Anne; Perchat, Nadia; Vergne, Carine; de Melo-Minardi, Raquel C.; Artiguenave, Francois; Weissenbach, Jean; Salanoubat, Marcel] Univ Evry Val Essonne, F-91057 Evry, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Zaparucha, A (corresponding author), IG Genoscope, Lab Chim Organ & Biocatalyse, 2 Rue Gaston Cremieux, F-91057 Evry, France.	azaparuc@genoscope.cns.fr; pedro.alzari@pasteur.fr	Zaparucha, Anne/ADO-0726-2022; InWeb, Inct/J-9839-2013	Zaparucha, Anne/0000-0003-2531-4148; Alzari, Pedro/0000-0002-4233-1903; C. de Melo-Minardi, Raquel/0000-0001-5190-100X; PERRET, Alain/0000-0002-8896-1978; Karine, Bastard/0000-0003-4898-7871; Bellinzoni, Marco/0000-0002-8887-6917	Institut Pasteur; CEA; CNRS; University of Evry	Institut Pasteur(European Commission); CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Evry	This work was supported by grants from the Institut Pasteur, the CEA, the CNRS, and the University of Evry.	Anstrom DM, 2003, PROTEIN SCI, V12, P1822, DOI 10.1110/ps.03174303; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER HA, 1980, J BACTERIOL, V143, P1165, DOI 10.1128/JB.143.3.1165-1170.1980; BARKER HA, 1982, J BACTERIOL, V152, P201; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davis FA, 1999, J ORG CHEM, V64, P1403, DOI 10.1021/jo9820622; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Kreimeyer A, 2007, J BIOL CHEM, V282, P7191, DOI 10.1074/jbc.M609829200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; YORIFUJI T, 1977, J BIOL CHEM, V252, P20; Zhang C, 2003, CURR OPIN CHEM BIOL, V7, P28, DOI 10.1016/S1367-5931(02)00015-7	32	11	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27399	27405		10.1074/jbc.M111.253260	http://dx.doi.org/10.1074/jbc.M111.253260			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21632536	Green Published, hybrid			2022-12-27	WOS:000293268700035
J	Jeon, J; Oh, H; Lee, G; Ryu, JH; Rhee, J; Kim, JH; Chung, KH; Song, WK; Chun, CH; Chun, JS				Jeon, Jimin; Oh, Hwanhee; Lee, Gyusuk; Ryu, Je-Hwang; Rhee, Jinseol; Kim, Jin-Hong; Chung, Kyung-Hwun; Song, Woo-Keun; Chun, Churl-Hong; Chun, Jang-Soo			Cytokine-like 1 Knock-out Mice (Cytl1(-/-)) Show Normal Cartilage and Bone Development but Exhibit Augmented Osteoarthritic Cartilage Destruction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II COLLAGEN EXPRESSION; ARTICULAR CHONDROCYTES; MECHANISMS; CHONDROGENESIS; APOPTOSIS; MOUSE; CELLS; MODEL	We have shown that cytokine-like 1 (Cytl1) is a novel autocrine regulatory factor that regulates chondrogenesis of mouse mesenchymal cells (Kim, J. S., Ryoo, Z. Y., and Chun, J. S. (2007) J. Biol. Chem. 282, 29359-29367). In this previous work, we found that Cytl1 expression was very low in mesenchymal cells, increased dramatically during chondrogenesis, and decreased during hypertrophic maturation, both in vivo and in vitro. Moreover, exogenous addition or ectopic expression of Cytl1 caused chondrogenic differentiation of mouse limb bud mesenchymal cells. In the current study, we generated a Cytl1 knockout (Cytl1(-/-)) mouse to investigate the in vivo role of Cytl1. Deletion of the Cytl1 gene did not affect chondrogenesis or cartilage development. Cytl1(-/-) mice also showed normal endochondral ossification and long bone development. Additionally, ultrastructural features of articular cartilage, such as matrix organization and chondrocyte morphology, were similar in wild-type and Cytl1(-/-) mice. However, Cytl1(-/-) mice were more sensitive to osteoarthritic (OA) cartilage destruction. Compared with wild-type littermates, Cytl1(-/-) mice showed more severe OA cartilage destruction upon destabilization of the medial meniscus of mouse knee joints. In addition, expression levels of Cytl1 were markedly decreased in OA cartilage of humans and experimental mice. Taken together, our results suggest that, rather than regulating cartilage and bone development, Cytl1 is required for the maintenance of cartilage homeostasis, and loss of Cytl1 function is associated with experimental OA cartilage destruction in mice.	[Chun, Churl-Hong] Wonkwang Univ, Sch Med, Dept Orthoped Surg, Iksan 570711, South Korea; [Jeon, Jimin; Oh, Hwanhee; Lee, Gyusuk; Ryu, Je-Hwang; Rhee, Jinseol; Kim, Jin-Hong; Chung, Kyung-Hwun; Song, Woo-Keun; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea; [Jeon, Jimin; Oh, Hwanhee; Lee, Gyusuk; Ryu, Je-Hwang; Rhee, Jinseol; Kim, Jin-Hong; Chung, Kyung-Hwun; Song, Woo-Keun; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea	Wonkwang University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Chun, CH (corresponding author), Wonkwang Univ, Sch Med, Dept Orthoped Surg, Iksan 570711, South Korea.	cch@wonkwang.ac.kr; jschun@gist.ac.kr		Jeon, Jimin/0000-0003-1843-4555; Kim, Jin-Hong/0000-0002-6480-1929	Korea Healthcare Technology RD project [A101793]	Korea Healthcare Technology RD project	This work was supported by a grant from the Korea Healthcare Technology R&D project (A101793).	Ficker M, 2004, DEV BIOL, V268, P7, DOI 10.1016/j.ydbio.2003.11.023; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hashimoto M, 2008, MED RES REV, V28, P464, DOI 10.1002/med.20113; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Huh YH, 2007, J BIOL CHEM, V282, P17123, DOI 10.1074/jbc.M700599200; Huh YH, 2009, GENE, V448, P7, DOI 10.1016/j.gene.2009.08.015; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Kleemann RU, 2005, OSTEOARTHR CARTILAGE, V13, P958, DOI 10.1016/j.joca.2005.06.008; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kurotani R, 2008, AM J RESP CRIT CARE, V178, P389, DOI 10.1164/rccm.200707-1104OC; Liu X, 2000, GENOMICS, V65, P283, DOI 10.1006/geno.2000.6170; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; Mason RM, 2001, OSTEOARTHR CARTILAGE, V9, P85, DOI 10.1053/joca.2000.0363; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Scott NJA, 2009, BBA-MOL BASIS DIS, V1792, P1175, DOI 10.1016/j.bbadis.2009.09.009; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153	23	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27206	27213		10.1074/jbc.M111.218065	http://dx.doi.org/10.1074/jbc.M111.218065			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652695	hybrid, Green Published			2022-12-27	WOS:000293268700016
J	Barry, AN; Otoikhian, A; Bhatt, S; Shinde, U; Tsivkovskii, R; Blackburn, NJ; Lutsenko, S				Barry, Amanda N.; Otoikhian, Adenike; Bhatt, Sujata; Shinde, Ujwal; Tsivkovskii, Ruslan; Blackburn, Ninian J.; Lutsenko, Svetlana			The Lumenal Loop Met(672)-Pro(707) of Copper-transporting ATPase ATP7A Binds Metals and Facilitates Copper Release from the Intramembrane Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ABSORPTION; ALPHA-AMIDATING MONOOXYGENASE; DISEASE PROTEIN; FUNCTIONAL-CHARACTERIZATION; CATALYTIC-ACTIVITY; NMR-SPECTROSCOPY; MENKES; EXPRESSION; COORDINATION; CELLS	The copper-transporting ATPase ATP7A has an essential role in human physiology. ATP7A transfers the copper cofactor to metalloenzymes within the secretory pathway; inactivation of ATP7A results in an untreatable neurodegenerative disorder, Menkes disease. Presently, the mechanism of ATP7A-mediated copper release into the secretory pathway is not understood. We demonstrate that the characteristic His/Met-rich segment Met(672)-Pro(707) ( HM-loop) that connects the first two transmembrane segments of ATP7A is important for copper release. Mutations within this loop do not prevent the ability of ATP7A to form a phosphorylated intermediate during ATP hydrolysis but inhibit subsequent dephosphorylation, a step associated with copper release. The HM-loop inserted into a scaffold protein forms two structurally distinct binding sites and coordinates copper in a mixed His-Met environment with an similar to 2:1 stoichiometry. Binding of either copper or silver, a Cu( I) analog, induces structural changes in the loop. Mutations of 4 Met residues to Ile or two His-His pairs to Ala-Gly decrease affinity for copper. Altogether, the data suggest a two-step process, where copper released from the transport sites binds to the first His-( Met)(2) site, triggering a structural change and binding to a second 2-coordinate His-His or His-Met site. We also show that copper binding within the HM-loop stabilizes Cu( I) and protects it from oxidation, which may further aid the transfer of copper from ATP7A to acceptor proteins. The mechanism of copper entry into the secretory pathway is discussed.	[Otoikhian, Adenike; Blackburn, Ninian J.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Portland, OR 97291 USA; [Barry, Amanda N.; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA; [Bhatt, Sujata; Shinde, Ujwal; Tsivkovskii, Ruslan] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97291 USA	Oregon Health & Science University; Johns Hopkins University; Oregon Health & Science University	Blackburn, NJ (corresponding author), Oregon Hlth & Sci Univ, Inst Environm Hlth, Portland, OR 97291 USA.	ninian@comcast.net; lutsenko@jhmi.edu		Barry, Amanda/0000-0002-7992-0322	National Institutes of Health [P01GM067166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK077429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01GM067166 (to S. L. and N. J. B.).	Andruzzi L, 2005, J AM CHEM SOC, V127, P16548, DOI 10.1021/ja0529539; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Blackburn NJ, 2000, J BIOL INORG CHEM, V5, P341, DOI 10.1007/PL00010663; di Patti MC, 2009, J BIOL CHEM, V284, P4545, DOI 10.1074/jbc.M805688200; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen K, 2003, J AM CHEM SOC, V125, P12088, DOI 10.1021/ja036070y; Chong LX, 2009, J AM CHEM SOC, V131, P3549, DOI 10.1021/ja807354z; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; GEORGE GN, 1995, EXAFSPAK; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Himes RA, 2008, ANGEW CHEM INT EDIT, V47, P9084, DOI 10.1002/anie.200803908; Himes RA, 2007, J AM CHEM SOC, V129, P5352, DOI 10.1021/ja0708013; Ibricevic A, 2010, TOXICOL APPL PHARM, V243, P315, DOI 10.1016/j.taap.2009.11.023; Kaler S G, 1998, Adv Pharmacol, V42, P66; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kuo YM, 1997, HUM MOL GENET, V6, P1043, DOI 10.1093/hmg/6.7.1043; Leonhardt K, 2009, J BIOL CHEM, V284, P7793, DOI 10.1074/jbc.M805145200; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Maio N, 2010, J BIOL CHEM, V285, P20507, DOI 10.1074/jbc.M109.090027; Michaiczyk A, 2008, J HISTOCHEM CYTOCHEM, V56, P389, DOI 10.1369/jhc.7A7300.2008; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; PICKERING IJ, 1993, J AM CHEM SOC, V115, P9498, DOI 10.1021/ja00074a014; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; SANYAL I, 1993, J AM CHEM SOC, V115, P11259, DOI 10.1021/ja00077a027; Sarret G, 2010, J AM CHEM SOC, V132, P3770, DOI 10.1021/ja9083896; Siluvai GS, 2010, J AM CHEM SOC, V132, P5215, DOI 10.1021/ja910759v; Steveson TC, 2003, ENDOCRINOLOGY, V144, P188, DOI 10.1210/en.2002-220716; Tchaparian EH, 2000, ARCH BIOCHEM BIOPHYS, V379, P71, DOI 10.1006/abbi.2000.1842; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200	39	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26585	26594		10.1074/jbc.M111.229039	http://dx.doi.org/10.1074/jbc.M111.229039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646353	hybrid, Green Published			2022-12-27	WOS:000293078200037
J	Juarez, O; Shea, ME; Makhatadze, GI; Barquera, B				Juarez, Oscar; Shea, Michael E.; Makhatadze, George I.; Barquera, Blanca			The Role and Specificity of the Catalytic and Regulatory Cation-binding Sites of the Na+-pumping NADH:Quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; PROSTHETIC GROUPS; REDOX PROPERTIES; NQRC SUBUNITS; SODIUM CYCLE; REDUCTASE; MARINE; ALGINOLYTICUS	The Na+-translocating NADH: quinone oxidoreductase is the entry site for electrons into the respiratory chain and the main sodium pump in Vibrio cholerae and many other pathogenic bacteria. In this work, we have employed steady-state and transient kinetics, together with equilibrium binding measurements to define the number of cation-binding sites and characterize their roles in the enzyme. Our results show that sodium and lithium ions stimulate enzyme activity, and that Na+-NQR enables pumping of Li+, as well as Na+ across the membrane. We also confirm that the enzyme is not able to translocate other monovalent cations, such as potassium or rubidium. Although potassium is not used as a substrate, Na+-NQR contains a regulatory site for this ion, which acts as a nonessential activator, increasing the activity and affinity for sodium. Rubidium can bind to the same site as potassium, but instead of being activated, enzyme turnover is inhibited. Activity measurements in the presence of both sodium and lithium indicate that the enzyme contains at least two functional sodium-binding sites. We also show that the binding sites are not exclusively responsible for ion selectivity, and other steps downstream in the mechanism also play a role. Finally, equilibrium-binding measurements with Na-22(+) show that, in both its oxidized and reduced states, Na+-NQR binds three sodium ions, and that the affinity for sodium is the same for both of these states.	[Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Barquera, B (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Rm 2239,110 8 St, Troy, NY 12180 USA.	barqub@rpi.edu		Juarez, Oscar/0000-0002-2915-8413	National Institutes of Health [GM 060036]; National Science Foundation [MCB 1052234]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 060036 and National Science Foundation Grant MCB 1052234.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arakaki LSL, 2007, APPL SPECTROSC, V61, P978, DOI 10.1366/000370207781745928; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; BENOS DJ, 1980, J GEN PHYSIOL, V76, P233, DOI 10.1085/jgp.76.2.233; Bogachev AV, 2007, BIOCHEMISTRY-US, V46, P10186, DOI 10.1021/bi700440w; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Casutt MS, 2010, ACTA CRYSTALLOGR F, V66, P1677, DOI [10.1107/S1744309110043125, 10.1107/S17443091100431]; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P449, DOI 10.1016/0005-2728(86)90113-1; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P458, DOI 10.1016/0005-2728(86)90114-3; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Duran-Pinedo AE, 2007, MOL MICROBIOL, V64, P1061, DOI 10.1111/j.1365-2958.2007.05717.x; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hayashi M, 1997, BIOCHEM MOL BIOL INT, V41, P41; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kato S, 2000, CAN J MICROBIOL, V46, P325, DOI 10.1139/cjm-46-4-325; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Noskov SY, 2007, J GEN PHYSIOL, V129, P135, DOI 10.1085/jgp.200609633; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pajor AM, 2010, BIOCHEMISTRY-US, V49, P8937, DOI 10.1021/bi100600j; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Rich P, 2003, NATURE, V421, P583, DOI 10.1038/421583a; Rich PR, 2008, J BIOENERG BIOMEMBR, V40, P407, DOI 10.1007/s10863-008-9173-7; Steuber J, 2001, BBA-BIOENERGETICS, V1505, P45, DOI 10.1016/S0005-2728(00)00276-0; Tao ML, 2006, ACTA CRYSTALLOGR F, V62, P110, DOI 10.1107/S174430910504306X; UNEMOTO T, 1993, J BIOENERG BIOMEMBR, V25, P385, DOI 10.1007/BF00762464; URRY DW, 1989, METHOD ENZYMOL, V171, P286; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020	47	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26383	26390		10.1074/jbc.M111.257873	http://dx.doi.org/10.1074/jbc.M111.257873			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652714	Green Published, hybrid			2022-12-27	WOS:000293078200015
J	Mostowy, S; Sancho-Shimizu, V; Hamon, MA; Simeone, R; Brosch, R; Johansen, T; Cossart, P				Mostowy, Serge; Sancho-Shimizu, Vanessa; Hamon, Melanie Anne; Simeone, Roxane; Brosch, Roland; Johansen, Terje; Cossart, Pascale			p62 and NDP52 Proteins Target Intracytosolic Shigella and Listeria to Different Autophagy Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN; ADAPTER; DEGRADATION; P62/SQSTM1; BACTERIA; ESCAPE; SYSTEM; FAMILY	Autophagy is an important mechanism of innate immune defense. We have recently shown that autophagy components are recruited with septins, a new and increasingly characterized cytoskeleton component, to intracytosolic Shigella that have started to polymerize actin. On the other hand, intracytosolic Listeria avoids autophagy recognition by expressing ActA, a bacterial effector required for actin polymerization. Here, we exploit Shigella and Listeria as intracytosolic tools to characterize different pathways of selective autophagy. We show that the ubiquitin-binding adaptor proteins p62 and NDP52 target Shigella to an autophagy pathway dependent upon septin and actin. In contrast, p62 or NDP52 targets the Listeria ActA mutant to an autophagy pathway independent of septin or actin. TNF-alpha, a host cytokine produced upon bacterial infection, stimulates p62-mediated autophagic activity and restricts the survival of Shigella and the Listeria ActA mutant. These data provide a new molecular framework to understand the emerging complexity of autophagy and its ability to achieve specific clearance of intracytosolic bacteria.	[Mostowy, Serge; Hamon, Melanie Anne; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Mostowy, Serge; Hamon, Melanie Anne; Cossart, Pascale] INSERM U604, F-75015 Paris, France; [Mostowy, Serge; Hamon, Melanie Anne; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Sancho-Shimizu, Vanessa] Necker Med Sch, INSERM U980, Lab Human Genet Infect Dis, Necker Branch, F-75015 Paris, France; [Sancho-Shimizu, Vanessa] Univ Paris 05, F-75015 Paris, France; [Simeone, Roxane; Brosch, Roland] Inst Pasteur, Unite Postulante Pathogen Mycobacterienne Integre, F-75015 Paris, France; [Johansen, Terje] Univ Tromso, Mol Canc Res Grp, Inst Med Biol, N-9037 Tromso, Norway	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UiT The Arctic University of Tromso	Mostowy, S (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	smostowy@pasteur.fr	Johansen, Terje/AAY-1753-2021; Brosch, Roland/AAZ-3850-2021; Brosch, Roland/ABB-4108-2021; Hamon, Melanie/B-3501-2013; Johansen, Terje/N-2971-2015	Johansen, Terje/0000-0003-1451-9578; Brosch, Roland/0000-0003-2587-3863; Johansen, Terje/0000-0003-1451-9578; Hamon, Melanie/0000-0001-5078-4083; SIMEONE, Roxane/0000-0002-7082-7842; Mostowy, Serge/0000-0002-7286-6503	European Research Council [233348]	European Research Council(European Research Council (ERC)European Commission)	International research scholar from the Howard Hughes Medical Institute and recipient of European Research Council Advanced Grant Award 233348.	Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mostowy S, 2012, BACTERIAL PATHOGENESIS: MOLECULAR AND CELLULAR MECHANISMS, P243; Mostowy S, 2011, AUTOPHAGY, V7, P780, DOI 10.4161/auto.7.7.15593; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Mostowy S, 2009, J BIOL CHEM, V284, P11613, DOI 10.1074/jbc.M900231200; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yap GS, 2007, AUTOPHAGY, V3, P163, DOI 10.4161/auto.3655; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	38	221	227	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26987	26995		10.1074/jbc.M111.223610	http://dx.doi.org/10.1074/jbc.M111.223610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646350	Green Published, hybrid			2022-12-27	WOS:000293078200072
J	Watanabe, M; Horai, Y; Houten, SM; Morimoto, K; Sugizaki, T; Arita, E; Mataki, C; Sato, H; Tanigawara, Y; Schoonjans, K; Itoh, H; Auwerx, J				Watanabe, Mitsuhiro; Horai, Yasushi; Houten, Sander M.; Morimoto, Kohkichi; Sugizaki, Taichi; Arita, Eri; Mataki, Chikage; Sato, Hiroyuki; Tanigawara, Yusuke; Schoonjans, Kristina; Itoh, Hiroshi; Auwerx, Johan			Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE FEEDBACK-REGULATION; ORPHAN-NUCLEAR-RECEPTOR; INSULIN SENSITIVITY; IN-VIVO; MICE; METABOLISM; EXPRESSION; SIGNAL; SHP; IDENTIFICATION	We evaluated the metabolic impact of farnesoid X receptor (FXR) activation by administering a synthetic FXR agonist (GW4064) to mice in which obesity was induced by a high fat diet. Administration of GW4064 accentuated body weight gain and glucose intolerance induced by the high fat diet and led to a pronounced worsening of the changes in liver and adipose tissue. Mechanistically, treatment with GW4064 decreased bile acid (BA) biosynthesis, BA pool size, and energy expenditure, whereas reconstitution of the BA pool in these GW4064-treated animals by BA administration dose-dependently reverted the metabolic abnormalities. Our data therefore suggest that activation of FXR with synthetic agonists is not useful for long term management of the metabolic syndrome, as it reduces the BA pool size and subsequently decreases energy expenditure, translating as weight gain and insulin resistance. In contrast, expansion of the BA pool size, which can be achieved by BA administration, could be an interesting strategy to manage the metabolic syndrome.	[Watanabe, Mitsuhiro; Horai, Yasushi; Morimoto, Kohkichi; Sugizaki, Taichi; Arita, Eri; Itoh, Hiroshi] Keio Univ, Dept Internal Med, Sch Med, Tokyo 1608582, Japan; [Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Mataki, Chikage; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Sato, Hiroyuki] Ehime Univ, Grad Sch Med, Dept Biosci, Ehime 7910295, Japan; [Tanigawara, Yusuke] Keio Univ, Dept Pharm, Sch Med, Tokyo 1608582, Japan	Keio University; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Ehime University; Keio University	Watanabe, M (corresponding author), Keio Univ, Dept Internal Med, Sch Med, Tokyo 1608582, Japan.	wmitsu@sc.itc.keio.ac.jp; johan.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Houten, Sander/Y-3599-2019	Houten, Sander/0000-0002-6167-9147; Auwerx, Johan/0000-0002-5065-5393; Schoonjans, Kristina/0000-0003-1247-4265	National Institutes of Health; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Sumitomo Foundation; Ono Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Novartis Foundation (Japan) for Promotion of Science; Japan Health Foundation; Kowa Life Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Ono Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Novartis Foundation (Japan) for Promotion of Science(Novartis); Japan Health Foundation(Japan Health Foundation); Kowa Life Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in whole or in part, by National Institutes of Health grants. This work was also supported by grants from the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, the Uehara Memorial Foundation, Takeda Science Foundation, the Sumitomo Foundation, Ono Medical Foundation, Astellas Foundation for Research on Metabolic Disorders, the Novartis Foundation (Japan) for Promotion of Science, the Japan Health Foundation, Kowa Life Science Foundation and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glicksman C, 2010, ANN CLIN BIOCHEM, V47, P482, DOI 10.1258/acb.2010.010040; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Houten SM, 2007, MOL ENDOCRINOL, V21, P1312, DOI 10.1210/me.2007-0113; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Houten SM, 2004, ANN MED, V36, P482, DOI 10.1080/07853890410018790; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Qiao L, 2003, MOL CELL BIOL, V23, P3052, DOI 10.1128/MCB.23.9.3052-3066.2003; Rizzo G, 2006, MOL PHARMACOL, V70, P1164, DOI 10.1124/mol.106.023820; SAKAKURA H, 1993, J CHROMATOGR-BIOMED, V621, P123, DOI 10.1016/0378-4347(93)80087-K; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stayrook KR, 2005, ENDOCRINOLOGY, V146, P984, DOI 10.1210/en.2004-0965; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	41	187	198	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26913	26920		10.1074/jbc.M111.248203	http://dx.doi.org/10.1074/jbc.M111.248203			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632533	Green Published, hybrid			2022-12-27	WOS:000293078200065
J	Chen, TC; Chien, SJ; Kuo, HC; Huang, WS; Sheen, JM; Lin, TH; Yen, CK; Sung, ML; Chen, CN				Chen, Te-Chuan; Chien, Shao-Ju; Kuo, Hsing-Chun; Huang, Wen-Shih; Sheen, Jiunn-Ming; Lin, Tseng-Hsi; Yen, Chia-Kuang; Sung, Mao-Lin; Chen, Cheng-Nan			High Glucose-treated Macrophages Augment E-Selectin Expression in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE PATHWAYS; SOLUBLE E-SELECTIN; FACTOR-KAPPA-B; INSULIN-RESISTANCE; ADHESION MOLECULES; SHEAR-STRESS; VASCULAR-DISEASE	E-selectin expression by endothelial cells (ECs) is crucial for leukocyte recruitment during the inflammatory response. Macrophage accumulation and serum E-selectin elevation are features of type 2 diabetes mellitus. However, the interactions between macrophages and ECs in regulating vascular endothelial function are not clearly understood. We investigated the mechanisms underlying the modulation of EC E-selectin expression by high glucose (HG)-treated macrophages. Macrophage-conditioned media (MCM) were prepared from HG-treated macrophages. EC stimulation with HG-MCM induced increases the expression and secretion of E-selectin. By using specific inhibitors and small interfering RNAs, we demonstrate that the activation of the JNK and p38 MAPK pathways are critical for HG-MCM-induced E-selectin expression. Transcription factor ELISA and chromatin immunoprecipitation assays further showed that HG-MCM increases the NF-kappa B- and AP-1 DNA-binding activities in ECs. The inhibition of NF-kappa B and AP-1 activation by specific siRNAs blocks the HG-MCM-induced E-selectin promoter activity and expression. Protein arrays and blocking assays using neutralizing antibodies demonstrated that macrophage inflammatory protein 1 alpha and 1 beta in HG-MCM are major mediators for the induction of EC E-selectin expression. These data support the hypothesis that E-selectin up-regulation stimulated by macrophages may play an active role in atherogenesis in the HG condition and suggest a new mechanism by which arterial disease is accelerated in diabetes.	[Yen, Chia-Kuang; Sung, Mao-Lin] St Martin de Porres Hosp, Dept Cardiol, Chiayi 600, Taiwan; [Chen, Te-Chuan] Chang Gung Mem Hosp, Div Nephrol, Kaohsiung 833, Taiwan; [Chien, Shao-Ju] Chang Gung Mem Hosp, Div Pediat Cardiol, Kaohsiung 833, Taiwan; [Sheen, Jiunn-Ming] Chang Gung Mem Hosp, Dept Pediat, Kaohsiung 833, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan; [Kuo, Hsing-Chun] Chron Dis & Hlth Promot Res Ctr, Dept Nursing, CGIT, Chiayi 613, Taiwan; [Huang, Wen-Shih] Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Chiayi 613, Taiwan; [Lin, Tseng-Hsi] Taichung Vet Gen Hosp, Dept Internal Med, Div Hematol, Taichung 407, Taiwan; [Chen, Cheng-Nan] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi 600, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Taichung Veterans General Hospital; National Chiayi University	Sung, ML (corresponding author), St Martin de Porres Hosp, Dept Cardiol, Chiayi 600, Taiwan.	sung1118@gmail.com; cnchen@mail.ncyu.edu.tw			Chang Gung Memorial Hospital; Chang Gung Institute of Technology Chiayi Campus [CZRPG880253, CMRPF680052, EZRPF390261]; St. Martin de Porres Hospital [P0919]; National Science Council, Taiwan [NSC97-2320-B-415-007-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung Institute of Technology Chiayi Campus; St. Martin de Porres Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital or Chang Gung Institute of Technology Chiayi Campus grants CZRPG880253, CMRPF680052, and EZRPF390261); St. Martin de Porres Hospital Project No. P0919); and the National Science Council, Taiwan Grant NSC97-2320-B-415-007-MY3.	Boulbou MS, 2005, INT J CARDIOL, V98, P39, DOI 10.1016/j.ijcard.2003.07.037; Chen CN, 2006, BLOOD, V107, P1933, DOI 10.1182/blood-2005-08-3137; Chiu JJ, 2007, BLOOD, V110, P519, DOI 10.1182/blood-2006-08-040097; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Chou MT, 2010, BIOMATERIALS, V31, P4367, DOI 10.1016/j.biomaterials.2010.02.011; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; De Caterina R, 2001, AM J HYPERTENS, V14, P259, DOI 10.1016/S0895-7061(00)01276-0; Hackman A, 1996, CIRCULATION, V93, P1334, DOI 10.1161/01.CIR.93.7.1334; Hwang SJ, 1997, CIRCULATION, V96, P4219; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Krentz AJ, 2007, DIABETES OBES METAB, V9, P781, DOI 10.1111/j.1463-1326.2007.00670.x; Liang CP, 2007, CIRC RES, V100, P1546, DOI 10.1161/CIRCRESAHA.107.152165; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin SJ, 2005, ARTERIOSCL THROM VAS, V25, P334, DOI 10.1161/01.ATV.0000152114.00114.d8; Marx N, 2004, ARTERIOSCL THROM VAS, V24, P540, DOI 10.1161/01.ATV.0000116027.81513.68; Matsumoto K, 2002, DIABETES RES CLIN PR, V55, P131, DOI 10.1016/S0168-8227(01)00296-0; Matsumoto K, 2001, DIABETIC MED, V18, P224, DOI 10.1046/j.1464-5491.2001.00457.x; Matsumoto K, 2010, METABOLISM, V59, P320, DOI 10.1016/j.metabol.2009.06.011; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Renard C, 2006, DIABETES METAB, V32, P15, DOI 10.1016/S1262-3636(07)70243-4; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sands WA, 2004, MOL PHARMACOL, V66, P1147, DOI 10.1124/mol.104.001107; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Sung ML, 2009, CIRC RES, V105, P755, DOI 10.1161/CIRCRESAHA.109.206524; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tesfamariam B, 2007, VASC PHARMACOL, V46, P229, DOI 10.1016/j.vph.2006.11.005; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865; Yeh CC, 2009, ARTHRITIS RHEUM-US, V60, P2350, DOI 10.1002/art.24680; Zhu WF, 2010, AM J PHYSIOL-CELL PH, V298, pC952, DOI 10.1152/ajpcell.00466.2009	36	17	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25564	25573		10.1074/jbc.M111.230540	http://dx.doi.org/10.1074/jbc.M111.230540			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21659524	Green Published, hybrid			2022-12-27	WOS:000293073000019
J	Guengerich, FP				Guengerich, F. Peter			Thematic Minireview Series on Biological Applications of Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Mass spectrometry is a powerful technique with many applications in biology as well as chemistry and physics. The increases in sensitivity and resolution of the instruments, coupled with improvements in the analysis of data, have opened new dimensions in analyses of complex biological systems. Examples presented here include drug metabolism, lipid analysis, metabolomics, quantitative proteomics, direct analysis of intact proteins, and imaging of both small molecules and proteins in tissues.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 221 Kirkland Hall, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu						[Anonymous], 2003, ENCY MASS SPECTROMET; Benyon J. H., 1978, INT J MASS SPECTROM, V27, P1	2	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25417	25417		10.1074/jbc.R111.266700	http://dx.doi.org/10.1074/jbc.R111.266700			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632545	hybrid, Green Published			2022-12-27	WOS:000293073000002
J	Lai, AL; Tamm, LK; Ellena, JF; Cafiso, DS				Lai, Alex L.; Tamm, Lukas K.; Ellena, Jeffrey F.; Cafiso, David S.			Synaptotagmin 1 Modulates Lipid Acyl Chain Order in Lipid Bilayers by Demixing Phosphatidylserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND ORIENTATION; PHASE-BEHAVIOR; C2 DOMAINS; PHOSPHOLIPID-MEMBRANES; VESICLE FUSION; BASIC PEPTIDES; SNARE FUNCTION; ACIDIC LIPIDS; BINDING; SPECTROSCOPY	Synaptotagmin 1 (syt1) functions as the Ca2+ sensor in neuronal exocytosis, and it has been proposed to act by modulating lipid bilayer curvature. Here we examine the effect of the two C2 domains (C2A and C2B) of syt1 on membrane lipid order and lateral organization. In mixtures of phosphatidylcholine and phosphatidylserine (PS), attenuated total internal reflection Fourier transform infrared spectroscopy indicates that a fragment containing both domains (C2AB) or C2B alone disorders the lipid acyl chains, whereas the C2A domain has little effect upon chain order. Two observations suggest that these changes reflect a demixing of PS. First, the changes in acyl chain order are reversed at higher protein concentration; second, selective lipid deuteration demonstrates that the changes in lipid order are associated only with the PS component of the bilayer. Independent evidence for lipid demixing is obtained from fluorescence self-quenching of labeled lipid and from natural abundance C-13 NMR, where heteronuclear single quantum correlation spectra reveal Ca2+-dependent chemical shift changes for PS, but not for phosphatidylcholine, in the presence of the syt1 C2 domains. The ability of syt1 to demix PS is observed in a range of lipid mixtures that includes cholesterol, phosphatidylethanolamine, and varied PS content. These data suggest that syt1 might facilitate SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptors)-mediated membrane fusion by phase separating PS, a process that is expected to locally buckle bilayers and disorder lipids due to the curvature tendencies of PS.	[Lai, Alex L.; Ellena, Jeffrey F.; Cafiso, David S.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22904 USA; [Lai, Alex L.; Tamm, Lukas K.; Ellena, Jeffrey F.; Cafiso, David S.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22904 USA	University of Virginia; University of Virginia; University of Virginia	Cafiso, DS (corresponding author), Univ Virginia, Dept Chem, McCormick Rd, Charlottesville, VA 22904 USA.	cafiso@virginia.edu	Lai, Alex/G-8668-2014		National Institutes of Health (NIGMS) [GM 072694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 072694 (NIGMS; to D. S. C. and L. K. T.).	Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; BACH D, 1992, CHEM PHYS LIPIDS, V63, P105, DOI 10.1016/0009-3084(92)90027-M; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; BOROCHOV N, 1995, CHEM PHYS LIPIDS, V76, P85, DOI 10.1016/0009-3084(94)02411-W; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Chae YK, 1998, J BIOL CHEM, V273, P25659, DOI 10.1074/jbc.273.40.25659; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Connell E, 2008, J MOL BIOL, V380, P42, DOI 10.1016/j.jmb.2008.01.084; Denisov G, 1998, BIOPHYS J, V74, P731, DOI 10.1016/S0006-3495(98)73998-0; Frazier AA, 2003, BIOCHEMISTRY-US, V42, P96, DOI 10.1021/bi0268145; FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Garg S, 2009, J STRUCT BIOL, V168, P11, DOI 10.1016/j.jsb.2009.04.001; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; GRUNER SM, 1989, J PHYS CHEM-US, V93, P7562, DOI 10.1021/j100359a011; Han X, 1999, BIOCHEMISTRY-US, V38, P15052, DOI 10.1021/bi991232h; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hinderliter A, 2001, BIOCHEMISTRY-US, V40, P4181, DOI 10.1021/bi0024299; HOEKSTRA D, 1982, BIOCHEMISTRY-US, V21, P1055, DOI 10.1021/bi00534a036; Huang H, 2008, BIOCHEMISTRY-US, V47, P12380, DOI 10.1021/bi801470m; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kuo WW, 2009, J MOL BIOL, V387, P284, DOI 10.1016/j.jmb.2009.01.064; LEPORE LS, 1992, BIOPHYS J, V61, P767, DOI 10.1016/S0006-3495(92)81881-7; LUNA EJ, 1977, BIOCHIM BIOPHYS ACTA, V470, P303, DOI 10.1016/0005-2736(77)90108-0; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MCLAUGHLIN S, 1981, J GEN PHYSIOL, V77, P445, DOI 10.1085/jgp.77.4.445; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; NEUMANN JM, 1985, EUR BIOPHYS J BIOPHY, V11, P219, DOI 10.1007/BF00261998; Radhakrishnan A, 2009, J BIOL CHEM, V284, P25749, DOI 10.1074/jbc.M109.042499; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rufener E, 2005, BIOCHEMISTRY-US, V44, P18, DOI 10.1021/bi048370d; Shahin V, 2008, BIOCHEMISTRY-US, V47, P2143, DOI 10.1021/bi701879g; SILVIUS JR, 1984, BIOCHEMISTRY-US, V23, P3232, DOI 10.1021/bi00309a018; STEWART TP, 1979, BIOCHIM BIOPHYS ACTA, V556, P1, DOI 10.1016/0005-2736(79)90415-2; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; TATULIAN SA, 1995, BIOCHEMISTRY-US, V34, P4448, DOI 10.1021/bi00013a038; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wolf C, 2001, BIOPHYS CHEM, V89, P163, DOI 10.1016/S0301-4622(00)00226-X; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691	50	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25291	25300		10.1074/jbc.M111.258848	http://dx.doi.org/10.1074/jbc.M111.258848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610074	Green Published, hybrid			2022-12-27	WOS:000292547900075
J	Zhang, JH; Ge, L; Qi, W; Zhang, LQ; Miao, HH; Li, BL; Yang, MJ; Song, BL				Zhang, Jin-Hui; Ge, Liang; Qi, Wei; Zhang, Liqing; Miao, Hong-Hua; Li, Bo-Liang; Yang, Maojun; Song, Bao-Liang			The N-terminal Domain of NPC1L1 Protein Binds Cholesterol and Plays Essential Roles in Cholesterol Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICK C1 PROTEIN; REGULATED TRANSLOCATION; STEROL BINDING; CELL-SURFACE; C2 DISEASE; METABOLISM; ABSORPTION; EZETIMIBE; REVEALS; IDENTIFICATION	Niemann-Pick C1-like 1 (NPC1L1) is a multitransmembrane protein playing a crucial role in dietary and biliary cholesterol absorption. Cholesterol promotes the formation and endocytosis of NPC1L1-flotillin-cholesterol membrane microdomains, which is an early step in cholesterol uptake. How cholesterol is sensed in this step is unknown. Here, we find that the N-terminal domain (NTD) of NPC1L1 binds cholesterol. Mutation of residue Leu-216 in NPC1L1-NTD eliminates cholesterol binding, decreases the formation of NPC1L1-flotillin-cholesterol membrane microdomains, and prevents NPC1L1-mediated cholesterol uptake in culture cells and mice livers. NPC1L1-NTD specifically binds cholesterol but not plant sterols, which may account for the selective cholesterol absorption in intestine. Furthermore, 25- or 27-hydroxycholesterol competes with cholesterol to bind NPC1L1-NTD and inhibits the cholesterol induced endocytosis of NPC1L1. Together, these results demonstrate that plasma membrane-localized NPC1L1 binds exogenous cholesterol via its NTD, and facilitates the formation of NPC1L1-flotillin-cholesterol membrane microdomains that are then internalized into cells through the clathrin-AP2 pathway. Our study uncovers the mechanism of cholesterol sensing by NPC1L1 and proposes a mechanism for selective cholesterol absorption.	[Zhang, Jin-Hui; Ge, Liang; Qi, Wei; Miao, Hong-Hua; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhang, Liqing; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tsinghua University	Song, BL (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	blsong@sibs.ac.cn	zhang, jinhui/GXF-6528-2022	Song, Bao-Liang/0000-0002-6397-5935; Qi, Wei/0000-0003-0813-5316; Yang, Maojun/0000-0002-6798-3094; Ge, Liang/0000-0002-7371-2039	Ministry of Science and Technology of China [2009CB919000, 2011CB910900]; National Natural Science Foundation of China [30925012]; Shanghai Science and Technology Committee [10QH1402900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by the Ministry of Science and Technology of China (Grants 2009CB919000 and 2011CB910900), the National Natural Science Foundation of China (Grant 30925012), and the Shanghai Science and Technology Committee (Grant 10QH1402900).	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Chen HY, 2010, J MOL CELL BIOL, V2, P366, DOI 10.1093/jmcb/mjq034; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; Chu BB, 2009, J BIOL CHEM, V284, P22481, DOI 10.1074/jbc.M109.034355; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; GLOVER J, 1958, BRIT MED BULL, V14, P226, DOI 10.1093/oxfordjournals.bmb.a069688; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Ioannou YA, 2000, MOL GENET METAB, V71, P175, DOI 10.1006/mgme.2000.3061; Kwon HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018722; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nies AT, 1998, HEPATOLOGY, V28, P1332, DOI 10.1002/hep.510280523; Schoenheimer R, 1931, SCIENCE, V74, P579, DOI 10.1126/science.74.1928.579; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Wang LJ, 2011, J BIOL CHEM, V286, P7397, DOI 10.1074/jbc.M110.178368; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200	35	77	86	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25088	25097		10.1074/jbc.M111.244475	http://dx.doi.org/10.1074/jbc.M111.244475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602275	hybrid, Green Published			2022-12-27	WOS:000292547900057
J	Fonseca, BD; Alain, T; Finestone, LK; Huang, BPH; Rolfe, M; Jiang, T; Yao, Z; Hernandez, G; Bennett, CF; Proud, CG				Fonseca, Bruno D.; Alain, Tommy; Finestone, Leona K.; Huang, Brandon P. H.; Rolfe, Mark; Jiang, Tian; Yao, Zhong; Hernandez, Greco; Bennett, Christopher F.; Proud, Christopher G.			Pharmacological and Genetic Evaluation of Proposed Roles of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK), Extracellular Signal-regulated Kinase (ERK), and p90(RSK) in the Control of mTORC1 Protein Signaling by Phorbol Esters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; TUMOR-SUPPRESSOR COMPLEX; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; CARDIAC-HYPERTROPHY; ADULT CARDIOMYOCYTES; 3-KINASE/AKT PATHWAY; CELL-GROWTH; RAG GTPASES; IN-VITRO	The mammalian target of rapamycin complex 1 (mTORC1) links the control of mRNA translation, cell growth, and metabolism to diverse stimuli. Inappropriate activation of mTORC1 can lead to cancer. Phorbol esters are naturally occurring products that act as potent tumor promoters. They activate isoforms of protein kinase C (PKCs) and stimulate the oncogenic MEK/ERK signaling cascade. They also activate mTORC1 signaling. Previous work indicated that mTORC1 activation by the phorbol ester PMA (phorbol 12-myristate 13-acetate) depends upon PKCs and may involve MEK. However, the precise mechanism(s) through which they activate mTORC1 remains unclear. Recent studies have implicated both the ERKs and the ERK-activated 90-kDa ribosomal S6 kinases (p90(RSK)) in activating mTORC1 signaling via phosphorylation of TSC2 (a regulator of mTORC1) and/or the mTORC1 component raptor. However, the relative importance of each of these kinases and phosphorylation events for the activation of mTORC1 signaling is unknown. The recent availability of MEK (PD184352) and p90(RSK) (BI-D1870) inhibitors of improved specificity allowed us to address the roles of these protein kinases in controlling mTORC1in a variety of human and rodent cell types. In parallel, we used specific shRNAs against p90(RSK1) and p90(RSK2) to further test their roles in regulating mTORC1 signaling. Our data indicate that p90(RSKs) are dispensable for the activation of mTORC1 signaling by phorbol esters in all cell types tested. Our data also reveal striking diversity in the requirements for MEK/ERK in the control of mTORC1 between different cell types, pointing to additional signaling connections between phorbol esters and mTORC1, which do not involve MEK/ERK. This study provides important information for the design of efficient strategies to combat the hyperactivation of mTORC1 signaling by oncogenic pathways.	[Fonseca, Bruno D.; Rolfe, Mark; Proud, Christopher G.] Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland; [Fonseca, Bruno D.; Huang, Brandon P. H.; Jiang, Tian; Yao, Zhong; Proud, Christopher G.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Fonseca, Bruno D.; Huang, Brandon P. H.; Jiang, Tian; Yao, Zhong; Proud, Christopher G.] Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada; [Proud, Christopher G.] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England; [Fonseca, Bruno D.; Alain, Tommy; Finestone, Leona K.; Hernandez, Greco; Bennett, Christopher F.] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada	University of Dundee; University of British Columbia; University of British Columbia; University of Southampton; McGill University	Proud, CG (corresponding author), Univ Southampton, Sch Biol Sci, Bldg 85, Southampton SO17 1BJ, Hants, England.	C.G.Proud@soton.ac.uk		Bennett, Christopher/0000-0003-1927-0732; Proud, Christopher/0000-0003-0704-6442	University of British Columbia; Heart and Stroke Foundation of British Columbia and the Yukon; British Heart Foundation; Canadian Institutes of Health Research; University of Dundee School of Life Sciences	University of British Columbia; Heart and Stroke Foundation of British Columbia and the Yukon; British Heart Foundation(British Heart Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Dundee School of Life Sciences	This work was supported in part by grants from the University of British Columbia, the Heart and Stroke Foundation of British Columbia and the Yukon, the British Heart Foundation, and Canadian Institutes of Health Research (all to C. G. P.).; Supported by the Morton Fellowship/University of Dundee School of Life Sciences Alumnus Fund and a Canadian Institutes of Health Research Post-doctoral Cancer Training Grant Award.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chen S, 2009, CELL SIGNAL, V21, P1984, DOI 10.1016/j.cellsig.2009.09.009; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Fonseca BD, 2008, BIOCHEM J, V411, P141, DOI 10.1042/BJ20071001; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hannan RD, 2003, CLIN EXP PHARMACOL P, V30, P517, DOI 10.1046/j.1440-1681.2003.03873.x; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Scheper GC, 2003, MOL CELL BIOL, V23, P5692, DOI 10.1128/MCB.23.16.5692-5705.2003; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Smith JA, 2005, CANCER RES, V65, P1027; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Squires MS, 2002, BIOCHEM J, V366, P673, DOI 10.1042/BJ20020372; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; Wang LJ, 2003, BIOCHEM J, V373, P603, DOI 10.1042/BJ20030454; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; Yu YJ, 2005, J VIROL, V79, P6882, DOI 10.1128/JVI.79.11.6882-6889.2005	54	36	36	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27111	27122		10.1074/jbc.M111.260794	http://dx.doi.org/10.1074/jbc.M111.260794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659537	Green Published, hybrid			2022-12-27	WOS:000293268700006
J	Demorest, ZL; Li, M; Harris, RS				Demorest, Zachary L.; Li, Ming; Harris, Reuben S.			Phosphorylation Directly Regulates the Intrinsic DNA Cytidine Deaminase Activity of Activation-induced Deaminase and APOBEC3G Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA EDITING ENZYME; ANTIBODY DIVERSIFICATION; SOMATIC HYPERMUTATION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; HIV-1 VIF; B-CELLS; FUNCTIONAL IMPLICATIONS; CYTOPLASMIC RETENTION; L1 RETROTRANSPOSITION	The beneficial effects of DNA cytidine deamination by activation-induced deaminase (AID; antibody gene diversification) and APOBEC3G (retrovirus restriction) are tempered by probable contributions to carcinogenesis. Multiple regulatory mechanisms serve to minimize this detrimental outcome. Here, we show that phosphorylation of a conserved threonine attenuates the intrinsic activity of activation-induced deaminase (Thr-27) and APOBEC3G (Thr-218). Phospho-null alanine mutants maintain intrinsic DNA deaminase activity, whereas phosphomimetic glutamate mutants are inactive. The phospho-mimetic variants fail to mediate isotype switching in activated mouse splenic B lymphocytes or suppress HIV-1 replication in human T cells. Our data combine to suggest a model in which this critical threonine acts as a phospho-switch that fine-tunes the adaptive and innate immune responses and helps protect mammalian genomic DNA from procarcinogenic lesions.	Univ Minnesota, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	rsh@umn.edu			National Institutes of Health [R01-AI064046, R01-GM080437, T32-AI007313]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI064046 and R01-GM080437 and National Institutes of Health Grant T32-AI007313 ( to Z. L. D.).	Albin JS, 2010, J VIROL, V84, P10209, DOI 10.1128/JVI.00632-10; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Demorest ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011660; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Farrow MA, 2011, J BIOL CHEM, V286, P2567, DOI 10.1074/jbc.M110.154377; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Hache G, 2008, CURR BIOL, V18, P819, DOI 10.1016/j.cub.2008.04.073; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; MacDuff DA, 2006, MOL IMMUNOL, V43, P1099, DOI 10.1016/j.molimm.2005.07.024; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; Maeda K, 2010, J BIOL CHEM, V285, P23945, DOI 10.1074/jbc.M110.131441; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015	51	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26568	26575		10.1074/jbc.M111.235721	http://dx.doi.org/10.1074/jbc.M111.235721			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659520	Green Published, hybrid			2022-12-27	WOS:000293078200035
J	Lu, Y; Zha, XM; Kim, EY; Schachtele, S; Dailey, ME; Hall, DD; Strack, S; Green, SH; Hoffman, DA; Hell, JW				Lu, Yuan; Zha, Xiang-ming; Kim, Eun Young; Schachtele, Scott; Dailey, Michael E.; Hall, Duane D.; Strack, Stefan; Green, Steven H.; Hoffman, Dax A.; Hell, Johannes W.			A Kinase Anchor Protein 150 (AKAP150)-associated Protein Kinase A Limits Dendritic Spine Density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR ACTIVATION; POSTSYNAPTIC DENSITIES; AMPA RECEPTORS; AKAP150-ANCHORED PKA; PLASTICITY; PHOSPHORYLATION; AKAP79; SCAFFOLD; GLUR1; MEMBRANE	The A kinase anchor protein AKAP150 recruits the cAMP-dependent protein kinase (PKA) to dendritic spines. Here we show that in AKAP150 (AKAP5) knock-out (KO) mice frequency of miniature excitatory post-synaptic currents (mEPSC) and inhibitory post-synaptic currents (mIPSC) are elevated at 2 weeks and, more modestly, 4 weeks of age in the hippocampal CA1 area versus litter mate WT mice. Linear spine density and ratio of AMPAR to NMDAR EPSC amplitudes were also increased. Amplitude and decay time of mEPSCs, decay time of mIPSCs, and spine size were unaltered. Mice in which the PKA anchoring C-terminal 36 residues of AKAP150 are deleted (D36) showed similar changes. Furthermore, whereas acute stimulation of PKA (2-4 h) increases spine density, prolonged PKA stimulation (48 h) reduces spine density in apical dendrites of CA1 pyramidal neurons in organotypic slice cultures. The data from the AKAP150 mutant mice show that AKAP150-anchored PKA chronically limits the number of spines with functional AMPARs at 2-4 weeks of age. However, synaptic transmission and spine density was normal at 8 weeks in KO and D36 mice. Thus AKAP150-independent mechanisms correct the aberrantly high number of active spines in juvenile AKAP150 KO and D36 mice during development.	[Lu, Yuan; Hall, Duane D.; Strack, Stefan; Hell, Johannes W.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Zha, Xiang-ming; Schachtele, Scott; Dailey, Michael E.; Green, Steven H.] Univ Iowa, Coll Liberal Arts & Sci, Dept Biol, Iowa City, IA 52242 USA; [Lu, Yuan] NIMH, Genes Cognit & Psychosis Program, Bethesda, MD 20892 USA; [Zha, Xiang-ming] Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Kim, Eun Young; Hoffman, Dax A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Neurophysiol & Biophys Unit, NIH, Bethesda, MD 20892 USA; [Hell, Johannes W.] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95615 USA	University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of South Alabama; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Davis	Lu, Y (corresponding author), Magnuson Clin Ctr, Bldg 10,7D38,10 Ctr Dr, Bethesda, MD 20892 USA.	luyuan@mail.nih.gov; jwhell@ucdavis.edu	Hall, Duane/ACD-6815-2022; Hoffman, Dax A/E-5155-2011; Hell, Johannes W./P-5085-2019	Hall, Duane/0000-0003-2228-0966; Hoffman, Dax A/0000-0001-6999-2157; Strack, Stefan/0000-0002-6175-7280; Zha, Xiangming/0000-0001-9490-2731	National Institutes of Health [DA015916, GM032875, NS043254, NS056244, NS057714, DC002961, NS035563, NS017502]; American Heart Association [0655764Z]; University of South Alabama; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008755] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563, R01NS056244, R01NS043254, R56NS056244, R01NS057714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002961, R01DC009405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA015916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of South Alabama; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by Grants DA015916, GM032875 (to G. S. M.), NS043254, NS056244, NS057714 (to S. S.), DC002961 (to S. H. G.), and NS035563, NS017502 (to J. W. H.) from the National Institutes of Health. This work was also supported by Grant 0655764Z (to M. E. D.) from the American Heart Association, startup funds from the University of South Alabama (to X. M. Z.), and the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; BREGMAN DB, 1991, J BIOL CHEM, V266, P7207; Brooks IM, 2011, J BIOL CHEM, V286, P6697, DOI 10.1074/jbc.M110.183558; CARR DW, 1992, J BIOL CHEM, V267, P16816; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Harris Kristen M., 2008, P1, DOI 10.1007/978-0-387-77232-5_1; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kim IH, 2009, J NEUROSCI, V29, P14039, DOI 10.1523/JNEUROSCI.2483-09.2009; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2005, CURR OPIN NEUROBIOL, V15, P67, DOI 10.1016/j.conb.2005.01.015; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Qin LX, 2001, J COMP NEUROL, V440, P284, DOI 10.1002/cne.1386; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Strack Stefan, 2008, P459, DOI 10.1007/978-0-387-77232-5_16; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Woolley CS, 1997, J NEUROSCI, V17, P1848; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zha XM, 2005, MOL CELL NEUROSCI, V29, P494, DOI 10.1016/j.mcn.2005.04.007; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	74	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26496	26506		10.1074/jbc.M111.254912	http://dx.doi.org/10.1074/jbc.M111.254912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652711	Green Published, hybrid			2022-12-27	WOS:000293078200028
J	Gu, C; Gu, YZ				Gu, Chen; Gu, Yuanzheng			Clustering and Activity Tuning of Kv1 Channels in Myelinated Hippocampal Axons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS PATIENTS; K+ CHANNELS; NEURITE OUTGROWTH; NEURONAL POLARITY; GLIA INTERACTIONS; JUXTAPARANODAL REGIONS; SURFACE EXPRESSION; POTASSIUM CHANNELS; SIGNALING PATHWAY; SCHWANN-CELLS	Precise localization of axonal ion channels is crucial for proper electrical and chemical functions of axons. In myelinated axons, Kv1 (Shaker) voltage-gated potassium (Kv) channels are clustered in the juxtaparanodal regions flanking the node of Ranvier. The clustering can be disrupted by deletion of various proteins in mice, including contactin-associated protein-like 2 (Caspr2) and transient axonal glycoprotein-1 (TAG-1), a glycosylphosphatidylinositol-anchored cell adhesion molecule. However, the mechanism and function of Kv1 juxtaparanodal clustering remain unclear. Here, using a new myelin coculture of hippocampal neurons and oligodendrocytes, we report that tyrosine phosphorylation plays a critical role in TAG-1-mediated clustering of axonal Kv1.2 channels. In the coculture, myelin specifically ensheathed axons but not dendrites of hippocampal neurons and clustered endogenous axonal Kv1.2 into internodes. The trans-homophilic interaction of TAG-1 was sufficient to position Kv1.2 clusters on axonal membranes in a neuron/HEK293 coculture. Mutating a tyrosine residue (Tyr(458)) in the Kv1.2 C terminus or blocking tyrosine phosphorylation disrupted myelin-and TAG-1-mediated clustering of axonal Kv1.2. Furthermore, Kv1.2 voltage dependence and activation threshold were reduced by TAG-1 coexpression. This effect was eliminated by the Tyr(458) mutation or by cholesterol depletion. Taken together, our studies suggest that myelin regulates both trafficking and activity of Kv1 channels along hippocampal axons through TAG-1.	[Gu, Chen] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gu, C (corresponding author), Ohio State Univ, Dept Neurosci, 182 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	gu.49@osu.edu	Gu, Chen/E-3163-2011		National Institutes of Health, NINDS [R01NS062720]; National Multiple Sclerosis Society [TA3012A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062720] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01NS062720 (to C. G.). This work was also supported by a Career Transition Fellowship Award from the National Multiple Sclerosis Society (Grant TA3012A1).	Bel C, 2009, J CELL SCI, V122, P3403, DOI 10.1242/jcs.050526; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chang MC, 2006, MOL CELL NEUROSCI, V31, P525, DOI 10.1016/j.mcn.2005.11.006; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Devaux J, 2003, J NEUROSCI, V23, P4509; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Galvan C, 2005, MOL CELL NEUROSCI, V30, P304, DOI 10.1016/j.mcn.2005.07.003; Geurts JJG, 2007, J NEUROPATH EXP NEUR, V66, P819, DOI 10.1097/nen.0b013e3181461f54; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Gu YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011931; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Ishibashi T, 2002, J NEUROSCI, V22, P6507; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kajta M, 2007, NEUROSCIENCE, V145, P592, DOI 10.1016/j.neuroscience.2006.11.059; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; McEwen DP, 2008, MOL PHARMACOL, V73, P678, DOI 10.1124/mol.107.042093; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; Ogawa Y, 2010, J NEUROSCI, V30, P1038, DOI 10.1523/JNEUROSCI.4661-09.2010; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rivera J, 2007, EUR J NEUROSCI, V25, P136, DOI 10.1111/j.1460-9568.2006.05277.x; Rivera JF, 2005, EUR J NEUROSCI, V22, P1853, DOI 10.1111/j.1460-9568.2005.04384.x; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Savvaki M, 2008, MOL CELL NEUROSCI, V39, P478, DOI 10.1016/j.mcn.2008.07.025; Savvaki M, 2010, J NEUROSCI, V30, P13943, DOI 10.1523/JNEUROSCI.2574-10.2010; Schaeren-Wiemers N, 2004, J CELL BIOL, V166, P731, DOI 10.1083/jcb.200406092; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Susuki K, 2008, CURR OPIN CELL BIOL, V20, P616, DOI 10.1016/j.ceb.2008.09.007; Tanaka H, 2009, J NEUROSCI, V29, P8363, DOI 10.1523/JNEUROSCI.3216-08.2009; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Traka M, 2002, J NEUROSCI, V22, P3016, DOI 10.1523/JNEUROSCI.22-08-03016.2002; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Waxman SG, 2002, ARCH NEUROL-CHICAGO, V59, P1377, DOI 10.1001/archneur.59.9.1377; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Xu MX, 2010, J NEUROSCI, V30, P15987, DOI 10.1523/JNEUROSCI.3565-10.2010; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Zhou L, 1998, J NEUROSCI, V18, P7200	66	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25835	25847		10.1074/jbc.M111.219113	http://dx.doi.org/10.1074/jbc.M111.219113			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21602278	Green Published, hybrid			2022-12-27	WOS:000293073000045
J	Alhashem, YN; Vinjamur, DS; Basu, M; Klingmuller, U; Gaensler, KML; Lloyd, JA				Alhashem, Yousef N.; Vinjamur, Divya S.; Basu, Mohua; Klingmueller, Ursula; Gaensler, Karin M. L.; Lloyd, Joyce A.			Transcription Factors KLF1 and KLF2 Positively Regulate Embryonic and Fetal beta-Globin Genes through Direct Promoter Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTORS; FACTOR EKLF; PRIMITIVE ERYTHROPOIESIS; TRANSGENIC MICE; STEM-CELLS; IN-VIVO; ERYTHROID-DIFFERENTIATION; DEVELOPMENTAL REGULATION; YOLK-SAC; LOCUS	Kruppel-like factors (KLFs) control cell differentiation and embryonic development. KLF1 (erythroid Kruppel-like factor) plays essential roles in embryonic and adult erythropoiesis. KLF2 is a positive regulator of the mouse and human embryonic beta-globin genes. KLF1 and KLF2 have highly homologous zinc finger DNA-binding domains. They have overlapping roles in embryonic erythropoiesis, as demonstrated using single and double KO mouse models. Ablation of the KLF1 or KLF2 gene causes embryonic lethality, but double KO embryos are more anemic and die sooner than either single KO. In this work, a dual human beta-globin locus transgenic and KLF knockout mouse model was used. The results demonstrate that the human epsilon-(embryonic) and gamma-globin (fetal) genes are positively regulated by KLF1 and KLF2 in embryos. Conditional KO mouse experiments indicate that the effect of KLF2 on embryonic globin gene regulation is at least partly erythroid cell-autonomous. KLF1 and KLF2 bind directly to the promoters of the human epsilon- and gamma-globin genes, the mouse embryonic Ey- and beta h1-globin genes, and also to the beta-globin locus control region, as demonstrated by ChIP assays with mouse embryonic blood cells. H3K9Ac and H3K4me3 marks indicate open chromatin and active transcription, respectively. These marks are diminished at the Ey-, beta h1-, epsilon- and gamma-globin genes and locus control region in KLF1(-/-) embryos, correlating with reduced gene expression. Therefore, KLF1 and KLF2 positively regulate the embryonic and fetal beta-globin genes through direct promoter binding. KLF1 is required for normal histone modifications in the beta-globin locus in mouse embryos.	[Alhashem, Yousef N.; Vinjamur, Divya S.; Basu, Mohua; Lloyd, Joyce A.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Lloyd, Joyce A.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Klingmueller, Ursula] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Gaensler, Karin M. L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Virginia Commonwealth University; Virginia Commonwealth University; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Francisco	Lloyd, JA (corresponding author), 401 Coll St,POB 980035, Richmond, VA 23298 USA.	jlloyd@vcu.edu	Klingmüller, Ursula/G-8477-2013	Klingmüller, Ursula/0000-0001-9845-3099; Alhashem, Yousef N./0000-0003-4435-3003; Vinjamur, Divya/0000-0002-9369-0412	National Institutes of Health [R01 DK074694]; Ministry of Higher Education, Saudi Arabia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Higher Education, Saudi Arabia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK074694 (to J. A. L.). This work was also supported by the Ministry of Higher Education, Saudi Arabia (to Y. N. A.).	Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Baron MH, 2005, CURR OPIN HEMATOL, V12, P217, DOI 10.1097/01.moh.0000163217.14462.58; Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bottardi S, 2006, EMBO J, V25, P3586, DOI 10.1038/sj.emboj.7601232; BROTHERTON TW, 1979, P NATL ACAD SCI USA, V76, P2853, DOI 10.1073/pnas.76.6.2853; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Fang XD, 2009, J MOL BIOL, V394, P197, DOI 10.1016/j.jmb.2009.09.046; FRASER P, 1990, NUCLEIC ACIDS RES, V18, P3503, DOI 10.1093/nar/18.12.3503; Fraser ST, 2007, BLOOD, V109, P343, DOI 10.1182/blood-2006-03-006569; Fromm G, 2009, BLOOD, V114, P3479, DOI 10.1182/blood-2009-03-210690; Fromm G, 2009, BIOCHEM CELL BIOL, V87, P781, DOI 10.1139/O09-048; Fujiwara Y, 2004, BLOOD, V103, P583, DOI 10.1182/blood-2003-08-2870; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hosey AM, 2010, EPIGENETICS-US, V5, P273, DOI 10.4161/epi.5.4.11522; Hosoya-Ohmura S, 2006, J BIOL CHEM, V281, P32820, DOI 10.1074/jbc.M605735200; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Isern J, 2010, BLOOD, V116, P3972, DOI 10.1182/blood-2010-04-281196; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kiefer CM, 2008, MUTAT RES-FUND MOL M, V647, P68, DOI 10.1016/j.mrfmmm.2008.07.014; Kim A, 2007, NUCLEIC ACIDS RES, V35, P5831, DOI 10.1093/nar/gkm620; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; LLOYD JA, 1989, NUCLEIC ACIDS RES, V17, P4339, DOI 10.1093/nar/17.11.4339; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012; Muntean AG, 2005, BLOOD, V106, P1223, DOI 10.1182/blood-2005-02-0551; Noordermeer D, 2008, IUBMB LIFE, V60, P824, DOI 10.1002/iub.129; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; Satta S, 2011, HAEMATOL-HEMATOL J, V96, P767, DOI 10.3324/haematol.2010.037333; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sengupta T, 2008, MOL CELL BIOL, V28, P6160, DOI 10.1128/MCB.00919-08; Siatecka M, 2010, P NATL ACAD SCI USA, V107, P15151, DOI 10.1073/pnas.1004996107; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhou DW, 2006, J BIOL CHEM, V281, P16052, DOI 10.1074/jbc.M601182200; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	56	32	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24819	24827		10.1074/jbc.M111.247536	http://dx.doi.org/10.1074/jbc.M111.247536			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610079	Green Published, hybrid			2022-12-27	WOS:000292547900032
J	Jiao, YX; Jalan-Sakrikar, N; Robison, AJ; Baucum, AJ; Bass, MA; Colbran, RJ				Jiao, Yuxia; Jalan-Sakrikar, Nidhi; Robison, A. J.; Baucum, Anthony J., II; Bass, Martha A.; Colbran, Roger J.			Characterization of a Central Ca2+/Calmodulin-dependent Protein Kinase II alpha/beta Binding Domain in Densin That Selectively Modulates Glutamate Receptor Subunit Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTOR; NR2B SUBUNIT; REGULATED INTERACTIONS; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; REPEAT PROTEIN; CAM KINASE; LOCALIZATION; BRAIN	The densin C-terminal domain can target Ca2+/calmodulin-dependent protein kinase II alpha (CaMKII alpha) in cells. Although the C-terminal domain selectively binds CaMKII alpha in vitro, full-length densin associates with CaMKII alpha or CaMKII beta in brain extracts and in transfected HEK293 cells. This interaction requires a second central CaMKII binding site, the densin-IN domain, and an "open" activated CaMKII conformation caused by Ca2+/calmodulin binding, autophosphorylation at Thr-286/287, or mutation of Thr-286/287 to Asp. Mutations in the densin-IN domain (L815E) or in the CaMKII alpha/beta catalytic domain (I205/206K) disrupt the interaction. The amino acid sequence of the densin-IN domain is similar to the CaMKII inhibitor protein, CaMKIIN, and a CaMKIIN peptide competitively blocks CaMKII binding to densin. CaMKII is inhibited by both CaMKIIN and the densin-IN domain, but the inhibition by densin is substrate-selective. Phosphorylation of a model peptide substrate, syntide-2, or of Ser-831 in AMPA receptor GluA1 subunits is fully inhibited by densin. However, CaMKII phosphorylation of Ser-1303 in NMDA receptor GluN2B subunits is not effectively inhibited by densin in vitro or in intact cells. Thus, densin can target multiple CaMKII isoforms to differentially modulate phosphorylation of physiologically relevant downstream targets.	[Jiao, Yuxia; Jalan-Sakrikar, Nidhi; Robison, A. J.; Baucum, Anthony J., II; Bass, Martha A.; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Colbran, RJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 702 Light Hall, Nashville, TN 37232 USA.	roger.colbran@vanderbilt.edu	Colbran, Roger/AAU-7708-2021; Robison, Alfred J/P-8521-2018; Baucum, Anthony/I-5109-2013; Jiao, Yuxia/H-3300-2019; Jalan-Sakrikar, Nidhi/S-8653-2019	Colbran, Roger/0000-0001-7401-8244; Robison, Alfred J/0000-0002-4150-9570; Baucum, Anthony/0000-0002-4756-9865; Jiao, Yuxia/0000-0002-8633-7047; Jalan-Sakrikar, Nidhi/0000-0001-6795-0121	National Institutes of Health [R01-MH063232, F32-MH068129, T32-MH065215]; American Heart Association [0815090E]; UNCF-Merck; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215, F31MH068129, R01MH063232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); UNCF-Merck(Merck & Company); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-MH063232 (to R. J. C.), F32-MH068129 (to A. J. R.), and T32-MH065215 (to A. J. B.). This work was also supported by American Heart Association Predoctoral Fellowship 0815090E (to N. J.-S.) and a UNCF-Merck postdoctoral fellowship (to A. J. B.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Apperson ML, 1996, J NEUROSCI, V16, P6839; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; BROCKE L, 1995, J NEUROSCI, V15, P6797; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Schulman H, 2004, J NEUROSCI, V24, P8399, DOI 10.1523/JNEUROSCI.3606-04.2004; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Thalhammer A, 2009, J NEUROCHEM, V109, P297, DOI 10.1111/j.1471-4159.2009.05951.x; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	46	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24806	24818		10.1074/jbc.M110.216010	http://dx.doi.org/10.1074/jbc.M110.216010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610080	Green Published, hybrid			2022-12-27	WOS:000292547900031
J	Musikacharoen, T; Bandow, K; Kakimoto, K; Kusuyama, J; Onishi, T; Yoshikai, Y; Matsuguchi, T				Musikacharoen, Tipayaratn; Bandow, Kenjiro; Kakimoto, Kyoko; Kusuyama, Joji; Onishi, Tomokazu; Yoshikai, Yasunobu; Matsuguchi, Tetsuya			Functional Involvement of Dual Specificity Phosphatase 16 (DUSP16), a c-Jun N-terminal Kinase-specific Phosphatase, in the Regulation of T Helper Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; HISTONE ACETYLATION; LINEAGE COMMITMENT; TH2 CELLS; IN-VIVO; EXPRESSION; PROTEIN; ACTIVATION; BET; INFLAMMATION	Naive CD4(+) Thelper (Th) cells differentiate into distinct subsets of effector cells (Th1, Th2, Th17, and induced regulatory T cells (iTreg)) expressing different sets of cytokines upon encounter with presented foreign antigens. It has been well established that Th1/Th2 balance is critical for the nature of the following immune responses. Previous reports have demonstrated important roles of c-Jun N-terminal kinase (JNK) in Th1/Th2 balance, whereas the regulatory mechanisms of JNK activity in Th cells have not been elucidated. Here, we show that dual specificity phosphatase 16 (DUSP16, also referred to as MKP-M or MKP-7), which preferentially inactivates JNK, is selectively expressed in Th2 cells. In the in vitro differentiation assay of naive CD4(+) cells, DUSP16 expression is up-regulated during Th2 differentiation and down-regulated during Th1 differentiation. Chromatin immunoprecipitation revealed the increased acetylation of histone H3/H4 at the dusp16 gene promoter in CD4(+) T cells under the Th2 condition. Adenoviral transduction of naive CD4(+) T cells with DUSP16 resulted in increased mRNA expression of IL-4 and GATA-3 in Th2 and decreased expression of IFN gamma and T-bet in Th1 differentiation. In contrast, transduction of a dominant negative form of DUSP16 had the reverse effects. Furthermore, upon immunization, T cell-specific dusp16 transgenic mice produced antigen-specific IgG2a at lower amounts, whereas DN dusp16 transgenic mice produced higher amounts of antigen-specific IgG2a accompanied by decreased amounts of antigen-specific IgG1 and IgE than those of control mice. Together, these data suggest the functional role of DUSP16 in Th1/Th2 balance.	[Musikacharoen, Tipayaratn; Bandow, Kenjiro; Kakimoto, Kyoko; Kusuyama, Joji; Onishi, Tomokazu; Matsuguchi, Tetsuya] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Biochem, Kagoshima 8908544, Japan; [Musikacharoen, Tipayaratn] Prince Songkla Univ, Fac Vet Sci, Hat Yai 90110, Thailand; [Yoshikai, Yasunobu] Kyushu Univ, Med Inst Bioregulat, Res Ctr Prevent Infect Dis, Fukuoka 8128582, Japan	Kagoshima University; Prince of Songkla University; Kyushu University	Matsuguchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Biochem, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	tmatsugu@dent.kagoshima-u.ac.jp	Musikacharoen, Tipayaratn/AAV-6514-2021; Matsuguchi, Tetsuya/HGU-0412-2022; Kusuyama, Joji/AAQ-7547-2020	Kusuyama, Joji/0000-0003-4054-1939; Bandow, Kenjiro/0000-0002-1362-3034	Ministry of Education, Science, and Culture of the Japanese Government	Ministry of Education, Science, and Culture of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from Ministry of Education, Science, and Culture of the Japanese Government.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Glimcher LH, 2000, GENE DEV, V14, P1693; Ishimitsu R, 2001, J IMMUNOL, V166, P1991, DOI 10.4049/jimmunol.166.3.1991; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; Matsuguchi T, 2001, MOL CELL BIOL, V21, P6999, DOI 10.1128/MCB.21.20.6999-7009.2001; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Musikacharoen T, 2003, J BIOL CHEM, V278, P9167, DOI 10.1074/jbc.M211829200; NAKAYAMA T, 1988, EUR J IMMUNOL, V18, P761, DOI 10.1002/eji.1830180516; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; REINER SL, 1994, J IMMUNOL METHODS, V173, P133, DOI 10.1016/0022-1759(94)90291-7; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rincon Mercedes, 1997, Genes and Function, V1, P51; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Strempel JM, 2007, J BIOL CHEM, V282, P3738, DOI 10.1074/jbc.M606615200; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Venkataraman C, 2000, J IMMUNOL, V165, P632, DOI 10.4049/jimmunol.165.2.632; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	35	17	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24896	24905		10.1074/jbc.M111.245019	http://dx.doi.org/10.1074/jbc.M111.245019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613215	hybrid, Green Published			2022-12-27	WOS:000292547900039
J	Tiwari, V; Liu, J; Valyi-Nagy, T; Shukla, D				Tiwari, Vaibhav; Liu, Jian; Valyi-Nagy, Tibor; Shukla, Deepak			Anti-heparan Sulfate Peptides That Block Herpes Simplex Virus Infection in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 ENTRY; HUMAN CYTOMEGALOVIRUS; PHAGE DISPLAY; HSV-1 ENTRY; BINDING; CELLS; RECEPTOR; SPREAD; PROTEOGLYCANS; ACTIVATION	Heparan sulfate (HS) and its highly modified form, 3-O-sulfated heparan sulfate (3-OS HS), contribute strongly to herpes simplex virus type-1 (HSV-1) infection in vitro. Here we report results from a random M13-phage display library screening to isolate 12-mer peptides that bind specifically to HS, 3-OS HS, and block HSV-1 entry. The screening identified representative candidates from two-different groups of anti-HS peptides with high positive charge densities. Group 1, represented by G1 peptide (LRSRTKIIRIRH), belongs to a class with alternating charges (XRXRXKXXRXRX), and group 2, represented by G2 peptide (MPRRRRIRRRQK), shows repetitive charges (XXR-RRRXRRRXK). Viral entry and glycoprotein D binding assays together with fluorescent microscopy data indicated that both G1 and G2 were potent in blocking HSV-1 entry into primary cultures of human corneal fibroblasts and CHO-K1 cells transiently expressing different glycoprotein D receptors. Interestingly, G2 peptide isolated against 3-OS HS displayed wider ability to inhibit entry of clinically relevant strains of HSV-1 and some divergent members of herpesvirus family including cytomegalovirus and human herpesvirus-8. To identify functional residues within G1 and G2, we performed point mutations and alanine-scanning mutagenesis. Several arginine and a lysine residues were needed for anti-HSV-1 activity, suggesting the importance of the positively charged residues in virus-cell binding and virus-induced membrane fusion. In vivo administration of G1 or G2 peptide as a prophylactic eye drop completely blocked HSV-1 spread in the mouse cornea as evident by immunohistochemistry. This result also highlights an in vivo significance of HS and 3-OS HS during ocular herpes infection.	[Tiwari, Vaibhav; Shukla, Deepak] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; [Shukla, Deepak] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Valyi-Nagy, Tibor] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA; [Tiwari, Vaibhav] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Dept Basic Med Sci, Pomona, CA 91766 USA; [Liu, Jian] Univ N Carolina, Coll Pharm, Dept Med Chem, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Western University of Health Sciences; University of North Carolina; University of North Carolina Chapel Hill	Shukla, D (corresponding author), 1855 W Taylor St,M-C 648, Chicago, IL 60612 USA.	dshukla@uic.edu		Shukla, Deepak/0000-0002-3039-6953	National Institutes of Health [RO1 AI057860, AI050050]; Glaucoma Foundation;  [EY001792]; NATIONAL EYE INSTITUTE [P30EY001792] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050, R01AI057860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI057860 (to D.S.) and AI050050 (to J.L.) and Core Grant EY001792 (to the University of Illinois at Chicago). Part of this work was made possible by an award from the Glaucoma Foundation (to D.S.).	Akhtar J, 2008, INVEST OPHTH VIS SCI, V49, P4026, DOI 10.1167/iovs.08-1807; Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Baleux F, 2009, NAT CHEM BIOL, V5, P743, DOI 10.1038/nchembio.207; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Copeland R, 2008, BIOCHEMISTRY-US, V47, P5774, DOI 10.1021/bi800205t; De Witte L, 2007, IMMUNOBIOLOGY, V212, P679, DOI 10.1016/j.imbio.2007.09.006; DEAN HJ, 1994, VIROLOGY, V199, P67, DOI 10.1006/viro.1994.1098; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Donalisio M, 2010, ANTIMICROB AGENTS CH, V54, P4290, DOI 10.1128/AAC.00471-10; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Liesegang TJ, 2001, CORNEA, V20, P1, DOI 10.1097/00003226-200101000-00001; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Luganini A, 2010, ANTIVIR RES, V85, P532, DOI 10.1016/j.antiviral.2010.01.003; LYCKE E, 1991, J GEN VIROL, V72, P1131, DOI 10.1099/0022-1317-72-5-1131; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Mullen LM, 2006, TRENDS MICROBIOL, V14, P141, DOI 10.1016/j.tim.2006.01.006; O'Donnell CD, 2006, VIROLOGY, V346, P452, DOI 10.1016/j.virol.2005.11.003; O'Donnell CD, 2010, VIROLOGY, V397, P389, DOI 10.1016/j.virol.2009.11.011; O'Donnell CD, 2009, J BIOL CHEM, V284, P29654, DOI 10.1074/jbc.M109.037960; O'Nuallain B, 2007, BIOCHEMISTRY-US, V46, P13049, DOI 10.1021/bi701255m; Oh MJ, 2010, BIOCHEM BIOPH RES CO, V391, P176, DOI 10.1016/j.bbrc.2009.11.027; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Tiwari V, 2005, BIOCHEM BIOPH RES CO, V338, P930, DOI 10.1016/j.bbrc.2005.10.056; Tiwari V, 2004, J GEN VIROL, V85, P805, DOI 10.1099/vir.0.19641-0; Tiwari V, 2008, FEBS J, V275, P5272, DOI 10.1111/j.1742-4658.2008.06655.x; Tiwari V, 2007, FEBS LETT, V581, P4468, DOI 10.1016/j.febslet.2007.08.029; Tiwari V, 2007, J GEN VIROL, V88, P1075, DOI 10.1099/vir.0.82476-0; Tiwari V, 2006, J VIROL, V80, P8970, DOI 10.1128/JVI.00296-06; Tiwari V, 2009, BIOCHEM BIOPH RES CO, V390, P382, DOI 10.1016/j.bbrc.2009.08.174; Trybala E, 2002, VIROLOGY, V302, P413, DOI 10.1006/viro.2002.1639; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Xu D, 2005, BIOCHEM J, V385, P451, DOI 10.1042/BJ20040908; Zhang ZZ, 2010, VIROLOGY, V406, P280, DOI 10.1016/j.virol.2010.07.030	43	79	86	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25406	25415		10.1074/jbc.M110.201103	http://dx.doi.org/10.1074/jbc.M110.201103			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596749	Green Published, hybrid			2022-12-27	WOS:000292547900086
J	Zaiss, AK; Lawrence, R; Elashoff, D; Esko, JD; Herschman, HR				Zaiss, Anne K.; Lawrence, Roger; Elashoff, David; Esko, Jeffrey D.; Herschman, Harvey R.			Differential Effects of Murine and Human Factor X on Adenovirus Transduction via Cell-surface Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; IN-VIVO; COAGULATION-FACTORS; BINDING-PROPERTIES; GENE-TRANSFER; LIVER; HEXON; PROTEOGLYCANS; INFECTION; RECEPTOR	Serum coagulation factor X (FX) is proposed to play a major role in adenovirus tropism, promoting transduction by bridging the virus to cell-surface heparan sulfate proteoglycans (HSPGs). Both murine FX and human FX increased transduction by Ad. CMVfLuc, an adenovirus vector, in murine hepatocyte-like cells and human hepatocarcinoma cells. In contrast, only hFX increased transduction of several non-hepatic cancer cell lines and Chinese hamster ovary (CHO) cells. Not only was mFX unable to promote transduction in these cells, it competitively blocked hFX-enhanced transduction. Competition and HSPG digestion experiments suggested mFX- and hFX-enhanced transduction in hepatocyte-derived cells, and hFX-enhanced transduction in epithelial cancer cells were dependent on HSPGs. Ad.hFX-mediated transduction of CHO mutants unable to produce HSPGs was also curtailed. Hepatocyte-derived cells expressed substantially more HSPGs than the cancer cell lines. Dose-response curves and heparin-Sepharose binding suggested Ad.hFX has greater affinity for HSPGs than does Ad.mFX. In coagulation factor-depleted mice hFX also had enhanced ability, compared with mFX, to reconstitute hepatic adenovirus transduction. The results suggest that differences in Ad.hFX and Ad.mFX affinity to HSPGs may result in differences in their ability to enhance adenovirus transduction of many cells. These findings may have implications for murine models of adenovirus vector targeting.	[Zaiss, Anne K.; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zaiss, Anne K.; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; [Elashoff, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Lawrence, Roger; Esko, Jeffrey D.] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego	Herschman, HR (corresponding author), 611 Charles E Young Dr E,341 MBI, Los Angeles, CA 90095 USA.	hherschman@mednet.ucla.edu			National Institutes of Health [P50 CA086306-08, HL57345, GM33063]; UCLA In Vivo Cellular and Molecular Imaging Center; NATIONAL CANCER INSTITUTE [P50CA086306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063, R01GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA In Vivo Cellular and Molecular Imaging Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA086306-08 (to H. R. H.) and HL57345 and GM33063 (to J. D. E.).; Recipient of a UCLA In Vivo Cellular and Molecular Imaging Center Career Development Award.	Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Gimenez-Alejandre M, 2008, HUM GENE THER, V19, P1415, DOI [10.1089/hum.2008.053, 10.1089/hgt.2008.053]; JI ZS, 1994, ARTERIOSCLER THROMB, V14, P2025, DOI 10.1161/01.ATV.14.12.2025; Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Liang QW, 2004, MOL IMAGING BIOL, V6, P395, DOI 10.1016/j.mibio.2004.09.002; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; Noureddini SC, 2005, MOL PHARMACEUT, V2, P341, DOI 10.1021/mp050045c; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Perabo L, 2006, J VIROL, V80, P7265, DOI 10.1128/JVI.00076-06; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Short JJ, 2010, MOL CANCER THER, V9, P2536, DOI 10.1158/1535-7163.MCT-10-0332; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tatrai P, 2010, J HISTOCHEM CYTOCHEM, V58, P429, DOI 10.1369/jhc.2010.955161; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9; ZOU S, 1992, COMP BIOCHEM PHYS B, V103, P889, DOI 10.1016/0305-0491(92)90210-I	34	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24535	24543		10.1074/jbc.M111.241562	http://dx.doi.org/10.1074/jbc.M111.241562			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596747	Green Published, hybrid			2022-12-27	WOS:000292547900003
J	Banerjee, D; Das, S; Molina, SA; Madgwick, D; Katz, MR; Jena, S; Bossmann, LK; Pal, D; Takemoto, DJ				Banerjee, Debarshi; Das, Satyabrata; Molina, Samuel A.; Madgwick, Dan; Katz, Melanie R.; Jena, Snehalata; Bossmann, Leonie K.; Pal, Debjani; Takemoto, Dolores J.			Investigation of the Reciprocal Relationship between the Expression of Two Gap Junction Connexin Proteins, Connexin46 and Connexin43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-CELL COMMUNICATION; INTERCELLULAR COMMUNICATION; DOWN-REGULATION; LIFE-CYCLE; PLASMA-MEMBRANE; GROWTH-CONTROL; PHORBOL-ESTER; BREAST-CANCER; LENS; PHOSPHORYLATION	Connexins are the transmembrane proteins that form gap junctions between adjacent cells. The function of the diverse connexin molecules is related to their tissue-specific expression and highly dynamic turnover. Although multiple connexins have been previously reported to compensate for each other's functions, little is known about how connexins influence their own expression or intracellular regulation. Of the three vertebrate lens connexins, two connexins, connexin43 (Cx43) and connexin46 (Cx46), show reciprocal expression and subsequent function in the lens and in lens cell culture. In this study, we investigate the reciprocal relationship between the expression of Cx43 and Cx46. Forced depletion of Cx43, by tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate, is associated with an up-regulation of Cx46 at both the protein and message level in human lens epithelial cells. An siRNA-mediated down-regulation of Cx43 results in an increase in the level of Cx46 protein, suggesting endogenous Cx43 is involved in the regulation of endogenous Cx46 turnover. Overexpression of Cx46, in turn, induces the depletion of Cx43 in rabbit lens epithelial cells. Cx46-induced Cx43 degradation is likely mediated by the ubiquitin-proteasome pathway, as (i) treatment with proteasome inhibitors restores the Cx43 protein level and (ii) there is an increase in Cx43 ubiquitin conjugation in Cx46-overexpressing cells. We also present data that shows that the C-terminal intracellular tail domain of Cx46 is essential to induce degradation of Cx43. Therefore, our study shows that Cx43 and Cx46 have novel functions in regulating each other's expression and turnover in a reciprocal manner in addition to their conventional roles as gap junction proteins in lens cells.	[Banerjee, Debarshi; Das, Satyabrata; Molina, Samuel A.; Madgwick, Dan; Katz, Melanie R.; Jena, Snehalata; Bossmann, Leonie K.; Pal, Debjani; Takemoto, Dolores J.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Molina, SA (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	smolina@ksu.edu	Das, Satyabrata/J-2629-2019; Molina, Samuel/I-5555-2015; banerjee, debarshi/AAF-5704-2020; PAL, DEBJANI/AAB-6284-2020	Molina, Samuel/0000-0002-5861-3390; PAL, DEBJANI/0000-0002-3030-2590	National Institutes of Health [EY13421]; NIH K-INBRE [P20RR016475]; Terry C. Johnson Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH K-INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY13421 (to D. J. T.) and NIH K-INBRE Grant P20RR016475 (to D. M.). This work was also supported by Terry C. Johnson Cancer Center Innovative Research Grant (to D. J. T.) and Terry C. Johnson Cancer Center Summer Stipend (to D. B. and S. D.).	Akoyev V, 2007, CELL SIGNAL, V19, P958, DOI 10.1016/j.cellsig.2006.11.007; Akoyev V, 2009, INVEST OPHTH VIS SCI, V50, P1271, DOI 10.1167/iovs.08-2599; Avanzo JL, 2006, LIFE SCI, V79, P2202, DOI 10.1016/j.lfs.2006.07.033; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; BEYER EC, 1989, J CELL BIOL, V108, P595, DOI 10.1083/jcb.108.2.595; BRISSETTE JL, 1991, MOL CELL BIOL, V11, P5364, DOI 10.1128/MCB.11.10.5364; Burr DB, 2011, EXP EYE RES, V92, P251, DOI 10.1016/j.exer.2011.02.003; Dahm R, 1999, EXP EYE RES, V69, P45, DOI 10.1006/exer.1999.0670; Das S, 2011, CURR EYE RES, V36, P620, DOI 10.3109/02713683.2011.573899; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Herve JC, 2007, J MEMBRANE BIOL, V217, P21, DOI 10.1007/s00232-007-9054-8; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Hombach S, 2004, EUR J NEUROSCI, V19, P2633, DOI 10.1111/j.0953-816X.2004.03360.x; Kanczuga-Koda L, 2005, ONCOL REP, V14, P325; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Koval M, 1997, J CELL BIOL, V137, P847, DOI 10.1083/jcb.137.4.847; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2007, J MEMBRANE BIOL, V217, P43, DOI 10.1007/s00232-007-9050-z; Li GY, 1998, GENE, V209, P139, DOI 10.1016/S0378-1119(98)00039-0; Loewenstein W R, 1980, Ann N Y Acad Sci, V339, P39, DOI 10.1111/j.1749-6632.1980.tb15966.x; MATESIC DF, 1994, MOL CARCINOGEN, V10, P226, DOI 10.1002/mc.2940100407; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Paemeleire K, 2000, MOL BIOL CELL, V11, P1815, DOI 10.1091/mbc.11.5.1815; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; RIVEDAL E, 1994, CARCINOGENESIS, V15, P689, DOI 10.1093/carcin/15.4.689; Rong P, 2002, DEVELOPMENT, V129, P167; Salameh A, 2006, ADV CARDIOL, V42, P57, DOI 10.1159/000092562; Shao Q, 2005, CANCER RES, V65, P2705, DOI 10.1158/0008-5472.CAN-04-2367; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; TENBROEK EM, 1994, INVEST OPHTH VIS SCI, V35, P215; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WHITE TW, 1994, J CELL BIOL, V125, P879, DOI 10.1083/jcb.125.4.879; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; Zampighi GA, 2005, INVEST OPHTH VIS SCI, V46, P3247, DOI 10.1167/iovs.04-1504	52	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24519	24533		10.1074/jbc.M110.217208	http://dx.doi.org/10.1074/jbc.M110.217208			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606502	Green Published, hybrid			2022-12-27	WOS:000292294900092
J	Fortini, BK; Pokharel, S; Polaczek, P; Balakrishnan, L; Bambara, RA; Campbell, JL				Fortini, Barbara K.; Pokharel, Subhash; Polaczek, Piotr; Balakrishnan, Lata; Bambara, Robert A.; Campbell, Judith L.			Characterization of the Endonuclease and ATP-dependent Flap Endo/Exonuclease of Dna2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; REPLICATION-PROTEIN-A; END RESECTION MACHINERIES; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; ENZYMATIC-PROPERTIES; ESCHERICHIA-COLI; POLYMERASE ALPHA; XENOPUS DNA2; IN-VIVO	Two processes, DNA replication and DNA damage repair, are key to maintaining genomic fidelity. The Dna2 enzyme lies at the heart of both of these processes, acting in conjunction with flap endonuclease 1 and replication protein A in DNA lagging strand replication and with BLM/Sgs1 and MRN/X in double strand break repair. In vitro, Dna2 helicase and flap endo/exonuclease activities require an unblocked 5' single-stranded DNA end to unwind or cleave DNA. In this study we characterize a Dna2 nuclease activity that does not require, and in fact can create, 5' single-stranded DNA ends. Both endonuclease and flap endo/exonuclease are abolished by the Dna2-K677R mutation, implicating the same active site in catalysis. In addition, we define a novel ATP-dependent flap endo/exonuclease activity, which is observed only in the presence of Mn2+. The endonuclease is blocked by ATP and is thus experimentally distinguishable from the flap endo/exonuclease function. Thus, Dna2 activities resemble those of RecB and AddAB nucleases even more closely than previously appreciated. This work has important implications for understanding the mechanism of action of Dna2 in multiprotein complexes, where dissection of enzymatic activities and cofactor requirements of individual components contributing to orderly and precise execution of multistep replication/repair processes depends on detailed characterization of each individual activity.	[Balakrishnan, Lata; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Fortini, Barbara K.; Pokharel, Subhash; Polaczek, Piotr; Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu; jcampbel@caltech.edu		Fortini, Barbara/0000-0003-3230-2604	National Institutes of Health [GM024441, GM078666]; Army Research Office [ARO 09-1-0041]; Ellison Foundation [AG-55-2143]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078666, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; Ellison Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024441 (to R. A. B.) and GM078666 (to J. L. C.). This work was also supported by Army Research Office Grant ARO 09-1-0041 and Ellison Foundation Grant AG-55-2143 (to J. L. C.).	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Balakrishnan L, 2010, J BIOL CHEM, V285, P38861, DOI 10.1074/jbc.M110.165191; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Formosa T, 1999, GENETICS, V151, P1459; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; KOOISTRA J, 1993, MOL MICROBIOL, V7, P915, DOI 10.1111/j.1365-2958.1993.tb01182.x; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Niu HY, 2009, GENE DEV, V23, P1481, DOI 10.1101/gad.1824209; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Sun JZ, 2006, BIOCHEMISTRY-US, V45, P131, DOI 10.1021/bi051150v; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Wawrousek KE, 2010, CELL CYCLE, V9, P1156, DOI 10.4161/cc.9.6.11049; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	48	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23763	23770		10.1074/jbc.M111.243071	http://dx.doi.org/10.1074/jbc.M111.243071			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572043	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000292294900018
J	Li, PF; Ham, BK; Lucas, WJ				Li, Pingfang; Ham, Byung-Kook; Lucas, William J.			CmRBP50 Protein Phosphorylation Is Essential for Assembly of a Stable Phloem-mobile High-affinity Ribonucleoprotein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; LONG-DISTANCE TRANSPORT; TRACT BINDING-PROTEIN; YELLOW-MOSAIC-VIRUS; SIGNALING PATHWAY; 7SK SNRNA; IN-VIVO; PLANTS; MOVEMENT; LOCALIZATION	RNA-binding proteins (RBPs) form ribonucleoprotein (RNP) complexes that play crucial roles in RNA processing for gene regulation. The angiosperm sieve tube system contains a unique population of transcripts, some of which function as long-distance signaling agents involved in regulating organ development. These phloem-mobile mRNAs are translocated as RNP complexes. One such complex is based on a phloem RBP named Cucurbita maxima RNA-binding protein 50 (CmRBP50), a member of the polypyrimidine track binding protein family. The core of this RNP complex contains six additional phloem proteins. Here, requirements for assembly of this CmRBP50 RNP complex are reported. Phosphorylation sites on CmRBP50 were mapped, and then coimmunoprecipitation and protein overlay studies established that the phosphoserine residues, located at the C terminus of CmRBP50, are critical for RNP complex assembly. In vitro pull-down experiments revealed that three phloem proteins, C. maxima phloem protein 16, C. maxima GTP-binding protein, and C. maxima phosphoinositide-specific phospholipase-like protein, bind directly with CmRBP50. This interaction required CmRBP50 phosphorylation. Gel mobility-shift assays demonstrated that assembly of the CmRBP50-based protein complex results in a system having enhanced binding affinity for phloem-mobile mRNAs carrying polypyrimidine track binding motifs. This property would be essential for effective long-distance translocation of bound mRNA to the target tissues.	[Li, Pingfang; Ham, Byung-Kook; Lucas, William J.] Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA; [Li, Pingfang] Zhejiang Univ, Dept Hort, Hangzhou 310029, Zhejiang, Peoples R China	University of California System; University of California Davis; Zhejiang University	Lucas, WJ (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA.	wjlucas@ucdavis.edu	Ham, Byung-Kook/AAU-7771-2020		National Science Foundation [IOS-0752997, IOS-0918433]; Chinese Scholarship Council	National Science Foundation(National Science Foundation (NSF)); Chinese Scholarship Council(China Scholarship Council)	This work was supported by National Science Foundation grants IOS-0752997 and IOS-0918433 (to W. J. L.). P. L. was supported in part by a graduate fellowship from the Chinese Scholarship Council.	Allemand E, 2007, NAT STRUCT MOL BIOL, V14, P630, DOI 10.1038/nsmb1257; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aoki K, 2005, PLANT CELL, V17, P1801, DOI 10.1105/tpc.105.031419; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Banerjee AK, 2006, PLANT CELL, V18, P3443, DOI 10.1105/tpc.106.042473; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Buhtz A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-64; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Czudnochowski N, 2010, J MOL BIOL, V395, P28, DOI 10.1016/j.jmb.2009.10.055; D'Orso I, 2001, J BIOL CHEM, V276, P15783, DOI 10.1074/jbc.M010959200; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Gomez G, 2005, PLANT J, V41, P107, DOI 10.1111/j.1365-313X.2004.02278.x; Gomez G, 2004, J VIROL, V78, P10104, DOI 10.1128/JVI.78.18.10104-10110.2004; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Ham BK, 2009, PLANT CELL, V21, P197, DOI 10.1105/tpc.108.061317; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Hsu CH, 2004, J ALLERGY CLIN IMMUN, V113, P1079, DOI 10.1016/j.jaci.2004.02.047; Ishmael FT, 2011, J IMMUNOL, V186, P1189, DOI 10.4049/jimmunol.1001794; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kehr J, 2008, J EXP BOT, V59, P85, DOI 10.1093/jxb/erm176; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Lee JY, 2003, SCIENCE, V299, P392, DOI 10.1126/science.1077813; Lin MK, 2009, MOL CELL PROTEOMICS, V8, P343, DOI 10.1074/mcp.M800420-MCP200; Lin SS, 2002, BOT BULL ACAD SINICA, V43, P261; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Lucas WJ, 2001, NAT REV MOL CELL BIO, V2, P849, DOI 10.1038/35099096; Ma Y, 2010, PLANT J, V64, P536, DOI 10.1111/j.1365-313X.2010.04347.x; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Shav-Tal Y, 2005, J CELL SCI, V118, P4077, DOI 10.1242/jcs.02543; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Taoka K, 2007, PLANT CELL, V19, P1866, DOI 10.1105/tpc.107.052522; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x; van Bel AJE, 2002, TRENDS PLANT SCI, V7, P126, DOI 10.1016/S1360-1385(01)02225-7; Wang C, 2004, EMBO J, V23, P1857, DOI 10.1038/sj.emboj.7600181; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767	47	30	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23142	23149		10.1074/jbc.M111.244129	http://dx.doi.org/10.1074/jbc.M111.244129			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21572046	Green Published, hybrid			2022-12-27	WOS:000292025000048
J	Allsopp, RC; El Ajouz, S; Schmid, R; Evans, RJ				Allsopp, Rebecca C.; El Ajouz, Sam; Schmid, Ralf; Evans, Richard J.			Cysteine Scanning Mutagenesis (Residues Glu(52)-Gly(96)) of the Human P2X1 Receptor for ATP MAPPING AGONIST BINDING AND CHANNEL GATING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P2X(1) RECEPTORS; SUBSTITUTION MUTANTS; AMINO-ACIDS; ION-CHANNEL; IDENTIFICATION; SITE; RECOGNITION; ANTAGONIST; LIGAND; ERRORS	P2X receptors are ATP-gated cation channels. The x-ray structure of a P2X4 receptor provided a major advance in understanding the molecular basis of receptor properties. However, how agonists are coordinated, the extent of the binding site, and the contribution of the vestibules in the extracellular domain to ionic permeation have not been addressed. We have used cysteine-scanning mutagenesis to determine the contribution of residues Glu(52)-Gly(96) to human P2X1 receptor properties. ATP potency was reduced for the mutants K68C, K70C, and F92C. The efficacy of the partial agonist BzATP was also reduced for several mutants forming the back of the proposed agonist binding site. Molecular docking in silico of both ATP and BzATP provided models of the agonist binding site consistent with these data. Individual cysteine mutants had no effect or slightly increased antagonism by suramin or pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate. Mutants at the entrance to and lining the upper vestibule were unaffected by cysteine-reactive methanethiosulfonate (MTS) reagents, suggesting that it does not contribute to ionic permeation. Mutants that were sensitive to modification by MTS reagents were predominantly found either around the proposed ATP binding pocket or on the strands connecting the binding pocket to the transmembrane region and lining the central vestibule. In particular, ATP sensitivity and currents were increased by a positively charged MTS reagent at the G60C mutant at the interface between the central and extracellular vestibule. This suggests that dilation of the base of the central vestibule contributes to gating of the receptor.	[Allsopp, Rebecca C.; El Ajouz, Sam; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk	Schmid, Ralf/ABE-1065-2020; Schmid, Ralf/E-6722-2011	Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023	Wellcome Trust; British Heart Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was supported by the Wellcome Trust and the British Heart Foundation.	Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Digby HR, 2005, J NEUROCHEM, V95, P1746, DOI 10.1111/j.1471-4159.2005.03494.x; DUNN PM, 1988, BRIT J PHARMACOL, V93, P243, DOI 10.1111/j.1476-5381.1988.tb11427.x; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; LAMBRECHT G, 1992, EUR J PHARMACOL, V217, P217, DOI 10.1016/0014-2999(92)90877-7; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Marquez-Klaka B, 2009, EUR BIOPHYS J BIOPHY, V38, P329, DOI 10.1007/s00249-008-0325-9; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; RALEVIC V, 1995, J PHYSIOL-LONDON, V483, P703, DOI 10.1113/jphysiol.1995.sp020615; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Roberts JA, 2009, J NEUROCHEM, V109, P1042, DOI 10.1111/j.1471-4159.2009.06035.x; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wolf C, 2011, MOL PHARMACOL, V79, P649, DOI 10.1124/mol.110.068700; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x	37	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29207	29217		10.1074/jbc.M111.260364	http://dx.doi.org/10.1074/jbc.M111.260364			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21690089	hybrid, Green Published			2022-12-27	WOS:000293837000056
J	Buhrmann, C; Mobasheri, A; Busch, F; Aldinger, C; Stahlmann, R; Montaseri, A; Shakibaei, M				Buhrmann, Constanze; Mobasheri, Ali; Busch, Franziska; Aldinger, Constance; Stahlmann, Ralf; Montaseri, Azadeh; Shakibaei, Mehdi			Curcumin Modulates Nuclear Factor kappa B (NF-kappa B)-mediated Inflammation in Human Tenocytes in Vitro ROLE OF THE PHOSPHATIDYLINOSITOL 3-KINASE/Akt PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN TENDON CELLS; HUMAN ARTICULAR CHONDROCYTES; PROTEIN-KINASE KINASE; ROTATOR CUFF DISEASES; I CLINICAL-TRIAL; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; CHEMOPREVENTIVE AGENT; TRANSCRIPTION FACTOR	Inflammatory processes play essential roles in the pathogenesis of tendinitis and tendinopathy. These events are accompanied by catabolic processes initiated by pro-inflammatory cytokines such as interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha). Pharmacological treatments for tendinitis are restricted to the use of non-steroidal anti-inflammatory drugs. Recent studies in various cell models have demonstrated that curcumin targets the NF-kappa B signaling pathway. However, its potential for the treatment of tendinitis has not been explored. Herein, we used an in vitro model of human tenocytes to study the mechanism of curcumin action on IL-1 beta-mediated inflammatory signaling. Curcumin at concentrations of 5-20 mu M inhibited IL-1 beta-induced inflammation and apoptosis in cultures of human tenocytes. The anti-inflammatory effects of curcumin included down-regulation of gene products that mediate matrix degradation (matrix metalloproteinase-1, -9, and -13), prostanoid production (cyclooxygenase-2), apoptosis (Bax and activated caspase-3), and stimulation of cell survival (Bcl-2), all known to be regulated by NF-kappa B. Furthermore, curcumin suppressed IL-1 beta-induced NF-kappa B activation via inhibition of phosphorylation and degradation of inhibitor of kappa B alpha, inhibition of inhibitor of kappa B-kinase activity, and inhibition of nuclear translocation of NF-kappa B. Furthermore, the effects of IL-1 beta were abrogated by wortmannin, suggesting a role for the phosphatidylinositol 3-kinase (PI-3K) pathway in IL-1 beta signaling. Curcumin suppressed IL-1 beta-induced PI-3K p85/Akt activation and its association with IKK. These results demonstrate, for the first time, a potential role for curcumin in treating tendon inflammation through modulation of NF-kappa B signaling, which involves PI-3K/Akt and the tendon-specific transcription factor scleraxis in tenocytes.	[Shakibaei, Mehdi] Univ Munich, Inst Anat, Musculoskeletal Res Grp, D-80336 Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Musculoskeletal Res Grp,Div Vet Med, Loughborough LE12 5RD, England; [Stahlmann, Ralf] Charite, Inst Clin Pharmacol & Toxicol, D-14195 Berlin, Germany; [Montaseri, Azadeh] Med Univ Tabriz, Fac Med, Dept Anat Sci, Tabriz, Iran	University of Munich; University of Nottingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Tabriz University of Medical Science	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Musculoskeletal Res Grp, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Mobasheri, Ali/D-5770-2011; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020; Montaseri, Azadeh/G-3871-2015	Mobasheri, Ali/0000-0001-6261-1286; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Montaseri, Azadeh/0000-0003-4250-3629; Buhrmann, Constanze/0000-0002-0786-0463	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust, UK	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust, UK(Wellcome Trust)	Supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and The Wellcome Trust, UK.	Aggarwal BB, 2005, CANC TREAT, V126, P103, DOI 10.1007/0-387-24361-5_5; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Almekinders L C, 1998, J Am Acad Orthop Surg, V6, P157; Archambault J, 2002, J ORTHOPAED RES, V20, P36, DOI 10.1016/S0736-0266(01)00075-4; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BernardBeaubois K, 1997, CELL BIOL TOXICOL, V13, P103, DOI 10.1023/B:CBTO.0000010395.51944.2a; Bharti AC, 2002, ANN NY ACAD SCI, V973, P392, DOI 10.1111/j.1749-6632.2002.tb04671.x; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240; Chan WH, 2006, FOOD CHEM TOXICOL, V44, P1362, DOI 10.1016/j.fct.2006.03.001; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Coffer PJ, 1998, BIOCHEM J, V329, P121; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gotoh M, 2002, J ORTHOP RES, V20, P1365, DOI 10.1016/S0736-0266(02)00063-3; Gotoh M, 2000, J RHEUMATOL, V27, P2886; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Jang MK, 2001, PLANTA MED, V67, P550, DOI 10.1055/s-2001-16482; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 1998, BIOCHEM PHARMACOL, V55, P775, DOI 10.1016/S0006-2952(97)00557-1; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; Ozes ON, 1999, NATURE, V401, P82; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Rees SG, 2000, BIOCHEM J, V350, P181, DOI 10.1042/0264-6021:3500181; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sandur SK, 2009, INT J RADIAT ONCOL, V75, P534, DOI 10.1016/j.ijrobp.2009.06.034; Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sendzik J, 2005, TOXICOLOGY, V212, P24, DOI 10.1016/j.tox.2005.04.002; Sendzik J, 2010, INT J ANTIMICROB AG, V35, P366, DOI 10.1016/j.ijantimicag.2009.10.009; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shankar S, 2007, INT J ONCOL, V30, P905; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Tsuzaki M, 2003, J CELL BIOCHEM, V89, P556, DOI 10.1002/jcb.10534; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang JHC, 2006, CLIN ORTHOP RELAT R, P320, DOI 10.1097/01.blo.0000195927.81845.46; WILLIAMS DH, 1992, BIOCHIM BIOPHYS ACTA, V1180, P9, DOI 10.1016/0925-4439(92)90020-N; Zhang CL, 2010, J INVEST DERMATOL, V130, P2110, DOI 10.1038/jid.2010.86	68	157	170	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28556	28566		10.1074/jbc.M111.256180	http://dx.doi.org/10.1074/jbc.M111.256180			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669872	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000293557800070
J	Scortegagna, M; Subtil, T; Qi, JF; Kim, H; Zhao, WH; Gu, W; Kluger, H; Ronai, ZA				Scortegagna, Marzia; Subtil, Tony; Qi, Jianfei; Kim, Hyungsoo; Zhao, Wenhui; Gu, Wei; Kluger, Harriet; Ronai, Ze'ev A.			USP13 Enzyme Regulates Siah2 Ligase Stability and Activity via Noncatalytic Ubiquitin-binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; TRANSCRIPTIONAL REPRESSOR; DEUBIQUITINATING ENZYME; PROLYL-HYDROXYLASES; SINA; HIF; TUMORIGENESIS; PROTEOLYSIS; HOMOLOGS; PROTEINS	The RING finger E3 ubiquitin ligase Siah2 is implicated in control of diverse cellular biological events, including MAPK signaling and hypoxia. Here we demonstrate that Siah2 is subject to regulation by the deubiquitinating enzyme USP13. Overexpression of USP13 increases Siah2 stability by attenuating its autodegradation. Consequently, the ability of Siah2 to target its substrates prolyl hydroxylase 3 and Spry2 (Sprouty2) for ubiquitin-mediated proteasomal degradation is attenuated. Conversely, inhibition of USP13 expression with corresponding shRNA decreases the stability of both Siah2 and its substrate Spry2. Thus, USP13 limits Siah2 autodegradation and its ubiquitin ligase activity against its target substrates. Strikingly, the effect of USP13 on Siah2 is not mediated by its isopeptidase activity: mutations in its ubiquitin-binding sequences positioned within the ubiquitin-specific processing protease and ubiquitin-binding domains, but not within putative catalytic sites, abolish USP13 binding to and effect on Siah2 autodegradation and targeted ubiquitination. Notably, USP13 expression is attenuated in melanoma cells maintained under hypoxia, thereby relieving Siah2 inhibition and increasing its activity under low oxygen levels. Significantly, on melanoma tissue microarray, high nuclear expression of USP13 coincided with high nuclear expression of Siah2. Overall, this study identifies a new layer of Siah2 regulation mediated by USP13 binding to ubiquitinated Siah2 protein with a concomitant inhibitory effect on its activity under normoxia.	[Scortegagna, Marzia; Qi, Jianfei; Kim, Hyungsoo; Ronai, Ze'ev A.] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92130 USA; [Subtil, Tony; Kluger, Harriet] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Zhao, Wenhui; Gu, Wei] Columbia Univ, Inst Canc Genet, Herbert Irving Canc Res Ctr, New York, NY 10032 USA	Sanford Burnham Prebys Medical Discovery Institute; Yale University; Columbia University	Ronai, ZA (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ronai@sbmri.org	qi, jianfei/O-9847-2014	RONAI, ZEEV/0000-0002-3859-0400; Kim, Hyungsoo/0000-0002-8189-5939; ZHAO, WENHUI/0000-0002-7703-7106	National Institutes of Health [CA128814]; XXXXXX; NATIONAL CANCER INSTITUTE [P01CA128814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); XXXXXX; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA128814 ( to Z. A. R.). This work was also supported by XXXXXX.	Ahmed AU, 2008, JNCI-J NATL CANCER I, V100, P1606, DOI 10.1093/jnci/djn365; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chen MF, 2011, P NATL ACAD SCI USA, V108, P9119, DOI 10.1073/pnas.1100028108; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Frew IJ, 2002, MOL CELL BIOL, V22, P8155, DOI 10.1128/MCB.22.23.8155-8164.2002; Habelhah H, 2004, J BIOL CHEM, V279, P53782, DOI 10.1074/jbc.M410315200; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Hu G, 1999, MOL CELL BIOL, V19, P724; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lacombe T, 2002, FEBS LETT, V531, P469, DOI 10.1016/S0014-5793(02)03586-X; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; McCarthy MM, 2006, CLIN CANCER RES, V12, P3856, DOI 10.1158/1078-0432.CCR-06-0190; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Russell Nathaniel S., 2005, V301, P207; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Timms KM, 1998, GENE, V217, P101, DOI 10.1016/S0378-1119(98)00341-2	33	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27333	27341		10.1074/jbc.M111.218214	http://dx.doi.org/10.1074/jbc.M111.218214			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659512	Green Published, hybrid			2022-12-27	WOS:000293268700029
J	Yan, Y; Pieretti, J; Ju, ZL; Wei, SN; Christin, JR; Bah, F; Birshtein, BK; Eckhardt, LA				Yan, Yi; Pieretti, Joyce; Ju, Zhongliang; Wei, Shiniu; Christin, John R.; Bah, Fatmata; Birshtein, Barbara K.; Eckhardt, Laurel A.			Homologous Elements hs3a and hs3b in the 3 ' Regulatory Region of the Murine Immunoglobulin Heavy Chain (Igh) Locus Are Both Dispensable for Class-switch Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; GERMLINE TRANSCRIPTION; ENHANCER; END; DELETION; REQUIRE; ALPHA; HS4; IDENTIFICATION; DOWNSTREAM	Immunoglobulin heavy chain (IgH) genes are formed, tested, and modified to yield diverse, specific, and high affinity antibody responses to antigen. The processes involved must be regulated, however, to avoid unintended damage to chromosomes. The 3' regulatory region of the Igh locus plays a major role in regulating class-switch recombination (CSR), the process by which antibody effector functions are modified during an immune response. Loss of all known enhancer-like elements in this region dramatically impairs CSR, but individual element deletions have no effect on this process. In the present study, we explored the hypothesis that an underlying functional redundancy in the homologous elements hs3a and hs3b was masking the importance of either element to CSR. Several transgenic mouse lines were generated, each carrying a bacterial artificial chromosome transgene that mimicked Igh locus structure but in which hs3a was missing and hs3b was flanked by loxP sites. Matings to Cyclization Recombination Enzyme-expressing mice established "pairs" of lines that differed only in the presence or absence of hs3b. Remarkably, CSR remained robust in the absence of both hs3a and hs3b, suggesting that the remaining two elements of the 3' regulatory region, hs1.2 and hs4, although individually dispensable for CSR, are, together, sufficient to support CSR.	[Yan, Yi; Pieretti, Joyce; Wei, Shiniu; Christin, John R.; Bah, Fatmata; Eckhardt, Laurel A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Yan, Yi; Eckhardt, Laurel A.] CUNY, Grad Ctr, New York, NY 10065 USA; [Ju, Zhongliang; Birshtein, Barbara K.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10804 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine	Eckhardt, LA (corresponding author), 927 Hunter N,695 Pk Ave, New York, NY 10065 USA.	eckhardt@genectr.hunter.cuny.edu		Christin, John/0000-0002-0479-0308	National Institutes of Health [RR003037, AI30653, AI13509]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030653, R37AI013509, R01AI013509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge Dr. Wesley Dunnick (University of Michigan Medical School, Ann Arbor, MI) for providing unmodified CHC BAC, Dr. Klaus Rajewsky (Harvard Medical School, Boston, MA) for the cloned B1-8V<INF>H</INF>gene, Dr. F. W. Alt(Harvard Medical School, Boston, MA) for the loxP vector used to flank hs3b with loxP sites, Dr. Karl Drlica (Public Health Research Institute, New York, NY) for human beta-globin plasmid, and Dr. Heiner Westphal (NICHD, National Institutes of Health) for EIIa-cre mice. We thank Joon Kim of the Hunter College Flow Cytometry Facility for expert help with cell sorting and Jodi-Ann Powell and Cheng Peng for expert technical support in mouse genotyping. Finally, we thank Dr. Benjamin Ortiz (Hunter College, The City University of New York) for helpful discussions and critical reading of the manuscript. The infrastructure and instrumentation at Hunter College are supported in part by a Research Centers in Minority Institutions award from the National Institutes of Health (RR003037).; This work was supported, in whole or in part, by National Institutes of Health Grants AI30653 (to L. A. E.) and AI13509 (to B. K. B.).	Bebin AG, 2010, J IMMUNOL, V184, P3710, DOI 10.4049/jimmunol.0901978; Chen CQ, 1997, J IMMUNOL, V159, P1310; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; Dunnick WA, 2005, J EXP MED, V201, P1459, DOI 10.1084/jem.20041988; Dunnick WA, 2004, J IMMUNOL, V173, P5531, DOI 10.4049/jimmunol.173.9.5531; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Ju ZL, 2007, J BIOL CHEM, V282, P35169, DOI 10.1074/jbc.M705719200; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li FB, 2009, J EXP MED, V206, P153, DOI 10.1084/jem.20081202; Lieberson R, 1995, EMBO J, V14, P6229, DOI 10.1002/j.1460-2075.1995.tb00313.x; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; MATTHIAS P, 1993, MOL CELL BIOL, V13, P1547, DOI 10.1128/MCB.13.3.1547; MCINTYRE TM, 1995, J IMMUNOL, V154, P3156; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; Mills FC, 1997, J EXP MED, V186, P845, DOI 10.1084/jem.186.6.845; Misulovin Z, 2001, J IMMUNOL METHODS, V257, P99, DOI 10.1016/S0022-1759(01)00452-5; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Shi XR, 2001, INT IMMUNOL, V13, P1003, DOI 10.1093/intimm/13.8.1003; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Vincent-Fabert C, 2009, J IMMUNOL, V182, P6926, DOI 10.4049/jimmunol.0900214; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; ZALLER DM, 1985, P NATL ACAD SCI USA, V82, P5088, DOI 10.1073/pnas.82.15.5088; Zhang BY, 2007, J IMMUNOL, V178, P6297, DOI 10.4049/jimmunol.178.10.6297	33	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27123	27131		10.1074/jbc.M111.230995	http://dx.doi.org/10.1074/jbc.M111.230995			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21673112	hybrid, Green Published			2022-12-27	WOS:000293268700007
J	Compton, ELR; Karinou, E; Naismith, JH; Gabel, F; Javelle, A				Compton, Emma L. R.; Karinou, Eleni; Naismith, James H.; Gabel, Frank; Javelle, Arnaud			Low Resolution Structure of a Bacterial SLC26 Transporter Reveals Dimeric Stoichiometry and Mobile Intracellular Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR PROTEIN PRESTIN; MULTIFUNCTIONAL ANION-EXCHANGERS; NEUTRON-SCATTERING; BIOLOGICAL STRUCTURES; ION-TRANSPORT; STAS DOMAIN; MODULATION; CHANNELS; COMPLEX; FAMILY	The SLC26/SulP (solute carrier/sulfate transporter) proteins are a superfamily of anion transporters conserved from bacteria to man, of which four have been identified in human diseases. Proteins within the SLC26/SulP family exhibit a wide variety of functions, transporting anions from halides to carboxylic acids. The proteins comprise a transmembrane domain containing between 10-12 transmembrane helices followed a by C-terminal cytoplasmic sulfate transporter and anti-sigma factor antagonist (STAS) domain. These proteins are expected to undergo conformational changes during the transport cycle; however, structural information for this family remains sparse, particularly for the full-length proteins. To address this issue, we conducted an expression and detergent screen on bacterial Slc26 proteins. The screen identified a Yersinia enterocolitica Slc26A protein as the ideal candidate for further structural studies as it can be purified to homogeneity. Partial proteolysis, co-purification, and analytical size exclusion chromatography demonstrate that the protein purifies as stable oligomers. Using small angle neutron scattering combined with contrast variation, we have determined the first low resolution structure of a bacterial Slc26 protein without spectral contribution from the detergent. The structure confirms that the protein forms a dimer stabilized via its transmembrane core; the cytoplasmic STAS domain projects away from the transmembrane domain and is not involved in dimerization. Supported by additional biochemical data, the structure suggests that large movements of the STAS domain underlie the conformational changes that occur during transport.	[Compton, Emma L. R.; Karinou, Eleni; Javelle, Arnaud] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland; [Naismith, James H.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Gabel, Frank] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct, F-38027 Grenoble, France	University of Dundee; University of St Andrews; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Javelle, A (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland.	ajavelle@dundee.ac.uk	Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Karinou, Eleni/0000-0002-1099-4964; Compton-Daw, Emma/0000-0002-3832-7194; Gabel, Frank/0000-0003-3446-2601	Tenovus Scotland [T08/26]; Royal Society [2008/R2]; Medical Research Council [G1000054]; College of Life Science (University of Dundee); Biotechnology and Biological Sciences Research Council [BB/F017022/1]; Scottish government/Royal Society of Edinburgh; MRC [G1000054] Funding Source: UKRI	Tenovus Scotland; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); College of Life Science (University of Dundee); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish government/Royal Society of Edinburgh; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Tenovus Scotland (T08/26), the Royal Society (2008/R2), and the Medical Research Council (G1000054).; Supported by the College of Life Science (University of Dundee).; Supported by a Biotechnology and Biological Sciences Research Council Doctoral Training Grant BB/F017022/1.; Supported by a Scottish government/Royal Society of Edinburgh personal research fellowship.	Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Gleitsman KR, 2009, AM J PHYSIOL-CELL PH, V297, pC290, DOI 10.1152/ajpcell.00647.2008; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heller WT, 2010, ACTA CRYSTALLOGR D, V66, P1213, DOI [10.1107/S0907444910017658, 10.1107/S090744491001]; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Mio K, 2008, J BIOL CHEM, V283, P1137, DOI 10.1074/jbc.M702681200; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Ohana E, 2011, J GEN PHYSIOL, V137, P239, DOI 10.1085/jgp.201010531; Pasqualetto E, 2010, J MOL BIOL, V400, P448, DOI 10.1016/j.jmb.2010.05.013; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; Sharma AK, 2011, J BIOL CHEM, V286, P8534, DOI 10.1074/jbc.M110.165449; Shelden MC, 2010, MOL MEMBR BIOL, V27, P11, DOI 10.3109/09687680903400120; Stewart CE, 2000, P NATL ACAD SCI USA, V97, P454, DOI 10.1073/pnas.97.1.454; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	27	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27058	27067		10.1074/jbc.M111.244533	http://dx.doi.org/10.1074/jbc.M111.244533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659513	Green Published, hybrid			2022-12-27	WOS:000293078200079
J	Kozjak-Pavlovic, V; Ott, C; Gotz, M; Rudel, T				Kozjak-Pavlovic, Vera; Ott, Christine; Goetz, Monika; Rudel, Thomas			Neisserial Omp85 Protein Is Selectively Recognized and Assembled into Functional Complexes in the Outer Membrane of Human Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BARREL PROTEINS; BIOGENESIS; MACHINERY; IMPORT; BACTERIA; SAM50; VDAC	As a consequence of their bacterial origin, mitochondria contain beta-barrel proteins in their outer membrane (OMM). These proteins require the translocase of the outer membrane (TOM) complex and the conserved sorting and assembly machinery (SAM) complex for transport and integration into the OMM. The SAM complex and the beta-barrel assembly machinery (BAM) required for biogenesis of beta-barrel proteins in bacteria are evolutionarily related. Despite this homology, we show that bacterial beta-barrel proteins are not universally recognized and integrated into the OMM of human mitochondria. Selectivity exists both at the level of the TOM and the SAM complex. Of all of the proteins we tested, human mitochondria imported only beta-barrel proteins originating from Neisseria sp., and only Omp85, the central component of the neisserial BAM complex, integrated into the OMM. PorB proteins from different Neisseria, although imported by the TOM, were not recognized by the SAM complex and formed membrane complexes only when functional Omp85 was present at the same time in mitochondria. Omp85 alone was capable of integrating other bacterial beta-barrel proteins in human mitochondria, but could not substitute for the function of its mitochondrial homolog Sam50. Thus, signals and machineries for transport and assembly of beta-barrel proteins in bacteria and human mitochondria differ enough to allow only a certain type of beta-barrel proteins to be targeted and integrated in mitochondrial membranes in human cells.	[Kozjak-Pavlovic, Vera; Ott, Christine; Goetz, Monika; Rudel, Thomas] Univ Wurzburg, Biozentrum, Dept Microbiol, D-97074 Wurzburg, Germany	University of Wurzburg	Kozjak-Pavlovic, V (corresponding author), Univ Wurzburg, Biozentrum, Dept Microbiol, D-97074 Wurzburg, Germany.	Vera.Kozjak@uni-wuerzburg.de; Thomas.Rudel@biozentrum.uni-wuerzburg.de	Kozjak-Pavlovic, Vera/E-1494-2013	Kozjak-Pavlovic, Vera/0000-0001-9658-7018	Deutsche Forschungsgemeinschaft [KO3882/1-1, RU 631/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KO3882/1-1 (to V. K.-P.) and RU 631/7-1 (to T. R.).	Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kozjak-Pavlovic V, 2010, J MOL BIOL, V397, P219, DOI 10.1016/j.jmb.2010.01.047; Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Walther DM, 2010, MOL BIOL EVOL, V27, P887, DOI 10.1093/molbev/msp294; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	24	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27019	27026		10.1074/jbc.M111.232249	http://dx.doi.org/10.1074/jbc.M111.232249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652692	hybrid, Green Published			2022-12-27	WOS:000293078200075
J	Tserel, L; Runnel, T; Kisand, K; Pihlap, M; Bakhoff, L; Kolde, R; Peterson, H; Vilo, J; Peterson, P; Rebane, A				Tserel, Liina; Runnel, Toomas; Kisand, Kai; Pihlap, Maire; Bakhoff, Lairi; Kolde, Raivo; Peterson, Hedi; Vilo, Jaak; Peterson, Paert; Rebane, Ana			MicroRNA Expression Profiles of Human Blood Monocyte-derived Dendritic Cells and Macrophages Reveal miR-511 as Putative Positive Regulator of Toll-like Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS; GENE-EXPRESSION; TARGET; DIFFERENTIATION; IMMUNOTHERAPY; PATHWAY	Dendritic cells (DCs) and macrophages (MFs) are important multifunctional immune cells. Like other cell types, they express hundreds of different microRNAs (miRNAs) that are recently discovered post-transcriptional regulators of gene expression. Here we present updated miRNA expression profiles of monocytes, DCs and MFs. Compared with monocytes, similar to 50 miRNAs were found to be differentially expressed in immature and mature DCs or MFs, with major expression changes occurring during the differentiation. Knockdown of DICER1, a protein needed for miRNA biosynthesis, led to lower DC-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) and enhanced CD14 protein levels, confirming the importance of miRNAs in DC differentiation in general. Inhibition of the two most highly up-regulated miRNAs, miR-511 and miR-99b, also resulted in reduced DC-SIGN level. Prediction of miRNA-511 targets revealed a number of genes with known immune functions, of which TLR4 and CD80 were validated using inhibition of miR-511 in DCs and luciferase assays in HEK293 cells. Interestingly, under the cell cycle arrest conditions, miR-511 seems to function as a positive regulator of TLR4. In conclusion, we have identified miR-511 as a novel potent modulator of human immune response. In addition, our data highlight that miRNA influence on gene expression is dependent on the cellular environment.	[Tserel, Liina; Runnel, Toomas; Kisand, Kai; Pihlap, Maire; Bakhoff, Lairi; Peterson, Paert; Rebane, Ana] Univ Tartu, Fac Med, EE-50411 Tartu, Estonia; [Kolde, Raivo; Peterson, Hedi; Vilo, Jaak] Univ Tartu, Inst Computater Sci, EE-50409 Tartu, Estonia; [Rebane, Ana] Swiss Inst Allergy & Asthma Res SIAF, CH-7270 Davos, Switzerland	University of Tartu; University of Tartu; Swiss Institute of Allergy & Asthma Research	Rebane, A (corresponding author), Univ Tartu, Fac Med, 19 Ravila St, EE-50411 Tartu, Estonia.	ana.rebane@ut.ee	Peterson, Hedi/C-7514-2012; Peterson, Hedi/ABA-3355-2020; Peterson, Hedi/F-4920-2017; Kolde, Raivo/AAB-8149-2022; Vilo, Jaak/A-7183-2008; Kisand, Kai/J-3483-2015; Rebane, Ana/D-4279-2013; Peterson, Pärt/A-5788-2009; Vilo, Jaak/AAK-2228-2020	Peterson, Hedi/0000-0001-9951-5116; Peterson, Hedi/0000-0001-9951-5116; Kolde, Raivo/0000-0003-2886-6298; Vilo, Jaak/0000-0001-5604-4107; Kisand, Kai/0000-0002-5426-4648; Rebane, Ana/0000-0001-6051-1361; Peterson, Pärt/0000-0001-6755-791X; Vilo, Jaak/0000-0001-5604-4107				Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin P, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-4; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Kramer JL, 2002, BRIT J HAEMATOL, V117, P727, DOI 10.1046/j.1365-2141.2002.03498.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; O'Connell MA, 2006, NAT STRUCT MOL BIOL, V13, P3, DOI 10.1038/nsmb0106-3; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tyagi RK, 2009, EXPERT REV ANTICANC, V9, P97, DOI 10.1586/14737140.9.1.97; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211	51	100	107	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26487	26495		10.1074/jbc.M110.213561	http://dx.doi.org/10.1074/jbc.M110.213561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646346	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000293078200027
J	De la Rosa, MB; Nelson, SW				De la Rosa, Metzere Bierlein; Nelson, Scott W.			An Interaction between the Walker A and D-loop Motifs Is Critical to ATP Hydrolysis and Cooperativity in Bacteriophage T4 Rad50	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA END-RESECTION; BIOCHEMICAL-CHARACTERIZATION; RECOMBINATION; COMPLEX; MRE11; 2-AMINOPURINE; MECHANISMS; FURIOSUS; BINDING; REPAIR	The ATP binding cassette (ABC) proteins make up a large superfamily with members coming from all kingdoms. The functional form of the ABC protein nucleotide binding domain (NBD) is dimeric with ATP binding sites shared between subunits. The NBD is defined by six motifs: the Walker A, Q-loop, Signature, Walker-B, D-loop, and H-loop. The D-loop contains a conserved aspartate whose function is not clear but has been proposed to be involved in cross-talk between ATP binding sites. Structures of various ABC proteins suggest an interaction between the D-loop aspartate and an asparagine residue located in Walker A loop of the opposing subunit. Here, we evaluate the functional role of the D-loop using a bacteriophage T4 ABC protein, Rad50 (gp46). Mutation of either the D-loop aspartate or the Walker A asparagine results in dramatic reductions in ATP affinity, hydrolysis rate, and cooperativity. The mutant proteins bind Mre11 (gp47) and DNA normally, but no longer support the ATP-dependent nuclease activities of Mre11. We propose that the D-loop aspartate functions to stabilize the Walker A asparagine in a position favorable for catalysis. We find that the asparagine is crucially important to the mechanism of ATP hydrolysis by increasing the affinity for ATP and positioning the gamma-phosphate of ATP for catalysis. Additionally, we propose that the asparagine acts as a gamma-phosphate sensor and, through its interaction with the conserved D-loop aspartate, transmits conformational changes across the dimer interface to the second ATP binding site.	[De la Rosa, Metzere Bierlein; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [De la Rosa, Metzere Bierlein] Iowa State Univ, Program Women Sci & Engn, Ames, IA 50011 USA; [De la Rosa, Metzere Bierlein] Grinnell Coll, Grinnell, IA 50112 USA	Iowa State University; Iowa State University	Nelson, SW (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	swn@iastate.edu			Carver Trust [10-3603]; Iowa State University	Carver Trust; Iowa State University	This work was supported by Carver Trust Young Investigator Grant 10-3603 (to S. W. N.) and Iowa State University institutional support (to S. W. N.).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bareil C, 2010, HUM MUTAT, V31, P1011, DOI 10.1002/humu.21316; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1577, DOI 10.1021/bi00405a027; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Frelet A, 2006, FEBS LETT, V580, P1064, DOI 10.1016/j.febslet.2006.01.024; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Herdendorf T. J., 2011, BIOCHEMISTR IN PRESS; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Hoeijmakers JHJ, 2007, MECH AGEING DEV, V128, P460, DOI 10.1016/j.mad.2007.05.002; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Jean JM, 2001, P NATL ACAD SCI USA, V98, P37, DOI 10.1073/pnas.011442198; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; KREUZER KN, 1988, J BIOL CHEM, V263, P11366; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Shi L, 2004, FRONT BIOSCI-LANDMRK, V9, P1382, DOI 10.2741/1318; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	37	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26258	26266		10.1074/jbc.M111.256305	http://dx.doi.org/10.1074/jbc.M111.256305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21610075	Green Published, hybrid			2022-12-27	WOS:000293073000083
J	Klemmer, P; Meredith, RM; Holmgren, CD; Klychnikov, OI; Stahl-Zeng, J; Loos, M; van der Schors, RC; Wortel, J; de Wit, H; Spijker, S; Rotaru, DC; Mansvelder, HD; Smit, AB; Li, KW				Klemmer, Patricia; Meredith, Rhiannon M.; Holmgren, Carl D.; Klychnikov, Oleg I.; Stahl-Zeng, Jianru; Loos, Maarten; van der Schors, Roel C.; Wortel, Joke; de Wit, Heidi; Spijker, Sabine; Rotaru, Diana C.; Mansvelder, Huibert D.; Smit, August B.; Li, Ka Wan			Proteomics, Ultrastructure, and Physiology of Hippocampal Synapses in a Fragile X Syndrome Mouse Model Reveal Presynaptic Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FMR1 KNOCKOUT MICE; MENTAL-RETARDATION SYNDROME; LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; SOMATOSENSORY CORTEX; NEUROBLASTOMA-CELLS; SPINE MORPHOGENESIS; DENDRITIC SPINES; ACTIN DYNAMICS	Fragile X syndrome (FXS), the most common form of hereditary mental retardation, is caused by a loss-of-function mutation of the Fmr1 gene, which encodes fragile X mental retardation protein (FMRP). FMRP affects dendritic protein synthesis, thereby causing synaptic abnormalities. Here, we used a quantitative proteomics approach in an FXS mouse model to reveal changes in levels of hippocampal synapse proteins. Sixteen independent pools of Fmr1 knock-out mice and wild type mice were analyzed using two sets of 8-plex iTRAQ experiments. Of 205 proteins quantified with atleast three distinct peptides in both iTRAQ series, the abundance of 23 proteins differed between Fmr1 knock-out and wild type synapses with a false discovery rate (q-value) <5%. Significant differences were confirmed by quantitative immunoblotting. A group of proteins that are known to be involved in cell differentiation and neurite outgrowth was regulated; they included Basp1 and Gap43, known PKC substrates, and Cend1. Basp1 and Gap43 are predominantly expressed in growth cones and presynaptic terminals. In line with this, ultrastructural analysis in developing hippocampal FXS synapses revealed smaller active zones with corresponding postsynaptic densities and smaller pools of clustered vesicles, indicative of immature presynaptic maturation. Asecond group of proteins involved in synaptic vesicle release was up-regulated in the FXS mouse model. In accordance, paired-pulse and short-term facilitation were significantly affected in these hippocampal synapses. Together, the altered regulation of presynaptically expressed proteins, immature synaptic ultrastructure, and compromised short-term plasticity points to presynaptic changes underlying glutamatergic transmission in FXS at this stage of development.	[Klemmer, Patricia; Klychnikov, Oleg I.; Loos, Maarten; van der Schors, Roel C.; Spijker, Sabine; Rotaru, Diana C.; Smit, August B.; Li, Ka Wan] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Meredith, Rhiannon M.; Holmgren, Carl D.; Rotaru, Diana C.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, NL-1081 HV Amsterdam, Netherlands; [Wortel, Joke; de Wit, Heidi] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [Stahl-Zeng, Jianru] AB Sciex, D-64293 Darmstadt, Germany	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Li, KW (corresponding author), Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	ka.wan.li@cncr.vu.nl	Loos, Maarten/A-2768-2012; Spijker, Sabine/F-2300-2011; Klychnikov, Oleg I./AAN-6167-2020; Meredith, Rhiannon/A-4657-2010; Smit, August B/E-8410-2011; Rotaru, Diana/AAZ-9058-2020; Mansvelder, Huibert/N-6138-2018	Loos, Maarten/0000-0003-1629-2928; Klychnikov, Oleg I./0000-0002-0383-9237; Mansvelder, Huibert/0000-0003-1365-5340; Meredith, Rhiannon/0000-0003-0228-4169; Spijker, Sabine/0000-0002-6814-2019; li, ka wan/0000-0001-6983-5055; Rotaru, Diana/0000-0002-0724-3596	NeuroBsik grant; Center for Medical Systems Biology (CMSB) Netherlands Organization for Scientific Research (NWO) [91710372]; Hersenstichting Nederland; Neuromics Marie Curie Early stage Training Grant [MEST-CT-2005-020919]	NeuroBsik grant; Center for Medical Systems Biology (CMSB) Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Hersenstichting Nederland; Neuromics Marie Curie Early stage Training Grant	This work was supported by the NeuroBsik grant to the Dutch Mouse Phenomics consortium and support of the Center for Medical Systems Biology (CMSB) Netherlands Organization for Scientific Research (NWO) (Grant 91710372) (to A. B. S., K. W. L., and R. C. v. d. S.), funding from Hersenstichting Nederland (to R. M. M.), and funding from Neuromics Marie Curie Early stage Training Grant MEST-CT-2005-020919 (to P. K.).	Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; Arikkath J, 2009, MOL NEUROBIOL, V40, P46, DOI 10.1007/s12035-009-8068-x; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Braun K, 2000, CEREB CORTEX, V10, P1045, DOI 10.1093/cercor/10.10.1045; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Castets M, 2005, HUM MOL GENET, V14, P835, DOI 10.1093/hmg/ddi077; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Ivanco TL, 2002, HIPPOCAMPUS, V12, P47, DOI 10.1002/hipo.10004; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000931; Klychnikov OI, 2010, PROTEOMICS, V10, P2531, DOI 10.1002/pmic.200900733; Koukoui SD, 2007, BRAIN RES REV, V53, P27, DOI 10.1016/j.brainresrev.2006.06.001; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Li KW, 2007, J PROTEOME RES, V6, P3127, DOI 10.1021/pr070086w; MAMALAKI A, 1995, J BIOL CHEM, V270, P14201, DOI 10.1074/jbc.270.23.14201; Mann EO, 2005, J PHYSIOL-LONDON, V562, P55, DOI 10.1113/jphysiol.2004.078758; Massey PV, 2001, EUR J NEUROSCI, V14, P145, DOI 10.1046/j.0953-816x.2001.01631.x; Meredith R. M., 2010, FRONT SYNAPTIC NEURO, V10, P2; Meredith RM, 2007, NEURON, V54, P627, DOI 10.1016/j.neuron.2007.04.028; Meredith RM, 2011, NEUROBIOL DIS, V41, P104, DOI 10.1016/j.nbd.2010.08.026; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Pilpel Y, 2009, J PHYSIOL-LONDON, V587, P787, DOI 10.1113/jphysiol.2008.160929; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; Roxas BAP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-187; Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Wilson BM, 2007, P NATL ACAD SCI USA, V104, P2454, DOI 10.1073/pnas.0610875104; Zhang J, 2009, J NEUROPHYSIOL, V101, P2572, DOI 10.1152/jn.90558.2008	50	71	73	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25495	25504		10.1074/jbc.M110.210260	http://dx.doi.org/10.1074/jbc.M110.210260			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596744	Green Published, hybrid			2022-12-27	WOS:000293073000012
J	Zhang, L; Jin, Y; Chen, M; Huang, M; Harvey, RG; Blair, IA; Penning, TM				Zhang, Li; Jin, Yi; Chen, Mo; Huang, Meng; Harvey, Ronald G.; Blair, Ian A.; Penning, Trevor M.			Detoxication of Structurally Diverse Polycyclic Aromatic Hydrocarbon (PAH) o-Quinones by Human Recombinant Catechol-O-methyltransferase (COMT) via O-Methylation of PAH Catechols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LUNG-CANCER; REACTIVE OXYGEN; A549 CELLS; IN-VITRO; ACTIVATION; METABOLISM; REDUCTASE; ADDUCTS; DNA; CARCINOGENESIS	Polycyclic aromatic hydrocarbons (PAH) are environmental and tobacco carcinogens. Metabolic activation of intermediate PAH trans-dihydrodiols by aldo-keto reductases (AKRs) leads to the formation of electrophilic and redox-active o-quinones. We investigated whether O-methylation by human recombinant soluble catechol-O-methyltransferase (S-COMT) is a feasible detoxication step for a panel of structurally diverse PAH-catechols produced during the redox-cycling process. Classes of PAH non-K-region o-quinones (bay region, methylated bay region, and fjord region o-quinones) produced by AKRs were employed in the studies. PAH o-quinones were reduced to the corresponding catechols by dithiothreitol under anaerobic conditions and then further O-methylated by human S-COMT in the presence of S-[H-3]adenosyl-L-methionine as a methyl group donor. The formation of the O-methylated catechols was detected by HPLC-UV coupled with in-line radiometric detection, and unlabeled products were also characterized by LC-MS/MS. Human S-COMT was able to catalyze O-methylation of all of the PAH-catechols and generated two isomeric metabolites in different proportions. LC-MS/MS showed that each isomer was a mono-O-methylated metabolite. H-1 NMR was used to assign the predominant positional isomer of benzo[a]pyrene-7,8-catechol as the O-8-monomethylated catechol. The catalytic efficiency (k(cat)/K-m) varied among different classes of PAH-catechols by 500-fold. The ability of S-COMT to produce two isomeric products from PAH-catechols was rationalized using the crystal structure of the enzyme. We provide evidence that O-8-monomethylated benzo[a]pyrene-7,8-catechol is formed in three different human lung cell lines. It is concluded that human S-COMT may play a critical role in the detoxication of PAH o-quinones generated by AKRs.	[Zhang, Li; Jin, Yi; Huang, Meng; Penning, Trevor M.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Zhang, Li; Jin, Yi; Huang, Meng; Penning, Trevor M.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Harvey, Ronald G.; Blair, Ian A.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Chicago	Penning, TM (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Ctr Excellence Environm Toxicol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@upenn.edu	Zhang, Li/F-9782-2013	Penning, Trevor/0000-0002-3937-1066	National Institutes of Health [P30-ES-013508, R01-CA39504, PA-DOH4100038714]; NATIONAL CANCER INSTITUTE [R01CA039504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-ES-013508, R01-CA39504, and PA-DOH4100038714.	AXELROD J, 1958, J BIOL CHEM, V233, P702; AXELROD J, 1966, PHARMACOL REV, V18, P95; Bai HW, 2007, CHEM RES TOXICOL, V20, P1409, DOI 10.1021/tx700174w; BALL P, 1972, J CLIN ENDOCR METAB, V34, P736, DOI 10.1210/jcem-34-4-736; Balu N, 2006, ANAL BIOCHEM, V355, P213, DOI 10.1016/j.ab.2006.05.023; Bolchi C, 2004, BIOORGAN MED CHEM, V12, P4937, DOI 10.1016/j.bmc.2004.06.040; Burczynski ME, 1998, BIOCHEMISTRY-US, V37, P6781, DOI 10.1021/bi972725u; CAVALIERI EL, 1995, XENOBIOTICA, V25, P677, DOI 10.3109/00498259509061885; CHENG KC, 1992, J BIOL CHEM, V267, P166; CONNEY AH, 1982, CANCER RES, V42, P4875; Cote ML, 2009, CARCINOGENESIS, V30, P626, DOI 10.1093/carcin/bgp033; Dawling S, 2001, CANCER RES, V61, P6716; FU PP, 1979, J ORG CHEM, V44, P4265, DOI 10.1021/jo01338a010; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Goodman JE, 2002, PHARMACOGENETICS, V12, P517, DOI 10.1097/00008571-200210000-00003; GRIMMER G, 1975, J ASSOC OFF ANA CHEM, V58, P725; GROSSMAN MH, 1985, J NEUROCHEM, V44, P421, DOI 10.1111/j.1471-4159.1985.tb05432.x; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; Harvey RG, 2004, J ORG CHEM, V69, P2024, DOI 10.1021/jo030348n; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; JEFFERY DR, 1984, J NEUROCHEM, V42, P826, DOI 10.1111/j.1471-4159.1984.tb02755.x; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Kim YH, 2004, J IND MICROBIOL BIOT, V31, P507, DOI 10.1007/s10295-004-0178-x; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mannisto PT, 1999, PHARMACOL REV, V51, P593; McCoull KD, 1999, CHEM RES TOXICOL, V12, P237, DOI 10.1021/tx980182z; MURTY VS, 1992, CHEM-BIOL INTERACT, V84, P169, DOI 10.1016/0009-2797(92)90077-X; MURTY VS, 1992, BIOCONJUGATE CHEM, V3, P218, DOI 10.1021/bc00015a003; Nolan KA, 2000, PSYCHIAT GENET, V10, P117, DOI 10.1097/00041444-200010030-00003; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Palackal NT, 2001, BIOCHEMISTRY-US, V40, P10901, DOI 10.1021/bi010872t; Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105; Park JH, 2006, CHEM RES TOXICOL, V19, P719, DOI 10.1021/tx0600245; Rutherford K, 2008, J MOL BIOL, V380, P120, DOI 10.1016/j.jmb.2008.04.040; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; Shen YM, 2006, CHEM RES TOXICOL, V19, P1441, DOI 10.1021/tx0601206; Shimada T, 1999, CHEM RES TOXICOL, V12, P623, DOI 10.1021/tx990028s; Shimada T, 1996, CANCER RES, V56, P2979; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Syvanen AC, 1997, PHARMACOGENETICS, V7, P65; TENHUNEN J, 1994, EUR J BIOCHEM, V223, P1049, DOI 10.1111/j.1432-1033.1994.tb19083.x; TENHUNEN J, 1993, BIOCHEM J, V296, P595, DOI 10.1042/bj2960595; UELAND PM, 1982, PHARMACOL REV, V34, P223; ULMANEN I, 1991, EUR J BIOCHEM, V202, P1013, DOI 10.1111/j.1432-1033.1991.tb16464.x; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m; Zienolddiny S, 2008, CARCINOGENESIS, V29, P1164, DOI 10.1093/carcin/bgn020	46	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25644	25654		10.1074/jbc.M111.240739	http://dx.doi.org/10.1074/jbc.M111.240739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622560	Green Published, hybrid			2022-12-27	WOS:000293073000026
J	Kim, EK; Park, JM; Lim, S; Choi, JW; Kim, HS; Seok, H; Seo, JK; Oh, K; Lee, DS; Kim, KT; Ryu, SH; Suh, PG				Kim, Eung-Kyun; Park, Ji-Man; Lim, Seyoung; Choi, Jung Woong; Kim, Hyeon Soo; Seok, Heon; Seo, Jeong Kon; Oh, Keunhee; Lee, Dong-Sup; Kim, Kyong Tai; Ryu, Sung Ho; Suh, Pann-Ghill			Activation of AMP-activated Protein Kinase Is Essential for Lysophosphatidic Acid-induced Cell Migration in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHOLIPASE-D; ENDOTHELIAL-CELLS; UP-REGULATION; RHO-GTPASES; PHOSPHORYLATION; PATHWAY; GROWTH; MOTILITY; ENERGY; RECEPTORS	Lysophosphatidic acid (LPA) is a bioactive phospholipid that affects various biological functions, such as cell proliferation, migration, and survival, through LPA receptors. Among them, the motility of cancer cells is an especially important activity for invasion and metastasis. Recently, AMP-activated protein kinase (AMPK), an energy-sensing kinase, was shown to regulate cell migration. However, the specific role of AMPK in cancer cell migration is unknown. The present study investigated whether LPA could induce AMPK activation and whether this process was associated with cell migration in ovarian cancer cells. We found that LPA led to a striking increase in AMPK phosphorylation in pathways involving the phospholipase C-beta 3 (PLC-beta 3) and calcium/calmodulin-dependent protein kinase kinase beta (CaMKK beta) in SKOV3 ovarian cancer cells. siRNA-mediated knockdown of AMPK beta 1, PLC-beta 3, or (CaMKK beta) impaired the stimulatory effects of LPA on cell migration. Furthermore, we found that knockdown of AMPK beta 1 abrogated LPA-induced activation of the small GTPase RhoA and ezrin/radixin/moesin proteins regulating membrane dynamics as membrane-cytoskeleton linkers. In ovarian cancer xenograft models, knockdown of AMPK significantly decreased peritoneal dissemination and lung metastasis. Taken together, our results suggest that activation of AMPK by LPA induces cell migration through the signaling pathway to cytoskeletal dynamics and increases tumor metastasis in ovarian cancer.	[Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, BioSignal Network Lab, Sch Nanobiosci & Chem Engn, Ulsan 689798, South Korea; [Kim, Eung-Kyun; Choi, Jung Woong; Kim, Kyong Tai; Ryu, Sung Ho; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; [Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea; [Oh, Keunhee; Lee, Dong-Sup] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Transplantat Res Inst, Seoul 110799, South Korea; [Seok, Heon] Jungwon Univ, Dept Biomed Engn, Goesan 367805, Chungcheongbukd, South Korea	Ulsan National Institute of Science & Technology (UNIST); Pohang University of Science & Technology (POSTECH); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Jungwon University	Suh, PG (corresponding author), Ulsan Natl Inst Sci & Technol, BioSignal Network Lab, Sch Nanobiosci & Chem Engn, Engn Bldg 104,100 Banyeon Ri, Ulsan 689798, South Korea.	pgsuh@unist.ac.kr	Lee, Dong-Sup/J-2777-2012; Seo, Jeong Kon/H-4770-2016; Suh, Pann-Ghill/F-3610-2010	KIM, KYONG-TAI/0000-0001-7292-2627; Ryu, Sung Ho/0000-0003-0913-3048	Korean Government [KRF-2007-341-C00027]; Korean Ministry of Education, Science and Technology (Anti-aging and Well-being Research Center)	Korean Government(Korean Government); Korean Ministry of Education, Science and Technology (Anti-aging and Well-being Research Center)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by National Research Foundation of Korea Grant KRF-2007-341-C00027 funded by the Korean Government and by a grant of the Korean Ministry of Education, Science and Technology (The Regional Core Research Program/Anti-aging and Well-being Research Center).	Bian DF, 2004, CANCER RES, V64, P4209, DOI 10.1158/0008-5472.CAN-04-0060; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chiu YC, 2009, CARCINOGENESIS, V30, P1651, DOI 10.1093/carcin/bgp156; Choi JW, 2010, CELL SIGNAL, V22, P1153, DOI 10.1016/j.cellsig.2010.03.010; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Eder AM, 2000, CLIN CANCER RES, V6, P2482; Estrella VC, 2007, INT J ONCOL, V31, P441; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; LIM S, 2010, STEM CELLS DEV; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Martinelli R, 2009, MOL BIOL CELL, V20, P995, DOI 10.1091/mbc.E08-06-0636; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Miranda L, 2010, BIOCHEM BIOPH RES CO, V396, P656, DOI 10.1016/j.bbrc.2010.04.151; Motobayashi Y, 2009, HYPERTENS RES, V32, P188, DOI 10.1038/hr.2008.19; Nakamoto T, 2005, J OBSTET GYNAECOL RE, V31, P344, DOI 10.1111/j.1447-0756.2005.00299.x; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Natsuizaka M, 2007, EXP CELL RES, V313, P3337, DOI 10.1016/j.yexcr.2007.06.013; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park SY, 2006, CELL SIGNAL, V18, P1063, DOI 10.1016/j.cellsig.2005.08.018; Pustilnik TB, 1999, CLIN CANCER RES, V5, P3704; Sawada K, 2002, GYNECOL ONCOL, V87, P252, DOI 10.1006/gyno.2002.6831; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sengupta S, 2003, FASEB J, V17, P1570, DOI 10.1096/fj.02-1145fje; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Stracke ML, 1997, ADV ENZYME REGUL, V37, P135, DOI 10.1016/S0065-2571(96)00017-9; Tang CH, 2009, PROSTATE, V69, P1781, DOI 10.1002/pros.21029; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; Wang P, 2007, GYNECOL ONCOL, V104, P714, DOI 10.1016/j.ygyno.2006.10.016; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378	56	50	55	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24036	24045		10.1074/jbc.M110.209908	http://dx.doi.org/10.1074/jbc.M110.209908			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21602274	Green Published, hybrid			2022-12-27	WOS:000292294900046
J	Shin, HJ; Park, YH; Kim, SU; Moon, HB; Park, DS; Han, YH; Lee, CH; Lee, DS; Song, IS; Lee, DH; Kim, M; Kim, NS; Kim, DG; Kim, JM; Kim, SK; Kim, YN; Kim, SS; Choi, CS; Kim, YB; Yu, DY				Shin, Hye-Jun; Park, Young-Ho; Kim, Sun-Uk; Moon, Hyung-Bae; Park, Do Sim; Han, Ying-Hao; Lee, Chul-Ho; Lee, Dong-Seok; Song, In-Sung; Lee, Dae Ho; Kim, Minhye; Kim, Nam-Soon; Kim, Dae-Ghon; Kim, Jin-Man; Kim, Sang-Keun; Kim, Yo Na; Kim, Su Sung; Choi, Cheol Soo; Kim, Young-Bum; Yu, Dae-Yeul			Hepatitis B Virus X Protein Regulates Hepatic Glucose Homeostasis via Activation of Inducible Nitric Oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; KAPPA-B; LIVER; GENE; TRANSCRIPTION; EXPRESSION; GLUCONEOGENESIS; PROMOTER; CANCER; RISK	Dysregulation of liver functions leads to insulin resistance causing type 2 diabetes mellitus and is often found in chronic liver diseases. However, the mechanisms of hepatic dysfunction leading to hepatic metabolic disorder are still poorly understood in chronic liver diseases. The current work investigated the role of hepatitis B virus X protein (HBx) in regulating glucose metabolism. We studied HBx-overexpressing (HBxTg) mice and HBxTg mice lacking inducible nitric oxide synthase (iNOS). Here we show that gene expressions of the key gluconeogenic enzymes were significantly increased in HepG2 cells expressing HBx (HepG2-HBx) and in non-tumor liver tissues of hepatitis B virus patients with high levels of HBx expression. In the liver of HBxTg mice, the expressions of gluconeogenic genes were also elevated, leading to hyperglycemia by increasing hepatic glucose production. However, this effect was insufficient to cause systemic insulin resistance. Importantly, the actions of HBx on hepatic glucose metabolism are thought to be mediated via iNOS signaling, as evidenced by the fact that deficiency of iNOS restored HBx-induced hyperglycemia by suppressing the gene expression of gluconeogenic enzymes. Treatment of HepG2-HBx cells with nitric oxide (NO) caused a significant increase in the expression of gluconeogenic genes, but JNK1 inhibition was completely normalized. Furthermore, hyperactivation of JNK1 in the liver of HBxTg mice was also suppressed in the absence of iNOS, indicating the critical role for JNK in the mutual regulation of HBx- and iNOS-mediated glucose metabolism. These findings establish a novel mechanism of HBx-driven hepatic metabolic disorder that is modulated by iNOS-mediated activation of JNK.	[Shin, Hye-Jun; Park, Young-Ho; Kim, Sun-Uk; Han, Ying-Hao; Lee, Chul-Ho; Lee, Dong-Seok; Yu, Dae-Yeul] Korea Res Inst Biosci & Biotechnol, Dis Model Res Lab, Aging Res Ctr, Taejon 305806, South Korea; [Shin, Hye-Jun; Park, Young-Ho; Kim, Sun-Uk; Han, Ying-Hao; Lee, Chul-Ho; Lee, Dong-Seok; Yu, Dae-Yeul] Korea Res Inst Biosci & Biotechnol, World Class Inst, Taejon 305806, South Korea; [Shin, Hye-Jun; Kim, Sang-Keun] Chungnam Natl Univ, Coll Vet Med, Taejon 305764, South Korea; [Park, Young-Ho; Yu, Dae-Yeul] Univ Sci & Technol, Dept Funct Genom, Taejon 305333, South Korea; [Moon, Hyung-Bae; Park, Do Sim] Wonkwang Univ Coll Med, Dept Pathol, Iksan 570749, South Korea; [Moon, Hyung-Bae; Park, Do Sim] Wonkwang Univ Coll Med, Inst Med Sci, Iksan 570749, South Korea; [Lee, Dong-Seok] Kyungpook Natl Univ, Coll Nat Sci, Taegu 702701, South Korea; [Song, In-Sung; Kim, Nam-Soon] Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon 305806, South Korea; [Lee, Dae Ho; Kim, Minhye; Kim, Young-Bum] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kim, Dae-Ghon] Chonbuk Natl Univ Med Sch & Hosp, Dept Internal Med, Jeonju 561756, South Korea; [Kim, Jin-Man] Chungnam Natl Univ, Coll Med, Taejon 305764, South Korea; [Kim, Yo Na; Kim, Su Sung; Choi, Cheol Soo] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Choi, Cheol Soo] Gachon Univ Med & Sci, Div Endocrinol, Gil Med Ctr, Inchon 406840, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Wonkwang University; Wonkwang University; Kyungpook National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Jeonbuk National University; Jeonbuk National University Hospital; Chungnam National University; Gachon University; Gachon University	Kim, YB (corresponding author), 330 Brookline Ave,CLS-736, Boston, MA USA.	ykim2@bidmc.harvard.edu; dyyu10@kribb.re.kr	Park, Do-Sim/B-6594-2013; Park, Do-Sim/P-1529-2019	Park, Do-Sim/0000-0002-6001-4223; Park, Do-Sim/0000-0002-6001-4223; Lee, Dong Seok/0000-0001-6348-8937; KIM, JIN MAN/0000-0003-0905-9730	21st Century Frontier Program in the Functional Human Genome Project [HGM0200934]; International Collaboration Program of Science and Technology [FGM0600914]; Ministry of Education, Science and Technology of Korea (MEST); Ministry for Health and Welfare [BCM0061011]; KRIBB Research Initiative [KGM3320911]; Ministry for Health, Welfare and Family Affairs, Korea [A084651]; National Institutes of Health [R01DK083567]; American Diabetes Association [1-09-RA-87]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083567] Funding Source: NIH RePORTER	21st Century Frontier Program in the Functional Human Genome Project; International Collaboration Program of Science and Technology; Ministry of Education, Science and Technology of Korea (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health and Welfare; KRIBB Research Initiative; Ministry for Health, Welfare and Family Affairs, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the 21st Century Frontier Program in the Functional Human Genome Project (Grant HGM0200934), by the International Collaboration Program of Science and Technology (Grant FGM0600914), by the World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology of Korea (MEST), by a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare (Grant BCM0061011), by the KRIBB Research Initiative Program Grant (Grant KGM3320911), by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Korea (Grant A084651) (to C. S. C.), and by National Institutes of Health Grant R01DK083567 (to Y. B. K.) and American Diabetes Association Grant 1-09-RA-87) (to Y. B. K.).	Cheng AYS, 2006, DIABETOLOGIA, V49, P1777, DOI 10.1007/s00125-006-0294-4; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Custro N, 2001, DIABETES METAB, V27, P476; Garcia-Compean D, 2009, ANN HEPATOL, V8, P13, DOI 10.1016/S1665-2681(19)31805-8; Gavin JR, 1999, DIABETES CARE, V22, pS5; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; KRUSZYNSKA YT, 1991, HEPATOLOGY, V14, P103, DOI 10.1002/hep.1840140117; Lara-Pezzi E, 1998, HEPATOLOGY, V28, P1013, DOI 10.1002/hep.510280416; LaVecchia C, 1997, INT J CANCER, V73, P204, DOI 10.1002/(SICI)1097-0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-#; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Majano P, 2001, HEPATOLOGY, V34, P1218, DOI 10.1053/jhep.2001.29626; Majano PL, 1998, J CLIN INVEST, V101, P1343, DOI 10.1172/JCI774; McGowder D, 1999, NITRIC OXIDE-BIOL CH, V3, P481, DOI 10.1006/niox.1999.0254; Nakashima Y, 2008, METABOLISM, V57, P1350, DOI 10.1016/j.metabol.2008.05.001; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Nguyen Mindie H, 2003, Rev Gastroenterol Disord, V3, P125; Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Pollack H., 2006, Morbidity and Mortality Weekly Report, V55, P505; Sprangers F, 1998, BIOCHEM J, V330, P1045, DOI 10.1042/bj3301045; Su F, 2001, J VIROL, V75, P215, DOI 10.1128/JVI.75.1.215-225.2001; Wang YY, 2010, METABOLISM, V59, P486, DOI 10.1016/j.metabol.2009.07.038; Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu DY, 1999, J HEPATOL, V31, P123, DOI 10.1016/S0168-8278(99)80172-X; Zhang JD, 2001, P NATL ACAD SCI USA, V98, P3756, DOI 10.1073/pnas.071054598	34	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29872	29881		10.1074/jbc.M111.259978	http://dx.doi.org/10.1074/jbc.M111.259978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21690090	Green Published, hybrid			2022-12-27	WOS:000294046600046
J	Havrylenko, S; Legouis, R; Negrutskii, B; Mirande, M				Havrylenko, Svitlana; Legouis, Renaud; Negrutskii, Boris; Mirande, Marc			Caenorhabditis elegans Evolves a New Architecture for the Multi-aminoacyl-tRNA Synthetase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGINYL-TRANSFER-RNA; ELONGATION-FACTOR; MACROMOLECULAR COMPLEXES; MULTISYNTHETASE COMPLEX; MULTIENZYME COMPLEX; PURIFICATION; PROTEIN; COMPONENT; SUBUNIT; ORGANIZATION	MARS is an evolutionary conserved supramolecular assembly of aminoacyl-tRNA synthetases found in eukaryotes. This complex was thought to be ubiquitous in the deuterostome and protostome clades of bilaterians because similar complexes were isolated from arthropods and vertebrates. However, several features of the component enzymes suggested that in the nematode Caenorhabditis elegans, a species grouped with arthropods in modern phylogeny, this complex might not exist, or should display a significantly different structural organization. C. elegans was also taken as a model system to study in a multicellular organism amenable to experimental approaches, the reason for existence of these supramolecular entities. Here, using a proteomic approach, we have characterized the components of MARS in C. elegans. We show that this organism evolved a specific structural organization of this complex, which contains several bona fide components of the MARS complexes known so far, but also displays significant variations. These data highlight molecular evolution events that took place after radiation of bilaterians. Remarkably, it shows that expansion of MARS assembly in metazoans is not linear, but is the result of additions but also of subtractions along evolution. We then undertook an experimental approach, using inactivation of the endogenous copy of methionyl-tRNA synthetase by RNAi and expression of transgenic variants, to understand the role in complex assembly and the in vivo functionality, of the eukaryotic-specific domains appended to aminoacyl-tRNA synthetases. We show that rescue of the worms and assembly of transgenic variants into MARS rest on the presence of these appended domains.	[Havrylenko, Svitlana; Mirande, Marc] CNRS, LEBS, F-91190 Gif Sur Yvette, France; [Legouis, Renaud] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [Havrylenko, Svitlana; Negrutskii, Boris] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-03143 Kiev, Ukraine	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Mirande, M (corresponding author), CNRS, LEBS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	mirande@lebs.cnrs-gif.fr	Legouis, Renaud/S-1250-2017; Legouis, Renaud/G-9088-2014; Negrutskii, Boris/G-6439-2016	Legouis, Renaud/0000-0002-2699-2584; Negrutskii, Boris/0000-0001-5974-1629	Association pour la Recherche sur le Cancer; CNRS; Bourse du Gouvernement Francais; Fondation pour la Recherche Medicale; NIH National Center for Research Resources (NCRR)	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); Bourse du Gouvernement Francais; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by grants from the "Association pour la Recherche sur le Cancer" and Projet International de Cooperation Scientifique-CNRS.; Recipient of a "Bourse du Gouvernement Francais" and of a fellowship from "Fondation pour la Recherche Medicale."; We thank Jerome Reboul (Laboratoire de Genomique Fonctionnelle, Marseille, France) for the gift of the pSB_GW::TAG vector, and Y. Kohara (National Institute of Genetics, Mishima, Japan) for the gift of the cDNA clone yk1416a08. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We also thank David Cornu and Manuela Argentini from the SICaPS facility of the CNRS campus of Gif-sur-Yvette for performing LC-MS/MS analyses.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; BEC G, 1994, J BIOL CHEM, V269, P2086; BEC G, 1989, J BIOL CHEM, V264, P21131; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; BRANDSMA M, 1995, EUR J BIOCHEM, V233, P277, DOI 10.1111/j.1432-1033.1995.277_1.x; BRENNER S, 1974, GENETICS, V77, P71; Cerini C, 1997, EUR J BIOCHEM, V244, P176, DOI 10.1111/j.1432-1033.1997.00176.x; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; CIRAKOGLU B, 1985, BIOCHIM BIOPHYS ACTA, V829, P173, DOI 10.1016/0167-4838(85)90186-4; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Francklyn CS, 2010, FEBS LETT, V584, P366, DOI 10.1016/j.febslet.2009.11.045; Frechin M, 2010, FEBS LETT, V584, P427, DOI 10.1016/j.febslet.2009.11.037; Golinelli-Cohen MP, 2007, MOL CELL BIOCHEM, V300, P47, DOI 10.1007/s11010-006-9367-4; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Hausmann CD, 2008, FEBS LETT, V582, P2178, DOI 10.1016/j.febslet.2008.05.043; Havrylenko S, 2010, PROTEIN SCI, V19, P2475, DOI 10.1002/pro.529; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jiang SL, 2005, FEBS LETT, V579, P6049, DOI 10.1016/j.febslet.2005.09.062; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; KAO J, 1994, J BIOL CHEM, V269, P9774; Karanasios E, 2010, FEBS LETT, V584, P3842, DOI 10.1016/j.febslet.2010.08.023; KELLERMANN O, 1979, EUR J BIOCHEM, V99, P541, DOI 10.1111/j.1432-1033.1979.tb13286.x; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; KERJAN P, 1994, BBA-GEN SUBJECTS, V1199, P293, DOI 10.1016/0304-4165(94)90009-4; KERJAN P, 1992, BIOCHIMIE, V74, P195, DOI 10.1016/0300-9084(92)90046-H; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; LAZARD M, 1993, GENE, V132, P237, DOI 10.1016/0378-1119(93)90201-D; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; MIRANDE M, 1983, EUR J BIOCHEM, V131, P163, DOI 10.1111/j.1432-1033.1983.tb07244.x; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; Mirande M, 2010, FEBS LETT, V584, P443, DOI 10.1016/j.febslet.2009.11.027; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Polanowska J, 2004, BIOTECHNIQUES, V36, P778, DOI 10.2144/04365BM05; Praitis V, 2001, GENETICS, V157, P1217; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Zheng YG, 2006, BIOCHEMISTRY-US, V45, P1338, DOI 10.1021/bi051675n	52	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28476	28487		10.1074/jbc.M111.254037	http://dx.doi.org/10.1074/jbc.M111.254037			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685384	hybrid, Green Published			2022-12-27	WOS:000293557800063
J	Wu, SC; Zhang, Y				Wu, Susan C.; Zhang, Yi			Cyclin-dependent Kinase 1 (CDK1)-mediated Phosphorylation of Enhancer of Zeste 2 (Ezh2) Regulates Its Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; EMBRYONIC STEM-CELLS; SUPPRESSES METHYLATION; POLYCOMB; CANCER; DROSOPHILA; GENE; COMPLEX; DIFFERENTIATION	The H3K27 histone methyltransferase, Ezh2 (enhancer of zeste 2), is a Polycomb group protein that plays important roles in many biological processes including cellular differentiation, stem cell biology, and cancer development. Up-regulation of Ezh2 is observed in various human cancers consistent with its role in cell proliferation. Thus, understanding the regulation of Ezh2 may reveal how it contributes to the cellular proliferation process. Here, we demonstrate that Ezh2 can be regulated by the cyclin-dependent kinase, CDK1, which phosphorylates Ezh2 at threonines 345 and 487. Consistent with the cell cycle phase during which CDK1 exhibits peak activity, Ezh2 phosphorylation is enriched in cells arrested in mitosis when compared with S-phase. Phosphorylation of Thr-345 and Thr-487 promotes Ezh2 ubiquitination and subsequent degradation by the proteasome. Furthermore, expression of T345A/T487A confers a proliferative disadvantage when compared with cells expressing wild-type Ezh2, which suggests that phosphorylation of Ezh2 is important for cell proliferation. Collectively, these results establish a novel function for CDK1-mediated Ezh2 phosphorylation and provide a mechanism by which Ezh2 protein levels can be regulated in cells.	[Wu, Susan C.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	National Institutes of Health [GM68804]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68804 (to Y. Z.).	Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dimri M, 2010, CARCINOGENESIS, V31, P489, DOI 10.1093/carcin/bgp305; DUNCAN IM, 1982, GENETICS, V102, P49; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139	31	92	95	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28511	28519		10.1074/jbc.M111.240515	http://dx.doi.org/10.1074/jbc.M111.240515			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659531	hybrid, Green Published			2022-12-27	WOS:000293557800066
J	Veit, G; Zwolanek, D; Eckes, B; Niland, S; Kapyla, J; Zweers, MC; Ishada-Yamamoto, A; Krieg, T; Heino, J; Eble, JA; Koch, M				Veit, Guido; Zwolanek, Daniela; Eckes, Beate; Niland, Stephan; Kapyla, Jarmo; Zweers, Manon C.; Ishada-Yamamoto, Akemi; Krieg, Thomas; Heino, Jyrki; Eble, Johannes A.; Koch, Manuel			Collagen XXIII, Novel Ligand for Integrin alpha(2)beta(1) in the Epidermis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; BRANCHING MORPHOGENESIS; CELL-ADHESION; A-DOMAIN; I-DOMAIN; ALPHA-2-BETA-1; EXPRESSION; MIGRATION; RECEPTOR; ALPHA(1)BETA(1)	Cellular receptors for collagens belong to the family of beta(1) integrins. In the epidermis, integrin alpha(2)beta(1) is the only collagen-binding integrin present. Its expression is restricted to basal keratinocytes with uniform distribution on the cell surface of those cells. Although alpha(2)beta(1) receptors localized at the basal surface interact with basement membrane proteins collagen IV and laminin 111 and 332, no interaction partners have been reported for these integrin molecules at the lateral and apical membranes of basal keratinocytes. Solid phase binding and surface plasmon resonance spectroscopy demonstrate that collagen XXIII, a member of the transmembrane collagens, directly interacts with integrin alpha(2)beta(1) in an ion-and conformation-dependent manner. The two proteins co-localize on the surface of basal keratinocytes. Furthermore, collagen XXIII is sufficient to induce adhesion and spreading of keratinocytes, a process that is significantly reduced in the absence of functional integrin alpha(2)beta(1).	[Koch, Manuel] Univ Cologne, Fac Med, Inst Oral & Musculoskeletal Biol, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Veit, Guido; Zwolanek, Daniela] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Eckes, Beate; Zweers, Manon C.; Krieg, Thomas] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Kapyla, Jarmo; Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland; [Niland, Stephan; Eble, Johannes A.] Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, D-60590 Frankfurt, Germany; [Ishada-Yamamoto, Akemi] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; [Koch, Manuel] Univ Cologne, Sch Dent, Inst Oral & Musculoskeletal Biol, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Turku; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Asahikawa Medical College; University of Cologne	Koch, M (corresponding author), Univ Cologne, Fac Med, Inst Oral & Musculoskeletal Biol, Ctr Mol Med Cologne, Kerpener Str 32, D-50931 Cologne, Germany.	manuel.koch@uni-koeln.de	Veit, Guido/C-9596-2009; Zwolanek, Daniela/AAN-8767-2020; Koch, Manuel/AAG-9914-2021; Zweers, Manon/E-5090-2016	Veit, Guido/0000-0002-6758-2696; Koch, Manuel/0000-0002-2962-7814; Kapyla, Jarmo/0000-0003-3036-713X	Deutsche Forschungsgemeinschaft [EC140/5-1, SFB/TR 23, SFB815, SFB829]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants EC140/5-1 (to B. E. and T. K.), SFB/TR 23 and SFB815 (to J. A. E.), and SFB829 (to M. K., T. K., and B. E.).	Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Banyard J, 2003, J BIOL CHEM, V278, P20989, DOI 10.1074/jbc.M210616200; Banyard J, 2007, CLIN CANCER RES, V13, P2634, DOI 10.1158/1078-0432.CCR-06-2163; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Decline F, 2001, J CELL SCI, V114, P811; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Eble JA, 2006, J BIOL CHEM, V281, P25745, DOI 10.1074/jbc.M509942200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Galle J, 2002, CELL COMMUN ADHES, V9, P161, DOI 10.1080/15419060214523; Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Kapyla J, 2007, J MED CHEM, V50, P2742, DOI 10.1021/jm070063t; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Koivisto L, 1999, CELL ADHES COMMUN, V7, P245, DOI 10.3109/15419069909010806; Kuijpers MJE, 2007, THROMB HAEMOSTASIS, V98, P1072, DOI 10.1160/TH07-02-0089; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; PFAFF M, 1994, EUR J BIOCHEM, V225, P975, DOI 10.1111/j.1432-1033.1994.0975b.x; SAELMAN EUM, 1995, J CELL SCI, V108, P3531; SCHARFFETTERKOCHANEK K, 1992, J INVEST DERMATOL, V98, P3, DOI 10.1111/1523-1747.ep12493266; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Werr J, 2000, BLOOD, V95, P1804, DOI 10.1182/blood.V95.5.1804.005k11_1804_1809; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; WU JE, 1994, DEV DYNAM, V199, P292, DOI 10.1002/aja.1001990405; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Zigrino P, 2001, EUR J CELL BIOL, V80, P68, DOI 10.1078/0171-9335-00134; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	49	33	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27804	27813		10.1074/jbc.M111.220046	http://dx.doi.org/10.1074/jbc.M111.220046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652699	Green Published, hybrid			2022-12-27	WOS:000293268700072
J	Wall-Lacelle, S; Hossain, MI; Sauve, R; Blunck, R; Parent, L				Wall-Lacelle, Sebastien; Hossain, Md. Israil; Sauve, Remy; Blunck, Rikard; Parent, Lucie			Double Mutant Cycle Analysis Identified a Critical Leucine Residue in the IIS4S5 Linker for the Activation of the Ca(V)2.3 Calcium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNELS; CLOSED-STATE INACTIVATION; GATED CA2+ CHANNELS; I-II LINKER; VOLTAGE SENSOR; S4-S5 LINKER; BETA-SUBUNIT; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; FUNCTIONAL EXPRESSION	Mutations in distal S6 were shown to significantly alter the stability of the open state of Ca(V)2.3 (Raybaud, A., Baspinar, E. E., Dionne, F., Dodier, Y., Sauve, R., and Parent, L. (2007) J. Biol. Chem. 282, 27944-27952). By analogy with K-V channels, we tested the hypothesis that channel activation involves electro-mechanical coupling between S6 and the S4S5 linker in Ca(V)2.3. Among the 11 positions tested in the S4S5 linker of domain II, mutations of the leucine residue at position 596 were found to destabilize significantly the closed state with a -50 mV shift in the activation potential and a -20 mV shift in its charge-voltage relationship as compared with Ca(V)2.3 wt. Adouble mutant cycle analysis was performed by introducing pairs of glycine residues between S4S5 and S6 of Domain II. Strong coupling energies (Delta Delta G(interact) > 2 kcal mol(-1)) were measured for the activation gating of 12 of 39 pairs of mutants. Leu-596 (IIS4S5) was strongly coupled with distal residues in IIS6 from Leu-699 to Asp-704. In particular, the double mutant L596G/I701G showed strong cooperativity with a Delta Delta G(interact) approximate to 6 kcal mol(-1) suggesting that both positions contribute to the activation gating of the channel. Altogether, our results highlight the role of a leucine residue in S4S5 and provide the first series of evidence that the IIS4S5 and IIS6 regions are energetically coupled during the activation of a voltage-gated Ca-V channel.	[Hossain, Md. Israil; Sauve, Remy; Parent, Lucie] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Wall-Lacelle, Sebastien; Blunck, Rikard] Univ Montreal, Membrane Prot Res Grp, Dept Phys, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Parent, L (corresponding author), Univ Montreal, Dept Physiol, POB 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca	Blunck, Rikard/L-4226-2013; Blunck, Rikard/AAM-3078-2020	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Canadian Institutes of Health Research [MOP13390]; Canadian Heart and Stroke Foundation; FRSQ	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Grant MOP13390 and a grant from the Canadian Heart and Stroke Foundation (to L. P.).; Members of the FRSQ-supported "Groupe d'etude des proteines membranaires."	Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Berrou L, 2005, J BIOL CHEM, V280, P494, DOI 10.1074/jbc.M410859200; Berrou L, 2001, BIOPHYS J, V80, P215, DOI 10.1016/S0006-3495(01)76008-0; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Findeisen F, 2009, J GEN PHYSIOL, V133, P327, DOI 10.1085/jgp.200810143; Gagnon DG, 2010, J GEN PHYSIOL, V136, P555, DOI 10.1085/jgp.201010487; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Haddad GA, 2011, J GEN PHYSIOL, V137, P455, DOI 10.1085/jgp.201010573; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kudrnac M, 2009, J BIOL CHEM, V284, P12276, DOI 10.1074/jbc.M808402200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kusch J, 2010, BIOPHYS J, V99, P2488, DOI 10.1016/j.bpj.2010.07.041; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; Meza U, 2007, MOL PHARMACOL, V71, P284, DOI 10.1124/mol.106.028530; Olcese R, 1996, J PHYSIOL-LONDON, V497, P675, DOI 10.1113/jphysiol.1996.sp021799; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Raybaud A, 2007, J BIOL CHEM, V282, P27944, DOI 10.1074/jbc.M703895200; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; SCHNEIDER T, 1994, RECEPTOR CHANNEL, V2, P255; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	47	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27197	27205		10.1074/jbc.M111.237412	http://dx.doi.org/10.1074/jbc.M111.237412			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652722	Green Published, hybrid			2022-12-27	WOS:000293268700015
J	Le May, M; Mach, H; Lacroix, N; Hou, CC; Chen, JH; Li, Q				Le May, Melanie; Mach, Hymn; Lacroix, Natascha; Hou, Chenchen; Chen, Jihong; Li, Qiao			Contribution of Retinoid X Receptor Signaling to the Specification of Skeletal Muscle Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; TRANSCRIPTIONAL COACTIVATOR P300; AKT/PROTEIN KINASE-B; STEM-CELLS; RXR-ALPHA; VALPROIC ACID; BETA-CATENIN; P19 CELLS; DIFFERENTIATION; EXPRESSION	Pluripotent stem cells possess a tremendous potential for the treatment of many diseases because of their capacity to differentiate into a variety of cell lineages. However, they provide little promise for muscle-related diseases, mainly because of the lack of small molecule inducers to efficiently direct myogenic conversion. Retinoic acid, acting through the retinoic acid receptor (RAR) and retinoid X receptor (RXR), affects stem cell fate determination in a concentration-dependent manner, but it only has a modest efficacy on the commitment of ES cells into skeletal muscle lineage. The RXR is very important for embryonic development but is generally considered to act as a silent partner of RAR in a non-permissive mode. In this study, we have examined whether activation of the RXR by rexinoid or RXR-specific signaling play a role in the specification of stem cells into muscle lineage. Our findings demonstrate that mouse ES cells generate skeletal myocytes effectively upon treatment with rexinoid at the early stage of differentiation and that on a molecular level, rexinoid-enhanced myogenesis simulates the sequential events observed in vivo. Moreover, RXR-mediated myogenic conversion requires the function of beta-catenin but not RAR. Our studies establish the feasibility of applying the RXR agonist in cell-based therapies to treat muscle-related diseases. The aptitude of mouse ES cells to generate skeletal myocytes following rexinoid induction also provides a model system to study the convergence of different signaling pathways in myogenesis.	[Mach, Hymn; Lacroix, Natascha; Hou, Chenchen; Chen, Jihong; Li, Qiao] Univ Ottawa, Dept Pathol & Lab Med, Fac Med, Ottawa, ON K1H 8M5, Canada; [Le May, Melanie; Li, Qiao] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Li, Q (corresponding author), Univ Ottawa, Dept Pathol & Lab Med, Fac Med, 451 Smyth Rd,Room 2537, Ottawa, ON K1H 8M5, Canada.	qiaoli@uottawa.ca		Li, Qiao/0000-0002-5941-1985; Chen, Jihong/0000-0001-7336-8808	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Natural Sciences and Engineering Research Council of Canada and by a graduate scholarship award from the Canadian Institutes of Health Research (to M. L.).	Allsopp TE, 2010, MEDCHEMCOMM, V1, P16, DOI 10.1039/c0md00055h; Berbis P, 2010, ANN DERMATOL VENER, V137, pS97, DOI 10.1016/S0151-9638(10)70036-3; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen J, 2004, CELL MOL LIFE SCI, V61, P1675, DOI 10.1007/s00018-004-4103-9; Chen JH, 2005, MOL CELL BIOL, V25, P525, DOI 10.1128/MCB.25.2.525-532.2005; Chen JH, 2007, EPIGENETICS-US, V2, P92, DOI 10.4161/epi.2.2.4326; Chen JH, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-71; Chen JH, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12224; Costa SL, 1996, EXP CELL RES, V225, P35, DOI 10.1006/excr.1996.0154; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Francetic T, 2011, TRANSCR-AUSTIN, V2, P109, DOI 10.4161/trns.2.3.15829; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Higazi A, 2011, EPIGENETICS-US, V6, P202, DOI 10.4161/epi.6.2.13658; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; PRATT MAC, 1990, MOL CELL BIOL, V10, P6445, DOI 10.1128/MCB.10.12.6445; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; RUDNICKI MA, 1989, DEVELOPMENT, V107, P361; Sapin V, 1997, DEV BIOL, V191, P29, DOI 10.1006/dbio.1997.8687; Sato Y, 2008, DEV BIOL, V320, P185, DOI 10.1016/j.ydbio.2008.05.524; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tanaka T, 2009, CANCER RES, V69, P4945, DOI 10.1158/0008-5472.CAN-08-4407; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Yokota Y, 1996, EXP CELL RES, V228, P1, DOI 10.1006/excr.1996.0291; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	45	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26806	26812		10.1074/jbc.M111.227058	http://dx.doi.org/10.1074/jbc.M111.227058			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653693	Green Published, hybrid			2022-12-27	WOS:000293078200056
J	Liang, QL; Wu, QA; Jiang, JH; Duan, JA; Wang, C; Smith, MD; Lu, H; Wang, Q; Nagarkatti, P; Fan, DP				Liang, Qiaoli; Wu, Qinan; Jiang, Jihong; Duan, Jin'ao; Wang, Chao; Smith, Mark D.; Lu, Hong; Wang, Qian; Nagarkatti, Prakash; Fan, Daping			Characterization of Sparstolonin B, a Chinese Herb-derived Compound, as a Selective Toll-like Receptor Antagonist with Potent Anti-inflammatory Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE CELLS; DOUBLE-BLIND; INNATE; ACTIVATION; EXPRESSION; TOLL-LIKE-RECEPTOR-4; INFLAMMATION; TAK-242; MICE; TLR	BlockadeofexcessiveToll-likereceptor(TLR) signalingisatherapeutic approach being actively pursued for many inflammatory diseases. Here we report a Chinese herb-derived compound, sparstoloninB(SsnB), which selectively blocks TLR2-and TLR4-mediated inflammatory signaling. SsnB was isolated from a Chinese herb, Spaganium stoloniferum; its structure was determined by NMR spectroscopy and x-ray crystallography. SsnB effectively inhibited inflammatory cytokine expression in mouse macrophages induced by lipopolysaccharide (LPS, a TLR4 ligand), Pam3CSK4 (a TLR1/TLR2 ligand), and Fsl-1 (a TLR2/TLR6 ligand) but not that by poly(I: C) (a TLR3 ligand) or ODN1668 (a TLR9 ligand). It suppressed LPS-induced cytokine secretion from macrophages and diminished phosphorylation of Erk1/2, p38a, I kappa B alpha, and JNK in these cells. In THP-1 cells expressing a chimeric receptor CD4-TLR4, which triggers constitutive NF-kappa Bactivation, SsnB effectively blunted the NF-kappa B activity. Co-immunoprecipitation showed that SsnB reduced the association of MyD88 with TLR4 and TLR2, but not that with TLR9, in HEK293T cells and THP-1 cells overexpressing MyD88 and TLRs. Furthermore, administration of SsnB suppressed splenocyte inflammatory cytokine expression in mice challenged with LPS. These results demonstrate that SsnB acts as a selective TLR2 and TLR4 antagonist by blocking the early intracellular events in the TLR2 and TLR4 signaling. Thus, SssB may serve as a promising lead for the development of selective TLR antagonistic agents for inflammatory diseases.	[Liang, Qiaoli; Lu, Hong; Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29209 USA; [Nagarkatti, Prakash] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA; [Liang, Qiaoli; Wu, Qinan; Duan, Jin'ao] Nanjing Univ Chinese Med, Sch Pharm, Nanjing 210046, Peoples R China; [Jiang, Jihong] Xuzhou Normal Univ, Key Lab Biotechnol Med Plant Jiangsu Prov, Xuzhou 221116, Peoples R China; [Wang, Chao; Smith, Mark D.; Wang, Qian] Univ S Carolina, Dept Chem & Biochem, Coll Arts & Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Nanjing University of Chinese Medicine; Jiangsu Normal University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Fan, DP (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29209 USA.	daping.fan@uscmed.sc.edu	Lu, Hong S./ABH-3929-2020	Lu, Hong/0000-0002-0577-2558; Nagarkatti, Prakash/0000-0003-2663-0759; Smith, Mark/0000-0001-6977-7131; Wang, Qian/0000-0002-2149-384X; Wu, Qinan/0000-0002-7836-0941	National Institutes of Health [P01AT003961, P20 RR-016434, P20 RR-016461]; National Science Foundation/EPSCoR under Cooperative Agreement [EPS-0903795]; National Natural Science Foundation of China [81073002]; Innovation Grant of Production, Study, and Research (Jiangsu, China) [BY2009116]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434, UL1RR029882, P20RR016461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation/EPSCoR under Cooperative Agreement(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Grant of Production, Study, and Research (Jiangsu, China); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AT003961, P20 RR-016434, and P20 RR-016461. This work was also supported by the National Science Foundation/EPSCoR under Cooperative Agreement EPS-0903795, the National Natural Science Foundation of China (81073002), and by an Innovation Grant of Production, Study, and Research (Jiangsu, China, BY2009116).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; [Anonymous], 2000, PHARMACOPOEIA COMM 1, P11; Barochia AV, 2010, CRIT CARE MED, V38, P306, DOI 10.1097/CCM.0b013e3181b77fe3; Bennett-Guerrero E, 2007, ANESTH ANALG, V104, P378, DOI 10.1213/01.ane.0000253501.07183.2a; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Caso JR, 2008, STROKE, V39, P1314, DOI 10.1161/STROKEAHA.107.498212; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; de Oliveira FJ, 2010, REV BRAS CIR CARDIOV, V25, P51, DOI 10.1590/S0102-76382010000100013; Gomariz RP, 2005, J LEUKOCYTE BIOL, V78, P491, DOI 10.1189/jlb.1004564; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hua HM, 2007, FITOTERAPIA, V78, P274, DOI 10.1016/j.fitote.2006.11.014; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Inaba H, 2010, J PHARMACOL SCI, V113, P103, DOI 10.1254/jphs.09R23FM; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kolek MJ, 2004, AM HEART J, V148, P1034, DOI 10.1016/j.ahj.2004.05.049; Kuno M, 2009, CLIN EXP PHARMACOL P, V36, P589, DOI 10.1111/j.1440-1681.2008.05121.x; Lakhani SA, 2003, CURR OPIN PEDIATR, V15, P278, DOI 10.1097/00008480-200306000-00009; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Ledeboer A, 2006, NEURON GLIA BIOL, V2, P279, DOI 10.1017/S1740925X0700035X; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lee SY, 2010, ARCH PHARM RES, V33, P515, DOI 10.1007/s12272-010-0404-1; Li SX, 2010, J ASIAN NAT PROD RES, V12, P331, DOI 10.1080/10286021003730330; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Opal SM, 2002, J ENDOTOXIN RES, V8, P473, DOI 10.1179/096805102125001109; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pinto MMM, 2005, CURR MED CHEM, V12, P2517, DOI 10.2174/092986705774370691; Pochet L, 2004, CURR PHARM DESIGN, V10, P3781, DOI 10.2174/1381612043382684; Qiu C., 2008, PHARM CLIN CHINESE M, V14, P7; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Salomao R, 2008, SHOCK, V30, P73, DOI 10.1097/SHK.0b013e318181af2a; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Xiong Y, 2009, ARCH PHARM RES, V32, P717, DOI 10.1007/s12272-009-1510-9; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yethon J. A., 2001, Current Drug Targets - Infectious Disorders, V1, P91, DOI 10.2174/1568005014606143; Zipris D, 2005, J IMMUNOL, V174, P131, DOI 10.4049/jimmunol.174.1.131	58	92	101	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26470	26479		10.1074/jbc.M111.227934	http://dx.doi.org/10.1074/jbc.M111.227934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21665946	hybrid, Green Published			2022-12-27	WOS:000293078200025
J	Nagata, E; Saiardi, A; Tsukamoto, H; Okada, Y; Itoh, Y; Satoh, T; Itoh, J; Margolis, RL; Takizawa, S; Sawa, A; Takagi, S				Nagata, Eiichiro; Saiardi, Adolfo; Tsukamoto, Hideo; Okada, Yoshinori; Itoh, Yoshiko; Satoh, Tadayuki; Itoh, Johbu; Margolis, Russell L.; Takizawa, Shunya; Sawa, Akira; Takagi, Shigeharu			Inositol Hexakisphosphate Kinases Induce Cell Death in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA; PYROPHOSPHATES; AUTOPHAGY; GROWTH; MODEL; AKT; POLYPHOSPHATES; LYMPHOBLASTS; LENGTH; MTOR	Inositol pyrophosphate diphosphoinositol pentakisphosphate is ubiquitously present in mammalian cells and contains highly energetic pyrophosphate bonds. We have previously reported that inositol hexakisphosphate kinase type 2 (InsP(6)K(2)), which converts inositol hexakisphosphate to inositol pyrophosphate diphosphoinositol pentakisphosphate, mediates apoptotic cell death via its translocation from the nucleus to the cytoplasm. Here, we report that InsP(6)K2 is localized mainly in the cytoplasm of lymphoblast cells from patients with Huntington disease (HD), whereas this enzyme is localized in the nucleus in control lymphoblast cells. The large number of autophagosomes detected in HD lymphoblast cells is consistent with the down-regulation of Akt in response to InsP(6)K2 activation. Consistent with these observations, the overexpression of InsP(6)Ks leads to the depletion of Akt phosphorylation and the induction of cell death. These results suggest that InsP(6)K2 activation is associated with the pathogenesis of HD.	[Nagata, Eiichiro; Takizawa, Shunya; Takagi, Shigeharu] Tokai Univ, Sch Med, Dept Neurol, Kanagawa 2591193, Japan; [Tsukamoto, Hideo; Okada, Yoshinori; Itoh, Yoshiko; Satoh, Tadayuki; Itoh, Johbu] Tokai Univ, Sch Med, Teaching & Res Support Ctr, Kanagawa 2591193, Japan; [Saiardi, Adolfo] UCL, Med Res Council Lab Mol Cell Biol, Cell Biol Unit, London WC1E 6BT, England; [Saiardi, Adolfo] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Margolis, Russell L.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Neurol, Baltimore, MD 21287 USA; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Tokai University; Tokai University; University of London; University College London; University of London; University College London; Johns Hopkins University; Johns Hopkins University	Nagata, E (corresponding author), Tokai Univ, Sch Med, Dept Neurol, 143 Shimo Kasuya, Kanagawa 2591193, Japan.	enagata@is.icc.u-tokai.ac.jp			MRC [MC_U122680443] Funding Source: UKRI; Medical Research Council [MC_U122680443] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Heng MY, 2010, HUM MOL GENET, V19, P3702, DOI 10.1093/hmg/ddq285; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Itoh Y, 1996, PATHOL INT, V46, P726, DOI 10.1111/j.1440-1827.1996.tb03541.x; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mikoshiba Katsuhiko, 1994, Seminars in Cell Biology, V5, P273, DOI 10.1006/scel.1994.1033; Morrison BH, 2002, ONCOGENE, V21, P1882, DOI 10.1038/sj.onc.1205265; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Nagata E, 2004, NEUROREPORT, V15, P1325, DOI 10.1097/01.wnr.0000127073.66692.8f; Nagata E, 2010, INT J BIOCHEM CELL B, V42, P2065, DOI 10.1016/j.biocel.2010.09.013; Penno M. B., 1993, Journal of Tissue Culture Methods, V15, P43, DOI 10.1007/BF02387289; Rhodes D, 2002, EMBO REP, V3, P1139, DOI 10.1093/embo-reports/kvf246; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305	33	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26680	26686		10.1074/jbc.M111.220749	http://dx.doi.org/10.1074/jbc.M111.220749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652713	hybrid, Green Published			2022-12-27	WOS:000293078200045
J	Yang, GD; Pei, YX; Teng, HJ; Cao, QJ; Wang, R				Yang, Guangdong; Pei, Yanxi; Teng, Huajian; Cao, Qiuhui; Wang, Rui			Specificity Protein-1 as a Critical Regulator of Human Cystathionine gamma-Lyase in Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; SP1 PHOSPHORYLATION; PROMOTER ACTIVITY; INTIMAL HYPERPLASIA; NEOINTIMA FORMATION; IN-VITRO; DIFFERENTIATION; H2S	Cystathionine gamma-lyase (CSE) is the major enzyme in vascular smooth muscle cells (SMCs) that catalyzes the endogenous production of H2S. Phenotypic switching of SMCs is affected by endogenous H2S level and alterations of this switching may result in vascular disorders. To date, the mechanisms underlying the alteration of CSE expression and H2S production in vascular proliferative diseases have been unclear. In the present study, we found that serum deprivation induced SMC differentiation marker gene expressions and increased CSE expression and H2S production in cultured human aorta SMCs (HASMCs). Carotid artery ligation in mice resulted in enhanced neointima formation and down-regulation of CSE expression, suggesting an important role of CSE in SMC differentiation. Transient transfection of HASMCs with human CSE (hCSE) promoter/luciferase reporter revealed that the region between -226 to + 140 base pair contains the core promoter for the hCSE gene. Deletion and mutation analysis demonstrated that two specificity protein-1 (Sp1) consensus binding sites were present in the core promoter region of the hCSE gene. Incubation of HASMCs with Sp1 binding inhibitor mithramycin inhibited CSE mRNA expression in a dose-dependent manner. Overexpression of Sp1 alone was sufficient to increase the activity of the hCSE core promoter and CSE protein expression. Chromatin immunoprecipitation assay showed that the binding of Sp1 to the hCSE promoter was increased in differentiated HASMCs compared with that in proliferated HASMCs. Exogenously applied H2S at 100 mu M stimulated SMC differentiation, which was reversed by p38 MAPK inhibitor SB203580. These results suggest that transcript factor Sp1 is a critical regulator of the hCSE expression during SMC differentiation, and CSE/H2S system is essential for maintenance of SMC phenotype.	[Yang, Guangdong] Lakehead Univ, Sch Kinesiol, Thunder Bay, ON P7B 5E1, Canada; [Pei, Yanxi; Teng, Huajian; Cao, Qiuhui; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Pei, Yanxi] Shanxi Univ, Coll Life Sci, Taiyuan 030006, Peoples R China	Lakehead University; Lakehead University; Shanxi University	Yang, GD (corresponding author), 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	gyang@lakeheadu.ca	Wang, Rui/C-7824-2012; Yang, Guangdong/G-4129-2011; Pei, Yanxi/H-1501-2016	Wang, Rui/0000-0003-3825-3620; Pei, Yanxi/0000-0002-8428-3399	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by grants from Canadian Institutes of Health Research (to G. Y. and R. W.).; Supported by a New Investigator Award from Heart and Stroke Foundation of Canada and a Maureen Andrew New Investigator award from Heart and Stroke Foundation of Ontario. To whom correspondence should be addressed: 955 Oliver Rd., Thunder Bay, Ontario, P7B 5E1, Canada. Tel.: 807-346-7937; Fax: 807-346-7873; E-mail: gyang@lakeheadu.ca.	Andres V, 2001, ARTERIOSCL THROM VAS, V21, P342, DOI 10.1161/01.ATV.21.3.342; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Ellenrieder V, 2008, ANTICANCER RES, V28, P1531; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Gao L, 2005, BBA-GENE STRUCT EXPR, V1681, P175, DOI 10.1016/j.bbaexp.2004.10.008; Ge YW, 2004, J NEUROCHEM, V90, P1432, DOI 10.1111/j.1471-4159.2004.02608.x; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; GLODE LM, 1981, CANCER RES, V41, P2249; Grond-Ginsbach C, 2010, CELL MOL LIFE SCI, V67, P1799, DOI 10.1007/s00018-010-0276-z; Han M, 2006, AM J PHYSIOL-CELL PH, V291, pC50, DOI 10.1152/ajpcell.00524.2005; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Hui DY, 2008, CURR DRUG TARGETS, V9, P251, DOI 10.2174/138945008783755601; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Jain MK, 1998, J BIOL CHEM, V273, P5993, DOI 10.1074/jbc.273.11.5993; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; KLEIN CE, 1988, CANCER, V62, P291, DOI 10.1002/1097-0142(19880715)62:2<291::AID-CNCR2820620211>3.0.CO;2-Q; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; LINK D, 1983, BLUT, V47, P31, DOI 10.1007/BF00321048; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Maruyama I, 2000, CURR EYE RES, V21, P886, DOI 10.1076/ceyr.21.5.886.5538; Matsushita T, 2007, EUR J CELL BIOL, V86, P617, DOI 10.1016/j.ejcb.2007.06.005; Meng QH, 2007, AM J PATHOL, V170, P1406, DOI 10.2353/ajpath.2007.060939; Metharom P, 2007, CURR VASC PHARMACOL, V5, P61, DOI 10.2174/157016107779317215; Okamoto Y, 2001, BIOCHEM BIOPH RES CO, V288, P940, DOI 10.1006/bbrc.2001.5860; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Ounallah-Saad H, 2009, GENE, V446, P81, DOI 10.1016/j.gene.2009.06.015; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Plath M, 2007, MOL ECOL, V16, P967, DOI 10.1111/j.1365-294X.2006.03212.x; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Reisinger K, 2003, J CELL SCI, V116, P225, DOI 10.1242/jcs.00237; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Santiago FS, 2007, CIRC RES, V101, P146, DOI 10.1161/CIRCRESAHA.106.145235; Santiago FS, 2004, CIRC RES, V95, P479, DOI 10.1161/01.RES.0000141135.36279.67; SASAGAWA M, 1987, PLACENTA, V8, P515, DOI 10.1016/0143-4004(87)90080-4; Schafer D, 1997, FEBS LETT, V417, P325, DOI 10.1016/S0014-5793(97)01314-8; Sellak H, 2002, CIRC RES, V90, P405, DOI 10.1161/hh0402.105898; Shi YX, 2007, AM J PHYSIOL-HEART C, V293, pH2093, DOI 10.1152/ajpheart.00088.2007; Sreejayan Nair, 2007, V139, P283; Sun XF, 2004, BIOCHEM PHARMACOL, V67, P147, DOI 10.1016/j.bcp.2003.08.041; Takeda T, 2007, PLACENTA, V28, P192, DOI 10.1016/j.placenta.2006.03.002; Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xuan ZY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2002-4-1-r1; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu XY, 2010, CELL MOL LIFE SCI, V67, P1119, DOI 10.1007/s00018-009-0250-9; Zu Xuyu, 2009, BMC Res Notes, V2, P175, DOI 10.1186/1756-0500-2-175	60	66	66	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26450	26460		10.1074/jbc.M111.266643	http://dx.doi.org/10.1074/jbc.M111.266643			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659522	hybrid, Green Published			2022-12-27	WOS:000293078200023
J	Dang, LT; Purvis, AR; Huang, RH; Westfield, LA; Sadler, JE				Dang, Luke T.; Purvis, Angie R.; Huang, Ren-Huai; Westfield, Lisa A.; Sadler, J. Evan			Phylogenetic and Functional Analysis of Histidine Residues Essential for pH-dependent Multimerization of von Willebrand Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN VONWILLEBRAND-FACTOR; SEQUENCE POLYMORPHISMS; TERMINAL DOMAINS; PROPEPTIDE; IDENTIFICATION; MUCIN; CDNA; ACTIVATION; EVOLUTION; CLEAVAGE	von Willebrand factor (VWF) is a multimeric plasma protein that mediates platelet adhesion to sites of vascular injury. The hemostatic function of VWF depends upon the formation of disulfide-linked multimers, which requires the VWF propeptide (D1D2 domains) and adjacent D'D3 domains. VWF multimer assembly occurs in the trans-Golgi at pH similar to 6.2 but not at pH 7.4, which suggests that protonation of one or more His residues (pK(a) similar to 6.0) mediates the pH dependence of multimerization. Alignment of 30 vertebrate VWF sequences identified 13 highly conserved His residues in the D1D2D'D3 domains, and His-to-Ala mutagenesis identified His(395) and His(460) in the D2 domain as critical for VWF multimerization. Replacement of His(395) with Lys or Arg prevented multimer assembly, suggesting that reversible protonation of this His residue is essential. In contrast, replacement of His(460) with Lys or Arg preserved normal multimer assembly, whereas Leu, Met, and Gln did not, indicating that the function of His(460) depends primarily upon the presence of a positive charge. These results suggest that pH sensing by evolutionarily conserved His residues facilitates the assembly and packaging of VWF multimers upon arrival in the trans-Golgi.	[Sadler, J. Evan] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Sadler, JE (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid,Box 8125, St Louis, MO 63110 USA.	esadler@dom.wustl.edu		Sadler, J. Evan/0000-0001-5705-469X	National Institutes of Health [HL72917]; American Heart Association [0825817G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL72917 (to J. E. S.) and by American Heart Association Midwest Affiliate Postdoctoral Fellowship Award 0825817G (to R. H. H.).	Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Bodo I, 2001, BLOOD, V98, P2973, DOI 10.1182/blood.V98.10.2973; BONTHRON D, 1986, NUCLEIC ACIDS RES, V14, P7125, DOI 10.1093/nar/14.17.7125; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kulkarni MV, 2010, J BIOL CHEM, V285, P38524, DOI 10.1074/jbc.M110.172072; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; MANCUSO DJ, 1991, BIOCHEMISTRY-US, V30, P253, DOI 10.1021/bi00215a036; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; MAYADAS TN, 1992, P NATL ACAD SCI USA, V89, P3531, DOI 10.1073/pnas.89.8.3531; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; PerezVilar J, 1996, J BIOL CHEM, V271, P9845, DOI 10.1074/jbc.271.16.9845; Purvis AR, 2004, J BIOL CHEM, V279, P49982, DOI 10.1074/jbc.M408727200; RAINES G, 1990, THROMB RES, V60, P201, DOI 10.1016/0049-3848(90)90181-B; REHEMTULLA A, 1992, BLOOD, V79, P2349; Rosenberg JB, 2002, BLOOD, V100, P1699, DOI 10.1182/blood-2002-03-0789; SADLER JE, 1985, P NATL ACAD SCI USA, V82, P6394, DOI 10.1073/pnas.82.19.6394; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; SHELTONINLOES BB, 1986, BIOCHEMISTRY-US, V25, P3164, DOI 10.1021/bi00359a014; SHELTONINLOES BB, 1987, BIOCHEM BIOPH RES CO, V144, P657, DOI 10.1016/S0006-291X(87)80016-5; TULEY EA, 1991, P NATL ACAD SCI USA, V88, P6377, DOI 10.1073/pnas.88.14.6377; VOORBERG J, 1990, EMBO J, V9, P797, DOI 10.1002/j.1460-2075.1990.tb08176.x; WAGNER DD, 1986, J CELL BIOL, V102, P1320, DOI 10.1083/jcb.102.4.1320; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905	37	21	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25763	25769		10.1074/jbc.M111.249151	http://dx.doi.org/10.1074/jbc.M111.249151			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21592973	Green Published, hybrid			2022-12-27	WOS:000293073000038
J	Dey, N; Das, F; Mariappan, MM; Mandal, CC; Ghosh-Choudhury, N; Kasinath, BS; Choudhury, GG				Dey, Nirmalya; Das, Falguni; Mariappan, Meenalakshmi M.; Mandal, Chandi Charan; Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh			MicroRNA-21 Orchestrates High Glucose-induced Signals to TOR Complex 1, Resulting in Renal Cell Pathology in Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; INDUCED COLLAGEN EXPRESSION; GROWTH-FACTOR-BETA; MESANGIAL CELLS; FIBRONECTIN EXPRESSION; SUPEROXIDE-DISMUTASE; EPITHELIAL-CELLS; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; TRANSGENIC MICE	Hyperglycemia induces a wide array of signaling pathways in the kidney that lead to hypertrophy and matrix expansion, eventually culminating in progressive kidney failure. High glucose-induced reduction of the tumor suppressor protein phosphatase and tensin homolog deleted in chromosome 10 (PTEN) contributes to renal cell hypertrophy and matrix expansion. We identified microRNA-21 (miR-21) as the molecular link between high glucose and PTEN suppression. Renal cortices from OVE26 type 1 diabetic mice showed significantly elevated levels of miR-21 associated with reduced PTEN and increased fibronectin content. In renal mesangial cells, high glucose increased the expression of miR-21, which targeted the 3'-UTR of PTEN mRNA to inhibit PTEN protein expression. Overexpression of miR-21 mimicked the action of high glucose, which included a reduction in PTEN expression and a concomitant increase in Akt phosphorylation. In contrast, expression of miR-21 Sponge, to inhibit endogenous miR-21, prevented down-regulation of PTEN and phosphorylation of Akt induced by high glucose. Interestingly, high glucose-stimulated miR-21 inactivated PRAS40, a negative regulator of TORC1. Finally, miR-21 enhanced high glucose-induced TORC1 activity, resulting in renal cell hypertrophy and fibronectin expression. Thus, our results identify a previously unrecognized function of miR-21 that is the reciprocal regulation of PTEN levels and Akt/TORC1 activity that mediate critical pathologic features of diabetic kidney disease.	[Dey, Nirmalya; Das, Falguni; Mariappan, Meenalakshmi M.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Mandal, Chandi Charan; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RO1 DK50190, RO1 AR52425, DK077295, RC2A 036613]; Juvenile Diabetes Research Foundation [1-2008-185]; Veterans Affairs; Cancer Therapy and Research Center, San Antonio, TX; Veterans Affairs Research Service; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190, R01DK077295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs(US Department of Veterans Affairs); Cancer Therapy and Research Center, San Antonio, TX; Veterans Affairs Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK50190 (to G. G. C.), RO1 AR52425 (to N. G. C.), and DK077295 and RC2A 036613 (to B. S. K.). This work was also supported by Juvenile Diabetes Research Foundation Grant 1-2008-185 (to G. G. C.).; Supported by a Veterans Affairs merit review grant and a Ronald P. Williams Orthopedic Oncology Developmental Research Award from the Cancer Therapy and Research Center, San Antonio, TX.; Supported by a grant from the Veterans Affairs Research Service.	Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chen JK, 2005, J AM SOC NEPHROL, V16, P1384, DOI 10.1681/ASN.2004100894; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Choudhury GG, 1998, J CLIN INVEST, V101, P2751, DOI 10.1172/JCI1044; Choundhury GG, 1999, J BIOL CHEM, V274, P10897; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Craven PA, 2001, DIABETES, V50, P2114, DOI 10.2337/diabetes.50.9.2114; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; DeRubertis FR, 2004, DIABETES, V53, P762, DOI 10.2337/diabetes.53.3.762; DeRubertis FR, 2007, METABOLISM, V56, P1256, DOI 10.1016/j.metabol.2007.04.024; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fonseca BD, 2008, BIOCHEM J, V411, P141, DOI 10.1042/BJ20071001; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Heilig Charles W., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010490; Heilig CW, 2001, AM J PHYSIOL-RENAL, V280, pF657, DOI 10.1152/ajprenal.2001.280.4.F657; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; HOSTETTER TH, 1995, ANNU REV PHYSIOL, V57, P263, DOI 10.1146/annurev.ph.57.030195.001403; Huang HC, 2000, KIDNEY INT, V58, P162, DOI 10.1046/j.1523-1755.2000.00151.x; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lehmann R, 2000, CLIN CHIM ACTA, V297, P135, DOI 10.1016/S0009-8981(00)00240-0; Liang MY, 2009, AM J PHYSIOL-RENAL, V297, pF553, DOI 10.1152/ajprenal.00045.2009; Linden KC, 2006, AM J PHYSIOL-RENAL, V290, pF205, DOI 10.1152/ajprenal.00237.2004; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang G, 2010, LAB INVEST, V90, P98, DOI 10.1038/labinvest.2009.118; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Wilson-O'Brien AL, 2008, ENDOCRINOLOGY, V149, P917, DOI 10.1210/en.2007-0985; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248	81	184	200	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25586	25603		10.1074/jbc.M110.208066	http://dx.doi.org/10.1074/jbc.M110.208066			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613227	Green Published, hybrid			2022-12-27	WOS:000293073000021
J	Kumar, S; Hinks, JA; Maman, J; Ravirajan, CT; Pearl, LH; Isenberg, DA				Kumar, Sanjeev; Hinks, John A.; Maman, Joseph; Ravirajan, Chelliah T.; Pearl, Laurence H.; Isenberg, David A.			p185, an Immunodominant Epitope, Is an Autoantigen Mimotope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTI-DNA ANTIBODIES; MONOCLONAL-ANTIBODY; PEPTIDE LIBRARIES; TYROSINE KINASES; CARCINOMA CELLS; MAMMALIAN DNA; NEU ONCOGENE; EXPRESSION; C-ERBB-2	An immunodominant peptide (p185(378-394)) derived from the c-erbB2 gene product, was recognized by an anti-DNA antibody, B3, and importantly by two classical DNA-binding proteins, Tgo polymerase and Pa-UDG. These reactivities were inhibited by DNA, confirming that the peptide mimicked DNA. BALB/c mice immunized with p185(378-394) developed significant titers of IgG anti-dsDNA antibodies. Screening of 39 human lupus sera revealed that 5% of these sera possessed reactivity toward p185(378-394). Representative mouse and human sera with anti-p185(378-394) reactivity bound intact p185, and this binding was inhibited by dsDNA. This is the first demonstration of a naturally occurring autoantigen mimotope. The present study identifies a potential antigenic stimulus that might trigger systemic lupus erythematosus in a subset of patients.	[Kumar, Sanjeev; Ravirajan, Chelliah T.; Isenberg, David A.] Univ Coll London Hosp, UCL Div Med, Ctr Rheumatol, London W1T 4JF, England; [Kumar, Sanjeev; Hinks, John A.; Maman, Joseph; Pearl, Laurence H.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Kumar, S (corresponding author), Univ Coll London Hosp, UCL Div Med, Ctr Rheumatol, London W1T 4JF, England.	s.kumar@ucl.ac.uk		Pearl, Laurence/0000-0002-6910-1809; Isenberg, David/0000-0001-9514-2455	Arthritis Research Campaign, UK	Arthritis Research Campaign, UK(Versus Arthritis)	This work was supported by the Arthritis Research Campaign, UK.	AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; BAST RC, 1993, CANCER, V71, P1597, DOI 10.1002/cncr.2820710426; Bollag D.M., 1991, PROTEIN METHODS; CALDERONI A, 1994, DEUT MED WOCHENSCHR, V119, P1194, DOI 10.1055/s-2008-1058821; DEPOTTER CR, 1989, HISTOPATHOLOGY, V15, P351; DESAI DD, 1993, J IMMUNOL, V151, P1614; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; Dimitrova I, 2010, LUPUS, V19, P1261, DOI 10.1177/0961203310371153; DOUGALL WC, 1993, J CELL BIOCHEM, V53, P61, DOI 10.1002/jcb.240530108; Ethier SP, 1996, MOL CARCINOGEN, V15, P134; FELICI F, 1993, GENE, V128, P21, DOI 10.1016/0378-1119(93)90148-V; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; Gaynor B, 1997, P NATL ACAD SCI USA, V94, P1955, DOI 10.1073/pnas.94.5.1955; GILKESON GS, 1995, J CLIN INVEST, V95, P1398, DOI 10.1172/JCI117793; Goldenberg MM, 1999, CLIN THER, V21, P309, DOI 10.1016/S0149-2918(00)88288-0; GOULD RJ, 1981, BIOCHEMISTRY-US, V20, P6776, DOI 10.1021/bi00527a006; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; Ignatovich O, 1997, J MOL BIOL, V268, P69, DOI 10.1006/jmbi.1997.0956; ISENBERG D, 1990, J AUTOIMMUN, V3, P393, DOI 10.1016/S0896-8411(05)80008-3; Isenberg D. A., 1998, OXFORD TXB RHEUMATOL, P1145; Isenberg DA, 1997, BRIT J RHEUMATOL, V36, P229; Kumar S, 2000, J BIOL CHEM, V275, P35129, DOI 10.1074/jbc.M001976200; LEPAGE SH, 1989, CLIN EXP IMMUNOL, V77, P314; LEWIS GD, 1993, CANCER IMMUNOL IMMUN, V37, P255, DOI 10.1007/BF01518520; Lundin K, 1996, IMMUNOLOGY, V89, P579, DOI 10.1046/j.1365-2567.1996.d01-772.x; MADAIO MP, 1984, J IMMUNOL, V132, P872; MARCHINI B, 1995, CLIN EXP RHEUMATOL, V13, P7; Mellemkjaer L, 1997, ARTHRITIS RHEUM-US, V40, P761, DOI 10.1002/art.1780400424; Molina R, 1997, TUMOR BIOL, V18, P188, DOI 10.1159/000218029; Mountain A, 1992, Biotechnol Genet Eng Rev, V10, P1; NATALI PG, 1990, INT J CANCER, V45, P457, DOI 10.1002/ijc.2910450314; OHNISHI Y, 1995, BRIT J CANCER, V71, P969, DOI 10.1038/bjc.1995.187; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651; PISETSKY DS, 1990, ARTHRITIS RHEUM, V33, P153, DOI 10.1002/art.1780330202; Putterman C, 1998, J EXP MED, V188, P29, DOI 10.1084/jem.188.1.29; Ramsey-Goldman R, 1998, J INVEST MED, V46, P217; Rekvig OP, 1997, METHODS, V11, P44, DOI 10.1006/meth.1996.0386; Sartori AA, 2001, J BIOL CHEM, V276, P29979, DOI 10.1074/jbc.M102985200; SCOTT JK, 1992, TRENDS BIOCHEM SCI, V17, P241, DOI 10.1016/0968-0004(92)90401-T; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spatz L, 1997, METHODS, V11, P70, DOI 10.1006/meth.1996.0389; SULKES A, 1991, CANCER, V68, P1389, DOI 10.1002/1097-0142(19910915)68:6<1389::AID-CNCR2820680635>3.0.CO;2-Y; Sultan SM, 2000, RHEUMATOLOGY, V39, P1147, DOI 10.1093/rheumatology/39.10.1147; SWAAK AJG, 1979, ARTHRITIS RHEUM, V22, P226, DOI 10.1002/art.1780220304; Tam JP, 1996, J IMMUNOL METHODS, V196, P17, DOI 10.1016/0022-1759(96)00066-X; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; TANAKA K, 1983, AM J EPIDEMIOL, V118, P728, DOI 10.1093/oxfordjournals.aje.a113683; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; VANDEVIJVER MJ, 1988, EUR J SURG ONCOL, V14, P111; WALLACH HW, 1977, ARCH INTERN MED, V137, P532, DOI 10.1001/archinte.137.4.532; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Williams SC, 1996, J MOL BIOL, V264, P220, DOI 10.1006/jmbi.1996.0636; ZABRECKY JR, 1991, J BIOL CHEM, V266, P1716; Zhou XX, 2010, J GASTROEN HEPATOL, V25, P1266, DOI 10.1111/j.1440-1746.2010.06287.x	56	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26220	26227		10.1074/jbc.M111.224303	http://dx.doi.org/10.1074/jbc.M111.224303			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21566138	hybrid, Green Published			2022-12-27	WOS:000293073000079
J	Li, XF; Ji, WD; Zhang, R; Folta-Stogniew, E; Min, W; Boggon, TJ				Li, Xiaofeng; Ji, Weidong; Zhang, Rong; Folta-Stogniew, Ewa; Min, Wang; Boggon, Titus J.			Molecular Recognition of Leucine-Aspartate Repeat (LD) Motifs by the Focal Adhesion Targeting Homology Domain of Cerebral Cavernous Malformation 3 (CCM3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20-LIKE KINASE-3 MST3; CELL-MIGRATION; BINDING DOMAIN; 4-HELIX BUNDLE; RHO-GTPASES; PAXILLIN; PROTEIN; MUTATIONS; GENE; VINCULIN	Cerebral cavernous malformation (CCM) is a disease that affects between 0.1 and 0.5% of the human population, with mutations in CCM3 accounting for similar to 15% of the autosomal dominant form of the disease. We recently reported that CCM3 contains an N-terminal dimerization domain (CCM3D) and a C-terminal focal adhesion targeting (FAT) homology domain. Intermolecular protein-protein interactions of CCM3 are mediated by a highly conserved surface on the FAT homology domain and are affected by CCM3 truncations in the human disease. Here we report the crystal structures of CCM3 in complex with three different leucine-aspartate repeat (LD) motifs (LD1, LD2, and LD4) from the scaffolding protein paxillin, at 2.8, 2.7, and 2.5 angstrom resolution. We show that CCM3 binds LD motifs using the highly conserved hydrophobic patch 1 (HP1) and that this binding is similar to the binding of focal adhesion kinase and Pyk2 FAT domains to paxillin LD motifs. We further show by surface plasmon resonance that CCM3 binds paxillin LD motifs with affinities in the micromolar range, similar to FAK family FAT domains. Finally, we show that endogenous CCM3 and paxillin co-localize in mouse cerebral pericytes. These studies provide a molecular-level framework to investigate the protein-protein interactions of CCM3.	[Boggon, Titus J.] Yale Univ Sch Med, Dept Pharmacol, SHM B316A, New Haven, CT 06520 USA; [Ji, Weidong; Min, Wang] Yale Univ Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Folta-Stogniew, Ewa] Yale Univ Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ Sch Med, Dept Pharmacol, SHM B316A, 333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu	Li, Xiaofeng/F-3735-2011; ji, weidong/AAX-7397-2020		National Institutes of Health [HL077357, HL085789, RR026992, AI075133, GM088240, DK087844]; Yale University; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077357, R01HL085789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077357 and HL085789 (to W. M.), RR026992 (to E. F.-S.), and AI075133, GM088240, and DK087844 (to T. J. B.). This work was also supported by startup funds to T. J. B. from Yale University.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Davenport WJ, 2001, NEUROLOGY, V56, P540, DOI 10.1212/WNL.56.4.540; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Ding JJ, 2010, BIOCHEM BIOPH RES CO, V399, P587, DOI 10.1016/j.bbrc.2010.07.119; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Lu TJ, 2006, J BIOL CHEM, V281, P38405, DOI 10.1074/jbc.M605035200; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nogueira E, 2008, J BIOL CHEM, V283, P16248, DOI 10.1074/jbc.M709724200; Pozzati E, 1996, NEUROSURGERY, V38, P662, DOI 10.1227/00006123-199604000-00006; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; TURNER CE, 1994, J CELL SCI, V107, P1583; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Voss K, 2009, HUM MUTAT, V30, P1003, DOI 10.1002/humu.20996; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	55	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26138	26147		10.1074/jbc.M110.211250	http://dx.doi.org/10.1074/jbc.M110.211250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632544	Green Published, hybrid			2022-12-27	WOS:000293073000071
J	Liu, Y; Han, ZP; Zhang, SS; Jing, YY; Bu, XX; Wang, CY; Sun, K; Jiang, GC; Zhao, X; Li, R; Gao, L; Zhao, QD; Wu, MC; Wei, LX				Liu, Yan; Han, Zhi-peng; Zhang, Shan-shan; Jing, Ying-ying; Bu, Xin-xin; Wang, Chen-yang; Sun, Kai; Jiang, Guo-cheng; Zhao, Xue; Li, Rong; Gao, Lu; Zhao, Qiu-dong; Wu, Meng-chao; Wei, Li-xin			Effects of Inflammatory Factors on Mesenchymal Stem Cells and Their Role in the Promotion of Tumor Angiogenesis in Colon Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CHICK CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL GROWTH-FACTOR; INTERFERON-GAMMA; STROMAL CELLS; IFN-GAMMA; INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; GENE-THERAPY	Mesenchymal stem cells (MSCs), which are modulated by cytokines present in the tumor microenvironment, play an important role in tumor progression. It is well documented that inflammation is an important part of the tumor microenvironment, so we investigated whether stimulation of MSCs by inflammatory cytokines would contribute to their ability to promote tumor growth. We first showed that MSCs could increase C26 colon cancer growth in mice. This growth-promoting effect was further accelerated when the MSCs were pre-stimulated by inflammatory factors IFN-gamma and TNF-alpha. At the same time, we demonstrated that MSCs pre-stimulated by both inflammatory factors could promote tumor angiogenesis in vivo to a greater degree than untreated MSCs or MSCs pre-stimulated by either IFN-gamma or TNF-alpha alone. A hen egg test-chorioallantoic membrane (HET-CAM) assay showed that treatment of MSC-conditioned medium can promote chorioallantoic membrane angiogenesis in vitro, especially treatment with conditioned medium of MSCs pretreated with IFN-gamma and TNF-alpha together. This mechanism of promoting angiogenesis appears to take place via an increase in the expression of vascular endothelial growth factor (VEGF), which itself takes place through an increase in signaling in the hypoxia-inducible factor 1 alpha (HIF-1 alpha)-dependent pathway. Inhibition of HIF-1 alpha in MSCs by siRNA was found to effectively reduce the ability of MSC to affect the growth of colon cancer in vivo in the inflammatory microenviroment. These results indicate that MSCs stimulated by inflammatory cytokines such as IFN-gamma and TNF-alpha in the tumor microenvironment express higher levels of VEGF via the HIF-1 alpha signaling pathway and that these MSCs then enhance tumor angiogenesis, finally leading to colon cancer growth in mice.	[Liu, Yan; Han, Zhi-peng; Zhang, Shan-shan; Jing, Ying-ying; Bu, Xin-xin; Wang, Chen-yang; Sun, Kai; Jiang, Guo-cheng; Zhao, Xue; Li, Rong; Gao, Lu; Zhao, Qiu-dong; Wu, Meng-chao; Wei, Li-xin] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai 200438, Peoples R China; [Liu, Yan; Han, Zhi-peng; Sun, Kai] Second Mil Med Univ, Stem Cell & Med Res Ctr, Shanghai 200438, Peoples R China	Naval Medical University; Naval Medical University	Wei, LX (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, 225 Changhai Rd, Shanghai 200438, Peoples R China.	lixinwei@smmu.edu.cn		Wei, Lixin/0000-0002-9526-5348	National Natural Science Foundation of China [30870974, 30801347, 30901722, 81000970, 81030041]; Shanghai Science and Technology Committee [11ZR1449500, 10411963100, 10ZR1439900, 10ZR1439600]; Key Basic Research Project of China [2010CB945600, 2011CB966200]; NSFC, China [30921006]; Stem Cell and Medicine Research Center; Second Military Medical University [SCOP101913, SCOP102004, SCOP101812]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Key Basic Research Project of China; NSFC, China(National Natural Science Foundation of China (NSFC)); Stem Cell and Medicine Research Center; Second Military Medical University	This work was supported by National Natural Science Foundation of China Grants 30870974, 30801347, 30901722, 81000970, and 81030041, Shanghai Science and Technology Committee Grants 11ZR1449500, 10411963100, 10ZR1439900, and 10ZR1439600, Key Basic Research Project of China Grants 2010CB945600 and 2011CB966200, Science Fund for Creative Research Groups, NSFC, China Grant 30921006, the Stem Cell and Medicine Research Center's Innovation Research Program, and Second Military Medical University Grants SCOP101913, SCOP102004, and SCOP101812.	Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Aller MA, 2004, EXP BIOL MED, V229, P170, DOI 10.1177/153537020422900206; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Atreya I, 2008, EXPERT REV ANTICANC, V8, P561, DOI 10.1586/14737140.8.4.561; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BALKWILL FR, 1987, CANCER RES, V47, P4755; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Caplan AI, 2000, CLIN ORTHOP RELAT R, pS67; Chiou SH, 2005, J REPROD IMMUNOL, V67, P35, DOI 10.1016/j.jri.2005.06.002; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; D'Agostino B, 2010, EXPERT OPIN BIOL TH, V10, P681, DOI 10.1517/14712591003610614; Das B, 2005, CANCER RES, V65, P7267, DOI 10.1158/0008-5472.CAN-04-4575; DEFOUW DO, 1989, MICROVASC RES, V38, P136, DOI 10.1016/0026-2862(89)90022-8; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Eriksson F, 2007, CANCER IMMUNOL IMMUN, V56, P677, DOI 10.1007/s00262-006-0227-6; Forooghian F, 2007, AM J OPHTHALMOL, V144, P761, DOI 10.1016/j.ajo.2007.07.022; Gessi S, 2010, ARTERIOSCL THROM VAS, V30, P90, DOI 10.1161/ATVBAHA.109.194902; Hamada H, 2005, CANCER SCI, V96, P149, DOI 10.1111/j.1349-7006.2005.00032.x; Harrison ML, 2007, J CLIN ONCOL, V25, P4542, DOI 10.1200/JCO.2007.11.2136; HATTORI A, 1994, FEBS LETT, V340, P177, DOI 10.1016/0014-5793(94)80132-0; Hiroishi K, 2000, J IMMUNOL, V164, P567, DOI 10.4049/jimmunol.164.2.567; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Lee AH, 2000, BIOCHEM J, V350, P131, DOI 10.1042/0264-6021:3500131; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Mazzini L, 2010, EXP NEUROL, V223, P229, DOI 10.1016/j.expneurol.2009.08.007; McClintock JY, 2005, J APPL PHYSIOL, V99, P861, DOI 10.1152/japplphysiol.00006.2005; Moreno M, 2008, J IMMUNOL, V181, P2446, DOI 10.4049/jimmunol.181.4.2446; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rizzo V, 1996, MICROVASC RES, V52, P245, DOI 10.1006/mvre.1996.0062; Sekine N, 2000, J CELL PHYSIOL, V184, P46, DOI 10.1002/(SICI)1097-4652(200007)184:1<46::AID-JCP5>3.0.CO;2-L; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Singh SK, 2003, CANCER RES, V63, P5821; Sun B, 2009, CYTOTHERAPY, V11, P289, DOI 10.1080/14653240902807026; Takata K, 2008, MOL CANCER THER, V7, P1551, DOI 10.1158/1535-7163.MCT-07-0428; Tang JM, 2009, EUR J CARDIO-THORAC, V36, P644, DOI 10.1016/j.ejcts.2009.04.052; Tang SJ, 2008, INT J CANCER, V123, P2840, DOI 10.1002/ijc.23888; Taylor RC, 2007, J CLIN ONCOL, V25, P869, DOI 10.1200/JCO.2006.08.9755; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Wang Y, 2008, AM J PHYSIOL-REG I, V295, pR1115, DOI 10.1152/ajpregu.90383.2008; Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Zheng W, 2001, AM J PHYSIOL-HEART C, V280, pH909, DOI 10.1152/ajpheart.2001.280.2.H909	50	138	150	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25007	25015		10.1074/jbc.M110.213108	http://dx.doi.org/10.1074/jbc.M110.213108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21592963	Green Published, hybrid			2022-12-27	WOS:000292547900049
J	Maesako, M; Uemura, K; Kuzuya, A; Sasaki, K; Asada, M; Watanabe, K; Ando, K; Kubota, M; Kihara, T; Kinoshita, A				Maesako, Masato; Uemura, Kengo; Kuzuya, Akira; Sasaki, Kazuki; Asada, Megumi; Watanabe, Kiwamu; Ando, Koichi; Kubota, Masakazu; Kihara, Takeshi; Kinoshita, Ayae			Presenilin Regulates Insulin Signaling via a gamma-Secretase-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-CATENIN; INTRACELLULAR DOMAIN; RECEPTOR; NOTCH; PATHWAY; KINASE; ADIPOGENESIS; CLEAVAGE; DISEASE	Presenilin ( PS), a causative molecule of familial Alzheimer disease, acts as a crucial component of the gamma-secretase complex, which is required to cleave type I transmembrane proteins such as amyloid precursor protein and Notch. However, it also functions through gamma-secretase-independent pathways. Recent reports suggested that PS could regulate the expression level of cell surface receptors, including the PDGF and EGF receptors, followed by modulating their downstream pathways via gamma-secretase-independent mechanisms. The main purpose of this study was to clarify the effect of PS on expression of the insulin receptor (IR) as well as on insulin signaling. Here, we demonstrate that PS inhibited IR transcription and reduced IR expression, and this was followed by down-regulation of insulin signaling. Moreover, we suggest that neither gamma-secretase activity nor Wnt/beta-catenin signaling can reduce the expression of IR, but a PS-mediated increase in the intracellular Ca2+ level can be associated with it. These results clearly indicate that PS can functionally regulate insulin signaling by controlling IR expression.	[Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Uemura, Kengo; Kuzuya, Akira; Watanabe, Kiwamu; Ando, Koichi] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Kinoshita, A (corresponding author), Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, 53 Shogoinkawahara Cho, Kyoto 6068507, Japan.	akinoshita@hs.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [20300124]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	The work was supported by Grant-in-aid 20300124 from the Ministry of Education, Culture, Sports, Science and Technology and a research grant from the Takeda Science Foundation.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Aoyagi N, 2010, BIOCHEM BIOPH RES CO, V391, P1240, DOI 10.1016/j.bbrc.2009.12.051; Aziz MH, 2007, MOL CARCINOGEN, V46, P646, DOI 10.1002/mc.20356; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen FS, 2000, J BIOL CHEM, V275, P36794, DOI 10.1074/jbc.M006986200; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Huang Y, 2010, CELL PROLIFERAT, V43, P147, DOI 10.1111/j.1365-2184.2009.00661.x; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kasuga K, 2007, BIOCHEM BIOPH RES CO, V360, P90, DOI 10.1016/j.bbrc.2007.06.022; KNUTSON VP, 1991, FASEB J, V5, P2130, DOI 10.1096/fasebj.5.8.2022311; Maesako M, 2011, NEUROSCIENCE, V177, P298, DOI 10.1016/j.neuroscience.2010.12.017; Maesako M, 2010, NEUROSCI LETT, V483, P157, DOI 10.1016/j.neulet.2010.07.055; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Meredith JE, 2002, BIOCHEM BIOPH RES CO, V299, P744, DOI 10.1016/S0006-291X(02)02747-X; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Raurell I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004080; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Uemura K, 2003, J NEUROSCI RES, V73, P166, DOI 10.1002/jnr.10641; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	40	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25309	25316		10.1074/jbc.M111.248922	http://dx.doi.org/10.1074/jbc.M111.248922			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622565	hybrid, Green Published			2022-12-27	WOS:000292547900077
J	Yuen, EY; Yan, Z				Yuen, Eunice Y.; Yan, Zhen			Cellular Mechanisms for Dopamine D-4 Receptor-induced Homeostatic Regulation of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPSE-ASSOCIATED PROTEIN-97; DEFICIT HYPERACTIVITY DISORDER; PREFRONTAL CORTEX NEURONS; EXON-III POLYMORPHISM; WORKING-MEMORY; GLUTAMATERGIC TRANSMISSION; KINASE-II; CORTICAL-NEURONS; D1 RECEPTORS; MICE LACKING	Aberrant dopamine D-4 receptor function has been implicated in mental illnesses, including schizophrenia and attention deficit-hyperactivity disorder. Recently we have found that D-4 receptor exerts an activity-dependent bi-directional regulation of AMPA receptor (AMPAR)-mediated synaptic currents in pyramidal neurons of prefrontal cortex (PFC) via the dual control of calcium/calmodulin kinase II (CaMKII) activity. In this study, we examined the signaling mechanisms downstream of CaMKII that govern the complex effects of D-4 on glutamatergic transmission. We found that in PFC neurons at high activity state, D-4 suppresses AMPAR responses by disrupting the kinesin motor-based transport of GluR2 along microtubules, which was accompanied by the D-4 reduction of microtubule stability via a mechanism dependent on CaMKII inhibition. On the other hand, in PFC neurons at the low activity state, D-4 potentiates AMPAR responses by facilitating synaptic targeting of GluR1 through the scaffold protein SAP97 via a mechanism dependent on CaMKII stimulation. Taken together, these results have identified distinct signaling mechanisms underlying the homeostatic regulation of glutamatergic transmission by D-4 receptors, which may be important for cognitive and emotional processes in which dopamine is involved.	[Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu			National Institutes of Health [MH84233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233, R25MH077823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH84233 (to Z. Y.).	Bananis E, 2000, J CELL BIOL, V151, P179, DOI 10.1083/jcb.151.1.179; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CACERES A, 1984, J NEUROSCI, V4, P394; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cheon KA, 2007, NEUROPSYCHOPHARMACOL, V32, P1377, DOI 10.1038/sj.npp.1301244; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Diaz-Anzaldua A, 2004, MOL PSYCHIATR, V9, P272, DOI 10.1038/sj.mp.4001411; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Durston S, 2005, MOL PSYCHIATR, V10, P678, DOI 10.1038/sj.mp.4001649; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Gao C, 2007, J NEUROSCI, V27, P14275, DOI 10.1523/JNEUROSCI.2925-07.2007; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; Gu ZL, 2006, MOL PHARMACOL, V69, P813, DOI 10.1124/mol.105.018853; Gu ZL, 2004, MOL PHARMACOL, V66, P948, DOI 10.1124/mol.104.001404; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Kapur S, 2001, ANNU REV MED, V52, P503, DOI 10.1146/annurev.med.52.1.503; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Kim CH, 2001, J NEUROSCI, V21, P4188, DOI 10.1523/JNEUROSCI.21-12-04188.2001; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Ray LA, 2010, J ABNORM PSYCHOL, V119, P115, DOI 10.1037/a0017550; Ray LA, 2009, ADDICT BIOL, V14, P238, DOI 10.1111/j.1369-1600.2008.00120.x; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; VANTOL HHM, 1992, NATURE, V358, P149; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; Wedzony K, 2000, J PHYSIOL PHARMACOL, V51, P205; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yuen EY, 2010, P NATL ACAD SCI USA, V107, P22308, DOI 10.1073/pnas.1010025108; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Yuen EY, 2005, J BIOL CHEM, V280, P29420, DOI 10.1074/jbc.M504499200; Zhang KH, 2004, NEUROPSYCHOPHARMACOL, V29, P1648, DOI 10.1038/sj.npp.1300491; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	54	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24957	24965		10.1074/jbc.M111.221416	http://dx.doi.org/10.1074/jbc.M111.221416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622557	hybrid, Green Published			2022-12-27	WOS:000292547900044
J	Freude, KK; Penjwini, M; Davis, JL; LaFerla, FM; Blurton-Jones, M				Freude, Kristine K.; Penjwini, Mahmud; Davis, Joy L.; LaFerla, Frank M.; Blurton-Jones, Mathew			Soluble Amyloid Precursor Protein Induces Rapid Neural Differentiation of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODELS; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; BETA-SECRETASE; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; NEURITE OUTGROWTH; NEUROGENESIS; APP; EXPRESSION	Human embryonic stem cells (hESCs) offer tremendous potential for not only treating neurological disorders but also for their ability to serve as vital reagents to model and investigate human disease. To further our understanding of a key protein involved in Alzheimer disease pathogenesis, we stably overexpressed amyloid precursor protein (APP) in hESCs. Remarkably, we found that APP overexpression in hESCs caused a rapid and robust differentiation of pluripotent stem cells toward a neural fate. Despite maintenance in standard hESC media, up to 80% of cells expressed the neural stem cell marker nestin, and 65% exhibited the more mature neural marker beta-3 tubulin within just 5 days of passaging. To elucidate the mechanism underlying the effects of APP on neural differentiation, we examined the proteolysis of APP and performed both gain of function and loss of function experiments. Taken together, our results demonstrate that the N-terminal secreted soluble forms of APP (in particular sAPP beta) robustly drive neural differentiation of hESCs. Our findings not only reveal a novel and intriguing role for APP in neural lineage commitment but also identify a straightforward and rapid approach to generate large numbers of neurons from human embryonic stem cells. These novel APP-hESC lines represent a valuable tool to investigate the potential role of APP in development and neurodegeneration and allow for insights into physiological functions of this protein.	[LaFerla, Frank M.; Blurton-Jones, Mathew] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	laferla@uci.edu; mblurton@uci.edu		Freude, Kristine/0000-0001-9480-2386; Blurton-Jones, Mathew/0000-0002-7770-7157	California Institute for Regenerative Medicine [RS1-00247, TR1-01245, T1-00008, NIA-K01AG029378]; Alzheimer Disease Research project [P50AG16573]; University of California Los Angeles Vector Core [JCCC/P30 CA016042, CURE/P30 DK041301]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG029378, P50AG016573, R01AG021982] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Alzheimer Disease Research project; University of California Los Angeles Vector Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by California Institute for Regenerative Medicine Grants RS1-00247 and TR1-01245 (to F. M. L.), T1-00008 (to K. K. F.), and NIA-K01AG029378 (M. B.-J.), and an Alzheimer Disease Research project grant funded by P50AG16573 (to M. B. J.). The University of California Los Angeles Vector Core is supported by Grants JCCC/P30 CA016042 and CURE/P30 DK041301.	ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Bergmans BA, 2010, STEM CELLS, V28, P399, DOI 10.1002/stem.296; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; De Strooper B, 2000, J CELL SCI, V113, P1857; Evin Genevieve, 2007, Recent Pat CNS Drug Discov, V2, P188, DOI 10.2174/157488907782411783; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; HAASS C, 1995, ARZNEIMITTEL-FORSCH, V45-1, P398; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kampers T, 1999, FEBS LETT, V451, P39, DOI 10.1016/S0014-5793(99)00522-0; Lahiri DK, 2004, ANN NY ACAD SCI, V1030, P310, DOI 10.1196/annals.1329.039; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MIRAGALL F, 1994, J COMP NEUROL, V341, P433, DOI 10.1002/cne.903410402; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Perez RG, 1997, J NEUROSCI, V17, P9407; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramasamy SK, 2010, MOL CELL BIOL, V30, P1946, DOI 10.1128/MCB.01419-09; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; TANAKA S, 1989, BIOCHEM BIOPH RES CO, V165, P1406, DOI 10.1016/0006-291X(89)92760-5; Wen JH, 2008, NEUROREPORT, V19, P413, DOI 10.1097/WNR.0b013e3282f64377; Wolfe MS, 2008, CURR ALZHEIMER RES, V5, P158, DOI 10.2174/156720508783954767; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	46	61	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24264	24274		10.1074/jbc.M111.227421	http://dx.doi.org/10.1074/jbc.M111.227421			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606494	Green Published, hybrid			2022-12-27	WOS:000292294900068
J	Margraf-Schonfeld, S; Bohm, C; Watzl, C				Margraf-Schoenfeld, Stefanie; Boehm, Carolin; Watzl, Carsten			Glycosylation Affects Ligand Binding and Function of the Activating Natural Killer Cell Receptor 2B4 (CD244) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTING NK CELLS; CUTTING EDGE; LYMPHOCYTE-ACTIVATION; IMPORTANT DETERMINANT; GRANULE POLARIZATION; IMMUNE REGULATION; CD48; SAP; RECOGNITION; MOLECULE	2B4 (CD244) is an important activating receptor for the regulation of natural killer (NK) cell responses. Here we show that 2B4 is heavily and differentially glycosylated in primary human NK cells and NK cell lines. The differential glycosylation could be attributed to sialic acid residues on N- and O-linked carbohydrates. Using a recombinant fusion protein of the extracellular domain of 2B4, we demonstrate that N-linked glycosylation of 2B4 is essential for the binding to its ligand CD48. In contrast, sialylation of 2B4 has a negative impact on ligand binding, as the interaction between 2B4 and CD48 is increased after the removal of sialic acids. This was confirmed in a functional assay system, where the desialylation of NK cells or the inhibition of O-linked glycosylation resulted in increased 2B4-mediated lysis of CD48-expressing tumor target cells. These data demonstrate that glycosylation has an important impact on 2B4-mediated NK cell function and suggest that regulated changes in glycosylation during NK cell development and activation might be involved in the regulation of NK cell responses.	[Margraf-Schoenfeld, Stefanie; Boehm, Carolin; Watzl, Carsten] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Watzl, C (corresponding author), Univ Heidelberg, Inst Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.	watzl@uni-hd.de	Watzl, Carsten/B-4911-2013	Watzl, Carsten/0000-0001-5195-0995	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [TRR83/TP16, WA1552/2-1]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by BioFuture Program of the Bundesministerium fur Bildung und Forschung and Deutsche Forschungsgemeinschaft Grant TRR83/TP16 and Grant WA1552/2-1.	Andre S, 2009, BIOL CHEM, V390, P557, DOI 10.1515/BC.2009.072; Assarsson E, 2005, J IMMUNOL, V175, P2045, DOI 10.4049/jimmunol.175.4.2045; Baum LG, 1996, J BIOL CHEM, V271, P10793, DOI 10.1074/jbc.271.18.10793; Benson V, 2010, INT IMMUNOL, V22, P167, DOI 10.1093/intimm/dxp123; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; CASABO LG, 1994, J IMMUNOL, V152, P397; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Claus M, 2008, FRONT BIOSCI-LANDMRK, V13, P956, DOI 10.2741/2735; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; DAVIS SJ, 1995, J BIOL CHEM, V270, P369, DOI 10.1074/jbc.270.1.369; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Endt J, 2007, EUR J IMMUNOL, V37, P193, DOI 10.1002/eji.200636341; KORNFELD K, 1981, J BIOL CHEM, V256, P6633; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Latchman Y, 1998, J IMMUNOL, V161, P5809; Latour S, 2004, SEMIN IMMUNOL, V16, P409, DOI 10.1016/j.smim.2004.08.020; Mathew SO, 2005, J IMMUNOL, V175, P1005, DOI 10.4049/jimmunol.175.2.1005; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Stark S, 2005, J IMMUNOL METHODS, V296, P149, DOI 10.1016/j.jim.2004.11.010; Tangye SG, 2000, MOL IMMUNOL, V37, P493, DOI 10.1016/S0161-5890(00)00076-6; Tangye SG, 1999, J IMMUNOL, V162, P6981; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Velikovsky CA, 2007, IMMUNITY, V27, P572, DOI 10.1016/j.immuni.2007.08.019; Watzl C, 2000, J IMMUNOL, V165, P3545, DOI 10.4049/jimmunol.165.7.3545; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Yamaji T, 2005, GLYCOBIOLOGY, V15, P667, DOI 10.1093/glycob/cwi048; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	36	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24142	24149		10.1074/jbc.M111.225334	http://dx.doi.org/10.1074/jbc.M111.225334			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606496	Green Published, hybrid			2022-12-27	WOS:000292294900056
J	Chinthalapudi, K; Taft, MH; Martin, R; Heissler, SM; Preller, M; Hartmann, FK; Brandstaetter, H; Kendrick-Jones, J; Tsiavaliaris, G; Gutzeit, HO; Fedorov, R; Buss, F; Knolker, HJ; Coluccio, LM; Manstein, DJ				Chinthalapudi, Krishna; Taft, Manuel H.; Martin, Rene; Heissler, Sarah M.; Preller, Matthias; Hartmann, Falk K.; Brandstaetter, Hemma; Kendrick-Jones, John; Tsiavaliaris, Georgios; Gutzeit, Herwig O.; Fedorov, Roman; Buss, Folma; Knoelker, Hans-Joachim; Coluccio, Lynne M.; Manstein, Dietmar J.			Mechanism and Specificity of Pentachloropseudilin-mediated Inhibition of Myosin Motor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; DICTYOSTELIUM; AFFINITY; DOMAIN	Here, we report that the natural compound pentachloropseudilin (PClP) acts as a reversible and allosteric inhibitor of myosin ATPase and motor activity. IC50 values are in the range from 1 to 5 mu M for mammalian class-1 myosins and greater than 90 mu M for class-2 and class-5 myosins, and no inhibition was observed with class-6 and class-7 myosins. We show that in mammalian cells, PClP selectively inhibits myosin-1c function. To elucidate the structural basis for PClP-induced allosteric coupling and isoform-specific differences in the inhibitory potency of the compound, we used a multifaceted approach combining direct functional, crystallographic, and in silico modeling studies. Our results indicate that allosteric inhibition by PClP is mediated by the combined effects of global changes in protein dynamics and direct communication between the catalytic and allosteric sites via a cascade of small conformational changes along a conserved communication pathway.	[Chinthalapudi, Krishna; Preller, Matthias; Fedorov, Roman; Manstein, Dietmar J.] Hannover Med Sch, Res Ctr Struct Anal, OE8830, D-30623 Hannover, Germany; [Taft, Manuel H.; Heissler, Sarah M.; Hartmann, Falk K.; Tsiavaliaris, Georgios; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, OE4350, D-30623 Hannover, Germany; [Martin, Rene; Knoelker, Hans-Joachim] Tech Univ Dresden, Dept Chem, D-01069 Dresden, Germany; [Brandstaetter, Hemma; Buss, Folma] Univ Cambridge, Cambridge Inst Med Res, Dept Clin Biochem, Wellcome Trust Med Res Council MRC, Cambridge CB2 0XY, England; [Kendrick-Jones, John] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Gutzeit, Herwig O.] Tech Univ Dresden, Dept Biol, D-01217 Dresden, Germany; [Coluccio, Lynne M.] Boston Biomed Res Inst, Watertown, MA 02472 USA	Hannover Medical School; Hannover Medical School; Technische Universitat Dresden; University of Cambridge; MRC Laboratory Molecular Biology; Technische Universitat Dresden; Boston Biomedical Research Institute	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	manstein.dietmar@mh-hannover.de	Taft, Manuel/O-1396-2019; Manstein, Dietmar J./AAG-2640-2019; Manstein, Dietmar J. J/M-1034-2013; Preller, Matthias/P-1176-2016; Taft, Manuel H/T-2508-2017; Knölker, Hans-Joachim/I-4954-2019; Chinthalapudi, Krishna/B-4550-2018	Taft, Manuel/0000-0001-5853-8629; Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147; Preller, Matthias/0000-0002-7784-4012; Taft, Manuel H/0000-0001-5853-8629; Knölker, Hans-Joachim/0000-0002-9631-5239; Buss, Folma/0000-0003-4457-3479; Chinthalapudi, Krishna/0000-0003-3669-561X; Fedorov, Roman/0000-0002-5240-4205	Deutsche Forschungsgemeinschaft (DFG) [MA 1081/16-1]; Cluster of Excellence "Rebirth"; Fonds der Chemischen Industrie; Wellcome Trust; National Institutes of Health [DC008793]; Medical Research Council; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC008793, R01DC008793] Funding Source: NIH RePORTER; MRC [MC_U105184323] Funding Source: UKRI; Medical Research Council [MC_U105184323] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cluster of Excellence "Rebirth"; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant MA 1081/16-1 and the Cluster of Excellence "Rebirth" (to D. J. M.), Fonds der Chemischen Industrie (to D. J. M. and H.-J. K.), a Wellcome Trust University Award (to F. B.), a Wellcome Trust Studentship (to H. B.), National Institutes of Health Grant DC008793 (to L. M. C.), and the Medical Research Council (J. K.-J.).	Adamek N, 2008, P NATL ACAD SCI USA, V105, P5710, DOI 10.1073/pnas.0710520105; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedorov R, 2009, NAT STRUCT MOL BIOL, V16, P80, DOI 10.1038/nsmb.1542; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Gulick AM, 2000, J BIOL CHEM, V275, P398, DOI 10.1074/jbc.275.1.398; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; Martin R, 2009, ANGEW CHEM INT EDIT, V48, P8042, DOI 10.1002/anie.200903743; Perreault-Micale C, 2000, J BIOL CHEM, V275, P21618, DOI 10.1074/jbc.M000363200; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; Preller M, 2011, J MED CHEM, V54, P3675, DOI 10.1021/jm200259f; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Walsh DP, 2006, CHEM REV, V106, P2476, DOI 10.1021/cr0404141; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	25	48	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29700	29708		10.1074/jbc.M111.239210	http://dx.doi.org/10.1074/jbc.M111.239210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21680745	Green Published, hybrid			2022-12-27	WOS:000294046600029
J	Ferreira, JS; Rooyakkers, A; She, K; Ribeiro, L; Carvalho, AL; Craig, AM				Ferreira, Joana S.; Rooyakkers, Amanda; She, Kevin; Ribeiro, Luis; Carvalho, Ana Luisa; Craig, Ann Marie			Activity and Protein Kinase C Regulate Synaptic Accumulation of N-Methyl-D-aspartate (NMDA) Receptors Independently of GluN1 Splice Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; ER RETENTION SIGNAL; NR1 SUBUNIT; SURFACE EXPRESSION; TERMINAL DOMAIN; MESSENGER-RNA; RAT-BRAIN; TRAFFICKING; PHOSPHORYLATION; SYNAPSES	NMDA receptors are calcium-permeable ionotropic receptors that detect coincident glutamate binding and membrane depolarization and are essential for many forms of synaptic plasticity in the mammalian brain. The obligatory GluN1 subunit of NMDA receptors is alternatively spliced at multiple sites, generating forms that vary in N-terminal N1 and C-terminal C1, C2, and C2' cassettes. Based on expression of GluN1 constructs in heterologous cells and in wild type neurons, the prevalent view is that the C-terminal cassettes regulate synaptic accumulation and its modulation by homeostatic activity blockade and by protein kinase C (PKC). Here, we tested the role of GluN1 splicing in regulated synaptic accumulation of NMDA receptors by lentiviral expression of individual GluN1 splice variants in hippocampal neurons cultured from GluN1 (-/-) mice. High efficiency transduction of GluN1 at levels similar to endogenous was achieved. Under control conditions, the C2' cassette mediated enhanced synaptic accumulation relative to the alternate C2 cassette, whereas the presence or absence of N1 or C1 had no effect. Surprisingly all GluN1 splice variants showed > 2-fold increased synaptic accumulation with chronic blockade of NMDA receptor activity. Furthermore, in this neuronal rescue system, all GluN1 splice variants were equally rapidly dispersed upon activation of PKC. These results indicate that the major mechanisms mediating homeostatic synaptic accumulation and PKC dispersal of NMDA receptors occur independently of GluN1 splice isoform.	[Ferreira, Joana S.; Ribeiro, Luis; Carvalho, Ana Luisa] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Ferreira, Joana S.; Ribeiro, Luis; Carvalho, Ana Luisa] Univ Coimbra, Dept Life Sci, P-3004517 Coimbra, Portugal; [Rooyakkers, Amanda; She, Kevin; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Rooyakkers, Amanda; She, Kevin; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada	Universidade de Coimbra; Universidade de Coimbra; University of British Columbia; University of British Columbia	Carvalho, AL (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.	alc@cnc.uc.pt; amcraig@interchange.ubc.ca	Craig, Ann Marie/M-2054-2014; Ferreira, Joana/AAY-8702-2020; Carvalho, Ana Luisa/K-6367-2013; Ribeiro, Luís Filipe/U-3826-2017; Ferreira, Joana/I-9447-2014	Ferreira, Joana/0000-0002-1049-8063; Carvalho, Ana Luisa/0000-0001-8368-6666; Ribeiro, Luís Filipe/0000-0003-1790-6848; Ferreira, Joana/0000-0002-1049-8063	Canadian Institutes of Health Research (CIHR) [MOP-69096]; Portuguese Foundation for Science and Technology (FCT) [PTDC/BIA-BCM/71789/2006, PTDC/SAU-NEU/099440/2008]; Canada Research Chair; Michael Smith Foundation; FCT [(SFRH/BD/37522/2007, SFRH/BD/47879/2008]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Michael Smith Foundation(Michael Smith Foundation for Health Research); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Canadian Institutes of Health Research (CIHR) MOP-69096 (to A. M. C.), by the Portuguese Foundation for Science and Technology (FCT) PTDC/BIA-BCM/71789/2006 and PTDC/SAU-NEU/099440/2008 (to A. L. C.), and by salary awards CIHR Frederick Banting and Charles Best Canada Graduate Scholarship (to K. S.), Canada Research Chair and Michael Smith Foundation for Health Research Senior Scholarship (to A. M. C.), and FCT Graduate Scholarships (SFRH/BD/37522/2007, to J. S. F. and SFRH/BD/47879/2008, to L. R.).	Al-Hallaq RA, 2001, J NEUROCHEM, V77, P110, DOI 10.1046/j.1471-4159.2001.t01-1-00210.x; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; Ehlers MD, 1998, J NEUROSCI, V18, P720; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Gomes AR, 2008, MOL CELL NEUROSCI, V37, P323, DOI 10.1016/j.mcn.2007.10.008; Goslin K., 1998, CULTURING NERVE CELL, P339; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Jeffrey RA, 2009, J NEUROSCI, V29, P15613, DOI 10.1523/JNEUROSCI.3314-09.2009; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Okabe S, 1999, J NEUROSCI, V19, P7781; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Traynelis SF, 1998, J NEUROSCI, V18, P6163; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Zhang J, 2009, J NEUROSCI, V29, P4274, DOI 10.1523/JNEUROSCI.5602-08.2009; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	53	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28331	28342		10.1074/jbc.M111.222539	http://dx.doi.org/10.1074/jbc.M111.222539			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676872	Green Published, hybrid			2022-12-27	WOS:000293557800050
J	Pereira, GJS; Hirata, H; Fimia, GM; do Carmo, LG; Bincoletto, C; Han, SW; Stilhano, RS; Ureshino, RP; Bloor-Young, D; Churchill, G; Piacentini, M; Patel, S; Smaili, SS				Pereira, Gustavo J. S.; Hirata, Hanako; Fimia, Gian M.; do Carmo, Lucia G.; Bincoletto, Claudia; Han, Sang W.; Stilhano, Roberta S.; Ureshino, Rodrigo P.; Bloor-Young, Duncan; Churchill, Grant; Piacentini, Mauro; Patel, Sandip; Smaili, Soraya S.			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Regulates Autophagy in Cultured Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ SIGNALS; CALCIUM; MACROAUTOPHAGY; ORGANELLES; RECEPTORS; AGONIST; MUSCLE; STORES	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a potent Ca2+-mobilizing messenger that in many cells releases Ca2+ from the endolysosomal system. Recent studies have shown that NAADP-induced Ca2+ mobilization is mediated by the two-pore channels (TPCs). Whether NAADP acts as a messenger in astrocytes is unclear, and downstream functional consequences have yet to be defined. Here, we show that intracellular delivery of NAADP evokes Ca2+ signals from acidic organelles in rat astrocytes and that these signals are potentiated upon overexpression of TPCs. We also show that NAADP increases acidic vesicular organelle formation and levels of the autophagic markers, LC3II and beclin-1. NAADP-mediated increases in LC3II levels were reduced in cells expressing a dominant-negative TPC2 construct. Our data provide evidence that NAADP-evoked Ca2+ signals mediated by TPCs regulate autophagy.	[Pereira, Gustavo J. S.; Hirata, Hanako; do Carmo, Lucia G.; Bincoletto, Claudia; Ureshino, Rodrigo P.; Smaili, Soraya S.] Univ Fed Sao Paulo, UNIFESP, Dept Pharmacol, BR-04044020 Sao Paulo, Brazil; [Fimia, Gian M.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Han, Sang W.; Stilhano, Roberta S.; Piacentini, Mauro] Univ Fed Sao Paulo, Interdisciplinary Ctr Gene Therapy, BR-09210170 Sao Paulo, Brazil; [Bloor-Young, Duncan; Churchill, Grant] Univ Oxford, Dept Pharmacol, Oxford OX1 2JD, England; [Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6, England	Universidade Federal de Sao Paulo (UNIFESP); University of Rome Tor Vergata; Universidade Federal de Sao Paulo (UNIFESP); University of Oxford; University of London; University College London	Smaili, SS (corresponding author), Univ Fed Sao Paulo, UNIFESP, Dept Pharmacol, Rua Tres de Maio 100, BR-04044020 Sao Paulo, Brazil.	ssmaili@unifesp.br	Piacentini, Mauro/I-2411-2016; Ureshino, Rodrigo/C-4095-2014; Smaili, Soraya/AAH-2129-2019; Pereira, Gustavo José Silva/ABH-1344-2020; Fimia, Gian Maria/K-3232-2016; Han, Sang W/D-4541-2012; STILHANO, roberta/F-6923-2015; Bincoletto, Claudia/H-4936-2012; Patel, Sandip/O-9591-2015; Pereira, Gustavo/H-4636-2012	Piacentini, Mauro/0000-0003-2919-1296; Ureshino, Rodrigo/0000-0003-3371-3376; Smaili, Soraya/0000-0001-5844-1368; Pereira, Gustavo José Silva/0000-0002-6765-1276; Fimia, Gian Maria/0000-0003-4438-3325; STILHANO, roberta/0000-0002-0653-5968; Patel, Sandip/0000-0001-7247-2013; Bincoletto, Claudia/0000-0001-6666-3673; Pereira, Gustavo/0000-0002-1789-3541	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Biotechnology and Biological Sciences Research Council [BB/G013721/1]; BBSRC [BB/G013721/1] Funding Source: UKRI	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Fundacao do Amparo a Pesquisa do Estado de Sao Paulo, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and the Biotechnology and Biological Sciences Research Council (Grant BB/G013721/1) (to S. P.).	Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carvalho ACP, 2004, CELL DEATH DIFFER, V11, P1265, DOI 10.1038/sj.cdd.4401508; Christensen KA, 2002, J CELL SCI, V115, P599; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Moreschi I, 2008, CELL CALCIUM, V43, P344, DOI 10.1016/j.ceca.2007.06.006; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Patel SD, 2010, SURG LAPARO ENDO PER, V20, P20, DOI 10.1097/SLE.0b013e3181cd45f2; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; ROBBINS E, 1963, J CELL BIOL, V18, P237, DOI 10.1083/jcb.18.2.237; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Smaili SS, 1999, CELL CALCIUM, V26, P121, DOI 10.1054/ceca.1999.0061; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P141, DOI 10.1016/S0014-2999(02)01838-1; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	37	84	87	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27875	27881		10.1074/jbc.C110.216580	http://dx.doi.org/10.1074/jbc.C110.216580			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21610076	hybrid, Green Published			2022-12-27	WOS:000293557800006
J	Fei, ZL; Bera, TK; Liu, XF; Xiang, LM; Pastan, I				Fei, Zhaoliang; Bera, Tapan K.; Liu, Xiufen; Xiang, Laiman; Pastan, Ira			Ankrd26 Gene Disruption Enhances Adipogenesis of Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; TRANSCRIPTIONAL REGULATION; 3T3-L1 PREADIPOCYTES; C/EBP-ALPHA; MAP KINASE; ACTIVATION; EXPRESSION; CELLS	We previously reported that partial disruption of the Ankrd26 gene in mice leads to hyperphagia and leptin-resistant obesity. To determine whether the Ankrd26 mutation can affect the development of adipocytes, we studied mouse embryo fibroblasts (MEFs) from the mutant mice. We found that Ankrd26(-/-) MEFs have a higher rate of spontaneous adipogenesis than normal MEFs and that adipocyte formation is greatly increased when the cells are induced with troglitazone alone or with a mixture of troglitazone, insulin, dexamethasone, and methyl-isobutylxanthine. Increased adipogenesis was detected as an increase in lipid droplet formation and in the expression of several markers of adipogenesis. There was an increase in expression of early stage adipogenesis genes such as Krox20, KLF5, C/EBP beta, C/EBP delta, and late stage adipogenesis regulators KLF15, C/EBP alpha, PPAR gamma, and aP2. There was also an increase in adipocyte stem cell markers CD34 and Sca-1 and preadipocyte markers Gata2 and Pref-1, indicating an increase in both stem cells and progenitor cells in the mutant MEFs. Furthermore, ERK was found constitutively activated in Anrd26(-/-) MEFs, and the addition of MEK inhibitors to mutant cells blocked ERK activation, decreased adipogenesis induction, and significantly reduced expression of C/EBP delta, KLF15, PPAR gamma 2, CD34, and Pref-1 genes. We conclude that Ankrd26 gene disruption promotes adipocyte differentiation at both the progenitor commitment and differentiation steps and that ERK activation plays a role in this process.	[Fei, Zhaoliang; Bera, Tapan K.; Liu, Xiufen; Xiang, Laiman; Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pastan, I (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Rm 5106, Bethesda, MD 20892 USA.	pastani@mail.nih.gov	pastan, ira/P-9319-2019; fei, zhaoliang/ADK-2083-2022	pastan, ira/0000-0002-9223-0270; fei, zhaoliang/0000-0002-5400-8126	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010298] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	Belmonte N, 2001, MOL ENDOCRINOL, V15, P2037, DOI 10.1210/me.15.11.2037; Bera TK, 2008, P NATL ACAD SCI USA, V105, P270, DOI 10.1073/pnas.0710978105; Bera TK, 2006, CANCER RES, V66, P52, DOI 10.1158/0008-5472.CAN-05-3014; Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; deMora JF, 1997, MOL CELL BIOL, V17, P6068, DOI 10.1128/MCB.17.10.6068; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Hahn Y, 2006, GENE, V366, P238, DOI 10.1016/j.gene.2005.07.045; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hishida T, 2009, BIOCHIMIE, V91, P654, DOI 10.1016/j.biochi.2009.02.002; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Liu XF, 2009, APOPTOSIS, V14, P1237, DOI 10.1007/s10495-009-0392-0; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2000, GENE DEV, V14, P1293; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; TOMIYAMA K, 1995, BIOCHEM BIOPH RES CO, V212, P263, DOI 10.1006/bbrc.1995.1965; Tong Q, 2003, DRUG NEWS PERSPECT, V16, P585, DOI 10.1358/dnp.2003.16.9.829340; Wang W, 2009, DEV CELL, V16, P764, DOI 10.1016/j.devcel.2009.04.006; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	32	36	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27761	27768		10.1074/jbc.M111.248435	http://dx.doi.org/10.1074/jbc.M111.248435			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669876	Green Published, hybrid			2022-12-27	WOS:000293268700068
J	Martin, Y; Gonzalez, YV; Cabrera, E; Rodriguez, C; Siverio, JM				Martin, Yuse; Gonzalez, Yelvis V.; Cabrera, Elisa; Rodriguez, Celia; Siverio, Jose M.			Npr1 Ser/Thr Protein Kinase Links Nitrogen Source Quality and Carbon Availability with the Yeast Nitrate Transporter (Ynt1) Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; HANSENULA-POLYMORPHA; PLASMA-MEMBRANE; INTRACELLULAR TRAFFICKING; DEUBIQUITINATING ENZYME; PHOSPHATE TRANSPORTER; ASPERGILLUS-NIDULANS; TRYPTOPHAN PERMEASE; SIGNALING PATHWAY	Ynt1, the single high affinity nitrate and nitrite transporter of the yeast Hansenula polymorpha, is regulated by the quality of nitrogen sources. Preferred nitrogen sources cause Ynt1 dephosphorylation, ubiquitinylation, endocytosis, and vacuolar degradation. In contrast, under nitrogen limitation Ynt1 is phosphorylated and sorted to the plasma membrane. We show here the involvement of the Ser/Thr kinase HpNpr1 in Ynt1 phosphorylation and regulation of Ynt1 levels in response to nitrogen source quality and the availability of carbon. In Delta npr1, Ynt1 phosphorylation does not take place, although Ynt1 ubiquitin conjugates increase. As a result, in this strain Ynt1 is sorted to the vacuole, from both plasma membrane and the later biosynthetic pathway in nitrogen-free conditions and nitrate. In contrast, overexpression of NPR1 blocks down-regulation of Ynt1, increasing Ynt1 phosphorylation at Ser-244 and -246 and reducing ubiquitinylation. Furthermore, Npr1 is phosphorylated in response to the preferred nitrogen sources, and indeed it is dephosphorylated in nitrogen-free medium. Under conditions where Npr1 is phosphorylated, Ynt1 is not and vice versa. We show for the first time that carbon starvation leads to Npr1 phosphorylation, whereas Ynt1 is dephosphorylated and degraded in the vacuole. Rapamycin prevents this, indicating a possible role of the target of rapamycin signaling pathway in this process. We concluded that Npr1 plays a key role in adapting Ynt1 levels to the nitrogen quality and availability of a source of carbon.	[Martin, Yuse; Gonzalez, Yelvis V.; Cabrera, Elisa; Rodriguez, Celia; Siverio, Jose M.] Univ La Laguna, Dpto Bioquim & Biol Mol, Inst Biomed Technol, Nitrogen Metab Grp, E-38206 Tenerife, Canarias, Spain	Universidad de la Laguna	Siverio, JM (corresponding author), Univ La Laguna, Dpto Bioquim & Biol Mol, Inst Biomed Technol, Nitrogen Metab Grp, Av Astrofis Fco Sanchez S-N, E-38206 Tenerife, Canarias, Spain.	jsiverio@ull.es	Rodríguez, Celia/HDL-7429-2022; Gonzalez, Yelvis V./E-9648-2011; Cabrera, Elisa/GPX-3455-2022; Siverio, José Manuel/K-7136-2014	Siverio, José Manuel/0000-0001-9404-2655	Ministerio de Ciencia e Innovacion [BFU2007-60172, BFU2010-16192]; Ministerio de Educacion y Ciencia (MEC); CajaCanarias-Universidad de La Laguna; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI), Gobierno de Canarias, Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Educacion y Ciencia (MEC)(Spanish Government); CajaCanarias-Universidad de La Laguna; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI), Gobierno de Canarias, Spain	This work was supported by Grants BFU2007-60172 and BFU2010-16192 (to J. M. S.) from the "Ministerio de Ciencia e Innovacion."; Recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia (MEC).; Recipient of a predoctoral fellowship from CajaCanarias-Universidad de La Laguna.; Recipient of a predoctoral fellowship from Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI), Gobierno de Canarias, Spain.	Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274; AVILA J, 1995, FEBS LETT, V366, P137, DOI 10.1016/0014-5793(95)00511-7; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; CRAWFORD NM, 1993, ANNU REV GENET, V27, P115, DOI 10.1146/annurev.ge.27.120193.000555; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Devasahayam G, 2006, P NATL ACAD SCI USA, V103, P17840, DOI 10.1073/pnas.0604303103; Estrella LA, 2008, J BIOL CHEM, V283, P5327, DOI 10.1074/jbc.M703630200; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Gander S, 2009, J PROTEOME RES, V8, P5305, DOI 10.1021/pr9005469; Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; GRENSON M, 1982, MOL GEN GENET, V188, P261, DOI 10.1007/BF00332685; GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Kaouass M, 1998, J BIOL CHEM, V273, P2109, DOI 10.1074/jbc.273.4.2109; Lagerstedt JO, 2002, FEBS LETT, V526, P31, DOI 10.1016/S0014-5793(02)03109-5; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Llamas A, 2002, PLANT J, V30, P261, DOI 10.1046/j.1365-313X.2002.01281.x; Machin F, 2004, YEAST, V21, P265, DOI 10.1002/yea.1075; Martinez P, 1998, J BACTERIOL, V180, P2253, DOI 10.1128/JB.180.8.2253-2256.1998; Narendja F, 2002, MOL MICROBIOL, V44, P573, DOI 10.1046/j.1365-2958.2002.02911.x; Navarro FJ, 2006, J BIOL CHEM, V281, P13268, DOI 10.1074/jbc.M601253200; Navarro FJ, 2003, FEMS YEAST RES, V4, P149, DOI 10.1016/S1567-1356(03)00163-6; Navarro FJ, 2008, J BIOL CHEM, V283, P31208, DOI 10.1074/jbc.M802170200; Neufeld TP, 2007, CELL METAB, V5, P3, DOI 10.1016/j.cmet.2006.12.008; Neuhauser B, 2011, EUKARYOT CELL, V10, P332, DOI 10.1128/EC.00293-10; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Omura F, 2004, FEMS MICROBIOL LETT, V230, P227, DOI 10.1016/S0378-1097(03)00918-2; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; Perez-Valle J, 2007, MOL CELL BIOL, V27, P5725, DOI 10.1128/MCB.01375-06; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rodriguez C, 2010, J BIOL CHEM, V285, P37551, DOI 10.1074/jbc.M110.146902; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1016/S0168-6445(02)00100-6; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang Y, 2007, NEW PHYTOL, V175, P699, DOI 10.1111/j.1469-8137.2007.02135.x; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	50	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27225	27235		10.1074/jbc.M111.265116	http://dx.doi.org/10.1074/jbc.M111.265116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652715	Green Published, hybrid			2022-12-27	WOS:000293268700018
J	Lopez-Huertas, MR; Mateos, E; Diaz-Gil, G; Gomez-Esquer, F; del Cojo, MS; Alcami, J; Coiras, M				Rosa Lopez-Huertas, Maria; Mateos, Elena; Diaz-Gil, Gema; Gomez-Esquer, Francisco; Sanchez del Cojo, Maria; Alcami, Jose; Coiras, Mayte			Protein Kinase C theta Is a Specific Target for Inhibition of the HIV Type 1 Replication in CD4(+) T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IMMUNODEFICIENCY-VIRUS TYPE-1; PKC-THETA; ANTIRETROVIRAL THERAPY; SELECTIVE INHIBITOR; ACTIVATION LOOP; CELL-CYCLE; INFECTION; ROTTLERIN; APOPTOSIS	Integration of HIV-1 genome in CD4(+) T cells produces latent reservoirs with long half-life that impedes the eradication of the infection. Control of viral replication is essential to reduce the size of latent reservoirs, mainly during primary infection when HIV-1 infects CD4(+) T cells massively. The addition of immunosuppressive agents to highly active antiretroviral therapy during primary infection would suppress HIV-1 replication by limiting T cell activation, but these agents show potential risk for causing lymphoproliferative disorders. Selective inhibition of PKC theta, crucial for T cell function, would limit T cell activation and HIV-1 replication without causing general immunosuppression due to PKC theta being mostly expressed in T cells. Accordingly, the effect of rottlerin, a dose-dependent PKC theta inhibitor, on HIV-1 replication was analyzed in T cells. Rottlerin was able to reduce HIV-1 replication more than 20-fold in MT-2 (IC50 = 5.2 mu M) and Jurkat (IC50 = 2.2 mu M) cells and more than 4-fold in peripheral blood lymphocytes (IC50 = 4.4 mu M). Selective inhibition of PKC theta, but not PKC delta or -zeta, was observed at <6.0 mu M, decreasing the phosphorylation at residue Thr(538) on the kinase catalytic domain activation loop and avoiding PKC theta translocation to the lipid rafts. Consequently, the main effector at the end of PKC theta pathway, NF-kappa B, was repressed. Rottlerin also caused a significant inhibition of HIV-1 integration. Recently, several specific PKC theta inhibitors have been designed for the treatment of autoimmune diseases. Using these inhibitors in combination with highly active antiretroviral therapy during primary infection could be helpful to avoid massive viral infection and replication from infected CD4(+) T cells, reducing the reservoir size at early stages of the infection.	[Rosa Lopez-Huertas, Maria; Mateos, Elena; Sanchez del Cojo, Maria; Alcami, Jose; Coiras, Mayte] Inst Salud Carlos III, Natl Ctr Microbiol, AIDS Immunopathol Unit, Madrid 28220, Spain; [Diaz-Gil, Gema; Gomez-Esquer, Francisco] Univ Rey Juan Carlos, Fac Hlth Sci, Madrid 28922, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad Rey Juan Carlos	Coiras, M (corresponding author), Ctra Majadahonda Pozuelo Km2, Madrid 28220, Spain.	mcoiras@isciii.es	Esquer, Francisco Gomez/K-8236-2017; Coiras, Mayte/R-9530-2019; Diaz-Gil, Gema/ABG-6454-2020; Alcami, Pepe/T-2242-2018; Lopez Huertas, Maria Rosa/J-6282-2014	Alcami, Pepe/0000-0003-0023-7377; Lopez Huertas, Maria Rosa/0000-0002-4183-2773; Coiras, Mayte/0000-0001-6464-5770; Diaz Gil, Gema/0000-0003-3480-1490; Gomez-Esquer, Francisco/0000-0002-5426-4349	Instituto de Salud Carlos III, Spanish Ministry of Health [FIS PI080752]; AIDS Network ISCIII-RETIC [RD06/0006]; Comunidad de Madrid (Spain), Network of Excellence EUROPRISE; FIPSE [36584/06, 36633/07, 360924/10]; European Union; Fondo de Investigaciones Sanitarias [FI09/00347]	Instituto de Salud Carlos III, Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); AIDS Network ISCIII-RETIC; Comunidad de Madrid (Spain), Network of Excellence EUROPRISE(Comunidad de Madrid); FIPSE; European Union(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by Instituto de Salud Carlos III, Spanish Ministry of Health (FIS PI080752); AIDS Network ISCIII-RETIC (RD06/0006); VIRHORST Network from Comunidad de Madrid (Spain), Network of Excellence EUROPRISE; FIPSE (36584/06, 36633/07, and 360924/10).; Supported by a fellowship of the European Union Programme Health 2009 (CHAARM).; Supported by a fellowship of Fondo de Investigaciones Sanitarias (FI09/00347).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; Altman A, 2000, IMMUNOL TODAY, V21, P567, DOI 10.1016/S0167-5699(00)01749-7; ARENZANASEISDEDOS F, 1993, J VIROL, V67, P6596, DOI 10.1128/JVI.67.11.6596-6604.1993; BACHELERIE F, 1991, NATURE, V350, P709, DOI 10.1038/350709a0; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; BAIER G, 1993, J BIOL CHEM, V268, P4997; Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Bedoya LM, 2009, BIOCHEM PHARMACOL, V77, P965, DOI 10.1016/j.bcp.2008.11.025; Berrey MM, 2001, J INFECT DIS, V183, P1466, DOI 10.1086/320189; Boschelli DH, 2010, BIOORG MED CHEM LETT, V20, P1965, DOI 10.1016/j.bmcl.2010.01.119; Boschelli DH, 2009, CURR TOP MED CHEM, V9, P640, DOI 10.2174/156802609789007372; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; de Lera TL, 1999, ONCOGENE, V18, P1581, DOI 10.1038/sj.onc.1202455; Deszo EL, 2001, J BIOL CHEM, V276, P10212, DOI 10.1074/jbc.M010589200; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Garcia-Perez J, 2007, J MED VIROL, V79, P127, DOI 10.1002/jmv.20770; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Gekeler V, 1996, BRIT J CANCER, V74, P897, DOI 10.1038/bjc.1996.454; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hoen B, 1999, J INFECT DIS, V180, P1342, DOI 10.1086/315002; ICHIMURA H, 1995, VIROLOGY, V211, P554, DOI 10.1006/viro.1995.1437; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Manicassamy S, 2009, CURR OPIN INVEST DR, V10, P1225; Marquez N, 2008, BIOCHEM PHARMACOL, V75, P1370, DOI 10.1016/j.bcp.2007.12.004; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; Matteucci C, 2004, J MED VIROL, V74, P473, DOI 10.1002/jmv.20201; Matz M, 2010, NEPHROL DIAL TRANSPL, V25, P2159, DOI 10.1093/ndt/gfp775; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Meller N, 1998, STEM CELLS, V16, P178, DOI 10.1002/stem.160178; Meller N, 1999, CELL IMMUNOL, V193, P185, DOI 10.1006/cimm.1999.1478; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; Pantaleo G, 1998, NAT MED, V4, P341, DOI 10.1038/nm0398-341; Pantaleo G, 1997, EUR J IMMUNOL, V27, P3166, DOI 10.1002/eji.1830271213; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; Powell JD, 1998, IMMUNOL REV, V165, P287, DOI 10.1111/j.1600-065X.1998.tb01246.x; Ringshausen I, 2006, LEUKEMIA, V20, P514, DOI 10.1038/sj.leu.2404113; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rullas J, 2004, ANTIVIR THER, V9, P545; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Sancho R, 2004, J BIOL CHEM, V279, P37349, DOI 10.1074/jbc.M401993200; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Solomou EE, 2001, J IMMUNOL, V166, P5665, DOI 10.4049/jimmunol.166.9.5665; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Villalba M, 1998, NEUROREPORT, V9, P1713, DOI 10.1097/00001756-199806010-00008; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Williams SA, 2007, CYTOKINE, V39, P63, DOI 10.1016/j.cyto.2007.05.017; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669	78	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27363	27377		10.1074/jbc.M110.210443	http://dx.doi.org/10.1074/jbc.M110.210443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669868	Green Published, hybrid			2022-12-27	WOS:000293268700032
J	Sharma, B; Altman, JK; Goussetis, DJ; Verma, AK; Platanias, LC				Sharma, Bhumika; Altman, Jessica K.; Goussetis, Dennis J.; Verma, Amit K.; Platanias, Leonidas C.			Protein Kinase R as Mediator of the Effects of Interferon (IFN) gamma and Tumor Necrosis Factor (TNF) alpha on Normal and Dysplastic Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MYELODYSPLASTIC-SYNDROME; APLASTIC-ANEMIA; SIGNALING PATHWAYS; I INTERFERONS; CELL-GROWTH; P38 MAPK; C-DELTA; ACTIVATION; PKR	IFN gamma and TNF alpha are potent inhibitors of hematopoiesis and have been implicated in the pathophysiology of bone marrow failure and myelodysplastic syndromes (MDS). We examined the role of protein kinase R (PKR) in the generation of the inhibitory effects of these myelosuppressive cytokines on hematopoiesis. Our data demonstrate that PKR is rapidly phosphorylated/activated in response to engagement of IFN gamma or TNF alpha receptors in normal human hematopoietic progenitors. Such engagement of PKR is important for the suppressive effects of these cytokines on normal hematopoiesis. Pharmacological targeting of PKR using a specific inhibitor or siRNA-mediated PKR knockdown results in partial reversal of the suppressive effects of IFN gamma and TNF alpha on normal human CD34+-derived myeloid (colony-forming unit-granulocyte-monocytic) and erythroid (burst-forming unit-erythroid) progenitors. Importantly, inhibition of PKR activity or expression increases hematopoietic colony formation from human MDS progenitors, suggesting that drugs that target PKR may provide a novel approach for the treatment of MDS and marrow failure syndromes. Altogether, our data establish that beyond its key role in the induction of IFN-antiviral responses, PKR plays important roles in signaling for IFN gamma and other myelosuppressive cytokine receptors as a common mediator of signals for hematopoietic suppression.	[Sharma, Bhumika; Altman, Jessica K.; Goussetis, Dennis J.; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Sch Med, Chicago, IL 60611 USA; [Sharma, Bhumika; Altman, Jessica K.; Goussetis, Dennis J.] Northwestern Univ, Div Hematol Oncol, Sch Med, Chicago, IL 60611 USA; Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Verma, Amit K.; Platanias, Leonidas C.] Albert Einstein Coll Med, Dept Med, Div Hematol Oncol, Bronx, NY 10461 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Yeshiva University; Albert Einstein College of Medicine	Platanias, LC (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Sch Med, 303 E Super St,Lurie, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [CA77816, CA121192, AG029138]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA121192, R01CA077816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA121192, and AG029138. This work was also supported by a merit review grant from the Department of Veterans Affairs.	Arnold R, 2007, CELL DEATH DIFFER, V14, P568, DOI 10.1038/sj.cdd.4402042; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Bodo M, 2009, J Stem Cells, V4, P57, DOI jsc.2009.4.1.57; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bruserud O, 2010, CURR TOP MICROBIOL, V341, P3, DOI 10.1007/82_2010_18; Chamuleau MED, 2009, HAEMATOL-HEMATOL J, V94, P496, DOI 10.3324/haematol.13612; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Follo MY, 2008, LEUKEMIA, V22, P2267, DOI 10.1038/leu.2008.122; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia-Manero G, 2010, HEMATOL-AM SOC HEMAT, P330, DOI 10.1182/asheducation-2010.1.330; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; George CX, 2009, J INTERF CYTOK RES, V29, P477, DOI 10.1089/jir.2009.0065; Gersuk GR, 1998, BRIT J HAEMATOL, V103, P176, DOI 10.1046/j.1365-2141.1998.00933.x; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Hofmann WK, 2005, ANNU REV MED, V56, P1, DOI 10.1146/annurev.med.56.082103.104704; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kambhampati S, 2003, J BIOL CHEM, V278, P32544, DOI 10.1074/jbc.M301523200; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaushansky K, 2009, J THROMB HAEMOST, V7, P235, DOI 10.1111/j.1538-7836.2009.03419.x; Kitagawa M, 1997, LEUKEMIA, V11, P2049, DOI 10.1038/sj.leu.2400844; Kochenderfer JN, 2002, BLOOD, V100, P3639, DOI 10.1182/blood-2002-01-0155; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; LOTEM J, 1991, CELL GROWTH DIFFER, V2, P421; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; NAUDE PJ, 2001, FEBS J, V278, P888; Navas T, 2008, LEUKEMIA LYMPHOMA, V49, P1963, DOI 10.1080/10428190802322919; Navas TA, 2006, BLOOD, V108, P4170, DOI 10.1182/blood-2006-05-023093; Olnes MJ, 2011, JAMA-J AM MED ASSOC, V305, P814, DOI 10.1001/jama.2011.194; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Redig AJ, 2007, J INTERF CYTOK RES, V27, P623, DOI 10.1089/jir.2007.0007; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Samuel CE, 1997, INT J HEMATOL, V65, P227; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sloand EM, 2005, BLOOD, V106, P841, DOI 10.1182/blood-2004-05-2017; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Uddin S, 2000, J BIOL CHEM, V275, P27634; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Wickrema A, 1999, J BIOL CHEM, V274, P24469, DOI 10.1074/jbc.274.35.24469; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470; Young NS, 1996, EUR J HAEMATOL, V57, P55; Young NS, 2002, ANN INTERN MED, V136, P534, DOI 10.7326/0003-4819-136-7-200204020-00011; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07	56	22	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27506	27514		10.1074/jbc.M111.238501	http://dx.doi.org/10.1074/jbc.M111.238501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659535	hybrid, Green Published			2022-12-27	WOS:000293268700045
J	Steckbeck, JD; Craigo, JK; Barnes, CO; Montelaro, RC				Steckbeck, Jonathan D.; Craigo, Jodi K.; Barnes, Christopher O.; Montelaro, Ronald C.			Highly Conserved Structural Properties of the C-terminal Tail of HIV-1 gp41 Protein Despite Substantial Sequence Variation among Diverse Clades IMPLICATIONS FOR FUNCTIONS IN VIRAL REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEMBRANE-SPANNING DOMAIN; CIRCULAR-DICHROISM SPECTRA; CELL-CELL FUSION; DE-NOVO PEPTIDE; RELATE 2 SETS; ENVELOPE GLYCOPROTEIN; CYTOPLASMIC TAIL; STRUCTURE PREDICTION; NEUTRALIZING ANTIBODIES	Although the HIV-1 Env gp120 and gp41 ectodomain have been extensively characterized in terms of structure and function, similar characterizations of the C-terminal tail (CTT) of HIV gp41 remain relatively limited and contradictory. The current study was designed to examine in detail CTT sequence conservation relative to gp120 and the gp41 ectodomain and to examine the conservation of predicted physicochemical and structural properties across a number of divergent HIV clades and groups. Results demonstrate that CTT sequences display intermediate levels of sequence evolution and diversity in comparison to the more diverse gp120 and the more conserved gp41 ectodomain. Despite the relatively high level of CTT sequence variation, the physicochemical properties of the lentivirus lytic peptide domains (LLPs) within the CTT are evidently highly conserved across clades/groups. Additionally, predictions using PEP-FOLD indicate a high level of structural similarity in the LLP regions that was confirmed by circular dichroism measurements of secondary structure of LLP peptides from clades B, C, and group O. Results demonstrate that LLP peptides adopt helical structure in the presence of SDS or trifluoroethanol but are predominantly unstructured in aqueous buffer. Thus, these data for the first time demonstrate strong conservations of characteristic CTT physicochemical and structural properties despite substantial sequence diversity, apparently indicating a delicate balance between evolutionary pressures and the conservation of CTT structure and associated functional roles in virus replication.	[Steckbeck, Jonathan D.; Craigo, Jodi K.; Barnes, Christopher O.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15261 USA; [Craigo, Jodi K.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Montelaro, RC (corresponding author), 3501 5th Ave,9014 BST3, Pittsburgh, PA 15261 USA.	rmont@pitt.edu			National Institutes of Health [1R01AI087533, 1P50GM082251, 5T32GM065100, 5T32AI065380]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087533, T32AI065380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251, T32GM065100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01AI087533, 1P50GM082251, 5T32GM065100, and 5T32AI065380.	Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; CHANH TC, 1986, EMBO J, V5, P3065, DOI 10.1002/j.1460-2075.1986.tb04607.x; CHERNOMORDIK L, 1994, J VIROL, V68, P7115, DOI 10.1128/JVI.68.11.7115-7123.1994; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Evans DT, 2001, IMMUNOL REV, V183, P141, DOI 10.1034/j.1600-065x.2001.1830112.x; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Gangupomu VK, 2010, BIOPHYS J, V99, P3438, DOI 10.1016/j.bpj.2010.09.054; Heap CJ, 2005, J GEN VIROL, V86, P1499, DOI 10.1099/vir.0.80414-0; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; HIRSCH VM, 1989, NATURE, V341, P573, DOI 10.1038/341573a0; HO DD, 1987, J VIROL, V61, P2024, DOI 10.1128/JVI.61.6.2024-2028.1987; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Jing WG, 2003, J BACTERIOL, V185, P4938, DOI 10.1128/JB.185.16.4938-4947.2003; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim JH, 2009, BBA-BIOMEMBRANES, V1788, P1804, DOI 10.1016/j.bbamem.2009.06.011; Kliger Y, 1997, BIOCHEMISTRY-US, V36, P5157, DOI 10.1021/bi962935r; KODAMA T, 1989, J VIROL, V63, P4709, DOI 10.1128/JVI.63.11.4709-4714.1989; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Lu L, 2008, J BIOL CHEM, V283, P16723, DOI 10.1074/jbc.M801083200; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Murakami T, 2008, MICROBIOL IMMUNOL, V52, P287, DOI 10.1111/j.1348-0421.2008.00008.x; Newman JT, 2007, VIROLOGY, V367, P102, DOI 10.1016/j.virol.2007.05.027; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; PIENIAZEK D, 1998, HUMAN RETROVIRUS AID, P112; Reading SA, 2003, VIROLOGY, V315, P362, DOI 10.1016/S0042-6822(03)00533-6; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; SRINIVAS SK, 1992, J BIOL CHEM, V267, P7121; Steckbeck JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015261; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tung CH, 2003, ADV DRUG DELIVER REV, V55, P281, DOI 10.1016/S0169-409X(02)00183-7; Viard M, 2008, BIOCHEMISTRY-US, V47, P1977, DOI 10.1021/bi701920f; West JT, 2001, J VIROL, V75, P9601, DOI 10.1128/JVI.75.20.9601-9612.2001; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; [No title captured]	64	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27156	27166		10.1074/jbc.M111.258855	http://dx.doi.org/10.1074/jbc.M111.258855			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659530	Green Published, hybrid			2022-12-27	WOS:000293268700011
J	Ghilarov, D; Serebryakova, M; Shkundina, I; Severinov, K				Ghilarov, Dmitry; Serebryakova, Marina; Shkundina, Irina; Severinov, Konstantin			A Major Portion of DNA Gyrase Inhibitor Microcin B17 Undergoes an N,O-Peptidyl Shift during Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERED BISHETEROCYCLIC SITES; POSTTRANSLATIONAL MODIFICATIONS; ESCHERICHIA-COLI; BACTERIAL TOXIN; PEPTIDE; HETEROCYCLIZATION; AUTOPROTEOLYSIS; BIOSYNTHESIS; REPLICATION; SYNTHETASE	Microcin B17 (McB) is a 43-amino acid antibacterial peptide targeting the DNA gyrase. The McB precursor is ribosomally produced and then post-translationally modified by the Mcb-BCD synthase. Active mature McB contains eight oxazole and thiazole heterocycles. Here, we show that a major portion of mature McB contains an additional unusual modification, a backbone ester bond connecting McB residues 51 and 52. The modification results from an N -> O shift of the Ser(52) residue located immediately downstream of one of McBthiazole heterocycles. We speculate that the N, O-peptidyl shift undergone by Ser(52) is an intermediate of post-translational modification reactions catalyzed by the McbBCD synthase that normally lead to formation of McB heterocycles.	[Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Ghilarov, Dmitry; Serebryakova, Marina; Shkundina, Irina; Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Serebryakova, Marina] Inst Physicochem Med Fed Medicobiol Agcy, Moscow 119992, Russia; [Shkundina, Irina; Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Severinov, Konstantin] Waksman Inst Microbiol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Russian Academy of Sciences	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, Dept Mol Biol & Biochem, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Ghilarov, Dmitry/N-4062-2015; Serebryakova, Marina/E-2986-2012	Serebryakova, Marina/0000-0002-5402-8215; Ghilarov, Dmitry/0000-0001-9325-3207	Russian Academy of Sciences Molecular and Cell Biology [02.740.11.0771]; Russian Foundation for Basic Research [09-04-00293-a]; Federal Program "Scientific and sicentific-pedagogical personnel of innovative Russia" [P1068]; Bortnik Foundation UMNIK	Russian Academy of Sciences Molecular and Cell Biology(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Program "Scientific and sicentific-pedagogical personnel of innovative Russia"; Bortnik Foundation UMNIK	This work was supported in part by the Russian Academy of Sciences Molecular and Cell Biology Program grant and Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia 2009-2013," state contract 02.740.11.0771 (to K. S.), Russian Foundation for Basic Research grant 09-04-00293-a, and Federal Program "Scientific and sicentific-pedagogical personnel of innovative Russia 2009-2013," state contract P1068 (to I. S.).; Supported by the Bortnik Foundation UMNIK program.	Allali N, 2002, J BACTERIOL, V184, P3224, DOI 10.1128/JB.184.12.3224-3231.2002; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Drlica K, 2009, CURR TOP MED CHEM, V9, P981, DOI 10.2174/156802609789630947; Duquesne S, 2007, J MOL MICROB BIOTECH, V13, P200, DOI 10.1159/000104748; ELLIOTT DF, 1952, BIOCHEM J, V50, P542, DOI 10.1042/bj0500542; GENILLOUD O, 1989, J BACTERIOL, V171, P1126, DOI 10.1128/jb.171.2.1126-1135.1989; Gonzalez DJ, 2010, J BIOL CHEM, V285, P28220, DOI 10.1074/jbc.M110.118554; Heddle JG, 2001, J MOL BIOL, V307, P1223, DOI 10.1006/jmbi.2001.4562; HERRERO M, 1986, J GEN MICROBIOL, V132, P393; Kelleher NL, 1999, BIOCHEMISTRY-US, V38, P15623, DOI 10.1021/bi9913698; Kelleher NL, 1998, J AM CHEM SOC, V120, P9716, DOI 10.1021/ja9822097; LAVINA M, 1986, J GEN MICROBIOL, V132, P1685; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; McIntosh JA, 2010, CHEMBIOCHEM, V11, P1413, DOI 10.1002/cbic.201000196; Milne JC, 1999, BIOCHEMISTRY-US, V38, P4768, DOI 10.1021/bi982975q; Mitchell DA, 2009, J BIOL CHEM, V284, P13004, DOI 10.1074/jbc.M900802200; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Onaka H, 2005, MICROBIOL-SGM, V151, P3923, DOI 10.1099/mic.0.28420-0; Parks WM, 2007, BIOCHIMIE, V89, P500, DOI 10.1016/j.biochi.2006.12.005; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Pierrat OA, 2005, BIOCHEMISTRY-US, V44, P4204, DOI 10.1021/bi0478751; Pierrat OA, 2003, J BIOL CHEM, V278, P35016, DOI 10.1074/jbc.M304516200; Roy RS, 1999, CHEM BIOL, V6, P305, DOI 10.1016/S1074-5521(99)80076-3; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; VIZAN JL, 1991, EMBO J, V10, P467, DOI 10.1002/j.1460-2075.1991.tb07969.x; Walsh CT, 2010, J BIOL CHEM, V285, P27525, DOI 10.1074/jbc.R110.135970; YORGEY P, 1994, P NATL ACAD SCI USA, V91, P4519, DOI 10.1073/pnas.91.10.4519; Zamble DB, 2001, P NATL ACAD SCI USA, V98, P7712, DOI 10.1073/pnas.141225698	32	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26308	26318		10.1074/jbc.M111.241315	http://dx.doi.org/10.1074/jbc.M111.241315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21628468	hybrid, Green Published			2022-12-27	WOS:000293078200007
J	Pedersen, JT; Ostergaard, J; Rozlosnik, N; Gammelgaard, B; Heegaard, NHH				Pedersen, Jeppe T.; Ostergaard, Jesper; Rozlosnik, Noemi; Gammelgaard, Bente; Heegaard, Niels H. H.			Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-beta Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMER A-BETA; BINDING-SITE; CU-II; MOLECULAR-MECHANISM; HYDROGEN-PEROXIDE; COPPER(II) IONS; FIBRIL GROWTH; DISEASE; PROTEIN; COORDINATION	Cu(II) ions are implicated in the pathogenesis of Alzheimer disease by influencing the aggregation of the amyloid-beta (A beta) peptide. Elucidating the underlying Cu(II)-inducedA beta aggregation is paramount for understanding the role of Cu(II) in the pathology of Alzheimer disease. The aim of this study was to characterize the qualitative and quantitative influence of Cu(II) on the extracellular aggregation mechanism and aggregate morphology of A beta(1-40) using spectroscopic, microelectrophoretic, mass spectrometric, and ultrastructural techniques. We found that the Cu(II):A beta ratio in solution has a major influence on (i) the aggregation kinetics/mechanism of A beta, because three different kinetic scenarios were observed depending on the Cu(II):A beta ratio, (ii) the metal: peptide stoichiometry in the aggregates, which increased to 1.4 at supra-equimolar Cu(II):A beta ratio; and (iii) the morphology of the aggregates, which shifted from fibrillar to non-fibrillar at increasing Cu(II):A beta ratios. We observed dynamic morphological changes of the aggregates, and that the formation of spherical aggregates appeared to be a common morphological end point independent on the Cu(II) concentration. Experiments with A beta(1-42) were compatible with the conclusions for A beta(1-40) even though the low solubility of A beta(1-42) precluded examination under the same conditions as for the A beta(1-40). Experiments with A beta(1-16) and A beta(1-28) showed that other parts than the Cu(II)-binding His residues were important for Cu(II)-induced A beta aggregation. Based on this study we propose three mechanistic models for the Cu(II)-induced aggregation of A beta(1-40) depending on the Cu(II):A beta ratio, and identify key reaction steps that may be feasible targets for preventing Cu(II)-associated aggregation or toxicity in Alzheimer disease.	[Pedersen, Jeppe T.; Ostergaard, Jesper; Gammelgaard, Bente] Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Rozlosnik, Noemi] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Heegaard, Niels H. H.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; Statens Serum Institut	Ostergaard, J (corresponding author), Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Fac Pharmaceut Sci, Univ Pk2, DK-2100 Copenhagen, Denmark.	joe@farma.ku.dk; nhe@ssi.dk	Rozlosnik, Noemi/A-3090-2012; Ostergaard, Jesper/A-9922-2011; Gammelgaard, Bente/A-7826-2013; Pedersen, Jeppe Trudslev/A-2600-2011	Ostergaard, Jesper/0000-0003-3448-4237; Gammelgaard, Bente/0000-0002-9149-1014	Statens Serum Institut; Drug Research Academy, The Faculty of Pharmaceutical Sciences, University of Copenhagen	Statens Serum Institut; Drug Research Academy, The Faculty of Pharmaceutical Sciences, University of Copenhagen	This work was supported by the Statens Serum Institut and The Drug Research Academy, The Faculty of Pharmaceutical Sciences, University of Copenhagen.	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Brzyska M, 2009, CHEMBIOCHEM, V10, P1045, DOI 10.1002/cbic.200800732; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Capanni C, 2004, CELL MOL LIFE SCI, V61, P982, DOI 10.1007/s00018-003-3447-3; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Dong J, 2007, P NATL ACAD SCI USA, V104, P13313, DOI 10.1073/pnas.0702669104; Dorlet P, 2009, ANGEW CHEM INT EDIT, V48, P9273, DOI 10.1002/anie.200904567; Drew SC, 2009, J AM CHEM SOC, V131, P1195, DOI 10.1021/ja808073b; Eakin CM, 2002, BIOCHEMISTRY-US, V41, P10646, DOI 10.1021/bi025944a; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; FRIEDEN C, 1985, ANNU REV BIOPHYS BIO, V14, P189, DOI 10.1146/annurev.bb.14.060185.001201; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Guilloreau L, 2006, J BIOL INORG CHEM, V11, P1024, DOI 10.1007/s00775-006-0154-1; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hatcher LQ, 2008, J PHYS CHEM B, V112, P8160, DOI 10.1021/jp710806s; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Jun SM, 2007, ANGEW CHEM INT EDIT, V46, P3959, DOI 10.1002/anie.200700318; Karr JW, 2008, BIOCHEMISTRY-US, V47, P5006, DOI 10.1021/bi702423h; Karr JW, 2007, J AM CHEM SOC, V129, P3796, DOI 10.1021/ja068952d; Karr JW, 2005, BIOCHEMISTRY-US, V44, P5478, DOI 10.1021/bi047611e; Karr JW, 2004, J AM CHEM SOC, V126, P13534, DOI 10.1021/ja0488028; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Kowalik-Jankowska T, 2003, J INORG BIOCHEM, V95, P270, DOI 10.1016/S0162-0134(03)00128-4; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014; Lim KH, 2007, BIOCHEMISTRY-US, V46, P13523, DOI 10.1021/bi701112z; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lovell MA, 1999, BRAIN RES, V823, P88, DOI 10.1016/S0006-8993(99)01114-2; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Ostergaard J, 2006, ELECTROPHORESIS, V27, P2590, DOI 10.1002/elps.200600047; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Pedersen JT, 2011, ANGEW CHEM INT EDIT, V50, P2532, DOI 10.1002/anie.201006335; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Raman B, 2005, J BIOL CHEM, V280, P16157, DOI 10.1074/jbc.M500309200; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Schlief ML, 2006, P NATL ACAD SCI USA, V103, P14919, DOI 10.1073/pnas.0605390103; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHEN CL, 1993, BIOPHYS J, V65, P2383, DOI 10.1016/S0006-3495(93)81312-2; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Talmard C, 2007, CHEMBIOCHEM, V8, P163, DOI 10.1002/cbic.200600319; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Viles JH, 2008, BIOCHEM SOC T, V36, P1288, DOI 10.1042/BST0361288; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Zou J, 2001, ANGEW CHEM INT EDIT, V40, P2274, DOI 10.1002/1521-3773(20010618)40:12<2274::AID-ANIE2274>3.0.CO;2-5	72	96	99	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26952	26963		10.1074/jbc.M111.220863	http://dx.doi.org/10.1074/jbc.M111.220863			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642429	hybrid, Green Published			2022-12-27	WOS:000293078200069
J	Casabuono, A; Petrocelli, S; Ottado, J; Orellano, EG; Couto, AS				Casabuono, Adriana; Petrocelli, Silvana; Ottado, Jorgelina; Orellano, Elena G.; Couto, Alicia S.			Structural Analysis and Involvement in Plant Innate Immunity of Xanthomonas axonopodis pv. citri Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESORPTION/IONIZATION MASS-SPECTROMETRY; GRAM-NEGATIVE BACTERIA; O-ANTIGEN; OXIDATIVE BURST; DEFENSE GENES; CAMPESTRIS; ARABIDOPSIS; RESISTANCE; INDUCTION; BIOSYNTHESIS	Xanthomonas axonopodis pv. citri (Xac) causes citrus canker, provoking defoliation and premature fruit drop with concomitant economical damage. In plant pathogenic bacteria, lipopolysaccharides are important virulence factors, and they are being increasingly recognized as major pathogen-associated molecular patterns for plants. In general, three domains are recognized in a lipopolysaccharide: the hydrophobic lipid A, the hydrophilic O-antigen polysaccharide, and the core oligosaccharide, connecting lipidA and O-antigen. In this work, we have determined the structure of purified lipopolysaccharides obtained from Xanthomonas axonopodis pv. citri wild type and a mutant of the O-antigen ABC transporter encoded by the wzt gene. High pH anion exchange chromatography and matrix-assisted laser desorption/ionization mass spectrum analysis were performed, enabling determination of the structure not only of the released oligosaccharides and lipid A moieties but also the intact lipopolysaccharides. The results demonstrate that Xac wild type and Xacwzt LPSs are composed mainly of a penta-or tetra-acylated diglucosamine backbone attached to either two pyrophosphorylethanolamine groups or to one pyrophosphorylethanolamine group and one phosphorylethanolamine group. The core region consists of a branched oligosaccharide formed by Kdo(2)Hex(6)GalA(3)Fuc(3)NAcRha(4) and two phosphate groups. As expected, the presence of a rhamnose homo-oligosaccharide as O-antigen was determined only in the Xac wild type lipopolysaccharide. In addition, we have examined how lipopolysaccharides from Xac function in the pathogenesis process. We analyzed the response of the different lipopolysaccharides during the stomata aperture closure cycle, the callose deposition, the expression of defense-related genes, and reactive oxygen species production in citrus leaves, suggesting a functional role of the O-antigen from Xac lipopolysaccharides in the basal response.	[Casabuono, Adriana; Couto, Alicia S.] Univ Buenos Aires, Fac Cs Exactas & Nat, Dept Quim Inorgan, Ctr Invest Hidratos Carbono, RA-1428 Buenos Aires, DF, Argentina; [Petrocelli, Silvana; Ottado, Jorgelina; Orellano, Elena G.] Consejo Nacl Invest Cient & Tecn IBR CONICET UNR, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, Div Mol Biol, Rosario, Santa Fe, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Couto, AS (corresponding author), Univ Buenos Aires, Fac Cs Exactas & Nat, Dept Quim Inorgan, Ctr Invest Hidratos Carbono, RA-1428 Buenos Aires, DF, Argentina.	acouto@qo.fcen.uba.ar			Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 01-12783, PME 125]; University of Buenos Aires; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by a grant from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 01-12783) (to E. G. O.), the University of Buenos Aires, and CONICET. The Ultraflex II (Bruker) TOF/TOF mass spectrometer was supported by an ANPCyT (Grant PME 125).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bedini E, 2005, J AM CHEM SOC, V127, P2414, DOI 10.1021/ja0452166; Braun SG, 2005, MOL PLANT MICROBE IN, V18, P674, DOI 10.1094/MPMI-18-0674; Brown I, 1998, PLANT J, V15, P333, DOI 10.1046/j.1365-313X.1998.00215.x; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Daurelio LD, 2011, J PLANT PHYSIOL, V168, P382, DOI 10.1016/j.jplph.2010.07.014; Daurelio L. D., 2009, BOOK PLANT BIOASSAYS, P187; DeLong JM, 2002, J AGR FOOD CHEM, V50, P248, DOI 10.1021/jf0106695; DONG XN, 1991, PLANT CELL, V3, P61, DOI 10.1105/tpc.3.1.61; DOW JM, 1995, MOL PLANT MICROBE IN, V8, P768, DOI 10.1094/MPMI-8-0768; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fujikawa T, 2006, MOL PLANT MICROBE IN, V19, P342, DOI 10.1094/MPMI-19-0342; Gomez-Gomez L, 2004, MOL IMMUNOL, V41, P1055, DOI 10.1016/j.molimm.2004.06.008; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Harvey DJ, 2009, MASS SPECTROM REV, V28, P273, DOI 10.1002/mas.20192; Harvey DJ, 2003, INT J MASS SPECTROM, V226, P1, DOI 10.1016/S1387-3806(02)00968-5; Holst O, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P29; Ingle RA, 2006, BIOESSAYS, V28, P880, DOI 10.1002/bies.20457; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kazan K, 2001, MOL PLANT PATHOL, V2, P177, DOI 10.1046/j.1364-3703.2001.00061.x; Keshavarzi M, 2004, MOL PLANT MICROBE IN, V17, P805, DOI 10.1094/MPMI.2004.17.7.805; Knirel YA, 2009, CARBOHYD RES, V344, P479, DOI 10.1016/j.carres.2008.12.012; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; Lindner B, 2000, METH MOL B, V145, P311; Marolda Cristina L., 2006, V347, P237; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Meyer A, 2001, PLANTA, V213, P214, DOI 10.1007/s004250000493; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Molinaro A, 1999, FEMS MICROBIOL LETT, V181, P49, DOI 10.1111/j.1574-6968.1999.tb08825.x; Molinaro A, 2003, CARBOHYD RES, V338, P277, DOI 10.1016/S0008-6215(02)00433-0; Molinaro A, 2002, EUR J BIOCHEM, V269, P4185, DOI 10.1046/j.1432-1033.2002.03138.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NEWMAN MA, 1995, MOL PLANT MICROBE IN, V8, P778, DOI 10.1094/MPMI-8-0778; Newman MA, 2000, MOL PLANT PATHOL, V1, P25, DOI 10.1046/j.1364-3703.2000.00004.x; Patil PB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-243; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rietschel E. T., 1999, ENDOTOXIN HLTH DIS; RIETSCHEL ET, 1975, J BACTERIOL, V122, P1180, DOI 10.1128/JB.122.3.1180-1188.1975; Sambrook J., 2002, MOL CLONING LAB MANU; Shashkov AS, 2000, CARBOHYD RES, V323, P235; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Silipo A, 2004, EUR J ORG CHEM, V2004, P1336, DOI 10.1002/ejoc.200300721; Silipo A, 2008, CHEMBIOCHEM, V9, P896, DOI 10.1002/cbic.200700693; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Therisod H, 2001, ANAL CHEM, V73, P3804, DOI 10.1021/ac010313s; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Worrall TA, 2000, J MASS SPECTROM, V35, P647, DOI 10.1002/(SICI)1096-9888(200005)35:5<647::AID-JMS973>3.0.CO;2-E; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	66	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25628	25643		10.1074/jbc.M110.186049	http://dx.doi.org/10.1074/jbc.M110.186049			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596742	hybrid, Green Published			2022-12-27	WOS:000293073000025
J	Gutierrez, DV; Mark, MD; Masseck, O; Maejima, T; Kuckelsberg, D; Hyde, RA; Krause, M; Kruse, W; Herlitze, S				Gutierrez, Davina V.; Mark, Melanie D.; Masseck, Olivia; Maejima, Takashi; Kuckelsberg, Denise; Hyde, Robert A.; Krause, Martin; Kruse, Wolfgang; Herlitze, Stefan			Optogenetic Control of Motor Coordination by G(i/o) Protein-coupled Vertebrate Rhodopsin in Cerebellar Purkinje Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(B) RECEPTORS; NEURONAL MICROCIRCUITS; OPTICAL-PROPERTIES; RAT CEREBELLUM; HUMAN BRAIN; ACTIVATION; LOCALIZATION; INHIBITION; ORGANIZATION; MODULATION	G protein-coupled receptors are involved in the modulation of complex neuronal networks in the brain. To investigate the impact of a cell-specific G(i/o) protein-mediated signaling pathway on brain function, we created a new optogenetic mouse model in which the G(i/o) protein-coupled receptor vertebrate rhodopsin can be cell-specifically expressed with the aid of Cre recombinase. Here we use this mouse model to study the functional impact of G(i/o) modulation in cerebellar Purkinje cells (PCs). We show that in vivo light activation of vertebrate rhodopsin specifically expressed in PCs reduces simple spike firing that is comparable with the reduction in firing observed for the activation of cerebellar G(i/o)-coupled GABA(B) receptors. Notably, the light exposure of the cerebellar vermis in freely moving mice changes the motor behavior. Thus, our studies directly demonstrate that spike modulation via G(i/o)-mediated signaling in cerebellar PCs affects motor coordination and show a new promising approach for studying the physiological function of G protein-coupled receptor-mediated signaling in a cell type-specific manner.	[Gutierrez, Davina V.; Hyde, Robert A.; Herlitze, Stefan] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Mark, Melanie D.; Masseck, Olivia; Maejima, Takashi; Kuckelsberg, Denise; Krause, Martin; Kruse, Wolfgang; Herlitze, Stefan] Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany	Case Western Reserve University; Ruhr University Bochum	Herlitze, S (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.	Stefan.Herlitze@rub.de	Mark, Melanie/ABF-9102-2020	Mark, Melanie/0000-0002-2788-6003; Masseck, Olivia Andrea/0000-0002-1541-2388	National Institutes of Health [MH081127]; Deutsche Forschungsgemeinschaft [HE2471/8-1]; Japan Society for the Promotion of Science [R36MH086283]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081127, R36MH086283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH081127 (to S. H.). This work was also supported by Deutsche Forschungsgemeinschaft Grant HE2471/8-1, Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (to T. M.), and R36MH086283 (to D. G.).	Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bevilacqua F, 1999, APPL OPTICS, V38, P4939, DOI 10.1364/AO.38.004939; BILLARD JM, 1993, NEUROSCI RES, V16, P65, DOI 10.1016/0168-0102(93)90010-N; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; CURTIS DR, 1974, BRAIN RES, V70, P493, DOI 10.1016/0006-8993(74)90257-1; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Hausser M, 2004, J NEUROSCI, V24, P9215, DOI 10.1523/JNEUROSCI.3375-04.2004; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Ige AO, 2000, MOL BRAIN RES, V83, P72, DOI 10.1016/S0169-328X(00)00199-6; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; Joyal CC, 1996, BRAIN RES, V739, P1, DOI 10.1016/S0006-8993(96)00333-2; Kamikubo Y, 2007, J PHYSIOL-LONDON, V585, P549, DOI 10.1113/jphysiol.2007.141010; Kawaguchi S, 2000, NEURON, V27, P339, DOI 10.1016/S0896-6273(00)00041-6; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Lalonde R, 2007, PROG NEUROBIOL, V81, P45, DOI 10.1016/j.pneurobio.2006.11.005; LeBeau FEN, 2005, TRENDS NEUROSCI, V28, P552, DOI 10.1016/j.tins.2005.08.005; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; Masseck OA, 2011, EXP PHYSIOL, V96, P51, DOI 10.1113/expphysiol.2010.055517; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Pei Y, 2008, PHYSIOLOGY, V23, P313, DOI 10.1152/physiol.00025.2008; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Tabata T, 2005, J PHYSIOL-LONDON, V563, P443, DOI 10.1113/jphysiol.2004.081000; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Timmann D, 1998, EXP BRAIN RES, V119, P73, DOI 10.1007/s002210050321; Vigot R, 1997, NEUROSCI RES, V29, P151, DOI 10.1016/S0168-0102(97)00087-4; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007	38	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25848	25858		10.1074/jbc.M111.253674	http://dx.doi.org/10.1074/jbc.M111.253674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628464	Green Published, hybrid			2022-12-27	WOS:000293073000046
J	Hirai, H; Takai, R; Iwano, M; Nakai, M; Kondo, M; Takayama, S; Isogai, A; Che, FS				Hirai, Hiroyuki; Takai, Ryota; Iwano, Megumi; Nakai, Masaru; Kondo, Machiko; Takayama, Seiji; Isogai, Akira; Che, Fang-Sik			Glycosylation Regulates Specific Induction of Rice Immune Responses by Acidovorax avenae Flagellin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERSENSITIVE CELL-DEATH; PSEUDOMONAS-AERUGINOSA; INCOMPATIBLE STRAIN; ESCHERICHIA-COLI; INNATE IMMUNITY; AMINO-ACIDS; N-TERMINUS; PERCEPTION; RECEPTOR; IDENTIFICATION	Plants have a sensitive system that detects various pathogen-derived molecules to protect against infection. Flagellin, a main component of the bacterial flagellum, from the rice avirulent N1141 strain of the Gram-negative phytopathogenic bacterium Acidovorax avenae induces plant immune responses including H2O2 generation, whereas flagellin from the rice virulent K1 strain of A. avenae does not induce these immune responses. To clarify the molecular mechanism that leads to these differing responses between the K1 and N1141 flagellins, recombinant K1 and N1141 flagellins were generated using an Escherichia coli expression system. When cultured rice cells were treated with recombinant K1 or N1141 flagellin, both flagellins equally induced H2O2 generation, suggesting that post-translational modifications of the flagellins are involved in the specific induction of immune responses. Mass spectrometry analyses using glycosyltransferase-deficient mutants showed that 1,600- and 2,150-Da glycans were present on the flagellins from N1141 and K1, respectively. A deglycosylated K1 flagellin induced immune responses in the same manner as N1141 flagellin. Site-directed mutagenesis revealed that glycans were attached to four amino acid residues (Ser(178), Ser(183), Ser(212), and Thr(351)) in K1 flagellin. Among mutant K1 flagellins in which each glycan-attached amino acid residue was changed to alanine, S178A and S183A, K1 flagellin induced a strong immune response in cultured rice cells, indicating that the glycans at Ser(178) and Ser(183) in K1 flagellin prevent epitope recognition in rice.	[Hirai, Hiroyuki; Takai, Ryota; Kondo, Machiko; Che, Fang-Sik] Nagahama Inst Biosci & Technol, Grad Sch Biosci, Shiga 5260829, Japan; [Iwano, Megumi; Nakai, Masaru; Takayama, Seiji; Isogai, Akira; Che, Fang-Sik] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Che, FS (corresponding author), Nagahama Inst Biosci & Technol, Grad Sch Biosci, 1266 Tamura, Shiga 5260829, Japan.	k_sai@nagahama-i-bio.ac.jp	Isogai, Akira/O-8897-2017	Isogai, Akira/0000-0001-8095-0441	Ministry of Education, Culture, Sports, Science and Technology of Japan [21380073]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry [500107]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	This work was supported in part by Grant-in-aid for Scientific Research (B) 21380073 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grant 500107 from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry.	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; BABA A, 1986, PLANT CELL PHYSIOL, V27, P463; Berthiaume F, 2010, FEMS MICROBIOL LETT, V311, P176, DOI 10.1111/j.1574-6968.2010.02088.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Che FS, 2000, J BIOL CHEM, V275, P32347, DOI 10.1074/jbc.M004796200; Che FS, 1999, PLANT CELL PHYSIOL, V40, P1036, DOI 10.1093/oxfordjournals.pcp.a029485; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Forsyth A, 2010, MOL PLANT MICROBE IN, V23, P1545, DOI 10.1094/MPMI-02-10-0047; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Iwano M, 2002, MOL PLANT PATHOL, V3, P1, DOI 10.1046/j.1464-6722.2001.00087.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kadota Ikuo, 1996, Annals of the Phytopathological Society of Japan, V62, P425, DOI 10.3186/jjphytopath.62.425; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Klarzynski O, 2000, PLANT PHYSIOL, V124, P1027, DOI 10.1104/pp.124.3.1027; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Laquitaine L, 2006, MOL PLANT MICROBE IN, V19, P1103, DOI 10.1094/MPMI-19-1103; Logan SM, 2009, FEBS J, V276, P1014, DOI 10.1111/j.1742-4658.2008.06840.x; Qutyan M, 2010, J BACTERIOL, V192, P5972, DOI 10.1128/JB.00007-10; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; SCHWACKE R, 1992, PLANTA, V187, P136, DOI 10.1007/BF00201635; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Takeuchi K, 2007, J BACTERIOL, V189, P6945, DOI 10.1128/JB.00500-07; Tanaka N, 2003, MOL PLANT MICROBE IN, V16, P422, DOI 10.1094/MPMI.2003.16.5.422; Tanaka N., 2001, PLANT BIOTECHNOL-NAR, V18, P295; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Verma A, 2006, J BACTERIOL, V188, P4395, DOI 10.1128/JB.01642-05; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200	45	38	41	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25519	25530		10.1074/jbc.M111.254029	http://dx.doi.org/10.1074/jbc.M111.254029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628471	hybrid, Green Published			2022-12-27	WOS:000293073000014
J	Yan, JZ; Xu, Z; Ren, SQ; Hu, B; Yao, W; Wang, SH; Liu, SY; Lu, W				Yan, Jing-Zhi; Xu, Zhuo; Ren, Si-Qiang; Hu, Bin; Yao, Wen; Wang, Shan-Hui; Liu, Su-Yi; Lu, Wei			Protein Kinase C Promotes N-Methyl-D-aspartate (NMDA) Receptor Trafficking by Indirectly Triggering Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) Autophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM-POTENTIATION; SYNAPTIC PLASTICITY; NR2A SUBUNIT; SURFACE EXPRESSION; LTP; PHOSPHORYLATION; TRANSLOCATION; BINDING; SRC; CHANNEL	Regulation of neuronal NMDA receptor (NMDAR) is critical in synaptic transmission and plasticity. Protein kinase C (PKC) promotes NMDAR trafficking to the cell surface via interaction with NMDAR-associated proteins (NAPs). Little is known, however, about the NAPs that are critical to PKC-induced NMDAR trafficking. Here, we showed that calcium/calmodulin-dependent protein kinase II (CaMKII) could be a NAP that mediates the potentiation of NMDAR trafficking by PKC. PKC activation promoted the level of autophosphorylated CaMKII and increased association with NMDARs, accompanied by functional NMDAR insertion, at postsynaptic sites. This potentiation, along with PKC-induced long term potentiation of the AMPA receptor-mediated response, was abolished by CaMKII antagonist or by disturbing the interaction between CaMKII and NR2A or NR2B. Further mutual occlusion experiments demonstrated that PKC and CaMKII share a common signaling pathway in the potentiation of NMDAR trafficking and long-term potentiation (LTP) induction. Our results revealed that PKC promotes NMDA receptor trafficking and induces synaptic plasticity through indirectly triggering CaMKII autophosphorylation and subsequent increased association with NMDARs.	[Yan, Jing-Zhi; Xu, Zhuo; Ren, Si-Qiang; Hu, Bin; Yao, Wen; Wang, Shan-Hui; Liu, Su-Yi; Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu Prov, Peoples R China; [Yan, Jing-Zhi; Xu, Zhuo; Ren, Si-Qiang; Hu, Bin; Yao, Wen; Wang, Shan-Hui; Liu, Su-Yi; Lu, Wei] Nanjing Med Univ, Key Lab Neurodegenerat Dis Jiangsu Prov, Nanjing 210029, Jiangsu Prov, Peoples R China; [Lu, Wei] Nanjing Med Univ, Lab Reprod Med, Nanjing 210029, Jiangsu Prov, Peoples R China; [Lu, Wei] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu Prov, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Lu, W (corresponding author), Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu Prov, Peoples R China.	lu@njmu.edu.cn			National Natural Science Foundation of China [31025011, 30970934]; Major State Basic Research Program of China [2010CB912002]; Education Department of Jiangsu Province [08KJA180004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); Education Department of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (Grants 31025011 and 30970934), the Major State Basic Research Program of China (Grant 2010CB912002), and the Education Department of Jiangsu Province (Grant 08KJA180004) (all to W. L.).	AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bultynck G, 2003, BIOCHEM BIOPH RES CO, V311, P1181, DOI 10.1016/j.bbrc.2003.08.084; Caputi A, 1999, EUR J NEUROSCI, V11, P141, DOI 10.1046/j.1460-9568.1999.00414.x; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Gardoni F, 1999, FEBS LETT, V456, P394, DOI 10.1016/S0014-5793(99)00985-0; Gardoni F, 2001, J BIOL CHEM, V276, P7609, DOI 10.1074/jbc.M009922200; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hashida H, 2004, BRIT J CANCER, V90, P1252, DOI 10.1038/sj.bjc.6601680; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MANGELS LA, 1990, MOL PHARMACOL, V37, P820; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Peng Y, 2010, HIPPOCAMPUS, V20, P646, DOI 10.1002/hipo.20654; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; WANG JH, 1995, NEURON, V15, P443, DOI 10.1016/0896-6273(95)90048-9; WANG JH, 1992, P NATL ACAD SCI USA, V89, P2576, DOI 10.1073/pnas.89.7.2576; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; WAXHAM MN, 1993, BIOCHEMISTRY-US, V32, P2923, DOI 10.1021/bi00062a024; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zha XM, 2009, J NEUROSCI RES, V87, P1969, DOI 10.1002/jnr.22033; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zheng CY, 2006, ACTA PHARMACOL SIN, V27, P1580, DOI 10.1111/j.1745-7254.2006.00434.x; Zheng X, 1999, P NATL ACAD SCI USA, V96, P15262, DOI 10.1073/pnas.96.26.15262; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	55	54	56	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25187	25200		10.1074/jbc.M110.192708	http://dx.doi.org/10.1074/jbc.M110.192708			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606495	Green Published, hybrid			2022-12-27	WOS:000292547900065
J	Carta, S; Tassi, S; Pettinati, I; Delfino, L; Dinarello, CA; Rubartelli, A				Carta, Sonia; Tassi, Sara; Pettinati, Ilaria; Delfino, Laura; Dinarello, Charles A.; Rubartelli, Anna			The Rate of Interleukin-1 beta Secretion in Different Myeloid Cells Varies with the Extent of Redox Response to Toll-like Receptor Triggering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SHOCK-PROTEIN 27; INFLAMMASOME ACTIVATION; THIOREDOXIN REDUCTASE; OXIDATIVE STRESS; IL-1-BETA; MONOCYTES; ATP; METABOLISM; EXPRESSION	Human myeloid cells activate the NLRP3 inflammasome and secrete interleukin (IL)-1 beta in response to various Toll-like receptor (TLR) ligands, but the rate of secretion is much higher in primary human monocytes than in cultured macrophages or THP-1 cells. The different myeloid cells also display different redox status under resting conditions and redox response to TLR activation. Resting monocytes display a balanced redox state, with low production of reactive oxygen species (ROS) and antioxidants. TLR engagement induces an effective redox response with increased ROS generation followed by a sustained antioxidant response, parallelled by efficient IL-1 beta secretion. Drugs blocking ROS production or the antioxidant response prevent the secretion of mature IL-1 beta but not the biosynthesis of pro-IL-1 beta, indicating that redox remodeling is responsible for IL-1 beta processing and release. Unlike monocytes, THP-1 cells and cultured macrophages have up-regulated antioxidant systems that buffer the oxidative hit provided by TLR triggering and suppress the consequent redox response. This aborted redox remodeling is paralleled by low efficiency IL-1 beta processing and secretion. High doses (5mM) of H2O2 overcome the high antioxidant capacity of THP-1 cells, restore an efficient redox response, and increase the rate of IL-1 beta secretion. Together these data indicate that a tightly controlled redox homeostasis in resting cells is a prerequisite for a robust redox response to TLR ligands, in turn necessary for the efficient inflammasome activation. Inflammasome activation by bacterial DNA is not modulated by redox responses, suggesting that redox-dependent regulation of IL-1 beta secretion is restricted to some inflammasomes including NLRP3 but excluding AIM-2.	[Carta, Sonia; Tassi, Sara; Pettinati, Ilaria; Delfino, Laura; Rubartelli, Anna] Natl Inst Canc Res, Cell Biol Unit, I-16132 Genoa, Italy; [Dinarello, Charles A.] Univ Colorado, Div Infect Dis, Dept Med, Aurora, CO 80045 USA	University of Genoa; IRCCS AOU San Martino IST; University of Colorado System; University of Colorado Anschutz Medical Campus	Rubartelli, A (corresponding author), Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	anna.rubartelli@istge.it	Dinarello, Charles/C-8524-2013; Rubartelli, Anna/AAA-1259-2021; carta, sonia/AAB-3799-2020	carta, sonia/0000-0002-1278-9761	Telethon, Italia [GGP09127]; Ministero Salute; Compagnia San Paolo	Telethon, Italia(Fondazione Telethon); Ministero Salute(Ministry of Health, Italy); Compagnia San Paolo(Compagnia di San Paolo)	The work was supported in part by grants from Telethon, Italia (GGP09127), Ministero Salute, and Compagnia San Paolo.	Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Carta S, 2009, J LEUKOCYTE BIOL, V86, P549, DOI 10.1189/jlb.1008598; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; HWANG C, 1991, PRODUCTION OF BIOLOGICALS FROM ANIMAL CELLS IN CULTURE, P548; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Ngai S, 2010, FEBS J, V277, P119, DOI 10.1111/j.1742-4658.2009.07458.x; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Powis G, 1998, CHEM-BIOL INTERACT, V112, P23, DOI 10.1016/S0009-2797(97)00148-8; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sido B, 2000, J EXP MED, V192, P907, DOI 10.1084/jem.192.6.907; Sido B, 2008, GASTROENTEROLOGY, V134, P179, DOI 10.1053/j.gastro.2007.11.001; Tartier L, 2000, CELL DEATH DIFFER, V7, P1002, DOI 10.1038/sj.cdd.4400726; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Tassi S, 2009, J IMMUNOL, V183, P1456, DOI 10.4049/jimmunol.0900578; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Vene R, 2010, ANTIOXID REDOX SIGN, V13, P1145, DOI 10.1089/ars.2009.3078; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; You WJ, 2009, SHOCK, V32, P108, DOI 10.1097/SHK.0b013e318199165d; Zhang X, 2010, HYPERTENSION, V55, P1412, DOI 10.1161/HYPERTENSIONAHA.109.147066; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	46	71	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27069	27080		10.1074/jbc.M110.203398	http://dx.doi.org/10.1074/jbc.M110.203398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21628463	hybrid, Green Published			2022-12-27	WOS:000293268700002
J	Ma, Q; Fang, HQ; Shang, W; Liu, L; Xu, ZS; Ye, T; Wang, XH; Zheng, M; Chen, Q; Cheng, HP				Ma, Qi; Fang, Huaqiang; Shang, Wei; Liu, Lei; Xu, Zhengshuang; Ye, Tao; Wang, Xianhua; Zheng, Ming; Chen, Quan; Cheng, Heping			Superoxide Flashes EARLY MITOCHONDRIAL SIGNALS FOR OXIDATIVE STRESS-INDUCED APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; HYDROGEN-PEROXIDE; CYCLOPHILIN-D; CELL-DEATH; BAX; BCL-2; CALCIUM; CHANNEL; DYSFUNCTION	Irreversible mitochondrial permeability transition and the resultant cytochrome c release signify the commitment of a cell to apoptotic death. However, the role of transient MPT (tMPT) because of flickering opening of the mitochondrial permeability transition pore remains elusive. Here we show that tMPT and the associated superoxide flashes (i.e. tMPT/superoxide flashes) constitute early mitochondrial signals during oxidative stress-induced apoptosis. Selenite (a ROS-dependent insult) but not staurosporine (a ROS-independent insult) stimulated an early and persistent increase in tMPT/superoxide flash activity prior to mitochondrial fragmentation and a global ROS rise, independently of Bax translocation and cytochrome c release. Selectively targeting tMPT/superoxide flash activity by manipulating cyclophilin D expression or scavenging mitochondrial ROS markedly impacted the progression of selenite-induced apoptosis while exerting little effect on the global ROS response. Furthermore, the tMPT/superoxide flash served as a convergence point for pro-and anti-apoptotic regulation mediated by cyclophilin D and Bcl-2 proteins. These results indicate that tMPT/superoxide flashes act as early mitochondrial signals mediating the apoptotic response during oxidative stress, and provide the first demonstration of highly efficacious local mitochondrial ROS signaling in deciding cell fate.	[Fang, Huaqiang; Shang, Wei; Wang, Xianhua; Zheng, Ming; Cheng, Heping] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Fang, Huaqiang; Shang, Wei; Wang, Xianhua; Zheng, Ming; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Ma, Qi; Liu, Lei; Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Joint Lab Apoptosis & Canc Biol, Beijing 100101, Peoples R China; [Ma, Qi; Liu, Lei] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Xu, Zhengshuang; Ye, Tao] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Ye, Tao] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Chen, Quan] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; University Town of Shenzhen; Hong Kong Polytechnic University; Nankai University	Zheng, M (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	zhengm@pku.edu.cn; chenq@ioz.ac.cn	cheng, heping/A-7299-2011; Heping, Cheng/AAE-2680-2019; Ye，PhD，FRSC, Tao/ABB-8698-2020	Heping, Cheng/0000-0002-9604-6702; Ye，PhD，FRSC, Tao/0000-0002-2780-9761; Chen, Quan/0000-0001-7539-8728	National Science Foundation [90713006, 30971062, 30910103910, 30630021]; National Key Basic Research Program of China [2007CB512100, 2011CB809102, 2011CB910903, 2010CB912204]; State Key Laboratory of Biomembrane and Membrane Biotechnology	National Science Foundation(National Science Foundation (NSF)); National Key Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Biomembrane and Membrane Biotechnology(Chinese Academy of Sciences)	This work was supported by grants from the National Science Foundation (90713006, 30971062, 30910103910, 30630021) the National Key Basic Research Program of China (2007CB512100, 2011CB809102, 2011CB910903, and 2010CB912204) and a special grant from State Key Laboratory of Biomembrane and Membrane Biotechnology.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Huang F, 2009, FREE RADICAL BIO MED, V46, P1186, DOI 10.1016/j.freeradbiomed.2009.01.026; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipp P, 1998, J PHYSIOL-LONDON, V508, P801, DOI 10.1111/j.1469-7793.1998.801bp.x; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Nilsonne G, 2006, FREE RADICAL BIO MED, V41, P874, DOI 10.1016/j.freeradbiomed.2006.04.031; Pallepati P, 2011, FREE RADICAL BIO MED, V50, P667, DOI 10.1016/j.freeradbiomed.2010.11.022; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Saotome M, 2009, AM J PHYSIOL-HEART C, V296, pH1125, DOI 10.1152/ajpheart.00436.2008; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Tritto I, 1997, CIRC RES, V80, P743, DOI 10.1161/01.RES.80.5.743; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XD, 2001, GENE DEV, V15, P2922; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wei H, 2010, J CELL BIOCHEM, V111, P967, DOI 10.1002/jcb.22785; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yaguchi Y, 2003, CIRC J, V67, P253; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zhao R, 2006, CANCER RES, V66, P2296, DOI 10.1158/0008-5472.CAN-05-2216; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	49	101	125	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27573	27581		10.1074/jbc.M111.241794	http://dx.doi.org/10.1074/jbc.M111.241794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659534	Green Published, hybrid			2022-12-27	WOS:000293268700051
J	Pocanschi, CL; Kozlov, G; Brockmeier, U; Brockmeier, A; Williams, DB; Gehring, K				Pocanschi, Cosmin L.; Kozlov, Guennadi; Brockmeier, Ulf; Brockmeier, Achim; Williams, David B.; Gehring, Kalle			Structural and Functional Relationships between the Lectin and Arm Domains of Calreticulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HISTOCOMPATIBILITY MOLECULES; ENDOPLASMIC-RETICULUM CHAPERONE; QUALITY-CONTROL; SUBSTRATE-BINDING; P-DOMAIN; CALNEXIN; PROTEIN; RECOGNITION; DEGRADATION; ERP57	Calreticulin and calnexin are key components in maintaining the quality control of glycoprotein folding within the endoplasmic reticulum. Although their lectin function of binding mono-glucosylated sugar moieties of glycoproteins is well documented, their chaperone activity in suppressing protein aggregation is less well understood. Here, we use a series of deletion mutants of calreticulin to demonstrate that its aggregation suppression function resides primarily within its lectin domain. Using hydrophobic peptides as substrate mimetics, we show that aggregation suppression is mediated through a single polypeptide binding site that exhibits a K-d for peptides of 0.5-1 mu M. This site is distinct from the oligosaccharide binding site and differs from previously identified sites of binding to thrombospondin and GABARAP (4-aminobutyrate type A receptor-associated protein). Although the arm domain of calreticulin was incapable of suppressing aggregation or binding hydrophobic peptides on its own, it did contribute to aggregation suppression in the context of the whole molecule. The high resolution x-ray crystal structure of calreticulin with a partially truncated arm domain reveals a marked difference in the relative orientations of the arm and lectin domains when compared with calnexin. Furthermore, a hydrophobic patch was detected on the arm domain that mediates crystal packing and may contribute to calreticulin chaperone function.	[Pocanschi, Cosmin L.; Brockmeier, Ulf; Brockmeier, Achim; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pocanschi, Cosmin L.; Brockmeier, Ulf; Brockmeier, Achim; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Kozlov, Guennadi; Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	University of Toronto; University of Toronto; McGill University	Williams, DB (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg,Rm 5316, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca; kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research [MOP-53310, MOP-81277]; Canadian Cancer Society; National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Canadian Institutes of Health Research Grants MOP-53310 and MOP-81277 (to D. B. W. and K. G.) and the Canadian Cancer Society (to D. B. W.).; For providing various Crt substrates, we gratefully acknowledge Drs. Arianna Rath and Charles Deber (6KAAF and KHP) and Dr. Dieter Willbold (GABARAP). We also thank Dr. Ronnie Lum for the FITC-labeling protocol, initial RCMLA probes, and helpful discussions as well as Myrna Cohen-Doyle for excellent technical assistance. Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source was supported by the National Science Foundation Award DMR 0225180 and the National Institutes of Health Award RR-01646.	Arnaud N, 1997, ANALYST, V122, P143, DOI 10.1039/a605279g; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; Culina S, 2004, J BIOL CHEM, V279, P54210, DOI 10.1074/jbc.M410841200; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Duus K, 2009, PROTEIN PEPTIDE LETT, V16, P1414, DOI 10.2174/092986609789353772; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; Kapoor M, 2003, J BIOL CHEM, V278, P6194, DOI 10.1074/jbc.M209132200; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; OKAZAKI A, 1994, NAT STRUCT BIOL, V1, P439, DOI 10.1038/nsb0794-439; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patil AR, 2000, J BIOL CHEM, V275, P24348, DOI 10.1074/jbc.M003102200; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Tan Y, 2006, BBA-GEN SUBJECTS, V1760, P745, DOI 10.1016/j.bbagen.2006.02.003; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Thielmann Y, 2009, FEBS J, V276, P1140, DOI 10.1111/j.1742-4658.2008.06857.x; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Urbanova N, 2008, ANAL SCI, V24, P727, DOI 10.2116/analsci.24.727; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	47	39	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27266	27277		10.1074/jbc.M111.258467	http://dx.doi.org/10.1074/jbc.M111.258467			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652723	hybrid, Green Published			2022-12-27	WOS:000293268700022
J	Ragheb, D; Dalal, S; Bompiani, KM; Ray, WK; Klemba, M				Ragheb, Daniel; Dalal, Seema; Bompiani, Kristin M.; Ray, W. Keith; Klemba, Michael			Distribution and Biochemical Properties of an M1-family Aminopeptidase in Plasmodium falciparum Indicate a Role in Vacuolar Hemoglobin Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUROMYCIN-SENSITIVE AMINOPEPTIDASE; ETCH VIRUS PROTEASE; RED-BLOOD-CELLS; MALARIA PARASITES; M1 FAMILY; NEUTRAL AMINOPEPTIDASE; LEUCYL AMINOPEPTIDASE; ERYTHROCYTIC STAGES; CYSTEINE PROTEASES; ESCHERICHIA-COLI	Aminopeptidases catalyze N-terminal peptide bond hydrolysis and occupy many diverse roles across all domains of life. Here we present evidence that an M1-family aminopeptidase, PfA-M1, has been recruited to specialized roles in the human malaria parasite Plasmodium falciparum. PfA-M1 is abundant in two subcellular compartments in asexual intraerythrocytic parasites; that is, the food vacuole, where the catabolism of host hemoglobin takes place, and the nucleus. A unique N-terminal extension contributes to the observed dual targeting by providing a signal peptide and putative alternate translation initiation sites. PfA-M1 exists as two major isoforms, a nuclear 120-kDa species and a processed species consisting of a complex of 68- and 35-kDa fragments. PfA-M1 is both stable and active at the acidic pH of the food vacuole lumen. Determination of steady-state kinetic parameters for both aminoacyl-beta-naphthylamide and unmodified dipeptide substrates over the pH range 5.0-8.5 reveals that k(cat) is relatively insensitive to pH, whereas K-m increases at pH values below 6.5. At the pH of the food vacuole lumen (5.0-5.5), the catalytic efficiency of PfA-M1 remains high. Consistent with the kinetic data, the affinity of peptidic competitive inhibitors is diminished at acidic pH. Together, these results support a catalytic role for PfA-M1 in the food vacuole and indicate the importance of evaluating the potency of peptidic inhibitors at physiologically relevant pH values. They also suggest a second, distinct function for this enzyme in the parasite nucleus.	[Ragheb, Daniel; Dalal, Seema; Bompiani, Kristin M.; Ray, W. Keith; Klemba, Michael] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Klemba, M (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, 306 Engel Hall, Blacksburg, VA 24061 USA.	klemba@vt.edu			National Institutes of Health [AI077638]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077638.	Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Albiston AL, 2004, PROTEIN PEPTIDE LETT, V11, P491, DOI 10.2174/0929866043406643; Allary M, 2002, PARASITOLOGY, V125, P1, DOI 10.1017/S0031182002001828; Azimzadeh O, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-189; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Breman JG, 2001, AM J TROP MED HYG, V64, P1; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; CORNISHBOWDEN A, 2004, FUNDAMENTALS ENZYME, P225; Cunningham E, 2008, ANTIMICROB AGENTS CH, V52, P3221, DOI 10.1128/AAC.01327-07; CURLEY GP, 1994, J EUKARYOT MICROBIOL, V41, P119, DOI 10.1111/j.1550-7408.1994.tb01483.x; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Florent I, 1998, MOL BIOCHEM PARASIT, V97, P149, DOI 10.1016/S0166-6851(98)00143-1; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HARLOW E, 1999, USING ANTIBODIES LAB, P311; HELLERSTEIN S, 1970, J LAB CLIN MED, V76, P10; Hwang SR, 2007, J NEUROCHEM, V100, P1340, DOI 10.1111/j.1471-4159.2006.04325.x; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; Lyczak R, 2006, DEVELOPMENT, V133, P4281, DOI 10.1242/dev.02615; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Ragheb D, 2009, J BIOL CHEM, V284, P24806, DOI 10.1074/jbc.M109.018424; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; Sanchez-Moran E, 2004, PLANT CELL, V16, P2895, DOI 10.1105/tpc.104.024992; Skinner-Adams TS, 2010, TRENDS BIOCHEM SCI, V35, P53, DOI 10.1016/j.tibs.2009.08.004; Small I, 1998, PLANT MOL BIOL, V38, P265, DOI 10.1023/A:1006081903354; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; SUDA H, 1976, J ANTIBIOT, V29, P100, DOI 10.7164/antibiotics.29.100; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; VANDERJAGT DL, 1984, MOL BIOCHEM PARASIT, V10, P45, DOI 10.1016/0166-6851(84)90017-3; Wang F, 2011, MOL BIOCHEM PARASIT, V175, P10, DOI 10.1016/j.molbiopara.2010.08.004; Whisstock JC, 2009, P NATL ACAD SCI USA, V106, pE56, DOI 10.1073/pnas.0903872106	53	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27255	27265		10.1074/jbc.M111.225318	http://dx.doi.org/10.1074/jbc.M111.225318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659511	hybrid, Green Published			2022-12-27	WOS:000293268700021
J	Janganan, TK; Bavro, VN; Zhang, L; Matak-Vinkovic, D; Barrera, NP; Venien-Bryan, C; Robinson, CV; Borges-Walmsley, MI; Walmsley, AR				Janganan, Thamarai K.; Bavro, Vassiliy N.; Zhang, Li; Matak-Vinkovic, Dijana; Barrera, Nelson P.; Venien-Bryan, Catherine; Robinson, Carol V.; Borges-Walmsley, Maria Ines; Walmsley, Adrian R.			Evidence for the Assembly of a Bacterial Tripartite Multidrug Pump with a Stoichiometry of 3:6:3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEINS; EFFLUX TRANSPORTER ACRB; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; PERIPLASMIC COMPONENT; BINDING CAPACITY; ABC-TRANSPORTER; TOLC	The multiple transferable resistance (mTR) pump from Neisseria gonorrhoeae MtrCDE multidrug pump is assembled from the inner and outer membrane proteins MtrD and MtrE and the periplasmic membrane fusion protein MtrC. Previously we established that while there is a weak interaction of MtrD and MtrE, MtrC binds with relatively high affinity to both MtrD and MtrE. MtrD conferred antibiotic resistance only when it was expressed with MtrE and MtrC, suggesting that these proteins form a functional tripartite complex in which MtrC bridges MtrD and MtrE. Furthermore, we demonstrated that MtrC interacts with an intraprotomer groove on the surface of MtrE, inducing channel opening. However, a second groove is apparent at the interface of the MtrE sub-units, which might also be capable of engaging MtrC. We have now established that MtrC can be cross-linked to cysteines placed in this interprotomer groove and that mutation of residues in the groove impair the ability of the pump to confer antibiotic resistance by locking MtrE in the closed channel conformation. Moreover, MtrE K390C forms an intermolecular disulfide bond with MtrC E149C locking MtrE in the open channel conformation, suggesting that a functional salt bridge forms between these residues during the transition from closed to open channel conformations. MtrC forms dimers that assemble into hexamers, and electron microscopy studies of single particles revealed that these hexamers are arranged into ring-like structures with an internal aperture sufficiently large to accommodate the MtrE trimer. Cross-linking of single cysteine mutants of MtrC to stabilize the dimer interface in the presence of MtrE, trapped an MtrC-MtrE complex with a molecular mass consistent with a stoichiometry of 3:6 (MtrE(3)MtrC(6)), suggesting that dimers of MtrC interact with MtrE, presumably by binding to the two grooves. As both MtrE and MtrD are trimeric, our studies suggest that the functional pump is assembled with a stoichiometry of 3:6:3.	[Janganan, Thamarai K.; Zhang, Li; Borges-Walmsley, Maria Ines; Walmsley, Adrian R.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Bavro, Vassiliy N.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Matak-Vinkovic, Dijana] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Barrera, Nelson P.] Pontificia Univ Catolica Chile, Dept Physiol, Santiago 8331150, Chile; [Venien-Bryan, Catherine] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QU, England	Durham University; University of Oxford; University of Cambridge; Pontificia Universidad Catolica de Chile; University of Oxford; University of Oxford	Walmsley, AR (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	a.r.walmsley@durham.ac.uk	Janganan, Thamarai/AAQ-8705-2020; Bavro, Vassiliy/I-4846-2019	Bavro, Vassiliy/0000-0003-2330-8924; robinson, carol/0000-0001-7829-5505; Venien-Bryan, Catherine/0000-0002-7328-3764; Barrera, Nelson/0000-0001-7825-1406	Wellcome Trust; European Union; Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (to M. I. B. W. and A. R. W.).; Supported by a Marie Curie Fellowship from the European Union during part of this work.; Support by the Biotechnology and Biological Sciences Research Council.	Andersen C, 2002, P NATL ACAD SCI USA, V99, P11103, DOI 10.1073/pnas.162039399; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; De Angelis F, 2010, P NATL ACAD SCI USA, V107, P11038, DOI 10.1073/pnas.1003908107; Gristwood T, 2008, MOL MICROBIOL, V69, P418, DOI 10.1111/j.1365-2958.2008.06291.x; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Janganan TK, 2011, J BIOL CHEM, V286, P5484, DOI 10.1074/jbc.M110.187658; Kim HS, 2010, J BACTERIOL, V192, P1377, DOI 10.1128/JB.01448-09; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kulathila R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015610; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Pietras Z, 2008, CURR DRUG TARGETS, V9, P719, DOI 10.2174/138945008785747743; Reffay M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005035; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Stegmeier JF, 2006, BIOCHEMISTRY-US, V45, P10303, DOI 10.1021/bi060320g; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2011, PROTEIN SCI, V20, P6, DOI 10.1002/pro.532; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Tikhonova EB, 2011, CHEM BIOL, V18, P454, DOI 10.1016/j.chembiol.2011.02.011; Tikhonova EB, 2009, P NATL ACAD SCI USA, V106, P16416, DOI 10.1073/pnas.0906601106; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Welch A, 2010, BIOCHEM J, V430, P355, DOI 10.1042/BJ20091860; Xu Y, 2011, J BIOL CHEM, V286, P17910, DOI 10.1074/jbc.M111.238535; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048	45	43	43	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26900	26912		10.1074/jbc.M111.246595	http://dx.doi.org/10.1074/jbc.M111.246595			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21610073	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000293078200064
J	Van Bogaert, T; Vandevyver, S; Dejager, L; Van Hauwermeiren, F; Pinheiro, I; Petta, I; Engblom, D; Kleyman, A; Schutz, G; Tuckermann, J; Libert, C				Van Bogaert, Tom; Vandevyver, Sofie; Dejager, Lien; Van Hauwermeiren, Filip; Pinheiro, Iris; Petta, Ioanna; Engblom, David; Kleyman, Anna; Schuetz, Guenther; Tuckermann, Jan; Libert, Claude			Tumor Necrosis Factor Inhibits Glucocorticoid Receptor Function in Mice A STRONG SIGNAL TOWARD LETHAL SHOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; STEROID-HORMONE RECEPTORS; FACTOR-ALPHA; DOWN-REGULATION; C-JUN; MOLECULAR-MECHANISMS; ENDOTOXIC-SHOCK; TNF-ALPHA; TRANSCRIPTIONAL ACTIVATION	As glucocorticoid resistance (GCR) and the concomitant burden pose a worldwide problem, there is an urgent need for a more effective glucocorticoid therapy, for which insights into the molecular mechanisms of GCR are essential. In this study, we addressed the hypothesis that TNF alpha, a strong pro-inflammatory mediator in numerous inflammatory diseases, compromises the protective function of the glucocorticoid receptor (GR) against TNF alpha-induced lethal inflammation. Indeed, protection of mice by dexamethasone against TNF alpha lethality was completely abolished when it was administered after TNF alpha stimulation, indicating compromised GR function upon TNF alpha challenge. TNF alpha-induced GCR was further demonstrated by impaired GR-dependent gene expression in the liver. Furthermore, TNF alpha down-regulates the levels of both GR mRNA and protein. However, this down-regulation seems to occur independently of GC production, as TNF alpha also resulted in down-regulation of GR levels in adrenalectomized mice. These findings suggest that the decreased amount of GR determines the GR response and outcome of TNF alpha-induced shock, as supported by our studies with GR heterozygous mice. We propose that by inducing GCR, TNF alpha inhibits a major brake on inflammation and thereby amplifies the pro-inflammatory response. Our findings might prove helpful in understanding GCR in inflammatory diseases in which TNF alpha is intimately involved.	[Petta, Ioanna; Libert, Claude] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Van Bogaert, Tom; Vandevyver, Sofie; Dejager, Lien; Van Hauwermeiren, Filip; Pinheiro, Iris; Petta, Ioanna; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Engblom, David; Schuetz, Guenther] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Kleyman, Anna; Tuckermann, Jan] Fritz Lipmann Inst eV, Leibniz Inst Age Res, D-07745 Jena, Germany	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Helmholtz Association; German Cancer Research Center (DKFZ); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Libert, C (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, FSVM Bldg,Technologiepk 927, B-9052 Ghent, Belgium.	Claude.Libert@ugent.be	Petta, Ioanna/AAD-9612-2019	Petta, Ioanna/0000-0002-3736-7530; Pinheiro, Iris/0000-0003-3098-4445	Fund for Scientific Research, Flanders; Belgian Interuniversity Attraction Poles program (IAP) [IAP VI/18]; Belgische Vereniging tegen Kanker	Fund for Scientific Research, Flanders(FWO); Belgian Interuniversity Attraction Poles program (IAP)(Belgian Federal Science Policy Office); Belgische Vereniging tegen Kanker	The work was supported by the Fund for Scientific Research, Flanders, the Belgian Interuniversity Attraction Poles program (IAP VI/18), and the Belgische Vereniging tegen Kanker.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bantel H, 2002, FASEB J, V16, P1832, DOI 10.1096/fj.02-0223fje; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; Bhandare R, 2010, AM J RESP CELL MOL, V42, P9, DOI 10.1165/rcmb.2009-0239RC; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; BROUCKAERT P, 1992, EUR J IMMUNOL, V22, P981, DOI 10.1002/eji.1830220416; BROUCKAERT PG, 1989, AGENTS ACTIONS, V26, P196, DOI 10.1007/BF02126607; BURNSTEIN KL, 1990, J BIOL CHEM, V265, P7284; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Cho YS, 2005, CLIN EXP ALLERGY, V35, P1625, DOI 10.1111/j.1365-2222.2005.02391.x; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Cucchiara S, 2007, J PEDIATR GASTR NUTR, V44, P171, DOI 10.1097/MPG.0b013e31802c41f3; Davies NM, 2003, INT J PHARMACEUT, V255, P175, DOI 10.1016/S0378-5173(03)00091-7; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Dejager L, 2010, J BIOL CHEM, V285, P31073, DOI 10.1074/jbc.M110.154484; Dekelbab BH, 2007, STEROIDS, V72, P705, DOI 10.1016/j.steroids.2007.05.007; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Falus A, 1995, ANN NY ACAD SCI, V762, P71; Fiers W, 1988, Dev Biol Stand, V69, P143; Franchimont D, 1999, J CLIN ENDOCR METAB, V84, P2834, DOI 10.1210/jc.84.8.2834; Hodges BL, 2003, EXPERT OPIN BIOL TH, V3, P911; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Herrero MJ, 2011, BIOL PHARM BULL, V34, P167, DOI 10.1248/bpb.34.167; KALINYAK JE, 1987, J BIOL CHEM, V262, P460; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kelley KW, 2004, BRAIN BEHAV IMMUN, V18, P95, DOI 10.1016/j.bbi.2003.10.003; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; Kino T, 2004, J STEROID BIOCHEM, V92, P357, DOI 10.1016/j.jsbmb.2004.09.003; Kino T, 2003, J BIOL CHEM, V278, P3023, DOI 10.1074/jbc.M209234200; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; Kreiner F, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3140; Leite RS, 2004, FASEB J, V18, P1418, DOI 10.1096/fj.04-1684fje; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; LIBERT C, 1991, J IMMUNOTHER, V10, P227, DOI 10.1097/00002371-199108000-00001; Liu DH, 2002, BURNS, V28, P315, DOI 10.1016/S0305-4179(02)00011-6; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; Mattsson C, 2007, CURR MED CHEM, V14, P2918, DOI 10.2174/092986707782359972; Matysiak M, 2008, MULT SCLER J, V14, P919, DOI 10.1177/1352458508090666; McCann SM, 1995, ANN NY ACAD SCI, V771, P386, DOI 10.1111/j.1749-6632.1995.tb44697.x; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; Mewar D., 2010, BRIT J PHARMACOL, V162, P785; Meyer AS, 1997, J STEROID BIOCHEM, V62, P97, DOI 10.1016/S0960-0760(97)00014-9; Miller AH, 1999, ADV EXP MED BIOL, V461, P107; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Nash PT, 2005, MED J AUSTRALIA, V183, P205, DOI 10.5694/j.1326-5377.2005.tb06998.x; Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Noti M, 2010, FASEB J, V24, P1340, DOI 10.1096/fj.09-140913; Noti M, 2009, SEMIN IMMUNOPATHOL, V31, P237, DOI 10.1007/s00281-009-0159-2; Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Piper RD, 1996, CRIT CARE MED, V24, P2059, DOI 10.1097/00003246-199612000-00021; Prigent H, 2004, CRIT CARE, V8, P243, DOI 10.1186/cc2878; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Schaaf MJM, 2002, J STEROID BIOCHEM, V83, P37, DOI 10.1016/S0960-0760(02)00263-7; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; Staelens J, 2004, MAMM GENOME, V15, P537, DOI 10.1007/s00335-004-3002-z; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tripathi Gaurav, 2008, Indian J Med Sci, V62, P383; Turner JD, 2010, BIOCHEM PHARMACOL, V80, P1860, DOI 10.1016/j.bcp.2010.06.037; Van Bogaert T, 2010, CYTOKINE GROWTH F R, V21, P275, DOI 10.1016/j.cytogfr.2010.04.003; van den Akker ELT, 2009, INTENS CARE MED, V35, P1247, DOI 10.1007/s00134-009-1468-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; VEDECKIS WV, 1989, CANCER RES, V49, pS2295; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; Wang YW, 2005, J LIPID RES, V46, P2377, DOI 10.1194/jlr.M500134-JLR200; WEBSTER JC, 1994, ANN NY ACAD SCI, V746, P216; Webster JC, 1997, J BIOL CHEM, V272, P9287; Wei P, 1997, ENDOCRINE, V7, P303, DOI 10.1007/BF02801323; Wielockx B, 2001, NAT MED, V7, P1202, DOI 10.1038/nm1101-1202; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	108	56	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26555	26567		10.1074/jbc.M110.212365	http://dx.doi.org/10.1074/jbc.M110.212365			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646349	Green Published, hybrid			2022-12-27	WOS:000293078200034
J	Adachi, S; Yasuda, I; Nakashima, M; Yamauchi, T; Kawaguchi, J; Shimizu, M; Itani, M; Nakamura, M; Nishii, Y; Yoshioka, T; Hirose, Y; Okano, Y; Moriwaki, H; Kozawa, O				Adachi, Seiji; Yasuda, Ichiro; Nakashima, Masanori; Yamauchi, Takahiro; Kawaguchi, Junji; Shimizu, Masahito; Itani, Masahiko; Nakamura, Momoko; Nishii, Yumi; Yoshioka, Takashi; Hirose, Yoshinobu; Okano, Yukio; Moriwaki, Hisataka; Kozawa, Osamu			Ultraviolet Irradiation Can Induce Evasion of Colon Cancer Cells from Stimulation of Epidermal Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAYS; FACTOR RECEPTOR; EGF RECEPTOR; (-)-EPIGALLOCATECHIN GALLATE; P38 MAPK; TYROSINE KINASES; IN-VITRO; PHOSPHORYLATION; INTERNALIZATION	Receptor down-regulation is the most prominent regulatory system of EGF receptor (EGFR) signal attenuation and a critical target for therapy against colon cancer, which is highly dependent on the function of the EGFR. In this study, we investigated the effect of ultraviolet-C (UV-C) on down-regulation of EGFR in human colon cancer cells (SW480, HT29, and DLD-1). UV-C caused inhibition of cell survival and proliferation, concurrently inducing the decrease in cell surface EGFR and subsequently its degradation. UV-C, as well as EGFR kinase inhibitors, decreased the expression level of cyclin D1 and the phosphorylated level of retinoblastoma, indicating that EGFR down-regulation is correlated to cell cycle arrest. Although UV-C caused a marked phosphorylation of EGFR at Ser-1046/1047, UV-C also induced activation of p38 MAPK, a stress-inducible kinase believed to negatively regulate tumorigenesis, and the inhibition of p38 MAPK canceled EGFR phosphorylation at Ser-1046/1047, as well as subsequent internalization and degradation, suggesting that p38 MAPK mediates EGFR down-regulation by UV-C. In addition, phosphorylation of p38 MAPK induced by UV-C was mediated through transforming growth factor-beta-activated kinase-1. Moreover, pretreatment of the cells with UV-C suppressed EGF-induced phosphorylation of EGFR at tyrosine residues in addition to cell survival signal, Akt. Together, these results suggest that UV-C irradiation induces the removal of EGFRs from the cell surface that can protect colon cancer cells from oncogenic stimulation of EGF, resulting in cell cycle arrest. Hence, UV-C might be applied for clinical strategy against human colon cancers.	[Adachi, Seiji; Itani, Masahiko; Nakamura, Momoko; Nishii, Yumi; Kozawa, Osamu] Gifu Univ Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Adachi, Seiji; Yasuda, Ichiro; Nakashima, Masanori; Yamauchi, Takahiro; Kawaguchi, Junji; Shimizu, Masahito; Moriwaki, Hisataka] Gifu Univ Grad Sch Med, Dept Gastroenterol, Gifu 5011194, Japan; [Yoshioka, Takashi; Okano, Yukio] Gifu Univ Grad Sch Med, Dept Mol Pathobiochem, Gifu 5011194, Japan; [Hirose, Yoshinobu] Gifu Univ Hosp, Div Pathol, Gifu 5011194, Japan	Gifu University; Gifu University; Gifu University; Gifu University	Adachi, S (corresponding author), 1-1 Yanagido, Gifu 5011194, Japan.	seijiadachi0123@gmail.com	Hirose, Yoshinobu/AAW-9079-2020	Hirose, Yoshinobu/0000-0002-3860-0293	Ministry of Education, Science, Sports and Culture of Japan [22790639]; Yokoyama Foundation for Clinical Pharmacology	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokoyama Foundation for Clinical Pharmacology(Yokoyama Foundation for Clinical Pharmacology)	This work was supported in part by Grant-in-Aid for Scientific Research 22790639 (to S. A) from the Ministry of Education, Science, Sports and Culture of Japan and a grant by the Yokoyama Foundation for Clinical Pharmacology.	Adachi S, 2008, CARCINOGENESIS, V29, P1986, DOI 10.1093/carcin/bgn128; Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; Adachi S, 2010, ONCOL REP, V23, P1709, DOI 10.3892/or_00000815; Adachi S, 2009, CARCINOGENESIS, V30, P1544, DOI 10.1093/carcin/bgp166; Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blumenthal RD, 2007, MOL BIOTECHNOL, V35, P185, DOI 10.1007/BF02686104; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; COUNTAWAY JL, 1990, J BIOL CHEM, V265, P3407; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Feng FY, 2007, ONCOGENE, V26, P3431, DOI 10.1038/sj.onc.1210129; FONG CJ, 1992, CANCER RES, V52, P5887; Habiro A, 2004, BIOCHEM BIOPH RES CO, V316, P71, DOI 10.1016/j.bbrc.2004.02.017; Hammaker DR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2215; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Jaramillo ML, 2006, EXP CELL RES, V312, P2778, DOI 10.1016/j.yexcr.2006.05.008; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Koizumi K, 2005, ANTICANCER RES, V25, P3347; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Masuda M, 2001, CLIN CANCER RES, V7, P4220; Matsuzawa A, 2001, J BIOCHEM-TOKYO, V130, P1; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; Milano G, 2008, BRIT J CANCER, V99, P1, DOI 10.1038/sj.bjc.6604373; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Nakashima M, 2010, INT J ONCOL, V36, P585, DOI 10.3892/ijo_00000533; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Norval M, 2001, J PHOTOCH PHOTOBIO B, V63, P28, DOI 10.1016/S1011-1344(01)00200-7; Oksvold MP, 2002, J CELL SCI, V115, P793; Pianetti S, 2002, CANCER RES, V62, P652; Rice PL, 2003, CANCER RES, V63, P616; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Rusch V, 1997, CLIN CANCER RES, V3, P515; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; THEROUX SJ, 1992, J BIOL CHEM, V267, P16620; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	56	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26178	26187		10.1074/jbc.M111.240630	http://dx.doi.org/10.1074/jbc.M111.240630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21646361	Green Published, hybrid			2022-12-27	WOS:000293073000075
J	Fernandez-Higuero, JA; Acebron, SP; Taneva, SG; del Castillo, U; Moro, F; Muga, A				Angel Fernandez-Higuero, Jose; Acebron, Sergio P.; Taneva, Stefka G.; del Castillo, Urko; Moro, Fernando; Muga, Arturo			Allosteric Communication between the Nucleotide Binding Domains of Caseinolytic Peptidase B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS CHAPERONE CLPB; PROTEIN-ACTIVATED ATPASE; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; AGGREGATED PROTEINS; SUBSTRATE-BINDING; COMMON MECHANISM; QUALITY CONTROL; CENTRAL PORE; HSP104	ClpB is a hexameric chaperone that solubilizes and reactivates protein aggregates in cooperation with the Hsp70/DnaK chaperone system. Each of the identical protein monomers contains two nucleotide binding domains (NBD), whose ATPase activity must be coupled to exert on the substrate the mechanical work required for its reactivation. However, how communication between these sites occurs is at present poorly understood. We have studied herein the affinity of each of the NBDs for nucleotides in WT ClpB and protein variants in which one or both sites are mutated to selectively impair nucleotide binding or hydrolysis. Our data show that the affinity of NBD2 for nucleotides (K-d = 3-7 mu M) is significantly higher than that of NBD1. Interestingly, the affinity of NBD1 depends on nucleotide binding to NBD2. Binding of ATP, but not ADP, to NBD2 increases the affinity of NBD1 (the Kd decreases from approximate to 160-300 to 50-60 mu M) for the corresponding nucleotide. Moreover, filling of the NBD2 ring with ATP allows the cooperative binding of this nucleotide and substrates to the NBD1 ring. Data also suggest that a minimum of four subunits cooperate to bind and reactivate two different aggregated protein substrates.	[Muga, Arturo] Univ Basque Country, Biophys Unit, Consejo Super Invest Cient, Euskal Herriko Unibertsitatea, E-48080 Bilbao, Spain; Univ Basque Country, Fac Sci & Technol, Dept Biochem & Mol Biol, Euskal Herriko Unibertsitatea, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Muga, A (corresponding author), Univ Basque Country, Biophys Unit, Consejo Super Invest Cient, Euskal Herriko Unibertsitatea, E-48080 Bilbao, Spain.	arturo.muga@ehu.es	Moro Pérez, Fernando/P-3891-2015; Muga, Arturo/N-1174-2014	Moro Pérez, Fernando/0000-0002-3568-3388; Muga, Arturo/0000-0003-0345-6882; del Castillo Rojo, Urko/0000-0002-4170-1749; Fernandez-Higuero, Jose Angel/0000-0002-4143-5532	Ministerio de Ciencia e Innovacion [BFU2007-64452, BFU2010-15443]; Universidad del Pais Vasco and Gobierno Vasco [IT-358-07]; Diputacion Foral de Bizkaia [DIPE08/18]; Ramon y Cajal	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad del Pais Vasco and Gobierno Vasco; Diputacion Foral de Bizkaia; Ramon y Cajal(Spanish Government)	This work was supported by Ministerio de Ciencia e Innovacion Grants BFU2007-64452 and BFU2010-15443, Universidad del Pais Vasco and Gobierno Vasco Grant IT-358-07, and Diputacion Foral de Bizkaia Grant DIPE08/18.; Supported by a Ramon y Cajal contract.	Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Beinker P, 2005, J BIOL CHEM, V280, P37965, DOI 10.1074/jbc.M506672200; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chesnokova LS, 2005, BIOCHEMISTRY-US, V44, P11224, DOI 10.1021/bi050787b; del Castillo U, 2010, FEBS LETT, V584, P929, DOI 10.1016/j.febslet.2010.01.029; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Farr CD, 1998, J BIOL CHEM, V273, P9744, DOI 10.1074/jbc.273.16.9744; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Kim KI, 2000, J MOL BIOL, V303, P655, DOI 10.1006/jmbi.2000.4165; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Leskovar A, 2008, ARCH BIOCHEM BIOPHYS, V473, P16, DOI 10.1016/j.abb.2008.02.035; Li JZ, 2002, J MOL BIOL, V318, P1127, DOI 10.1016/S0022-2836(02)00188-2; Mehl AF, 2001, BIOCHEM BIOPH RES CO, V282, P562, DOI 10.1006/bbrc.2001.4567; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Mogk A, 2004, CURR BIOL, V14, pR78, DOI 10.1016/j.cub.2003.12.051; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Nagy M, 2009, PROTEIN SCI, V18, P287, DOI 10.1002/pro.36; Neuwald AF, 1999, GENOME RES, V9, P27; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Taneva SG, 2010, BIOCHEMISTRY-US, V49, P1338, DOI 10.1021/bi901847q; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Werbeck ND, 2011, BIOCHEMISTRY-US, V50, P899, DOI 10.1021/bi1018286; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; WOO KM, 1992, J BIOL CHEM, V267, P20429; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Zietkiewicz S, 2010, BIOPOLYMERS, V93, P47, DOI 10.1002/bip.21294; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	56	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25547	25555		10.1074/jbc.M111.231365	http://dx.doi.org/10.1074/jbc.M111.231365			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642426	Green Published, hybrid			2022-12-27	WOS:000293073000017
J	Begum, N; Hockman, S; Manganiello, VC				Begum, Najma; Hockman, Steven; Manganiello, Vincent C.			Phosphodiesterase 3A (PDE3A) Deletion Suppresses Proliferation of Cultured Murine Vascular Smooth Muscle Cells (VSMCs) via Inhibition of Mitogen-activated Protein Kinase (MAPK) Signaling and Alterations in Critical Cell Cycle Regulatory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE PHOSPHODIESTERASES; DIFFERENTIAL REGULATION; INSULIN REGULATION; MESANGIAL CELLS; GROWTH-FACTOR; NITRIC-OXIDE; CAMP; EXPRESSION; MIGRATION; ATHEROSCLEROSIS	Cyclic nucleotide phosphodiesterase 3 (PDE3) is an important regulator of cyclic adenosine monophosphate (cAMP) signaling within the cardiovascular system. In this study, we examined the role of PDE3A and PDE3B isoforms in regulation of growth of cultured vascular smooth muscle cells (VSMCs) and the mechanisms by which they may affect signaling pathways that mediate mitogen-induced VSMC proliferation. Serum-and PDGF-induced DNA synthesis in VSMCs grown from aortas of PDE3A-deficient (3A-KO) mice was markedly less than that in VSMCs from PDE3A wild type (3A-WT) and PDE3B-deficient (3B-KO) mice. The reduced growth response was accompanied by significantly less phosphorylation of extracellular signal-regulated kinase (ERK) in 3A-KO VSMCs, most likely due to a combination of greater site-specific inhibitory phosphorylation of Raf-1(Ser-259) by protein kinase A (PKA) and enhanced dephosphorylation of ERKs due to elevated mitogen-activated protein kinase phosphatase 1 (MKP-1). Furthermore, 3A-KO VSMCs, compared with 3A-WT, exhibited higher basal PKA activity and cAMP response element-binding protein (CREB) phosphorylation, higher levels of p53 and p53 phosphorylation, and elevated p21 protein together with lower levels of Cyclin-D1 and retinoblastoma (Rb) protein and Rb phosphorylation. Adenoviral overexpression of inactive CREB partially restored growth effects of serum in 3A-KO VSMCs. In contrast, exposure of 3A-WT VSMCs to VP16 CREB (active CREB) was associated with inhibition of serum-induced DNA synthesis similar to that in untreated 3A-KO VSMCs. Transfection of 3A-KO VSMCs with p53 siRNA reduced p21 and MKP-1 levels and completely restored growth without affecting amounts of Cyclin-D1 and Rb phosphorylation. We conclude that PDE3A regulates VSMC growth via two complementary pathways, i.e. PKA-catalyzed inhibitory phosphorylation of Raf-1 with resulting inhibition of MAPK signaling and PKA/CREB-mediated induction of p21, leading to G(0)/G(1) cell cycle arrest, as well as by increased accumulation of p53, which induces MKP-1, p21, and WIP1, leading to inhibition of G(1) to S cell cycle progression.	[Begum, Najma; Hockman, Steven; Manganiello, Vincent C.] NHLBI, Cardiovasc Pulm Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Begum, N (corresponding author), NHLBI, Cardiovasc Pulm Branch, NIH, 10 Ctr Dr,Bldg 10,Rm 5N322,MSC-1076, Bethesda, MD 20892 USA.	begumn@mail.nih.gov			National Institutes of Health through NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002540] Funding Source: NIH RePORTER	National Institutes of Health through NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health through the Intramural Research Program of the NHLBI.	Adler V, 1997, P NATL ACAD SCI USA, V94, P1686, DOI 10.1073/pnas.94.5.1686; Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Aoki M, 2001, DIABETOLOGIA, V44, P1034, DOI 10.1007/s001250100593; Begum N, 1998, AM J PHYSIOL-CELL PH, V275, pC42, DOI 10.1152/ajpcell.1998.275.1.C42; Begum N, 2002, DIABETES, V51, P2256, DOI 10.2337/diabetes.51.7.2256; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; Cai Xinjiang, 2006, Expert Rev Cardiovasc Ther, V4, P789, DOI 10.1586/14779072.4.6.789; Cheng JF, 2004, AM J PHYSIOL-RENAL, V287, pF940, DOI 10.1152/ajprenal.00079.2004; Chini CCS, 1997, J BIOL CHEM, V272, P9854; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Ducommun B, 1991, Semin Cell Biol, V2, P233; Fukumoto S, 1999, CIRC RES, V85, P985; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hayashi S, 2000, HYPERTENSION, V35, P237, DOI 10.1161/01.HYP.35.1.237; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Inoue Y, 2000, BRIT J PHARMACOL, V130, P231, DOI 10.1038/sj.bjp.0703287; Isenovic Esma R., 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P172; Jacob A, 2004, AM J PHYSIOL-CELL PH, V287, pC1077, DOI 10.1152/ajpcell.00477.2003; Jacob A, 2002, AM J PHYSIOL-CELL PH, V283, pC704, DOI 10.1152/ajpcell.00110.2002; Kass DA, 2007, CARDIOVASC RES, V75, P303, DOI 10.1016/j.cardiores.2007.02.031; Koyama H, 2001, J CELL PHYSIOL, V186, P1; Kusari AB, 2000, MOL CELL BIOCHEM, V211, P27, DOI 10.1023/A:1007102428735; LAFONT A, 1995, CIRC RES, V76, P996, DOI 10.1161/01.RES.76.6.996; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lugnier C, 1999, J PHYSIOL PHARMACOL, V50, P639; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; MATOUSOVIC K, 1995, J CLIN INVEST, V96, P401, DOI 10.1172/JCI118049; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Morishita R, 2005, ATHEROSCLEROSIS SUPP, V6, P41, DOI 10.1016/j.atherosclerosissup.2005.09.007; Nelson PR, 1998, J VASC SURG, V27, P117, DOI 10.1016/S0741-5214(98)70298-8; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Onishi T, 1997, J BONE MINER RES, V12, P1596, DOI 10.1359/jbmr.1997.12.10.1596; Osinski MT, 2001, MOL PHARMACOL, V59, P1044, DOI 10.1124/mol.59.5.1044; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Phillips PG, 2005, AM J PHYSIOL-LUNG C, V288, pL103, DOI 10.1152/ajplung.00095.2004; Plevin R, 1997, CELL SIGNAL, V9, P323, DOI 10.1016/S0898-6568(96)00193-3; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Waning DL, 2010, PHARMACEUTICALS, V3, P1576, DOI 10.3390/ph3051576; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7; Zhao H, 2008, EUR J PHARMACOL, V590, P29, DOI 10.1016/j.ejphar.2008.05.016	53	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26238	26249		10.1074/jbc.M110.214155	http://dx.doi.org/10.1074/jbc.M110.214155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632535	Green Published, hybrid			2022-12-27	WOS:000293073000081
J	Kern, J; Wilton, R; Zhang, RG; Binkowski, TA; Joachimiak, A; Schneewind, O				Kern, Justin; Wilton, Rosemarie; Zhang, Rongguang; Binkowski, T. Andrew; Joachimiak, Andrzej; Schneewind, Olaf			Structure of Surface Layer Homology (SLH) Domains from Bacillus anthracis Surface Array Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL POLYSACCHARIDE; S-LAYER; CHOLERA-TOXIN; MACROMOLECULAR STRUCTURES; CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; BINDING; CRYSTALLIZATION; ATTACHMENT; MECHANISM	Surface (S)-layers, para-crystalline arrays of protein, are deposited in the envelope of most bacterial species. These surface organelles are retained in the bacterial envelope through the non-covalent association of proteins with cell wall carbohydrates. Bacillus anthracis, a Gram-positive pathogen, produces S-layers of the protein Sap, which uses three consecutive repeats of the surface-layer homology (SLH) domain to engage secondary cell wall polysaccharides (SCWP). Using x-ray crystallography, we reveal here the structure of these SLH domains, which assume the shape of a three-prong spindle. Each SLH domain contributes to a three-helical bundle at the spindle base, whereas another alpha-helix and its connecting loops generate the three prongs. The inter-prong grooves contain conserved cationic and anionic residues, which are necessary for SLH domains to bind the B. anthracis SCWP. Modeling experiments suggest that the SLH domains of other S-layer proteins also fold into three-prong spindles and capture bacterial envelope carbohydrates by a similar mechanism.	[Kern, Justin; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Wilton, Rosemarie; Zhang, Rongguang; Binkowski, T. Andrew; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Wilton, Rosemarie; Zhang, Rongguang; Binkowski, T. Andrew; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA; [Joachimiak, Andrzej] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Schneewind, O (corresponding author), 920 E 58th St, Chicago, IL USA.	oschnee@bsd.uchicago.edu		Wilton, Rosemarie/0000-0001-5221-6354	National Institutes of Health [GM074942, AI69227, GM007183]; Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases) [1-U54-AI-057153]; U.S. Dept. of Energy Office of Science laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI069227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942, T32GM007183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Dept. of Energy Office of Science laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM074942 (to A. J.) and AI69227 (to O. S.) from the National Institutes of Health.; Supported by National Institutes of Health Training Grant GM007183.; Membership within and support from the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award 1-U54-AI-057153). To whom correspondence should be addressed: 920 E. 58<SUP>th</SUP> St., Chicago, IL 6063. Fax: 773-834-8150; E-mail: oschnee@bsd.uchicago.edu.; The submitted manuscript has been created by University of Chicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne"). Argonne, a U.S. Dept. of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The U. S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUCKNER V, 1953, NATURE, V172, P508, DOI 10.1038/172508a0; Candela T, 2005, MICROBIOL-SGM, V151, P1485, DOI 10.1099/mic.0.27832-0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cava F, 2004, MOL MICROBIOL, V52, P677, DOI 10.1111/j.1365-2958.2004.04011.x; Chauvaux S, 1999, J BACTERIOL, V181, P2455, DOI 10.1128/JB.181.8.2455-2458.1999; CHICH JF, 1995, PROTEINS, V23, P278, DOI 10.1002/prot.340230216; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; Couture-Tosi E, 2002, J BACTERIOL, V184, P6448, DOI 10.1128/JB.184.23.6448-6456.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070; Engelhardt H, 2007, J STRUCT BIOL, V160, P115, DOI 10.1016/j.jsb.2007.08.003; ETIENNETOUMELIN I, 1995, J BACTERIOL, V177, P614, DOI 10.1128/jb.177.3.614-620.1995; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; FUJINO T, 1993, J BACTERIOL, V175, P1891, DOI 10.1128/JB.175.7.1891-1899.1993; Houwink A.L., 1952, PHYS VERHANDLUNG, V3, P98; HOUWINK AL, 1953, BIOCHIM BIOPHYS ACTA, V10, P360, DOI 10.1016/0006-3002(53)90266-2; HOUWINK AL, 1956, J GEN MICROBIOL, V15, P146, DOI 10.1099/00221287-15-1-146; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leoff C, 2009, GLYCOBIOLOGY, V19, P665, DOI 10.1093/glycob/cwp036; LUPAS A, 1994, J BACTERIOL, V176, P1224, DOI 10.1128/jb.176.5.1224-1233.1994; Lupas A, 1996, MOL MICROBIOL, V20, P897, DOI 10.1111/j.1365-2958.1996.tb02528.x; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; May A, 2006, ARCH MICROBIOL, V185, P263, DOI 10.1007/s00203-006-0092-x; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Mesnage S, 1997, MOL MICROBIOL, V23, P1147, DOI 10.1046/j.1365-2958.1997.2941659.x; Mesnage S, 2002, J BACTERIOL, V184, P331, DOI 10.1128/JB.184.1.331-334.2002; Mesnage S, 1999, MOL MICROBIOL, V31, P927, DOI 10.1046/j.1365-2958.1999.01232.x; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mesnage S, 1998, J BACTERIOL, V180, P52, DOI 10.1128/JB.180.1.52-58.1998; Mignot T, 2002, MOL MICROBIOL, V43, P1615, DOI 10.1046/j.1365-2958.2002.02852.x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pavkov T, 2008, STRUCTURE, V16, P1226, DOI 10.1016/j.str.2008.05.012; Richter S, 2009, MOL MICROBIOL, V71, P404, DOI 10.1111/j.1365-2958.2008.06533.x; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sleytr UB, 1997, FEMS MICROBIOL REV, V20, P5, DOI 10.1016/S0168-6445(97)00039-9; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANHEYNINGEN WE, 1971, J INFECT DIS, V124, P415, DOI 10.1093/infdis/124.4.415; ZHANG RG, 1995, J MOL BIOL, V251, P550, DOI 10.1006/jmbi.1995.0455	47	63	63	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26042	26049		10.1074/jbc.M111.248070	http://dx.doi.org/10.1074/jbc.M111.248070			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21572039	Green Published, hybrid			2022-12-27	WOS:000293073000062
J	Xu, LM; Salloum, D; Medlin, PS; Saqcena, M; Yellen, P; Perrella, B; Foster, DA				Xu, Limei; Salloum, Darin; Medlin, Phil S.; Saqcena, Mahesh; Yellen, Paige; Perrella, Benjamin; Foster, David A.			Phospholipase D Mediates Nutrient Input to Mammalian Target of Rapamycin Complex 1 (mTORC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID REGULATION; HUMAN CANCER-CELLS; TUBEROUS-SCLEROSIS; PHOSPHATIDIC-ACID; SURVIVAL SIGNAL; RAG GTPASES; H-RAS; ACTIVATION; RALA; RHEB	The mammalian target of rapamycin (mTOR) is a critical sensor of nutritional sufficiency. Although much is known about the regulation of mTOR in response to growth factors, much less is known about the regulation of mTOR in response to nutrients. Amino acids have no impact on the signals that regulate Rheb, a GTPase required for the activation of mTOR complex 1 (mTORC1). Phospholipase D (PLD) generates a metabolite, phosphatidic acid, that facilitates association between mTOR and the mTORC1 co-factor Raptor. We report here that elevated PLD activity in human cancer cells is dependent on both amino acids and glucose and that amino acid-and glucose-induced increases in mTORC1 activity are dependent on PLD. Amino acid-and glucose-induced PLD and mTORC1 activity were also dependent on the GTPases RalA and ARF6 and the type III phosphatidylinositol-3-kinase hVps34. Thus, a key stimulatory event for mTORC1 activation in response to nutrients is the generation of phosphatidic acid by PLD.	[Xu, Limei; Salloum, Darin; Medlin, Phil S.; Saqcena, Mahesh; Yellen, Paige; Perrella, Benjamin; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10065 USA.	foster@genectr.hunter.cuny.edu	Saqcena, Mahesh/U-5973-2017	Saqcena, Mahesh/0000-0002-2210-3444	National Institutes of Health, NCI [CA148677]; National Center for Research Resources of the National Institutes of Health [RR-03039]; NATIONAL CENTER FOR RESEARCH RESOURCES [S03RR003039] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA148677. This work was also supported by Research Centers in Minority Institutions Award RR-03039 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Biological Sciences Department at Hunter College.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster David A, 2004, Expert Rev Anticancer Ther, V4, P691, DOI 10.1586/14737140.4.4.691; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Frohman MA, 1999, CHEM PHYS LIPIDS, V98, P127, DOI 10.1016/S0009-3084(99)00025-0; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; Garcia AS, 2008, AQUACULT NUTR, V14, P14, DOI 10.1111/j.1365-2095.2007.00500.x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Ha SH, 2006, CELL SIGNAL, V18, P2283, DOI 10.1016/j.cellsig.2006.05.021; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Luo JQ, 1997, BIOCHEM BIOPH RES CO, V235, P854, DOI 10.1006/bbrc.1997.6793; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; Ma WN, 2010, EXP MOL MED, V42, P456, DOI 10.3858/emm.2010.42.6.047; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Nobukuni T, 2007, CURR OPIN CELL BIOL, V19, P135, DOI 10.1016/j.ceb.2007.02.019; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sancak Y, 2009, BIOCHEM SOC T, V37, P289, DOI 10.1042/BST0370289; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Xu LZ, 2003, MOL CELL BIOL, V23, P645, DOI 10.1128/MCB.23.2.645-654.2003; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	50	72	77	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25477	25486		10.1074/jbc.M111.249631	http://dx.doi.org/10.1074/jbc.M111.249631			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622984	Green Published, hybrid			2022-12-27	WOS:000293073000010
J	Farghaian, H; Turnley, AM; Sutherland, C; Cole, AR				Farghaian, Hovik; Turnley, Ann M.; Sutherland, Calum; Cole, Adam R.			Bioinformatic Prediction and Confirmation of beta-Adducin as a Novel Substrate of Glycogen Synthase Kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE MEDIATOR PROTEIN-2; RABBIT SKELETAL-MUSCLE; ALZHEIMERS-DISEASE; PHOSPHOPROTEOMIC ANALYSIS; DIFFERENTIAL REGULATION; IN-VIVO; SYNAPTIC PLASTICITY; MOUSE-BRAIN; A-BETA; PHOSPHORYLATION	It is important to identify the true substrates of protein kinases because this illuminates the primary function of any kinase. Here, we used bioinformatics and biochemical validation to identify novel brain substrates of the Ser/Thr kinase glycogen synthase kinase 3 (GSK3). Briefly, sequence databases were searched for proteins containing a conserved GSK3 phosphorylation consensus sequence ((S/T)PXX(S/T)P or (S/T)PXXX(S/T)P), as well as other criteria of interest (e.g. brain proteins). Importantly, candidates were highlighted if they had previously been reported to be phosphorylated at these sites by large-scale phosphoproteomic studies. These criteria identified the brain-enriched cytoskeleton-associated protein beta-adducin as a likely substrate of GSK3. To confirm this experimentally, it was cloned and subjected to a combination of cell culture and in vitro kinase assays that demonstrated direct phosphorylation by GSK3 in vitro and in cells. Phosphosites were mapped to three separate regions near the C terminus and confirmed using phosphospecific antibodies. Prior priming phosphorylation by Cdk5 enhanced phosphorylation by GSK3. Expression of wild type, but not non-phosphorylatable (GSK3 insensitive), beta-adducin increased axon and dendrite elongation in primary cortical neurons. Therefore, phosphorylation of beta-adducin by GSK3 promotes efficient neurite outgrowth in neurons.	[Farghaian, Hovik; Cole, Adam R.] Garvan Inst Med Res, Neurosignalling Grp, Sydney, NSW 2010, Australia; [Turnley, Ann M.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Sutherland, Calum] Univ Dundee, Biomed Res Inst, Dundee DD1 9SY, Scotland	Garvan Institute of Medical Research; University of Melbourne; University of Dundee	Cole, AR (corresponding author), Garvan Inst Med Res, Neurosignalling Grp, 384 Victoria St, Sydney, NSW 2010, Australia.	a.cole@garvan.org.au	Turnley, Ann/A-8125-2010	Turnley, Ann/0000-0002-8442-127X; Sutherland, Calum/0000-0003-4398-7434	Mason Foundation; Contributing to Australian Scholarship and Science (CASS) Foundation; Australian National Health and Medical Research Council (NHMRC) [454886]; Alzheimers Research UK [ART-PG2005-1] Funding Source: researchfish	Mason Foundation; Contributing to Australian Scholarship and Science (CASS) Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by grants from the Mason Foundation and the Contributing to Australian Scholarship and Science (CASS) Foundation.; Supported by Australian National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship 454886. To whom correspondence should be addressed: Neurosignalling Group, Garvan Institute of Medical Research, 384 Victoria St., Darlinghurst, Sydney, NSW 2010, Australia. Tel.: 61-2-9295-8289; Fax: 61-2-9295-8281; E-mail: a. cole@garvan.org.au.	Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; BENNETT V, 1988, J BIOL CHEM, V263, P5860; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; GARDNER K, 1986, J BIOL CHEM, V261, P1339; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Leroy K, 2002, ACTA NEUROPATHOL, V103, P91; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; MIYAZAKI M, 1994, BIOCHEM BIOPH RES CO, V205, P460, DOI 10.1006/bbrc.1994.2688; Mukai F, 2002, J NEUROCHEM, V81, P1073, DOI 10.1046/j.1471-4159.2002.00918.x; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Porro F, 2010, GENES BRAIN BEHAV, V9, P84, DOI 10.1111/j.1601-183X.2009.00537.x; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; SEIDEL B, 1995, BRAIN RES, V700, P13, DOI 10.1016/0006-8993(95)00962-P; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; YANG SD, 1981, FEBS LETT, V126, P57, DOI 10.1016/0014-5793(81)81032-0; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yotsumoto K, 2009, J BIOL CHEM, V284, P16840, DOI 10.1074/jbc.M109.003277; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130	55	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25274	25283		10.1074/jbc.M111.251629	http://dx.doi.org/10.1074/jbc.M111.251629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606488	hybrid, Green Published			2022-12-27	WOS:000292547900073
J	Ishimaru, Y; Kakei, Y; Shimo, H; Bashir, K; Sato, Y; Sato, Y; Uozumi, N; Nakanishi, H; Nishizawa, NK				Ishimaru, Yasuhiro; Kakei, Yusuke; Shimo, Hugo; Bashir, Khurram; Sato, Yutaka; Sato, Yuki; Uozumi, Nobuyuki; Nakanishi, Hiromi; Nishizawa, Naoko K.			A Rice Phenolic Efflux Transporter Is Essential for Solubilizing Precipitated Apoplasmic Iron in the Plant Stele	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALUMINUM TOXICITY; ACID; DEFICIENCY; MECHANISMS; RESISTANCE; TOLERANCE; PROTEIN; GROWTH; IRT1	Iron deficiency is one of the major agricultural problems, as 30% of the arable land of the world is too alkaline for optimal crop production, rendering plants short of available iron despite its abundance. To take up apoplasmic precipitated iron, plants secrete phenolics such as protocatechuic acid (PCA) and caffeic acid. The molecular pathways and genes of iron uptake strategies are already characterized, whereas the molecular mechanisms of phenolics synthesis and secretion have not been clarified, and no phenolics efflux transporters have been identified in plants yet. Here we describe the identification of a phenolics efflux transporter in rice. We identified a cadmium-accumulating rice mutant in which the amount of PCA and caffeic acid in the xylem sap was dramatically reduced and hence named it phenolics efflux zero 1 (pez1). PEZ1 localized to the plasma membrane and transported PCA when expressed in Xenopus laevis oocytes. PEZ1 localized mainly in the stele of roots. In the roots of pez1, precipitated apoplasmic iron increased. The growth of PEZ1 overexpression lines was severely restricted, and these lines accumulated more iron as a result of the high solubilization of precipitated apoplasmic iron in the stele. We show that PEZ1 is responsible for an increase of PCA concentration in the xylem sap and is essential for the utilization of apoplasmic precipitated iron in the stele.	[Ishimaru, Yasuhiro; Kakei, Yusuke; Shimo, Hugo; Bashir, Khurram; Nakanishi, Hiromi; Nishizawa, Naoko K.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Sato, Yutaka] Natl Inst Agrobiol Sci, Genome Resource Ctr, Tsukuba, Ibaraki 3058602, Japan; [Sato, Yuki; Uozumi, Nobuyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan; Tohoku University; Ishikawa Prefecture University	Nishizawa, NK (corresponding author), Yayoi 1-1-1,Bunkyo Ku, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Bashir, Khurram/C-6870-2011; ISHIMARU, Yasuhiro/AAS-5947-2020; Kakei, Yusuke/AAF-7408-2020; Uozumi, Nobuyuki/AAG-3252-2019; Bashir, Khurram/Z-5650-2019; Nakanishi, Hiromi/C-6461-2015	Bashir, Khurram/0000-0001-7123-8380; ISHIMARU, Yasuhiro/0000-0003-4723-8844; Bashir, Khurram/0000-0001-7123-8380; Uozumi, Nobuyuki/0000-0003-4268-1126; Nakanishi, Hiromi/0000-0001-5556-5058	Programme for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [GMB0001]	Programme for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by the Programme for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and Grant GMB0001 from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation).	Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Bashir K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1326; Cesco S, 2010, PLANT SOIL, V329, P1, DOI 10.1007/s11104-009-0266-9; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Ishimaru Y, 2009, MOL PLANT, V2, P1059, DOI 10.1093/mp/ssp051; Jeong J, 2009, TRENDS PLANT SCI, V14, P280, DOI 10.1016/j.tplants.2009.02.006; Jin CW, 2007, PLANT PHYSIOL, V144, P278, DOI 10.1104/pp.107.095794; Kakei Y, 2009, PLANT CELL PHYSIOL, V50, P1988, DOI 10.1093/pcp/pcp141; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Kidd PS, 2001, J EXP BOT, V52, P1339, DOI 10.1093/jexbot/52.359.1339; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Maron LG, 2010, PLANT J, V61, P728, DOI 10.1111/j.1365-313X.2009.04103.x; Marschner H., 1995, MINERAL NUTR HIGHER, P313, DOI DOI 10.1016/B978-012473542-2/50011-0; Nakanishi H, 2006, SOIL SCI PLANT NUTR, V52, P464, DOI 10.1111/j.1747-0765.2006.00055.x; Ogawa I, 2009, PLANT SOIL, V325, P97, DOI 10.1007/s11104-009-0116-9; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Popa VI, 2008, IND CROP PROD, V27, P144, DOI 10.1016/j.indcrop.2007.07.019; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rios JL, 2009, CURR PHARM DESIGN, V15, P1212, DOI 10.2174/138161209787846874; ROMHELD V, 1983, PLANT PHYSIOL, V71, P949, DOI 10.1104/pp.71.4.949; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Yoshino M, 1998, ANAL BIOCHEM, V257, P40, DOI 10.1006/abio.1997.2522	31	121	127	3	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24649	24655		10.1074/jbc.M111.221168	http://dx.doi.org/10.1074/jbc.M111.221168			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21602276	Green Published, hybrid			2022-12-27	WOS:000292547900015
J	Pham, P; Calabrese, P; Park, SJ; Goodman, MF				Pham, Phuong; Calabrese, Peter; Park, Soo Jung; Goodman, Myron F.			Analysis of a Single-stranded DNA-scanning Process in Which Activation-induced Deoxycytidine Deaminase (AID) Deaminates C to U Haphazardly and Inefficiently to Ensure Mutational Diversity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; T7 RNA-POLYMERASE; SOMATIC HYPERMUTATION; FACILITATED DIFFUSION; RESTRICTION ENZYMES; TARGETED DNA; DEMETHYLATION; SEQUENCE; PROTEIN; REPAIR	Enzymes that scan single-stranded (ss) DNA have been studied far less extensively than those that scan double-stranded (ds) DNA. Activation-induced deoxycytidine deaminase (AID) deaminates C to U on single-stranded DNA to initiate immunological diversity. Except for processive deaminations favoring WRC hot motifs(W = (A/T) and R = (G/C)), the rules governing AID scanning remain vague. Here, we examine the patterns of deaminations on naked single-stranded DNA and during transcription of dsDNA by embedding cassettes containing combinations of motifs within a lacZ mutational reporter gene. Deaminations arise randomly, spatially distributed as isolated events and in clusters. The deamination frequency depends on the motif and its surrounding sequence. We propose a random walk model that fits the data well, having a deamination probability of 1-7% per motif encounter. We suggest that inefficient, haphazard deamination produces antibody diversity associated with AID.	[Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.	mgoodman@usc.edu			National Institutes of Health [GM21422, ES013192]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422, R01GM021422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM21422 and ES013192.	Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; BENNETT SE, 1995, BIOCHEMISTRY-US, V34, P6109, DOI 10.1021/bi00018a014; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Canugovi C, 2009, FASEB J, V23, P34, DOI 10.1096/fj.08-115352; Carey DC, 1999, BIOCHEMISTRY-US, V38, P16553, DOI 10.1021/bi9907429; Chahwan R, 2010, TRENDS GENET, V26, P443, DOI 10.1016/j.tig.2010.07.005; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; DOWD DR, 1990, J BIOL CHEM, V265, P3424; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Halford SE, 2001, BIOCHEM SOC T, V29, P363, DOI 10.1042/BST0290363; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; MacCarthy T, 2009, P NATL ACAD SCI USA, V106, P8629, DOI 10.1073/pnas.0903803106; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ross S. M., 1994, 1 COURSE PROBABILITY, P167; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Sohn YH, 2005, P NATL ACAD SCI USA, V102, P75, DOI 10.1073/pnas.0406581101; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200	48	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24931	24942		10.1074/jbc.M111.241208	http://dx.doi.org/10.1074/jbc.M111.241208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21572036	Green Published, hybrid			2022-12-27	WOS:000292547900042
J	Thi, TTT; Poirier, H; Clement, L; Nassir, F; Pelsers, MMAL; Petit, V; Degrace, P; Monnot, MC; Glatz, JFC; Abumrad, NA; Besnard, P; Niot, I				Thi Thu Trang Tran; Poirier, Helene; Clement, Lionel; Nassir, Fatiha; Pelsers, Maurice M. A. L.; Petit, Valerie; Degrace, Pascal; Monnot, Marie-Claude; Glatz, Jan F. C.; Abumrad, Nada A.; Besnard, Philippe; Niot, Isabelle			Luminal Lipid Regulates CD36 Levels and Downstream Signaling to Stimulate Chylomicron Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; INTESTINAL-ABSORPTION; DENSITY-LIPOPROTEIN; APOLIPOPROTEIN B48; INSULIN-RESISTANCE; CHOLESTEROL UPTAKE; SKELETAL-MUSCLE; DIETARY LIPIDS; BRUSH-BORDER; HEPG2 CELLS	The membrane glycoprotein CD36 binds nanomolar concentrations of long chain fatty acids (LCFA) and is highly expressed on the luminal surface of enterocytes. CD36 deficiency reduces chylomicron production through unknown mechanisms. In this report, we provide novel insights into some of the underlying mechanisms. Our in vivo data demonstrate that CD36 gene deletion in mice does not affect LCFA uptake and subsequent esterification into triglycerides by the intestinal mucosa exposed to the micellar LCFA concentrations prevailing in the intestine. In rodents, the CD36 protein disappears early from the luminal side of intestinal villi during the postprandial period, but only when the diet contains lipids. This drop is significant 1 h after a lipid supply and associates with ubiquitination of CD36. Using CHO cells expressing CD36, it is shown that the digestion products LCFA and diglycerides trigger CD36 ubiquitination. In vivo treatment with the proteasome inhibitor MG132 prevents the lipid-mediated degradation of CD36. In vivo and ex vivo, CD36 is shown to be required for lipid activation of ERK1/2, which associates with an increase of the key chylomicron synthesis proteins, apolipoprotein B48 and microsomal triglyceride transfer protein. Therefore, intestinal CD36, possibly through ERK1/2-mediated signaling, is involved in the adaptation of enterocyte metabolism to the postprandial lipid challenge by promoting the production of large triglyceride-rich lipoproteins that are rapidly cleared in the blood. This suggests that CD36 may be a therapeutic target for reducing the postprandial hypertriglyceridemia and associated cardiovascular risks.	[Thi Thu Trang Tran; Poirier, Helene; Clement, Lionel; Petit, Valerie; Monnot, Marie-Claude; Besnard, Philippe; Niot, Isabelle] AgroSup Dijon, Physiol Nutr, Univ Bourgogne, INSERM,U866, F-21000 Dijon, France; [Pelsers, Maurice M. A. L.; Glatz, Jan F. C.] Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Nassir, Fatiha; Abumrad, Nada A.] Washington Univ, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Maastricht University; Washington University (WUSTL)	Niot, I (corresponding author), AgroSup Dijon, Physiol Nutr, Univ Bourgogne, INSERM,U866, 1 Esplanade Erasme, F-21000 Dijon, France.	niot@u-bourgogne.fr	Degrace, Pascal/AAF-5531-2021	Nassir, Fatiha/0000-0002-3653-3621	National Institute of Health and Medical Research (INSERM); French National Research Agency (L'Agence Nationale de la Recherche, ANR); Burgundy Council; National Institutes of Health [R01 DK60022, DK33301]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK033301, R01DK060022] Funding Source: NIH RePORTER	National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Research Agency (L'Agence Nationale de la Recherche, ANR)(French National Research Agency (ANR)); Burgundy Council(Region Bourgogne-Franche-Comte); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institute of Health and Medical Research (INSERM) and by grants from the Research Program in Human Nutrition SensoFAT of the French National Research Agency (L'Agence Nationale de la Recherche, ANR) (to P. B.) and from the Burgundy Council (to P. B.). This work was also supported by National Institutes of Health Grants R01 DK60022 and DK33301 (to N. A. A.).	Au WS, 2003, DIABETES, V52, P1073, DOI 10.2337/diabetes.52.5.1073; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; Chen CH, 1997, ARTERIOSCL THROM VAS, V17, P1303, DOI 10.1161/01.ATV.17.7.1303; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; DAHLQVIST A, 1970, ENZYMOL BIOL CLIN, V11, P52, DOI 10.1159/000458348; DELSAL JL, 1954, B SOC CHIM BIOL, V36, P1329; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Federico LM, 2006, DIABETES, V55, P1316, DOI 10.2337/db04-1084; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Pardo VG, 2007, BIOGERONTOLOGY, V8, P13, DOI 10.1007/s10522-006-9031-0; Habets DDJ, 2007, BIOCHEM BIOPH RES CO, V355, P204, DOI 10.1016/j.bbrc.2007.01.141; Hansen GH, 2003, GUT, V52, P1424, DOI 10.1136/gut.52.10.1424; Hevener AL, 2001, DIABETES, V50, P2316, DOI 10.2337/diabetes.50.10.2316; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Lo CM, 2008, AM J PHYSIOL-GASTR L, V294, pG344, DOI 10.1152/ajpgi.00123.2007; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Pelsers MMAL, 1999, BIOCHEM J, V337, P407, DOI 10.1042/0264-6021:3370407; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; QUARFORD.SH, 1966, BIOCHIM BIOPHYS ACTA, V116, P382, DOI 10.1016/0005-2760(66)90019-1; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; SHIRAZIBEECHEY SP, 1990, GASTROENTEROLOGY, V98, P676, DOI 10.1016/0016-5085(90)90288-C; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Tsai J, 2007, ARTERIOSCL THROM VAS, V27, P211, DOI 10.1161/01.ATV.0000249861.80471.96; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4	48	90	93	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25201	25210		10.1074/jbc.M111.233551	http://dx.doi.org/10.1074/jbc.M111.233551			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610069	hybrid, Green Published			2022-12-27	WOS:000292547900066
J	Yan, BX; Boyd, D				Yan, Boxu; Boyd, Daniel			Breaking the Light and Heavy Chain Linkage of Human Immunoglobulin G1 (IgG1) by Radical Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE AMINO-ACIDS; HYDROGEN-PEROXIDE; CATALYTIC DECOMPOSITION; MONOCLONAL-ANTIBODY; SELENOAMINO ACIDS; ELECTRON-TRANSFER; PULSE-RADIOLYSIS; RADIATION DAMAGE; AQUEOUS-SOLUTION; OXYGEN RADICALS	We report that the production of hydrogen peroxide by radical chain reductions of molecular oxygen into water in buffers leads to hinge degradation of a human IgG1 under thermal incubation conditions. The production of the hydrogen peroxide can be accelerated by superoxide dismutase or redox active metal ions or inhibited by free radical scavengers. The hydrogen peroxide production rate correlates well with the hinge cleavage. In addition to radical reaction mechanisms described previously, new degradation pathways and products were observed. These products were determined to be generated via radical reactions initiated by electron transfer and addition to the inter-chain disulfide bond between Cys(215) of the light chain and Cys(225) of the heavy chain. Decomposition of the resulting disulfide bond radical anion breaks the C-S bond at the side chain of Cys, converting it into dehydroalanine and generating a sulfur radical adduct at its counterpart. The hydrolysis of the unsaturated dehydropeptides removes Cys and yields an amide at the C terminus of the new fragment. Meanwhile, the competition between the carbonyl (-(CONH)-O-alpha-) and the side chain of Cys allows an electron transfer to the alpha carbon, forming a new intermediate radical species (-C-center dot(alpha)(O-)NH-) at Cys(225). Dissociative deamidation occurs along the N-C-alpha bond, resulting in backbone cleavage. Given that hydrogen peroxide is a commonly observed product of thermal stress and plays a role in mediating the unique degradation of an IgG1, strategies for improving stability of human antibody therapeutics are discussed.	[Yan, Boxu; Boyd, Daniel] Genentech Inc, Dept Pharma Tech Dev, Oceanside, CA 92056 USA	Roche Holding; Genentech	Yan, BX (corresponding author), Genentech Inc, Dept Pharma Tech Dev, Oceanside, CA 92056 USA.	yan.boxu@gene.com						Barton J. P., 1970, INT J RADIAT PHYS CH, V22, P25; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; CHAN PC, 1973, J AM CHEM SOC, V95, P5504, DOI 10.1021/ja00798a012; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Cordoba AJ, 2005, J CHROMATOGR B, V818, P115, DOI 10.1016/j.jchromb.2004.12.033; CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9; Datta D, 2002, P NATL ACAD SCI USA, V99, P2636, DOI 10.1073/pnas.052709399; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; Davies M. J., 1997, RADICAL MEDIATED PRO, P50; DAVIES MJ, 1987, CHEM-BIOL INTERACT, V61, P177, DOI 10.1016/0009-2797(87)90038-X; DAVIES MJ, 1987, BIOCHEM J, V246, P725, DOI 10.1042/bj2460725; Dillon TM, 2006, J CHROMATOGR A, V1120, P112, DOI 10.1016/j.chroma.2006.01.016; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Gaza-Bulseco G, 2008, PHARM RES-DORDR, V25, P1881, DOI 10.1007/s11095-008-9606-3; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; HAYWARD MA, 1987, METHOD ENZYMOL, V143, P279; HILLER KO, 1981, J AM CHEM SOC, V103, P2734, DOI 10.1021/ja00400a042; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jacob C, 2006, BIOL CHEM, V387, P1385, DOI 10.1515/BC.2006.174; Lin SS, 1998, ENVIRON SCI TECHNOL, V32, P1417, DOI 10.1021/es970648k; MacManus-Spencer LA, 2005, J AM CHEM SOC, V127, P8954, DOI 10.1021/ja052045b; Nathan C, 2003, NATURE, V422, P675, DOI 10.1038/422675a; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Ouellette D, 2009, ANAL BIOCHEM, V389, P107, DOI 10.1016/j.ab.2009.03.027; POOLE LB, 1989, J BIOL CHEM, V264, P12322; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; ROSEN GM, 1995, FASEB J, V9, P200, DOI 10.1096/fasebj.9.2.7540156; SCHUBERT J, 1968, J AM CHEM SOC, V90, P4476, DOI 10.1021/ja01018a061; SHIMAZU F, 1964, RADIAT RES, V23, P203, DOI 10.2307/3571600; SHIMAZU F, 1964, RADIAT RES, V23, P210, DOI 10.2307/3571601; SHIMAZU F, 1964, RADIAT RES, V22, P276, DOI 10.2307/3571659; SHIMAZU F, 1964, SCIENCE, V143, P369, DOI 10.1126/science.143.3604.369; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; STIPANUK MH, 1987, METHOD ENZYMOL, V143, P155; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Wang PX, 2007, J AM SOC NEPHROL, V18, P1239, DOI 10.1681/ASN.2006111299; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Yan BX, 2009, J BIOL CHEM, V284, P35390, DOI 10.1074/jbc.M109.064147; Yates Z, 2010, J BIOL CHEM, V285, P18662, DOI 10.1074/jbc.M110.108597; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zhu XY, 2004, P NATL ACAD SCI USA, V101, P2247, DOI 10.1073/pnas.0307311101	52	14	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24674	24684		10.1074/jbc.M111.255026	http://dx.doi.org/10.1074/jbc.M111.255026			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606498	hybrid, Green Published			2022-12-27	WOS:000292547900018
J	Cochran, BJ; Croucher, DR; Lobov, S; Saunders, DN; Ranson, M				Cochran, Blake J.; Croucher, David R.; Lobov, Sergei; Saunders, Darren N.; Ranson, Marie			Dependence on Endocytic Receptor Binding via a Minimal Binding Motif Underlies the Differential Prognostic Profiles of SerpinE1 and SerpinB2 in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; DENSITY-LIPOPROTEIN RECEPTOR; BREAST-CANCER; COMPLEX-FORMATION; UROKINASE; PROTEIN; SYSTEM; LIGAND; SITE; PAI-2	Tumor overexpression of urokinase-type plasminogen activator (uPA) and its specific inhibitor SerpinE1 (plasminogen activator inhibitor type-1) correlates with poor prognosis and increased metastatic potential. Conversely, tumor expression of uPA and another specific inhibitor, SerpinB2 (plasminogen activator inhibitor type-2), are associated with favorable outcome and relapse-free survival. It is not known how overexpression of these uPA inhibitors results in such disparate outcomes. A possible explanation may be related to the presence of a proposed low density lipoprotein receptor (LDLR)-binding motif in SerpinE1 responsible for mitogenic signaling via ERK that is absent in SerpinB2. We now show that complementation of such a LDLR-binding motif in SerpinB2 by mutagenesis of two key residues enabled high affinity binding to very LDLR (VLDLR). Furthermore, the VLDLR-binding SerpinB2 form behaved in a manner indistinguishable from SerpinE1 in terms of enhanced uPA-SerpinB2 complex endocytosis and subsequent ERK phosphorylation and cell proliferation; that is, the introduction of the LDLR-binding motif to SerpinB2 was necessary and sufficient to allow it to acquire characteristics of SerpinE1 associated with malignancy. In conclusion, this study defines the structural elements underlying the distinct interactions of SerpinE1 versus SerpinB2 with endocytic receptors and how differential VLDLR binding impacts on downstream cellular behavior. This has clear relevance to understanding the paradoxical disease outcomes associated with overexpression of these serpins in cancer.	[Cochran, Blake J.; Ranson, Marie] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Cochran, Blake J.; Lobov, Sergei; Ranson, Marie] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Croucher, David R.; Saunders, Darren N.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia	University of Wollongong; University of Wollongong; Garvan Institute of Medical Research	Ranson, M (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.	mranson@uow.edu.au	Lobov, Sergei A/A-8803-2011; Ranson, Marie/AAC-4468-2019; Ranson, Marie/GRO-5792-2022; Saunders, Darren/B-7677-2008; Ranson, Marie/A-6324-2008	Ranson, Marie/0000-0002-5570-9645; Ranson, Marie/0000-0002-5570-9645; Ranson, Marie/0000-0002-5570-9645; Saunders, Darren/0000-0003-0924-0513; Cochran, Blake/0000-0002-9615-7939; Croucher, David/0000-0003-4965-8674	Australian Postgraduate Award; University of Wollongong through the Centre for Medical Bioscience; University of Wollongong; Cancer Institute New South Wales	Australian Postgraduate Award(Australian Government); University of Wollongong through the Centre for Medical Bioscience; University of Wollongong; Cancer Institute New South Wales	This work was financially supported by an Australian Postgraduate Award (to B. J. C.), by the University of Wollongong through the Centre for Medical Bioscience, by a University of Wollongong Small Grant, and by Cancer Institute New South Wales Fellowships (to M. R., D. N. S., and D. R. C.).	AERTGEERTS K, 1995, NAT STRUCT BIOL, V2, P891, DOI 10.1038/nsb1095-891; Al-Ejeh F, 2004, EXP CELL RES, V297, P259, DOI 10.1016/j.yexcr.2004.03.030; ARGRAVES KM, 1995, J BIOL CHEM, V270, P26550, DOI 10.1074/jbc.270.44.26550; ASTEDT B, 1987, Fibrinolysis, V1, P203, DOI 10.1016/0268-9499(87)90037-3; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Bouchet C, 1999, J CLIN ONCOL, V17, P3048, DOI 10.1200/JCO.1999.17.10.3048; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; Cochran BJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-43; Croucher D, 2006, J BIOL CHEM, V281, P10206, DOI 10.1074/jbc.M513645200; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Croucher DR, 2007, BIOCHEM J, V408, P203, DOI 10.1042/BJ20070767; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Deng G, 1996, J BIOL CHEM, V271, P12716, DOI 10.1074/jbc.271.22.12716; Di Giusto DA, 2005, J MOL BIOL, V353, P1069, DOI 10.1016/j.jmb.2005.09.008; Di Y, 2010, FEBS LETT, V584, P3469, DOI 10.1016/j.febslet.2010.07.005; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO;2-9; EHRLICH HJ, 1992, J BIOL CHEM, V267, P11606; ELLIS V, 1990, J BIOL CHEM, V265, P9904; Foekens JA, 2000, CANCER RES, V60, P636; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; Look MP, 2002, JNCI-J NATL CANCER I, V94, P116, DOI 10.1093/jnci/94.2.116; MIKUS P, 1993, EUR J BIOCHEM, V218, P1071, DOI 10.1111/j.1432-1033.1993.tb18467.x; Ohba K, 2005, J UROLOGY, V174, P461, DOI 10.1097/01.ju.0000165150.46006.92; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rodenburg KW, 1998, BIOCHEM J, V329, P55; Scherrer A, 1999, BRIT J HAEMATOL, V105, P920, DOI 10.1046/j.1365-2141.1999.01432.x; Schmitt M, 2000, FIBRINOLYSIS PROTEOL, V14, P114, DOI 10.1054/fipr.2000.0079; Skeldal S, 2006, FEBS J, V273, P5143, DOI 10.1111/j.1742-4658.2006.05511.x; Stefansson S, 2003, CURR PHARM DESIGN, V9, P1545, DOI 10.2174/1381612033454621; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670	40	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24467	24475		10.1074/jbc.M111.225706	http://dx.doi.org/10.1074/jbc.M111.225706			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606492	Green Published, hybrid			2022-12-27	WOS:000292294900087
J	Karuppiah, V; Derrick, JP				Karuppiah, Vijaykumar; Derrick, Jeremy P.			Structure of the PilM-PilN Inner Membrane Type IV Pilus Biogenesis Complex from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION SYSTEM; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; PATHOGENIC NEISSERIA; CYTOPLASMIC DOMAIN; VIBRIO-CHOLERAE; CELL-DIVISION; X-RAY; PROTEIN; FTSA	Type IV pili are surface-exposed filaments, which extend from a variety of bacterial pathogens and play a major role in pathogenesis, motility, and DNA uptake. Here, we present the crystal structure of a complex between a cytoplasmic component of the type IV pilus biogenesis system from Thermus thermophilus, PilM, in complex with a peptide derived from the cytoplasmic portion of the inner membrane protein PilN. PilM also binds ATP, and its structure is most similar to the actin-like protein FtsA. PilN binds in a narrow channel between the 1A and 1C subdomains in PilM; the binding site is well conserved in other Gram-negative bacteria, notably Neisseria meningitidis, Pseudomonas aeruginosa, and Vibrio cholerae. We find no evidence for the catalysis of ATP hydrolysis by PilM; fluorescence data indicate that the protein is likely to be saturated by ATP at physiological concentrations. In addition, binding of the PilN peptide appears to influence the environment of the ATP binding site. This is the first reported structure of a complex between two type IV pilus biogenesis proteins. We propose a model in which PilM binds ATP and then PilN as one of the first steps in the formation of the inner membrane platform of the type IV pilus biogenesis complex.	[Karuppiah, Vijaykumar; Derrick, Jeremy P.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Derrick, JP (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Derrick@manchester.ac.uk		Karuppiah, Vijaykumar/0000-0002-9645-7958; Derrick, Jeremy/0000-0002-4350-5354				Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Abendroth J, 2009, J STRUCT BIOL, V168, P313, DOI 10.1016/j.jsb.2009.07.022; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; de Graaff RAG, 2001, ACTA CRYSTALLOGR D, V57, P1857, DOI 10.1107/S0907444901016535; Derrick JP, 1999, J MOL BIOL, V293, P81, DOI 10.1006/jmbi.1999.3144; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Morand PC, 2001, MOL MICROBIOL, V40, P846, DOI 10.1046/j.1365-2958.2001.02452.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nassif X, 1999, MOL MICROBIOL, V32, P1124, DOI 10.1046/j.1365-2958.1999.01416.x; Ness SR, 2004, STRUCTURE, V12, P1753, DOI 10.1016/j.str.2004.07.018; Pannu NS, 2004, ACTA CRYSTALLOGR D, V60, P22, DOI 10.1107/S0907444903020808; Pannu NS, 2003, ACTA CRYSTALLOGR D, V59, P1801, DOI 10.1107/S090744490301936X; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popp D, 2010, J BIOL CHEM, V285, P15858, DOI 10.1074/jbc.M109.095901; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonjum T, 2007, FEBS J, V274, P341; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	59	65	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24434	24442		10.1074/jbc.M111.243535	http://dx.doi.org/10.1074/jbc.M111.243535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596754	hybrid, Green Published			2022-12-27	WOS:000292294900083
J	Farshi, P; Ohlig, S; Pickhinke, U; Hoing, S; Jochmann, K; Lawrence, R; Dreier, R; Dierker, T; Grobe, K				Farshi, Pershang; Ohlig, Stefanie; Pickhinke, Ute; Hoeing, Susanne; Jochmann, Katja; Lawrence, Roger; Dreier, Rita; Dierker, Tabea; Grobe, Kay			Dual Roles of the Cardin-Weintraub Motif in Multimeric Sonic Hedgehog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NDST1 GENE-FUNCTION; GLYPICAN DALLY-LIKE; HEPARAN-SULFATE; CHOLESTEROL MODIFICATION; CELLS; DROSOPHILA; PROTEINS; PATHWAY; DOMAIN; PROTEOGLYCANS	The fly morphogen Hedgehog (Hh) and its mammalian orthologs, Sonic, Indian, and Desert hedgehog, are secreted signaling molecules that mediate tissue patterning during embryogenesis and function in tissue homeostasis and regeneration in the adult. The function of all Hh family members is regulated at the levels of morphogen multimerization on the surface of producing cells, multimer release, multimer diffusion to target cells, and signal reception. These mechanisms are all known to depend on interactions of positively charged Hh amino acids (the Cardin-Weintraub (CW) motif) with negatively charged heparan sulfate (HS) glycosaminoglycan chains. However, a precise mechanistic understanding of these interactions is still lacking. In this work, we characterized ionic HS interactions of multimeric Sonic hedgehog (called ShhNp) as well as mutant forms lacking one or more CW residues. We found that deletion of all five CW residues as well as site-directed mutagenesis of CW residues Lys(33), Arg(35), and Lys(39) (mouse nomenclature) abolished HS binding. In contrast, CW residues Arg(34) and Lys(38) did not contribute to HS binding. Analysis and validation of Shh crystal lattice contacts provided an explanation for this finding. We demonstrate that CW residues Arg(34) and Lys(38) make contact with an acidic groove on the adjacent molecule in the multimer, suggesting a new function of these residues in ShhNp multimerization rather than HS binding. Therefore, the recombinant monomeric morphogen (called ShhN) differs in CW-dependent HS binding and biological activity from physiologically relevant ShhNp multimers, providing new explanations for functional differences observed between ShhN and ShhNp.	[Farshi, Pershang; Ohlig, Stefanie; Pickhinke, Ute; Dreier, Rita] Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Hoeing, Susanne] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Jochmann, Katja; Dierker, Tabea] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany; [Lawrence, Roger] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Max Planck Society; University of Duisburg Essen; University of California System; University of California San Diego		kgrobe@uni-muenster.de	Grobe, Kay/F-2399-2011	Dierker, Tabea/0000-0003-1991-2723	Deutsche Forschungsgemeinschaft (German Research Council) [SFB 492-B15, GRK1549/1]	Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (German Research Council) Grants SFB 492-B15 and GRK1549/1.	Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Chan JA, 2009, NAT NEUROSCI, V12, P409, DOI 10.1038/nn.2287; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Dierker T, 2009, J BIOL CHEM, V284, P32562, DOI 10.1074/jbc.M109.044867; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Goetz JA, 2002, BIOESSAYS, V24, P157, DOI 10.1002/bies.10056; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Huang X, 2007, DEVELOPMENT, V134, P2095, DOI 10.1242/dev.000729; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Pallerla SR, 2007, DEV DYNAM, V236, P556, DOI 10.1002/dvdy.21038; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tian H, 2005, DEVELOPMENT, V132, P133, DOI 10.1242/dev.01563; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Williams KP, 1999, J CELL SCI, V112, P4405; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang FM, 2007, BIOCHEMISTRY-US, V46, P3933, DOI 10.1021/bi6025424	43	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23608	23619		10.1074/jbc.M110.206474	http://dx.doi.org/10.1074/jbc.M110.206474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21572042	hybrid, Green Published			2022-12-27	WOS:000292025000091
J	Chen, CJ; Rayment, I; Gilbert, SP				Chen, Chun Ju; Rayment, Ivan; Gilbert, Susan P.			Kinesin Kar3Cik1 ATPase Pathway for Microtubule Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; MOTOR DOMAIN; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; BINDING-SITES; PLUS ENDS; NCD TAIL; IN-VIVO; PROTEIN	Kar3Cik1 is a Saccharomyces cerevisiae kinesin-14 that functions to shorten cytoplasmic microtubules (MTs) during yeast mating yet maintains mitotic spindle stability by cross-linking anti-parallel interpolar MTs. Kar3 contains both an ATP-and a MT-binding site, yet there is no evidence of a nucleotide-binding site in Cik1. Presteady-state and steady-state kinetic experiments were pursued to define the regulation of Kar3Cik1 interactions with the MT lattice expected during interpolar MT cross-linking. The results reveal that association of Kar3Cik1 with the MT occurs at 4.9 mu M-1 s(-1), followed by a 5-s(-1) structural transition that limits ADP release from the Kar3 head. Mant-ATP binding occurred at 2.1 mu M-1 s(-1), and the pulsechase experiments revealed an ATP-promoted isomerization at 69 s(-1). ATPhydrolysis was observed as a rapid step at 26 s(-1) and was required for the Kar3Cik1 motor to detach from MT. The conformational change at 5 s(-1) that occurred after Kar3Cik1 MTassociation and prior toADPrelease was hypothesized to be the rate-limiting step for steady-state ATP turnover. We propose a model in which Kar3Cik1 interacts with the MT lattice through an alternating cycle of Cik1 MT collision followed by Kar3 MT binding with head-head communication between Kar3 and Cik1 modulated by the Kar3 nucleotide state and intramolecular strain.	[Chen, Chun Ju; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Chen, Chun Ju; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, BT 2237,110 8th St, Troy, NY 12180 USA.	sgilbert@rpi.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [GM54141, K02-AR47841, GM086351]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR047841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054141, R01GM086351, R37GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54141, Career Development Award K02-AR47841 (to S. P. G.), and Grant GM086351 (to I. R.).	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Benanti JA, 2009, MOL CELL, V33, P581, DOI 10.1016/j.molcel.2009.01.032; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Foster KA, 1998, J BIOL CHEM, V273, P35307, DOI 10.1074/jbc.273.52.35307; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Fridman V, 2009, EMBO REP, V10, P387, DOI 10.1038/embor.2009.7; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hildebrandt ER, 2006, J BIOL CHEM, V281, P26004, DOI 10.1074/jbc.M604817200; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hirose K, 1996, P NATL ACAD SCI USA, V93, P9539, DOI 10.1073/pnas.93.18.9539; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; Klumpp LM, 2003, J BIOL CHEM, V278, P39059, DOI 10.1074/jbc.M304250200; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Kocik E, 2009, J BIOL CHEM, V284, P35735, DOI 10.1074/jbc.M109.024240; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Molk JN, 2006, J CELL BIOL, V172, P27, DOI 10.1083/jcb.200510032; Oladipo A, 2007, MOL BIOL CELL, V18, P3601, DOI 10.1091/mbc.e06-12-1085; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; ROMBERG L, 1993, NATURE, V361, P168, DOI 10.1038/361168a0; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Song H, 1996, BIOCHEMISTRY-US, V35, P11203, DOI 10.1021/bi960997b; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; Wendt T, 2003, J MOL BIOL, V333, P541, DOI 10.1016/j.jmb.2003.08.051; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	53	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29261	29272		10.1074/jbc.M111.255554	http://dx.doi.org/10.1074/jbc.M111.255554			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21680740	Green Published, hybrid			2022-12-27	WOS:000293837000061
J	Bah, A; Gilson, E; Wellinger, RJ				Bah, Amadou; Gilson, Eric; Wellinger, Raymund J.			Telomerase Is Required to Protect Chromosomes with Vertebrate-type T(2)AG(3) 3 ' Ends in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TELOMERES; MAMMALIAN TELOMERES; LENGTH REGULATION; BUDDING YEAST; G-TAILS; REPLICATION; MAINTENANCE; ELONGATION; SENESCENCE; RAP1	Telomeres containing vertebrate-type DNA repeats can be stably maintained in Saccharomyces cerevisiae cells. We show here that telomerase is required for growth of yeast cells containing these vertebrate-type telomeres. When present at the chromosome termini, these heterologous repeats elicit a DNA damage response and a certain deprotection of telomeres. The data also show that these phenotypes are due only to the terminal localization of the vertebrate repeats because if they are sandwiched between native yeast repeats, no phenotype is observed. Indeed and quite surprisingly, in this latter situation, telomeres are of virtually normal lengths, despite the presence of up to 50% of heterologous repeats. Furthermore, the presence of the distal vertebrate-type repeats can cause increased problems of the replication fork. These results show that in budding yeast the integrity of the 3' overhang is required for proper termination of telomere replication as well as protection.	[Bah, Amadou; Wellinger, Raymund J.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Grp ARN,RNA Grp, Sherbrooke, PQ J1H 5N4, Canada; [Bah, Amadou; Gilson, Eric] Univ Lyon, CNRS UMR 5239, Ecole Normale Super Lyon, Lab Biol Mol Cellule, F-69364 Lyon, France; [Gilson, Eric] Univ Nice Sophia Antipolis, CNRS UMR 6267, Inst Natl Sante & Rech Med U998, Lab Biol & Pathol Genomes, F-06107 Nice, France; [Gilson, Eric] Ctr Hosp Univ Nice, Dept Med Genet, F-06202 Nice, France	University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Gilson, E (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Grp ARN,RNA Grp, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Eric.Gilson@unice.fr; Raymund.Wellinger@USherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759	Canadian Institutes of Health Research (CIHR) [MOP-110982]; Association de la Recherche contre le Cancer (ARC); Institut National du Cancer; Agence Nationale de la Recherche (ANR); European Community [F2-2007-200950]; French Ministry of Foreign Affairs	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Association de la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Community(European Commission); French Ministry of Foreign Affairs	This work was supported Canadian Institutes of Health Research (CIHR) Grant MOP-110982) (to R. J. W.) and by grants from the Association de la Recherche contre le Cancer (ARC), from the Institut National du Cancer (Program TELOFUN), from the Agence Nationale de la Recherche (ANR) (Program TELOREP and INNATELO), and from the European Community (TELOMARKER Health Grant F2-2007-200950) (to E. G.). This work was also supported by the Lavoisier Grant from the French Ministry of Foreign Affairs (to A. B.).	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Alexander MK, 2003, EMBO J, V22, P1688, DOI 10.1093/emboj/cdg154; Arneric M, 2007, EMBO REP, V8, P1080, DOI 10.1038/sj.embor.7401082; Bah A, 2004, NUCLEIC ACIDS RES, V32, P1917, DOI 10.1093/nar/gkh511; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Berthiau AS, 2006, EMBO J, V25, P846, DOI 10.1038/sj.emboj.7600975; Brachmann CB, 1998, YEAST, V14, P115; Brevet V, 2003, EMBO J, V22, P1697, DOI 10.1093/emboj/cdg155; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Dehe PM, 2010, FEBS LETT, V584, P3725, DOI 10.1016/j.febslet.2010.07.045; di Domenico EG, 2009, DNA REPAIR, V8, P209, DOI 10.1016/j.dnarep.2008.10.005; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Giraud-Panis MJ, 2010, FEBS LETT, V584, P3785, DOI 10.1016/j.febslet.2010.08.004; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Henning KA, 1998, P NATL ACAD SCI USA, V95, P5667, DOI 10.1073/pnas.95.10.5667; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; LeBel C, 2005, J CELL SCI, V118, P2785, DOI 10.1242/jcs.02394; LeBel Catherine, 2006, Methods Mol Biol, V313, P265; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Lundblad V, 2002, ONCOGENE, V21, P522, DOI 10.1038/sj.onc.1205079; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Paciotti V, 2000, GENE DEV, V14, P2046; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Pike BL, 2003, J BIOL CHEM, V278, P30421, DOI 10.1074/jbc.C300227200; Ray A, 1999, MOL CELL BIOL, V19, P31; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; ROSENBERG M, 1990, MICROBIAL CELL SURFA, P1; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Vega LR, 2007, PLOS GENET, V3, P1065, DOI 10.1371/journal.pgen.0030105; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032	48	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27132	27138		10.1074/jbc.M111.220186	http://dx.doi.org/10.1074/jbc.M111.220186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676873	hybrid, Green Published			2022-12-27	WOS:000293268700008
J	Furukawa, Y; Kaneko, K; Nukina, N				Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki			Tau Protein Assembles into Isoform- and Disulfide-dependent Polymorphic Fibrils with Distinct Structural Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-LIKE FILAMENTS; IN-VITRO; AMYLOID FIBRILS; DISEASE; AGGREGATION; PHOSPHORYLATION; POLYMERIZATION; CYSTEINE-322; TAUOPATHIES	Tauopathies are neurodegenerative diseases in which insoluble fibrillar aggregates of a microtubule-binding protein, Tau, are abnormally accumulated. Pathological Tau fibrils often exhibit structural polymorphisms that differ among phenotypically distinct tauopathies; however, a molecular mechanism to generate polymorphic Tau fibrils remains obscure. Here, we note the formation of a disulfide bond in isoforms of full-length Tau and show that the thiol-disulfide status as well as the isoform composition determines structural and morphological properties of Tau fibrils in vitro. Mainly two regions in a Tau primary sequence are found to act as structural blocks for building a protease-resistant core of Tau fibrils. Interactions among those two blocks for building a core structure depend upon the thiol-disulfide status in each isoform of Tau, which results in the formation of polymorphic fibrils with distinct structural properties. Furthermore, we have found that more diverse structures of Tau fibrils emerge through a cross-seeded fibrillation between heterologous pairs of Tau isoforms. We thus propose that isoform-and disulfide-dependent combinatorial interactions among multiple regions in a Tau sequence endow Tau fibrils with various structures, i.e. polymorphism.	[Furukawa, Yoshiaki] Keio Univ, Dept Chem, Kanagawa 2238522, Japan; [Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	Keio University; RIKEN	Furukawa, Y (corresponding author), 3-14-1 Hiyoshi, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp; nukina@brain.riken.jp	Furukawa, Yoshiaki/F-2871-2014; Nukina, Nobuyuki/GPP-6265-2022	Furukawa, Yoshiaki/0000-0002-1918-372X; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [22240037, 22110004, 22770162]; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-Aid 22240037 (to N. N.), 22110004 for Scientific Research on Innovative Areas (to N. N.), and 22770162 (to Y. F.), and the Strategic Research Program for Brain Science (to N. N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by funds from the Uehara Memorial Foundation (to Y. F.).	Abraha A, 2000, J CELL SCI, V113, P3737; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Arima K, 2006, NEUROPATHOLOGY, V26, P475, DOI 10.1111/j.1440-1789.2006.00669.x; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Bhattacharya K, 2001, BIOCHEM BIOPH RES CO, V285, P20, DOI 10.1006/bbrc.2001.5116; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; Ksiezak-Reding H, 2005, MICROSC RES TECHNIQ, V67, P126, DOI 10.1002/jemt.20188; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; MUNOZGARCIA D, 1984, ANN NEUROL, V16, P467, DOI 10.1002/ana.410160408; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; NUKINA N, 1985, J BIOCHEM-TOKYO, V98, P1715, DOI 10.1093/oxfordjournals.jbchem.a135443; Parchi P, 2011, ACTA NEUROPATHOL, V121, P91, DOI 10.1007/s00401-010-0779-6; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Westermark GT, 2009, FEBS LETT, V583, P2685, DOI 10.1016/j.febslet.2009.04.026; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Yanagawa H, 1998, BIOCHEMISTRY-US, V37, P1979, DOI 10.1021/bi9724265	37	43	43	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27236	27246		10.1074/jbc.M111.248963	http://dx.doi.org/10.1074/jbc.M111.248963			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659525	Green Published, hybrid			2022-12-27	WOS:000293268700019
J	Ilioaia, C; Johnson, MP; Liao, PN; Pascal, AA; van Grondelle, R; Walla, PJ; Ruban, AV; Robert, B				Ilioaia, Cristian; Johnson, Matthew P.; Liao, Pen-Nan; Pascal, Andrew A.; van Grondelle, Rienk; Walla, Peter J.; Ruban, Alexander V.; Robert, Bruno			Photoprotection in Plants Involves a Change in Lutein 1 Binding Domain in the Major Light-harvesting Complex of Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; ENERGY-DISSIPATION; GREEN PLANTS; LHC-II; CHLOROPHYLL FLUORESCENCE; CATION FORMATION; ZEAXANTHIN; DYNAMICS; ANTENNA; ARABIDOPSIS	Nonphotochemical quenching (NPQ) is the fundamental process by which plants exposed to high light intensities dissipate the potentially harmful excess energy as heat. Recently, it has been shown that efficient energy dissipation can be induced in the major light-harvesting complexes of photosystem II (LHCII) in the absence of protein-protein interactions. Spectroscopic measurements on these samples (LHCII gels) in the quenched state revealed specific alterations in the absorption and circular dichroism bands assigned to neoxanthin and lutein 1 molecules. In this work, we investigate the changes in conformation of the pigments involved in NPQ using resonance Raman spectroscopy. By selective excitation we show that, as well as the twisting of neoxanthin that has been reported previously, the lutein 1 pigment also undergoes a significant change in conformation when LHCII switches to the energy dissipative state. Selective two-photon excitation of carotenoid (Car) dark states (Car S-1) performed on LHCII gels shows that the extent of electronic interactions between Car S-1 and chlorophyll states correlates linearly with chlorophyll fluorescence quenching, as observed previously for isolated LHCII (aggregated versus trimeric) and whole plants (with versus without NPQ).	[Ilioaia, Cristian; van Grondelle, Rienk] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Ilioaia, Cristian; Pascal, Andrew A.; Robert, Bruno] Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; [Ilioaia, Cristian; Pascal, Andrew A.; Robert, Bruno] CNRS URA 2096, F-91191 Gif Sur Yvette, France; [Johnson, Matthew P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Liao, Pen-Nan; Walla, Peter J.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany; [Walla, Peter J.] Max Planck Inst Biophys Chem, Dept Spect & Photochem Kinet, D-37077 Gottingen, Germany	Vrije Universiteit Amsterdam; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; Queen Mary University London; Braunschweig University of Technology; Max Planck Society	Ilioaia, C (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, De Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	cristian.ilioaia@cea.fr; bruno.robert@cea.fr	pascal, andrew a/B-6186-2014; Robert, Bruno/D-1264-2012	pascal, andrew a/0000-0002-1844-6065; Robert, Bruno/0000-0001-5999-4538; ILIOAIA, Cristian/0000-0001-7505-1900; Johnson, Matthew/0000-0002-1663-0205	Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences; European Union [ERG 224796]; United Kingdom Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; German Science Foundation; Fondation of the Ecole Normale Superieure; European Research Council	Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences; European Union(European Commission); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); German Science Foundation(German Research Foundation (DFG)); Fondation of the Ecole Normale Superieure; European Research Council(European Research Council (ERC)European Commission)	This work was supported by The Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences (to C. I. and R. v. G.), the European Union FP7 Marie Curie Reintegration Grant ERG 224796 (to C. I.), research and equipment grants from the United Kingdom Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council (to A. V. R. and M. P. J.), the German Science Foundation (to P.-N. L. and P. J. W.), Blaise Pascal Chair from the Fondation of the Ecole Normale Superieure (to R. v. G.), a European Union FP7 Marie Curie HARVEST Network grant and European Research Council Grant PhotProt (to B. R. and R. v. G.).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; Bode S, 2008, CHEM PHYS LETT, V450, P379, DOI 10.1016/j.cplett.2007.11.035; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; Dreuw A, 2006, J PHYS CHEM A, V110, P4592, DOI 10.1021/jp057385y; Frahmcke JS, 2006, CHEM PHYS LETT, V430, P397, DOI 10.1016/j.cplett.2006.09.009; Frank HA, 2000, BIOCHEMISTRY-US, V39, P2831, DOI 10.1021/bi9924664; Hilbert M, 2004, J PHYS CHEM B, V108, P13022, DOI 10.1021/jp048576o; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ilioaia C, 2008, J BIOL CHEM, V283, P29505, DOI 10.1074/jbc.M802438200; Ilioaia C, 2011, J BIOL CHEM, V286, P91, DOI 10.1074/jbc.M110.184887; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Johnson MP, 2009, J BIOL CHEM, V284, P23592, DOI 10.1074/jbc.M109.013557; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kruger TPJ, 2010, BIOPHYS J, V98, P3093, DOI 10.1016/j.bpj.2010.03.028; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liao PN, 2010, CHEM PHYS, V373, P50, DOI 10.1016/j.chemphys.2010.01.006; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; Lutz M., 1984, ADV INFRARED RAMAN S, V11, P211; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; ROBERT B, 1986, BIOCHEMISTRY-US, V25, P2303, DOI 10.1021/bi00357a001; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2002, J BIOL CHEM, V277, P7785, DOI 10.1074/jbc.M110693200; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; RUBAN AV, 1995, BIOCHEMISTRY-US, V34, P2333, DOI 10.1021/bi00007a029; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; VANOORT B, 2011, PHYS CHEM C IN PRESS; Wehling A, 2005, J PHYS CHEM B, V109, P24510, DOI 10.1021/jp053890j	47	57	58	3	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27247	27254		10.1074/jbc.M111.234617	http://dx.doi.org/10.1074/jbc.M111.234617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646360	hybrid, Green Published			2022-12-27	WOS:000293268700020
J	Xie, T; He, Y; Korkeamaki, H; Zhang, YB; Imhoff, R; Lohi, O; Radhakrishnan, I				Xie, Tao; He, Yuan; Korkeamaki, Hanna; Zhang, Yongbo; Imhoff, Rebecca; Lohi, Olli; Radhakrishnan, Ishwar			Structure of the 30-kDa Sin3-associated Protein (SAP30) in Complex with the Mammalian Sin3A Corepressor and Its Role in Nucleic Acid Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; CHROMATIN-MODIFYING COMPLEX; AUTOMATED NOE ASSIGNMENT; DNA-BINDING; NMR-SPECTROSCOPY; TRANSCRIPTIONAL COREPRESSOR; SACCHAROMYCES-CEREVISIAE; MACROMOLECULAR STRUCTURE; GENE-EXPRESSION; FAMILY PROTEINS	The similar to 2-megadalton evolutionarily conserved histone deacetylase-associated Rpd3L/Sin3L complex plays critical roles in altering the histone code and repressing transcription of a broad range of genes involved in many aspects of cellular physiology. Targeting of this complex to specific regions of the genome is presumed to rely on interactions involving one or more of at least 10 distinct subunits in the complex. Here we describe the solution structure of the complex formed by the interacting domains of two constitutively associated subunits, mSin3A and SAP30. The mSin3A paired amphipathic helix 3 (PAH3) domain in the complex adopts the left-handed four-helix bundle structure characteristic of PAH domains. The SAP30 Sin3 interaction domain (SID) binds to PAH3 via a tripartite structural motif, including a C-terminal helix that targets the canonical PAH hydrophobic cleft while two other helices and an N-terminal extension target a discrete surface formed largely by the PAH3 alpha 2, alpha 3, and alpha 3' helices. The protein-protein interface is extensive (similar to 1400 angstrom(2)), accounting for the high affinity of the interaction and the constitutive association of the SAP30 subunit with the Rpd3L/Sin3L complex. We further show using NMR that the mSin3A PAH3-SAP30 SID complex can bind to nucleic acids, hinting at a role for a nucleolar localization sequence in the SID alpha A helix in targeting the Rpd3L/Sin3L complex for silencing ribosomal RNA genes.	[Korkeamaki, Hanna; Lohi, Olli] Univ Tampere, Sch Med, Pediat Res Ctr, Tampere 33520, Finland; [Korkeamaki, Hanna; Lohi, Olli] Tampere Univ Hosp, Tampere 33520, Finland; [Xie, Tao; He, Yuan; Zhang, Yongbo; Imhoff, Rebecca; Radhakrishnan, Ishwar] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Tampere University; Tampere University; Tampere University Hospital; Northwestern University	Lohi, O (corresponding author), Univ Tampere, Sch Med, Pediat Res Ctr, Tampere 33520, Finland.	olli.lohi@uta.fi; i-radhakrishnan@northwestern.edu	Radhakrishnan, Ishwar/AHA-7392-2022; Radhakrishnan, Ishwar/R-8442-2018; Lohi, Olli/AAW-6157-2021; He, Yuan/GVT-7268-2022; He, Yuan/C-7341-2015	Radhakrishnan, Ishwar/0000-0002-0195-9710; Radhakrishnan, Ishwar/0000-0002-0195-9710; Lohi, Olli/0000-0001-9195-0797; He, Yuan/0000-0002-1455-3963; He, Yuan/0000-0002-1455-3963	National Institutes of Health [R01 GM064715]; Foundation for Pediatric Research in Finland; Finnish Medical Foundation; Tampere University Hospital [9K073]; Nona and Kullervo Vare Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern University [P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Pediatric Research in Finland; Finnish Medical Foundation; Tampere University Hospital; Nona and Kullervo Vare Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM064715 (to I. R.). This work was also supported by the Foundation for Pediatric Research in Finland, the Finnish Medical Foundation, the Competitive Research Funding of Tampere University Hospital (Grant 9K073), and the Nona and Kullervo Vare Foundation (to O. L.) and by Grant P30 CA060553 from the Robert H. Lurie Comprehensive Cancer Center at Northwestern University.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Brubaker K, 2000, CELL, V103, P655, DOI 10.1016/S0092-8674(00)00168-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen Jie, 2010, Virologica Sinica, V25, P417, DOI 10.1007/s12250-010-3147-8; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; He Y, 2009, NUCLEIC ACIDS RES, V37, P2142, DOI 10.1093/nar/gkp051; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Huang NE, 2003, BIOCHEM BIOPH RES CO, V306, P267, DOI 10.1016/S0006-291X(03)00966-5; Jelinic P, 2011, MOL CELL BIOL, V31, P54, DOI 10.1128/MCB.00840-10; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Kumar GS, 2011, J MOL BIOL, V408, P987, DOI 10.1016/j.jmb.2011.03.043; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Loewith R, 2001, J BIOL CHEM, V276, P24068, DOI 10.1074/jbc.M102176200; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Nomura M, 2005, J MOL BIOL, V354, P903, DOI 10.1016/j.jmb.2005.10.008; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sahu SC, 2008, J MOL BIOL, V375, P1444, DOI 10.1016/j.jmb.2007.11.079; Salerno WJ, 2004, NUCLEIC ACIDS RES, V32, pW566, DOI 10.1093/nar/gkh434; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V467, P67, DOI 10.1016/j.abb.2007.08.015; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Spronk CAEM, 2000, NAT STRUCT BIOL, V7, P1100; Sun ZW, 1999, GENETICS, V152, P921; Suzuki R, 2009, PROTEINS, V75, P336, DOI 10.1002/prot.22243; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; van Ingen H, 2004, BIOCHEMISTRY-US, V43, P46, DOI 10.1021/bi0355645; Viiri KM, 2006, NUCLEIC ACIDS RES, V34, P3288, DOI 10.1093/nar/gkl401; Viiri KM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-149; Viiri KM, 2009, MOL CELL BIOL, V29, P342, DOI 10.1128/MCB.01213-08; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	67	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27814	27824		10.1074/jbc.M111.252494	http://dx.doi.org/10.1074/jbc.M111.252494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676866	Green Published, hybrid			2022-12-27	WOS:000293268700073
J	Broer, A; Juelich, T; Vanslambrouck, JM; Tietze, N; Solomon, PS; Holst, J; Bailey, CG; Rasko, JEJ; Broer, S				Broeer, Angelika; Juelich, Torsten; Vanslambrouck, Jessica M.; Tietze, Nadine; Solomon, Peter S.; Holst, Jeff; Bailey, Charles G.; Rasko, John E. J.; Broeer, Stefan			Impaired Nutrient Signaling and Body Weight Control in a Na+ Neutral Amino Acid Cotransporter (Slc6a19)-deficient Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HARTNUP DISORDER; MOLECULAR-CLONING; PLASMA-MEMBRANE; TRANSPORTER; B(0)AT1; MUTATIONS; COMPLEX; PROTEIN; SYSTEM; COLLECTRIN	Amino acid uptake in the intestine and kidney is mediated by a variety of amino acid transporters. To understand the role of epithelial neutral amino acid uptake in whole body homeostasis, we analyzed mice lacking the apical broad-spectrum neutral (0) amino acid transporter B(0)AT1 (Slc6a19). A general neutral aminoaciduria was observed similar to human Hartnup disorder which is caused by mutations in SLC6A19. Na+-dependent uptake of neutral amino acids into the intestine and renal brush-border membrane vesicles was abolished. No compensatory increase of peptide transport or other neutral amino acid transporters was detected. Mice lacking B(0)AT1 showed a reduced body weight. When adapted to a standard 20% protein diet, B(0)AT1-deficient mice lost body weight rapidly on diets containing 6 or 40% protein. Secretion of insulin in response to food ingestion after fasting was blunted. In the intestine, amino acid signaling to the mammalian target of rapamycin ( mTOR) pathway was reduced, whereas the GCN2/ATF4 stress response pathway was activated, indicating amino acid deprivation in epithelial cells. The results demonstrate that epithelial amino acid uptake is essential for optimal growth and body weight regulation.	[Broeer, Angelika; Juelich, Torsten; Tietze, Nadine; Solomon, Peter S.; Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Vanslambrouck, Jessica M.; Holst, Jeff; Bailey, Charles G.; Rasko, John E. J.] Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW 2050, Australia; [Rasko, John E. J.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia	Australian National University; University of Sydney; Centenary Institute; University of Sydney	Broer, S (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	Stefan.broer@anu.edu.au	Broer, Stefan/A-1286-2008; Solomon, Peter/C-9301-2009; Rasko, John EJ/F-5754-2013; Holst, Jeff/H-7634-2012	Broer, Stefan/0000-0002-8040-1634; Solomon, Peter/0000-0002-5130-7307; Holst, Jeff/0000-0002-0377-9318; Bailey, Charles/0000-0002-4725-7829; rasko, John/0000-0003-2975-807X	National Health and Medical Research Council [525415]; Australian Research Council [DP0877897]; University of Sydney Bridging [RIMS2009-02579]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Sydney Bridging(University of Sydney)	This work was supported by National Health and Medical Research Council Grant 525415, Australian Research Council Grant DP0877897, University of Sydney Bridging Grant RIMS2009-02579), and by an anonymous foundation.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Avissar NE, 2001, AM J PHYSIOL-CELL PH, V281, pC963, DOI 10.1152/ajpcell.2001.281.3.C963; Bailey CG, 2011, J CLIN INVEST, V121, P446, DOI 10.1172/JCI44474; BARON DN, 1956, LANCET, V271, P421; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Bohmer C, 2005, BIOCHEM J, V389, P745; Broer S, 2009, IUBMB LIFE, V61, P591, DOI 10.1002/iub.210; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; EVERS J, 1976, BIOCHIM BIOPHYS ACTA, V426, P598, DOI 10.1016/0005-2736(76)90124-3; FASS SJ, 1977, J BIOL CHEM, V252, P583; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Imai Y, 2010, CIRC J, V74, P405, DOI 10.1253/circj.CJ-10-0045; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kowalczuk S, 2005, BIOCHEM J, V386, P417, DOI 10.1042/BJ20050100; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Lieberman M., 2009, BASIC MED BIOCH CLIN, P12; Matthews D. M., 1991, PROTEIN ABSORPTION; MATTHEWS DM, 1972, P NUTR SOC, V31, P171, DOI 10.1079/PNS19720033; Nassl A. M., 2011, AM J PHYSL IN PRESS; Oppedisano F, 2004, BBA-BIOMEMBRANES, V1667, P122, DOI 10.1016/j.bbamem.2004.09.007; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Quan H, 2004, MOL CELL BIOL, V24, P4166, DOI 10.1128/MCB.24.10.4166-4173.2004; Ray EC, 2003, J SURG RES, V115, P164, DOI 10.1016/S0022-4804(03)00225-7; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; SCRIVER CR, 1987, AM J HUM GENET, V40, P401; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Singer D, 2009, J BIOL CHEM, V284, P19953, DOI 10.1074/jbc.M109.011171; Son DO, 2004, BIOFACTORS, V21, P395, DOI 10.1002/biof.552210177; STEVENS BR, 1982, J MEMBRANE BIOL, V66, P213, DOI 10.1007/BF01868496; Symula DJ, 1997, MAMM GENOME, V8, P98, DOI 10.1007/s003359900366; Symula DJ, 1997, MAMM GENOME, V8, P102, DOI 10.1007/s003359900367; Vanslambrouck JM, 2010, BIOCHEM J, V428, P397, DOI 10.1042/BJ20091667	40	59	61	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26638	26651		10.1074/jbc.M111.241323	http://dx.doi.org/10.1074/jbc.M111.241323			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636576	hybrid, Green Published			2022-12-27	WOS:000293078200042
J	Bond, PJ; Faraldo-Gomez, JD				Bond, Peter J.; Faraldo-Gomez, Jose D.			Molecular Mechanism of Selective Recruitment of Syk Kinases by the Membrane Antigen-Receptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; PHOSPHORYLATED ITAM PEPTIDE; TERMINAL SH2 DOMAIN; TYROSINE KINASE; SIGNAL-TRANSDUCTION; ACTIVATION MOTIFS; PLASMON RESONANCE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ZAP-70	ZAP-70 and Syk are essential tyrosine kinases in intracellular immunological signaling. Both contain an inhibitory SH2 domain tandem, which assembles onto the catalytic domain. Upon binding to doubly phosphorylated ITAM motifs on activated antigen receptors, the arrangement of the SH2 domains changes. From available structures, this event is not obviously conducive to dissociation of the autoinhibited complex, yet it ultimately translates into kinase activation through a mechanism not yet understood. We present a comprehensive theoretical study of this molecular mechanism, using atomic resolution simulations and free-energy calculations, totaling >10 mu s of simulation time. Through these, we dissect the microscopic mechanism coupling stepwise ITAM engagement and SH2 tandem structural change and reveal key differences between ZAP-70 and Syk. Importantly, we show that a subtle conformational bias in the inter-SH2 connector causes ITAM to bind preferentially to kinase-dissociated tandems. We thus propose that phosphorylated antigen receptors selectively recruit kinases that are uninhibited and that the resulting population shift in the membrane vicinity sustains signal transduction.	Max Planck Inst Biophys, D-60438 Frankfurt, Germany; Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany	Max Planck Society	Faraldo-Gomez, JD (corresponding author), Max von Laue Str 3, D-60438 Frankfurt, Germany.	jose.faraldo@biophys.mpg.de	Faraldo-Gomez, Jose/H-7127-2016	Bond, Peter/0000-0003-2900-098X	Deutsche Forschungsgemeinschaft (DFG); Leibniz Supercomputer Center; European Molecular Biology Organization (EMBO) [ALTF 1021-2007]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Leibniz Supercomputer Center; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Macromolecular Complexes" and by the Leibniz Supercomputer Center.; Supported by a European Molecular Biology Organization (EMBO) long-term fellowship (ALTF 1021-2007).	Arias-Palomo E, 2009, BBA-PROTEINS PROTEOM, V1794, P1211, DOI 10.1016/j.bbapap.2009.04.010; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Deindl S, 2009, P NATL ACAD SCI USA, V106, P20699, DOI 10.1073/pnas.0911512106; Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104; Folmer RHA, 2002, BIOCHEMISTRY-US, V41, P14176, DOI 10.1021/bi026465e; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; Grazioli L, 1998, J BIOL CHEM, V273, P8916, DOI 10.1074/jbc.273.15.8916; Grucza RA, 1999, BIOCHEMISTRY-US, V38, P5024, DOI 10.1021/bi9829938; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Labadia ME, 1997, ARCH BIOCHEM BIOPHYS, V342, P117, DOI 10.1006/abbi.1997.0118; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; NARULA SS, 1995, STRUCTURE, V3, P1061, DOI 10.1016/S0969-2126(01)00242-8; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Taylor JD, 2008, PROTEINS, V73, P929, DOI 10.1002/prot.22119; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; van Oers N S, 1995, Semin Immunol, V7, P227, DOI 10.1006/smim.1995.0027; Vely F, 1997, EUR J IMMUNOL, V27, P3010, DOI 10.1002/eji.1830271138; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105; Zhang YY, 2009, BIOCHEMISTRY-US, V48, P11075, DOI 10.1021/bi9012462	28	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25872	25881		10.1074/jbc.M111.223321	http://dx.doi.org/10.1074/jbc.M111.223321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21602568	Green Published, hybrid			2022-12-27	WOS:000293073000048
J	Botelho, TO; Guevara, T; Marrero, A; Arede, P; Fluxa, VS; Reymond, JL; Oliveira, DC; Gomis-Ruth, FX				Botelho, Tiago O.; Guevara, Tibisay; Marrero, Aniebrys; Arede, Pedro; Fluxa, Viviana S.; Reymond, Jean-Louis; Oliveira, Duarte C.; Xavier Gomis-Rueth, F.			Structural and Functional Analyses Reveal That Staphylococcus aureus Antibiotic Resistance Factor HmrA Is a Zinc-dependent Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; METHICILLIN RESISTANCE; CRYSTAL-STRUCTURE; BINDING PROTEIN; TRANSCRIPTIONAL REGULATION; TERNARY COMPLEX; CELL-WALL; GENE; EXPRESSION; MECA	HmrA is an antibiotic resistance factor of methicillin-resistant Staphylococcus aureus. Molecular analysis of this protein revealed that it is not a muramidase or beta-lactamase but a nonspecific double-zinc endopeptidase consisting of a catalytic domain and an inserted oligomerization domain, which probably undergo a relative interdomain hinge rotation upon substrate binding. The active-site cleft is located at the domain interface. Four HmrA protomers assemble to a large similar to 170-kDa homotetrameric complex of 125 angstrom. All four active sites are fully accessible and similar to 50-70 angstrom apart, far enough apart to act on a large meshwork substrate independently but simultaneously. In vivo studies with four S. aureus strains of variable resistance levels revealed that the extracellular addition of HmrA protects against loss of viability in the presence of oxacillin and that this protection depends on proteolytic activity. All of these results indicate that HmrA is a peptidase that participates in resistance mechanisms in vivo in the presence of beta-lactams. Furthermore, our results have implications for most S. aureus strains of known genomic sequences and several other cocci and bacilli, which harbor close orthologs. This suggests that HmrA may be a new widespread antibiotic resistance factor in bacteria.	[Botelho, Tiago O.; Guevara, Tibisay; Marrero, Aniebrys; Xavier Gomis-Rueth, F.] Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, E-08028 Barcelona, Spain; [Arede, Pedro; Oliveira, Duarte C.] Univ Nova Lisboa, Ctr Microbiol Resources, Dept Life Sci, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal; [Fluxa, Viviana S.; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, CH-301 Bern, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Universidade Nova de Lisboa; University of Bern	Botelho, TO (corresponding author), Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, Barcelona Sci Pk,Helix Bldg,C Baldiri Reixac 15-2, E-08028 Barcelona, Spain.	xgrcri@ibmb.csic.es	Oliveira, Duarte/B-4097-2008; Arede, Pedro/H-1690-2015	Arede, Pedro/0000-0002-5693-3147; Oliveira, Duarte/0000-0002-9591-1039; Guevara Puig, Tibisay/0000-0002-1366-8507; Oliveira Botelho, Tiago/0000-0002-2456-8421; Reymond, Jean-Louis/0000-0003-2724-2942; Gomis-Ruth, F. Xavier/0000-0002-6848-6874	European Synchrotron Radiation Facility; Foundation for Science and Technology of the Portuguese Ministry for Science and Higher Education [SFRH/BD/15852/2005, SFRH/BD/38316/2007];  [FP7-HEALTH-F3-2009-223101];  [FP7-HEALTH-2010-261460];  [BIO2008-04080-E];  [BIO2009-10334];  [CSD2006-00015];  [PSE-010000-2009-8];  [2009SGR1036];  [100372];  [POCTI/BIA-MIC/60320/2004];  [PTDC/BIA-MIC/64071/2006];  [SNF200020/125020/1]	European Synchrotron Radiation Facility; Foundation for Science and Technology of the Portuguese Ministry for Science and Higher Education; ; ; ; ; ; ; ; ; ; ; 	This study was supported in part by grants from European, Portuguese, Spanish, Swiss, and Catalan agencies (FP7-HEALTH-F3-2009-223101 "AntiPathoGN," FP7-HEALTH-2010-261460 " Gums&Joints," BIO2008-04080-E, BIO2009-10334, CSD2006-00015, PSE-010000-2009-8, 2009SGR1036, Fundacio "La Marato de TV3" 100372, POCTI/BIA-MIC/60320/2004, PTDC/BIA-MIC/64071/2006, SNF200020/125020/1). Funding provided by the European Synchrotron Radiation Facility partially covered the cost of data collection.; Recipient of Fellowship SFRH/BD/15852/2005 from the Foundation for Science and Technology of the Portuguese Ministry for Science and Higher Education.; Recipient of fellowship SFRH/BD/38316/2007 from the Foundation for Science and Technology of the Portuguese Ministry for Science and Higher Education.	Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; AULD DS, 2004, HDB PROTEOLYTIC ENZY, P268; AULD DS, 2004, HDB PROTEOLYTIC ENZY, P812; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger-Bachi B, 1999, CELL MOL LIFE SCI, V56, P764, DOI 10.1007/s000180050023; Berger-Bachi B, 2002, ARCH MICROBIOL, V178, P165, DOI 10.1007/s00203-002-0436-0; Bitto E, 2009, PROTEINS, V74, P61, DOI 10.1002/prot.22124; BRANDEN CI, 1980, Q REV BIOPHYS, V13, P317, DOI 10.1017/S0033583500001712; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campanella JJ, 2008, J PLANT GROWTH REGUL, V27, P26, DOI 10.1007/s00344-007-9027-2; Carranza C., 1999, 9039 CNRSUPR, P89; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; DELENCASTRE H, 1993, EUR J CLIN MICROBIOL, V12, P13; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fabiola F, 2006, ACTA CRYSTALLOGR D, V62, P227, DOI 10.1107/S0907444905040680; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; Garcia-Castellanos R, 2004, J BIOL CHEM, V279, P17888, DOI 10.1074/jbc.M313123200; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Ghuysen JM, 1997, INT J ANTIMICROB AG, V8, P45, DOI 10.1016/S0924-8579(96)00358-5; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Gomis-Ruth F. X., 2011, BIOCH BIOPH IN PRESS, P1814; GomisRuth FX, 1997, J MOL BIOL, V269, P861, DOI 10.1006/jmbi.1997.1040; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Hausrath AC, 2002, ACTA CRYSTALLOGR D, V58, P1002, DOI 10.1107/S090744490200584X; HIRAMATSU K, 1992, FEBS LETT, V298, P133, DOI 10.1016/0014-5793(92)80039-J; HIRAMATSU K, 1995, MICROBIOL IMMUNOL, V39, P531, DOI 10.1111/j.1348-0421.1995.tb02239.x; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Ito Teruyo, 2004, Kansenshogaku Zasshi, V78, P459; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Kondo N, 2001, ANTIMICROB AGENTS CH, V45, P815, DOI 10.1128/AAC.45.3.815-824.2001; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LITTLE JW, 1985, P NATL ACAD SCI USA, V82, P2301, DOI 10.1073/pnas.82.8.2301; Lundgren S, 2003, J BIOL CHEM, V278, P51851, DOI 10.1074/jbc.M308674200; Lundgren S, 2007, J BIOL CHEM, V282, P36037, DOI 10.1074/jbc.M705517200; Mallorqui-Fernandez G, 2004, FEMS MICROBIOL LETT, V235, P1, DOI 10.1016/j.femsle.2004.04.035; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; Marrero A, 2006, J MOL BIOL, V361, P506, DOI 10.1016/j.jmb.2006.06.046; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; McKinney TK, 2001, J BACTERIOL, V183, P6862, DOI 10.1128/JB.183.23.6862-6868.2001; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nocek BP, 2010, J MOL BIOL, V397, P617, DOI 10.1016/j.jmb.2010.01.062; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ray SS, 2003, PROTEINS, V50, P170, DOI 10.1002/prot.10272; RICHARDSON JS, 1985, METHOD ENZYMOL, V115, P359; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; RYFFEL C, 1992, ANTIMICROB AGENTS CH, V36, P25, DOI 10.1128/AAC.36.1.25; Sharma VK, 1998, J BACTERIOL, V180, P2160, DOI 10.1128/JB.180.8.2160-2166.1998; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi DS, 2007, BIOPHYS CHEM, V126, P86, DOI 10.1016/j.bpc.2006.05.013; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Unno H, 2008, J BIOL CHEM, V283, P27289, DOI 10.1074/jbc.M801657200; VALLEE BL, 1993, P NATL ACAD SCI USA, V90, P2715, DOI 10.1073/pnas.90.7.2715; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Yang YZ, 2005, MOL BIOSYST, V1, P57, DOI 10.1039/b419446b	71	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25697	25709		10.1074/jbc.M111.247437	http://dx.doi.org/10.1074/jbc.M111.247437			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622555	hybrid, Green Published			2022-12-27	WOS:000293073000031
J	Eades, G; Yao, Y; Yang, MH; Zhang, YS; Chumsri, S; Zhou, Q				Eades, Gabriel; Yao, Yuan; Yang, Muhua; Zhang, Yongshu; Chumsri, Saranya; Zhou, Qun			miR-200a Regulates SIRT1 Expression and Epithelial to Mesenchymal Transition (EMT)-like Transformation in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; DNA METHYLATION; DOWN-REGULATION; BREAST-CANCER; HISTONE DEACETYLASE; PROSTATE-CANCER; HUMAN GENES; MICRORNAS; FAMILY; GROWTH	Evidence supports a critical role for microRNAs (miRNAs) in regulation of tissue-specific differentiation and development. Signifying a disruption of these programs, expression profiling has revealed extensive miRNA dysregulation in tumors compared with healthy tissue. The miR-200 family has been established as a key regulator of epithelial phenotype and, as such, is deeply involved in epithelial to mesenchymal transition (EMT) processes in breast cancer. However, the effects of the miR-200 family on transformation of normal mammary epithelial cells have yet to be fully characterized. By examining a TGF-beta driven model of transformation of normal mammary epithelium, we demonstrate that the class III histone deacetylase silent information regulator 1 (SIRT1), a proposed oncogene in breast cancer, is overexpressed upon EMT-like transformation and that epigenetic silencing of miR-200a contributes at least in part to the overexpression of SIRT1. We have established the SIRT1 transcript as subject to regulation by miR-200a, through miR-200a targeting of SIRT1 3'-UTR. We also observed SIRT1 and miR-200a participation in a negative feedback regulatory loop. Restoration of miR-200a or the knockdown of SIRT1 prevented transformation of normal mammary epithelial cells evidenced by decreased anchorage-independent growth and decreased cell migration. Finally, we observed SIRT1 overexpression in association with decreased miR-200a in breast cancer patient samples. These observations provide further evidence for a critical tumor suppressive role of the miR-200 family in breast epithelium in addition to identifying a novel regulatory mechanism, which may contribute to SIRT1 up-regulation in breast cancer.	[Eades, Gabriel; Yao, Yuan; Yang, Muhua; Zhang, Yongshu; Zhou, Qun] Univ Maryland Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Chumsri, Saranya] Univ Maryland Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhou, Q (corresponding author), Univ Maryland Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu			Flight Attendants Medical Research Institute [FAMRI YCSA072084]; Maryland Stem Cell Research Fund [2010-MSCRFE-0179-00]; NATIONAL CANCER INSTITUTE [P30CA134274, T32CA154274] Funding Source: NIH RePORTER	Flight Attendants Medical Research Institute; Maryland Stem Cell Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Flight Attendants Medical Research Institute Grant FAMRI YCSA072084 (to Q. Z.) and the Maryland Stem Cell Research Fund Grant 2010-MSCRFE-0179-00 (to Q. Z.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aoyagi S, 2008, MOL CELL BIOL, V28, P30, DOI 10.1128/MCB.01158-07; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jang KY, 2009, PATHOLOGY, V41, P366, DOI 10.1080/00313020902884451; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Neugebauer RC, 2008, CURR PHARM DESIGN, V14, P562; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388; Zillikens MC, 2009, DIABETES, V58, P2828, DOI 10.2337/db09-0536	52	219	228	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25992	26002		10.1074/jbc.M111.229401	http://dx.doi.org/10.1074/jbc.M111.229401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596753	hybrid, Green Published			2022-12-27	WOS:000293073000058
J	Jiang, Y; Guo, Y; Xi, XY; Cui, LX; He, W				Jiang, Yan; Guo, Yang; Xi, Xueyan; Cui, Lianxian; He, Wei			Flanking V and J Sequences of Complementary Determining Region 3 of T Cell Receptor (TCR) delta 1 (CDR3 delta 1) Determine the Structure and Function of TCR gamma 4 delta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-DELTA; PERIPHERAL-BLOOD; ANTIGEN RECEPTOR; PROLIFERATIVE RESPONSES; DAUDI CELLS; IN-VITRO; RECOGNITION; LYMPHOCYTES; EXPRESSION; CHAIN	The gamma delta T cell receptor (TCR) differs from immunoglobulin and alpha beta TCR in its overall binding mode. In human, genes delta 1, delta 2, and delta 3 are used for TCR delta chains. Previously, we have studied antigen binding determinants of TCR delta 2 derived from dominant gamma delta T cells residing in peripheral blood. In this study we have investigated the critical determinants for antigen recognition and TCR function in TCR delta 1 originated from gastric tumor-infiltrating gamma delta T lymphocytes using three independent experimental strategies including complementary determining region 3 (CDR3) of TCR delta 1 (CDR3 delta 1)-peptide mediated binding, CDR3 delta 1-grafted TCR fusion protein-mediated binding, and TCR gamma 4 delta 1- and mutant-expressing cell-mediated binding. All three approaches consistently showed that the conserved flanking V and J sequences but not the diverse D segment in CDR3 delta 1 determine the antigen binding. Most importantly, we found that mutations in the V and J regions of CDR3 delta 1 also abolish the assembly of TCR and TCR-CD3 complexes in TCR gamma 4 delta 1-transduced J. RT3-T3.5 cells. Together with our previous studies on CDR3 delta 2 binding, our finding suggests that both human TCR delta 1 and TCR delta 2 recognize antigen predominately via flanking V and J regions. These results indicate that TCR gamma delta recognizes antigens using conserved parts in their CDR3, which provides an explanation for a diverse repertoire of gamma delta TCRs only recognizing a limited number of antigens.	[He, Wei] Chinese Acad Med Sci, Dept Immunol, Inst Basic Med Sci, Beijing 100005, Peoples R China; Peking Union Med Coll, Natl Key Lab Med Mol Biol, Sch Basic Med, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, W (corresponding author), Chinese Acad Med Sci, Dept Immunol, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hewei@moh.gov.cn			Ministry of Science and Technology, China PR [2004CB518706]; Ministry of Science and Technology, China [2006AA02A245, 2007AA021109]; National Natural Science Foundation of China PR [30490244]	Ministry of Science and Technology, China PR(National High Technology Research and Development Program of China); Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation of China PR(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Program for Key Basic Research Projects, Ministry of Science and Technology, China PR (2004CB518706), the National High Technology Research and Development Program, Ministry of Science and Technology, China (2006AA02A245 and 2007AA021109), and by the National Natural Science Foundation of China PR (30490244).	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; CHUNG S, 1995, P NATL ACAD SCI USA, V92, P3712, DOI 10.1073/pnas.92.9.3712; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Das H, 2001, BLOOD, V98, P1616, DOI 10.1182/blood.V98.5.1616; Davis M., 2003, FUNDAMENTAL IMMUNOLO, P227; ELLIOTT JF, 1988, NATURE, V331, P627; FALINI B, 1989, J IMMUNOL, V143, P2480; FISCH P, 1992, J IMMUNOL, V148, P2315; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Holtmeier W, 2003, CRIT REV IMMUNOL, V23, P473; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Jones S, 2009, HUM GENE THER, V20, P630, DOI 10.1089/hum.2008.048; Kabelitz D, 2005, INT ARCH ALLERGY IMM, V137, P73, DOI 10.1159/000085107; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KAUR I, 1994, CELL IMMUNOL, V156, P54, DOI 10.1006/cimm.1994.1152; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Konigshofer Y, 2006, CURR OPIN IMMUNOL, V18, P527, DOI 10.1016/j.coi.2006.07.008; Li HS, 2007, J INFECT DIS, V195, P37, DOI 10.1086/509823; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Rothenfusser S, 2002, CELL IMMUNOL, V215, P32, DOI 10.1016/S0008-8749(02)00001-1; RUST CJJ, 1990, NATURE, V346, P572, DOI 10.1038/346572a0; SCHONDELMAIER S, 1993, IMMUNOL LETT, V38, P121, DOI 10.1016/0165-2478(93)90176-3; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; STINISSEN P, 1995, J IMMUNOL, V154, P4883; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Urban EM, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/732893; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Xi XY, 2009, J BIOL CHEM, V284, P27449, DOI 10.1074/jbc.M109.011684; Xu B, 2011, P NATL ACAD SCI USA, V108, P2414, DOI 10.1073/pnas.1015433108; Xu CP, 2007, MOL IMMUNOL, V44, P302, DOI 10.1016/j.molimm.2006.03.010; Yaacob NS, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-42; Zhao JP, 2006, BIOCHEM BIOPH RES CO, V339, P232, DOI 10.1016/j.bbrc.2005.10.198; Zhu XP, 2008, CHINESE MED J-PEKING, V121, P2180, DOI 10.1097/00029330-200811010-00014; Zocchi MR, 2004, FRONT BIOSCI-LANDMRK, V9, P2588, DOI 10.2741/1419	39	1	1	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25611	25619		10.1074/jbc.M111.239624	http://dx.doi.org/10.1074/jbc.M111.239624			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21606499	Green Published, hybrid			2022-12-27	WOS:000293073000023
J	Miyashita, H; Maruyama, Y; Isshiki, H; Osawa, S; Ogura, T; Mio, K; Sato, C; Tomita, T; Iwatsubo, T				Miyashita, Hiroyuki; Maruyama, Yuusuke; Isshiki, Hayato; Osawa, Satoko; Ogura, Toshihiko; Mio, Kazuhiro; Sato, Chikara; Tomita, Taisuke; Iwatsubo, Takeshi			Three-dimensional Structure of the Signal Peptide Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE COMPLEX; AUTOMATIC PARTICLE PICKUP; INTRAMEMBRANE PROTEOLYSIS; ASPARTIC PROTEASE; ENDOPLASMIC-RETICULUM; BETA-PEPTIDE; PRESENILIN 2; INHIBITORS; RECONSTRUCTION; IDENTIFICATION	Signal peptide peptidase (SPP) is an atypical aspartic protease that hydrolyzes peptide bonds within the transmembrane domain of substrates and is implicated in several biological and pathological functions. Here, we analyzed the structure of human SPP by electron microscopy and reconstructed the three-dimensional structure at a resolution of 22 angstrom. Enzymatically active SPP forms a slender, bullet-shaped homotetramer with dimensions of 85 x 85 x 130 angstrom. The SPP complex has four concaves on the rhombus-like sides, connected to a large chamber inside the molecule. Intriguingly, the N-terminal region of SPP is sufficient for the tetrameric assembly. Moreover, overexpression of the N-terminal region inhibited the formation of the endogenous SPP tetramer and the proteolytic activity within cells. These data suggest that the homotetramer is the functional unit of SPP and that its N-terminal region, which works as the structural scaffold, has a novel modulatory function for the intramembrane-cleaving activity of SPP.	[Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba 3058561, Japan; [Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tsukuba 3058561, Japan; [Miyashita, Hiroyuki; Isshiki, Hayato; Osawa, Satoko; Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Agcy, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Sato, C (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba 3058561, Japan.	ti-sato@aist.go.jp; taisuke@mol.f.u-tokyo.ac.jp	Ogura, Toshihiko/M-4089-2018; Mio, Kazuhiro/L-7488-2018; Tomita, Taisuke/L-5427-2015; Sato, Chikara/M-7183-2016	Mio, Kazuhiro/0000-0002-1655-8231; Tomita, Taisuke/0000-0002-0075-5943; Sato, Chikara/0000-0001-5543-4496	Japan Society for the Promotion of Science (JSPS); JST; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Core Research for Evolutional Science and Technology of JST, Japan; Grants-in-Aid for Scientific Research [23591263] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology of JST, Japan(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported in part by grants-in-aid for young scientists (S) (to T. T.) from the Japan Society for the Promotion of Science (JSPS), by grants from the Strategic Japanese-Swiss Cooperative Program of the JST (to C. S.), by a grant-in-aid for scientific research on innovative areas, structural basis of cell-signaling complexes mediating signal perception, transduction and responses of a Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to C. S.), by the Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST) (to T. T., T. I., C. S.), and by the Core Research for Evolutional Science and Technology of JST (to T. T. and T. I.), Japan.	Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Crawshaw SG, 2004, BIOCHEM J, V384, P9, DOI 10.1042/BJ20041216; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Frank J, 2006, 3 DIMENSIONAL ELECT; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; HARAUZ G, 1986, OPTIK, V73, P146; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Sato T, 2008, J BIOL CHEM, V283, P33287, DOI 10.1074/jbc.M805670200; Schrul B, 2010, BIOCHEM J, V427, P523, DOI 10.1042/BJ20091005; Shirotani K, 1999, NEUROSCI LETT, V262, P37, DOI 10.1016/S0304-3940(99)00037-3; Takasugi N, 2002, J BIOL CHEM, V277, P50198, DOI 10.1074/jbc.M205352200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Urban S, 2008, CURR OPIN STRUC BIOL, V18, P432, DOI 10.1016/j.sbi.2008.03.005; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	54	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26188	26197		10.1074/jbc.M111.260273	http://dx.doi.org/10.1074/jbc.M111.260273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636854	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000293073000076
J	Nyman, E; Brannmark, C; Palmer, R; Brugard, J; Nystrom, FH; Stralfors, P; Cedersund, G				Nyman, Elin; Brannmark, Cecilia; Palmer, Robert; Brugard, Jan; Nystrom, Fredrik H.; Stralfors, Peter; Cedersund, Gunnar			A Hierarchical Whole-body Modeling Approach Elucidates the Link between in Vitro Insulin Signaling and in Vivo Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; SYSTEMS BIOLOGY; PHOSPHORYLATION; ADIPOCYTES; TRANSPORT; RESISTANCE; BINDING; LEVEL; MASS; OBESITY	Type 2 diabetes is a metabolic disease that profoundly affects energy homeostasis. The disease involves failure at several levels and subsystems and is characterized by insulin resistance in target cells and tissues (i.e. by impaired intracellular insulin signaling). We have previously used an iterative experimental-theoretical approach to unravel the early insulin signaling events in primary human adipocytes. That study, like most insulin signaling studies, is based on in vitro experimental examination of cells, and the in vivo relevance of such studies for human beings has not been systematically examined. Herein, we develop a hierarchical model of the adipose tissue, which links intracellular insulin control of glucose transport in human primary adipocytes with whole-body glucose homeostasis. An iterative approach between experiments and minimal modeling allowed us to conclude that it is not possible to scale up the experimentally determined glucose uptake by the isolated adipocytes to match the glucose uptake profile of the adipose tissue in vivo. However, a model that additionally includes insulin effects on blood flow in the adipose tissue and GLUT4 translocation due to cell handling can explain all data, but neither of these additions is sufficient independently. We also extend the minimal model to include hierarchical dynamic links to more detailed models (both to our own models and to those by others), which act as submodules that can be turned on or off. The resulting multilevel hierarchical model can merge detailed results on different subsystems into a coherent understanding of whole-body glucose homeostasis. This hierarchical modeling can potentially create bridges between other experimental model systems and the in vivo human situation and offers a framework for systematic evaluation of the physiological relevance of in vitro obtained molecular/cellular experimental data.	[Nyman, Elin; Brannmark, Cecilia; Palmer, Robert; Stralfors, Peter; Cedersund, Gunnar] Linkoping Univ, Dept Clin & Expt Med Diabet & Integrat Syst Biol, SE-58185 Linkoping, Sweden; [Nystrom, Fredrik H.] Linkoping Univ, Dept Med & Hlth Sci, SE-58185 Linkoping, Sweden; [Brugard, Jan] MathCore Engn AB, SE-58330 Linkoping, Sweden; [Cedersund, Gunnar] Freiburg Inst Adv Sci, Sch Life Sci, D-79104 Freiburg, Germany	Linkoping University; Linkoping University	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med Diabet & Integrat Syst Biol, SE-58185 Linkoping, Sweden.	peter.stralfors@liu.se; gunnar.cedersund@liu.se	Nyman, Elin/I-3363-2019; Brännmark, Cecilia/K-2132-2012	Nyman, Elin/0000-0002-4261-0291; Nystrom, Fredrik/0000-0002-1680-1000; Stralfors, Peter/0000-0002-1196-1806	European Commission Commission Networks of Excellence Biosim and BioBridge; Ostergotland County Council; Novo Nordisk Foundation; Lions, Swedish Diabetes Association; Swedish Research Council	European Commission Commission Networks of Excellence Biosim and BioBridge; Ostergotland County Council; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lions, Swedish Diabetes Association; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the European Commission Networks of Excellence Biosim and BioBridge, Ostergotland County Council, Novo Nordisk Foundation, Lions, Swedish Diabetes Association, and Swedish Research Council. J. B. is employed by MatchCore Engineering AB, the company developing MathModelica.	Basu R, 2003, AM J PHYSIOL-ENDOC M, V284, pE55, DOI 10.1152/ajpendo.00190.2001; Basu R, 2006, DIABETES, V55, P2001, DOI 10.2337/db05-1692; Bergman RN, 2003, J CLIN ENDOCR METAB, V88, P4556, DOI 10.1210/jc.2003-031431; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Cedersund G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000096; Chew YH, 2009, MOL CELL ENDOCRINOL, V303, P13, DOI 10.1016/j.mce.2009.01.018; COBELLI C, 1983, MED BIOL ENG COMPUT, V21, P390, DOI 10.1007/BF02442625; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Erlingsson S, 2009, METABOLISM, V58, P995, DOI 10.1016/j.metabol.2009.02.028; FROST SC, 1987, J BIOL CHEM, V262, P9872; Gerich JE, 2000, DIABETES OBES METAB, V2, P345, DOI 10.1046/j.1463-1326.2000.00085.x; Ghosh S., 2007, C P IEEE ENG MED BIO, P3292; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; JANSSON PA, 1988, AM J PHYSIOL, V255, pE218, DOI 10.1152/ajpendo.1988.255.2.E218; Johnston AM, 2003, FEBS LETT, V546, P32, DOI 10.1016/S0014-5793(03)00438-1; Jones D, 2008, NAT REV DRUG DISCOV, V7, P278, DOI 10.1038/nrd2565; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; Kim J, 2007, ANN BIOMED ENG, V35, P69, DOI [10.1007/s10439-006-9201-x, 10.1007/s10439-006-9210-x]; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kitano H, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00003; Li Q, 2009, J MED INVESTIG, V56, P142, DOI 10.2152/jmi.56.142; Lindpointner S, 2010, DIABETES CARE, V33, P833, DOI 10.2337/dc09-1531; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; MARTIN TJ, 1986, J RECEPTOR RES, V6, P323, DOI 10.3109/10799898609074818; Mitrou P, 2009, J CLIN ENDOCR METAB, V94, P2958, DOI 10.1210/jc.2008-2297; Ost A, 2007, FASEB J, V21, P3696, DOI 10.1096/fj.07-8173com; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Pettersson T., 2008, THESIS LINKOPING U; Schaupp L, 1999, AM J PHYSIOL-ENDOC M, V276, pE401, DOI 10.1152/ajpendo.1999.276.2.E401; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; VEGA FV, 1979, ARCH BIOCHEM BIOPHYS, V192, P120, DOI 10.1016/0003-9861(79)90077-8; Virtanen KA, 2005, DIABETES, V54, P2720, DOI 10.2337/diabetes.54.9.2720; Wanant S, 2000, J THEOR BIOL, V205, P355, DOI 10.1006/jtbi.2000.2069; Wu M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008040; Zielinski R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-88	41	57	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26028	26041		10.1074/jbc.M110.188987	http://dx.doi.org/10.1074/jbc.M110.188987			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21572040	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000293073000061
J	Suvasini, R; Shruti, B; Thota, B; Shinde, SV; Friedmann-Morvinski, D; Nawaz, Z; Prasanna, KV; Thennarasu, K; Hegde, AS; Arivazhagan, A; Chandramouli, BA; Santosh, V; Somasundaram, K				Suvasini, Ramaswamy; Shruti, Bhargava; Thota, Balaram; Shinde, Sridevi Vijay; Friedmann-Morvinski, Dinorah; Nawaz, Zahid; Prasanna, Krishnarao Venkatesh; Thennarasu, Kandavel; Hegde, Alangar Sathyaranjandas; Arivazhagan, Arimappamagan; Chandramouli, Bangalore Ashwathnarayanarao; Santosh, Vani; Somasundaram, Kumaravel			Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMAS; MESSENGER-RNA; MALIGNANT GLIOMAS; MOLECULAR-MARKER; PREDICT METASTASIS; IMP3 EXPRESSION; CANCER; BIOMARKER; KOC; INVASION	Glioblastoma is the most common and malignant form of primary astrocytoma. Upon investigation of the insulin-like growth factor (IGF) pathway, we found the IGF2BP3/IMP3 transcript and protein to be up-regulated in GBMs but not in lower grade astrocytomas (p<0.0001). IMP3 is an RNA binding protein known to bind to the 5'-untranslated region of IGF-2 mRNA, thereby activating its translation. Overexpression-and knockdown-based studies establish a role for IMP3 in promoting proliferation, anchorage-independent growth, invasion, and chemoresistance. IMP3 overexpressing B16F10 cells also showed increased tumor growth, angiogenesis, and metastasis, resulting in poor survival in a mouse model. Additionally, the infiltrating front, perivascular, and subpial regions in a majority of the GBMs stained positive for IMP3. Furthermore, two different murine glioma models were used to substantiate the above findings. In agreement with the translation activation functions of IMP3, we also found increased IGF-2 protein in the GBM tumor samples without a corresponding increase in its transcript levels. Also, in vitro IMP3 overexpression/knockdown modulated the IGF-2 protein levels without altering its transcript levels. Additionally, IGF-2 neutralization and supplementation studies established that the proproliferative effects of IMP3 were indeed mediated through IGF-2. Concordantly, PI3K and MAPK, the downstream effectors of IGF-2, are activated by IMP3 and are found to be essential for IMP3-induced cell proliferation. Thus, we have identified IMP3 as a GBM-specific proproliferative and proinvasive marker acting through IGF-2 resulting in the activation of oncogenic PI3K and MAPK pathways.	[Suvasini, Ramaswamy; Shruti, Bhargava; Shinde, Sridevi Vijay; Nawaz, Zahid; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Thennarasu, Kandavel] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore 560029, Karnataka, India; [Arivazhagan, Arimappamagan; Chandramouli, Bangalore Ashwathnarayanarao] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India; [Thota, Balaram; Santosh, Vani] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Prasanna, Krishnarao Venkatesh; Hegde, Alangar Sathyaranjandas] Sri Satya Sai Inst Higher Med Sci, Bangalore 560066, Karnataka, India; [Friedmann-Morvinski, Dinorah] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Salk Institute	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in		Friedmann-Morvinski, Dinorah/0000-0002-6394-9876; Nawaz, Zahid/0000-0002-4972-0637	Council of Scientific and Industrial Research, Government of India under the New Millennium Indian Technology Leadership Initiative; Council of Scientific and Industrial Research; IUBMB Wood Whelan fellowship; Indian Council of Medical Research; Department of Biotechnology; Department of Science; University Grants Commission	Council of Scientific and Industrial Research, Government of India under the New Millennium Indian Technology Leadership Initiative(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); IUBMB Wood Whelan fellowship; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology; Department of Science; University Grants Commission(University Grants Commission, India)	This work was supported by a grant from Council of Scientific and Industrial Research, Government of India under the New Millennium Indian Technology Leadership Initiative program.; Recipient of a Council of Scientific and Industrial Research fellowship and a IUBMB Wood Whelan fellowship.; We thank professors Inder Verma, M. R. S. Rao, P. Kondaiah, and U. Varshney for help and valuable suggestions. We also thank A. A. Srinivas, Cini Samuel, K. Premkumar, and K. Chandrasekar. Infrastructural support by funding from Indian Council of Medical Research, Department of Biotechnology, Department of Science, and University Grants Commission to the Department of Microbiology and Cell Biology is acknowledged. The Central Animal Facility of the Indian Institute of Science is acknowledged for animal experiments.	Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bellezza G, 2009, HUM PATHOL, V40, P1205, DOI 10.1016/j.humpath.2009.03.019; Do SI, 2008, ONCOL RES, V17, P269, DOI 10.3727/096504008786991639; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gennigens C, 2006, CRIT REV ONCOL HEMAT, V58, P124, DOI 10.1016/j.critrevonc.2005.10.003; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Grimberg A, 2003, CANCER BIOL THER, V2, P630; Hoffmann NE, 2008, CANCER-AM CANCER SOC, V112, P1471, DOI 10.1002/cncr.23296; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Jerome L, 2003, ENDOCR-RELAT CANCER, V10, P561, DOI 10.1677/erc.0.0100561; Jiang Z, 2008, CLIN CANCER RES, V14, P5579, DOI 10.1158/1078-0432.CCR-08-0504; Jiang Z, 2008, CANCER-AM CANCER SOC, V112, P2676, DOI 10.1002/cncr.23484; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Kapoor S, 2008, CLIN CANCER RES, V14, P5640, DOI 10.1158/1078-0432.CCR-08-0813; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Li C, 2007, MODERN PATHOL, V20, P1263, DOI 10.1038/modpathol.3800960; Li CZ, 2007, MODERN PATHOL, V20, P242, DOI 10.1038/modpathol.3800735; Li DW, 2009, ANN SURG ONCOL, V16, P3499, DOI 10.1245/s10434-009-0648-5; Li L, 2008, HUM PATHOL, V39, P1205, DOI 10.1016/j.humpath.2007.12.012; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Lonning Per Eystein, 2004, Novartis Found Symp, V262, P205; Lu D, 2009, AM J SURG PATHOL, V33, P521, DOI 10.1097/PAS.0b013e31818aada9; Manousos O, 1999, INT J CANCER, V83, P15, DOI 10.1002/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Meyer MA, 2008, NEW ENGL J MED, V359, P1850, DOI 10.1056/NEJMc086380; Monzavi R, 2002, BEST PRACT RES CL EN, V16, P433, DOI 10.1053/beem.2002.0212; Moschos SJ, 2002, ONCOLOGY-BASEL, V63, P317, DOI 10.1159/000066230; Mueller F, 2003, BRIT J CANCER, V88, P699, DOI 10.1038/sj.bjc.6600790; Mueller-Pillasch F, 1999, MECH DEVELOP, V88, P95, DOI 10.1016/S0925-4773(99)00160-4; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Noske A, 2009, INT J GYNECOL PATHOL, V28, P203, DOI 10.1097/PGP.0b013e318189a724; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Riener MO, 2009, HUM PATHOL, V40, P1377, DOI 10.1016/j.humpath.2009.01.024; Sitnikova L, 2008, CLIN CANCER RES, V14, P1701, DOI 10.1158/1078-0432.CCR-07-2039; Slosar M, 2009, ENDOCR PATHOL, V20, P149, DOI 10.1007/s12022-009-9079-x; Sonoda Y, 2001, CANCER RES, V61, P6674; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Toretsky JA, 1996, J ENDOCRINOL, V149, P367, DOI 10.1677/joe.0.1490367; van Roozendaal CEP, 1998, FEBS LETT, V437, P107, DOI 10.1016/S0014-5793(98)01211-3; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xu HD, 2008, EXPERT REV MOL DIAGN, V8, P557, DOI 10.1586/14737159.8.5.557; Yantiss RK, 2005, AM J SURG PATHOL, V29, P188, DOI 10.1097/01.pas.0000149688.98333.54; Yuan RH, 2009, ANN SURG ONCOL, V16, P1711, DOI 10.1245/s10434-009-0446-0; Zheng WX, 2008, AM J SURG PATHOL, V32, P304, DOI 10.1097/PAS.0b013e3181483ff8	50	101	110	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25882	25890		10.1074/jbc.M110.178012	http://dx.doi.org/10.1074/jbc.M110.178012			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613208	Green Published, hybrid			2022-12-27	WOS:000293073000049
J	Kulkarni, K; Yang, J; Zhang, ZG; Barford, D				Kulkarni, Kiran; Yang, Jing; Zhang, Ziguo; Barford, David			Multiple Factors Confer Specific Cdc42 and Rac Protein Activation by Dedicator of Cytokinesis (DOCK) Nucleotide Exchange Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; CYTOSKELETAL REORGANIZATION; CRKII/DOCK180/RAC PATHWAY; OVERLAP EXTENSION; STRUCTURAL BASIS; CELL-MIGRATION; BINDING; DOMAIN; MEMBRANE; FAMILY	DOCK (dedicator of cytokinesis) guanine nucleotide exchange factors (GEFs) activate the Rho-family GTPases Rac and Cdc42 to control cell migration, morphogenesis, and phagocytosis. The DOCK A and B subfamilies activate Rac, whereas the DOCK D subfamily activates Cdc42. Nucleotide exchange is catalyzed by a conserved DHR2 domain (DOCKDHR2). Although the molecular basis for DOCKDHR2-mediated GTPase activation has been elucidated through structures of a DOCK9(DHR2)-Cdc42 complex, the factors determining recognition of specific GTPases are unknown. To understand the molecular basis for DOCK-GTPase specificity, we have determined the crystal structure of DOCK2(DHR2) in complex with Rac1. DOCK2(DHR2) and DOCK9(DHR2) exhibit similar tertiary structures and homodimer interfaces and share a conserved GTPase-activating mechanism. Multiple structural differences between DOCK2(DHR2) and DOCK9(DHR2) account for their selectivity toward Rac1 and Cdc42. Key determinants of selectivity of Cdc42 and Rac for their cognate DOCK(DHR)2 are a Phe or Trp residue within beta 3 (residue 56) and the ability of DOCK proteins to exploit differences in the GEF-induced conformational changes of switch 1 dependent on a divergent residue at position 27. DOCK proteins, therefore, differ from DH-PH GEFs that select their cognate GTPases through recognition of structural differences within the beta 2/beta 3 strands.	[Kulkarni, Kiran; Yang, Jing; Zhang, Ziguo; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	David.Barford@icr.ac.uk		Zhang, Ziguo/0000-0002-7268-9631; Yang, Jing/0000-0002-8984-4503	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by a program grant from Cancer Research UK (to D.B.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balagopalan L, 2006, MOL CELL BIOL, V26, P9442, DOI 10.1128/MCB.00016-06; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Garrard SM, 2003, EMBO J, V22, P1125, DOI 10.1093/emboj/cdg110; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kobayashi S, 2001, BIOCHEM J, V354, P73, DOI 10.1042/0264-6021:3540073; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Kwofie MA, 2008, J BIOL CHEM, V283, P3088, DOI 10.1074/jbc.M705170200; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Meller N, 2004, J BIOL CHEM, V279, P37470, DOI 10.1074/jbc.M404535200; Meller N, 2008, BIOCHEM J, V409, P525, DOI 10.1042/BJ20071263; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rudolph MG, 1999, PROTEIN SCI, V8, P778; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wu X, 2011, BIOCHEMISTRY-US, V50, P1070, DOI 10.1021/bi100971y; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	51	67	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25341	25351		10.1074/jbc.M111.236455	http://dx.doi.org/10.1074/jbc.M111.236455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613211	Green Published, hybrid			2022-12-27	WOS:000292547900080
J	Barkefors, I; Fuchs, PF; Heldin, J; Bergstrom, T; Forsberg-Nilsson, K; Kreuger, J				Barkefors, Irmeli; Fuchs, Peder Fredlund; Heldin, Johan; Bergstrom, Tobias; Forsberg-Nilsson, Karin; Kreuger, Johan			Exocyst Complex Component 3-like 2 (EXOC3L2) Associates with the Exocyst Complex and Mediates Directional Migration of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIP CELLS; ANGIOGENESIS; CHEMOTAXIS; RECEPTOR; TRAFFICKING; MECHANISMS; EXOCYTOSIS; FILOPODIA; DISEASE; GROWTH	The exocyst is a protein complex that ensures spatial targeting of exocytotic vesicles to the plasma membrane. We present microarray data obtained from differentiating mouse embryonic stem cell cultures that identify an up-regulation of exocyst complex component 3-like 2 (exoc3l2) mRNA in sprouting blood vessels. Vascular expression of exoc3l2 is confirmed by qPCR analysis of different mouse tissues and immunofluorescence analyses of mouse brain sections. We detect an up-regulation of exoc3l2 mRNA synthesis in primary human endothelial cells in response to VEGFA, and this response is enhanced when the cells are grown on a three-dimensional collagen I matrix. Myc-tagged EXOC3L2 co-precipitates with the exocyst protein EXOC4, and immunofluorescence detection of EXOC3L2 shows partial subcellular colocalization with EXOC4 and EXOC7. Finally, we show that exoc3l2 silencing inhibits VEGF receptor 2 phosphorylation and VEGFA-directed migration of cultured endothelial cells.	[Barkefors, Irmeli; Fuchs, Peder Fredlund; Heldin, Johan; Kreuger, Johan] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, SE-75123 Uppsala, Sweden; [Bergstrom, Tobias; Forsberg-Nilsson, Karin] Uppsala Univ, Dept Genet & Pathol, Sci Life Lab, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University	Kreuger, J (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Husargatan 3,POB 582, SE-75123 Uppsala, Sweden.	Johan.Kreuger@imbim.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Kreuger, Johan/HDM-1503-2022; Heldin, Johan/AAF-1095-2021	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Heldin, Johan/0000-0002-0915-5303; Bergstrom, Tobias/0000-0002-4557-2390	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Foundation for Strategic Research; Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Uppsala University	This work was supported by grants from the Swedish Research Council, Swedish Cancer Society, Swedish Childhood Cancer Foundation, Swedish Foundation for Strategic Research, and Uppsala University (to J. K.).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Califano JP, 2010, J BIOMECH, V43, P79, DOI 10.1016/j.jbiomech.2009.09.012; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jakobsson L, 2007, J CELL BIOL, V177, P751, DOI 10.1083/jcb.200701146; Larrivee B, 2007, GENE DEV, V21, P2433, DOI 10.1101/gad.437807; Lundkvist Andrea, 2007, Novartis Found Symp, V283, P194; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Murthy M, 2010, DEVELOPMENT, V137, P2773, DOI 10.1242/dev.048330; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Navankasattusas S, 2008, DEVELOPMENT, V135, P659, DOI 10.1242/dev.013623; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Oztan A, 2007, MOL BIOL CELL, V18, P3978, DOI 10.1091/mbc.E07-02-0097; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Saito T, 2008, BIOMED RES-TOKYO, V29, P85, DOI 10.2220/biomedres.29.85; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Sugita S, 2008, ACTA PHYSIOL, V192, P185, DOI 10.1111/j.1748-1716.2007.01803.x; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333; Zajac A, 2005, MOL BIOL CELL, V16, P1500, DOI 10.1091/mbc.E04-10-0896	32	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24189	24199		10.1074/jbc.M110.212209	http://dx.doi.org/10.1074/jbc.M110.212209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566143	Green Published, hybrid			2022-12-27	WOS:000292294900061
J	Sasaki, K; Tsurumaru, Y; Yamamoto, H; Yazaki, K				Sasaki, Kanako; Tsurumaru, Yusuke; Yamamoto, Hirobumi; Yazaki, Kazufumi			Molecular Characterization of a Membrane-bound Prenyltransferase Specific for Isoflavone from Sophora flavescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; PRENYLATED ISOFLAVONOIDS; HOMOGENTISATE PHYTYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; UBIQUINONE BIOSYNTHESIS; VAR ANGUSTIFOLIA; FLAVONOIDS; ARABIDOPSIS; GENE; PHYTOALEXIN	Prenylated isoflavones are secondary metabolites that are mainly distributed in legume plants. They often possess divergent biological activities such as anti-bacterial, anti-fungal, and anti-oxidant activities and thus attract much attention in food, medicinal, and agricultural research fields. Prenyltransferase is the key enzyme in the biosynthesis of prenylated flavonoids by catalyzing a rate-limiting step, i.e. the coupling process of two major metabolic pathways, the isoprenoid pathway and shikimate/polyketide pathway. However, so far only two genes have been isolated as prenyltransferases involved in the biosynthesis of prenylated flavonoids, namely naringenin 8-dimethylallyltransferase from Sophora flavescens (SfN8DT-1) specific for some limited flavanones and glycinol 4-dimethylallyltransferase from Glycine max (G4DT), specific for pterocarpan substrate. We have in this study isolated two novel genes coding for membrane-bound flavonoid prenyltransferases from S. flavescens, an isoflavone-specific prenyltransferase (SfG6DT) responsible for the prenylation of the genistein at the 6-position and a chalcone-specific prenyltransferase designated as isoliquiritigenin dimethylallyltransferase (SfiLDT). These prenyltransferases were enzymatically characterized using a yeast expression system. Analysis on the substrate specificity of chimeric enzymes between SfN8DT-1 and SfG6DT suggested that the determinant region for the specificity of the flavonoids was the domain neighboring the fifth transmembrane alpha-helix of the prenyltransferases.	[Sasaki, Kanako; Tsurumaru, Yusuke; Yazaki, Kazufumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Kyoto 6110011, Japan; [Yamamoto, Hirobumi] Toyo Univ, Plant Regulat Res Ctr, Fac Life Sci, Gunma 3740193, Japan	Kyoto University; Toyo University	Yazaki, K (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Kyoto 6110011, Japan.	yazaki@rish.kyoto-u.ac.jp			Ministry of Economy, Trade, and Industry (METI) of Japan [17310126]; Japan Society for the Promotion of Science [183424]; Grants-in-Aid for Scientific Research [22657014] Funding Source: KAKEN	Ministry of Economy, Trade, and Industry (METI) of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grant-in-aid for Scientific Research 17310126 (to K. Y.), by a research and development project "Development of Fundamental Technologies for Production of High-value Materials using Transgenic Plants" funded by the Ministry of Economy, Trade, and Industry (METI) of Japan, and by the Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists (Grant 183424 to K. S.).	Ahmed-Belkacem A, 2005, CANCER RES, V65, P4852, DOI 10.1158/0008-5472.CAN-04-1817; AHN BZ, 1995, J MED CHEM, V38, P1044, DOI 10.1021/jm00006a025; Akashi T, 2009, PLANT PHYSIOL, V149, P683, DOI 10.1104/pp.108.123679; Barron D, 1996, PHYTOCHEMISTRY, V43, P921, DOI 10.1016/S0031-9422(96)00344-5; Botta B, 2009, CURR MED CHEM, V16, P3414, DOI 10.2174/092986709789057662; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; CORNFORTH RH, 1969, METHOD ENZYMOL, V15, P359; DANIEL M, 1995, HDB PHYTOALEXIN META, P333; DHILLON DS, 1976, ARCH BIOCHEM BIOPHYS, V177, P74, DOI 10.1016/0003-9861(76)90417-3; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Han AR, 2006, J NAT PROD, V69, P719, DOI 10.1021/np0600346; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Kitajima A, 2009, PLANT CELL, V21, P2844, DOI 10.1105/tpc.109.068288; Koeduka T, 2011, PLANT BIOLOGY, V13, P411, DOI 10.1111/j.1438-8677.2010.00409.x; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; LAFLAMME P, 1993, PHYTOCHEMISTRY, V34, P147, DOI 10.1016/S0031-9422(00)90796-9; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; Maitrejean M, 2000, BIOORG MED CHEM LETT, V10, P157, DOI 10.1016/S0960-894X(99)00636-8; Marks MD, 2009, J EXP BOT, V60, P3715, DOI 10.1093/jxb/erp210; Murakami A, 2000, BIOORG MED CHEM LETT, V10, P59, DOI 10.1016/S0960-894X(99)00578-8; Ohara K, 2006, PLANT CELL PHYSIOL, V47, P581, DOI 10.1093/pcp/pcj025; Ohara K, 2009, BIOCHEM J, V421, P231, DOI 10.1042/BJ20081968; Okada K, 2004, PLANT MOL BIOL, V55, P567, DOI 10.1007/s11103-004-1298-4; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Sasaki K, 2005, FEBS LETT, V579, P2514, DOI 10.1016/j.febslet.2005.03.066; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Sasaki K, 2009, BIOSCI BIOTECH BIOCH, V73, P759, DOI 10.1271/bbb.80729; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; Schledz M, 2001, FEBS LETT, V499, P15, DOI 10.1016/S0014-5793(01)02508-X; TAHARA S, 1995, PHYTOCHEMISTRY, V38, P1073, DOI 10.1016/0031-9422(94)00788-U; Tsurumaru Y, 2010, PLANT BIOTECHNOL-NAR, V27, P199, DOI 10.5511/plantbiotechnology.27.199; TURBEK CS, 1992, FEMS MICROBIOL LETT, V94, P187, DOI 10.1111/j.1574-6968.1992.tb05312.x; Vitali A, 2004, FEBS LETT, V557, P33, DOI 10.1016/S0014-5793(03)01398-X; Wang BH, 1997, PHYTOCHEMISTRY, V44, P787, DOI 10.1016/S0031-9422(96)00664-4; Xiang W, 2005, J AGR FOOD CHEM, V53, P267, DOI 10.1021/jf0483117; YAMAMOTO H, 1991, Z NATURFORSCH C, V46, P172; Yamamoto H, 1996, PHYTOCHEMISTRY, V43, P603, DOI 10.1016/0031-9422(96)00321-4; Yamamoto H, 2002, PHYTOCHEMISTRY, V60, P263, DOI 10.1016/S0031-9422(02)00111-5; YAMAMOTO H, 1992, Z NATURFORSCH C, V47, P535; Yazaki K, 2002, J BIOL CHEM, V277, P6240, DOI 10.1074/jbc.M106387200; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; ZAHRINGER U, 1977, H-S Z PHYSIOL CHEM, V358, P1303	43	62	63	7	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24125	24134		10.1074/jbc.M111.244426	http://dx.doi.org/10.1074/jbc.M111.244426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576242	hybrid, Green Published			2022-12-27	WOS:000292294900054
J	Banerjee, A; Lang, JY; Hung, MC; Sengupta, K; Banerjee, SK; Baksi, K; Banerjee, DK				Banerjee, Aditi; Lang, Jing-Yu; Hung, Mien-Chie; Sengupta, Krishanu; Banerjee, Sushanta K.; Baksi, Krishna; Banerjee, Dipak K.			Unfolded Protein Response Is Required in nu/nu Mice Microvasculature for Treating Breast Tumor with Tunicamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL PROLIFERATION; CANCER GROWTH; IN-VITRO; ANGIOGENESIS; GLYCOSYLATION; EXPRESSION; INHIBITORS; SILIBININ; SYNTHASE; CAMP	Up-regulation of the dolichol pathway, a "hallmark" of asparagine-linked protein glycosylation, enhances angiogenesis in vitro. The dynamic relationship between these two processes is now evaluated with tunicamycin. Capillary endothelial cells treated with tunicamycin were growth inhibited and could not be reversed with exogenous VEGF(165). Inhibition of angiogenesis is supported by down-regulation of (i) phosphorylated VEGFR1 and VEGFR2 receptors; (ii) VEGF(165)-specific phosphotyrosine kinase activity; and (iii) Matrigel (TM) invasion and chemotaxis. In vivo, tunicamycin prevented the vessel development in Matrigel (TM) implants in athymic Balb/c (nu/nu) mice. Immunohistochemical analysis of CD34 (p < 0.001) and CD144 (p < 0.001) exhibited reduced vascularization. A 3.8-fold increased expression of TSP-1, an endogenous angiogenesis inhibitor in Matrigel (TM) implants correlated with that in tunicamycin (32 h)-treated capillary endothelial cells. Intravenous injection of tunicamycin (0.5 mg/kg to 1.0 mg/kg) per week slowed down a double negative (MDA-MB-435) grade III breast adenocarcinoma growth by similar to 50-60% in 3 weeks. Histopathological analysis of the paraffin sections indicated significant reduction in vessel size, the microvascular density and tumor mitotic index. Ki-67 and VEGF expression in tumor tissue were also reduced. A significant reduction of N-glycan expression in tumor microvessel was also observed. High expression of GRP-78 in CD144-positive cells supported unfolded protein response-mediated ER stress in tumor microvasculature. similar to 65% reduction of a triple negative (MDA-MB-231) breast tumor xenograft in 1 week with tunicamycin (0.25 mg/kg) given orally and the absence of systemic and/or organ failure strongly supported tunicamycin's potential for a powerful glycotherapeutic treatment of breast cancer in the clinic.	[Banerjee, Aditi; Banerjee, Dipak K.] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Lang, Jing-Yu; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Sengupta, Krishanu; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Vet Affairs Med Ctr, Canc Res Unit, Kansas City, KS 66160 USA; [Sengupta, Krishanu; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Div Hematol & Oncol, Dept Med, Kansas City, KS 66160 USA; [Baksi, Krishna] Univ Cent Caribe, Sch Med, Dept Anat & Cell Biol, Bayamon, PR 00960 USA; [Banerjee, Dipak K.] Univ Puerto Rico, Inst Funct Nanomat, San Juan, PR 00931 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Puerto Rico	Banerjee, DK (corresponding author), Univ Puerto Rico, Sch Med, Dept Biochem, Med Sci Campus, San Juan, PR 00936 USA.	dipak.banerjee@upr.edu	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Sengupta, Krishanu/0000-0001-6600-2621	National Institutes of Health (NIH) [U54-CA096297]; Susan G. Komen for the Cure [BCTR0600582]; VA Merit Grant; NIH/NCRR/RCMI [G12-RR03035]; NATIONAL CANCER INSTITUTE [U54CA096297] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); VA Merit Grant; NIH/NCRR/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by Grant U54-CA096297 from the National Institutes of Health (NIH) and Susan G. Komen for the Cure BCTR0600582 (to D. K. B.), a VA Merit Grant (to S. K. B.), and NIH/NCRR/RCMI Grant G12-RR03035 (to K. B.).	Baksi K, 2008, CURR DRUG TARGETS, V9, P262, DOI 10.2174/138945008783954916; Banerjee DK, 2011, ADV EXP MED BIOL, V705, P453, DOI 10.1007/978-1-4419-7877-6_24; Banerjee DK, 2005, J BIOL CHEM, V280, P4174, DOI 10.1074/jbc.M406962200; BANERJEE DK, 1993, INDIAN J BIOCHEM BIO, V30, P389; BANERJEE DK, 1985, P NATL ACAD SCI USA, V82, P4702, DOI 10.1073/pnas.82.14.4702; BANERJEE DK, 2008, ANGIOGENESIS BASIC S, P287; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; DAS SK, 1994, MOL CELL BIOCHEM, V140, P49, DOI 10.1007/BF00928365; Dass CR, 2007, J DENT RES, V86, P927, DOI 10.1177/154405910708601005; Erlichman C, 2001, ANN ONCOL, V12, P389, DOI 10.1023/A:1011183905848; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FOLKMAN J, 1994, J CLIN ONCOL, V12, P441, DOI 10.1200/JCO.1994.12.3.441; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Grossfeld GD, 1997, J NATL CANCER I, V89, P219, DOI 10.1093/jnci/89.3.219; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Martinez JA, 1999, CELL MOL BIOL, V45, P137; Martinez JA, 2006, GLYCOCONJUGATE J, V23, P209, DOI 10.1007/s10719-006-7926-2; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Munoz R, 2005, BREAST, V14, P466, DOI 10.1016/j.breast.2005.08.026; NGUYEN M, 1992, J BIOL CHEM, V267, P26157; NGUYEN M, 1993, NATURE, V365, P267, DOI 10.1038/365267a0; OLIVEIRA CM, 1990, J CELL PHYSIOL, V144, P467, DOI 10.1002/jcp.1041440314; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; PILI R, 1995, CANCER RES, V55, P2920; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Schneider BP, 2005, J CLIN ONCOL, V23, P1782, DOI 10.1200/JCO.2005.12.017; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Singh RP, 2008, CANCER RES, V68, P2043, DOI 10.1158/0008-5472.CAN-07-6247; Singh RP, 2006, J NATL CANCER I, V98, P846, DOI 10.1093/jnci/djj231; TIGANIS T, 1992, EXP CELL RES, V198, P191, DOI 10.1016/0014-4827(92)90371-E; VARTANIAN RK, 1994, AM J PATHOL, V144, P1188; Weidner Noel, 1996, P167; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang ZB, 2010, BIOCATAL BIOTRANSFOR, V28, P90, DOI 10.3109/10242420903411629; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161	45	67	67	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29127	29138		10.1074/jbc.M110.169771	http://dx.doi.org/10.1074/jbc.M110.169771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21676868	Green Published, hybrid			2022-12-27	WOS:000293837000049
J	Huang, SZ; Ma, J; Liu, XL; Zhang, YG; Luo, LF				Huang, Sizhou; Ma, Jun; Liu, Xiaolin; Zhang, Yaoguang; Luo, Lingfei			Retinoic Acid Signaling Sequentially Controls Visceral and Heart Laterality in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-RIGHT ASYMMETRY; NODAL-RELATED GENE; PANCREAS DEVELOPMENT; OPPOSING FGF; BODY AXIS; EXPRESSION; EMBRYO; MORPHOGENESIS; PATHWAYS; MOUSE	During zebrafish development, the left-right (LR) asymmetric signals are first established around the Kupffer vesicle (KV), a ciliated organ generating directional fluid flow. Then, LR asymmetry is conveyed and stabilized in the lateral plate mesoderm. Although numerous molecules and signaling pathways are involved in controlling LR asymmetry, mechanistic difference and concordance between different organs during LR patterning are poorly understood. Here we show that RA signaling regulates laterality decisions at two stages in zebrafish. Before the 2-somite stage (2So), inhibition of RA signaling leads to randomized visceral laterality through bilateral expression of nodal/spaw in the lateral plate mesoderm, which is mediated by increases in cilia length and defective directional fluid flow in KV. Fgf8 is required for the regulation of cilia length by RA signaling. Blockage of RA signaling before 2So also leads to mild defects of heart laterality, which become much more severe through perturbation of cardiac bmp4 asymmetry when RA signaling is blocked after 2So. At this stage, visceral laterality and the left-sided Nodal remain unaffected. These findings suggest that RA signaling controls visceral laterality through the left-sided Nodal signal before 2So, and regulates heart laterality through cardiac bmp4 mainly after 2So, first identifying sequential control and concordance of visceral and heart laterality.	[Huang, Sizhou; Ma, Jun; Liu, Xiaolin; Zhang, Yaoguang; Luo, Lingfei] Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China; [Huang, Sizhou; Ma, Jun; Liu, Xiaolin; Luo, Lingfei] Southwest Univ, Sch Life Sci, Lab Mol Dev Biol, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Luo, LF (corresponding author), Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China.	lluo@swu.edu.cn			National Basic Research Program of China [2009CB941200]; National Natural Science Foundation of China [30925022]; Program for Changjiang Scholars and Innovative Research Team Program Grant [IRT0859]; Program for New Century Excellent Talents (NCET) Program Grant [NCET-07-0713]; CQ Chongqing Science and Technology Commission [2009BA5041]; Southwest University [Kb2009008]; Par-Eu Scholars Program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team Program Grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents (NCET) Program Grant(Program for New Century Excellent Talents in University (NCET)); CQ Chongqing Science and Technology Commission; Southwest University(Southwest University - China); Par-Eu Scholars Program	This work was supported by National Basic Research Program of China Grant 2009CB941200, National Natural Science Foundation of China Grant 30925022, Program for Changjiang Scholars and Innovative Research Team Program Grant IRT0859, Program for New Century Excellent Talents (NCET) Program Grant NCET-07-0713, CQ Chongqing Science and Technology Commission Grant 2009BA5041, Southwest University Grant Kb2009008, and the Par-Eu Scholars Program.	Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Alexa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008261; Anderson RM, 2009, DEV BIOL, V334, P213, DOI 10.1016/j.ydbio.2009.07.017; Baker K, 2008, P NATL ACAD SCI USA, V105, P13924, DOI 10.1073/pnas.0802159105; Carl M, 2007, NEURON, V55, P393, DOI 10.1016/j.neuron.2007.07.007; Chang H, 2000, DEV BIOL, V219, P71, DOI 10.1006/dbio.1999.9594; Chazaud C, 1999, DEVELOPMENT, V126, P2589; Chen JN, 1997, DEVELOPMENT, V124, P4373; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Ellertsdottir E, 2006, DEV DYNAM, V235, P1794, DOI 10.1002/dvdy.20800; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Esteban CR, 1999, NATURE, V401, P243, DOI 10.1038/45738; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Jiang Z, 2008, PLOS BIOL, V6, P2450, DOI 10.1371/journal.pbio.0060293; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007; Liu XL, 2009, J CELL BIOL, V184, P805, DOI 10.1083/jcb.200806074; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Lustig KD, 1996, DEVELOPMENT, V122, P3275; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Osborne N, 2003, ANNU REV PHYSIOL, V65, P23, DOI 10.1146/annurev.physiol.65.092101.142235; Peterkin T, 2007, DEV BIOL, V311, P623, DOI 10.1016/j.ydbio.2007.08.018; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Ramsdell AF, 1999, DEVELOPMENT, V126, P5195; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Schulze GE, 2001, TOXICOL SCI, V59, P297, DOI 10.1093/toxsci/59.2.297; Smith KA, 2008, DEV CELL, V14, P287, DOI 10.1016/j.devcel.2007.11.015; Smith SM, 1997, DEV BIOL, V182, P162, DOI 10.1006/dbio.1996.8474; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Wasiak S, 1999, DEV BIOL, V215, P332, DOI 10.1006/dbio.1999.9465; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Yokouchi Y, 1999, CELL, V98, P573, DOI 10.1016/S0092-8674(00)80045-8; Yost HJ, 2003, CURR BIOL, V13, pR808, DOI 10.1016/j.cub.2003.09.051	51	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28533	28543		10.1074/jbc.M111.244327	http://dx.doi.org/10.1074/jbc.M111.244327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669875	hybrid, Green Published			2022-12-27	WOS:000293557800068
J	Lott, K; Bhardwaj, A; Sims, PJ; Cingolani, G				Lott, Kaylen; Bhardwaj, Anshul; Sims, Peter J.; Cingolani, Gino			A Minimal Nuclear Localization Signal (NLS) in Human Phospholipid Scramblase 4 That Binds Only the Minor NLS-binding Site of Importin alpha 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; CRYSTALLOGRAPHIC ANALYSIS; STRUCTURAL BASIS; RECOGNITION; BETA; PHOSPHORYLATION; IDENTIFICATION; PALMITOYLATION; MONOPARTITE; MECHANISM	Importin alpha 1 can bind classical nuclear localization signals (NLSs) in two NLS-binding sites, known as "major" and "minor." The major site is located between ARM repeats 2-4, whereas the minor site spans ARM 7-8. In this study, we have characterized the cellular localization of human phospholipid scramblase 4 (hPLSCR4), a member of the phospholipid scramblase protein family. We identified a minimal NLS in hPLSCR4 ((273)GSIIRKWN(280)) that contains only two basic amino acids. This NLS is both necessary for nuclear localization of hPLSCR4 in transfected HeLa cells and sufficient for nuclear import of a non-diffusible cargo in permeabilized cells. Mutation of only one of the two basic residues, Arg(277), correlates with loss of nuclear localization, suggesting this amino acid plays a key role in nuclear transport. Crystallographic analysis of mammalian importin alpha 1 in complex with the hPLSCR4-NLS reveals this minimal NLS binds specifically and exclusively to the minor binding site of importin alpha. These data provide the first structural and functional evidence of a novel NLS-binding mode in importin alpha 1 that uses only the minor groove as the exclusive site for nuclear import of nonclassical cargos.	[Lott, Kaylen; Bhardwaj, Anshul; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Lott, Kaylen] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Sims, Peter J.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Rochester	Cingolani, G (corresponding author), 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu		Bhardwaj, Anshul/0000-0002-0897-979X	National Institutes of Health [5R01GM074846, 5R01HL063819]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM074846 (to G. C.) and 5R01HL063819 (to P. J. S.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2009, BIOINFORMATICS, V25, P159, DOI 10.1093/bioinformatics/btn595; Ben-Efraim I, 2004, BIOCHEMISTRY-US, V43, P3518, DOI 10.1021/bi0356911; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Chen CW, 2011, J LEUKOCYTE BIOL, V90, P221, DOI 10.1189/jlb.0111006; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; COLLEDGE WH, 1986, MOL CELL BIOL, V6, P4136, DOI 10.1128/MCB.6.11.4136; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; DeLano W.L, PYMOL MOL GRAPHICS S; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Ilmarinen T, 2006, FEBS J, V273, P315, DOI 10.1111/j.1742-4658.2005.05065.x; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Lott K, 2010, J BIOL CHEM, V285, P13769, DOI 10.1074/jbc.M109.095760; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2004, P NATL ACAD SCI USA, V101, P13296, DOI 10.1073/pnas.0405354101; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Wyles JP, 2007, NUCLEIC ACIDS RES, V35, P4076, DOI 10.1093/nar/gkm434; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603; Zhao J, 1998, BIOCHEMISTRY-US, V37, P6361, DOI 10.1021/bi980218m; Zhou QS, 2000, BLOOD, V95, P2593, DOI 10.1182/blood.V95.8.2593.008k32_2593_2599; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271	53	52	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28160	28169		10.1074/jbc.M111.228007	http://dx.doi.org/10.1074/jbc.M111.228007			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21690087	Green Published, hybrid			2022-12-27	WOS:000293557800034
J	Zou, CB; Ellis, BM; Smith, RM; Chen, BB; Zhao, YT; Mallampalli, RK				Zou, Chunbin; Ellis, Bryon M.; Smith, Rebecca M.; Chen, Bill B.; Zhao, Yutong; Mallampalli, Rama K.			Acyl-CoA:Lysophosphatidylcholine Acyltransferase I (Lpcat1) Catalyzes Histone Protein O-Palmitoylation to Regulate mRNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLCHOLINE SYNTHESIS; CHROMATIN-STRUCTURE; PHOSPHORYLATION; MAINTENANCE; DROSOPHILA; STABILITY; HORMONE; YEAST; COA	The enzyme acyl-CoA:lysophosphatidylcholine acyltransferase (Lpcat1) is a critical cytosolic enzyme needed for lung surfactant synthesis that catalyzes an acyltransferase reaction by adding a palmitate to the sn-2 position of lysophospholipids. Here we report that histone H4 protein is subject to palmitoylation catalyzed by Lpcat1 in a calcium-regulated manner. Cytosolic Lpcat1 was observed to shift into the nucleus in lung epithelia in response to exogenous Ca2+. Nuclear Lpcat1 colocalizes with and binds to histone H4, where it catalyzes histone H4 palmitoylation. Mutagenesis studies demonstrated that Ser(47) within histone H4 serves as a putative acceptor site, indicative of Lpcat1-mediated O-palmitoylation. Lpcat1 knockdown or expression of a histone H4 Ser(47A) mutant protein in cells decreased cellular mRNA synthesis. These findings provide the first evidence of a protein substrate for Lpcat1 and reveal that histone lipidation may occur through its O-palmitoylation as a novel post-translational modification. This epigenetic modification regulates global gene transcriptional activity.	[Zou, Chunbin] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Zou, CB (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Acute Lung Injury Ctr Excellence, BST E1 103,200 Lathrop St, Pittsburgh, PA 15213 USA.	zouc@upmc.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	National Institutes of Health [R01 HL096376, HL097376, HL098174]; United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; United States Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098174, R01HL096376, R01HL097376, R01HL091916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL096376, HL097376, and HL098174 (to R. K. M.). This material is based upon work supported, in part, by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. This work was also supported by a Merit Review Award from the United States Department of Veterans Affairs.	Agassandian M, 2010, FASEB J, V24, P1271, DOI 10.1096/fj.09-136044; Brown E M, 1984, Prog Clin Biol Res, V168, P139; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Cheng L, 2009, AM J PHYSIOL-ENDOC M, V297, pE1276, DOI 10.1152/ajpendo.00475.2009; Cooley J, 2008, J LEUKOCYTE BIOL, V83, P946, DOI 10.1189/jlb.1007684; Favale NO, 2010, BBA-MOL CELL BIOL L, V1801, P1184, DOI 10.1016/j.bbalip.2010.07.003; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hemsley PA, 2008, TRENDS PLANT SCI, V13, P295, DOI 10.1016/j.tplants.2008.04.006; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kotova E, 2011, P NATL ACAD SCI USA, V108, P6205, DOI 10.1073/pnas.1019644108; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mansilla F, 2009, J MOL MED, V87, P85, DOI 10.1007/s00109-008-0409-0; Matsuda S, 2008, GENES CELLS, V13, P879, DOI 10.1111/j.1365-2443.2008.01212.x; Mazzarelli P, 2007, CANCER BIOL THER, V6, P1606, DOI 10.4161/cbt.6.10.4742; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Pszczolkowski MA, 1999, MOL CELL ENDOCRINOL, V158, P163, DOI 10.1016/S0303-7207(99)00167-7; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ryan AJ, 2008, J BIOL CHEM, V283, P24628, DOI 10.1074/jbc.M801167200; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; Sorek N, 2009, CURR OPIN PLANT BIOL, V12, P714, DOI 10.1016/j.pbi.2009.09.003; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Wilson J. P., 2011, MOL CELL PR IN PRESS; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zempleni J, 2008, NUTR REV, V66, pS46, DOI 10.1111/j.1753-4887.2008.00073.x; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	30	57	59	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28019	28025		10.1074/jbc.M111.253385	http://dx.doi.org/10.1074/jbc.M111.253385			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685381	hybrid, Green Published			2022-12-27	WOS:000293557800020
J	Bielefeld, KA; Amini-Nik, S; Whetstone, H; Poon, R; Youn, A; Wang, J; Alman, BA				Bielefeld, Kirsten A.; Amini-Nik, Saeid; Whetstone, Heather; Poon, Raymond; Youn, Andrew; Wang, Jian; Alman, Benjamin A.			Fibronectin and beta-Catenin Act in a Regulatory Loop in Dermal Fibroblasts to Modulate Cutaneous Healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; DEPENDENT TRANSCRIPTIONAL ACTIVATION; GLYCOGEN-SYNTHASE KINASE-3; SIGNALING PATHWAY; SPLICE VARIANTS; CELL-ADHESION; BRANCHING MORPHOGENESIS; EXTRACELLULAR-MATRIX; EPITHELIAL CANCERS; CARCINOMA CELLS	beta-Catenin is an important regulator of dermal fibroblasts during cutaneous wound repair. However, the factors that modulate beta-Catenin activity in this process are not completely understood. We investigated the role of the extracellular matrix in regulating beta-Catenin and found an increase in beta-Catenin-mediated Tcf-dependent transcriptional activity in fibroblasts exposed to various extracellular matrix components. This occurs through an integrin-mediated GSK3 beta-dependent pathway. The physiologic role of this mechanism was demonstrated during wound repair in extra domain A-fibronectin-deficient mice, which exhibited decreased beta-Catenin-mediated signaling during the proliferative phase of healing. Extra domain A-fibronectin-deficient mice have wounds that fail at a lower tensile strength and contain fewer fibroblasts compared with wild type mice. This phenotype was rescued by genetic or pharmacologic activation of beta-Catenin signaling. Because fibronectin is a transcriptional target of beta-Catenin, this suggests the existence of a feedback loop between these two molecules that regulates dermal fibroblast cell behavior during wound repair.	[Alman, Benjamin A.] Hosp Sick Children, Res Inst, Dept Dev & Stem Cell Biol, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Bielefeld, Kirsten A.; Alman, Benjamin A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Wang, Jian] Univ Toronto, Fac Dent, Toronto, ON M5S 1A8, Canada; [Alman, Benjamin A.] Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Alman, BA (corresponding author), Hosp Sick Children, Res Inst, Dept Dev & Stem Cell Biol, Program Dev & Stem Cell Biol, Toronto Med Discovery Tower,East Tower,101 Coll S, Toronto, ON M5G 1L7, Canada.	benjamin.alman@sickkids.ca	Nik, Saeid Amini/B-6640-2014	Nik, Saeid Amini/0000-0002-9185-9456	Canadian Institutes of Health Research [RFN 15136]; Natural Sciences and Engineering Research Council of Canada; Ontario Student Opportunity Trust; Hospital for Sick Children Foundation Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Student Opportunity Trust; Hospital for Sick Children Foundation Fund	This work was supported by Canadian Institutes of Health Research Grant RFN 15136.; Recipient of a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada and of a studentship from the Ontario Student Opportunity Trust Fund, Hospital for Sick Children Foundation Student Scholarship Program.	Acconcia F, 2007, P NATL ACAD SCI USA, V104, P6782, DOI 10.1073/pnas.0701999104; Alman BA, 1997, AM J PATHOL, V151, P329; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; BAUER JS, 1992, J CELL BIOL, V116, P477, DOI 10.1083/jcb.116.2.477; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Brault V, 2001, DEVELOPMENT, V128, P1253; BROWN LF, 1993, AM J PATHOL, V142, P793; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen Q, 2010, J MOL NEUROSCI, V40, P284, DOI 10.1007/s12031-009-9218-3; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cheon S, 2005, LAB INVEST, V85, P416, DOI 10.1038/labinvest.3700237; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; CLARK RAF, 1990, J INVEST DERMATOL, V94, P128; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; DARBY I, 1990, LAB INVEST, V63, P21; Defilippi P, 2005, J CELL BIOL, V168, P1099, DOI 10.1083/jcb.200405116; Dehpour AR, 2002, PHARMACOL TOXICOL, V90, P89, DOI 10.1034/j.1600-0773.2002.900206.x; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Disatnik MH, 2002, J CELL SCI, V115, P2151; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; ECKES E, 1996, MOL CELLULAR BIOL BI, P493; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Gurung A, 2009, AM J PATHOL, V174, P248, DOI 10.2353/ajpath.2009.080576; Hanai J, 2002, J CELL BIOL, V158, P529, DOI 10.1083/jcb.200203064; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HAUTANEN A, 1989, J BIOL CHEM, V264, P1437; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hunter MP, 2010, AM J PHYSIOL-CELL PH, V299, pC21, DOI 10.1152/ajpcell.00543.2009; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kilian O, 2008, CALCIFIED TISSUE INT, V83, P101, DOI 10.1007/s00223-008-9156-z; Kilian O, 2004, BONE, V35, P1334, DOI 10.1016/j.bone.2004.08.008; Kim J, 2010, MATRIX BIOL, V29, P369, DOI 10.1016/j.matbio.2010.04.001; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Larsen MC, 2004, TOXICOL SCI, V82, P46, DOI 10.1093/toxsci/kfh242; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Li AQ, 2010, ONCOL REP, V23, P1247, DOI 10.3892/or_00000757; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Niedermeyer J, 1997, INT J CANCER, V71, P383, DOI 10.1002/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H; Okuse T, 2005, WOUND REPAIR REGEN, V13, P491, DOI 10.1111/j.1067-1927.2005.00069.x; Olaso E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-5; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; PURKIS PE, 1990, J CELL SCI, V97, P39; Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878; Rybak JN, 2007, CANCER RES, V67, P10948, DOI 10.1158/0008-5472.CAN-07-1436; Saito S, 1999, J BIOL CHEM, V274, P30756, DOI 10.1074/jbc.274.43.30756; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Singh P, 2004, J INVEST DERMATOL, V123, P1176, DOI 10.1111/j.0022-202X.2004.23485.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tvorogov D, 2005, J CELL SCI, V118, P601, DOI 10.1242/jcs.01643; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vi L, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-72; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; YAMAMOTO M, 1995, EXP CELL RES, V219, P249, DOI 10.1006/excr.1995.1225; Zhang DL, 2009, BIOCHEM BIOPH RES CO, V378, P149, DOI 10.1016/j.bbrc.2008.11.011; Zhang T, 2009, BLOOD, V114, P4081, DOI 10.1182/blood-2009-05-219881; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161	77	52	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27687	27697		10.1074/jbc.M111.261677	http://dx.doi.org/10.1074/jbc.M111.261677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652705	Green Published, hybrid			2022-12-27	WOS:000293268700061
J	Chou, CY; Streets, AJ; Watson, PF; Huang, LH; Verderio, EAM; Johnson, TS				Chou, Che-Yi; Streets, Andrew J.; Watson, Philip F.; Huang, Linghong; Verderio, Elisabetta A. M.; Johnson, Timothy S.			A Crucial Sequence for Transglutaminase Type 2 Extracellular Trafficking in Renal Tubular Epithelial Cells Lies in Its N-terminal beta-Sandwich Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; TISSUE TRANSGLUTAMINASE; CROSS-LINKING; SURFACE TRANSGLUTAMINASE; PLASMA-MEMBRANE; FIBRONECTIN; EXPRESSION; MATRIX; PURINOCEPTOR; ACTIVATION	Transglutaminase type 2 (TG2) catalyzes the formation of an is an element of-(gamma-glutamyl)-lysine isopeptide bond between adjacent peptides or proteins including those of the extracellular matrix (ECM). Elevated extracellular TG2 leads to accelerated ECM deposition and reduced clearance that underlie tissue scarring and fibrosis. The extracellular trafficking of TG2 is crucial to its role in ECM homeostasis; however, the mechanism by which TG2 escapes the cell is unknown as it has no signal leader peptide and therefore cannot be transported classically. Understanding TG2 transport may highlight novel mechanisms to interfere with the extracellular function of TG2 as isoform-specific TG2 inhibitors remain elusive. Mammalian expression vectors were constructed containing domain deletions of TG2. These were transfected into three kidney tubular epithelial cell lines, and TG2 export was assessed to identify critical domains. Point mutation was then used to highlight specific sequences within the domain required for TG2 export. The removal of beta-sandwich domain prevented all TG2 export. Mutations of Asp(94) and Asp(97) within the N-terminal beta-sandwich domain were identified as crucial for TG2 externalization. These form part of a previously identified fibronectin binding domain ((88)WTATVVDQQDCTLSLQLTT(106)). However, siRNA knockdown of fibronectin failed to affect TG2 export. The sequence (88)WTATVVDQQDCTLSLQLTT(106) within the beta-sandwich domain of TG2 is critical to its export in tubular epithelial cell lines. The extracellular trafficking of TG2 is independent of fibronectin.	[Johnson, Timothy S.] Univ Sheffield, Sch Med, Acad Nephrol Unit, Sheffield Kidney Inst, Sheffield S10 2RZ, S Yorkshire, England; [Watson, Philip F.] Univ Sheffield, Dept Human Metab, Sheffield S10 2RZ, S Yorkshire, England; [Chou, Che-Yi] China Med Univ Hosp, Dept Internal Med, Inst Nephrol, Taichung 40402, Taiwan; [Chou, Che-Yi] China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung 40402, Taiwan; [Verderio, Elisabetta A. M.] Nottingham Trent Univ, Sch Sci & Technol, Biomed Life & Hlth Res Ctr, Nottingham NG11 8NS, England	University of Sheffield; University of Sheffield; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Nottingham Trent University	Johnson, TS (corresponding author), Univ Sheffield, Sch Med, Acad Nephrol Unit, Sheffield Kidney Inst, Beech Hill Rd, Sheffield S10 2RZ, S Yorkshire, England.	T.Johnson@Sheffield.ac.uk	Verderio, Elisabetta/H-2789-2016; Chou, Che-Yi/N-8887-2015	Verderio, Elisabetta/0000-0001-9153-8997; Chou, Che-Yi/0000-0003-4029-9097				ACHYUTHAN KE, 1995, J IMMUNOL METHODS, V180, P69, DOI 10.1016/0022-1759(94)00300-L; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Auld GC, 2001, ARTERIOSCL THROM VAS, V21, P1689, DOI 10.1161/hq1001.097063; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; BO XN, 1992, J BIOL CHEM, V267, P17581; BOUGERET C, 1992, J IMMUNOL, V148, P318; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; Fisher M, 2009, MATRIX BIOL, V28, P20, DOI 10.1016/j.matbio.2008.10.003; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GENTILE V, 1991, J BIOL CHEM, V266, P478; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; HEROLD C, 1995, INT IMMUNOL, V7, P1, DOI 10.1093/intimm/7.1.1; Huang LH, 2010, NEPHROL DIAL TRANSPL, V25, P3897, DOI 10.1093/ndt/gfq291; Huang LH, 2009, KIDNEY INT, V76, P383, DOI 10.1038/ki.2009.230; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P6900, DOI 10.1021/bi00370a025; ICHINOSE A, 1988, P NATL ACAD SCI USA, V85, P5829, DOI 10.1073/pnas.85.16.5829; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Johnson TS, 2007, J AM SOC NEPHROL, V18, P3078, DOI 10.1681/ASN.2006070690; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; Johnson TS, 1999, J AM SOC NEPHROL, V10, P2146; Jones RA, 1997, J CELL SCI, V110, P2461; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Juschke C, 2004, CURR BIOL, V14, P406, DOI 10.1016/j.cub.2004.02.034; Kuncio GS, 1998, AM J PHYSIOL-GASTR L, V274, pG240, DOI 10.1152/ajpgi.1998.274.2.G240; Lodish H., 2007, MOL CELL BIOL; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; MALSTROM K, 1987, BIOCHIM BIOPHYS ACTA, V902, P269, DOI 10.1016/0005-2736(87)90305-1; MOSHER DF, 1984, MOL CELL BIOCHEM, V58, P63, DOI 10.1007/BF00240605; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Skill NJ, 2001, LAB INVEST, V81, P705, DOI 10.1038/labinvest.3780279; Small K, 1999, J BIOL CHEM, V274, P21291, DOI 10.1074/jbc.274.30.21291; SUTO N, 1993, J BIOL CHEM, V268, P7469; Trigwell SM, 2004, ANAL BIOCHEM, V330, P164, DOI 10.1016/j.ab.2004.03.068; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio E, 2010, THESCIENTIFICWORLDJO, V10, P1073, DOI 10.1100/tsw.2010.102; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103	47	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27825	27835		10.1074/jbc.M111.226340	http://dx.doi.org/10.1074/jbc.M111.226340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652693	Green Published, hybrid			2022-12-27	WOS:000293268700074
J	Qin, W; Sundaram, M; Wang, YW; Zhou, H; Zhong, SM; Chang, CC; Manhas, S; Yao, EF; Parks, RJ; McFie, PJ; Stone, SJ; Jiang, ZHG; Wang, CR; Figeys, D; Jia, WP; Yao, ZM				Qin, Wen; Sundaram, Meenakshi; Wang, Yuwei; Zhou, Hu; Zhong, Shumei; Chang, Chia-Ching; Manhas, Sanjay; Yao, Erik F.; Parks, Robin J.; McFie, Pamela J.; Stone, Scot J.; Jiang, Zhenghui G.; Wang, Congrong; Figeys, Daniel; Jia, Weiping; Yao, Zemin			Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins EVIDENCE THAT ApoC-III PLAYS A MAJOR ROLE IN THE FORMATION OF LIPID PRECURSORS WITHIN THE MICROSOMAL LUMEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; FATTY LIVER-DISEASE; APOLIPOPROTEIN-C; HEPATIC VLDL; INHIBITION; METABOLISM; CELLS; DEFICIENCY; MICROSOMES; FRAGMENTS	Hepatic assembly of triacylglycerol (TAG)-rich very low density lipoproteins (VLDL) is achieved through recruitment of bulk TAG (presumably in the form of lipid droplets within the microsomal lumen) into VLDL precursor containing apolipoprotein (apo) B-100. We determined protein/lipid components of lumenal lipid droplets (LLD) in cells expressing recombinant human apoC-III (C3wt) or a mutant form (K58E, C3KE) initially identified in humans that displayed hypotriglyceridemia. Although expression of C3wt markedly stimulated secretion of TAGand apoB-100 as VLDL1, the K58E mutation (located at the C-terminal lipid binding domain) abolished the effect in transfected McA-RH7777 cells and in apoc3-null mice. Metabolic labeling studies revealed that accumulation of TAG in LLD was decreased (by 50%) in cells expressing C3KE. A Fat Western lipid protein overlay assay showed drastically reduced lipid binding of the mutant protein. Substituting Lys(58) with Arg demonstrated that the positive charge at position 58 is crucial for apoC-III binding to lipid and for promoting TAG secretion. On the other hand, substituting both Lys(58) and Lys(60) with Glu resulted in almost entire elimination of lipid binding and loss of function in promoting TAG secretion. Thus, the lipid binding domain of apoC-III plays a key role in the formation of LLD for hepatic VLDL assembly and secretion.	[Sundaram, Meenakshi; Wang, Yuwei; Zhou, Hu; Zhong, Shumei; Manhas, Sanjay; Yao, Erik F.; Figeys, Daniel; Yao, Zemin] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Qin, Wen; Wang, Congrong; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai Clin Ctr Diabet,Shanghai Diabet Inst, Shanghai 200233, Peoples R China; [Parks, Robin J.] Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada; [McFie, Pamela J.; Stone, Scot J.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Chang, Chia-Ching] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan; [Chang, Chia-Ching] Acad Sinica, Inst Phys, Taipei 11529, Taiwan; [Jiang, Zhenghui G.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	University of Ottawa; Shanghai Jiao Tong University; University of Ottawa; Ottawa Hospital Research Institute; University of Saskatchewan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Boston University	Yao, ZM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	zyao@uottawa.ca	Jiang, Z. Gordon/U-5256-2017; Chang, Chia-Ching/F-1247-2011; 王, 从容/HDM-0959-2022	Jiang, Z. Gordon/0000-0003-0495-9940; Chang, Chia-Ching/0000-0002-3444-0894; 王, 从容/0000-0002-8645-1114; Figeys, Daniel/0000-0002-5373-7546	Heart and Stroke Foundation of Ontario [NA-7026]; China-Canada Health Research Initiative [CCI 92211, 30811120437]; J.-Louis Levesque Foundation; Shanghai Jiao Tong University	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); China-Canada Health Research Initiative; J.-Louis Levesque Foundation; Shanghai Jiao Tong University	This work was supported by the Heart and Stroke Foundation of Ontario (NA-7026 (to Z. Y.), China-Canada Health Research Initiative Grants CCI 92211 (to Z. Y.), and 30811120437 (to W. J.), and by the J.-Louis Levesque Foundation (to D. F.).; Recipient of Special Funding for Visiting Doctoral Students Program from Shanghai Jiao Tong University.	Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; CHANG TY, 1981, ANAL BIOCHEM, V116, P298, DOI 10.1016/0003-2697(81)90360-2; DOWLER S, 2002, SCI STKE, P16, DOI DOI 10.1126/STKE.2002.129; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Liu HQ, 2000, BIOCHEMISTRY-US, V39, P9201, DOI 10.1021/bi0009441; McLeod RS, 1996, J BIOL CHEM, V271, P18445, DOI 10.1074/jbc.271.31.18445; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Rogers L, 2008, CARDIOVASC RES, V78, P167, DOI 10.1093/cvr/cvn005; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SPARROW JT, 1973, P NATL ACAD SCI USA, V70, P2124, DOI 10.1073/pnas.70.7.2124; SPARROW JT, 1977, BIOCHEMISTRY-US, V16, P5427, DOI 10.1021/bi00644a004; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; VANCE DE, 1984, BIOCHIM BIOPHYS ACTA, V792, P39, DOI 10.1016/0005-2760(84)90280-7; VONECKARDSTEIN A, 1991, J CLIN INVEST, V87, P1724, DOI 10.1172/JCI115190; Wang H, 2007, J BIOL CHEM, V282, P33218, DOI 10.1074/jbc.M706841200; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Zheng CY, 2008, AM J CLIN NUTR, V88, P272, DOI 10.1093/ajcn/88.2.272; Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200; Zhong SM, 2010, J BIOL CHEM, V285, P6453, DOI 10.1074/jbc.M109.060467	34	82	85	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27769	27780		10.1074/jbc.M110.203679	http://dx.doi.org/10.1074/jbc.M110.203679			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676879	Green Published, hybrid			2022-12-27	WOS:000293268700069
J	Talley, JM; DeZwaan, DC; Maness, LD; Freeman, BC; Friedman, KL				Talley, Jennell M.; DeZwaan, Diane C.; Maness, Leslie D.; Freeman, Brian C.; Friedman, Katherine L.			Stimulation of Yeast Telomerase Activity by the Ever Shorter Telomere 3 (Est3) Subunit Is Dependent on Direct Interaction with the Catalytic Protein Est2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERASE; REVERSE-TRANSCRIPTASE; SHUTTLE VECTORS; BUDDING YEAST; OB-FOLD; RNA; DNA; REPLICATION; COMPLEX; RECRUITMENT	Telomerase is a multisubunit enzyme that maintains genome stability through its role in telomere replication. Although the Est3 protein is long recognized as an essential telomerase component, how it associates with and functions in the telomerase complex has remained enigmatic. Here we provide the first evidence of a direct interaction between Saccharomyces cerevisiae Est3p and the catalytic protein subunit (Est2p) by demonstrating that recombinant Est3p binds the purified telomerase essential N-terminal (TEN) domain of Est2p in vitro. Mutations in a small cluster of amino acids predicted to lie on the surface of Est3p disrupt this interaction with Est2p, reduce assembly of Est3p with telomerase in vivo, and cause telomere shortening and senescence. We also show that recombinant Est3p stimulates telomerase activity above basal levels in vitro in a manner dependent on the Est2p TEN domain interaction. Together, these results define a direct binding interaction between Est3p and Est2p and reconcile the effect of S. cerevisiae Est3p with previous experiments showing that Est3p homologs in related yeast species influence telomerase activity. Additionally, it contributes functional support to the idea that Est3p is structurally related to the mammalian shelterin protein, TPP1, which also influences telomerase activity through interaction with the Est2p homolog, TERT.	[Talley, Jennell M.; Maness, Leslie D.; Friedman, Katherine L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [DeZwaan, Diane C.; Freeman, Brian C.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Vanderbilt University; University of Illinois System; University of Illinois Urbana-Champaign	Friedman, KL (corresponding author), Vanderbilt Univ, Dept Biol Sci, Stn B,Box 351634, Nashville, TN 37235 USA.	katherine.friedman@vanderbilt.edu			National Institutes of Health [GM080393, T32 GM08554]; Vanderbilt Discovery Grant; Computational Molecular Biology-National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080393, T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Discovery Grant; Computational Molecular Biology-National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080393. This work was also supported by Vanderbilt Discovery Grant (to K. L. F.).; Supported in part by National Institutes of Health Grant T32 GM08554.; Supported by a Computational Molecular Biology-National Institutes of Health training grant. Present address: Dept. of Anatomy and Cell Biology, the University of Iowa, Iowa City, IA 52242.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Chapon C, 1997, RNA, V3, P1337; Chappell AS, 2004, MOL CELL BIOL, V24, P7720, DOI 10.1128/MCB.24.17.7720-7736.2004; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DeZwaan DC, 2009, P NATL ACAD SCI USA, V106, P17337, DOI 10.1073/pnas.0905703106; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Friedman KL, 2003, MOL BIOL CELL, V14, P1, DOI 10.1091/mbc.E02-06-0327; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Hsu M, 2007, EUKARYOT CELL, V6, P1330, DOI 10.1128/EC.00069-07; Hughes TR, 2000, CURR BIOL, V10, P809, DOI 10.1016/S0960-9822(00)00562-5; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P990, DOI 10.1038/nsmb.1472; Lee J, 2010, NUCLEIC ACIDS RES, V38, P2279, DOI 10.1093/nar/gkp1173; Lendvay TS, 1996, GENETICS, V144, P1399; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Livengood AJ, 2002, MOL CELL BIOL, V22, P2366, DOI 10.1128/MCB.22.7.2366-2374.2002; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Osterhage JL, 2006, NAT STRUCT MOL BIOL, V13, P720, DOI 10.1038/nsmb1125; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Seto AG, 2002, GENE DEV, V16, P2800, DOI 10.1101/gad.1029302; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Sharanov YS, 2006, FEBS LETT, V580, P4683, DOI 10.1016/j.febslet.2006.07.048; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Toogun OA, 2008, MOL CELL BIOL, V28, P457, DOI 10.1128/MCB.01417-07; Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104; Tuzon CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002060; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Yu EY, 2008, NAT STRUCT MOL BIOL, V15, P985, DOI 10.1038/nsmb.1471; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810	34	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26431	26439		10.1074/jbc.M111.228635	http://dx.doi.org/10.1074/jbc.M111.228635			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659533	Green Published, hybrid			2022-12-27	WOS:000293078200021
J	Wang, H; Hota, PK; Tong, YF; Li, BR; Shen, LM; Nedyalkova, L; Borthakur, S; Kim, S; Tempel, W; Buck, M; Park, HW				Wang, Hui; Hota, Prasanta K.; Tong, Yufeng; Li, Buren; Shen, Limin; Nedyalkova, Lyudmila; Borthakur, Susmita; Kim, SoonJeung; Tempel, Wolfram; Buck, Matthias; Park, Hee-Won			Structural Basis of Rnd1 Binding to Plexin Rho GTPase Binding Domains (RBDs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; SEMAPHORIN RECEPTOR; AXON GUIDANCE; CELLS; COMPLEXES; MODEL; MORPHOGENESIS; INTEGRATION; VALIDATION; REFINEMENT	Plexin receptors regulate cell adhesion, migration, and guidance. The Rho GTPase binding domain (RBD) of plexin-A1 and -B1 can bind GTPases, including Rnd1. By contrast, plexin-C1 and -D1 reportedly bind Rnd2 but associate with Rnd1 only weakly. The structural basis of this differential Rnd1 GTPase binding to plexin RBDs remains unclear. Here, we solved the structure of the plexin-A2 RBD in complex with Rnd1 and the structures of the plexin-C1 and plexin-D1 RBDs alone, also compared with the previously determined plexin-B1 RBD. Rnd1 complex structure. The plexin-A2 RBD.Rnd1 complex is a heterodimer, whereas plexin-B1 and -A2 RBDs homodimerize at high concentration in solution, consistent with a proposed model for plexin activation. Plexin-C1 and -D1 RBDs are monomeric, consistent with major residue changes in the homodimerization loop. In plexin-A2 and -B1, the RBD beta 3-beta 4 loop adjusts its conformation to allow Rnd1 binding, whereas minimal structural changes occur in Rnd1. The plexin-C1 and -D1 RBDs lack several key non-polar residues at the corresponding GTPase binding surface and do not significantly interact with Rnd1. Isothermal titration calorimetry measurements on plexin-C1 and -D1 mutants reveal that the introduction of non-polar residues in this loop generates affinity for Rnd1. Structure and sequence comparisons suggest a similar mode of Rnd1 binding to the RBDs, whereas mutagenesis suggests that the interface with the highly homologous Rnd2 GTPase is different in detail. Our results confirm, from a structural perspective, that Rnd1 does not play a role in the activation of plexin-C1 and -D1. Plexin functions appear to be regulated by subfamily-specific mechanisms, some of which involve different Rho family GTPases.	[Hota, Prasanta K.; Borthakur, Susmita; Kim, SoonJeung; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Wang, Hui; Tong, Yufeng; Li, Buren; Shen, Limin; Nedyalkova, Lyudmila; Tempel, Wolfram; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Toronto; Structural Genomics Consortium; University of Toronto	Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Robbins Blvd,Rm E607,10900 Euclid Ave, Cleveland, OH 44106 USA.	matthias.buck@case.edu; heewon.park@utoronto.ca	Tong, Yufeng/D-2785-2011; Hota, Prasanta Kumar/J-4319-2019; Buck, Matthias/B-2106-2017	Tong, Yufeng/0000-0001-7740-1812; Hota, Prasanta Kumar/0000-0002-4057-1831; Buck, Matthias/0000-0002-2958-0403	National Institutes of Health [R01GM73071, K02HL084384, R01GM092851]; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NCI from National Institutes of Health [Y1-CO-1020, Y1-GM-1104]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092851, R01GM073071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NCI from National Institutes of Health; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM73071, K02HL084384, and R01GM092851 (to M. B.). This work was supported in part by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; We thank Shufen Cao for assistance with Rnd1 and Rnd2 protein preparation and Drs. Christina Kiel and Luis Serrano (EMBL-CRG, Barcelona) for introducing us to Fold-X. Crystallographic data shown in this report were derived from work performed at Argonne National Laboratory, Structural Biology Center, beam line 19ID, at the Advanced Photon Source. Data collection at The National Institute of General Medical Sciences and National Cancer Institute Collaborative Access Team, beam line 23ID-B, was supported by NCI Grant Y1-CO-1020 and NIGM Grant Y1-GM-1104 from the National Institutes of Health. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Churchill CDM, 2009, J PHYS CHEM B, V113, P16046, DOI 10.1021/jp907887y; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiorucci S, 2010, PROTEINS, V78, P3131, DOI 10.1002/prot.22808; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; GIESEN PLA, 1991, J BIOL CHEM, V266, P18720; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Goryachev AB, 2006, PLOS COMPUT BIOL, V2, P1511, DOI 10.1371/journal.pcbi.0020172; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Heo WD, 2003, CELL, V113, P315; Hota PK, 2009, PROTEIN SCI, V18, P1060, DOI 10.1002/pro.116; Janin J, 2010, PROTEINS, V78, P3067, DOI 10.1002/prot.22774; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Li XF, 2010, PROTEINS, V78, P3189, DOI 10.1002/prot.22770; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moretti S, 2006, CURR NEUROVASC RES, V3, P295, DOI 10.2174/156720206778792939; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; O'Connor BP, 2008, IMMUNOL RES, V41, P217, DOI 10.1007/s12026-008-8026-0; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Puschel AW, 2007, ADV EXP MED BIOL, V600, P12; Roodink I, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-297; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tong YF, 2005, STRUCTURE, V13, P7, DOI 10.1016/j.str.2004.10.018; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Beijnum Judy R, 2009, Front Biosci (Schol Ed), V1, P216; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walzer T, 2005, EUR J IMMUNOL, V35, P391, DOI 10.1002/eji.200425669; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	55	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26093	26106		10.1074/jbc.M110.197053	http://dx.doi.org/10.1074/jbc.M110.197053			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21610070	Green Published, hybrid			2022-12-27	WOS:000293073000067
J	Zhang, JL; Xue, FQ; Whiteaker, P; Li, CK; Wu, W; Shen, BC; Huang, Y; Lukas, RJ; Chang, YC				Zhang, Jianliang; Xue, Fenqin; Whiteaker, Paul; Li, Chaokun; Wu, Wen; Shen, Benchang; Huang, Yao; Lukas, Ronald J.; Chang, Yongchang			Desensitization of alpha 7 Nicotinic Receptor Is Governed by Coupling Strength Relative to Gate Tightness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; ACETYLCHOLINE-RECEPTOR; ION-CHANNEL; AGONIST BINDING; RAPID DESENSITIZATION; ALLOSTERIC RECEPTORS; GABA(A) RECEPTOR; OPEN STATE; MECHANISM; DOMAIN	Binding of a neurotransmitter to its membrane receptor opens an integral ion conducting pore. However, prolonged exposure to the neurotransmitter drives the receptor to a refractory state termed desensitization, which plays an important role in shaping synaptic transmission. Despite intensive research in the past, the structural mechanism of desensitization is still elusive. Using mutagenesis and voltage clamp in an oocyte expression system, we provide several lines of evidence supporting a novel hypothesis that uncoupling between binding and gating machinery is the underlying mechanism for alpha 7 nicotinic receptor (nAChR) desensitization. First, the decrease in gate tightness was highly correlated to the reduced desensitization. Second, nonfunctional mutants in three important coupling loops (loop 2, loop 7, and the M2-M3 linker) could be rescued by a gating mutant. Furthermore, the decrease in coupling strength in these rescued coupling loop mutants reversed the gating effect on desensitization. Finally, coupling between M1 and hinge region of the M2-M3 linker also influenced the receptor desensitization. Thus, the uncoupling between N-terminal domain and transmembrane domain, governed by the balance of coupling strength and gate tightness, underlies the mechanism of desensitization for the alpha 7 nAChR.	[Zhang, Jianliang; Xue, Fenqin; Whiteaker, Paul; Li, Chaokun; Shen, Benchang; Lukas, Ronald J.; Chang, Yongchang] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA; [Wu, Wen; Huang, Yao] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ 85013 USA; [Shen, Benchang] Guangzhou Med Coll, Dept Med Genet & Cell Biol, Guangzhou 510182, Guangdong, Peoples R China	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Guangzhou Medical University	Chang, YC (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	yongchang.chang@chw.edu	Wu, Wen/V-7065-2017		NIGMS, National Institutes of Health [R01GM085237]; Arizona Biological Research Commission [ABRC0702]; Barrow Neurological Foundation; St. Joseph's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Arizona Biological Research Commission; Barrow Neurological Foundation; St. Joseph's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIGMS, National Institutes of Health Grant R01GM085237. This work was also supported by Arizona Biological Research Commission Grant ABRC0702 and the Barrow Neurological Foundation (to Y.C.) and in part by a St. Joseph's Foundation startup fund (to Y.H.).	Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bohler S, 2001, BIOCHEMISTRY-US, V40, P2066, DOI 10.1021/bi0020022; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Chang YC, 2002, J NEUROSCI, V22, P7982; Chang YC, 2009, ACTA PHARMACOL SIN, V30, P663, DOI 10.1038/aps.2009.51; Changeux JP, 2010, ANNU REV PHARMACOL, V50, P1, DOI 10.1146/annurev.pharmtox.010909.105741; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Fenster CP, 1997, J NEUROSCI, V17, P5747; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Gonzales EB, 2008, NEUROSCI LETT, V431, P184, DOI 10.1016/j.neulet.2007.11.039; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hill DG, 2006, BIOPHYS J, V91, P705, DOI 10.1529/biophysj.106.082693; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; McCormack TJ, 2010, J PHYSIOL-LONDON, V588, P4415, DOI 10.1113/jphysiol.2010.195495; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; OCHOA ELM, 1989, CELL MOL NEUROBIOL, V9, P141, DOI 10.1007/BF00713026; Paradiso KG, 2003, J PHYSIOL-LONDON, V553, P857, DOI 10.1113/jphysiol.2003.053447; Placzek AN, 2004, MOL PHARMACOL, V66, P169, DOI 10.1124/mol.66.1.169; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; Zhang JL, 2008, MOL PHARMACOL, V74, P941, DOI 10.1124/mol.108.048710; Zhang JL, 2009, J PHYSIOL-LONDON, V587, P139, DOI 10.1113/jphysiol.2008.160093	50	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25331	25340		10.1074/jbc.M111.221754	http://dx.doi.org/10.1074/jbc.M111.221754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21610071	Green Published, hybrid			2022-12-27	WOS:000292547900079
J	Castillo, DD; Zarco-Zavala, M; Olvera-Sanchez, S; Pardo, JP; Juarez, O; Martinez, F; Mendoza-Hernandez, G; Garcia-Trejo, JJ; Flores-Herrera, O				De Los Rios Castillo, Daniela; Zarco-Zavala, Mariel; Olvera-Sanchez, Sofia; Pablo Pardo, Juan; Juarez, Oscar; Martinez, Federico; Mendoza-Hernandez, Guillermo; Garcia-Trejo, Jose J.; Flores-Herrera, Oscar			Atypical Cristae Morphology of Human Syncytiotrophoblast Mitochondria ROLE FOR COMPLEX V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; MEMBRANE-PROTEIN COMPLEXES; YEAST F1FO-ATP SYNTHASE; ATP SYNTHASE; INHIBITOR PROTEIN; F1F0-ATP SYNTHASE; INNER MEMBRANE; SUBUNIT-E; OXIDATIVE-PHOSPHORYLATION; PARACOCCUS-DENITRIFICANS	Mitochondrial complexes I, III2, and IV from human cytotrophoblast and syncytiotrophoblast associate to form supercomplexes or respirasomes, with the following stoichiometries: I-1:(III2)(1) and I-1:(III2)(1-2):IV1-4. The content of respirasomes was similar in both cell types after isolating mitochondria. However, syncytiotrophoblast mitochondria possess low levels of dimeric complex V and do not have orthodox cristae morphology. In contrast, cytotrophoblast mitochondria show normal cristae morphology and a higher content of ATP synthase dimer. Consistent with the dimerizing role of the ATPase inhibitory protein (IF1) (Garcia, J.J., Morales-Rios, E., Cortes-Hernandez, P., and Rodriguez-Zavala, J. S. (2006) Biochemistry 45, 12695-12703), higher relative amounts of IF1 were observed in cytotrophoblast when compared with syncytiotrophoblast mitochondria. Therefore, there is a correlation between dimerization of complex V, IF1 expression, and the morphology of mitochondrial cristae in human placental mitochondria. The possible relationship between cristae architecture and the physiological function of the syncytiotrophoblast mitochondria is discussed.	[De Los Rios Castillo, Daniela; Olvera-Sanchez, Sofia; Pablo Pardo, Juan; Martinez, Federico; Mendoza-Hernandez, Guillermo; Flores-Herrera, Oscar] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem & Mol Biol, Mexico City 04510, DF, Mexico; [Zarco-Zavala, Mariel; Garcia-Trejo, Jose J.] Univ Nacl Autonoma Mexico, Fac Chem, Dept Biol, Mexico City 04510, DF, Mexico; [Juarez, Oscar] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Troy, NY 12180 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Rensselaer Polytechnic Institute	Flores-Herrera, O (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Apdo Postal 70-159, Mexico City 04510, DF, Mexico.	oflores@bq.unam.mx	Martinez, Federico/Y-2411-2018	Juarez, Oscar/0000-0002-2915-8413; ZARCO-ZAVALA, MARIEL/0000-0002-9892-0758	Direccion General de Asuntos del Personal Academico (DGAPA) from Universidad Nacional Autonoma de Mexico [IN238402, IN213809, IN217609]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [52211, 59855]	Direccion General de Asuntos del Personal Academico (DGAPA) from Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Research Grants IN238402 (to O. F.-H.), The latter contains two functionally different layers, the IN217609 (to F. M.), and IN213809 (to J. J. G.-T.) from Direccion General de Asuntos del Personal Academico (DGAPA) from Universidad Nacional Autonoma de Mexico and Grants 52211 (to O. F.-H.) and 59855 (to J. P. P.) from Consejo Nacional de Ciencia y Tecnologia (CONACyT).	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; Brand C, 1998, J BIOL CHEM, V273, P6410, DOI 10.1074/jbc.273.11.6410; Bravo C, 2004, J BIOENERG BIOMEMBR, V36, P257, DOI 10.1023/B:JOBB.0000031977.99479.ea; Brunner S, 2002, J BIOL CHEM, V277, P48484, DOI 10.1074/jbc.M209382200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2002, J BIOL CHEM, V277, P41334, DOI 10.1074/jbc.M207169200; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cano-Estrada A, 2010, BBA-BIOENERGETICS, V1797, P1439, DOI 10.1016/j.bbabio.2010.02.024; CHERRADI N, 1994, ENDOCRINOLOGY, V134, P1358, DOI 10.1210/en.134.3.1358; Couoh-Cardel SJ, 2010, J BIOL CHEM, V285, P36447, DOI 10.1074/jbc.M110.144907; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Everard-Gigot V, 2005, EUKARYOT CELL, V4, P346, DOI 10.1128/EC.4.2.346-355.2005; Flores-Herrera O, 2002, BBA-MOL CELL BIOL L, V1585, P11, DOI 10.1016/S1388-1981(02)00302-5; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; Gonzalez-Zamnorano M, 2009, J PROTEOME RES, V8, P721, DOI 10.1021/pr800756a; Gordon-Smith DJ, 2001, J MOL BIOL, V308, P325, DOI 10.1006/jmbi.2001.4570; Maldonado-Mercado MG, 2008, INT J BIOCHEM CELL B, V40, P901, DOI 10.1016/j.biocel.2007.10.026; KAO LC, 1988, DEV BIOL, V130, P693, DOI 10.1016/0012-1606(88)90361-2; Lenaz G, 2001, FEBS LETT, V509, P151, DOI 10.1016/S0014-5793(01)03172-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; Martinez F, 1997, ENDOCRINOLOGY, V138, P2172, DOI 10.1210/en.138.5.2172; Miller WL, 1998, CLIN PERINATOL, V25, P799, DOI 10.1016/S0095-5108(18)30084-8; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Morales-Rios E, 2010, FASEB J, V24, P599, DOI 10.1096/fj.09-137356; OLIVERA AA, 1975, BIOCHIM BIOPHYS ACTA, V376, P426, DOI 10.1016/0005-2728(75)90164-4; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Prince FP, 2002, MITOCHONDRION, V1, P381, DOI 10.1016/S1567-7249(01)00038-1; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Rexroth S, 2004, BBA-BIOENERGETICS, V1658, P202, DOI 10.1016/j.bbabio.2004.05.014; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; TUCKEY RC, 1992, J STEROID BIOCHEM, V42, P883, DOI 10.1016/0960-0760(92)90097-3; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6	54	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23911	23919		10.1074/jbc.M111.252056	http://dx.doi.org/10.1074/jbc.M111.252056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572045	Green Published, hybrid			2022-12-27	WOS:000292294900033
J	Mushegian, A; Conaway, JW				Mushegian, Arcady; Conaway, Joan W.			Thematic Minireview Series on Computational Systems Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Mushegian, Arcady; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Mushegian, Arcady] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA; [Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlc@stowers.org	Mushegian, Arcady/ABF-5387-2021	Mushegian, Arcady/0000-0002-6809-9225; Conaway, Joan/0000-0002-2786-0663					0	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23621	23622		10.1074/jbc.R111.260398	http://dx.doi.org/10.1074/jbc.R111.260398			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566145	Green Published, hybrid			2022-12-27	WOS:000292294900001
J	Rao, VS; Clobes, AM; Guilford, WH				Rao, Vijay S.; Clobes, Amy M.; Guilford, William H.			Force Spectroscopy Reveals Multiple "Closed States" of the Muscle Thin Filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-TROPOMYOSIN COMPLEX; MYOSIN SUBFRAGMENT-1; ACTIN-FILAMENT; COOPERATIVE BINDING; ALPHA-TROPOMYOSIN; ESCHERICHIA-COLI; SKELETAL-MUSCLE; RABBIT SKELETAL; CARDIAC-MUSCLE; FIMH ADHESIN	Tropomyosin (Tm) plays a critical role in regulating the contraction of striated muscle. The three-state model of activation posits that Tm exists in three positions on the thin filament: "blocked" in the absence of calcium when myosin cannot bind, "closed" when calcium binds troponin and Tm partially covers the myosin binding site, and "open" after myosin binding forces Tm completely off neighboring sites. However, we recently showed that actin filaments decorated with phosphorylated Tm are driven by myosin with greater force than bare actin filaments. This result cannot be explained by simple steric hindrance and suggests that Tm may have additional effects on actin-myosin interactions. We therefore tested the hypothesis that Tm and its phosphorylation state affect the rate at which single actin-myosin bonds form and rupture. Using a laser trap, we measured the time necessary for the first bond to form between actin and rigor heavy meromyosin and the load-dependent durations of those bonds. Measurements were repeated in the presence of subsaturating myosin-S1 to force Tm from the closed to the open state. Maximum bond lifetimes increased in the open state, but only when Tm was phosphorylated. While the frequency with which bonds formed was extremely low in the closed state, when a bond did form it took significantly less time to do so than with bare actin. These data suggest there are at least two closed states of the thin filament, and that Tm provides additional points of contact for myosin.	[Rao, Vijay S.; Clobes, Amy M.; Guilford, William H.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia	Guilford, WH (corresponding author), Univ Virginia, Dept Biomed Engn, Box 800759, Charlottesville, VA 22908 USA.	whg2n@virginia.edu		Guilford, William/0000-0002-6543-5713	National Institutes of Health NSF [MCB0718430]; National Institutes of Health [GM080186, HL07284]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080186] Funding Source: NIH RePORTER	National Institutes of Health NSF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NSF Graduate Training Grant MCB0718430 (to the University of Virginia), National Institutes of Health Biophysics Graduate Training Grant GM080186 (to the University of Virginia), and National Institutes of Health Cardiovascular Graduate Training Grant HL07284 (to the University of Virginia).	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Cassell M, 1996, J BIOL CHEM, V271, P12867, DOI 10.1074/jbc.271.22.12867; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; EATON BL, 1976, SCIENCE, V192, P1337, DOI 10.1126/science.131972; EDWARDS BFP, 1980, BIOCHEMISTRY-US, V19, P2577, DOI 10.1021/bi00553a007; EDWARDS BFP, 1981, BIOCHEMISTRY-US, V20, P4193, DOI 10.1021/bi00517a037; EDWARDS BFP, 1978, BIOCHEMISTRY-US, V17, P684, DOI 10.1021/bi00597a020; Gaffin RD, 2006, AM J PHYSIOL-HEART C, V291, pH552, DOI 10.1152/ajpheart.00688.2005; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; Guilford WH, 2004, ANAL BIOCHEM, V326, P153, DOI 10.1016/j.ab.2003.11.025; Guo B, 2004, CELL MOTIL CYTOSKEL, V59, P264, DOI 10.1002/cm.20040; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; HEELEY DH, 1989, J BIOL CHEM, V264, P2424; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Korman VL, 2000, J BIOL CHEM, V275, P22470, DOI 10.1074/jbc.M002939200; LEHRER SS, 1984, J BIOL CHEM, V259, P2070; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; MAK A, 1978, P NATL ACAD SCI USA, V75, P3588, DOI 10.1073/pnas.75.8.3588; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; NAGASHIMA H, 1982, J MOL BIOL, V155, P409, DOI 10.1016/0022-2836(82)90479-X; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pereverzev YV, 2005, BIOPHYS J, V89, P1446, DOI 10.1529/biophysj.105.062158; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; Rao VS, 2007, AM J PHYSIOL-HEART C, V293, pH654, DOI 10.1152/ajpheart.01314.2006; Rao VS, 2009, CELL MOTIL CYTOSKEL, V66, P10, DOI 10.1002/cm.20321; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rinko LJ, 2004, BIOPHYS J, V86, P544, DOI 10.1016/S0006-3495(04)74133-8; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Snook JH, 2010, CELL MOL BIOENG, V3, P128, DOI 10.1007/s12195-010-0110-6; Sokurenko EV, 2008, CELL HOST MICROBE, V4, P314, DOI 10.1016/j.chom.2008.09.005; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; VanBuren P, 1999, P NATL ACAD SCI USA, V96, P12488, DOI 10.1073/pnas.96.22.12488; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	51	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24135	24141		10.1074/jbc.M110.167957	http://dx.doi.org/10.1074/jbc.M110.167957			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21597115	hybrid, Green Published			2022-12-27	WOS:000292294900055
J	Vazquez, V; Liang, XW; Horndahl, JK; Ganesh, VK; Smeds, E; Foster, TJ; Hook, M				Vazquez, Vanessa; Liang, Xiaowen; Horndahl, Jenny K.; Ganesh, Vannakambadi K.; Smeds, Emanuel; Foster, Timothy J.; Hook, Magnus			Fibrinogen Is a Ligand for the Staphylococcus aureus Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) Bone Sialoprotein-binding Protein (Bbp)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUMPING FACTOR-B; ESCHERICHIA-COLI; EXPRESSION; CHAIN; CLFB; ADHERENCE; FAMILY; LOCK; DOCK; SDRG	Microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) are bacterial surface proteins mediating adherence of the microbes to components of the extracellular matrix of the host. On Staphylococci, the MSCRAMMs often have multiple ligands. Consequently, we hypothesized that the Staphylococcus aureus MSCRAMM bone sialoprotein-binding protein (Bbp) might recognize host molecules other than the identified bone protein. A ligand screen revealed that Bbp binds human fibrinogen (Fg) but not Fg from other mammals. We have characterized the interaction between Bbp and Fg. The binding site for Bbp was mapped to residues 561-575 in the Fg A alpha chain using recombinant Fg chains and truncation mutants in Far Western blots and solid-phase binding assays. Surface plasmon resonance was used to determine the affinity of Bbp for Fg. The interaction of Bbp with Fg peptides corresponding to the mapped residues was further characterized using isothermal titration calorimetry. In addition, Bbp expressed on the surface of bacteria mediated adherence to immobilized Fg A alpha. Also, Bbp interferes with thrombin-induced Fg coagulation. Together these data demonstrate that human Fg is a ligand for Bbp and that Bbp can manipulate the biology of the Fg ligand in the host.	[Vazquez, Vanessa; Liang, Xiaowen; Horndahl, Jenny K.; Ganesh, Vannakambadi K.; Smeds, Emanuel; Hook, Magnus] Texas A&M Univ Syst Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Inst Biosci & Technol, Houston, TX 77030 USA; [Vazquez, Vanessa] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Foster, Timothy J.] Trinity Coll Dublin, Dept Microbiol, Moyne Inst Prevent Med, Dublin 2, Ireland	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Trinity College Dublin	Hook, M (corresponding author), Texas A&M Univ Syst Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Inst Biosci & Technol, 2121 W Holcombe Blvd,Ste 603, Houston, TX 77030 USA.	mhook@ibt.tamhsc.edu	Sarathy, Vanessa V./U-7803-2019	Sarathy, Vanessa V./0000-0002-1262-2101; Liang, Xiaowen/0000-0002-6174-2951	Science Foundation Ireland; National Institutes of Health [AI 20624]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Science Foundation Ireland.; Supported by Grant AI 20624 from the National Institutes of Health. To whom correspondence should be addressed: Center for Infectious and Inflammatory Diseases, Texas A&M University System Health Science Center, Institute of Biosciences and Technology, 2121 West Holcombe Blvd., Ste. 603, Houston, TX 77030. Tel.: 713-677-7551; Fax: 713-677-7576; E-mail: mhook@ibt.tamhsc.edu.	BOLYARD MG, 1989, BLOOD, V73, P1202; BOLYARD MG, 1988, GENE, V66, P183, DOI 10.1016/0378-1119(88)90355-1; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 1999, ACTA CRYSTALLOGR D, V55, P554, DOI 10.1107/S0907444998012426; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LORD ST, 1985, DNA-J MOLEC CELL BIO, V4, P33, DOI 10.1089/dna.1985.4.33; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Suehiro K, 2000, J BIOCHEM, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; Walsh EJ, 2004, J BIOL CHEM, V279, P50691, DOI 10.1074/jbc.M408713200; Walsh EJ, 2008, MICROBIOL-SGM, V154, P550, DOI 10.1099/mic.0.2007/010868-0; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863	27	63	64	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29797	29805		10.1074/jbc.M110.214981	http://dx.doi.org/10.1074/jbc.M110.214981			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21642438	Green Published, hybrid			2022-12-27	WOS:000294046600039
J	Patra, D; DeLassus, E; Hayashi, S; Sandell, LJ				Patra, Debabrata; DeLassus, Elizabeth; Hayashi, Shinya; Sandell, Linda J.			Site-1 Protease Is Essential to Growth Plate Maintenance and Is a Critical Regulator of Chondrocyte Hypertrophic Differentiation in Postnatal Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BONE-FORMATION; ENDOCHONDRAL SKELETON; CARTILAGE; CLEAVAGE; IHH; PROLIFERATION; REVEALS; RANGE; FEMUR	Site-1 protease (S1P) is a proprotein convertase with essential functions in lipid homeostasis and unfolded protein response pathways. We previously studied a mouse model of cartilage-specific knock-out of S1P in chondroprogenitor cells. These mice exhibited a defective cartilage matrix devoid of type II collagen protein (Col II) and displayed chondrodysplasia with no endochondral bone formation even though the molecular program for endochondral bone development appeared intact. To gain insights into S1P function, we generated and studied a mouse model in which S1P is ablated in postnatal chondrocytes. Postnatal ablation of S1P results in chondrodysplasia. However, unlike early embryonic ablations, the growth plates of these mice exhibit a lack of Ihh, PTHrP-R, and Col10 expression indicating a loss of chondrocyte hypertrophic differentiation and thus disruption of the molecular program required for endochondral bone development. S1P ablation results in rapid growth plate disruption due to intracellular Col II entrapment concomitant with loss of chondrocyte hypertrophy suggesting that these two processes are related. Entrapment of Col II in the chondrocytes of the prospective secondary ossification center precludes its development. Trabecular bone formation is dramatically diminished in the primary spongiosa and is eventually lost. The primary growth plate is eradicated by apoptosis but is gradually replaced by a fully functional new growth plate from progenitor stem cells capable of supporting new bone growth. Our study thus demonstrates that S1P has fundamental roles in the preservation of postnatal growth plate through chondrocyte differentiation and Col II deposition and functions to couple growth plate maturation to trabecular bone development in growing mice.	[Patra, Debabrata; DeLassus, Elizabeth; Hayashi, Shinya; Sandell, Linda J.] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Sandell, Linda J.] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Patra, D (corresponding author), Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Orthopaed Surg, 660 S Euclid Ave,Box 8233, St Louis, MO 63110 USA.	patrad@wudosis.wustl.edu; sandelll@wustl.edu			National Institutes of Health [RO1 AR050847, RO1 AR045550, P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR045550, R01AR050847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR050847 and RO1 AR045550 (to L. J. S.) and by Grant P30 AR057235 to the Washington University Center for Musculoskeletal Research.	Baron R.A., 1983, BONE HISTOMORPHOMETR, P13; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Farnum CE, 2006, ANAT REC PART A, V288A, P91, DOI 10.1002/ar.a.20272; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hilton MJ, 2007, DEV BIOL, V308, P93, DOI 10.1016/j.ydbio.2007.05.011; Hirai T, 2011, P NATL ACAD SCI USA, V108, P191, DOI 10.1073/pnas.1005011108; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Lerner AL, 1997, J ORTHOP RES, V15, P353, DOI 10.1002/jor.1100150307; Liu X, 2010, BIOMATERIALS, V31, P9406, DOI 10.1016/j.biomaterials.2010.08.052; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Long FX, 2001, DEVELOPMENT, V128, P5099; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Togo T, 2006, LAB INVEST, V86, P445, DOI 10.1038/labinvest.3700409; Xie C, 2008, BONE, V43, P1075, DOI 10.1016/j.bone.2008.08.109; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	29	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29227	29240		10.1074/jbc.M110.208686	http://dx.doi.org/10.1074/jbc.M110.208686			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21652717	Green Published, hybrid			2022-12-27	WOS:000293837000058
J	Breunig, E; Kludt, E; Czesnik, D; Schild, D				Breunig, Esther; Kludt, Eugen; Czesnik, Dirk; Schild, Detlev			The Styryl Dye FM1-43 Suppresses Odorant Responses in a Subset of Olfactory Neurons by Blocking Cyclic Nucleotide-gated (CNG) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS TADPOLES; MECHANOSENSITIVE ION CHANNELS; RECEPTOR NEURONS; HAIR-CELLS; PERMEANT BLOCKER; BULB NEURONS; AMINO-ACIDS; IN-VIVO; AMILORIDE; SELECTIVITY	Many olfactory receptor neurons use a cAMP-dependent transduction mechanism to transduce odorants into depolarizations. This signaling cascade is characterized by a sequence of two currents: a cation current through cyclic nucleotide-gated channels followed by a chloride current through calcium-activated chloride channels. To date, it is not possible to interfere with these generator channels under physiological conditions with potent and specific blockers. In this study we identified the styryl dye FM1-43 as a potent blocker of native olfactory cyclic nucleotide-gated channels. Furthermore, we characterized this substance to stain olfactory receptor neurons that are endowed with cAMP-dependent transduction. This allows optical differentiation and pharmacological interference with olfactory receptor neurons at the level of the signal transduction.	[Breunig, Esther; Kludt, Eugen; Czesnik, Dirk; Schild, Detlev] Univ Gottingen, Dept Neurophys & Cellular Biophys, D-37073 Gottingen, Germany; [Schild, Detlev] Univ Gottingen, Deutsch Forsch Gemeinschaft Cluster Excellence 17, D-37073 Gottingen, Germany; [Schild, Detlev] Univ Gottingen, Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Schild, D (corresponding author), Univ Gottingen, Dept Neurophys & Cellular Biophys, Humboldtallee 23, D-37073 Gottingen, Germany.	dschild@gwdg.de			Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain; Excellence Cluster 171; Gottingen Neuroscience Graduate School	Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); Excellence Cluster 171; Gottingen Neuroscience Graduate School	This work was supported by the Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain, the Excellence Cluster 171, and the Gottingen Neuroscience Graduate School.	ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; BOUVET JF, 1988, NEUROSCI RES, V5, P214, DOI 10.1016/0168-0102(88)90050-8; Brown RL, 2006, CURR PHARM DESIGN, V12, P3597; Brown RL, 1999, P NATL ACAD SCI USA, V96, P754, DOI 10.1073/pnas.96.2.754; CAPRIO J, 1984, J GEN PHYSIOL, V84, P403, DOI 10.1085/jgp.84.3.403; CARR WES, 1990, CHEM SENSES, V15, P181, DOI 10.1093/chemse/15.2.181; CARR WES, 1986, J CHEM ECOL, V12, P989, DOI 10.1007/BF01638992; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Czesnik D, 2006, EUR J NEUROSCI, V23, P119, DOI 10.1111/j.1460-9568.2005.04533.x; Czesnik D, 2007, P NATL ACAD SCI USA, V104, P2967, DOI 10.1073/pnas.0609067104; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-1; FRINGS S, 1993, J GEN PHYSIOL, V101, P183, DOI 10.1085/jgp.101.2.183; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Ghatpande AS, 2003, BIOCHEMISTRY-US, V42, P265, DOI 10.1021/bi027031m; Gliem S, 2009, EUR J NEUROSCI, V29, P2315, DOI 10.1111/j.1460-9568.2009.06778.x; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; Hille B., 2001, IONIC CHANNELS EXCIT, P539; Iida A, 1999, J GEN PHYSIOL, V114, P85, DOI 10.1085/jgp.114.1.85; KANG JS, 1995, J NEUROPHYSIOL, V73, P172, DOI 10.1152/jn.1995.73.1.172; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kawai F, 1999, NAT NEUROSCI, V2, P133, DOI 10.1038/5686; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kidokoro Y, 2004, BRAIN RES REV, V47, P18, DOI 10.1016/j.brainresrev.2004.05.004; Kleene SJ, 2000, J MEMBRANE BIOL, V178, P49, DOI 10.1007/s002320010014; KOCH KW, 1985, J BIOL CHEM, V260, P6788; Lapierre LA, 2000, ADV DRUG DELIVER REV, V41, P255, DOI 10.1016/S0169-409X(00)00045-4; LeindersZufall T, 1995, J NEUROPHYSIOL, V74, P2759, DOI 10.1152/jn.1995.74.6.2759; Manzini I, 2004, J GEN PHYSIOL, V123, P99, DOI 10.1085/jgp.200308970; Manzini I, 2003, J PHYSIOL-LONDON, V551, P115, DOI 10.1113/jphysiol.2003.043059; Manzini I, 2002, J PHYSIOL-LONDON, V545, P475, DOI 10.1113/jphysiol.2002.031914; Manzini I, 2008, J NEUROSCI METH, V167, P140, DOI 10.1016/j.jneumeth.2007.07.018; Meyer J, 2001, HEARING RES, V161, P10, DOI 10.1016/S0378-5955(01)00338-0; Meyers JR, 2003, J NEUROSCI, V23, P4054; Neher RA, 2009, BIOPHYS J, V96, P3791, DOI 10.1016/j.bpj.2008.10.068; NICOL GD, 1987, J GEN PHYSIOL, V90, P651, DOI 10.1085/jgp.90.5.651; Nieuwkoop P.D., 1994, NORMAL TABLE XENOPUS, P252; Nishikawa S, 1996, J HISTOCHEM CYTOCHEM, V44, P733, DOI 10.1177/44.7.8675994; Oka Y, 2004, CHEM SENSES, V29, P815, DOI 10.1093/chemse/bjh247; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Rankin ML, 1999, J NEUROCHEM, V72, P541, DOI 10.1046/j.1471-4159.1999.0720541.x; Rolen SH, 2007, J NEUROPHYSIOL, V97, P4058, DOI 10.1152/jn.00247.2007; Rolen SH, 2003, J EXP BIOL, V206, P1683, DOI 10.1242/jeb.00338; Rospars JP, 2003, EUR J NEUROSCI, V18, P1135, DOI 10.1046/j.1460-9568.2003.02766.x; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sato K, 2001, CHEM SENSES, V26, P1145, DOI 10.1093/chemse/26.9.1145; Schild D, 2004, EUR J NEUROSCI, V20, P2111, DOI 10.1111/j.1460-9568.2004.03672.x; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Strassmaier T, 2005, J MED CHEM, V48, P5805, DOI 10.1021/jm0502485; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; ZHUANG YX, 1984, BIOCHEMISTRY-US, V23, P4481, DOI 10.1021/bi00314a038	60	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28041	28048		10.1074/jbc.M111.233890	http://dx.doi.org/10.1074/jbc.M111.233890			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21646359	Green Published, hybrid			2022-12-27	WOS:000293557800022
J	Murga-Zamalloa, CA; Ghosh, AK; Patil, SB; Reed, NA; Chan, LS; Davuluri, S; Peranen, J; Hurd, TW; Rachel, RA; Khanna, H				Murga-Zamalloa, Carlos A.; Ghosh, Amiya K.; Patil, Suresh B.; Reed, Nathan A.; Chan, Lan Sze; Davuluri, Supriya; Peranen, Johan; Hurd, Toby W.; Rachel, Rivka A.; Khanna, Hemant			Accumulation of the Raf-1 Kinase Inhibitory Protein (Rkip) Is Associated with Cep290-mediated Photoreceptor Degeneration in Ciliopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; BARDET-BIEDL-SYNDROME; RETINAL DEGENERATION; VERTEBRATE PHOTORECEPTOR; INTRAFLAGELLAR TRANSPORT; OUTER SEGMENTS; PRIMARY CILIA; CENTROSOMAL PROTEIN; JOUBERT-SYNDROME; SENSORY CILIUM	Primary cilia regulate polarized protein trafficking in photo-receptors, which are dynamic and highly compartmentalized sensory neurons of retina. The ciliary protein Cep290 modulates cilia formation and is frequently mutated in syndromic and non-syndromic photoreceptor degeneration. However, the underlying mechanism of associated retinopathy is unclear. Using the Cep290 mutant mouse rd16 (retinal degeneration 16), we show that Cep290-mediated photoreceptor degeneration is associated with aberrant accumulation of its novel interacting partner Rkip (Raf-1 kinase inhibitory protein). This effect is phenocopied by morpholino-mediated depletion of cep290 in zebrafish. We further demonstrate that ectopic accumulation of Rkip leads to defective cilia formation in zebrafish and cultured cells, an effect mediated by its interaction with the ciliary GTPase Rab8A. Our data suggest that Rkip prevents cilia formation and is associated with Cep290-mediated photoreceptor degeneration. Furthermore, our results indicate that preventing accumulation of Rkip could potentially ameliorate such degeneration.	[Murga-Zamalloa, Carlos A.; Ghosh, Amiya K.; Patil, Suresh B.; Reed, Nathan A.; Chan, Lan Sze; Davuluri, Supriya; Khanna, Hemant] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Hurd, Toby W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; [Patil, Suresh B.; Davuluri, Supriya; Khanna, Hemant] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01605 USA; [Peranen, Johan] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Rachel, Rivka A.] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Khanna, H (corresponding author), 381 Plantat St,Biotech 5,Suite 250, Worcester, MA 01605 USA.	hemant.khanna@umassmed.edu	Murga-Zamalloa, Carlos/AAX-9387-2021	Murga-Zamalloa, Carlos/0000-0002-2238-5066	National Institutes of Health [EY007961, 5P60 DK20572]; Michigan Diabetes Research and Training Center; Foundation for Fighting Blindness; Midwest Eye Banks and Transplantation Center; Vision Core Facilities [EY07003]; NATIONAL EYE INSTITUTE [P30EY007003, R29EY007961, F31EY007003, R01EY007961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center; Foundation for Fighting Blindness; Midwest Eye Banks and Transplantation Center; Vision Core Facilities; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY007961 and 5P60 DK20572 to the Michigan Diabetes Research and Training Center, the Foundation for Fighting Blindness, and Midwest Eye Banks and Transplantation Center, and Vision Core Facilities Grant EY07003.	Adams NA, 2007, OPHTHALMIC GENET, V28, P113, DOI 10.1080/13816810701537424; ARSHAVSKY VY, 2003, SCI STKE, pPE43; Besharse J.C., 1986, RETINA MODEL CELL BI; BESHARSE JC, 1977, J CELL BIOL, V75, P507, DOI 10.1083/jcb.75.2.507; Besharse JC, 2003, ADV EXP MED BIOL, V533, P157; BESHARSE JC, 1977, SCIENCE, V196, P536, DOI 10.1126/science.300504; BESHARSE JC, 1976, J EXP ZOOL, V198, P287, DOI 10.1002/jez.1401980302; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; DERETIC D, 1995, J CELL SCI, V108, P215; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Ghosh AK, 2010, HUM MOL GENET, V19, P90, DOI 10.1093/hmg/ddp469; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hodges ME, 2010, J CELL SCI, V123, P1407, DOI 10.1242/jcs.064873; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Klysik J, 2008, CELL SIGNAL, V20, P1, DOI 10.1016/j.cellsig.2007.07.003; LAVAIL MM, 1973, J CELL BIOL, V58, P650, DOI 10.1083/jcb.58.3.650; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; Murga-Zamalloa CA, 2010, HUM MOL GENET, V19, P3591, DOI 10.1093/hmg/ddq275; Murga-Zamalloa CA, 2009, J GENET, V88, P399, DOI 10.1007/s12041-009-0061-7; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Noorwez SM, 2009, J BIOL CHEM, V284, P33333, DOI 10.1074/jbc.M109.043364; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; PETERS KR, 1983, J CELL BIOL, V96, P265, DOI 10.1083/jcb.96.1.265; Rosenbaum JL, 1999, J CELL BIOL, V144, P385, DOI 10.1083/jcb.144.3.385; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Simister PC, 2002, ACTA CRYSTALLOGR D, V58, P1077, DOI 10.1107/S090744490200522X; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Strissel KJ, 2005, J BIOL CHEM, V280, P29250, DOI 10.1074/jbc.M501789200; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Theroux S, 2007, BRAIN RES BULL, V71, P559, DOI 10.1016/j.brainresbull.2006.11.010; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Williams DS, 2002, VISION RES, V42, P455, DOI 10.1016/S0042-6989(01)00228-0; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; Yoder BK, 2006, DEV CELL, V10, P541, DOI 10.1016/j.devcel.2006.04.010; YOUNG RW, 1968, J ULTRA MOL STRUCT R, V23, P462, DOI 10.1016/S0022-5320(68)80111-X; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]	60	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28276	28286		10.1074/jbc.M111.237560	http://dx.doi.org/10.1074/jbc.M111.237560			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685394	Green Published, hybrid			2022-12-27	WOS:000293557800045
J	Charlot-Rabiega, P; Bardel, E; Dietrich, C; Kastelein, R; Devergne, O				Charlot-Rabiega, Pascaline; Bardel, Emilie; Dietrich, Celine; Kastelein, Robert; Devergne, Odile			Signaling Events Involved in Interleukin 27 (IL-27)-induced Proliferation of Human Naive CD4(+) T Cells and B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE PROGRESSION; TH1 DIFFERENTIATION; IL-27; EXPRESSION; INDUCTION; STAT1; BET; MYC; ACTIVATION; RECEPTOR	IL-27 induces stronger proliferation of naive than memory human B cells and CD4(+) T cells. In B cells, this differential response is associated with similar levels of IL-27 receptor chains, IL-27R alpha and gp130, in both subsets and stronger STAT1 and STAT3 activation by IL-27 in naive B cells. Here, we show that the stronger proliferative response of CD3-stimulated naive CD4(+) T cells to IL-27 is associated with lower levels of IL-27R alpha but higher levels of gp130 compared with memory CD4(+) T cells. IL-27 signaling differs between naive and memory CD4(+) T cells, as shown by more sustained STAT1, -3, and -5 activation and weaker activation of SHP-2 in naive CD4(+) T cells. In the latter, IL-27 increases G0/G1 to S phase transition, cell division and, in some cases, cell survival. IL-27 proliferative effect on naive CD4(+) T cells is independent of MAPK, but is dependent on c-Myc and Pim-1 induction by IL-27 and is associated with induction of cyclin D2, cyclin D3, and CDK4 by IL-27 in a c-Myc and Pim-1-dependent manner. In BCR-stimulated naive B cells, IL-27 only increases entry in the S phase and induces the expression of Pim-1 and of cyclins A, D2, and D3. In these cells, inhibition of Pim-1 inhibits IL-27 effect on proliferation and cyclin induction. Altogether, these data indicate that IL-27 mediates proliferation of naive CD4(+) T cells and B cells through induction of both common and distinct sets of cell cycle regulators.	[Charlot-Rabiega, Pascaline; Bardel, Emilie; Dietrich, Celine; Devergne, Odile] Univ Paris 05, CNRS, UMR 8147, F-75015 Paris, France; [Kastelein, Robert] Schering Plough Biopharma, Palo Alto, CA 94304 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Merck & Company	Devergne, O (corresponding author), Hop Necker Enfants Malad, CNRS, UMR 8147, Batiment Sevres,161 Rue Sevres, F-75015 Paris, France.	odile.devergne@inserm.fr	Devergne, Odile/M-6633-2017	Devergne, Odile/0000-0002-2838-7564	Association de Recherche contre le Cancer [3733]	Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by Grant 3733 from the Association de Recherche contre le Cancer.	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Appleman LJ, 2002, J IMMUNOL, V168, P2729, DOI 10.4049/jimmunol.168.6.2729; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Brender C, 2007, BLOOD, V110, P2528, DOI 10.1182/blood-2006-08-041541; Coulomb-L'Hermine A, 2007, PLACENTA, V28, P1133, DOI 10.1016/j.placenta.2007.06.004; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Diveu C, 2008, CURR OPIN IMMUNOL, V20, P663, DOI 10.1016/j.coi.2008.09.003; El-behi M, 2009, J IMMUNOL, V183, P4957, DOI 10.4049/jimmunol.0900735; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Kanda N, 2008, EUR J IMMUNOL, V38, P1287, DOI 10.1002/eji.200738051; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Naud JF, 2007, NAT CELL BIOL, V9, P873, DOI 10.1038/ncb0807-873; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Owaki T, 2008, J IMMUNOL, V180, P2903, DOI 10.4049/jimmunol.180.5.2903; Owaki T, 2006, J IMMUNOL, V177, P7579, DOI 10.4049/jimmunol.177.11.7579; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Seita J, 2008, BLOOD, V111, P1903, DOI 10.1182/blood-2007-06-093328; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Wang S, 2007, J IMMUNOL, V179, P6421, DOI 10.4049/jimmunol.179.10.6421; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Yoshida H, 2008, IMMUNOL REV, V226, P234, DOI 10.1111/j.1600-065X.2008.00710.x; Yoshimoto T, 2004, J IMMUNOL, V173, P2479, DOI 10.4049/jimmunol.173.4.2479; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377	41	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27350	27362		10.1074/jbc.M111.221010	http://dx.doi.org/10.1074/jbc.M111.221010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669870	Green Published, hybrid			2022-12-27	WOS:000293268700031
J	Lu, CY; Tilan, JU; Everhart, L; Czarnecka, M; Soldin, SJ; Mendu, DR; Jeha, D; Hanafy, J; Lee, CK; Sun, JF; Izycka-Swieszewska, E; Toretsky, JA; Kitlinska, J				Lu, Congyi; Tilan, Jason U.; Everhart, Lindsay; Czarnecka, Magdalena; Soldin, Steven J.; Mendu, Damodara R.; Jeha, Dima; Hanafy, Jailan; Lee, Christina K.; Sun, Junfeng; Izycka-Swieszewska, Ewa; Toretsky, Jeffrey A.; Kitlinska, Joanna			Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors IMPLICATIONS FOR TUMOR BIOLOGY AND THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST ACTIVATION PROTEIN; APOPTOSIS-INDUCING FACTOR; NEUROPEPTIDE-Y; SUBSTRATE-SPECIFICITY; POTENTIAL TARGETS; CELL-LINES; IV; EXPRESSION; CANCER; RECEPTOR	Ewing sarcoma family of tumors (ESFT) is a group of aggressive pediatric malignancies driven by the EWS-FLI1 fusion protein, an aberrant transcription factor up-regulating specific target genes, such as neuropeptide Y (NPY) and its Y1 and Y5 receptors (Y5Rs). Previously, we have shown that both exogenous NPY and endogenous NPY stimulate ESFT cell death via its Y1 and Y5Rs. Here, we demonstrate that this effect is prevented by dipeptidyl peptidases (DPPs), which cleave NPY to its shorter form, NPY3-36, not active at Y1Rs. We have shown that NPY-induced cell death can be abolished by overexpression of DPPs and enhanced by their down-regulation. Both NPY treatment and DPP blockade activated the same cell death pathway mediated by poly(ADP-ribose) polymerase (PARP-1) and apoptosis-inducing factor (AIF). Moreover, the decrease in cell survival induced by DPP inhibition was blocked by Y1 and Y5R antagonists, confirming its dependence on endogenous NPY. Interestingly, similar levels of NPY-driven cell death were achieved by blocking membrane DPPIV and cytosolic DPP8 and DPP9. Thus, this is the first evidence of these intracellular DPPs cleaving releasable peptides, such as NPY, in live cells. In contrast, another membrane DPP, fibroblast activation protein (FAP), did not affect NPY actions. In conclusion, DPPs act as survival factors for ESFT cells and protect them from cell death induced by endogenous NPY. This is the first demonstration that intracellular DPPs are involved in regulation of ESFT growth and may become potential therapeutic targets for these tumors.	[Jeha, Dima; Hanafy, Jailan; Lee, Christina K.; Kitlinska, Joanna] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Soldin, Steven J.] Georgetown Univ, Dept Pharmacol, Washington, DC 20057 USA; [Mendu, Damodara R.] Georgetown Univ, Georgetown Howard Univ Ctr Clin & Translat Sci, Washington, DC 20057 USA; [Toretsky, Jeffrey A.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Sun, Junfeng] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA; [Izycka-Swieszewska, Ewa] Med Univ Gdansk, Dept Pathomorphol, PL-80211 Gdansk, Poland	Georgetown University; Georgetown University; Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; Fahrenheit Universities; Medical University Gdansk	Kitlinska, J (corresponding author), 3900 Reservoir Rd NW,Basic Sci Bldg,Rm 231A, Washington, DC 20057 USA.	jbk4@georgetown.edu	Lu, Congyi/G-3984-2013; Izycka-Swieszewska, Ewa/AAX-5191-2020	izycka-swieszewska, ewa/0000-0001-7550-1326	National Institutes of Health [1RO1CA123211-01]; Children's Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA138212, R01CA123211, R01CA133662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1CA123211-01 (to J. K.) and funding from the Children's Cancer Foundation (to J. K.).	Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Ajami K, 2008, FEBS LETT, V582, P819, DOI 10.1016/j.febslet.2008.02.005; Bjelke JR, 2006, BIOCHEM J, V396, P391, DOI 10.1042/BJ20060079; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Busek P, 2004, INT J BIOCHEM CELL B, V36, P408, DOI 10.1016/S1357-2725(03)00262-0; Cunningham CC, 2007, EXPERT OPIN INV DRUG, V16, P1459, DOI 10.1517/13543784.16.9.1459; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Edosada CY, 2006, J BIOL CHEM, V281, P7437, DOI 10.1074/jbc.M511112200; Frerker N, 2007, PEPTIDES, V28, P257, DOI 10.1016/j.peptides.2006.09.027; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; HONG WJ, 1988, J BIOL CHEM, V263, P16892; Jacques D, 2003, CAN J PHYSIOL PHARM, V81, P288, DOI 10.1139/Y02-165; Kaipio K, 2005, BIOCHEM BIOPH RES CO, V337, P633, DOI 10.1016/j.bbrc.2005.09.093; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; Kitlinska J, 2005, CANCER RES, V65, P1719, DOI 10.1158/0008-5472.CAN-04-2192; Kitlinska J, 2006, ADV EXP MED BIOL, V575, P223; Korner M, 2008, CLIN CANCER RES, V14, P5043, DOI 10.1158/1078-0432.CCR-07-4551; Lambeir AM, 2008, BIOCHEM PHARMACOL, V76, P1637, DOI 10.1016/j.bcp.2008.07.029; Lee EW, 2003, J CLIN INVEST, V111, P1853, DOI 10.1172/JCI200316929; Lu C, 2010, ONCOGENE, V29, P5630, DOI 10.1038/onc.2010.301; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; Maes MB, 2007, J LEUKOCYTE BIOL, V81, P1252, DOI 10.1189/jlb.0906546; MENTLEIN R, 1993, REGUL PEPTIDES, V49, P133, DOI 10.1016/0167-0115(93)90435-B; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Narra K, 2007, CANCER BIOL THER, V6, P1691, DOI 10.4161/cbt.6.11.4874; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Pitman MR, 2009, FRONT BIOSCI-LANDMRK, V14, P3619, DOI 10.2741/3476; Pons J, 2003, CAN J PHYSIOL PHARM, V81, P177, DOI 10.1139/Y02-166; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Sheriff' S, 1998, REGUL PEPTIDES, V75-6, P309, DOI 10.1016/S0167-0115(98)00083-4; Sheriff S, 2002, PEPTIDES, V23, P87, DOI 10.1016/S0196-9781(01)00583-6; Silva AP, 2005, BIOL CELL, V97, P457, DOI 10.1042/BC20040102; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Son MY, 2011, J CELL MOL MED, V15, P152, DOI 10.1111/j.1582-4934.2009.00956.x; Uren A, 2003, ONCOGENE, V22, P2334, DOI 10.1038/sj.onc.1206330; Van der Veken P, 2007, J MED CHEM, V50, P5568, DOI 10.1021/jm701005a; VANVALEN F, 1992, J CANCER RES CLIN, V118, P529, DOI 10.1007/BF01225268; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Wassberg E, 1999, UPSALA J MED SCI, V104, P1; Wilson MJ, 2000, J ANDROL, V21, P220; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zukowska-Grojec Z, 1998, CIRC RES, V83, P187, DOI 10.1161/01.RES.83.2.187	49	45	47	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27494	27505		10.1074/jbc.M111.224089	http://dx.doi.org/10.1074/jbc.M111.224089			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21680731	hybrid, Green Published			2022-12-27	WOS:000293268700044
J	Poomvanicha, M; Wegener, JW; Blaich, A; Fischer, S; Domes, K; Moosmang, S; Hofmann, F				Poomvanicha, Montatip; Wegener, Joerg W.; Blaich, Anne; Fischer, Stefanie; Domes, Katrin; Moosmang, Sven; Hofmann, Franz			Facilitation and Ca2+-dependent Inactivation Are Modified by Mutation of the Ca(v)1.2 Channel IQ Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN KINASE-II; RAT VENTRICULAR MYOCYTES; GATED CA2+ CHANNELS; CALCIUM-CHANNEL; PROTEIN-KINASE; DEPENDENT FACILITATION; ION CHANNELS; VOLTAGE; PHOSPHORYLATION; IDENTIFICATION	The heart muscle responds to physiological needs with a short-term modulation of cardiac contractility. This process is determined mainly by properties of the cardiac L-type Ca2+ channel (Ca(v)1.2), including facilitation and Ca2+-dependent inactivation (CDI). Both facilitation and CDI involve the interaction of calmodulin with the IQ motif of the Ca(v)1.2 channel, especially with Ile-1624. To verify this hypothesis, we created a mouse line in which Ile-1624 was mutated to Glu (Ca(v)1.2(I1624E) mice). Homozygous Ca(v)1.2(I1624E) mice were not viable. Therefore, we inactivated the floxed Ca(v)1.2 gene of heterozygous Ca(v)1.2(I1624E) mice by the alpha-myosin heavy chain-MerCreMer system. The resulting I/E mice were studied at day 10 after treatment with tamoxifen. Electrophysiological recordings in ventricular cardiomyocytes revealed a reduced Ca(v)1.2 current (I-Ca) density in I/E mice. Steady-state inactivation and recovery from inactivation were modified in I/E versus control mice. In addition, voltage-dependent facilitation was almost abolished in I/E mice. The time course of I-Ca inactivation in I/E mice was not influenced by the use of Ba2+ as a charge carrier. Using 1,2-bis(o-aminophenoxy)ethane-N,N,N ',N '-tetraacetic acid as a chelating agent for intracellular Ca2+, inactivation of ICa was slowed down in control but not I/E mice. The results show that the I/E mutation abolishes Ca2+/calmodulin-dependent regulation of Ca(v)1.2. The Ca(v)1.2(I1624E) mutation transforms the channel to a phenotype mimicking CDI.	[Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, FOR923, Forschergrp 923, D-80802 Munich, Germany	Technical University of Munich	Hofmann, F (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, FOR923, Forschergrp 923, Biedersteiner Str 29, D-80802 Munich, Germany.	franz.hofmann@mytum.de		Wegener, Jorg/0000-0002-8129-1537	Deutsche Forschungsgemeinschaft; Fond der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Fond der Chemischen Industrie.	ANDERSON ME, 1994, CIRC RES, V75, P854, DOI 10.1161/01.RES.75.5.854; Anderson ME, 2001, J MOL CELL CARDIOL, V33, P639, DOI 10.1006/jmcc.2000.1354; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; Blaich A, 2010, P NATL ACAD SCI USA, V107, P10285, DOI 10.1073/pnas.0914287107; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Guo JQ, 2006, J PHYSIOL-LONDON, V574, P509, DOI 10.1113/jphysiol.2006.109199; HALLING DB, 2006, SCI STKE, pER1, DOI DOI 10.1126/STKE.3152005RE15; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; KLOCKNER U, 1987, AM J PHYSIOL, V253, pH1601, DOI 10.1152/ajpheart.1987.253.6.H1601; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Li L, 1997, J PHYSIOL-LONDON, V501, P17, DOI 10.1111/j.1469-7793.1997.017bo.x; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; ROSS J, 1995, CIRCULATION, V92, P2327, DOI 10.1161/01.CIR.92.8.2327; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Sham JSK, 1997, J PHYSIOL-LONDON, V500, P285, DOI 10.1113/jphysiol.1997.sp022020; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; YUAN WL, 1994, AM J PHYSIOL, V267, pH982, DOI 10.1152/ajpheart.1994.267.3.H982; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	34	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26702	26707		10.1074/jbc.M111.247841	http://dx.doi.org/10.1074/jbc.M111.247841			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21665954	Green Published, hybrid			2022-12-27	WOS:000293078200047
J	Xiao, XJ; Mukherjee, A; Ross, LE; Lowe, ME				Xiao, Xunjun; Mukherjee, Amitava; Ross, Leah E.; Lowe, Mark E.			Pancreatic Lipase-related Protein-2 (PLRP2) Can Contribute to Dietary Fat Digestion in Human Newborns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-STIMULATED LIPASE; COLIPASE INTERACTIONS; YEAST-CELLS; HUMAN-MILK; ACTIVATION; MICELLES; EXPRESSION; ENZYMES; ABSORPTION; SECRETION	In newborn mice, PLRP2 is essential for fat digestion. In human infants, the role of PLRP2 in fat digestion is unclear, as it has poor activity against long-chain triglycerides in vitro. Also, many infants carry a genetic polymorphism resulting in a truncated protein, PLRP2 W340X, which may impact function significantly. We re-examined the properties of recombinant human PLRP2 and studied the impact of W340X mutation on its function. In the presence of bile salt micelles and colipase, human PLRP2 hydrolyzed long-chain tri-, di-, and monoglycerides. It hydrolyzed triolein at a level much lower than that of pancreatic triglyceride lipase, but close to that of carboxyl ester lipase, after a long lag phase, which could be eliminated by the addition of oleic acids. Human PLRP2 W340X was poorly secreted and largely retained inside the cell. The retention of the mutant protein triggered endoplasmic reticulum stress and unfolded protein responses. Our results show that earlier studies underestimated human PLRP2 activity against triolein by employing suboptimal assay conditions. In vivo, dietary fat emulsions contain fatty acids as a result of the action of gastric lipase. Consequently, PLRP2 can contribute to fat digestion during early infancy. Furthermore, infants with homozygous W340X alleles will not secrete functional PLRP2 and may have inefficient dietary fat digestion, particularly when breastfeeding is unavailable. Additionally, the aberrant folding of W340X mutant may cause chronic cellular stress and increase susceptibility of pancreatic exocrine cells to other metabolic stressors.	[Xiao, Xunjun; Mukherjee, Amitava; Ross, Leah E.; Lowe, Mark E.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Dept Pediat, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lowe, ME (corresponding author), 1 Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.	Mark.lowe@chp.edu	Mukherjee, Amitava/AAK-4002-2020	Mukherjee, Amitava/0000-0001-5603-5147; Xiao, Xunjun/0000-0001-5930-4664	National Institutes of Health [DK080820]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080820.	Amara S, 2009, BBA-MOL CELL BIOL L, V1791, P983, DOI 10.1016/j.bbalip.2009.05.002; Andersson L, 1996, BBA-LIPID LIPID MET, V1302, P236, DOI 10.1016/0005-2760(96)00068-9; Andersson Y, 2007, ACTA PAEDIATR, V96, P1445, DOI 10.1111/j.1651-2227.2007.00450.x; BORGSTROM B, 1980, GASTROENTEROLOGY, V78, P954; BROCKMAN HL, 1973, J BIOL CHEM, V248, P4965; Cao HN, 2003, J HUM GENET, V48, P443, DOI 10.1007/s10038-003-0051-1; CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876, DOI 10.1016/0016-5085(93)90908-U; Chahinian H, 2002, BIOCHEMISTRY-US, V41, P13725, DOI 10.1021/bi0257944; Cordle RA, 1998, J LIPID RES, V39, P1759; Crandall WV, 2001, J BIOL CHEM, V276, P12505, DOI 10.1074/jbc.M009986200; CYGLER M, 1993, PROTEIN SCI, V2, P366; D'Agostino D, 2004, J NUTR, V134, P132, DOI 10.1093/jn/134.1.132; D'Agostino D, 2002, J BIOL CHEM, V277, P7170, DOI 10.1074/jbc.M108328200; Eydoux C, 2008, BIOCHEMISTRY-US, V47, P9553, DOI 10.1021/bi8005576; Eydoux C, 2007, J LIPID RES, V48, P1539, DOI 10.1194/jlr.M600486-JLR200; FOMON SJ, 1970, AM J CLIN NUTR, V23, P1299; FREDRIKZON B, 1978, PEDIATR RES, V12, P1048, DOI 10.1203/00006450-197811000-00004; Freie AB, 2006, J BIOL CHEM, V281, P7793, DOI 10.1074/jbc.M512984200; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; HANSSON L, 1993, J BIOL CHEM, V268, P26692; Hermoso J, 1997, EMBO J, V16, P5531, DOI 10.1093/emboj/16.18.5531; JENNENS ML, 1995, J LIPID RES, V36, P1029; LARSSON A, 1986, BIOCHIM BIOPHYS ACTA, V876, P543, DOI 10.1016/0005-2760(86)90042-1; Lowe ME, 1997, METHOD ENZYMOL, V284, P285; Lowe ME, 1998, J BIOL CHEM, V273, P31215, DOI 10.1074/jbc.273.47.31215; PATTON JS, 1978, BIOCHIM BIOPHYS ACTA, V529, P67, DOI 10.1016/0005-2760(78)90104-2; PAYNE RM, 1994, AM J PHYSIOL, V266, pG914, DOI 10.1152/ajpgi.1994.266.5.G914; Pignol D, 2000, J BIOL CHEM, V275, P4220, DOI 10.1074/jbc.275.6.4220; Reboul E, 2006, BBA-MOL CELL BIOL L, V1761, P4, DOI 10.1016/j.bbalip.2005.12.013; Sahasrabudhe AV, 1998, PROTEIN EXPRES PURIF, V14, P425, DOI 10.1006/prep.1998.0974; Sias B, 2004, BIOCHEMISTRY-US, V43, P10138, DOI 10.1021/bi049818d; van Tilbeurgh H, 1999, BBA-MOL CELL BIOL L, V1441, P173, DOI 10.1016/S1388-1981(99)00149-3; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; Verger R, 1980, Methods Enzymol, V64, P340; Verger R., 1984, LIPASES, P84; WANG CS, 1989, AM J CLIN NUTR, V49, P457, DOI 10.1093/ajcn/49.3.457; WIELOCH T, 1982, J BIOL CHEM, V257, P1523; Yang YQ, 2000, J LIPID RES, V41, P48; Yang YQ, 1998, PROTEIN EXPRES PURIF, V13, P36, DOI 10.1006/prep.1998.0874; Yang YQ, 2000, PEDIATR RES, V47, P184, DOI 10.1203/00006450-200002000-00006	40	29	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26353	26363		10.1074/jbc.M111.249813	http://dx.doi.org/10.1074/jbc.M111.249813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652702	hybrid, Green Published			2022-12-27	WOS:000293078200012
J	Johansen, C; Riis, JL; Gedebjerg, A; Kragballe, K; Iversen, L				Johansen, Claus; Riis, Jette L.; Gedebjerg, Anne; Kragballe, Knud; Iversen, Lars			Tumor Necrosis Factor alpha-Mediated Induction of Interleukin 17C in Human Keratinocytes Is Controlled by Nuclear Factor kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LESIONAL PSORIATIC SKIN; IL-17 CYTOKINE FAMILY; TRANSCRIPTION FACTORS; ATOPIC-DERMATITIS; SIGNALING PATHWAY; KEY ROLE; ACTIVATION; P65; PHOSPHORYLATION; RECEPTORS	IL-17C is a member of the IL-17 family of cytokines. The expression of IL-17C has been demonstrated to be strongly induced by TNF alpha in human keratinocytes, and recently the level of IL-17C was found to be increased in the inflammatory skin disease psoriasis. However, little is known about the molecular mechanisms involved in the regulation of IL-17C. Here, we show that pretreatment of cultured human keratinocytes with the inhibitor of kappa B kinase 2 inhibitor, SC-514, resulted in a significant reduction in both IL-17C mRNA and protein expression, indicating the significance of this pathway in the regulation of IL-17C. NF-kappa B binding sites were identified upstream from the IL-17C gene, and by electrophoretic mobility shift assay NF-kappa B was shown to bind to all three identified binding sites. Moreover, NF-kappa B binding to these sites was inducible by TNF alpha Supershift analysis revealed binding of the NF-kappa B subunits p65 and p50 to all three NF-kappa B binding sites. To determine the contribution of NF-kappa B in IL-17C expression, we conducted luciferase gene reporter experiments and demonstrated that a 3204-bp promoter fragment of IL-17C containing three putative NF-kappa B binding sites was strongly activated by TNF alpha. Interestingly, mutations of the three NF-kappa B binding sites revealed that one specific NF-kappa B binding site was crucial for the TNF alpha-mediated IL-17C induction because mutation of this specific site completely abolished TNF alpha-induced IL-17C promoter activation. We conclude that the activation of NF-kappa B (p65/p50) is crucial for the TNF alpha-induced stimulation of IL-17C expression in human keratinocytes.	[Johansen, Claus; Riis, Jette L.; Gedebjerg, Anne; Kragballe, Knud; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark	Aarhus University	Johansen, C (corresponding author), Aarhus Univ Hosp, Dept Dermatol, PP Oerumsgade 11, DK-8000 Aarhus C, Denmark.	claus.johansen@ki.au.dk		Iversen, Lars/0000-0003-1816-4508; Johansen, Claus/0000-0002-5665-5212; Johansen, Claus/0000-0003-0240-5127				Abeyama K, 2000, J CLIN INVEST, V105, P1751, DOI 10.1172/JCI9745; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Dajee M, 2006, J INVEST DERMATOL, V126, P1792, DOI 10.1038/sj.jid.5700307; Danning CL, 2000, ARTHRITIS RHEUM-US, V43, P1244, DOI 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2; Gaffen SL, 2006, VITAM HORM, V74, P255, DOI 10.1016/S0083-6729(06)74010-9; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Huber MA, 2002, J BIOL CHEM, V277, P1268, DOI 10.1074/jbc.M109358200; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Johansen C, 2005, J INVEST DERMATOL, V124, P1284, DOI 10.1111/j.0022-202X.2005.23749.x; Johansen C, 2010, BRIT J DERMATOL, V163, P1194, DOI 10.1111/j.1365-2133.2010.10036.x; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Johansen C, 2000, J INVEST DERMATOL, V114, P1174, DOI 10.1046/j.1523-1747.2000.00003.x; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KRAGBALLE K, 1985, BRIT J DERMATOL, V112, P263, DOI 10.1111/j.1365-2133.1985.tb04852.x; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; Nakagami H, 2006, CURR PHARM BIOTECHNO, V7, P95, DOI 10.2174/138920106776597702; Nakamura H, 2002, GENE THER, V9, P1221, DOI 10.1038/sj.gt.3301724; Nickoloff BJ, 2007, CLIN REV ALLERG IMMU, V33, P45, DOI 10.1007/s12016-007-0039-2; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sarkar FH, 2008, INT REV IMMUNOL, V27, P293, DOI 10.1080/08830180802276179; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	42	41	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25487	25494		10.1074/jbc.M111.240671	http://dx.doi.org/10.1074/jbc.M111.240671			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628458	Green Published, hybrid			2022-12-27	WOS:000293073000011
J	Majerle, A; Pristovsek, P; Mancek-Keber, M; Jerala, R				Majerle, Andreja; Pristovsek, Primoz; Mancek-Keber, Mateja; Jerala, Roman			Interaction of the HIV-1 gp120 Viral Protein V3 Loop with Bacterial Lipopolysaccharide A PATTERN RECOGNITION INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRINCIPAL NEUTRALIZING DETERMINANT; ENVELOPE GLYCOPROTEIN; ALTERNATIVE CONFORMATIONS; STRUCTURAL ELEMENTS; CORECEPTOR BINDING; FLUORESCENT-PROBE; PEPTIDE REVEALS; NMR STRUCTURE; LIPID-A	HIV-1 represents an elusive target for therapeutic compounds due to its high rate of mutation. Targeting structural patterns instead of a constantly changing specific three-dimensional structure may represent an approach that is less sensitive to viral mutations. The V3 loop of gp120 of HIV-1, which is responsible for binding of viral gp120 to CCR5 or CXCR4 coreceptors, has already been identified as an effective target for the inhibition of viral entry. The peptide derived from the V3 loop of gp120 specifically interacts with the lipid A moiety of LPS, as does the full gp120 protein. NMR analysis of V3 in complex with LPS shows formation of an amphipathic turn. The interaction between LPS and V3 relies on the structural pattern, comprising a combination of hydrophobic and charge interactions, similar to the interaction between antimicrobial peptides and LPS. LPS inhibited binding of gp120 to the surface of target T cells. Nonendotoxic LPS antagonists inhibited viral infection, demonstrating the possibility for the development of an inhibitor of HIV-1 attachment to T cells based on the recognition of a conserved structural pattern.	[Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Majerle, Andreja; Mancek-Keber, Mateja; Jerala, Roman] Excellent NMR Future Innovat Sustainable Technol, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Dept Biotechnol, Hajdrihova Ulica 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si		Pristovsek, Primoz/0000-0002-2304-1791	Slovenian Research Agency; Excellent NMR(right arrow)Future Innovation for Sustainable Technologies Centre of Excellence, Ljubljana, Slovenia	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Excellent NMR(right arrow)Future Innovation for Sustainable Technologies Centre of Excellence, Ljubljana, Slovenia	This work was supported by the Slovenian Research Agency and Excellent NMR -> Future Innovation for Sustainable Technologies Centre of Excellence, Ljubljana, Slovenia.	Andrianov AM, 2007, J BIOMOL STRUCT DYN, V24, P597, DOI 10.1080/07391102.2007.10507149; Basmaciogullari S, 2002, J VIROL, V76, P10791, DOI 10.1128/JVI.76.21.10791-10800.2002; BATINIC D, 1992, J BIOL CHEM, V267, P6664; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Bjorndal A, 1997, J VIROL, V71, P7478; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cole AM, 2003, FEBS LETT, V535, P195, DOI 10.1016/S0014-5793(02)03860-7; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; Del Prete GQ, 2010, J VIROL, V84, P8777, DOI 10.1128/JVI.00333-10; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; Fantini J, 1997, J BIOL CHEM, V272, P7245, DOI 10.1074/jbc.272.11.7245; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Franchin G, 2000, J IMMUNOL, V164, P2592, DOI 10.4049/jimmunol.164.5.2592; FREED EO, 1991, J VIROL, V65, P190, DOI 10.1128/JVI.65.1.190-194.1991; Geng MY, 2003, ANTIVIR RES, V59, P127, DOI 10.1016/S0166-3542(03)00068-8; Genois N, 2000, J LEUKOCYTE BIOL, V68, P854; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GURGO C, 1988, VIROLOGY, V164, P531, DOI 10.1016/0042-6822(88)90568-5; HARROP HA, 1994, AIDS, V8, P183, DOI 10.1097/00002030-199402000-00005; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAROSA GJ, 1990, SCIENCE, V249, P932, DOI 10.1126/science.2392685; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mancek-Keber M, 2006, FASEB J, V20, P1836, DOI 10.1096/fj.06-5862com; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Melendez Johana, 2001, Cellular and Molecular Biology Online Papers, V47, pOL51; Mor A, 2009, BIOCHEMISTRY-US, V48, P3288, DOI 10.1021/bi802308n; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Pristovsek P, 1999, J MED CHEM, V42, P4604, DOI 10.1021/jm991031b; Pristovsek P, 2005, J MED CHEM, V48, P1666, DOI 10.1021/jm049217k; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; Seydel U, 2005, FEBS J, V272, P327, DOI 10.1111/j.1742-4658.2004.04471.x; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Sharpe S, 2004, J AM CHEM SOC, V126, P4979, DOI 10.1021/ja0392162; Simard S, 2008, CLIN IMMUNOL, V127, P198, DOI 10.1016/j.clim.2008.01.007; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Tugarinov V, 2000, STRUCT FOLD DES, V8, P385, DOI 10.1016/S0969-2126(00)00119-2; Vaara M, 1999, ANTIMICROB AGENTS CH, V43, P1459, DOI 10.1128/AAC.43.6.1459; Verani A, 2002, J IMMUNOL, V168, P6388, DOI 10.4049/jimmunol.168.12.6388; Wood SJ, 2004, COMB CHEM HIGH T SCR, V7, P239; Wu G, 2000, J BIOL CHEM, V275, P36645, DOI 10.1074/jbc.M005369200; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wuthrich K, 1986, NMR PROTEINS NUCL AC	60	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26228	26237		10.1074/jbc.M111.220434	http://dx.doi.org/10.1074/jbc.M111.220434			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636577	Green Published, hybrid			2022-12-27	WOS:000293073000080
J	Ouda, R; Onomoto, K; Takahasi, K; Edwards, MR; Kato, H; Yoneyama, M; Fujita, T				Ouda, Ryota; Onomoto, Koji; Takahasi, Kiyohiro; Edwards, Michael R.; Kato, Hiroki; Yoneyama, Mitsutoshi; Fujita, Takashi			Retinoic Acid-inducible Gene I-inducible miR-23b Inhibits Infections by Minor Group Rhinoviruses through Down-regulation of the Very Low Density Lipoprotein Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSES; HEPATITIS-C VIRUS; RIG-I; RNA; EXPRESSION; PROTEINS; ASTHMA; STAT1; EXACERBATIONS	In mammals, viral infections are detected by innate immune receptors, including Toll-like receptor and retinoic acid inducible gene I (RIG-I)-like receptor (RLR), which activate the type I interferon (IFN) system. IFN essentially activates genes encoding antiviral proteins that inhibit various steps of viral replication as well as facilitate the subsequent activation of acquired immune responses. In this study, we investigated the expression of non-coding RNA upon viral infection or RLR activation. Using a microarray, we identified several microRNAs (miRNA) specifically induced to express by RLR signaling. As suggested by Bioinformatics (miRBase Target Data base), one of the RLR-inducible miRNAs, miR-23b, actually knocked down the expression of very low density lipoprotein receptor (VLDLR) and LDLR-related protein 5 (LRP5). Transfection of miR-23b specifically inhibited infection of rhinovirus 1B (RV1B), which utilizes the low density lipoprotein receptor (LDLR) family for viral entry. Conversely, introduction of anti-miRNA-23b enhanced the viral yield. Knockdown experiments using small interfering RNA (siRNA) revealed that VLDLR, but not LRP5, is critical for an efficient infection by RV1B. Furthermore, experiments with the transfection of infectious viral RNA revealed that miR-23b did not affect post-entry viral replication. Our results strongly suggest that RIG-I signaling results in the inhibitions of infections of RV1B through the miR-23b-mediated down-regulation of its receptor VLDLR.	[Ouda, Ryota; Onomoto, Koji; Takahasi, Kiyohiro; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Mol Genet Lab, Inst Virus Res, Kyoto 6068507, Japan; [Ouda, Ryota; Fujita, Takashi] Kyoto Univ, Mol Cell Biol Lab, Grad Sch Biostudies, Kyoto 6068507, Japan; [Takahasi, Kiyohiro] Kyoto Univ, Inst Innovat NanoBio Drug Discovery & Dev, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Yoneyama, Mitsutoshi] Chiba Univ, Med Mycol Res Ctr, Chiba 2608673, Japan; [Yoneyama, Mitsutoshi] PRESTO Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Edwards, Michael R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, London SW7 2AZ, England; [Edwards, Michael R.] MRC, London SE1 9RT, England; [Edwards, Michael R.] Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England; [Edwards, Michael R.] Ctr Resp Infect, London SW7 2AZ, England	Kyoto University; Kyoto University; Kyoto University; Chiba University; Japan Science & Technology Agency (JST); Imperial College London; University of London; King's College London	Fujita, T (corresponding author), Kyoto Univ, Mol Genet Lab, Inst Virus Res, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017; Ouda, Ryota/P-9681-2019	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Edwards, Michael Robert/0000-0001-6837-0532	Ministry of Education, Science, Sports and Culture in Japan; Ministry of Health, Labor, and Welfare; PRESTO Japan Science and Technology Agency; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Nippon Boehringer Ingelheim; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre] Funding Source: researchfish	Ministry of Education, Science, Sports and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); PRESTO Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Nippon Boehringer Ingelheim(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	This work was supported in part by a Grant-in-aid from the Ministry of Education, Science, Sports and Culture in Japan, the Ministry of Health, Labor, and Welfare, the PRESTO Japan Science and Technology Agency, the Uehara Memorial Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and Nippon Boehringer Ingelheim.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grunberg K, 2000, CLIN EXP ALLERGY, V30, P1015; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Johnston Sebastian L, 2005, Proc Am Thorac Soc, V2, P150, DOI 10.1513/pats.200502-018AW; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lehtonen A, 1997, J IMMUNOL, V159, P794; Marlovits TC, 1998, J VIROL, V72, P10246, DOI 10.1128/JVI.72.12.10246-10250.1998; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nizet S, 2005, J VIROL, V79, P14730, DOI 10.1128/JVI.79.23.14730-14736.2005; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okun VM, 2001, J BIOL CHEM, V276, P1057, DOI 10.1074/jbc.M008039200; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Savolainen Carita, 2003, Paediatr Respir Rev, V4, P91, DOI 10.1016/S1526-0542(03)00030-7; Shingai M, 2007, J IMMUNOL, V179, P6123, DOI 10.4049/jimmunol.179.9.6123; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Vaucheret H, 2001, J CELL SCI, V114, P3083; Vlasak M, 2005, J VIROL, V79, P7389, DOI 10.1128/JVI.79.12.7389-7395.2005; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wu AJ, 1997, J CELL PHYSIOL, V173, P110, DOI 10.1002/(SICI)1097-4652(199710)173:1<110::AID-JCP13>3.0.CO;2-M; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	43	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26210	U901		10.1074/jbc.M111.229856	http://dx.doi.org/10.1074/jbc.M111.229856			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642441	hybrid, Green Published			2022-12-27	WOS:000293073000078
J	Wakabayashi, H; Griffiths, AE; Fay, PJ				Wakabayashi, Hironao; Griffiths, Amy E.; Fay, Philip J.			Increasing Hydrophobicity or Disulfide Bridging at the Factor VIII A1 and C2 Domain Interface Enhances Procofactor Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT DISSOCIATION; A1/A3-C1-C2 DIMER; COFACTOR ACTIVITY; CHARGED RESIDUES; CA2+ BINDING; MUTATIONS; ASSOCIATION; CHAINS; PH	Factor VIII (FVIII) consists of a heavy (A1A2B domains) and light chain (A3C1C2 domains), whereas the contiguous A1A2 domains are separate subunits in the cofactor, FVIIIa. FVIII x-ray structures show close contacts between A1 and C2 domains. To explore the role of this region in FVIII(a) stability, we generated a variant containing a disulfide bond between A1 and C2 domains by mutating Arg-121 and Leu-2302 to Cys (R121C/L2302C) and a second variant with a bulkier hydrophobic group (A108I) to better occupy a cavity between A1 and C2 domains. Disulfide bonding in the R121C/L2302C variant was >90% efficient as judged by Western blots. Binding affinity between the A108I A1 and A3C1C2 subunits was increased similar to 3.7-fold in the variant as compared with WT as judged by changes in fluorescence of acrylodan-labeled A1 subunits. FVIII thermal and chemical stability were monitored following rates of loss of FVIII activity at 57 C or in guanidinium by factor Xa generation assays. The rate of decay of FVIIIa activity was monitored at 23 C following activation by thrombin. Both R121C/L2302C and A108I variants showed up to similar to 4-fold increases in thermal stability but minimal improvements in chemical stability. The purified A1 subunit of A108I reconstituted with the A3C1C2 subunit showed an similar to 4.6-fold increase in thermal stability, whereas reconstitution of the variant A1 with a truncated A3C1 subunit showed similar stability values as compared with WTA1. Together, these results suggest that altering contacts at this A1-C2 junction by covalent modification or increasing hydrophobicity increases inter-chain affinity and functionally enhances FVIII stability.	[Wakabayashi, Hironao; Griffiths, Amy E.; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Sch Med, Dept Biochem & Biophys, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL38199, HL76213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076213, R01HL038199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL38199 and HL76213 (to P. J. F.). Preliminary accounts of portions of this work were presented at the 22nd Congress of the International Society on Thrombosis and Hemostasis, July 13, 2009, Boston, MA and the 51st Annual Meeting of the American Society of Hematology, December 5, 2009, New Orleans, LA.	Ansong C, 2005, BIOCHEMISTRY-US, V44, P8850, DOI 10.1021/bi050145o; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Hakeos WH, 2002, THROMB HAEMOSTASIS, V88, P781, DOI 10.1055/s-0037-1613302; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; OVER J, 1984, SCAND J HAEMATOL, V33, P13; Pipe SW, 2001, BLOOD, V97, P685, DOI 10.1182/blood.V97.3.685; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Wakabayashi H, 2005, BIOCHEMISTRY-US, V44, P10298, DOI 10.1021/bi050638t; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2002, BIOCHEMISTRY-US, V41, P8485, DOI 10.1021/bi025589o; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Wakabayashi H, 2008, J BIOL CHEM, V283, P11645, DOI 10.1074/jbc.M710252200; Wakabayashi H, 2006, BBA-PROTEINS PROTEOM, V1764, P1094, DOI 10.1016/j.bbapap.2006.04.004; Wakabayashi H, 2010, J BIOL CHEM, V285, P25176, DOI 10.1074/jbc.M110.106906	26	10	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25748	25755		10.1074/jbc.M111.241109	http://dx.doi.org/10.1074/jbc.M111.241109			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628455	Green Published, hybrid			2022-12-27	WOS:000293073000036
J	Wong, CYA; Wuriyanghan, H; Xie, Y; Lin, MF; Abel, PW; Tu, YP				Wong, Chuu-Yun A.; Wuriyanghan, Hada; Xie, Yan; Lin, Ming-Fong; Abel, Peter W.; Tu, Yaping			Epigenetic Regulation of Phosphatidylinositol 3,4,5-Triphosphate-dependent Rac Exchanger 1 Gene Expression in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; BETA-GAMMA-SUBUNITS; P-REX1; ACTIVATION; MIGRATION; PROMOTER; PROTEIN; SP1; TRANSCRIPTION; TARGET	Aberrant up-regulation of P-Rex1 expression plays important roles in cancer progression and metastasis. The present study investigated the regulatory mechanism underlying P-Rex1 gene expression in prostate cancer cells. We showed that P-Rex1 expression was much higher in metastatic prostate cancer cells than in prostate epithelial cells and non-metastatic prostate cancer cells. Histone deacetylase (HDAC) inhibitors or silence of endogenous HDAC1 and HDAC2 markedly elevated P-Rex1 transcription in non-metastatic prostate cancer cells, whereas overexpression of recombinant HDAC1 in metastatic prostate cancer cells suppressed P-Rex1 expression. HDAC inhibitor trichostatin A (TSA) also significantly increased P-Rex1 promoter activity and caused acetylated histones to accumulate and associate with the P-Rex1 promoter. One Sp1 site, essential for basal promoter activity, was identified as critical for the TSA effect. TSA treatment did not alter the DNA-binding activity of Sp1 toward the P-Rex1 promoter; however, it facilitated the dissociation of the repressive HDAC1 and HDAC2 from the Sp1 binding region. Interestingly, HDAC1 association with Sp1 and with the P-Rex1 promoter were much weaker in metastatic prostate cancer PC-3 cells than in non-metastatic prostate cancer cells, and HDAC inhibitors only had very modest stimulatory effects on P-Rex1 promoter activity and P-Rex1 expression in PC-3 cells. Altogether, our studies demonstrate that HDACs could regulate P-Rex1 gene transcription by interaction with Sp1 and by region-specific changes in histone acetylation within the P-Rex1 promoter. Disassociation of HDACs from Sp1 on the P-Rex1 promoter may contribute to aberrant up-regulation of P-Rex1 in cancer.	[Wong, Chuu-Yun A.; Wuriyanghan, Hada; Xie, Yan; Abel, Peter W.; Tu, Yaping] Creighton Univ, Dept Pharmacol, Sch Med, Omaha, NE 68178 USA; [Lin, Ming-Fong] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68131 USA	Creighton University; University of Nebraska System; University of Nebraska Medical Center	Tu, YP (corresponding author), 2500 Calif Plaza, Omaha, NE 68178 USA.	yapingtu@creighton.edu		Abel, Peter/0000-0002-6588-1676	National Institutes of Health [CA125661, CA88184]; U.S. Dept. of Defense [W81XWH-07-1-0189]; NATIONAL CANCER INSTITUTE [R01CA125661, R01CA088184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA125661 (to Y. T.) and CA88184 (to M. F. L.). This work was also supported by the U.S. Dept. of Defense Prostate Cancer Research Program (Grant W81XWH-07-1-0189 to Y. T.).	Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bicaku E, 2008, CANCER RES, V68, P1513, DOI 10.1158/0008-5472.CAN-07-2822; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Camarero N, 2003, NUCLEIC ACIDS RES, V31, P1693, DOI 10.1093/nar/gkg262; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Jackson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011962; Kang JE, 2005, CELL PHYSIOL BIOCHEM, V16, P23, DOI 10.1159/000087728; Knight-Krajewski S, 2004, ONCOGENE, V23, P5513, DOI 10.1038/sj.onc.1207708; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Murillo H, 2006, GENE CHROMOSOME CANC, V45, P702, DOI 10.1002/gcc.20333; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sellak H, 2002, CIRC RES, V90, P405, DOI 10.1161/hh0402.105898; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; VanLint C, 1996, GENE EXPRESSION, V5, P245; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wolff D. W., 2011, INT J CANC IN PRESS; Wolffe AP, 1997, NATURE, V387, P16, DOI 10.1038/387016a0; Xie Y, 2007, MOL PHARMACOL, V72, P73, DOI 10.1124/mol.107.033894; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Zhao TM, 2007, J LEUKOCYTE BIOL, V81, P1127, DOI 10.1189/jlb.0406251	37	21	23	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25813	25822		10.1074/jbc.M110.211292	http://dx.doi.org/10.1074/jbc.M110.211292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636851	Green Published, hybrid			2022-12-27	WOS:000293073000043
J	Xie, F; Liu, T; Qian, WJ; Petyuk, VA; Smith, RD				Xie, Fang; Liu, Tao; Qian, Wei-Jun; Petyuk, Vladislav A.; Smith, Richard D.			Liquid Chromatography-Mass Spectrometry-based Quantitative Proteomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COMPLEX PROTEIN MIXTURES; ABSOLUTE QUANTIFICATION; SIGNALING NETWORKS; ACCURATE MASS; IN-VIVO; EXPRESSION PROTEOMICS; PEPTIDES; STRATEGY; PLASMA; TAGS	LC-MS-based quantitative proteomics has become increasingly applied to a wide range of biological applications due to growing capabilities for broad proteome coverage and good accuracy and precision in quantification. Herein, we review the current LC-MS-based quantification methods with respect to their advantages and limitations and highlight their potential applications.	[Xie, Fang; Liu, Tao; Qian, Wei-Jun; Petyuk, Vladislav A.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Smith, RD (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	rds@pnl.gov	QIAN, Wei-Jun/AAC-1907-2021; Qian, Wei-Jun/C-6167-2011; Smith, Richard D/J-3664-2012; Liu, Tao/A-9020-2013	QIAN, Wei-Jun/0000-0002-5393-2827; Smith, Richard D/0000-0002-2381-2349; Liu, Tao/0000-0001-9529-6550; Petyuk, Vladislav/0000-0003-4076-151X	National Institutes of Health from the National Center for Research Resources for Integrative Biology [RR018522]; United States Department of Energy; Battelle for the Department of Energy [DE-AC05-76RLO 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources for Integrative Biology; United States Department of Energy(United States Department of Energy (DOE)); Battelle for the Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR018522 from the National Center for Research Resources for Integrative Biology (to R. D. S.). This work was also supported by a United States Department of Energy early career research award (to W.-J. Q.). Experimental work was performed in the Environmental Molecular Sciences Laboratory, a Department of Energy/Biological and Environmental Research national scientific user facility on the Pacific Northwest National Laboratory campus in Richland, WA. Pacific Northwest National Laboratory is a multiprogram national laboratory operated by Battelle for the Department of Energy under Contract DE-AC05-76RLO 1830. This is the fourth article in the Thematic Minireview Series on Biological Applications of Mass Spectrometry. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Brun V, 2007, MOL CELL PROTEOMICS, V6, P2139, DOI 10.1074/mcp.M700163-MCP200; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Duncan MW, 2010, NAT BIOTECHNOL, V28, P659, DOI 10.1038/nbt0710-659; Elliott MH, 2009, J MASS SPECTROM, V44, P1637, DOI 10.1002/jms.1692; Fenselau C, 2009, J PROTEOME RES, V8, P2140, DOI 10.1021/pr8009879; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Havlis J, 2004, ANAL CHEM, V76, P3029, DOI 10.1021/ac035286f; Jaffe JD, 2006, MOL CELL PROTEOMICS, V5, P1927, DOI 10.1074/mcp.M600222-MCP200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kiyonami R., 2011, MOL CELL PR IN PRESS; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Li XJ, 2005, MOL CELL PROTEOMICS, V4, P1328, DOI 10.1074/mcp.M500141-MCP200; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu T, 2004, ANAL CHEM, V76, P5345, DOI 10.1021/ac049485q; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Mason CJ, 2007, MOL CELL PROTEOMICS, V6, P305, DOI 10.1074/mcp.M600148-MCP200; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Nita-Lazar A, 2008, PROTEOMICS, V8, P4433, DOI 10.1002/pmic.200800231; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Petritis BO, 2009, J PROTEOME RES, V8, P2157, DOI 10.1021/pr800971w; Petyuk VA, 2007, GENOME RES, V17, P328, DOI 10.1101/gr.5799207; Petyuk VA, 2010, METHODS, V50, P77, DOI 10.1016/j.ymeth.2009.07.009; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Pratt JM, 2006, NAT PROTOC, V1, P1029, DOI 10.1038/nprot.2006.129; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Qian WJ, 2010, J PROTEOME RES, V9, P4779, DOI 10.1021/pr1005026; Qian WJ, 2009, J PROTEOME RES, V8, P290, DOI 10.1021/pr800467r; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Qian WJ, 2005, PROTEOMICS, V5, P572, DOI 10.1002/pmic.200400942; Ramos-Fernandez A, 2007, MOL CELL PROTEOMICS, V6, P1274, DOI 10.1074/mcp.T600029-MCP200; Reynolds KJ, 2002, J PROTEOME RES, V1, P27, DOI 10.1021/pr0100016; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schmidt A, 2003, J AM SOC MASS SPECTR, V14, P492, DOI 10.1016/S1044-0305(03)00128-4; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Stewart II, 2001, RAPID COMMUN MASS SP, V15, P2456, DOI 10.1002/rcm.525; Strittmatter EF, 2003, J AM SOC MASS SPECTR, V14, P980, DOI 10.1016/S1044-0305(03)00146-6; Tabb DL, 2003, ANAL CHEM, V75, P2470, DOI 10.1021/ac026424o; Tang KQ, 2004, J AM SOC MASS SPECTR, V15, P1416, DOI 10.1016/j.jasms.2004.04.034; Wilm M, 2009, PROTEOMICS, V9, P4590, DOI 10.1002/pmic.200900299; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Yao XD, 2003, J PROTEOME RES, V2, P147, DOI 10.1021/pr025572s; Yi EC, 2005, PROTEOMICS, V5, P380, DOI 10.1002/pmic.200400970; Zhang RJ, 2002, J PROTEOME RES, V1, P139, DOI 10.1021/pr015516b; Zhang RJ, 2001, ANAL CHEM, V73, P5142, DOI 10.1021/ac010583a; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887; Zhou JY, 2010, J PROTEOME RES, V9, P5698, DOI 10.1021/pr100508p	64	136	142	2	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25443	25449		10.1074/jbc.R110.199703	http://dx.doi.org/10.1074/jbc.R110.199703			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632532	hybrid, Green Published			2022-12-27	WOS:000293073000006
J	Ye, R; Selby, CP; Ozturk, N; Annayev, Y; Sancar, A				Ye, Rui; Selby, Christopher P.; Ozturk, Nuri; Annayev, Yunus; Sancar, Aziz			Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEEDBACK LOOP; POSTTRANSLATIONAL REGULATION; TRANSCRIPTIONAL ACTIVATORS; NEGATIVE FEEDBACK; DNA-BINDING; IN-VIVO; PHOSPHORYLATION; MECHANISM; CRYPTOCHROMES; PER2	The current consensus model for the circadian clock in mammals is based on a transcription-translation feedback loop. In this model, CRY and PER proteins repress their own transcription by suppressing the transactivator function of the CLOCK: BMAL1 heterodimer directly (physical model) and by facilitating post-translational modifications (chemical model). Most of the data for this model come from genetic and cell biological experiments. Here, we have purified all of the core clock proteins and performed in vitro and in vivo biochemical experiments to test the physical model. We find that CLOCK:BMAL1 binds to an E-box sequence in DNA and that CRY binds stably to the CLOCK:BMAL1:E-box ternary complex independently of PER. Both CRY and PER bind to CLOCK and BMAL1 off DNA but, in contrast to CRY, PER does not bind to the CLOCK: BMAL1:E-box complex. Unexpectedly, PER actually interferes with the binding of CRY to the CLOCK:BMAL1:E-box ternary complex. CRY likely destabilizes the CLOCK:BMAL1 heterodimer on DNA by a post-translational mechanism after binding to the complex. These findings support some aspects of the canonical model, but also suggest that some key features of the model need to be revised.	[Ye, Rui; Selby, Christopher P.; Ozturk, Nuri; Annayev, Yunus; Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), 120 Mason Farm Rd,Genet Med Bldg,Suite 3010,CB 72, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Ozturk, Nuri/F-4140-2011	Ozturk, Nuri/0000-0001-5206-4127	National Institutes of Health [GM31082]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031082, R01GM031082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM31082.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gauger MA, 2005, CANCER RES, V65, P6828, DOI 10.1158/0008-5472.CAN-05-1119; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Ishikawa T, 2002, GENES CELLS, V7, P1073, DOI 10.1046/j.1365-2443.2002.00579.x; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kondratov RV, 2006, CELL CYCLE, V5, P890, DOI 10.4161/cc.5.8.2684; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Ozgur S, 2006, BIOCHEMISTRY-US, V45, P13369, DOI 10.1021/bi061556n; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Partch CL, 2006, P NATL ACAD SCI USA, V103, P10467, DOI 10.1073/pnas.0604138103; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Walhout AJM, 1997, NUCLEIC ACIDS RES, V25, P1493, DOI 10.1093/nar/25.8.1493; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	49	92	101	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25891	25902		10.1074/jbc.M111.254680	http://dx.doi.org/10.1074/jbc.M111.254680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613214	Green Published, hybrid			2022-12-27	WOS:000293073000050
J	Endsley, MP; Hu, YQ; Deng, Y; He, XL; Warejcka, DJ; Twining, SS; Gonias, SL; Zhang, M				Endsley, Michael P.; Hu, Yanqiu; Deng, Yong; He, Xiaolin; Warejcka, Debra J.; Twining, Sally S.; Gonias, Steven L.; Zhang, Ming			Maspin, the Molecular Bridge between the Plasminogen Activator System and beta 1 Integrin That Facilitates Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT SIGNALING PATHWAYS; TUMOR-SUPPRESSING ACTIVITY; MAMMARY EPITHELIAL-CELLS; RECEPTOR-RELATED PROTEIN; UROKINASE-TYPE; BREAST-CANCER; IN-VITRO; INTRACELLULAR SERPIN; EXTRACELLULAR-MATRIX; CRYSTAL-STRUCTURE	Maspin is a non-inhibitory serine protease inhibitor (serpin) that influences many cellular functions including adhesion, migration, and invasion. The underlying molecular mechanisms that facilitate these actions are still being elucidated. In this study we determined the mechanism by which maspin mediates increased MCF10A cell adhesion. Utilizing competition peptides and mutation analyses, we discovered two unique regions (amino acid residues 190-202 and 260-275) involved in facilitating the increased adhesion function of maspin. In addition, we demonstrate that the urokinase-type plasminogen activator (uPA)/uPA receptor (uPAR) complex is required for the localization and adhesion function of maspin. Finally, we showed that maspin, uPAR, and beta 1 integrin co-immunoprecipitate, suggesting a novel maspin-uPA-uPAR-beta 1 integrin mega-complex that regulates mammary epithelial cell adhesion.	[Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Warejcka, Debra J.; Twining, Sally S.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92093 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Medical College of Wisconsin; University of California System; University of California San Diego	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Mol Pharmacol & Biol Chem, Lurie 6-115,303 E Super St, Chicago, IL 60611 USA.	m-zhang@northwestern.edu		Endsley, Michael/0000-0002-5915-9281	National Institutes of Health [CA79736, EY12731, T32 CA070085]; NATIONAL CANCER INSTITUTE [R01CA079736, T32CA070085] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014168, R01EY021152, R01EY012731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA79736 (to M. Z.) and EY12731 (to S. S. T.).; Supported by NIH Institutional NRSA Training Program in Signal Transduction and Cancer Grant T32 CA070085.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Al-Ayyoubi M, 2007, J BIOL CHEM, V282, P19502, DOI 10.1074/jbc.M702445200; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bass R, 2009, J BIOL CHEM, V284, P27712, DOI 10.1074/jbc.M109.038919; Biliran H, 2001, CANCER RES, V61, P8676; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; Conlon M., 2002, PROTEIN PROTOCOLS HD, P971; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Degryse B, 2001, ONCOGENE, V20, P2032, DOI 10.1038/sj.onc.1204261; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Jo MJ, 2003, J BIOL CHEM, V278, P46692, DOI 10.1074/jbc.M308808200; Khalkhali-Ellis Z, 2007, CANCER RES, V67, P3535, DOI 10.1158/0008-5472.CAN-06-4767; LANGHOFER M, 1993, J CELL SCI, V105, P753; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Maass N, 2000, ACTA ONCOL, V39, P931; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazar A P, 1999, Angiogenesis, V3, P15, DOI 10.1023/A:1009095825561; McGowen R, 2000, CANCER RES, V60, P4771; Ngamkitidechakul C, 2001, INVEST OPHTH VIS SCI, V42, P3135; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Pemberton PA, 1997, J HISTOCHEM CYTOCHEM, V45, P1697, DOI 10.1177/002215549704501213; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; Qin L, 2010, J BIOL CHEM, V285, P32360, DOI 10.1074/jbc.M110.131045; Ravenhill L, 2010, J BIOL CHEM, V285, P36285, DOI 10.1074/jbc.M110.177253; Seftor REB, 1998, CANCER RES, V58, P5681; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Shi HY, 2002, MOL THER, V5, P755, DOI 10.1006/mthe.2002.0602; Shi HY, 2001, CANCER RES, V61, P6945; Sidenius N, 2000, FEBS LETT, V475, P52, DOI 10.1016/S0014-5793(00)01624-0; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200; Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200; Teoh SSY, 2010, J BIOL CHEM, V285, P10862, DOI 10.1074/jbc.M109.073171; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wilhelm OG, 1999, J CELL PHYSIOL, V180, P225, DOI 10.1002/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2; Yebra M, 1999, EXP CELL RES, V250, P231, DOI 10.1006/excr.1999.4510; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Zhang M, 2000, ONCOGENE, V19, P6053, DOI 10.1038/sj.onc.1204006; Zhang M, 1997, MOL MED, V3, P49, DOI 10.1007/BF03401667; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang M, 1999, DEV BIOL, V215, P278, DOI 10.1006/dbio.1999.9442; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	57	25	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24599	24607		10.1074/jbc.M111.235788	http://dx.doi.org/10.1074/jbc.M111.235788			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606500	Green Published, hybrid			2022-12-27	WOS:000292547900010
J	Novgorodov, SA; Wu, BX; Gudz, TI; Bielawski, J; Ovchinnikova, TV; Hannun, YA; Obeid, LM				Novgorodov, Sergei A.; Wu, Bill X.; Gudz, Tatyana I.; Bielawski, Jacek; Ovchinnikova, Tatiana V.; Hannun, Yusuf A.; Obeid, Lina M.			Novel Pathway of Ceramide Production in Mitochondria THIOESTERASE AND NEUTRAL CERAMIDASE PRODUCE CERAMIDE FROM SPHINGOSINE AND ACYL-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; PERMEABILITY TRANSITION PORE; RADIATION-INDUCED APOPTOSIS; LONG-CHAIN; SPHINGOLIPID METABOLISM; COA THIOESTERASES; MOLECULAR-CLONING; ENDOPLASMIC-RETICULUM; ENZYMATIC HYDROLYSIS; RESPIRATORY-CHAIN	Reports suggest that excessive ceramide accumulation in mitochondria is required to initiate the intrinsic apoptotic pathway and subsequent cell death, but how ceramide accumulates is unclear. Here we report that liver mitochondria exhibit ceramide formation from sphingosine and palmitoyl-CoA and from sphingosine and palmitate. Importantly, this activity was markedly decreased in liver from neutral ceramidase (NCDase)-deficient mice. Moreover, the levels of ceramide were dissimilar in liver mitochondria of WT and NCDase KO mice. These results suggest that NCDase is a key participant of ceramide formation in liver mitochondria. We also report that highly purified liver mitochondria have ceramidase, reverse ceramidase, and thioesterase activities. Increased accessibility of palmitoyl-CoA to the mitochondrial matrix with the pore-forming peptide zervamicin IIB resulted in 2-fold increases in palmitoyl-CoA hydrolysis by thioesterase. This increased hydrolysis was accompanied by an increase in ceramide formation, demonstrating that both outer membrane and matrix localized thioesterases can regulate ceramide formation. Also, ceramide formation might occur both in the outer mitochondrial membrane and in the mitochondrial matrix, suggesting the existence of distinct ceramide pools. Taken together, these results suggest that the reverse activity of NCDase contributes to sphingolipid homeostasis in this organelle in vivo.	[Novgorodov, Sergei A.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Novgorodov, Sergei A.; Wu, Bill X.; Bielawski, Jacek; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Gudz, Tatyana I.; Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Ovchinnikova, Tatiana V.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, 114 Doughty St,MSC779, Charleston, SC 29425 USA.	obeidl@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health [AG16583, CA87584, P20RR17677-04]; Russian Federal Target Program [NK-602P/19, P1159]; Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina; National Center for Research Resources [C06 RR018823]; NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823, UL1RR029882, P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Federal Target Program; Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina(US Department of Veterans Affairs); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG16583 (to L.M.O.), CA87584 (to Y.A.H.), and P20RR17677-04 (to T.I.G.). This work was also supported by the Russian Federal Target Program "Scientific and Science-Educational Personnel of Innovative Russia" (project NK-602P/19, state contract P1159) (to T.V.O.). This manuscript is based upon work supported in part by a MERIT Awards by the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina (to L.M.O. and T.I.G.).; We thank Kathy Wiita-Fisk for administrative assistance, Stefka Spassieva for critical reading of the manuscript, and Christian Frezza for valuable advice related to isolation of mouse mitochondria. We thank Dr. Richard Proia for generously providing anti-NCDase antibody. We thank Dr. Jennifer G. Schnellmann for help with preparation of the manuscript. Measurement of sphingolipids was conducted by the Lipidomics Core of MUSC in a facility constructed with support from the National Institutes of Health Grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources.	Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Balashova TA, 2000, FEBS LETT, V466, P333, DOI 10.1016/S0014-5793(99)01707-X; BERGE RK, 1979, EUR J BIOCHEM, V96, P393, DOI 10.1111/j.1432-1033.1979.tb13051.x; BERGE RK, 1979, EUR J BIOCHEM, V95, P89, DOI 10.1111/j.1432-1033.1979.tb12942.x; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; BRECHER P, 1983, MOL CELL BIOCHEM, V57, P3; Castilla R, 2008, ENDOCRINOLOGY, V149, P3743, DOI 10.1210/en.2007-1580; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2004, J BIOENERG BIOMEMBR, V36, P165, DOI 10.1023/B:JOBB.0000023619.97392.0c; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 2001, J BIOL CHEM, V276, P16758, DOI 10.1074/jbc.M009331200; el Bawab Samer, 2002, Subcell Biochem, V36, P187; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Ganesan V, 2010, FEBS LETT, V584, P2128, DOI 10.1016/j.febslet.2010.02.032; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; GATT S, 1966, J BIOL CHEM, V241, P3724; Gerber LK, 2006, AM J PHYSIOL-CELL PH, V291, pC1198, DOI 10.1152/ajpcell.00246.2006; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636; Graham J. M., 1999, CURRENT PROTOCOLS CE, V1, P346; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; King KL, 2007, J LIPID RES, V48, P1511, DOI 10.1194/jlr.M600364-JLR200; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; LEE KY, 1979, J BIOL CHEM, V254, P4516; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Maloberti P, 2002, EUR J BIOCHEM, V269, P5599, DOI 10.1046/j.1432-1033.2002.03267.x; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Martinez-Abundis E, 2009, FEBS J, V276, P5579, DOI 10.1111/j.1742-4658.2009.07239.x; Matsko CM, 2001, BIOCHEM BIOPH RES CO, V287, P1112, DOI 10.1006/bbrc.2001.5696; Means G. E., 1971, CHEM MODIFICATION PR, P220; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mitsutake S, 2001, J BIOL CHEM, V276, P26249, DOI 10.1074/jbc.M102233200; Monette JS, 2010, BIOCHEM BIOPH RES CO, V398, P272, DOI 10.1016/j.bbrc.2010.06.077; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Noygorodov SA, 2009, J CARDIOVASC PHARM, V53, P198, DOI 10.1097/FJC.0b013e31819b52d5; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Pillai BK, 2009, J BIOL CHEM, V284, P33296, DOI 10.1074/jbc.M109.043737; RENAUD G, 1985, ARCH INT PHYSIOL BIO, V93, P313, DOI 10.3109/13813458509079612; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; SANSOM MSP, 1993, EUR BIOPHYS J BIOPHY, V21, P369, DOI 10.1007/BF00185864; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Schulze H, 2000, METHOD ENZYMOL, V311, P22; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; STONER CD, 1969, J CELL BIOL, V43, P521, DOI 10.1083/jcb.43.3.521; SVENSSON LT, 1995, J BIOL CHEM, V270, P12177, DOI 10.1074/jbc.270.20.12177; Svensson LT, 1998, BIOCHEM J, V329, P601, DOI 10.1042/bj3290601; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tani M, 2003, J BIOL CHEM, V278, P10523, DOI 10.1074/jbc.M207932200; Tani M, 1999, J BIOCHEM-TOKYO, V125, P746; Tani M, 2000, J BIOL CHEM, V275, P3462, DOI 10.1074/jbc.275.5.3462; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; Usta J, 2001, BIOCHEMISTRY-US, V40, P9657, DOI 10.1021/bi010535k; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yabu T, 2009, J BIOL CHEM, V284, P20349, DOI 10.1074/jbc.M109.004580; YAVIN E, 1969, BIOCHEMISTRY-US, V8, P1692, DOI 10.1021/bi00832a052; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200	96	72	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25352	25362		10.1074/jbc.M110.214866	http://dx.doi.org/10.1074/jbc.M110.214866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613224	hybrid, Green Published			2022-12-27	WOS:000292547900081
J	Yu, Y; Li, WG; Chen, Z; Cao, H; Yang, HY; Jiang, HL; Xu, TL				Yu, Ye; Li, Wei-Guang; Chen, Zhi; Cao, Hui; Yang, Huaiyu; Jiang, Hualiang; Xu, Tian-Le			Atomic Level Characterization of the Nonproton Ligand-sensing Domain of ASIC3 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; MOLECULAR-DYNAMICS; EXTRACELLULAR DOMAIN; NEURONS; PORE; 1A; DESENSITIZATION; ION-CHANNEL-1; MODULATION; ACIDOSIS	Acid-sensing ion channels (ASICs) are known to be primarily activated by extracellular protons. Recently, we characterized a novel nonproton ligand (2-guanidine-4-methylquinazoline, GMQ), which activates the ASIC3 channel subtype at neutral pH. Using an interactive computational-experimental approach, here we extend our investigation to delineate the architecture of the GMQ-sensing domain in the ASIC3 channels. We first established a GMQ binding mode and revealed that residues Glu-423, Glu-79, Leu-77, Arg-376, Gln-271, and Gln-269 play key roles in forming the GMQ-sensing domain. We then verified the GMQ binding mode using ab initio calculation and mutagenesis and demonstrated the critical role of the above GMQ-binding residues in the interplay among GMQ, proton, and Ca2+ in regulating the function of ASIC3. Additionally, we showed that the same residues involved in coordinating GMQ responses are also critical for activation of the ASIC3(E79C) mutant by thiol-reactive compound DTNB. Thus, a range of complementary techniques provide independent evidence for the structural details of the GMQ-sensing domain at atomic level, laying the foundation for further investigations of endogenous nonproton ligands and gating mechanisms of the ASIC3 channels.	[Chen, Zhi; Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Yu, Ye; Li, Wei-Guang; Cao, Hui; Xu, Tian-Le] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Yu, Ye; Li, Wei-Guang; Cao, Hui; Xu, Tian-Le] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Yu, Ye; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Jiang, HL (corresponding author), 555 Zu Chong Zhi Rd,Zhang Jiang Hi Tech Pk, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; xu-happiness@shsmu.edu.cn		Yu, Ye/0000-0002-4054-8543	National Natural Science Foundation of China [30830035, 9091300]; National Basic Research Program of China [2011CBA00408]; Shanghai Municipal Government [09XD1404900]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Government; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	This work was supported by National Natural Science Foundation of China Grants 30830035 and 9091300, National Basic Research Program of China Grant 2011CBA00408, the Shanghai Municipal Government Grant 09XD1404900, and the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program 2009.	Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Canessa CM, 2007, NATURE, V449, P293, DOI 10.1038/449293a; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grabowski SJ, 2004, J PHYS ORG CHEM, V17, P18, DOI 10.1002/poc.685; Gurtovenko AA, 2004, BIOPHYS J, V86, P3461, DOI 10.1529/biophysj.103.038760; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Klein ML, 2008, SCIENCE, V321, P798, DOI 10.1126/science.1157834; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WG, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-88; Li WG, 2011, ACS CHEM NEUROSCI, V2, P26, DOI 10.1021/cn100094b; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; VANBUUREN AR, 1993, J PHYS CHEM-US, V97, P9206, DOI 10.1021/j100138a023; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang QM, 2002, DRUG METAB DISPOS, V30, P86, DOI 10.1124/dmd.30.1.86; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	48	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24996	25006		10.1074/jbc.M111.239558	http://dx.doi.org/10.1074/jbc.M111.239558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21586569	Green Published, hybrid			2022-12-27	WOS:000292547900048
J	Nagyeri, G; Radacs, M; Ghassemi-Nejad, S; Tryniszewska, B; Olasz, K; Hutas, G; Gyorfy, Z; Hascall, VC; Glant, TT; Mikecz, K				Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida; Tryniszewska, Beata; Olasz, Katalin; Hutas, Gabor; Gyorfy, Zsuzsa; Hascall, Vincent C.; Glant, Tibor T.; Mikecz, Katalin			TSG-6 Protein, a Negative Regulator of Inflammatory Arthritis, Forms a Ternary Complex with Murine Mast Cell Tryptases and Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOGLYCAN-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; ALPHA-TRYPSIN INHIBITOR; LINK MODULE; EXTRACELLULAR-MATRIX; STIMULATED GENE-6; INNATE IMMUNITY; MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; BINDING DOMAIN	TSG-6 (TNF-alpha-stimulated gene/protein 6), a hyaluronan (HA)-binding protein, has been implicated in the negative regulation of inflammatory tissue destruction. However, little is known about the tissue/cell-specific expression of TSG-6 in inflammatory processes, due to the lack of appropriate reagents for the detection of this protein in vivo. Here, we report on the development of a highly sensitive detection system and its use in cartilage proteoglycan (aggrecan)-induced arthritis, an autoimmune murine model of rheumatoid arthritis. We found significant correlation between serum concentrations of TSG-6 and arthritis severity throughout the disease process, making TSG-6 a better biomarker of inflammation than any of the other arthritis-related cytokines measured in this study. TSG-6 was present in arthritic joint tissue extracts together with the heavy chains of inter-alpha-inhibitor (I alpha I). Whereas TSG-6 was broadly detectable in arthritic synovial tissue, the highest level of TSG-6 was co-localized with tryptases in the heparin-containing secretory granules of mast cells. In vitro, TSG-6 formed complexes with the tryptases murine mast cell protease-6 and -7 via either heparin or HA. In vivo TSG-6-tryptase association could also be detected in arthritic joint extracts by co-immunoprecipitation. TSG-6 has been reported to suppress inflammatory tissue destruction by enhancing the serine protease-inhibitory activity of I alpha I against plasmin. TSG-6 achieves this by transferring heavy chains from I alpha I to HA, thus liberating the active bikunin subunit of I alpha I. Because bikunin is also present in mast cell granules, we propose that TSG-6 can promote inhibition of tryptase activity via a mechanism similar to inhibition of plasmin.	[Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida; Tryniszewska, Beata; Olasz, Katalin; Hutas, Gabor; Gyorfy, Zsuzsa; Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Dept Orthoped Surg,Sect Rheumatol, Chicago, IL 60612 USA; [Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida; Tryniszewska, Beata; Olasz, Katalin; Hutas, Gabor; Gyorfy, Zsuzsa; Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Dept Biochem,Sect Rheumatol, Chicago, IL 60612 USA; [Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida; Tryniszewska, Beata; Olasz, Katalin; Hutas, Gabor; Gyorfy, Zsuzsa; Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Dept Med,Sect Rheumatol, Chicago, IL 60612 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA	Rush University; Rush University; Rush University; Cleveland Clinic Foundation	Glant, TT (corresponding author), Rush Univ, Med Ctr, Sect Mol Med, Dept Orthoped Surg,Sect Rheumatol, Cohn Res Bldg,1735 W Harrison St, Chicago, IL 60612 USA.	Tibor_Glant@rush.edu; Katalin_Mikecz@rush.edu		Mikecz, Katalin/0000-0003-1506-4296	National Institutes of Health [P01 AR45652, R01 AR051163, R01 AR40310, R01 HL081064]; Grainger Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR045652, R01AR040310, R01AR051163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grainger Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AR45652, R01 AR051163, R01 AR40310, and R01 HL081064. This work was also supported by a grant from the Grainger Foundation.	Adarichev VA, 2005, ARTHRITIS RES THER, V7, pR196, DOI 10.1186/ar1472; Adarichev VA, 2003, J IMMUNOL, V170, P2283, DOI 10.4049/jimmunol.170.5.2283; Angyal A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2954; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; BJELLE A, 1982, SCAND J RHEUMATOL, V11, P124, DOI 10.3109/03009748209098176; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; CRISP AJ, 1984, ARTHRITIS RHEUM, V27, P845, DOI 10.1002/art.1780270802; EGGLI PS, 1993, J INVEST DERMATOL, V100, P121, DOI 10.1111/1523-1747.ep12462777; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Giant TT, 2004, METH MOLEC MED, V102, P313; Glant TT, 2003, CRIT REV IMMUNOL, V23, P199, DOI 10.1615/CritRevImmunol.v23.i3.20; GLANT TT, 1987, ARTHRITIS RHEUM-US, V30, P201, DOI 10.1002/art.1780300211; Glant TT, 1998, ARTHRITIS RHEUM, V41, P1007, DOI 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6; GLANT TT, 1986, BIOCHEM J, V234, P31, DOI 10.1042/bj2340031; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Hutas G, 2008, BLOOD, V112, P4999, DOI 10.1182/blood-2008-04-150383; Ide H, 1999, CELL TISSUE RES, V297, P149, DOI 10.1007/s004410051342; ITOH H, 1994, J BIOL CHEM, V269, P3818; Jaen O, 2009, IMMUNOLOGY, V126, P35, DOI 10.1111/j.1365-2567.2008.02875.x; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Major B, 2010, J BIOL CHEM, V285, P11863, DOI 10.1074/jbc.M109.098541; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanggaard KW, 2010, BBA-PROTEINS PROTEOM, V1804, P1011, DOI 10.1016/j.bbapap.2010.01.013; Shi M, 2001, J IMMUNOL, V167, P123, DOI 10.4049/jimmunol.167.1.123; Shin K, 2006, ARTHRITIS RHEUM-US, V54, P2863, DOI 10.1002/art.22058; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; STANKER LH, 1985, J IMMUNOL METHODS, V76, P157, DOI 10.1016/0022-1759(85)90488-0; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zielen S, 1996, J IMMUNOL METHODS, V193, P1, DOI 10.1016/0022-1759(96)00033-6	58	31	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23559	23569		10.1074/jbc.M111.222026	http://dx.doi.org/10.1074/jbc.M111.222026			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566135	hybrid, Green Published			2022-12-27	WOS:000292025000086
J	Bloemink, MJ; Melkani, GC; Dambacher, CM; Bernstein, SI; Geeves, MA				Bloemink, Marieke J.; Melkani, Girish C.; Dambacher, Corey M.; Bernstein, Sanford I.; Geeves, Michael A.			Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONS DIFFERENTIALLY AFFECT; DILATED CARDIOMYOPATHY; MUSCLE MYOSIN; HYPERTROPHIC CARDIOMYOPATHY; MICROGRAM QUANTITIES; ALPHA-TROPOMYOSIN; CARDIAC MYOSIN; THIN-FILAMENTS; MOTOR FUNCTION; SWISS-MODEL	Two Drosophila myosin II point mutations (D45 and Mhc(5)) generate Drosophila cardiac phenotypes that are similar to dilated or restrictive human cardiomyopathies. Our homology models suggest that the mutations (A261T in D45, G200D in Mhc(5)) could stabilize (D45) or destabilize (Mhc(5)) loop 1 of myosin, a region known to influence ADP release. To gain insight into the molecular mechanism that causes the cardiomyopathic phenotypes to develop, we determined whether the kinetic properties of the mutant molecules have been altered. We used myosin subfragment 1 (S1) carrying either of the two mutations (S1(A261T) and S1(G200D)) from the indirect flight muscles of Drosophila. The kinetic data show that the two point mutations have an opposite effect on the enzymatic activity of S1. S1(A261T) is less active (reduced ATPase, higher ADP affinity for S1 and actomyosin subfragment 1 (actin.S1), and reduced ATP-induced dissociation of actin.S1), whereas S1(G200D) shows increased enzymatic activity (enhanced ATPase, reduced ADP affinity for both S1 and actin.S1). The opposite changes in the myosin properties are consistent with the induced cardiac phenotypes for S1(A261T) (dilated) and S1(G200D) (restrictive). Our results provide novel insights into the molecular mechanisms that cause different cardiomyopathy phenotypes for these mutants. In addition, we report that S1(A261T) weakens the affinity of S1.ADP for actin, whereas S1(G200D) increases it. This may account for the suppression (A261T) or enhancement (G200D) of the skeletal muscle hypercontraction phenotype induced by the troponin I held-up(2) mutation in Drosophila.	[Melkani, Girish C.; Dambacher, Corey M.; Bernstein, Sanford I.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Melkani, Girish C.; Dambacher, Corey M.; Bernstein, Sanford I.] San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA; [Bloemink, Marieke J.; Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	California State University System; San Diego State University; California State University System; San Diego State University; University of Kent	Bernstein, SI (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	sbernst@sciences.sdsu.edu; m.a.geeves@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Melkani, Girish/0000-0003-0353-4633; Bloemink, Marieke Johanna/0000-0001-9441-2783; Bernstein, Sanford/0000-0001-7094-5390	National Institutes of Health [GM32443]; Wellcome Trust [085309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443, R37GM032443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM32443 (to G. C. M., C. M. D., and S. I. B.). This work was also supported by Wellcome Trust Program Grant 085309 (to M. A. G. and M. J. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker JE, 2002, BIOPHYS J, V82, P2134, DOI 10.1016/S0006-3495(02)75560-4; Bloemink MJ, 2009, J MOL BIOL, V389, P707, DOI 10.1016/j.jmb.2009.04.036; Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Cammarato A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018497; Clark RJ, 2003, J MUSCLE RES CELL M, V24, P315; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Geeves MA, 2005, CELL MOL LIFE SCI, V62, P1462, DOI 10.1007/s00018-005-5015-5; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Kronert WA, 1999, J CELL BIOL, V144, P989, DOI 10.1083/jcb.144.5.989; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lin N, 2011, CIRC RES, V108, P1306, DOI 10.1161/CIRCRESAHA.110.238105; Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2; Miller BM, 2007, J MOL BIOL, V368, P1051, DOI 10.1016/j.jmb.2007.02.042; Miller BM, 2003, J BIOL CHEM, V278, P50293, DOI 10.1074/jbc.M308318200; Nanni L, 2003, BIOCHEM BIOPH RES CO, V309, P391, DOI 10.1016/j.bbrc.2003.08.014; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; O'Connell CB, 2007, BBA-MOL CELL RES, V1773, P615, DOI 10.1016/j.bbamcr.2006.06.012; Ocorr KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000601; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Palmer BM, 2004, AM J PHYSIOL-HEART C, V287, pH91, DOI 10.1152/ajpheart.01015.2003; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Swank DM, 2003, J BIOL CHEM, V278, P17475, DOI 10.1074/jbc.M212727200; Swank DM, 2006, P NATL ACAD SCI USA, V103, P17543, DOI 10.1073/pnas.0604972103; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Vikhorev PG, 2010, J MUSCLE RES CELL M, V31, P171, DOI 10.1007/s10974-010-9221-x; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; Webb MR, 2001, BIOPHYS J, V81, P1562, DOI 10.1016/S0006-3495(01)75810-9; Weiss S, 2000, J MUSCLE RES CELL M, V21, P423, DOI 10.1023/A:1005690106951; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103	36	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28435	28443		10.1074/jbc.M111.258228	http://dx.doi.org/10.1074/jbc.M111.258228			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680742	hybrid, Green Published			2022-12-27	WOS:000293557800059
J	Boucher, JM; Peterson, SM; Urs, S; Zhang, CX; Liaw, L				Boucher, Joshua M.; Peterson, Sarah M.; Urs, Sumithra; Zhang, Chunxiang; Liaw, Lucy			The miR-143/145 Cluster Is a Novel Transcriptional Target of Jagged-1/Notch Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOTCH LIGAND; ALPHA-ACTIN; MICRORNAS; EXPRESSION; DIFFERENTIATION; MODULATION; ACTIVATION; PHENOTYPE; DISEASES; PATHWAY	Activation of Notch signaling by Jagged-1 (Jag-1) in vascular smooth muscle cells (VSMC) promotes a differentiated phenotype characterized by increased expression of contractile proteins. Recent studies show that microRNAs (miR)-143/145 regulates VSMC phenotype. The serum response factor (SRF)/myocardin complex binds to CArG sequences to activate miR-143/145 transcription, but no other regulators are known in VSMC. Using miR arrays, we found miR-143/145 induced following expression of a constitutively active Notch1 intracellular domain (N1ICD). We hypothesized that miR-143/145 is required for Jag-1/Notch-induced VSMC differentiation. Activation of Notch receptors by Jag-1 caused CBF1-dependent up-regulation of miR-143/145, increased differentiation, and decreased proliferation. Conversely, inhibiting basal Notch signaling decreased steady state levels of miR-143/145. Using SRF knockdown, we found that Jag-1/Notch induction of miR-143/145 is SRF independent, although full acquisition of contractile markers requires SRF. Using miR-143/145 promoter reporter constructs we show Jag-1/Notch increases promoter activity, and this is dependent on intact CBF1 consensus sites within the promoter. Chromatin immunoprecipitation (ChIP) assays revealed that N1ICD-containing complexes bind to CBF1 sites in the miR-143/145 promoter. We also identified N1ICD complex binding to CBF1 sites within the endogenous human miR-143/145 promoter. Using miR-143/145-interfering oligonucleotides, we demonstrate that Jag-1/Notch signaling requires induction of both miR-143 and miR-145 to promote the VSMC contractile phenotype. Thus, miR-143/145 is a novel transcriptional target of Jag-1/Notch signaling in VSMC. We propose miR-143/145 as activated independently by Jag-1/Notch and SRF in parallel pathways. Multiple pathways converging on miR-143/145 provides potential for fine-tuning or amplification of VSMC differentiation signals.	[Boucher, Joshua M.; Peterson, Sarah M.; Urs, Sumithra; Liaw, Lucy] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Boucher, Joshua M.; Peterson, Sarah M.; Liaw, Lucy] Univ Maine, Grad Sch Biomed Sci, Orono, ME 04473 USA; [Zhang, Chunxiang] Univ Med & Dent New Jersey, Dept Anesthesiol, Newark, NJ 07101 USA	Maine Medical Center; University of Maine System; University of Maine Orono; Rutgers State University New Brunswick; Rutgers State University Medical Center	Liaw, L (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	liawl@mmc.org	zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495	National Institutes of Health [R01 HL070865]; National Center for Research Resources [P20RR15555]; Graduate School of Biomedical Sciences at the University of Maine, Orono; American Heart Association [10PRE3680003]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555, P20RR018789] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Graduate School of Biomedical Sciences at the University of Maine, Orono; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL070865 (to L. L.) and P20RR15555 from the National Center for Research Resources (to R. E. Friesel and L. L.).; Supported by fellowships from the Graduate School of Biomedical Sciences at the University of Maine, Orono, and a predoctoral fellowship from the Founders Affiliate of the American Heart Association (10PRE3680003).; Supported by fellowships from the Graduate School of Biomedical Sciences at the University of Maine, Orono.	Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; GRIDLEY T, 2007, DEVELOPMENT; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Iio A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-136; Kartha RV, 2010, J CARDIOVASC TRANSL, V3, P256, DOI 10.1007/s12265-010-9172-z; King-Briggs KE, 2000, DIFFERENTIATION, V66, P43, DOI 10.1046/j.1432-0436.2000.066001043.x; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Liu Y, 2010, ACTA PHARMACOL SIN, V31, P10, DOI 10.1038/aps.2009.185; Louvi A, 2006, DEV NEUROSCI-BASEL, V28, P5, DOI 10.1159/000090748; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Montgomery RL, 2010, CURR DRUG TARGETS, V11, P936; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Parmacek MS, 2009, J CLIN INVEST, V119, P2526, DOI 10.1172/JCI40503; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Proweller A, 2007, P NATL ACAD SCI USA, V104, P16275, DOI 10.1073/pnas.0707950104; Quillard T, 2008, ARTERIOSCL THROM VAS, V28, P2258, DOI 10.1161/ATVBAHA.108.174995; Rozen S, 2000, Methods Mol Biol, V132, P365; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Song ZF, 2010, J CARDIOVASC TRANSL, V3, P246, DOI 10.1007/s12265-010-9163-0; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tang Sung-Chun, 2009, Acta Neurol Taiwan, V18, P81; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Thyberg J, 1998, HISTOL HISTOPATHOL, V13, P871, DOI 10.14670/HH-13.871; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zhang CX, 2009, CELL CYCLE, V8, P3469, DOI 10.4161/cc.8.21.9837	44	109	114	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28312	28321		10.1074/jbc.M111.221945	http://dx.doi.org/10.1074/jbc.M111.221945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685392	Green Published, hybrid			2022-12-27	WOS:000293557800048
J	Thotsaporn, K; Chenprakhon, P; Sucharitakul, J; Mattevi, A; Chaiyen, P				Thotsaporn, Kittisak; Chenprakhon, Pirom; Sucharitakul, Jeerus; Mattevi, Andrea; Chaiyen, Pimchai			Stabilization of C4a-Hydroperoxyflavin in a Two-component Flavin-dependent Monooxygenase Is Achieved through Interactions at Flavin N5 and C4a Atoms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; 4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; CRYSTAL-STRUCTURES; CYCLOHEXANONE MONOOXYGENASE; ACINETOBACTER-BAUMANNII; OXYGENASE COMPONENT; MECHANISM; REDUCTASE; BIOSYNTHESIS; HYDROXYLASE	p-Hydroxyphenylacetate (HPA) 3-hydroxylase is a two-component flavin-dependent monooxygenase. Based on the crystal structure of the oxygenase component (C-2), His-396 is 4.5 angstrom from the flavin C4a locus, whereas Ser-171 is 2.9 angstrom from the flavin N5 locus. We investigated the roles of these two residues in the stability of the C4a-hydroperoxy-FMN intermediate. The results indicated that the rate constant for C4a-hydroperoxy-FMN formation decreased similar to 30-fold in H396N, 100-fold in H396A, and 300-fold in the H396V mutant, compared with the wild-type enzyme. Lesser effects of the mutations were found for the subsequent step of H2O2 elimination. Studies on pH dependence showed that the rate constant of H2O2 eliminationinH396N and H396V increased when pH increased with pK(a)> 9.6 and > 9.7, respectively, similar to the wild-type enzyme (pK(a) > 9.4). These data indicated that His-396 is important for the formation of the C4a-hydroperoxy-FMN intermediate but is not involved in H2O2 elimination. Transient kinetics of the Ser-171 mutants with oxygen showed that the rate constants for the H2O2 elimination in S171A and S171T were similar to 1400-fold and 8-fold greater than the wild type, respectively. Studies on the pH dependence of S171A with oxygen showed that the rate constant of H2O2 elimination increased with pH rise and exhibited an approximate pK(a) of 8.0. These results indicated that the interaction of the hydroxyl group side chain of Ser-171 and flavin N5 is required for the stabilization of C4a-hydroperoxy-FMN. The double mutant S171A/H396V reacted with oxygen to directly form the oxidized flavin without stabilizing the C4a-hydroperoxy-FMN intermediate, which confirmed the findings based on the single mutation that His-396 was important for formation and Ser-171 for stabilization of the C4a-hydroperoxy FMN intermediate in C-2.	[Thotsaporn, Kittisak; Chenprakhon, Pirom; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Thotsaporn, Kittisak; Chenprakhon, Pirom; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok 10330, Thailand; [Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	Mahidol University; Mahidol University; Chulalongkorn University; University of Pavia	Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.	scpcy@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019; mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019	Chaiyen, Pimchai/0000-0002-8533-1604; mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; Chenprakhon, Pirom/0000-0002-5927-6920	Thailand Research Fund [BRG5480001, MRG5380240]; Faculty of Science, Mahidol University; Royal Golden Jubilee Ph. D. Program [PHD/0008/2549]; Institute for the Promotion of Teaching Science and Technology	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Royal Golden Jubilee Ph. D. Program(Thailand Research Fund (TRF)); Institute for the Promotion of Teaching Science and Technology	This work was supported by the Thailand Research Fund Grant BRG5480001 and a grant from the Faculty of Science, Mahidol University (to P. C.).; Supported by the Royal Golden Jubilee Ph. D. Program Grant PHD/0008/2549.; Supported by the Institute for the Promotion of Teaching Science and Technology.; Supported by the Thailand Research Fund Grant MRG5380240.	Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Bitto E, 2008, PROTEINS, V70, P289, DOI 10.1002/prot.21627; Bruender NA, 2010, BIOCHEMISTRY-US, V49, P3517, DOI 10.1021/bi100318v; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Heemstra JR, 2008, J AM CHEM SOC, V130, P14024, DOI 10.1021/ja806467a; Hu Y, 2008, J AM CHEM SOC, V130, P15756, DOI 10.1021/ja8051415; Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Li L, 2008, J MOL BIOL, V376, P453, DOI 10.1016/j.jmb.2007.11.069; Lin SJ, 2008, J AM CHEM SOC, V130, P6616, DOI 10.1021/ja710601d; MASSEY V, 1971, FLAVINS FLAVOPROTEIN, P349; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2011, J BIOL CHEM, V286, P16900, DOI 10.1074/jbc.M111.222976; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Ukaegbu UE, 2010, BIOCHEMISTRY-US, V49, P1678, DOI 10.1021/bi901693u; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VENKATARAM UV, 1984, J CHEM SOC CHEM COMM, P899, DOI 10.1039/c39840000899; Vey JL, 2010, BIOCHEMISTRY-US, V49, P9306, DOI 10.1021/bi101336u; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhang H, 2007, J AM CHEM SOC, V129, P14670, DOI 10.1021/ja0744854	48	54	56	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28170	28180		10.1074/jbc.M111.241836	http://dx.doi.org/10.1074/jbc.M111.241836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680741	hybrid, Green Published			2022-12-27	WOS:000293557800035
J	Yap, TL; Gruschus, JM; Velayati, A; Westbroek, W; Goldin, E; Moaven, N; Sidransky, E; Lee, JC				Yap, Thai Leong; Gruschus, James M.; Velayati, Arash; Westbroek, Wendy; Goldin, Ehud; Moaven, Nima; Sidransky, Ellen; Lee, Jennifer C.			alpha-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BETA-GLUCOSIDASE; HUMAN SAPOSIN-C; X-RAY-STRUCTURE; MUTATIONS; GENE; PROTEIN; AGGREGATION; BINDING; NEURODEGENERATION; FIBRILLATION	The presynaptic protein alpha-synuclein (alpha-syn), particularly in its amyloid form, is widely recognized for its involvement in Parkinson disease (PD). Recent genetic studies reveal that mutations in the gene GBA are the most widespread genetic risk factor for parkinsonism identified to date. GBA encodes for glucocerebrosidase (GCase), the enzyme deficient in the lysosomal storage disorder, Gaucher disease (GD). In this work, we investigated the possibility of a physical linkage between alpha-syn and GCase, examining both wild type and the GD-related N370S mutant enzyme. Using fluorescence and nuclear magnetic resonance spectroscopy, we determined that alpha-syn and GCase interact selectively under lysosomal solution conditions (pH 5.5) and mapped the interaction site to the alpha-syn C-terminal residues, 118-137. This alpha-syn-GCase complex does not form at pH 7.4 and is stabilized by electrostatics, with dissociation constants ranging from 1.2 to 22 mu M in the presence of 25 to 100mM NaCl. Intriguingly, the N370S mutant form of GCase has a reduced affinity for alpha-syn, as does the inhibitor conduritol-beta-epoxidebound enzyme. Immunoprecipitation and immunofluorescence studies verified this interaction in human tissue and neuronal cell culture, respectively. Although our data do not preclude protein-protein interactions in other cellular milieux, we suggest that the alpha-syn-GCase association is favored in the lysosome, and that this noncovalent interaction provides the groundwork to explore molecular mechanisms linking PD with mutant GBA alleles.	[Yap, Thai Leong; Gruschus, James M.; Lee, Jennifer C.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Velayati, Arash; Westbroek, Wendy; Goldin, Ehud; Moaven, Nima; Sidransky, Ellen] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Sidransky, E (corresponding author), 35 Convent Dr,Room 1A213, Bethesda, MD 20892 USA.	sidranse@mail.nih.gov; leej4@mail.nih.gov	Lee, Jennifer/E-9658-2015	Lee, Jennifer/0000-0003-0506-8349	National Institutes of Health; NHLBI; NHGRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001055, ZIAHL006144] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Program at the National Institutes of Health, NHLBI and NHGRI.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Butters TD, 2007, CURR OPIN CHEM BIOL, V11, P412, DOI 10.1016/j.cbpa.2007.05.035; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Croke RL, 2011, PROTEIN SCI, V20, P256, DOI 10.1002/pro.556; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; de Alba E, 2003, BIOCHEMISTRY-US, V42, P14729, DOI 10.1021/bi0301338; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Goker-Alpan O, 2006, NEUROLOGY, V67, P908, DOI 10.1212/01.wnl.0000230215.41296.18; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Goldin E, 2010, MOL GENET METAB, V101, P307, DOI 10.1016/j.ymgme.2010.08.004; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; GRACE ME, 1994, J BIOL CHEM, V269, P2283; Gruschus JM, 2008, AMYLOID, V15, P160, DOI 10.1080/13506120802193746; Hawkins CA, 2005, J MOL BIOL, V346, P1381, DOI 10.1016/j.jmb.2004.12.045; Hruska KS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/78549; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kacher Y, 2008, BIOL CHEM, V389, P1361, DOI 10.1515/BC.2008.163; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee JC, 2004, P NATL ACAD SCI USA, V101, P16466, DOI 10.1073/pnas.0407307101; Lee JC, 2008, J AM CHEM SOC, V130, P6898, DOI 10.1021/ja711415b; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; MEIVARLEVY I, 1994, BIOCHEM J, V303, P377, DOI 10.1042/bj3030377; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; Nath S, 2010, BIOPHYS J, V98, P1302, DOI 10.1016/j.bpj.2009.12.4290; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van Raaij ME, 2008, BIOPHYS J, V95, P4871, DOI 10.1529/biophysj.107.127464; Velayati A, 2010, CURR NEUROL NEUROSCI, V10, P190, DOI 10.1007/s11910-010-0102-x; Wei RR, 2011, J BIOL CHEM, V286, P299, DOI 10.1074/jbc.M110.150433; Yap TL, 2011, BIOCHEMISTRY-US, V50, P1963, DOI 10.1021/bi2000824; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	77	126	135	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28080	28088		10.1074/jbc.M111.237859	http://dx.doi.org/10.1074/jbc.M111.237859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21653695	hybrid, Green Published			2022-12-27	WOS:000293557800026
J	Cheng, CJ; Lin, SH; Lo, YF; Yang, SS; Hsu, YJ; Cannon, SC; Huang, CL				Cheng, Chih-Jen; Lin, Shih-Hua; Lo, Yi-Fen; Yang, Sung-Sen; Hsu, Yu-Juei; Cannon, Stephen C.; Huang, Chou-Long			Identification and Functional Characterization of Kir2.6 Mutations Associated with Non-familial Hypokalemic Periodic Paralysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE PATIENTS; MOLECULAR ANALYSIS; EXTRACELLULAR K+; CHANNEL MUTATION; GATING PORE; MUSCLE; NA+; DEPOLARIZATION; GENES	Hypokalemic periodic paralysis (hypoKPP) is characterized by episodic flaccid paralysis of muscle and acute hypokalemia during attacks. Familial forms of hypoKPP are predominantly caused by mutations of either voltage-gated Ca2(+) or Na+ channels. The pathogenic gene mutation in non-familial hypoKPP, consisting mainly of thyrotoxic periodic paralysis (TPP) and sporadic periodic paralysis (SPP), is largely unknown. Recently, mutations in KCNJ18, which encodes a skeletal muscle-specific inwardly rectifying K+ channel Kir2.6, were reported in some TPP patients. Whether mutations of Kir2.6 occur in other patients with non-familial hypoKPP and how mutations of the channel predispose patients to paralysis are unknown. Here, we report one conserved heterozygous mutation in KCNJ18 in two TPP patients and two separate heterozygous mutations in two SPP patients. These mutations result in V168M, R43C, and A200P amino acid substitution of Kir2.6, respectively. Compared with the wild type channel, whole-cell currents of R43C and V168M mutants were reduced by similar to 78 and 43%, respectively. No current was detected for the A200P mutant. Single channel conductance and open probability were reduced for R43C and V168M, respectively. Biotinylation assays showed reduced cell surface abundance for R43C and A200P. All three mutants exerted dominant negative inhibition on wild type Kir2.6 as well as wild type Kir2.1, another Kir channel expressed in the skeletal muscle. Thus, mutations of Kir2.6 are associated with SPP as well as TPP. We suggest that decreased outward K+ current from hypofunction of Kir2.6 predisposes the sarcolemma to hypokalemia-induced paradoxical depolarization during attacks, which in turn leads to Na+ channel inactivation and inexcitability of muscles.	[Cheng, Chih-Jen; Lin, Shih-Hua; Lo, Yi-Fen; Yang, Sung-Sen; Hsu, Yu-Juei] Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, Taipei 114, Taiwan; [Cheng, Chih-Jen; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Div Nephrol, Dept Med, Dallas, TX 75390 USA; [Cannon, Stephen C.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Cannon, Stephen C.] Univ Texas SW Med Ctr Dallas, Program Neurosci, Dallas, TX 75390 USA	National Defense Medical Center; Tri-Service General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lin, SH (corresponding author), Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan.	l521116@ndmctsgh.edu.tw; chou-long.huang@utsouthwestern.edu	Cheng, Chih-Jen/AAM-3305-2021; Cannon, Stephen/V-5343-2019	Cannon, Stephen/0000-0001-8428-3690	National Institutes of Health [DK59530, P30DK079328]; National Science Council, Taiwan [NSC 93-2314-B-016-031]; Tri-Service General Hospital [SGH-C-93-51]; Ministry of Defense, Taiwan; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR042703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, R01DK059530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Ministry of Defense, Taiwan; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59530 (to C.-L. H.) and P30DK079328 (UT Southwestern Medical Center O'Brien Center). This study was also supported by the National Science Council, Taiwan (NSC 93-2314-B-016-031 (to S.-H. L.)) and the Research Fund of Tri-Service General Hospital (SGH-C-93-51 (to S.-H. L.)). Functional experiments were performed by C.-J. Cheng in partial fulfillment of the requirements of the Ph.D. degree at the University of Texas Southwestern Medical Center at Dallas.; Supported by a scholarship grant from the Ministry of Defense, Taiwan.	Bowen LN, 2010, NEUROLOGY, V74, P1546, DOI 10.1212/WNL.0b013e3181e222ee; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Chang HK, 2010, J BIOL CHEM, V285, P23113, DOI 10.1074/jbc.M110.121186; Chen L, 2003, EUR NEUROL, V49, P227, DOI 10.1159/000070191; Dassau L, 2011, J BIOL CHEM, V286, P9526, DOI 10.1074/jbc.M110.170597; GRUENER R, 1975, J NEUROL SCI, V24, P339, DOI 10.1016/0022-510X(75)90254-3; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HOFMANN WW, 1972, AM J PHYSIOL, V223, P283, DOI 10.1152/ajplegacy.1972.223.2.283; Jurkat-Rott K, 2009, P NATL ACAD SCI USA, V106, P4036, DOI 10.1073/pnas.0811277106; KELLEY DE, 1989, ARCH INTERN MED, V149, P2597, DOI 10.1001/archinte.149.11.2597; Kung AWC, 2006, J CLIN ENDOCR METAB, V91, P2490, DOI 10.1210/jc.2006-0356; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lin SH, 2005, MAYO CLIN PROC, V80, P99, DOI 10.1016/S0025-6196(11)62965-0; Lin SH, 2001, QJM-MON J ASSOC PHYS, V94, P133, DOI 10.1093/qjmed/94.3.133; Lin SHH, 2005, AM J MED SCI, V329, P66, DOI 10.1097/00000441-200502000-00003; Liu TA, 2011, BBA-BIOMEMBRANES, V1808, P1772, DOI 10.1016/j.bbamem.2011.02.016; Matthews E, 2009, NEUROLOGY, V72, P1544, DOI 10.1212/01.wnl.0000342387.65477.46; Ng WY, 2004, THYROID, V14, P187, DOI 10.1089/105072504773297858; OBER KP, 1992, MEDICINE, V71, P109, DOI 10.1097/00005792-199205000-00001; OKINAKA S, 1957, J CLIN ENDOCR METAB, V17, P1454, DOI 10.1210/jcem-17-12-1454; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; PTACEK LJ, 1994, CELL, V77, P863; Puwanant A, 2010, MUSCLE NERVE, V42, P315, DOI 10.1002/mus.21693; Ruff RL, 1999, NEUROLOGY, V53, P1556, DOI 10.1212/WNL.53.7.1556; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Schalin-Jantti C, 2005, HORM RES, V63, P139, DOI 10.1159/000084689; Shiang JC, 2009, EUR J ENDOCRINOL, V161, P911, DOI 10.1530/EJE-09-0553; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; STEDWELL RE, 1992, AM J EMERG MED, V10, P143, DOI 10.1016/0735-6757(92)90048-3; Struyk AF, 2008, MUSCLE NERVE, V37, P326, DOI 10.1002/mus.20928; Struyk AF, 2007, J GEN PHYSIOL, V130, P11, DOI 10.1085/jgp.200709755; Wang WQ, 2006, MOL GENET METAB, V87, P359, DOI 10.1016/j.ymgme.2005.10.020; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	33	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27425	27435		10.1074/jbc.M111.249656	http://dx.doi.org/10.1074/jbc.M111.249656			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21665951	Green Published, hybrid			2022-12-27	WOS:000293268700038
J	Cheng, F; Cappai, R; Ciccotosto, GD; Svensson, G; Multhaup, G; Fransson, LA; Mani, K				Cheng, Fang; Cappai, Roberto; Ciccotosto, Giuseppe D.; Svensson, Gabriel; Multhaup, Gerd; Fransson, Lars-Ake; Mani, Katrin			Suppression of Amyloid beta A11 Antibody Immunoreactivity by Vitamin C POSSIBLE ROLE OF HEPARAN SULFATE OLIGOSACCHARIDES DERIVED FROM GLYPICAN-1 BY ASCORBATE-INDUCED, NITRIC OXIDE (NO)-CATALYZED DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYPICAN-1 HEPARAN-SULFATE; PRECURSOR PROTEIN APP; INSOLUBLE MEMBRANE COMPARTMENT; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; DEPENDENT AUTOCLEAVAGE; MULTIVESICULAR BODIES; RECYCLING GLYPICAN-1; NEURITE OUTGROWTH	Amyloid beta (A beta) is generated from the copper- and heparan sulfate (HS)-binding amyloid precursor protein (APP) by proteolytic processing. APP supports S-nitrosylation of the HS proteoglycan glypican-1 (Gpc-1). In the presence of ascorbate, there is NO-catalyzed release of anhydromannose (anMan)-containing oligosaccharides from Gpc-1-nitrosothiol. We investigated whether these oligosaccharides interact with A beta during APP processing and plaque formation. anMan immunoreactivity was detected in amyloid plaques of Alzheimer (AD) and APP transgenic (Tg2576) mouse brains by immunofluorescence microscopy. APP/APP degradation products detected by antibodies to the C terminus of APP, but not A beta oligomers detected by the anti-A beta A11 antibody, colocalized with anMan immunoreactivity in Tg2576 fibroblasts. A50-55-kDa anionic, sodium dodecyl sulfate-stable, anMan- and A beta-immunoreactive species was obtained from Tg2576 fibroblasts using immunoprecipitation with anti-APP (C terminus). anMan-containing HS oligo- and disaccharide preparations modulated or suppressed A11 immunoreactivity and oligomerization of A beta 42 peptide in an in vitro assay. A11 immunoreactivity increased in Tg2576 fibroblasts when Gpc-1 autoprocessing was inhibited by 3-beta[2(diethylamino) ethoxy] androst-5-en-17-one (U18666A) and decreased when Gpc-1 autoprocessing was stimulated by ascorbate. Neither overexpression of Gpc-1 in Tg2576 fibroblasts nor addition of copper ion and NO donor to hippocampal slices from 3xTg-AD mice affected A11 immunoreactivity levels. However, A11 immunoreactivity was greatly suppressed by the subsequent addition of ascorbate. We speculate that temporary interaction between the A beta domain and small, anMan-containing oligosaccharides may preclude formation of toxic A beta oligomers. A portion of the oligosaccharides are co-secreted with the A beta peptides and deposited in plaques. These results support the notion that an inadequate supply of vitamin C could contribute to late onset AD in humans.	[Cheng, Fang; Svensson, Gabriel; Fransson, Lars-Ake; Mani, Katrin] Lund Univ, Glycobiol Grp, Div Neurosci, Dept Expt Med Sci,Biomed Ctr A13, SE-22184 Lund, Sweden; [Cappai, Roberto; Ciccotosto, Giuseppe D.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Cappai, Roberto; Ciccotosto, Giuseppe D.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Multhaup, Gerd] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany	Lund University; University of Melbourne; University of Melbourne; Free University of Berlin	Fransson, LA (corresponding author), Lund Univ, Glycobiol Grp, Div Neurosci, Dept Expt Med Sci,Biomed Ctr A13, BMC A13, SE-22184 Lund, Sweden.	Lars-Ake.Fransson@med.lu.se; katrin.mani@med.lu.se	Cappai, Roberto/B-3347-2010	Cappai, Roberto/0000-0002-9505-8496; Mani, Katrin/0000-0002-1821-0634	Swedish Science Council (VR-M); Bergvall Foundation; Crafoord Foundation; Hedborg Foundation; Kock Foundation; Segerfalk Foundation; Zoega Foundation; Osterlund Foundation; Medical Faculty of Lund University; National Health and Medical Research Council of Australia; Deutsche Forschungsgemeinschaft	Swedish Science Council (VR-M); Bergvall Foundation; Crafoord Foundation; Hedborg Foundation; Kock Foundation; Segerfalk Foundation; Zoega Foundation; Osterlund Foundation; Medical Faculty of Lund University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Swedish Science Council (VR-M); the Bergvall, Crafoord, Hedborg, Kock, Segerfalk, Zoega, and Osterlund Foundations; and the Medical Faculty of Lund University (to L.-A.F. and K. M.) and in part by the National Health and Medical Research Council of Australia (to R. C.) and the Deutsche Forschungsgemeinschaft (to G. M.).	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Burns M, 2003, J NEUROSCI, V23, P5645; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Cappai R, 2005, J BIOL CHEM, V280, P13913, DOI 10.1074/jbc.M409179200; Cappai R, 2008, NEUROCHEM RES, V33, P526, DOI 10.1007/s11064-007-9469-8; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Cheng F, 2006, J NEUROCHEM, V98, P1445, DOI 10.1111/j.1471-4159.2006.03981.x; Davis W, 2008, CURR ALZHEIMER RES, V5, P448, DOI 10.2174/156720508785908900; Ding K, 2002, J BIOL CHEM, V277, P33353, DOI 10.1074/jbc.M203383200; Ding K, 2001, J BIOL CHEM, V276, P3885, DOI 10.1074/jbc.M005238200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; FRANSSON LA, 1990, BIOCHEM J, V269, P381, DOI 10.1042/bj2690381; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; FRANSSON LA, 1980, EUR J BIOCHEM, V106, P59; Fransson LA, 2007, TRENDS MOL MED, V13, P143, DOI 10.1016/j.molmed.2007.02.005; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harrison FE, 2009, PHARMACOL BIOCHEM BE, V93, P443, DOI 10.1016/j.pbb.2009.06.006; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Lofgren K, 2008, EUR J NEUROSCI, V28, P964, DOI 10.1111/j.1460-9568.2008.06386.x; Mani K, 2000, GLYCOBIOLOGY, V10, P577, DOI 10.1093/glycob/10.6.577; Mani K, 2004, J BIOL CHEM, V279, P12918, DOI 10.1074/jbc.M313678200; Mani K, 2003, J BIOL CHEM, V278, P38956, DOI 10.1074/jbc.M300394200; Mani K, 2007, J BIOL CHEM, V282, P21934, DOI 10.1074/jbc.M701200200; Mani K, 2006, GLYCOBIOLOGY, V16, P1251, DOI 10.1093/glycob/cwl045; Mani K, 2006, GLYCOBIOLOGY, V16, P711, DOI 10.1093/glycob/cwj121; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Multhaup G, 2006, NEURODEGENER DIS, V3, P270, DOI 10.1159/000095266; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; PEJLER G, 1988, J BIOL CHEM, V263, P5197; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMALL DH, 1994, J NEUROSCI, V14, P2117; SNOW AD, 1994, AM J PATHOL, V144, P337; SNOW AD, 1990, AM J PATHOL, V137, P1253; SNOW AD, 1988, AM J PATHOL, V133, P456; Spector R, 2009, J NEUROCHEM, V111, P315, DOI 10.1111/j.1471-4159.2009.06326.x; Svensson G, 2009, GLYCOCONJUGATE J, V26, P1247, DOI 10.1007/s10719-009-9243-z; Svensson G, 2009, BIOCHEMISTRY-US, V48, P9994, DOI 10.1021/bi901402x; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; van Horssen J, 2001, ACTA NEUROPATHOL, V102, P604; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Watanabe N, 2004, FASEB J, V18, P1013, DOI 10.1096/fj.03-1040fje; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Wilhelmus MMM, 2007, MOL NEUROBIOL, V35, P203, DOI 10.1007/s12035-007-0029-7; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6	80	29	30	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27559	27572		10.1074/jbc.M111.243345	http://dx.doi.org/10.1074/jbc.M111.243345			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21642435	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000293268700050
J	Liu, J; Liu, MY; Nguyen, JB; Bhagat, A; Mooney, V; Yan, ECY				Liu, Jian; Liu, Monica Yun; Nguyen, Jennifer B.; Bhagat, Aditi; Mooney, Victoria; Yan, Elsa C. Y.			Thermal Properties of Rhodopsin INSIGHT INTO THE MOLECULAR MECHANISM OF DIM-LIGHT VISION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HYDROGEN-BOND NETWORK; VISUAL PIGMENTS; SCHIFF-BASE; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; 1ST STEP; ACTIVATION; ISOMERIZATION; INTERMEDIATE	Rhodopsin has developed mechanisms to optimize its sensitivity to light by suppressing dark noise and enhancing quantum yield. We propose that an intramolecular hydrogen-bonding network formed by similar to 20 water molecules, the hydrophilic residues, and peptide backbones in the transmembrane region is essential to restrain thermal isomerization, the source of dark noise. We studied the thermal stability of rhodopsin at 55 degrees C with single point mutations (E181Q and S186A) that perturb the hydrogen-bonding network at the active site. We found that the rate of thermal isomerization increased by 1-2 orders of magnitude in the mutants. Our results illustrate the importance of the intact hydrogen-bonding network for dim-light detection, revealing the functional roles of water molecules in rhodopsin. We also show that thermal isomerization of 11-cis-retinal in solution can be catalyzed by wild-type opsin and that this catalytic property is not affected by the mutations. We characterize the catalytic effect and propose that it is due to steric interactions in the retinal-binding site and increases quantum yield by predetermining the trajectory of photoisomerization. Thus, our studies reveal a balancing act between dark noise and quantum yield, which have opposite effects on the thermal isomerization rate. The acquisition of the hydrogen-bonding network and the tuning of the steric interactions at the retinal-binding site are two important factors in the development of dim-light vision.	[Liu, Jian; Liu, Monica Yun; Nguyen, Jennifer B.; Bhagat, Aditi; Mooney, Victoria; Yan, Elsa C. Y.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Yan, ECY (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	elsa.yan@yale.edu	Nguyen, Jennifer/GVS-4347-2022; Liu, Jian/A-9302-2013	Liu, Monica Yun/0000-0003-3936-9377; Yan, Elsa/0000-0002-3583-1627	National Science Foundation [MCB-0955407]; Anderson postdoctoral fellowship; Yale College; National Institutes of Health	National Science Foundation(National Science Foundation (NSF)); Anderson postdoctoral fellowship; Yale College; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Science Foundation Career Grant MCB-0955407.; Recipient of an Anderson postdoctoral fellowship.; Recipient of a Yale College Dean's research fellowship.; Supported by the National Institutes of Health Predoctoral Training Program in Biophysics.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BIRGE RR, 1990, ANNU REV PHYS CHEM, V41, P683, DOI 10.1146/annurev.pc.41.100190.003343; Crozier PS, 2003, J MOL BIOL, V333, P493, DOI 10.1016/j.jmb.2003.08.045; Del Valle LJ, 2003, CELL MOL LIFE SCI, V60, P2532, DOI 10.1007/s00018-003-3113-9; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; HUG SJ, 1990, BIOCHEMISTRY-US, V29, P1475, DOI 10.1021/bi00458a019; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; KANDORI H, 1995, J AM CHEM SOC, V117, P2669, DOI 10.1021/ja00114a040; KHORANA HG, 1992, J BIOL CHEM, V267, P1; KITO Y, 1968, NATURE, V218, P955, DOI 10.1038/218955a0; Kochendoerfer GG, 1996, BIOCHEMISTRY-US, V35, P16230, DOI 10.1021/bi961951l; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu J, 2009, J AM CHEM SOC, V131, P8750, DOI 10.1021/ja903154u; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; MIN KC, 1993, J BIOL CHEM, V268, P9400; Nakagawa M, 1999, P NATL ACAD SCI USA, V96, P6189, DOI 10.1073/pnas.96.11.6189; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Orban T, 2010, BIOCHEMISTRY-US, V49, P827, DOI 10.1021/bi901889t; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PETEANU LA, 1993, P NATL ACAD SCI USA, V90, P11762, DOI 10.1073/pnas.90.24.11762; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; RANDALL CE, 1991, J AM CHEM SOC, V113, P3473, DOI 10.1021/ja00009a037; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; Yan ECY, 2007, J PHYS CHEM C, V111, P8843, DOI 10.1021/jp067172o	39	24	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27622	27629		10.1074/jbc.M111.233312	http://dx.doi.org/10.1074/jbc.M111.233312			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659526	Green Published, hybrid			2022-12-27	WOS:000293268700055
J	Parkkinen, T; Boer, H; Janis, J; Andberg, M; Penttila, M; Koivula, A; Rouvinen, J				Parkkinen, Tarja; Boer, Harry; Janis, Janne; Andberg, Martina; Penttila, Merja; Koivula, Anu; Rouvinen, Juha			Crystal Structure of Uronate Dehydrogenase from Agrobacterium tumefaciens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID	Uronate dehydrogenase from Agrobacterium tumefaciens (AtUdh) belongs to the short-chain dehydrogenase/reductase superfamily and catalyzes the oxidation of D-galacturonic acid and D-glucuronic acid with NAD(+) as a cofactor. We have determined the crystal structures of an apo-form of AtUdh, a ternary form in complex with NADH and product (substrate-soaked structure), and an inactive Y136A mutant in complex with NAD(+). The crystal structures suggest AtUdh to be a homohexamer, which has also been observed to be the major form in solution. The monomer contains a Rossmann fold, essential for nucleotide binding and a common feature of the short-chain dehydrogenase/reductase family enzymes. The ternary complex structure reveals a product, D-galactaro-1,5-lactone, which is bound above the nicotinamide ring. This product rearranges in solution to D-galactaro-1,4-lactone as verified by mass spectrometry analysis, which agrees with our previous NMR study. The crystal structure of the mutant with the catalytic residue Tyr-136 substituted with alanine shows changes in the position of Ile-74 and Ser-75. This probably altered the binding of the nicotinamide end of NAD(+), which was not visible in the electron density map. The structures presented provide novel insights into cofactor and substrate binding and the reaction mechanism of AtUdh. This information can be applied to the design of efficient microbial conversion of D-galacturonic acid-based waste materials.	[Parkkinen, Tarja; Janis, Janne; Rouvinen, Juha] Univ Eastern Finland, Dept Chem, FI-80101 Joensuu, Finland; [Boer, Harry; Andberg, Martina; Penttila, Merja; Koivula, Anu] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland	University of Eastern Finland; VTT Technical Research Center Finland	Rouvinen, J (corresponding author), Univ Eastern Finland, Dept Chem, POB 111, FIN-80101 Joensuu, Finland.	juha.rouvinen@uef.fi	Penttilä, Merja E/A-4710-2013; Jänis, Janne/B-7326-2014	Boer, Harry/0000-0002-1685-2270; Rouvinen, Juha/0000-0003-1843-5718; Koivula, Anu/0000-0002-7600-5700; Parkkinen, Tarja/0000-0002-2348-0508; Blomster Andberg, Martina/0000-0002-8021-9947; Penttila, Merja/0000-0002-6929-1032	Academy of Finland through the Finnish Centre of Excellence in White Biotechnology-Green Chemistry [118573]	Academy of Finland through the Finnish Centre of Excellence in White Biotechnology-Green Chemistry(Academy of Finland)	This work was supported by the Academy of Finland through the Finnish Centre of Excellence in White Biotechnology-Green Chemistry (Decision 118573).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allard STM, 2004, J BIOL CHEM, V279, P2211, DOI 10.1074/jbc.M310134200; Boer H, 2010, APPL MICROBIOL BIOT, V86, P901, DOI 10.1007/s00253-009-2333-9; CHANG YF, 1970, J BACTERIOL, V102, P85, DOI 10.1128/JB.102.1.85-96.1970; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KILGORE WW, 1959, NATURE, V183, P1412, DOI 10.1038/1831412a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pasanen S, 2007, INT J MASS SPECTROM, V263, P22, DOI 10.1016/j.ijms.2006.12.002; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Richard P, 2009, APPL MICROBIOL BIOT, V82, P597, DOI 10.1007/s00253-009-1870-6; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; UEBERSCH.KH, 1974, EUR J BIOCHEM, V48, P389, DOI 10.1111/j.1432-1033.1974.tb03780.x; WAGNER G, 1976, EUR J BIOCHEM, V61, P589, DOI 10.1111/j.1432-1033.1976.tb10054.x; Yasutake Y, 2007, J MOL BIOL, V367, P1034, DOI 10.1016/j.jmb.2007.01.029; Yoon SH, 2009, J BACTERIOL, V191, P1565, DOI 10.1128/JB.00586-08; ZAJIC JE, 1959, J BACTERIOL, V78, P734, DOI 10.1128/JB.78.5.734-735.1959	23	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27294	27300		10.1074/jbc.M111.254854	http://dx.doi.org/10.1074/jbc.M111.254854			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676870	hybrid, Green Published			2022-12-27	WOS:000293268700025
J	Chien, CD; Kirilyuk, A; Li, JV; Zhang, WT; Lahusen, T; Schmidt, MO; Oh, AS; Wellstein, A; Riegel, AT				Chien, Christopher D.; Kirilyuk, Alexander; Li, Jordan V.; Zhang, Wentao; Lahusen, Tyler; Schmidt, Marcel O.; Oh, Annabell S.; Wellstein, Anton; Riegel, Anna T.			Role of the Nuclear Receptor Coactivator AIB1-Delta 4 Splice Variant in the Control of Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER METASTASIS; TYROSINE PHOSPHORYLATION; AIB1; IMPORT; ESTROGEN; ACTIVATION; EXPRESSION; PROTEIN; LOCALIZATION; HORMONE	The oncogene amplified in breast cancer 1 (AIB1) is a nuclear receptor coactivator that plays a major role in the progression of various cancers. We previously identified a splice variant of AIB1 called AIB1-Delta 4 that is overexpressed in breast cancer. Using mass spectrometry, we define the translation initiation of AIB1-Delta 4 at Met(224) of the full-length AIB1 sequence and have raised an antibody to a peptide representing the acetylated N terminus. We show that AIB1-Delta 4 is predominantly localized in the cytoplasm, although leptomycin B nuclear export inhibition demonstrates that AIB1-Delta 4 can enter and traffic through the nucleus. Our data indicate an import mechanism enhanced by other coactivators such as p300/CBP. Wereport that the endogenously and exogenously expressed AIB1-Delta 4 is recruited as efficiently as full-length AIB1 to estrogen-response elements of genes, and it enhances estrogen-dependent transcription more effectively than AIB1. Expression of an N-terminal AIB1 protein fragment, which is lost in the AIB1-Delta 4 isoform, potentiates AIB1 as a coactivator. This suggests a model whereby the transcriptional activity of AIB1 is squelched by a repressive mechanism utilizing the N-terminal domain and that the increased coactivator function of AIB1-Delta 4 is due to the loss of this inhibitory domain. Finally, we show, using Scorpion primer technology, that AIB1-Delta 4 expression is correlated with metastatic capability of human cancer cell lines.	[Riegel, Anna T.] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Canc Ctr, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Dept Pharmacol, Lombardi Canc Ctr, Washington, DC 20007 USA	Georgetown University; Georgetown University	Riegel, AT (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Canc Ctr, Washington, DC 20007 USA.	ariege01@georgetown.edu	Schmidt, Marcel/AAV-8054-2021	Schmidt, Marcel/0000-0002-3991-2766; Kirilyuk, Alexander/0000-0001-6403-8882; Wellstein, Anton/0000-0002-0570-4950; Oh, Annabell S./0000-0002-0676-1164	National Institutes of Health, NCI [R01 CA113477, P30-CA051008]; Department of Defense [BC083320]; Center of Excellence [W81XWH-06-10590]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA113477, T32CA009686] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA113477 from NCI (to A. T. R.). This work was also supported by Department of Defense Breast Cancer Research Program Grant BC083320 (to C. D. C.) and Center of Excellence Grant W81XWH-06-10590 (to V. C. Jordan, A. W., and A. T. R.).; Mass spectrometric analysis was performed in the Proteomics and Metabolomics Shared Resource, and microscopy was performed in the Microscopy and Imaging Shared Resource, which are supported in part by National Institutes of Health NCI Grant P30-CA051008. We also thank Geoffrey Storchan for help with chromatin immunoprecipitation experimental design.	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bautista S, 1998, CLIN CANCER RES, V4, P2925; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Cai D, 2010, CANCER RES, V70, P6477, DOI 10.1158/0008-5472.CAN-10-0005; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; DRIESSEN HPC, 1985, CRIT REV BIOCHEM MOL, V18, P281, DOI 10.3109/10409238509086784; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Hanover JA, 2009, J BIOL CHEM, V284, P12593, DOI 10.1074/jbc.R800076200; Harigopal M, 2009, BREAST CANCER RES TR, V115, P77, DOI 10.1007/s10549-008-0063-9; Henke RT, 2004, CLIN CANCER RES, V10, P6134, DOI 10.1158/1078-0432.CCR-04-0561; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kuang SQ, 2005, CANCER RES, V65, P7993, DOI 10.1158/0008-5472.CAN-05-1179; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lahusen T, 2007, CANCER RES, V67, P7256, DOI 10.1158/0008-5472.CAN-07-1013; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Li C., 2011, ONCOGENE IN PRESS; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Lodrini M, 2008, NUCLEIC ACIDS RES, V36, P1847, DOI 10.1093/nar/gkn029; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Mani A, 2006, CANCER RES, V66, P8680, DOI 10.1158/0008-5472.CAN-06-0557; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Nakles RE, 2011, MOL ENDOCRINOL, V25, P549, DOI 10.1210/me.2010-0114; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Qutob MS, 2002, MOL CELL BIOL, V22, P6611, DOI 10.1128/MCB.22.18.6611-6626.2002; Reiter R, 2004, ONCOGENE, V23, P403, DOI 10.1038/sj.onc.1207202; Reiter R, 2001, J BIOL CHEM, V276, P39736, DOI 10.1074/jbc.M104744200; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; SUNDSTROM SA, 1989, J BIOL CHEM, V264, P16941; Taveau M, 2002, ANAL BIOCHEM, V305, P227, DOI 10.1006/abio.2002.5664; Thelwell N, 2000, NUCLEIC ACIDS RES, V28, P3752, DOI 10.1093/nar/28.19.3752; Thompson ME, 2010, FEBS J, V277, P3072, DOI 10.1111/j.1742-4658.2010.07733.x; Thorat MA, 2008, HISTOPATHOLOGY, V53, P634, DOI 10.1111/j.1365-2559.2008.03155.x; Tilli MT, 2005, MOL ENDOCRINOL, V19, P644, DOI 10.1210/me.2004-0106; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yeung PL, 2006, BIOCHEM BIOPH RES CO, V348, P13, DOI 10.1016/j.bbrc.2006.06.163; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367	61	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26813	26827		10.1074/jbc.M110.216200	http://dx.doi.org/10.1074/jbc.M110.216200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636853	Green Published, hybrid			2022-12-27	WOS:000293078200057
J	Nakamura, M; Uehara, Y; Asada, M; Honda, E; Nagai, N; Kimata, K; Suzuki, M; Imamura, T				Nakamura, Masao; Uehara, Yuriko; Asada, Masahiro; Honda, Emi; Nagai, Naoko; Kimata, Koji; Suzuki, Masashi; Imamura, Toru			Sulfated Glycosaminoglycans Are Required for Specific and Sensitive Fibroblast Growth Factor (FGF) 19 Signaling via FGF Receptor 4 and betaKlotho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; HEPATOCELLULAR-CARCINOMA; SUBFAMILY MEMBERS; TRANSGENIC MICE; METABOLIC-RATE; FACTOR FAMILY; FIBROBLAST-GROWTH-FACTOR-19; KLOTHO; LIVER; EXPRESSION	Secreted from intestine, human fibroblast growth factor 19 (hFGF19) is an endocrine metabolic regulator that controls bile acid synthesis in the liver. Earlier studies have suggested that hFGF19 at 10-100 nM levels signals through FGF receptor 4 (FGFR4) in the presence of a co-receptor, betaKlotho, but its activity and receptor specificity at physiological concentrations (picomolar levels) remain unclear. Here we report that hFGF19 at picomolar levels require sulfated glycosaminoglycans (sGAGs), such as heparan sulfate, heparin, and chondroitin sulfates, for its signaling via human FGFR4 in the presence of human betaKlotho. Importantly, sGAGs isolated from liver are highly active in enhancing the picomolar hFGF19 signaling. At nanomolar levels, in contrast, hFGF19 activates all types of human FGFRs, i.e. FGFR1c, FGFR2c, FGFR3c, and FGFR4 in the co-presence of betaKlotho and heparin and activates FGFR4 even in the absence of betaKlotho. These results show that sGAGs play crucial roles in specific and sensitive hFGF19 signaling via FGF receptors and suggest that hepatic sGAGs are involved in the highly potent and specific signaling of picomolar hFGF19 through FGFR4 and betaKlotho. The results further suggest that hFGF19 at pathological concentrations may evoke aberrant signaling through various FGF receptors.	[Nakamura, Masao; Uehara, Yuriko; Asada, Masahiro; Honda, Emi; Suzuki, Masashi; Imamura, Toru] Natl Inst Adv Ind Sci & Technol, Signaling Mol Res Grp, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Nakamura, Masao; Suzuki, Masashi] Ibaraki Univ, Grad Sch Sci & Engn, Mito, Ibaraki 3108512, Japan; [Nagai, Naoko; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Ibaraki University; Aichi Medical University	Suzuki, M (corresponding author), Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	suzuki-m@aist.go.jp; imamura-toru@aist.go.jp	Suzuki, Masashi/M-1696-2018; ASADA, MASAHIRO/M-4086-2018	Suzuki, Masashi/0000-0002-7218-0923; ASADA, MASAHIRO/0000-0001-6092-2080	National Institute of Advanced Industrial Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [22590296] Funding Source: KAKEN	National Institute of Advanced Industrial Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the National Institute of Advanced Industrial Science and Technology and by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Dostalova I, 2008, J CLIN ENDOCR METAB, V93, P3627, DOI 10.1210/jc.2008-0746; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kimura A, 2008, J HEPATO-BILIARY-PAN, V15, P608, DOI 10.1007/s00534-007-1321-7; Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Smith SML, 2007, MATRIX BIOL, V26, P175, DOI 10.1016/j.matbio.2006.10.012; Strack AM, 2004, ENDOCRINOLOGY, V145, P2591, DOI 10.1210/en.2004-0367; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007; Wright TJ, 2004, DEV BIOL, V269, P264, DOI 10.1016/j.ydbio.2004.02.003; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Yoneda A, 2000, NAT BIOTECHNOL, V18, P641, DOI 10.1038/76487	32	17	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26418	26423		10.1074/jbc.M111.251140	http://dx.doi.org/10.1074/jbc.M111.251140			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653700	hybrid, Green Published			2022-12-27	WOS:000293078200019
J	Shen, XK; Fang, JP; Lv, XF; Pei, ZC; Wang, Y; Jiang, SS; Ding, K				Shen, Xiaokun; Fang, Jianping; Lv, Xiaofen; Pei, Zhicao; Wang, Ying; Jiang, Songshan; Ding, Kan			Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARINS; CANCER-ASSOCIATED THROMBOSIS; SULFATE PROTEOGLYCANS; ENDOTHELIAL-CELLS; VENOUS THROMBOEMBOLISM; TUMOR ANGIOGENESIS; TUBE FORMATION; BREAST-CANCER; GROWTH; METASTASIS	Heparin, which has been used as an anticoagulant drug for decades, inhibits angiogenesis, whereas thrombin promotes tumor-associated angiogenesis. However, the mechanisms underlying the regulation of angiogenesis by heparin and thrombin are not well understood. Here, we show that microRNA-10b (miR-10b) is down-regulated by heparin and up-regulated by thrombin in human microvascular endothelial cells (HMEC-1). Overexpression of miR-10b induces HMEC-1 cell migration, tube formation, and angiogenesis, and down-regulates homeobox D10 (HoxD10) expression via direct binding of miR-10b to the putative 3 ' UTR of HoxD10. In addition, HMEC-1 cell migration and tube formation are induced by HoxD10 knockdown, whereas angiogenesis is arrested when HoxD10 expression is increased after anti-miR-10b or heparin treatments. Furthermore, expression of miR-10b and its transcription factor Twist are up-regulated by thrombin, whereas HoxD10 expression is impaired by thrombin. Using quartz crystal microbalance analysis, we show that heparin binds to thrombin, thereby inhibiting thrombin-induced expression of Twist and miR-10b. However, the expression of miR-10b is not attenuated by heparin any more after thrombin expression is silenced by its siRNA. Interestingly, we find that heparin attenuates miR-10b expression and induces HoxD10 expression in vivo to inhibit angiogenesis and impair the growth of MDA-MB-231 tumor xenografts. These results provide insight into the molecular mechanism by which heparin and thrombin regulate angiogenesis.	[Shen, Xiaokun; Fang, Jianping; Lv, Xiaofen; Wang, Ying; Jiang, Songshan; Ding, Kan] Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, Shanghai 200031, Peoples R China; [Pei, Zhicao] NW A&F Univ, Coll Sci, Yangling, Shanxi, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, MOE Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Northwest A&F University - China; Sun Yat Sen University; Sun Yat Sen University	Jiang, SS (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, Shanghai 200031, Peoples R China.	jiangssh@mail.sysu.edu.cn; kding@mail.shcnc.ac.cn		Ding, Kan/0000-0002-8140-9259	National Natural Science Foundation of China [30770484]; Chinese Academy of Sciences, China; Chinese Academy of Sciences, China ( to K. D.), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2009ZX09301-001, 2009ZX09501-011, 2009ZX09103-071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences, China(Chinese Academy of Sciences); Chinese Academy of Sciences, China ( to K. D.), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"(Chinese Academy of Sciences)	This work was supported National Natural Science Foundation of China Grant 30770484, "100 Talents Project" of Chinese Academy of Sciences, China ( to K. D.), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grants 2009ZX09301-001, 2009ZX09501-011, and 2009ZX09103-071.	Agorogiannis EI, 2002, LANCET, V359, P1440, DOI 10.1016/S0140-6736(02)08385-X; Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; BARSHAVIT R, 1989, J CLIN INVEST, V84, P1096, DOI 10.1172/JCI114272; Bick RL, 2003, NEW ENGL J MED, V349, P109, DOI 10.1056/NEJMp030086; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Castelli R, 2004, VASC MED, V9, P205, DOI 10.1191/1358863x04vm566ra; Chai GL, 2010, CANCER SCI, V101, P1997, DOI 10.1111/j.1349-7006.2010.01616.x; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Collen A, 2000, CANCER RES, V60, P6196; Costantini V, 1998, BLOOD COAGUL FIBRIN, V9, P79, DOI 10.1097/00001721-199801000-00010; Daly ME, 2003, JNCI-J NATL CANCER I, V95, P1660, DOI 10.1093/jnci/djg101; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Fu Y, 2009, BIOCHEMISTRY-US, V48, P11655, DOI 10.1021/bi901265z; Girardin EP, 2005, J BIOL CHEM, V280, P38059, DOI 10.1074/jbc.M507997200; Hasan J, 2005, CLIN CANCER RES, V11, P8172, DOI 10.1158/1078-0432.CCR-05-0452; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu L, 2008, CANCER RES, V68, P4296, DOI 10.1158/0008-5472.CAN-08-0067; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Khorana AA, 2010, THROMB RES, V125, P490, DOI 10.1016/j.thromres.2009.12.023; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Laubli H, 2009, CANCER INVEST, V27, P474, DOI 10.1080/07357900802647136; Lee AYY, 2007, THROMB RES, V120, pS121, DOI 10.1016/S0049-3848(07)70140-8; Li G, 2010, CANCER LETT, V299, P29, DOI 10.1016/j.canlet.2010.07.021; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Marchetti M, 2008, THROMB RES, V121, P637, DOI 10.1016/j.thromres.2007.06.015; MERTENS G, 1992, J BIOL CHEM, V267, P20435; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; Mousa SA, 2004, CARDIOVASC DRUG REV, V22, P121; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Noble S, 2010, BRIT J CANCER, V102, pS2, DOI 10.1038/sj.bjc.6605599; Norrby K, 2006, APMIS, V114, P79, DOI 10.1111/j.1600-0463.2006.apm_235.x; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Qiu H, 2010, J BIOL CHEM, V285, P32638, DOI 10.1074/jbc.M110.105544; Rodrigues CA, 2010, J THROMB THROMBOLYS, V30, P67, DOI 10.1007/s11239-010-0441-0; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; SHIBATA S, 1993, CLIN IMMUNOL IMMUNOP, V67, P264, DOI 10.1006/clin.1993.1074; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; Snyder KM, 2008, SEMIN THROMB HEMOST, V34, P734, DOI 10.1055/s-0029-1145255; Solari V, 2010, BRIT J CANCER, V103, P593, DOI 10.1038/sj.bjc.6605808; Soncin F, 1997, J BIOL CHEM, V272, P9818; Tan HX, 2010, MED ONCOL, V27, P654, DOI 10.1007/s12032-009-9264-2; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Vlodavsky I, 2007, THROMB RES, V120, pS112, DOI 10.1016/S0049-3848(07)70139-1; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zacharski LR, 2002, CANCER LETT, V186, P1, DOI 10.1016/S0304-3835(02)00258-6; Zhang WQ, 2006, J BIOL CHEM, V281, P37302, DOI 10.1074/jbc.M604905200	58	62	69	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26616	26627		10.1074/jbc.M111.224212	http://dx.doi.org/10.1074/jbc.M111.224212			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642433	hybrid, Green Published			2022-12-27	WOS:000293078200040
J	Raspail, C; Graindorge, M; Moreau, Y; Crouzy, S; Lefebvre, B; Robin, AY; Dumas, R; Matringe, M				Raspail, Corinne; Graindorge, Matthieu; Moreau, Yohann; Crouzy, Serge; Lefebvre, Bertrand; Robin, Adeline Y.; Dumas, Renaud; Matringe, Michel			4-Hydroxyphenylpyruvate Dioxygenase Catalysis IDENTIFICATION OF CATALYTIC RESIDUES AND PRODUCTION OF A HYDROXYLATED INTERMEDIATE SHARED WITH A STRUCTURALLY UNRELATED ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLPYRUVATE DIOXYGENASE; NONHEME IRON ENZYMES; (4-HYDROXYPHENYL)PYRUVATE DIOXYGENASE; HYDROXYMANDELATE SYNTHASE; STREPTOMYCES-AVERMITILIS; HEREDITARY TYROSINEMIA; CRYSTAL-STRUCTURES; POTENT INHIBITOR; ACID; DENSITY	4-Hydroxyphenylpyruvate dioxygenase (HPPD) catalyzes the conversion of 4-hydroxyphenylpyruvate (HPP) into homogentisate. HPPD is the molecular target of very effective synthetic herbicides. HPPD inhibitors may also be useful in treating life-threatening tyrosinemia type I and are currently in trials for treatment of Parkinson disease. The reaction mechanism of this key enzyme in both plants and animals has not yet been fully elucidated. In this study, using site-directed mutagenesis supported by quantum mechanical/molecular mechanical theoretical calculations, we investigated the role of catalytic residues potentially interacting with the substrate/intermediates. These results highlight the following: (i) the central role of Gln-272, Gln-286, and Gln-358 in HPP binding and the first nucleophilic attack; (ii) the important movement of the aromatic ring of HPP during the reaction, and (iii) the key role played by Asn-261 and Ser-246 in C1 hydroxylation and the final ortho-rearrangement steps (numbering according to the Arabidopsis HPPD crystal structure 1SQD). Furthermore, this study reveals that the last step of the catalytic reaction, the 1,2 shift of the acetate side chain, which was believed to be unique to the HPPD activity, is also catalyzed by a structurally unrelated enzyme.	[Graindorge, Matthieu; Moreau, Yohann] Univ Grenoble 1, F-38054 Grenoble, France; [Matringe, Michel] Inst Natl Rech Agron, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, UMR 1200, F-38054 Grenoble, France; [Moreau, Yohann; Crouzy, Serge] Commissariat Energie Atom, CNRS UMR Lab Chim & Biol Met 5249, Direct Sci Vivant, Inst Rech Technol & Sci Vivant, F-38054 Grenoble, France; [Dumas, Renaud] CNRS, UMR 5168, Lab Physiol Cellulaire & Vegetale, F-38054 Grenoble, France; [Raspail, Corinne; Graindorge, Matthieu; Robin, Adeline Y.; Dumas, Renaud; Matringe, Michel] Commissariat Energie Atom, Direct Sci Vivant, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, F-38054 Grenoble, France; [Lefebvre, Bertrand] Ctr Rech Serv Sante Armees, Unite Biospectrometrie, F-38702 La Tronche, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Matringe, M (corresponding author), Inst Natl Rech Agron, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, UMR 1200, 17 Rue Martyrs, F-38054 Grenoble, France.	mmatringe@cea.fr	Dumas, Renaud/E-1835-2011	Robin, Adeline/0000-0002-1199-2135				BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Borowski T, 2004, BIOCHEMISTRY-US, V43, P12331, DOI 10.1021/bi049503y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brownlee JM, 2004, BIOCHEMISTRY-US, V43, P6370, DOI 10.1021/bi049317s; Brownlee J, 2008, BIOCHEMISTRY-US, V47, P2002, DOI 10.1021/bi701438r; Crouch NP, 1997, TETRAHEDRON, V53, P6993, DOI 10.1016/S0040-4020(97)00398-0; ELLIS MK, 1995, TOXICOL APPL PHARM, V133, P12, DOI 10.1006/taap.1995.1121; ENDO F, 1983, PEDIATR RES, V17, P92, DOI 10.1203/00006450-198302000-00002; Ferre N, 2003, J AM CHEM SOC, V125, P6868, DOI 10.1021/ja035087d; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Frisch M.J., 2016, GAUSSIAN16 REV B01; Fritze IM, 2004, PLANT PHYSIOL, V134, P1388, DOI 10.1104/pp.103.034082; Garcia I, 1999, PLANT PHYSIOL, V119, P1507, DOI 10.1104/pp.119.4.1507; Garcia I, 2000, BIOCHEMISTRY-US, V39, P7501, DOI 10.1021/bi000135h; Gunsior M, 2004, BIOCHEMISTRY-US, V43, P663, DOI 10.1021/bi035762w; GUROFF G, 1967, SCIENCE, V157, P1524, DOI 10.1126/science.157.3796.1524; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; Johnson-Winters K, 2003, BIOCHEMISTRY-US, V42, P2072, DOI 10.1021/bi026499m; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Luscombe B. M., 1995, BRIGHTON CROP PROT C, V2, P35; Matringe M, 2005, PEST MANAG SCI, V61, P269, DOI 10.1002/ps.997; Neidig ML, 2006, P NATL ACAD SCI USA, V103, P12966, DOI 10.1073/pnas.0605067103; NIEDERWIESER A, 1978, CLIN CHIM ACTA, V90, P195, DOI 10.1016/0009-8981(78)90522-3; PASCAL RA, 1985, BIOCHEMISTRY-US, V24, P3158, DOI 10.1021/bi00334a013; Ponder J.W, 2001, TINKER SOFTWARE TOOL; Prisbylla M. P., 1993, WEEDS, P731; Romagni JG, 2000, FEBS LETT, V480, P301, DOI 10.1016/S0014-5793(00)01907-4; RUNDGREN M, 1977, J BIOL CHEM, V252, P5094; SCHULZ A, 1993, FEBS LETT, V318, P162, DOI 10.1016/0014-5793(93)80013-K; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; SECOR J, 1994, PLANT PHYSIOL, V106, P1429, DOI 10.1104/pp.106.4.1429; Serre L, 1999, STRUCTURE, V7, P977, DOI 10.1016/S0969-2126(99)80124-5; SOLL J, 1980, ARCH BIOCHEM BIOPHYS, V204, P544, DOI 10.1016/0003-9861(80)90066-1; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Suemori A, 1996, J FERMENT BIOENG, V81, P133, DOI 10.1016/0922-338X(96)87590-8; THOMAS G, 1974, BIOCHEM J, V142, P437, DOI 10.1042/bj1420437; Tomoeda K, 2000, MOL GENET METAB, V71, P506, DOI 10.1006/mgme.2000.3085; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Yang C, 2004, BIOCHEMISTRY-US, V43, P10414, DOI 10.1021/bi049323o; Zink O., 2000, Patent application FR, Patent No. [00/13942, 0013942]	45	54	58	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26061	26070		10.1074/jbc.M111.227595	http://dx.doi.org/10.1074/jbc.M111.227595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21613226	hybrid, Green Published			2022-12-27	WOS:000293073000064
J	Goulet, A; Lai-Kee-Him, J; Veesler, D; Auzat, I; Robin, G; Shepherd, DA; Ashcroft, AE; Richard, E; Lichiere, J; Tavares, P; Cambillau, C; Bron, P				Goulet, Adeline; Lai-Kee-Him, Josephine; Veesler, David; Auzat, Isabelle; Robin, Gautier; Shepherd, Dale A.; Ashcroft, Alison E.; Richard, Eric; Lichiere, Julie; Tavares, Paulo; Cambillau, Christian; Bron, Patrick			The Opening of the SPP1 Bacteriophage Tail, a Prevalent Mechanism in Gram-positive-infecting Siphophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; ELECTRON-MICROSCOPY; ESCHERICHIA-COLI; MEMBRANE-RECEPTOR; STRUCTURE REVEALS; PROTEIN; LAMBDA; PHAGES; FIBER	The SPP1 siphophage uses its long non-contractile tail and tail tip to recognize and infect the Gram-positive bacterium Bacillus subtilis. The tail-end cap and its attached tip are the critical components for host recognition and opening of the tail tube for genome exit. In the present work, we determined the cryo-electron microscopic (cryo-EM) structure of a complex formed by the cap protein gp19.1 (Dit) and the N terminus of the downstream protein of gp19.1 in the SPP1 genome, gp21(1-552) (Tal). This complex assembles two back-to-back stacked gp19.1 ring hexamers, interacting loosely, and two gp21(1-552) trimers interacting with gp19.1 at both ends of the stack. Remarkably, one gp21(1-552) trimer displays a "closed" conformation, whereas the second is "open" delineating a central channel. The two conformational states dock nicely into the EM map of the SPP1 cap domain, respectively, before and after DNA release. Moreover, the open/closed conformations of gp19.1-gp21(1-552) are consistent with the structures of the corresponding proteins in the siphophage p2 baseplate, where the Tal protein (ORF16) attached to the ring of Dit (ORF15) was also found to adopt these two conformations. Therefore, the present contribution allowed us to revisit the SPP1 tail distal-end architectural organization. Considering the sequence conservation among Dit and the N-terminal region of Tal-like proteins in Gram-positive-infecting Siphoviridae, it also reveals the Tal opening mechanism as a hallmark of siphophages probably involved in the generation of the firing signal initiating the cascade of events that lead to phage DNA release in vivo.	[Goulet, Adeline; Veesler, David; Lichiere, Julie; Cambillau, Christian] CNRS, UMR 6098, F-13288 Marseille 09, France; [Goulet, Adeline; Veesler, David; Lichiere, Julie; Cambillau, Christian] Univ Aix Marseille 1, F-13288 Marseille 09, France; [Goulet, Adeline; Veesler, David; Lichiere, Julie; Cambillau, Christian] Univ Aix Marseille 2, F-13288 Marseille 09, France; [Goulet, Adeline; Lai-Kee-Him, Josephine; Robin, Gautier; Richard, Eric; Bron, Patrick] CNRS, UMR 5048, INSERM, UMR 1054,Ctr Biochim Struct, F-34090 Montpellier, France; [Goulet, Adeline; Lai-Kee-Him, Josephine; Robin, Gautier; Richard, Eric; Bron, Patrick] Univ Montpellier 1, F-34090 Montpellier, France; [Goulet, Adeline; Lai-Kee-Him, Josephine; Robin, Gautier; Richard, Eric; Bron, Patrick] Univ Montpellier 2, F-34090 Montpellier, France; [Auzat, Isabelle; Tavares, Paulo] CNRS, Ctr Rech Gif, UPR 3296, Lab Virol Mol & Struct, F-91198 Gif Sur Yvette, France; [Auzat, Isabelle; Tavares, Paulo] CNRS, IFR 115, F-91198 Gif Sur Yvette, France; [Shepherd, Dale A.; Ashcroft, Alison E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Leeds	Cambillau, C (corresponding author), CNRS, UMR 6098, Campus Luminy,Case 932, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr; patrick.bron@cbs.cnrs.fr	Veesler, David/HCH-3986-2022	LAI KEE HIM, Josephine/0000-0001-6303-1224; Goulet, Adeline/0000-0002-5971-9488; bron, patrick/0000-0002-3354-9513; Richard, Eric/0000-0003-0277-4141; Cooper-Shepherd, Dale/0000-0001-9301-1777; Tavares, Paulo/0000-0002-2566-4546	ANR, Structural insights on Siphoviridae Bacteriophages infection [BLAN07-1_191968]; Conseil Regional Languedoc-Roussillon; Montpellier I University; INSERM; BBSRC [BB/E012558/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012558/1] Funding Source: researchfish	ANR, Structural insights on Siphoviridae Bacteriophages infection(French National Research Agency (ANR)); Conseil Regional Languedoc-Roussillon(Region Occitanie); Montpellier I University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by ANR BLAN07-1_191968 Structural insights on Siphoviridae Bacteriophages infection, Conseil Regional Languedoc-Roussillon, Montpellier I University and INSERM.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Bebeacua C, 2010, J BIOL CHEM, V285, P39079, DOI 10.1074/jbc.M110.175646; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Brondsted L, 2001, APPL ENVIRON MICROB, V67, P5626, DOI 10.1128/AEM.67.12.5626-5633.2001; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; Casjens S, 1988, CONTROL MECH DSDNA B; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081; HARRIS JR, 1994, J STRUCT BIOL, V112, P216, DOI 10.1006/jsbi.1994.1022; JOHNSEN MG, 1995, VIROLOGY, V212, P595, DOI 10.1006/viro.1995.1517; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; KATSURA I, 1975, J MOL BIOL, V91, P257, DOI 10.1016/0022-2836(75)90379-4; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Molineux IJ, 2006, VIROLOGY, V344, P221, DOI 10.1016/j.virol.2005.09.014; MONTEVILLE MR, 1994, APPL ENVIRON MICROB, V60, P3204, DOI 10.1128/AEM.60.9.3204-3211.1994; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; SANTOS MA, 1984, J GEN VIROL, V65, P2067, DOI 10.1099/0022-1317-65-11-2067; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sao-Jose C, 2004, J BACTERIOL, V186, P8337, DOI 10.1128/JB.186.24.8337-8346.2004; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Thomassen E, 2003, J MOL BIOL, V331, P361, DOI 10.1016/s0022-2836(03)00755-1; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204; VANHEEL M, 1986, OPTIK, V73, P119; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Veesler D, 2010, PROTEIN SCI, V19, P1812, DOI 10.1002/pro.464; Veesler D, 2010, PROTEIN SCI, V19, P1439, DOI 10.1002/pro.416; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	45	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25397	25405		10.1074/jbc.M111.243360	http://dx.doi.org/10.1074/jbc.M111.243360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622577	Green Published, hybrid			2022-12-27	WOS:000292547900085
J	Norholm, MHH; Shulga, YV; Aoki, S; Epand, RM; von Heijne, G				Norholm, Morten H. H.; Shulga, Yulia V.; Aoki, Satoko; Epand, Richard M.; von Heijne, Gunnar			Flanking Residues Help Determine Whether a Hydrophobic Segment Adopts a Monotopic or Bitopic Topology in the Endoplasmic Reticulum Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL-KINASE-EPSILON; TRANSMEMBRANE HELICES; PROTEIN TOPOLOGY; MOLECULAR CODE; CAVEOLIN; INSERTION; RECOGNITION; PROPENSITY; TRANSLOCON; PREDICTION	Proteins interacting with membranes via a single hydrophobic segment can be classified as either monotopic or bitopic. Here, we probe the topology of a membrane-attached enzyme, the epsilon isoform of human diacylglycerol kinase (DGK epsilon), when inserted into rough microsomes and compare it with the monotopic membrane protein mouse caveolin-1. In contrast to previous findings, the N-terminal hydrophobic stretch in DGK epsilon attains a bitopic rather than a monotopic topology in our experimental system. In addition, we find that charged flanking residues as well as proline residues embedded in the hydrophobic segment are important determinants of monotopic versus bitopic topology.	[Norholm, Morten H. H.; von Heijne, Gunnar] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17121 Solna, Sweden; [Shulga, Yulia V.; Aoki, Satoko; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	Stockholm University; Stockholm University; McMaster University	von Heijne, G (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011; , Richard/R-2316-2019	von Heijne, Gunnar/0000-0002-4490-8569; , Richard/0000-0002-9602-9558; Norholm, Morten/0000-0002-7871-5191	Human Frontiers Science Program [RGP0039/2007]; European Research Council [ERC-2008-AdG 232648]; Swedish Foundation for Strategic Research; Swedish Cancer Foundation, the Swedish Cancer Foundation; Natural Sciences and Engineering Research Council of Canada [9848]; Lundbeck Foundation	Human Frontiers Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Foundation, the Swedish Cancer Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lundbeck Foundation(Lundbeckfonden)	This work was supported by Human Frontiers Science Program Grant RGP0039/2007, European Research Council Grant ERC-2008-AdG 232648, grants from the Swedish Foundation for Strategic Research and the Swedish Research Council, the Swedish Cancer Foundation (to G. v. H.), and Natural Sciences and Engineering Research Council of Canada Grant 9848 (to R. M. E.).; Supported by a grant from the Lundbeck Foundation.	Aoki S, 2010, J BIOL CHEM, V285, P33371, DOI 10.1074/jbc.M110.153569; Bernsel A, 2005, PROTEIN SCI, V14, P1723, DOI 10.1110/ps.051395305; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Decaffmeyer M, 2008, J MOL BIOL, V383, P797, DOI 10.1016/j.jmb.2008.08.076; Dicu AO, 2007, BIOCHEMISTRY-US, V46, P6109, DOI 10.1021/bi6024726; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Glukhov E, 2007, BBA-BIOMEMBRANES, V1768, P2549, DOI 10.1016/j.bbamem.2007.06.012; Hedin LE, 2010, J MOL BIOL, V396, P221, DOI 10.1016/j.jmb.2009.11.036; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Lerch-Bader M, 2008, P NATL ACAD SCI USA, V105, P4127, DOI 10.1073/pnas.0711580105; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Monne M, 1999, J MOL BIOL, V293, P807, DOI 10.1006/jmbi.1999.3183; Norholm MHH, 2011, J MOL BIOL, V407, P171, DOI 10.1016/j.jmb.2011.01.035; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214	27	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25284	25290		10.1074/jbc.M111.244616	http://dx.doi.org/10.1074/jbc.M111.244616			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21606504	Green Published, hybrid			2022-12-27	WOS:000292547900074
J	Flannery, SM; Keating, SE; Szymak, J; Bowie, AG				Flannery, Sinead M.; Keating, Sinead E.; Szymak, Joanna; Bowie, Andrew G.			Human Interleukin-1 Receptor-associated Kinase-2 Is Essential for Toll-like Receptor-mediated Transcriptional and Post-transcriptional Regulation of Tumor Necrosis Factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; CHEMOKINE MESSENGER-RNA; BACTERIAL-INFECTIONS; SIGNALING PATHWAYS; INNATE IMMUNITY; RICH ELEMENTS; MICE LACKING; IL-1; STABILIZATION	Toll-like receptors (TLRs) are pattern-recognition receptors that recognize microbial ligands and subsequently trigger intracellular signaling pathways involving transcription factors such as NF kappa B and MAPKs such as p38. TLR signaling can regulate both transcriptional and post-transcriptional events leading to altered gene expression and thus appropriate immune responses. The interleukin-1 receptor-associated kinase (IRAK) family comprises four kinases that regulate TLR signaling. However, the role of IRAK-2 has remained unclear, especially in human cells. Recent studies using cells from in-bred Irak2(-/-) mice showed that murine IRAK-2 was not required for early TLR signaling events but had a role in delayed NF kappa B activation and in cytokine production. IRAK-2 in mice has four splice variants, two of which are inhibitory, whereas human IRAK-2 has no splice variants. Thus IRAK-2 in mice and humans may function differently, and therefore we analyzed the role of IRAK-2 in TLR responses in primary human cells. siRNA knockdown of IRAK-2 expression in human peripheral blood mononuclear cells showed a role for human IRAK-2 in both TLR4- and TLR8-mediated early NF kappa B and p38 MAPK activation and in induction of TNF mRNA. These data conflict with findings from the in-bred Irak2(-/-) mice but concur with what has been seen in wild-derived mice for TLR2. Moreover, human IRAK-2 was required for regulating MyD88-dependent TNF alpha mRNA stability via the TNF 3'UTR. Collectively, these data demonstrate for the first time an essential role for IRAK-2 in primary human cells for both transcriptional and post-transcriptional TLR responses.	[Flannery, Sinead M.; Keating, Sinead E.; Szymak, Joanna; Bowie, Andrew G.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373	Science Foundation of Ireland; Irish Health Research Board	Science Foundation of Ireland(Science Foundation Ireland); Irish Health Research Board	This work was supported by the Science Foundation of Ireland and by the Irish Health Research Board.	Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Conner JR, 2009, J EXP MED, V206, P1615, DOI 10.1084/jem.20090490; Datta S, 2004, J IMMUNOL, V173, P2755, DOI 10.4049/jimmunol.173.4.2755; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hartupee J, 2008, J BIOL CHEM, V283, P15689, DOI 10.1074/jbc.M801346200; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Rosati O, 2002, BIOCHEM BIOPH RES CO, V297, P52, DOI 10.1016/S0006-291X(02)02130-7; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; SHEN SH, 1981, CELL, V26, P191, DOI 10.1016/0092-8674(81)90302-0; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thomas JA, 1999, J IMMUNOL, V163, P978; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wan YZ, 2011, J IMMUNOL, V186, P3006, DOI 10.4049/jimmunol.1003217; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yin WG, 2011, J INTERF CYTOK RES, V31, P415, DOI 10.1089/jir.2010.0094; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	43	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23688	23697		10.1074/jbc.M111.248351	http://dx.doi.org/10.1074/jbc.M111.248351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606490	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000292294900010
J	Mendez, JA; Bourque, MJ; Fasano, C; Kortleven, C; Trudeau, LE				Mendez, Jose Alfredo; Bourque, Marie-Josee; Fasano, Caroline; Kortleven, Christian; Trudeau, Louis-Eric			Somatodendritic Dopamine Release Requires Synaptotagmin 4 and 7 and the Participation of Voltage-gated Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL TEGMENTAL AREA; SUBSTANTIA-NIGRA NEURONS; OPERATED CA2+ CHANNELS; CA2+-DEPENDENT EXOCYTOSIS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; PARS COMPACTA; PC12 CELLS; RAT; VII	Somatodendritic (STD) dopamine (DA) release is a key mechanism for the autoregulatory control of DA release in the brain. However, its molecular mechanism remains undetermined. We tested the hypothesis that differential expression of synaptotagmin (Syt) isoforms explains some of the differential properties of terminal and STD DA release. Down-regulation of the dendritically expressed Syt4 and Syt7 severely reduced STD DA release, whereas terminal release required Syt1. Moreover, we found that although mobilization of intracellular Ca2+ stores is inefficient, Ca2+ influx through N- and P/Q-type voltage-gated channels is critical to trigger STD DA release. Our findings provide an explanation for the differential Ca2+ requirement of terminal and STD DA release. In addition, we propose that not all sources of intracellular Ca2+ are equally efficient to trigger this release mechanism. Our findings have implications for a better understanding of a fundamental cell biological process mediating transcellular signaling in a system critical for diseases such as Parkinson disease.	[Mendez, Jose Alfredo; Bourque, Marie-Josee; Fasano, Caroline; Kortleven, Christian; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Mendez, J Alfredo/E-2031-2015; Tuluc, Petronel/C-2527-2011; Trudeau, Louis-Eric/AAE-4782-2020	Mendez, J Alfredo/0000-0002-2859-7086; Trudeau, Louis-Eric/0000-0003-4684-1377	Canadian Institutes of Health Research; National Alliance for Research on Schizophrenia and Depression; Neuroscience Canada; Fonds de la Recherche en Sante du Quebec; Groupe de Recherche sur le Systeme Nerveux Central; FRSQ (Quebec)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Alliance for Research on Schizophrenia and Depression(NARSAD); Neuroscience Canada; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Groupe de Recherche sur le Systeme Nerveux Central; FRSQ (Quebec)(Fonds de la Recherche en Sante du Quebec)	This work was funded by grants from the Canadian Institutes of Health Research, National Alliance for Research on Schizophrenia and Depression, and Neuroscience Canada (to L.-E. T.) and by a Fonds de la Recherche en Sante du Quebec infrastructure grant to the Groupe de Recherche sur le Systeme Nerveux Central.; Supported by a postdoctoral fellowship from the Groupe de Recherche sur le Systeme Nerveux Central.; Supported by a senior investigator grant from the FRSQ (Quebec). To whom correspondence should be addressed: Faculty of Medicine, Universite de Montreal. C. P. 6128, Succursale Centre-Ville, Montreal, Quebec H3C 3J7, Canada. Tel.: 514-343-5692; Fax: 514-343-2291; E-mail: louis-eric.trudeau@umontreal.ca.	Adell A, 2004, NEUROSCI BIOBEHAV R, V28, P415, DOI 10.1016/j.neubiorev.2004.05.001; Andersson DR, 2006, EUR J NEUROSCI, V24, P617, DOI 10.1111/j.1460-9568.2006.04953.x; Andrews NW, 2005, TRENDS CELL BIOL, V15, P626, DOI 10.1016/j.tcb.2005.09.001; Arthur CP, 2010, NEUROSCIENCE, V167, P135, DOI 10.1016/j.neuroscience.2010.01.056; Barber CF, 2009, J CELL BIOL, V187, P295, DOI 10.1083/jcb.200903098; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bergquist F, 2003, NEUROSCIENCE, V120, P757, DOI 10.1016/S0306-4522(03)00385-3; Bergquist F, 1998, J NEUROCHEM, V70, P1532; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Bjijou Y, 1996, J PHARMACOL EXP THER, V277, P1177; BJORKLUND A, 1975, BRAIN RES, V83, P531, DOI 10.1016/0006-8993(75)90849-5; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Bustos G, 2004, BRAIN RES REV, V47, P126, DOI 10.1016/j.brainresrev.2004.05.002; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chen BT, 2006, J NEUROCHEM, V96, P645, DOI 10.1111/j.1471-4159.2005.03519.x; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; Cragg SJ, 1997, J NEUROSCI, V17, P5738; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Deng CY, 2009, NEUROPSYCHOPHARMACOL, V34, P1233, DOI 10.1038/npp.2008.143; Durante P, 2004, J NEUROPHYSIOL, V91, P1450, DOI 10.1152/jn.01015.2003; Elverfors A, 1997, SYNAPSE, V26, P359, DOI 10.1002/(SICI)1098-2396(199708)26:4<359::AID-SYN4>3.0.CO;2-5; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; FASANO C, 2008, CURR PROTOC NEUROSCI, V44, P1; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Fortin GD, 2006, J NEUROCHEM, V96, P1740, DOI 10.1111/j.1471-4159.2006.03699.x; Fukuda M, 2004, J BIOL CHEM, V279, P52677, DOI 10.1074/jbc.M409241200; Fukuda M, 2004, BIOCHEM J, V380, P875, DOI 10.1042/BJ20040096; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Glavan G, 2005, NEUROSCIENCE, V135, P545, DOI 10.1016/j.neuroscience.2005.05.050; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; HEERINGA MJ, 1995, J NEUROCHEM, V65, P192; Hu ZT, 2008, BIOCHEM BIOPH RES CO, V371, P781, DOI 10.1016/j.bbrc.2008.04.174; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Johnson SL, 2010, NAT NEUROSCI, V13, P45, DOI 10.1038/nn.2456; Kim Y, 2008, BIOCHEM BIOPH RES CO, V373, P665, DOI 10.1016/j.bbrc.2008.06.099; Kim Y, 2009, NEUROSCI LETT, V465, P31, DOI 10.1016/j.neulet.2009.08.066; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lindgren N, 2001, EUR J NEUROSCI, V13, P773, DOI 10.1046/j.0953-816x.2000.01443.x; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Patel JC, 2009, J NEUROSCI, V29, P6568, DOI 10.1523/JNEUROSCI.0181-09.2009; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; RICE ME, 1994, EXP BRAIN RES, V100, P395, DOI 10.1007/BF02738400; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; St-Gelais F, 2004, J NEUROSCI, V24, P2566, DOI 10.1523/JNEUROSCI.5376-03.2004; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Thuret S, 2004, MOL CELL NEUROSCI, V25, P394, DOI 10.1016/j.mcn.2003.11.004; Ting JT, 2006, J NEUROSCI, V26, P372, DOI 10.1523/JNEUROSCI.3997-05.2006; Tobin VA, 2004, EUR J NEUROSCI, V19, P2909, DOI 10.1111/j.1460-9568.2004.03388.x; Vandecasteele M, 2008, P NATL ACAD SCI USA, V105, P4904, DOI 10.1073/pnas.0703121105; Vezina P, 1996, J NEUROSCI, V16, P2411; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101; Zhou FW, 2009, J NEUROSCI, V29, P10424, DOI 10.1523/JNEUROSCI.4402-08.2009	61	42	44	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23928	23937		10.1074/jbc.M111.218032	http://dx.doi.org/10.1074/jbc.M111.218032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576241	Green Published, hybrid			2022-12-27	WOS:000292294900035
J	Shang, X; Cancelas, JA; Li, LN; Guo, FK; Liu, W; Johnson, JF; Ficker, A; Daria, D; Geiger, H; Ratner, N; Zheng, Y				Shang, Xun; Cancelas, Jose A.; Li, Lina; Guo, Fukun; Liu, Wei; Johnson, James F.; Ficker, Ashley; Daria, Deidre; Geiger, Hartmut; Ratner, Nancy; Zheng, Yi			R-Ras and Rac GTPase Cross-talk Regulates Hematopoietic Progenitor Cell Migration, Homing, and Mobilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST EPITHELIAL-CELLS; STEM-CELL; INTEGRIN ACTIVATION; BONE-MARROW; RHO-GTPASES; NICHE; ADHESION; CDC42; IDENTIFICATION; ORGANIZATION	Adult hematopoietic progenitor cells (HPCs) are maintained by highly coordinated signals in the bone marrow. The molecular mechanisms linking intracellular signaling network of HPCs with their microenvironment remain poorly defined. The Rho family GTPase Rac1/Rac2 has previously been implicated in cell functions involved in HPC maintenance, including adhesion, migration, homing, and mobilization. In the present studies we have identified R-Ras, a member of the Ras family, as a key signal mediator required for Rac1/Rac2 activation. We found that whereas Rac1 activity is up-regulated upon stem cell factor, integrin, or CXCL12 stimulation, R-Ras activity is inversely up-regulated. Expression of a constitutively active R-Ras mutant resulted in down-regulation of Rac1-activity whereas deletion of R-Ras led to an increase in Rac1/Rac2 activity and signaling. R-Ras(-/-) HPCs displayed a constitutively assembled cortical actin structure and showed increased directional migration. Rac1/Rac2 inhibition reversed the migration phenotype of R-Ras(-/-) HPCs, similar to that by expressing an R-Ras active mutant. Furthermore, R-Ras(-/-) mice showed enhanced responsiveness to G-CSF for HPC mobilization and exhibited decreased bone marrow homing. Transplantation experiments indicate that the R-Ras deficiency-induced HPC mobilization is a HPC intrinsic property. These results indicate that R-Ras is a critical regulator of Rac signaling required for HPC migration, homing, and mobilization.	[Shang, Xun; Cancelas, Jose A.; Li, Lina; Guo, Fukun; Liu, Wei; Johnson, James F.; Ficker, Ashley; Daria, Deidre; Geiger, Hartmut; Ratner, Nancy; Zheng, Yi] Univ Cincinnati, Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015; Cancelas, Jose/AAR-9324-2020	Zheng, Yi/0000-0001-7089-6074; RATNER, NANCY/0000-0001-5030-9354	National Institutes of Health [R01 CA125658, R01 CA141341, P30 DK090971, R01 HL087159]; NATIONAL CANCER INSTITUTE [R01CA125658, R01CA141341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA125658, R01 CA141341, and P30 DK090971 (to Y. Z.) and R01 HL087159 (to J. A. C.).	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Cancelas JA, 2006, EXP HEMATOL, V34, P976, DOI 10.1016/j.exphem.2006.03.016; Cancelas JA, 2009, CURR OPIN HEMATOL, V16, P249, DOI 10.1097/MOH.0b013e32832c4b80; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GINSBERG MH, 1992, COLD SPRING HARB SYM, V57, P221, DOI 10.1101/SQB.1992.057.01.027; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Jeong HW, 2005, CANCER RES, V65, P507; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; LOWE DG, 1987, MOL CELL BIOL, V7, P2845, DOI 10.1128/MCB.7.8.2845; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nakada M, 2005, AM J PATHOL, V167, P565, DOI 10.1016/S0002-9440(10)62998-7; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; SAEZ R, 1994, ONCOGENE, V9, P2977; SELF AJ, 1993, ONCOGENE, V8, P655; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; Straub AC, 2009, AM J PATHOL, V174, P1949, DOI 10.2353/ajpath.2009.081016; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	42	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24068	24078		10.1074/jbc.M111.226951	http://dx.doi.org/10.1074/jbc.M111.226951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572048	hybrid, Green Published			2022-12-27	WOS:000292294900049
J	Yang, W; Manna, PT; Zou, JE; Luo, JH; Beech, DJ; Sivaprasadarao, A; Jiang, LH				Yang, Wei; Manna, Paul T.; Zou, Jie; Luo, Jianhong; Beech, David J.; Sivaprasadarao, Asipu; Jiang, Lin-Hua			Zinc Inactivates Melastatin Transient Receptor Potential 2 Channels via the Outer Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; TRPM2 CHANNEL; FUNCTIONAL INHIBITION; SUBUNIT INTERACTION; SECRETORY GRANULES; HYDROGEN-PEROXIDE; P2X(7) RECEPTORS; K+ CHANNEL; ADP-RIBOSE; ZN2+	Zinc ion (Zn2+) is an endogenous allosteric modulator that regulates the activity of a wide variety of ion channels in a reversible and concentration-dependent fashion. Here we used patch clamp recording to study the effects of Zn2+ on the melastatin transient receptor potential 2 (TRPM2) channel. Zn2+ inhibited the human (h) TRPM2 channel currents, and the steady-state inhibition was largely not reversed upon washout and concentration-independent in the range of 30-1000 mu M, suggesting that Zn2+ induces channel inactivation. Zn2+ inactivated the channels fully when they conducted inward currents, but only by half when they passed outward currents, indicating profound influence of the permeant ion on Zn2+ inactivation. Alanine substitution scanning mutagenesis of 20 Zn2+-interacting candidate residues in the outer pore region of the hTRPM2 channel showed that mutation of Lys(952) in the extracellular end of the fifth transmembrane segment and Asp(1002) in the large turret strongly attenuated or abolished Zn2+ inactivation, and mutation of several other residues dramatically changed the inactivation kinetics. The mouse (m) TRPM2 channels were also inactivated by Zn2+, but the kinetics were remarkably slower. Reciprocal mutation of His(995) in the hTRPM2 channel and the equivalent Gln(992) in the mTRPM2 channel completely swapped the kinetics, but no such opposing effects resulted from exchanging another pair of species-specific residues, Arg(961)/Ser(958). We conclude from these results that Zn2+ inactivates the TRPM2 channels and that residues in the outer pore are critical determinants of the inactivation.	[Yang, Wei; Manna, Paul T.; Zou, Jie; Beech, David J.; Sivaprasadarao, Asipu; Jiang, Lin-Hua] Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Yang, Wei; Luo, Jianhong] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China	University of Leeds; Zhejiang University	Jiang, LH (corresponding author), Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	l.h.jiang@leeds.ac.uk	Jiang, Lin-Hua/AAU-1078-2020; Luo, jian/HGE-7331-2022; Jiang, Lin-Hua/D-2030-2010	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Sivaprasadarao, Asipu/0000-0002-6755-3502; Manna, Paul Thomas/0000-0002-2260-2075; Beech, David/0000-0002-7683-9422	Royal Society; University of Leeds-Chinese Scholarship Council; Alzheimer Research Trust; Alzheimers Research UK [ART-PPG2009A-2] Funding Source: researchfish	Royal Society(Royal Society of London); University of Leeds-Chinese Scholarship Council; Alzheimer Research Trust; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by a Royal Society Incoming Fellowship (to W. Y.), a University of Leeds-Chinese Scholarship Council Research Scholarship (to J. Z.), and an Alzheimer Research Trust grant (to L.-H. J.).	Amuzescu B, 2003, PFLUG ARCH EUR J PHY, V446, P69, DOI 10.1007/s00424-002-0998-3; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Bloc A, 2000, J PHYSIOL-LONDON, V529, P723, DOI 10.1111/j.1469-7793.2000.00723.x; Bradley HJ, 2011, J BIOL CHEM, V286, P8176, DOI 10.1074/jbc.M110.211284; Chen J, 2008, J NEUROSCI, V28, P5063, DOI 10.1523/JNEUROSCI.0047-08.2008; FERNANDES G, 1979, P NATL ACAD SCI USA, V76, P457, DOI 10.1073/pnas.76.1.457; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; FRAKER PJ, 1986, FASEB J, V45, P1474; FREDERICKSON CJ, 1983, BRAIN RES, V273, P335, DOI 10.1016/0006-8993(83)90858-2; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Gruss M, 2004, MOL PHARMACOL, V66, P530; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; HARRISON NL, 1994, NEUROPHARMACOLOGY, V33, P935, DOI 10.1016/0028-3908(94)90152-X; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Hou SW, 2010, J BIOL CHEM, V285, P6434, DOI 10.1074/jbc.M109.069211; Huang EP, 1997, P NATL ACAD SCI USA, V94, P13386, DOI 10.1073/pnas.94.25.13386; Hubbard PC, 2000, EUR J PHARMACOL, V394, P189, DOI 10.1016/S0014-2999(00)00143-6; HUTTON JC, 1983, BIOCHEM J, V210, P297, DOI 10.1042/bj2100297; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Jia YS, 2002, J PHYSIOL-LONDON, V543, P35, DOI 10.1113/jphysiol.2002.020172; Jiang LH, 2007, BIOCHEM SOC T, V35, P86, DOI 10.1042/BST0350086; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jiang LH, 2010, EXPERT OPIN THER TAR, V14, P973, DOI 10.1517/14728222.2010.510135; Kerchner GA, 2000, J PHYSIOL-LONDON, V528, P39, DOI 10.1111/j.1469-7793.2000.00039.x; Kim JS, 2005, J PHARMACOL EXP THER, V314, P618, DOI 10.1124/jpet.105.084418; Klionsky L, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-39; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Kuo CC, 2004, J GEN PHYSIOL, V124, P27, DOI 10.1085/jgp.200409054; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Laube B, 2000, J PHYSIOL-LONDON, V522, P215, DOI 10.1111/j.1469-7793.2000.t01-1-00215.x; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Liu X, 2009, BRIT J PHARMACOL, V156, P135, DOI 10.1111/j.1476-5381.2008.00002.x; Liu X, 2008, MOL PHARMACOL, V73, P252, DOI 10.1124/mol.107.039651; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Lorca RA, 2005, J NEUROCHEM, V95, P499, DOI 10.1111/j.1471-4159.2005.03387.x; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Noh J, 2010, NEUROSCI RES, V66, P353, DOI 10.1016/j.neures.2009.12.005; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Paoletti P, 1997, J NEUROSCI, V17, P5711; Pedretti A, 2009, BBA-BIOMEMBRANES, V1788, P973, DOI 10.1016/j.bbamem.2009.02.007; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Prost AL, 2004, J PHYSIOL-LONDON, V559, P157, DOI 10.1113/jphysiol.2004.065094; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Ragozzino D, 2000, J PHYSIOL-LONDON, V529, P83, DOI 10.1111/j.1469-7793.2000.00083.x; Riera CE, 2007, AM J PHYSIOL-REG I, V293, pR626, DOI 10.1152/ajpregu.00286.2007; Sandstead HH, 2000, J NUTR, V130, p496S, DOI 10.1093/jn/130.2.496S; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sheline CT, 2002, NEUROBIOL DIS, V10, P41, DOI 10.1006/nbdi.2002.0497; Spelta V, 2003, BRIT J PHARMACOL, V138, P131, DOI 10.1038/sj.bjp.0705018; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Teisseyre A, 2002, BIOCHEM PHARMACOL, V64, P595, DOI 10.1016/S0006-2952(02)01227-3; Tittle RK, 2008, J NEUROSCI, V28, P11131, DOI 10.1523/JNEUROSCI.2763-08.2008; Traboulsie A, 2007, J PHYSIOL-LONDON, V578, P159, DOI 10.1113/jphysiol.2006.114496; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; WANG TL, 1995, J NEUROSCI, V15, P7684; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WHITE JA, 1993, NEURON, V11, P1037, DOI 10.1016/0896-6273(93)90217-F; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Yang W, 2010, J BIOL CHEM, V285, P30411, DOI 10.1074/jbc.M110.139774; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Zhang ST, 2001, J PHYSIOL-LONDON, V532, P349, DOI 10.1111/j.1469-7793.2001.0349f.x; Zhang WY, 2007, AM J PHYSIOL-CELL PH, V292, pC1746, DOI 10.1152/ajpcell.00569.2006; Zhang WY, 2006, AM J PHYSIOL-CELL PH, V290, pC1146, DOI 10.1152/ajpcell.00205.2005; ZOU J, 2011, PFLUGERS AR IN PRESS	82	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23789	23798		10.1074/jbc.M111.247478	http://dx.doi.org/10.1074/jbc.M111.247478			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21602277	Green Published, hybrid			2022-12-27	WOS:000292294900021
J	Chew, SL; Or, MY; Chang, CXL; Gehring, AJ; Bertoletti, A; Grotenbreg, GM				Chew, Shi Ling; Or, Ming Yan; Chang, Cynthia Xin Lei; Gehring, Adam J.; Bertoletti, Antonio; Grotenbreg, Gijsbert M.			Stability Screening of Arrays of Major Histocompatibility Complexes on Combinatorially Encoded Flow Cytometry Beads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL EPITOPE; CLASS-I MOLECULES; PEPTIDE-BINDING; MURINE; HLA; SPECIFICITY; COMPETITION; DISCOVERY; H-2D(B); LIGANDS	The binding and stabilization capacity of potential T cell epitopes to class I MHC molecules form the basis for their immunogenicity and provide fundamental insight into factors that dictate cellular immune responses. We have developed a versatile high throughput cell-free method to measure MHC stability by capturing a variety of MHC products on the surface of streptavidin-coated particles followed by flow cytometry analysis. Arrays of peptide-MHC combinations, generated by exchanging conditional ligand-loaded MHC, could be probed in a single experiment, thus combining the molecular precision of biochemically purified MHCs with high content multiparametric flow cytometry-based assays. Semiquantitative determination of the peptide affinity for the restriction element could also be accomplished through competition experiments using this bead-based assay. Furthermore, the generated peptide-MHC reagents could directly be applied to antigen-specific CD8(+) T lymphocyte analysis. The combinatorial labeling of beads allowed straightforward identification by their unique fluorescent signatures and provided a convenient means for extended assay multiplexing.	[Grotenbreg, Gijsbert M.] Natl Univ Singapore, Inst Life Sci, Immunol Programme, Ctr Life Sci 03 05, Singapore 117456, Singapore; [Chew, Shi Ling; Or, Ming Yan; Chang, Cynthia Xin Lei; Grotenbreg, Gijsbert M.] Natl Univ Singapore, Dept Biol Sci, Dept Microbiol, Singapore 117456, Singapore; [Chang, Cynthia Xin Lei; Grotenbreg, Gijsbert M.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Inst Life Sci, Singapore 117456, Singapore; [Gehring, Adam J.; Bertoletti, Antonio] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Brenner Ctr Mol Med, Singapore 117609, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Grotenbreg, GM (corresponding author), Natl Univ Singapore, Inst Life Sci, Immunol Programme, Ctr Life Sci 03 05, 28 Med Dr, Singapore 117456, Singapore.	grotenbreg@nus.edu.sg	Bertoletti, Antonio/AAD-4830-2022	Bertoletti, Antonio/0000-0002-2942-0485; Gehring, Adam/0000-0003-1150-5840	Singapore National Research Foundation [NRF2007NRF-RF001-226]; National University of Singapore Graduate School for Integrative Science and Engineering	Singapore National Research Foundation(National Research Foundation, Singapore); National University of Singapore Graduate School for Integrative Science and Engineering(National University of Singapore)	This work was supported by Singapore National Research Foundation Research Fellowship NRF2007NRF-RF001-226.; Recipient of a National University of Singapore Graduate School for Integrative Science and Engineering graduate scholarship.	Achour A, 2006, J MOL BIOL, V356, P382, DOI 10.1016/j.jmb.2005.11.068; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; BERTOLETTI A, 1993, J VIROL, V67, P2376, DOI 10.1128/JVI.67.4.2376-2380.1993; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Bertoletti A, 1997, HEPATOLOGY, V26, P1027, DOI 10.1002/hep.510260435; Chang CXL, 2011, FRONT BIOSCI-LANDMRK, V16, P3014, DOI 10.2741/3895; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Glithero A, 2006, J BIOL CHEM, V281, P12699, DOI 10.1074/jbc.M511683200; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Grotenbreg GM, 2008, P NATL ACAD SCI USA, V105, P3831, DOI 10.1073/pnas.0711504105; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; Hadrup SR, 2009, METHODS MOL BIOL, V524, P383, DOI 10.1007/978-1-59745-450-6_28; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; Kessler JH, 2003, HUM IMMUNOL, V64, P245, DOI 10.1016/S0198-8859(02)00787-5; Klug F, 2009, CURR PHARM DESIGN, V15, P3221, DOI 10.2174/138161209789105180; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; PARKER KC, 1992, J IMMUNOL, V149, P1896; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; Pira GL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/325720; Provenzano M, 2006, TRENDS MOL MED, V12, P465, DOI 10.1016/j.molmed.2006.08.008; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Rodenko B, 2009, J AM CHEM SOC, V131, P12305, DOI 10.1021/ja9037565; Shields MJ, 1998, MOL IMMUNOL, V35, P919, DOI 10.1016/S0161-5890(98)00083-2; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; vanderBurg SH, 1995, HUM IMMUNOL, V44, P189, DOI 10.1016/0198-8859(95)00105-0; Wilson DC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000815	32	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28466	28475		10.1074/jbc.M111.262691	http://dx.doi.org/10.1074/jbc.M111.262691			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680737	hybrid, Green Published			2022-12-27	WOS:000293557800062
J	Henderson, WR; Oslund, RC; Bollinger, JG; Ye, X; Tien, YT; Xue, J; Gelb, MH				Henderson, William R., Jr.; Oslund, Rob C.; Bollinger, James G.; Ye, Xin; Tien, Ying-tzang; Xue, Jun; Gelb, Michael H.			Blockade of Human Group X Secreted Phospholipase A(2) (GX-sPLA(2))-induced Airway Inflammation and Hyperresponsiveness in a Mouse Asthma Model by a Selective GX-sPLA(2) Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE SET; BINDING; LAVAGE	Group X (GX) phospholipase A(2), a member of a large group of secreted phospholipases A(2) (sPLA(2)s), has recently been demonstrated to play an important in vivo role in the release of arachidonic acid and subsequent formation of eicosanoids. In a Th2 cytokine-driven mouse asthma model, deficiency of mouse GX (mGX)-sPLA(2) significantly impairs development of the asthma phenotype. In this study, we generated mGX-sPLA(2)(-/-) mice with knock-in of human GX (hGX)-sPLA(2) (i.e. hGX-sPLA(2)(+/+) knock-in mice) to understand more fully the role of GX-sPLA(2) in these allergic pulmonary responses and to assess the effect of pharmacological blockade of the GX-sPLA(2)-mediated responses. Knock-in of hGX-sPLA(2) in mGX-sPLA(2)(-/-) mice restored the allergen-induced airway infiltration by inflammatory cells, including eosinophils, goblet cell metaplasia, and hyperresponsiveness to methacholine in the mGX-sPLA(2)-deficient mice. This knock-in mouse model enabled the use of a highly potent indole-based inhibitor of hGX-sPLA(2), RO061606 (which is ineffective against mGX-sPLA(2)), to assess the potential utility of GX-sPLA(2) blockade as a therapeutic intervention in asthma. Delivery of RO061606 via mini-osmotic pumps enabled the maintenance in vivo in the mouse asthma model of plasma inhibitor concentrations near 10 mu M, markedly higher than the IC50 for inhibition of hGX-sPLA(2) in vitro. RO061606 significantly decreased allergen-induced airway inflammation, mucus hypersecretion, and hyperresponsiveness in the hGX-sPLA(2)(+/+) knock-in mouse. Thus, development of specific hGX-sPLA(2) inhibitors may provide a new pharmacological opportunity for the treatment of patients with asthma.	[Henderson, William R., Jr.; Ye, Xin; Tien, Ying-tzang; Xue, Jun] Univ Washington, Ctr Allergy & Inflammat, Dept Med, Seattle, WA 98195 USA; [Oslund, Rob C.; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Henderson, WR (corresponding author), Univ Washington, Ctr Allergy & Inflammat, UW Med S Lake Union, 815 Mercer St, Seattle, WA 98109 USA.	wrhchem@u.washington.edu; gelb@chem.washington.edu		gelb, michael/0000-0001-7000-5219	National Institutes of Health [R01 AI42989, R37 HL036235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42989 (to W. R. H.) and R37 HL036235 (to M. H. G.).	Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; Chilton FH, 1996, J EXP MED, V183, P2235, DOI 10.1084/jem.183.5.2235; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Hallstrand T. S., 2011, CLIN EXP AL IN PRESS; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hallstrand TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008583; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Kraus JM, 2009, J MED CHEM, V52, P1639, DOI 10.1021/jm801313t; Lai Y, 2010, J BIOL CHEM, V285, P41491, DOI 10.1074/jbc.M110.153338; Nevalainen TJ, 2005, BBA-MOL CELL BIOL L, V1733, P210, DOI 10.1016/j.bbalip.2004.12.012; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Smart BP, 2004, BIOORGAN MED CHEM, V12, P1737, DOI 10.1016/j.bmc.2004.01.022; Smart BP, 2006, J MED CHEM, V49, P2858, DOI 10.1021/jm060136t; STADEL JM, 1994, AM J RESP CELL MOL, V11, P108, DOI 10.1165/ajrcmb.11.1.8018333; Triggiani M, 2009, J ALLERGY CLIN IMMUN, V124, P558, DOI 10.1016/j.jaci.2009.04.035; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4	18	29	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28049	28055		10.1074/jbc.M111.235812	http://dx.doi.org/10.1074/jbc.M111.235812			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21652694	Green Published, hybrid			2022-12-27	WOS:000293557800023
J	Hillmann, F; Argentini, M; Buddelmeijer, N				Hillmann, Falk; Argentini, Manuela; Buddelmeijer, Nienke			Kinetics and Phospholipid Specificity of Apolipoprotein N-Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-RETINOL ACYLTRANSFERASE; PROLIPOPROTEIN SIGNAL PEPTIDASE; OUTER-MEMBRANE LIPOPROTEIN; ESCHERICHIA-COLI; BACTERIAL PROLIPOPROTEIN; ENZYME INTERMEDIATE; SDS-PAGE; PROTEIN; IDENTIFICATION; TRANSLOCATION	The enzyme apolipoprotein N-acyltransferase (Lnt) is an integral membrane protein that catalyzes the last step in the post-translational modification of bacterial lipoproteins. Lnt undergoes covalent modification in the presence of phospholipids resulting in a thioester acyl-enzyme intermediate. It then transfers the acyl chain to the alpha-amino group of the N-terminal diacylglyceryl-modified cysteine of apolipoprotein, leading to the formation of mature triacylated lipoprotein. To gain insight into the catalytic mechanism of this two-step reaction, we overproduced and purified the enzyme of Escherichia coli and studied its N-acyltransferase activity using a novel in vitro assay. The purified enzyme was fully active, as judged by its ability to form a stable thioester acyl-enzyme intermediate and N-acylate the apo-form of the murein lipoprotein Lpp in vitro. Incorporation of [H-3] palmitate and mass spectrometry analysis demonstrated that Lnt recognized the synthetic diacylglyceryl-modified lipopeptide FSL-1 as a substrate in a mixed micelle assay. Kinetics of Lnt using phosphatidylethanolamine as an acyl donor and FSL-1 as a substrate were consistent with a ping-pong type mechanism, demonstrating slow acyl-enzyme intermediate formation and rapid N-acyl transfer to the apolipopeptide in vitro. In contrast to earlier in vitro observations, the N-acyltransferase activity was strongly affected by the phospholipid headgroup and acyl chain composition.	[Hillmann, Falk; Buddelmeijer, Nienke] Inst Pasteur, Mol Genet Unit, CNRS URA 2172, F-75724 Paris 15, France; [Argentini, Manuela] CNRS, Inst Chim Subst Nat, Ctr Rech GIF, F-91198 Gif Sur Yvette, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Buddelmeijer, N (corresponding author), Inst Pasteur, Mol Genet Unit, CNRS URA 2172, 25 Rue Docteur Roux, F-75724 Paris 15, France.	niebud@pasteur.fr	Buddelmeijer, Nienke/AAM-3312-2021	Hillmann, Falk/0000-0002-5493-930X	German Academic Exchange Service (DAAD)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Supported by a postdoctoral fellowship of the German Academic Exchange Service (DAAD). Present address: Dept. of Molecular and Applied Microbiology, Leibniz Inst. for Natural Product Research and Infection Biology, Hans-Knoll-Institut, Beutenbergstr. 11a, D-07745 Jena, Germany.	Adu-Bobie J, 2004, INFECT IMMUN, V72, P1914, DOI 10.1128/IAI.72.4.1914-1919.2004; Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; Asanuma M, 2011, FEBS J, V278, P716, DOI 10.1111/j.1742-4658.2010.07990.x; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; BRAUN V, 1969, EUR J BIOCHEM, V10, P426, DOI 10.1111/j.1432-1033.1969.tb00707.x; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Buddelmeijer N, 2010, BIOCHEMISTRY-US, V49, P341, DOI 10.1021/bi9020346; COOPER CL, 1989, J BIOL CHEM, V264, P7384; DENFERT C, 1989, J BACTERIOL, V171, P3673, DOI 10.1128/jb.171.7.3673-3679.1989; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; FRAIPONT C, 1994, BIOCHEM J, V298, P189, DOI 10.1042/bj2980189; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Gimenez MI, 2007, MOL MICROBIOL, V66, P1597, DOI 10.1111/j.1365-2958.2007.06034.x; Golczak M, 2010, J BIOL CHEM, V285, P29217, DOI 10.1074/jbc.M110.152314; GUPTA SD, 1993, J BIOL CHEM, V268, P16551; GUPTA SD, 1991, FEMS MICROBIOL LETT, V78, P37; GUPTA SD, 1991, J BIOL CHEM, V266, P9983; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; KONTINEN VP, 1993, MOL MICROBIOL, V8, P727, DOI 10.1111/j.1365-2958.1993.tb01616.x; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; MUNOA FJ, 1991, J BIOL CHEM, V266, P17667; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P151, DOI 10.1111/j.1348-0421.2002.tb02680.x; Narita S, 2010, METHODS MOL BIOL, V619, P117, DOI 10.1007/978-1-60327-412-8_7; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; Rando RR, 2002, BIOCHEM BIOPH RES CO, V292, P1243, DOI 10.1006/bbrc.2001.2021; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; SANKARAN K, 1995, METHOD ENZYMOL, V250, P683; SANKARAN K, 1995, METHOD ENZYMOL, V248, P169; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; TOKUNAGA M, 1982, J BIOL CHEM, V257, P9922; Tschumi A, 2009, J BIOL CHEM, V284, P27146, DOI 10.1074/jbc.M109.022715; Valente FMA, 2007, FEBS LETT, V581, P3341, DOI 10.1016/j.febslet.2007.06.020; Vidal-Ingigliardi D, 2007, J BACTERIOL, V189, P4456, DOI 10.1128/JB.00099-07; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; WILLIAMS MG, 1989, J BACTERIOL, V171, P565, DOI 10.1128/jb.171.1.565-568.1989	49	40	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27936	27946		10.1074/jbc.M111.243519	http://dx.doi.org/10.1074/jbc.M111.243519			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676878	Green Published, hybrid			2022-12-27	WOS:000293557800012
J	Liaset, B; Hao, Q; Jorgensen, H; Hallenborg, P; Du, ZY; Ma, T; Marschall, HU; Kruhoffer, M; Li, RQ; Li, QB; Yde, CC; Criales, G; Bertram, HC; Mellgren, G; Ofjord, ES; Lock, EJ; Espe, M; Froyland, L; Madsen, L; Kristiansen, K				Liaset, Bjorn; Hao, Qin; Jorgensen, Henry; Hallenborg, Philip; Du, Zhen-Yu; Ma, Tao; Marschall, Hanns-Ulrich; Kruhoffer, Mogens; Li, Ruiqiang; Li, Qibin; Yde, Christian Clement; Criales, Gabriel; Bertram, Hanne C.; Mellgren, Gunnar; Ofjord, Erik Snorre; Lock, Erik-Jan; Espe, Marit; Froyland, Livar; Madsen, Lise; Kristiansen, Karsten			Nutritional Regulation of Bile Acid Metabolism Is Associated with Improved Pathological Characteristics of the Metabolic Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESOID-X-RECEPTOR; LOW-DENSITY LIPOPROTEIN; NUCLEAR RECEPTOR; GENE-EXPRESSION; BROWN ADIPOCYTES; DIETARY TAURINE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ENZYMATIC-HYDROLYSIS; TARGETED DISRUPTION	Bile acids (BAs) are powerful regulators of metabolism, and mice treated orally with cholic acid are protected from diet-induced obesity, hepatic lipid accumulation, and increased plasma triacylglycerol (TAG) and glucose levels. Here, we show that plasma BA concentration in rats was elevated by exchanging the dietary protein source from casein to salmon protein hydrolysate (SPH). Importantly, the SPH-treated rats were resistant to diet-induced obesity. SPH-treated rats had reduced fed state plasma glucose and TAG levels and lower TAG in liver. The elevated plasma BA concentration was associated with induction of genes involved in energy metabolism and uncoupling, Dio2, Pgc-1 alpha, and Ucp1, in interscapular brown adipose tissue. Interestingly, the same transcriptional pattern was found in white adipose tissue depots of both abdominal and subcutaneous origin. Accordingly, rats fed SPH-based diet exhibited increased whole body energy expenditure and heat dissipation. In skeletal muscle, expressions of the peroxisome proliferator-activated receptor beta/delta target genes (Cpt-1b, Angptl4, Adrp, and Ucp3) were induced. Pharmacological removal of BAs by inclusion of 0.5 weight % cholestyramine to the high fat SPH diet attenuated the reduction in abdominal obesity, the reduction in liver TAG, and the decrease in nonfasted plasma TAG and glucose levels. Induction of Ucp3 gene expression in muscle by SPH treatment was completely abolished by cholestyramine inclusion. Taken together, our data provide evidence that bile acid metabolism can be modulated by diet and that such modulation may prevent/ameliorate the characteristic features of the metabolic syndrome.	[Liaset, Bjorn; Du, Zhen-Yu; Criales, Gabriel; Lock, Erik-Jan; Espe, Marit; Froyland, Livar; Madsen, Lise] Natl Inst Nutr & Seafood Res, N-5817 Bergen, Norway; [Hao, Qin; Ma, Tao; Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Jorgensen, Henry; Yde, Christian Clement] Aarhus Univ, Dept Anim Hlth Welf & Nutr, DK-8830 Tjele, Denmark; [Hallenborg, Philip] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Acad, Inst Med, S-40530 Gothenburg, Sweden; [Kruhoffer, Mogens] AROS Appl Biotechnol, DK-8200 Aarhus, Denmark; [Li, Ruiqiang; Li, Qibin] Beijing Genom Inst, Shenzhen 518083, Peoples R China; [Bertram, Hanne C.] Aarhus Univ, Dept Food Sci, DK-5792 Aarslev, Denmark; [Mellgren, Gunnar] Univ Bergen, Inst Med, N-5021 Bergen, Norway; [Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Ofjord, Erik Snorre] Ctr Clin Trials, N-5094 Bergen, Norway	University of Copenhagen; Aarhus University; University of Southern Denmark; University of Gothenburg; Beijing Genomics Institute (BGI); Aarhus University; University of Bergen; University of Bergen; Haukeland University Hospital	Liaset, B (corresponding author), Natl Inst Nutr & Seafood Res, POB 2029 Nordnes, N-5817 Bergen, Norway.	bli@nifes.no; kk@bio.ku.dk	Bertram, Hanne Christine/I-8439-2019; Kristiansen, Karsten/J-5148-2014; Lock, Erik-Jan/AAM-9766-2020; Mellgren, Gunnar/AAG-6573-2020; Lock, Erik-Jan/B-7523-2012; Madsen, Lise/C-6246-2012; Lock, Erik-Jan/F-3115-2012; Marschall, Hanns-Ulrich/K-8842-2017	Bertram, Hanne Christine/0000-0002-1882-5321; Kristiansen, Karsten/0000-0002-6024-0917; Mellgren, Gunnar/0000-0001-6282-4986; Madsen, Lise/0000-0003-4468-1947; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Lock, Erik-Jan/0000-0002-8157-5249; Hao, Qin/0000-0002-6775-2181; Du, Zhen-Yu/0000-0001-6581-5313; Liaset, Bjorn/0000-0002-8652-7801	Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation [2101-06-0005]; University of Bergen; Program Committee on Nutrition; Eckbo Foundation; Norwegian Research Council [200515-I30]; Innovation Norway; RUBIN; Danish Council for Strategic Research [2101-06-0005]	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); University of Bergen; Program Committee on Nutrition; Eckbo Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Innovation Norway; RUBIN; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish Natural Science Research Council, The Novo Nordisk Foundation, The Carlsberg Foundation (performed as part of the research program of the Danish Obesity Research Centre supported by the Danish Council for Strategic Research Grant 2101-06-0005), University of Bergen, Program Committee on Nutrition, The Eckbo Foundation, and Norwegian Research Council Grant 200515-I30. This work was carried out as a part of the "DOCMAR" research program funded by Innovation Norway and RUBIN and supported by the Danish Council for Strategic Research Grant 2101-06-0005.	Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617; Bar A, 1999, REGUL TOXICOL PHARM, V29, pS11, DOI 10.1006/rtph.1998.1266; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BAS S, 1983, ARCH BIOCHEM BIOPHYS, V222, P416, DOI 10.1016/0003-9861(83)90539-8; Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296; Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Enochsson L, 2010, NUTRITION, V26, P405, DOI 10.1016/j.nut.2009.05.005; Esteller A, 2008, WORLD J GASTROENTERO, V14, P5641, DOI 10.3748/wjg.14.5641; Evans MJ, 2009, AM J PHYSIOL-GASTR L, V296, pG543, DOI 10.1152/ajpgi.90585.2008; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Ghorbani M, 1997, BIOCHEM PHARMACOL, V54, P121, DOI 10.1016/S0006-2952(97)00162-7; Glicksman C, 2010, ANN CLIN BIOCHEM, V47, P482, DOI 10.1258/acb.2010.010040; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; HARDISON WGM, 1978, GASTROENTEROLOGY, V75, P71; Hirokane H, 2004, J BIOL CHEM, V279, P45685, DOI 10.1074/jbc.M404255200; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Ikemoto S, 1997, AM J PHYSIOL-ENDOC M, V273, pE37, DOI 10.1152/ajpendo.1997.273.1.E37; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kast HR, 2001, MOL ENDOCRINOL, V15, P1720, DOI 10.1210/me.15.10.1720; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; LARUSSO NF, 1978, AM J DIG DIS, V23, P385, DOI 10.1007/BF01072919; Lauridsen C, 2008, J SCI FOOD AGR, V88, P720, DOI 10.1002/jsfa.3142; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2008, PROCESS BIOCHEM, V43, P42, DOI 10.1016/j.procbio.2007.10.007; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Madsen L, 1999, LIPIDS, V34, P447, DOI 10.1007/s11745-999-0384-6; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7; Martens HA, 1998, CHEMOMETR INTELL LAB, V44, P99, DOI 10.1016/S0169-7439(98)00167-1; Martin IV, 2010, BIOL CHEM, V391, P1441, DOI 10.1515/BC.2010.141; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Muhfeld A, 2003, ARCH BIOCHEM BIOPHYS, V413, P32, DOI 10.1016/S0003-9861(03)00098-5; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Park T, 1999, NUTR RES, V19, P1777, DOI 10.1016/S0271-5317(99)00118-9; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pauli-Magnus C, 2005, J HEPATOL, V43, P342, DOI 10.1016/j.jhep.2005.03.017; Pizarro M, 2004, GUT, V53, P1837, DOI 10.1136/gut.2003.037689; Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Shonsey EM, 2005, METHOD ENZYMOL, V400, P374, DOI 10.1016/S0076-6879(05)00022-4; Simoncic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-96; Sinal CJ, 2001, J BIOL CHEM, V276, P47154, DOI 10.1074/jbc.M107000200; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sirvent A, 2004, FEBS LETT, V566, P173, DOI 10.1016/j.febslet.2004.04.026; SUCKLING KE, 1991, ATHEROSCLEROSIS, V89, P183, DOI 10.1016/0021-9150(91)90059-C; SUGIYAMA K, 1989, AGR BIOL CHEM TOKYO, V53, P1647, DOI 10.1080/00021369.1989.10869537; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; VESSEY DA, 1983, BIOCHEM J, V214, P923, DOI 10.1042/bj2140923; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yokogoshi H, 1999, J NUTR, V129, P1705, DOI 10.1093/jn/129.9.1705; ZHANG RW, 1992, AM J PHYSIOL, V262, pG351, DOI 10.1152/ajpgi.1992.262.2.G351; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	82	49	54	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28382	28395		10.1074/jbc.M111.234732	http://dx.doi.org/10.1074/jbc.M111.234732			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680746	hybrid, Green Published			2022-12-27	WOS:000293557800054
J	Yan, JP; Diaz, J; Jiao, J; Wang, RR; You, JX				Yan, Junpeng; Diaz, Jason; Jiao, Jing; Wang, Ranran; You, Jianxin			Perturbation of BRD4 Protein Function by BRD4-NUT Protein Abrogates Cellular Differentiation in NUT Midline Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROMODOMAIN-CONTAINING PROTEIN; HOST MITOTIC CHROMOSOMES; S-PHASE; P-TEFB; AGGRESSIVE CARCINOMA; ACETYLATED CHROMATIN; GENE-TRANSCRIPTION; FUSION ONCOGENE; EXPRESSION; INTERACTS	NUT midline carcinoma (NMC) belongs to a class of highly lethal and poorly differentiated epithelial cancers arising mainly in human midline organs. NMC is caused by the chromosome translocation-mediated fusion of the NUT (nuclear protein in testis) gene on chromosome 15 to a few other genes, most frequently the BRD4 gene on chromosome 19. The mechanism by which the BRD4-NUT fusion product blocks NMC cellular differentiation and contributes to oncogenesis remains elusive. In this study, we show that BRD4-NUT and BRD4 colocalize in discrete nuclear foci that are hyperacetylated but transcriptionally inactive. BRD4-NUT recruits histone acetyltransferases to induce histone hyperacetylation in these chromatin foci, which provide docking sites for accumulation of additional BRD4 and associated P-TEFB (positive transcription elongation factor b) complexes in the transcriptionally inactive BRD4-NUT foci. These molecular events lead to repression of a BRD4.P-TEFB downstream target gene c-fos, a component of activator protein 1 (AP-1), that directly regulates epithelial differentiation. Knockdown of BRD4-NUT in NMC cells disperses the transcriptionally inactive chromatin foci and releases the transcriptional activators to stimulate c-fos expression, leading to restoration of cellular differentiation. Our study provides a novel mechanism by which the BRD4-NUT oncogene perturbs BRD4 functions to block cellular differentiation and to contribute to the oncogenic progression in the highly aggressive NMC.	[Yan, Junpeng; Diaz, Jason; Jiao, Jing; Wang, Ranran; You, Jianxin] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	You, JX (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu		Wang, Ranran/0000-0002-7920-0704	NCI;  [R01CA148768];  [R01CA142723]; NATIONAL CANCER INSTITUTE [R01CA142723, R01CA148768] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health HIV-associated Malignancies Pilot Project Award from NCI and Grants R01CA148768 and R01CA142723.	*AM JOINT COMM CAN, 2002, AJCC CANC STAG MAN; BIREK C, 1993, AM J PATHOL, V142, P917; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Boussouar F, 2008, CELL CYCLE, V7, P3499, DOI 10.4161/cc.7.22.6975; Brenner JC, 2009, BBA-REV CANCER, V1796, P201, DOI 10.1016/j.bbcan.2009.04.005; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Cho WK, 2007, J VIROL, V81, P11179, DOI 10.1128/JVI.00408-07; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; den Bakker MA, 2009, AM J SURG PATHOL, V33, P1253, DOI 10.1097/PAS.0b013e3181abe120; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Edwards PAW, 2010, J PATHOL, V220, P244, DOI 10.1002/path.2632; Engleson J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-69; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; French CA, 2003, CANCER RES, V63, P304; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; Haruki N, 2005, J MED GENET, V42, P558, DOI 10.1136/jmg.2004.029686; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; KLIMPFINGER M, 1990, VIRCHOWS ARCH B, V59, P165, DOI 10.1007/BF02899401; Lee HY, 1998, ONCOGENE, V16, P3039, DOI 10.1038/sj.onc.1201843; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Lin A, 2008, J VIROL, V82, P12009, DOI 10.1128/JVI.01680-08; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mertens F, 2007, PEDIATR BLOOD CANCER, V49, P1015, DOI 10.1002/pbc.20755; Milde-Langosch K, 2003, BREAST CANCER RES TR, V77, P265, DOI 10.1023/A:1021887100216; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Okada Y, 2008, JPN J OPHTHALMOL, V52, P1, DOI 10.1007/s10384-007-0499-1; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Rorke EA, 2010, ONCOGENE, V29, P5873, DOI 10.1038/onc.2010.315; Schweiger MR, 2007, J VIROL, V81, P9612, DOI 10.1128/JVI.00447-07; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Smith JA, 2010, P NATL ACAD SCI USA, V107, P3752, DOI 10.1073/pnas.0914818107; Stelow EB, 2008, AM J SURG PATHOL, V32A, P828, DOI 10.1097/PAS.0b013e31815a3900; Teixeira Manuel R., 2006, Critical Reviews in Oncogenesis, V12, P257; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; You JX, 2009, MOL CELL BIOL, V29, P5094, DOI 10.1128/MCB.00299-09; Ziai J, 2010, HEAD NECK PATHOL, V4, P163, DOI 10.1007/s12105-010-0174-6	54	35	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27663	27675		10.1074/jbc.M111.246975	http://dx.doi.org/10.1074/jbc.M111.246975			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652721	Green Published, hybrid			2022-12-27	WOS:000293268700059
J	Nagaosa, K; Okada, R; Nonaka, S; Takeuchi, K; Fujita, Y; Miyasaka, T; Manaka, J; Ando, I; Nakanishi, Y				Nagaosa, Kaz; Okada, Ryo; Nonaka, Saori; Takeuchi, Kazuki; Fujita, Yu; Miyasaka, Tomoyuki; Manaka, Junko; Ando, Istvan; Nakanishi, Yoshinobu			Integrin beta nu-mediated Phagocytosis of Apoptotic Cells in Drosophila Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CAENORHABDITIS-ELEGANS; C-ELEGANS; ALPHA-V-BETA-5 INTEGRIN; ENGULFMENT RECEPTOR; CORPSE ENGULFMENT; ACTIVATION; PROTEIN; CLEARANCE; HOMOLOG	To identify molecules that play roles in the clearance of apoptotic cells by Drosophila phagocytes, we examined a series of monoclonal antibodies raised against larval hemocytes for effects on phagocytosis in vitro. One antibody that inhibited phagocytosis recognized terribly reduced optic lobes (Trol), a core protein of the perlecan-type proteoglycan, and the level of phagocytosis in embryos of a Trol-lacking fly line was lower than in a control line. The treatment of a hemocyte cell line with a recombinant Trol protein containing the amino acid sequence RGD augmented the phosphorylation of focal adhesion kinase, a hallmark of integrin activation. A loss of integrin beta nu, one of the two beta subunits of Drosophila integrin, brought about a reduction in the level of apoptotic cell clearance in embryos. The presence of integrin beta nu at the surface of embryonic hemocytes was confirmed, and forced expression of integrin beta nu in hemocytes of an integrin beta nu-lacking fly line recovered the defective phenotype of phagocytosis. Finally, the level of phagocytosis in a fly line that lacks both integrin beta nu and Draper, another receptor required for the phagocytosis of apoptotic cells, was lower than that in a fly line lacking either protein. We suggest that integrin beta nu serves as a phagocytosis receptor responsible for the clearance of apoptotic cells in Drosophila, independent of Draper.	[Nagaosa, Kaz; Okada, Ryo; Nonaka, Saori; Fujita, Yu; Manaka, Junko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Nagaosa, Kaz; Takeuchi, Kazuki; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Nagaosa, Kaz; Miyasaka, Tomoyuki; Nakanishi, Yoshinobu] Kanazawa Univ, Sch Pharm, Kanazawa, Ishikawa 9201192, Japan; [Ando, Istvan] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary	Kanazawa University; Kanazawa University; Kanazawa University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Nakanishi, Y (corresponding author), Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	nakanaka@p.kanazawa-u.ac.jp	Nagaosa, Kaz/G-3857-2014; Nakanishi, Yoshinobu/D-4602-2014; Nonaka, Saori/L-4092-2015	Nagaosa, Kaz/0000-0002-1695-2562; Nakanishi, Yoshinobu/0000-0002-8767-3587; Nonaka, Saori/0000-0003-2672-3082	Japan Society for the Promotion of Science [19370051, 22370049, 22657033]; Hungarian National Research Fund Orszagos Tudomonyos Kutatasi Alap [NK78024]; Fuji Foundation for Protein Research; Grants-in-Aid for Scientific Research [22370049] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hungarian National Research Fund Orszagos Tudomonyos Kutatasi Alap; Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research 19370051, 22370049, and 22657033 from the Japan Society for the Promotion of Science (to Y. N.), the Hungarian National Research Fund Orszagos Tudomonyos Kutatasi Alap (National Scientific Research Fund) Grant NK78024 (to I. A.), and a grant from the Fuji Foundation for Protein Research (to K. N.).	Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; BUNCH TA, 1992, GENETICS, V132, P519; Cabello J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000297; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Fujimoto J, 1999, J BIOL CHEM, V274, P29196, DOI 10.1074/jbc.274.41.29196; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hsu TY, 2010, CURR BIOL, V20, P477, DOI 10.1016/j.cub.2010.01.062; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Liao J, 2005, MED HYPOTHESES, V65, P23, DOI 10.1016/j.mehy.2005.01.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Metheniti A, 2001, FEBS LETT, V496, P55, DOI 10.1016/S0014-5793(01)02405-X; Nakanishi Y, 2011, DEV GROWTH DIFFER, V53, P149, DOI 10.1111/j.1440-169X.2010.01224.x; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Palmer RH, 1999, J BIOL CHEM, V274, P35621, DOI 10.1074/jbc.274.50.35621; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, J BIOL CHEM, V283, P10593, DOI 10.1074/jbc.M709105200; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Singh S, 2007, BIOCHEM BIOPH RES CO, V364, P540, DOI 10.1016/j.bbrc.2007.10.049; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	47	46	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25770	25777		10.1074/jbc.M110.204503	http://dx.doi.org/10.1074/jbc.M110.204503			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21592968	hybrid, Green Published			2022-12-27	WOS:000293073000039
J	Zhang, HT; Chen, LL; Chen, J; Jiang, HL; Shen, X				Zhang, Haitao; Chen, Lili; Chen, Jing; Jiang, Hualiang; Shen, Xu			Structural Basis for Retinoic X Receptor Repression on the Tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; THYROID-HORMONE; COREPRESSOR; RESISTANCE	Retinoic X receptor (RXR) is a master nuclear receptor in the processes of cell development and homeostasis. Unliganded RXR exists in an autorepressed tetramer, and agonists can induce RXR dimerization and coactivator recruitment for activation. However, the molecular mechanisms involving the corepressor recruitment and antagonist-mediated repression of RXR are still elusive. Here we report the crystal structure of RXR alpha ligand-binding domain (LBD) complexed with silencing mediator for retinoid and thyroid hormone receptors (SMRT) corepressor motif. As the first structural report on the unliganded nuclear receptor bound to the corepressor motif, RXR alpha LBD-SMRT exhibits a significant structural rearrangement, compared with apoRXR alpha LBD tetramer. To elucidate further the molecular determinants for RXR repression by its antagonist, we also determine the crystal structure of RXR alpha LBD-SMRT complexed with the identified antagonist rhein. In the structure, two rhein molecules and two SMRT peptides are in the RXR alpha LBD tetramer, different from the case in RXR alpha LBD-SMRT structure, where four SMRT peptides bind to RXR alpha LBD tetramer. It seems that rhein induces a displacement of SMRT motif by activation function 2 (AF-2) motif binding to the receptor. Combining our current work with the published results, structural superposition of RXR alpha LBDs in different states reveals that RXR uses an overlapped binding site for coactivator, corepressor, and AF-2 motifs, whereas the AF-2 motif adopts different conformations for agonist or antagonist interaction and coactivator or corepressor recruitment. Taken together, we thus propose a molecular model of RXR repression on the tetramer.	[Zhang, Haitao; Chen, Lili; Chen, Jing; Jiang, Hualiang; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn	Zhang, Haitao/L-7612-2015	Zhang, Haitao/0000-0003-4879-2951	State Key Program of Basic Research of China [2010CB912501, 2007CB914304, 2009CB918502]; National High-Tech R&D Program of China [2011AA090071-2]; National Natural Science Foundation of China [30925040, 30890044, 30801415, 10979072]; Science Foundation of Shanghai [08431902900]; Shanghai Science and Technology Commission [11ZR1444500]; Shanghai Rising-Star Program [09QA1406800]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Rising-Star Program	This work was supported by State Key Program of Basic Research of China Grants 2010CB912501, 2007CB914304, and 2009CB918502, National High-Tech R&D Program of China Grant 2011AA090071-2, National Natural Science Foundation of China Grants 30925040, 30890044, 30801415, and 10979072, Science Foundation of Shanghai Grant 08431902900, Shanghai Basic Research Project from the Shanghai Science and Technology Commission Grant 11ZR1444500, and Shanghai Rising-Star Program Grant 09QA1406800.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Fernandez-Majada V, 2007, CELL CYCLE, V6, P1748, DOI 10.4161/cc.6.14.4429; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Gao Q, 2010, PLANTA MED, V76, P27, DOI 10.1055/s-0029-1185948; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Ghosh JC, 2002, P NATL ACAD SCI USA, V99, P5842, DOI 10.1073/pnas.092043399; He ZH, 2009, J ETHNOPHARMACOL, V121, P313, DOI 10.1016/j.jep.2008.11.008; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Jia ZH, 2007, EXP CLIN ENDOCR DIAB, V115, P571, DOI 10.1055/s-2007-981469; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; McKenna NJ, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Safer JD, 1998, J BIOL CHEM, V273, P30175, DOI 10.1074/jbc.273.46.30175; Uchikawa J, 2003, CANCER, V98, P2207, DOI 10.1002/cncr.11760; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yoh SM, 1997, MOL ENDOCRINOL, V11, P470, DOI 10.1210/me.11.4.470; Zhang HT, 2011, J MOL BIOL, V407, P13, DOI 10.1016/j.jmb.2011.01.032; Zhang HT, 2011, J BIOL CHEM, V286, P1868, DOI 10.1074/jbc.M110.166215; Zhang JS, 1999, MOL CELL BIOL, V19, P6448	24	37	37	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24593	24598		10.1074/jbc.M111.245498	http://dx.doi.org/10.1074/jbc.M111.245498			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613212	hybrid, Green Published			2022-12-27	WOS:000292547900009
J	Bhunia, A; Saravanan, R; Mohanram, H; Mangoni, ML; Bhattacharjya, S				Bhunia, Anirban; Saravanan, Rathi; Mohanram, Harini; Mangoni, Maria L.; Bhattacharjya, Surajit			NMR Structures and Interactions of Temporin-1Tl and Temporin-1Tb with Lipopolysaccharide Micelles MECHANISTIC INSIGHTS INTO OUTER MEMBRANE PERMEABILIZATION AND SYNERGISTIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER DIFFERENCE NMR; HOST-DEFENSE PEPTIDES; HELICAL ANTIMICROBIAL PEPTIDES; GRAM-NEGATIVE BACTERIA; ENDOTOXIN NEUTRALIZATION; INNATE IMMUNITY; MOLECULAR-BASIS; LIGAND-BINDING; SPECTROSCOPY; RESISTANCE	Temporins are a group of closely related short antimicrobial peptides from frog skin. Lipopolysaccharide (LPS), the major constituent of the outer membrane of Gram-negative bacteria, plays important roles in the activity of temporins. Earlier studies have found that LPS induces oligomerization of temporin-1Tb (TB) thus preventing its translocation across the outer membrane and, as a result, reduces its activity on Gram-negative bacteria. On the other hand, temporin-1Tl (TL) exhibits higher activity, presumably because of lack of such oligomerization. A synergistic mechanism was proposed, involving TL and TB in overcoming the LPS-mediated barrier. Here, to gain insights into interactions of TL and TB within LPS, we investigated the structures and interactions of TL, TB, and TL+TB in LPS micelles, using NMR and fluorescence spectroscopy. In the context of LPS, TL assumes a novel antiparallel dimeric helical structure sustained by intimate packing between aromatic-aromatic and aromatic-aliphatic residues. By contrast, independent TB has populations of helical and aggregated conformations in LPS. The LPS-induced aggregated states of TB are largely destabilized in the presence of TL. Saturation transfer difference NMR studies have delineated residues of TL and TB in close contact with LPS and enhanced interactions of these two peptides with LPS, when combined together. Fluorescence resonance energy transfer and P-31 NMR have pointed out the proximity of TL and TB in LPS and conformational changes of LPS, respectively. Importantly, these results provide the first structural insights into the mode of action and synergism of antimicrobial peptides at the level of the LPS-outer membrane.	[Bhunia, Anirban; Saravanan, Rathi; Mohanram, Harini; Bhattacharjya, Surajit] Nanyang Technol Univ, Div Struct & Computat Biol, Sch Biol Sci, Singapore 637551, Singapore; [Mangoni, Maria L.] Univ Roma La Sapienza, Dipartimento Sci Biochim, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Fondazione Cenci Bolognetti; Sapienza University Rome	Bhattacharjya, S (corresponding author), 60 Nanyang Dr, Singapore 637551, Singapore.	surajit@ntu.edu.sg	Bhattacharjya, SURAJIT/A-2183-2011; Mohanram, Harini/L-9207-2019	Mohanram, Harini/0000-0002-8179-2665; Bhunia, Anirban/0000-0002-8752-2842; Saravanan, Rathi/0000-0002-3884-6023; Mangoni, Maria Luisa/0000-0002-5991-5868	A*Star Biomedical Research Council, Singapore [06/1/22/19/446, 08/1/22/19/556]	A*Star Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Grants 06/1/22/19/446 and 08/1/22/19/556 from A*Star Biomedical Research Council, Singapore.	ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; Bhattacharjya S, 2010, CURR MED CHEM, V17, P3080, DOI 10.2174/092986710791959756; Bhattacharjya S, 2007, BIOCHEMISTRY-US, V46, P5864, DOI 10.1021/bi6025159; Bhattacharjya S, 2009, FEBS J, V276, P6465, DOI 10.1111/j.1742-4658.2009.07357.x; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; Bhunia A, 2011, BIOPOLYMERS, V96, P273, DOI 10.1002/bip.21530; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; Bhunia A, 2009, BIOPOLYMERS, V92, P9, DOI 10.1002/bip.21104; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Carotenuto A, 2008, J MED CHEM, V51, P2354, DOI 10.1021/jm701604t; CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Egal M, 1999, INT J ANTIMICROB AG, V13, P57, DOI 10.1016/S0924-8579(99)00094-1; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; FINK PF, 1990, HDB CRITICAL CARE, P619; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Giacometti A, 2006, ANTIMICROB AGENTS CH, V50, P2478, DOI 10.1128/AAC.01553-05; Gottler LM, 2009, BBA-BIOMEMBRANES, V1788, P1680, DOI 10.1016/j.bbamem.2008.10.009; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Haney EF, 2009, BBA-BIOMEMBRANES, V1788, P1639, DOI 10.1016/j.bbamem.2009.01.002; Haselhorst T, 2001, J AM CHEM SOC, V123, P10705, DOI 10.1021/ja011156h; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Jerala R, 2004, CURR TOP MED CHEM, V4, P1173, DOI 10.2174/1568026043388079; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Mangoni ML, 2007, J PEPT SCI, V13, P603, DOI 10.1002/psc.853; Mangoni ML, 2009, BBA-BIOMEMBRANES, V1788, P1610, DOI 10.1016/j.bbamem.2009.04.021; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mor A, 2009, FEBS J, V276, P6474, DOI 10.1111/j.1742-4658.2009.07358.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; Pristovsek P, 2004, CURR TOP MED CHEM, V4, P1185, DOI 10.2174/1568026043388105; Rademacher C, 2008, J AM CHEM SOC, V130, P3669, DOI 10.1021/ja710854r; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rath A, 2006, J BIOL CHEM, V281, P15546, DOI 10.1074/jbc.M600434200; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; STRAIN SM, 1983, J BIOL CHEM, V258, P3466; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Tossi A, 2000, BIOPOLYMERS, V55, P4; Weinstein RA, 2001, EMERG INFECT DIS, V7, P188, DOI 10.3201/eid0702.010206; WILKINSON SG, 1981, BIOCHEM J, V199, P833, DOI 10.1042/bj1990833; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao HX, 2002, J BIOL CHEM, V277, P25170, DOI 10.1074/jbc.M203186200; Zhao HX, 2002, BIOCHEMISTRY-US, V41, P4425, DOI 10.1021/bi011929e	78	80	81	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24394	24406		10.1074/jbc.M110.189662	http://dx.doi.org/10.1074/jbc.M110.189662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586570	Green Published, hybrid			2022-12-27	WOS:000292294900079
J	Giang, KTN; Zhang, S; Ngan, TKN; Phuong, QTN; Chiu, MS; Hardjojo, A; Tam, JP				Giang Kien Truc Nguyen; Zhang, Sen; Ngan Thi Kim Nguyen; Phuong Quoc Thuc Nguyen; Chiu, Ming Sheau; Hardjojo, Antony; Tam, James P.			Discovery and Characterization of Novel Cyclotides Originated from Chimeric Precursors Consisting of Albumin-1 Chain a and Cyclotide Domains in the Fabaceae Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLITORIA-TERNATEA; ANTIMICROBIAL PEPTIDES; KALATA B1; PLANT CYCLOTIDES; 4-KDA PEPTIDE; BINDING; PROTEIN; DEFENSINS; EXPRESSION; ELEMENTS	The tropical plant Clitoria ternatea is a member of the Fabaceae family well known for its medicinal values. Heat extraction of C. ternatea revealed that the bioactive fractions contained heat-stable cysteine-rich peptides (CRPs). The CRP family of A1b (Albumin-1 chain b/leginsulins), which is a linear cystine knot CRP, has been shown to present abundantly in the Fabaceae. In contrast, the cyclotide family, which also belongs to the cystine knot CRPs but with a cyclic structure, is commonly found in the Rubiaceae, Violaceae, and Cucurbitaceae families. In this study, we report the discovery of a panel of 15 heat-stable CRPs, of which 12 sequences (cliotide T1-T12) are novel. We show unambiguously that the cliotides are cyclotides and not A1bs, as determined by their sequence homology, disulfide connectivity, and membrane active properties indicated by their antimicrobial activities against Escherichia coli and cytotoxicities to HeLa cells. We also show that cliotides are prevalent in C. ternatea and are found in every plant tissue examined, including flowers, seeds, and nodules. In addition, we demonstrate that their precursors are chimeras, half from cyclotide and the other half from Albumin-1, with the cyclotide domain displacing the A1b domain in the precursor. Their chimeric structures likely originate from either horizontal gene transfer or convergent evolution in plant nuclear genomes, which are exceedingly rare events. Such atypical genetic arrangement also implies a different mechanism of biosynthetic processing of cyclotides in the Fabaceae and provides new understanding of their evolution in plants.	[Giang Kien Truc Nguyen; Zhang, Sen; Ngan Thi Kim Nguyen; Phuong Quoc Thuc Nguyen; Chiu, Ming Sheau; Hardjojo, Antony; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X; Hardjojo, Antony/0000-0002-2823-7996; Zhang, Sen/0000-0003-1409-5795	A*STAR Biomedical Research Council [09/1/22/19/612]; Ministry of Education in Singapore [ARC21/08]	A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education in Singapore(Ministry of Education, Singapore)	This work was supported by A*STAR Biomedical Research Council Grant 09/1/22/19/612 and Academic Research Fund Grant ARC21/08 from the Ministry of Education in Singapore.	Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; Broekaert WF, 1997, CRIT REV PLANT SCI, V16, P297, DOI 10.1080/713608148; Carvalho AD, 2009, PEPTIDES, V30, P1007, DOI 10.1016/j.peptides.2009.01.018; Chen JJ, 2004, J AGR FOOD CHEM, V52, P2256, DOI 10.1021/jf030662i; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Da Silva P, 2009, BIOPOLYMERS, V92, P436, DOI 10.1002/bip.21217; Daisy P, 2009, AFR J MICROBIOL RES, V3, P287; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; Devi BP, 2003, FITOTERAPIA, V74, P345, DOI 10.1016/S0367-326X(03)00057-1; Dun XP, 2008, PEPTIDES, V29, P891, DOI 10.1016/j.peptides.2008.01.013; Dun XP, 2007, FEBS J, V274, P751, DOI 10.1111/j.1742-4658.2006.05619.x; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Graham MA, 2008, CROP SCI, V48, pS3, DOI 10.2135/cropsci2007.04.0236tpg; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; Hanada K, 2003, EUR J BIOCHEM, V270, P2583, DOI 10.1046/j.1432-1033.2003.03627.x; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; HIGGINS TJV, 1986, J BIOL CHEM, V261, P1124; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2006, BIOCHEM J, V400, P1, DOI 10.1042/BJ20060627; Jain NN, 2003, PHARMACOL BIOCHEM BE, V75, P529, DOI 10.1016/S0091-3057(03)00130-8; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; KULKARNI C, 1988, INDIAN J EXP BIOL, V26, P957; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Le Gall M, 2005, J NUTR, V135, P1215, DOI 10.1093/jn/135.5.1215; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lindholm P, 2002, MOL CANCER THER, V1, P365; Louis S, 2004, PLANT SCI, V167, P705, DOI 10.1016/j.plantsci.2004.04.018; Louis S, 2007, PHYTOCHEMISTRY, V68, P521, DOI 10.1016/j.phytochem.2006.11.032; Meyer B, 1996, PLANT PHYSIOL, V112, P615, DOI 10.1104/pp.112.2.615; Mukherjeea PK, 2008, J ETHNOPHARMACOL, V120, P291, DOI 10.1016/j.jep.2008.09.009; NISHIZAWA NK, 1994, PLANT CELL PHYSIOL, V35, P1079; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Rahioui I, 2007, BIOCHIMIE, V89, P1539, DOI 10.1016/j.biochi.2007.07.021; Rai Kiranmai S., 2001, Indian Journal of Physiology and Pharmacology, V45, P305; Rai KS, 2002, FITOTERAPIA, V73, P685, DOI 10.1016/S0367-326X(02)00249-6; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Sze SK, 2009, ANAL CHEM, V81, P1079, DOI 10.1021/ac802175r; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Tan Jian-zhong, 2003, Yichuan, V25, P168; Trabi M, 2009, ORG BIOMOL CHEM, V7, P2378, DOI 10.1039/b823020j; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; WATANABE Y, 1994, EUR J BIOCHEM, V224, P167, DOI 10.1111/j.1432-1033.1994.tb20008.x; Whittington CM, 2008, GENOME RES, V18, P986, DOI 10.1101/gr.7149808; Whittington CM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r95; Yamazaki T, 2003, EUR J BIOCHEM, V270, P1269, DOI 10.1046/j.1432-1033.2003.03489.x	58	128	149	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24275	24287		10.1074/jbc.M111.229922	http://dx.doi.org/10.1074/jbc.M111.229922			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21596752	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000292294900069
J	Kim, S; Kunapuli, SP				Kim, Soochong; Kunapuli, Satya P.			Negative Regulation of G(q)-mediated Pathways in Platelets by G(12/13) Pathways through Fyn Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; PROTEIN-TYROSINE KINASES; SHAPE CHANGE; INTEGRIN ALPHA(IIB)BETA(3); ADENOSINE-DIPHOSPHATE; AKT PHOSPHORYLATION; RECEPTOR ACTIVATION; SIGNALING PATHWAYS; THROMBOXANE A(2); GLYCOPROTEIN-VI	Platelets contain high levels of Src family kinases (SFKs), but their functional role downstream of G protein pathways has not been completely understood. We found that platelet shape change induced by selective G(12/13) stimulation was potentiated by SFK inhibitors, which was abolished by intracellular calcium chelation. Platelet aggregation, secretion, and intracellular Ca2+ mobilization mediated by low concentrations of SFLLRN or YFLLRNP were potentiated by SFK inhibitors. However, 2-methylthio-ADP-induced intracellular Ca2+ mobilization and platelet aggregation were not affected by PP2, suggesting the contribution of SFKs downstream of G(12/13), but not G(q)/G(i), as a negative regulator to platelet activation. Moreover, PP2 potentiated YFLLRNP- and AYPGKF-induced PKC activation, indicating that SFKs downstream of G(12/13) regulate platelet responses through the negative regulation of PKC activation as well as calcium response. SFK inhibitors failed to potentiate platelet responses in the presence of G(q)-selective inhibitor YM254890 or in G(q)-deficient platelets, indicating that SFKs negatively regulate platelet responses through modulation of G(q) pathways. Importantly, AYPGKF-induced platelet aggregation and PKC activation were potentiated in Fyn-deficient but not in Lyn-deficient mice compared with wild-type littermates. We conclude that SFKs, especially Fyn, activated downstream of G(12/13) negatively regulate platelet responses by inhibiting intracellular calcium mobilization and PKC activation through G(q) pathways.	[Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA; [Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kunapuli, SP (corresponding author), Temple Univ, Dept Physiol, Sch Med, 3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu			National Institutes of Health [HL60683, HL93231, HL81322]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060683, R01HL081322, R01HL093231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grants HL60683, HL93231, and HL81322 (to S. P. K.).	Bauer M, 1999, BLOOD, V94, P1665, DOI 10.1182/blood.V94.5.1665.417k33_1665_1672; Bauer M, 2001, THROMB HAEMOSTASIS, V85, P331, DOI 10.1055/s-0037-1615689; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BRASS LF, 1988, J BIOL CHEM, V263, P5348; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; BRASS LP, 1993, ADV EXP MED BIOL, V344, P17; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; CLARK EA, 1994, TRENDS BIOCHEM SCI, V19, P464, DOI 10.1016/0968-0004(94)90131-7; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Dorsam RT, 2005, BLOOD, V105, P2749, DOI 10.1182/blood-2004-07-2821; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; FEINSTEIN MB, 1975, J GEN PHYSIOL, V66, P561, DOI 10.1085/jgp.66.5.561; FEINSTEIN MB, 1977, PROSTAGLANDINS, V14, P1075, DOI 10.1016/0090-6980(77)90286-6; Garcia A, 2005, BLOOD, V106, P3410, DOI 10.1182/blood-2005-05-1933; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Jen CJ, 1996, BLOOD, V87, P3775, DOI 10.1182/blood.V87.9.3775.bloodjournal8793775; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 2009, BIOCHEM PHARMACOL, V77, P835, DOI 10.1016/j.bcp.2008.11.017; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Li ZY, 2010, J BIOL CHEM, V285, P12559, DOI 10.1074/jbc.M109.098756; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; NEGRESCU EV, 1995, J BIOL CHEM, V270, P1057, DOI 10.1074/jbc.270.3.1057; Nieswandt B, 2002, J BIOL CHEM, V277, P39493, DOI 10.1074/jbc.M207256200; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Paul BZS, 2003, PLATELETS, V14, P159, DOI 10.1080/0953710031000092794; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Quek LS, 2000, BLOOD, V96, P4246; Quinter PG, 2007, J THROMB HAEMOST, V5, P362, DOI 10.1111/j.1538-7836.2007.02309.x; RASMUSSEN UB, 1993, J BIOL CHEM, V268, P14322; Reddy KB, 2008, J CELL SCI, V121, P1641, DOI 10.1242/jcs.014076; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Stenberg PE, 1997, BLOOD, V89, P2384, DOI 10.1182/blood.V89.7.2384; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TROTTER PJ, 1995, BIOCHEM J, V308, P591, DOI 10.1042/bj3080591; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; WORNER P, 1975, THROMB RES, V6, P295, DOI 10.1016/0049-3848(75)90079-1; Yin H, 2008, BLOOD, V112, P1139, DOI 10.1182/blood-2008-02-140970	54	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24170	24179		10.1074/jbc.M110.212274	http://dx.doi.org/10.1074/jbc.M110.212274			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21592972	hybrid, Green Published			2022-12-27	WOS:000292294900059
J	Liu, DB; Wang, C; Li, C; Zhang, X; Zhang, BZ; Mi, ZQ; An, XP; Tong, YG				Liu, Dabin; Wang, Chen; Li, Cun; Zhang, Xin; Zhang, Baozhong; Mi, Zhiqiang; An, Xiaoping; Tong, Yigang			Production and Characterization of a Humanized Single-chain Antibody against Human Integrin alpha v alpha 3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(V)BETA(3) INTEGRIN; MONOCLONAL-ANTIBODIES; TUMOR-REGRESSION; ANGIOGENESIS; THERAPY; CANCER; FRAGMENTS; ADHESION; BINDING; VITAXIN	Anti-angiogenesis therapy is an emerging strategy for cancer treatment. This therapy has many advantages over existing treatments, such as fewer side effects, fewer resistance problems, and a broader tumor type spectrum. Integrin alpha v beta 3 is a heterodimeric transmembrane glycoprotein that has been demonstrated to play a key role in tumor angiogenesis and metastasis. We have used a phage antibody display to humanize a mouse monoclonal antibody (mAb E10) against human integrin alpha v beta 3 with a predetermined CDR3 gene. Three human phage antibodies were developed. Analysis of the humanized phage antibodies by phage ELISA revealed that the antibodies retained high antigen-binding activity and detected the same epitope as the parent mAb E10. A humanized single chain Fv (scFv) antibody was expressed in Escherichia coli in a soluble form. Analysis of the purified scFv indicated that it has the same specificity and affinity as the original mAb. Cell viability assays and xenograft model results suggested that the humanized scFv possesses anti-tumor growth activity in vitro and in vivo. This successful production of a humanized scFv with the ability to inhibit alpha v beta 3-mediated cancer cell growth may provide a novel candidate for integrin alpha v beta 3-targeted therapy.	[Liu, Dabin; Wang, Chen; Li, Cun; Zhang, Xin; Zhang, Baozhong; Mi, Zhiqiang; An, Xiaoping; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Tong, YG (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	tong.yigang@gmail.com	Li, Cun/ABD-9346-2020; Liu, Dabin/GNH-2648-2022	Liu, Dabin/0000-0002-3811-8317; Tong, Yigang/0000-0002-8503-8045	Hi-Tech Research and Development (863) Program of China [2009AA02Z111]; National Natural Science Foundation of China [30872223]	Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Hi-Tech Research and Development (863) Program of China Grant 2009AA02Z111 and National Natural Science Foundation of China Grant 30872223.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Black WR, 1998, NATURE, V391, P450, DOI 10.1038/35064; Borras L, 2010, J BIOL CHEM, V285, P9054, DOI 10.1074/jbc.M109.072876; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brereton HM, 2007, J BIOTECHNOL, V129, P539, DOI 10.1016/j.jbiotec.2007.01.008; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cai Weibo, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P407, DOI 10.2174/187152006778226530; Cavallaro U, 2000, J NEURO-ONCOL, V50, P63, DOI 10.1023/A:1006414621286; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Gutheil JC, 2000, CLIN CANCER RES, V6, P3056; Hedley SJ, 2006, GENE THER, V13, P88, DOI 10.1038/sj.gt.3302603; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Keshet E, 1999, J CLIN INVEST, V104, P1497, DOI 10.1172/JCI8849; Klohs WD, 1999, CURR OPIN BIOTECH, V10, P544, DOI 10.1016/S0958-1669(99)00033-6; Kogelberg H, 2008, J MOL BIOL, V382, P385, DOI 10.1016/j.jmb.2008.07.013; Kuan CT, 2010, INT J CANCER, V127, P598, DOI 10.1002/ijc.25062; Landen CN, 2008, NEOPLASIA, V10, P1259, DOI 10.1593/neo.08740; Liu ZF, 2011, MOL IMAGING BIOL, V13, P112, DOI 10.1007/s11307-010-0302-4; Luk JM, 2006, CLIN EXP PHARMACOL P, V33, P482, DOI 10.1111/j.1440-1681.2006.04396.x; Mayer Marcus, 2004, Methods Mol Med, V94, P239; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; PANTOLIANO MW, 1991, BIOCHEMISTRY-US, V30, P10117, DOI 10.1021/bi00106a007; Patel SR, 2001, CANCER, V92, P1347, DOI 10.1002/1097-0142(20010901)92:5<1347::AID-CNCR1456>3.0.CO;2-0; Rader C, 2002, FASEB J, V16, P2000, DOI 10.1096/fj.02-0281fje; Rader C, 1998, P NATL ACAD SCI USA, V95, P8910, DOI 10.1073/pnas.95.15.8910; Reinmuth N, 2003, CANCER RES, V63, P2079; Rosenfeld Philip J, 2006, Ophthalmol Clin North Am, V19, P361; Tsui P, 2002, J IMMUNOL METHODS, V263, P123, DOI 10.1016/S0022-1759(02)00032-7; Wu L, 2008, GRAEF ARCH CLIN EXP, V246, P81, DOI 10.1007/s00417-007-0660-z; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Yang J, 2010, APPL MICROBIOL BIOT, V86, P1067, DOI 10.1007/s00253-009-2379-8	33	12	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24500	24507		10.1074/jbc.M110.211847	http://dx.doi.org/10.1074/jbc.M110.211847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21606501	hybrid, Green Published			2022-12-27	WOS:000292294900090
J	Tammali, R; Saxena, A; Srivastava, SK; Ramana, KV				Tammali, Ravinder; Saxena, Ashish; Srivastava, Satish K.; Ramana, Kota V.			Aldose Reductase Inhibition Prevents Hypoxia-induced Increase in Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) and Vascular Endothelial Growth Factor (VEGF) by Regulating 26 S Proteasome-mediated Protein Degradation in Human Colon Cancer Cells (Publication with Expression of Concern. See vol. 294, pg. 1634, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Publication with Expression of Concern							B SIGNALING PATHWAY; FACTOR-I; UP-REGULATION; EXPRESSION; CARCINOMA; ANGIOGENESIS; ACTIVATION; INVASION; INFLAMMATION; METASTASIS	The development of intratumoral hypoxia, a hallmark of rapidly progressing solid tumors, renders tumor cells resistant to chemotherapy and radiation therapy. We have recently shown that inhibition of aldose reductase (AR), an enzyme that catalyzes the reduction of lipid aldehydes and their glutathione conjugates, prevents human colon cancer cell growth in culture as well as in nude mouse xenografts by inhibiting the NF-kappa B-dependent activation of oxidative stress-mediated inflammatory and carcinogenic markers. However, the role of AR in mediating hypoxic stress signals is not known. We therefore investigated the molecular mechanisms by which AR inhibition prevents the hypoxia-inducedhumancolon cancer cells growth and invasion. Our results indicate that AR inhibition by the pharmacological inhibitor fidarestat or ablation by AR-specific siRNA prevents hypoxia-induced proliferation of HT29, SW480, and Caco-2 colon cancer cells. Furthermore, hypoxia-induced increase in the level of HIF-1 alpha in colon cancer cells was significantly decreased by AR inhibition. During hypoxic conditions, treatment of HT29 cells with the AR inhibitor fidarestat significantly decreased the expression of vascular endothelial growth factor, a down target of HIF-1 alpha, at both mRNA and protein levels and also prevented the activation of PI3K/AKT, GSK3 beta, Snail, and lysyl oxidase. Furthermore, inhibition of hypoxia-induced HIF-1 alpha protein accumulation by AR inhibition was abolished in the presence of MG132, a potent inhibitor of the 26 S proteasome. In addition, AR inhibition also prevented the hypoxia-induced inflammatory molecules such as Cox-2 and PGE2 and expression of extracellular matrix proteins such as MMP2, vimentin, uPAR, and lysyl oxidase 2. In conclusion, our results indicate that AR mediates hypoxic signals, leading to tumor progression and invasion.	[Tammali, Ravinder; Saxena, Ashish; Srivastava, Satish K.; Ramana, Kota V.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Ramana, KV (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	kvramana@utmb.edu	Ramana, Kota/C-5460-2012	Ramana, Kota/0000-0001-6502-7800	National Institutes of Health [GM71036, CA129383, DK36118]; NATIONAL CANCER INSTITUTE [R01CA129383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118, R01DK036118, R37DK036118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM71036 (to K. V. R.) and CA129383 and DK36118 (to S. K. S.).	Aggarwal BB, 2006, EXPERT OPIN THER TAR, V10, P87, DOI 10.1517/14728222.10.1.87; Aydemir ABC, 2010, BONE, V46, P167, DOI 10.1016/j.bone.2009.08.061; Bae MK, 2006, ONCOL REP, V15, P1557; Ben-Yosef Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1321, DOI 10.1152/ajpcell.00079.2005; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; DeClerck K, 2010, FRONT BIOSCI-LANDMRK, V15, P213, DOI 10.2741/3616; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gulati N, 2006, ANTICANCER RES, V26, P1177; Hwang MK, 2009, INT J BIOCHEM CELL B, V41, P1592, DOI 10.1016/j.biocel.2009.01.014; Ichikawa H, 2007, CURR PHARM DESIGN, V13, P3400, DOI 10.2174/138161207782360492; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kousidou OC, 2004, ANTICANCER RES, V24, P4025; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Krishnamachary B, 2003, CANCER RES, V63, P1138; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Mann JR, 2005, NAT CLIN PRACT ONCOL, V2, P202, DOI 10.1038/ncponc0140; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nagle DG, 2006, CURR DRUG TARGETS, V7, P355, DOI 10.2174/138945006776054979; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Oh SJ, 2010, FOOD CHEM TOXICOL, V48, P3227, DOI 10.1016/j.fct.2010.08.028; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Ramana KV, 2006, J BIOL CHEM, V281, P17652, DOI 10.1074/jbc.M600270200; Ramana KV, 2010, MOL CANCER THER, V9, P813, DOI 10.1158/1535-7163.MCT-09-0795; Ramana KV, 2010, INT J BIOCHEM CELL B, V42, P17, DOI 10.1016/j.biocel.2009.09.009; Ramasamy R, 2010, CIRC RES, V106, P1449, DOI 10.1161/CIRCRESAHA.109.213447; Reddy Aramati B M, 2010, Recent Pat Cardiovasc Drug Discov, V5, P25; Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Shimizu M, 2010, CHEM-BIOL INTERACT, V185, P247, DOI 10.1016/j.cbi.2010.03.036; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Stahtea XN, 2007, INT J CANCER, V121, P2808, DOI 10.1002/ijc.23029; Tafani M, 2010, CANCER SCI, V101, P1014, DOI 10.1111/j.1349-7006.2010.01493.x; Tammali R, 2007, CANCER LETT, V252, P299, DOI 10.1016/j.canlet.2007.01.001; Tammali R, 2006, CANCER RES, V66, P9705, DOI 10.1158/0008-5472.CAN-06-2105; Tammali R, 2009, CARCINOGENESIS, V30, P799, DOI 10.1093/carcin/bgn246; Tang WH, 2008, FREE RADICAL BIO MED, V45, P602, DOI 10.1016/j.freeradbiomed.2008.05.003; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Wu HZ, 2008, BIOMED PHARMACOTHER, V62, P613, DOI 10.1016/j.biopha.2008.06.036; Yang ZF, 2010, J CELL PHYSIOL, V225, P266, DOI 10.1002/jcp.22261; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhang QZ, 2006, MOL CANCER THER, V5, P1227, DOI 10.1158/1535-7163.MCT-05-0490; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	54	33	35	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24089	24100		10.1074/jbc.M111.219733	http://dx.doi.org/10.1074/jbc.M111.219733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576240	Green Published, hybrid			2022-12-27	WOS:000292294900051
J	Stys, A; Galy, B; Starzynski, RR; Smuda, E; Drapier, JC; Lipinski, P; Bouton, C				Stys, Agnieszka; Galy, Bruno; Starzynski, Rafal R.; Smuda, Ewa; Drapier, Jean-Claude; Lipinski, Pawel; Bouton, Cecile			Iron Regulatory Protein 1 Outcompetes Iron Regulatory Protein 2 in Regulating Cellular Iron Homeostasis in Response to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR MESSENGER-RNA; NEURODEGENERATIVE DISEASE; FERRITIN SYNTHESIS; NITROGEN MONOXIDE; J774 MACROPHAGES; S-NITROSYLATION; DOWN-REGULATION; METABOLISM; IRP2; MICE	In mammals, iron regulatory proteins (IRPs) 1 and 2 posttranscriptionally regulate expression of genes involved in iron metabolism, including transferrin receptor 1, the ferritin (Ft) H and L subunits, and ferroportin by binding mRNA motifs called iron responsive elements (IREs). IRP1 is a bifunctional protein that mostly exists in a non-IRE-binding, [4Fe-4S] cluster aconitase form, whereas IRP2, which does not assemble an Fe-S cluster, spontaneously binds IREs. Although both IRPs fulfill a trans-regulatory function, only mice lacking IRP2 misregulate iron metabolism. NO stimulates the IRE-binding activity of IRP1 by targeting its Fe-S cluster. IRP2 has also been reported to sense NO, but the intrinsic function of IRP1 and IRP2 in NO-mediated regulation of cellular iron metabolism is controversial. In this study, we exposed bone marrow macrophages from Irp1(-/-) and Irp2(-/-) mice to NO and showed that the generated apo-IRP1 was entirely responsible for the posttranscriptional regulation of transferrin receptor 1, H-Ft, L-Ft, and ferroportin. The powerful action of NO on IRP1 also remedies the defects of iron storage found in IRP2-null bone marrow macrophages by efficiently reducing Ft overexpression. We also found that NO-dependent IRP1 activation, resulting in increased iron uptake and reduced iron sequestration and export, maintains enough intracellular iron to fuel the Fe-S cluster biosynthetic pathway for efficient restoration of the citric acid cycle aconitase in mitochondria. Thus, IRP1 is the dominant sensor and transducer of NO for posttranscriptional regulation of iron metabolism and participates in Fe-S cluster repair after exposure to NO.	[Lipinski, Pawel] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, PL-05552 Jastrzebiec, Wolka Kosowska, Poland; [Stys, Agnieszka; Drapier, Jean-Claude; Bouton, Cecile] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, UPR2301, F-91190 Gif Sur Yvette, France; [Galy, Bruno] European Mol Biol Lab, D-69117 Heidelberg, Germany	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL)	Lipinski, P (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, Ul Postepu 1, PL-05552 Jastrzebiec, Wolka Kosowska, Poland.	p.lipinski@ighz.pl	Bouton, Cecile/J-8663-2013	Galy, Bruno/0000-0002-0501-6357; , Rafal/0000-0002-7470-0507	Embassy of France in Poland, Regional Council of Ile-de-France [09SETCI019]; Polish State Committee for Scientific Research [N N303 373636, 1365/1]	Embassy of France in Poland, Regional Council of Ile-de-France; Polish State Committee for Scientific Research(Polish State Committee for Scientific Research)	This work was supported by a French government scholarship (These en Cotutelle) granted by the Embassy of France in Poland, Regional Council of Ile-de-France Grant 09SETCI019, Polish State Committee for Scientific Research Grant N N303 373636 (cofinanced within the framework of Integrated Regional Development Operational Programme (PhD student scholarship no. 1365/1).	Andersen JK, 2004, J ALZHEIMERS DIS, V6, pS47; Bouton C, 1996, J BIOL CHEM, V271, P2300, DOI 10.1074/jbc.271.4.2300; Bouton C, 1998, J BIOL CHEM, V273, P9403, DOI 10.1074/jbc.273.16.9403; Bouton C, 2002, J BIOL CHEM, V277, P31220, DOI 10.1074/jbc.M203276200; BOUTON C, 2003, SCI STKE, pPE17; Corna G, 2006, J MOL MED, V84, P551, DOI 10.1007/s00109-006-0068-y; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Garcia-Caldero H, 2011, J HEPATOL, V54, P660, DOI 10.1016/j.jhep.2010.07.034; Ghosh MC, 2008, P NATL ACAD SCI USA, V105, P12028, DOI 10.1073/pnas.0805361105; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Inami K, 2006, NITRIC OXIDE-BIOL CH, V14, P309, DOI 10.1016/j.niox.2006.01.003; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kim S, 1999, J BIOL CHEM, V274, P33035, DOI 10.1074/jbc.274.46.33035; Kim S, 2004, MOL CELL BIOL, V24, P330, DOI 10.1128/MCB.24.1.330-337.2004; Kim S, 2000, J BIOL CHEM, V275, P6220, DOI 10.1074/jbc.275.9.6220; Kim SW, 2002, P NATL ACAD SCI USA, V99, P12214, DOI 10.1073/pnas.192316099; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu XM, 2007, CARDIOVASC RES, V75, P381, DOI 10.1016/j.cardiores.2007.03.004; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mulero V, 1999, BLOOD, V94, P2383, DOI 10.1182/blood.V94.7.2383.419k20_2383_2389; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Oliveira L, 2000, P NATL ACAD SCI USA, V97, P6550, DOI 10.1073/pnas.120571797; PANTOPOULOS K, 1995, P NATL ACAD SCI USA, V92, P1267, DOI 10.1073/pnas.92.5.1267; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Phillips JD, 1996, BLOOD, V87, P2983, DOI 10.1182/blood.V87.7.2983.bloodjournal8772983; Recalcati S, 1998, BLOOD, V91, P1059, DOI 10.1182/blood.V91.3.1059.1059_1059_1066; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Soule BP, 2007, FREE RADICAL BIO MED, V42, P1632, DOI 10.1016/j.freeradbiomed.2007.02.030; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; Soum E, 2003, J BIOL INORG CHEM, V8, P226, DOI 10.1007/s00775-002-0412-9; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Viatte L, 2009, J MOL MED, V87, P913, DOI 10.1007/s00109-009-0494-8; Wang J, 2005, MOL CELL BIOL, V25, P1347, DOI 10.1128/MCB.25.4.1347-1353.2005; Wang J, 2006, MOL CELL BIOL, V26, P1948, DOI 10.1128/MCB.26.5.1948-1954.2006; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Watts RN, 2003, BIOCHEM J, V369, P429, DOI 10.1042/BJ20021302; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x	51	48	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22846	22854		10.1074/jbc.M111.231902	http://dx.doi.org/10.1074/jbc.M111.231902			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566147	Green Published, hybrid			2022-12-27	WOS:000292025000019
J	Lee, HW; Dominy, BN; Cao, WG				Lee, Hyun-Wook; Dominy, Brian N.; Cao, Weiguo			New Family of Deamination Repair Enzymes in Uracil-DNA Glycosylase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DEOXYINOSINE; RECOGNITION; IDENTIFICATION; MUTAGENESIS; MUTATIONS; XANTHINE; BINDING	DNA glycosylases play a major role in the repair of deaminated DNA damage. Previous investigations identified five families within the uracil-DNA glycosylase (UDG) superfamily. All enzymes within the superfamily studied thus far exhibit uracil-DNA glycosylase activity. Here we identify a new class of DNA glycosylases in the UDG superfamily that lacks UDG activity. Instead, these enzymes act as hypoxanthine-DNA glycosylases in vitro and in vivo. Molecular modeling and structure-guided mutational analysis allowed us to identify a unique catalytic center in this class of DNA glycosylases. Based on unprecedented biochemical properties and phylogenetic analysis, we propose this new class of DNA repair glycosylases that exists in bacteria, archaea, and eukaryotes as family 6 and designate it as the hypoxanthine-DNA glycosylase family. This study demonstrates the structural evolvability that underlies substrate specificity and catalytic flexibility in the evolution of enzymatic function.	[Lee, Hyun-Wook; Cao, Weiguo] Clemson Univ, Dept Biochem & Genet, S Carolina Expt Stn, Clemson, SC 29634 USA; [Dominy, Brian N.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University; Clemson University	Cao, WG (corresponding author), Clemson Univ, Dept Biochem & Genet, S Carolina Expt Stn, Rm 219 Biosyst Res Complex,51 New Cherry St, Clemson, SC 29634 USA.	wgc@clemson.edu	Dominy, Brian/AAA-4541-2020	Dominy, Brian/0000-0002-5635-2879	National Institutes of Health [GM090141]; Cooperative State Research, Education, and Extension Service/United States Department of Agriculture [SC-1700274, 5905]; United States Department of Defense [W81XWH-10-1-0385]; National Science Foundation [MCB-0953783]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooperative State Research, Education, and Extension Service/United States Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM090141 (to W. C.). This work was also supported by Cooperative State Research, Education, and Extension Service/United States Department of Agriculture Grant SC-1700274 (Technical Contribution Number 5905), United States Department of Defense Grant W81XWH-10-1-0385 (to W. C.), and National Science Foundation Grant MCB-0953783 (to B. N. D.).	Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; CASEGREEN SC, 1994, NUCLEIC ACIDS RES, V22, P131, DOI 10.1093/nar/22.2.131; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Josephy PD, 2000, MUTAT RES-FUND MOL M, V455, P71, DOI 10.1016/S0027-5107(00)00063-4; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Lee HW, 2010, J BIOL CHEM, V285, P41483, DOI 10.1074/jbc.M110.150003; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Mi RJ, 2009, J MOL BIOL, V385, P761, DOI 10.1016/j.jmb.2008.09.038; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Schouten KA, 1999, MUTAT RES-DNA REPAIR, V435, P245, DOI 10.1016/S0921-8777(99)00049-X; Shroyer MJN, 1999, BIOCHEMISTRY-US, V38, P4834, DOI 10.1021/bi982986j; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918	27	41	46	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31282	31287		10.1074/jbc.M111.249524	http://dx.doi.org/10.1074/jbc.M111.249524			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21642431	Green Published, hybrid			2022-12-27	WOS:000294487500023
J	Mitsutake, S; Zama, K; Yokota, H; Yoshida, T; Tanaka, M; Mitsui, M; Ikawa, M; Okabe, M; Tanaka, Y; Yamashita, T; Takemoto, H; Okazaki, T; Watanabe, K; Igarashi, Y				Mitsutake, Susumu; Zama, Kota; Yokota, Hazuki; Yoshida, Tetsuya; Tanaka, Miki; Mitsui, Masaru; Ikawa, Masahito; Okabe, Masaru; Tanaka, Yoshikazu; Yamashita, Tadashi; Takemoto, Hiroshi; Okazaki, Toshiro; Watanabe, Ken; Igarashi, Yasuyuki			Dynamic Modification of Sphingomyelin in Lipid Microdomains Controls Development of Obesity, Fatty Liver, and Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ACID SPHINGOMYELINASE; CELL-GROWTH; SYNTHASE 2; MICE; CERAMIDE; ENDOCYTOSIS; CAVEOLIN-1; RAFTS; ATHEROSCLEROSIS	Lipid microdomains or caveolae, small invaginations of plasma membrane, have emerged as important elements for lipid uptake and glucose homeostasis. Sphingomyelin (SM) is one of the major phospholipids of the lipid microdomains. In this study, we investigated the physiological function of sphingomyelin synthase 2 (SMS2) using SMS2 knock-out mice, and we found that SMS2 deficiency prevents high fat diet-induced obesity and insulin resistance. Interestingly, in the liver of SMS2 knock-out mice, large and mature lipid droplets were scarcely observed. Treatment with siRNA for SMS2 also decreased the large lipid droplets in HepG2 cells. Additionally, the siRNA of SMS2 decreased the accumulation of triglyceride in liver of leptin-deficient (ob/ob) mice, strongly suggesting that SMS2 is involved in lipid droplet formation. Furthermore, we found that SMS2 exists in lipid microdomains and partially associates with the fatty acid transporter CD36/FAT and with caveolin 1, a scaffolding protein of caveolae. Because CD36/FAT and caveolin 1 exist in lipid microdomains and are coordinately involved in lipid droplet formation, SMS2 is implicated in the modulation of the SM in lipid microdomains, resulting in the regulation of CD36/FAT and caveolae. Here, we established new cell lines, in which we can completely distinguish SMS2 activity from SMS1 activity, and we demonstrated that SMS2 could convert ceramide produced in the outer leaflet of the plasma membrane into SM. Our findings demonstrate the novel and dynamic regulation of lipid microdomains via conformational changes in lipids on the plasma membrane by SMS2, which is responsible for obesity and type 2 diabetes.	[Mitsutake, Susumu; Zama, Kota; Yokota, Hazuki; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan; [Yamashita, Tadashi] Hokkaido Univ, Fac Adv Life Sci, Dept Dev Biotechnol, Sapporo, Hokkaido 0010021, Japan; [Yoshida, Tetsuya; Tanaka, Miki; Mitsui, Masaru; Tanaka, Yoshikazu; Takemoto, Hiroshi] Shionogi & Co Ltd, Shionogi Innovat Ctr Drug Discovery, Sapporo, Hokkaido 0010021, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Res Inst Microbial Dis & Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Okazaki, Toshiro] Tottori Univ, Fac Med, Dept Clin Lab, Tottori 6838503, Japan; [Watanabe, Ken] Natl Ctr Geriatr & Geriatr & Gerontol, Dept Bone & Joint Dis, Aichi 4748511, Japan	Hokkaido University; Hokkaido University; Shionogi & Company Limited; Osaka University; Tottori University; National Center for Geriatrics & Gerontology	Mitsutake, S (corresponding author), Kita 21,Nishi 11,Kita Ku, Sapporo, Hokkaido 0010021, Japan.	susumu-m@pharm.hokudai.ac.jp	Mitsutake, Susumu/A-4082-2012; ikawa, masahito/A-5315-2009; Watanabe, Ken/I-3960-2013; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Watanabe, Ken/0000-0003-0664-3915; Takemoto, Hiroshi/0000-0001-9893-0609; Okabe, Masaru/0000-0002-0803-9044	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [20670006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Future Drug Discovery and Medical Care Innovation Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fujimoto T, 2000, J CELL SCI, V113, P3509; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Houjou T, 2004, RAPID COMMUN MASS SP, V18, P3123, DOI 10.1002/rcm.1737; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Mitsutake S, 2007, BIOCHEM BIOPH RES CO, V363, P519, DOI 10.1016/j.bbrc.2007.09.010; Mitsutake S, 2007, BIOCHEM BIOPH RES CO, V359, P622, DOI 10.1016/j.bbrc.2007.05.160; Mitsutake S, 2010, J DERMATOL SCI, V60, P128, DOI 10.1016/j.jdermsci.2010.08.012; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Ortegren U, 2007, TRENDS ENDOCRIN MET, V18, P344, DOI 10.1016/j.tem.2007.08.007; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Takagi S, 2003, J CLIN INVEST, V112, P1372, DOI 10.1172/JCI200318513; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	43	132	138	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28544	28555		10.1074/jbc.M111.255646	http://dx.doi.org/10.1074/jbc.M111.255646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669879	Green Published, hybrid			2022-12-27	WOS:000293557800069
J	Horejs, C; Ristl, R; Tscheliessnig, R; Sleytr, UB; Pum, D				Horejs, Christine; Ristl, Robin; Tscheliessnig, Rupert; Sleytr, Uwe B.; Pum, Dietmar			Single-molecule Force Spectroscopy Reveals the Individual Mechanical Unfolding Pathways of a Surface Layer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL POLYMER; N-TERMINAL PART; S-LAYER; STRUCTURAL INSIGHTS; BINDING; STABILITY; TITIN; SBSB; FIBRONECTIN; CONFORMATIONS	Surface layers (S-layers) represent an almost universal feature of archaeal cell envelopes and are probably the most abundant bacterial cell proteins. S-layers are monomolecular crystalline structures of single protein or glycoprotein monomers that completely cover the cell surface during all stages of the cell growth cycle, thereby performing their intrinsic function under a constant intra- and intermolecular mechanical stress. In Gram-positive bacteria, the individual S-layer proteins are anchored by a specific binding mechanism to polysaccharides (secondary cell wall polymers) that are linked to the underlying peptidoglycan layer. In this work, atomic force microscopy-based single-molecule force spectroscopy and a polyprotein approach are used to study the individual mechanical unfolding pathways of an S-layer protein. We uncover complex unfolding pathways involving the consecutive unfolding of structural intermediates, where a mechanical stability of 87 pN is revealed. Different initial extensibilities allow the hypothesis that S-layer proteins adapt highly stable, mechanically resilient conformations that are not extensible under the presence of a pulling force. Interestingly, a change of the unfolding pathway is observed when individual S-layer proteins interact with secondary cell wall polymers, which is a direct signature of a conformational change induced by the ligand. Moreover, the mechanical stability increases up to 110 pN. This work demonstrates that single-molecule force spectroscopy offers a powerful tool to detect subtle changes in the structure of an individual protein upon binding of a ligand and constitutes the first conformational study of surface layer proteins at the single-molecule level.	[Horejs, Christine; Ristl, Robin; Sleytr, Uwe B.; Pum, Dietmar] Univ Nat Resources & Life Sci, Dept Nanobiotechnol, A-1190 Vienna, Austria; [Tscheliessnig, Rupert] Univ Nat Resources & Life Sci, Inst Biotechnol, Austrian Ctr Ind Biotechnol, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology; University of Natural Resources & Life Sciences, Vienna	Pum, D (corresponding author), Muthgasse 11, A-1190 Vienna, Austria.	pum@boku.ac.at		Pum, Dietmar/0000-0002-1895-4940; Ristl, Robin/0000-0002-4163-9236; Horejs, Christine-Maria/0000-0002-8614-7737	Air Force [FA9550-09-1-0342, FA9550-10-1-0223]; Austrian Science Fund [P19047-B12, P21954-B20]; Federal Ministry of Economy, Family and Youth (BMWFJ); Federal Ministry of Traffic, Innovation, and Technology (BMVIT); Styrian Business Promotion Agency; Standortagentur Tirol; Technology Agency of the City of Vienna through the COMET; Austrian Academy of Sciences	Air Force; Austrian Science Fund(Austrian Science Fund (FWF)); Federal Ministry of Economy, Family and Youth (BMWFJ); Federal Ministry of Traffic, Innovation, and Technology (BMVIT); Styrian Business Promotion Agency; Standortagentur Tirol; Technology Agency of the City of Vienna through the COMET; Austrian Academy of Sciences	This work was supported by the Air Force projects FA9550-09-1-0342, and FA9550-10-1-0223, by the Austrian Science Fund Projects P19047-B12 and P21954-B20 (to C. S.), and by the Federal Ministry of Economy, Family and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation, and Technology (BMVIT), the Styrian Business Promotion Agency, the Standortagentur Tirol, and Technology Agency of the City of Vienna through the COMET Funding Program managed by the Austrian Research Promotion Agency FFG.; Holds a DOC-fFORTE fellowship of the Austrian Academy of Sciences.	Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998; Bertz M, 2008, J MOL BIOL, V378, P447, DOI 10.1016/j.jmb.2008.02.025; BREITWIESER A, 1992, J BACTERIOL, V174, P8008, DOI 10.1128/JB.174.24.8008-8015.1992; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2008, J MOL BIOL, V378, P1132, DOI 10.1016/j.jmb.2008.03.046; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Cao Y, 2011, BIOPHYS J, V100, P1794, DOI 10.1016/j.bpj.2011.02.030; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chung S, 2010, P NATL ACAD SCI USA, V107, P16536, DOI 10.1073/pnas.1008280107; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; EGELSEER EM, 2009, S LAYERS MICROBIAL B, P4424; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; Greene DN, 2008, BIOPHYS J, V95, P1360, DOI 10.1529/biophysj.108.130237; Hann E, 2007, BIOPHYS J, V92, pL79, DOI 10.1529/biophysj.106.102475; Hertadi R, 2003, J MOL BIOL, V333, P993, DOI 10.1016/j.jmb.2003.09.010; Horejs C, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2826375; Horejs C, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565457; Horejs C, 2011, ACS NANO, V5, P2288, DOI 10.1021/nn1035729; Horejs C, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3489682; Howorka S, 2000, J BIOL CHEM, V275, P37876, DOI 10.1074/jbc.M003838200; JAENICKE R, 1985, BIOL CHEM H-S, V366, P663, DOI 10.1515/bchm3.1985.366.2.663; Jarosch M, 2001, MICROBIOL-SGM, V147, P1353, DOI 10.1099/00221287-147-5-1353; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Junker JP, 2009, P NATL ACAD SCI USA, V106, P14361, DOI 10.1073/pnas.0904654106; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Junker JP, 2005, BIOPHYS J, V89, pL46, DOI 10.1529/biophysj.105.072066; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kinns H, 2008, J MOL BIOL, V377, P589, DOI 10.1016/j.jmb.2008.01.019; Kinns H, 2010, J MOL BIOL, V395, P742, DOI 10.1016/j.jmb.2009.10.012; Kuen B, 1997, J BACTERIOL, V179, P1664, DOI 10.1128/jb.179.5.1664-1670.1997; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; LUPAS A, 1994, J BACTERIOL, V176, P1224, DOI 10.1128/jb.176.5.1224-1233.1994; Mader C, 2004, J BACTERIOL, V186, P1758, DOI 10.1128/JB.186.6.1758-1768.2004; Messner P, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P53, DOI 10.1007/978-3-642-05062-6_2; Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170; Norville JE, 2007, J STRUCT BIOL, V160, P313, DOI 10.1016/j.jsb.2007.06.002; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Pavkov T, 2003, ACTA CRYSTALLOGR D, V59, P1466, DOI 10.1107/S0907444903010990; Pavkov T, 2008, STRUCTURE, V16, P1226, DOI 10.1016/j.str.2008.05.012; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Petersen BO, 2008, CARBOHYD RES, V343, P1346, DOI 10.1016/j.carres.2008.03.029; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Puchner EM, 2010, ANGEW CHEM INT EDIT, V49, P1147, DOI 10.1002/anie.200905956; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Ries W, 1997, J BACTERIOL, V179, P3892, DOI 10.1128/jb.179.12.3892-3898.1997; Runzler D, 2004, J BIOL CHEM, V279, P5207, DOI 10.1074/jbc.M308819200; Sambrook J., 2001, MOL CLONING LAB MANU; Sara M, 1998, J BACTERIOL, V180, P6780; Sara M, 2001, TRENDS MICROBIOL, V9, P47, DOI 10.1016/S0966-842X(00)01905-3; SARA M, 1987, J BACTERIOL, V169, P4092, DOI 10.1128/jb.169.9.4092-4098.1987; Sara M, 1998, J BACTERIOL, V180, P4146; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x; Shaub A, 1999, NAT CELL BIOL, V1, pE173, DOI 10.1038/15608; Sleytr U. B., 1989, ELECT MICROSCOPY SUB, P13; Sleytr U. B., 2005, SUPRAMOLECULAR POLYM, P583; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; SLEYTR UB, 1975, J ULTRA MOL STRUCT R, V50, P103, DOI 10.1016/S0022-5320(75)90012-X; SLEYTR UB, 1983, ANNU REV MICROBIOL, V37, P311, DOI 10.1146/annurev.mi.37.100183.001523; Sleytr UB, 1988, CRYSTALLINE BACTERIA; Verbelen C, 2007, ULTRAMICROSCOPY, V107, P1004, DOI 10.1016/j.ultramic.2007.02.040; Vogel V, 2001, TRENDS BIOTECHNOL, V19, P416, DOI 10.1016/S0167-7799(01)01737-1; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Wang CC, 2011, BIOPHYS J, V100, P1094, DOI 10.1016/j.bpj.2011.01.011; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875; Whitelam S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.088102	79	12	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27416	27424		10.1074/jbc.M111.251322	http://dx.doi.org/10.1074/jbc.M111.251322			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21690085	hybrid, Green Published			2022-12-27	WOS:000293268700037
J	Jay, SM; Kurtagic, E; Alvarez, LM; de Picciotto, S; Sanchez, E; Hawkins, JF; Prince, RN; Guerrero, Y; Treasure, CL; Lee, RT; Griffith, LG				Jay, Steven M.; Kurtagic, Elma; Alvarez, Luis M.; de Picciotto, Seymour; Sanchez, Edgar; Hawkins, Jessica F.; Prince, Robin N.; Guerrero, Yadir; Treasure, Carolyn L.; Lee, Richard T.; Griffith, Linda G.			Engineered Bivalent Ligands to Bias ErbB Receptor-mediated Signaling and Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER CELLS; EGF-RECEPTOR; HEREGULIN; PROLIFERATION; INHIBITOR; INSIGHTS; COMPLEX; MUTANT; HER3	The ErbB receptor family is dysregulated in many cancers, and its therapeutic manipulation by targeted antibodies and kinase inhibitors has resulted in effective chemotherapies. However, many malignancies remain refractory to current interventions. We describe a new approach that directs ErbB receptor interactions, resulting in biased signaling and phenotypes. Due to known receptor-ligand affinities and the necessity of ErbB receptors to dimerize to signal, bivalent ligands, formed by the synthetic linkage of two neuregulin-1 beta (NRG) moieties, two epidermal growth factor(EGF) moieties, or an EGF and a NRG moiety, can potentially drive homotypic receptor interactions and diminish formation of HER2-containing heterodimers, which are implicated in many malignancies and are a prevalent outcome of stimulation by native, monovalent EGF, or NRG. We demonstrate the therapeutic potential of this approach by showing that bivalent NRG(NN) can bias signaling in HER3-expressing cancer cells, resulting in some cases in decreased migration, inhibited proliferation, and increased apoptosis, whereas native NRG stimulation increased the malignant potential of the same cells. Hence, this new approach may have therapeutic relevance in ovarian, breast, lung, and other cancers in which HER3 has been implicated.	[Jay, Steven M.; Kurtagic, Elma; Alvarez, Luis M.; de Picciotto, Seymour; Sanchez, Edgar; Prince, Robin N.; Guerrero, Yadir] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Griffith, Linda G.] MIT, Ctr Gynepathol Res, Cambridge, MA 02139 USA; [Griffith, Linda G.] MIT, Koch Inst Canc Res, Cambridge, MA 02139 USA; [Jay, Steven M.; Lee, Richard T.; Griffith, Linda G.] Harvard Stem Cell Inst, Cambridge, MA 02139 USA; [Jay, Steven M.; Hawkins, Jessica F.; Prince, Robin N.; Treasure, Carolyn L.; Lee, Richard T.; Griffith, Linda G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Dept Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Griffith, LG (corresponding author), MIT Biol Engn, 77 Massachusetts Ave,Rm 16-429, Cambridge, MA 02139 USA.	griff@mit.edu	Jay, Steven/ABD-4344-2021	Jay, Steven/0000-0002-3827-5988; Lee, Richard/0000-0003-4687-1381; Griffith, Linda/0000-0002-1801-5548	National Institutes of Health [AG032977, DE019523, EB003805, U54-CA112967]; Army (Armed Forces Institute for Regenerative Medicine); Brigham and Women's Hospital; United States Department of Defense Breast Cancer Research [W81XWH-11-1-0035]; Radcliffe Institute; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020, P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army (Armed Forces Institute for Regenerative Medicine); Brigham and Women's Hospital; United States Department of Defense Breast Cancer Research(United States Department of Defense); Radcliffe Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG032977 (to R. T. L.), DE019523 (to L. G. G.), EB003805 (to L. G. G. and R. T. L.), and U54-CA112967 (to L. G. G. via D. A. Lauffenburger). This work was also supported by the Army (Armed Forces Institute for Regenerative Medicine (to L. G. G.). Brigham and Women's Hospital and the Massachusetts Institute of Technology have filed for patents pertaining to the described bivalent ligand technology, listing L. M. A., S. M. J., R. T. L., and L. G. G. as inventors.; Supported by United States Department of Defense Breast Cancer Research Program Postdoctoral Fellowship W81XWH-11-1-0035.; Supported by the Radcliffe Institute for Advanced Studies.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Berger MB, 2004, FEBS LETT, V569, P332, DOI 10.1016/j.febslet.2004.06.014; BERKERS JAM, 1991, J BIOL CHEM, V266, P922; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Cardo-Vila M, 2010, P NATL ACAD SCI USA, V107, P5118, DOI 10.1073/pnas.0915146107; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Chuu CP, 2008, MOL CANCER RES, V6, P885, DOI 10.1158/1541-7786.MCR-07-0369; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Crovello CS, 1998, J BIOL CHEM, V273, P26954, DOI 10.1074/jbc.273.41.26954; De P, 2010, J CLIN ONCOL, V28, P1091, DOI 10.1200/JCO.2009.25.8624; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Hutcheson IR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2848; HUTCHINGS SE, 1978, P NATL ACAD SCI USA, V75, P901, DOI 10.1073/pnas.75.2.901; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Iyer AKV, 2007, J CELL PHYSIOL, V211, P748, DOI 10.1002/jcp.20986; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kani K, 2005, J BIOL CHEM, V280, P8238, DOI 10.1074/jbc.M410944200; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Lindzen M, 2010, P NATL ACAD SCI USA, V107, P12559, DOI 10.1073/pnas.1006218107; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Liu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005544; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Moll JR, 2001, PROTEIN SCI, V10, P649, DOI 10.1110/ps.39401; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakaji-Hirabayashi T, 2009, BIOCONJUGATE CHEM, V20, P102, DOI 10.1021/bc800331t; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Oksvold MP, 2000, J HISTOCHEM CYTOCHEM, V48, P21, DOI 10.1177/002215540004800103; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Park E, 2008, BIOCHEMISTRY-US, V47, P11992, DOI 10.1021/bi8004208; Pinkas-Kramarski R, 1998, ONCOGENE, V16, P1249, DOI 10.1038/sj.onc.1201642; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sithanandam G, 2005, ONCOGENE, V24, P1847, DOI 10.1038/sj.onc.1208381; Soler M, 2009, INT J CANCER, V125, P2565, DOI 10.1002/ijc.24651; Starr A, 2006, INT J CANCER, V119, P269, DOI 10.1002/ijc.21818; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vadlamudi R, 1999, CANCER RES, V59, P2843; van der Woning SP, 2009, BIOCHEM BIOPH RES CO, V378, P285, DOI 10.1016/j.bbrc.2008.11.034; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Ware CF, 1996, J CELL BIOCHEM, V60, P47, DOI 10.1002/(SICI)1097-4644(19960101)60:1<47::AID-JCB8>3.3.CO;2-H; Warren CM, 2006, J BIOL CHEM, V281, P27306, DOI 10.1074/jbc.M512887200; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Xia WL, 2004, ONCOGENE, V23, P646, DOI 10.1038/sj.onc.1207166; Xue CS, 2006, CANCER RES, V66, P1418, DOI 10.1158/0008-5472.CAN-05-0550; Yamada T, 2010, CLIN CANCER RES, V16, P174, DOI 10.1158/1078-0432.CCR-09-1204; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658	67	18	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27729	27740		10.1074/jbc.M111.221093	http://dx.doi.org/10.1074/jbc.M111.221093			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21622572	Green Published, hybrid			2022-12-27	WOS:000293268700065
J	Lee, SF; Srinivasan, B; Sephton, CF; Dries, DR; Wang, B; Yu, C; Wang, Y; Dewey, CM; Shah, S; Jiang, J; Yu, G				Lee, Sheu-Fen; Srinivasan, Bhooma; Sephton, Chantelle F.; Dries, Daniel R.; Wang, Bing; Yu, Cong; Wang, Yun; Dewey, Colleen M.; Shah, Sanjiv; Jiang, Jin; Yu, Gang			gamma-Secretase-regulated Proteolysis of the Notch Receptor by Mitochondrial Intermediate Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; DROSOPHILA-MELANOGASTER; INTRACELLULAR DOMAIN; PRECURSOR PROTEIN; INDUCED APOPTOSIS; ACTIVATED NOTCH; NUCLEAR ACCESS; IN-VIVO; B-CELLS; PRESENILIN	Notch is a transmembrane receptor that controls a diverse array of cellular processes including cell proliferation, differentiation, survival, and migration. The cellular outcome of Notch signaling is dependent on extracellular and intracellular signals, but the complexities of its regulation are not well understood. Canonical Notch signaling involves ligand association that triggers sequential and regulated proteolysis of Notch at several sites. Ligand-dependent proteolysis at the S2 site removes the bulk of the extracellular domain of Notch. Subsequent gamma-secretase-mediated intramembrane proteolysis of the remaining membrane-tethered Notch fragment at the S3 site produces a nuclear-destined Notch intracellular domain (NICD). Here we show that following gamma-secretase cleavage, Notch is proteolyzed at a novel S5 site. We have identified this S5 site to be eight amino acids downstream of the S3 site. Biochemical fractionation and purification resulted in the identification of the S5 site protease as the mitochondrial intermediate peptidase (MIPEP). Expression of the MIPEP-cleaved NICD (Delta NICD) results in a decrease in cell viability and mitochondria membrane potential. The sequential and regulated proteolysis by gamma-secretase and MIPEP suggests a new means by which Notch function can be modulated.	[Wang, Bing; Jiang, Jin] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Lee, Sheu-Fen; Srinivasan, Bhooma; Sephton, Chantelle F.; Dries, Daniel R.; Yu, Cong; Wang, Yun; Dewey, Colleen M.; Shah, Sanjiv; Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Shah, Sanjiv] Merck Res Labs, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Merck & Company	Jiang, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Jin.Jiang@UTSouthwestern.edu; Gang.Yu@UTSouthwestern.edu		DRIES, DANIEL/0000-0002-0530-5212	National Institutes of Health [F32AG031625, R01AG023104, R01AG029547, R01GM067045]; Ted Nash Long Life Foundation; Welch Foundation [I-1776, I-1603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067045, R01GM061269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029547, R01AG023104, F32AG031625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ted Nash Long Life Foundation; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F32AG031625 (to D. R. D.), R01AG023104 and R01AG029547 (to G. Y.), and R01GM067045 (to J. J.). This work was also supported by the Ted Nash Long Life Foundation and by Welch Foundation Grants I-1776 (to G. Y.) and I-1603 (to J. J.).	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barrick D, 2006, CELL, V124, P883, DOI 10.1016/j.cell.2006.02.028; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; DAUM G, 1982, J BIOL CHEM, V257, P3075; de la Pena P, 2001, NEUROLOGY, V57, P1235, DOI 10.1212/WNL.57.7.1235; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dotti MT, 2004, ARCH NEUROL-CHICAGO, V61, P942, DOI 10.1001/archneur.61.6.942; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jehn BM, 1999, J IMMUNOL, V162, P635; Lathion S, 2003, CANCER RES, V63, P8687; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Miller DT, 1998, DEVELOPMENT, V125, P2327; Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200; Mourikis P, 2006, P NATL ACAD SCI USA, V103, P1307, DOI 10.1073/pnas.0510564103; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pavlov PF, 2011, FASEB J, V25, P78, DOI 10.1096/fj.10-157230; Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Romer S, 2003, CELL DEATH DIFFER, V10, P833, DOI 10.1038/sj.cdd.4401253; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tammam J, 2009, BRIT J PHARMACOL, V158, P1183, DOI 10.1111/j.1476-5381.2009.00389.x; THORIG GEW, 1981, GENETICS, V99, P65; THORIG GEW, 1981, MOL GEN GENET, V182, P31, DOI 10.1007/BF00422763; Verheyen EM, 1996, GENETICS, V144, P1127; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	57	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27447	27453		10.1074/jbc.M111.243154	http://dx.doi.org/10.1074/jbc.M111.243154			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21685396	Green Published			2022-12-27	WOS:000293268700040
J	Zhaorigetu, S; Yang, ZQ; Toma, I; McCaffrey, TA; Hu, CAA				Zhaorigetu, Siqin; Yang, Zhaoqing; Toma, Ian; McCaffrey, Timothy A.; Hu, Chien-An A.			Apolipoprotein L6, Induced in Atherosclerotic Lesions, Promotes Apoptosis and Blocks Beclin 1-dependent Autophagy in Atherosclerotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; BCL-2 PROTEIN FAMILY; MAMMALIAN AUTOPHAGY; MEDIATED APOPTOSIS; CANCER-CELLS; X-L; DEATH; DEGRADATION; PROGRESSION; EXPRESSION	Inflammatory cytokine-regulated apoptosis and autophagy play pivotal roles in plaque rupture and thrombosis of atherosclerotic lesions. However, the molecular interplay between apoptosis and autophagy in vascular cells has not been investigated. Our prior study showed that human apolipoprotein L6 (ApoL6), a pro-apoptotic BH3-only member of the Bcl-2 family, was one of the downstream targets of interferon-gamma (INF gamma), which sensitizes atherosclerotic lesion-derived cells (LDCs) to Fas-induced apoptosis. To investigate whether ApoL6 plays a causal role in atherosclerotic apoptosis and autophagy, in this study, we demonstrate that IFN gamma treatment itself strongly induces ApoL6, and ApoL6 is highly expressed and partially co-localized with activated caspase 3 in activated smooth muscle cells in atherosclerotic lesions. In addition, overexpression of ApoL6 promotes reactive oxygen species (ROS) generation, caspase activation, and subsequent apoptosis, which can be blocked by pan caspase inhibitor and ROS scavenger. Knockdown of ApoL6 expression by siApoL6 suppresses INF gamma- and Fas-mediated apoptosis. Further, ApoL6 binds Bcl-X-L, one of the most abundant anti-death proteins in LDCs. Interestingly, forced ApoL6 expression in LDCs induces degradation of Beclin 1, accumulation of p62, and subsequent attenuation of LC3-II formation and translocation and thus autophagy, whereas siApoL6 treatment reverts the phenotype. Taken together, our results suggest that ApoL6 regulates both apoptosis and autophagy in SMCs. IFN gamma-initiated, ApoL6-induced apoptosis in vascular cells may be an important factor causing plaque instability and a potential therapeutic target for treating atherosclerosis and cardiovascular disease.	[Zhaorigetu, Siqin; Hu, Chien-An A.] Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, Albuquerque, NM 87131 USA; [Yang, Zhaoqing; Toma, Ian; McCaffrey, Timothy A.] George Washington Univ, Dept Med, Div Genom Med, Washington, DC 20037 USA; [Yang, Zhaoqing; Toma, Ian; McCaffrey, Timothy A.] George Washington Univ, Richard B & Lynne V Cheney Cardiovasc Inst, Washington, DC 20037 USA	University of New Mexico; George Washington University; George Washington University	Hu, CAA (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, MSC08 4670,1 Univ New Mexico, Albuquerque, NM 87131 USA.	AHu@salud.unm.edu	Toma, Ian/D-8833-2014	Toma, Ian/0000-0002-9637-5899	National Institutes of Health [3P20RR016480-04, AG12712]; NATIONAL CANCER INSTITUTE [R01CA106644] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012712, R01AG012712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 3P20RR016480-04 (to C. A. A. H.) and AG12712 (to T. A. M.).	Bauriedel G, 1999, CARDIOVASC RES, V41, P480, DOI 10.1016/S0008-6363(98)00318-6; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; Chan SW, 2000, CIRC RES, V86, P1038, DOI 10.1161/01.RES.86.10.1038; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Clarke M, 2006, AM J NEPHROL, V26, P531, DOI 10.1159/000097815; Clarke M, 2006, CELL CYCLE, V5, P2329, DOI 10.4161/cc.5.20.3383; Donald SP, 2001, CANCER RES, V61, P1810; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Du BH, 2000, J BIOL CHEM, V275, P39039, DOI 10.1074/jbc.M005159200; Gagarin D, 2005, J MOL CELL CARDIOL, V39, P453, DOI 10.1016/j.yjmcc.2005.01.015; Geng YH, 2002, ARTERIOSCL THROM VAS, V22, P1370, DOI 10.1161/01.ATV.0000031341.84618.A4; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hayakawa Y, 1999, ARTERIOSCL THROM VAS, V19, P2066, DOI 10.1161/01.ATV.19.9.2066; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Imanishi T, 2002, ATHEROSCLEROSIS, V161, P143, DOI 10.1016/S0021-9150(01)00631-1; Jia GH, 2007, AUTOPHAGY, V3, P63, DOI 10.4161/auto.3427; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kavurma MM, 2008, ARTERIOSCL THROM VAS, V28, P1694, DOI 10.1161/ATVBAHA.107.155143; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; KOLODGIE FD, 2001, CARDIOL CLIN, V19, P9; Kolodgie Frank D., 2001, Cardiology Clinics, V19, P127, DOI 10.1016/S0733-8651(05)70199-5; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kutuk O, 2006, APOPTOSIS, V11, P1661, DOI 10.1007/s10495-006-9402-7; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Liu ZH, 2005, MOL CANCER RES, V3, P21; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Niemann A, 2001, J HISTOCHEM CYTOCHEM, V49, P177, DOI 10.1177/002215540104900205; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Saxena A, 2002, J PATHOL, V196, P335, DOI 10.1002/path.1040; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yang ZQ, 2007, J VASC RES, V44, P483, DOI 10.1159/000106466; Yang ZQ, 2009, ARTERIOSCL THROM VAS, V29, P1213, DOI 10.1161/ATVBAHA.109.189407; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	56	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27389	27398		10.1074/jbc.M110.210245	http://dx.doi.org/10.1074/jbc.M110.210245			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646352	Green Published, hybrid			2022-12-27	WOS:000293268700034
J	Mushrush, DJ; Koteiche, HA; Sammons, MA; Link, AJ; Mchaourab, HS; Lacy, DB				Mushrush, Darren J.; Koteiche, Hanane A.; Sammons, Morgan A.; Link, Andrew J.; Mchaourab, Hassane S.; Lacy, D. Borden			Studies of the Mechanistic Details of the pH-dependent Association of Botulinum Neurotoxin with Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN T-DOMAIN; DIPHTHERIA-TOXIN; HEAVY-CHAIN; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; LIPID-BILAYERS; FORMS CHANNELS; ION CHANNELS; SIDE-CHAINS; LIGHT-CHAIN	Botulinum neurotoxin (BoNT) belongs to a large class of toxic proteins that act by enzymatically modifying cytosolic substrates within eukaryotic cells. The process by which a catalytic moiety is transferred across a membrane to enter the cytosol is not understood for any such toxin. BoNT is known to form pH-dependent pores important for the translocation of the catalytic domain into the cytosol. As a first step toward understanding this process, we investigated the mechanism by which the translocation domain of BoNT associates with a model liposome membrane. We report conditions that allow pH-dependent proteoliposome formation and identify a sequence at the translocation domain C terminus that is protected from proteolytic degradation in the context of the proteoliposome. Fluorescence quenching experiments suggest that residues within this sequence move to a hydrophobic environment upon association with liposomes. EPR analyses of spin-labeled mutants reveal major conformational changes in a distinct region of the structure upon association and indicate the formation of an oligomeric membrane-associated intermediate. Together, these data support a model of how BoNT orients with membranes in response to low pH.	[Mushrush, Darren J.; Link, Andrew J.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Koteiche, Hanane A.; Mchaourab, Hassane S.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Sammons, Morgan A.] Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37232 USA; [Sammons, Morgan A.] Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37232 USA; [Link, Andrew J.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Lacy, DB (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, A-5301 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	borden.lacy@vanderbilt.edu	Lacy, D. Borden/AFQ-2203-2022	Lacy, Borden/0000-0003-2273-8121	National Institutes of Health [AI075259, R21 AR055231, R01 GM64779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064779, T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI075259.; Supported by National Institutes of Health Grants R21 AR055231 and R01 GM64779.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; BLAUSTEIN RO, 1987, FEBS LETT, V226, P115, DOI 10.1016/0014-5793(87)80562-8; Borjesson SI, 2008, CELL BIOCHEM BIOPHYS, V52, P149, DOI 10.1007/s12013-008-9032-5; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; DONOVAN JJ, 1986, BIOCHEMISTRY-US, V25, P2872, DOI 10.1021/bi00358a020; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Fu FN, 2002, BIOPHYS CHEM, V99, P17, DOI 10.1016/S0301-4622(02)00135-7; Galloux M, 2008, J BIOL CHEM, V283, P27668, DOI 10.1074/jbc.M802557200; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; GIMENEZ DF, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P421; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lai B, 2010, J MEMBRANE BIOL, V236, P191, DOI 10.1007/s00232-010-9292-z; Link AJ, 2005, METHODS, V35, P274, DOI 10.1016/j.ymeth.2004.08.019; Masuyer G, 2009, BIOCHEM BIOPH RES CO, V381, P50, DOI 10.1016/j.bbrc.2009.02.003; McAfee KJ, 2006, MOL CELL PROTEOMICS, V5, P1497, DOI 10.1074/mcp.T500027-MCP200; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; OBLATTMONTAL M, 1995, PROTEIN SCI, V4, P1490, DOI 10.1002/pro.5560040806; Oh KJ, 1996, SCIENCE, V273, P810, DOI 10.1126/science.273.5276.810; Oh KJ, 2000, METH MOL B, V145, P147; Rosconi MP, 2002, J BIOL CHEM, V277, P16517, DOI 10.1074/jbc.M200442200; SCHIAVO G, 1994, ANN NY ACAD SCI, V710, P65, DOI 10.1111/j.1749-6632.1994.tb26614.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SHIN YK, 1993, SCIENCE, V259, P960, DOI 10.1126/science.8382373; SHONE CC, 1987, EUR J BIOCHEM, V167, P175, DOI 10.1111/j.1432-1033.1987.tb13320.x; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wang Y, 1997, J BIOL CHEM, V272, P25091, DOI 10.1074/jbc.272.40.25091	37	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27011	27018		10.1074/jbc.M111.256982	http://dx.doi.org/10.1074/jbc.M111.256982			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652698	Green Published, hybrid			2022-12-27	WOS:000293078200074
J	Reiss, K; Cornelsen, I; Husmann, M; Gimpl, G; Bhakdi, S				Reiss, Karina; Cornelsen, Isabell; Husmann, Matthias; Gimpl, Gerald; Bhakdi, Sucharit			Unsaturated Fatty Acids Drive Disintegrin and Metalloproteinase (ADAM)-dependent Cell Adhesion, Proliferation, and Migration by Modulating Membrane Fluidity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; L-SELECTIN; ADAM17; ALPHA; ACTIVATION; RECEPTOR; CADHERIN; SURFACE; ATHEROSCLEROSIS; PATHOGENESIS	The disintegrin-metalloproteinases ADAM10 and ADAM17 mediate the release of several cell signaling molecules and cell adhesion molecules such as vascular endothelial cadherin or L-selectin affecting endothelial permeability and leukocyte transmigration. Dysregulation of ADAM activity may contribute to the pathogenesis of vascular diseases, but the mechanisms underlying the control of ADAM functions are still incompletely understood. Atherosclerosis is characterized by lipid plaque formation and local accumulation of unsaturated free fatty acids (FFA). Here, we show that unsaturated FFA increase ADAM-mediated substrate cleavage. We demonstrate that these alterations are not due to genuine changes in enzyme activity, but correlate with changes in membrane fluidity as revealed by measurement of 1,6-diphenyl-1,3,5-hexatriene fluorescence anisotropy and fluorescence recovery after photobleaching analyses. ELISA and immunoblot experiments conducted with granulocytes, endothelial cells, and keratinocytes revealed rapid increase of ectodomain shedding of ADAM10 and ADAM17 substrates upon membrane fluidization. Large amounts of unsaturated FFA may be liberated from cholesteryl esters in LDL that is entrapped in atherosclerotic lesions. Incubation of cells with thus modified LDL resulted in rapid cleavage of ADAM substrates with corresponding functional consequences on cell proliferation, cell migration, and endothelial permeability, events of high significance in atherogenesis. We propose that FFA represent critical regulators of ADAM function that may assume relevance in many biological settings through their influence on mobility of enzyme and substrate in lipid bilayers.	[Reiss, Karina] Univ Kiel, Dept Dermatol, D-24098 Kiel, Germany; [Cornelsen, Isabell; Husmann, Matthias; Bhakdi, Sucharit] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Gimpl, Gerald] Johannes Gutenberg Univ Mainz, Dept Biochem, D-55128 Mainz, Germany	University of Kiel; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Reiss, K (corresponding author), Univ Kiel, Dept Dermatol, Olshaussenstr 40, D-24098 Kiel, Germany.	kreiss@dermatology.uni-kiel.de; sbhakdi@uni-mainz.de	Gimpl, Gerald/R-3722-2019; Reiss, Karina/B-3175-2010	Gimpl, Gerald/0000-0002-5703-1989	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 490]; Cluster of Excellence "Inflammation at Interfaces";  [CRC877]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; 	This work was supported by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich Grant 490 (to S. B. and M. H.), Grant CRC877 (to K. R.), and by the Cluster of Excellence "Inflammation at Interfaces" (to K. R.).	BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959; Bhakdi S, 2004, CIRCULATION, V109, P1870, DOI 10.1161/01.CIR.0000124228.08972.26; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Carrie I, 2009, CURR PHARM DESIGN, V15, P4173, DOI 10.2174/138161209789909764; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Gimpl G, 2000, EUR J BIOCHEM, V267, P2483, DOI 10.1046/j.1432-1327.2000.01280.x; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Leskovjan AC, 2010, ANAL CHEM, V82, P2711, DOI 10.1021/ac1002728; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; MERRILL AR, 1987, BIOCHIM BIOPHYS ACTA, V896, P89, DOI 10.1016/0005-2736(87)90359-2; Muller WE, 1998, AMYLOID, V5, P10, DOI 10.3109/13506129809007284; MULLER WE, 1995, BRAIN RES, V674, P133, DOI 10.1016/0006-8993(94)01463-R; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Nogueira AC, 2008, SHOCK, V29, P342, DOI 10.1097/SHK.0b013e31815abbc6; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Pucadyil TJ, 2004, BIOCHEMISTRY-US, V43, P15852, DOI 10.1021/bi0480887; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; SEIFERT PS, 1990, J EXP MED, V172, P547, DOI 10.1084/jem.172.2.547; Suriyaphol P, 2002, CIRCULATION, V106, P2581, DOI 10.1161/01.CIR.0000038366.11851.D0; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Valeva A, 2004, J BIOL CHEM, V279, P25143, DOI 10.1074/jbc.M313913200; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Yang XG, 2010, J LIPID RES, V51, P957, DOI 10.1194/jlr.M002287	41	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26931	26942		10.1074/jbc.M111.243485	http://dx.doi.org/10.1074/jbc.M111.243485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642425	Green Published, hybrid			2022-12-27	WOS:000293078200067
J	Baranova, NS; Nileback, E; Haller, FM; Briggs, DC; Svedhem, S; Day, AJ; Richter, RP				Baranova, Natalia S.; Nileback, Erik; Haller, F. Michael; Briggs, David C.; Svedhem, Sofia; Day, Anthony J.; Richter, Ralf P.			The Inflammation-associated Protein TSG-6 Cross-links Hyaluronan via Hyaluronan-induced TSG-6 Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; QUARTZ-CRYSTAL MICROBALANCE; FACTOR-STIMULATED GENE-6; EXTRACELLULAR-MATRIX; TRYPSIN INHIBITOR; RHEUMATOID-ARTHRITIS; BINDING-PROTEINS; SYNOVIAL-FLUID; OOCYTE COMPLEX; HEAVY-CHAINS	Tumor necrosis factor-stimulated gene-6 (TSG-6) is a hyaluronan (HA)-binding protein that plays important roles in inflammation and ovulation. TSG-6-mediated cross-linking of HA has been proposed as a functional mechanism (e. g. for regulating leukocyte adhesion), but direct evidence for cross-linking is lacking, and we know very little about its impact on HA ultrastructure. Here we used films of polymeric and oligomeric HA chains, end-grafted to a solid support, and a combination of surface-sensitive biophysical techniques to quantify the binding of TSG-6 into HA films and to correlate binding to morphological changes. We find that full-length TSG-6 binds with pronounced positive cooperativity and demonstrate that it can cross-link HA at physiologically relevant concentrations. Our data indicate that cooperative binding of full-length TSG-6 arises from HA-induced protein oligomerization and that the TSG-6 oligomers act as cross-linkers. In contrast, the HA-binding domain of TSG-6 (the Link module) alone binds without positive cooperativity and weaker than the full-length protein. Both the Link module and full-length TSG-6 condensed and rigidified HA films, and the degree of condensation scaled with the affinity between the TSG-6 constructs and HA. We propose that condensation is the result of protein-mediated HA cross-linking. Our findings firmly establish that TSG-6 is a potent HA cross-linking agent and might hence have important implications for the mechanistic understanding of the biological function of TSG-6 (e.g. in inflammation).	[Briggs, David C.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Baranova, Natalia S.; Day, Anthony J.; Richter, Ralf P.] CIC BiomaGUNE, Biosurfaces Unit, Donostia San Sebastian 20009, Spain; [Richter, Ralf P.] Max Planck Inst Met Res, D-70569 Stuttgart, Germany; [Nileback, Erik; Svedhem, Sofia] Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden; [Nileback, Erik] Q Sense, S-42677 Vastra Frolunda, Sweden; [Haller, F. Michael] Hyalose LLC, Oklahoma City, OK 73104 USA	University of Manchester; CIC biomaGUNE; Max Planck Society; Chalmers University of Technology	Day, AJ (corresponding author), CIC BiomaGUNE, Biosurfaces Unit, Paseo Miramon 182, Donostia San Sebastian 20009, Spain.	anthony.day@manchester.ac.uk; rrichter@cicbiomagune.es	Day, Anthony/O-1658-2015; Richter, Ralf Peter/B-3343-2013; Svedhem, Sofia/AAC-8727-2020; biomaGUNE, CIC/J-9136-2014	Day, Anthony/0000-0002-1415-3134; Richter, Ralf Peter/0000-0003-3071-2837; Briggs, David/0000-0002-9793-7339; biomaGUNE, CIC/0000-0001-7690-0660; Baranova, Natalia/0000-0002-3086-9124	German Federal Ministry of Education and Research (BMBF) [0315157]; Spanish Ministry of Science and Innovation (MICINN) [MAT2008-04192, RYC2009-04275]; Department of Industry of the Basque Government; Max-Planck-Society; Arthritis Research UK [16539, 18472]; Medical Research Council [G0701180]; MRC [G0701180] Funding Source: UKRI; Versus Arthritis [18472] Funding Source: researchfish	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Department of Industry of the Basque Government; Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	Supported by German Federal Ministry of Education and Research (BMBF) Grant 0315157, Spanish Ministry of Science and Innovation (MICINN) Grants MAT2008-04192 and RYC2009-04275), the Department of Industry of the Basque Government, and the Max-Planck-Society.; Supported by Arthritis Research UK Grants 16539 and 18472 and Medical Research Council Grant G0701180.	Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Blundell C. D., 2002, HYALURONAN, P161; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; CAMAIONI A, 1993, J BIOL CHEM, V268, P20473; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; Colby R.H., 2003, POLYM PHYS; Day A. J., 2004, HASYLAB DESY ANN REP; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501; Hook F., 2002, ENCY SURFACE COLLOID, P774; Jessen TE, 2004, OSTEOARTHR CARTILAGE, V12, P142, DOI 10.1016/j.joca.2003.10.004; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kuznetsova SA, 2005, J BIOL CHEM, V280, P30899, DOI 10.1074/jbc.M500701200; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Steinmetz NF, 2008, BIOMACROMOLECULES, V9, P456, DOI 10.1021/bm700797b; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tan KT, 2011, J EUR ACAD DERMATOL, V25, P317, DOI 10.1111/j.1468-3083.2010.03792.x; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200	70	105	112	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25675	25686		10.1074/jbc.M111.247395	http://dx.doi.org/10.1074/jbc.M111.247395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21596748	Green Published, hybrid			2022-12-27	WOS:000293073000029
J	Kleinau, G; Hoyer, I; Kreuchwig, A; Haas, AK; Rutz, C; Furkert, J; Worth, CL; Krause, G; Schulein, R				Kleinau, Gunnar; Hoyer, Inna; Kreuchwig, Annika; Haas, Ann-Karin; Rutz, Claudia; Furkert, Jens; Worth, Catherine L.; Krause, Gerd; Schuelein, Ralf			From Molecular Details of the Interplay between Transmembrane Helices of the Thyrotropin Receptor to General Aspects of Signal Transduction in Family A G-protein-coupled Receptors (GPCRs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN HORMONE-RECEPTORS; HYPERFUNCTIONING THYROID-NODULES; HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; TSH RECEPTOR; CONFORMATIONAL-CHANGES; SQUID RHODOPSIN; LIGAND-BINDING; ACTIVATION; MUTATIONS	Transmembrane helices (TMHs) 5 and 6 are known to be important for signal transduction by G-protein-coupled receptors (GPCRs). Our aim was to characterize the interface between TMH5 and TMH6 of the thyrotropin receptor (TSHR) to gain molecular insights into aspects of signal transduction and regulation. A proline at TMH5 position 5.50 is highly conserved in family A GPCRs and causes a twist in the helix structure. Mutation of the TSHR-specific alanine (Ala-593(5.50)) at this position to proline resulted in a 20-fold reduction of cell surface expression. This indicates that TMH5 in the TSHR might have a conformation different from most other family A GPCRs by forming a regular alpha-helix. Furthermore, linking our own and previous data from directed mutagenesis with structural information led to suggestions of distinct pairs of interacting residues between TMH5 and TMH6 that are responsible for stabilizing either the basal or the active state. Our insights suggest that the inactive state conformation is constrained by a core set of polar interactions among TMHs 2, 3, 6, and 7 and in contrast that the active state conformation is stabilized mainly by non-polar interactions between TMHs 5 and 6. Our findings might be relevant for all family A GPCRs as supported by a statistical analysis of residue properties between the TMHs of a vast number of GPCR sequences.	[Kleinau, Gunnar; Hoyer, Inna; Kreuchwig, Annika; Haas, Ann-Karin; Rutz, Claudia; Furkert, Jens; Krause, Gerd; Schuelein, Ralf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Worth, Catherine L.] Charite, Inst Physiol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Krause, G (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	GKrause@FMP-Berlin.de	Kleinau, Gunnar/GPX-6330-2022	Worth, Catherine/0000-0002-1796-9606	Deutsche Forschungsgemeinschaft [KR1273/4-1, KL2334/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants KR1273/4-1 and KL2334/2-1.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Biebermann H, 2010, FRONT BIOSCI-LANDMRK, V15, P913, DOI 10.2741/3654; Blois TM, 2009, PROTEIN SCI, V18, P1335, DOI 10.1002/pro.165; Castro I, 2009, THYROID, V19, P645, DOI 10.1089/thy.2009.0002; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Claeysen S, 2002, FEBS LETT, V517, P195, DOI 10.1016/S0014-5793(02)02620-0; Claus M, 2006, J MOL MED, V84, P943, DOI 10.1007/s00109-006-0087-8; Cordella A., 2007, ENDOCR ABSTR, V14; Deflorian F, 2008, PROTEINS, V71, P783, DOI 10.1002/prot.21763; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; Fricke-Otto S, 2005, EXP CLIN ENDOCR DIAB, V113, P582, DOI 10.1055/s-2005-865914; Gozu H, 2005, THYROID, V15, P389, DOI 10.1089/thy.2005.15.389; Gozu HI, 2006, EUR J ENDOCRINOL, V155, P535, DOI 10.1530/eje.1.02253; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; Hallmen C, 2006, J COMPUT AID MOL DES, V20, P673, DOI 10.1007/s10822-006-9088-5; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Karges B, 2005, J ENDOCRINOL, V186, P377, DOI 10.1677/joe.1.06208; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2010, FASEB J, V24, P2347, DOI 10.1096/fj.09-149146; Kleinau G, 2010, HUM MUTAT, V31, pE1519, DOI 10.1002/humu.21265; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kosugi S, 1996, BIOCHEM BIOPH RES CO, V222, P713, DOI 10.1006/bbrc.1996.0809; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lodowski DT, 2009, PHOTOCHEM PHOTOBIOL, V85, P425, DOI 10.1111/j.1751-1097.2008.00516.x; Mueller S, 2010, METHOD ENZYMOL, V485, P421, DOI [10.1016/S0076-6879(10)85023-2, 10.1016/B978-0-12-381296-4.00023-3]; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Neumann S, 2001, MOL ENDOCRINOL, V15, P1294, DOI 10.1210/me.15.8.1294; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Nygaard R, 2010, J BIOL CHEM, V285, P19625, DOI 10.1074/jbc.M110.106021; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Persani L, 2007, NAT CLIN PRACT ENDOC, V3, P180, DOI 10.1038/ncpendmet0401; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Rashid M, 2003, LIFE SCI, V73, P193, DOI 10.1016/S0024-3205(03)00227-3; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; RAYMOND JR, 1995, AM J PHYSIOL-RENAL, V269, pF141, DOI 10.1152/ajprenal.1995.269.2.F141; Ringkananont U, 2006, MOL ENDOCRINOL, V20, P893, DOI 10.1210/me.2005-0339; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheerer P, 2009, P NATL ACAD SCI USA, V106, P10660, DOI 10.1073/pnas.0900072106; Schertler GFX, 2008, NATURE, V453, P292, DOI 10.1038/453292a; Schoneberg T, 2002, REV PHYSIOL BIOCH P, V144, P143; Schulz A, 2000, J BIOL CHEM, V275, P37860, DOI 10.1074/jbc.M006709200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; SMITH BJ, 1993, APPL BIOCHEM BIOTECH, V41, P189, DOI 10.1007/BF02916422; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Sykiotis GP, 2003, BIOCHEM BIOPH RES CO, V301, P1051, DOI 10.1016/S0006-291X(03)00071-8; Tarnow P, 2008, OBESITY FACTS, V1, P155, DOI 10.1159/000138251; Tikhonova IG, 2008, J AM CHEM SOC, V130, P10141, DOI 10.1021/ja0765520; Tonacchera M, 1998, J CLIN ENDOCR METAB, V83, P492, DOI 10.1210/jc.83.2.492; Tsunekawa K, 2006, THYROID, V16, P471, DOI 10.1089/thy.2006.16.471; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	84	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25859	25871		10.1074/jbc.M110.196980	http://dx.doi.org/10.1074/jbc.M110.196980			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21586576	hybrid, Green Published			2022-12-27	WOS:000293073000047
J	Liu, R; Shi, Y; Yang, HJ; Wang, L; Zhang, S; Xia, YY; Wong, JLJ; Feng, ZW				Liu, Rui; Shi, Yu; Yang, Hai Jie; Wang, Lei; Zhang, Si; Xia, Yin Yan; Wong, Jing Lin Jack; Feng, Zhi Wei			Neural Cell Adhesion Molecule Potentiates the Growth of Murine Melanoma via beta-Catenin Signaling by Association with Fibroblast Growth Factor Receptor and Glycogen Synthase Kinase-3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVATION; TUMOR-GROWTH; PHOSPHATIDYLINOSITOL 3-KINASE; NEURITE OUTGROWTH; FGF-RECEPTOR; EXON 3; C-FOS; NCAM; EXPRESSION; WNT	The neural cell adhesion molecule (NCAM) was recently shown to be involved in the progression of various tumors with diverse effects. We previously demonstrated that NCAM potentiates the cellular invasion and metastasis of melanoma. Here we further report that the growth of melanoma is obviously retarded when the expression of NCAM is silenced. We found that the proliferation of murine B16F0 melanoma cells, their colony formation on soft agar, and growth of transplanted melanoma in vivo are clearly inhibited by the introduction of NCAM siRNA. Interestingly, change of NCAM expression level is shown to regulate the activity of Wnt signaling molecule, beta-catenin, markedly. This novel machinery requires the function of FGF receptor and glycogen synthase kinase-3 beta but is independent of the Wnt receptors, MAPK-Erk and PI3K/Akt pathways. In addition, NCAM is found to form a functional complex with beta-catenin, FGF receptor, and glycogen synthase kinase-3 beta. Moreover, up-regulation of NCAM140 and NCAM180 appears more potent than NCAM120 in activation of beta-catenin, suggesting that the intracellular domain of NCAM is required for facilitating the beta-catenin signaling. Furthermore, the melanoma cells also exhibit distinct differentiation phenotypes with the NCAM silencing. Our findings reveal a novel regulatory role of NCAM in the progression of melanoma that might serve as a new therapeutic target for the treatment of melanoma.	[Shi, Yu; Yang, Hai Jie; Wang, Lei; Zhang, Si; Xia, Yin Yan; Wong, Jing Lin Jack; Feng, Zhi Wei] Nanyang Technol Univ, Sch Biol Sci, Genom & Genet Div, Singapore 637551, Singapore; [Liu, Rui] Xi An Jiao Tong Univ, Sch Med, Xian 710061, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Xi'an Jiaotong University	Feng, ZW (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Genom & Genet Div, 60 Nanyang Dr, Singapore 637551, Singapore.	zwfeng@ntu.edu.sg	Liu, Rui/H-1813-2011					Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Balch CM, 2000, CANCER-AM CANCER SOC, V88, P1484, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Berezin V, 2010, ADV EXP MED BIOL, V663, P337, DOI 10.1007/978-1-4419-1170-4_21; Blaheta RA, 2002, CELL COMMUN ADHES, V9, P131, DOI 10.1080/15419060214520; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Chamberlain AJ, 2003, J AM ACAD DERMATOL, V48, P694, DOI 10.1067/mjd.2003.216; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Cohen C, 2002, CLIN CANCER RES, V8, P3728; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; DENTON KJ, 1992, J PATHOL, V167, P187, DOI 10.1002/path.1711670205; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Ditlevsen DK, 2003, J NEUROCHEM, V84, P546, DOI 10.1046/j.1471-4159.2003.01538.x; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Ely SA, 2002, AM J PATHOL, V160, P1293, DOI 10.1016/S0002-9440(10)62556-4; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Geertsen R, 1999, INT J CANCER, V83, P135, DOI 10.1002/(SICI)1097-0215(19990924)83:1<135::AID-IJC23>3.0.CO;2-2; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Huerta S, 2001, SURGERY, V130, P834, DOI 10.1067/msy.2001.116415; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jessen U, 2001, J NEUROCHEM, V79, P1149, DOI 10.1046/j.1471-4159.2001.00636.x; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Klehr M, 2009, J IMMUNOTHER, V32, P442, DOI 10.1097/CJI.0b013e31819f8b69; Kolkova K, 2005, J NEUROCHEM, V92, P886, DOI 10.1111/j.1471-4159.2004.02919.x; Kolkova K, 2000, J NEUROSCI, V20, P2238; Larue L, 2003, PIGM CELL RES, V16, P312, DOI 10.1034/j.1600-0749.2003.00050.x; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Li G, 2001, CANCER RES, V61, P3819; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lutz RJ, 2009, MABS-AUSTIN, V1, P548, DOI 10.4161/mabs.1.6.10029; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; Meier F, 2006, INT J CANCER, V119, P549, DOI 10.1002/ijc.21880; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Miyahara R, 2001, J SURG ONCOL, V77, P49, DOI 10.1002/jso.1065; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MOOY CM, 1995, HUM PATHOL, V26, P1185, DOI 10.1016/0046-8177(95)90191-4; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Pollock PM, 2002, MELANOMA RES, V12, P183, DOI 10.1097/00008390-200204000-00013; Reifenberger J, 2002, INT J CANCER, V100, P549, DOI 10.1002/ijc.10512; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Satyamoorthy K, 2003, CANCER RES, V63, P756; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; Shi Y, 2011, INT J BIOCHEM CELL B, V43, P682, DOI 10.1016/j.biocel.2011.01.016; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Takahashi Y, 2008, INT J CANCER, V123, P2315, DOI 10.1002/ijc.23812; Takahashi Y, 2006, J CONTROL RELEASE, V116, P90, DOI 10.1016/j.jconrel.2006.09.002; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Kilsdonk JWJ, 2008, CANCER RES, V68, P3671, DOI 10.1158/0008-5472.CAN-07-5767; VANWOERT MH, 1971, J INVEST DERMATOL, V56, P343, DOI 10.1111/1523-1747.ep12261194; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Xie SH, 1997, CANCER RES, V57, P2295; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474; Zecchini S, 2010, ADV EXP MED BIOL, V663, P319, DOI 10.1007/978-1-4419-1170-4_20; Zhang S, 2010, NEUROCHEM INT, V56, P919, DOI 10.1016/j.neuint.2010.03.023	85	13	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26127	26137		10.1074/jbc.M111.237297	http://dx.doi.org/10.1074/jbc.M111.237297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628472	Green Published, hybrid			2022-12-27	WOS:000293073000070
J	Lee, GH; Kim, DS; Kim, HT; Lee, JW; Chung, CH; Ahn, T; Lim, JM; Kim, IK; Chae, HJ; Kim, HR				Lee, Geum-Hwa; Kim, Do-Sung; Kim, Hyung-Tae; Lee, Jung-Wook; Chung, Chin-Ha; Ahn, Taeho; Lim, Jung Min; Kim, In-Ki; Chae, Han-Jung; Kim, Hyung-Ryong			Enhanced Lysosomal Activity Is Involved in Bax Inhibitor-1-induced Regulation of the Endoplasmic Reticulum (ER) Stress Response and Cell Death against ER Stress INVOLVEMENT OF VACUOLAR H+-ATPASE (V-ATPASE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; AUTOPHAGY; APOPTOSIS; PATHWAY; BRAIN; DEGRADATION; BI-1; PH; ACIDIFICATION; ARABIDOPSIS	Bax inhibitor-1 (BI-1) is an evolutionarily conserved protein that protects cells against endoplasmic reticulum (ER) stress while also affecting the ER stress response. In this study, we examined BI-1-induced regulation of the ER stress response as well as the control of the protein over cell death under ER stress. In BI-1-overexpressing cells (BI-1 cells), proteasome activity was similar to that of control cells; however, the lysosomal fraction of BI-1 cells showed sensitivity to degradation of BSA. In addition, areas and polygonal lengths of lysosomes were greater in BI-1 cells than in control cells, as assessed by fluorescence and electron microscopy. In BI-1 cells, lysosomal pH was lower than in control cells and lysosomal vacuolar H+-ATPase(V-ATPase), a proton pump, was activated, suggesting high H+ uptake into lysosomes. Even when exposed to ER stress, BI-1 cells maintained high levels of lysosomal activities, including V-ATPase activity. Bafilomycin, a V-ATPase inhibitor, leads to the reversal of BI-1-induced regulation of ER stress response and cell death due to ER stress. In BI-1 knock-out mouse embryo fibroblasts, lysosomal activity and number per cell were relatively lower than in BI-1 wild-type cells. This study suggests that highly maintained lysosomal activity may be one of the mechanisms by which BI-1 exerts its regulatory effects on the ER stress response and cell death.	[Lee, Geum-Hwa; Kim, Do-Sung; Chae, Han-Jung] Chonbuk Natl Univ, Dept Pharmacol, Sch Med, Jeonju 560180, Chonbuk, South Korea; [Lee, Geum-Hwa; Kim, Do-Sung; Chae, Han-Jung] Chonbuk Natl Univ, Cardiovasc Res Inst, Sch Med, Jeonju 560180, Chonbuk, South Korea; [Kim, Hyung-Tae; Lim, Jung Min] Chonbuk Natl Univ, Dept Anat, Sch Med, Jeonju 560180, Chonbuk, South Korea; [Lee, Jung-Wook; Chung, Chin-Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Ahn, Taeho] Chonnam Natl Univ, Coll Vet Med, Dept Biochem, Kwangju 500757, South Korea; [Kim, In-Ki] ASAN Inst Life Sci, Seoul 138736, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Wonkwang Dent Res Inst, Dept Dent Pharmacol, Iksan 570749, Chonbuk, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Seoul National University (SNU); Chonnam National University; Wonkwang University	Chae, HJ (corresponding author), Chonbuk Natl Univ, Dept Pharmacol, Sch Med, Jeonju 570749, Chonbuk, South Korea.	hjchae@chonbuk.ac.kr; hrkimdp@wonkwang.ac.kr		Chae, Han-Jung/0000-0003-4190-9889	Korea Science and Engineering Foundation (KOSEF) [R01-2007-000-20275-0]; Korean government [2010-0029497]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korean government(Korean Government)	This work was supported by Grant R01-2007-000-20275-0 from the Korea Science and Engineering Foundation (KOSEF). This work was also supported in part by a National Research Foundation of Korea grant funded by the Korean government (Grant 2010-0029497).	Ahn T, 2010, CELL CALCIUM, V47, P387, DOI 10.1016/j.ceca.2010.02.003; Arsham AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006068; Baek D, 2004, PLANT MOL BIOL, V56, P15, DOI 10.1007/s11103-004-3096-4; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Carnevalli LS, 2006, BIOCHEM J, V397, P187, DOI 10.1042/BJ20051643; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; CORAZZI L, 1991, J NEUROCHEM, V56, P207, DOI 10.1111/j.1471-4159.1991.tb02582.x; Cox BE, 2007, J LIPID RES, V48, P1012, DOI 10.1194/jlr.M600390-JLR200; Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200; Farina C, 2002, CURR PHARM DESIGN, V8, P2033, DOI 10.2174/1381612023393369; Foufelle F, 2007, M S-MED SCI, V23, P291, DOI 10.1051/medsci/2007233291; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Hamanaka R, 2008, BBA-MOL BASIS DIS, V1782, P408, DOI 10.1016/j.bbadis.2008.03.001; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Krajewska M, 2011, BRAIN RES, V1370, P227, DOI 10.1016/j.brainres.2010.11.015; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; Trivedi NS, 2000, PHOTOCHEM PHOTOBIOL, V71, P634, DOI 10.1562/0031-8655(2000)071<0634:QAOPLI>2.0.CO;2; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yoon J, 2010, MOL CELL BIOCHEM, V340, P175, DOI 10.1007/s11010-010-0415-8; Yoshida Y, 2010, BBA-GEN SUBJECTS, V1800, P172, DOI 10.1016/j.bbagen.2009.07.029; Youmans SJ, 2001, J EXP BIOL, V204, P2911	42	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24743	24753		10.1074/jbc.M110.167734	http://dx.doi.org/10.1074/jbc.M110.167734			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21586565	Green Published, hybrid			2022-12-27	WOS:000292547900025
J	Bernard, E; Rolain, T; Courtin, P; Guillot, A; Langella, P; Hols, P; Chapot-Chartier, MP				Bernard, Elvis; Rolain, Thomas; Courtin, Pascal; Guillot, Alain; Langella, Philippe; Hols, Pascal; Chapot-Chartier, Marie-Pierre			Characterization of O-Acetylation of N-Acetylglucosamine A NOVEL STRUCTURAL VARIATION OF BACTERIAL PEPTIDOGLYCAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOCOCCUS-LACTIS PEPTIDOGLYCAN; LACTOBACILLUS-PLANTARUM; ENTEROCOCCUS-FAECALIS; CELL-WALL; D-LACTATE; RESISTANCE; IDENTIFICATION; TRANSFORMATION; DEACETYLATION; BIOSYNTHESIS	Peptidoglycan (PG) N-acetyl muramic acid (MurNAc) O-acetylation is widely spread in Gram-positive bacteria and is generally associated with resistance against lysozyme and endogenous autolysins. We report here the presence of O-acetylation on N-acetylglucosamine (GlcNAc) in Lactobacillus plantarum PG. This modification of glycan strands was never described in bacteria. Fine structural characterization of acetylated muropeptides released from L. plantarum PG demonstrated that both MurNAc and GlcNAc are O-acetylated in this species. These two PG post-modifications rely on two dedicated O-acetyltransferase encoding genes, named oatA and oatB, respectively. By analyzing the resistance to cell wall hydrolysis of mutant strains, we showed that GlcNAc O-acetylation inhibits N-acetylglucosaminidase Acm2, the major L. plantarum autolysin. In this bacterial species, inactivation of oatA, encoding MurNAc O-acetyltransferase, resulted in marked sensitivity to lysozyme. Moreover, MurNAc over-O-acetylation was shown to activate autolysis through the putative N-acetylmuramoyl-L-alanine amidase LytH enzyme. Our data indicate that in L. plantarum, two different O-acetyltransferases play original and antagonistic roles in the modulation of the activity of endogenous autolysins.	[Bernard, Elvis; Courtin, Pascal; Guillot, Alain; Langella, Philippe; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Bernard, Elvis; Courtin, Pascal; Guillot, Alain; Langella, Philippe; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Bernard, Elvis; Rolain, Thomas; Hols, Pascal] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite Catholique Louvain	Chapot-Chartier, MP (corresponding author), INRA, Micalis UMR1319, F-78352 Jouy En Josas, France.	Marie-Pierre.Chapot@jouy.inra.fr	Langella, Philippe/N-8368-2017	Langella, Philippe/0000-0001-5960-4341; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	Institut National de la Recherche Agronomique (INRA); National Fund for Scientific Research; Universite catholique de Louvain (Fonds Speciaux de Recherche); Research Department of the Communaute Francaise de Belgique (Concerted Research Action); Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture;  [MEST-CT-2004-514428]	Institut National de la Recherche Agronomique (INRA); National Fund for Scientific Research; Universite catholique de Louvain (Fonds Speciaux de Recherche); Research Department of the Communaute Francaise de Belgique (Concerted Research Action); Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS); 	This work was supported by a Jeune Equipe grant from the Institut National de la Recherche Agronomique (INRA) (to M.-P. C.-C.) and the National Fund for Scientific Research, the Universite catholique de Louvain (Fonds Speciaux de Recherche), and the Research Department of the Communaute Francaise de Belgique (Concerted Research Action) (all to P. H.).; Recipient of a Marie Curie Fellowship for Early Stage Research Training of the FP6 LabHeath Project (MEST-CT-2004-514428).; Recipient of a doctoral fellowship from Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture.	Aukrust T W, 1995, Methods Mol Biol, V47, P201; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Chapot-Chartier MP, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P383, DOI 10.1007/978-3-642-05062-6_13; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; CORNETT JB, 1978, J BACTERIOL, V135, P153, DOI 10.1128/JB.135.1.153-160.1978; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Deghorain M, 2007, J BACTERIOL, V189, P4332, DOI 10.1128/JB.01829-06; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Emirian A, 2009, FEBS LETT, V583, P3033, DOI 10.1016/j.febslet.2009.08.010; Ferain T, 1996, J BACTERIOL, V178, P5431, DOI 10.1128/JB.178.18.5431-5437.1996; Goffin P, 2005, J BACTERIOL, V187, P6750, DOI 10.1128/JB.187.19.6750-6761.2005; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Huard C, 2003, MICROBIOL-SGM, V149, P695, DOI 10.1099/mic.0.25875-0; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Laaberki MH, 2011, J BIOL CHEM, V286, P5278, DOI 10.1074/jbc.M110.183236; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251	37	82	84	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23950	23958		10.1074/jbc.M111.241414	http://dx.doi.org/10.1074/jbc.M111.241414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21586574	hybrid, Green Published			2022-12-27	WOS:000292294900037
J	Imanishi, Y; Hu, B; Xiao, GT; Yao, XB; Cheng, SY				Imanishi, Yorihisa; Hu, Bo; Xiao, Gutian; Yao, Xuebiao; Cheng, Shi-Yuan			Angiopoietin-2, an Angiogenic Regulator, Promotes Initial Growth and Survival of Breast Cancer Metastases to the Lung through the Integrin-linked Kinase (ILK)-AKT-B Cell Lymphoma 2 (Bcl-2) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; ACTIVATION; AKT1; DISSEMINATION; SUPPRESSION; INHIBITION; EXPRESSION; INVASION; ROLES; ALPHA	The early onsets of breast cancer metastasis involve cell retention, survival, and resistant to apoptosis and subsequent growth at target vascular beds and tissues in distant organs. We previously reported that angiopoietin-2 (Ang2), an angiogenic regulator stimulates MCF-7 breast tumor metastasis from their orthotopic sites to distant organs through the alpha(5)beta(1) integrin/integrin-linked kinase (ILK)/Akt pathway. Here, by using an experimental tumor metastasis model and in vitro studies, we further dissect the underlying mechanism by which Ang2 promotes the initial growth and survival of MCF-7 breast cancer metastasis in the lung of animals. We show that Ang2 increases cell survival and suppresses cell apoptosis through ILK-induced phosphorylation of Akt1, Akt2, and up-regulation of Bcl-2 in breast cancer cells. Inhibition of ILK, Akt1, and Akt2, and their effector Bcl-2 diminishes Ang2-stimulated breast cancer cell survival and Ang2-attenuated apoptosis in vitro, and initial survival and growth of breast cancer metastasis in the lung of animals. Additionally, siRNA knockdown of endogenous Ang2 in three human metastatic breast cancer cell lines also inhibits phosphorylation of Akt, expression of Bcl-2, and tumor cell survival, migration, and increases cell apoptosis. Since increased expression of Ang2 correlates with elevated potential of human breast cancer metastasis in clinic, our data underscore the importance that up-regulated Ang2 not only stimulates breast cancer growth and metastasis at late stages of the process, but is also critical at the initiating stages of metastases onset, thereby suggesting Ang2 as a promising therapeutic target for treating patients with metastatic breast cancer.	[Imanishi, Yorihisa; Hu, Bo; Xiao, Gutian; Yao, Xuebiao; Cheng, Shi-Yuan] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA; [Imanishi, Yorihisa; Cheng, Shi-Yuan] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Hu, Bo] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Xiao, Gutian] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Imanishi, Yorihisa] Keio Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Anhui Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Keio University; Morehouse School of Medicine	Hu, B (corresponding author), Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA.	hub@upmc.edu; chengs@upmc.edu	Yao, Xuebiao/P-5771-2014; Imanishi, Yorihisa/AAL-3018-2021	Imanishi, Yorihisa/0000-0003-0047-7987	National Institutes of Health [CA130966, CA116616, CA132389]; Pennsylvania Dept. of Health and Innovative Research of Hillman Foundation; American Cancer Society [RSG-06-066-01-MGO]; Chinese Academy of Sciences [KSCX-YW-R65]; Chinese 973 Projects [2007CB914503, 2010CB912103]; NATIONAL CANCER INSTITUTE [R01CA116616, R01CA130966, P20CA132389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Dept. of Health and Innovative Research of Hillman Foundation; American Cancer Society(American Cancer Society); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese 973 Projects(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Grant CA130966 from the National Institutes of Health and the Pennsylvania Dept. of Health and Innovative Research Scholar Awards of the Hillman Foundation (to S. Y. C. and B. H.); National Institutes of Health CA116616, American Cancer Society RSG-06-066-01-MGO (to G. X.), and National Institutes of Health Grant CA132389; Chinese Academy of Sciences KSCX-YW-R65 and Chinese 973 Projects 2007CB914503 and 2010CB912103 (to X. Y.).	Arboleda MJ, 2003, CANCER RES, V63, P196; Arisan ED, 2010, BREAST CANCER RES TR, V119, P271, DOI 10.1007/s10549-009-0343-z; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Brown JL, 2010, MOL CANCER THER, V9, P145, DOI 10.1158/1535-7163.MCT-09-0554; Cascio S, 2008, ONCOGENE, V27, P540, DOI 10.1038/sj.onc.1210660; Chae SS, 2010, CLIN CANCER RES, V16, P3618, DOI 10.1158/1078-0432.CCR-09-3073; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Hu B, 2003, P NATL ACAD SCI USA, V100, P8904, DOI 10.1073/pnas.1533394100; Hu B, 2009, CURR ONCOL REP, V11, P111, DOI 10.1007/s11912-009-0017-3; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kirkegaard T, 2010, HISTOPATHOLOGY, V56, P203, DOI 10.1111/j.1365-2559.2009.03467.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nasarre P, 2009, CANCER RES, V69, P1324, DOI 10.1158/0008-5472.CAN-08-3030; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Niu GL, 2007, CANCER RES, V67, P1487, DOI 10.1158/0008-5472.CAN-06-3155; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Sun M, 2001, CANCER RES, V61, P5985; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Wang JH, 2008, CHEM MATER, V20, P20, DOI 10.1021/cm702375e; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670	37	30	33	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29249	29260		10.1074/jbc.M111.235689	http://dx.doi.org/10.1074/jbc.M111.235689			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21680733	Green Published, hybrid			2022-12-27	WOS:000293837000060
J	McFie, PJ; Banman, SL; Kary, S; Stone, SJ				McFie, Pamela J.; Banman, Shanna L.; Kary, Steven; Stone, Scot J.			Murine Diacylglycerol Acyltransferase-2 (DGAT2) Can Catalyze Triacylglycerol Synthesis and Promote Lipid Droplet Formation Independent of Its Localization to the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; HEPATITIS-C VIRUS; COA-MONOACYLGLYCEROL ACYLTRANSFERASE; MITOCHONDRIA-ASSOCIATED MEMBRANES; YEAST SACCHAROMYCES-CEREVISIAE; ACYL-COA; TRIGLYCERIDE SYNTHESIS; TRANSMEMBRANE DOMAIN; HYDROPHOBIC-DOMAIN; CORE PROTEIN	Triacylglycerol (TG) is the major form of stored energy in eukaryotic organisms and is synthesized by two distinct acylCoA: diacylglycerol acyltransferase (DGAT) enzymes, DGAT1 and DGAT2. Both DGAT enzymes reside in the endoplasmic reticulum (ER), but DGAT2 also co-localizes with mitochondria and lipid droplets. In this report, we demonstrate that murine DGAT2 is part of a multimeric complex consisting of several DGAT2 subunits. We also identified the region of DGAT2 responsible for its localization to the ER. ADGAT2 mutant lacking both its transmembrane domains, although still associated with membranes, was absent from the ER and instead localized to mitochondria. Unexpectedly, this mutant was still active and capable of interacting with lipid droplets to promote TG storage. Additional experiments indicated that the ER targeting signal was present in the first transmembrane domain (TMD1) of DGAT2. When fused to a fluorescent reporter, TMD1, but not TMD2, was sufficient to target mCherry to the ER. Finally, the interaction of DGAT2 with lipid droplets was dependent on the C terminus of DGAT2. DGAT2 mutants, in which regions of the C terminus were either truncated or specific regions were deleted, failed to co-localize with lipid droplets when cells were oleate loaded to stimulate TG synthesis. Our findings demonstrate that DGAT2 is capable of catalyzing TG synthesis and promote its storage in cytosolic lipid droplets independent of its localization in the ER.	[McFie, Pamela J.; Banman, Shanna L.; Kary, Steven; Stone, Scot J.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Stone, SJ (corresponding author), 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	scot.stone@usask.ca			Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health [FRN 88063]; University of Saskatchewan, Natural Sciences and Engineering Research Council of Canada	Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan, Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by a Heart and Stroke Foundation of Saskatchewan Grant-in-aid, Canadian Institutes of Health Research Regional Partnership Program Grant FRN 88063, and the University of Saskatchewan President's Natural Sciences and Engineering Research Council of Canada Fund.	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Caldas H, 2003, HUM MOL GENET, V12, P2981, DOI 10.1093/hmg/ddg321; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 2004, DEVELOPMENT, V131, P3047, DOI 10.1242/dev.01158; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; CUI Z, 1993, J BIOL CHEM, V268, P16655; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gidda SK, 2011, TRAFFIC, V12, P452, DOI 10.1111/j.1600-0854.2011.01160.x; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Honsho M, 1998, J BIOL CHEM, V273, P20860, DOI 10.1074/jbc.273.33.20860; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Horiguchi Y, 2008, ARCH BIOCHEM BIOPHYS, V479, P121, DOI 10.1016/j.abb.2008.08.020; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Mullner H, 2004, BBA-BIOMEMBRANES, V1663, P9, DOI 10.1016/S0005-2736(04)00079-3; Nakamura N, 2003, BIOCHEM BIOPH RES CO, V306, P333, DOI 10.1016/S0006-291X(03)00979-3; Ostermeyer AG, 2004, J CELL BIOL, V164, P69, DOI 10.1083/jcb.200303037; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; STEMBERGER BH, 1984, CELL TISSUE RES, V236, P471, DOI 10.1007/BF00214252; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wakimoto K, 2003, BIOCHEM BIOPH RES CO, V310, P296, DOI 10.1016/j.bbrc.2003.09.015; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700	68	107	112	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28235	28246		10.1074/jbc.M111.256008	http://dx.doi.org/10.1074/jbc.M111.256008			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680734	Green Published, hybrid			2022-12-27	WOS:000293557800041
J	Gehi, R; Shao, Q; Laird, DW				Gehi, Ruchi; Shao, Qing; Laird, Dale W.			Pathways Regulating the Trafficking and Turnover of Pannexin1 Protein and the Role of the C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP RELEASE; 1 CHANNELS; GAP; ACTIVATION; CLATHRIN; RECEPTOR; INTERNALIZATION; INFLAMMASOME; EXPRESSION; JUNCTIONS	Pannexin1 (Panx1) is an integral membrane protein comprised of three species as follows: an unglycosylated core-Gly0, a high mannose-Gly1, and a complex glycosylated Gly2 species. Although Panx1 channels mediate several cellular responses, the domain regulating its oligomerization and cell surface trafficking and the mechanisms governing its internalization and degradation have not been identified. This study characterizes the role of the Panx1 C-tail domain by truncating the polypeptide at residue 307 and expressing the mutant in BICR-M1R(k) and HEK-293T cells. Enzymatic digestion and immunolabeling assays revealed that the Panx1(T307)-RFP was glycosylated primarily to the high mannose species consistent with its retention in the endoplasmic reticulum. Co-expression of Panx1(T307)-RFP with Panx1 followed by co-immunoprecipitation assays revealed that the mutant and Panx1 could interact, whereas biotinylation assays showed that this interaction inhibited Panx1 from maturing into the Gly2 species and reaching the cell surface. Additional inhibitor studies indicated that the degradation of the mutant was via proteasomes, whereas Panx1 was degraded by lysosomes. Analysis of the pathways important in Panx1 internalization revealed partial co-distribution of Panx1 with many molecular constituents of the endocytic machinery that include clathrin, AP2, dynamin II, caveolin-1, and caveolin-2. However, co-immunoprecipitation assays together with the disruption of lipid rafts by methyl-beta-cyclodextrin suggest that Panx1 does not engage this endocytic machinery. Furthermore, dominant-negative and pharmacological studies revealed that Panx1 internalization was dynamin II-independent. Collectively, these results indicate that the oligomerization and trafficking of Panx1 are regulated by the C-terminal domain, whereas internalization of long lived Panx1 channels occurs in a manner that is distinct from classical endocytic pathways.	[Gehi, Ruchi; Shao, Qing; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Dent Sci Bldg, London, ON N6A 5C1, Canada.	Dale.Laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; 	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by a Canadian Institutes of Health Research operating grant (to D. W. L.) and an Natural Sciences and Engineering Research Council of Canada Studentship (to R. B.).	Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bunse S, 2010, J BIOL CHEM, V285, P38444, DOI 10.1074/jbc.M110.101014; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Darby PJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1226, DOI 10.1152/ajplung.2000.279.6.L1226; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gumpert AM, 2008, FEBS LETT, V582, P2887, DOI 10.1016/j.febslet.2008.07.024; HRESKO RC, 1994, J BIOL CHEM, V269, P32110; Jordan K, 2001, J CELL SCI, V114, P763; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Nickel BM, 2008, BIOCHEM BIOPH RES CO, V374, P679, DOI 10.1016/j.bbrc.2008.07.108; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Simek J, 2009, J CELL SCI, V122, P554, DOI 10.1242/jcs.036970; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Trouet D, 1999, J PHYSIOL-LONDON, V520, P113, DOI 10.1111/j.1469-7793.1999.t01-1-00113.x; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Yanez RA, 2010, CELL BIOCHEM FUNCT, V28, P66, DOI 10.1002/cbf.1622	40	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27639	27653		10.1074/jbc.M111.260711	http://dx.doi.org/10.1074/jbc.M111.260711			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659516	Green Published, hybrid			2022-12-27	WOS:000293268700057
J	Syed, S; Saez, L; Young, MW				Syed, Sheyum; Saez, Lino; Young, Michael W.			Kinetics of Doubletime Kinase-dependent Degradation of the Drosophila Period Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-TIME; NUCLEAR ENTRY; CLOCK GENE; SLIMB; PHOSPHORYLATION; MUTATIONS; ROLES	Robust circadian oscillations of the proteins PERIOD (PER) and TIMELESS (TIM) are hallmarks of a functional clock in the fruit fly Drosophila melanogaster. Early morning phosphorylation of PER by the kinase Doubletime (DBT) and subsequent PER turnover is an essential step in the functioning of the Drosophila circadian clock. Here using time-lapse fluorescence microscopy we study PER stability in the presence of DBT and its short, long, arrhythmic, and inactive mutants in S2 cells. We observe robust PER degradation in a DBT allele-specific manner. With the exception of doubletime-short (DBTS), all mutants produce differential PER degradation profiles that show direct correspondence with their respective Drosophila behavioral phenotypes. The kinetics of PER degradation with DBTS in cell culture resembles that with wild-type DBT and posits that, in flies DBTS likely does not modulate the clock by simply affecting PER degradation kinetics. For all the other tested DBT alleles, the study provides a simple model in which the changes in Drosophila behavioral rhythms can be explained solely by changes in the rate of PER degradation.	[Syed, Sheyum; Saez, Lino; Young, Michael W.] Rockefeller Univ, Genet Lab, New York, NY 10065 USA	Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, New York, NY 10065 USA.	young@mail.rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020		National Institutes of Health [GM054339, NS053087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054339, R01GM054339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM054339 and NS053087 (to M. W. Y.).	Bao S, 2001, J NEUROSCI, V21, P7117, DOI 10.1523/JNEUROSCI.21-18-07117.2001; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Landskron J, 2009, PLOS BIOL, V7, P820, DOI 10.1371/journal.pbio.1000003; Meyer P, 2006, SCIENCE, V311, P226, DOI 10.1126/science.1118126; Muskus MJ, 2007, MOL CELL BIOL, V27, P8049, DOI 10.1128/MCB.00680-07; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Saez L, 2007, COLD SPRING HARB SYM, V72, P69, DOI 10.1101/sqb.2007.72.034; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Sekine T, 2008, J BIOL RHYTHM, V23, P3, DOI 10.1177/0748730407311652; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Suri V, 2000, J NEUROSCI, V20, P7547; THUMMEL CS, 1991, DROSOPHILA INFORM NE, P71; Tyson JJ, 1999, BIOPHYS J, V77, P2411, DOI 10.1016/S0006-3495(99)77078-5; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08	27	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27654	27662		10.1074/jbc.M111.243618	http://dx.doi.org/10.1074/jbc.M111.243618			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659538	Green Published, hybrid			2022-12-27	WOS:000293268700058
J	Hamill, KJ; Hopkinson, SB; Jonkman, MF; Jones, JCR				Hamill, Kevin J.; Hopkinson, Susan B.; Jonkman, Marcel F.; Jones, Jonathan C. R.			Type XVII Collagen Regulates Lamellipod Stability, Cell Motility, and Signaling to Rac1 by Targeting Bullous Pemphigoid Antigen 1e to alpha 6 beta 4 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-4 INTEGRIN; ALPHA-3-BETA-1 INTEGRIN; MIGRATION; HEMIDESMOSOME; ADHESION; SUBUNIT; STABILIZATION; PROTEIN; BP180; COMPONENTS	Rac1 activity, polarity, lamellipodial dynamics, and directed motility are defective in keratinocytes exhibiting deficiency in beta 4 integrin or knockdown of the plakin protein Bullous Pemphigoid Antigen 1e (BPAG1e). The activity of Rac, formation of stable lamellipodia, and directed migration are restored in beta 4 integrin-deficient cells by inducing expression of a truncated form of beta 4 integrin, which lacks binding sites for BPAG1e and plectin. In these same cells, BPAG1e, the truncated beta 4 integrin, and type XVII collagen (Col XVII), a transmembrane BPAG1e-binding protein, but not plectin, colocalize along the substratum-attached surface. This finding suggested to us that Col XVII mediates the association of BPAG1e and alpha 6 beta 4 integrin containing the truncated beta 4 subunit and supports directed migration. To test these possibilities, we knocked down Col XVII expression in keratinocytes expressing both full-length and truncated beta 4 integrin proteins. Col XVII-knockdown keratinocytes exhibit a loss in BPAG1e-alpha 6 beta 4 integrin interaction, a reduction in lamellipodial stability, an impairment in directional motility, and a decrease in Rac1 activity. These defects are rescued by a mutant Col XVII protein truncated at its carboxyl terminus. In summary, our results suggest that in motile cells Col XVII recruits BPAG1e to alpha 6 beta 4 integrin and is necessary for activation of signaling pathways, motile behavior, and lamellipodial stability.	[Hamill, Kevin J.; Hopkinson, Susan B.; Jones, Jonathan C. R.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Jonkman, Marcel F.] Univ Groningen, Dept Dermatol, Univ Med Ctr Groningen, NL-9713 G2 Groningen, Netherlands	Northwestern University; Feinberg School of Medicine; University of Groningen	Jones, JCR (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Hamill, Kevin/F-8983-2012; Jones, Jonathan C R/T-9467-2017; Hamill, Kevin/ABF-9727-2020; Jonkman, Marcel F./H-4647-2011	Jones, Jonathan C R/0000-0002-1496-4922; Hamill, Kevin/0000-0002-7852-1944; 	National Institutes of Health [R01 AR054184]; Dermatology Foundation; Vlinderkind (the Butterfly Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Vlinderkind (the Butterfly Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR054184 (to J. C. R. J.). This work was also supported by a Dermatology Foundation research grant (to K. J. H.).; Supported by Vlinderkind (the Butterfly Foundation).	Chodniewicz D, 2004, EXP CELL RES, V301, P31, DOI 10.1016/j.yexcr.2004.08.006; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; GIPSON IK, 1993, EXP CELL RES, V207, P86, DOI 10.1006/excr.1993.1166; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Gonzales M, 1999, MOL BIOL CELL, V10, P259, DOI 10.1091/mbc.10.2.259; Gonzalez AM, 2001, J CELL SCI, V114, P4197; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Hamill KJ, 2009, MOL BIOL CELL, V20, P2954, DOI 10.1091/mbc.E09-01-0051; Harlow E., 1988, ANTIBODIES LAB MANUA; HASHIMOTO T, 1993, J INVEST DERMATOL, V100, P310, DOI 10.1111/1523-1747.ep12469916; Herold-Mende C, 2001, CELL TISSUE RES, V306, P399, DOI 10.1007/s004410100462; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Hopkinson SB, 1998, J INVEST DERMATOL, V111, P1015, DOI 10.1046/j.1523-1747.1998.00452.x; HOPKINSON SB, 1995, J CELL BIOL, V130, P117, DOI 10.1083/jcb.130.1.117; Hopkinson SB, 2000, MOL BIOL CELL, V11, P277, DOI 10.1091/mbc.11.1.277; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Jonkman MF, 2002, J INVEST DERMATOL, V119, P1275, DOI 10.1046/j.1523-1747.2002.19609.x; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; KLATTE DH, 1994, J INVEST DERMATOL, V102, P39, DOI 10.1111/1523-1747.ep12371728; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; LANGHOFER M, 1993, J CELL SCI, V105, P753; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Niessen CM, 1997, J CELL SCI, V110, P1705; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Parikka M, 2006, EXP CELL RES, V312, P1431, DOI 10.1016/j.yexcr.2006.01.015; Parikka M, 2003, J HISTOCHEM CYTOCHEM, V51, P921, DOI 10.1177/002215540305100707; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Qiao HJ, 2009, J INVEST DERMATOL, V129, P2288, DOI 10.1038/jid.2009.20; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; RIDDELLE KS, 1991, J CELL BIOL, V112, P159, DOI 10.1083/jcb.112.1.159; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Schlegel N, 2008, AM J PHYSIOL-CELL PH, V294, pC178, DOI 10.1152/ajpcell.00273.2007; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; Tsuruta D, 2003, CELL MOTIL CYTOSKEL, V54, P122, DOI 10.1002/cm.10089; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; Werner ME, 2007, J BIOL CHEM, V282, P5560, DOI 10.1074/jbc.M603669200; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	53	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26768	26780		10.1074/jbc.M110.203646	http://dx.doi.org/10.1074/jbc.M110.203646			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642434	Green Published, hybrid			2022-12-27	WOS:000293078200053
J	Hausmann, M; Leucht, K; Ploner, C; Kiessling, S; Villunger, A; Becker, H; Hofmann, C; Falk, W; Krebs, M; Kellermeier, S; Fried, M; Scholmerich, J; Obermeier, F; Rogler, G				Hausmann, Martin; Leucht, Katharina; Ploner, Christian; Kiessling, Stephan; Villunger, Andreas; Becker, Helen; Hofmann, Claudia; Falk, Werner; Krebs, Michaela; Kellermeier, Silvia; Fried, Michael; Schoelmerich, Juergen; Obermeier, Florian; Rogler, Gerhard			BCL-2 Modifying Factor (BMF) Is a Central Regulator of Anoikis in Human Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; DIFFERENTIAL EXPRESSION; IN-SITU; CASPASES; ACTIVATION; BIM; HOMEOSTASIS; CADHERINS; COLITIS; MUCOSA	BCL-2 modifying factor (BMF) is a sentinel considered to register damage at the cytoskeleton and to convey a death signal to B-cell lymphoma 2. B-cell lymphoma 2 is neutralized by BMF and thereby facilitates cytochrome C release from mitochondria. We investigated the role of BMF for intestinal epithelial cell (IEC) homeostasis. Acute colitis was induced in Bmf-deficient mice (Bmf(-/-)) with dextran sulfate sodium. Colonic crypt length in Bmf(-/-) mice was significantly increased as compared with WT mice. Dextran sulfate sodium induced less signs of colitis in Bmf(-/-) mice, as weight loss was reduced compared with the WT. Primary human IEC exhibited increased BMF in the extrusion zone. Quantitative PCR showed a significant up-regulation of BMF expression after initiation of anoikis in primary human IEC. BMF was found on mitochondria during anoikis, as demonstrated by Western blot analysis. RNAi mediated knockdown of BMF reduced the number of apoptotic cells and led to reduced caspase 3 activity. A significant increase in phospho-AKT was determined after RNAi treatment. BMF knockdown supports survival of IEC. BMF is induced in human IEC by the loss of cell attachment and is likely to play an important role in the regulation of IEC survival.	[Hausmann, Martin; Leucht, Katharina; Krebs, Michaela; Kellermeier, Silvia; Fried, Michael; Rogler, Gerhard] Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Ploner, Christian] Med Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria; [Kiessling, Stephan; Villunger, Andreas; Becker, Helen] Med Univ Innsbruck, Bioctr, Div Dev Immunol, A-6020 Innsbruck, Austria; [Hofmann, Claudia; Falk, Werner; Schoelmerich, Juergen; Obermeier, Florian] Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany	University of Zurich; University Zurich Hospital; Medical University of Innsbruck; Medical University of Innsbruck; University of Regensburg	Hausmann, M (corresponding author), Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Raemistr 100, CH-8091 Zurich, Switzerland.	martin.hausmann@usz.ch	Rogler, Gerhard/O-5308-2015	Rogler, Gerhard/0000-0002-1733-9188; Hausmann, Martin/0000-0002-0696-0251; Ploner, Christian/0000-0002-0313-2960	Swiss National Science Foundation (SNF) [SNF 31003A_ 127247, SNF 310030 120312]; Deutsche Forschungsgemeinschaft [RO 1236/13-1]; Bundesministerium fur Bildung und Forschung Kompetenznetz Chronisch Entzundliche Darmerkrankungen; Zurich Center for Integrative Human Physiology (ZIHP); Swiss Inflammatory Bowel Disease Cohort Study (SIBDC); Austrian Research Foundation [SFB-F021]; German Research Foundation [OB135/10-1]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung Kompetenznetz Chronisch Entzundliche Darmerkrankungen(Federal Ministry of Education & Research (BMBF)); Zurich Center for Integrative Human Physiology (ZIHP); Swiss Inflammatory Bowel Disease Cohort Study (SIBDC); Austrian Research Foundation(Austrian Science Fund (FWF)); German Research Foundation(German Research Foundation (DFG))	This study was supported by grants from the Swiss National Science Foundation (SNF 31003A_ 127247 (to M. H.) and SNF 310030 120312 (to G. R.)), by the Deutsche Forschungsgemeinschaft (RO 1236/13-1), and the Bundesministerium fur Bildung und Forschung Kompetenznetz Chronisch Entzundliche Darmerkrankungen. Support also received from the Zurich Center for Integrative Human Physiology (ZIHP, to M. H. and G. R.) and from the Swiss Inflammatory Bowel Disease Cohort Study (SIBDC, to G. R.).; Supported by grant SFB-F021 from the Austrian Research Foundation.; Supported by grant OB135/10-1 from the German Research Foundation.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; BEAULIEU JF, 1992, J CELL SCI, V102, P427; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Grespi F, 2010, CELL DEATH DIFFER, V17, P1672, DOI 10.1038/cdd.2010.97; Grossmann J, 2003, EUR J CELL BIOL, V82, P262, DOI 10.1078/0171-9335-00312; Grossmann J, 2002, AM J GASTROENTEROL, V97, P1421, DOI 10.1016/S0002-9270(02)04143-6; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; KORETZ K, 1991, AM J PATHOL, V138, P741; Kutuk O, 2010, CELL DEATH DIFFER, V17, P1624, DOI 10.1038/cdd.2010.41; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; MERRITT AJ, 1995, J CELL SCI, V108, P2261; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; POTTEN CS, 1977, J ULTRA MOL STRUCT R, V60, P272, DOI 10.1016/S0022-5320(77)80071-3; PROBSTMEIER R, 1990, DEVELOPMENT, V109, P313; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Riedl S, 1992, EXS, V61, P277; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; STRATER J, 1995, GUT, V37, P819, DOI 10.1136/gut.37.6.819; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Suzuki H. I., 2010, AUTOPHAGY IN PRESS; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Wick W, 1996, ONCOGENE, V12, P973; ZUTTER MM, 1990, AM J PATHOL, V137, P113	40	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26533	26540		10.1074/jbc.M111.265322	http://dx.doi.org/10.1074/jbc.M111.265322			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21673109	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000293078200032
J	Yamamoto, H; Kokame, K; Okuda, T; Nakajo, Y; Yanamoto, H; Miyata, T				Yamamoto, Hitomi; Kokame, Koichi; Okuda, Tomohiko; Nakajo, Yukako; Yanamoto, Hiroji; Miyata, Toshiyuki			NDRG4 Protein-deficient Mice Exhibit Spatial Learning Deficits and Vulnerabilities to Cerebral Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWNSTREAM REGULATED GENE-2; CENTRAL-NERVOUS-SYSTEM; QT INTERVAL DURATION; NEUROTROPHIC FACTOR; NDRG1-DEFICIENT MICE; COMMON VARIANTS; BRAIN; CELLS; EXPRESSION; RAT	The N-myc downstream-regulated gene (NDRG) family consists of four related proteins, NDRG1-NDRG4, in mammals. We previously generated NDRG1-deficient mice that were unable to maintain myelin sheaths in peripheral nerves. This condition was consistent with human hereditary motor and sensory neuropathy, Charcot-Marie-Tooth disease type 4D, caused by a nonsense mutation of NDRG1. In contrast, the effects of genetic defects of the other NDRG members remain unknown. In this study, we focused on NDRG4, which is specifically expressed in the brain and heart. In situ mRNA hybridization on the brain revealed that NDRG4 was expressed in neurons of various areas. We generated NDRG4-deficient mice that were born normally with the expected Mendelian frequency. Immunochemical analysis demonstrated that the cortex of the NDRG4-deficient mice contained decreased levels of brain-derived neurotrophic factor (BDNF) and normal levels of glial cell line-derived neurotrophic factor, NGF, neurotrophin-3, and TGF-beta 1. Consistent with BDNF reduction, NDRG4-deficient mice had impaired spatial learning and memory but normal motor function in the Morris water maze test. When temporary focal ischemia of the brain was induced, the sizes of the infarct lesions were larger, and the neurological deficits were more severe in NDRG4-deficient mice compared with the control mice. These findings indicate that NDRG4 contributes to the maintenance of intracerebral BDNF levels within the normal range, which is necessary for the preservation of spatial learning and the resistance to neuronal cell death caused by ischemic stress.	[Yamamoto, Hitomi; Kokame, Koichi; Okuda, Tomohiko; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Osaka 5658565, Japan; [Nakajo, Yukako; Yanamoto, Hiroji] Natl Cerebral & Cardiovasc Ctr, Lab Neurol & Neurosurg, Osaka 5658565, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Kokame, K (corresponding author), 5-7-1 Fujishirodai, Osaka 5658565, Japan.	kame@ri.ncvc.go.jp; hyanamot@res.ncvc.go.jp	yanamoto, hiroji/ABB-3923-2020; Yanamoto, Hiroji/ABF-7320-2020	Kokame, Koichi/0000-0002-9654-6299	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan; from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan.	Agarwala KL, 2000, BIOCHEM BIOPH RES CO, V272, P641, DOI 10.1006/bbrc.2000.2833; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Burchfield JG, 2004, J BIOL CHEM, V279, P18623, DOI 10.1074/jbc.M401504200; Choi SC, 2003, FEBS LETT, V553, P413, DOI 10.1016/S0014-5793(03)01030-5; Drogemuller C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011258; Dupays L, 2009, DEV BIOL, V333, P121, DOI 10.1016/j.ydbio.2009.06.025; Echaniz-Laguna A, 2007, NEUROMUSCULAR DISORD, V17, P163, DOI 10.1016/j.nmd.2006.10.002; Endres M, 2000, J CEREBR BLOOD F MET, V20, P139, DOI 10.1097/00004647-200001000-00018; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kitowska A, 2010, ACTA BIOCHIM POL, V57, P15; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kolarow R, 2007, J NEUROSCI, V27, P10350, DOI 10.1523/JNEUROSCI.0692-07.2007; Lin H, 2002, CIRCULATION, V105, P1962, DOI 10.1161/01.CIR.0000015365.49180.05; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nishimoto S, 2003, EUR J BIOCHEM, V270, P2521, DOI 10.1046/j.1432-1033.2003.03626.x; Ohki T, 2002, DEV BRAIN RES, V135, P55; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Santhanam AVR, 2010, STROKE, V41, P350, DOI 10.1161/STROKEAHA.109.564492; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schilling SH, 2009, J BIOL CHEM, V284, P25160, DOI 10.1074/jbc.M109.012484; Takagi T, 1998, DEVELOPMENT, V125, P21; Takahashi K, 2005, INT J NEUROPSYCHOPH, V8, P381, DOI 10.1017/S1461145705005134; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yamamoto H, 2003, EXP NEUROL, V182, P261, DOI 10.1016/S0014-4886(03)00116-X; Yanamoto H, 2004, BRAIN RES, V1019, P178, DOI 10.1016/j.brainres.2004.05.105; Yanamoto H, 2001, STROKE, V32, P232, DOI 10.1161/01.STR.32.1.232; Yanamoto H, 2000, BRAIN RES, V859, P240, DOI 10.1016/S0006-8993(00)01966-1; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	42	59	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26158	26165		10.1074/jbc.M111.256446	http://dx.doi.org/10.1074/jbc.M111.256446			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636852	Green Published, hybrid			2022-12-27	WOS:000293073000073
J	Albershardt, TC; Salerni, BL; Soderquist, RS; Bates, DJP; Pletnev, AA; Kisselev, AF; Eastman, A				Albershardt, Tina C.; Salerni, Bethany L.; Soderquist, Ryan S.; Bates, Darcy J. P.; Pletnev, Alexandre A.; Kisselev, Alexei F.; Eastman, Alan			Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; BCL-2 PROTEINS; CYTOCHROME-C; ER STRESS; APOPTOSIS; BAX; RESISTANCE; SENSITIVITY; INHIBITORS; RELEASE	BH3 mimetics are small molecules designed or discovered to mimic the binding of BH3-only proteins to the hydrophobic groove of antiapoptotic BCL2 proteins. The selectivity of these molecules for BCL2, BCL-XL, or MCL1 has been established in vitro; whether they inhibit these proteins in cells has not been rigorously investigated. In this study, we used a panel of leukemia cell lines to assess the ability of seven putative BH3 mimetics to inhibit antiapoptotic proteins in a cell-based system. We show that ABT-737 is the only BH3 mimetic that inhibits BCL2 as assessed by displacement of BAD and BIM from BCL2. The other six BH3 mimetics activate the endoplasmic reticulum stress response inducing ATF4, ATF3, and NOXA, which can then bind to and inhibit MCL1. In most cancer cells, inhibition of one antiapoptotic protein does not acutely induce apoptosis. However, by combining two BH3 mimetics, one that inhibits BCL2 and one that induces NOXA, apoptosis is induced within 6 h in a BAX/BAK-dependent manner. Because MCL1 is a major mechanism of resistance to ABT-737, these results suggest a novel strategy to overcome this resistance. Our findings highlight a novel signaling pathway through which many BH3 mimetics inhibit MCL1 and suggest the potential use of these agents as adjuvants in combination with various chemotherapy strategies.	[Eastman, Alan] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA; [Pletnev, Alexandre A.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Eastman, A (corresponding author), Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Rubin Bldg,Level 6, Lebanon, NH 03756 USA.	alan.r.eastman@dartmouth.edu			National Institutes of Health [CA50224, T32 09658]; Cancer Center [CA23108]; NATIONAL CANCER INSTITUTE [P30CA023108, T32CA009658, R01CA050224, R55CA050224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA50224 (to A. E.). This work was also supported by Cancer Center Support Grant CA23108 to the Norris Cotton Cancer Center and National Institutes of Health Training Grant T32 09658 (to B. L. S., R. S. S., and D. J. P. B.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Altun M, 2005, CANCER RES, V65, P7896, DOI 10.1158/0008-5472.CAN-05-0506; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Downward J, 1999, NAT CELL BIOL, V1, pE33, DOI 10.1038/10026; Ganju N, 2003, CELL DEATH DIFFER, V10, P652, DOI 10.1038/sj.cdd.4401234; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salerni BL, 2010, MOL CANCER THER, V9, P791, DOI 10.1158/1535-7163.MCT-10-0028; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Single B, 1998, CELL DEATH DIFFER, V5, P1001, DOI 10.1038/sj.cdd.4400462; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	38	88	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24882	24895		10.1074/jbc.M111.255828	http://dx.doi.org/10.1074/jbc.M111.255828			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21628457	Green Published, hybrid			2022-12-27	WOS:000292547900038
J	Henriques, ST; Huang, YH; Rosengren, KJ; Franquelim, HG; Carvalho, FA; Johnson, A; Sonza, S; Tachedjian, G; Castanho, MARB; Daly, NL; Craik, DJ				Henriques, Sonia Troeira; Huang, Yen-Hua; Rosengren, K. Johan; Franquelim, Henri G.; Carvalho, Filomena A.; Johnson, Adam; Sonza, Secondo; Tachedjian, Gilda; Castanho, Miguel A. R. B.; Daly, Norelle L.; Craik, David J.			Decoding the Membrane Activity of the Cyclotide Kalata B1 THE IMPORTANCE OF PHOSPHATIDYLETHANOLAMINE PHOSPHOLIPIDS AND LIPID ORGANIZATION ON HEMOLYTIC AND ANTI-HIV ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; CYCLIC-CYSTINE-KNOT; SURFACE-PLASMON RESONANCE; ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; SCANNING MUTAGENESIS; MACROCYCLIC PEPTIDES; MOLECULAR-MECHANISM; OLDENLANDIA-AFFINIS; BIOLOGICAL-ACTIVITY	Cyclotides, a large family of cyclic peptides from plants, have a broad range of biological activities, including insecticidal, cytotoxic, and anti-HIV activities. In all of these activities, cell membranes seem likely to be the primary target for cyclotides. However, the mechanistic role of lipid membranes in the activity of cyclotides remains unclear. To determine the role of lipid organization in the activity of the prototypic cyclotide, kalata B1 (kB1), and synthetic analogs, their bioactivities and affinities for model membranes were evaluated. We found that the bioactivity of kB1 is dependent on the lipid composition of target cell membranes. In particular, the activity of kB1 requires specific interactions with phospholipids containing phosphatidylethanolamine (PE) headgroups but is further modulated by nonspecific peptide-lipid hydrophobic interactions, which are favored in raft-like membranes. Negatively charged phospholipids do not favor high kB1 affinity. This lipid selectivity explains trends in antimicrobial and hemolytic activities of kB1; it does not target bacterial cell walls, which are negatively charged and lacking PE-phospholipids but can insert in the membranes of red blood cells, which have a low PE content and raft domains in their outer layer. We further show that the anti-HIV activity of kB1 is the result of its ability to target and disrupt the membranes of HIV particles, which are raft-like membranes very rich in PE-phospholipids.	[Henriques, Sonia Troeira; Huang, Yen-Hua; Rosengren, K. Johan; Daly, Norelle L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Henriques, Sonia Troeira; Franquelim, Henri G.; Carvalho, Filomena A.; Castanho, Miguel A. R. B.] Univ Lisbon, Sch Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Johnson, Adam; Sonza, Secondo; Tachedjian, Gilda] Burnet Inst, Ctr Virol, Melbourne, Vic 3004, Australia; [Sonza, Secondo; Tachedjian, Gilda] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Tachedjian, Gilda] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia	University of Queensland; Universidade de Lisboa; Burnet Institute; Monash University; Monash University		d.craik@imb.uq.edu.au	Huang, Yen-Hua/J-9056-2014; Craik, David/B-1695-2010; Tachedjian, Gilda/AAF-1327-2020; Rosengren, K. Johan/P-4450-2016; Henriques, Sonia Troeira/J-3500-2016; Carvalho, Filomena A./M-9202-2013; Daly, Norelle L/D-4302-2013; Franquelim, Henri/P-4985-2017	Huang, Yen-Hua/0000-0001-6937-2660; Craik, David/0000-0003-0007-6796; Tachedjian, Gilda/0000-0002-7733-7037; Rosengren, K. Johan/0000-0002-5007-8434; Henriques, Sonia Troeira/0000-0001-9564-9651; Carvalho, Filomena A./0000-0001-6088-3894; Daly, Norelle L/0000-0002-4697-6602; Franquelim, Henri/0000-0001-6229-4276; Castanho, Miguel/0000-0001-7891-7562; FCCN, Bogus/0000-0003-1034-3552; FCCN, Bogus/0000-0001-6282-8004	Australian Research Council [DP0880105]; European Community [PIOF-GA-2008-220318]; National Health and Medical Research Council; Fundacao para a Ciencia e Tecnologia [SFRH/BD/39039/2007]	Australian Research Council(Australian Research Council); European Community(European Commission); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was supported by Australian Research Council Grant DP0880105 and by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program (PIOF-GA-2008-220318).; A National Health and Medical Research Council Biomedical Career Development Award Fellow.; Recipient of a Fundacao para a Ciencia e Tecnologia scholarship (SFRH/BD/39039/2007).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ahn T, 2002, J BIOL CHEM, V277, P26157, DOI 10.1074/jbc.M203445200; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Bedoya VI, 2006, AIDS RES HUM RETROV, V22, P897, DOI 10.1089/aid.2006.22.897; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P171, DOI 10.1016/0005-2736(88)90192-7; CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P180, DOI 10.1016/0005-2736(88)90193-9; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; DALEKE DL, 1989, J CELL BIOL, V108, P1375, DOI 10.1083/jcb.108.4.1375; Daly NL, 2000, J BIOL CHEM, V275, P19068, DOI 10.1074/jbc.M000450200; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; FATTAL E, 1994, BIOCHEMISTRY-US, V33, P6721, DOI 10.1021/bi00187a044; Figueiredo A, 2006, PLOS PATHOG, V2, P1051, DOI 10.1371/journal.ppat.0020119; Fletcher PS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-46; Glukhov E, 2008, BIOPOLYMERS, V89, P360, DOI 10.1002/bip.20917; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2010, CHEMBIOCHEM, V11, P2148, DOI 10.1002/cbic.201000400; Henriques ST, 2010, BIOPOLYMERS, V94, P314, DOI 10.1002/bip.21367; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Henriques ST, 2004, BIOCHEMISTRY-US, V43, P9716, DOI 10.1021/bi036325k; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Kol MA, 2003, J BIOL CHEM, V278, P24586, DOI 10.1074/jbc.M301875200; LIN SS, 1994, BIOCHEMISTRY-US, V33, P7337, DOI 10.1021/bi00189a039; Lindholm P, 2002, MOL CANCER THER, V1, P365; Machaidze G, 2003, BIOCHEMISTRY-US, V42, P12570, DOI 10.1021/bi035225b; Makino A, 2003, J BIOL CHEM, V278, P3204, DOI 10.1074/jbc.M210347200; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; Nuttall J, 2010, DRUGS, V70, P1231, DOI 10.2165/10898650-000000000-00000; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Richer SM, 2008, BIOCHEMISTRY-US, V47, P13455, DOI 10.1021/bi801535f; Rusconi S, 2007, CURR TOP MED CHEM, V7, P1273; Schoepke T., 1993, SCI PHARM, V61, P145; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; YANAGIDA N, 1986, J BACTERIOL, V166, P937, DOI 10.1128/jb.166.3.937-944.1986; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	63	126	133	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24231	24241		10.1074/jbc.M111.253393	http://dx.doi.org/10.1074/jbc.M111.253393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576247	Green Published, hybrid			2022-12-27	WOS:000292294900065
J	Liu, JC; Lengner, CJ; Gaur, T; Lou, Y; Hussain, S; Jones, MD; Borodic, B; Colby, JL; Steinman, HA; van Wijnen, AJ; Stein, JL; Jones, SN; Stein, GS; Lian, JB				Liu, Julie C.; Lengner, Christopher J.; Gaur, Tripti; Lou, Yang; Hussain, Sadiq; Jones, Marci D.; Borodic, Brent; Colby, Jennifer L.; Steinman, Heather A.; van Wijnen, Andre J.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; Lian, Jane B.			Runx2 Protein Expression Utilizes the Runx2 P1 Promoter to Establish Osteoprogenitor Cell Number for Normal Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; GENE-EXPRESSION; SKELETAL DEVELOPMENT; CHONDROCYTE MATURATION; RUNX/CBFA/AML FACTORS; CBFA1-DEFICIENT MICE; COLLAGEN GENE; CBFA1; RUNX2/CBFA1	The Runt-related transcription factor, Runx2, is essential for osteogenesis and is controlled by both distal (P1) and proximal (P2) promoters. To understand Runx2 function requires determination of the spatiotemporal activity of P1 and P2 to Runx2 protein production. We generated a mouse model in which the P1-derived transcript was replaced with a lacZ reporter allele, resulting in loss of P1-derived protein while simultaneously allowing discrimination between the activities of the two promoters. Loss of P1-driven expression causes developmental defects with cleidocranial dysplasia-like syndromes that persist in the postnatal skeleton. P1 activity is robust in preosteogenic mesenchyme and at the onset of bone formation but decreases as bone matures. Homozygous Runx2-P1(lacZ/lacZ) mice have a normal life span but exhibit severe osteopenia and compromised bone repair in adult mice because of osteoblastic defects and not increased osteoclastic resorption. Gene expression profiles of bone, immunohistochemical studies, and ex vivo differentiation using calvarial osteoblasts and marrow stromal cells identified mechanisms for the skeletal phenotype. The findings indicate that P1 promoter activity is necessary for generating a threshold level of Runx2 protein to commit sufficient osteoprogenitor numbers for normal bone formation. P1 promoter function is not compensated via the P2 promoter. However, the P2 transcript with compensatory mechanisms from bone morphogenetic protein (BMP) and Wnt signaling is adequate for mineralization of the bone tissue that does form. We conclude that selective utilization of the P1 and P2 promoters enables the precise spatiotemporal expression of Runx2 necessary for normal skeletogenesis and the maintenance of bone mass in the adult.	[Liu, Julie C.; Lengner, Christopher J.; Gaur, Tripti; Lou, Yang; Hussain, Sadiq; Borodic, Brent; Colby, Jennifer L.; Steinman, Heather A.; van Wijnen, Andre J.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Liu, Julie C.; Lengner, Christopher J.; Gaur, Tripti; Lou, Yang; Hussain, Sadiq; Borodic, Brent; Colby, Jennifer L.; Steinman, Heather A.; van Wijnen, Andre J.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Jones, Marci D.] Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lian, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	jane.lian@umassmed.edu	Liu, Julie C/H-7496-2013; van Wijnen, Andre J./AAG-3578-2019	Liu, Julie C/0000-0003-0784-2529; van Wijnen, Andre J./0000-0002-4458-0946; Lengner, Christopher/0000-0002-0574-5189	National Institutes of Health [P01 AR048818, R01 AR039588, R37 DE012528, 1F32AR055030]; NIDDK [DK32520]; NATIONAL CANCER INSTITUTE [R01CA077735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR039588, F32AR055030, P01AR048818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01 AR048818 and R01 AR039588 (to G. S. S.), R37 DE012528 (to J. B. L.), and 1F32AR055030 (to J. C. L.).; We thank Douglas J. Adams at the University of Connecticut Health Center for initial microCT studies, Mary Mac-Dougall for helpful discussions, Dana Frederick for technical assistance, Judy Rask for manuscript preparation, and other members of our laboratory for helpful discussions. Core resources supported by National Institutes of Health Diabetes Endocrinology Research Center Grant DK32520 from the NIDDK were used.	Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; BECK KM, 1991, NUCLEIC ACIDS RES, V19, P4975, DOI 10.1093/nar/19.18.4975; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; FOCHT RJ, 1984, MOL CELL BIOL, V4, P1843, DOI 10.1128/MCB.4.9.1843; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Kitazawa R, 2008, J CELL BIOCHEM, V105, P1289, DOI 10.1002/jcb.21929; Kobayashi I, 2006, BONE, V38, P836, DOI 10.1016/j.bone.2005.10.026; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lengner CJ, 2002, MECH DEVELOP, V114, P167, DOI 10.1016/S0925-4773(02)00050-3; Levanon D, 2003, BLOOD CELL MOL DIS, V30, P161, DOI 10.1016/S1079-9796(03)00023-8; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Lian JB, 2003, J CELL PHYSIOL, V196, P301, DOI 10.1002/jcp.10316; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; LUFKIN T, 1992, NATURE, V359, P835, DOI 10.1038/359835a0; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Ng CEL, 2007, GENE, V399, P162, DOI 10.1016/j.gene.2007.05.014; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; Pratap J, 2003, CANCER RES, V63, P5357; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; Sudhakar S, 2001, BIOCHEM BIOPH RES CO, V289, P616, DOI 10.1006/bbrc.2001.6033; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Terkeltaub R, 1998, ARTHRITIS RHEUM-US, V41, P2152, DOI 10.1002/1529-0131(199812)41:12<2152::AID-ART10>3.3.CO;2-O; Terry A, 2004, GENE, V336, P115, DOI 10.1016/j.gene.2004.04.015; Thompson Z, 2002, J ORTHOPAED RES, V20, P1091, DOI 10.1016/S0736-0266(02)00017-7; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Yamashiro T, 2002, MECH DEVELOP, V119, pS107, DOI 10.1016/S0925-4773(03)00101-1; Zaidi SK, 2010, MOL CELL BIOL, V30, P4758, DOI 10.1128/MCB.00646-10; Zelzer E, 2005, CURR TOP DEV BIOL, V65, P169; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]	52	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30057	30070		10.1074/jbc.M111.241505	http://dx.doi.org/10.1074/jbc.M111.241505			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21676869	Green Published, hybrid			2022-12-27	WOS:000294046600064
J	Calvo, E; Mizurini, DM; Sa-Nunes, A; Ribeiro, JMC; Andersen, JF; Mans, BJ; Monteiro, RQ; Kotsyfakis, M; Francischetti, IMB				Calvo, Eric; Mizurini, Daniella M.; Sa-Nunes, Anderson; Ribeiro, Jose M. C.; Andersen, John F.; Mans, Ben J.; Monteiro, Robson Q.; Kotsyfakis, Michail; Francischetti, Ivo M. B.			Alboserpin, a Factor Xa Inhibitor from the Mosquito Vector of Yellow Fever, Binds Heparin and Membrane Phospholipids and Exhibits Antithrombotic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C; OXIDIZED PHOSPHOLIPIDS; ARTHROPOD SALIVA; HIGH-AFFINITY; TICK; PHOSPHATIDYLETHANOLAMINE; ANTICOAGULANT; MECHANISM; THROMBIN; EXOSITE	The molecular mechanism of factor Xa (FXa) inhibition by Alboserpin, the major salivary gland anticoagulant from the mosquito and yellow fever vector Aedes albopictus, has been characterized. cDNA of Alboserpin predicts a 45-kDa protein that belongs to the serpin family of protease inhibitors. Recombinant Alboserpin displays stoichiometric, competitive, reversible and tight binding to FXa (picomolar range). Binding is highly specific and is not detectable for FX, catalytic site-blocked FXa, thrombin, and 12 other enzymes. Alboserpin displays high affinity binding to heparin (K-D similar to 20 nM), but no change in FXa inhibition was observed in the presence of the cofactor, implying that bridging mechanisms did not take place. Notably, Alboserpin was also found to interact with phosphatidylcholine and phosphatidylethanolamine but not with phosphatidylserine. Further, annexin V (in the absence of Ca2+) or heparin outcompetes Alboserpin for binding to phospholipid vesicles, suggesting a common binding site. Consistent with its activity, Alboserpin blocks prothrombinase activity and increases both prothrombin time and activated partial thromboplastin time in vitro or ex vivo. Furthermore, Alboserpin prevents thrombus formation provoked by ferric chloride injury of the carotid artery and increases bleeding in a dose-dependent manner. Alboserpin emerges as an atypical serpin that targets FXa and displays unique phospholipid specificity. It conceivably uses heparin and phosphatidylcholine/phosphatidylethanolamine as anchors to increase protein localization and effective concentration at sites of injury, cell activation, or inflammation.	[Calvo, Eric; Sa-Nunes, Anderson; Ribeiro, Jose M. C.; Andersen, John F.; Mans, Ben J.; Kotsyfakis, Michail; Francischetti, Ivo M. B.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Bethesda, MD 20852 USA; [Mizurini, Daniella M.; Monteiro, Robson Q.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941 Rio De Janeiro, Brazil; [Sa-Nunes, Anderson] Univ Sao Paulo, Expt Immunol Lab, Dept Immunol, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil; [Mans, Ben J.] Onderstepoort Vet Inst, Agr Res Council, ZA-0110 Onderstepoort, South Africa; [Kotsyfakis, Michail] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Lab Genom & Prote Dis Vectors, Ceske Budejovice 37009, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Francischetti, IMB (corresponding author), NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, 12735 Twinbrook Pkwy,Rm 2E-28, Bethesda, MD 20852 USA.	ifrancischetti@niaid.nih.gov	Sa-Nunes, Anderson/M-5654-2019; de Queiroz Monteiro, Robson/M-7097-2019; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Mans, Ben J./M-2427-2017; Calvo, Eric/ABB-4935-2021; Kotsyfakis, Michail/G-9525-2014; Monteiro, Robson/GRX-0672-2022; Sa-Nunes, Anderson/D-8667-2012	Sa-Nunes, Anderson/0000-0002-1859-4973; Mans, Ben J./0000-0002-0177-0029; Calvo, Eric/0000-0001-7880-2730; Kotsyfakis, Michail/0000-0002-7526-1876; Monteiro, Robson/0000-0002-5260-2332; Sa-Nunes, Anderson/0000-0002-1859-4973; Ribeiro, Jose/0000-0002-9107-0818	Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the Division of Intramural Research, NIAID, National Institutes of Health.	Andersen JF, 2004, BIOCHEMISTRY-US, V43, P6987, DOI 10.1021/bi049655t; Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bouton MC, 2007, CIRC RES, V100, P1174, DOI 10.1161/01.RES.0000265066.92923.ee; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Calvo E, 2010, FEBS J, V277, P413, DOI 10.1111/j.1742-4658.2009.07494.x; CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138; Dai JF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001205; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; GEBBINK RK, 1993, BIOCHEMISTRY-US, V32, P1675, DOI 10.1021/bi00057a035; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILBERT GE, 1995, J BIOL CHEM, V270, P18500, DOI 10.1074/jbc.270.31.18500; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huntington J, 2009, CELL MOL LIFE SCI, V66, P113, DOI 10.1007/s00018-008-8371-0; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kenneth KR, 1998, J BIOL CHEM, V273, P20802, DOI 10.1074/jbc.273.33.20802; Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221; Kotsyfakis M, 2007, J BIOL CHEM, V282, P29256, DOI 10.1074/jbc.M703143200; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LAVOIPIERRE M. M. J., 1959, ANN TROP MED AND PARASITOL, V53, P235; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Levy JH, 2010, ANESTHESIOLOGY, V113, P726, DOI 10.1097/ALN.0b013e3181ebdb15; Maffey KG, 2001, ANN CLIN LAB SCI, V31, P85; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Medcalf RL, 2005, FEBS J, V272, P4841, DOI 10.1111/j.1742-4658.2005.04904.x; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Nishioka J, 1998, J BIOL CHEM, V273, P11281, DOI 10.1074/jbc.273.18.11281; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Rezaie AR, 2010, CURR MED CHEM, V17, P2059, DOI 10.2174/092986710791233706; Rezaie AR, 2000, TRENDS CARDIOVAS MED, V10, P333, DOI 10.1016/S1050-1738(01)00070-6; RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rubin H, 1996, NAT MED, V2, P632, DOI 10.1038/nm0696-632; Ruf W, 2004, CRIT CARE MED, V32, pS287, DOI 10.1097/01.CCM.0000126364.46191.12; Sa-Nunes A, 2007, J IMMUNOL, V179, P1497, DOI 10.4049/jimmunol.179.3.1497; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Stassen JM, 2004, CURR MED CHEM, V11, P2245, DOI 10.2174/0929867043364603; Thorpe PE, 2010, THROMB RES, V125, pS134, DOI 10.1016/S0049-3848(10)70031-1; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Tollefsen DM, 2010, PROG MOL BIOL TRANSL, V93, P351, DOI 10.1016/S1877-1173(10)93015-9; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; WESSELSCHMIDT R, 1993, BLOOD COAGUL FIBRIN, V4, P661, DOI 10.1097/00001721-199304050-00001; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Williams J W, 1979, Methods Enzymol, V63, P437	60	37	43	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27998	28010		10.1074/jbc.M111.247924	http://dx.doi.org/10.1074/jbc.M111.247924			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673107	Green Published, hybrid			2022-12-27	WOS:000293557800018
J	Li, X; Yeung, DF; Fiegen, AM; Sodroski, J				Li, Xing; Yeung, Darwin F.; Fiegen, Ann M.; Sodroski, Joseph			Determinants of the Higher Order Association of the Restriction Factor TRIM5 beta and Other Tripartite Motif (TRIM) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-BOX 2; RETROVIRAL RESTRICTION; TRIM5-ALPHA PROTEIN; RHESUS TRIM5-ALPHA; B30.2(SPRY) DOMAIN; MONKEY TRIM5-ALPHA; CYTOPLASMIC BODIES; HIV-1 INFECTION; CAPSID BINDING	Many tripartite motif (TRIM) proteins self-associate, forming dimers and higher order complexes. For example, dimers of TRIM5 alpha, a host factor that restricts retrovirus infection, assemble into higher order arrays on the surface of the viral capsid, resulting in an increase in avidity. Here we show that the higher order association of different TRIM proteins exhibits a wide range of efficiencies. Homologous association (self-association) was more efficient than the heterologous association of different TRIM proteins, indicating that specificity determinants of higher order self-association exist. To investigate the structural determinants of higher order self-association, we studied TRIM mutants and chimeras. These studies revealed the following: 1) the RING domain contributes to the efficiency of higher order self-association, which enhances the binding of TRIM5 alpha to the human immunodeficiency virus (HIV-1) capsid; 2) the RING and B-box 2 domains work together as a homologous unit to promote higher order association of dimers; 3) dimerization is probably required for efficient higher order self-association; 4) the Linker 2 region contributes to higher order self-association, independently of effects of Linker 2 changes on TRIM dimerization; and 5) for efficiently self-associating TRIM proteins, the B30.2(SPRY) domain is not required for higher order self-association. These results support a model in which both ends of the core TRIM dimer (RING-B-box 2 at one end and Linker 2 at the other) contribute to the formation of higher order arrays.	[Li, Xing; Yeung, Darwin F.; Fiegen, Ann M.; Sodroski, Joseph] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Sodroski, J (corresponding author), Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Canc Immunol & AIDS, 450 Brookline Ave,CLS 1010, Boston, MA 02215 USA.	joseph_sodroski@dfci.harvard.edu		Durbin, Ann/0000-0002-7348-5243	National Institutes of Health [AI063987, AI076094]; Center for AIDS Research [AI06354]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063987, R21AI076094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063987 and AI076094 and Center for AIDS Research Award AI06354. This work was also supported by the International AIDS Vaccine Initiative and the late William F. McCarty-Cooper.	Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hennig J, 2005, J BIOL CHEM, V280, P33250, DOI 10.1074/jbc.M503066200; Hennig J, 2008, J MOL BIOL, V377, P431, DOI 10.1016/j.jmb.2008.01.005; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Kar AK, 2008, J VIROL, V82, P11669, DOI 10.1128/JVI.01559-08; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Li X, 2007, VIROLOGY, V366, P234, DOI 10.1016/j.virol.2007.04.022; Li X, 2007, VIROLOGY, V360, P419, DOI 10.1016/j.virol.2006.10.035; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Maillard PV, 2007, PLOS PATHOG, V3, P2052, DOI 10.1371/journal.ppat.0030200; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mische CC, 2005, J VIROL, V79, P14446, DOI 10.1128/JVI.79.22.14446-14450.2005; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ottosson L, 2006, MOL IMMUNOL, V43, P588, DOI 10.1016/j.molimm.2005.04.013; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Sastri J, 2010, VIROLOGY, V405, P259, DOI 10.1016/j.virol.2010.06.015; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sebastian S, 2009, J VIROL, V83, P3365, DOI 10.1128/JVI.00432-08; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yap MW, 2007, VIROLOGY, V365, P302, DOI 10.1016/j.virol.2007.04.005; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; YEE JK, 1994, METHOD CELL BIOL, V43, P99	46	45	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27959	27970		10.1074/jbc.M111.260406	http://dx.doi.org/10.1074/jbc.M111.260406			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680743	hybrid, Green Published			2022-12-27	WOS:000293557800014
J	Burg, JS; Espenshade, PJ				Burg, John S.; Espenshade, Peter J.			Glucose Controls Phosphoregulation of Hydroxymethylglutaryl Coenzyme A Reductase through the Protein Phosphatase 2A-related Phosphatase Protein, Ppe1, and Insig in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; SCHIZOSACCHAROMYCES-POMBE; CHOLESTEROL-SYNTHESIS; CELLULAR-ENERGY; CBS DOMAINS; KINASE; SENSOR; PHOSPHORYLATION; STEROLS; PATHWAY	HMG-CoA reductase (HMGR) catalyzes a rate-limiting step in sterol biosynthesis and is a key control point in the feedback inhibition that regulates this pathway. Through the action of the membrane protein Insig, HMGR synthesis and degradation are regulated to maintain sterol homeostasis. The fission yeast Schizosaccharomyces pombe encodes homologs of HMGR and Insig called hmg1(+) and ins1(+), respectively. In contrast to the mammalian system, Ins1 regulates Hmg1 by a nondegradative mechanism involving phosphorylation of the Hmg1 active site. Here, we investigate the role of the Ins1-Hmg1 system in coupling glucose sensing to regulation of sterol biosynthesis. We show that Ins1-dependent Hmg1 phosphorylation is strongly induced in response to glucose withdrawal and that HMGR activity is correspondingly reduced. We also find that inability to activate Hmg1 phosphorylation under nutrient limiting conditions results in overaccumulation of sterol pathway intermediates. Furthermore, we show that regulation of Hmg1 phosphorylation requires the protein phosphatase 2A-related phosphatase Ppe1 and its regulator Sds23. These results describe a mechanism by which cells tune the rate of sterol synthesis to match nutrient availability.	[Burg, John S.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu			National Institutes of Health [HL-077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-077588.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hughes AL, 2007, J BIOL CHEM, V282, P24388, DOI 10.1074/jbc.M701326200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P275, DOI 10.1111/j.1432-1033.1983.tb07359.x; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Matsuzawa T, 2011, J BIOSCI BIOENG, V111, P158, DOI 10.1016/j.jbiosc.2010.10.007; MITCHISON JM, 1969, J CELL SCI, V5, P373; MORENO S, 1985, ARCH MICROBIOL, V142, P370, DOI 10.1007/BF00491906; OMKUMAR RV, 1994, J BIOL CHEM, V269, P6810; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SHIMANUKI M, 1993, MOL BIOL CELL, V4, P303, DOI 10.1091/mbc.4.3.303; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	29	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27139	27146		10.1074/jbc.M111.233452	http://dx.doi.org/10.1074/jbc.M111.233452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21680738	Green Published, hybrid			2022-12-27	WOS:000293268700009
J	Kotake, T; Hirata, N; Degi, Y; Ishiguro, M; Kitazawa, K; Takata, R; Ichinose, H; Kaneko, S; Igarashi, K; Samejima, M; Tsumuraya, Y				Kotake, Toshihisa; Hirata, Naohiro; Degi, Yuta; Ishiguro, Maki; Kitazawa, Kiminari; Takata, Ryohei; Ichinose, Hitomi; Kaneko, Satoshi; Igarashi, Kiyohiko; Samejima, Masahiro; Tsumuraya, Yoichi			Endo-beta-1,3-galactanase from Winter Mushroom Flammulina velutipes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSIDE HYDROLASE FAMILY-16; ACID-SEQUENCE SIMILARITIES; ARABINOGALACTAN-PROTEINS; PHANEROCHAETE-CHRYSOSPORIUM; CELL EXPANSION; TRICHODERMA-VIRIDE; KAPPA-CARRAGEENASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; YARIV REAGENT	Arabinogalactan proteins are proteoglycans found on the cell surface and in the cell walls of higher plants. The carbohydrate moieties of most arabinogalactan proteins are composed of beta-1,3-galactan main chains and beta-1,6-galactan side chains, to which other auxiliary sugars are attached. For the present study, an endo-beta-1,3-galactanase, designated FvEn3GAL, was first purified and cloned from winter mushroom Flammulina velutipes. The enzyme specifically hydrolyzed beta-1,3-galactan, but didnot act on beta-1,3-glucan, beta-1,3: 1,4-glucan, xyloglucan, and agarose. It released various beta-1,3-galactooligosaccharides together with Gal from beta-1,3-galactohexaose in the early phase of the reaction, demonstrating that it acts on beta-1,3-galactan in an endo-fashion. Phylogenetic analysis revealed that FvEn3GAL is member of a novel subgroup distinct from known glycoside hydrolases such as endo-beta-1,3-glucanase and endo-beta-1,3: 1,4-glucanase in glycoside hydrolase family 16. Point mutations replacing the putative catalytic Glu residues conserved for enzymes in this family with Asp abolished activity. These results indicate that FvEn3GAL is a highly specific glycoside hydrolase 16 endo-beta-1,3-galactanase.	[Kotake, Toshihisa; Hirata, Naohiro; Kitazawa, Kiminari; Takata, Ryohei; Tsumuraya, Yoichi] Saitama Univ, Fac Sci, Div Life Sci, Grad Sch Sci & Engn,Sakura Ku, Saitama 3388570, Japan; [Kotake, Toshihisa] Saitama Univ, Fac Sci, Inst Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Degi, Yuta] Saitama Univ, Fac Sci, Dept Biochem & Mol Biol, Sakura Ku, Saitama 3388570, Japan; [Ishiguro, Maki; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Ichinose, Hitomi; Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan	Saitama University; Saitama University; Saitama University; University of Tokyo; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Kotake, T (corresponding author), Saitama Univ, Fac Sci, Div Life Sci, Grad Sch Sci & Engn,Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	kotake@molbiol.saitama-u.ac.jp	ISHIGURO, Maki/GRJ-6273-2022; KOTAKE, TOSHIHISA/F-1117-2011; Igarashi, Kiyohiko/E-6799-2016; Tsumuraya, Yoichi/C-7903-2012	KOTAKE, TOSHIHISA/0000-0002-1110-5006; Igarashi, Kiyohiko/0000-0001-5152-7177; 	Ministry of Agriculture, Forestry, and Fisheries of Japan	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by a grant-in-aid (Development of Biomass Utilization Technologies for Revitalizing Rural Areas) from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Dekker R F, 1976, Adv Carbohydr Chem Biochem, V32, P277; Ding L, 1997, PLANTA, V203, P289, DOI 10.1007/s004250050194; Fibriansah G, 2007, PROTEINS, V69, P683, DOI 10.1002/prot.21589; FINCHER GB, 1983, ANNU REV PLANT PHYS, V34, P47, DOI 10.1146/annurev.pp.34.060183.000403; Gao MG, 1999, PLANT J, V19, P321, DOI 10.1046/j.1365-313X.1999.00544.x; HAHN M, 1995, J BIOL CHEM, V270, P3081, DOI 10.1074/jbc.270.7.3081; HASHIMOTO Y, 1971, Nippon Nogeikagaku Kaishi, V45, P147; HASHIMOTO Y, 1969, Nippon Nogeikagaku Kaishi, V43, P831; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; Kawai R, 2006, APPL MICROBIOL BIOT, V71, P898, DOI 10.1007/s00253-005-0214-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiyohara H, 2002, PHYTOMEDICINE, V9, P614, DOI 10.1078/094471102321616427; KOMALAVILAS P, 1991, J BIOL CHEM, V266, P15956; KOOIMAN P, 1961, RECL TRAV CHIM PAY B, V80, P849; Kotake T, 2004, BIOCHEM J, V377, P749, DOI 10.1042/bj20031145; Kotake T, 2009, BIOSCI BIOTECH BIOCH, V73, P2303, DOI 10.1271/bbb.90433; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Majewska-Sawka A, 2000, PLANT PHYSIOL, V122, P3, DOI 10.1104/pp.122.1.3; Masuda S, 2006, EXTREMOPHILES, V10, P251, DOI 10.1007/s00792-006-0514-3; MATSUURA F, 1988, GLYCOCONJUGATE J, V5, P13, DOI 10.1007/BF01048328; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02613; Nelson N, 1944, J BIOL CHEM, V153, P375; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Okemoto K, 2003, CARBOHYD RES, V338, P219, DOI 10.1016/S0008-6215(02)00405-6; Park MH, 2003, PLANT PHYSIOL, V131, P1450, DOI 10.1104/pp.015628; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUMURAYA Y, 1984, CARBOHYD RES, V134, P215, DOI 10.1016/0008-6215(84)85039-9; TSUMURAYA Y, 1990, J BIOL CHEM, V265, P7207; TSUMURAYA Y, 1988, PLANT PHYSIOL, V86, P155, DOI 10.1104/pp.86.1.155; Vasur J, 2009, FEBS J, V276, P4282, DOI 10.1111/j.1742-4658.2009.07099.x; Willats WGT, 1996, PLANT J, V9, P919, DOI 10.1046/j.1365-313X.1996.9060919.x; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X; YARIV J, 1962, BIOCHEM J, V85, P383, DOI 10.1042/bj0850383	47	31	35	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27848	27854		10.1074/jbc.M111.251736	http://dx.doi.org/10.1074/jbc.M111.251736			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21653698	Green Published, hybrid			2022-12-27	WOS:000293268700076
J	Poncet-Montange, G; Martin, SJS; Bogatova, OV; Prusiner, SB; Shoichet, BK; Ghaemmaghami, S				Poncet-Montange, Guillaume; Martin, Susan J. St.; Bogatova, Olga V.; Prusiner, Stanley B.; Shoichet, Brian K.; Ghaemmaghami, Sina			A Survey of Antiprion Compounds Reveals the Prevalence of Non-PrP Molecular Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PRION PROTEIN; SCRAPIE ISOFORM; NEUROBLASTOMA-CELLS; BRANCHED POLYAMINES; CRYSTAL-STRUCTURE; CULTURED-CELLS; N-TERMINUS; DISEASE; REPLICATION; INHIBITORS	Prion diseases are fatal neurodegenerative diseases caused by the accumulation of the misfolded isoform (PrPSc) of the prion protein (PrPC). Cell-based screens have identified several compounds that induce a reduction in PrPSc levels in infected cultured cells. However, the molecular targets of most antiprion compounds remain unknown. We undertook a large-scale, unbiased, cell-based screen for antiprion compounds and then investigated whether a representative subset of the active molecules had measurable affinity for PrP, increased the susceptibility of PrPSc to proteolysis, or altered the cellular localization or expression level of PrPC. None of the antiprion compounds showed in vitro affinity for PrP or had the ability to disaggregate PrPSc in infected brain homogenates. These observations suggest that most antiprion compounds identified in cell-based screens deploy their activity via non-PrP targets in the cell. Our findings indicate that in comparison to PrP conformers themselves, proteins that play auxiliary roles in prion propagation may be more effective targets for future drug discovery efforts.	[Prusiner, Stanley B.; Ghaemmaghami, Sina] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Poncet-Montange, Guillaume; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Poncet-Montange, Guillaume; Martin, Susan J. St.; Bogatova, Olga V.; Prusiner, Stanley B.; Ghaemmaghami, Sina] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ghaemmaghami, S (corresponding author), 513 Parnassus Ave,HSE-744, San Francisco, CA 94143 USA.	sina@ind.ucsf.edu		Poncet-Montange, Guillaume/0000-0002-9884-7378; Ghaemmaghami, Sina/0000-0002-8696-2950	National Institutes of Health [AG02132, AG031220, AG021601]; Hillblom Foundation; Sherman Fairchild Foundation; NATIONAL INSTITUTE ON AGING [R37AG031220, P01AG002132, P01AG021601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Foundation; Sherman Fairchild Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG02132, AG031220, and AG021601, the Hillblom Foundation, and the Sherman Fairchild Foundation.	BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Caughey WS, 2007, ANTIMICROB AGENTS CH, V51, P3887, DOI 10.1128/AAC.01599-06; Charveriat M, 2009, J GEN VIROL, V90, P1294, DOI 10.1099/vir.0.009084-0; Choi S, 2010, J AM CHEM SOC, V132, P1359, DOI 10.1021/ja908562q; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Ghaemmaghami S, 2010, J VIROL, V84, P3408, DOI 10.1128/JVI.02145-09; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kocisko DA, 2005, NEUROSCI LETT, V388, P106, DOI 10.1016/j.neulet.2005.06.053; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; May BCH, 2003, P NATL ACAD SCI USA, V100, P3416, DOI 10.1073/pnas.2627988100; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Mizoue LS, 2004, ANAL BIOCHEM, V326, P125, DOI 10.1016/j.ab.2003.10.048; MORTON A, 1995, BIOCHEMISTRY-US, V34, P8564, DOI 10.1021/bi00027a006; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; PAN YT, 1983, BIOCHEMISTRY-US, V22, P3975, DOI 10.1021/bi00285a038; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2000, P NATL ACAD SCI USA, V97, P6073, DOI 10.1073/pnas.97.11.6073; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1987, ANNU REV MED, V38, P381, DOI 10.1146/annurev.me.38.020187.002121; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Vedadi M, 2010, J STRUCT BIOL, V172, P107, DOI 10.1016/j.jsb.2010.05.005; Vogtherr M, 2003, J MED CHEM, V46, P3563, DOI 10.1021/jm034093h; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	53	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27718	27728		10.1074/jbc.M111.234393	http://dx.doi.org/10.1074/jbc.M111.234393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21610081	Green Published, hybrid			2022-12-27	WOS:000293268700064
J	Carow, B; Ye, XQ; Gavier-Widen, D; Bhuju, S; Oehlmann, W; Singh, M; Skold, M; Ignatowicz, L; Yoshimura, A; Wigzell, H; Rottenberg, ME				Carow, Berit; Ye, Xiang Qun; Gavier-Widen, Dolores; Bhuju, Sabin; Oehlmann, Wulf; Singh, Mahavir; Skold, Markus; Ignatowicz, Lech; Yoshimura, Akihiko; Wigzell, Hans; Rottenberg, Martin E.			Silencing Suppressor of Cytokine Signaling-1 (SOCS1) in Macrophages Improves Mycobacterium tuberculosis Control in an Interferon-gamma (IFN-gamma)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; IFN-GAMMA; CHLAMYDIA-PNEUMONIAE; NEGATIVE REGULATION; IMMUNE-RESPONSE; INFECTION; GENE; EXPRESSION; MICE; INDUCTION	Protection against infection with Mycobacterium tuberculosis demands IFN-gamma. SOCS1 has been shown to inhibit responses to IFN-gamma and might thereby play a central role in the outcome of infection. We found that M. tuberculosis is a highly efficient stimulator of SOCS1 expression in murine and human macrophages and in tissues from infected mice. Surprisingly, SOCS1 reduced responses to IL-12, resulting in an impaired IFN-gamma secretion by macrophages that in turn accounted for a deteriorated intracellular mycobacterial control. Despite SOCS1 expression, mycobacteria-infected macrophages responded to exogenously added IFN-gamma. SOCS1 attenuated the expression of the majority of genes modulated by M. tuberculosis infection of macrophages. Using a conditional knockdown strategy in mice, we found that SOCS1 expression by macrophages hampered M. tuberculosis clearance early after infection in vivo in an IFN-gamma -dependent manner. On the other hand, at later time points, SOCS1 expression by non-macrophage cells protected the host from infection-induced detrimental inflammation.	[Carow, Berit; Ye, Xiang Qun; Skold, Markus; Ignatowicz, Lech; Wigzell, Hans; Rottenberg, Martin E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Gavier-Widen, Dolores] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, S-75007 Uppsala, Sweden; [Bhuju, Sabin; Oehlmann, Wulf; Singh, Mahavir] Lionex GmbH, D-38126 Braunschweig, Germany; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo 1608582, Japan	Karolinska Institutet; Swedish University of Agricultural Sciences; Keio University	Rottenberg, ME (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.	Martin.Rottenberg@ki.se	Ignatowicz, Lech/F-2601-2013; Carow, Berit/AAE-3970-2020; Yoshimura, Akihiko/K-5515-2013	Rottenberg, Martin/0000-0003-0514-7434; Carow, Berit/0000-0002-8760-6253	European Community [200732 HOMITB]; Karolinska Institutet; Swedish Research Council	European Community(European Commission); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by European Community Grant 200732 HOMITB, the Karolinska Institutet, and the Swedish Research Council.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Ahmed CM, 2009, J VIROL, V83, P1402, DOI 10.1128/JVI.01138-08; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chong MMW, 2005, BLOOD, V106, P1668, DOI 10.1182/blood-2004-08-3049; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cornish AL, 2003, J BIOL CHEM, V278, P22755, DOI 10.1074/jbc.M303021200; Davey GM, 2006, TISSUE ANTIGENS, V67, P1, DOI 10.1111/j.1399-0039.2005.00532.x; Davies John Q, 2005, Methods Mol Biol, V290, P105; de Jong R, 1998, SCIENCE, V280, P1435; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Evel-Kabler K, 2006, J CLIN INVEST, V116, P90, DOI 10.1172/JCI26169; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Flowers LO, 2004, J IMMUNOL, V172, P7510, DOI 10.4049/jimmunol.172.12.7510; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07; Hanada T, 2005, J IMMUNOL, V174, P4325, DOI 10.4049/jimmunol.174.7.4325; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Hashimoto M, 2009, CANCER SCI, V100, P730, DOI 10.1111/j.1349-7006.2009.01098.x; Hmama Z, 1998, J IMMUNOL, V161, P4882; Hoshino K, 1999, J IMMUNOL, V162, P3749; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Hussain S, 1999, J IMMUNOL, V163, P2041; Imai K, 2003, FEMS IMMUNOL MED MIC, V39, P173, DOI 10.1016/S0928-8244(03)00231-1; Kile BT, 2001, CELL MOL LIFE SCI, V58, P1627, DOI 10.1007/PL00000801; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Musikadharoen T, 2005, BLOOD, V105, P711, DOI 10.1182/blood-2004-03-0842; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Puddu P, 1997, J IMMUNOL, V159, P3490; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Rothfuchs AG, 2006, J IMMUNOL, V176, P6982, DOI 10.4049/jimmunol.176.11.6982; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Srivastava V, 2009, J BIOL CHEM, V284, P25532, DOI 10.1074/jbc.M109.006221; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Yang TB, 2008, J IMMUNOL, V180, P4040, DOI 10.4049/jimmunol.180.6.4040; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	56	44	45	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26873	26887		10.1074/jbc.M111.238287	http://dx.doi.org/10.1074/jbc.M111.238287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21622562	Green Published, hybrid			2022-12-27	WOS:000293078200062
J	Guryanova, OA; Drazba, JA; Frolova, EI; Chumakov, PM				Guryanova, Olga A.; Drazba, Judith A.; Frolova, Elena I.; Chumakov, Peter M.			Actin Cytoskeleton Remodeling by the Alternatively Spliced Isoform of PDLIM4/RIL Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-LIM PROTEIN; 20S PROTEASOMAL DEGRADATION; KLF6 TUMOR-SUPPRESSOR; ALPHA-ACTININ; DOMAIN PROTEIN; QUINONE OXIDOREDUCTASE-1; ORNITHINE-DECARBOXYLASE; CAENORHABDITIS-ELEGANS; ENDOTHELIAL-CELLS; HEART DEVELOPMENT	RIL (product of PDLIM4 gene) is an actin-associated protein that has previously been shown to stimulate actin bundling by interacting with actin-cross-linking protein alpha-actinin-1 and increasing its affinity to filamentous actin. Here, we report that the alternatively spliced isoform of RIL, denoted here as RILaltCterm, functions as a dominant-negative modulator of RIL-mediated actin reorganization. RILaltCterm is regulated at the level of protein stability, and this protein isoform accumulates particularly in response to oxidative stress. We show that the alternative C-terminal segment of RILaltCterm has a disordered structure that directs the protein to rapid degradation in the core 20 S proteasomes. Such degradation is ubiquitin-independent and can be blocked by binding to NAD(P) H quinone oxidoreductase NQO1, a detoxifying enzyme induced by prolonged exposure to oxidative stress. We show that either overexpression of RILaltCterm or its stabilization by stresses counteracts the effects produced by full-length RIL on organization of actin cytoskeleton and cell motility. Taken together, the data suggest a mechanism for fine-tuning actin cytoskeleton rearrangement in response to stresses.	[Guryanova, Olga A.; Drazba, Judith A.; Chumakov, Peter M.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Guryanova, Olga A.; Frolova, Elena I.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Chumakov, Peter M.] VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; [Chumakov, Peter M.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Cleveland Clinic Foundation; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Novosibirsk State University	Chumakov, PM (corresponding author), 9500 Euclid Ave,Mail Code NE20, Cleveland, OH 44195 USA.	chumakp@ccf.org	Chumakov, Peter M/E-7731-2014	Chumakov, Peter/0000-0002-8078-2908; Guryanova, Olga/0000-0002-6514-8466	National Institutes of Health [R01 CA104903, AG025276]; Howard Hughes Medical Institute [55005603]; Russian Foundation for Basic Research [08-04-00686a, 11-04-01210]; Government of Russian Federation [11.G34.31.0034]; Russian Academy of Sciences; NATIONAL CANCER INSTITUTE [R01CA104903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Government of Russian Federation; Russian Academy of Sciences(Russian Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA104903 and AG025276 (to P. M. C.). This work was also supported by Howard Hughes Medical Institute Grant 55005603 (to P. M. C.), Russian Foundation for Basic Research Grants 08-04-00686a (to P. M. C.) and 11-04-01210 (to E. I. F.), a grant from the Russian Academy of Sciences Program on Molecular and Cellular Biology (to P. M. C.), and Government of Russian Federation Grant 11.G34.31.0034 (to P. M. C.).	Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Au YH, 2004, STRUCTURE, V12, P611, DOI 10.1016/j.str.2004.02.019; Bashirova AA, 1998, GENE, V210, P239, DOI 10.1016/S0378-1119(98)00080-8; Bauer K, 2000, BLOOD, V96, P4236; Begleiter A, 2004, METHOD ENZYMOL, V382, P320; Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Benna C, 2009, CELL TISSUE RES, V337, P463, DOI 10.1007/s00441-009-0813-y; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Bordone L, 2002, J BIOL CHEM, V277, P26673, DOI 10.1074/jbc.M112037200; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Cuppen E, 1998, MOL BIOL CELL, V9, P671, DOI 10.1091/mbc.9.3.671; Davies KJA, 2006, NEUROLOGY, V66, pS93, DOI 10.1212/01.wnl.0000192308.43151.63; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Fu SL, 2000, ONCOGENE, V19, P3537, DOI 10.1038/sj.onc.1203691; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323; Gonzalez-Juarrero M, 2009, AM J RESP CELL MOL, V40, P398, DOI 10.1165/rcmb.2008-0248OC; Gur'ianova O A, 2006, Mol Biol (Mosk), V40, P448; Guy PM, 1999, MOL BIOL CELL, V10, P1973, DOI 10.1091/mbc.10.6.1973; Han HF, 2009, MOL BIOL CELL, V20, P2361, DOI 10.1091/mbc.E08-06-0584; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; He ML, 2009, PROSTATE, V69, P1643, DOI 10.1002/pros.21013; Herrick S, 2010, MOL CELL NEUROSCI, V43, P188, DOI 10.1016/j.mcn.2009.10.009; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Kesari A, 2008, AM J PATHOL, V173, P1476, DOI 10.2353/ajpath.2008.080098; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; Klaavuniemi T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-22; Kotaka M, 2000, J CELL BIOCHEM, V78, P558, DOI 10.1002/1097-4644(20000915)78:4<558::AID-JCB5>3.0.CO;2-I; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Liu H, 2008, P NATL ACAD SCI USA, V105, P15926, DOI 10.1073/pnas.0808346105; Mazurek N, 2005, CANCER RES, V65, P10767, DOI 10.1158/0008-5472.CAN-04-3333; McKeown CR, 2006, DEV DYNAM, V235, P530, DOI 10.1002/dvdy.20633; Mills JC, 2001, P NATL ACAD SCI USA, V98, P13687, DOI 10.1073/pnas.231332398; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Nakagawa N, 2000, BIOCHEM BIOPH RES CO, V272, P505, DOI 10.1006/bbrc.2000.2787; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Pomies P, 1999, J BIOL CHEM, V274, P29242, DOI 10.1074/jbc.274.41.29242; Qin T, 2007, CLIN CANCER RES, V13, P4225, DOI 10.1158/1078-0432.CCR-06-2762; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Szpirer C, 1996, MAMM GENOME, V7, P701, DOI 10.1007/s003359900211; Talalay P, 2004, METHOD ENZYMOL, V382, P355; Te Velthuis Aartjan J W, 2007, PLoS One, V2, pe189, DOI 10.1371/journal.pone.0000189; Thurau M, 2009, J VIROL, V83, P598, DOI 10.1128/JVI.00629-08; Torrado M, 2004, INVEST OPHTH VIS SCI, V45, P3955, DOI 10.1167/iovs.04-0721; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xing YL, 2006, MOL GENET METAB, V88, P71, DOI 10.1016/j.ymgme.2005.11.009; Yamazaki T, 2010, CARDIOVASC RES, V86, P374, DOI 10.1093/cvr/cvq023; Yea S, 2008, GASTROENTEROLOGY, V134, P1521, DOI 10.1053/j.gastro.2008.02.015; Zhang YJ, 2009, J CELL BIOL, V184, P785, DOI 10.1083/jcb.200810155; Zheng M, 2010, J MOL CELL BIOL, V2, P96, DOI 10.1093/jmcb/mjp038; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	79	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26849	26859		10.1074/jbc.M111.241554	http://dx.doi.org/10.1074/jbc.M111.241554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636573	hybrid, Green Published			2022-12-27	WOS:000293078200060
J	Storbeck, S; Saha, S; Krausze, J; Klink, BU; Heinz, DW; Layer, G				Storbeck, Sonja; Saha, Sayantan; Krausze, Joern; Klink, Bjoern U.; Heinz, Dirk W.; Layer, Gunhild			Crystal Structure of the Heme d(1) Biosynthesis Enzyme NirE in Complex with Its Substrate Reveals New Insights into the Catalytic Mechanism of S-Adenosyl-L-methionine-dependent Uroporphyrinogen III Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSG GENE ENCODES; ESCHERICHIA-COLI; TETRAPYRROLE BIOSYNTHESIS; MULTIFUNCTIONAL PROTEIN; SIROHEME BIOSYNTHESIS; C-METHYLTRANSFERASE; SYNTHASE; PURIFICATION; METHYLASE; VITAMIN-B12	During the biosynthesis of heme d(1), the essential cofactor of cytochrome cd(1) nitrite reductase, the NirE protein catalyzes the methylation of uroporphyrinogen III to precorrin-2 using S-adenosyl- L-methionine (SAM) as the methyl group donor. The crystal structure of Pseudomonas aeruginosa NirE in complex with its substrate uroporphyrinogen III and the reaction by-product S-adenosyl-L-homocysteine (SAH) was solved to 2.0 angstrom resolution. This represents the first enzyme-substrate complex structure for a SAM-dependent uroporphyrinogen III methyltransferase. The large substrate binds on top of the SAH in a "puckered" conformation in which the two pyrrole rings facing each other point into the same direction either upward or downward. Three arginine residues, a histidine, and a methionine are involved in the coordination of uroporphyrinogen III. Through site-directed mutagenesis of the nirE gene and biochemical characterization of the corresponding NirE variants the amino acid residues Arg-111, Glu-114, and Arg-149 were identified to be involved in NirE catalysis. Based on our structural and biochemical findings, we propose a potential catalytic mechanism for NirE in which the methyl transfer reaction is initiated by an arginine catalyzed proton abstraction from the C-20 position of the substrate.	[Storbeck, Sonja; Layer, Gunhild] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Saha, Sayantan; Krausze, Joern; Klink, Bjoern U.; Heinz, Dirk W.] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Klink, Bjoern U.] Duke Univ, Med Ctr, Durham, NC 27705 USA	Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Duke University	Layer, G (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	g.layer@tu-braunschweig.de			Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie;  [FOR 1220]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); 	This work was supported by grants from the Deutsche Forschungsgemeinschaft Emmy-Noether Program (to G. L.) and FOR 1220 (to D. W. H.) and by the Fonds der Chemischen Industrie (to G. L. and D. W. H.).	Aiyar A, 1996, Methods Mol Biol, V57, P177; Anderson PJ, 2001, GENE, V281, P63, DOI 10.1016/S0378-1119(01)00820-4; Battersby AR, 2000, NAT PROD REP, V17, P507, DOI 10.1039/b002635m; BLANCHE F, 1989, J BACTERIOL, V171, P4222, DOI 10.1128/JB.171.8.4222-4231.1989; BLANCHE F, 1991, J BACTERIOL, V173, P4637, DOI 10.1128/jb.173.15.4637-4645.1991; BRUNT RD, 1989, J CHEM SOC CHEM COMM, P428, DOI 10.1039/c39890000428; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan J, 2006, PROTEIN EXPRES PURIF, V46, P40, DOI 10.1016/j.pep.2005.07.010; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; Leech HK, 2003, J BIOL CHEM, V278, P41900, DOI 10.1074/jbc.M306112200; LEEPER FJ, 1985, NAT PROD REP, V2, P561, DOI 10.1039/np9850200561; Leustek T, 1997, J BIOL CHEM, V272, P2744, DOI 10.1074/jbc.272.5.2744; Lobo SAL, 2009, BIOCHEM J, V420, P317, DOI 10.1042/BJ20090151; MASCARO L, 1977, J AM CHEM SOC, V99, P273, DOI 10.1021/ja00443a062; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Minor W, 2002, ACTA PHYS POL A, V101, P613, DOI 10.12693/APhysPolA.101.613; Montange RK, 2010, J MOL BIOL, V396, P761, DOI 10.1016/j.jmb.2009.12.007; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Rehse PH, 2005, ACTA CRYSTALLOGR D, V61, P913, DOI 10.1107/S0907444905008838; ROBIN C, 1991, J BACTERIOL, V173, P4893, DOI 10.1128/jb.173.15.4893-4896.1991; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Schubert HL, 2008, BIOCHEMISTRY-US, V47, P8648, DOI 10.1021/bi800635y; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SCOTT AI, 1989, J CHEM SOC CHEM COMM, P522, DOI 10.1039/c39890000522; SPENCER JB, 1993, FEBS LETT, V335, P57, DOI 10.1016/0014-5793(93)80438-Z; Storbeck S, 2009, FEBS J, V276, P5973, DOI 10.1111/j.1742-4658.2009.07306.x; Stroupe ME, 2003, NAT STRUCT BIOL, V10, P1064, DOI 10.1038/nsb1007; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vevodova J, 2004, J MOL BIOL, V344, P419, DOI 10.1016/j.jmb.2004.09.020; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WARREN MJ, 1994, CIBA F SYMP, V180, P26; WARREN MJ, 1990, BIOCHEM J, V265, P725, DOI 10.1042/bj2650725; WARREN MJ, 1994, BIOCHEM J, V302, P837, DOI 10.1042/bj3020837; WARREN MJ, 1990, J AM CHEM SOC, V112, P5343, DOI 10.1021/ja00169a048; Woodcock SC, 1998, BIOCHEM J, V330, P121; Zajicek RS, 2009, FEBS J, V276, P6399, DOI 10.1111/j.1742-4658.2009.07354.x; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	43	25	26	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26754	26767		10.1074/jbc.M111.239855	http://dx.doi.org/10.1074/jbc.M111.239855			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632530	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000293078200052
J	Taschner, M; Bhogaraju, S; Vetter, M; Morawetz, M; Lorentzen, E				Taschner, Michael; Bhogaraju, Sagar; Vetter, Melanie; Morawetz, Michaela; Lorentzen, Esben			Biochemical Mapping of Interactions within the Intraflagellar Transport (IFT) B Core Complex IFT52 BINDS DIRECTLY TO FOUR OTHER IFT-B SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT INTERMEDIATE CHAIN; CAENORHABDITIS-ELEGANS; CHLAMYDOMONAS-REINHARDTII; CYTOPLASMIC DYNEIN; PROTEIN SEQUENCES; DISEASE GENE; CILIA; PREDICTION; PARTICLES; COMPONENT	Cilia and flagella are complex structures emanating from the surface of most eukaroytic cells and serve important functions including motility, signaling, and sensory reception. A process called intraflagellar transport (IFT) is of central importance to ciliary assembly and maintenance. The IFT complex is required for this transport and consists of two distinct multisubunit sub-complexes, IFT-A and IFT-B. Despite the importance of the IFT complex, little is known about its overall architecture. This paper presents a biochemical dissection of the molecular interactions within the IFT-B core complex. Two stable subcomplexes consisting of IFT88/70/52/46 and IFT81/74/27/25 were recombinantly co-expressed and purified. We identify a novel interaction between IFT70/52 and map the interaction domains between IFT52 and the other subunits within the IFT88/70/52/46 complex. Additionally, we show that IFT52 binds directly to the IFT81/74/27/25 complex, indicating that it could mediate the interaction between the two subcomplexes. Our data lead to an improved architectural map for the IFT-B core complex with new interactions as well as domain resolution mapping for several subunits.	[Taschner, Michael; Bhogaraju, Sagar; Vetter, Melanie; Morawetz, Michaela; Lorentzen, Esben] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Lorentzen, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	lorentze@biochem.mpg.de	Lorentzen, Esben/AAX-8077-2020	Bhogaraju, Sagar/0000-0001-9998-5927; Lorentzen, Esben/0000-0001-6493-7220; Vetter, Melanie/0000-0003-1777-2376; Taschner, Michael/0000-0002-8881-3705; Taschner, Michael/0000-0002-3789-5077	Austrian Science Fund [J 3148-B12]	Austrian Science Fund(Austrian Science Fund (FWF))	Recipient of an Erwin-Schroedinger-stipend granted by the Austrian Science Fund J 3148-B12.	Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Beatson S, 2004, TRENDS BIOCHEM SCI, V29, P396, DOI 10.1016/j.tibs.2004.06.002; Behal RH, 2009, METHOD CELL BIOL, V93, P179, DOI 10.1016/S0091-679X(08)93010-7; Bhogaraju S, 2011, EMBO J, V30, P1907, DOI 10.1038/emboj.2011.110; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collet J, 1998, GENETICS, V148, P187; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Fribourg S, 2001, J MOL BIOL, V306, P363, DOI 10.1006/jmbi.2000.4376; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goodenough UW, 1989, CURR OPIN CELL BIOL, V1, P58, DOI 10.1016/S0955-0674(89)80037-7; Hou YQ, 2004, MOL BIOL CELL, V15, P4382, DOI 10.1091/mbc.E04-05-0377; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Pozsgai E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-233; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schafer JC, 2006, J CELL SCI, V119, P4088, DOI 10.1242/jcs.03187; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195	40	55	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26344	26352		10.1074/jbc.M111.254920	http://dx.doi.org/10.1074/jbc.M111.254920			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642430	Green Published, hybrid			2022-12-27	WOS:000293078200011
J	Zhu, F; Erlandsen, H; Ding, L; Li, JZ; Huang, Y; Zhou, MX; Liang, XB; Ma, JB; Wu, H				Zhu, Fan; Erlandsen, Heidi; Ding, Lei; Li, Jingzhi; Huang, Ying; Zhou, Meixian; Liang, Xiaobo; Ma, Jinbiao; Wu, Hui			Structural and Functional Analysis of a New Subfamily of Glycosyltransferases Required for Glycosylation of Serine-rich Streptococcal Adhesins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-GSPB; ACCESSORY SEC LOCUS; CRYSTAL-STRUCTURE; SURFACE PROTEIN; HUMAN PLATELETS; GLUCOSYLTRANSFERASE; GORDONII; IDENTIFICATION; PARASANGUINIS; BIOSYNTHESIS	Serine-rich repeat glycoproteins (SRRPs) are a growing family of bacterial adhesins found in many streptococci and staphylococci; they play important roles in bacterial biofilm formation and pathogenesis. Glycosylation of this family of adhesins is essential for their biogenesis. A glucosyltransferase (Gtf3) catalyzes the second step of glycosylation of a SRRP (Fap1) from an oral streptococcus, Streptococcus parasanguinis. Although Gtf3 homologs are highly conserved in SRRP-containing streptococci, they share minimal homology with functionally known glycosyltransferases. We report here the 2.3 angstrom crystal structure of Gtf3. The structural analysis indicates that Gtf3 forms a tetramer and shares significant structural homology with glycosyltransferases from GT4, GT5, and GT20 subfamilies. Combining crystal structural analysis with site-directed mutagenesis and in vitro glycosyltransferase assays, we identified residues that are required for UDP-or UDP-glucose binding and for oligomerization of Gtf3 and determined their contribution to the enzymatic activity of Gtf3. Further in vivo studies revealed that the critical amino acid residues identified by the structural analysis are crucial for Fap1 glycosylation in S. parasanguinis in vivo. Moreover, Gtf3 homologs from other streptococci were able to rescue the gtf3 knock-out mutant of S. parasanguinis in vivo and catalyze the sugar transfer to the modified SRRP substrate in vitro, demonstrating the importance and conservation of the Gtf3 homologs in glycosylation of SRRPs. As the Gtf3 homologs only exist in SRRP-containing streptococci, we conclude that the Gtf3 homologs represent a unique subfamily of glycosyltransferases.	[Zhu, Fan; Zhou, Meixian; Liang, Xiaobo; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent & Microbiol, Birmingham, AL 35294 USA; [Zhu, Fan; Zhou, Meixian; Liang, Xiaobo; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Pediat Dent & Microbiol, Birmingham, AL 35294 USA; [Erlandsen, Heidi] Univ Alabama Birmingham, Sch Dent, Dept Periodontol, Birmingham, AL 35294 USA; [Erlandsen, Heidi] Univ Alabama Birmingham, Sch Med, Dept Periodontol, Birmingham, AL 35294 USA; [Ding, Lei; Huang, Ying; Ma, Jinbiao] Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Ding, Lei; Huang, Ying; Ma, Jinbiao] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Li, Jingzhi] Univ Alabama Birmingham, Sch Dent, Dept Cell Biol, Birmingham, AL 35294 USA; [Li, Jingzhi] Univ Alabama Birmingham, Sch Med, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wu, H (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, 802 SDB, Birmingham, AL 35294 USA.	hwu@uab.edu			National Institutes of Health [R01DE011000, R01DE017954]; National Natural Science Foundation of China [30900034]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE011000 and R01DE017954 (to H. W.). This work was also supported by National Natural Science Foundation of China Grant 30900034 (to M. Z.).	Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Doro F, 2009, MOL CELL PROTEOMICS, V8, P1728, DOI 10.1074/mcp.M800486-MCP200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Goedl C, 2008, FEBS J, V275, P903, DOI [10.1111/j.1742-4658.2008.06254.x, 10.1111/j.1742-4658.2007.06254.x]; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Hashimoto K, 2010, J MOL BIOL, V399, P196, DOI 10.1016/j.jmb.2010.03.059; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Leipold MD, 2007, J BIOL CHEM, V282, P1257, DOI 10.1074/jbc.M608164200; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Takahashi Y, 2002, INFECT IMMUN, V70, P1209, DOI 10.1128/IAI.70.3.1209-1218.2002; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Yuan YQ, 2007, P NATL ACAD SCI USA, V104, P5348, DOI 10.1073/pnas.0701160104; Zhang ZD, 2003, J MOL BIOL, V332, P127, DOI 10.1016/S0022-2836(03)00858-1; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	39	23	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27048	27057		10.1074/jbc.M110.208629	http://dx.doi.org/10.1074/jbc.M110.208629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653318	hybrid, Green Published			2022-12-27	WOS:000293078200078
J	Hadian, K; Griesbach, RA; Dornauer, S; Wanger, TM; Nagel, D; Metlitzky, M; Beisker, W; Schmidt-Supprian, M; Krappmann, D				Hadian, Kamyar; Griesbach, Richard A.; Dornauer, Scarlett; Wanger, Tim M.; Nagel, Daniel; Metlitzky, Moritz; Beisker, Wolfgang; Schmidt-Supprian, Marc; Krappmann, Daniel			NF-kappa B Essential Modulator (NEMO) Interaction with Linear and Lys-63 Ubiquitin Chains Contributes to NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; ASSEMBLY COMPLEX; IKK COMPLEX; STEM-CELLS; TNF-ALPHA; BINDING; COMPONENT; DOMAIN; OLIGOMERIZATION; RECOGNITION	The I kappa B kinase (IKK) complex acts as a gatekeeper of canonical NF-kappa B signaling in response to upstream stimulation. IKK activation requires sensing of ubiquitin chains by the essential IKK regulatory subunit IKK gamma/NEMO. However, it has remained enigmatic whether NEMO binding to Lys-63-linked or linear ubiquitin chains is critical for triggering IKK activation. We show here that the NEMOC terminus, comprising the ubiquitin binding region and a zinc finger, has a high preference for binding to linear ubiquitin chains. However, immobilization of NEMO, which may be reminiscent of cellular oligomerization, facilitates the interaction with Lys-63 ubiquitin chains. Moreover, selective mutations in NEMO that abolish association with linear ubiquitin but do not affect binding to Lys-63 ubiquitin are only partially compromising NF-kappa B signaling in response to TNF alpha stimulation in fibroblasts and T cells. In line with this, TNF alpha-triggered expression of NF-kappa B target genes and induction of apoptosis was partially compromised by NEMO mutations that selectively impair the binding to linear ubiquitin chains. Thus, in vivo NEMO interaction with linear and Lys-63 ubiquitin chains is required for optimal IKK activation, suggesting that both type of chains are cooperating in triggering canonical NF-kappa B signaling.	[Hadian, Kamyar; Griesbach, Richard A.; Wanger, Tim M.; Nagel, Daniel; Metlitzky, Moritz; Beisker, Wolfgang; Krappmann, Daniel] Inst Toxicol, German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Cellular Signal Integrat, D-85764 Neuherberg, Germany; [Schmidt-Supprian, Marc] Max Planck Inst Biochem, Inst Mol Immunol & Signal Transduct, D-82152 Martinsried, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society	Krappmann, D (corresponding author), Inst Toxicol, German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Cellular Signal Integrat, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	daniel.krappmann@helmholtz-muenchen.de	Krappmann, Daniel/AAT-4354-2021; Hadian, Kamyar/B-6314-2013; Krappmann, Daniel/ABF-4038-2021; Schmidt-Supprian, Marc/F-5893-2011	Krappmann, Daniel/0000-0001-7640-3234; Hadian, Kamyar/0000-0001-8727-2575; Krappmann, Daniel/0000-0001-7640-3234; Schmidt-Supprian, Marc/0000-0002-8543-6166	Deutsche Forschungsgemeinschaft [SPP1365]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft Priority Program SPP1365 (to D. K.).	Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Cordier F, 2009, J BIOL CHEM, V284, P2902, DOI 10.1074/jbc.M806655200; Courtois G, 2000, Sci STKE, V2000, ppe1; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Fusco F, 2008, HUM MUTAT, V29, P595, DOI 10.1002/humu.20739; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Grubisha O, 2010, J MOL BIOL, V395, P89, DOI 10.1016/j.jmb.2009.10.018; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Smahi A, 2000, NATURE, V405, P466; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Ye JJ, 2000, J BIOL CHEM, V275, P9882, DOI 10.1074/jbc.275.13.9882; Yoshikawa A, 2009, FEBS LETT, V583, P3317, DOI 10.1016/j.febslet.2009.09.028	35	84	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26107	26117		10.1074/jbc.M111.233163	http://dx.doi.org/10.1074/jbc.M111.233163			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21622571	Green Published, hybrid			2022-12-27	WOS:000293073000068
J	Ryu, YS; Lee, Y; Lee, KW; Hwang, CY; Maeng, JS; Kim, JH; Seo, YS; You, KH; Song, B; Kwon, KS				Ryu, Yeung Sook; Lee, Younglang; Lee, Keun Woo; Hwang, Chae Young; Maeng, Jin-Soo; Kim, Jeong-Hoon; Seo, Yeon-Soo; You, Kwan-Hee; Song, Byeongwoon; Kwon, Ki-Sun			TRIM32 Protein Sensitizes Cells to Tumor Necrosis Factor (TNF alpha)-induced Apoptosis via Its RING Domain-dependent E3 Ligase Activity against X-linked Inhibitor of Apoptosis (XIAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DYSTROPHY TYPE 2H; COILED-COIL PROTEIN; UBIQUITIN LIGASE; ANTIVIRAL ACTIVITY; CASPASE ACTIVITY; OPITZ-SYNDROME; GENE; FINGER; IAP	TRIM32, which belongs to the tripartite motif (TRIM) protein family, has the RING finger, B-box, and coiled-coil domain structures common to this protein family, along with an additional NHL domain at the C terminus. TRIM32 reportedly functions as an E3 ligase for actin, a protein inhibitor of activated STAT y (PIASy), dysbindin, and c-Myc, and it has been associated with diseases such as muscular dystrophy and epithelial carcinogenesis. Here, we identify a new substrate of TRIM32 and propose a mechanism through which TRIM32 might regulate apoptosis. Our overexpression and knockdown experiments demonstrate that TRIM32 sensitizes cells to TNF alpha-induced apoptosis. The RING domain is necessary for this pro-apoptotic function of TRM32 as well as being responsible for its E3 ligase activity. TRIM32 colocalizes and directly interacts with X-linked inhibitor of apoptosis (XIAP), a well known cancer therapeutic target, through its coiled-coil and NHL domains. TRIM32 overexpression enhances XIAP ubiquitination and subsequent proteasome-mediated degradation, whereas TRIM32 knockdown has the opposite effect, indicating that XIAP is a substrate of TRIM32. In vitro reconstitution assay reveals that XIAP is directly ubiquitinated by TRIM32. Our novel results collectively suggest that TRIM32 sensitizes TNF alpha-induced apoptosis by antagonizing XIAP, an anti-apoptotic downstream effector of TNF alpha signaling. This function may be associated with TRIM32-mediated tumor suppressive mechanism.	[Ryu, Yeung Sook; Lee, Younglang; Lee, Keun Woo; Hwang, Chae Young; Maeng, Jin-Soo; Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Lab Cell Signaling, Taejon 305806, South Korea; [Kim, Jeong-Hoon; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [You, Kwan-Hee] Chungnam Natl Univ, Sch Biol Sci, Taejon 305764, South Korea; [Song, Byeongwoon] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Emory University	Kwon, KS (corresponding author), Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Lab Cell Signaling, 52 Oun Dong, Taejon 305333, South Korea.	kwonks@kribb.re.kr	Seo, Yeonsoo/C-1605-2011		Korea Research Council of Fundamental Science and Technology (KRCF); National Research Foundation (NRF) of Korea [20110002141, 2010-0014635]	Korea Research Council of Fundamental Science and Technology (KRCF); National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	This work was supported by grants from the Korea Research Council of Fundamental Science and Technology (KRCF) and the National Research Foundation (NRF) of Korea (Grants 20110002141 and 2010-0014635) (to K. S. K.).	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Dal Zotto L, 1998, HUM MOL GENET, V7, P489, DOI 10.1093/hmg/7.3.489; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dho SH, 2003, J BIOL CHEM, V278, P31902, DOI 10.1074/jbc.M304062200; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eldin P, 2009, J GEN VIROL, V90, P536, DOI 10.1099/vir.0.006288-0; Frank DJ, 2002, DEVELOPMENT, V129, P399; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hasegawa N, 1996, BIOCHEM BIOPH RES CO, V225, P627, DOI 10.1006/bbrc.1996.1221; Horn EJ, 2004, CARCINOGENESIS, V25, P157, DOI 10.1093/carcin/bgh003; Ikeda K, 2000, FEBS LETT, V472, P9, DOI 10.1016/S0014-5793(00)01421-6; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Kim JH, 2004, NUCLEIC ACIDS RES, V32, P2287, DOI 10.1093/nar/gkh534; Kimura F, 2003, J BIOL CHEM, V278, P25046, DOI 10.1074/jbc.M303438200; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Lee SS, 2009, EXP CELL RES, V315, P1313, DOI 10.1016/j.yexcr.2008.11.021; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Li JL, 2001, ENDOCRINOLOGY, V142, P370, DOI 10.1210/en.142.1.370; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Niikura T, 2003, EUR J NEUROSCI, V17, P1150, DOI 10.1046/j.1460-9568.2003.02553.x; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shyu HW, 2003, EXP CELL RES, V287, P301, DOI 10.1016/S0014-4827(03)00110-1; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Takahata M, 2008, MOL IMMUNOL, V45, P2045, DOI 10.1016/j.molimm.2007.10.023; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 2007, CLIN CANCER RES, V13, P5995, DOI 10.1158/1078-0432.CCR-07-0729; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; ZETTERQVIST O, 1976, BIOCHEM BIOPH RES CO, V70, P696, DOI 10.1016/0006-291X(76)90648-3; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373	61	47	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25729	25738		10.1074/jbc.M111.241893	http://dx.doi.org/10.1074/jbc.M111.241893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628460	Green Published, hybrid			2022-12-27	WOS:000293073000034
J	Budry, L; Couture, C; Balsalobre, A; Drouin, J				Budry, Lionel; Couture, Catherine; Balsalobre, Aurelio; Drouin, Jacques			The Ets Factor Etv1 Interacts with Tpit Protein for Pituitary Pro-opiomelanocortin (POMC) Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX FACTOR; RIEGER-SYNDROME; FACTOR ER81; HOMEOBOX 1; CELL; PTX1; EXPRESSION; MUTATIONS; PITX2; RAS	Pro-opiomelanocortin (POMC) is expressed in two lineages of the pituitary, the anterior lobe corticotrophs and the intermediate lobe melanotrophs. POMC expression in these two lineages is highly dependent on the cell-restricted transcription factor Tpit. As Tpit intervenes relatively late in differentiation of those lineages, we have been searching for other transcription factors that may participate in their gene expression program. On the basis of similarity with the Tpit expression profile, we identified Ets variant gene 1 (Etv1/Er81) as a putative POMC transcription factor. Using Etv1-lacZ knockin mice, we describe preferential Etv1 expression in pituitary POMC cells and also in posterior lobe pituicytes. We further show that Etv1 enhances POMC transcription on its own and in synergy with Tpit. The Ets-binding site located within the Tpit/Pitx regulatory element is necessary for Etv1 activity in POMC-expressing AtT-20 cells but dispensable for synergy with Tpit. Etv1 and Tpit interact together in coimmunoprecipitation experiments. Furthermore, Etv1 is present at the POMC promoter, and siRNA-mediated knockdown of Etv1 in AtT-20 cells produces a significant decrease in POMC expression. Etv1 knockout pituitaries show normal POMC cell distribution and normal POMC mRNA abundance, suggesting compensation by other factors. The coordinate expression of Etv1 with POMC cell differentiation and its interaction with the highly cell-restricted Tpit factor indicate that Etv1 participates in a combinatorial code for pituitary cell-specific gene expression.	[Budry, Lionel; Couture, Catherine; Balsalobre, Aurelio; Drouin, Jacques] Inst Rech Clin Montreal, Mol Genet Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Drouin, J (corresponding author), Inst Rech Clin Montreal, Mol Genet Lab, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	jacques.drouin@ircm.qc.ca	Pillay, Nischalan/F-9536-2012	Drouin, Jacques/0000-0001-8226-5691	Canadian Institutes of Health Research [CIHR MT-86650, MOP-89716]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants CIHR MT-86650 from the Canadian Institutes of Health Research (to J.D.).; We thank Drs. T. Jessell and S. Arber for providing the Er81-nlslacZ mice. We also thank Brian Wilkes and Peter W. Schiller (CIHR Grant MOP-89716) for help in computer modeling of protein interactions with Tpit/PitxRE. We thank Dr. S. J. Rhodes for rabbit anti-Pit1, K. Moroashi for rabbit anti-SF1, S. Arber for anti-Etv1 antiserum, and X. Sun for anti-Etv5. We also thank E. Massicotte and M. Dupuis of the Institut de Recherches Cliniques de Montreal FACS Facility for FACS sorting of POMC-EGFP cells. We thank A. Vallee for expertly preparing histology sections at the Institut de Recherches Cliniques de Montreal Histology Facility. We also thank people at the McGill University and Genome Quebec Innovation Center for expression arrays hybridization and all members of the laboratory for unconditional support and thoughtful comments during the course of this work.	Allaerts W, 2005, EUR J ENDOCRINOL, V153, P1, DOI 10.1530/eje.1.01949; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Bradford AP, 1996, J BIOL CHEM, V271, P24639, DOI 10.1074/jbc.271.40.24639; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Chaney BA, 2005, BIOCHEMISTRY-US, V44, P7497, DOI 10.1021/bi0473253; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Drouin J., 2010, PITUITARY, P3; Duan WR, 2002, MOL ENDOCRINOL, V16, P221, DOI 10.1210/me.16.2.221; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; GOURDJI D, 1994, MOL CELL ENDOCRINOL, V100, P133, DOI 10.1016/0303-7207(94)90292-5; Gutierrez-Hartmann A, 2007, TRENDS ENDOCRIN MET, V18, P150, DOI 10.1016/j.tem.2007.03.002; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamolet B, 2004, MOL ENDOCRINOL, V18, P995, DOI 10.1210/me.2003-0127; Lanctot C, 1999, ENDOCRINOLOGY, V140, P1416, DOI 10.1210/en.140.3.1416; Langlais D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000224; Lavoie PL, 2008, MOL ENDOCRINOL, V22, P1647, DOI 10.1210/me.2007-0567; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Maira M, 2003, J BIOL CHEM, V278, P46523, DOI 10.1074/jbc.M305626200; Maniatis T., 1982, MOL CLONING LAB MANU; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Paez-Pereda Marcelo, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P259, DOI 10.2174/1568008054863817; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Pulichino AM, 2003, GENE DEV, V17, P738, DOI 10.1101/gad.1065703; Pulichino AM, 2003, GENE DEV, V17, P711, DOI 10.1101/gad.1065603; Schweppe RE, 2003, J BIOL CHEM, V278, P16863, DOI 10.1074/jbc.M213063200; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Stirnimann CU, 2010, J MOL BIOL, V400, P71, DOI 10.1016/j.jmb.2010.04.052; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Vallette-Kasic S, 2007, J CLIN ENDOCR METAB, V92, P3991, DOI 10.1210/jc.2007-0284; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Zhao LP, 2001, DEVELOPMENT, V128, P147	44	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25387	25396		10.1074/jbc.M110.202788	http://dx.doi.org/10.1074/jbc.M110.202788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21622576	hybrid, Green Published			2022-12-27	WOS:000292547900084
J	Koch, D; Chan, ACK; Murphy, MEP; Lilie, H; Grass, G; Nies, DH				Koch, Doreen; Chan, Anson C. K.; Murphy, Michael E. P.; Lilie, Hauke; Grass, Gregor; Nies, Dietrich H.			Characterization of a Dipartite Iron Uptake System from Uropathogenic Escherichia coli Strain F11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; COPPER TOLERANCE; OXIDASE; PROTEIN; TRANSPORTER; DETERMINANT; AFFINITY; BACTERIA; CUEO; HOMEOSTASIS	In the uropathogenic Escherichia coli strain F11, in silico genome analysis revealed the dicistronic iron uptake operon fetMP, which is under iron-regulated control mediated by the Fur regulator. The expression of fetMP in a mutant strain lacking known iron uptake systems improved growth under iron depletion and increased cellular iron accumulation. FetM is a member of the iron/lead transporter superfamily and is essential for iron uptake by the Fet system. FetP is a periplasmic protein that enhanced iron uptake by FetM. Recombinant FetP bound Cu(II) and the iron analog Mn(II) at distinct sites. The crystal structure of the FetP dimer reveals a copper site in each FetP subunit that adopts two conformations: CuA with a tetrahedral geometry composed of His(44), Met(90), His(97), and His(127), and CuB, a second degenerate octahedral geometry with the addition of Glu(46). The copper ions of each site occupy distinct positions and are separated by similar to 1.3 angstrom. Nearby, a putative additional Cu(I) binding site is proposed as an electron source that may function with CuA/CuB displacement to reduce Fe(III) for transport by FetM. Together, these data indicate that FetMP is an additional iron uptake system composed of a putative iron permease and an iron-scavenging and potentially iron-reducing periplasmic protein.	[Grass, Gregor] Univ Nebraska, Sch Biol Sci, Beadle Ctr, Lincoln, NE 68588 USA; [Lilie, Hauke] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Chan, Anson C. K.; Murphy, Michael E. P.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Grass, Gregor] Bundeswehr Inst Microbiol, D-80937 Munich, Germany	University of Nebraska System; University of Nebraska Lincoln; Martin Luther University Halle Wittenberg; University of British Columbia; Bundeswehr Institute of Microbiology (IMB)	Grass, G (corresponding author), Univ Nebraska, Sch Biol Sci, Beadle Ctr, Lincoln, NE 68588 USA.	gregorgrass@bundeswehr.org	Grass, Gregor/A-9981-2009; Murphy, Michael/R-6805-2017; Nies, Dietrich H/H-4143-2011	Grass, Gregor/0000-0002-8002-7718; Murphy, Michael/0000-0003-2589-0014; Chan, Anson/0000-0001-6625-8942	Deutsche Forschungsgemeinschaft [Ni262/8-2, GR2061/1-3]; Natural Sciences and Engineering Research Council of Canada (NSERC); Nebraska Tobacco Settlement Biomedical Research Development Funds; Department of Energy; Office of Biological and Environmental Research; NCRR; National Institutes of Health (NIH); Biomedical Technology Program; NIGMS, NIH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nebraska Tobacco Settlement Biomedical Research Development Funds; Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Program; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grants Ni262/8-2 (to D.H.N. and G.G.) and GR2061/1-3 (to G.G.) and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (to M.E.P.M.).; Supported in part by the Nebraska Tobacco Settlement Biomedical Research Development Funds. To whom correspondence should be addressed. Fax: 49-89-3168-3983; E-mail: gregorgrass@bundeswehr.org.; We thank Dr. Wolfgang Rabsch of the Robert Koch-Institut for allowing us to perform beta-galactosidase assays with E. coli strain F11 under S2 biosafety conditions in Wernigerode, Cecile Wandersman (Insitut Pasteur, Paris) for assaying heme-iron acquisition via Fet, and Dr. Angelika Schierhorn for the MALDI-TOF and the MALDI-In-Source-Decay-TOF-MS analysis. We thank Dr. Christian Lange for discussions and suggestions concerning ITC experiments. We thank Karola Otto for skillful technical assistance. Strain ECA458 was constructed by Nadine Taudte. We thank Herbert P. Schweizer (Colorado State University) for Tn7-bearing plasmids. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the NCRR, National Institutes of Health (NIH), Biomedical Technology Program, and NIGMS, NIH.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anton A, 2004, J BACTERIOL, V186, P7499, DOI 10.1128/JB.186.22.7499-7507.2004; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borremans B, 2001, J BACTERIOL, V183, P5651, DOI 10.1128/JB.183.19.5651-5658.2001; Braun V, 2002, CURR OPIN MICROBIOL, V5, P194, DOI 10.1016/S1369-5274(02)00298-9; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; CHAKRABARTI P, 1989, BIOCHEMISTRY-US, V28, P6081, DOI 10.1021/bi00440a052; Chan ACK, 2010, J MOL BIOL, V401, P590, DOI 10.1016/j.jmb.2010.06.038; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; Debut AJ, 2006, J MOL MICROB BIOTECH, V11, P1, DOI 10.1159/000092814; Deka RK, 2007, J BIOL CHEM, V282, P5944, DOI 10.1074/jbc.M610215200; deSilva D, 1997, J BIOL CHEM, V272, P14208, DOI 10.1074/jbc.272.22.14208; Dubbels BL, 2004, MICROBIOL-SGM, V150, P2931, DOI 10.1099/mic.0.27233-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman S, 2010, BIOMETALS, V23, P275, DOI 10.1007/s10534-009-9286-4; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Grosse C, 1999, J BACTERIOL, V181, P2385; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; Haber F, 1932, NATURWISSENSCHAFTEN, V20, P948, DOI 10.1007/BF01504715; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Koch D, 2007, BIOMETALS, V20, P759, DOI 10.1007/s10534-006-9039-6; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Millero FJ, 1998, EARTH PLANET SC LETT, V154, P323, DOI 10.1016/S0012-821X(97)00179-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neilands J. B., 1980, ACS SYM SER, V140, P264; Nies D.H., 2009, ECOSAL ESCHERICHIA C; Nies DH, 2007, MOL MICROBIOLOGY HEA, V6, P118; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; Sedlak E, 2008, P NATL ACAD SCI USA, V105, P19258, DOI 10.1073/pnas.0806431105; Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; STAPLETON A, 1991, J INFECT DIS, V163, P773, DOI 10.1093/infdis/163.4.773; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Thieme D, 2008, APPL ENVIRON MICROB, V74, P7463, DOI 10.1128/AEM.01370-08; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	59	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25317	25330		10.1074/jbc.M111.222745	http://dx.doi.org/10.1074/jbc.M111.222745			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21596746	hybrid, Green Published			2022-12-27	WOS:000292547900078
J	Tamura, T; Cormier, JH; Hebert, DN				Tamura, Taku; Cormier, James H.; Hebert, Daniel N.			Characterization of Early EDEM1 Protein Maturation Events and Their Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; RETICULUM-ASSOCIATED DEGRADATION; CELL RECEPTOR-CD3 COMPLEX; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; INFLUENZA HEMAGGLUTININ; SIGNAL SEQUENCES; MEMBRANE	The endoplasmic reticulum (ER) quality control factor EDEM1 associates with a number of ER proteins and ER-associated degradation (ERAD) substrates; however, an understanding of its role in ERAD is unclear. The early maturation events for EDEM1 including signal sequence cleavage and glycosylation were analyzed, and their relationship to the function of EDEM1 was determined. EDEM1 has five N-linked glycosylation sites with the most C-terminal site recognized poorly cotranslationally, resulting in the accumulation of EDEM1 containing four or five glycans. The fifth site was modified post-translationally when bypassed cotranslationally. Signal sequence cleavage of EDEM1 was found to be a slow and inefficient process. Signal sequence cleavage produced a soluble form of EDEM1 that efficiently associated with the oxidoreductase ERdj5 and most effectively accelerated the turnover of a soluble ERAD substrate. In contrast, a type-II membrane form of EDEM1 was generated when the signal sequence was uncleaved, creating an N-terminal transmembrane segment. The membrane form of EDEM1 efficiently associated with the ER membrane protein SEL1L and accelerated the turnover of a membrane-associated ERAD substrate. Together, these results demonstrated that signal sequence cleavage functionally regulated the association of EDEM1-soluble and membrane-integrated isoforms with distinct ERAD machinery and substrates.	[Tamura, Taku; Cormier, James H.; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Cormier, James H.; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hebert, DN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	dhebert@biochem.umass.edu		Tamura, Taku/0000-0001-6074-9273	National Institutes of Health [CA79864, GM086874]; The Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [R01CA079864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA79864 and GM086874 (United States Public Health; to D. N. H.). This work was also supported by The Uehara Memorial Foundation (to T. T.).	Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Bonfanti R, 2009, DIABETES CARE, V32, P123, DOI 10.2337/dc08-0783; Cali T, 2008, BIOCHEM BIOPH RES CO, V371, P405, DOI 10.1016/j.bbrc.2008.04.098; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; Kosmaoglou M, 2009, J CELL SCI, V122, P4465, DOI 10.1242/jcs.055228; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; NICCHITTA CV, 1995, J CELL BIOL, V129, P957, DOI 10.1083/jcb.129.4.957; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; PETERSON JR, 1995, MOL BIOL CELL, V6, P1173, DOI 10.1091/mbc.6.9.1173; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rane NS, 2010, J CELL BIOL, V188, P515, DOI 10.1083/jcb.200911115; Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Rutkowski DT, 2003, J BIOL CHEM, V278, P30365, DOI 10.1074/jbc.M302117200; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Svedine S, 2004, J CELL SCI, V117, P2937, DOI 10.1242/jcs.01154; Termine DJ, 2009, J CELL SCI, V122, P976, DOI 10.1242/jcs.037291; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Zuber C, 2007, P NATL ACAD SCI USA, V104, P4407, DOI 10.1073/pnas.0700154104	59	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24906	24915		10.1074/jbc.M111.243998	http://dx.doi.org/10.1074/jbc.M111.243998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21632540	Green Published, hybrid			2022-12-27	WOS:000292547900040
J	Warr, MR; Mills, JR; Nguyen, M; Lemaire-Ewing, S; Baardsnes, J; Sun, KLW; Malina, A; Young, JC; Jeyaraju, DV; O'Connor-McCourt, M; Pellegrini, L; Pelletier, J; Shore, GC				Warr, Matthew R.; Mills, John R.; Mai Nguyen; Lemaire-Ewing, Stephanie; Baardsnes, Jason; Sun, Karen L. W.; Malina, Abba; Young, Jason C.; Jeyaraju, Danny V.; O'Connor-McCourt, Maureen; Pellegrini, Luca; Pelletier, Jerry; Shore, Gordon C.			Mitochondrion-dependent N-terminal Processing of Outer Membrane Mcl-1 Protein Removes an Essential Mule/Lasu1 Protein-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; APOPTOSIS; EXPRESSION; BCL-2; SURVIVAL; DIFFERENTIATION; DESTRUCTION; DEGRADATION; CANCERS; FAMILY	Mcl-1, a pro-survival member of the Bcl-2 family located at the mitochondrial outer membrane, is subject to constitutive ubiquitylation by the Bcl-2 homology 3-only E3 ligase, Mule/Lasu1, resulting in rapid steady-state degradation via the proteasome. Insertion of newly synthesized Mcl-1 into the mitochondrial outer membrane is dependent on its C-terminal transmembrane segment, but once inserted, the N terminus of a portion of the Mcl-1 molecules can be subject to proteolytic processing. Remarkably, this processing requires an intact electrochemical potential across the inner membrane. Three lines of evidence directed at the endogenous protein, however, indicate that the resulting Mcl-1 Delta N isoform resides in the outer membrane: (i) full-length Mcl-1 and Mcl-1 Delta N resist extraction by alkali but are accessible to exogenous protease; (ii) almost the entire populations of Mcl-1 and Mcl-1 Delta N are accessible to the membrane-impermeant Cys-reactive agent 4-acetamido-4'-[(iodoacetyl)amino]stilbene-2,2'-disulfonic acid; and (iii) Mcl-1 and Mcl-1 Delta N exhibit equivalent chemical cross-linking to Bak in intact mitochondria, an Mcl-1 binding partner located in the outer membrane. In addition to the Mule Bcl-2 homology 3 domain, we show that interaction between Mcl-1 and Mule also requires the extreme N terminus of Mcl-1, which is lacking in Mcl-1 Delta N. Thus, Mcl-1 Delta N does not interact with Mule, exhibits reduced steady-state ubiquitylation, evades the hyper-rapid steady-state degradation that is observed for full-length Mcl-1 in response to treatments that limit global protein synthesis, and confers resistance to UV stress-induced cell death.	[Warr, Matthew R.; Mills, John R.; Mai Nguyen; Lemaire-Ewing, Stephanie; Sun, Karen L. W.; Malina, Abba; Young, Jason C.; Pelletier, Jerry; Shore, Gordon C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Baardsnes, Jason; O'Connor-McCourt, Maureen] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Jeyaraju, Danny V.; Pellegrini, Luca] Univ Laval, Ctr Rech, Quebec City, PQ G1J 2G3, Canada	McGill University; National Research Council Canada; Laval University	Shore, GC (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	gordon.shore@mcgill.ca		Malina, Abba/0000-0002-8511-9005; Jeyaraju, Danny/0000-0002-5562-3833; Pellegrini, Luca/0000-0002-4235-7708	Canadian Institutes of Health Research; National Cancer Institute of Canada; National Research Council, Canada; Cole Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); National Research Council, Canada; Cole Foundation	This work was supported in part by research grants from the Canadian Institutes of Health Research (to G. C. S., J. P., J. C. Y., and L. P.), the National Cancer Institute of Canada (to G. C. S. and J. P.), and the National Research Council, Canada (to M. O. M.).; Recipient of a fellowship from the Cole Foundation.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cho-Vega JH, 2004, HUM PATHOL, V35, P1095, DOI 10.1016/j.humpath.2004.04.018; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Chung TKH, 2002, CANCER LETT, V180, P63, DOI 10.1016/S0304-3835(01)00842-4; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Huang CR, 2010, FEBS LETT, V584, P3323, DOI 10.1016/j.febslet.2010.07.013; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Liu QA, 2010, J BIOL CHEM, V285, P41202, DOI 10.1074/jbc.M110.144857; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Miyamoto Y, 1999, ONCOLOGY-BASEL, V56, P73, DOI 10.1159/000011933; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Opferman JT, 2006, CELL DEATH DIFFER, V13, P1260, DOI 10.1038/sj.cdd.4401978; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Rinkenberger JL, 2000, GENE DEV, V14, P23; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Warr MR, 2008, CURR MOL MED, V8, P138; Warr MR, 2005, FEBS LETT, V579, P5603, DOI 10.1016/j.febslet.2005.09.028; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	36	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25098	25107		10.1074/jbc.M111.218321	http://dx.doi.org/10.1074/jbc.M111.218321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21613222	Green Published, hybrid			2022-12-27	WOS:000292547900058
J	Chou, CY; Tong, L				Chou, Chi-Yuan; Tong, Liang			Structural and Biochemical Studies on the Regulation of Biotin Carboxylase by Substrate Inhibition and Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A CARBOXYLASE; VELOCITY ANALYTICAL ULTRACENTRIFUGATION; AUREUS PYRUVATE-CARBOXYLASE; ACETYL-COA CARBOXYLASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CATALYTIC-ACTIVITY; INDUCED SYNERGISM; MAIN PROTEASE; ATP BINDING	Biotin carboxylase (BC) activity is shared among biotin-dependent carboxylases and catalyzes the Mg-ATP-dependent carboxylation of biotin using bicarbonate as the CO2 donor. BC has been studied extensively over the years by structural, kinetic, and mutagenesis analyses. Here we report three new crystal structures of Escherichia coli BC at up to 1.9 angstrom resolution, complexed with different ligands. Two structures are wild-type BC in complex with two ADP molecules and two Ca2+ ions or two ADP molecules and one Mg2+ ion. One ADP molecule is in the position normally taken by the ATP substrate, whereas the other ADP molecule occupies the binding sites of bicarbonate and biotin. One Ca2+ ion and the Mg2+ ion are associated with the ADP molecule in the active site, and the other Ca2+ ion is coordinated by Glu-87, Glu-288, and Asn-290. Our kinetic studies confirm that ATP shows substrate inhibition and that this inhibition is competitive against bicarbonate. The third structure is on the R16E mutant in complex with bicarbonate and Mg-ADP. Arg-16 is located near the dimer interface. The R16E mutant has only a 2-fold loss in catalytic activity compared with the wild-type enzyme. Analytical ultracentrifugation experiments showed that the mutation significantly destabilized the dimer, although the presence of substrates can induce dimer formation. The binding modes of bicarbonate and Mg-ADP are essentially the same as those to the wild-type enzyme. However, the mutation greatly disrupted the dimer interface and caused a large re-organization of the dimer. The structures of these new complexes have implications for the catalysis by BC.	[Chou, Chi-Yuan; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chou, Chi-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	Columbia University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Tong, Liang/0000-0002-0563-6468; Chou, Chi-Yuan/0000-0002-3400-171X	National Institutes of Health [DK067238]; National Science Council, Taiwan [98-2320-B-010-026-MY3]; National Health Research Institute, Taiwan [NHRI-EX99-9947SI]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK067238 (to L. T.). This work was also supported by grants from the National Science Council, Taiwan (98-2320-B-010-026-MY3) and the National Health Research Institute, Taiwan (NHRI-EX99-9947SI, to C.-Y.C.)	Bai Y, 2007, MOL CELL, V25, P863, DOI 10.1016/j.molcel.2007.01.034; Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho YS, 2008, PROTEINS, V70, P268, DOI 10.1002/prot.21611; Cho YS, 2010, BIOCHEM BIOPH RES CO, V391, P187, DOI 10.1016/j.bbrc.2009.11.029; Chou CY, 2011, METHODS, V54, P76, DOI 10.1016/j.ymeth.2010.11.002; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; GUCHHAIT RB, 1974, J BIOL CHEM, V249, P6633; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Hoschle B, 2005, MICROBIOL-SGM, V151, P3649, DOI 10.1099/mic.0.28260-0; Hsu WC, 2005, J BIOL CHEM, V280, P22741, DOI 10.1074/jbc.M502556200; Huang CS, 2010, NATURE, V466, P1001, DOI 10.1038/nature09302; Janiyani K, 2001, J BIOL CHEM, V276, P29864, DOI 10.1074/jbc.M104102200; Jiang H, 2005, J BIOL CHEM, V280, P27719, DOI 10.1074/jbc.M413281200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanamori T, 2004, J BACTERIOL, V186, P2532, DOI 10.1128/JB.186.9.2532-2539.2004; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kondo S, 2004, ACTA CRYSTALLOGR D, V60, P486, DOI 10.1107/S0907444904000423; Kondo S, 2007, ACTA CRYSTALLOGR D, V63, P885, DOI 10.1107/S0907444907029423; KUKKO E, 1982, EUR J BIOCHEM, V127, P347, DOI 10.1111/j.1432-1033.1982.tb06878.x; Lin PY, 2008, ARCH BIOCHEM BIOPHYS, V472, P34, DOI 10.1016/j.abb.2008.01.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng B, 2008, ANAL BIOCHEM, V376, P131, DOI 10.1016/j.ab.2008.01.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Sloane V, 2004, J BIOL CHEM, V279, P15772, DOI 10.1074/jbc.M311982200; Sloane V, 2001, J BIOL CHEM, V276, P24991, DOI 10.1074/jbc.M101472200; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; TIPTON PA, 1988, BIOCHEMISTRY-US, V27, P4317, DOI 10.1021/bi00412a019; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	42	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24417	24425		10.1074/jbc.M111.220517	http://dx.doi.org/10.1074/jbc.M111.220517			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21592965	Green Published, hybrid			2022-12-27	WOS:000292294900081
J	Ghayor, C; Correro, RM; Lange, K; Karfeld-Sulzer, LS; Gratz, KW; Weber, FE				Ghayor, Chafik; Correro, Rita M.; Lange, Katrin; Karfeld-Sulzer, Lindsay S.; Graetz, Klaus W.; Weber, Franz E.			Inhibition of Osteoclast Differentiation and Bone Resorption by N-Methylpyrrolidone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B LIGAND RANKL; KAPPA-B; C-FOS; RECEPTOR ACTIVATOR; IN-VITRO; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; KINASE; OSTEOPOROSIS; CELLS	Regulation of RANKL (receptor activator of nuclear factor kappa B ligand)-induced osteoclast differentiation is of current interest in the development of antiresorptive agents. Osteoclasts are multinucleated cells that play a crucial role in bone resorption. In this study, we investigated the effects of N-methylpyrrolidone (NMP) on the regulation of RANKL-induced osteoclastogenesis. NMP inhibited RANKL-induced tartrate-resistant acid phosphatase activity and the formation of tartrate-resistant acid phosphatase-positive multinucleated cells. The RANKL-induced expression of NFATc1 (nuclear factor of activated T cells, cytoplasmic 1) and c-Fos, which are key transcription factors for osteoclastogenesis, was also reduced by treatment with NMP. Furthermore, NMP induced disruption of the actin rings and decreased the mRNAs of cathepsin K and MMP-9 (matrix metalloproteinase-9), both involved in bone resorption. Taken together, these results suggest that NMP inhibits osteoclast differentiation and attenuates bone resorption. Therefore, NMP could prove useful for the treatment of osteoporosis or other bone diseases associated with excessive bone resorption.	[Weber, Franz E.] Univ Zurich, Univ Spital Zurich, Dept Cranio Maxillofacial Surg, Klin Kiefer & Gesichtschirurg Oral Biotechnol & B, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Weber, FE (corresponding author), Univ Zurich, Univ Spital Zurich, Dept Cranio Maxillofacial Surg, Klin Kiefer & Gesichtschirurg Oral Biotechnol & B, Frauenklin Str 24,Nord2,B-843, CH-8091 Zurich, Switzerland.	franz.weber@zzm.uzh.ch	Weber, Franz E./I-7831-2019	Weber, Franz E./0000-0003-1670-2296; Ghayor, Chafik/0000-0002-3016-3412	Swiss National Science Foundation [310000-116240]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by Swiss National Science Foundation Grant 310000-116240.	BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; Body JJ, 2002, BONE, V30, p75S; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chambers TJ, 2000, J PATHOL, V192, P4; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Ghayor C, 2009, BIOCHEM BIOPH RES CO, V381, P247, DOI 10.1016/j.bbrc.2009.02.032; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Goldhahn J, 2010, BONE, V46, P267, DOI 10.1016/j.bone.2009.10.004; Ha H, 2011, BIOCHEM BIOPH RES CO, V406, P546, DOI 10.1016/j.bbrc.2011.02.085; Howard PA, 2010, AM J CARDIOVASC DRUG, V10, P359, DOI 10.2165/11584720-000000000-00000; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Lerner UH, 2004, CRIT REV ORAL BIOL M, V15, P64, DOI 10.1177/154411130401500202; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miguel BS, 2009, TISSUE ENG PT A, V15, P2955, DOI [10.1089/ten.tea.2009.0009, 10.1089/ten.TEA.2009.0009]; Mohamed SGK, 2007, BONE, V41, P592, DOI 10.1016/j.bone.2007.05.016; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Mulari MTK, 2003, TRAFFIC, V4, P113, DOI 10.1034/j.1600-0854.2003.40206.x; O'Regan RM, 2001, ONCOLOGY-NY, V15, P1177; Odvina CV, 2006, J INVEST MED, V54, P114, DOI 10.2310/6650.2006.05037; REPONEN P, 1994, ANN NY ACAD SCI, V732, P472, DOI 10.1111/j.1749-6632.1994.tb24789.x; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Takahashi Naoyuki, 2007, V135, P285; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tsubaki M, 2010, J CELL BIOCHEM, V111, P1661, DOI 10.1002/jcb.22907; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200	39	47	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24458	24466		10.1074/jbc.M111.223297	http://dx.doi.org/10.1074/jbc.M111.223297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21613210	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000292294900086
J	Kamishikiryo, J; Fukuhara, H; Okabe, Y; Kuroki, K; Maenaka, K				Kamishikiryo, Jun; Fukuhara, Hideo; Okabe, Yuki; Kuroki, Kimiko; Maenaka, Katsumi			Molecular Basis for LLT1 Protein Recognition by Human CD161 Protein (NKRP1A/KLRB1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER-CELL RECEPTORS; MISSING SELF-RECOGNITION; CLASS-I; HUMAN NKR-P1A; CUTTING EDGE; PEPTIDE-MHC; THERMODYNAMICS; BINDING; LIGAND; ENGAGEMENT	Human Th17 cells express high levels of CD161, a member of the killer cell lectin-like receptor (KLR) family (also referred to as NK receptor-P1A (NKRP1A) or KLRB1), as a representative marker. CD161 is also expressed on natural killer (NK) cells and NKT cells. Lectin-like transcript 1 (LLT1), another KLR family member, was recently identified as a ligand for CD161. This interaction may play pivotal roles in the immunomodulatory functions of Th17 cells as well as those of NK and NKT cells. However, the molecular basis for the interaction is poorly understood. Here we show that the extracellular domain of CD161 bound directly to LLT1 with a K-d of 48 mu M and with the fast kinetics typical of cell-cell recognition receptors. Mutagenesis revealed that the similar membrane-distal beta-sheet and loop regions of both CD161 and LLT1 were utilized for the binding, and notably, these regions correspond to the ligand-binding sites for major histocompatibility complex (MHC)-recognizing KLRs. Furthermore, we found a pair of detrimental mutations for both molecules that restored the binding. These results reveal a new template model for the recognition mode between the KLR family members and provide insights into the molecular mechanism underlying Th17/NK/NKT-mediated immune responses.	[Kamishikiryo, Jun; Fukuhara, Hideo; Okabe, Yuki; Kuroki, Kimiko; Maenaka, Katsumi] Hokkaido Univ, Lab Biomol Sci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Kamishikiryo, Jun] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima 7290292, Japan; [Kamishikiryo, Jun] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128582, Japan; [Maenaka, Katsumi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Fukuyama University; Kyushu University; Japan Science & Technology Agency (JST)	Maenaka, K (corresponding author), Hokkaido Univ, Lab Biomol Sci, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	maenaka@pharm.hokudai.ac.jp	Kuroki, Kimiko/F-6906-2012	Kamishikiryo, Jun/0000-0002-7505-7429	Japan Society for the Promotion of Science; New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22121007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by a Japan Society for the Promotion of Science postdoctoral fellowship for young researchers.; Supported in part by the New Energy and Industrial Technology Development Organization (NEDO) of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan. To whom correspondence should be addressed: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan. Tel.: 81-11-706-3970; Fax: 81-11-706-4986; E-mail: maenaka@pharm.hokudai.ac.jp.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1114, DOI 10.1107/S0907444906029805; Bennett IM, 1996, J EXP MED, V184, P1845, DOI 10.1084/jem.184.5.1845; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; COSMI L, 2011, ARTHRITIS R IN PRESS; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Germain C, 2010, J BIOL CHEM, V285, P36207, DOI 10.1074/jbc.M110.179622; Huarte E, 2008, BLOOD, V112, P1259, DOI 10.1182/blood-2007-12-130773; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; Mesci A, 2006, IMMUNOL RES, V35, P13, DOI 10.1385/IR:35:1:13; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Shiroishi M, 2006, J MOL BIOL, V355, P237, DOI 10.1016/j.jmb.2005.10.057; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7	33	36	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23823	23830		10.1074/jbc.M110.214254	http://dx.doi.org/10.1074/jbc.M110.214254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572041	Green Published, hybrid			2022-12-27	WOS:000292294900025
J	Yin, J; Deng, ZX; Zhao, GP; Huang, X				Yin, Jun; Deng, Zixin; Zhao, Guoping; Huang, Xi			The N-terminal Nucleophile Serine of Cephalosporin Acylase Executes the Second Autoproteolytic Cleavage and Acylpeptide Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							7-AMINOCEPHALOSPORANIC ACID ACYLASE; HOMOSERINE LACTONE ACYLASE; ANGSTROM CRYSTAL-STRUCTURE; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; PENICILLIN ACYLASE; INTRAMOLECULAR AUTOPROTEOLYSIS; ENZYMATIC CATALYSIS; PSEUDOMONAS STRAIN; SUBSTRATE-BINDING	Cephalosporin acylase (CA) precursor is translated as a single polypeptide chain and folds into a self-activating pre-protein. Activation requires two peptide bond cleavages that excise an internal spacer to form the mature alpha beta heterodimer. Using Q-TOF LC-MS, we located the second cleavage site between Glu(159) and Gly(160), and detected the corresponding 10-aa spacer (160)GDPPDLADQG(169) of CA mutants. The site of the second cleavage depended on Glu(159): moving Glu into the spacer or removing 5-10 residues from the spacer sequence resulted in shorter spacers with the cleavage at the carboxylic side of Glu. The mutant E159D was cleaved more slowly than the wild-type, as were mutants G160A and G160L. This allowed kinetic measurements showing that the second cleavage reaction was a first-order, intra-molecular process. Glutaryl-7-aminocephalosporanic acid is the classic substrate of CA, in which the N-terminal Ser(170) of the beta-subunit, is the nucleophile. Glu and Asp resemble glutaryl, suggesting that CA might also remove N-terminal Glu or Asp from peptides. This was indeed the case, suggesting that the N-terminal nucleophile also performed the second proteolytic cleavage. We also found that CA is an acylpeptide hydrolase rather than a previously expected acylamino acid acylase. It only exhibited exopeptidase activity for the hydrolysis of an externally added peptide, supporting the intra-molecular interaction. We propose that the final CA activation is an intramolecular process performed by an N-terminal nucleophile, during which large conformational changes in the alpha-subunit C-terminal region are required to bridge the gap between Glu(159) and Ser(170).	[Yin, Jun; Deng, Zixin; Huang, Xi] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Yin, Jun; Deng, Zixin; Huang, Xi] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Huang, X (corresponding author), 1954 Huashan Rd, Shanghai 200030, Peoples R China.	xhuang@sjtu.edu.cn		Zhao, Guo-Ping/0000-0002-7621-6620	National Natural Science Foundation of China [30970064]; National High Technology Research and Development Program of China [863]; Major State Basic Research Development Program [973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Development Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 30970064, National High Technology Research and Development Program of China Grant 863, and Major State Basic Research Development Program Grant 973.	BALDWIN JE, 1988, NAT PROD REP, V5, P129, DOI 10.1039/np9880500129; Bokhove M, 2010, P NATL ACAD SCI USA, V107, P686, DOI 10.1073/pnas.0911839107; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Chilov GG, 2007, BIOCHEMISTRY-MOSCOW+, V72, P495, DOI 10.1134/S0006297907050057; Cho KJ, 2009, BIOCHEM BIOPH RES CO, V390, P342, DOI 10.1016/j.bbrc.2009.09.134; CHOI KS, 1992, J BACTERIOL, V174, P6270, DOI 10.1128/JB.174.19.6270-6276.1992; Dai MH, 1999, ACTA BIOCH BIOPH SIN, V31, P558; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fritz-Wolf K, 2002, PROTEIN SCI, V11, P92, DOI 10.1110/ps.ps.27502; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Guo HC, 1998, J BIOL CHEM, V273, P20205, DOI 10.1074/jbc.273.32.20205; Hewitt L, 2000, J MOL BIOL, V302, P887, DOI 10.1006/jmbi.2000.4105; Huang X, 2002, J BIOL CHEM, V277, P10256, DOI 10.1074/jbc.M108683200; ISHII Y, 1994, J FERMENT BIOENG, V77, P591, DOI 10.1016/0922-338X(94)90138-4; Isupov MN, 1996, STRUCTURE, V4, P801, DOI 10.1016/S0969-2126(96)00087-1; JONES WM, 1991, P NATL ACAD SCI USA, V88, P2194, DOI 10.1073/pnas.88.6.2194; Kasche V, 1999, BBA-PROTEIN STRUCT M, V1433, P76, DOI 10.1016/S0167-4838(99)00155-7; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Kim JK, 2006, P NATL ACAD SCI USA, V103, P1732, DOI 10.1073/pnas.0507862103; Kim JK, 2003, BIOCHEMISTRY-US, V42, P4084, DOI 10.1021/bi027181x; Kim S, 2001, J BIOL CHEM, V276, P48376, DOI 10.1074/jbc.M109603200; Kim Y, 2002, J BIOL CHEM, V277, P2823, DOI 10.1074/jbc.M108888200; Kim Y, 2001, CHEM BIOL, V8, P1253, DOI 10.1016/S1074-5521(01)00092-8; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; Lee YS, 1998, J BACTERIOL, V180, P4576, DOI 10.1128/JB.180.17.4576-4582.1998; Lee YS, 2000, J BIOL CHEM, V275, P39200, DOI 10.1074/jbc.M002504200; Li Y, 1998, PROTEIN EXPRES PURIF, V12, P233, DOI 10.1006/prep.1997.0823; Li Y, 1999, EUR J BIOCHEM, V262, P713, DOI 10.1046/j.1432-1327.1999.00417.x; Liu Y, 1998, J BIOL CHEM, V273, P9688, DOI 10.1074/jbc.273.16.9688; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Mao X, 2004, PROTEIN J, V23, P197, DOI 10.1023/B:JOPC.0000026415.96041.27; MATSUDA A, 1985, J BACTERIOL, V163, P1222, DOI 10.1128/JB.163.3.1222-1228.1985; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Michalska K, 2006, J MOL BIOL, V360, P105, DOI 10.1016/j.jmb.2006.04.066; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Perrotta AT, 1999, NUCLEIC ACIDS RES, V27, P795, DOI 10.1093/nar/27.3.795; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; SHIBUYA Y, 1981, AGR BIOL CHEM TOKYO, V45, P1561, DOI 10.1080/00021369.1981.10864767; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; SMITH JL, 1994, SCIENCE, V264, P1427, DOI 10.1126/science.8197456; SYKES RB, 1981, NATURE, V291, P489, DOI 10.1038/291489a0; Thomas JM, 2009, J AM CHEM SOC, V131, P1135, DOI 10.1021/ja807790e; Wang YM, 2007, J MOL BIOL, V366, P82, DOI 10.1016/j.jmb.2006.09.051; Wang YM, 2010, J MOL BIOL, V403, P120, DOI 10.1016/j.jmb.2010.08.038; Williams K, 2009, BIOCHEMISTRY-US, V48, P2459, DOI 10.1021/bi8014955	49	11	14	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24476	24486		10.1074/jbc.M111.242313	http://dx.doi.org/10.1074/jbc.M111.242313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21576250	Green Published, hybrid			2022-12-27	WOS:000292294900088
